,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
2578,GO:0005886,7.55958100568805e-10,1,173,2818,plasma membrane,CC,IFITM1;ITGB6;TGFBI;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;KCNJ15;PTPRS;PHF7;GPNMB;ADGRB2;EPHB2;HTRA1;PRR9;SLITRK6;CADM4;GPRC5C;ADGRL1;ST3GAL5;FLNC;SLC13A5;NCR3LG1;SHROOM2;COL6A1;EGFR;ADAM19;CYBA;FGFR4;EPB41L3;APCDD1;NLGN2;VIPR1;ANO9;TENM2;PSD4;SFRP1;ARHGEF4;TNFSF10;INSR;VAV3;SLC16A5;CYBRD1;SLC29A4;GAA;SV2A;PKD2;SIRPB2;RGMA;RTN2;DNM1;SDK2;LDLRAP1;RIMS3;ETV5;NT5E;SYT8;SERPINE2;WNT3;LY6E;NSG1;PARVB;BOC;DAB2IP;TMEM231;OBSCN;SHC2;SCN4B;KCNC4;RAB40B;MARVELD1;NRSN2;ANO8;EPHA4;TENM4;OLFM2;F2R;CSMD2;CTSV;LRIG3;TUB;HOMER2;PLCD3;SCART1;ACSL1;EPS8L2;ZBTB42;ERBB3;HGSNAT;S100A6;SLC38A4;CDK14;ATP6V0A2;VAMP3;PPL;PLXND1;GJB5;CSPG4;RDH12;DMTN;GRK6;PIK3R1;SDC3;TMEM204;ACVR1B;SYTL1;XPC;ATP12A;TYRO3;RHOD;CXCR1;SLC2A1;CPT1C;BCAM;ZP3;STOM;VAMP2;PLEKHH2;EFNB3;SPRY2;LRRC8E;TNFRSF19;SLC2A9;TRPV4;GPC4;SYNM;ITGB5;NDRG1;CA11;SDHA;ADORA2B;PLEKHN1;MRC2;RTN4RL1;AMACR;PDLIM4;MC1R;NEO1;CRTC1;GPR68;GPR153;ANKRD13D;ERBB2;C2CD4C;PCDH1;TULP3;ACKR3;PLCD1;SLC5A1;SLC39A6;MARCKSL1;FURIN;IL20RB;PLPP2;GJC2;SLC1A4;SLC13A3;ASIC1;PLXNB1;RASA4;SMURF1;KREMEN1;CAPNS2;TCIRG1;NISCH;AIF1L;SLC47A1;ST6GALNAC6;ABCC1;SORT1;VANGL2;APBA1
15500,GO:0071944,1.68130580918187e-09,1,175,2890,cell periphery,CC,IFITM1;ITGB6;TGFBI;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;KCNJ15;PTPRS;PHF7;GPNMB;ADGRB2;EPHB2;HTRA1;PRR9;SLITRK6;CADM4;GPRC5C;ADGRL1;ST3GAL5;FLNC;SLC13A5;NCR3LG1;SHROOM2;COL6A1;EGFR;ADAM19;CYBA;FGFR4;EPB41L3;APCDD1;NLGN2;VIPR1;ANO9;TENM2;PSD4;SFRP1;ARHGEF4;TNFSF10;INSR;VAV3;SLC16A5;CYBRD1;SLC29A4;GAA;SV2A;PKD2;SIRPB2;RGMA;RTN2;DNM1;SDK2;LDLRAP1;RIMS3;ETV5;NT5E;SYT8;SERPINE2;WNT3;LY6E;NSG1;PARVB;BOC;DAB2IP;TMEM231;OBSCN;SHC2;SCN4B;WIPF1;KCNC4;RAB40B;MARVELD1;NRSN2;ANO8;EPHA4;TENM4;OLFM2;F2R;CSMD2;CTSV;LRIG3;TUB;HOMER2;PLCD3;SCART1;ACSL1;EPS8L2;ZBTB42;ERBB3;HGSNAT;S100A6;SLC38A4;CDK14;ATP6V0A2;VAMP3;PPL;FRY;PLXND1;GJB5;CSPG4;RDH12;DMTN;GRK6;PIK3R1;SDC3;TMEM204;ACVR1B;SYTL1;XPC;ATP12A;TYRO3;RHOD;CXCR1;SLC2A1;CPT1C;BCAM;ZP3;STOM;VAMP2;PLEKHH2;EFNB3;SPRY2;LRRC8E;TNFRSF19;SLC2A9;TRPV4;GPC4;SYNM;ITGB5;NDRG1;CA11;SDHA;ADORA2B;PLEKHN1;MRC2;RTN4RL1;AMACR;PDLIM4;MC1R;NEO1;CRTC1;GPR68;GPR153;ANKRD13D;ERBB2;C2CD4C;PCDH1;TULP3;ACKR3;PLCD1;SLC5A1;SLC39A6;MARCKSL1;FURIN;IL20RB;PLPP2;GJC2;SLC1A4;SLC13A3;ASIC1;PLXNB1;RASA4;SMURF1;KREMEN1;CAPNS2;TCIRG1;NISCH;AIF1L;SLC47A1;ST6GALNAC6;ABCC1;SORT1;VANGL2;APBA1
7239,GO:0031226,5.49197389172238e-09,1,66,772,intrinsic component of plasma membrane,CC,ITGB6;KCNJ15;PTPRS;GPNMB;EPHB2;SLITRK6;CADM4;GPRC5C;ST3GAL5;SLC13A5;EGFR;CYBA;FGFR4;APCDD1;NLGN2;VIPR1;TENM2;TNFSF10;INSR;SLC16A5;PKD2;LY6E;BOC;DAB2IP;SCN4B;KCNC4;EPHA4;TENM4;OLFM2;F2R;ERBB3;SLC38A4;PLXND1;CSPG4;ACVR1B;ATP12A;TYRO3;SLC2A1;CPT1C;BCAM;STOM;VAMP2;EFNB3;LRRC8E;SLC2A9;TRPV4;GPC4;ITGB5;ADORA2B;MRC2;RTN4RL1;MC1R;NEO1;GPR68;ERBB2;PCDH1;SLC5A1;SLC39A6;PLPP2;SLC1A4;SLC13A3;ASIC1;PLXNB1;RASA4;TCIRG1;ABCC1
2579,GO:0005887,1.08679103313098e-08,1,63,734,integral component of plasma membrane,CC,ITGB6;KCNJ15;PTPRS;GPNMB;EPHB2;SLITRK6;CADM4;GPRC5C;ST3GAL5;SLC13A5;EGFR;CYBA;FGFR4;APCDD1;NLGN2;VIPR1;TENM2;TNFSF10;INSR;SLC16A5;PKD2;LY6E;BOC;SCN4B;KCNC4;EPHA4;TENM4;OLFM2;F2R;ERBB3;SLC38A4;PLXND1;CSPG4;ACVR1B;ATP12A;TYRO3;SLC2A1;CPT1C;BCAM;STOM;VAMP2;EFNB3;LRRC8E;SLC2A9;TRPV4;GPC4;ITGB5;ADORA2B;MRC2;MC1R;NEO1;GPR68;ERBB2;PCDH1;SLC5A1;SLC39A6;PLPP2;SLC1A4;SLC13A3;ASIC1;PLXNB1;TCIRG1;ABCC1
4268,GO:0009653,1.03657387109345e-07,1,111,1693,anatomical structure morphogenesis,BP,TNFAIP3;POSTN;TGFBI;APOE;ALDH1A3;ULK2;PTPRS;OBSL1;GPNMB;NDN;ADGRB2;EPHB2;NINJ1;HTRA1;PRICKLE2;SLITRK6;GAMT;SHROOM2;COL6A1;EGFR;THRA;GLI2;FGFR4;EPB41L3;BCL6;TENM2;BRSK1;SFRP1;FHOD3;UNK;INSR;VAV3;GAA;MATN2;PKD2;ZFPM1;SDK2;ETV5;SERPINE2;VEGFB;WWTR1;FOXO1;WNT3;PARVB;RASIP1;BOC;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;KLK5;WIPF1;TET1;FAM20C;EPHA4;WNT9A;TENM4;F2R;KIF26B;CTSV;LRIG3;RPS6KA5;ARHGEF19;HEXB;PLCD3;ACTA2;S100A6;VAMP3;FRY;PLXND1;GJB5;CSPG4;DMTN;PIK3R1;NAB2;NFATC4;TYRO3;RHOD;HYAL1;RTF1;ZP3;MBOAT7;EFNB3;SPRY2;TRPV4;GPC4;ITGB5;KLK8;FBXW4;NAGLU;IMPACT;NEO1;ERBB2;LAMB2;STAT1;TULP3;ACKR3;PLCD1;ZMYM3;ARPIN;PLXNB1;SMURF1;DOK4;CAMK1;MAP3K3;MDFI;ZSWIM8;SP100;NRK;VANGL2
10879,GO:0044459,1.32330236140032e-07,1,98,1444,plasma membrane part,CC,ITGB6;KCNJ15;PTPRS;GPNMB;EPHB2;SLITRK6;CADM4;GPRC5C;ADGRL1;ST3GAL5;SLC13A5;SHROOM2;EGFR;CYBA;FGFR4;EPB41L3;APCDD1;NLGN2;VIPR1;TENM2;PSD4;ARHGEF4;TNFSF10;INSR;SLC16A5;CYBRD1;SLC29A4;PKD2;RTN2;DNM1;LDLRAP1;RIMS3;SERPINE2;LY6E;NSG1;BOC;DAB2IP;TMEM231;SCN4B;KCNC4;EPHA4;TENM4;OLFM2;F2R;CTSV;HOMER2;PLCD3;SCART1;EPS8L2;ERBB3;S100A6;SLC38A4;VAMP3;PLXND1;GJB5;CSPG4;RDH12;DMTN;ACVR1B;SYTL1;ATP12A;TYRO3;SLC2A1;CPT1C;BCAM;STOM;VAMP2;EFNB3;SPRY2;LRRC8E;SLC2A9;TRPV4;GPC4;ITGB5;CA11;SDHA;ADORA2B;MRC2;RTN4RL1;PDLIM4;MC1R;NEO1;GPR68;ERBB2;PCDH1;SLC5A1;SLC39A6;PLPP2;GJC2;SLC1A4;SLC13A3;ASIC1;PLXNB1;RASA4;TCIRG1;AIF1L;ABCC1;VANGL2
10348,GO:0043202,7.46049195387514e-07,0.999999885112659,14,71,lysosomal lumen,CC,GAA;CTSB;NSG1;SGSH;CTSV;HEXB;CSPG4;SDC3;CTSL;HYAL1;GPC4;NAGLU;CTSF;IDUA
3446,GO:0007275,8.31412130091012e-07,1,181,3292,multicellular organism development,BP,TNFAIP3;POSTN;TGFBI;TAGLN;APOE;ALDH1A3;ULK2;PTPRS;OBSL1;GPNMB;NDN;S100A4;ADGRB2;EPHB2;NINJ1;ASH2L;HTRA1;PRICKLE2;PRR9;SLITRK6;GAMT;TXNRD3;ADGRL1;SRSF5;SHROOM2;COL6A1;EGFR;ADAM19;THRA;OAS2;GLI2;FGFR4;EPB41L3;APCDD1;NLGN2;RAPGEF5;BCL6;TENM2;BRSK1;SFRP1;FHOD3;UNK;POU3F1;TNFSF10;MN1;DHTKD1;INSR;VAV3;GAA;MATN2;PKD2;ZFPM1;RGMA;SDK2;CXCL14;CTSB;ETV5;SERPINE2;SALL2;VEGFB;WWTR1;FOXO1;WNT3;RASIP1;BOC;SOX12;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;KLK5;TRERF1;GAS8;MNT;TET1;MARVELD1;FAM20C;FAM213A;EPHA4;WNT9A;DIXDC1;TENM4;SMARCA1;KIF26B;TCFL5;CTSV;LRIG3;RPS6KA5;TUB;ARHGEF19;HEXB;LTBP1;PLCD3;ZBTB42;ACTA2;ERBB3;KIF26A;S100A6;SPOCK1;PPL;FRY;PLXND1;GJB5;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;PTHLH;TMEM204;CTSL;NCK2;ACVR1B;KCTD11;UNC119B;NAB2;NFATC4;FAM210B;TYRO3;SLC2A1;HYAL1;RTF1;ZP3;MBOAT7;EFNB3;SPRY2;TNFRSF19;MDK;TRPV4;GPC4;ITGB5;NDRG1;SDHA;KLK8;LTBP4;FBXW4;NAGLU;MYL9;RTN4RL1;MARK4;BTBD2;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;GPR68;MICALL1;ERBB2;HSD11B1;LAMB2;PCDH1;STAT1;TULP3;CDK20;ACKR3;PLCD1;BLOC1S4;ZMYM3;FURIN;IFI16;SUN1;GJC2;DBP;PLXNB1;ALOXE3;SMURF1;KREMEN1;DOK4;CAMK1;VPS33B;MAP3K3;MDFI;SCMH1;ZSWIM8;SP100;NRK;SORT1;VANGL2;APBA1
6034,GO:0019199,8.40925482160033e-07,0.999999894687216,12,50,transmembrane receptor protein kinase activity,MF,EPHB2;EGFR;FGFR4;INSR;EPHA4;LTBP1;ERBB3;ACVR1B;TYRO3;EFNB3;LTBP4;ERBB2
9634,GO:0038023,1.21756557760921e-06,0.999999557230701,37,384,signaling receptor activity,MF,ADGRB2;EPHB2;ADGRF4;GPRC5C;ADGRL1;EGFR;THRA;FGFR4;VIPR1;SFRP1;INSR;RGMA;EPHA4;F2R;LTBP1;ERBB3;PLXND1;ACVR1B;TYRO3;CXCR1;BCAM;EFNB3;TNFRSF19;TRPV4;GPC4;LTBP4;ADORA2B;MRC2;MC1R;GPR68;GPR153;ERBB2;ACKR3;CRY2;IL20RB;PLXNB1;SORT1
13576,GO:0060089,1.21756557760921e-06,0.999999557230701,37,384,molecular transducer activity,MF,ADGRB2;EPHB2;ADGRF4;GPRC5C;ADGRL1;EGFR;THRA;FGFR4;VIPR1;SFRP1;INSR;RGMA;EPHA4;F2R;LTBP1;ERBB3;PLXND1;ACVR1B;TYRO3;CXCR1;BCAM;EFNB3;TNFRSF19;TRPV4;GPC4;LTBP4;ADORA2B;MRC2;MC1R;GPR68;GPR153;ERBB2;ACKR3;CRY2;IL20RB;PLXNB1;SORT1
2098,GO:0004888,1.3252400259165e-06,0.999999544606232,33,324,transmembrane signaling receptor activity,MF,ADGRB2;EPHB2;ADGRF4;GPRC5C;ADGRL1;EGFR;FGFR4;VIPR1;SFRP1;INSR;EPHA4;F2R;LTBP1;ERBB3;PLXND1;ACVR1B;TYRO3;CXCR1;BCAM;EFNB3;TNFRSF19;TRPV4;LTBP4;ADORA2B;MRC2;MC1R;GPR68;GPR153;ERBB2;ACKR3;IL20RB;PLXNB1;SORT1
7904,GO:0032501,1.75404046741845e-06,0.99999931082287,218,4160,multicellular organismal process,BP,TNFAIP3;POSTN;IFITM1;ITGB6;TGFBI;TAGLN;APOE;ALDH1A3;ULK2;PTPRS;OBSL1;LMF1;GPNMB;NDN;S100A4;ADGRB2;EPHB2;NINJ1;ASH2L;HTRA1;PRICKLE2;PRR9;SLITRK6;GAMT;TXNRD3;ADGRL1;SRSF5;SHROOM2;COL6A1;EGFR;ADAM19;THRA;CYBA;OAS2;GLI2;FGFR4;EPB41L3;APCDD1;NLGN2;RAPGEF5;BCL6;TENM2;BRSK1;SFRP1;FHOD3;UNK;POU3F1;TNFSF10;MN1;DHTKD1;INSR;VAV3;GAA;MATN2;PKD2;ESPN;ZFPM1;RGMA;DNM1;SDK2;CXCL14;LDLRAP1;CTSB;ETV5;SERPINE2;SALL2;TP53INP2;VEGFB;WWTR1;FOXO1;WNT3;RASIP1;BOC;SOX12;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;PRSS3;KLK5;TRERF1;SCN4B;CRTAP;GAS8;MNT;TET1;MARVELD1;FAM20C;FAM213A;EPHA4;WNT9A;DIXDC1;TENM4;OLFM2;F2R;SMARCA1;KIF26B;TCFL5;CTSV;LRIG3;RPS6KA5;TUB;HOMER2;ARHGEF19;HEXB;LTBP1;PLCD3;EPS8L2;ZBTB42;DDX60;ACTA2;ERBB3;KIF26A;S100A6;SPOCK1;PPL;FRY;PLXND1;GJB5;SREBF1;CSPG4;RDH12;DMTN;ENDOG;PIK3R1;PTHLH;TMEM204;CTSL;NCK2;ACVR1B;KCTD11;UCN2;UNC119B;NAB2;NFATC4;FAM210B;TYRO3;CLEC11A;SLC2A1;HYAL1;RTF1;ZP3;MBOAT7;EFNB3;SPRY2;TNFRSF19;CABYR;MDK;TRPV4;MTHFR;GPC4;SYNM;ITGB5;NDRG1;SDHA;KLK8;LTBP4;ADORA2B;FBXW4;SERPING1;NAGLU;MRC2;MYL9;RTN4RL1;MARK4;BTBD2;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;GPR68;MICALL1;ERBB2;HSD11B1;RNF135;LAMB2;PCDH1;STAT1;TULP3;CDK20;ACKR3;PLCD1;SLC5A1;CRY2;COX5B;BLOC1S4;ZMYM3;FURIN;IFI16;IL20RB;CCDC88B;SUN1;GJC2;SLC1A4;DBP;ASIC1;PER3;PLXNB1;ALOXE3;SMURF1;KREMEN1;DOK4;CAMK1;NISCH;VPS33B;MAP3K3;MDFI;REEP6;SCMH1;ZSWIM8;SP100;NRK;SORT1;CBR3;VANGL2;APBA1
3483,GO:0007399,3.22483332508657e-06,0.999998492103459,95,1466,nervous system development,BP,POSTN;APOE;ALDH1A3;ULK2;PTPRS;OBSL1;NDN;ADGRB2;EPHB2;NINJ1;SLITRK6;ADGRL1;SHROOM2;EGFR;THRA;GLI2;FGFR4;EPB41L3;APCDD1;NLGN2;RAPGEF5;BCL6;TENM2;BRSK1;SFRP1;UNK;POU3F1;MATN2;PKD2;RGMA;SDK2;ETV5;SERPINE2;SALL2;WNT3;BOC;SOX12;DAB2IP;TBX1;GAS8;MARVELD1;EPHA4;WNT9A;DIXDC1;TENM4;SMARCA1;CTSV;RPS6KA5;HEXB;ERBB3;KIF26A;S100A6;SPOCK1;FRY;PLXND1;CSPG4;PIK3R1;NCK2;ACVR1B;KCTD11;UNC119B;NAB2;NFATC4;TYRO3;SLC2A1;MBOAT7;EFNB3;MDK;TRPV4;NDRG1;SDHA;KLK8;NAGLU;RTN4RL1;MARK4;BTBD2;IMPACT;NEO1;CRTC1;MICALL1;ERBB2;LAMB2;PCDH1;TULP3;BLOC1S4;SUN1;GJC2;PLXNB1;SMURF1;DOK4;CAMK1;ZSWIM8;NRK;VANGL2;APBA1
4244,GO:0009605,3.92262661450709e-06,0.999998194240849,86,1315,response to external stimulus,BP,TNFAIP3;POSTN;IFITM1;APOE;ALDH1A3;ULK2;PTPRS;GPNMB;MAP3K14;EPHB2;HTRA1;SLITRK6;SHROOM2;EGFR;CYBA;OAS2;GLI2;BCL6;SFRP1;CKLF;VAV3;MATN2;PKD2;RGMA;CXCL14;NT5E;SERPINE2;VEGFB;FOXO1;WNT3;BOC;DAB2IP;PRSS3;KLK5;WIPF1;GLUL;EPHA4;F2R;CTSV;RPS6KA5;ACSL1;DDX60;ACTA2;KIF26A;PPL;PLXND1;SREBF1;DMTN;ENDOG;PIK3R1;TRIM22;UCN2;XPC;TYRO3;CXCR1;SLC2A1;HYAL1;ZP3;EFNB3;TRPV4;MTHFR;KLK8;ADORA2B;SERPING1;RTN4RL1;IMPACT;NEO1;CRTC1;ERBB2;LAMB2;STAT1;WIPI2;ACKR3;CRY2;IFI16;IL20RB;CCDC88B;SUN1;PER3;PLXNB1;DOK4;VPS33B;REEP6;ZSWIM8;ABCC1;VANGL2
3766,GO:0008347,5.03723178712008e-06,0.999999496536902,9,33,glial cell migration,BP,NDN;APCDD1;MATN2;DAB2IP;EPHA4;HEXB;CSPG4;MBOAT7;SUN1
12319,GO:0048731,6.47795616685881e-06,0.999996342269102,162,2928,system development,BP,TNFAIP3;POSTN;TGFBI;TAGLN;APOE;ALDH1A3;ULK2;PTPRS;OBSL1;GPNMB;NDN;S100A4;ADGRB2;EPHB2;NINJ1;ASH2L;HTRA1;PRICKLE2;PRR9;SLITRK6;GAMT;ADGRL1;SRSF5;SHROOM2;EGFR;ADAM19;THRA;OAS2;GLI2;FGFR4;EPB41L3;APCDD1;NLGN2;RAPGEF5;BCL6;TENM2;BRSK1;SFRP1;FHOD3;UNK;POU3F1;TNFSF10;DHTKD1;INSR;VAV3;GAA;MATN2;PKD2;ZFPM1;RGMA;SDK2;CXCL14;CTSB;ETV5;SERPINE2;SALL2;VEGFB;WWTR1;FOXO1;WNT3;RASIP1;BOC;SOX12;DAB2IP;TMEM231;TBX1;KLK5;GAS8;MARVELD1;FAM20C;FAM213A;EPHA4;WNT9A;DIXDC1;TENM4;SMARCA1;KIF26B;CTSV;LRIG3;RPS6KA5;TUB;ARHGEF19;HEXB;LTBP1;PLCD3;ZBTB42;ACTA2;ERBB3;KIF26A;S100A6;SPOCK1;PPL;FRY;PLXND1;GJB5;SREBF1;CSPG4;DMTN;PIK3R1;PTHLH;TMEM204;CTSL;NCK2;ACVR1B;KCTD11;UNC119B;NAB2;NFATC4;FAM210B;TYRO3;SLC2A1;HYAL1;ZP3;MBOAT7;EFNB3;SPRY2;TNFRSF19;MDK;TRPV4;GPC4;NDRG1;SDHA;KLK8;FBXW4;NAGLU;MYL9;RTN4RL1;MARK4;BTBD2;IMPACT;NEO1;CRTC1;IGFBP4;GPR68;MICALL1;ERBB2;HSD11B1;LAMB2;PCDH1;STAT1;TULP3;ACKR3;PLCD1;BLOC1S4;FURIN;IFI16;SUN1;GJC2;DBP;PLXNB1;ALOXE3;SMURF1;DOK4;CAMK1;VPS33B;MAP3K3;MDFI;ZSWIM8;SP100;NRK;VANGL2;APBA1
7133,GO:0031012,6.96700555244779e-06,0.999997741883505,26,241,extracellular matrix,CC,POSTN;TGFBI;SMOC2;APOE;HTRA1;SLITRK6;COL6A1;SFRP1;MATN2;SERPINE2;TNXB;WNT3;COL7A1;CRTAP;WNT9A;LTBP1;SPOCK1;CSPG4;SDC3;BCAM;ZP3;ADAMTS15;GPC4;LTBP4;LAMB2;MMP1
12374,GO:0048856,9.35230349819762e-06,0.999994334477664,191,3599,anatomical structure development,BP,TNFAIP3;POSTN;TGFBI;TAGLN;APOE;ALDH1A3;ULK2;PTPRS;OBSL1;GPNMB;NDN;S100A4;ADGRB2;EPHB2;NINJ1;ASH2L;HTRA1;PRICKLE2;PRR9;SLITRK6;GAMT;TXNRD3;ADGRL1;SRSF5;TST;FLNC;SHROOM2;COL6A1;EGFR;ADAM19;THRA;OAS2;GLI2;FGFR4;EPB41L3;APCDD1;NLGN2;RAPGEF5;BCL6;TENM2;BRSK1;SFRP1;FHOD3;UNK;POU3F1;TNFSF10;MN1;DHTKD1;INSR;VAV3;GAA;MATN2;PKD2;ZFPM1;RGMA;SDK2;CXCL14;CTSB;ETV5;SERPINE2;SALL2;VEGFB;WWTR1;FOXO1;WNT3;PARVB;RASIP1;BOC;SOX12;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;KLK5;TRERF1;GAS8;WIPF1;MNT;TET1;MARVELD1;FAM20C;FAM213A;EPHA4;WNT9A;DIXDC1;TENM4;OLFM2;F2R;SMARCA1;KIF26B;TCFL5;CTSV;LRIG3;RPS6KA5;TUB;ARHGEF19;HEXB;LTBP1;PLCD3;ZBTB42;ACTA2;ERBB3;KIF26A;S100A6;SPOCK1;VAMP3;PPL;FRY;PLXND1;GJB5;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;PTHLH;TMEM204;CTSL;NCK2;ACVR1B;KCTD11;UNC119B;NAB2;NFATC4;FAM210B;TYRO3;RHOD;SLC2A1;HYAL1;RTF1;ZP3;MBOAT7;EFNB3;SPRY2;TNFRSF19;CABYR;MDK;TRPV4;GPC4;ITGB5;NDRG1;SDHA;KLK8;LTBP4;FBXW4;NAGLU;MYL9;RTN4RL1;MARK4;BTBD2;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;GPR68;MICALL1;ERBB2;HSD11B1;LAMB2;PCDH1;STAT1;TULP3;CDK20;ACKR3;PLCD1;BLOC1S4;ZMYM3;FURIN;IFI16;SUN1;GJC2;ARPIN;DBP;PLXNB1;ALOXE3;SMURF1;KREMEN1;DOK4;CAMK1;VPS33B;MAP3K3;MDFI;SCMH1;ZSWIM8;SP100;NRK;SORT1;VANGL2;APBA1
6237,GO:0019838,1.04451485683919e-05,0.999997924560048,14,86,growth factor binding,MF,HTRA1;COL6A1;EGFR;FGFR4;INSR;RHBDF1;LTBP1;ERBB3;ACVR1B;LTBP4;IGFBP4;ERBB2;FURIN;SORT1
3362,GO:0007155,1.07857078727161e-05,0.999994818976443,58,789,cell adhesion,BP,POSTN;ITGB6;TGFBI;SMOC2;LGALS7B;PTPRS;GPNMB;MAP3K14;NINJ1;CADM4;ADGRL1;COL6A1;EGFR;GLI2;NLGN2;BCL6;TENM2;SFRP1;VAV3;SDK2;NT5E;SERPINE2;TNXB;PARVB;BOC;COL7A1;EPHA4;TENM4;KIF26B;ERBB3;SPOCK1;VAMP3;PLXND1;CGREF1;DMTN;PIK3R1;NCK2;TYRO3;RHOD;HYAL1;BCAM;ZP3;EFNB3;TRPV4;ITGB5;MYL9;NEO1;ERBB2;LAMB2;PCDH1;ACKR3;BLOC1S4;IL20RB;CCDC88B;NUAK1;PLXNB1;VPS33B;APBA1
6574,GO:0022610,1.2005180914075e-05,0.999994211872372,58,792,biological adhesion,BP,POSTN;ITGB6;TGFBI;SMOC2;LGALS7B;PTPRS;GPNMB;MAP3K14;NINJ1;CADM4;ADGRL1;COL6A1;EGFR;GLI2;NLGN2;BCL6;TENM2;SFRP1;VAV3;SDK2;NT5E;SERPINE2;TNXB;PARVB;BOC;COL7A1;EPHA4;TENM4;KIF26B;ERBB3;SPOCK1;VAMP3;PLXND1;CGREF1;DMTN;PIK3R1;NCK2;TYRO3;RHOD;HYAL1;BCAM;ZP3;EFNB3;TRPV4;ITGB5;MYL9;NEO1;ERBB2;LAMB2;PCDH1;ACKR3;BLOC1S4;IL20RB;CCDC88B;NUAK1;PLXNB1;VPS33B;APBA1
6542,GO:0022008,1.20083116784746e-05,0.999993874223205,70,1013,neurogenesis,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;APCDD1;BCL6;TENM2;BRSK1;SFRP1;UNK;POU3F1;MATN2;RGMA;SDK2;ETV5;SERPINE2;WNT3;BOC;DAB2IP;EPHA4;WNT9A;DIXDC1;TENM4;SMARCA1;RPS6KA5;HEXB;ERBB3;S100A6;SPOCK1;FRY;PLXND1;CSPG4;PIK3R1;NCK2;KCTD11;UNC119B;NAB2;NFATC4;MBOAT7;EFNB3;TRPV4;NDRG1;KLK8;NAGLU;RTN4RL1;BTBD2;IMPACT;NEO1;CRTC1;MICALL1;ERBB2;LAMB2;TULP3;BLOC1S4;SUN1;GJC2;PLXNB1;SMURF1;DOK4;CAMK1;ZSWIM8;NRK;VANGL2
2392,GO:0005576,1.34970212403384e-05,0.999991770401548,150,2770,extracellular region,CC,TNFAIP3;POSTN;ITGB6;TGFBI;SMOC2;APOE;ALDH1A3;MVB12B;LGALS7B;PTPRS;S100A4;EPHB2;KDSR;HTRA1;SLITRK6;CADM4;GAMT;GPRC5C;GPX7;GPX3;TST;MXRA5;SHROOM2;COL6A1;EGFR;FBXO2;HEBP1;FGFR4;PINLYP;IRF2BPL;CALML3;PGM1;XYLT1;SFRP1;CKLF;GAREM2;TNFSF10;DHRS4L2;INSR;VAV3;CYBRD1;GAA;CES2;MATN2;PKD2;RGMA;ARSI;DNM1;CXCL14;CTSB;NT5E;SERPINE2;TNXB;VEGFB;WNT3;LY6E;BPHL;DAB2IP;COL7A1;PRSS3;SGSH;KLK5;CRTAP;FAM20C;GLUL;FAM213A;WNT9A;MAGEF1;OLFM2;F2R;CTSV;LRIG3;NXPH4;TUB;SEC14L2;TXNDC17;HEXB;LTBP1;PGLS;EPS8L2;ACTA2;ERBB3;S100A6;SPOCK1;PPL;CGREF1;CSPG4;PTHLH;SDC3;APPL2;CTSL;ACVR1B;UCN2;SYTL1;SNX29;XPC;CLEC11A;SLC2A1;METTL7A;HYAL1;BCAM;ZP3;STOM;CKMT1A;VAMP2;ADAMTS15;SCG5;MDK;ZDHHC1;GPC4;ITGB5;NDRG1;CA11;KLK8;LTBP4;ALDH2;SERPING1;NAGLU;RTN4RL1;IAH1;IGFBP4;TOM1L2;H2AFJ;LAMB2;TULP3;PLCD1;SLC5A1;CRY2;COX5B;MARCKSL1;FURIN;PCSK1;THNSL2;NINL;PEX11B;CTSF;SLC1A4;SLC13A3;MMP1;PLXNB1;SMURF1;CCDC3;ZNF446;AIF1L;RAB43;ELFN2;ABCC1;MTMR11;IDUA;CBR3
3679,GO:0008201,1.64003351562244e-05,0.999996844783657,13,79,heparin binding,MF,POSTN;SMOC2;APOE;PTPRS;GPNMB;FGFR4;SFRP1;SERPINE2;TNXB;VEGFB;ADAMTS15;MDK;RTN4RL1
3439,GO:0007267,1.8279651214333e-05,0.999990683347739,63,903,cell-cell signaling,BP,APOE;GPNMB;EPHB2;PRICKLE2;EGFR;GLI2;APCDD1;NLGN2;BRSK1;SFRP1;TNFSF10;SV2A;DNM1;CXCL14;RIMS3;ETV5;SYT8;SERPINE2;WWTR1;FOXO1;WNT3;NSG1;DAB2IP;SCN4B;KCNC4;GLUL;EPHA4;WNT9A;DIXDC1;F2R;ARHGEF19;CDK14;SREBF1;GRK6;PTHLH;SYTL1;NFATC4;SLC2A1;RTF1;VAMP2;EFNB3;SCG5;TRPV4;GPC4;LTBP4;FBXW4;PDLIM4;CRTC1;IGFBP4;GPR68;C2CD4C;PCDH1;PCSK1;FRAT1;GJC2;SLC1A4;ASIC1;SMURF1;KREMEN1;NISCH;MDFI;VANGL2;APBA1
7237,GO:0031224,2.09824214565524e-05,0.999986891933307,151,2755,intrinsic component of membrane,CC,IFITM1;ITGB6;IFI6;LAMP3;KCNJ15;PTPRS;LMF1;GPNMB;ADGRB2;EPHB2;ADGRF4;NINJ1;KDSR;SLITRK6;CADM4;GPRC5C;ADGRL1;ST3GAL5;SLC13A5;NCR3LG1;EGFR;ADAM19;CYBA;NYNRIN;SNN;FGFR4;APCDD1;NLGN2;VIPR1;ANO9;TENM2;XYLT1;CERS4;SFRP1;CKLF;TNFSF10;INSR;SLC16A5;CYBRD1;SLC29A4;SV2A;PKD2;TMEM200B;SIRPB2;RGMA;RTN2;TMEM134;SDK2;NT5E;SYT8;RHBDF1;TMEM129;LY6E;NSG1;BOC;DAB2IP;TMEM231;SCN4B;C14ORF132;KCNC4;MARVELD1;NRSN2;ANO8;EPHA4;B3GNT9;TENM4;OLFM2;F2R;CSMD2;CTXN1;LRIG3;SCART1;ACSL1;ORAI3;ERBB3;HGSNAT;SLC38A4;ATP6V0A2;VAMP3;PLXND1;GJB5;SREBF1;CSPG4;SDC3;TMEM204;ACVR1B;ATP12A;FAM210B;TYRO3;CXCR1;SLC2A1;CPT1C;BCAM;ZP3;STOM;VAMP2;MBOAT7;AVL9;EFNB3;ADCK5;LRRC8E;TNFRSF19;SLC2A9;TMX4;TRPV4;ZDHHC1;PQLC2;GPC4;ITGB5;ADORA2B;MRC2;RTN4RL1;MC1R;NEO1;GPR68;GPR153;ERBB2;HSD11B1;PCDH1;TMEM54;NIPAL4;ACKR3;SLC5A1;MARCH9;SLC39A6;TMEM164;FURIN;CLCN7;IL20RB;PLPP2;SUN1;PEX11B;GJC2;SLC1A4;SLC13A3;ASIC1;XYLT2;PLXNB1;RASA4;KREMEN1;TCIRG1;ELFN2;SLC47A1;ST6GALNAC6;REEP6;DIRC2;ABCC1;PIGZ;SORT1;VANGL2;TP53I11
1981,GO:0004714,2.23242334830853e-05,0.999997226925249,9,38,transmembrane receptor protein tyrosine kinase activity,MF,EPHB2;EGFR;FGFR4;INSR;EPHA4;ERBB3;TYRO3;EFNB3;ERBB2
1696,GO:0004252,2.60654454800811e-05,0.999995164577416,12,72,serine-type endopeptidase activity,MF,HTRA1;CTSB;RHBDF1;PRSS3;KLK5;TYSND1;CTSV;CTSL;KLK8;FURIN;PCSK1;MMP1
7905,GO:0032502,2.64614043492988e-05,0.999982716846165,201,3884,developmental process,BP,TNFAIP3;POSTN;IFITM1;TGFBI;TAGLN;APOE;ALDH1A3;ULK2;PTPRS;OBSL1;GPNMB;NDN;S100A4;ADGRB2;EPHB2;NINJ1;ASH2L;HTRA1;PRICKLE2;PRR9;SLITRK6;GAMT;TXNRD3;ADGRL1;SRSF5;TST;FLNC;SHROOM2;COL6A1;EGFR;ADAM19;THRA;CITED4;OAS2;GLI2;FGFR4;EPB41L3;APCDD1;NLGN2;RAPGEF5;IRF2BPL;BCL6;TENM2;BRSK1;SFRP1;FHOD3;UNK;POU3F1;TNFSF10;MN1;DHTKD1;INSR;VAV3;GAA;MATN2;PKD2;ZFPM1;RGMA;PPP2R2C;SDK2;CXCL14;CTSB;ETV5;SERPINE2;SALL2;TP53INP2;VEGFB;WWTR1;FOXO1;WNT3;PARVB;RASIP1;BOC;SOX12;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;KLK5;TRERF1;GAS8;WIPF1;MNT;TET1;MARVELD1;FAM20C;FAM213A;EPHA4;WNT9A;DIXDC1;TENM4;OLFM2;F2R;SMARCA1;KIF26B;TCFL5;CTSV;LRIG3;RPS6KA5;TUB;ARHGEF19;HEXB;LTBP1;PLCD3;ZBTB42;ACTA2;ERBB3;KIF26A;S100A6;SPOCK1;VAMP3;PPL;FRY;PLXND1;GJB5;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;PTHLH;TMEM204;CTSL;NCK2;ACVR1B;KCTD11;UNC119B;NAB2;NFATC4;FAM210B;TYRO3;RHOD;SLC2A1;HYAL1;RTF1;ZP3;MBOAT7;EFNB3;SPRY2;TP53INP1;TNFRSF19;CABYR;MDK;TRPV4;GPC4;ITGB5;NDRG1;SDHA;KLK8;LTBP4;FBXW4;SERPING1;NAGLU;MRC2;MYL9;RTN4RL1;MARK4;BTBD2;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;GPR68;MICALL1;ERBB2;HSD11B1;LAMB2;PCDH1;STAT1;TULP3;CDK20;ACKR3;PLCD1;BLOC1S4;ZMYM3;FURIN;IFI16;SUN1;GJC2;ARPIN;DBP;NUAK1;PLXNB1;ALOXE3;SMURF1;KREMEN1;CCDC3;DOK4;CAMK1;VPS33B;MAP3K3;MDFI;SCMH1;ZSWIM8;SP100;NRK;SORT1;VANGL2;APBA1
2659,GO:0006027,2.68845450709193e-05,0.999996550706435,9,40,glycosaminoglycan catabolic process,BP,SGSH;HEXB;HGSNAT;CSPG4;SDC3;HYAL1;GPC4;NAGLU;IDUA
9805,GO:0042063,2.73126451972469e-05,0.999991905616358,20,173,gliogenesis,BP,NDN;EGFR;APCDD1;POU3F1;MATN2;ETV5;SERPINE2;DAB2IP;EPHA4;TENM4;HEXB;ERBB3;CSPG4;NAB2;MBOAT7;NDRG1;ERBB2;LAMB2;SUN1;GJC2
3389,GO:0007186,3.01300887845044e-05,0.999987794671565,33,378,G-protein coupled receptor signaling pathway,BP,APOE;ADGRB2;ADGRF4;GPRC5C;ADGRL1;HEBP1;VIPR1;SFRP1;ARHGEF4;INSR;VAV3;NSG1;OBSCN;KLK5;F2R;NXPH4;HOMER2;ARHGEF19;GRK6;PIK3R1;PTHLH;UCN2;TYRO3;CXCR1;SCG5;ADORA2B;MC1R;GPR68;GPR153;TULP3;ACKR3;PLXNB1;SORT1
2091,GO:0004871,3.56550544504919e-05,0.999982637362075,50,676,signal transducer activity,MF,IFITM1;ADGRB2;MAP3K14;EPHB2;ADGRF4;GPRC5C;ADGRL1;EGFR;THRA;FGFR4;VIPR1;SFRP1;INSR;PKD2;RGMA;EPHA4;F2R;LTBP1;PLCD3;ERBB3;PLXND1;SREBF1;CSPG4;PIK3R1;ACVR1B;TYRO3;RHOD;CXCR1;BCAM;EFNB3;TNFRSF19;TRPV4;GPC4;LTBP4;ADORA2B;MRC2;MC1R;GPR68;GPR153;ERBB2;STAT1;ACKR3;PLCD1;CRY2;IL20RB;PLXNB1;CXXC5;MAP3K3;NRK;SORT1
2658,GO:0006026,4.11130532151398e-05,0.999994382781373,9,42,aminoglycan catabolic process,BP,SGSH;HEXB;HGSNAT;CSPG4;SDC3;HYAL1;GPC4;NAGLU;IDUA
3361,GO:0007154,4.17875465760947e-05,0.999972274522173,202,3940,cell communication,BP,TNFAIP3;POSTN;IFITM1;ITGB6;SMOC2;APOE;IFI6;MVB12B;ULK2;PTPRS;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRF4;HTRA1;PRICKLE2;GPRC5C;GIGYF1;ADGRL1;RALGDS;EGFR;THRA;CYBA;OAS2;GLI2;HEBP1;FGFR4;APCDD1;NLGN2;RAPGEF5;VIPR1;BCL6;TENM2;PSD4;BRSK1;SFRP1;ARHGEF4;CKLF;TNFSF10;INSR;VAV3;SV2A;PKD2;RGMA;DNM1;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;SYT8;SERPINE2;SALL2;VEGFB;WWTR1;RHBDF1;FOXO1;WNT3;LY6E;NSG1;RASIP1;BOC;DAB2IP;TMEM231;OBSCN;TBX1;KLK5;SHC2;SCN4B;SH3BP2;WIPF1;KCNC4;MNT;RAB40B;FAM20C;GLUL;EPHA4;WNT9A;DIXDC1;TENM4;F2R;CTSV;NXPH4;RPS6KA5;HOMER2;TXNDC17;ARHGEF19;LTBP1;PLCD3;ACSL1;EPS8L2;DDX60;ERBB3;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;PLXND1;GJB5;SREBF1;CSPG4;DMTN;GRK6;PIK3R1;PTHLH;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;IMPA2;ARHGAP40;NFATC4;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;BCAM;RTF1;ZP3;VAMP2;RBCK1;EFNB3;PCBP4;SPRY2;SCG5;LRRC8E;TP53INP1;TNFRSF19;MDK;TRPV4;GPC4;ITGB5;NDRG1;LTBP4;ADORA2B;FBXW4;MRC2;RTN4RL1;PDLIM4;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;GPR68;TOM1L2;GPR153;ERBB2;C2CD4C;EPM2A;PCDH1;STAT1;TULP3;ACKR3;PLCD1;CRY2;FURIN;RHPN1;IFI16;IL20RB;PCSK1;PLPP2;THNSL2;PEX11B;FRAT1;GJC2;SLC1A4;ASIC1;MMP1;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;CCDC3;CXXC5;CAMK1;TCIRG1;NISCH;MT2A;RAB43;MAP3K3;MDFI;SP100;NRK;SORT1;VANGL2;APBA1
12292,GO:0048681,4.35961411459727e-05,0.999998169028396,5,11,negative regulation of axon regeneration,BP,PTPRS;RGMA;EPHA4;KLK8;RTN4RL1
7315,GO:0031345,4.46546611212492e-05,0.999988440111741,16,123,negative regulation of cell projection organization,BP,APOE;ULK2;PTPRS;EPHB2;RGMA;WNT3;EVI5L;EPHA4;SPOCK1;NFATC4;EFNB3;SPRY2;TRPV4;KLK8;RTN4RL1;ARPIN
6717,GO:0030154,4.52924564375403e-05,0.999971300730301,139,2511,cell differentiation,BP,POSTN;IFITM1;TGFBI;TAGLN;APOE;ULK2;PTPRS;OBSL1;GPNMB;NDN;S100A4;EPHB2;ASH2L;HTRA1;PRR9;SLITRK6;TXNRD3;TST;FLNC;COL6A1;EGFR;THRA;GLI2;FGFR4;EPB41L3;APCDD1;BCL6;TENM2;BRSK1;SFRP1;FHOD3;UNK;POU3F1;DHTKD1;INSR;MATN2;ZFPM1;RGMA;SDK2;CXCL14;CTSB;ETV5;SERPINE2;TP53INP2;WWTR1;FOXO1;WNT3;PARVB;RASIP1;BOC;SOX12;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;KLK5;TET1;FAM20C;FAM213A;EPHA4;WNT9A;DIXDC1;TENM4;OLFM2;SMARCA1;TCFL5;CTSV;RPS6KA5;HEXB;ACTA2;ERBB3;S100A6;SPOCK1;VAMP3;PPL;FRY;PLXND1;GJB5;SREBF1;CSPG4;DMTN;PIK3R1;PTHLH;TMEM204;CTSL;NCK2;ACVR1B;KCTD11;UNC119B;NAB2;NFATC4;FAM210B;TYRO3;RTF1;ZP3;MBOAT7;EFNB3;SPRY2;TP53INP1;CABYR;MDK;TRPV4;ITGB5;NDRG1;KLK8;LTBP4;NAGLU;MRC2;MYL9;RTN4RL1;BTBD2;IMPACT;NEO1;CRTC1;GPR68;MICALL1;ERBB2;LAMB2;STAT1;TULP3;ACKR3;BLOC1S4;FURIN;IFI16;SUN1;GJC2;PLXNB1;ALOXE3;SMURF1;CCDC3;DOK4;CAMK1;VPS33B;MDFI;ZSWIM8;NRK;SORT1;VANGL2
1983,GO:0004716,4.5442886305146e-05,0.999999206594611,4,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,EGFR;INSR;TYRO3;ERBB2
12384,GO:0048869,4.65619886962624e-05,0.999970271146589,146,2667,cellular developmental process,BP,POSTN;IFITM1;TGFBI;TAGLN;APOE;ULK2;PTPRS;OBSL1;GPNMB;NDN;S100A4;EPHB2;ASH2L;HTRA1;PRR9;SLITRK6;TXNRD3;TST;FLNC;COL6A1;EGFR;THRA;GLI2;FGFR4;EPB41L3;APCDD1;BCL6;TENM2;BRSK1;SFRP1;FHOD3;UNK;POU3F1;DHTKD1;INSR;MATN2;ZFPM1;RGMA;SDK2;CXCL14;CTSB;ETV5;SERPINE2;TP53INP2;WWTR1;FOXO1;WNT3;PARVB;RASIP1;BOC;SOX12;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;KLK5;WIPF1;MNT;TET1;FAM20C;FAM213A;EPHA4;WNT9A;DIXDC1;TENM4;OLFM2;SMARCA1;TCFL5;CTSV;RPS6KA5;HEXB;ACTA2;ERBB3;S100A6;SPOCK1;VAMP3;PPL;FRY;PLXND1;GJB5;SREBF1;CSPG4;DMTN;PIK3R1;PTHLH;TMEM204;CTSL;NCK2;ACVR1B;KCTD11;UNC119B;NAB2;NFATC4;FAM210B;TYRO3;RHOD;RTF1;ZP3;MBOAT7;EFNB3;SPRY2;TP53INP1;CABYR;MDK;TRPV4;ITGB5;NDRG1;KLK8;LTBP4;NAGLU;MRC2;MYL9;RTN4RL1;BTBD2;IMPACT;NEO1;CRTC1;GPR68;MICALL1;ERBB2;LAMB2;STAT1;TULP3;ACKR3;BLOC1S4;ZMYM3;FURIN;IFI16;SUN1;GJC2;ARPIN;NUAK1;PLXNB1;ALOXE3;SMURF1;CCDC3;DOK4;CAMK1;VPS33B;MAP3K3;MDFI;ZSWIM8;NRK;SORT1;VANGL2
11249,GO:0045596,4.90534606723841e-05,0.999979014904898,35,419,negative regulation of cell differentiation,BP,POSTN;APOE;ULK2;PTPRS;EPHB2;EGFR;GLI2;BCL6;SFRP1;ZFPM1;RGMA;CXCL14;WWTR1;FOXO1;WNT3;DAB2IP;TBX1;EPHA4;WNT9A;DIXDC1;SPOCK1;DMTN;PIK3R1;PTHLH;KCTD11;NFATC4;EFNB3;TP53INP1;TRPV4;KLK8;RTN4RL1;GPR68;ERBB2;STAT1;SORT1
1977,GO:0004709,4.91950417565e-05,0.999992101775455,10,51,MAP kinase kinase kinase activity,MF,MAP3K14;EPHB2;EGFR;FGFR4;INSR;EPHA4;ERBB3;TYRO3;ERBB2;MAP3K3
7362,GO:0031434,5.28701653999644e-05,0.999992532066948,9,42,mitogen-activated protein kinase kinase binding,MF,EPHB2;EGFR;FGFR4;INSR;DAB2IP;EPHA4;ERBB3;TYRO3;ERBB2
5294,GO:0016021,5.33409152651327e-05,0.999965654575757,146,2690,integral component of membrane,CC,IFITM1;ITGB6;IFI6;LAMP3;KCNJ15;PTPRS;LMF1;GPNMB;ADGRB2;EPHB2;ADGRF4;NINJ1;KDSR;SLITRK6;CADM4;GPRC5C;ADGRL1;ST3GAL5;SLC13A5;NCR3LG1;EGFR;ADAM19;CYBA;NYNRIN;SNN;FGFR4;APCDD1;NLGN2;VIPR1;ANO9;TENM2;XYLT1;CERS4;SFRP1;CKLF;TNFSF10;INSR;SLC16A5;CYBRD1;SLC29A4;SV2A;PKD2;TMEM200B;SIRPB2;RTN2;TMEM134;SDK2;SYT8;RHBDF1;TMEM129;LY6E;NSG1;BOC;TMEM231;SCN4B;C14ORF132;KCNC4;MARVELD1;NRSN2;ANO8;EPHA4;B3GNT9;TENM4;OLFM2;F2R;CSMD2;CTXN1;LRIG3;SCART1;ACSL1;ORAI3;ERBB3;HGSNAT;SLC38A4;ATP6V0A2;VAMP3;PLXND1;GJB5;SREBF1;CSPG4;SDC3;TMEM204;ACVR1B;ATP12A;FAM210B;TYRO3;CXCR1;SLC2A1;CPT1C;BCAM;ZP3;STOM;VAMP2;MBOAT7;AVL9;EFNB3;ADCK5;LRRC8E;TNFRSF19;SLC2A9;TMX4;TRPV4;ZDHHC1;PQLC2;GPC4;ITGB5;ADORA2B;MRC2;MC1R;NEO1;GPR68;GPR153;ERBB2;HSD11B1;PCDH1;TMEM54;NIPAL4;ACKR3;SLC5A1;MARCH9;SLC39A6;TMEM164;FURIN;CLCN7;IL20RB;PLPP2;SUN1;PEX11B;GJC2;SLC1A4;SLC13A3;ASIC1;XYLT2;PLXNB1;KREMEN1;TCIRG1;ELFN2;SLC47A1;ST6GALNAC6;REEP6;DIRC2;ABCC1;PIGZ;SORT1;VANGL2;TP53I11
3566,GO:0007626,5.37508226742171e-05,0.999987414692864,14,99,locomotory behavior,BP,APOE;ALDH1A3;SLITRK6;NLGN2;GAA;ESPN;DNM1;ETV5;EPHA4;OLFM2;HEXB;EFNB3;NAGLU;APBA1
6628,GO:0023052,6.01970888666912e-05,0.999959625641557,200,3913,signaling,BP,TNFAIP3;POSTN;IFITM1;ITGB6;SMOC2;APOE;IFI6;MVB12B;ULK2;PTPRS;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRF4;HTRA1;PRICKLE2;GPRC5C;GIGYF1;ADGRL1;RALGDS;EGFR;THRA;CYBA;OAS2;GLI2;HEBP1;FGFR4;APCDD1;NLGN2;RAPGEF5;VIPR1;BCL6;TENM2;PSD4;BRSK1;SFRP1;ARHGEF4;CKLF;TNFSF10;INSR;VAV3;SV2A;PKD2;RGMA;DNM1;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;SYT8;SERPINE2;SALL2;VEGFB;WWTR1;RHBDF1;FOXO1;WNT3;LY6E;NSG1;RASIP1;BOC;DAB2IP;TMEM231;OBSCN;TBX1;KLK5;SHC2;SCN4B;SH3BP2;WIPF1;KCNC4;MNT;RAB40B;FAM20C;GLUL;EPHA4;WNT9A;DIXDC1;TENM4;F2R;NXPH4;RPS6KA5;HOMER2;TXNDC17;ARHGEF19;LTBP1;PLCD3;ACSL1;EPS8L2;DDX60;ERBB3;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;VAMP3;PLXND1;SREBF1;CSPG4;DMTN;GRK6;PIK3R1;PTHLH;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;IMPA2;ARHGAP40;NFATC4;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;BCAM;RTF1;ZP3;VAMP2;RBCK1;EFNB3;PCBP4;SPRY2;SCG5;LRRC8E;TP53INP1;TNFRSF19;MDK;TRPV4;GPC4;ITGB5;NDRG1;LTBP4;ADORA2B;FBXW4;MRC2;RTN4RL1;PDLIM4;MC1R;NEO1;CRTC1;IGFBP4;GPR68;TOM1L2;GPR153;ERBB2;C2CD4C;EPM2A;PCDH1;STAT1;TULP3;ACKR3;PLCD1;CRY2;FURIN;RHPN1;IFI16;IL20RB;PCSK1;PLPP2;THNSL2;PEX11B;FRAT1;GJC2;SLC1A4;ASIC1;MMP1;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;CCDC3;CXXC5;CAMK1;TCIRG1;NISCH;MT2A;RAB43;MAP3K3;MDFI;SP100;NRK;SORT1;VANGL2;APBA1
12630,GO:0050877,6.03472050361188e-05,0.999974245146156,34,406,nervous system process,BP,TGFBI;APOE;ALDH1A3;NDN;EPHB2;SLITRK6;EGFR;THRA;NLGN2;INSR;GAA;ESPN;DNM1;SERPINE2;TBX1;TENM4;OLFM2;F2R;TUB;HOMER2;HEXB;EPS8L2;RDH12;SPRY2;MDK;KLK8;CRTC1;LAMB2;BLOC1S4;SLC1A4;ASIC1;ALOXE3;REEP6;CBR3
12643,GO:0050896,6.18832265818118e-05,0.999958010648581,266,5509,response to stimulus,BP,TNFAIP3;POSTN;IFITM1;ITGB6;TGFBI;SMOC2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;PTPRS;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRF4;NINJ1;ASH2L;HTRA1;PRICKLE2;SLITRK6;GPRC5C;TXNRD3;GIGYF1;ADGRL1;GPX7;SRSF5;GPX3;MXRA5;SLC13A5;RALGDS;NCR3LG1;SHROOM2;COL6A1;EGFR;FBXO2;THRA;CITED4;CYBA;SNN;OAS2;GLI2;HEBP1;FGFR4;APCDD1;NLGN2;RAPGEF5;VIPR1;BCL6;PGM1;TENM2;PSD4;BRSK1;SFRP1;ARHGEF4;CKLF;TNFSF10;INSR;VAV3;CYBRD1;GAA;CES2;MATN2;PKD2;ZFPM1;RGMA;DNM1;CXCL14;LDLRAP1;CTSB;ETV5;NT5E;SERPINE2;SALL2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;LY6E;NSG1;RASIP1;BPHL;BOC;UROS;DDB2;DAB2IP;TMEM231;OBSCN;TBX1;PRSS3;KLK5;SHC2;SH3BP2;WIPF1;MNT;RAB40B;FAM20C;GLUL;FAM213A;EPHA4;WNT9A;RPL13A;MAGEF1;DIXDC1;TENM4;F2R;CTSV;NXPH4;RPS6KA5;TUB;HOMER2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;SCART1;ACSL1;EPS8L2;DDX60;ACTA2;ERBB3;HGSNAT;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;VAMP3;PPL;PLXND1;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;IMPA2;XPC;ARHGAP40;NFATC4;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;METTL7A;HYAL1;BCAM;RTF1;ZP3;STOM;VAMP2;RBCK1;EFNB3;PCBP4;SPRY2;SCG5;LRRC8E;TP53INP1;TNFRSF19;TMX4;MDK;TRPV4;MTHFR;PQLC2;SPATA18;GPC4;MSRB2;ITGB5;NDRG1;KLK8;LTBP4;ADORA2B;FBXW4;SERPING1;MRC2;MYL9;RTN4RL1;BTBD2;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;GPR68;TOM1L2;GPR153;MICALL1;ERBB2;EPM2A;RNF135;LAMB2;STAT1;TULP3;WIPI2;ACKR3;PLCD1;CRY2;BLOC1S4;FURIN;CLCN7;RHPN1;IFI16;IL20RB;CCDC88B;PLPP2;MLYCD;SUN1;THNSL2;PEX11B;FRAT1;GJC2;SLC13A3;ASIC1;MMP1;PER3;NUAK1;PLXNB1;ALOXE3;RASA4;HCP5;SMURF1;KREMEN1;CCDC3;DOK4;CXXC5;CAMK1;TCIRG1;NISCH;MT2A;RAB43;VPS33B;SLC47A1;MAP3K3;PPP1R14A;MDFI;REEP6;ZSWIM8;SP100;MPG;ABCC1;NRK;SORT1;CBR3;VANGL2
12271,GO:0048646,6.34611851060975e-05,0.999968258772432,50,686,anatomical structure formation involved in morphogenesis,BP,TNFAIP3;TGFBI;ALDH1A3;OBSL1;GPNMB;ADGRB2;EPHB2;HTRA1;COL6A1;GLI2;FGFR4;EPB41L3;BCL6;SFRP1;FHOD3;VAV3;ZFPM1;SDK2;VEGFB;FOXO1;WNT3;RASIP1;DAB2IP;COL7A1;OBSCN;TBX1;KLK5;TET1;FAM20C;TENM4;KIF26B;PLCD3;PLXND1;CSPG4;NFATC4;HYAL1;RTF1;ZP3;MBOAT7;SPRY2;ITGB5;ERBB2;STAT1;TULP3;ACKR3;PLCD1;CAMK1;MAP3K3;SP100;VANGL2
2382,GO:0005539,8.01798471871555e-05,0.999980426370663,14,104,glycosaminoglycan binding,MF,POSTN;SMOC2;APOE;PTPRS;GPNMB;FGFR4;SFRP1;SERPINE2;TNXB;VEGFB;ADAMTS15;MDK;LTBP4;RTN4RL1
16737,GO:0098590,9.3271403544916e-05,0.999953941703832,46,621,plasma membrane region,CC,PTPRS;ADGRL1;SHROOM2;EGFR;CYBA;EPB41L3;NLGN2;TENM2;PSD4;ARHGEF4;INSR;CYBRD1;SLC29A4;PKD2;DNM1;LDLRAP1;RIMS3;NSG1;TMEM231;KCNC4;EPHA4;OLFM2;F2R;HOMER2;PLCD3;EPS8L2;ERBB3;VAMP3;PLXND1;CSPG4;RDH12;DMTN;SYTL1;ATP12A;SLC2A1;SPRY2;SLC2A9;TRPV4;CA11;PDLIM4;ERBB2;SLC39A6;TCIRG1;AIF1L;ABCC1;VANGL2
9761,GO:0040011,9.50423888593004e-05,0.999946342318637,70,1085,locomotion,BP,POSTN;IFITM1;APOE;GPNMB;NDN;EPHB2;TNS1;SHROOM2;EGFR;GLI2;FGFR4;APCDD1;SFRP1;CKLF;UNK;INSR;VAV3;MATN2;CXCL14;SERPINE2;VEGFB;RHBDF1;WNT3;BOC;DAB2IP;TBX1;PRSS3;GAS8;EPHA4;DIXDC1;F2R;RPS6KA5;HEXB;ERBB3;SPOCK1;PLXND1;CSPG4;DMTN;PIK3R1;SDC3;NCK2;ACVR1B;TYRO3;RHOD;CXCR1;HYAL1;ZP3;MBOAT7;AVL9;EFNB3;SPRY2;TP53INP1;MDK;TRPV4;MAFIP;NEO1;ERBB2;LAMB2;ACKR3;SUN1;ARPIN;MMP1;PLXNB1;DOK4;NISCH;MAP3K3;ZSWIM8;SP100;ABCC1;VANGL2
2394,GO:0005578,0.000101851863643714,0.999966582700057,20,187,proteinaceous extracellular matrix,CC,POSTN;TGFBI;SMOC2;SLITRK6;COL6A1;SFRP1;MATN2;TNXB;WNT3;COL7A1;CRTAP;WNT9A;LTBP1;SPOCK1;ZP3;ADAMTS15;GPC4;LTBP4;LAMB2;MMP1
14792,GO:0070571,0.000114237040603247,0.999993605480778,5,13,negative regulation of neuron projection regeneration,BP,PTPRS;RGMA;EPHA4;KLK8;RTN4RL1
6738,GO:0030182,0.00011583478405283,0.999937553207389,58,851,neuron differentiation,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;BCL6;TENM2;BRSK1;SFRP1;UNK;MATN2;RGMA;SDK2;ETV5;WNT3;BOC;DAB2IP;EPHA4;WNT9A;DIXDC1;TENM4;SMARCA1;RPS6KA5;S100A6;SPOCK1;FRY;PLXND1;PIK3R1;NCK2;KCTD11;UNC119B;NFATC4;EFNB3;TRPV4;KLK8;NAGLU;RTN4RL1;IMPACT;NEO1;CRTC1;MICALL1;ERBB2;LAMB2;TULP3;BLOC1S4;PLXNB1;SMURF1;DOK4;CAMK1;ZSWIM8;NRK;VANGL2
3244,GO:0006928,0.000120979942408624,0.999929204207162,78,1252,movement of cell or subcellular component,BP,POSTN;IFITM1;APOE;GPNMB;NDN;EPHB2;TNS1;SHROOM2;EGFR;GLI2;FGFR4;APCDD1;BCL6;SFRP1;CKLF;UNK;INSR;VAV3;MATN2;CXCL14;SERPINE2;VEGFB;RHBDF1;WNT3;BOC;DAB2IP;TBX1;PRSS3;SCN4B;GAS8;WIPF1;EPHA4;DIXDC1;F2R;KIF26B;RPS6KA5;HEXB;ERBB3;KIF26A;SPOCK1;PLXND1;CSPG4;DMTN;PIK3R1;SDC3;NCK2;ACVR1B;TYRO3;RHOD;CXCR1;HYAL1;ZP3;MBOAT7;AVL9;EFNB3;SPRY2;TP53INP1;CABYR;MDK;TRPV4;MAFIP;NEO1;ERBB2;LAMB2;ACKR3;BLOC1S4;SUN1;ARPIN;MMP1;PLXNB1;DOK4;NISCH;MAP3K3;ZSWIM8;SP100;ABCC1;VANGL2;APBA1
7190,GO:0031102,0.000131234869008245,0.999981782945898,8,38,neuron projection regeneration,BP,APOE;PTPRS;MATN2;RGMA;EPHA4;KLK8;RTN4RL1;LAMB2
11117,GO:0045202,0.000145333321723779,0.999931052542635,39,509,synapse,CC,POSTN;PTPRS;EPHB2;ADGRL1;EGFR;FBXO2;EPB41L3;NLGN2;TENM2;BRSK1;SV2A;DNM1;SDK2;RIMS3;SYT8;SERPINE2;NSG1;KCNC4;RAB40B;GLUL;EPHA4;OLFM2;F2R;HOMER2;SPOCK1;VAMP3;DMTN;NCK2;SYTL1;CPT1C;VAMP2;MTHFR;PDLIM4;CRTC1;C2CD4C;LAMB2;ASIC1;DTNB;APBA1
322,GO:0000902,0.000150154814376052,0.999922448247953,49,687,cell morphogenesis,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;BCL6;TENM2;BRSK1;UNK;MATN2;ZFPM1;WNT3;PARVB;BOC;DAB2IP;WIPF1;EPHA4;TENM4;RPS6KA5;HEXB;S100A6;VAMP3;FRY;PLXND1;DMTN;PIK3R1;NFATC4;TYRO3;RHOD;EFNB3;KLK8;IMPACT;NEO1;ERBB2;LAMB2;ZMYM3;ARPIN;PLXNB1;SMURF1;DOK4;ZSWIM8;NRK;VANGL2
17215,GO:0120039,0.000201774015332955,0.999906770052565,35,441,plasma membrane bounded cell projection morphogenesis,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;BRSK1;MATN2;WNT3;BOC;DAB2IP;EPHA4;RPS6KA5;S100A6;PLXND1;PIK3R1;NFATC4;EFNB3;KLK8;IMPACT;NEO1;ERBB2;LAMB2;ARPIN;PLXNB1;SMURF1;DOK4;ZSWIM8;NRK;VANGL2
17705,GO:1901681,0.000203073340251021,0.999939418532741,16,142,sulfur compound binding,MF,POSTN;SMOC2;APOE;PTPRS;GPNMB;FGFR4;SFRP1;DHTKD1;NAT6;SERPINE2;TNXB;VEGFB;ADAMTS15;MDK;GPC4;RTN4RL1
12376,GO:0048858,0.000210049564486192,0.999902725879597,35,442,cell projection morphogenesis,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;BRSK1;MATN2;WNT3;BOC;DAB2IP;EPHA4;RPS6KA5;S100A6;PLXND1;PIK3R1;NFATC4;EFNB3;KLK8;IMPACT;NEO1;ERBB2;LAMB2;ARPIN;PLXNB1;SMURF1;DOK4;ZSWIM8;NRK;VANGL2
3440,GO:0007268,0.00021675119761851,0.999912331650988,26,295,chemical synaptic transmission,BP,APOE;EPHB2;EGFR;NLGN2;BRSK1;SV2A;DNM1;RIMS3;ETV5;SYT8;SERPINE2;NSG1;KCNC4;GLUL;EPHA4;F2R;SYTL1;NFATC4;VAMP2;PDLIM4;CRTC1;C2CD4C;SLC1A4;ASIC1;NISCH;APBA1
16895,GO:0098916,0.00021675119761851,0.999912331650988,26,295,anterograde trans-synaptic signaling,BP,APOE;EPHB2;EGFR;NLGN2;BRSK1;SV2A;DNM1;RIMS3;ETV5;SYT8;SERPINE2;NSG1;KCNC4;GLUL;EPHA4;F2R;SYTL1;NFATC4;VAMP2;PDLIM4;CRTC1;C2CD4C;SLC1A4;ASIC1;NISCH;APBA1
3701,GO:0008236,0.000238534368089203,0.999942814242517,12,90,serine-type peptidase activity,MF,HTRA1;CTSB;RHBDF1;PRSS3;KLK5;TYSND1;CTSV;CTSL;KLK8;FURIN;PCSK1;MMP1
17013,GO:0099537,0.000241763126160753,0.999901483184344,26,297,trans-synaptic signaling,BP,APOE;EPHB2;EGFR;NLGN2;BRSK1;SV2A;DNM1;RIMS3;ETV5;SYT8;SERPINE2;NSG1;KCNC4;GLUL;EPHA4;F2R;SYTL1;NFATC4;VAMP2;PDLIM4;CRTC1;C2CD4C;SLC1A4;ASIC1;NISCH;APBA1
17012,GO:0099536,0.00025565562852611,0.999895422836824,26,298,synaptic signaling,BP,APOE;EPHB2;EGFR;NLGN2;BRSK1;SV2A;DNM1;RIMS3;ETV5;SYT8;SERPINE2;NSG1;KCNC4;GLUL;EPHA4;F2R;SYTL1;NFATC4;VAMP2;PDLIM4;CRTC1;C2CD4C;SLC1A4;ASIC1;NISCH;APBA1
12352,GO:0048812,0.000255689181462179,0.999881685067585,34,429,neuron projection morphogenesis,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;BRSK1;MATN2;WNT3;BOC;DAB2IP;EPHA4;RPS6KA5;S100A6;PLXND1;PIK3R1;NFATC4;EFNB3;KLK8;IMPACT;NEO1;ERBB2;LAMB2;PLXNB1;SMURF1;DOK4;ZSWIM8;NRK;VANGL2
12279,GO:0048666,0.000262103111085426,0.99986103162279,49,705,neuron development,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;TENM2;BRSK1;SFRP1;UNK;MATN2;RGMA;WNT3;BOC;DAB2IP;EPHA4;TENM4;RPS6KA5;S100A6;SPOCK1;FRY;PLXND1;PIK3R1;NCK2;NFATC4;EFNB3;TRPV4;KLK8;NAGLU;RTN4RL1;IMPACT;NEO1;CRTC1;MICALL1;ERBB2;LAMB2;BLOC1S4;PLXNB1;SMURF1;DOK4;CAMK1;ZSWIM8;NRK;VANGL2
2418,GO:0005615,0.000264684214130304,0.999824953160757,126,2385,extracellular space,CC,TNFAIP3;POSTN;ITGB6;TGFBI;APOE;ALDH1A3;MVB12B;LGALS7B;PTPRS;S100A4;KDSR;HTRA1;SLITRK6;CADM4;GAMT;GPRC5C;GPX3;TST;MXRA5;SHROOM2;COL6A1;EGFR;FBXO2;HEBP1;IRF2BPL;CALML3;PGM1;SFRP1;CKLF;GAREM2;TNFSF10;INSR;VAV3;CYBRD1;GAA;CES2;MATN2;PKD2;RGMA;DNM1;CXCL14;CTSB;NT5E;SERPINE2;TNXB;VEGFB;WNT3;BPHL;DAB2IP;COL7A1;PRSS3;SGSH;KLK5;CRTAP;FAM20C;GLUL;FAM213A;WNT9A;MAGEF1;CTSV;LRIG3;SEC14L2;TXNDC17;HEXB;LTBP1;PGLS;EPS8L2;ACTA2;ERBB3;S100A6;SPOCK1;PPL;CSPG4;PTHLH;APPL2;CTSL;ACVR1B;UCN2;SYTL1;SNX29;XPC;CLEC11A;SLC2A1;METTL7A;HYAL1;BCAM;ZP3;STOM;CKMT1A;VAMP2;ADAMTS15;ZDHHC1;GPC4;ITGB5;NDRG1;KLK8;LTBP4;ALDH2;SERPING1;NAGLU;RTN4RL1;IAH1;IGFBP4;TOM1L2;H2AFJ;LAMB2;PLCD1;SLC5A1;COX5B;MARCKSL1;FURIN;PCSK1;THNSL2;PEX11B;CTSF;SLC1A4;SLC13A3;SMURF1;ZNF446;AIF1L;RAB43;ELFN2;ABCC1;MTMR11;IDUA;CBR3
8203,GO:0032989,0.000279729825574958,0.999849342064374,51,744,cellular component morphogenesis,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;BCL6;TENM2;BRSK1;FHOD3;UNK;MATN2;ZFPM1;WNT3;PARVB;BOC;DAB2IP;OBSCN;WIPF1;EPHA4;TENM4;RPS6KA5;HEXB;S100A6;VAMP3;FRY;PLXND1;DMTN;PIK3R1;NFATC4;TYRO3;RHOD;EFNB3;KLK8;IMPACT;NEO1;ERBB2;LAMB2;ZMYM3;ARPIN;PLXNB1;SMURF1;DOK4;ZSWIM8;NRK;VANGL2
1970,GO:0004702,0.000282745581671403,0.999931072614118,12,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,MAP3K14;EPHB2;EGFR;FGFR4;INSR;EPHA4;ERBB3;ACVR1B;TYRO3;ERBB2;MAP3K3;NRK
6753,GO:0030207,0.000286806652655194,0.999988134349541,4,9,chondroitin sulfate catabolic process,BP,HEXB;CSPG4;HYAL1;IDUA
12579,GO:0050803,0.000313937301307105,0.999916901433245,13,102,regulation of synapse structure or activity,BP,APOE;ADGRB2;EPHB2;SLITRK6;ADGRL1;NLGN2;DNM1;ETV5;DAB2IP;EPHA4;NFATC4;KLK8;CAMK1
4770,GO:0010977,0.000320981547117674,0.999914785929944,13,103,negative regulation of neuron projection development,BP,APOE;ULK2;PTPRS;EPHB2;RGMA;WNT3;EPHA4;SPOCK1;NFATC4;EFNB3;TRPV4;KLK8;RTN4RL1
4249,GO:0009612,0.000326702763143416,0.999902705178894,15,132,response to mechanical stimulus,BP,POSTN;MAP3K14;SLITRK6;EGFR;CYBA;GLI2;PKD2;SERPINE2;PPL;ENDOG;XPC;SLC2A1;TRPV4;STAT1;SUN1
5847,GO:0017171,0.000331608519776113,0.999917335941643,12,93,serine hydrolase activity,MF,HTRA1;CTSB;RHBDF1;PRSS3;KLK5;TYSND1;CTSV;CTSL;KLK8;FURIN;PCSK1;MMP1
1243,GO:0003008,0.000374015505468426,0.999793353341162,53,802,system process,BP,POSTN;TGFBI;APOE;ALDH1A3;OBSL1;NDN;EPHB2;SLITRK6;GAMT;EGFR;THRA;CYBA;NLGN2;INSR;GAA;ESPN;DNM1;SERPINE2;VEGFB;FOXO1;TBX1;SCN4B;TENM4;OLFM2;F2R;TUB;HOMER2;HEXB;EPS8L2;ACTA2;SREBF1;RDH12;SPRY2;MDK;TRPV4;MTHFR;SYNM;ITGB5;KLK8;ADORA2B;SERPING1;MYL9;CRTC1;LAMB2;STAT1;SLC5A1;BLOC1S4;SLC1A4;ASIC1;ALOXE3;NISCH;REEP6;CBR3
3544,GO:0007600,0.000379746186677707,0.999861254687785,20,211,sensory perception,BP,TGFBI;NDN;SLITRK6;NLGN2;ESPN;DNM1;SERPINE2;TBX1;OLFM2;F2R;TUB;HOMER2;HEXB;EPS8L2;RDH12;SPRY2;LAMB2;ASIC1;ALOXE3;REEP6
10849,GO:0044421,0.000400616974520343,0.999730315297811,130,2496,extracellular region part,CC,TNFAIP3;POSTN;ITGB6;TGFBI;SMOC2;APOE;ALDH1A3;MVB12B;LGALS7B;PTPRS;S100A4;KDSR;HTRA1;SLITRK6;CADM4;GAMT;GPRC5C;GPX3;TST;MXRA5;SHROOM2;COL6A1;EGFR;FBXO2;HEBP1;IRF2BPL;CALML3;PGM1;SFRP1;CKLF;GAREM2;TNFSF10;INSR;VAV3;CYBRD1;GAA;CES2;MATN2;PKD2;RGMA;DNM1;CXCL14;CTSB;NT5E;SERPINE2;TNXB;VEGFB;WNT3;BPHL;DAB2IP;COL7A1;PRSS3;SGSH;KLK5;CRTAP;FAM20C;GLUL;FAM213A;WNT9A;MAGEF1;CTSV;LRIG3;SEC14L2;TXNDC17;HEXB;LTBP1;PGLS;EPS8L2;ACTA2;ERBB3;S100A6;SPOCK1;PPL;CSPG4;PTHLH;SDC3;APPL2;CTSL;ACVR1B;UCN2;SYTL1;SNX29;XPC;CLEC11A;SLC2A1;METTL7A;HYAL1;BCAM;ZP3;STOM;CKMT1A;VAMP2;ADAMTS15;ZDHHC1;GPC4;ITGB5;NDRG1;KLK8;LTBP4;ALDH2;SERPING1;NAGLU;RTN4RL1;IAH1;IGFBP4;TOM1L2;H2AFJ;LAMB2;PLCD1;SLC5A1;COX5B;MARCKSL1;FURIN;PCSK1;THNSL2;NINL;PEX11B;CTSF;SLC1A4;SLC13A3;MMP1;SMURF1;ZNF446;AIF1L;RAB43;ELFN2;ABCC1;MTMR11;IDUA;CBR3
8204,GO:0032990,0.000427569827082997,0.999793729128389,35,460,cell part morphogenesis,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;BRSK1;MATN2;WNT3;BOC;DAB2IP;EPHA4;RPS6KA5;S100A6;PLXND1;PIK3R1;NFATC4;EFNB3;KLK8;IMPACT;NEO1;ERBB2;LAMB2;ARPIN;PLXNB1;SMURF1;DOK4;ZSWIM8;NRK;VANGL2
12385,GO:0048870,0.000427895134789959,0.99975370877847,60,941,cell motility,BP,POSTN;IFITM1;APOE;GPNMB;NDN;TNS1;SHROOM2;EGFR;FGFR4;APCDD1;SFRP1;CKLF;UNK;INSR;VAV3;MATN2;CXCL14;SERPINE2;VEGFB;RHBDF1;DAB2IP;TBX1;PRSS3;GAS8;EPHA4;DIXDC1;F2R;HEXB;ERBB3;SPOCK1;PLXND1;CSPG4;DMTN;PIK3R1;SDC3;NCK2;ACVR1B;TYRO3;RHOD;CXCR1;HYAL1;ZP3;MBOAT7;AVL9;SPRY2;TP53INP1;MDK;TRPV4;MAFIP;ERBB2;ACKR3;SUN1;ARPIN;MMP1;PLXNB1;NISCH;MAP3K3;SP100;ABCC1;VANGL2
13088,GO:0051674,0.000427895134789959,0.99975370877847,60,941,localization of cell,BP,POSTN;IFITM1;APOE;GPNMB;NDN;TNS1;SHROOM2;EGFR;FGFR4;APCDD1;SFRP1;CKLF;UNK;INSR;VAV3;MATN2;CXCL14;SERPINE2;VEGFB;RHBDF1;DAB2IP;TBX1;PRSS3;GAS8;EPHA4;DIXDC1;F2R;HEXB;ERBB3;SPOCK1;PLXND1;CSPG4;DMTN;PIK3R1;SDC3;NCK2;ACVR1B;TYRO3;RHOD;CXCR1;HYAL1;ZP3;MBOAT7;AVL9;SPRY2;TP53INP1;MDK;TRPV4;MAFIP;ERBB2;ACKR3;SUN1;ARPIN;MMP1;PLXNB1;NISCH;MAP3K3;SP100;ABCC1;VANGL2
3551,GO:0007610,0.000430983450482541,0.999817183539157,26,309,behavior,BP,APOE;ALDH1A3;EPHB2;SLITRK6;EGFR;THRA;NLGN2;INSR;GAA;ESPN;DNM1;ETV5;SERPINE2;TBX1;EPHA4;OLFM2;HOMER2;HEXB;EFNB3;MDK;KLK8;NAGLU;CRTC1;ASIC1;PER3;APBA1
7224,GO:0031175,0.000436371790522826,0.999769290112908,45,645,neuron projection development,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;BRSK1;SFRP1;MATN2;RGMA;WNT3;BOC;DAB2IP;EPHA4;RPS6KA5;S100A6;SPOCK1;FRY;PLXND1;PIK3R1;NCK2;NFATC4;EFNB3;TRPV4;KLK8;RTN4RL1;IMPACT;NEO1;CRTC1;MICALL1;ERBB2;LAMB2;BLOC1S4;PLXNB1;SMURF1;DOK4;CAMK1;ZSWIM8;NRK;VANGL2
12859,GO:0051241,0.000452848892765085,0.999758324319675,46,679,negative regulation of multicellular organismal process,BP,TNFAIP3;APOE;ULK2;PTPRS;GPNMB;ADGRB2;EPHB2;EGFR;CYBA;GLI2;BCL6;SFRP1;ZFPM1;RGMA;SERPINE2;FOXO1;WNT3;DAB2IP;EPHA4;WNT9A;DIXDC1;F2R;RPS6KA5;SPOCK1;PIK3R1;PTHLH;KCTD11;NFATC4;EFNB3;SPRY2;TRPV4;KLK8;ADORA2B;SERPING1;RTN4RL1;MC1R;GPR68;ERBB2;RNF135;STAT1;TULP3;FURIN;IL20RB;SMURF1;KREMEN1;SP100
12584,GO:0050808,0.000479319714338298,0.999832541825733,18,178,synapse organization,BP,APOE;ADGRB2;EPHB2;SLITRK6;ADGRL1;NLGN2;INSR;SDK2;ETV5;DAB2IP;EPHA4;F2R;PLXND1;NFATC4;KLK8;ERBB2;LAMB2;CAMK1
2507,GO:0005775,0.000492355144236888,0.999854504462218,14,125,vacuolar lumen,CC,GAA;CTSB;NSG1;SGSH;CTSV;HEXB;CSPG4;SDC3;CTSL;HYAL1;GPC4;NAGLU;CTSF;IDUA
12759,GO:0051093,0.000492788906674523,0.999748064692106,40,563,negative regulation of developmental process,BP,POSTN;APOE;ULK2;PTPRS;ADGRB2;EPHB2;EGFR;GLI2;BCL6;SFRP1;ZFPM1;RGMA;CXCL14;WWTR1;FOXO1;WNT3;DAB2IP;TBX1;EPHA4;WNT9A;DIXDC1;SPOCK1;DMTN;PIK3R1;PTHLH;KCTD11;NFATC4;EFNB3;SPRY2;TP53INP1;TRPV4;KLK8;RTN4RL1;GPR68;ERBB2;STAT1;TULP3;ARPIN;MAP3K3;SORT1
12583,GO:0050807,0.000519522378903177,0.99986362219829,12,94,regulation of synapse organization,BP,APOE;ADGRB2;EPHB2;SLITRK6;ADGRL1;NLGN2;ETV5;DAB2IP;EPHA4;NFATC4;KLK8;CAMK1
9837,GO:0042127,0.000526920009837807,0.999690051148949,63,1023,regulation of cell proliferation,BP,TNFAIP3;IFITM1;APOE;GPNMB;NDN;ASH2L;HTRA1;EGFR;FBXO2;CYBA;GLI2;FGFR4;VIPR1;BCL6;SFRP1;INSR;VAV3;PKD2;ETV5;SERPINE2;VEGFB;WWTR1;FOXO1;WNT3;DAB2IP;TBX1;GAS8;MNT;TET1;GLUL;WNT9A;F2R;TCFL5;CTSV;PLCD3;ERBB3;S100A6;CGREF1;PTHLH;NCK2;KCTD11;CLEC11A;HYAL1;ZP3;SPRY2;TP53INP1;NDRG1;FBXW4;MVD;ERBB2;RNF187;STAT1;PLCD1;MARCKSL1;IL20RB;CCDC88B;GJC2;NUAK1;PLXNB1;TCIRG1;MAP3K3;NRK;TP53I11
5496,GO:0016477,0.000532717121021343,0.999696207179703,56,869,cell migration,BP,POSTN;IFITM1;APOE;GPNMB;NDN;TNS1;SHROOM2;EGFR;FGFR4;APCDD1;SFRP1;CKLF;UNK;INSR;VAV3;MATN2;CXCL14;SERPINE2;VEGFB;RHBDF1;DAB2IP;TBX1;PRSS3;EPHA4;DIXDC1;F2R;HEXB;SPOCK1;PLXND1;CSPG4;DMTN;PIK3R1;SDC3;NCK2;ACVR1B;TYRO3;RHOD;CXCR1;HYAL1;ZP3;MBOAT7;AVL9;SPRY2;TP53INP1;MDK;TRPV4;ACKR3;SUN1;ARPIN;MMP1;PLXNB1;NISCH;MAP3K3;SP100;ABCC1;VANGL2
12302,GO:0048699,0.000534352199514029,0.999689420199762,60,943,generation of neurons,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;BCL6;TENM2;BRSK1;SFRP1;UNK;MATN2;RGMA;SDK2;ETV5;SERPINE2;WNT3;BOC;DAB2IP;EPHA4;WNT9A;DIXDC1;TENM4;SMARCA1;RPS6KA5;S100A6;SPOCK1;FRY;PLXND1;PIK3R1;NCK2;KCTD11;UNC119B;NFATC4;EFNB3;TRPV4;KLK8;NAGLU;RTN4RL1;IMPACT;NEO1;CRTC1;MICALL1;ERBB2;LAMB2;TULP3;BLOC1S4;GJC2;PLXNB1;SMURF1;DOK4;CAMK1;ZSWIM8;NRK;VANGL2
9997,GO:0042472,0.000580008818436553,0.99989683898519,8,46,inner ear morphogenesis,BP,ALDH1A3;EPHB2;SLITRK6;GLI2;TBX1;LRIG3;SPRY2;VANGL2
9996,GO:0042471,0.000587777972860978,0.999880387738213,9,58,ear morphogenesis,BP,ALDH1A3;EPHB2;SLITRK6;GLI2;TBX1;LRIG3;SPRY2;NAGLU;VANGL2
7438,GO:0031594,0.000606353771232061,0.999907931598522,7,36,neuromuscular junction,CC,POSTN;SV2A;SERPINE2;KCNC4;EPHA4;F2R;SPOCK1
12290,GO:0048679,0.000622708743504064,0.999944013555061,5,18,regulation of axon regeneration,BP,PTPRS;RGMA;EPHA4;KLK8;RTN4RL1
12572,GO:0050793,0.000623890466578888,0.999597301580639,93,1645,regulation of developmental process,BP,TNFAIP3;POSTN;IFITM1;APOE;ULK2;PTPRS;OBSL1;GPNMB;ADGRB2;EPHB2;ASH2L;PRICKLE2;SLITRK6;GAMT;ADGRL1;EGFR;THRA;OAS2;GLI2;EPB41L3;NLGN2;BCL6;SFRP1;INSR;ZFPM1;RGMA;CXCL14;ETV5;SERPINE2;VEGFB;WWTR1;FOXO1;WNT3;PARVB;BOC;DAB2IP;TBX1;WIPF1;FAM20C;FAM213A;EPHA4;WNT9A;DIXDC1;TENM4;OLFM2;TCFL5;CTSV;ARHGEF19;HEXB;ERBB3;SPOCK1;PLXND1;DMTN;PIK3R1;PTHLH;CTSL;ACVR1B;KCTD11;NAB2;NFATC4;FAM210B;RHOD;HYAL1;ZP3;EFNB3;SPRY2;TP53INP1;TRPV4;GPC4;KLK8;LTBP4;MYL9;RTN4RL1;IMPACT;CRTC1;GPR68;ERBB2;STAT1;TULP3;ZMYM3;GJC2;ARPIN;NUAK1;PLXNB1;SMURF1;CCDC3;CAMK1;MAP3K3;ZSWIM8;SP100;NRK;SORT1;VANGL2
4351,GO:0009986,0.000633071964662437,0.999710227551149,29,369,cell surface,CC,ITGB6;TNS1;SLITRK6;EGFR;NLGN2;SFRP1;INSR;NT5E;SERPINE2;EPHA4;F2R;CTSV;SCART1;VAMP3;CSPG4;SDC3;ACVR1B;BCAM;ADAMTS15;TRPV4;GPC4;ITGB5;RTN4RL1;ACKR3;SLC39A6;FURIN;SLC1A4;ASIC1;SORT1
12678,GO:0050954,0.000638892768352983,0.999853490678902,10,72,sensory perception of mechanical stimulus,BP,SLITRK6;ESPN;DNM1;SERPINE2;TBX1;TUB;HOMER2;HEXB;EPS8L2;SPRY2
5330,GO:0016101,0.000641513267432417,0.99988360732649,8,48,diterpenoid metabolic process,BP,APOE;ALDH1A3;EGFR;CYP27C1;RDH12;SDC3;GPC4;RETSAT
12582,GO:0050806,0.000647220280230308,0.99983786440023,11,84,positive regulation of synaptic transmission,BP,APOE;EPHB2;EGFR;NLGN2;RIMS3;SERPINE2;NSG1;GLUL;EPHA4;VAMP2;CRTC1
14308,GO:0061564,0.00066545275604926,0.999703962403478,27,330,axon development,BP,APOE;ULK2;PTPRS;NDN;EPHB2;SLITRK6;GLI2;BRSK1;MATN2;RGMA;WNT3;BOC;EPHA4;RPS6KA5;S100A6;PLXND1;PIK3R1;EFNB3;KLK8;RTN4RL1;NEO1;ERBB2;LAMB2;PLXNB1;DOK4;ZSWIM8;VANGL2
3373,GO:0007166,0.000672526692783912,0.999557335133823,102,1851,cell surface receptor signaling pathway,BP,TNFAIP3;POSTN;IFITM1;ITGB6;APOE;IFI6;MVB12B;NDN;ADGRB2;MAP3K14;EPHB2;ADGRF4;HTRA1;PRICKLE2;GIGYF1;ADGRL1;EGFR;CYBA;OAS2;GLI2;FGFR4;APCDD1;NLGN2;VIPR1;BCL6;SFRP1;TNFSF10;INSR;VAV3;RGMA;DNM1;SERPINE2;VEGFB;WWTR1;RHBDF1;FOXO1;WNT3;LY6E;BOC;DAB2IP;TMEM231;SHC2;WIPF1;FAM20C;EPHA4;WNT9A;DIXDC1;RPS6KA5;HOMER2;TXNDC17;ARHGEF19;LTBP1;ACSL1;ERBB3;CDK14;ATP6V0A2;PLXND1;SREBF1;CSPG4;DMTN;GRK6;PIK3R1;TMEM204;TRIM22;NCK2;ACVR1B;KCTD11;NFATC4;CXCR1;RTF1;RBCK1;EFNB3;SPRY2;TNFRSF19;MDK;GPC4;ITGB5;LTBP4;ADORA2B;FBXW4;RTN4RL1;NEO1;IGFBP4;ERBB2;STAT1;TULP3;ACKR3;FURIN;IL20RB;FRAT1;MMP1;PLXNB1;SMURF1;KREMEN1;CCDC3;TCIRG1;MT2A;MAP3K3;MDFI;SP100;SORT1;VANGL2
14683,GO:0070374,0.000674809907635867,0.999804974126234,13,112,positive regulation of ERK1 and ERK2 cascade,BP,GPNMB;EPHB2;EGFR;FGFR4;INSR;EPHA4;F2R;ERBB3;TYRO3;SPRY2;TRPV4;ERBB2;ACKR3
6750,GO:0030204,0.000707297423053425,0.999910916548787,6,27,chondroitin sulfate metabolic process,BP,XYLT1;HEXB;CSPG4;HYAL1;XYLT2;IDUA
18189,GO:1903034,0.000752358357421287,0.999793124889915,12,100,regulation of response to wounding,BP,TNFAIP3;APOE;PTPRS;RGMA;SERPINE2;EPHA4;F2R;DMTN;KLK8;SERPING1;RTN4RL1;VPS33B
3587,GO:0008037,0.000761600863800507,0.999838521892553,9,61,cell recognition,BP,NDN;EPHB2;CADM4;EPHA4;TUB;NCK2;ZP3;EFNB3;ST6GALNAC6
3364,GO:0007157,0.000789767772929331,0.999924193497955,5,19,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,LGALS7B;CADM4;ADGRL1;TENM2;TENM4
17425,GO:1900271,0.000817251105500538,0.999920947001365,5,19,regulation of long-term synaptic potentiation,BP,APOE;EPHB2;NSG1;EPHA4;CRTC1
3489,GO:0007411,0.000825642619430033,0.999707203262221,17,170,axon guidance,BP,EPHB2;GLI2;MATN2;WNT3;BOC;EPHA4;RPS6KA5;PLXND1;PIK3R1;EFNB3;NEO1;ERBB2;LAMB2;PLXNB1;DOK4;ZSWIM8;VANGL2
8186,GO:0032963,0.000851155989726287,0.999796879041348,10,74,collagen metabolic process,BP,COL6A1;CTSB;TNXB;COL7A1;F2R;CTSL;MRC2;FURIN;MMP1;VPS33B
12474,GO:0050654,0.000867353711412181,0.999885693336034,6,28,chondroitin sulfate proteoglycan metabolic process,BP,XYLT1;HEXB;CSPG4;HYAL1;XYLT2;IDUA
16586,GO:0097485,0.000880176866860381,0.999685939370147,17,171,neuron projection guidance,BP,EPHB2;GLI2;MATN2;WNT3;BOC;EPHA4;RPS6KA5;PLXND1;PIK3R1;EFNB3;NEO1;ERBB2;LAMB2;PLXNB1;DOK4;ZSWIM8;VANGL2
17213,GO:0120036,0.000904326077955924,0.999455469802268,63,1025,plasma membrane bounded cell projection organization,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;TENM2;BRSK1;SFRP1;ARHGEF4;INSR;VAV3;MATN2;ESPN;RGMA;WWTR1;WNT3;PARVB;BOC;DAB2IP;TMEM231;GAS8;EVI5L;EPHA4;RPS6KA5;EPS8L2;S100A6;SPOCK1;FRY;PLXND1;DMTN;PIK3R1;NCK2;UNC119B;NFATC4;RHOD;EFNB3;TRPV4;KLK8;MAFIP;RTN4RL1;MARK4;IMPACT;NEO1;CRTC1;MICALL1;ERBB2;LAMB2;BLOC1S4;NINL;ARPIN;PLXNB1;SMURF1;DOK4;CAMK1;ZSWIM8;NRK;VANGL2
6651,GO:0030030,0.000911469092292732,0.999448881204573,64,1046,cell projection organization,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;EGFR;GLI2;EPB41L3;TENM2;BRSK1;SFRP1;ARHGEF4;INSR;VAV3;MATN2;ESPN;RGMA;WWTR1;WNT3;PARVB;BOC;DAB2IP;TMEM231;GAS8;EVI5L;EPHA4;RPS6KA5;EPS8L2;S100A6;SPOCK1;FRY;PLXND1;DMTN;PIK3R1;NCK2;UNC119B;NFATC4;RHOD;EFNB3;SPRY2;TRPV4;KLK8;MAFIP;RTN4RL1;MARK4;IMPACT;NEO1;CRTC1;MICALL1;ERBB2;LAMB2;BLOC1S4;NINL;ARPIN;PLXNB1;SMURF1;DOK4;CAMK1;ZSWIM8;NRK;VANGL2
464,GO:0001503,0.000939249326142169,0.999620068107365,21,239,ossification,BP,IFITM1;GPNMB;COL6A1;EGFR;THRA;GLI2;SFRP1;MN1;TP53INP2;WWTR1;WNT3;FAM20C;PTHLH;NAB2;CLEC11A;MRC2;SUN1;PLXNB1;SMURF1;KREMEN1;SORT1
3372,GO:0007165,0.000951729280334418,0.999318035313512,181,3654,signal transduction,BP,TNFAIP3;POSTN;IFITM1;ITGB6;SMOC2;APOE;IFI6;MVB12B;ULK2;PTPRS;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRF4;HTRA1;PRICKLE2;GPRC5C;GIGYF1;ADGRL1;RALGDS;EGFR;THRA;CYBA;OAS2;GLI2;HEBP1;FGFR4;APCDD1;NLGN2;RAPGEF5;VIPR1;BCL6;TENM2;PSD4;BRSK1;SFRP1;ARHGEF4;CKLF;TNFSF10;INSR;VAV3;PKD2;RGMA;DNM1;CXCL14;LDLRAP1;CTSB;SERPINE2;SALL2;VEGFB;WWTR1;RHBDF1;FOXO1;WNT3;LY6E;NSG1;RASIP1;BOC;DAB2IP;TMEM231;OBSCN;TBX1;KLK5;SHC2;SH3BP2;WIPF1;MNT;RAB40B;FAM20C;EPHA4;WNT9A;DIXDC1;TENM4;F2R;NXPH4;RPS6KA5;HOMER2;TXNDC17;ARHGEF19;LTBP1;PLCD3;ACSL1;EPS8L2;DDX60;ERBB3;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;PLXND1;SREBF1;CSPG4;DMTN;GRK6;PIK3R1;PTHLH;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;IMPA2;ARHGAP40;NFATC4;TYRO3;RHOD;CXCR1;CLEC11A;BCAM;RTF1;ZP3;RBCK1;EFNB3;PCBP4;SPRY2;SCG5;LRRC8E;TP53INP1;TNFRSF19;MDK;TRPV4;GPC4;ITGB5;NDRG1;LTBP4;ADORA2B;FBXW4;MRC2;RTN4RL1;MC1R;NEO1;IGFBP4;GPR68;TOM1L2;GPR153;ERBB2;EPM2A;STAT1;TULP3;ACKR3;PLCD1;CRY2;FURIN;RHPN1;IFI16;IL20RB;PLPP2;THNSL2;PEX11B;FRAT1;ASIC1;MMP1;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;CCDC3;CXXC5;CAMK1;TCIRG1;NISCH;MT2A;RAB43;MAP3K3;MDFI;SP100;NRK;SORT1;VANGL2
13682,GO:0060291,0.000957163047159251,0.999841254256588,7,39,long-term synaptic potentiation,BP,APOE;EPHB2;SERPINE2;NSG1;EPHA4;VAMP2;CRTC1
10852,GO:0044425,0.00098907687966873,0.999290201470589,182,3688,membrane part,CC,IFITM1;ITGB6;IFI6;MVB12B;LAMP3;KCNJ15;PTPRS;LMF1;GPNMB;ADGRB2;EPHB2;ADGRF4;NINJ1;KDSR;SLITRK6;CADM4;GPRC5C;ADGRL1;ST3GAL5;SLC13A5;NCR3LG1;SHROOM2;EGFR;ADAM19;CYBA;NYNRIN;SNN;FGFR4;EPB41L3;APCDD1;NLGN2;VIPR1;ANO9;TENM2;XYLT1;CYP4F22;PSD4;CERS4;SFRP1;ARHGEF4;CKLF;TNFSF10;INSR;SLC16A5;CYBRD1;SLC29A4;SV2A;PKD2;TMEM200B;SIRPB2;RGMA;RTN2;DNM1;TMEM134;SDK2;LDLRAP1;RIMS3;NT5E;SYT8;SERPINE2;RHBDF1;TMEM129;LY6E;NSG1;BOC;DAB2IP;TMEM231;SCN4B;C14ORF132;KCNC4;MARVELD1;NRSN2;ANO8;EPHA4;B3GNT9;TENM4;OLFM2;F2R;CSMD2;CTXN1;CTSV;LRIG3;HOMER2;PLCD3;SCART1;ACSL1;EPS8L2;ORAI3;ERBB3;HGSNAT;S100A6;SLC38A4;ATP6V0A2;VAMP3;PLXND1;GJB5;SREBF1;CSPG4;RDH12;DMTN;PIK3R1;SDC3;TMEM204;ACVR1B;SYTL1;ATP12A;SNX33;FAM210B;TYRO3;CXCR1;SLC2A1;CPT1C;BCAM;ZP3;STOM;VAMP2;MBOAT7;AVL9;EFNB3;ADCK5;SPRY2;LRRC8E;TNFRSF19;SLC2A9;TMX4;TRPV4;ZDHHC1;PQLC2;GPC4;ITGB5;RETSAT;CA11;NDUFA4L2;SDHA;ADORA2B;MRC2;RTN4RL1;PDLIM4;MC1R;NEO1;GPR68;GPR153;MICALL1;ERBB2;HSD11B1;PCDH1;TMEM54;NIPAL4;WIPI2;ACKR3;SLC5A1;MARCH9;COX5B;SLC39A6;TMEM164;FURIN;CLCN7;IL20RB;PLPP2;SUN1;PEX11B;GJC2;SLC1A4;SLC13A3;ASIC1;XYLT2;PLXNB1;RASA4;KREMEN1;TCIRG1;AIF1L;VPS33B;ELFN2;SLC47A1;ST6GALNAC6;REEP6;DIRC2;ABCC1;PIGZ;SORT1;VANGL2;TP53I11
3729,GO:0008283,0.00099869640569811,0.999369825346633,76,1318,cell proliferation,BP,TNFAIP3;IFITM1;TGFBI;APOE;GPNMB;NDN;ASH2L;HTRA1;EGFR;FBXO2;CYBA;GLI2;FGFR4;VIPR1;BCL6;SFRP1;CKLF;INSR;VAV3;PKD2;ETV5;SERPINE2;VEGFB;WWTR1;RHBDF1;FOXO1;WNT3;DAB2IP;TBX1;GAS8;MNT;TET1;GLUL;WNT9A;DIXDC1;TENM4;F2R;TCFL5;CTSV;PLCD3;ERBB3;S100A6;CGREF1;CSPG4;PTHLH;APPL2;NCK2;KCTD11;NAB2;CLEC11A;HYAL1;ZP3;SPRY2;TP53INP1;GPC4;NDRG1;KLK8;FBXW4;MVD;IGFBP4;ERBB2;RNF187;STAT1;PLCD1;MARCKSL1;FURIN;IFI16;IL20RB;CCDC88B;GJC2;NUAK1;PLXNB1;TCIRG1;MAP3K3;NRK;TP53I11
6627,GO:0023051,0.00105266526295453,0.999275797969691,123,2334,regulation of signaling,BP,TNFAIP3;POSTN;APOE;IFI6;MVB12B;PTPRS;GPNMB;S100A4;MAP3K14;EPHB2;HTRA1;EGFR;THRA;CYBA;GLI2;FGFR4;APCDD1;NLGN2;BCL6;PSD4;SFRP1;ARHGEF4;CKLF;TNFSF10;INSR;VAV3;PKD2;DNM1;CXCL14;LDLRAP1;RIMS3;SERPINE2;VEGFB;WWTR1;RHBDF1;FOXO1;WNT3;NSG1;DAB2IP;OBSCN;TBX1;KLK5;SHC2;SH3BP2;KCNC4;MNT;FAM20C;GLUL;EPHA4;WNT9A;DIXDC1;F2R;HOMER2;ARHGEF19;LTBP1;EPS8L2;DDX60;ERBB3;KIF26A;CDK14;VAMP3;SREBF1;CSPG4;DMTN;GRK6;PIK3R1;PTHLH;APPL2;TMEM204;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;UCN2;ARHGAP40;NFATC4;TYRO3;RHOD;CLEC11A;SLC2A1;ZP3;VAMP2;RBCK1;SPRY2;SCG5;TP53INP1;TNFRSF19;MDK;TRPV4;GPC4;LTBP4;ADORA2B;RTN4RL1;MC1R;NEO1;CRTC1;IGFBP4;GPR68;ERBB2;EPM2A;STAT1;TULP3;ACKR3;CRY2;FURIN;THNSL2;ASIC1;NUAK1;PLXNB1;RASA4;SMURF1;KREMEN1;CCDC3;CXXC5;NISCH;MAP3K3;MDFI;SP100;NRK;VANGL2;APBA1
14791,GO:0070570,0.00105998595334311,0.999890104016653,5,20,regulation of neuron projection regeneration,BP,PTPRS;RGMA;EPHA4;KLK8;RTN4RL1
10267,GO:0043062,0.00108713523341946,0.999554922322512,21,240,extracellular structure organization,BP,POSTN;ITGB6;TGFBI;SMOC2;APOE;HTRA1;COL6A1;ADAM19;FGFR4;TNXB;COL7A1;KLK5;CTSV;CTSL;HYAL1;ITGB5;LAMB2;FURIN;MMP1;CAPNS2;VPS33B
12204,GO:0048513,0.00117696626705012,0.999197295430384,113,2121,animal organ development,BP,TNFAIP3;TGFBI;TAGLN;ALDH1A3;PTPRS;OBSL1;GPNMB;S100A4;EPHB2;NINJ1;ASH2L;HTRA1;PRICKLE2;PRR9;SLITRK6;GAMT;SRSF5;SHROOM2;EGFR;ADAM19;THRA;OAS2;GLI2;APCDD1;BCL6;SFRP1;FHOD3;POU3F1;TNFSF10;DHTKD1;INSR;GAA;PKD2;ZFPM1;SDK2;CXCL14;CTSB;ETV5;SERPINE2;SALL2;VEGFB;WWTR1;FOXO1;WNT3;SOX12;DAB2IP;TMEM231;TBX1;KLK5;GAS8;FAM20C;FAM213A;EPHA4;WNT9A;DIXDC1;TENM4;SMARCA1;KIF26B;CTSV;LRIG3;TUB;ARHGEF19;LTBP1;PLCD3;ZBTB42;ACTA2;ERBB3;PPL;PLXND1;GJB5;SREBF1;DMTN;PIK3R1;PTHLH;CTSL;ACVR1B;NAB2;NFATC4;FAM210B;TYRO3;SLC2A1;HYAL1;ZP3;MBOAT7;SPRY2;TNFRSF19;MDK;TRPV4;GPC4;KLK8;FBXW4;NAGLU;MYL9;RTN4RL1;GPR68;ERBB2;HSD11B1;LAMB2;STAT1;TULP3;PLCD1;FURIN;IFI16;SUN1;GJC2;DBP;PLXNB1;ALOXE3;SMURF1;VPS33B;MDFI;NRK;VANGL2
6928,GO:0030574,0.00119840766569114,0.999792720171881,7,40,collagen catabolic process,BP,COL6A1;CTSB;COL7A1;CTSL;MRC2;FURIN;MMP1
3117,GO:0006721,0.00124123007446892,0.999747984349074,8,53,terpenoid metabolic process,BP,APOE;ALDH1A3;EGFR;CYP27C1;RDH12;SDC3;GPC4;RETSAT
16086,GO:0090128,0.00126579464104023,0.999960062609135,3,6,regulation of synapse maturation,BP,ADGRL1;DAB2IP;NFATC4
4631,GO:0010771,0.00126766932150377,0.999709650691633,9,64,negative regulation of cell morphogenesis involved in differentiation,BP,POSTN;ULK2;PTPRS;EPHB2;WNT3;EPHA4;DMTN;NFATC4;EFNB3
9758,GO:0040007,0.0012867328665178,0.99929011673314,43,648,growth,BP,POSTN;APOE;ULK2;PTPRS;NDN;NINJ1;HTRA1;SLITRK6;GAMT;EGFR;CYBA;GLI2;EPB41L3;BCL6;SFRP1;INSR;SERPINE2;WWTR1;WNT3;DAB2IP;YEATS4;EPHA4;TENM4;KIF26B;KIF26A;SPOCK1;ACVR1B;KCTD11;HYAL1;RTF1;ZP3;SPRY2;LTBP4;IMPACT;IGFBP4;ERBB2;LAMB2;PLXNB1;SMURF1;MT2A;NRK;VANGL2;APBA1
5454,GO:0016406,0.00129800856582211,0.999958680513196,3,6,carnitine O-acyltransferase activity,MF,CPT2;CRAT;CPT1C
4547,GO:0010646,0.00131908529793539,0.999087902204174,121,2303,regulation of cell communication,BP,TNFAIP3;POSTN;APOE;IFI6;MVB12B;PTPRS;GPNMB;S100A4;MAP3K14;EPHB2;HTRA1;EGFR;THRA;CYBA;GLI2;FGFR4;APCDD1;NLGN2;BCL6;PSD4;SFRP1;ARHGEF4;CKLF;TNFSF10;INSR;VAV3;PKD2;DNM1;CXCL14;LDLRAP1;RIMS3;SERPINE2;VEGFB;WWTR1;RHBDF1;FOXO1;WNT3;NSG1;DAB2IP;OBSCN;TBX1;KLK5;SHC2;SH3BP2;KCNC4;MNT;FAM20C;GLUL;EPHA4;WNT9A;DIXDC1;F2R;HOMER2;ARHGEF19;LTBP1;EPS8L2;DDX60;ERBB3;KIF26A;CDK14;SREBF1;CSPG4;DMTN;GRK6;PIK3R1;PTHLH;APPL2;TMEM204;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;UCN2;ARHGAP40;NFATC4;TYRO3;RHOD;CLEC11A;SLC2A1;ZP3;VAMP2;RBCK1;SPRY2;SCG5;TP53INP1;TNFRSF19;MDK;TRPV4;GPC4;LTBP4;ADORA2B;RTN4RL1;MC1R;NEO1;CRTC1;IGFBP4;GPR68;ERBB2;EPM2A;STAT1;TULP3;ACKR3;CRY2;FURIN;THNSL2;ASIC1;NUAK1;PLXNB1;RASA4;SMURF1;KREMEN1;CCDC3;CXXC5;NISCH;MAP3K3;MDFI;SP100;NRK;VANGL2
4319,GO:0009888,0.00132980497866576,0.999163182150927,71,1219,tissue development,BP,POSTN;TGFBI;TAGLN;ALDH1A3;PTPRS;OBSL1;GPNMB;S100A4;NINJ1;PRICKLE2;PRR9;SLITRK6;TST;COL6A1;EGFR;THRA;GLI2;APCDD1;SFRP1;FHOD3;POU3F1;INSR;GAA;PKD2;ZFPM1;CTSB;ETV5;SERPINE2;SALL2;WWTR1;FOXO1;WNT3;RASIP1;DAB2IP;COL7A1;TMEM231;TBX1;KLK5;FAM20C;EPHA4;WNT9A;TENM4;KIF26B;CTSV;ARHGEF19;ACTA2;ERBB3;PPL;PLXND1;GJB5;PTHLH;CTSL;ACVR1B;NAB2;NFATC4;HYAL1;RTF1;SPRY2;TNFRSF19;TRPV4;GPC4;ITGB5;KLK8;FBXW4;LAMB2;STAT1;TULP3;FURIN;SMURF1;NRK;VANGL2
2632,GO:0005984,0.00134284740298381,0.999956736190738,3,6,disaccharide metabolic process,BP,GAA;SLC2A1;IDUA
6744,GO:0030198,0.00138107219601794,0.999452147734172,19,211,extracellular matrix organization,BP,POSTN;ITGB6;TGFBI;SMOC2;HTRA1;COL6A1;ADAM19;FGFR4;TNXB;COL7A1;KLK5;CTSV;CTSL;ITGB5;LAMB2;FURIN;MMP1;CAPNS2;VPS33B
4950,GO:0015077,0.00138193545513819,0.999502420233337,16,168,monovalent inorganic cation transmembrane transporter activity,MF,KCNJ15;SLC13A5;SHROOM2;PKD2;SCN4B;KCNC4;ATP6V0A2;ATP12A;SLC2A9;NDUFA4L2;SLC5A1;COX5B;SLC13A3;ASIC1;TCIRG1;SLC47A1
620,GO:0001807,0.00138984368886461,1,2,2,regulation of type IV hypersensitivity,BP,ZP3;IL20RB
1205,GO:0002883,0.00138984368886461,1,2,2,regulation of hypersensitivity,BP,ZP3;IL20RB
15243,GO:0071467,0.00143151419838652,0.999893962621924,4,13,cellular response to pH,BP,HYAL1;IMPACT;GPR68;ASIC1
12182,GO:0048468,0.00144298997641985,0.999078438410632,75,1292,cell development,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;FLNC;EGFR;GLI2;EPB41L3;BCL6;TENM2;BRSK1;SFRP1;FHOD3;UNK;POU3F1;MATN2;ZFPM1;RGMA;ETV5;SERPINE2;WNT3;PARVB;BOC;DAB2IP;OBSCN;TBX1;FAM20C;EPHA4;DIXDC1;TENM4;RPS6KA5;HEXB;ACTA2;S100A6;SPOCK1;VAMP3;FRY;PLXND1;DMTN;PIK3R1;PTHLH;NCK2;KCTD11;NFATC4;FAM210B;TYRO3;ZP3;EFNB3;CABYR;TRPV4;NDRG1;KLK8;NAGLU;RTN4RL1;IMPACT;NEO1;CRTC1;GPR68;MICALL1;ERBB2;LAMB2;BLOC1S4;GJC2;PLXNB1;SMURF1;DOK4;CAMK1;VPS33B;ZSWIM8;NRK;VANGL2
2183,GO:0005057,0.00147314151704626,0.999534141021921,13,119,signal transducer activity, downstream of receptor,MF,IFITM1;MAP3K14;EPHB2;EGFR;FGFR4;INSR;EPHA4;ERBB3;ACVR1B;TYRO3;ERBB2;MAP3K3;NRK
4335,GO:0009925,0.00149467358561169,0.999830836784754,5,21,basal plasma membrane,CC,EGFR;PKD2;LDLRAP1;ERBB3;ERBB2
5785,GO:0017057,0.00155294487303349,1,2,2,6-phosphogluconolactonase activity,MF,H6PD;PGLS
4174,GO:0009268,0.00157282026550477,0.999818430406573,5,22,response to pH,BP,HYAL1;IMPACT;GPR68;CLCN7;ASIC1
2200,GO:0005102,0.00157510190544774,0.999068163556515,53,864,signaling receptor binding,MF,ITGB6;TGFBI;APOE;GPNMB;S100A4;EPHB2;CADM4;EGFR;CRAT;NLGN2;SFRP1;CKLF;TNFSF10;INSR;VAV3;PKD2;RGMA;DNM1;CXCL14;LDLRAP1;SERPINE2;TNXB;VEGFB;WNT3;NSG1;DAB2IP;SHC2;EPHA4;WNT9A;F2R;NXPH4;HOMER2;DMTN;PIK3R1;PTHLH;UCN2;SYTL1;NFATC4;CLEC11A;ZP3;EFNB3;MDK;LTBP4;AMACR;IGFBP4;ERBB2;LAMB2;STAT1;MLYCD;THNSL2;PLXNB1;NISCH;IDUA
478,GO:0001523,0.00162255048290706,0.999701793916686,7,43,retinoid metabolic process,BP,APOE;ALDH1A3;CYP27C1;RDH12;SDC3;GPC4;RETSAT
3548,GO:0007605,0.00166683846388122,0.999600887910388,9,68,sensory perception of sound,BP,SLITRK6;ESPN;DNM1;TBX1;TUB;HOMER2;HEXB;EPS8L2;SPRY2
5063,GO:0015318,0.00173759400391964,0.999147708259932,29,395,inorganic molecular entity transmembrane transporter activity,MF,KCNJ15;SLC13A5;SHROOM2;ANO9;SLC16A5;PKD2;SCN4B;KCNC4;ANO8;ORAI3;SLC38A4;ATP6V0A2;ATP12A;LRRC8E;SLC2A9;TRPV4;PQLC2;NDUFA4L2;NIPAL4;SLC5A1;COX5B;SLC39A6;CLCN7;SLC1A4;SLC13A3;ASIC1;TCIRG1;SLC47A1;ABCC1
7191,GO:0031103,0.0017895975462519,0.999722921249139,6,32,axon regeneration,BP,PTPRS;RGMA;EPHA4;KLK8;RTN4RL1;LAMB2
10038,GO:0042562,0.00182267909237347,0.999657281900239,7,44,hormone binding,MF,ALDH1A3;EGFR;THRA;VIPR1;INSR;PIK3R1;UCN2
16907,GO:0098936,0.00188784103629212,1,2,2,intrinsic component of postsynaptic membrane,CC,PTPRS;NLGN2
16944,GO:0099055,0.00188784103629212,1,2,2,integral component of postsynaptic membrane,CC,PTPRS;NLGN2
16985,GO:0099240,0.00188784103629212,1,2,2,intrinsic component of synaptic membrane,CC,PTPRS;NLGN2
17062,GO:0099699,0.00188784103629212,1,2,2,integral component of synaptic membrane,CC,PTPRS;NLGN2
10369,GO:0043235,0.0019412443078628,0.999251574409803,17,184,receptor complex,CC,ITGB6;EPHB2;GPRC5C;EGFR;FGFR4;VIPR1;INSR;EPHA4;OLFM2;ERBB3;PLXND1;ACVR1B;TYRO3;CPT1C;ITGB5;ERBB2;PLXNB1
6580,GO:0022617,0.00196470715915884,0.999568746893277,8,56,extracellular matrix disassembly,BP,HTRA1;FGFR4;KLK5;CTSV;CTSL;FURIN;MMP1;CAPNS2
7580,GO:0031982,0.0020663090452952,0.998511935216198,150,3044,vesicle,CC,TNFAIP3;ITGB6;TGFBI;APOE;ALDH1A3;MVB12B;LAMP3;ULK2;LGALS7B;PTPRS;GPNMB;S100A4;HTRA1;CADM4;GAMT;GPRC5C;GPX3;TST;MXRA5;SHROOM2;COL6A1;EGFR;FBXO2;CYBA;HEBP1;FGFR4;CALML3;PGM1;BRSK1;SFRP1;GAREM2;TNFSF10;INSR;VAV3;CYBRD1;GAA;SV2A;PKD2;RGMA;DNM1;LDLRAP1;CTSB;NT5E;SYT8;SERPINE2;TNXB;TP53INP2;VEGFB;WNT3;NSG1;BPHL;DAB2IP;COL7A1;PRSS3;SGSH;KLK5;WIPF1;RAB40B;NRSN2;FAM20C;GLUL;FAM213A;EPHA4;WNT9A;MAGEF1;F2R;HERC3;CTSV;LRIG3;SEC14L2;TXNDC17;HEXB;PGLS;EPS8L2;ACTA2;HGSNAT;S100A6;ATP6V0A2;VAMP3;PPL;SREBF1;CSPG4;DMTN;APPL2;CTSL;NCK2;ACVR1B;SYTL1;SNX29;XPC;SNX33;RHOD;CXCR1;SLC2A1;METTL7A;HYAL1;BCAM;STOM;CKMT1A;VAMP2;AVL9;SCG5;TP53INP1;TRPV4;ZDHHC1;GPC4;ITGB5;NDRG1;KLK8;LTBP4;ALDH2;SERPING1;NAGLU;RTN4RL1;PDLIM4;TBC1D17;IAH1;TOM1L2;ANKRD13D;MICALL1;ERBB2;C2CD4C;H2AFJ;LAMB2;ACKR3;PLCD1;SLC5A1;COX5B;MARCKSL1;FURIN;CLCN7;PCSK1;SUN1;PEX11B;CTSF;SLC1A4;SLC13A3;SMURF1;TCIRG1;NISCH;AIF1L;RAB43;VPS33B;SLC47A1;ABCC1;MTMR11;IDUA;SORT1;VANGL2;APBA1
18190,GO:1903035,0.00208962082008384,0.999536103699435,8,57,negative regulation of response to wounding,BP,APOE;PTPRS;RGMA;SERPINE2;EPHA4;KLK8;SERPING1;RTN4RL1
7843,GO:0032426,0.00211221481843275,0.999911856492413,3,7,stereocilium tip,CC,ESPN;HOMER2;EPS8L2
10350,GO:0043204,0.00212358603754846,0.999527330345029,8,57,perikaryon,CC,PTPRS;NDN;GLUL;EPHA4;CTSV;ENDOG;RTN4RL1;GJC2
3488,GO:0007409,0.00223341033170374,0.998967225282325,24,305,axonogenesis,BP,APOE;ULK2;PTPRS;NDN;EPHB2;SLITRK6;GLI2;BRSK1;MATN2;WNT3;BOC;EPHA4;RPS6KA5;S100A6;PLXND1;PIK3R1;EFNB3;NEO1;ERBB2;LAMB2;PLXNB1;DOK4;ZSWIM8;VANGL2
13232,GO:0051960,0.00223753663919825,0.998784090362766,37,545,regulation of nervous system development,BP,APOE;ULK2;PTPRS;OBSL1;ADGRB2;EPHB2;SLITRK6;ADGRL1;GLI2;NLGN2;BCL6;SFRP1;RGMA;ETV5;SERPINE2;WNT3;DAB2IP;EPHA4;DIXDC1;TENM4;SPOCK1;PLXND1;KCTD11;NFATC4;EFNB3;TRPV4;KLK8;RTN4RL1;IMPACT;CRTC1;TULP3;GJC2;PLXNB1;SMURF1;CAMK1;ZSWIM8;VANGL2
3116,GO:0006720,0.00226032369494454,0.999431665528623,9,72,isoprenoid metabolic process,BP,APOE;ALDH1A3;EGFR;CYP27C1;RDH12;SDC3;GPC4;RETSAT;MVD
3249,GO:0006935,0.00226834714525877,0.998913595451201,26,347,chemotaxis,BP,GPNMB;EPHB2;GLI2;CKLF;VAV3;MATN2;CXCL14;VEGFB;WNT3;BOC;EPHA4;RPS6KA5;PLXND1;PIK3R1;CXCR1;EFNB3;TRPV4;NEO1;ERBB2;LAMB2;ACKR3;PLXNB1;DOK4;ZSWIM8;ABCC1;VANGL2
9929,GO:0042330,0.00226834714525877,0.998913595451201,26,347,taxis,BP,GPNMB;EPHB2;GLI2;CKLF;VAV3;MATN2;CXCL14;VEGFB;WNT3;BOC;EPHA4;RPS6KA5;PLXND1;PIK3R1;CXCR1;EFNB3;TRPV4;NEO1;ERBB2;LAMB2;ACKR3;PLXNB1;DOK4;ZSWIM8;ABCC1;VANGL2
10460,GO:0043394,0.00229901926239153,0.999708144224648,5,23,proteoglycan binding,MF,PTPRS;GPNMB;CTSB;CTSL;GPC4
13868,GO:0060560,0.00231774492705893,0.999153054329757,15,156,developmental growth involved in morphogenesis,BP,POSTN;APOE;ULK2;PTPRS;NDN;SFRP1;WNT3;EPHA4;KIF26B;SPRY2;IMPACT;LAMB2;PLXNB1;SMURF1;VANGL2
1471,GO:0003779,0.00233674417912711,0.998935235665324,23,290,actin binding,MF,TAGLN;OBSL1;S100A4;TNS1;FLNC;SHROOM2;EGFR;EPB41L3;FHOD3;ESPN;PARVB;WIPF1;CORO6;DIXDC1;HOMER2;EPS8L2;DMTN;PLEKHH2;TRPV4;MSRB2;IMPACT;MARCKSL1;AIF1L
2286,GO:0005272,0.00233748486898941,0.999797671001649,4,14,sodium channel activity,MF,SHROOM2;PKD2;SCN4B;ASIC1
8099,GO:0032809,0.00233952782261462,0.99989874244023,3,7,neuronal cell body membrane,CC,INSR;DAB2IP;KCNC4
10777,GO:0044298,0.00233952782261462,0.99989874244023,3,7,cell body membrane,CC,INSR;DAB2IP;KCNC4
4949,GO:0015075,0.00239221851265323,0.998769987505159,31,441,ion transmembrane transporter activity,MF,KCNJ15;SLC13A5;SHROOM2;ANO9;SLC16A5;PKD2;SCN4B;KCNC4;ANO8;ORAI3;S100A6;SLC38A4;ATP6V0A2;ATP12A;SLC2A1;LRRC8E;SLC2A9;TRPV4;PQLC2;NDUFA4L2;NIPAL4;SLC5A1;COX5B;SLC39A6;CLCN7;SLC1A4;SLC13A3;ASIC1;TCIRG1;SLC47A1;ABCC1
7255,GO:0031256,0.00241877167950044,0.999230993579586,12,112,leading edge membrane,CC,EPB41L3;PSD4;ARHGEF4;INSR;KCNC4;EPS8L2;PLXND1;CSPG4;SPRY2;TRPV4;SLC39A6;AIF1L
11305,GO:0045665,0.00243873999609099,0.999140320505159,14,143,negative regulation of neuron differentiation,BP,APOE;ULK2;PTPRS;EPHB2;RGMA;WNT3;EPHA4;DIXDC1;SPOCK1;NFATC4;EFNB3;TRPV4;KLK8;RTN4RL1
15083,GO:0071214,0.00275997203667273,0.998831949661637,19,229,cellular response to abiotic stimulus,BP,MAP3K14;EGFR;CYBA;SFRP1;PKD2;DDB2;PIK3R1;XPC;NFATC4;SLC2A1;HYAL1;TP53INP1;TRPV4;MC1R;IMPACT;GPR68;CRY2;IFI16;ASIC1
17144,GO:0104004,0.00275997203667273,0.998831949661637,19,229,cellular response to environmental stimulus,BP,MAP3K14;EGFR;CYBA;SFRP1;PKD2;DDB2;PIK3R1;XPC;NFATC4;SLC2A1;HYAL1;TP53INP1;TRPV4;MC1R;IMPACT;GPR68;CRY2;IFI16;ASIC1
5279,GO:0015985,0.0028089261558597,0.999861664099965,3,8,energy coupled proton transport, down electrochemical gradient,BP,ATP6V0A2;COX5B;TCIRG1
5280,GO:0015986,0.0028089261558597,0.999861664099965,3,8,ATP synthesis coupled proton transport,BP,ATP6V0A2;COX5B;TCIRG1
10654,GO:0043954,0.00280937099591759,0.99962384436948,5,24,cellular component maintenance,BP,APOE;NLGN2;INSR;F2R;MTHFR
16449,GO:0097186,0.00282451406999114,0.999737966065125,4,15,amelogenesis,BP,FOXO1;TBX1;KLK5;FAM20C
15662,GO:0072243,0.00290590930112476,0.999728255999893,4,15,metanephric nephron epithelium development,BP,PKD2;WWTR1;LAMB2;STAT1
2655,GO:0006022,0.00293217422070787,0.999043850227571,12,116,aminoglycan metabolic process,BP,XYLT1;SGSH;B3GNT9;HEXB;HGSNAT;CSPG4;SDC3;HYAL1;GPC4;NAGLU;XYLT2;IDUA
14291,GO:0061515,0.00300664797488317,0.999377860201029,7,47,myeloid cell development,BP,BCL6;ZFPM1;FAM20C;DMTN;FAM210B;GPR68;VPS33B
2660,GO:0006029,0.00303301053063095,0.999282615190728,8,59,proteoglycan metabolic process,BP,XYLT1;SGSH;HEXB;CSPG4;HYAL1;XYLT2;IDUA;VANGL2
10241,GO:0043015,0.00312116739263702,0.99956914340891,5,25,gamma-tubulin binding,MF,NDN;BRSK1;DIXDC1;NDRG1;MARK4
7188,GO:0031099,0.0032008520991583,0.998943637002033,12,119,regeneration,BP,POSTN;APOE;PTPRS;NINJ1;SRSF5;EGFR;MATN2;RGMA;EPHA4;KLK8;RTN4RL1;LAMB2
479,GO:0001525,0.00324817673125693,0.998451260618033,24,317,angiogenesis,BP,TNFAIP3;TGFBI;GPNMB;ADGRB2;EPHB2;FGFR4;SFRP1;VAV3;VEGFB;RASIP1;DAB2IP;TBX1;PLCD3;PLXND1;CSPG4;NFATC4;HYAL1;SPRY2;ERBB2;STAT1;ACKR3;PLCD1;MAP3K3;SP100
12289,GO:0048678,0.00336909215182552,0.999285845247631,7,49,response to axon injury,BP,PTPRS;MATN2;RGMA;EPHA4;KLK8;RTN4RL1;LAMB2
3730,GO:0008284,0.00337549072698768,0.998149337991059,35,533,positive regulation of cell proliferation,BP,TNFAIP3;ASH2L;HTRA1;EGFR;CYBA;GLI2;FGFR4;VIPR1;BCL6;SFRP1;INSR;VAV3;ETV5;VEGFB;WWTR1;TBX1;TET1;GLUL;F2R;S100A6;PTHLH;NCK2;CLEC11A;HYAL1;ZP3;FBXW4;MVD;ERBB2;RNF187;STAT1;MARCKSL1;CCDC88B;GJC2;TCIRG1;MAP3K3
12637,GO:0050885,0.00345558740058627,0.99951140852561,5,25,neuromuscular process controlling balance,BP,ALDH1A3;NLGN2;GAA;HEXB;BLOC1S4
5127,GO:0015672,0.00346071311375133,0.998466788187524,20,253,monovalent inorganic cation transport,BP,KCNJ15;SLC13A5;SHROOM2;PKD2;SERPINE2;SCN4B;KCNC4;SLC38A4;ATP6V0A2;ATP12A;STOM;VAMP2;SLC2A9;NDUFA4L2;SLC5A1;COX5B;SLC13A3;ASIC1;TCIRG1;SLC47A1
10247,GO:0043025,0.00346584323560791,0.998430311663049,21,268,neuronal cell body,CC,APOE;PTPRS;NDN;EPHB2;CYBA;INSR;SV2A;DAB2IP;KCNC4;NRSN2;GLUL;EPHA4;CTSV;HOMER2;ENDOG;RTN4RL1;CRTC1;GJC2;SLC1A4;SMURF1;SORT1
3414,GO:0007218,0.00354080479533,0.999640862514853,4,17,neuropeptide signaling pathway,BP,NXPH4;TYRO3;SCG5;SORT1
323,GO:0000904,0.00358962377888832,0.998061866857669,33,482,cell morphogenesis involved in differentiation,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;GLI2;BRSK1;UNK;MATN2;ZFPM1;WNT3;PARVB;BOC;EPHA4;RPS6KA5;S100A6;VAMP3;PLXND1;DMTN;PIK3R1;NFATC4;TYRO3;EFNB3;NEO1;ERBB2;LAMB2;PLXNB1;DOK4;ZSWIM8;VANGL2
3441,GO:0007269,0.00359982056326644,0.999026604358656,9,75,neurotransmitter secretion,BP,BRSK1;RIMS3;SYT8;KCNC4;SYTL1;VAMP2;C2CD4C;ASIC1;APBA1
17061,GO:0099643,0.00359982056326644,0.999026604358656,9,75,signal release from synapse,BP,BRSK1;RIMS3;SYT8;KCNC4;SYTL1;VAMP2;C2CD4C;ASIC1;APBA1
12580,GO:0050804,0.00363563253697625,0.998552206982148,16,183,modulation of chemical synaptic transmission,BP,APOE;EPHB2;EGFR;NLGN2;RIMS3;SERPINE2;NSG1;KCNC4;GLUL;EPHA4;F2R;NFATC4;VAMP2;CRTC1;ASIC1;NISCH
16982,GO:0099177,0.00363563253697625,0.998552206982148,16,183,regulation of trans-synaptic signaling,BP,APOE;EPHB2;EGFR;NLGN2;RIMS3;SERPINE2;NSG1;KCNC4;GLUL;EPHA4;F2R;NFATC4;VAMP2;CRTC1;ASIC1;NISCH
5366,GO:0016209,0.00382085374409204,0.999166304299838,7,53,antioxidant activity,MF,APOE;TXNRD3;GPX7;GPX3;FAM213A;TXNDC17;TP53INP1
9173,GO:0035584,0.00385264916983236,0.999777682110966,3,9,calcium-mediated signaling using intracellular calcium source,BP,ADGRL1;HOMER2;DMTN
1197,GO:0002864,0.00390725915291084,0.999951376411706,2,3,regulation of acute inflammatory response to antigenic stimulus,BP,ZP3;IL20RB
4588,GO:0010721,0.00392384658674837,0.998374362488541,17,200,negative regulation of cell development,BP,POSTN;APOE;ULK2;PTPRS;EPHB2;RGMA;WNT3;EPHA4;DIXDC1;SPOCK1;DMTN;KCTD11;NFATC4;EFNB3;TRPV4;KLK8;RTN4RL1
13108,GO:0051716,0.00395609824142661,0.997014227801611,218,4649,cellular response to stimulus,BP,TNFAIP3;POSTN;IFITM1;ITGB6;SMOC2;APOE;IFI6;MVB12B;ULK2;PTPRS;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRF4;ASH2L;HTRA1;PRICKLE2;GPRC5C;TXNRD3;GIGYF1;ADGRL1;GPX7;SRSF5;GPX3;RALGDS;SHROOM2;COL6A1;EGFR;FBXO2;THRA;CYBA;OAS2;GLI2;HEBP1;FGFR4;APCDD1;NLGN2;RAPGEF5;VIPR1;BCL6;TENM2;PSD4;BRSK1;SFRP1;ARHGEF4;CKLF;TNFSF10;INSR;VAV3;CES2;MATN2;PKD2;RGMA;DNM1;CXCL14;LDLRAP1;CTSB;ETV5;SERPINE2;SALL2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;LY6E;NSG1;RASIP1;BPHL;BOC;UROS;DDB2;DAB2IP;TMEM231;OBSCN;TBX1;KLK5;SHC2;SH3BP2;WIPF1;MNT;RAB40B;FAM20C;GLUL;FAM213A;EPHA4;WNT9A;RPL13A;MAGEF1;DIXDC1;TENM4;F2R;CTSV;NXPH4;RPS6KA5;HOMER2;TXNDC17;ARHGEF19;LTBP1;PLCD3;ACSL1;EPS8L2;DDX60;ERBB3;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;VAMP3;PLXND1;SREBF1;CSPG4;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;IMPA2;XPC;ARHGAP40;NFATC4;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;HYAL1;BCAM;RTF1;ZP3;VAMP2;RBCK1;EFNB3;PCBP4;SPRY2;SCG5;LRRC8E;TP53INP1;TNFRSF19;TMX4;MDK;TRPV4;SPATA18;GPC4;ITGB5;NDRG1;KLK8;LTBP4;ADORA2B;FBXW4;MRC2;RTN4RL1;MC1R;IMPACT;NEO1;IGFBP4;GPR68;TOM1L2;GPR153;MICALL1;ERBB2;EPM2A;LAMB2;STAT1;TULP3;ACKR3;PLCD1;CRY2;FURIN;RHPN1;IFI16;IL20RB;PLPP2;THNSL2;PEX11B;FRAT1;ASIC1;MMP1;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;CCDC3;CXXC5;CAMK1;TCIRG1;NISCH;MT2A;RAB43;MAP3K3;PPP1R14A;MDFI;SP100;MPG;ABCC1;NRK;SORT1;CBR3;VANGL2
2117,GO:0004930,0.00398334434633027,0.998576466320801,13,139,G-protein coupled receptor activity,MF,ADGRB2;ADGRF4;GPRC5C;ADGRL1;VIPR1;SFRP1;F2R;CXCR1;ADORA2B;MC1R;GPR68;GPR153;ACKR3
6491,GO:0021885,0.0040520162906349,0.999247582245595,6,37,forebrain cell migration,BP,EGFR;DAB2IP;DIXDC1;TYRO3;MBOAT7;SUN1
6718,GO:0030155,0.00406070267293032,0.997882518307037,29,417,regulation of cell adhesion,BP,POSTN;TGFBI;SMOC2;GPNMB;MAP3K14;NINJ1;GLI2;BCL6;SFRP1;VAV3;SERPINE2;KIF26B;ERBB3;SPOCK1;PLXND1;DMTN;PIK3R1;NCK2;RHOD;HYAL1;ZP3;EFNB3;TRPV4;ERBB2;IL20RB;CCDC88B;NUAK1;PLXNB1;VPS33B
16744,GO:0098609,0.00411619258540711,0.997825933455246,30,437,cell-cell adhesion,BP,LGALS7B;GPNMB;MAP3K14;CADM4;ADGRL1;EGFR;GLI2;NLGN2;BCL6;TENM2;SDK2;NT5E;SERPINE2;TENM4;KIF26B;DMTN;PIK3R1;NCK2;TYRO3;ZP3;EFNB3;TRPV4;ITGB5;MYL9;ERBB2;PCDH1;BLOC1S4;IL20RB;CCDC88B;VPS33B
714,GO:0001944,0.00415580081010305,0.997779315163781,31,452,vasculature development,BP,TNFAIP3;TGFBI;APOE;GPNMB;ADGRB2;EPHB2;FGFR4;SFRP1;VAV3;PKD2;VEGFB;FOXO1;RASIP1;DAB2IP;TMEM231;TBX1;LTBP1;PLCD3;ACTA2;PLXND1;CSPG4;TMEM204;NFATC4;HYAL1;SPRY2;ERBB2;STAT1;ACKR3;PLCD1;MAP3K3;SP100
10877,GO:0044456,0.0042863850949833,0.997755889599514,29,418,synapse part,CC,PTPRS;EPHB2;ADGRL1;FBXO2;EPB41L3;NLGN2;TENM2;BRSK1;SV2A;DNM1;RIMS3;SYT8;NSG1;KCNC4;RAB40B;GLUL;EPHA4;OLFM2;F2R;HOMER2;SPOCK1;DMTN;NCK2;SYTL1;VAMP2;PDLIM4;C2CD4C;LAMB2;APBA1
1953,GO:0004674,0.00432160414503052,0.997764416543744,28,395,protein serine/threonine kinase activity,MF,ULK2;MAP3K14;EPHB2;EGFR;FGFR4;CDK18;BRSK1;INSR;OBSCN;FAM20C;EPHA4;RPS6KA5;LTBP1;ERBB3;CDK14;GRK6;ACVR1B;CAMKK1;TYRO3;ADCK5;LTBP4;MARK4;ERBB2;CDK20;NUAK1;CAMK1;MAP3K3;NRK
5305,GO:0016049,0.00434260108881717,0.997844484053896,25,346,cell growth,BP,POSTN;APOE;ULK2;PTPRS;NDN;HTRA1;EGFR;CYBA;EPB41L3;BCL6;SFRP1;SERPINE2;WNT3;EPHA4;KIF26A;SPOCK1;ACVR1B;HYAL1;LTBP4;IMPACT;IGFBP4;ERBB2;LAMB2;PLXNB1;SMURF1
619,GO:0001806,0.00438299644992174,0.999942100645399,2,3,type IV hypersensitivity,BP,ZP3;IL20RB
1016,GO:0002524,0.00438299644992174,0.999942100645399,2,3,hypersensitivity,BP,ZP3;IL20RB
1281,GO:0003105,0.00460630901358309,0.999937556318705,2,3,negative regulation of glomerular filtration,BP,CYBA;F2R
7650,GO:0032101,0.00463551903314087,0.997558274765232,29,426,regulation of response to external stimulus,BP,TNFAIP3;APOE;PTPRS;HTRA1;EGFR;CYBA;BCL6;RGMA;CXCL14;NT5E;SERPINE2;VEGFB;WNT3;KLK5;EPHA4;F2R;DDX60;DMTN;TYRO3;ZP3;TRPV4;KLK8;ADORA2B;SERPING1;RTN4RL1;STAT1;IL20RB;VPS33B;ZSWIM8
3496,GO:0007422,0.00470034614133922,0.99893752373786,7,51,peripheral nervous system development,BP,ADGRB2;POU3F1;ERBB3;NAB2;NDRG1;ERBB2;LAMB2
16575,GO:0097458,0.00472486366554834,0.997018054538179,55,939,neuron part,CC,APOE;PTPRS;NDN;S100A4;EPHB2;ADGRL1;FBXO2;CYBA;EPB41L3;NLGN2;TENM2;BRSK1;INSR;SV2A;ESPN;DNM1;LDLRAP1;RIMS3;SYT8;NSG1;BOC;DAB2IP;KCNC4;RAB40B;NRSN2;GLUL;EPHA4;TENM4;CTSV;HOMER2;EPS8L2;SPOCK1;VAMP3;RDH12;DMTN;ENDOG;NCK2;SYTL1;CPT1C;VAMP2;TRPV4;SYNM;RTN4RL1;MARK4;PDLIM4;CRTC1;C2CD4C;STAT1;BLOC1S4;GJC2;SLC1A4;SMURF1;REEP6;SORT1;APBA1
15641,GO:0072207,0.00474896656851812,0.999476501304383,4,17,metanephric epithelium development,BP,PKD2;WWTR1;LAMB2;STAT1
3559,GO:0007619,0.00475529559949209,0.999934458805421,2,3,courtship behavior,BP,THRA;HEXB
16450,GO:0097187,0.00476763415066204,0.999934199951551,2,3,dentinogenesis,BP,HTRA1;FAM20C
17022,GO:0099550,0.00478626256786245,0.999933808469792,2,3,trans-synaptic signaling, modulating synaptic transmission,BP,EPHB2;F2R
2322,GO:0005355,0.00486484019866736,0.999694563379355,3,9,glucose transmembrane transporter activity,MF,SLC2A1;SLC2A9;SLC5A1
4981,GO:0015141,0.00488891739621661,0.999931636724041,2,3,succinate transmembrane transporter activity,MF,SLC13A5;SLC13A3
5164,GO:0015744,0.00488891739621661,0.999931636724041,2,3,succinate transport,BP,SLC13A5;SLC13A3
15213,GO:0071422,0.00488891739621661,0.999931636724041,2,3,succinate transmembrane transport,BP,SLC13A5;SLC13A3
10474,GO:0043410,0.00499906777439602,0.997529041657121,24,330,positive regulation of MAPK cascade,BP,GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;INSR;DAB2IP;TBX1;SHC2;EPHA4;F2R;ERBB3;CSPG4;TYRO3;SPRY2;TNFRSF19;TRPV4;ADORA2B;IGFBP4;ERBB2;ACKR3;MAP3K3;NRK;VANGL2
15722,GO:0072358,0.00501784181285738,0.997282062244826,31,458,cardiovascular system development,BP,TNFAIP3;TGFBI;APOE;GPNMB;ADGRB2;EPHB2;FGFR4;SFRP1;VAV3;PKD2;VEGFB;FOXO1;RASIP1;DAB2IP;TMEM231;TBX1;LTBP1;PLCD3;ACTA2;PLXND1;CSPG4;TMEM204;NFATC4;HYAL1;SPRY2;ERBB2;STAT1;ACKR3;PLCD1;MAP3K3;SP100
13563,GO:0060074,0.00502192200535538,0.99968104185002,3,9,synapse maturation,BP,ADGRL1;DAB2IP;NFATC4
6632,GO:0023061,0.0050314407445652,0.997744616696398,19,241,signal release,BP,EGFR;NLGN2;BRSK1;SFRP1;RIMS3;SYT8;KCNC4;GLUL;SREBF1;SYTL1;SLC2A1;VAMP2;SCG5;TRPV4;LTBP4;GPR68;C2CD4C;ASIC1;APBA1
16597,GO:0097500,0.00505271690122299,0.999928121283538,2,3,receptor localization to non-motile cilium,BP,TUB;TULP3
13233,GO:0051961,0.00505774431841228,0.997913069662868,16,188,negative regulation of nervous system development,BP,APOE;ULK2;PTPRS;EPHB2;RGMA;WNT3;EPHA4;DIXDC1;SPOCK1;KCTD11;NFATC4;EFNB3;TRPV4;KLK8;RTN4RL1;TULP3
14565,GO:0070166,0.00507017063899945,0.999676856750657,3,9,enamel mineralization,BP,FOXO1;TBX1;FAM20C
15723,GO:0072359,0.00507476317291111,0.996990355104428,42,673,circulatory system development,BP,TNFAIP3;TGFBI;APOE;OBSL1;GPNMB;ADGRB2;EPHB2;EGFR;ADAM19;GLI2;FGFR4;SFRP1;FHOD3;INSR;VAV3;GAA;PKD2;ZFPM1;VEGFB;FOXO1;RASIP1;DAB2IP;TMEM231;TBX1;TENM4;LTBP1;PLCD3;ACTA2;ERBB3;PLXND1;CSPG4;TMEM204;NFATC4;HYAL1;SPRY2;ERBB2;STAT1;ACKR3;PLCD1;MAP3K3;SP100;VANGL2
14761,GO:0070527,0.00509250365845699,0.999001289370939,6,40,platelet aggregation,BP,SERPINE2;DMTN;TYRO3;MYL9;BLOC1S4;VPS33B
7253,GO:0031253,0.00513493033050254,0.997812517607238,17,204,cell projection membrane,CC,EPB41L3;PSD4;ARHGEF4;INSR;CYBRD1;PKD2;TMEM231;KCNC4;EPS8L2;PLXND1;CSPG4;DMTN;SYTL1;SPRY2;TRPV4;SLC39A6;AIF1L
19659,GO:2000026,0.00517137840126626,0.996554694816334,70,1264,regulation of multicellular organismal development,BP,TNFAIP3;APOE;ULK2;PTPRS;OBSL1;GPNMB;ADGRB2;EPHB2;ASH2L;PRICKLE2;SLITRK6;ADGRL1;EGFR;OAS2;GLI2;NLGN2;BCL6;SFRP1;INSR;ZFPM1;RGMA;ETV5;SERPINE2;VEGFB;WWTR1;WNT3;DAB2IP;TBX1;FAM20C;FAM213A;EPHA4;WNT9A;DIXDC1;TENM4;CTSV;ARHGEF19;ERBB3;SPOCK1;PLXND1;PIK3R1;PTHLH;CTSL;ACVR1B;KCTD11;NFATC4;FAM210B;HYAL1;ZP3;EFNB3;SPRY2;TRPV4;GPC4;KLK8;MYL9;RTN4RL1;IMPACT;CRTC1;GPR68;ERBB2;STAT1;TULP3;GJC2;PLXNB1;SMURF1;CAMK1;MAP3K3;ZSWIM8;SP100;NRK;VANGL2
12284,GO:0048671,0.00518847993746278,0.99992516139742,2,3,negative regulation of collateral sprouting,BP,ULK2;PTPRS
10043,GO:0042572,0.00520312314148479,0.999405280114611,4,18,retinol metabolic process,BP,ALDH1A3;CYP27C1;RDH12;RETSAT
5048,GO:0015280,0.00521188864663672,0.999924646854411,2,3,ligand-gated sodium channel activity,MF,SHROOM2;ASIC1
6721,GO:0030158,0.00524234318360306,0.999923975603585,2,3,protein xylosyltransferase activity,MF,XYLT1;XYLT2
6749,GO:0030203,0.00525616671530625,0.998251510579712,11,109,glycosaminoglycan metabolic process,BP,XYLT1;SGSH;HEXB;HGSNAT;CSPG4;SDC3;HYAL1;GPC4;NAGLU;XYLT2;IDUA
4318,GO:0009887,0.00528367762646076,0.996899453834167,40,640,animal organ morphogenesis,BP,TNFAIP3;ALDH1A3;EPHB2;HTRA1;PRICKLE2;SLITRK6;GAMT;SHROOM2;EGFR;THRA;GLI2;SFRP1;INSR;GAA;PKD2;ZFPM1;SDK2;ETV5;WWTR1;FOXO1;TBX1;KLK5;FAM20C;WNT9A;KIF26B;LRIG3;ARHGEF19;ACTA2;PLXND1;NAB2;HYAL1;SPRY2;TRPV4;GPC4;NAGLU;STAT1;TULP3;SMURF1;MDFI;VANGL2
17010,GO:0099531,0.00535661650684544,0.998454436782067,9,80,presynaptic process involved in chemical synaptic transmission,BP,BRSK1;RIMS3;SYT8;KCNC4;SYTL1;VAMP2;C2CD4C;ASIC1;APBA1
10032,GO:0042552,0.00565255587422918,0.998355292700431,9,80,myelination,BP,EPB41L3;POU3F1;MARVELD1;TENM4;HEXB;NAB2;NDRG1;KLK8;ERBB2
12280,GO:0048667,0.00568311050599233,0.997035608702754,27,383,cell morphogenesis involved in neuron differentiation,BP,APOE;ULK2;PTPRS;OBSL1;NDN;EPHB2;SLITRK6;GLI2;BRSK1;UNK;MATN2;WNT3;BOC;EPHA4;RPS6KA5;S100A6;PLXND1;PIK3R1;NFATC4;EFNB3;NEO1;ERBB2;LAMB2;PLXNB1;DOK4;ZSWIM8;VANGL2
4345,GO:0009966,0.00573962455665061,0.995879245743564,109,2132,regulation of signal transduction,BP,TNFAIP3;POSTN;APOE;IFI6;MVB12B;PTPRS;GPNMB;S100A4;MAP3K14;EPHB2;HTRA1;EGFR;THRA;CYBA;GLI2;FGFR4;APCDD1;NLGN2;BCL6;PSD4;SFRP1;ARHGEF4;CKLF;TNFSF10;INSR;VAV3;PKD2;DNM1;CXCL14;LDLRAP1;SERPINE2;VEGFB;WWTR1;RHBDF1;FOXO1;WNT3;DAB2IP;OBSCN;TBX1;KLK5;SHC2;SH3BP2;MNT;FAM20C;EPHA4;WNT9A;DIXDC1;F2R;HOMER2;ARHGEF19;LTBP1;EPS8L2;DDX60;ERBB3;KIF26A;CDK14;CSPG4;DMTN;GRK6;PIK3R1;PTHLH;APPL2;TMEM204;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;UCN2;ARHGAP40;NFATC4;TYRO3;RHOD;CLEC11A;ZP3;RBCK1;SPRY2;TP53INP1;TNFRSF19;MDK;TRPV4;GPC4;LTBP4;ADORA2B;RTN4RL1;MC1R;NEO1;IGFBP4;ERBB2;EPM2A;STAT1;TULP3;ACKR3;CRY2;FURIN;THNSL2;NUAK1;PLXNB1;RASA4;SMURF1;KREMEN1;CCDC3;CXXC5;MAP3K3;MDFI;SP100;NRK;VANGL2
487,GO:0001540,0.00574187463234835,0.998842892180986,6,41,amyloid-beta binding,MF,APOE;EPHB2;FBXO2;INSR;LDLRAP1;APBA1
12361,GO:0048839,0.00595861909098172,0.998109988110733,10,95,inner ear development,BP,ALDH1A3;EPHB2;SLITRK6;GLI2;CXCL14;TBX1;LRIG3;SPRY2;NAGLU;VANGL2
4248,GO:0009611,0.00598185049944519,0.996825648309764,28,415,response to wounding,BP,TNFAIP3;POSTN;APOE;PTPRS;NINJ1;EGFR;VAV3;MATN2;ZFPM1;RGMA;SERPINE2;EPHA4;F2R;ARHGEF19;ERBB3;DMTN;PIK3R1;TYRO3;MDK;KLK8;SERPING1;MYL9;RTN4RL1;ERBB2;LAMB2;BLOC1S4;VPS33B;VANGL2
12347,GO:0048791,0.00604229260392942,0.999279112460985,4,18,calcium ion-regulated exocytosis of neurotransmitter,BP,RIMS3;SYT8;SYTL1;C2CD4C
11705,GO:0046578,0.00624260291081374,0.997365112360506,16,189,regulation of Ras protein signal transduction,BP,APOE;EPHB2;BCL6;PSD4;ARHGEF4;VAV3;DAB2IP;OBSCN;F2R;ARHGEF19;EPS8L2;APPL2;IQSEC1;ACAP3;SPRY2;RASA4
10571,GO:0043583,0.00624867062667693,0.997870025473223,11,111,ear development,BP,ALDH1A3;EPHB2;SLITRK6;SHROOM2;GLI2;CXCL14;TBX1;LRIG3;SPRY2;NAGLU;VANGL2
509,GO:0001573,0.00625682588090849,0.999554948606248,3,10,ganglioside metabolic process,BP,ST3GAL5;HEXB;ST6GALNAC6
12699,GO:0051004,0.00627373024209309,0.999553306317164,3,10,regulation of lipoprotein lipase activity,BP,LMF1;FURIN;SORT1
12552,GO:0050768,0.00633823143667803,0.997405391434985,15,176,negative regulation of neurogenesis,BP,APOE;ULK2;PTPRS;EPHB2;RGMA;WNT3;EPHA4;DIXDC1;SPOCK1;KCTD11;NFATC4;EFNB3;TRPV4;KLK8;RTN4RL1
4953,GO:0015081,0.00638368580646828,0.9982766846473,8,66,sodium ion transmembrane transporter activity,MF,SLC13A5;SHROOM2;PKD2;SCN4B;ATP12A;SLC5A1;SLC13A3;ASIC1
6570,GO:0022603,0.0064654031473216,0.996084227263339,43,707,regulation of anatomical structure morphogenesis,BP,TNFAIP3;POSTN;APOE;ULK2;PTPRS;OBSL1;GPNMB;ADGRB2;EPHB2;PRICKLE2;EPB41L3;BCL6;SFRP1;ETV5;VEGFB;WNT3;PARVB;DAB2IP;TBX1;WIPF1;EPHA4;TENM4;ARHGEF19;HEXB;PLXND1;DMTN;NFATC4;RHOD;HYAL1;EFNB3;SPRY2;GPC4;ERBB2;STAT1;ZMYM3;ARPIN;PLXNB1;SMURF1;CAMK1;MAP3K3;ZSWIM8;SP100;VANGL2
6656,GO:0030036,0.00649266531611051,0.996416250114997,31,467,actin cytoskeleton organization,BP,OBSL1;SHROOM2;EPB41L3;BCL6;SFRP1;FHOD3;ESPN;TNXB;PARVB;OBSCN;WIPF1;CORO6;DIXDC1;CTSV;ARHGEF19;EPS8L2;FRY;DMTN;PIK3R1;IQSEC1;NCK2;ARHGAP40;RHOD;PLEKHH2;TRPV4;MSRB2;ITGB5;PDLIM4;ARPIN;NISCH;VANGL2
6606,GO:0022857,0.00652292188356165,0.996294158083357,34,532,transmembrane transporter activity,MF,KCNJ15;SLC13A5;SHROOM2;ANO9;SLC16A5;SLC29A4;SV2A;PKD2;SCN4B;KCNC4;ANO8;ORAI3;S100A6;SLC38A4;ATP6V0A2;ATP12A;SLC2A1;LRRC8E;SLC2A9;TRPV4;PQLC2;NDUFA4L2;NIPAL4;SLC5A1;COX5B;SLC39A6;CLCN7;GJC2;SLC1A4;SLC13A3;ASIC1;TCIRG1;SLC47A1;ABCC1
12205,GO:0048514,0.00655790415392534,0.996584920786395,26,372,blood vessel morphogenesis,BP,TNFAIP3;TGFBI;APOE;GPNMB;ADGRB2;EPHB2;FGFR4;SFRP1;VAV3;PKD2;VEGFB;RASIP1;DAB2IP;TBX1;PLCD3;PLXND1;CSPG4;NFATC4;HYAL1;SPRY2;ERBB2;STAT1;ACKR3;PLCD1;MAP3K3;SP100
3444,GO:0007272,0.00665096353626803,0.9980121421909,9,82,ensheathment of neurons,BP,EPB41L3;POU3F1;MARVELD1;TENM4;HEXB;NAB2;NDRG1;KLK8;ERBB2
3777,GO:0008366,0.00665096353626803,0.9980121421909,9,82,axon ensheathment,BP,EPB41L3;POU3F1;MARVELD1;TENM4;HEXB;NAB2;NDRG1;KLK8;ERBB2
4986,GO:0015149,0.00667523877988483,0.999513817733822,3,10,hexose transmembrane transporter activity,MF,SLC2A1;SLC2A9;SLC5A1
8823,GO:0034644,0.00678386249432524,0.998144673073052,8,69,cellular response to UV,BP,DDB2;PIK3R1;XPC;NFATC4;HYAL1;TP53INP1;MC1R;IMPACT
11304,GO:0045664,0.00680580377901682,0.996353160047937,28,410,regulation of neuron differentiation,BP,APOE;ULK2;PTPRS;OBSL1;EPHB2;GLI2;BCL6;SFRP1;RGMA;ETV5;WNT3;DAB2IP;EPHA4;DIXDC1;SPOCK1;PLXND1;KCTD11;NFATC4;EFNB3;TRPV4;KLK8;RTN4RL1;IMPACT;CRTC1;PLXNB1;SMURF1;CAMK1;ZSWIM8
10765,GO:0044273,0.00714511837340881,0.998766846322986,5,31,sulfur compound catabolic process,BP,HEXB;CSPG4;HYAL1;MLYCD;IDUA
3616,GO:0008092,0.00720762451349467,0.995658633016725,41,668,cytoskeletal protein binding,MF,TAGLN;APOE;OBSL1;NDN;S100A4;TNS1;FLNC;SHROOM2;EGFR;EPB41L3;BRSK1;FHOD3;PKD2;ESPN;DNM1;PARVB;OBSCN;CLIP2;GAS8;WIPF1;CORO6;DIXDC1;KIF26B;HOMER2;EPS8L2;KIF26A;S100A6;DMTN;NCK2;PLEKHH2;TRPV4;MSRB2;SYNM;NDRG1;MARK4;PDLIM4;CCDC69;IMPACT;MARCKSL1;CCDC88B;AIF1L
3755,GO:0008324,0.00720950202074403,0.996442431229829,22,305,cation transmembrane transporter activity,MF,KCNJ15;SLC13A5;SHROOM2;PKD2;SCN4B;KCNC4;ORAI3;ATP6V0A2;ATP12A;SLC2A9;TRPV4;PQLC2;NDUFA4L2;NIPAL4;SLC5A1;COX5B;SLC39A6;SLC1A4;SLC13A3;ASIC1;TCIRG1;SLC47A1
6610,GO:0022890,0.00723375907969265,0.996564557515736,20,268,inorganic cation transmembrane transporter activity,MF,KCNJ15;SLC13A5;SHROOM2;PKD2;SCN4B;KCNC4;ORAI3;ATP6V0A2;ATP12A;SLC2A9;TRPV4;NDUFA4L2;NIPAL4;SLC5A1;COX5B;SLC39A6;SLC13A3;ASIC1;TCIRG1;SLC47A1
3374,GO:0007167,0.0073375465127045,0.995547765032036,42,691,enzyme linked receptor protein signaling pathway,BP,MVB12B;NDN;EPHB2;HTRA1;GIGYF1;EGFR;CYBA;FGFR4;SFRP1;INSR;VAV3;RGMA;DNM1;VEGFB;WWTR1;RHBDF1;FOXO1;DAB2IP;SHC2;FAM20C;EPHA4;RPS6KA5;LTBP1;ERBB3;ATP6V0A2;SREBF1;CSPG4;PIK3R1;TMEM204;NCK2;ACVR1B;EFNB3;SPRY2;ITGB5;LTBP4;NEO1;IGFBP4;ERBB2;FURIN;SMURF1;TCIRG1;SORT1
4456,GO:0010469,0.00735308485704986,0.996834086769648,16,204,regulation of signaling receptor activity,BP,GPNMB;EPHB2;NLGN2;CKLF;TNFSF10;CXCL14;VEGFB;WNT3;WNT9A;PTHLH;NCK2;UCN2;CLEC11A;ZP3;MDK;THNSL2
505,GO:0001568,0.00744311506085293,0.995936821897668,29,432,blood vessel development,BP,TNFAIP3;TGFBI;APOE;GPNMB;ADGRB2;EPHB2;FGFR4;SFRP1;VAV3;PKD2;VEGFB;FOXO1;RASIP1;DAB2IP;TBX1;LTBP1;PLCD3;ACTA2;PLXND1;CSPG4;NFATC4;HYAL1;SPRY2;ERBB2;STAT1;ACKR3;PLCD1;MAP3K3;SP100
12236,GO:0048568,0.00745345169842767,0.996450457631771,20,267,embryonic organ development,BP,ALDH1A3;EPHB2;SLITRK6;EGFR;GLI2;PKD2;ZFPM1;TBX1;WNT9A;LRIG3;PLCD3;GJB5;HYAL1;SPRY2;NAGLU;TULP3;PLCD1;MDFI;NRK;VANGL2
4814,GO:0014037,0.00747242003964607,0.998700679123733,5,30,Schwann cell differentiation,BP,POU3F1;ERBB3;NAB2;NDRG1;LAMB2
6917,GO:0030545,0.0075027601208751,0.996974090101528,14,170,receptor regulator activity,MF,GPNMB;CKLF;TNFSF10;CXCL14;VEGFB;WNT3;LY6E;WNT9A;PTHLH;UCN2;CLEC11A;ZP3;MDK;THNSL2
16803,GO:0098754,0.0075154291333511,0.99790011508574,8,74,detoxification,BP,APOE;TXNRD3;GPX7;GPX3;FAM213A;TXNDC17;TP53INP1;MT2A
19419,GO:1990138,0.00752888727293904,0.99736573259915,11,112,neuron projection extension,BP,POSTN;APOE;ULK2;PTPRS;NDN;WNT3;EPHA4;IMPACT;LAMB2;PLXNB1;SMURF1
6447,GO:0021795,0.00753983300062566,0.998686087541997,5,30,cerebral cortex cell migration,BP,EGFR;DAB2IP;DIXDC1;MBOAT7;SUN1
12232,GO:0048562,0.00774466678679627,0.996868763316337,14,163,embryonic organ morphogenesis,BP,ALDH1A3;EPHB2;SLITRK6;GLI2;PKD2;TBX1;WNT9A;LRIG3;HYAL1;SPRY2;NAGLU;TULP3;MDFI;VANGL2
1224,GO:0002922,0.00782241092065944,0.999803305912176,2,4,positive regulation of humoral immune response,BP,KLK5;ZP3
4835,GO:0014065,0.00786910810495839,0.997581533854497,9,84,phosphatidylinositol 3-kinase signaling,BP,EGFR;SERPINE2;DAB2IP;F2R;ERBB3;PIK3R1;TYRO3;ERBB2;PLXNB1
12033,GO:0048018,0.00799696381485942,0.996877156566487,13,154,receptor ligand activity,MF,GPNMB;CKLF;TNFSF10;CXCL14;VEGFB;WNT3;WNT9A;PTHLH;UCN2;CLEC11A;ZP3;MDK;THNSL2
5040,GO:0015267,0.00800759846656371,0.996748934525753,14,164,channel activity,MF,KCNJ15;SHROOM2;ANO9;PKD2;SCN4B;KCNC4;ANO8;ORAI3;LRRC8E;TRPV4;CLCN7;GJC2;SLC1A4;ASIC1
6587,GO:0022803,0.00800759846656371,0.996748934525753,14,164,passive transmembrane transporter activity,MF,KCNJ15;SHROOM2;ANO9;PKD2;SCN4B;KCNC4;ANO8;ORAI3;LRRC8E;TRPV4;CLCN7;GJC2;SLC1A4;ASIC1
8635,GO:0034220,0.00812459413423882,0.995235792941464,36,579,ion transmembrane transport,BP,KCNJ15;CPT2;EPHB2;SLC13A5;SHROOM2;CYBA;NLGN2;ANO9;PKD2;SCN4B;KCNC4;ANO8;F2R;ORAI3;S100A6;SLC38A4;ATP6V0A2;ATP12A;STOM;VAMP2;LRRC8E;SLC2A9;TRPV4;PQLC2;NDUFA4L2;NIPAL4;COX5B;SLC39A6;CLCN7;GJC2;SLC1A4;SLC13A3;ASIC1;TCIRG1;SLC47A1;ABCC1
12857,GO:0051239,0.00820672817511092,0.994142660394784,94,1818,regulation of multicellular organismal process,BP,TNFAIP3;POSTN;IFITM1;APOE;ULK2;PTPRS;OBSL1;GPNMB;ADGRB2;EPHB2;ASH2L;PRICKLE2;SLITRK6;GAMT;ADGRL1;EGFR;THRA;CYBA;OAS2;GLI2;NLGN2;BCL6;SFRP1;INSR;GAA;ZFPM1;RGMA;ETV5;SERPINE2;VEGFB;WWTR1;FOXO1;WNT3;DAB2IP;TBX1;SCN4B;FAM20C;FAM213A;EPHA4;WNT9A;DIXDC1;TENM4;F2R;CTSV;RPS6KA5;ARHGEF19;DDX60;ERBB3;SPOCK1;PLXND1;SREBF1;DMTN;PIK3R1;PTHLH;CTSL;ACVR1B;KCTD11;NFATC4;FAM210B;HYAL1;ZP3;EFNB3;SPRY2;TRPV4;GPC4;KLK8;ADORA2B;SERPING1;MYL9;RTN4RL1;MC1R;IMPACT;CRTC1;GPR68;ERBB2;RNF135;STAT1;TULP3;FURIN;IFI16;IL20RB;CCDC88B;GJC2;PER3;PLXNB1;SMURF1;KREMEN1;CAMK1;VPS33B;MAP3K3;ZSWIM8;SP100;NRK;VANGL2
7314,GO:0031344,0.00822840280044292,0.995472770068189,29,436,regulation of cell projection organization,BP,APOE;ULK2;PTPRS;OBSL1;EPHB2;TENM2;SFRP1;ESPN;RGMA;WNT3;DAB2IP;EVI5L;EPHA4;EPS8L2;SPOCK1;PLXND1;DMTN;NFATC4;EFNB3;SPRY2;TRPV4;KLK8;RTN4RL1;CRTC1;ARPIN;PLXNB1;SMURF1;CAMK1;ZSWIM8
14681,GO:0070372,0.00832021818026261,0.99660525966105,14,166,regulation of ERK1 and ERK2 cascade,BP,GPNMB;EPHB2;EGFR;FGFR4;INSR;DAB2IP;EPHA4;F2R;ERBB3;TYRO3;SPRY2;TRPV4;ERBB2;ACKR3
8707,GO:0034382,0.00839321839932725,0.999781007739779,2,4,chylomicron remnant clearance,BP,APOE;LMF1
15441,GO:0071830,0.00839321839932725,0.999781007739779,2,4,triglyceride-rich lipoprotein particle clearance,BP,APOE;LMF1
12729,GO:0051044,0.00863349550882551,0.999290994114571,3,11,positive regulation of membrane protein ectodomain proteolysis,BP,APOE;SNX33;FURIN
14954,GO:0070914,0.0086965512179342,0.999283896867021,3,11,UV-damage excision repair,BP,DDB2;XPC;MC1R
9006,GO:0035249,0.00871580775961382,0.998421061319727,5,31,synaptic transmission, glutamatergic,BP,EGFR;NLGN2;SERPINE2;GLUL;SLC1A4
3557,GO:0007617,0.00871787740938728,0.999281492069966,3,11,mating behavior,BP,THRA;SERPINE2;HEXB
6729,GO:0030168,0.00889427926540024,0.996997362626773,10,102,platelet activation,BP,APOE;VAV3;SERPINE2;F2R;DMTN;PIK3R1;TYRO3;MYL9;BLOC1S4;VPS33B
9759,GO:0040008,0.00899063269375655,0.9950177593167,29,445,regulation of growth,BP,APOE;ULK2;PTPRS;NDN;HTRA1;GAMT;EGFR;CYBA;EPB41L3;BCL6;SFRP1;INSR;SERPINE2;WNT3;DAB2IP;YEATS4;EPHA4;KIF26A;SPOCK1;ACVR1B;KCTD11;HYAL1;ZP3;LTBP4;IGFBP4;ERBB2;SMURF1;MT2A;NRK
510,GO:0001574,0.00899764213359245,0.999756497367279,2,4,ganglioside biosynthetic process,BP,ST3GAL5;ST6GALNAC6
4985,GO:0015145,0.00903445983518172,0.999245532730729,3,11,monosaccharide transmembrane transporter activity,MF,SLC2A1;SLC2A9;SLC5A1
3369,GO:0007162,0.00903690803926476,0.996275437924011,14,167,negative regulation of cell adhesion,BP,POSTN;TGFBI;GPNMB;BCL6;SERPINE2;ERBB3;SPOCK1;PLXND1;DMTN;PIK3R1;TRPV4;ERBB2;IL20RB;PLXNB1
9413,GO:0036021,0.00906752771478887,0.999753604985762,2,4,endolysosome lumen,CC,CTSB;CTSL
15256,GO:0071482,0.00910258660632297,0.997131607165179,9,87,cellular response to light stimulus,BP,DDB2;PIK3R1;XPC;NFATC4;HYAL1;TP53INP1;MC1R;IMPACT;CRY2
13234,GO:0051962,0.00910846069747578,0.995332152266548,23,325,positive regulation of nervous system development,BP,APOE;OBSL1;ADGRB2;EPHB2;SLITRK6;ADGRL1;GLI2;NLGN2;BCL6;ETV5;SERPINE2;WNT3;DAB2IP;EPHA4;TENM4;PLXND1;KCTD11;IMPACT;CRTC1;GJC2;PLXNB1;SMURF1;CAMK1
5505,GO:0016494,0.00911111814049919,0.999751794831831,2,4,C-X-C chemokine receptor activity,MF,CXCR1;ACKR3
6295,GO:0019958,0.00925097741256642,0.999745955668903,2,4,C-X-C chemokine binding,MF,CXCR1;ACKR3
10776,GO:0044297,0.00925325563460554,0.995327579456709,22,312,cell body,CC,APOE;PTPRS;NDN;EPHB2;CYBA;INSR;SV2A;DAB2IP;KCNC4;NRSN2;GLUL;EPHA4;CTSV;HOMER2;ACTA2;ENDOG;RTN4RL1;CRTC1;GJC2;SLC1A4;SMURF1;SORT1
2654,GO:0006021,0.00926070343231027,0.999745547834866,2,4,inositol biosynthetic process,BP,IMPA2;ISYNA1
18417,GO:1903546,0.00928103112893149,0.999744694707184,2,4,protein localization to photoreceptor outer segment,BP,TUB;TULP3
2156,GO:0005003,0.00931235841550787,0.99921357000312,3,11,ephrin receptor activity,MF,EPHB2;EPHA4;EFNB3
2158,GO:0005005,0.00931235841550787,0.99921357000312,3,11,transmembrane-ephrin receptor activity,MF,EPHB2;EPHA4;EFNB3
10299,GO:0043125,0.00932866320356539,0.999742691726016,2,4,ErbB-3 class receptor binding,MF,PIK3R1;ERBB2
4338,GO:0009950,0.00941585602051544,0.999201572579136,3,11,dorsal/ventral axis specification,BP,SFRP1;WNT3;MDFI
6395,GO:0021675,0.00953379649172554,0.997848399390801,6,44,nerve development,BP,EPHB2;SLITRK6;SERPINE2;TBX1;CTSV;ERBB3
2260,GO:0005216,0.00958826922007741,0.996172473403068,13,150,ion channel activity,MF,KCNJ15;SHROOM2;ANO9;PKD2;SCN4B;KCNC4;ANO8;ORAI3;LRRC8E;TRPV4;CLCN7;SLC1A4;ASIC1
12555,GO:0050771,0.00963949460667245,0.997819380650513,6,44,negative regulation of axonogenesis,BP,ULK2;PTPRS;EPHB2;WNT3;EPHA4;EFNB3
4486,GO:0010543,0.00964211942353328,0.998651397202699,4,21,regulation of platelet activation,BP,APOE;SERPINE2;DMTN;VPS33B
3190,GO:0006842,0.00965457569923104,0.999728840072508,2,4,tricarboxylic acid transport,BP,SLC13A5;SLC13A3
4979,GO:0015137,0.00965457569923104,0.999728840072508,2,4,citrate transmembrane transporter activity,MF,SLC13A5;SLC13A3
4982,GO:0015142,0.00965457569923104,0.999728840072508,2,4,tricarboxylic acid transmembrane transporter activity,MF,SLC13A5;SLC13A3
5165,GO:0015746,0.00965457569923104,0.999728840072508,2,4,citrate transport,BP,SLC13A5;SLC13A3
12648,GO:0050905,0.00965767949378456,0.997814380843919,6,44,neuromuscular process,BP,ALDH1A3;SLITRK6;NLGN2;GAA;HEXB;BLOC1S4
16865,GO:0098869,0.00970143136294692,0.997453619993948,7,62,cellular oxidant detoxification,BP,APOE;TXNRD3;GPX7;GPX3;FAM213A;TXNDC17;TP53INP1
12030,GO:0048015,0.00972940531198671,0.996670870686059,10,102,phosphatidylinositol-mediated signaling,BP,EGFR;SERPINE2;DAB2IP;F2R;ERBB3;PIK3R1;TYRO3;ZP3;ERBB2;PLXNB1
11248,GO:0045595,0.00973705372799401,0.993438675364169,63,1150,regulation of cell differentiation,BP,POSTN;IFITM1;APOE;ULK2;PTPRS;OBSL1;EPHB2;ASH2L;EGFR;THRA;GLI2;BCL6;SFRP1;ZFPM1;RGMA;CXCL14;ETV5;SERPINE2;WWTR1;FOXO1;WNT3;BOC;DAB2IP;TBX1;FAM20C;FAM213A;EPHA4;WNT9A;DIXDC1;TENM4;OLFM2;TCFL5;CTSV;SPOCK1;PLXND1;DMTN;PIK3R1;PTHLH;CTSL;ACVR1B;KCTD11;NFATC4;FAM210B;EFNB3;SPRY2;TP53INP1;TRPV4;KLK8;LTBP4;MYL9;RTN4RL1;IMPACT;CRTC1;GPR68;ERBB2;STAT1;GJC2;PLXNB1;SMURF1;CCDC3;CAMK1;ZSWIM8;SORT1
12949,GO:0051393,0.00974609966184581,0.999162956126273,3,11,alpha-actinin binding,MF,OBSL1;PKD2;PDLIM4
1637,GO:0004095,0.00978136329340339,0.999723382818895,2,4,carnitine O-palmitoyltransferase activity,MF,CPT2;CPT1C
5463,GO:0016416,0.00978136329340339,0.999723382818895,2,4,O-palmitoyltransferase activity,MF,CPT2;CPT1C
6741,GO:0030193,0.0100050414193896,0.997710977564951,6,46,regulation of blood coagulation,BP,APOE;SERPINE2;F2R;DMTN;SERPING1;VPS33B
17315,GO:1900046,0.0100050414193896,0.997710977564951,6,46,regulation of hemostasis,BP,APOE;SERPINE2;F2R;DMTN;SERPING1;VPS33B
5836,GO:0017153,0.0100501952518482,0.99971168577594,2,4,sodium:dicarboxylate symporter activity,MF,SLC13A5;SLC13A3
8600,GO:0034144,0.0101229675552289,0.999708490189697,2,4,negative regulation of toll-like receptor 4 signaling pathway,BP,TNFAIP3;DAB2IP
12025,GO:0048010,0.0101360823905941,0.997018618150914,8,73,vascular endothelial growth factor receptor signaling pathway,BP,CYBA;VAV3;VEGFB;DAB2IP;SHC2;PIK3R1;TMEM204;NCK2
6451,GO:0021799,0.0101936445787185,0.998550820925116,4,21,cerebral cortex radially oriented cell migration,BP,DAB2IP;DIXDC1;MBOAT7;SUN1
12179,GO:0048406,0.0103551828071783,0.999698210549944,2,4,nerve growth factor binding,MF,FURIN;SORT1
2250,GO:0005178,0.0104335604610546,0.996915460617075,8,73,integrin binding,MF,ITGB6;TGFBI;GPNMB;EGFR;TNXB;LTBP4;LAMB2;NISCH
10551,GO:0043548,0.0105080013171603,0.998492743027504,4,21,phosphatidylinositol 3-kinase binding,MF,INSR;DAB2IP;PIK3R1;TYRO3
16821,GO:0098793,0.0106158306629587,0.995238368802612,16,207,presynapse,CC,PTPRS;ADGRL1;NLGN2;BRSK1;SV2A;DNM1;RIMS3;SYT8;KCNC4;RAB40B;GLUL;EPHA4;SYTL1;VAMP2;C2CD4C;APBA1
1418,GO:0003402,0.0106895743653342,0.999683188811359,2,4,planar cell polarity pathway involved in axis elongation,BP,SFRP1;VANGL2
13492,GO:0055114,0.0106968632816986,0.993387255609955,41,714,oxidation-reduction process,BP,ALDH1A3;CPT2;KDSR;TXNRD3;GPX7;GPX3;CRAT;CYBA;PGM1;CYP4F22;DHRS4L2;DHTKD1;INSR;CYBRD1;GAA;HR;PDPR;PPP1R3E;H6PD;SDR9C7;TET1;CYP27C1;FAM213A;TYSND1;TXNDC17;RDH12;NFATC4;CPT1C;TMX4;MTHFR;MSRB2;RETSAT;NDUFA4L2;SDHA;ALDH2;AMACR;HSD11B1;COX5B;MLYCD;ALOXE3;CBR3
3175,GO:0006814,0.0107433477631192,0.996038953654479,11,119,sodium ion transport,BP,SLC13A5;SHROOM2;PKD2;SERPINE2;SCN4B;SLC38A4;ATP12A;STOM;SLC5A1;SLC13A3;ASIC1
5260,GO:0015929,0.0107981442374037,0.999016979765594,3,12,hexosaminidase activity,MF,HEXB;HYAL1;NAGLU
12283,GO:0048670,0.0108064762154559,0.999015939442711,3,12,regulation of collateral sprouting,BP,ULK2;PTPRS;WNT3
3887,GO:0008544,0.0108290825477237,0.994755704838086,19,264,epidermis development,BP,PRR9;SLITRK6;EGFR;APCDD1;POU3F1;INSR;COL7A1;KLK5;CTSV;PPL;GJB5;PTHLH;CTSL;ACVR1B;NAB2;TNFRSF19;KLK8;FURIN;VANGL2
11252,GO:0045599,0.0108530155058767,0.997912113310004,5,33,negative regulation of fat cell differentiation,BP,ZFPM1;WWTR1;FOXO1;TRPV4;SORT1
1686,GO:0004175,0.0109091292413992,0.994955081807758,17,228,endopeptidase activity,MF,HTRA1;ADAM19;SFRP1;CTSB;RHBDF1;PRSS3;KLK5;TYSND1;CTSV;CTSL;ADAMTS15;KLK8;FURIN;PCSK1;CTSF;MMP1;CAPNS2
7769,GO:0032331,0.0110927286095296,0.998980012816228,3,12,negative regulation of chondrocyte differentiation,BP,GLI2;WNT9A;PTHLH
6596,GO:0022838,0.011093897749135,0.995485554850379,13,153,substrate-specific channel activity,MF,KCNJ15;SHROOM2;ANO9;PKD2;SCN4B;KCNC4;ANO8;ORAI3;LRRC8E;TRPV4;CLCN7;SLC1A4;ASIC1
16075,GO:0090102,0.0117004054941379,0.998257128248406,4,22,cochlea development,BP,SLITRK6;GLI2;TBX1;VANGL2
12032,GO:0048017,0.0118204791516564,0.995829280371388,10,105,inositol lipid-mediated signaling,BP,EGFR;SERPINE2;DAB2IP;F2R;ERBB3;PIK3R1;TYRO3;ZP3;ERBB2;PLXNB1
17212,GO:0120035,0.0118376769283904,0.993367821496886,28,429,regulation of plasma membrane bounded cell projection organization,BP,APOE;ULK2;PTPRS;OBSL1;EPHB2;TENM2;SFRP1;ESPN;RGMA;WNT3;DAB2IP;EVI5L;EPHA4;EPS8L2;SPOCK1;PLXND1;DMTN;NFATC4;EFNB3;TRPV4;KLK8;RTN4RL1;CRTC1;ARPIN;PLXNB1;SMURF1;CAMK1;ZSWIM8
16076,GO:0090103,0.0118452775391309,0.998883873814526,3,12,cochlea morphogenesis,BP,GLI2;TBX1;VANGL2
12707,GO:0051015,0.01185971682558,0.995562438604483,11,121,actin filament binding,MF,TAGLN;OBSL1;FLNC;SHROOM2;EGFR;ESPN;WIPF1;CORO6;DMTN;TRPV4;AIF1L
13237,GO:0051965,0.011893811104113,0.997659228462662,5,33,positive regulation of synapse assembly,BP,ADGRB2;EPHB2;SLITRK6;ADGRL1;NLGN2
11869,GO:0046934,0.0120026071341331,0.997632450926941,5,33,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,EGFR;FGFR4;ERBB3;PIK3R1;ERBB2
8585,GO:0034122,0.0121993712494671,0.998160231387887,4,22,negative regulation of toll-like receptor signaling pathway,BP,TNFAIP3;PTPRS;DAB2IP;TYRO3
8776,GO:0034505,0.012331932575278,0.998820432055939,3,12,tooth mineralization,BP,FOXO1;TBX1;FAM20C
9035,GO:0035295,0.0123532857607569,0.992387766372083,39,648,tube development,BP,TNFAIP3;TGFBI;APOE;GPNMB;ADGRB2;EPHB2;EGFR;THRA;GLI2;FGFR4;SFRP1;VAV3;PKD2;ETV5;SERPINE2;SALL2;VEGFB;WWTR1;RASIP1;DAB2IP;TBX1;EPHA4;KIF26B;PLCD3;PLXND1;SREBF1;CSPG4;NFATC4;HYAL1;SPRY2;ERBB2;HSD11B1;STAT1;TULP3;ACKR3;PLCD1;MAP3K3;SP100;VANGL2
3111,GO:0006706,0.0126727197185551,0.998755156503555,3,13,steroid catabolic process,BP,APOE;TRERF1;HSD11B1
6975,GO:0030676,0.0127912348634086,0.998759664269134,3,12,Rac guanyl-nucleotide exchange factor activity,MF,ARHGEF4;VAV3;EPS8L2
6798,GO:0030276,0.0127923211822429,0.996908285216227,6,47,clathrin binding,MF,LDLRAP1;SYT8;NSG1;SYTL1;TOM1L2;C2CD4C
15252,GO:0071478,0.0127950313513939,0.994912093498401,12,141,cellular response to radiation,BP,CYBA;SFRP1;DDB2;PIK3R1;XPC;NFATC4;HYAL1;TP53INP1;MC1R;IMPACT;CRY2;IFI16
1954,GO:0004675,0.0128227819911527,0.998755459118199,3,12,transmembrane receptor protein serine/threonine kinase activity,MF,LTBP1;ACVR1B;LTBP4
3588,GO:0008038,0.0128352083203408,0.998034979628805,4,22,neuron recognition,BP,NDN;EPHB2;EPHA4;EFNB3
6550,GO:0022029,0.0128752935398581,0.997408451296984,5,34,telencephalon cell migration,BP,EGFR;DAB2IP;DIXDC1;MBOAT7;SUN1
6597,GO:0022839,0.012991139708917,0.995346004609771,10,107,ion gated channel activity,MF,KCNJ15;SHROOM2;ANO9;PKD2;SCN4B;KCNC4;ANO8;TRPV4;CLCN7;ASIC1
6650,GO:0030029,0.0130995110007128,0.992304830576797,32,511,actin filament-based process,BP,OBSL1;SHROOM2;EPB41L3;BCL6;SFRP1;FHOD3;ESPN;TNXB;PARVB;OBSCN;SCN4B;WIPF1;CORO6;DIXDC1;CTSV;ARHGEF19;EPS8L2;FRY;DMTN;PIK3R1;IQSEC1;NCK2;ARHGAP40;RHOD;PLEKHH2;TRPV4;MSRB2;ITGB5;PDLIM4;ARPIN;NISCH;VANGL2
6703,GO:0030133,0.0131258990000821,0.993654659720609,18,250,transport vesicle,CC,PTPRS;FGFR4;BRSK1;SV2A;DNM1;LDLRAP1;SYT8;RAB40B;NRSN2;VAMP3;SREBF1;SYTL1;VAMP2;C2CD4C;FURIN;PCSK1;SORT1;APBA1
12591,GO:0050818,0.0133701271857482,0.996728094106293,6,49,regulation of coagulation,BP,APOE;SERPINE2;F2R;DMTN;SERPING1;VPS33B
1081,GO:0002676,0.0134500262822371,0.99947912129985,2,5,regulation of chronic inflammatory response,BP,TNFAIP3;ADORA2B
19569,GO:1990748,0.0134801796866874,0.99621551098045,7,66,cellular detoxification,BP,APOE;TXNRD3;GPX7;GPX3;FAM213A;TXNDC17;TP53INP1
8007,GO:0032673,0.0135059029884436,0.998641355053664,3,13,regulation of interleukin-4 production,BP,ZFPM1;ZP3;IL20RB
501,GO:0001558,0.0135700536151743,0.993139281838925,20,286,regulation of cell growth,BP,APOE;ULK2;PTPRS;HTRA1;EGFR;CYBA;EPB41L3;BCL6;SFRP1;SERPINE2;WNT3;EPHA4;KIF26A;SPOCK1;ACVR1B;HYAL1;LTBP4;IGFBP4;ERBB2;SMURF1
11446,GO:0045940,0.0136660014841372,0.998619170277473,3,13,positive regulation of steroid metabolic process,BP,APOE;LDLRAP1;SREBF1
4768,GO:0010975,0.0136719413051953,0.992838995966689,22,318,regulation of neuron projection development,BP,APOE;ULK2;PTPRS;OBSL1;EPHB2;SFRP1;RGMA;WNT3;DAB2IP;EPHA4;SPOCK1;PLXND1;NFATC4;EFNB3;TRPV4;KLK8;RTN4RL1;CRTC1;PLXNB1;SMURF1;CAMK1;ZSWIM8
6595,GO:0022836,0.0138044798842695,0.995006371983241,10,108,gated channel activity,MF,KCNJ15;SHROOM2;ANO9;PKD2;SCN4B;KCNC4;ANO8;TRPV4;CLCN7;ASIC1
8660,GO:0034308,0.0138820829839513,0.997138712893832,5,36,primary alcohol metabolic process,BP,ALDH1A3;CYP27C1;RDH12;RETSAT;ALDH2
3187,GO:0006836,0.0139249202595326,0.994661523770027,11,125,neurotransmitter transport,BP,BRSK1;SV2A;RIMS3;SYT8;KCNC4;GLUL;SYTL1;VAMP2;C2CD4C;ASIC1;APBA1
3921,GO:0008625,0.0139519733902861,0.996062860865458,7,64,extrinsic apoptotic signaling pathway via death domain receptors,BP,TNFAIP3;SFRP1;TNFSF10;DAB2IP;PIK3R1;SP100;SORT1
12243,GO:0048589,0.0140655573764301,0.992187876743913,26,394,developmental growth,BP,POSTN;APOE;ULK2;PTPRS;NDN;NINJ1;SLITRK6;GAMT;GLI2;SFRP1;INSR;WWTR1;WNT3;EPHA4;TENM4;KIF26B;RTF1;ZP3;SPRY2;IMPACT;LAMB2;PLXNB1;SMURF1;NRK;VANGL2;APBA1
12731,GO:0051046,0.0142302281022858,0.99199174173043,27,423,regulation of secretion,BP,POSTN;EGFR;CYBA;OAS2;NLGN2;SFRP1;SV2A;RIMS3;SYT8;RHBDF1;KCNC4;RAB40B;GLUL;F2R;ERBB3;VAMP3;SREBF1;SYTL1;SLC2A1;ZP3;VAMP2;SCG5;TRPV4;ADORA2B;GPR68;C2CD4C;ASIC1
16119,GO:0090181,0.0142969433160504,0.996449415742819,6,49,regulation of cholesterol metabolic process,BP,APOE;LMF1;LDLRAP1;SEC14L2;SREBF1;MVD
8998,GO:0035239,0.0143084927378139,0.991466065802844,33,533,tube morphogenesis,BP,TNFAIP3;TGFBI;APOE;GPNMB;ADGRB2;EPHB2;EGFR;GLI2;FGFR4;SFRP1;VAV3;PKD2;ETV5;VEGFB;RASIP1;DAB2IP;TBX1;EPHA4;KIF26B;PLCD3;PLXND1;CSPG4;NFATC4;HYAL1;SPRY2;ERBB2;STAT1;TULP3;ACKR3;PLCD1;MAP3K3;SP100;VANGL2
6553,GO:0022038,0.0143384782457677,0.998524892797434,3,13,corpus callosum development,BP,PTPRS;EPHB2;RTN4RL1
6285,GO:0019932,0.014387481626424,0.993936884993414,13,160,second-messenger-mediated signaling,BP,APOE;ADGRB2;ADGRL1;EGFR;PKD2;HOMER2;ERBB3;DMTN;PTHLH;UCN2;NFATC4;ADORA2B;MC1R
16300,GO:0090596,0.0144057369095912,0.994177823184817,12,141,sensory organ morphogenesis,BP,ALDH1A3;EPHB2;SLITRK6;SHROOM2;GLI2;SDK2;TBX1;WNT9A;LRIG3;SPRY2;NAGLU;VANGL2
105,GO:0000220,0.0144155331336551,0.999420806671808,2,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,ATP6V0A2;TCIRG1
3112,GO:0006707,0.0144385983654236,0.999419386934213,2,5,cholesterol catabolic process,BP,APOE;TRERF1
5337,GO:0016127,0.0144385983654236,0.999419386934213,2,5,sterol catabolic process,BP,APOE;TRERF1
12078,GO:0048167,0.0146281121523455,0.995003825960461,9,93,regulation of synaptic plasticity,BP,APOE;EPHB2;RIMS3;SERPINE2;NSG1;EPHA4;NFATC4;VAMP2;CRTC1
10335,GO:0043184,0.0147471073691576,0.999400279192237,2,5,vascular endothelial growth factor receptor 2 binding,MF,VEGFB;DAB2IP
8093,GO:0032803,0.0147640740086946,0.999399221998924,2,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE;FURIN
14688,GO:0070382,0.0147693473091857,0.994593919046132,10,112,exocytic vesicle,CC,PTPRS;BRSK1;SV2A;DNM1;SYT8;RAB40B;SYTL1;VAMP2;C2CD4C;APBA1
3376,GO:0007169,0.0148646813758358,0.991258495095426,31,499,transmembrane receptor protein tyrosine kinase signaling pathway,BP,MVB12B;NDN;EPHB2;GIGYF1;EGFR;CYBA;FGFR4;INSR;VAV3;DNM1;VEGFB;RHBDF1;FOXO1;DAB2IP;SHC2;FAM20C;EPHA4;RPS6KA5;ERBB3;ATP6V0A2;SREBF1;CSPG4;PIK3R1;TMEM204;NCK2;EFNB3;SPRY2;IGFBP4;ERBB2;TCIRG1;SORT1
7346,GO:0031410,0.0149105276529943,0.98928172536951,82,1601,cytoplasmic vesicle,CC,APOE;MVB12B;LAMP3;ULK2;PTPRS;GPNMB;GPRC5C;EGFR;CYBA;FGFR4;PGM1;BRSK1;INSR;GAA;SV2A;PKD2;DNM1;LDLRAP1;CTSB;SYT8;SERPINE2;TP53INP2;VEGFB;WNT3;NSG1;DAB2IP;COL7A1;PRSS3;KLK5;WIPF1;RAB40B;NRSN2;EPHA4;F2R;HERC3;CTSV;LRIG3;HEXB;HGSNAT;ATP6V0A2;VAMP3;SREBF1;DMTN;APPL2;CTSL;SYTL1;SNX33;RHOD;CXCR1;SLC2A1;METTL7A;HYAL1;STOM;VAMP2;AVL9;SCG5;TP53INP1;TRPV4;ITGB5;NDRG1;KLK8;SERPING1;PDLIM4;TBC1D17;ANKRD13D;MICALL1;ERBB2;C2CD4C;ACKR3;FURIN;CLCN7;PCSK1;SUN1;SLC1A4;TCIRG1;NISCH;RAB43;VPS33B;IDUA;SORT1;VANGL2;APBA1
10586,GO:0043615,0.0149676686450989,0.999386484599393,2,5,astrocyte cell migration,BP,APCDD1;HEXB
6653,GO:0030032,0.0151278990559463,0.996195962074543,6,49,lamellipodium assembly,BP,ARHGEF4;VAV3;PARVB;DMTN;NCK2;RHOD
2365,GO:0005509,0.0152098813252927,0.991708622810798,24,362,calcium ion binding,MF,SMOC2;S100A4;CALML3;TENM2;MATN2;PKD2;SYT8;PRSS3;FKBP9;FAM20C;LTBP1;S100A6;SPOCK1;CGREF1;SYTL1;CABYR;LTBP4;MYL9;C2CD4C;PCDH1;PLCD1;NINL;CAPNS2;AIF1L
14658,GO:0070324,0.0152292751654284,0.999369979159702,2,5,thyroid hormone binding,MF,ALDH1A3;THRA
16087,GO:0090129,0.0152468771065186,0.999368863031909,2,5,positive regulation of synapse maturation,BP,ADGRL1;DAB2IP
17518,GO:1901136,0.0152802564627061,0.994054372089094,11,130,carbohydrate derivative catabolic process,BP,FBXO2;NT5E;SGSH;HEXB;HGSNAT;CSPG4;SDC3;HYAL1;GPC4;NAGLU;IDUA
18883,GO:1904659,0.0153440487237305,0.995591639266985,7,63,glucose transmembrane transport,BP,INSR;RTN2;PIK3R1;SLC2A1;SLC2A9;SLC5A1;SORT1
16674,GO:0097708,0.0153764043675876,0.988930642008427,82,1603,intracellular vesicle,CC,APOE;MVB12B;LAMP3;ULK2;PTPRS;GPNMB;GPRC5C;EGFR;CYBA;FGFR4;PGM1;BRSK1;INSR;GAA;SV2A;PKD2;DNM1;LDLRAP1;CTSB;SYT8;SERPINE2;TP53INP2;VEGFB;WNT3;NSG1;DAB2IP;COL7A1;PRSS3;KLK5;WIPF1;RAB40B;NRSN2;EPHA4;F2R;HERC3;CTSV;LRIG3;HEXB;HGSNAT;ATP6V0A2;VAMP3;SREBF1;DMTN;APPL2;CTSL;SYTL1;SNX33;RHOD;CXCR1;SLC2A1;METTL7A;HYAL1;STOM;VAMP2;AVL9;SCG5;TP53INP1;TRPV4;ITGB5;NDRG1;KLK8;SERPING1;PDLIM4;TBC1D17;ANKRD13D;MICALL1;ERBB2;C2CD4C;ACKR3;FURIN;CLCN7;PCSK1;SUN1;SLC1A4;TCIRG1;NISCH;RAB43;VPS33B;IDUA;SORT1;VANGL2;APBA1
13378,GO:0052813,0.0153772906109959,0.99675542172281,5,35,phosphatidylinositol bisphosphate kinase activity,MF,EGFR;FGFR4;ERBB3;PIK3R1;ERBB2
12551,GO:0050767,0.0154300116122308,0.990900016821547,31,497,regulation of neurogenesis,BP,APOE;ULK2;PTPRS;OBSL1;EPHB2;GLI2;BCL6;SFRP1;RGMA;ETV5;SERPINE2;WNT3;DAB2IP;EPHA4;DIXDC1;TENM4;SPOCK1;PLXND1;KCTD11;NFATC4;EFNB3;TRPV4;KLK8;RTN4RL1;IMPACT;CRTC1;GJC2;PLXNB1;SMURF1;CAMK1;ZSWIM8
14680,GO:0070371,0.0155077174863279,0.99315665490298,14,179,ERK1 and ERK2 cascade,BP,GPNMB;EPHB2;EGFR;FGFR4;INSR;DAB2IP;EPHA4;F2R;ERBB3;TYRO3;SPRY2;TRPV4;ERBB2;ACKR3
1596,GO:0004030,0.0156258054563819,0.999344665975409,2,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,ALDH1A3;ALDH2
10811,GO:0044340,0.0157946486122201,0.999333780450276,2,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,SFRP1;WNT3
1061,GO:0002634,0.0158360367912748,0.999331102389972,2,5,regulation of germinal center formation,BP,TNFAIP3;BCL6
13240,GO:0051968,0.0159421140030535,0.998293167084961,3,13,positive regulation of synaptic transmission, glutamatergic,BP,EGFR;NLGN2;GLUL
11100,GO:0045178,0.0160374298868317,0.996571970376484,5,36,basal part of cell,CC,EGFR;PKD2;LDLRAP1;ERBB3;ERBB2
5432,GO:0016323,0.0161096082562926,0.99368944157327,11,126,basolateral plasma membrane,CC,EGFR;PKD2;LDLRAP1;ERBB3;ATP12A;SLC2A1;SLC2A9;CA11;ERBB2;ABCC1;VANGL2
11162,GO:0045309,0.01618708065146,0.996531830991889,5,36,protein phosphorylated amino acid binding,MF,LDLRAP1;SH3BP2;PIK3R1;NCK2;RTF1
17531,GO:1901184,0.0162628506835928,0.994772081356249,8,80,regulation of ERBB signaling pathway,BP,MVB12B;EGFR;RHBDF1;DAB2IP;ERBB3;NCK2;SPRY2;ERBB2
7471,GO:0031659,0.0163253715541403,0.999299151340371,2,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;PKD2
16583,GO:0097479,0.0163545858505144,0.994740218651424,8,79,synaptic vesicle localization,BP,NLGN2;DNM1;RIMS3;SYT8;SYTL1;VAMP2;C2CD4C;BLOC1S4
13238,GO:0051966,0.0163662054565681,0.997277949748294,4,24,regulation of synaptic transmission, glutamatergic,BP,EGFR;NLGN2;SERPINE2;GLUL
13524,GO:0060028,0.0165026706404566,0.999287444240399,2,5,convergent extension involved in axis elongation,BP,SFRP1;VANGL2
10860,GO:0044437,0.0167159521580947,0.990357517705475,28,451,vacuolar part,CC,LAMP3;COL6A1;CYBRD1;GAA;CTSB;NSG1;SGSH;CTSV;HEXB;HGSNAT;ATP6V0A2;CSPG4;SDC3;CTSL;HYAL1;STOM;PQLC2;GPC4;NAGLU;MARCH9;CLCN7;CTSF;TCIRG1;VPS33B;DIRC2;ABCC1;IDUA;SORT1
14474,GO:0065008,0.0167363557734334,0.987370155353181,116,2379,regulation of biological quality,BP,TNFAIP3;POSTN;APOE;ALDH1A3;IFI6;ULK2;PTPRS;NDN;ADGRB2;EPHB2;SLITRK6;TXNRD3;ADGRL1;EGFR;THRA;CYBA;OAS2;FGFR4;EPB41L3;NLGN2;BCL6;ANO9;BRSK1;SFRP1;FHOD3;INSR;VAV3;CYBRD1;GAA;SV2A;PKD2;ZFPM1;DNM1;LDLRAP1;RIMS3;ETV5;SYT8;SERPINE2;TP53INP2;FOXO1;WNT3;NSG1;PARVB;DAB2IP;TRERF1;SCN4B;CRTAP;WIPF1;KCNC4;CYP27C1;GLUL;EPHA4;F2R;TUB;HOMER2;HEXB;LTBP1;EPS8L2;ATP6V0A2;PLXND1;SREBF1;RDH12;DMTN;ENDOG;PIK3R1;NCK2;ACVR1B;SYTL1;ARHGAP40;NFATC4;ATP12A;FAM210B;TYRO3;RHOD;SLC2A1;VAMP2;PLEKHH2;PCBP4;SCG5;TMX4;TRPV4;PQLC2;RETSAT;KLK8;LTBP4;ADORA2B;SERPING1;MYL9;NEO1;CRTC1;GPR68;C2CD4C;HSD11B1;STAT1;CRY2;SLC39A6;BLOC1S4;FURIN;IL20RB;PCSK1;SUN1;PEX11B;ARPIN;ASIC1;PER3;PLXNB1;ALOXE3;CAMK1;TCIRG1;NISCH;MT2A;VPS33B;MDFI;SP100;ABCC1;APBA1
5301,GO:0016042,0.0167517977247631,0.992291989730595,15,202,lipid catabolic process,BP,APOE;CPT2;CRAT;THRA;CES2;TRERF1;TYSND1;HEXB;PLCD3;CPT1C;AMACR;IAH1;HSD11B1;PLCD1;MLYCD
10295,GO:0043121,0.0167929704169108,0.999268127123777,2,5,neurotrophin binding,MF,FURIN;SORT1
3493,GO:0007417,0.0171013129152126,0.989500795615786,35,585,central nervous system development,BP,ALDH1A3;PTPRS;NDN;EPHB2;SHROOM2;EGFR;THRA;GLI2;FGFR4;SFRP1;POU3F1;PKD2;SERPINE2;WNT3;SOX12;DAB2IP;TBX1;GAS8;EPHA4;DIXDC1;TENM4;SMARCA1;SPOCK1;ACVR1B;TYRO3;SLC2A1;MBOAT7;MDK;NAGLU;RTN4RL1;ERBB2;LAMB2;TULP3;SUN1;GJC2
11362,GO:0045785,0.0171070511493929,0.991680338869015,17,236,positive regulation of cell adhesion,BP,SMOC2;MAP3K14;NINJ1;GLI2;BCL6;SFRP1;VAV3;KIF26B;DMTN;PIK3R1;NCK2;RHOD;HYAL1;ZP3;EFNB3;ERBB2;CCDC88B
3731,GO:0008285,0.0171150206967446,0.990007483657722,29,470,negative regulation of cell proliferation,BP,TNFAIP3;IFITM1;APOE;GPNMB;NDN;FBXO2;BCL6;SFRP1;PKD2;SERPINE2;DAB2IP;GAS8;MNT;WNT9A;F2R;CTSV;CGREF1;PTHLH;NCK2;KCTD11;SPRY2;TP53INP1;NDRG1;ERBB2;STAT1;IL20RB;PLXNB1;NRK;TP53I11
10559,GO:0043559,0.0171400231246823,0.999244793078981,2,5,insulin binding,MF,INSR;PIK3R1
14115,GO:0061037,0.0171908839337108,0.998080490570336,3,14,negative regulation of cartilage development,BP,GLI2;WNT9A;PTHLH
4826,GO:0014051,0.0172398281650872,0.999238034498065,2,5,gamma-aminobutyric acid secretion,BP,SV2A;APBA1
12934,GO:0051371,0.017339796028113,0.999231243399675,2,5,muscle alpha-actinin binding,MF,OBSL1;PKD2
8584,GO:0034121,0.0174044670111817,0.996193389654566,5,37,regulation of toll-like receptor signaling pathway,BP,TNFAIP3;PTPRS;CYBA;DAB2IP;TYRO3
11099,GO:0045177,0.0175010833582754,0.991679633672043,16,216,apical part of cell,CC,SHROOM2;EGFR;CYBA;SLC29A4;CTSV;HOMER2;ERBB3;VAMP3;CSPG4;SLC2A1;SLC2A9;TRPV4;ERBB2;TCIRG1;REEP6;VANGL2
462,GO:0001501,0.0175598398457885,0.990725274239494,21,309,skeletal system development,BP,POSTN;TGFBI;THRA;GLI2;SFRP1;ZFPM1;TBX1;FAM20C;WNT9A;HEXB;PTHLH;NAB2;HYAL1;TRPV4;FBXW4;IGFBP4;GPR68;TULP3;PLXNB1;VPS33B;MDFI
16632,GO:0097581,0.0175607746481362,0.994808749709765,7,65,lamellipodium organization,BP,ARHGEF4;VAV3;PARVB;DMTN;NCK2;RHOD;ARPIN
17831,GO:1902106,0.0176814778653945,0.995385554133124,6,51,negative regulation of leukocyte differentiation,BP,BCL6;SFRP1;ZFPM1;PIK3R1;GPR68;ERBB2
1194,GO:0002861,0.0177877476836808,0.999132454847399,2,6,regulation of inflammatory response to antigenic stimulus,BP,ZP3;IL20RB
3746,GO:0008307,0.0178781595020872,0.996932808108875,4,25,structural constituent of muscle,MF,OBSL1;OBSCN;SYNM;MYL9
676,GO:0001890,0.0180432283942469,0.993181237208879,10,114,placenta development,BP,HTRA1;EGFR;PKD2;CTSB;CTSV;PLCD3;GJB5;PLCD1;MDFI;NRK
12774,GO:0051119,0.0180878130944859,0.997941081607702,3,14,sugar transmembrane transporter activity,MF,SLC2A1;SLC2A9;SLC5A1
13790,GO:0060429,0.0181927464811139,0.988108279194016,45,803,epithelium development,BP,TAGLN;ALDH1A3;PTPRS;PRICKLE2;PRR9;SLITRK6;TST;EGFR;THRA;GLI2;APCDD1;SFRP1;POU3F1;PKD2;CTSB;ETV5;SERPINE2;SALL2;WWTR1;WNT3;RASIP1;TMEM231;TBX1;KLK5;FAM20C;EPHA4;KIF26B;CTSV;ARHGEF19;ACTA2;PPL;PLXND1;CTSL;ACVR1B;NFATC4;SPRY2;TNFRSF19;GPC4;KLK8;LAMB2;STAT1;TULP3;FURIN;SMURF1;VANGL2
16766,GO:0098655,0.0182591976436988,0.989618617172932,26,412,cation transmembrane transport,BP,KCNJ15;EPHB2;SHROOM2;CYBA;NLGN2;PKD2;SCN4B;KCNC4;F2R;ORAI3;ATP6V0A2;ATP12A;STOM;VAMP2;SLC2A9;TRPV4;PQLC2;NDUFA4L2;NIPAL4;COX5B;SLC39A6;GJC2;SLC1A4;ASIC1;TCIRG1;SLC47A1
10618,GO:0043687,0.0183106628953187,0.990282719313489,21,319,post-translational protein modification,BP,APOE;FBXO41;OBSL1;DCAF16;FBXO2;ARSI;LY6E;DDB2;CRTAP;FAM20C;ANO8;LTBP1;CUL9;FBXW4;RTN4RL1;IGFBP4;LAMB2;FBXL8;WIPI2;FBXW5;FBXO44
15644,GO:0072210,0.01835228802326,0.996826498189575,4,25,metanephric nephron development,BP,PKD2;KIF26B;LAMB2;STAT1
5838,GO:0017156,0.0187588243879367,0.994376298556813,7,66,calcium ion regulated exocytosis,BP,RIMS3;SYT8;VAMP3;SYTL1;ZP3;VAMP2;C2CD4C
15656,GO:0072234,0.0188689009132806,0.997817441149134,3,14,metanephric nephron tubule development,BP,PKD2;WWTR1;STAT1
6535,GO:0021987,0.0189083475748812,0.993748630823063,8,81,cerebral cortex development,BP,PTPRS;EGFR;DAB2IP;DIXDC1;SLC2A1;MBOAT7;MDK;SUN1
15637,GO:0072202,0.0189189300679821,0.997809452151237,3,14,cell differentiation involved in metanephros development,BP,WWTR1;LAMB2;STAT1
10225,GO:0042995,0.0189310028149315,0.986583749324682,69,1311,cell projection,CC,APOE;PTPRS;NDN;S100A4;EPHB2;ADGRL1;FBXO2;CYBA;GLI2;EPB41L3;TENM2;PSD4;ARHGEF4;INSR;CYBRD1;SV2A;PKD2;ESPN;DNM1;LDLRAP1;NSG1;PARVB;BOC;DAB2IP;TMEM231;GAS8;WIPF1;KCNC4;GLUL;EPHA4;TENM4;CTSV;TUB;HOMER2;EPS8L2;ACTA2;S100A6;SPOCK1;VAMP3;PLXND1;CSPG4;DMTN;SYTL1;UNC119B;CPT1C;VAMP2;PLEKHH2;SPRY2;CABYR;MDK;TRPV4;MAFIP;RTN4RL1;MARK4;PDLIM4;CRTC1;STAT1;TULP3;CDK20;SLC39A6;BLOC1S4;GJC2;SLC1A4;ARPIN;SMURF1;AIF1L;REEP6;SORT1;APBA1
3491,GO:0007413,0.0192599538113724,0.99775477393787,3,14,axonal fasciculation,BP,NDN;EPHB2;EPHA4
17159,GO:0106030,0.0192599538113724,0.99775477393787,3,14,neuron projection fasciculation,BP,NDN;EPHB2;EPHA4
16802,GO:0098751,0.0193112582429435,0.996608826760873,4,25,bone cell development,BP,ZFPM1;FAM20C;GPR68;VPS33B
6747,GO:0030201,0.0194202786130601,0.99658386006003,4,25,heparan sulfate proteoglycan metabolic process,BP,XYLT1;SGSH;XYLT2;VANGL2
6521,GO:0021952,0.0194722444439033,0.997720542470702,3,14,central nervous system projection neuron axonogenesis,BP,EPHB2;GLI2;EPHA4
975,GO:0002438,0.019654201388437,0.998988920487292,2,6,acute inflammatory response to antigenic stimulus,BP,ZP3;IL20RB
13678,GO:0060284,0.0198348562859091,0.987774637512802,34,568,regulation of cell development,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;EPHB2;GLI2;BCL6;SFRP1;RGMA;ETV5;SERPINE2;WNT3;DAB2IP;EPHA4;DIXDC1;TENM4;SPOCK1;PLXND1;DMTN;KCTD11;NFATC4;EFNB3;TRPV4;KLK8;RTN4RL1;IMPACT;CRTC1;GPR68;GJC2;PLXNB1;SMURF1;CAMK1;ZSWIM8
12494,GO:0050679,0.0198556059357667,0.992377234928194,10,116,positive regulation of epithelial cell proliferation,BP,TNFAIP3;HTRA1;EGFR;CYBA;SFRP1;VEGFB;TBX1;GLUL;HYAL1;ERBB2
6049,GO:0019216,0.019891056227242,0.989936054334686,18,258,regulation of lipid metabolic process,BP,APOE;LMF1;CPT2;THRA;FGFR4;VAV3;LDLRAP1;PDPR;DAB2IP;TYSND1;SEC14L2;ACSL1;SREBF1;PIK3R1;ZP3;MVD;MLYCD;CCDC3
12225,GO:0048546,0.019934606495311,0.996465476206026,4,25,digestive tract morphogenesis,BP,EGFR;GLI2;SFRP1;VANGL2
7011,GO:0030804,0.0200264797591827,0.99760341573855,3,15,positive regulation of cyclic nucleotide biosynthetic process,BP,APOE;PTHLH;ADORA2B
2385,GO:0005543,0.0201281294383946,0.989401337660248,20,295,phospholipid binding,MF,APOE;PSD4;LDLRAP1;SYT8;DAB2IP;TUB;SEC14L2;SYTL1;SNX29;SNX33;VAMP2;MICALL1;C2CD4C;TULP3;NME4;WIPI2;PLCD1;RASA4;SMURF1;NISCH
4186,GO:0009311,0.0205354875716045,0.994445102297691,6,53,oligosaccharide metabolic process,BP,ST3GAL5;GAA;HEXB;SLC2A1;ST6GALNAC6;IDUA
3930,GO:0008645,0.0208135984737237,0.993623214589049,7,67,hexose transmembrane transport,BP,INSR;RTN2;PIK3R1;SLC2A1;SLC2A9;SLC5A1;SORT1
7651,GO:0032102,0.0211914725608469,0.990257219462577,14,188,negative regulation of response to external stimulus,BP,TNFAIP3;APOE;PTPRS;HTRA1;RGMA;NT5E;SERPINE2;WNT3;EPHA4;TYRO3;KLK8;SERPING1;RTN4RL1;IL20RB
2518,GO:0005788,0.021367874706883,0.990168179525946,14,186,endoplasmic reticulum lumen,CC,APOE;GPX7;COL6A1;CES2;ARSI;WNT3;COL7A1;H6PD;CRTAP;FAM20C;ANO8;LTBP1;IGFBP4;LAMB2
6345,GO:0021545,0.0213905297693461,0.996109595970083,4,26,cranial nerve development,BP,EPHB2;SLITRK6;TBX1;ERBB3
16596,GO:0097499,0.0213918482539165,0.998848383557069,2,6,protein localization to non-motile cilium,BP,TUB;TULP3
7033,GO:0030828,0.0214457869798275,0.998843917093929,2,6,positive regulation of cGMP biosynthetic process,BP,APOE;ADORA2B
9954,GO:0042379,0.0216181196807163,0.997310444438872,3,16,chemokine receptor binding,MF,CKLF;CXCL14;STAT1
17293,GO:1900006,0.0216343915199145,0.994085109645995,6,52,positive regulation of dendrite development,BP,APOE;OBSL1;DAB2IP;EPHA4;CRTC1;CAMK1
9219,GO:0035641,0.0216874481482309,0.998823830127431,2,6,locomotory exploration behavior,BP,APOE;NLGN2
9313,GO:0035850,0.0216928265873144,0.996037704190886,4,26,epithelial cell differentiation involved in kidney development,BP,WWTR1;ACTA2;LAMB2;STAT1
1951,GO:0004672,0.0217980070458194,0.987014958242187,29,469,protein kinase activity,MF,ULK2;MAP3K14;EPHB2;EGFR;FGFR4;CDK18;BRSK1;INSR;OBSCN;FAM20C;EPHA4;RPS6KA5;LTBP1;ERBB3;CDK14;GRK6;ACVR1B;CAMKK1;TYRO3;EFNB3;ADCK5;LTBP4;MARK4;ERBB2;CDK20;NUAK1;CAMK1;MAP3K3;NRK
8591,GO:0034135,0.0218146983652279,0.99881320328361,2,6,regulation of toll-like receptor 2 signaling pathway,BP,TNFAIP3;CYBA
17426,GO:1900272,0.0218825282038161,0.99880752473047,2,6,negative regulation of long-term synaptic potentiation,BP,APOE;EPHA4
8573,GO:0034109,0.0219232081913926,0.993975016687948,6,54,homotypic cell-cell adhesion,BP,SERPINE2;DMTN;TYRO3;MYL9;BLOC1S4;VPS33B
10192,GO:0042895,0.0220989660017357,0.998789340190899,2,6,antibiotic transmembrane transporter activity,MF,SLC13A5;SLC13A3
2089,GO:0004867,0.0223198127311653,0.994757706934941,5,41,serine-type endopeptidase inhibitor activity,MF,SERPINE2;COL7A1;SPOCK1;SERPING1;FURIN
3579,GO:0008021,0.0224465563365718,0.991725334570879,9,103,synaptic vesicle,CC,PTPRS;BRSK1;SV2A;DNM1;SYT8;RAB40B;VAMP2;C2CD4C;APBA1
5168,GO:0015749,0.0224778967516693,0.992999745491317,7,68,monosaccharide transmembrane transport,BP,INSR;RTN2;PIK3R1;SLC2A1;SLC2A9;SLC5A1;SORT1
9583,GO:0036477,0.0225266241532995,0.986540868488028,29,476,somatodendritic compartment,CC,APOE;PTPRS;NDN;EPHB2;FBXO2;CYBA;TENM2;INSR;SV2A;DNM1;NSG1;DAB2IP;KCNC4;NRSN2;GLUL;EPHA4;CTSV;HOMER2;ENDOG;CPT1C;RTN4RL1;PDLIM4;CRTC1;STAT1;GJC2;SLC1A4;SMURF1;SORT1;APBA1
7623,GO:0032056,0.0226766237393208,0.998740325639909,2,6,positive regulation of translation in response to stress,BP,NCK2;IMPACT
5778,GO:0017046,0.0226991540547746,0.997150504511293,3,15,peptide hormone binding,MF,VIPR1;INSR;PIK3R1
12622,GO:0050866,0.0227251935266062,0.991607743790319,9,102,negative regulation of cell activation,BP,TNFAIP3;APOE;GPNMB;BCL6;SFRP1;SERPINE2;TYRO3;ERBB2;IL20RB
678,GO:0001892,0.0228819003853889,0.992843008949864,7,69,embryonic placenta development,BP,EGFR;PKD2;PLCD3;GJB5;PLCD1;MDFI;NRK
15612,GO:0072170,0.0229653899574984,0.997104172935615,3,15,metanephric tubule development,BP,PKD2;WWTR1;STAT1
9009,GO:0035252,0.0230405007962057,0.99870909347916,2,6,UDP-xylosyltransferase activity,MF,XYLT1;XYLT2
9905,GO:0042285,0.0230405007962057,0.99870909347916,2,6,xylosyltransferase activity,MF,XYLT1;XYLT2
2281,GO:0005253,0.0230919812250503,0.994537721151942,5,40,anion channel activity,MF,ANO9;ANO8;LRRC8E;CLCN7;SLC1A4
16394,GO:0097090,0.023143658737666,0.99870018936216,2,6,presynaptic membrane organization,BP,APOE;NLGN2
6560,GO:0022407,0.0232543042311087,0.988553465192047,16,227,regulation of cell-cell adhesion,BP,GPNMB;MAP3K14;GLI2;BCL6;SERPINE2;KIF26B;DMTN;PIK3R1;NCK2;ZP3;EFNB3;TRPV4;ERBB2;IL20RB;CCDC88B;VPS33B
16489,GO:0097264,0.0233359680845669,0.998683531472408,2,6,self proteolysis,BP,TENM2;TENM4
9076,GO:0035374,0.0235324681242361,0.998666431960603,2,6,chondroitin sulfate binding,MF,PTPRS;RTN4RL1
13528,GO:0060033,0.0235492831499543,0.998664965027479,2,6,anatomical structure regression,BP,NINJ1;GLI2
10168,GO:0042805,0.0235695139304212,0.996998246631426,3,15,actinin binding,MF,OBSL1;PKD2;PDLIM4
20059,GO:2000766,0.0237133091451758,0.998650625101631,2,6,negative regulation of cytoplasmic translation,BP,UNK;RPL13A
16142,GO:0090205,0.0237268274792726,0.998649440808572,2,6,positive regulation of cholesterol metabolic process,BP,LDLRAP1;SREBF1
10880,GO:0044463,0.0237967779652866,0.983898118938213,49,893,cell projection part,CC,APOE;EPHB2;ADGRL1;FBXO2;CYBA;GLI2;EPB41L3;TENM2;PSD4;ARHGEF4;INSR;CYBRD1;SV2A;PKD2;ESPN;DNM1;NSG1;BOC;DAB2IP;TMEM231;GAS8;KCNC4;GLUL;EPHA4;HOMER2;EPS8L2;SPOCK1;PLXND1;CSPG4;DMTN;SYTL1;UNC119B;CPT1C;VAMP2;SPRY2;CABYR;TRPV4;MARK4;PDLIM4;CRTC1;STAT1;TULP3;SLC39A6;BLOC1S4;GJC2;SLC1A4;AIF1L;SORT1;APBA1
17214,GO:0120038,0.0237967779652866,0.983898118938213,49,893,plasma membrane bounded cell projection part,CC,APOE;EPHB2;ADGRL1;FBXO2;CYBA;GLI2;EPB41L3;TENM2;PSD4;ARHGEF4;INSR;CYBRD1;SV2A;PKD2;ESPN;DNM1;NSG1;BOC;DAB2IP;TMEM231;GAS8;KCNC4;GLUL;EPHA4;HOMER2;EPS8L2;SPOCK1;PLXND1;CSPG4;DMTN;SYTL1;UNC119B;CPT1C;VAMP2;SPRY2;CABYR;TRPV4;MARK4;PDLIM4;CRTC1;STAT1;TULP3;SLC39A6;BLOC1S4;GJC2;SLC1A4;AIF1L;SORT1;APBA1
11126,GO:0045217,0.0240260447030741,0.998623131926973,2,6,cell-cell junction maintenance,BP,NLGN2;F2R
13193,GO:0051897,0.0241157865211198,0.991642171044011,8,85,positive regulation of protein kinase B signaling,BP,EGFR;FGFR4;INSR;ERBB3;PIK3R1;SPRY2;MC1R;ERBB2
6571,GO:0022604,0.0241217388168935,0.986637350762979,22,336,regulation of cell morphogenesis,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;EPHB2;EPB41L3;WNT3;PARVB;WIPF1;EPHA4;HEXB;PLXND1;DMTN;NFATC4;RHOD;EFNB3;ZMYM3;ARPIN;PLXNB1;SMURF1;ZSWIM8
8485,GO:0033689,0.0241772537512224,0.998609767412819,2,6,negative regulation of osteoblast proliferation,BP,SFRP1;PLXNB1
5195,GO:0015812,0.0241874410833975,0.998608865341938,2,6,gamma-aminobutyric acid transport,BP,SV2A;APBA1
3876,GO:0008528,0.0243910481644654,0.995349681518431,4,28,G-protein coupled peptide receptor activity,MF,F2R;CXCR1;MC1R;ACKR3
17207,GO:0120025,0.0243941656503737,0.982594047749278,66,1262,plasma membrane bounded cell projection,CC,APOE;PTPRS;S100A4;EPHB2;ADGRL1;FBXO2;CYBA;GLI2;EPB41L3;TENM2;PSD4;ARHGEF4;INSR;CYBRD1;SV2A;PKD2;ESPN;DNM1;LDLRAP1;NSG1;PARVB;BOC;DAB2IP;TMEM231;GAS8;WIPF1;KCNC4;GLUL;EPHA4;TENM4;CTSV;TUB;HOMER2;EPS8L2;ACTA2;S100A6;SPOCK1;VAMP3;PLXND1;CSPG4;DMTN;SYTL1;UNC119B;CPT1C;VAMP2;PLEKHH2;SPRY2;CABYR;TRPV4;MAFIP;MARK4;PDLIM4;CRTC1;STAT1;TULP3;CDK20;SLC39A6;BLOC1S4;GJC2;SLC1A4;ARPIN;SMURF1;AIF1L;REEP6;SORT1;APBA1
6506,GO:0021910,0.024417648604359,0.998588424764005,2,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,GLI2;TULP3
10196,GO:0042908,0.0246389613952569,0.998568672926081,2,6,xenobiotic transport,BP,SLC2A1;ABCC1
10197,GO:0042910,0.0246389613952569,0.998568672926081,2,6,xenobiotic transmembrane transporter activity,MF,SLC2A1;ABCC1
12621,GO:0050865,0.0246584003734885,0.986728535765802,20,306,regulation of cell activation,BP,TNFAIP3;APOE;GPNMB;MAP3K14;GLI2;BCL6;SFRP1;VAV3;SERPINE2;DMTN;PIK3R1;NCK2;TYRO3;ZP3;EFNB3;ADORA2B;ERBB2;IL20RB;CCDC88B;VPS33B
11353,GO:0045765,0.0246751922368683,0.988802951714475,13,171,regulation of angiogenesis,BP,TNFAIP3;GPNMB;ADGRB2;SFRP1;VEGFB;DAB2IP;PLXND1;HYAL1;SPRY2;ERBB2;STAT1;MAP3K3;SP100
7983,GO:0032633,0.0247792500925973,0.996751721528576,3,16,interleukin-4 production,BP,ZFPM1;ZP3;IL20RB
3901,GO:0008589,0.0248279119780454,0.992980780262678,6,54,regulation of smoothened signaling pathway,BP,GLI2;SFRP1;SERPINE2;WNT9A;KCTD11;TULP3
15668,GO:0072257,0.0248636152363994,0.998548521960583,2,6,metanephric nephron tubule epithelial cell differentiation,BP,WWTR1;STAT1
15692,GO:0072307,0.0248636152363994,0.998548521960583,2,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,WWTR1;STAT1
10000,GO:0042475,0.0251555037620636,0.992859574159443,6,55,odontogenesis of dentin-containing tooth,BP,HTRA1;GLI2;FOXO1;TBX1;KLK5;FAM20C
12248,GO:0048598,0.0253287273782987,0.985511885765123,24,379,embryonic morphogenesis,BP,ALDH1A3;EPHB2;SLITRK6;COL6A1;GLI2;SFRP1;PKD2;WNT3;COL7A1;TMEM231;TBX1;WNT9A;TENM4;LRIG3;GJB5;HYAL1;RTF1;SPRY2;ITGB5;FBXW4;NAGLU;TULP3;MDFI;VANGL2
720,GO:0001953,0.0253409790822774,0.995127843366912,4,27,negative regulation of cell-matrix adhesion,BP,POSTN;BCL6;DMTN;PIK3R1
2371,GO:0005520,0.0253938819674433,0.99663962022249,3,16,insulin-like growth factor binding,MF,HTRA1;INSR;IGFBP4
615,GO:0001784,0.0254666204234424,0.99509622532628,4,27,phosphotyrosine residue binding,MF,LDLRAP1;SH3BP2;PIK3R1;NCK2
16770,GO:0098660,0.0256015969363365,0.985159352594737,25,404,inorganic ion transmembrane transport,BP,KCNJ15;SHROOM2;CYBA;ANO9;PKD2;SCN4B;KCNC4;F2R;ORAI3;ATP6V0A2;ATP12A;STOM;VAMP2;SLC2A9;TRPV4;NDUFA4L2;NIPAL4;COX5B;SLC39A6;CLCN7;GJC2;SLC1A4;ASIC1;TCIRG1;SLC47A1
11093,GO:0045165,0.0257028897312907,0.989705853750316,10,119,cell fate commitment,BP,GLI2;SFRP1;ZFPM1;WNT3;SOX12;TBX1;WNT9A;TENM4;RTF1;SPRY2
13473,GO:0055085,0.0258619845406031,0.982543365970632,47,866,transmembrane transport,BP,KCNJ15;CPT2;EPHB2;TST;SLC13A5;SHROOM2;CYBA;NLGN2;ANO9;INSR;SLC16A5;SLC29A4;SV2A;PKD2;RTN2;SCN4B;KCNC4;ANO8;F2R;ORAI3;S100A6;SLC38A4;ATP6V0A2;DMTN;PIK3R1;ATP12A;SLC2A1;STOM;VAMP2;LRRC8E;SLC2A9;TRPV4;PQLC2;NDUFA4L2;NIPAL4;SLC5A1;COX5B;SLC39A6;CLCN7;GJC2;SLC1A4;SLC13A3;ASIC1;TCIRG1;SLC47A1;ABCC1;SORT1
8634,GO:0034219,0.0259600776125623,0.991661647953313,7,70,carbohydrate transmembrane transport,BP,INSR;RTN2;PIK3R1;SLC2A1;SLC2A9;SLC5A1;SORT1
16228,GO:0090330,0.0263549958828901,0.996462138340289,3,16,regulation of platelet aggregation,BP,SERPINE2;DMTN;VPS33B
8924,GO:0035004,0.0264809337034767,0.993508657316443,5,40,phosphatidylinositol 3-kinase activity,MF,EGFR;FGFR4;ERBB3;PIK3R1;ERBB2
12858,GO:0051240,0.0265425565516492,0.981712550122882,52,967,positive regulation of multicellular organismal process,BP,TNFAIP3;POSTN;IFITM1;APOE;OBSL1;ADGRB2;EPHB2;SLITRK6;ADGRL1;EGFR;CYBA;GLI2;NLGN2;BCL6;ZFPM1;ETV5;SERPINE2;VEGFB;WWTR1;WNT3;DAB2IP;TBX1;FAM20C;EPHA4;TENM4;F2R;DDX60;ERBB3;PLXND1;DMTN;PIK3R1;ACVR1B;KCTD11;NFATC4;FAM210B;HYAL1;ZP3;TRPV4;ADORA2B;IMPACT;CRTC1;GPR68;RNF135;STAT1;IFI16;IL20RB;CCDC88B;GJC2;PLXNB1;SMURF1;CAMK1;MAP3K3
5433,GO:0016324,0.0266076503585053,0.987798309830292,13,172,apical plasma membrane,CC,SHROOM2;EGFR;CYBA;SLC29A4;ERBB3;VAMP3;CSPG4;SLC2A1;SLC2A9;TRPV4;ERBB2;TCIRG1;VANGL2
7252,GO:0031252,0.0267614830522197,0.985475207829867,20,301,cell leading edge,CC,EPB41L3;PSD4;ARHGEF4;INSR;PKD2;PARVB;WIPF1;KCNC4;EPS8L2;ACTA2;S100A6;PLXND1;CSPG4;PLEKHH2;SPRY2;TRPV4;PDLIM4;SLC39A6;ARPIN;AIF1L
9180,GO:0035591,0.0267913412656321,0.992284516473366,6,55,signaling adaptor activity,MF,VAV3;LDLRAP1;DAB2IP;SH3BP2;PIK3R1;NCK2
11707,GO:0046580,0.0273599726612527,0.993224144190534,5,41,negative regulation of Ras protein signal transduction,BP,EPHB2;BCL6;DAB2IP;SPRY2;RASA4
2192,GO:0005088,0.0275059143128831,0.987332033550031,13,170,Ras guanyl-nucleotide exchange factor activity,MF,EGFR;FGFR4;RAPGEF5;ARHGEF4;VAV3;OBSCN;SHC2;TRAPPC2L;ARHGEF19;EPS8L2;ERBB3;ERBB2;ALS2CL
534,GO:0001653,0.0275957959638534,0.994517868241834,4,29,peptide receptor activity,MF,F2R;CXCR1;MC1R;ACKR3
7540,GO:0031904,0.0276227529772975,0.996192546613344,3,17,endosome lumen,CC,CTSB;CTSL;PDLIM4
530,GO:0001649,0.0276281750048475,0.988230205443627,11,138,osteoblast differentiation,BP,IFITM1;GPNMB;COL6A1;GLI2;SFRP1;TP53INP2;WWTR1;WNT3;FAM20C;PTHLH;MRC2
17451,GO:1900426,0.0276539318753337,0.998198391469299,2,7,positive regulation of defense response to bacterium,BP,CYBA;KLK5
10365,GO:0043230,0.0278808573998016,0.978899288253743,97,2038,extracellular organelle,CC,TNFAIP3;ITGB6;TGFBI;APOE;ALDH1A3;MVB12B;LGALS7B;PTPRS;S100A4;HTRA1;CADM4;GAMT;GPRC5C;GPX3;TST;MXRA5;SHROOM2;COL6A1;FBXO2;HEBP1;CALML3;PGM1;SFRP1;GAREM2;TNFSF10;INSR;VAV3;CYBRD1;GAA;PKD2;RGMA;DNM1;CTSB;NT5E;SERPINE2;TNXB;WNT3;BPHL;DAB2IP;PRSS3;SGSH;FAM20C;GLUL;FAM213A;WNT9A;MAGEF1;CTSV;SEC14L2;TXNDC17;HEXB;PGLS;EPS8L2;ACTA2;S100A6;PPL;CSPG4;APPL2;CTSL;ACVR1B;SYTL1;SNX29;XPC;SLC2A1;METTL7A;HYAL1;BCAM;STOM;CKMT1A;VAMP2;ZDHHC1;GPC4;ITGB5;NDRG1;LTBP4;ALDH2;SERPING1;NAGLU;RTN4RL1;IAH1;TOM1L2;H2AFJ;LAMB2;PLCD1;SLC5A1;COX5B;MARCKSL1;FURIN;PEX11B;CTSF;SLC1A4;SLC13A3;SMURF1;AIF1L;RAB43;ABCC1;MTMR11;IDUA
18424,GO:1903561,0.0278808573998016,0.978899288253743,97,2038,extracellular vesicle,CC,TNFAIP3;ITGB6;TGFBI;APOE;ALDH1A3;MVB12B;LGALS7B;PTPRS;S100A4;HTRA1;CADM4;GAMT;GPRC5C;GPX3;TST;MXRA5;SHROOM2;COL6A1;FBXO2;HEBP1;CALML3;PGM1;SFRP1;GAREM2;TNFSF10;INSR;VAV3;CYBRD1;GAA;PKD2;RGMA;DNM1;CTSB;NT5E;SERPINE2;TNXB;WNT3;BPHL;DAB2IP;PRSS3;SGSH;FAM20C;GLUL;FAM213A;WNT9A;MAGEF1;CTSV;SEC14L2;TXNDC17;HEXB;PGLS;EPS8L2;ACTA2;S100A6;PPL;CSPG4;APPL2;CTSL;ACVR1B;SYTL1;SNX29;XPC;SLC2A1;METTL7A;HYAL1;BCAM;STOM;CKMT1A;VAMP2;ZDHHC1;GPC4;ITGB5;NDRG1;LTBP4;ALDH2;SERPING1;NAGLU;RTN4RL1;IAH1;TOM1L2;H2AFJ;LAMB2;PLCD1;SLC5A1;COX5B;MARCKSL1;FURIN;PEX11B;CTSF;SLC1A4;SLC13A3;SMURF1;AIF1L;RAB43;ABCC1;MTMR11;IDUA
12760,GO:0051094,0.0280689027940477,0.981111014144494,45,819,positive regulation of developmental process,BP,TNFAIP3;IFITM1;APOE;OBSL1;ADGRB2;EPHB2;SLITRK6;ADGRL1;THRA;GLI2;NLGN2;BCL6;SFRP1;INSR;ETV5;SERPINE2;VEGFB;WWTR1;WNT3;BOC;DAB2IP;TBX1;FAM20C;EPHA4;WNT9A;TENM4;OLFM2;ERBB3;PLXND1;DMTN;ACVR1B;KCTD11;FAM210B;HYAL1;ZP3;IMPACT;CRTC1;GPR68;STAT1;GJC2;PLXNB1;SMURF1;CCDC3;CAMK1;MAP3K3
4951,GO:0015078,0.028086481696975,0.990802693231063,7,75,proton transmembrane transporter activity,MF,ATP6V0A2;ATP12A;SLC2A9;NDUFA4L2;COX5B;TCIRG1;SLC47A1
19737,GO:2000194,0.0283000633389834,0.998133086957925,2,7,regulation of female gonad development,BP,INSR;ZP3
4216,GO:0009411,0.0284162974348583,0.988419101001689,10,123,response to UV,BP,EGFR;BRSK1;DDB2;PIK3R1;XPC;NFATC4;HYAL1;TP53INP1;MC1R;IMPACT
3030,GO:0006600,0.0285542682191461,0.998107164770874,2,7,creatine metabolic process,BP,GAMT;CKMT1A
5840,GO:0017158,0.0286553652615858,0.992805121624215,5,42,regulation of calcium ion-dependent exocytosis,BP,RIMS3;SYT8;SYTL1;ZP3;C2CD4C
2005,GO:0004745,0.028677030755127,0.998094600001621,2,7,retinol dehydrogenase activity,MF,SDR9C7;RDH12
12239,GO:0048583,0.0287822739675655,0.977568351217598,128,2698,regulation of response to stimulus,BP,TNFAIP3;POSTN;IFITM1;APOE;IFI6;MVB12B;PTPRS;GPNMB;S100A4;MAP3K14;EPHB2;HTRA1;NCR3LG1;EGFR;THRA;CYBA;GLI2;FGFR4;APCDD1;NLGN2;BCL6;PSD4;SFRP1;ARHGEF4;CKLF;TNFSF10;INSR;VAV3;PKD2;RGMA;DNM1;CXCL14;LDLRAP1;CTSB;NT5E;SERPINE2;VEGFB;WWTR1;RHBDF1;FOXO1;WNT3;DAB2IP;OBSCN;TBX1;KLK5;SHC2;SH3BP2;WIPF1;MNT;FAM20C;EPHA4;WNT9A;MAGEF1;DIXDC1;F2R;RPS6KA5;HOMER2;ARHGEF19;LTBP1;EPS8L2;DDX60;ERBB3;KIF26A;CDK14;CSPG4;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;UCN2;ARHGAP40;NFATC4;TYRO3;RHOD;CLEC11A;ZP3;RBCK1;SPRY2;TP53INP1;TNFRSF19;MDK;TRPV4;GPC4;KLK8;LTBP4;ADORA2B;SERPING1;RTN4RL1;MC1R;IMPACT;NEO1;IGFBP4;GPR68;ERBB2;EPM2A;RNF135;STAT1;TULP3;ACKR3;CRY2;FURIN;IFI16;IL20RB;THNSL2;NUAK1;PLXNB1;RASA4;SMURF1;KREMEN1;CCDC3;CXXC5;VPS33B;MAP3K3;MDFI;ZSWIM8;SP100;NRK;VANGL2
12554,GO:0050770,0.0288321036747475,0.988230586444069,10,120,regulation of axonogenesis,BP,APOE;ULK2;PTPRS;EPHB2;WNT3;EPHA4;PLXND1;EFNB3;PLXNB1;ZSWIM8
2685,GO:0006066,0.0289946735747649,0.985332791933202,16,233,alcohol metabolic process,BP,APOE;ALDH1A3;LMF1;LDLRAP1;TRERF1;CYP27C1;SEC14L2;PLCD3;SREBF1;RDH12;IMPA2;RETSAT;ALDH2;MVD;PLCD1;ISYNA1
6787,GO:0030258,0.0290207941675782,0.986086264795347,14,194,lipid modification,BP,APOE;CPT2;EGFR;CRAT;FGFR4;TYSND1;ERBB3;PIK3R1;IMPA2;CPT1C;AMACR;ERBB2;PLPP2;MLYCD
6190,GO:0019722,0.0291141840869868,0.989525873650167,8,89,calcium-mediated signaling,BP,ADGRB2;ADGRL1;EGFR;PKD2;HOMER2;ERBB3;DMTN;NFATC4
12062,GO:0048102,0.0294963078131012,0.998009979874266,2,7,autophagic cell death,BP,CTSV;TP53INP1
16992,GO:0099503,0.0296582472431813,0.981122560049848,34,605,secretory vesicle,CC,LAMP3;PTPRS;CYBA;PGM1;BRSK1;GAA;SV2A;DNM1;CTSB;SYT8;SERPINE2;VEGFB;PRSS3;KLK5;RAB40B;CTSV;HEXB;HGSNAT;ATP6V0A2;VAMP3;SYTL1;CXCR1;METTL7A;STOM;VAMP2;SCG5;KLK8;SERPING1;C2CD4C;PCSK1;SUN1;TCIRG1;VPS33B;APBA1
7587,GO:0031995,0.0296678800745828,0.997992090682388,2,7,insulin-like growth factor II binding,MF,INSR;IGFBP4
527,GO:0001637,0.0297946932497966,0.997978831110458,2,7,G-protein coupled chemoattractant receptor activity,MF,CXCR1;ACKR3
2127,GO:0004950,0.0297946932497966,0.997978831110458,2,7,chemokine receptor activity,MF,CXCR1;ACKR3
7032,GO:0030826,0.0298996863927013,0.997967829126484,2,7,regulation of cGMP biosynthetic process,BP,APOE;ADORA2B
2189,GO:0005085,0.029924265137315,0.984811832396955,16,227,guanyl-nucleotide exchange factor activity,MF,RALGDS;EGFR;FGFR4;RAPGEF5;PSD4;ARHGEF4;VAV3;OBSCN;SHC2;TRAPPC2L;ARHGEF19;EPS8L2;ERBB3;IQSEC1;ERBB2;ALS2CL
3497,GO:0007423,0.029967925617442,0.983531597125961,20,306,sensory organ development,BP,ALDH1A3;EPHB2;NINJ1;SLITRK6;SHROOM2;EGFR;GLI2;SDK2;CXCL14;SALL2;TMEM231;TBX1;WNT9A;LRIG3;TUB;SPRY2;NAGLU;LAMB2;TULP3;VANGL2
12287,GO:0048675,0.0300154489930802,0.989148169608434,8,87,axon extension,BP,APOE;ULK2;PTPRS;NDN;WNT3;EPHA4;LAMB2;PLXNB1
6013,GO:0019098,0.0301249363811613,0.995705749681393,3,17,reproductive behavior,BP,THRA;SERPINE2;HEXB
5501,GO:0016486,0.0301651364251379,0.995697790568718,3,17,peptide hormone processing,BP,SCG5;FURIN;PCSK1
12281,GO:0048668,0.0302428151076652,0.995682398950365,3,17,collateral sprouting,BP,ULK2;PTPRS;WNT3
2282,GO:0005254,0.0303028319954881,0.993802743556517,4,29,chloride channel activity,MF,ANO9;ANO8;CLCN7;SLC1A4
6399,GO:0021681,0.0303298960550642,0.997922522878497,2,7,cerebellar granular layer development,BP,SERPINE2;MDK
1147,GO:0002762,0.0305210911957691,0.993744141854059,4,29,negative regulation of myeloid leukocyte differentiation,BP,SFRP1;ZFPM1;PIK3R1;GPR68
5110,GO:0015556,0.0305727836795654,0.99789678423217,2,7,C4-dicarboxylate transmembrane transporter activity,MF,SLC13A5;SLC13A3
10191,GO:0042891,0.0306590399569965,0.997887616070414,2,7,antibiotic transport,BP,SLC13A5;SLC13A3
2559,GO:0005859,0.0308118595117445,0.997871337413764,2,7,muscle myosin complex,CC,OBSL1;MYL9
3437,GO:0007265,0.0308942314382939,0.982205987967536,23,366,Ras protein signal transduction,BP,APOE;EPHB2;RALGDS;BCL6;PSD4;ARHGEF4;VAV3;DAB2IP;OBSCN;SHC2;RAB40B;F2R;ARHGEF19;EPS8L2;APPL2;IQSEC1;ACAP3;RHOD;SPRY2;RASA4;NISCH;RAB43;VANGL2
523,GO:0001618,0.0309451239482255,0.992059047661455,5,43,virus receptor activity,MF,ITGB6;EGFR;TYRO3;EFNB3;ITGB5
17145,GO:0104005,0.0309451239482255,0.992059047661455,5,43,hijacked molecular function,MF,ITGB6;EGFR;TYRO3;EFNB3;ITGB5
12741,GO:0051056,0.0309966652566105,0.983505315316585,18,265,regulation of small GTPase mediated signal transduction,BP,APOE;EPHB2;BCL6;PSD4;ARHGEF4;VAV3;DAB2IP;OBSCN;F2R;ARHGEF19;EPS8L2;APPL2;IQSEC1;ACAP3;ARHGAP40;RHOD;SPRY2;RASA4
11825,GO:0046851,0.0310012299546856,0.997851102429734,2,7,negative regulation of bone remodeling,BP,TNFAIP3;SFRP1
15675,GO:0072273,0.0310542025736215,0.995520670872815,3,17,metanephric nephron morphogenesis,BP,PKD2;KIF26B;STAT1
18371,GO:1903441,0.0311355810545485,0.997836704378804,2,7,protein localization to ciliary membrane,BP,TUB;TULP3
12625,GO:0050869,0.0315029922945396,0.995430472884024,3,17,negative regulation of B cell activation,BP,TNFAIP3;BCL6;SFRP1
6453,GO:0021801,0.0315160572025671,0.995427839209984,3,17,cerebral cortex radial glia guided migration,BP,DAB2IP;MBOAT7;SUN1
6551,GO:0022030,0.0315160572025671,0.995427839209984,3,17,telencephalon glial cell migration,BP,DAB2IP;MBOAT7;SUN1
6806,GO:0030285,0.0316249422335861,0.997783966337061,2,7,integral component of synaptic vesicle membrane,CC,PTPRS;SV2A
1251,GO:0003016,0.0318277338954292,0.995364878570003,3,17,respiratory system process,BP,NDN;NLGN2;GAA
11852,GO:0046903,0.0320611960464424,0.977638439064187,52,990,secretion,BP,POSTN;ITGB6;LMF1;EGFR;CYBA;OAS2;NLGN2;PGM1;BRSK1;SFRP1;CKLF;GAA;SV2A;RIMS3;CTSB;SYT8;SERPINE2;VEGFB;RHBDF1;PRSS3;KCNC4;RAB40B;GLUL;OLFM2;F2R;HEXB;ERBB3;HGSNAT;VAMP3;SREBF1;DMTN;SYTL1;TYRO3;CXCR1;SLC2A1;METTL7A;ZP3;STOM;VAMP2;SCG5;TRPV4;LTBP4;ADORA2B;SERPING1;GPR68;C2CD4C;FURIN;ASIC1;TCIRG1;NISCH;VPS33B;APBA1
10994,GO:0044877,0.0322701831440779,0.978928899559944,37,662,protein-containing complex binding,MF,ITGB6;TGFBI;TAGLN;APOE;OBSL1;GPNMB;EPHB2;FLNC;SHROOM2;EGFR;INSR;ESPN;LDLRAP1;CTSB;TNXB;DDB2;DAB2IP;CRTAP;WIPF1;CORO6;SMARCA1;DMTN;PIK3R1;CTSL;ACVR1B;RTF1;TRPV4;MTHFR;SYNM;LTBP4;MRC2;IMPACT;RNF135;LAMB2;SMURF1;NISCH;AIF1L
8349,GO:0033270,0.0322733123891462,0.997713383839191,2,7,paranode region of axon,CC,EPB41L3;GJC2
11250,GO:0045597,0.0323438370107253,0.979273699884974,34,594,positive regulation of cell differentiation,BP,IFITM1;APOE;OBSL1;EPHB2;THRA;GLI2;BCL6;SFRP1;ETV5;SERPINE2;WWTR1;WNT3;BOC;DAB2IP;TBX1;FAM20C;EPHA4;WNT9A;TENM4;OLFM2;PLXND1;DMTN;ACVR1B;KCTD11;FAM210B;IMPACT;CRTC1;GPR68;STAT1;GJC2;PLXNB1;SMURF1;CCDC3;CAMK1
16381,GO:0097060,0.0325089559240356,0.985198845460288,12,157,synaptic membrane,CC,PTPRS;ADGRL1;NLGN2;TENM2;DNM1;RIMS3;NSG1;EPHA4;OLFM2;F2R;HOMER2;PDLIM4
1222,GO:0002920,0.0325142185800839,0.995190817303508,3,18,regulation of humoral immune response,BP,KLK5;ZP3;SERPING1
12194,GO:0048488,0.0325326121788012,0.993197633336338,4,29,synaptic vesicle endocytosis,BP,NLGN2;DNM1;SYT8;C2CD4C
13451,GO:0055037,0.0325441924449355,0.985765009703156,11,143,recycling endosome,CC,LDLRAP1;NSG1;VAMP3;AVL9;NDRG1;PDLIM4;TBC1D17;MICALL1;ACKR3;NISCH;VPS33B
6455,GO:0021814,0.0325697220257014,0.997680848913479,2,7,cell motility involved in cerebral cortex radial glia guided migration,BP,DAB2IP;SUN1
10224,GO:0042994,0.0325790741277574,0.995177477735205,3,18,cytoplasmic sequestering of transcription factor,BP,THRA;PKD2;MDFI
3520,GO:0007528,0.0326272473962455,0.993171640533227,4,29,neuromuscular junction development,BP,ETV5;F2R;ERBB2;LAMB2
15618,GO:0072176,0.0326588030049121,0.997671038429957,2,7,nephric duct development,BP,PKD2;EPHA4
3573,GO:0008009,0.0327236756454337,0.997577613612013,2,8,chemokine activity,MF,CKLF;CXCL14
8172,GO:0032940,0.0327444612485564,0.977369349492629,49,927,secretion by cell,BP,POSTN;ITGB6;LMF1;EGFR;CYBA;NLGN2;PGM1;BRSK1;SFRP1;CKLF;GAA;RIMS3;CTSB;SYT8;SERPINE2;VEGFB;RHBDF1;PRSS3;KCNC4;RAB40B;GLUL;OLFM2;F2R;HEXB;HGSNAT;VAMP3;SREBF1;DMTN;SYTL1;TYRO3;CXCR1;SLC2A1;METTL7A;ZP3;STOM;VAMP2;SCG5;TRPV4;LTBP4;ADORA2B;SERPING1;GPR68;C2CD4C;FURIN;ASIC1;TCIRG1;NISCH;VPS33B;APBA1
14506,GO:0070062,0.0327682941158016,0.975036961888027,96,2029,extracellular exosome,CC,TNFAIP3;ITGB6;TGFBI;APOE;ALDH1A3;MVB12B;LGALS7B;PTPRS;S100A4;HTRA1;CADM4;GAMT;GPRC5C;GPX3;TST;MXRA5;SHROOM2;COL6A1;FBXO2;HEBP1;CALML3;PGM1;SFRP1;GAREM2;TNFSF10;INSR;VAV3;CYBRD1;GAA;PKD2;RGMA;DNM1;CTSB;NT5E;TNXB;WNT3;BPHL;DAB2IP;PRSS3;SGSH;FAM20C;GLUL;FAM213A;WNT9A;MAGEF1;CTSV;SEC14L2;TXNDC17;HEXB;PGLS;EPS8L2;ACTA2;S100A6;PPL;CSPG4;APPL2;CTSL;ACVR1B;SYTL1;SNX29;XPC;SLC2A1;METTL7A;HYAL1;BCAM;STOM;CKMT1A;VAMP2;ZDHHC1;GPC4;ITGB5;NDRG1;LTBP4;ALDH2;SERPING1;NAGLU;RTN4RL1;IAH1;TOM1L2;H2AFJ;LAMB2;PLCD1;SLC5A1;COX5B;MARCKSL1;FURIN;PEX11B;CTSF;SLC1A4;SLC13A3;SMURF1;AIF1L;RAB43;ABCC1;MTMR11;IDUA
13523,GO:0060027,0.0327859821022485,0.997657006100554,2,7,convergent extension involved in gastrulation,BP,SFRP1;VANGL2
3172,GO:0006811,0.032841032130201,0.977561868972759,46,856,ion transport,BP,APOE;KCNJ15;CPT2;EPHB2;SLC13A5;SHROOM2;CYBA;NLGN2;ANO9;SLC16A5;SV2A;PKD2;SERPINE2;SCN4B;KCNC4;ANO8;F2R;HOMER2;ACSL1;ORAI3;S100A6;SLC38A4;ATP6V0A2;ATP12A;SLC2A1;STOM;VAMP2;LRRC8E;SLC2A9;TRPV4;PQLC2;NDUFA4L2;NIPAL4;SLC5A1;CRY2;COX5B;SLC39A6;CLCN7;GJC2;SLC1A4;SLC13A3;ASIC1;TCIRG1;SLC47A1;ABCC1;APBA1
10754,GO:0044255,0.0328757230837707,0.978034209370848,41,752,cellular lipid metabolic process,BP,APOE;ALDH1A3;LMF1;CPT2;KDSR;ST3GAL5;EGFR;CRAT;FGFR4;CERS4;VAV3;CES2;ARSI;PDPR;DAB2IP;CYP27C1;TYSND1;HEXB;ACSL1;ERBB3;SREBF1;RDH12;PIK3R1;SDC3;IMPA2;CPT1C;ZP3;MBOAT7;GPC4;RETSAT;AMACR;MVD;ERBB2;PLCD1;PLPP2;MLYCD;THNSL2;ALOXE3;ST6GALNAC6;ISYNA1;PIGZ
8670,GO:0034331,0.0329396929884371,0.997640005462993,2,7,cell junction maintenance,BP,NLGN2;F2R
6321,GO:0021513,0.0330761335202693,0.997624877491043,2,7,spinal cord dorsal/ventral patterning,BP,GLI2;TULP3
7185,GO:0031094,0.0335005730566778,0.99757759270116,2,7,platelet dense tubular network,CC,F2R;DMTN
11384,GO:0045834,0.0335393120081626,0.988602142701056,7,75,positive regulation of lipid metabolic process,BP,APOE;VAV3;LDLRAP1;SREBF1;ZP3;MLYCD;CCDC3
16932,GO:0099003,0.033612859472737,0.98756484971946,8,90,vesicle-mediated transport in synapse,BP,NLGN2;DNM1;RIMS3;SYT8;SYTL1;VAMP2;C2CD4C;BLOC1S4
16144,GO:0090207,0.0337682595017163,0.994930974350029,3,18,regulation of triglyceride metabolic process,BP,APOE;LMF1;SREBF1
7454,GO:0031638,0.0337779696018008,0.992814777089047,4,31,zymogen activation,BP,SERPINE2;PRSS3;FURIN;IFI16
2166,GO:0005024,0.0338870781080854,0.997534239256198,2,7,transforming growth factor beta-activated receptor activity,MF,LTBP1;LTBP4
6629,GO:0023056,0.0340836797733283,0.975630446054379,59,1145,positive regulation of signaling,BP,APOE;GPNMB;S100A4;MAP3K14;EPHB2;EGFR;CYBA;FGFR4;NLGN2;SFRP1;TNFSF10;INSR;VAV3;PKD2;LDLRAP1;RIMS3;SERPINE2;WNT3;NSG1;DAB2IP;TBX1;KLK5;SHC2;SH3BP2;GLUL;EPHA4;WNT9A;DIXDC1;F2R;DDX60;ERBB3;VAMP3;CSPG4;DMTN;PIK3R1;TRIM22;NCK2;ACVR1B;NFATC4;TYRO3;VAMP2;RBCK1;SPRY2;TP53INP1;TNFRSF19;TRPV4;ADORA2B;MC1R;NEO1;CRTC1;IGFBP4;GPR68;ERBB2;ACKR3;PLXNB1;CXXC5;MAP3K3;NRK;VANGL2
3053,GO:0006635,0.0342133532349918,0.989516600964444,6,61,fatty acid beta-oxidation,BP,CPT2;CRAT;TYSND1;CPT1C;AMACR;MLYCD
8472,GO:0033674,0.0343142965927228,0.979543178353539,25,412,positive regulation of kinase activity,BP,MAP3K14;EPHB2;EGFR;FGFR4;INSR;VAV3;PKD2;DAB2IP;SHC2;EPHA4;F2R;ACSL1;ERBB3;CSPG4;CAMKK1;NAB2;TYRO3;SPRY2;ADORA2B;ERBB2;CDK20;CAMK1;MAP3K3;NRK;VANGL2
6968,GO:0030666,0.0344022402913099,0.986298224513799,9,111,endocytic vesicle membrane,CC,APOE;EGFR;CYBA;LDLRAP1;WNT3;ATP6V0A2;VAMP3;TCIRG1;RAB43
759,GO:0002016,0.0345194810263772,1,1,1,regulation of blood volume by renin-angiotensin,BP,CYBA
761,GO:0002019,0.0345194810263772,1,1,1,regulation of renal output by angiotensin,BP,CYBA
1270,GO:0003083,0.0345194810263772,1,1,1,negative regulation of renal output by angiotensin,BP,CYBA
1282,GO:0003106,0.0345194810263772,1,1,1,negative regulation of glomerular filtration by angiotensin,BP,CYBA
4917,GO:0014895,0.0345194810263772,1,1,1,smooth muscle hypertrophy,BP,CYBA
466,GO:0001505,0.0345922264431267,0.984091699240177,12,162,regulation of neurotransmitter levels,BP,BRSK1;INSR;PKD2;RIMS3;SYT8;KCNC4;GLUL;SYTL1;VAMP2;C2CD4C;ASIC1;APBA1
6869,GO:0030421,0.0349910147411915,1,1,1,defecation,BP,MDK
3558,GO:0007618,0.0350030091087563,0.994671239880822,3,18,mating,BP,THRA;SERPINE2;HEXB
12728,GO:0051043,0.0350595752472508,0.994659249689604,3,18,regulation of membrane protein ectodomain proteolysis,BP,APOE;SNX33;FURIN
11552,GO:0046164,0.0351489635055032,0.992429166042626,4,31,alcohol catabolic process,BP,APOE;TRERF1;IMPA2;ALDH2
3031,GO:0006601,0.0352533348168297,1,1,1,creatine biosynthetic process,BP,GAMT
6999,GO:0030731,0.0352533348168297,1,1,1,guanidinoacetate N-methyltransferase activity,MF,GAMT
1515,GO:0003905,0.0354506011470321,1,1,1,alkylbase DNA N-glycosylase activity,MF,MPG
3943,GO:0008725,0.0354506011470321,1,1,1,DNA-3-methyladenine glycosylase activity,MF,MPG
10622,GO:0043733,0.0354506011470321,1,1,1,DNA-3-methylbase glycosylase activity,MF,MPG
10641,GO:0043916,0.0354506011470321,1,1,1,DNA-7-methylguanine glycosylase activity,MF,MPG
13380,GO:0052821,0.0354506011470321,1,1,1,DNA-7-methyladenine glycosylase activity,MF,MPG
13381,GO:0052822,0.0354506011470321,1,1,1,DNA-3-methylguanine glycosylase activity,MF,MPG
9682,GO:0038127,0.0354506573238478,0.985001848462656,10,126,ERBB signaling pathway,BP,MVB12B;EGFR;RHBDF1;DAB2IP;RPS6KA5;ERBB3;PIK3R1;NCK2;SPRY2;ERBB2
11787,GO:0046718,0.0354626559850363,0.987799093208358,7,76,viral entry into host cell,BP,IFITM1;ITGB6;EGFR;CTSB;TYRO3;EFNB3;ITGB5
17536,GO:1901193,0.035553980485314,1,1,1,regulation of formation of translation preinitiation complex,BP,RPL13A
17537,GO:1901194,0.035553980485314,1,1,1,negative regulation of formation of translation preinitiation complex,BP,RPL13A
18896,GO:1904689,0.035553980485314,1,1,1,negative regulation of cytoplasmic translational initiation,BP,RPL13A
14077,GO:0060976,0.0356248498218213,0.9923141340138,4,30,coronary vasculature development,BP,VEGFB;TBX1;LTBP1;PLXND1
8690,GO:0034363,0.0356848454966027,1,1,1,intermediate-density lipoprotein particle,CC,APOE
8692,GO:0034365,0.0356848454966027,1,1,1,discoidal high-density lipoprotein particle,CC,APOE
8698,GO:0034371,0.0356848454966027,1,1,1,chylomicron remodeling,BP,APOE
11855,GO:0046911,0.0356848454966027,1,1,1,metal chelating activity,MF,APOE
16340,GO:0090731,0.0356848454966027,1,1,1,cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
17676,GO:1901630,0.0356848454966027,1,1,1,negative regulation of presynaptic membrane organization,BP,APOE
18170,GO:1903000,0.0356848454966027,1,1,1,regulation of lipid transport across blood brain barrier,BP,APOE
18171,GO:1903002,0.0356848454966027,1,1,1,positive regulation of lipid transport across blood brain barrier,BP,APOE
19336,GO:1905853,0.0356848454966027,1,1,1,regulation of heparan sulfate binding,BP,APOE
19337,GO:1905855,0.0356848454966027,1,1,1,positive regulation of heparan sulfate binding,BP,APOE
19338,GO:1905858,0.0356848454966027,1,1,1,regulation of heparan sulfate proteoglycan binding,BP,APOE
19339,GO:1905860,0.0356848454966027,1,1,1,positive regulation of heparan sulfate proteoglycan binding,BP,APOE
19347,GO:1905890,0.0356848454966027,1,1,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
19241,GO:1905502,0.0357186183677952,1,1,1,acetyl-CoA binding,MF,NAT6
8168,GO:0032930,0.0358623179434642,0.997209254409559,2,8,positive regulation of superoxide anion generation,BP,EGFR;CYBA
19467,GO:1990384,0.0359518607838377,1,1,1,hyaloid vascular plexus regression,BP,NINJ1
8308,GO:0033179,0.0359950512972952,0.997193260856671,2,8,proton-transporting V-type ATPase, V0 domain,CC,ATP6V0A2;TCIRG1
12242,GO:0048588,0.036043614277351,0.983982104154263,11,142,developmental cell growth,BP,POSTN;APOE;ULK2;PTPRS;NDN;WNT3;EPHA4;IMPACT;LAMB2;PLXNB1;SMURF1
16478,GO:0097229,0.0360908776349399,1,1,1,sperm end piece,CC,CABYR
5052,GO:0015293,0.0361262324253083,0.987528602601367,7,75,symporter activity,MF,SLC13A5;SLC16A5;SLC38A4;SLC2A9;SLC5A1;SLC1A4;SLC13A3
2076,GO:0004852,0.0361684517911685,1,1,1,uroporphyrinogen-III synthase activity,MF,UROS
15210,GO:0071418,0.0361684517911685,1,1,1,cellular response to amine stimulus,BP,UROS
10791,GO:0044317,0.0362075791926242,1,1,1,rod spherule,CC,REEP6
622,GO:0001809,0.0362610489668416,1,1,1,positive regulation of type IV hypersensitivity,BP,ZP3
1207,GO:0002885,0.0362610489668416,1,1,1,positive regulation of hypersensitivity,BP,ZP3
13819,GO:0060467,0.0362610489668416,1,1,1,negative regulation of fertilization,BP,ZP3
19836,GO:2000359,0.0362610489668416,1,1,1,regulation of binding of sperm to zona pellucida,BP,ZP3
19837,GO:2000360,0.0362610489668416,1,1,1,negative regulation of binding of sperm to zona pellucida,BP,ZP3
19856,GO:2000387,0.0362610489668416,1,1,1,regulation of antral ovarian follicle growth,BP,ZP3
19857,GO:2000388,0.0362610489668416,1,1,1,positive regulation of antral ovarian follicle growth,BP,ZP3
14759,GO:0070524,0.0363163724002289,1,1,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,HSD11B1
12864,GO:0051250,0.0364038806382387,0.98739888080979,7,77,negative regulation of lymphocyte activation,BP,TNFAIP3;GPNMB;BCL6;SFRP1;TYRO3;ERBB2;IL20RB
4790,GO:0012506,0.0364420668417093,0.977092857932282,30,522,vesicle membrane,CC,APOE;LAMP3;ULK2;PTPRS;GPRC5C;EGFR;CYBA;GAA;SV2A;PKD2;LDLRAP1;SYT8;WNT3;NSG1;RAB40B;LRIG3;HGSNAT;ATP6V0A2;VAMP3;SREBF1;NCK2;SNX33;CXCR1;STOM;VAMP2;C2CD4C;SUN1;TCIRG1;RAB43;SORT1
4629,GO:0010769,0.0364610777748916,0.981967133418199,14,197,regulation of cell morphogenesis involved in differentiation,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;EPHB2;WNT3;EPHA4;PLXND1;DMTN;NFATC4;EFNB3;PLXNB1;ZSWIM8
12966,GO:0051431,0.0365231962302813,1,1,1,corticotropin-releasing hormone receptor 2 binding,MF,UCN2
12300,GO:0048696,0.0365644415291887,1,1,1,regulation of collateral sprouting in absence of injury,BP,WNT3
12301,GO:0048697,0.0365644415291887,1,1,1,positive regulation of collateral sprouting in absence of injury,BP,WNT3
13554,GO:0060064,0.0365644415291887,1,1,1,Spemann organizer formation at the anterior end of the primitive streak,BP,WNT3
19237,GO:1905474,0.0365644415291887,1,1,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,WNT3
9683,GO:0038128,0.0366521352526274,0.992000589480121,4,31,ERBB2 signaling pathway,BP,EGFR;ERBB3;PIK3R1;ERBB2
1980,GO:0004713,0.0366837206972278,0.985233114699349,9,108,protein tyrosine kinase activity,MF,EPHB2;EGFR;FGFR4;INSR;EPHA4;ERBB3;TYRO3;EFNB3;ERBB2
6390,GO:0021644,0.0366866813139786,1,1,1,vagus nerve morphogenesis,BP,TBX1
14466,GO:0062013,0.0368110372857702,0.98612351896823,8,93,positive regulation of small molecule metabolic process,BP,APOE;INSR;LDLRAP1;FOXO1;SREBF1;PTHLH;ADORA2B;MLYCD
16089,GO:0090131,0.0368218560297042,1,1,1,mesenchyme migration,BP,ACTA2
11988,GO:0047658,0.037185367522989,1,1,1,alpha-amino-acid esterase activity,MF,BPHL
6410,GO:0021695,0.0372448797110164,0.99182995490617,4,31,cerebellar cortex development,BP,GLI2;SERPINE2;MDK;NAGLU
15508,GO:0071963,0.0373453454093614,1,1,1,establishment or maintenance of cell polarity regulating cell shape,BP,PARVB
3813,GO:0008430,0.0373917052752983,1,1,1,selenium binding,MF,GPX3
12195,GO:0048489,0.0373963181718615,0.986987965018134,7,76,synaptic vesicle transport,BP,DNM1;RIMS3;SYT8;SYTL1;VAMP2;C2CD4C;BLOC1S4
16584,GO:0097480,0.0373963181718615,0.986987965018134,7,76,establishment of synaptic vesicle localization,BP,DNM1;RIMS3;SYT8;SYTL1;VAMP2;C2CD4C;BLOC1S4
1678,GO:0004163,0.0375257045276918,1,1,1,diphosphomevalonate decarboxylase activity,MF,MVD
13235,GO:0051963,0.0375427850718084,0.989842023487317,5,44,regulation of synapse assembly,BP,ADGRB2;EPHB2;SLITRK6;ADGRL1;NLGN2
7411,GO:0031532,0.0375546210188337,0.986914270367109,7,77,actin cytoskeleton reorganization,BP,PARVB;CTSV;FRY;DMTN;RHOD;TRPV4;PDLIM4
4983,GO:0015143,0.0377582058429157,1,1,1,urate transmembrane transporter activity,MF,SLC2A9
5166,GO:0015747,0.0377582058429157,1,1,1,urate transport,BP,SLC2A9
17713,GO:1901702,0.0377582058429157,1,1,1,salt transmembrane transporter activity,MF,SLC2A9
7477,GO:0031668,0.0377911000798486,0.981764320925264,13,184,cellular response to extracellular stimulus,BP,POSTN;CYBA;SFRP1;FOXO1;GLUL;CTSV;KIF26A;SREBF1;UCN2;SLC2A1;ADORA2B;IMPACT;IFI16
13725,GO:0060342,0.037803251750071,1,1,1,photoreceptor inner segment membrane,CC,RDH12
4651,GO:0010817,0.0378048442392015,0.97939125550359,18,280,regulation of hormone levels,BP,ALDH1A3;EGFR;NLGN2;SFRP1;TRERF1;CYP27C1;GLUL;SREBF1;RDH12;SLC2A1;SCG5;TRPV4;RETSAT;LTBP4;GPR68;HSD11B1;FURIN;PCSK1
1029,GO:0002545,0.0378067240640776,1,1,1,chronic inflammatory response to non-antigenic stimulus,BP,ADORA2B
1203,GO:0002880,0.0378067240640776,1,1,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,ADORA2B
1204,GO:0002882,0.0378067240640776,1,1,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,ADORA2B
5199,GO:0015819,0.0378275791725676,1,1,1,lysine transport,BP,PQLC2
661,GO:0001868,0.0378432440527129,1,1,1,regulation of complement activation, lectin pathway,BP,SERPING1
662,GO:0001869,0.0378432440527129,1,1,1,negative regulation of complement activation, lectin pathway,BP,SERPING1
3594,GO:0008049,0.0378973504863306,1,1,1,male courtship behavior,BP,HEXB
784,GO:0002053,0.0379152457654959,0.994043748196371,3,18,positive regulation of mesenchymal cell proliferation,BP,TBX1;FBXW4;STAT1
6752,GO:0030206,0.0379169383037669,0.994043377543871,3,18,chondroitin sulfate biosynthetic process,BP,XYLT1;CSPG4;XYLT2
2245,GO:0005172,0.0379787995238822,0.996950284803697,2,8,vascular endothelial growth factor receptor binding,MF,VEGFB;DAB2IP
6588,GO:0022804,0.0380027912906514,0.981091777566889,14,200,active transmembrane transporter activity,MF,SLC13A5;SLC16A5;SLC29A4;SLC38A4;ATP6V0A2;ATP12A;SLC2A9;SLC5A1;CLCN7;SLC1A4;SLC13A3;TCIRG1;SLC47A1;ABCC1
3625,GO:0008111,0.0381318312363914,1,1,1,alpha-methylacyl-CoA racemase activity,MF,AMACR
621,GO:0001808,0.0383729132320735,1,1,1,negative regulation of type IV hypersensitivity,BP,IL20RB
1198,GO:0002865,0.0383729132320735,1,1,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,IL20RB
1206,GO:0002884,0.0383729132320735,1,1,1,negative regulation of hypersensitivity,BP,IL20RB
7031,GO:0030825,0.0383762340600509,0.996900723443585,2,8,positive regulation of cGMP metabolic process,BP,APOE;ADORA2B
8817,GO:0034637,0.0384182634420073,0.987902117692783,6,61,cellular carbohydrate biosynthetic process,BP,PGM1;INSR;B3GNT9;IMPA2;SLC2A1;ISYNA1
2036,GO:0004795,0.0386358438812232,1,1,1,threonine synthase activity,MF,THNSL2
4033,GO:0009088,0.0386358438812232,1,1,1,threonine biosynthetic process,BP,THNSL2
11606,GO:0046360,0.0386358438812232,1,1,1,2-oxobutyrate biosynthetic process,BP,THNSL2
11607,GO:0046361,0.0386358438812232,1,1,1,2-oxobutyrate metabolic process,BP,THNSL2
10469,GO:0043405,0.0386582356435327,0.979279546144269,17,259,regulation of MAP kinase activity,BP,APOE;MAP3K14;EPHB2;EGFR;SFRP1;INSR;DAB2IP;SHC2;EPHA4;F2R;CSPG4;SPRY2;ADORA2B;ERBB2;MAP3K3;NRK;VANGL2
12553,GO:0050769,0.0388312111165544,0.978390806562352,19,295,positive regulation of neurogenesis,BP,APOE;OBSL1;EPHB2;GLI2;BCL6;ETV5;SERPINE2;WNT3;DAB2IP;EPHA4;TENM4;PLXND1;KCTD11;IMPACT;CRTC1;GJC2;PLXNB1;SMURF1;CAMK1
12402,GO:0050080,0.0389177629447887,1,1,1,malonyl-CoA decarboxylase activity,MF,MLYCD
20262,GO:2001294,0.0389177629447887,1,1,1,malonyl-CoA catabolic process,BP,MLYCD
1534,GO:0003940,0.0389213766230771,1,1,1,L-iduronidase activity,MF,IDUA
6755,GO:0030209,0.0389213766230771,1,1,1,dermatan sulfate catabolic process,BP,IDUA
11832,GO:0046873,0.0389968635369598,0.980530400751295,14,199,metal ion transmembrane transporter activity,MF,KCNJ15;SLC13A5;SHROOM2;PKD2;SCN4B;KCNC4;ORAI3;ATP12A;TRPV4;NIPAL4;SLC5A1;SLC39A6;SLC13A3;ASIC1
8904,GO:0034777,0.0390712013227762,1,1,1,recycling endosome lumen,CC,PDLIM4
10080,GO:0042628,0.039164852785323,1,1,1,mating plug formation,BP,SERPINE2
11160,GO:0045297,0.039164852785323,1,1,1,post-mating behavior,BP,SERPINE2
14157,GO:0061107,0.039164852785323,1,1,1,seminal vesicle development,BP,SERPINE2
14158,GO:0061108,0.039164852785323,1,1,1,seminal vesicle epithelium development,BP,SERPINE2
1837,GO:0004512,0.0391702489968877,1,1,1,inositol-3-phosphate synthase activity,MF,ISYNA1
5709,GO:0016872,0.0391702489968877,1,1,1,intramolecular lyase activity,MF,ISYNA1
4646,GO:0010812,0.0393292657731333,0.989210212162672,5,45,negative regulation of cell-substrate adhesion,BP,POSTN;BCL6;SPOCK1;DMTN;PIK3R1
3435,GO:0007263,0.0393385807475099,0.996779508734376,2,8,nitric oxide mediated signal transduction,BP,APOE;EGFR
1838,GO:0004513,0.0393388547058136,1,1,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,ST3GAL5
11947,GO:0047291,0.0393388547058136,1,1,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,ST3GAL5
6963,GO:0030659,0.0393730882179124,0.975282090466257,29,505,cytoplasmic vesicle membrane,CC,APOE;LAMP3;ULK2;PTPRS;GPRC5C;EGFR;CYBA;GAA;SV2A;PKD2;LDLRAP1;SYT8;WNT3;NSG1;RAB40B;LRIG3;HGSNAT;ATP6V0A2;VAMP3;SREBF1;SNX33;CXCR1;STOM;VAMP2;C2CD4C;SUN1;TCIRG1;RAB43;SORT1
4836,GO:0014066,0.0394744327424529,0.987489288843847,6,61,regulation of phosphatidylinositol 3-kinase signaling,BP,EGFR;SERPINE2;DAB2IP;F2R;ERBB3;PLXNB1
7017,GO:0030810,0.0395746550818772,0.991129235365722,4,32,positive regulation of nucleotide biosynthetic process,BP,APOE;INSR;PTHLH;ADORA2B
17439,GO:1900373,0.0395746550818772,0.991129235365722,4,32,positive regulation of purine nucleotide biosynthetic process,BP,APOE;INSR;PTHLH;ADORA2B
1274,GO:0003093,0.0396315630358456,0.996742267934903,2,8,regulation of glomerular filtration,BP,CYBA;F2R
4012,GO:0009061,0.0396475725760873,1,1,1,anaerobic respiration,BP,SDHA
11149,GO:0045274,0.0396475725760873,1,1,1,plasma membrane respiratory chain complex II,CC,SDHA
11153,GO:0045282,0.0396475725760873,1,1,1,plasma membrane succinate dehydrogenase complex,CC,SDHA
835,GO:0002153,0.0397299627886667,1,1,1,steroid receptor RNA activator RNA binding,MF,THRA
11434,GO:0045925,0.0397299627886667,1,1,1,positive regulation of female receptivity,BP,THRA
95,GO:0000186,0.0399379554406373,0.98899768701071,5,45,activation of MAPKK activity,BP,MAP3K14;EGFR;F2R;MAP3K3;NRK
2112,GO:0004918,0.039939596669433,1,1,1,interleukin-8 receptor activity,MF,CXCR1
6296,GO:0019959,0.039939596669433,1,1,1,interleukin-8 binding,MF,CXCR1
9677,GO:0038112,0.039939596669433,1,1,1,interleukin-8-mediated signaling pathway,BP,CXCR1
3197,GO:0006855,0.0402035604670729,0.988890622588508,5,46,drug transmembrane transport,BP,SLC13A5;PQLC2;SLC13A3;SLC47A1;ABCC1
4611,GO:0010750,0.0402135423537609,1,1,1,positive regulation of nitric oxide mediated signal transduction,BP,EGFR
8432,GO:0033594,0.0402135423537609,1,1,1,response to hydroxyisoflavone,BP,EGFR
10235,GO:0043006,0.0402135423537609,1,1,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,EGFR
16589,GO:0097489,0.0402135423537609,1,1,1,multivesicular body, internal vesicle lumen,CC,EGFR
19436,GO:1990188,0.0404217938285209,1,1,1,euchromatin binding,MF,ASH2L
4358,GO:0010001,0.040576723555186,0.982421749172419,10,130,glial cell differentiation,BP,EGFR;POU3F1;SERPINE2;EPHA4;TENM4;ERBB3;NAB2;NDRG1;ERBB2;LAMB2
10045,GO:0042574,0.0407797914284374,0.996594809759364,2,8,retinal metabolic process,BP,ALDH1A3;CYP27C1
9483,GO:0036179,0.0408276481981648,1,1,1,osteoclast maturation,BP,FAM20C
18013,GO:1902600,0.0408384066844508,0.985478000892354,7,82,proton transmembrane transport,BP,ATP6V0A2;ATP12A;SLC2A9;NDUFA4L2;COX5B;TCIRG1;SLC47A1
5390,GO:0016250,0.0408662166092618,1,1,1,N-sulfoglucosamine sulfohydrolase activity,MF,SGSH
5681,GO:0016826,0.0408662166092618,1,1,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,SGSH
1870,GO:0004561,0.0409014909573406,1,1,1,alpha-N-acetylglucosaminidase activity,MF,NAGLU
2153,GO:0004999,0.0409509127700852,1,1,1,vasoactive intestinal polypeptide receptor activity,MF,VIPR1
1636,GO:0004092,0.0410223866028117,1,1,1,carnitine O-acetyltransferase activity,MF,CRAT
17658,GO:1901585,0.041025215181463,1,1,1,regulation of acid-sensing ion channel activity,BP,STOM
6051,GO:0019218,0.0411530469672696,0.985362470089724,7,79,regulation of steroid metabolic process,BP,APOE;LMF1;FGFR4;LDLRAP1;SEC14L2;SREBF1;MVD
5670,GO:0016807,0.0412121329167738,1,1,1,cysteine-type carboxypeptidase activity,MF,CTSV
8243,GO:0033058,0.0412121329167738,1,1,1,directional locomotion,BP,ARPIN
8444,GO:0033608,0.0412121329167738,1,1,1,formyl-CoA transferase activity,MF,SUGCT
9174,GO:0035585,0.0412121329167738,1,1,1,calcium-mediated signaling using extracellular calcium source,BP,DMTN
10937,GO:0044736,0.0412121329167738,1,1,1,acid-sensing ion channel activity,MF,ASIC1
11956,GO:0047369,0.0412121329167738,1,1,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,SUGCT
12421,GO:0050262,0.0412121329167738,1,1,1,ribosylnicotinamide kinase activity,MF,NMRK1
12657,GO:0050915,0.0412121329167738,1,1,1,sensory perception of sour taste,BP,ASIC1
14046,GO:0060912,0.0412121329167738,1,1,1,cardiac cell fate specification,BP,TENM4
14408,GO:0061769,0.0412121329167738,1,1,1,ribosylnicotinate kinase activity,MF,NMRK1
14479,GO:0070004,0.0412121329167738,1,1,1,cysteine-type exopeptidase activity,MF,CTSV
14782,GO:0070560,0.0412121329167738,1,1,1,protein secretion by platelet,BP,DMTN
16659,GO:0097655,0.0412121329167738,1,1,1,serpin family protein binding,MF,CTSL
17050,GO:0099627,0.0412121329167738,1,1,1,neurotransmitter receptor cycle,BP,NSG1
17052,GO:0099630,0.0412121329167738,1,1,1,postsynaptic neurotransmitter receptor cycle,BP,NSG1
19169,GO:1905319,0.0412121329167738,1,1,1,mesenchymal stem cell migration,BP,ACKR3
19170,GO:1905320,0.0412121329167738,1,1,1,regulation of mesenchymal stem cell migration,BP,ACKR3
19171,GO:1905322,0.0412121329167738,1,1,1,positive regulation of mesenchymal stem cell migration,BP,ACKR3
18133,GO:1902939,0.0412148028474431,1,1,1,negative regulation of intracellular calcium activated chloride channel activity,BP,ANO9
4984,GO:0015144,0.0412978006819762,0.993247386058261,3,19,carbohydrate transmembrane transporter activity,MF,SLC2A1;SLC2A9;SLC5A1
5032,GO:0015238,0.0413021765650768,0.986758315974873,6,62,drug transmembrane transporter activity,MF,SLC13A5;PQLC2;SLC1A4;SLC13A3;SLC47A1;ABCC1
10315,GO:0043153,0.0413370053703337,0.993238435500471,3,19,entrainment of circadian clock by photoperiod,BP,CRTC1;CRY2;PER3
3814,GO:0008431,0.0416101981928973,1,1,1,vitamin E binding,MF,SEC14L2
7256,GO:0031258,0.041688357274663,0.993158063133704,3,19,lamellipodium membrane,CC,PLXND1;CSPG4;SLC39A6
2145,GO:0004980,0.0417071599490859,1,1,1,melanocyte-stimulating hormone receptor activity,MF,MC1R
10670,GO:0043990,0.0417093969545608,1,1,1,histone H2A-S1 phosphorylation,BP,RPS6KA5
2171,GO:0005034,0.0418452350486998,1,1,1,osmosensor activity,MF,TRPV4
6684,GO:0030103,0.0418452350486998,1,1,1,vasopressin secretion,BP,TRPV4
16594,GO:0097497,0.0418452350486998,1,1,1,blood vessel endothelial cell delamination,BP,TRPV4
18373,GO:1903444,0.0418452350486998,1,1,1,negative regulation of brown fat cell differentiation,BP,TRPV4
18508,GO:1903759,0.0418452350486998,1,1,1,signal transduction involved in regulation of aerobic respiration,BP,TRPV4
14510,GO:0070070,0.0419061820079682,0.99644783953268,2,8,proton-transporting V-type ATPase complex assembly,BP,ATP6V0A2;TCIRG1
14512,GO:0070072,0.0419061820079682,0.99644783953268,2,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,ATP6V0A2;TCIRG1
5283,GO:0015991,0.0419452937779722,0.993060643335167,3,20,ATP hydrolysis coupled proton transport,BP,ATP6V0A2;ATP12A;TCIRG1
19515,GO:1990523,0.041987332298792,1,1,1,bone regeneration,BP,POSTN
1326,GO:0003195,0.0420226422241892,1,1,1,tricuspid valve formation,BP,ZFPM1
9820,GO:0042097,0.0420226422241892,1,1,1,interleukin-4 biosynthetic process,BP,ZFPM1
11198,GO:0045402,0.0420226422241892,1,1,1,regulation of interleukin-4 biosynthetic process,BP,ZFPM1
11199,GO:0045403,0.0420226422241892,1,1,1,negative regulation of interleukin-4 biosynthetic process,BP,ZFPM1
13748,GO:0060375,0.0420226422241892,1,1,1,regulation of mast cell differentiation,BP,ZFPM1
13749,GO:0060377,0.0420226422241892,1,1,1,negative regulation of mast cell differentiation,BP,ZFPM1
4587,GO:0010720,0.0420674564209348,0.975632796099982,21,338,positive regulation of cell development,BP,APOE;OBSL1;EPHB2;GLI2;BCL6;ETV5;SERPINE2;WNT3;DAB2IP;EPHA4;TENM4;PLXND1;DMTN;KCTD11;IMPACT;CRTC1;GPR68;GJC2;PLXNB1;SMURF1;CAMK1
13141,GO:0051786,0.0421561243586861,1,1,1,all-trans-retinol 13,14-reductase activity,MF,RETSAT
16480,GO:0097232,0.0422009759362116,1,1,1,lamellar body membrane,CC,LAMP3
16481,GO:0097233,0.0422009759362116,1,1,1,alveolar lamellar body membrane,CC,LAMP3
335,GO:0000931,0.0422734395197973,0.996399427960526,2,8,gamma-tubulin large complex,CC,MZT2A;MZT2B
3722,GO:0008274,0.0422734395197973,0.996399427960526,2,8,gamma-tubulin ring complex,CC,MZT2A;MZT2B
3173,GO:0006812,0.0424118450018322,0.972570794180776,32,572,cation transport,BP,KCNJ15;EPHB2;SLC13A5;SHROOM2;CYBA;NLGN2;PKD2;SERPINE2;SCN4B;KCNC4;F2R;HOMER2;ORAI3;SLC38A4;ATP6V0A2;ATP12A;STOM;VAMP2;SLC2A9;TRPV4;PQLC2;NDUFA4L2;NIPAL4;SLC5A1;COX5B;SLC39A6;GJC2;SLC1A4;SLC13A3;ASIC1;TCIRG1;SLC47A1
6431,GO:0021768,0.0424629623372167,1,1,1,nucleus accumbens development,BP,ALDH1A3
11790,GO:0046725,0.0425661297822032,1,1,1,negative regulation by virus of viral protein levels in host cell,BP,STAT1
15623,GO:0072183,0.0425661297822032,1,1,1,negative regulation of nephron tubule epithelial cell differentiation,BP,STAT1
15693,GO:0072308,0.0425661297822032,1,1,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,STAT1
3981,GO:0008900,0.0425800510677898,1,1,1,potassium:proton exchanging ATPase activity,MF,ATP12A
808,GO:0002086,0.0426115140354322,1,1,1,diaphragm contraction,BP,GAA
1880,GO:0004574,0.0426115140354322,1,1,1,oligo-1,6-glucosidase activity,MF,GAA
2633,GO:0005985,0.0426115140354322,1,1,1,sucrose metabolic process,BP,GAA
10333,GO:0043181,0.0426115140354322,1,1,1,vacuolar sequestering,BP,GAA
54,GO:0000111,0.0426289587140554,1,1,1,nucleotide-excision repair factor 2 complex,CC,XPC
3296,GO:0007015,0.0426829079562704,0.976394578169729,18,280,actin filament organization,BP,OBSL1;SHROOM2;SFRP1;FHOD3;ESPN;WIPF1;EPS8L2;FRY;DMTN;PIK3R1;NCK2;ARHGAP40;RHOD;PLEKHH2;TRPV4;MSRB2;ITGB5;ARPIN
16962,GO:0099094,0.0427077716323685,0.990192015671546,4,32,ligand-gated cation channel activity,MF,KCNJ15;SHROOM2;PKD2;ASIC1
2525,GO:0005796,0.0427401524557078,0.987977817178096,5,47,Golgi lumen,CC,WNT3;CSPG4;SDC3;GPC4;FURIN
13213,GO:0051932,0.0428030813394199,0.992901202212107,3,19,synaptic transmission, GABAergic,BP,NLGN2;DNM1;NISCH
6722,GO:0030159,0.0428047108567751,0.992900824664486,3,19,receptor signaling complex scaffold activity,MF,LDLRAP1;HOMER2;NCK2
15902,GO:0072755,0.0428066003144762,1,1,1,cellular response to benomyl,BP,IMPACT
17643,GO:1901561,0.0428066003144762,1,1,1,response to benomyl,BP,IMPACT
17024,GO:0099552,0.0428554900400445,1,1,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,F2R
17025,GO:0099553,0.0428554900400445,1,1,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,F2R
17360,GO:1900134,0.0428554900400445,1,1,1,negative regulation of renin secretion into blood stream,BP,F2R
7868,GO:0032458,0.0429274574720876,1,1,1,slow endocytic recycling,BP,MICALL1
6319,GO:0021511,0.0430067291698863,0.996302046732772,2,8,spinal cord patterning,BP,GLI2;TULP3
4548,GO:0010647,0.0430242529740281,0.968868732903615,58,1139,positive regulation of cell communication,BP,APOE;GPNMB;S100A4;MAP3K14;EPHB2;EGFR;CYBA;FGFR4;NLGN2;SFRP1;TNFSF10;INSR;VAV3;PKD2;LDLRAP1;RIMS3;SERPINE2;WNT3;NSG1;DAB2IP;TBX1;KLK5;SHC2;SH3BP2;GLUL;EPHA4;WNT9A;DIXDC1;F2R;DDX60;ERBB3;CSPG4;DMTN;PIK3R1;TRIM22;NCK2;ACVR1B;NFATC4;TYRO3;VAMP2;RBCK1;SPRY2;TP53INP1;TNFRSF19;TRPV4;ADORA2B;MC1R;NEO1;CRTC1;IGFBP4;GPR68;ERBB2;ACKR3;PLXNB1;CXXC5;MAP3K3;NRK;VANGL2
19555,GO:1990715,0.0430947305908325,1,1,1,mRNA CDS binding,MF,UNK
5074,GO:0015362,0.0430979694528662,1,1,1,high-affinity sodium:dicarboxylate symporter activity,MF,SLC13A3
14813,GO:0070615,0.043115119947548,1,1,1,nucleosome-dependent ATPase activity,MF,SMARCA1
16284,GO:0090537,0.043115119947548,1,1,1,CERF complex,CC,SMARCA1
7192,GO:0031104,0.0431198288490423,1,1,1,dendrite regeneration,BP,MATN2
19705,GO:2000118,0.0431570416638553,1,1,1,regulation of sodium-dependent phosphate transport,BP,CRY2
13504,GO:0060005,0.0431840522604128,1,1,1,vestibular reflex,BP,SLITRK6
13505,GO:0060007,0.0431840522604128,1,1,1,linear vestibuloocular reflex,BP,SLITRK6
6006,GO:0019082,0.0431931247468333,1,1,1,viral protein processing,BP,FURIN
16266,GO:0090472,0.0431931247468333,1,1,1,dibasic protein processing,BP,FURIN
5012,GO:0015195,0.0432661839215432,1,1,1,L-threonine transmembrane transporter activity,MF,SLC1A4
5205,GO:0015826,0.0432661839215432,1,1,1,threonine transport,BP,SLC1A4
8790,GO:0034589,0.0432661839215432,1,1,1,hydroxyproline transport,BP,SLC1A4
8791,GO:0034590,0.0432661839215432,1,1,1,L-hydroxyproline transmembrane transporter activity,MF,SLC1A4
9242,GO:0035695,0.0432676723811158,1,1,1,mitophagy by induced vacuole formation,BP,SPATA18
1742,GO:0004356,0.0433007996998944,1,1,1,glutamate-ammonia ligase activity,MF,GLUL
2981,GO:0006542,0.0433007996998944,1,1,1,glutamine biosynthetic process,BP,GLUL
5367,GO:0016211,0.0433007996998944,1,1,1,ammonia ligase activity,MF,GLUL
6180,GO:0019676,0.0433007996998944,1,1,1,ammonia assimilation cycle,BP,GLUL
8602,GO:0034146,0.0433358128846902,1,1,1,toll-like receptor 5 signaling pathway,BP,TNFAIP3
8603,GO:0034147,0.0433358128846902,1,1,1,regulation of toll-like receptor 5 signaling pathway,BP,TNFAIP3
8604,GO:0034148,0.0433358128846902,1,1,1,negative regulation of toll-like receptor 5 signaling pathway,BP,TNFAIP3
14710,GO:0070425,0.0433358128846902,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,TNFAIP3
14713,GO:0070428,0.0433358128846902,1,1,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,TNFAIP3
14714,GO:0070429,0.0433358128846902,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,TNFAIP3
14717,GO:0070433,0.0433358128846902,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,TNFAIP3
15813,GO:0072573,0.0433358128846902,1,1,1,tolerance induction to lipopolysaccharide,BP,TNFAIP3
16199,GO:0090291,0.0433358128846902,1,1,1,negative regulation of osteoclast proliferation,BP,TNFAIP3
19830,GO:2000349,0.0433358128846902,1,1,1,negative regulation of CD40 signaling pathway,BP,TNFAIP3
10814,GO:0044343,0.0433518239300548,1,1,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,SFRP1
10816,GO:0044345,0.0433518239300548,1,1,1,stromal-epithelial cell signaling involved in prostate gland development,BP,SFRP1
16169,GO:0090246,0.0433518239300548,1,1,1,convergent extension involved in somitogenesis,BP,SFRP1
19663,GO:2000040,0.0433518239300548,1,1,1,regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP1
19664,GO:2000041,0.0433518239300548,1,1,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP1
19674,GO:2000054,0.0433518239300548,1,1,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
19686,GO:2000079,0.0433518239300548,1,1,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,SFRP1
19687,GO:2000080,0.0433518239300548,1,1,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,SFRP1
10780,GO:0044301,0.0433613721837027,1,1,1,climbing fiber,CC,DAB2IP
19389,GO:1990032,0.0433613721837027,1,1,1,parallel fiber,CC,DAB2IP
7008,GO:0030801,0.0434156900187877,0.992718570171892,3,20,positive regulation of cyclic nucleotide metabolic process,BP,APOE;PTHLH;ADORA2B
16411,GO:0097116,0.0434254557902468,1,1,1,gephyrin clustering involved in postsynaptic density assembly,BP,NLGN2
5457,GO:0016409,0.0434353178923075,0.989948607258583,4,33,palmitoyltransferase activity,MF,CPT2;CPT1C;ZDHHC1;GOLGA7B
2360,GO:0005502,0.0434403698395015,1,1,1,11-cis retinal binding,MF,CYP27C1
2361,GO:0005503,0.0434403698395015,1,1,1,all-trans retinal binding,MF,CYP27C1
14445,GO:0061896,0.0434403698395015,1,1,1,all-trans retinol 3,4-desaturase activity,MF,CYP27C1
14446,GO:0061897,0.0434403698395015,1,1,1,all-trans retinal 3,4-desaturase activity,MF,CYP27C1
14447,GO:0061898,0.0434403698395015,1,1,1,all-trans retinoic acid 3,4-desaturase activity,MF,CYP27C1
14448,GO:0061899,0.0434403698395015,1,1,1,11-cis-retinal 3,4-desaturase activity,MF,CYP27C1
17019,GO:0099545,0.0434919204294122,1,1,1,trans-synaptic signaling by trans-synaptic complex,BP,EPHB2
17026,GO:0099557,0.0434919204294122,1,1,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,EPHB2
17158,GO:0106028,0.0434919204294122,1,1,1,neuron projection retraction,BP,EPHB2
17453,GO:1900450,0.0434919204294122,1,1,1,negative regulation of glutamate receptor signaling pathway,BP,EPHB2
18947,GO:1904782,0.0434919204294122,1,1,1,negative regulation of NMDA glutamate receptor activity,BP,EPHB2
6524,GO:0021955,0.0435106034732639,0.992736711267014,3,19,central nervous system neuron axonogenesis,BP,EPHB2;GLI2;EPHA4
1283,GO:0003127,0.0435254114020052,1,1,1,detection of nodal flow,BP,PKD2
12337,GO:0048763,0.0435254114020052,1,1,1,calcium-induced calcium release activity,MF,PKD2
15241,GO:0071464,0.0435254114020052,1,1,1,cellular response to hydrostatic pressure,BP,PKD2
15544,GO:0072055,0.0435254114020052,1,1,1,renal cortex development,BP,PKD2
15545,GO:0072059,0.0435254114020052,1,1,1,cortical collecting duct development,BP,PKD2
15631,GO:0072194,0.0435254114020052,1,1,1,kidney smooth muscle tissue development,BP,PKD2
15642,GO:0072208,0.0435254114020052,1,1,1,metanephric smooth muscle tissue development,BP,PKD2
15646,GO:0072214,0.0435254114020052,1,1,1,metanephric cortex development,BP,PKD2
15651,GO:0072219,0.0435254114020052,1,1,1,metanephric cortical collecting duct development,BP,PKD2
3077,GO:0006666,0.0435409721981334,1,1,1,3-keto-sphinganine metabolic process,BP,KDSR
11979,GO:0047560,0.0435409721981334,1,1,1,3-dehydrosphinganine reductase activity,MF,KDSR
4937,GO:0015019,0.0435430478287465,1,1,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,HGSNAT
19790,GO:2000297,0.0435485992568917,1,1,1,negative regulation of synapse maturation,BP,NFATC4
15877,GO:0072702,0.0435578929849866,1,1,1,response to methyl methanesulfonate,BP,TP53INP1
15878,GO:0072703,0.0435578929849866,1,1,1,cellular response to methyl methanesulfonate,BP,TP53INP1
14389,GO:0061736,0.0435581343148569,1,1,1,engulfment of target by autophagosome,BP,SMURF1
14400,GO:0061753,0.0435581343148569,1,1,1,substrate localization to autophagosome,BP,SMURF1
2162,GO:0005009,0.043558156160794,1,1,1,insulin-activated receptor activity,MF,INSR
1732,GO:0004344,0.0435581561607941,1,1,1,glucose dehydrogenase activity,MF,H6PD
1822,GO:0004489,0.0435581561607941,1,1,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,MTHFR
2157,GO:0005004,0.0435581561607941,1,1,1,GPI-linked ephrin receptor activity,MF,EPHA4
2169,GO:0005030,0.0435581561607941,1,1,1,neurotrophin receptor activity,MF,SORT1
2402,GO:0005590,0.0435581561607941,1,1,1,collagen type VII trimer,CC,COL7A1
3598,GO:0008057,0.0435581561607941,1,1,1,eye pigment granule organization,BP,SHROOM2
4452,GO:0010465,0.0435581561607941,1,1,1,nerve growth factor receptor activity,MF,SORT1
5092,GO:0015420,0.0435581561607941,1,1,1,cobalamin-transporting ATPase activity,MF,ABCC1
5094,GO:0015431,0.0435581561607941,1,1,1,glutathione S-conjugate-exporting ATPase activity,MF,ABCC1
5950,GO:0018400,0.0435581561607941,1,1,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,CRTAP
6317,GO:0021508,0.0435581561607941,1,1,1,floor plate formation,BP,GLI2
6863,GO:0030379,0.0435581561607941,1,1,1,neurotensin receptor activity, non-G-protein coupled,MF,SORT1
7371,GO:0031443,0.0435581561607941,1,1,1,fast-twitch skeletal muscle fiber contraction,BP,SYNM
8351,GO:0033274,0.0435581561607941,1,1,1,response to vitamin B2,BP,MTHFR
8401,GO:0033505,0.0435581561607941,1,1,1,floor plate morphogenesis,BP,GLI2
8611,GO:0034164,0.0435581561607941,1,1,1,negative regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
8815,GO:0034634,0.0435581561607941,1,1,1,glutathione transmembrane transporter activity,MF,ABCC1
8902,GO:0034775,0.0435581561607941,1,1,1,glutathione transmembrane transport,BP,ABCC1
9101,GO:0035443,0.0435581561607941,1,1,1,tripeptide transmembrane transport,BP,ABCC1
10201,GO:0042937,0.0435581561607941,1,1,1,tripeptide transmembrane transporter activity,MF,ABCC1
11729,GO:0046623,0.0435581561607941,1,1,1,sphingolipid-translocating ATPase activity,MF,ABCC1
12015,GO:0047936,0.0435581561607941,1,1,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,H6PD
12288,GO:0048677,0.0435581561607941,1,1,1,axon extension involved in regeneration,BP,LAMB2
13527,GO:0060032,0.0435581561607941,1,1,1,notochord regression,BP,GLI2
15514,GO:0071997,0.0435581561607941,1,1,1,glutathione S-conjugate-transporting ATPase activity,MF,ABCC1
15663,GO:0072244,0.0435581561607941,1,1,1,metanephric glomerular epithelium development,BP,LAMB2
15664,GO:0072248,0.0435581561607941,1,1,1,metanephric glomerular visceral epithelial cell differentiation,BP,LAMB2
15665,GO:0072249,0.0435581561607941,1,1,1,metanephric glomerular visceral epithelial cell development,BP,LAMB2
15676,GO:0072274,0.0435581561607941,1,1,1,metanephric glomerular basement membrane development,BP,LAMB2
15697,GO:0072312,0.0435581561607941,1,1,1,metanephric glomerular epithelial cell differentiation,BP,LAMB2
15698,GO:0072313,0.0435581561607941,1,1,1,metanephric glomerular epithelial cell development,BP,LAMB2
16432,GO:0097156,0.0435581561607941,1,1,1,fasciculation of motor neuron axon,BP,EPHA4
16436,GO:0097161,0.0435581561607941,1,1,1,DH domain binding,MF,EPHA4
16763,GO:0098648,0.0435581561607941,1,1,1,collagen anchoring fibril,CC,COL7A1
16765,GO:0098652,0.0435581561607941,1,1,1,collagen type VII anchoring fibril,CC,COL7A1
16911,GO:0098948,0.0435581561607941,1,1,1,intrinsic component of postsynaptic specialization membrane,CC,PTPRS
16939,GO:0099039,0.0435581561607941,1,1,1,sphingolipid translocation,BP,ABCC1
16945,GO:0099060,0.0435581561607941,1,1,1,integral component of postsynaptic specialization membrane,CC,PTPRS
16946,GO:0099061,0.0435581561607941,1,1,1,integral component of postsynaptic density membrane,CC,PTPRS
16974,GO:0099146,0.0435581561607941,1,1,1,intrinsic component of postsynaptic density membrane,CC,PTPRS
18028,GO:1902630,0.0435581561607941,1,1,1,regulation of membrane hyperpolarization,BP,CRTC1
18029,GO:1902631,0.0435581561607941,1,1,1,negative regulation of membrane hyperpolarization,BP,CRTC1
18815,GO:1904477,0.0435581561607941,1,1,1,positive regulation of Ras GTPase binding,BP,EPHA4
19095,GO:1905099,0.0435581561607941,1,1,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,EPHA4
19526,GO:1990578,0.0435581561607941,1,1,1,perinuclear endoplasmic reticulum membrane,CC,PIK3R1
20167,GO:2001108,0.0435581561607941,1,1,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,EPHA4
15481,GO:0071902,0.0436136047117335,0.976267597654475,17,263,positive regulation of protein serine/threonine kinase activity,BP,MAP3K14;EGFR;INSR;PKD2;DAB2IP;SHC2;EPHA4;F2R;ACSL1;CSPG4;SPRY2;ADORA2B;ERBB2;CAMK1;MAP3K3;NRK;VANGL2
9985,GO:0042445,0.0441584329771296,0.981574827405469,9,116,hormone metabolic process,BP,ALDH1A3;TRERF1;CYP27C1;RDH12;SCG5;RETSAT;HSD11B1;FURIN;PCSK1
3492,GO:0007416,0.0441820729145408,0.984058473775384,7,77,synapse assembly,BP,ADGRB2;EPHB2;SLITRK6;ADGRL1;NLGN2;SDK2;PLXND1
2277,GO:0005248,0.0442740449085001,0.996131500378167,2,8,voltage-gated sodium channel activity,MF,PKD2;SCN4B
3861,GO:0008509,0.04438805202358,0.978071955297414,13,186,anion transmembrane transporter activity,MF,SLC13A5;ANO9;SLC16A5;ANO8;SLC38A4;SLC2A1;LRRC8E;SLC2A9;PQLC2;CLCN7;SLC1A4;SLC13A3;ABCC1
13428,GO:0055003,0.0444545517776694,0.99610697886591,2,8,cardiac myofibril assembly,BP,OBSL1;FHOD3
8306,GO:0033177,0.0445214233576076,0.99599310293791,2,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,ATP6V0A2;TCIRG1
14118,GO:0061041,0.0446633949700293,0.983823327967981,7,80,regulation of wound healing,BP,TNFAIP3;APOE;SERPINE2;F2R;DMTN;SERPING1;VPS33B
2488,GO:0005751,0.0455022017301745,0.995769947587874,2,10,mitochondrial respiratory chain complex IV,CC,NDUFA4L2;COX5B
3554,GO:0007613,0.0455253819187132,0.98504910846342,6,63,memory,BP,APOE;INSR;MDK;KLK8;CRTC1;ASIC1
6667,GO:0030054,0.0455274389389735,0.968167018708036,46,869,cell junction,CC,ITGB6;PTPRS;OBSL1;TNS1;CADM4;ADGRL1;FLNC;SHROOM2;EGFR;CYBA;FGFR4;EPB41L3;NLGN2;TENM2;BRSK1;SV2A;PKD2;SDK2;RIMS3;PARVB;DDB2;SCN4B;EPHA4;RPL13A;DIXDC1;OLFM2;HOMER2;VAMP3;PPL;GJB5;CSPG4;PIK3R1;TMEM204;SLC2A1;CPT1C;VAMP2;TRPV4;SYNM;ITGB5;NDRG1;MRC2;PDLIM4;PCDH1;GJC2;AIF1L;VANGL2
3050,GO:0006629,0.0457229255632492,0.967557796229554,50,969,lipid metabolic process,BP,APOE;ALDH1A3;LMF1;CPT2;KDSR;ST3GAL5;EGFR;CRAT;THRA;FGFR4;CERS4;VAV3;CES2;ARSI;LDLRAP1;PDPR;DAB2IP;TRERF1;CYP27C1;TYSND1;SEC14L2;HEXB;PLCD3;ACSL1;ERBB3;SREBF1;RDH12;PIK3R1;SDC3;IMPA2;CPT1C;ZP3;MBOAT7;GPC4;RETSAT;AMACR;MVD;IAH1;ERBB2;HSD11B1;HINT2;PLCD1;PLPP2;MLYCD;THNSL2;ALOXE3;CCDC3;ST6GALNAC6;ISYNA1;PIGZ
6763,GO:0030218,0.0457472212201474,0.983344435309585,7,80,erythrocyte differentiation,BP,THRA;BCL6;ZFPM1;DMTN;ACVR1B;FAM210B;STAT1
17591,GO:1901342,0.0457489205535148,0.977297112048183,13,187,regulation of vasculature development,BP,TNFAIP3;GPNMB;ADGRB2;SFRP1;VEGFB;DAB2IP;PLXND1;HYAL1;SPRY2;ERBB2;STAT1;MAP3K3;SP100
11380,GO:0045824,0.0460084944671672,0.989132566312579,4,34,negative regulation of innate immune response,BP,TNFAIP3;TYRO3;SERPING1;IFI16
12743,GO:0051058,0.0460981850695206,0.986763109376384,5,47,negative regulation of small GTPase mediated signal transduction,BP,EPHB2;BCL6;DAB2IP;SPRY2;RASA4
8051,GO:0032753,0.0461177980090279,0.995767846037639,2,9,positive regulation of interleukin-4 production,BP,ZP3;IL20RB
4340,GO:0009953,0.0461317587993065,0.986735755081332,5,48,dorsal/ventral pattern formation,BP,GLI2;SFRP1;WNT3;TULP3;MDFI
12963,GO:0051428,0.0461882336731389,0.995757802764979,2,9,peptide hormone receptor binding,MF,PTHLH;UCN2
12359,GO:0048821,0.0465180585636685,0.991980934923896,3,20,erythrocyte development,BP,BCL6;DMTN;FAM210B
16993,GO:0099504,0.0468469596228771,0.982863851373375,7,79,synaptic vesicle cycle,BP,NLGN2;DNM1;RIMS3;SYT8;SYTL1;VAMP2;C2CD4C
8931,GO:0035023,0.0468881540275281,0.981448972927167,8,95,regulation of Rho protein signal transduction,BP,APOE;BCL6;ARHGEF4;VAV3;OBSCN;F2R;ARHGEF19;EPS8L2
5281,GO:0015988,0.0468995891438584,0.991848622806671,3,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,ATP6V0A2;ATP12A;TCIRG1
11124,GO:0045214,0.0472963993391303,0.991792551693333,3,20,sarcomere organization,BP,OBSL1;FHOD3;OBSCN
3419,GO:0007224,0.047334286178393,0.981224146496848,8,97,smoothened signaling pathway,BP,GLI2;SFRP1;SERPINE2;BOC;TMEM231;WNT9A;KCTD11;TULP3
7055,GO:0030863,0.0473461382326422,0.982641237700524,7,79,cortical cytoskeleton,CC,SHROOM2;RIMS3;WIPF1;DMTN;SLC2A1;PLEKHH2;TRPV4
14098,GO:0061005,0.0474708539631763,0.988697254108439,4,33,cell differentiation involved in kidney development,BP,WWTR1;ACTA2;LAMB2;STAT1
7433,GO:0031589,0.0475125229435491,0.974975398154971,15,224,cell-substrate adhesion,BP,POSTN;ITGB6;SMOC2;NINJ1;BCL6;SFRP1;PARVB;SPOCK1;VAMP3;DMTN;PIK3R1;TYRO3;RHOD;BCAM;ITGB5
3260,GO:0006954,0.0475167408843378,0.97208988083408,21,351,inflammatory response,BP,TNFAIP3;ITGB6;APOE;EGFR;CYBA;BCL6;NT5E;DAB2IP;F2R;RPS6KA5;NFATC4;TYRO3;HYAL1;ZP3;TRPV4;ADORA2B;SERPING1;IGFBP4;GPR68;IFI16;IL20RB
1393,GO:0003338,0.0475249754907195,0.991736979527281,3,20,metanephros morphogenesis,BP,PKD2;KIF26B;STAT1
2505,GO:0005773,0.0475390882704173,0.968735633665789,33,600,vacuole,CC,TNFAIP3;PEG3;LAMP3;COL6A1;CYBRD1;GAA;CTSB;TP53INP2;NSG1;SGSH;CTSV;HEXB;HGSNAT;ATP6V0A2;CSPG4;SDC3;CTSL;HYAL1;STOM;TP53INP1;PQLC2;GPC4;NAGLU;TBC1D17;MARCH9;CLCN7;CTSF;TCIRG1;VPS33B;DIRC2;ABCC1;IDUA;SORT1
12026,GO:0048011,0.0477448630294168,0.991683413320635,3,20,neurotrophin TRK receptor signaling pathway,BP,NDN;SPRY2;SORT1
17532,GO:1901185,0.047760621835815,0.986121213081621,5,49,negative regulation of ERBB signaling pathway,BP,EGFR;DAB2IP;ERBB3;SPRY2;ERBB2
544,GO:0001664,0.0479381729654207,0.979687767648717,9,117,G-protein coupled receptor binding,MF,SFRP1;CKLF;DNM1;CXCL14;WNT3;WNT9A;HOMER2;UCN2;STAT1
16319,GO:0090662,0.0481261685282543,0.991548740848717,3,21,ATP hydrolysis coupled transmembrane transport,BP,ATP6V0A2;ATP12A;TCIRG1
16971,GO:0099131,0.0481261685282543,0.991548740848717,3,21,ATP hydrolysis coupled ion transmembrane transport,BP,ATP6V0A2;ATP12A;TCIRG1
5311,GO:0016055,0.0482521067556429,0.970883054374734,23,389,Wnt signaling pathway,BP,APOE;PRICKLE2;APCDD1;SFRP1;WWTR1;FOXO1;WNT3;DAB2IP;WNT9A;DIXDC1;ARHGEF19;CDK14;GRK6;NFATC4;RTF1;GPC4;FBXW4;IGFBP4;FRAT1;SMURF1;KREMEN1;MDFI;VANGL2
6318,GO:0021510,0.0482911482621688,0.98593966457362,5,48,spinal cord development,BP,PTPRS;GLI2;PKD2;SOX12;TULP3
10472,GO:0043408,0.0487623127124739,0.969305505597601,27,470,regulation of MAPK cascade,BP,APOE;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;SFRP1;INSR;FOXO1;DAB2IP;TBX1;SHC2;EPHA4;F2R;ERBB3;CSPG4;TYRO3;SPRY2;TNFRSF19;TRPV4;ADORA2B;IGFBP4;ERBB2;ACKR3;MAP3K3;NRK;VANGL2
12470,GO:0050650,0.0488364058599334,0.991415968210929,3,20,chondroitin sulfate proteoglycan biosynthetic process,BP,XYLT1;CSPG4;XYLT2
741,GO:0001977,0.0488551345356935,0.995371111334259,2,9,renal system process involved in regulation of blood volume,BP,CYBA;F2R
14836,GO:0070663,0.0491115705426493,0.979087145871066,9,119,regulation of leukocyte proliferation,BP,TNFAIP3;GPNMB;BCL6;VAV3;NCK2;ZP3;ERBB2;IL20RB;CCDC88B
9346,GO:0035904,0.0491598859801708,0.988162403574405,4,33,aorta development,BP,PKD2;TBX1;LTBP1;PLXND1
4939,GO:0015026,0.0494805438666071,0.991256951263456,3,20,coreceptor activity,MF,RGMA;GPC4;ACKR3
19097,GO:1905114,0.0497863343818913,0.969191416734626,25,431,cell surface receptor signaling pathway involved in cell-cell signaling,BP,APOE;PRICKLE2;GLI2;APCDD1;NLGN2;SFRP1;WWTR1;FOXO1;WNT3;DAB2IP;WNT9A;DIXDC1;ARHGEF19;CDK14;GRK6;NFATC4;RTF1;GPC4;FBXW4;IGFBP4;FRAT1;SMURF1;KREMEN1;MDFI;VANGL2
4932,GO:0015012,0.0499960254137616,0.991129062191142,3,20,heparan sulfate proteoglycan biosynthetic process,BP,XYLT1;XYLT2;VANGL2
11122,GO:0045211,0.0500889703135852,0.978618870516785,9,114,postsynaptic membrane,CC,PTPRS;NLGN2;TENM2;DNM1;NSG1;EPHA4;F2R;HOMER2;PDLIM4
6751,GO:0030205,0.0501152073958703,0.99518409254251,2,9,dermatan sulfate metabolic process,BP,CSPG4;IDUA
11406,GO:0045879,0.0501453751590597,0.991091904315932,3,20,negative regulation of smoothened signaling pathway,BP,SERPINE2;KCTD11;TULP3
12842,GO:0051219,0.0502418983852107,0.983090334301141,6,64,phosphoprotein binding,MF,PKD2;LDLRAP1;SH3BP2;PIK3R1;NCK2;RTF1
15096,GO:0071229,0.0503622299056896,0.977338077924054,10,134,cellular response to acid chemical,BP,COL6A1;EGFR;CYBA;SFRP1;PKD2;WNT3;TBX1;WNT9A;SREBF1;NFATC4
4837,GO:0014067,0.0504028958441856,0.995141009835502,2,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,SERPINE2;DAB2IP
16482,GO:0097237,0.0504571920665429,0.976265827240226,11,158,cellular response to toxic substance,BP,TNFAIP3;APOE;TXNRD3;GPX7;GPX3;FOXO1;FAM213A;TXNDC17;ENDOG;TP53INP1;IMPACT
17290,GO:0198738,0.05056262967166,0.969335465793323,23,391,cell-cell signaling by wnt,BP,APOE;PRICKLE2;APCDD1;SFRP1;WWTR1;FOXO1;WNT3;DAB2IP;WNT9A;DIXDC1;ARHGEF19;CDK14;GRK6;NFATC4;RTF1;GPC4;FBXW4;IGFBP4;FRAT1;SMURF1;KREMEN1;MDFI;VANGL2
16772,GO:0098662,0.0505634346558321,0.969702782280138,22,371,inorganic cation transmembrane transport,BP,KCNJ15;SHROOM2;CYBA;PKD2;SCN4B;KCNC4;F2R;ORAI3;ATP6V0A2;ATP12A;STOM;VAMP2;SLC2A9;TRPV4;NDUFA4L2;NIPAL4;COX5B;SLC39A6;GJC2;ASIC1;TCIRG1;SLC47A1
17147,GO:0106003,0.0506234267651437,0.995107887950699,2,9,amyloid-beta complex,CC,APOE;INSR
15679,GO:0072283,0.0507974353083805,0.995081694414615,2,9,metanephric renal vesicle morphogenesis,BP,KIF26B;STAT1
19984,GO:2000644,0.0508588571205307,0.99507243618075,2,9,regulation of receptor catabolic process,BP,APOE;FURIN
8119,GO:0032868,0.05097586099213,0.974285420440929,13,191,response to insulin,BP,SRSF5;TNFSF10;INSR;FOXO1;ATP6V0A2;SREBF1;PIK3R1;SLC2A1;VAMP2;TRPV4;STAT1;TCIRG1;SORT1
7913,GO:0032515,0.0515774576539623,0.987335480618667,4,35,negative regulation of phosphoprotein phosphatase activity,BP,PPP1R35;CRY2;ELFN2;PPP1R14A
3575,GO:0008015,0.0518557856234267,0.971726765662094,16,249,blood circulation,BP,POSTN;APOE;EGFR;THRA;CYBA;GAA;VEGFB;SCN4B;F2R;SREBF1;TRPV4;MTHFR;ADORA2B;SERPING1;STAT1;NISCH
15553,GO:0072075,0.0520445000251826,0.994892458124532,2,9,metanephric mesenchyme development,BP,PKD2;STAT1
11251,GO:0045598,0.0521093663619448,0.980462947806161,7,82,regulation of fat cell differentiation,BP,SFRP1;ZFPM1;WWTR1;FOXO1;TRPV4;CCDC3;SORT1
5161,GO:0015740,0.0521377177514112,0.99487820628223,2,9,C4-dicarboxylate transport,BP,SLC13A5;SLC13A3
8574,GO:0034110,0.0521457102009743,0.990543511388436,3,21,regulation of homotypic cell-cell adhesion,BP,SERPINE2;DMTN;VPS33B
8676,GO:0034341,0.0521912458385801,0.977512403139387,9,121,response to interferon-gamma,BP,IFITM1;OAS2;RPL13A;VAMP3;TRIM22;STAT1;MT2A;RAB43;SP100
9390,GO:0035987,0.0522160607106772,0.987152176242352,4,34,endodermal cell differentiation,BP,COL6A1;COL7A1;RTF1;ITGB5
8381,GO:0033363,0.0522660740643974,0.990512887238552,3,21,secretory granule organization,BP,SERPINE2;F2R;VPS33B
11098,GO:0045176,0.0525036463307068,0.994822117637244,2,9,apical protein localization,BP,SHROOM2;VANGL2
4264,GO:0009648,0.0528033362113516,0.990375826266936,3,21,photoperiodism,BP,CRTC1;CRY2;PER3
15622,GO:0072182,0.0530898528805597,0.994731792413712,2,9,regulation of nephron tubule epithelial cell differentiation,BP,WWTR1;STAT1
712,GO:0001941,0.0531836683900612,0.990278439801281,3,21,postsynaptic membrane organization,BP,APOE;NLGN2;ETV5
713,GO:0001942,0.0532667331035955,0.981791348401469,6,66,hair follicle development,BP,EGFR;APCDD1;CTSV;ACVR1B;TNFRSF19;VANGL2
16281,GO:0090527,0.0532879757330191,0.994701133451559,2,9,actin filament reorganization,BP,FRY;DMTN
9520,GO:0036312,0.053429334073608,0.994679218157922,2,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,DAB2IP;PIK3R1
6972,GO:0030672,0.0537627771095423,0.983825941208495,5,51,synaptic vesicle membrane,CC,PTPRS;SV2A;SYT8;VAMP2;C2CD4C
16991,GO:0099501,0.0537627771095423,0.983825941208495,5,51,exocytic vesicle membrane,CC,PTPRS;SV2A;SYT8;VAMP2;C2CD4C
9024,GO:0035270,0.0537844737943738,0.981570811415836,6,66,endocrine system development,BP,THRA;GLI2;INSR;FOXO1;TBX1;MDK
15716,GO:0072349,0.0538483050735509,0.994614065842476,2,9,modified amino acid transmembrane transporter activity,MF,SLC1A4;ABCC1
5215,GO:0015849,0.053936301450081,0.973413526412014,12,173,organic acid transport,BP,APOE;CPT2;SLC13A5;SLC16A5;SV2A;ACSL1;SLC38A4;VAMP2;PQLC2;SLC1A4;SLC13A3;APBA1
11873,GO:0046942,0.053936301450081,0.973413526412014,12,173,carboxylic acid transport,BP,APOE;CPT2;SLC13A5;SLC16A5;SV2A;ACSL1;SLC38A4;VAMP2;PQLC2;SLC1A4;SLC13A3;APBA1
2955,GO:0006509,0.0540523643228608,0.986524267590579,4,35,membrane protein ectodomain proteolysis,BP,APOE;ADAM19;SNX33;FURIN
11151,GO:0045277,0.0541242881920346,0.994370595868264,2,11,respiratory chain complex IV,CC,NDUFA4L2;COX5B
719,GO:0001952,0.0546297730254282,0.97930346158352,7,82,regulation of cell-matrix adhesion,BP,POSTN;NINJ1;BCL6;SFRP1;DMTN;PIK3R1;RHOD
11827,GO:0046854,0.0547792979793066,0.981157407636168,6,65,phosphatidylinositol phosphorylation,BP,EGFR;FGFR4;ERBB3;PIK3R1;IMPA2;ERBB2
1248,GO:0003013,0.0551686627575259,0.969669871411986,16,251,circulatory system process,BP,POSTN;APOE;EGFR;THRA;CYBA;GAA;VEGFB;SCN4B;F2R;SREBF1;TRPV4;MTHFR;ADORA2B;SERPING1;STAT1;NISCH
12639,GO:0050890,0.0553766293770884,0.973560690454923,11,155,cognition,BP,APOE;EPHB2;EGFR;THRA;INSR;MDK;KLK8;CRTC1;SLC1A4;ASIC1;CBR3
5323,GO:0016079,0.055706326569936,0.983091621847238,5,50,synaptic vesicle exocytosis,BP,RIMS3;SYT8;SYTL1;VAMP2;C2CD4C
15265,GO:0071496,0.0557664687048337,0.969955964600698,15,234,cellular response to external stimulus,BP,POSTN;MAP3K14;EGFR;CYBA;SFRP1;FOXO1;GLUL;CTSV;KIF26A;SREBF1;UCN2;SLC2A1;ADORA2B;IMPACT;IFI16
8112,GO:0032835,0.0561932739964417,0.985811997596075,4,35,glomerulus development,BP,WWTR1;ACTA2;LAMB2;VANGL2
1403,GO:0003351,0.0562900850219579,0.994110908222018,2,10,epithelial cilium movement,BP,GAS8;CABYR
12492,GO:0050673,0.056721483166781,0.968697035349804,16,253,epithelial cell proliferation,BP,TNFAIP3;APOE;HTRA1;EGFR;CYBA;SFRP1;VEGFB;DAB2IP;TBX1;GLUL;CTSV;HYAL1;KLK8;IGFBP4;ERBB2;STAT1
8012,GO:0032680,0.0567729755132718,0.980263172685681,6,68,regulation of tumor necrosis factor production,BP,TNFAIP3;GPNMB;CYBA;PIK3R1;NFATC4;MC1R
6562,GO:0022409,0.0568510043758862,0.973844627591547,10,139,positive regulation of cell-cell adhesion,BP,MAP3K14;GLI2;BCL6;KIF26B;DMTN;PIK3R1;NCK2;ZP3;EFNB3;CCDC88B
15763,GO:0072498,0.0568634370051531,0.994017125600227,2,10,embryonic skeletal joint development,BP,WNT9A;HYAL1
12924,GO:0051346,0.0571013463608241,0.967827335353333,17,277,negative regulation of hydrolase activity,BP,IFI6;LAMP3;SERPINE2;DAB2IP;COL7A1;WNT9A;SPOCK1;SPRY2;PPP1R35;SERPING1;CRY2;FURIN;IFI16;RASA4;ELFN2;PPP1R14A;SORT1
12144,GO:0048306,0.0571316102706902,0.985446196368836,4,37,calcium-dependent protein binding,MF,S100A4;SYT8;S100A6;VAMP2
5980,GO:0019005,0.0574250042164746,0.982388032071524,5,52,SCF ubiquitin ligase complex,CC,FBXO2;FBXW4;BTBD2;FBXW5;FBXO44
6338,GO:0021537,0.0576749830096194,0.972272338882937,11,156,telencephalon development,BP,ALDH1A3;PTPRS;EPHB2;EGFR;DAB2IP;DIXDC1;SLC2A1;MBOAT7;MDK;RTN4RL1;SUN1
5645,GO:0016773,0.0577042482613022,0.961652199122479,32,575,phosphotransferase activity, alcohol group as acceptor,MF,ULK2;MAP3K14;EPHB2;EGFR;FGFR4;CDK18;BRSK1;INSR;OBSCN;FAM20C;EPHA4;RPS6KA5;LTBP1;ERBB3;CDK14;GRK6;PIK3R1;ACVR1B;CAMKK1;TYRO3;EFNB3;ADCK5;LTBP4;NMRK1;MARK4;ERBB2;CDK20;NUAK1;CAMK1;NADK;MAP3K3;NRK
4803,GO:0014015,0.057848935150684,0.985228159198437,4,36,positive regulation of gliogenesis,BP,ETV5;SERPINE2;TENM4;GJC2
12880,GO:0051270,0.0578854999469714,0.961268886701039,33,603,regulation of cellular component movement,BP,POSTN;IFITM1;APOE;GPNMB;EGFR;BCL6;SFRP1;INSR;CXCL14;SERPINE2;VEGFB;WNT3;DAB2IP;F2R;ERBB3;PLXND1;DMTN;PIK3R1;ACVR1B;RHOD;HYAL1;ZP3;SPRY2;TP53INP1;TRPV4;ERBB2;ACKR3;ARPIN;PLXNB1;NISCH;MAP3K3;ZSWIM8;SP100
11672,GO:0046500,0.0580372514955776,0.993823405438955,2,10,S-adenosylmethionine metabolic process,BP,GAMT;MTHFR
12557,GO:0050773,0.0580891860971845,0.975963051287265,8,100,regulation of dendrite development,BP,APOE;PTPRS;OBSL1;DAB2IP;EPHA4;NFATC4;CRTC1;CAMK1
4295,GO:0009790,0.0581210676991945,0.960414042219775,36,665,embryo development,BP,ALDH1A3;EPHB2;SLITRK6;COL6A1;EGFR;GLI2;SFRP1;INSR;PKD2;ZFPM1;SALL2;WNT3;COL7A1;TMEM231;TBX1;TET1;WNT9A;TENM4;LRIG3;PLCD3;GJB5;ENDOG;ACVR1B;HYAL1;RTF1;ZP3;SPRY2;ITGB5;FBXW4;NAGLU;TULP3;PLCD1;MDFI;NRK;VANGL2;APBA1
1269,GO:0003081,0.058129055431262,0.993808157470119,2,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,CYBA;F2R
12493,GO:0050678,0.0582532828326438,0.969179527099176,14,215,regulation of epithelial cell proliferation,BP,TNFAIP3;APOE;HTRA1;EGFR;CYBA;SFRP1;VEGFB;DAB2IP;TBX1;GLUL;CTSV;HYAL1;ERBB2;STAT1
763,GO:0002021,0.0584872319487937,0.993748532619831,2,10,response to dietary excess,BP,APOE;TRPV4
18404,GO:1903530,0.0586036080810685,0.963884277452052,23,398,regulation of secretion by cell,BP,POSTN;EGFR;NLGN2;SFRP1;RIMS3;SYT8;RHBDF1;KCNC4;RAB40B;GLUL;F2R;VAMP3;SREBF1;SYTL1;SLC2A1;ZP3;VAMP2;SCG5;TRPV4;ADORA2B;GPR68;C2CD4C;ASIC1
2599,GO:0005922,0.0586981655193534,0.993713319051397,2,10,connexin complex,CC,GJB5;GJC2
11286,GO:0045646,0.0587486101546295,0.984922398306007,4,36,regulation of erythrocyte differentiation,BP,ZFPM1;ACVR1B;FAM210B;STAT1
5293,GO:0016020,0.0588080858460396,0.951269623203104,250,5727,membrane,CC,IFITM1;ITGB6;TGFBI;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;KCNJ15;ULK2;PTPRS;PHF7;LMF1;CPT2;GPNMB;ADGRB2;EPHB2;ADGRF4;NINJ1;KDSR;HTRA1;PRICKLE2;PRR9;SLITRK6;CADM4;GPRC5C;ADGRL1;ST3GAL5;TST;FLNC;SLC13A5;NCR3LG1;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;CYBA;NYNRIN;SNN;OAS2;GLI2;FGFR4;EPB41L3;APCDD1;NLGN2;VIPR1;ANO9;TENM2;XYLT1;CYP4F22;PSD4;CERS4;SFRP1;ARHGEF4;CKLF;TNFSF10;INSR;VAV3;SLC16A5;CYBRD1;SLC29A4;GAA;SV2A;PKD2;TMEM200B;SIRPB2;RGMA;RTN2;DNM1;TMEM134;SDK2;LDLRAP1;RIMS3;ETV5;NT5E;SYT8;SERPINE2;VEGFB;RHBDF1;TMEM129;WNT3;LY6E;NSG1;PARVB;BPHL;BOC;DAB2IP;COL7A1;TMEM231;OBSCN;SHC2;SCN4B;C14ORF132;YEATS4;KCNC4;RAB40B;MARVELD1;NRSN2;CYP27C1;ANO8;EPHA4;TRAPPC2L;RPL13A;B3GNT9;TENM4;OLFM2;F2R;CSMD2;TYSND1;CTXN1;CTSV;LRIG3;TUB;HOMER2;HEXB;PLCD3;SCART1;ACSL1;EPS8L2;ZBTB42;ORAI3;ERBB3;HGSNAT;S100A6;SLC38A4;CDK14;ATP6V0A2;VAMP3;PPL;PLXND1;GJB5;SREBF1;CSPG4;RDH12;DMTN;GRK6;PIK3R1;SDC3;APPL2;TMEM204;IQSEC1;ACAP3;NCK2;ACVR1B;SYTL1;XPC;ATP12A;SNX33;FAM210B;TYRO3;RHOD;CXCR1;SLC2A1;CPT1C;METTL7A;BCAM;ZP3;STOM;CKMT1A;VAMP2;PLEKHH2;MBOAT7;AVL9;EFNB3;ADCK5;SPRY2;LRRC8E;TNFRSF19;SLC2A9;TMX4;TRPV4;ZDHHC1;PQLC2;SPATA18;GPC4;SYNM;ITGB5;NDRG1;RETSAT;CA11;NDUFA4L2;SDHA;ADORA2B;PLEKHN1;MRC2;RTN4RL1;AMACR;PDLIM4;MC1R;GOLGA7B;NEO1;CRTC1;STON1;GPR68;GPR153;ANKRD13D;MICALL1;ERBB2;C2CD4C;HSD11B1;PCDH1;TMEM54;TULP3;NME4;NIPAL4;WIPI2;ACKR3;PLCD1;SLC5A1;MARCH9;COX5B;SLC39A6;MARCKSL1;TMEM164;FURIN;CLCN7;IFI16;IL20RB;CCDC88B;PLPP2;SUN1;PEX11B;GJC2;SLC1A4;SLC13A3;ASIC1;XYLT2;PLXNB1;RASA4;SMURF1;KREMEN1;CAPNS2;TCIRG1;NISCH;AIF1L;RAB43;VPS33B;ELFN2;SLC47A1;ST6GALNAC6;REEP6;DIRC2;ABCC1;PIGZ;SORT1;VANGL2;APBA1;TP53I11
13685,GO:0060294,0.0588938704423641,0.993680581626796,2,10,cilium movement involved in cell motility,BP,GAS8;MAFIP
11306,GO:0045666,0.0589340742383216,0.968013556067219,15,231,positive regulation of neuron differentiation,BP,APOE;OBSL1;GLI2;BCL6;ETV5;WNT3;DAB2IP;EPHA4;PLXND1;KCTD11;IMPACT;CRTC1;PLXNB1;SMURF1;CAMK1
4354,GO:0009991,0.0592286651997971,0.964808493355803,20,338,response to extracellular stimulus,BP,POSTN;APOE;ULK2;EGFR;CYBA;SFRP1;FOXO1;GLUL;CTSV;ACSL1;KIF26A;SREBF1;UCN2;SLC2A1;TRPV4;MTHFR;ADORA2B;IMPACT;STAT1;IFI16
8590,GO:0034134,0.0592394493355165,0.993622618087074,2,10,toll-like receptor 2 signaling pathway,BP,TNFAIP3;CYBA
16812,GO:0098772,0.059498580333554,0.956247301985887,56,1119,molecular function regulator,MF,APOE;GPNMB;RALGDS;EGFR;FGFR4;PINLYP;RAPGEF5;PSD4;ARHGEF4;CKLF;TNFSF10;VAV3;PPP2R2C;CXCL14;SERPINE2;VEGFB;WNT3;LY6E;DAB2IP;COL7A1;OBSCN;SHC2;SCN4B;EVI5L;WNT9A;TRAPPC2L;ARHGEF19;EPS8L2;ERBB3;SPOCK1;FRY;PIK3R1;PTHLH;APPL2;IQSEC1;ACAP3;UCN2;ARHGAP40;CLEC11A;ZP3;SPRY2;SCG5;MDK;PPP1R35;SERPING1;RTN4RL1;TBC1D17;ERBB2;CDK20;FURIN;THNSL2;ALS2CL;PLXNB1;RASA4;ELFN2;PPP1R14A
10234,GO:0043005,0.0597456339089837,0.958397436998136,40,755,neuron projection,CC,APOE;PTPRS;S100A4;EPHB2;ADGRL1;FBXO2;CYBA;EPB41L3;TENM2;INSR;SV2A;ESPN;DNM1;LDLRAP1;NSG1;BOC;DAB2IP;KCNC4;GLUL;EPHA4;TENM4;CTSV;HOMER2;EPS8L2;SPOCK1;VAMP3;CPT1C;VAMP2;TRPV4;MARK4;PDLIM4;CRTC1;STAT1;BLOC1S4;GJC2;SLC1A4;SMURF1;REEP6;SORT1;APBA1
14895,GO:0070820,0.0599037855986994,0.975019472087057,8,105,tertiary granule,CC,CYBA;PGM1;GAA;PRSS3;HGSNAT;METTL7A;STOM;TCIRG1
2203,GO:0005109,0.0600747119670775,0.988412970463211,3,22,frizzled binding,MF,SFRP1;WNT3;WNT9A
16813,GO:0098773,0.0601029151655945,0.978809512662534,6,68,skin epidermis development,BP,EGFR;APCDD1;CTSV;ACVR1B;TNFRSF19;VANGL2
6557,GO:0022404,0.0603678638588793,0.978692900871642,6,68,molting cycle process,BP,EGFR;APCDD1;CTSV;ACVR1B;TNFRSF19;VANGL2
6558,GO:0022405,0.0603678638588793,0.978692900871642,6,68,hair cycle process,BP,EGFR;APCDD1;CTSV;ACVR1B;TNFRSF19;VANGL2
693,GO:0001917,0.0604338858104684,0.988315392703139,3,22,photoreceptor inner segment,CC,DNM1;RDH12;REEP6
6459,GO:0021819,0.0606673084468997,0.993381030544073,2,10,layer formation in cerebral cortex,BP,DAB2IP;MBOAT7
11288,GO:0045648,0.0607090510811749,0.988240468117333,3,22,positive regulation of erythrocyte differentiation,BP,ACVR1B;FAM210B;STAT1
10470,GO:0043406,0.0608481738429096,0.968466577372175,13,195,positive regulation of MAP kinase activity,BP,MAP3K14;EGFR;INSR;DAB2IP;SHC2;EPHA4;F2R;CSPG4;ADORA2B;ERBB2;MAP3K3;NRK;VANGL2
19027,GO:1904948,0.0608585371826941,0.993348420290241,2,10,midbrain dopaminergic neuron differentiation,BP,SFRP1;WNT3
17989,GO:1902533,0.0609467791457499,0.958542774719368,35,655,positive regulation of intracellular signal transduction,BP,GPNMB;S100A4;MAP3K14;EPHB2;EGFR;FGFR4;TNFSF10;INSR;PKD2;DAB2IP;TBX1;SHC2;EPHA4;F2R;DDX60;ERBB3;CSPG4;PIK3R1;TRIM22;NCK2;TYRO3;RBCK1;SPRY2;TNFRSF19;TRPV4;ADORA2B;MC1R;IGFBP4;ERBB2;ACKR3;PLXNB1;CXXC5;MAP3K3;NRK;VANGL2
6823,GO:0030308,0.0610443754388165,0.972903317194457,9,122,negative regulation of cell growth,BP,ULK2;PTPRS;BCL6;SFRP1;SERPINE2;WNT3;EPHA4;ACVR1B;HYAL1
8599,GO:0034143,0.0613141452695905,0.993270483398156,2,10,regulation of toll-like receptor 4 signaling pathway,BP,TNFAIP3;DAB2IP
7586,GO:0031994,0.0613291969756247,0.99326790282375,2,10,insulin-like growth factor I binding,MF,INSR;IGFBP4
13895,GO:0060600,0.0614499116937317,0.993247193182094,2,10,dichotomous subdivision of an epithelial terminal unit,BP,PLXND1;VANGL2
16387,GO:0097067,0.0614564006825099,0.993246079264439,2,10,cellular response to thyroid hormone stimulus,BP,CTSB;CTSL
4966,GO:0015108,0.0616021736328215,0.983941730347379,4,36,chloride transmembrane transporter activity,MF,ANO9;ANO8;CLCN7;SLC1A4
13952,GO:0060707,0.0618227081352034,0.993183086150296,2,10,trophoblast giant cell differentiation,BP,GJB5;MDFI
4786,GO:0010998,0.0618615566455854,0.993176392581083,2,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,NCK2;IMPACT
16368,GO:0097038,0.0618887059527648,0.99317171331141,2,10,perinuclear endoplasmic reticulum,CC,CYBA;PIK3R1
991,GO:0002467,0.0624320240991054,0.993077817645988,2,10,germinal center formation,BP,TNFAIP3;BCL6
9795,GO:0042043,0.0624754612474204,0.993070290097457,2,10,neurexin family protein binding,MF,NLGN2;SYTL1
8083,GO:0032793,0.0628504095352707,0.993005184768618,2,10,positive regulation of CREB transcription factor activity,BP,RPS6KA5;CRTC1
5142,GO:0015698,0.0628773550061556,0.975389925208915,7,85,inorganic anion transport,BP,ANO9;ANO8;LRRC8E;CRY2;CLCN7;SLC1A4;ABCC1
16979,GO:0099173,0.0630576363446322,0.977501281143414,6,68,postsynapse organization,BP,APOE;EPHB2;NLGN2;INSR;ETV5;EPHA4
15194,GO:0071392,0.063109915830565,0.987531641902478,3,23,cellular response to estradiol stimulus,BP,EGFR;SFRP1;FAM210B
1099,GO:0002695,0.0632954173118162,0.975170268088531,7,87,negative regulation of leukocyte activation,BP,TNFAIP3;GPNMB;BCL6;SFRP1;TYRO3;ERBB2;IL20RB
12386,GO:0048871,0.0633094031059925,0.966982925178114,13,198,multicellular organismal homeostasis,BP,TNFAIP3;NDN;EGFR;TP53INP2;FOXO1;F2R;TUB;HOMER2;RDH12;TRPV4;CRTC1;IL20RB;ALOXE3
4328,GO:0009897,0.0633578843318955,0.97328049694276,8,104,external side of plasma membrane,CC,ITGB6;INSR;SERPINE2;CTSV;SCART1;BCAM;GPC4;RTN4RL1
18421,GO:1903555,0.0634472860553044,0.977302223809895,6,70,regulation of tumor necrosis factor superfamily cytokine production,BP,TNFAIP3;GPNMB;CYBA;PIK3R1;NFATC4;MC1R
12024,GO:0048009,0.0634868201651488,0.987475936432803,3,22,insulin-like growth factor receptor signaling pathway,BP,GIGYF1;PIK3R1;IGFBP4
10296,GO:0043122,0.0635368809572016,0.967831160358811,12,180,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNFAIP3;S100A4;MAP3K14;TNFSF10;DAB2IP;F2R;TRIM22;RBCK1;TNFRSF19;STAT1;CXXC5;MAP3K3
10769,GO:0044282,0.0635698689324239,0.963034610700008,18,305,small molecule catabolic process,BP,APOE;CPT2;CRAT;PGM1;NT5E;TRERF1;GLUL;TYSND1;HEXB;IMPA2;CPT1C;HYAL1;ALDH2;AMACR;MLYCD;THNSL2;IDUA;CBR3
6645,GO:0030018,0.0635982299105451,0.977247235800507,6,69,Z disc,CC,OBSL1;FLNC;FHOD3;PARVB;OBSCN;SLC2A1
15807,GO:0072562,0.0636281771787059,0.983181062599478,4,38,blood microparticle,CC,APOE;SLC2A1;STOM;SERPING1
2653,GO:0006020,0.0636922839064257,0.992858170892666,2,10,inositol metabolic process,BP,IMPA2;ISYNA1
10848,GO:0044420,0.0640545967916135,0.97483437651975,7,84,extracellular matrix component,CC,TGFBI;SMOC2;MATN2;TNXB;COL7A1;LTBP1;LAMB2
5502,GO:0016491,0.0640895589564167,0.958184536834409,28,526,oxidoreductase activity,MF,ALDH1A3;KDSR;TXNRD3;GPX7;GPX3;CYBA;CYP4F22;DHRS4L2;DHTKD1;CYBRD1;HR;PDPR;H6PD;SDR9C7;TET1;CYP27C1;TXNDC17;RDH12;MTHFR;MSRB2;RETSAT;NDUFA4L2;SDHA;ALDH2;HSD11B1;COX5B;ALOXE3;CBR3
13896,GO:0060601,0.0640941346236059,0.992787591962616,2,10,lateral sprouting from an epithelium,BP,GLI2;VANGL2
10461,GO:0043395,0.0641165448546265,0.992783648259952,2,10,heparan sulfate proteoglycan binding,MF,PTPRS;GPC4
3765,GO:0008344,0.064216627832167,0.98300063017765,4,37,adult locomotory behavior,BP,SLITRK6;DNM1;EPHA4;EFNB3
3178,GO:0006820,0.0643744584134499,0.961374773773868,20,337,anion transport,BP,APOE;CPT2;SLC13A5;ANO9;SLC16A5;SV2A;ANO8;ACSL1;SLC38A4;SLC2A1;VAMP2;LRRC8E;SLC2A9;PQLC2;CRY2;CLCN7;SLC1A4;SLC13A3;ABCC1;APBA1
2266,GO:0005229,0.0643999746112976,0.992733700905051,2,10,intracellular calcium activated chloride channel activity,MF,ANO9;ANO8
14412,GO:0061778,0.0643999746112976,0.992733700905051,2,10,intracellular chloride channel activity,MF,ANO9;ANO8
15159,GO:0071346,0.0644683805589837,0.97269234258466,8,107,cellular response to interferon-gamma,BP,OAS2;RPL13A;VAMP3;TRIM22;STAT1;MT2A;RAB43;SP100
10560,GO:0043560,0.0644771599841496,0.992720076459367,2,10,insulin receptor substrate binding,MF,INSR;PIK3R1
13503,GO:0060004,0.0645342987437608,0.992709984368468,2,10,reflex,BP,ALDH1A3;SLITRK6
2656,GO:0006023,0.0645953901927277,0.974553771171582,7,86,aminoglycan biosynthetic process,BP,XYLT1;B3GNT9;CSPG4;SDC3;HYAL1;GPC4;XYLT2
8569,GO:0034101,0.0645987888287669,0.97454248229891,7,87,erythrocyte homeostasis,BP,THRA;BCL6;ZFPM1;DMTN;ACVR1B;FAM210B;STAT1
11310,GO:0045670,0.0647432872117102,0.982814859459833,4,37,regulation of osteoclast differentiation,BP,SFRP1;FAM213A;PIK3R1;GPR68
15606,GO:0072160,0.0648313639496179,0.992657430628389,2,10,nephron tubule epithelial cell differentiation,BP,WWTR1;STAT1
3101,GO:0006694,0.0651110318462711,0.970721443977983,9,125,steroid biosynthetic process,BP,APOE;FGFR4;TRERF1;SEC14L2;SREBF1;AMACR;MVD;HSD11B1;HINT2
3535,GO:0007585,0.0653619919303859,0.982595933047036,4,37,respiratory gaseous exchange,BP,NDN;NLGN2;GAA;COX5B
4265,GO:0009649,0.0657036566916082,0.986803670354553,3,23,entrainment of circadian clock,BP,CRTC1;CRY2;PER3
8166,GO:0032928,0.0660792176399644,0.99231412516527,2,11,regulation of superoxide anion generation,BP,EGFR;CYBA
9802,GO:0042058,0.0661569385749234,0.976084518457174,6,70,regulation of epidermal growth factor receptor signaling pathway,BP,MVB12B;EGFR;RHBDF1;DAB2IP;NCK2;SPRY2
12799,GO:0051149,0.0664017273860262,0.978748955726801,5,54,positive regulation of muscle cell differentiation,BP,THRA;BOC;TBX1;OLFM2;CAMK1
9043,GO:0035308,0.0664111399101059,0.982195079257435,4,38,negative regulation of protein dephosphorylation,BP,PPP1R35;CRY2;ELFN2;PPP1R14A
1028,GO:0002544,0.0664376093618865,0.99224882459879,2,11,chronic inflammatory response,BP,TNFAIP3;ADORA2B
17666,GO:1901616,0.0665625259169754,0.982141015076722,4,38,organic hydroxy compound catabolic process,BP,APOE;TRERF1;IMPA2;ALDH2
824,GO:0002116,0.0665945701573143,0.992342583800464,2,10,semaphorin receptor complex,CC,PLXND1;PLXNB1
5837,GO:0017154,0.0665945701573143,0.992342583800464,2,10,semaphorin receptor activity,MF,PLXND1;PLXNB1
14021,GO:0060840,0.0666003289170536,0.978704219641129,5,52,artery development,BP,APOE;PKD2;TBX1;LTBP1;PLXND1
5597,GO:0016668,0.0666423692097236,0.992211423051028,2,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,TXNRD3;TXNDC17
12574,GO:0050795,0.0666878632955787,0.986524120500788,3,23,regulation of behavior,BP,APOE;MDK;PER3
9999,GO:0042474,0.0667307759976399,0.99219525364796,2,11,middle ear morphogenesis,BP,TBX1;NAGLU
8304,GO:0033173,0.0668280545639058,0.986484153895402,3,23,calcineurin-NFAT signaling cascade,BP,ADGRB2;ERBB3;NFATC4
9804,GO:0042060,0.066926639412106,0.959649074344371,20,342,wound healing,BP,TNFAIP3;POSTN;APOE;NINJ1;EGFR;VAV3;ZFPM1;SERPINE2;F2R;ARHGEF19;ERBB3;DMTN;PIK3R1;TYRO3;SERPING1;MYL9;ERBB2;BLOC1S4;VPS33B;VANGL2
15518,GO:0072006,0.0669882855168651,0.973393452290306,7,86,nephron development,BP,PKD2;WWTR1;KIF26B;ACTA2;LAMB2;STAT1;VANGL2
2391,GO:0005575,0.0670511266227197,0.964982973451402,479,11676,cellular_component,CC,TNFAIP3;POSTN;IFITM1;ITGB6;PEG3;TGFBI;SMOC2;TAGLN;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;KCNJ15;ULK2;LGALS7B;PTPRS;NOL4L;PHF7;FBXO41;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRF4;NINJ1;KDSR;ASH2L;TNS1;HTRA1;PRICKLE2;PRR9;SLITRK6;CADM4;GAMT;GPRC5C;TXNRD3;GIGYF1;ADGRL1;GPX7;SRSF5;ST3GAL5;GPX3;TST;DCAF16;MXRA5;FLNC;SLC13A5;RALGDS;NCR3LG1;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;NYNRIN;SNN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;PINLYP;APCDD1;NLGN2;CDK18;RAPGEF5;IRF2BPL;VIPR1;CALML3;BCL6;PGM1;ANO9;TENM2;XYLT1;CYP4F22;PSD4;ZNF318;CERS4;BRSK1;SFRP1;ARHGEF4;CKLF;FHOD3;UNK;POU3F1;GAREM2;TNFSF10;MN1;DHRS4L2;DHTKD1;INSR;VAV3;FAM185A;SLC16A5;KMT5C;NPEPL1;CYBRD1;SLC29A4;GAA;DHX32;CES2;MATN2;SV2A;PKD2;TMEM200B;ESPN;SIRPB2;ZFPM1;RGMA;RTN2;NAT6;ARSI;DNM1;TMEM134;PPP2R2C;SDK2;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;TNXB;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;LY6E;ZSCAN18;NSG1;PARVB;RASIP1;BPHL;BOC;SOX12;UROS;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;PRSS3;H6PD;CLIP2;TSC22D1;SGSH;KLK5;TRERF1;SHC2;SCN4B;CRTAP;GAS8;C14ORF132;YEATS4;EVI5L;WIPF1;KRBA1;FKBP9;KCNC4;MNT;SDR9C7;RAB40B;TET1;MARVELD1;NRSN2;CYP27C1;FAM20C;GLUL;FAM213A;ANO8;EPHA4;ZNF266;WNT9A;MZT2A;TRAPPC2L;RPL13A;B3GNT9;RNPEPL1;CORO6;MAGEF1;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;HERC3;CSMD2;TCFL5;MPLKIP;TYSND1;CTXN1;CTSV;LRIG3;NXPH4;RPS6KA5;TUB;HOMER2;KLHDC8B;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;ZNF362;SCART1;PGLS;ACSL1;EPS8L2;ZBTB42;ORAI3;DDX60;ACTA2;ERBB3;HGSNAT;KIF26A;S100A6;SPOCK1;SLC38A4;CDK14;ATP6V0A2;VAMP3;PPL;CUL9;FRY;PLXND1;GJB5;CGREF1;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;SNX29;IMPA2;UNC119B;XPC;ARHGAP40;NAB2;NFATC4;ATP12A;SNX33;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;CPT1C;METTL7A;HYAL1;BCAM;RTF1;ZP3;STOM;CKMT1A;VAMP2;PLEKHH2;ADAMTS15;RBCK1;MBOAT7;AVL9;EFNB3;PCBP4;ZNF554;ADCK5;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;TNFRSF19;CABYR;SLC2A9;TMX4;MDK;TRPV4;ZDHHC1;MTHFR;PQLC2;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;RETSAT;CA11;NDUFA4L2;SDHA;KLK8;PTMS;LTBP4;ALDH2;ADORA2B;FBXW4;SERPING1;PLEKHN1;NAGLU;NMRK1;MRC2;MAFIP;MYL9;RTN4RL1;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;MC1R;IMPACT;LGALS9B;TBC1D17;MVD;GOLGA7B;IAH1;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;STON1;GPR68;TOM1L2;GPR153;ANKRD13D;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;EPM2A;RNF135;H2AFJ;LAMB2;PCDH1;STAT1;TMEM54;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;NIPAL4;WIPI2;ACKR3;PLCD1;H1FX;SLC5A1;CRY2;MARCH9;COX5B;SLC39A6;BLOC1S4;MARCKSL1;TMEM164;ZMYM3;FURIN;FBXW5;CLCN7;RHPN1;IFI16;IL20RB;CCDC88B;PCSK1;PLPP2;MLYCD;SUN1;OXLD1;THNSL2;NINL;PEX11B;FRAT1;CTSF;GJC2;ANGEL1;SLC1A4;ARPIN;SLC13A3;RPRD2;DBP;BEX2;ASIC1;MMP1;ALS2CL;PER3;XYLT2;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;CAPNS2;MEX3A;CCDC3;DOK4;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;AIF1L;MT2A;NADK;RAB43;FAM117A;VPS33B;ELFN2;SLC47A1;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;REEP6;SCMH1;ZSWIM8;DTNB;SP100;DIRC2;MPG;ABCC1;DDX59;MTMR11;IDUA;NRK;ISYNA1;PIGZ;FBXO44;SORT1;CBR3;VANGL2;APBA1;TP53I11
5494,GO:0016471,0.0672511900346512,0.992099815061273,2,11,vacuolar proton-transporting V-type ATPase complex,CC,ATP6V0A2;TCIRG1
7988,GO:0032640,0.0672537897172478,0.975574777832161,6,71,tumor necrosis factor production,BP,TNFAIP3;GPNMB;CYBA;PIK3R1;NFATC4;MC1R
5306,GO:0016050,0.0674761592794451,0.959857013103969,19,320,vesicle organization,BP,SHROOM2;VAV3;DNM1;SYT8;SERPINE2;COL7A1;EVI5L;TRAPPC2L;F2R;VAMP3;SYTL1;SNX33;VAMP2;TBC1D17;C2CD4C;BLOC1S4;ALS2CL;VPS33B;SORT1
8180,GO:0032956,0.0676546088592181,0.962542446641428,15,239,regulation of actin cytoskeleton organization,BP,SFRP1;FHOD3;WIPF1;DIXDC1;CTSV;ARHGEF19;EPS8L2;DMTN;PIK3R1;NCK2;ARHGAP40;RHOD;PLEKHH2;ARPIN;VANGL2
10782,GO:0044304,0.0679268057455305,0.981680529223439,4,37,main axon,CC,EPB41L3;DNM1;SPOCK1;GJC2
3392,GO:0007189,0.0683577798774297,0.981496543356498,4,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,PTHLH;UCN2;ADORA2B;MC1R
5419,GO:0016301,0.0684477483690517,0.953231339247249,34,629,kinase activity,MF,ULK2;MAP3K14;EPHB2;EGFR;FGFR4;CDK18;BRSK1;INSR;OBSCN;FAM20C;EPHA4;RPS6KA5;LTBP1;ERBB3;CDK14;GRK6;PIK3R1;ACVR1B;CAMKK1;TYRO3;CKMT1A;EFNB3;ADCK5;LTBP4;NMRK1;MARK4;ERBB2;NME4;CDK20;NUAK1;CAMK1;NADK;MAP3K3;NRK
13646,GO:0060228,0.0685045293408045,0.998787294303051,1,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,APOE
14089,GO:0060996,0.0687410900243498,0.974924038010405,6,69,dendritic spine development,BP,APOE;PTPRS;EPHB2;EPHA4;NCK2;CAMK1
12882,GO:0051272,0.069027640517,0.958818768366828,19,320,positive regulation of cellular component movement,BP,POSTN;GPNMB;EGFR;BCL6;INSR;CXCL14;VEGFB;DAB2IP;F2R;DMTN;PIK3R1;ACVR1B;RHOD;HYAL1;ZP3;SPRY2;TRPV4;ACKR3;MAP3K3
12071,GO:0048147,0.0690288729678598,0.98580171119386,3,24,negative regulation of fibroblast proliferation,BP,SFRP1;DAB2IP;TP53INP1
12333,GO:0048754,0.06904018020381,0.970361209419204,8,104,branching morphogenesis of an epithelial tube,BP,GLI2;PKD2;ETV5;RASIP1;PLXND1;NFATC4;SPRY2;VANGL2
9575,GO:0036465,0.0694096630662008,0.981145578990496,4,37,synaptic vesicle recycling,BP,NLGN2;DNM1;SYT8;C2CD4C
4820,GO:0014044,0.0694522361037792,0.985729313376949,3,23,Schwann cell development,BP,POU3F1;NDRG1;LAMB2
10044,GO:0042573,0.0695592815234743,0.991671282861586,2,11,retinoic acid metabolic process,BP,ALDH1A3;CYP27C1
19368,GO:1905939,0.0696164467253953,0.991660560974395,2,11,regulation of gonad development,BP,INSR;ZP3
12784,GO:0051129,0.0697093174319543,0.954521239481448,27,488,negative regulation of cellular component organization,BP,POSTN;APOE;ULK2;PTPRS;EPHB2;THRA;FHOD3;ESPN;RGMA;WNT3;EVI5L;TET1;EPHA4;RPL13A;SPOCK1;DMTN;NFATC4;SNX33;PLEKHH2;EFNB3;SPRY2;TRPV4;KLK8;RTN4RL1;IMPACT;TOM1L2;ARPIN
16862,GO:0098858,0.0697239327743537,0.968243930721607,9,123,actin-based cell projection,CC,TENM2;ESPN;EPHA4;CTSV;HOMER2;EPS8L2;ACTA2;SYTL1;TRPV4
1417,GO:0003401,0.0699431068556406,0.985586708244989,3,23,axis elongation,BP,SFRP1;SPRY2;VANGL2
4451,GO:0010464,0.0699564815349609,0.985582816539585,3,23,regulation of mesenchymal cell proliferation,BP,TBX1;FBXW4;STAT1
1196,GO:0002863,0.0700697618749841,0.998730193599861,1,2,positive regulation of inflammatory response to antigenic stimulus,BP,ZP3
1199,GO:0002866,0.0700697618749841,0.998730193599861,1,2,positive regulation of acute inflammatory response to antigenic stimulus,BP,ZP3
3779,GO:0008374,0.0701515579625595,0.98084651192691,4,38,O-acyltransferase activity,MF,CPT2;CRAT;CPT1C;MBOAT7
16448,GO:0097180,0.0705138915280923,0.998713743296164,1,2,serine protease inhibitor complex,CC,KLK8
1266,GO:0003071,0.070534182565907,0.991487717568319,2,11,renal system process involved in regulation of systemic arterial blood pressure,BP,CYBA;F2R
8697,GO:0034370,0.0705571382126853,0.998712135596439,1,2,triglyceride-rich lipoprotein particle remodeling,BP,APOE
8699,GO:0034372,0.0705571382126853,0.998712135596439,1,2,very-low-density lipoprotein particle remodeling,BP,APOE
2086,GO:0004864,0.0706174229656789,0.985338313664431,3,24,protein phosphatase inhibitor activity,MF,PPP1R35;ELFN2;PPP1R14A
12843,GO:0051220,0.0706603024871442,0.985325741256688,3,24,cytoplasmic sequestering of protein,BP,THRA;PKD2;MDFI
4224,GO:0009439,0.0707551024591953,0.998704762957946,1,2,cyanate metabolic process,BP,TST
4225,GO:0009440,0.0707551024591953,0.998704762957946,1,2,cyanate catabolic process,BP,TST
7743,GO:0032281,0.0708103159556607,0.991435449197695,2,11,AMPA glutamate receptor complex,CC,OLFM2;CPT1C
8571,GO:0034104,0.0709347684219062,0.99141185241357,2,11,negative regulation of tissue remodeling,BP,TNFAIP3;SFRP1
16829,GO:0098801,0.0710239143337363,0.991394934810479,2,11,regulation of renal system process,BP,CYBA;F2R
6836,GO:0030325,0.07103487869877,0.991392853184979,2,11,adrenal gland development,BP,INSR;MDK
11106,GO:0045185,0.0710978072454797,0.971345266686508,7,89,maintenance of protein location,BP,THRA;EPB41L3;PKD2;LTBP1;SUN1;MDFI;SP100
3275,GO:0006982,0.0711198925226023,0.998691120157422,1,2,response to lipid hydroperoxide,BP,GPX3
16822,GO:0098794,0.0711801282449451,0.95948593703163,16,257,postsynapse,CC,PTPRS;EPHB2;FBXO2;EPB41L3;NLGN2;TENM2;DNM1;NSG1;EPHA4;F2R;HOMER2;SPOCK1;DMTN;NCK2;PDLIM4;APBA1
10827,GO:0044375,0.0712224963391074,0.998687269507912,1,2,regulation of peroxisome size,BP,PEX11B
16825,GO:0098797,0.0712333564134937,0.958685819013342,17,280,plasma membrane protein complex,CC,ITGB6;EGFR;CYBA;INSR;LDLRAP1;SCN4B;KCNC4;OLFM2;GJB5;ACVR1B;ATP12A;CPT1C;VAMP2;ITGB5;SDHA;NEO1;GJC2
9872,GO:0042221,0.0712532247898185,0.942207531203281,126,2764,response to chemical,BP,TNFAIP3;POSTN;IFITM1;APOE;IFI6;LAMP3;GPNMB;NDN;MAP3K14;EPHB2;HTRA1;TXNRD3;GPX7;SRSF5;GPX3;MXRA5;SLC13A5;COL6A1;EGFR;FBXO2;THRA;CYBA;SNN;OAS2;GLI2;FGFR4;BCL6;SFRP1;CKLF;TNFSF10;INSR;VAV3;CYBRD1;CES2;MATN2;PKD2;RGMA;CXCL14;CTSB;ETV5;VEGFB;TMEM129;FOXO1;WNT3;BPHL;BOC;UROS;DAB2IP;TBX1;FAM20C;GLUL;FAM213A;EPHA4;WNT9A;RPL13A;F2R;CTSV;RPS6KA5;TUB;HOMER2;TXNDC17;LTBP1;ACSL1;ATP6V0A2;VAMP3;PLXND1;SREBF1;DMTN;ENDOG;PIK3R1;TMEM204;CTSL;TRIM22;NCK2;UCN2;XPC;NFATC4;FAM210B;CXCR1;SLC2A1;HYAL1;VAMP2;RBCK1;EFNB3;SPRY2;TP53INP1;TNFRSF19;MDK;TRPV4;MTHFR;PQLC2;ITGB5;NDRG1;LTBP4;RTN4RL1;IMPACT;NEO1;GPR68;MICALL1;ERBB2;LAMB2;STAT1;ACKR3;CRY2;FURIN;IL20RB;GJC2;SLC13A3;MMP1;PLXNB1;RASA4;SMURF1;CCDC3;DOK4;TCIRG1;MT2A;RAB43;SLC47A1;MAP3K3;PPP1R14A;ZSWIM8;SP100;ABCC1;SORT1;CBR3;VANGL2
6872,GO:0030424,0.0712603398998814,0.956151623711946,21,360,axon,CC,PTPRS;EPHB2;ADGRL1;EPB41L3;TENM2;INSR;SV2A;DNM1;LDLRAP1;BOC;DAB2IP;KCNC4;GLUL;EPHA4;SPOCK1;CPT1C;TRPV4;STAT1;BLOC1S4;GJC2;SMURF1
4441,GO:0010447,0.0713195165207798,0.991338746921728,2,11,response to acidic pH,BP,IMPACT;ASIC1
9218,GO:0035640,0.0713212414189292,0.991338418647633,2,11,exploration behavior,BP,APOE;NLGN2
7685,GO:0032190,0.0713363368728197,0.998682990283331,1,2,acrosin binding,MF,ZP3
9298,GO:0035803,0.0713363368728197,0.998682990283331,1,2,egg coat formation,BP,ZP3
2283,GO:0005261,0.0714552880512227,0.969094921653193,8,105,cation channel activity,MF,KCNJ15;SHROOM2;PKD2;SCN4B;KCNC4;ORAI3;TRPV4;ASIC1
12085,GO:0048185,0.0714993407806191,0.991304498290638,2,11,activin binding,MF,ACVR1B;SMURF1
4353,GO:0009988,0.0715049136292946,0.985029198201449,3,25,cell-cell recognition,BP,NCK2;ZP3;ST6GALNAC6
12475,GO:0050655,0.0716982760915162,0.991266550195863,2,11,dermatan sulfate proteoglycan metabolic process,BP,CSPG4;IDUA
16472,GO:0097223,0.0717343046668076,0.971019848130741,7,90,sperm part,CC,SYT8;GAS8;HEXB;ATP6V0A2;CABYR;MAFIP;SUN1
4222,GO:0009437,0.0717819889200769,0.991250562757107,2,11,carnitine metabolic process,BP,CRAT;CPT1C
7838,GO:0032420,0.0718437431547853,0.984977433156426,3,24,stereocilium,CC,ESPN;HOMER2;EPS8L2
18976,GO:1904844,0.0719778149525366,0.998658742221562,1,2,response to L-glutamine,BP,CYBA
18977,GO:1904845,0.0719778149525366,0.998658742221562,1,2,cellular response to L-glutamine,BP,CYBA
12841,GO:0051216,0.0722972200627272,0.968645618490908,8,106,cartilage development,BP,TGFBI;THRA;GLI2;WNT9A;PTHLH;HYAL1;TRPV4;FBXW4
11266,GO:0045620,0.0723435718332628,0.984829562116676,3,24,negative regulation of lymphocyte differentiation,BP,BCL6;SFRP1;ERBB2
5689,GO:0016838,0.0723614117542015,0.998644132413799,1,2,carbon-oxygen lyase activity, acting on phosphates,MF,THNSL2
19912,GO:2000501,0.0725614850045331,0.998636479740467,1,2,regulation of natural killer cell chemotaxis,BP,CXCL14
19913,GO:2000503,0.0725614850045331,0.998636479740467,1,2,positive regulation of natural killer cell chemotaxis,BP,CXCL14
5351,GO:0016175,0.072589225014884,0.998635416937539,1,2,superoxide-generating NADPH oxidase activity,MF,CYBA
10242,GO:0043020,0.072589225014884,0.998635416937539,1,2,NADPH oxidase complex,CC,CYBA
3617,GO:0008093,0.0726429770979105,0.99108548918722,2,11,cytoskeletal adaptor activity,MF,OBSL1;NCK2
1488,GO:0003845,0.07274612164054,0.998629397663564,1,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,HSD11B1
13821,GO:0060478,0.0728986444972233,0.998623532998887,1,2,acrosomal vesicle exocytosis,BP,ZP3
19840,GO:2000367,0.0728986444972233,0.998623532998887,1,2,regulation of acrosomal vesicle exocytosis,BP,ZP3
19841,GO:2000368,0.0728986444972233,0.998623532998887,1,2,positive regulation of acrosomal vesicle exocytosis,BP,ZP3
868,GO:0002225,0.0729525083632665,0.998621458769171,1,2,positive regulation of antimicrobial peptide production,BP,KLK5
1145,GO:0002760,0.0729525083632665,0.998621458769171,1,2,positive regulation of antimicrobial humoral response,BP,KLK5
1164,GO:0002803,0.0729525083632665,0.998621458769171,1,2,positive regulation of antibacterial peptide production,BP,KLK5
4866,GO:0014802,0.0730001293072476,0.998619623595521,1,2,terminal cisterna,CC,RTN2
12863,GO:0051249,0.0730302505570605,0.959108111276626,15,245,regulation of lymphocyte activation,BP,TNFAIP3;GPNMB;MAP3K14;GLI2;BCL6;SFRP1;VAV3;PIK3R1;NCK2;TYRO3;ZP3;EFNB3;ERBB2;IL20RB;CCDC88B
3366,GO:0007159,0.0731075138804582,0.962116465476506,12,185,leukocyte cell-cell adhesion,BP,GPNMB;MAP3K14;GLI2;BCL6;NT5E;PIK3R1;NCK2;ZP3;EFNB3;ERBB2;IL20RB;CCDC88B
12028,GO:0048013,0.0731200414753276,0.972865160329418,6,72,ephrin receptor signaling pathway,BP,EPHB2;VAV3;DNM1;EPHA4;NCK2;EFNB3
19464,GO:1990379,0.0732043859784432,0.998611737748762,1,2,lipid transport across blood brain barrier,BP,APOE
1083,GO:0002678,0.0732112405364908,0.998611472706514,1,2,positive regulation of chronic inflammatory response,BP,ADORA2B
7478,GO:0031669,0.0732240681198405,0.963304862202088,11,164,cellular response to nutrient levels,BP,POSTN;CYBA;SFRP1;FOXO1;GLUL;CTSV;SREBF1;UCN2;SLC2A1;IMPACT;IFI16
535,GO:0001654,0.0733092624837491,0.959872152663129,14,219,eye development,BP,ALDH1A3;EPHB2;NINJ1;SLITRK6;SHROOM2;EGFR;SDK2;SALL2;TMEM231;WNT9A;TUB;NAGLU;LAMB2;TULP3
16679,GO:0097720,0.0733191396236136,0.984539649440935,3,24,calcineurin-mediated signaling,BP,ADGRB2;ERBB3;NFATC4
19328,GO:1905809,0.0733802998344899,0.990943196836658,2,11,negative regulation of synapse organization,BP,APOE;NFATC4
4697,GO:0010877,0.0734670148562332,0.998601564002038,1,2,lipid transport involved in lipid storage,BP,APOE
2335,GO:0005402,0.0735910432062933,0.99090236944345,2,11,carbohydrate:cation symporter activity,MF,SLC2A9;SLC5A1
13584,GO:0060119,0.073594136985559,0.984457618670675,3,24,inner ear receptor cell development,BP,SLITRK6;NAGLU;VANGL2
3153,GO:0006780,0.0735977841759443,0.998596483853273,1,2,uroporphyrinogen III biosynthetic process,BP,UROS
11674,GO:0046502,0.0735977841759443,0.998596483853273,1,2,uroporphyrinogen III metabolic process,BP,UROS
4473,GO:0010513,0.0738956960179598,0.998584874781599,1,2,positive regulation of phosphatidylinositol biosynthetic process,BP,ZP3
2182,GO:0005055,0.0739260410825596,0.998583689502284,1,2,laminin receptor activity,MF,BCAM
7848,GO:0032431,0.0739847117461935,0.998581396361738,1,2,activation of phospholipase A2 activity,BP,EGFR
4219,GO:0009416,0.0740021458713178,0.95942335914467,14,223,response to light stimulus,BP,EGFR;BRSK1;DDB2;PIK3R1;XPC;NFATC4;HYAL1;TP53INP1;MC1R;IMPACT;CRTC1;CRY2;PER3;REEP6
17427,GO:1900273,0.0741272355192084,0.990798178529912,2,11,positive regulation of long-term synaptic potentiation,BP,EPHB2;CRTC1
6970,GO:0030669,0.0743514404315465,0.984231018186705,3,24,clathrin-coated endocytic vesicle membrane,CC,APOE;EGFR;LDLRAP1
15555,GO:0072077,0.0743885501211421,0.990747237581746,2,11,renal vesicle morphogenesis,BP,KIF26B;STAT1
15561,GO:0072087,0.0743885501211421,0.990747237581746,2,11,renal vesicle development,BP,KIF26B;STAT1
800,GO:0002076,0.0745887162129769,0.99070814472249,2,11,osteoblast development,BP,GLI2;PTHLH
20021,GO:2000696,0.0747826076027776,0.990670217603544,2,11,regulation of epithelial cell differentiation involved in kidney development,BP,WWTR1;STAT1
159,GO:0000323,0.074983630685562,0.950314903822799,28,518,lytic vacuole,CC,TNFAIP3;LAMP3;COL6A1;CYBRD1;GAA;CTSB;NSG1;SGSH;CTSV;HEXB;HGSNAT;ATP6V0A2;CSPG4;SDC3;CTSL;HYAL1;STOM;PQLC2;GPC4;NAGLU;MARCH9;CLCN7;CTSF;TCIRG1;VPS33B;DIRC2;IDUA;SORT1
2497,GO:0005764,0.074983630685562,0.950314903822799,28,518,lysosome,CC,TNFAIP3;LAMP3;COL6A1;CYBRD1;GAA;CTSB;NSG1;SGSH;CTSV;HEXB;HGSNAT;ATP6V0A2;CSPG4;SDC3;CTSL;HYAL1;STOM;PQLC2;GPC4;NAGLU;MARCH9;CLCN7;CTSF;TCIRG1;VPS33B;DIRC2;IDUA;SORT1
6522,GO:0021953,0.0753154060401914,0.96924268520966,7,89,central nervous system neuron differentiation,BP,EPHB2;GLI2;SFRP1;WNT3;EPHA4;SPOCK1;TULP3
8893,GO:0034762,0.0753437065445078,0.956766322845064,16,262,regulation of transmembrane transport,BP,KCNJ15;EPHB2;CYBA;NLGN2;ANO9;INSR;PKD2;RTN2;SCN4B;KCNC4;F2R;PIK3R1;SLC2A1;STOM;VAMP2;GJC2
7124,GO:0030984,0.0753945430761283,0.998525713001734,1,2,kininogen binding,MF,CTSV
18300,GO:1903305,0.0754434154770335,0.971779981266728,6,72,regulation of regulated secretory pathway,BP,RIMS3;SYT8;SYTL1;ZP3;ADORA2B;C2CD4C
16452,GO:0097191,0.0755453161708109,0.961923182501546,11,167,extrinsic apoptotic signaling pathway,BP,TNFAIP3;IFI6;SFRP1;TNFSF10;DAB2IP;ERBB3;PIK3R1;ACVR1B;RBCK1;SP100;SORT1
14489,GO:0070032,0.0758931165425977,0.998505754198463,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,VAMP2
14490,GO:0070033,0.0758931165425977,0.998505754198463,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,VAMP2
9951,GO:0042374,0.0759364585732129,0.99850401254229,1,2,phylloquinone metabolic process,BP,CBR3
9952,GO:0042376,0.0759364585732129,0.99850401254229,1,2,phylloquinone catabolic process,BP,CBR3
17692,GO:1901662,0.0759364585732129,0.99850401254229,1,2,quinone catabolic process,BP,CBR3
8802,GO:0034612,0.0760755629935413,0.959137113568428,13,211,response to tumor necrosis factor,BP,TNFAIP3;POSTN;MAP3K14;CYBA;SFRP1;DAB2IP;TXNDC17;ENDOG;HYAL1;RBCK1;TNFRSF19;STAT1;CCDC3
7953,GO:0032589,0.0761265546720187,0.983695867653985,3,24,neuron projection membrane,CC,EPB41L3;INSR;KCNC4
14259,GO:0061430,0.0761564920090099,0.990399792168383,2,11,bone trabecula morphogenesis,BP,SFRP1;PLXNB1
5050,GO:0015291,0.0761985952284884,0.964675346506869,9,125,secondary active transmembrane transporter activity,MF,SLC13A5;SLC16A5;SLC38A4;SLC2A9;SLC5A1;CLCN7;SLC1A4;SLC13A3;SLC47A1
13522,GO:0060026,0.0763889453271581,0.990353747235536,2,11,convergent extension,BP,SFRP1;VANGL2
10334,GO:0043183,0.076518827470312,0.998480508238901,1,2,vascular endothelial growth factor receptor 1 binding,MF,VEGFB
12211,GO:0048522,0.0765821705125934,0.936804309300877,156,3464,positive regulation of cellular process,BP,TNFAIP3;POSTN;IFITM1;PEG3;APOE;ALDH1A3;OBSL1;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ASH2L;HTRA1;SLITRK6;ADGRL1;SRSF5;EGFR;THRA;CITED4;CYBA;TCEA2;GLI2;FGFR4;NLGN2;IRF2BPL;VIPR1;BCL6;TENM2;ZNF318;SFRP1;ARHGEF4;POU3F1;TNFSF10;INSR;VAV3;PKD2;ESPN;ZFPM1;RGMA;CXCL14;LDLRAP1;RIMS3;ETV5;SERPINE2;SALL2;TP53INP2;VEGFB;WWTR1;FOXO1;WNT3;TRIM65;NSG1;BOC;SOX12;DDB2;DAB2IP;OBSCN;TBX1;KLK5;TRERF1;SHC2;SH3BP2;YEATS4;WIPF1;TET1;FAM20C;GLUL;EPHA4;WNT9A;MAGEF1;DIXDC1;TENM4;OLFM2;F2R;SMARCA1;RPS6KA5;TUB;SEC14L2;ARHGEF19;HEXB;ACSL1;EPS8L2;DDX60;ERBB3;S100A6;VAMP3;PLXND1;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;NAB2;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CLEC11A;HYAL1;RTF1;ZP3;VAMP2;RBCK1;EFNB3;PCBP4;SPRY2;TP53INP1;TNFRSF19;MDK;TRPV4;NDRG1;ADORA2B;FBXW4;MARK4;MC1R;IMPACT;MVD;NEO1;CRTC1;IGFBP4;GPR68;ERBB2;RNF187;EPM2A;STAT1;CDK20;ACKR3;MARCKSL1;FURIN;IFI16;CCDC88B;MLYCD;GJC2;ARPIN;DBP;MMP1;PLXNB1;SMURF1;CCDC3;CXXC5;CAMK1;TCIRG1;MAP3K3;SP100;NRK;SORT1;VANGL2
18192,GO:1903037,0.0766677641500288,0.961258779222797,11,167,regulation of leukocyte cell-cell adhesion,BP,GPNMB;MAP3K14;GLI2;BCL6;PIK3R1;NCK2;ZP3;EFNB3;ERBB2;IL20RB;CCDC88B
12944,GO:0051387,0.0767722469325307,0.998470220731631,1,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
19280,GO:1905602,0.0767998113635631,0.998469099581247,1,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,LDLRAP1
8095,GO:0032805,0.0768272972883375,0.99846798119837,1,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE
6281,GO:0019912,0.0768302698744004,0.998467860220471,1,2,cyclin-dependent protein kinase activating kinase activity,MF,CDK20
18940,GO:1904768,0.076916600158728,0.998464344593505,1,2,all-trans-retinol binding,MF,CYP27C1
14952,GO:0070905,0.0769625190821216,0.998462472929257,1,2,serine binding,MF,THNSL2
6061,GO:0019233,0.0770537999508635,0.978228107626869,4,40,sensory perception of pain,BP,NDN;NLGN2;F2R;ALOXE3
19637,GO:1990967,0.0770627000299347,0.998458385415855,1,2,multi-organism toxin transport,BP,RAB40B
13963,GO:0060720,0.0770752150680976,0.998457874389067,1,2,spongiotrophoblast cell proliferation,BP,NRK
13964,GO:0060721,0.0770752150680976,0.998457874389067,1,2,regulation of spongiotrophoblast cell proliferation,BP,NRK
13965,GO:0060722,0.0770752150680976,0.998457874389067,1,2,cell proliferation involved in embryonic placenta development,BP,NRK
13966,GO:0060723,0.0770752150680976,0.998457874389067,1,2,regulation of cell proliferation involved in embryonic placenta development,BP,NRK
16149,GO:0090214,0.0770752150680976,0.998457874389067,1,2,spongiotrophoblast layer developmental growth,BP,NRK
16197,GO:0090289,0.0771416180532182,0.998455161479885,1,2,regulation of osteoclast proliferation,BP,TNFAIP3
11958,GO:0047374,0.0771697744065454,0.998454010396258,1,2,methylumbelliferyl-acetate deacetylase activity,MF,CES2
9452,GO:0036117,0.0772425991051914,0.998451031118354,1,2,hyaluranon cable,CC,HYAL1
13614,GO:0060166,0.0772662430951255,0.998450063194329,1,2,olfactory pit development,BP,ALDH1A3
5060,GO:0015307,0.0772795490533854,0.998449518344275,1,2,drug:proton antiporter activity,MF,SLC47A1
11724,GO:0046618,0.0772795490533854,0.998449518344275,1,2,drug export,BP,SLC47A1
1245,GO:0003010,0.0772835998396329,0.998449352453594,1,2,voluntary skeletal muscle contraction,BP,SYNM
4850,GO:0014721,0.0772835998396329,0.998449352453594,1,2,twitch skeletal muscle contraction,BP,SYNM
9237,GO:0035674,0.0773114852675518,0.99844821021899,1,2,tricarboxylic acid transmembrane transport,BP,SLC13A5
5446,GO:0016361,0.0773170199690874,0.998447983456116,1,2,activin receptor activity, type I,MF,ACVR1B
12083,GO:0048179,0.0773170199690874,0.998447983456116,1,2,activin receptor complex,CC,ACVR1B
10342,GO:0043196,0.0773301443910957,0.998447445665012,1,2,varicosity,CC,DNM1
3424,GO:0007231,0.0773352462511539,0.998447236583153,1,2,osmosensory signaling pathway,BP,TRPV4
16330,GO:0090677,0.0773592228062506,0.99844625379175,1,2,reversible differentiation,BP,OLFM2
16331,GO:0090678,0.0773592228062506,0.99844625379175,1,2,cell dedifferentiation involved in phenotypic switching,BP,OLFM2
19119,GO:1905174,0.0773592228062506,0.99844625379175,1,2,regulation of vascular smooth muscle cell dedifferentiation,BP,OLFM2
19631,GO:1990936,0.0773592228062506,0.99844625379175,1,2,vascular smooth muscle cell dedifferentiation,BP,OLFM2
19032,GO:1904954,0.0773645777071344,0.998446034251835,1,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3
867,GO:0002224,0.0773910438537939,0.968175174472497,7,91,toll-like receptor signaling pathway,BP,TNFAIP3;PTPRS;CYBA;CTSB;DAB2IP;CTSL;TYRO3
9526,GO:0036324,0.0773986394646045,0.998444637411851,1,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,DAB2IP
18142,GO:1902952,0.0775426012916437,0.99843872645861,1,2,positive regulation of dendritic spine maintenance,BP,APOE
11679,GO:0046513,0.0776289102952734,0.978010630795004,4,40,ceramide biosynthetic process,BP,ST3GAL5;CERS4;ALOXE3;ST6GALNAC6
8059,GO:0032764,0.0776795565109808,0.998433092355212,1,2,negative regulation of mast cell cytokine production,BP,BCL6
16410,GO:0097114,0.0776916990121052,0.998432592323518,1,2,NMDA glutamate receptor clustering,BP,APOE
17675,GO:1901629,0.0776916990121052,0.998432592323518,1,2,regulation of presynaptic membrane organization,BP,APOE
18165,GO:1902994,0.0776916990121052,0.998432592323518,1,2,regulation of phospholipid efflux,BP,APOE
18166,GO:1902995,0.0776916990121052,0.998432592323518,1,2,positive regulation of phospholipid efflux,BP,APOE
7247,GO:0031235,0.0777094664611054,0.990090585607635,2,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,DAB2IP;RASA4
7590,GO:0031998,0.0777426830702897,0.990083931212797,2,11,regulation of fatty acid beta-oxidation,BP,TYSND1;MLYCD
15809,GO:0072566,0.0777521457222771,0.99843010187446,1,2,chemokine (C-X-C motif) ligand 1 production,BP,TRPV4
19820,GO:2000338,0.0777521457222771,0.99843010187446,1,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,TRPV4
19821,GO:2000340,0.0777521457222771,0.99843010187446,1,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,TRPV4
19739,GO:2000196,0.077792669182542,0.998428431125226,1,2,positive regulation of female gonad development,BP,ZP3
19855,GO:2000386,0.077792669182542,0.998428431125226,1,2,positive regulation of ovarian follicle development,BP,ZP3
2143,GO:0004977,0.0778837420359558,0.998424672888788,1,2,melanocortin receptor activity,MF,MC1R
15945,GO:0080184,0.0779632576548776,0.9984213877538,1,2,response to phenylpropanoid,BP,EGFR
17334,GO:1900101,0.078213558045116,0.983005284645047,3,25,regulation of endoplasmic reticulum unfolded protein response,BP,DAB2IP;PIK3R1;NCK2
6046,GO:0019212,0.0782711468915986,0.982987565819562,3,25,phosphatase inhibitor activity,MF,PPP1R35;ELFN2;PPP1R14A
10809,GO:0044338,0.0782743737626227,0.998408499941947,1,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,WNT3
14939,GO:0070889,0.0783698253651278,0.998404534970695,1,2,platelet alpha granule organization,BP,VPS33B
13796,GO:0060437,0.0784192217607575,0.998402481072303,1,2,lung growth,BP,SPRY2
9685,GO:0038131,0.0784331234990155,0.998401902790895,1,2,neuregulin receptor activity,MF,ERBB3
10128,GO:0042743,0.0784399462013425,0.982885491377893,3,26,hydrogen peroxide metabolic process,BP,GPX3;EGFR;CYBA
9385,GO:0035981,0.0784789705318136,0.998399994883606,1,2,tongue muscle cell differentiation,BP,TBX1
18085,GO:1902811,0.0784789705318136,0.998399994883606,1,2,positive regulation of skeletal muscle fiber differentiation,BP,TBX1
20149,GO:2001035,0.0784789705318136,0.998399994883606,1,2,regulation of tongue muscle cell differentiation,BP,TBX1
20150,GO:2001037,0.0784789705318136,0.998399994883606,1,2,positive regulation of tongue muscle cell differentiation,BP,TBX1
18381,GO:1903487,0.0784804198000607,0.99839993455351,1,2,regulation of lactation,BP,OAS2
13553,GO:0060061,0.078533053744421,0.998397742706254,1,2,Spemann organizer formation,BP,WNT3
8094,GO:0032804,0.0785940807903403,0.998395199386412,1,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,FURIN
6360,GO:0021564,0.0786499790292527,0.998392867967135,1,2,vagus nerve development,BP,TBX1
18379,GO:1903464,0.0786680614256769,0.998392113404081,1,2,negative regulation of mitotic cell cycle DNA replication,BP,BCL6
8100,GO:0032810,0.0786702217394443,0.998392023243682,1,2,sterol response element binding,MF,SREBF1
15392,GO:0071706,0.0786937130165098,0.970217546973305,6,74,tumor necrosis factor superfamily cytokine production,BP,TNFAIP3;GPNMB;CYBA;PIK3R1;NFATC4;MC1R
1082,GO:0002677,0.0787059771765151,0.998390530612887,1,2,negative regulation of chronic inflammatory response,BP,TNFAIP3
2576,GO:0005884,0.0787302729854739,0.970214288052557,6,73,actin filament,CC,PKD2;ESPN;WIPF1;DMTN;PDLIM4;AIF1L
17905,GO:1902287,0.07892908478178,0.989845139648231,2,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,PLXND1;PLXNB1
5045,GO:0015276,0.0790828187935539,0.977489245958426,4,39,ligand-gated ion channel activity,MF,KCNJ15;SHROOM2;PKD2;ASIC1
6593,GO:0022834,0.0790828187935539,0.977489245958426,4,39,ligand-gated channel activity,MF,KCNJ15;SHROOM2;PKD2;ASIC1
14724,GO:0070447,0.0790963572177223,0.998374187028079,1,2,positive regulation of oligodendrocyte progenitor proliferation,BP,GJC2
19578,GO:1990769,0.0792719349095399,0.998366808267568,1,2,proximal neuron projection,CC,GJC2
8256,GO:0033084,0.0793006478913587,0.998365599930244,1,2,regulation of immature T cell proliferation in thymus,BP,ERBB2
8259,GO:0033088,0.0793006478913587,0.998365599930244,1,2,negative regulation of immature T cell proliferation in thymus,BP,ERBB2
2159,GO:0005006,0.0793246074752945,0.998364591275181,1,2,epidermal growth factor-activated receptor activity,MF,EGFR
6789,GO:0030260,0.079442849682658,0.967133633293296,7,91,entry into host cell,BP,IFITM1;ITGB6;EGFR;CTSB;TYRO3;EFNB3;ITGB5
10841,GO:0044409,0.079442849682658,0.967133633293296,7,91,entry into host,BP,IFITM1;ITGB6;EGFR;CTSB;TYRO3;EFNB3;ITGB5
13156,GO:0051806,0.079442849682658,0.967133633293296,7,91,entry into cell of other organism involved in symbiotic interaction,BP,IFITM1;ITGB6;EGFR;CTSB;TYRO3;EFNB3;ITGB5
13163,GO:0051828,0.079442849682658,0.967133633293296,7,91,entry into other organism involved in symbiotic interaction,BP,IFITM1;ITGB6;EGFR;CTSB;TYRO3;EFNB3;ITGB5
15938,GO:0080144,0.0794519229626871,0.99835922608343,1,2,amino acid homeostasis,BP,PQLC2
10289,GO:0043112,0.0795106249245894,0.962809094604148,9,128,receptor metabolic process,BP,APOE;DNM1;LDLRAP1;NSG1;VAMP3;CXCR1;ACKR3;FURIN;SMURF1
18699,GO:1904207,0.0795161607048775,0.998356515569582,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
18700,GO:1904209,0.0795161607048775,0.998356515569582,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
10065,GO:0042599,0.0795408969600265,0.989589225133801,2,12,lamellar body,CC,LAMP3;KLK5
3464,GO:0007340,0.0796957880203437,0.989557357086091,2,12,acrosome reaction,BP,SYT8;ZP3
6070,GO:0019254,0.0797535230586007,0.998346479827127,1,2,carnitine metabolic process, CoA-linked,BP,CRAT
11516,GO:0046086,0.0798611281870033,0.998341919762397,1,2,adenosine biosynthetic process,BP,NT5E
1971,GO:0004703,0.0799577275609553,0.998337820520197,1,2,G-protein coupled receptor kinase activity,MF,GRK6
11993,GO:0047696,0.0799577275609553,0.998337820520197,1,2,beta-adrenergic receptor kinase activity,MF,GRK6
12775,GO:0051120,0.0800464350803323,0.998334051524795,1,2,hepoxilin A3 synthase activity,MF,ALOXE3
16806,GO:0098758,0.0800665964721319,0.99833319428908,1,2,response to interleukin-8,BP,CXCR1
16807,GO:0098759,0.0800665964721319,0.99833319428908,1,2,cellular response to interleukin-8,BP,CXCR1
8816,GO:0034635,0.0801327781441585,0.998330378715824,1,2,glutathione transport,BP,ABCC1
10203,GO:0042939,0.0801327781441585,0.998330378715824,1,2,tripeptide transport,BP,ABCC1
4501,GO:0010572,0.0802562968360391,0.998325117220697,1,2,positive regulation of platelet activation,BP,DMTN
17721,GO:1901731,0.0802562968360391,0.998325117220697,1,2,positive regulation of platelet aggregation,BP,DMTN
7922,GO:0032535,0.0802765744466391,0.953520441881364,16,265,regulation of cellular component size,BP,APOE;ULK2;PTPRS;FHOD3;VAV3;WNT3;WIPF1;EPHA4;EPS8L2;DMTN;NCK2;ARHGAP40;PLEKHH2;TRPV4;PEX11B;ARPIN
18132,GO:1902938,0.0802909675375661,0.998323638809944,1,2,regulation of intracellular calcium activated chloride channel activity,BP,ANO9
7944,GO:0032571,0.0803383888810841,0.998321615591327,1,2,response to vitamin K,BP,POSTN
15134,GO:0071307,0.0803383888810841,0.998321615591327,1,2,cellular response to vitamin K,BP,POSTN
5783,GO:0017055,0.080393176333809,0.998319276515325,1,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
2336,GO:0005412,0.0804943929835385,0.998314950739649,1,2,glucose:sodium symporter activity,MF,SLC5A1
13632,GO:0060199,0.0805747166176862,0.998311513758527,1,2,clathrin-sculpted glutamate transport vesicle,CC,VAMP2
13635,GO:0060203,0.0805747166176862,0.998311513758527,1,2,clathrin-sculpted glutamate transport vesicle membrane,CC,VAMP2
19454,GO:1990269,0.0806063527913903,0.998310159070615,1,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,RTF1
5102,GO:0015467,0.0806590195206956,0.998307902579626,1,2,G-protein activated inward rectifier potassium channel activity,MF,KCNJ15
7203,GO:0031117,0.0806877007367034,0.998306673080648,1,2,positive regulation of microtubule depolymerization,BP,TRPV4
14719,GO:0070435,0.0807019872299267,0.99830606047716,1,2,Shc-EGFR complex,CC,EGFR
5518,GO:0016524,0.0807291608321694,0.998304894956698,1,2,latrotoxin receptor activity,MF,ADGRL1
6001,GO:0019075,0.0807291608321694,0.998304894956698,1,2,virus maturation,BP,MVB12B
19929,GO:2000543,0.0807291608321694,0.998304894956698,1,2,positive regulation of gastrulation,BP,TENM4
12309,GO:0048708,0.0807878534720124,0.976805645771138,4,40,astrocyte differentiation,BP,EGFR;SERPINE2;EPHA4;LAMB2
16046,GO:0090066,0.0810301903588797,0.950665436551915,19,327,regulation of anatomical structure size,BP,APOE;ULK2;PTPRS;EGFR;FHOD3;VAV3;WNT3;WIPF1;EPHA4;F2R;EPS8L2;DMTN;NCK2;ARHGAP40;PLEKHH2;TRPV4;ADORA2B;PEX11B;ARPIN
19422,GO:1990164,0.0810390049050334,0.998291575667174,1,2,histone H2A phosphorylation,BP,RPS6KA5
1739,GO:0004351,0.0811438511778943,0.998287056318637,1,2,glutamate decarboxylase activity,MF,GLUL
17814,GO:1902044,0.0811941560206356,0.998284885741323,1,2,regulation of Fas signaling pathway,BP,SP100
3379,GO:0007173,0.0812352656264382,0.963863939071512,8,109,epidermal growth factor receptor signaling pathway,BP,MVB12B;EGFR;RHBDF1;DAB2IP;RPS6KA5;PIK3R1;NCK2;SPRY2
1733,GO:0004345,0.0812909244135874,0.998280706300177,1,2,glucose-6-phosphate dehydrogenase activity,MF,H6PD
20222,GO:2001226,0.0813337113104272,0.998278856635792,1,2,negative regulation of chloride transport,BP,ANO9
13545,GO:0060053,0.081448468596273,0.998273890589882,1,2,neurofilament cytoskeleton,CC,SYNM
6507,GO:0021914,0.081480954425677,0.998272483431276,1,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,TULP3
8851,GO:0034685,0.0815157347105501,0.998270976222699,1,2,integrin alphav-beta6 complex,CC,ITGB6
537,GO:0001656,0.0815451965938804,0.972276110456455,5,56,metanephros development,BP,PKD2;WWTR1;KIF26B;LAMB2;STAT1
3595,GO:0008050,0.0815609502953945,0.998269015773558,1,2,female courtship behavior,BP,THRA
11433,GO:0045924,0.0815609502953945,0.998269015773558,1,2,regulation of female receptivity,BP,THRA
6845,GO:0030335,0.0816088570450189,0.950999066538729,18,306,positive regulation of cell migration,BP,POSTN;GPNMB;EGFR;INSR;CXCL14;VEGFB;DAB2IP;F2R;DMTN;PIK3R1;ACVR1B;RHOD;HYAL1;ZP3;SPRY2;TRPV4;ACKR3;MAP3K3
12293,GO:0048682,0.0816359449728793,0.998265761612098,1,2,sprouting of injured axon,BP,LAMB2
15352,GO:0071642,0.0817187737763338,0.998262163806587,1,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,TRPV4
14266,GO:0061441,0.0817431552997376,0.99826110401374,1,2,renal artery morphogenesis,BP,PKD2
15551,GO:0072073,0.0817806078334357,0.965949877008603,7,90,kidney epithelium development,BP,SFRP1;PKD2;WWTR1;EPHA4;KIF26B;LAMB2;STAT1
16462,GO:0097201,0.0817825705492319,0.989124397193119,2,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,NCK2;IMPACT
17016,GO:0099541,0.0818460054637108,0.998256629709666,1,2,trans-synaptic signaling by lipid,BP,F2R
17017,GO:0099542,0.0818460054637108,0.998256629709666,1,2,trans-synaptic signaling by endocannabinoid,BP,F2R
13794,GO:0060434,0.0818970619028116,0.998254406366066,1,2,bronchus morphogenesis,BP,TULP3
6349,GO:0021549,0.0821491022749603,0.972010940412175,5,56,cerebellum development,BP,PTPRS;GLI2;SERPINE2;MDK;NAGLU
15119,GO:0071277,0.0821907137001372,0.976264918250685,4,40,cellular response to calcium ion,BP,PKD2;DMTN;ENDOG;RASA4
18948,GO:1904783,0.0822707917558051,0.998238086594295,1,2,positive regulation of NMDA glutamate receptor activity,BP,EPHB2
11398,GO:0045860,0.0823138886010989,0.948461138499051,21,369,positive regulation of protein kinase activity,BP,MAP3K14;EGFR;INSR;PKD2;DAB2IP;SHC2;EPHA4;F2R;ACSL1;ERBB3;CSPG4;CAMKK1;NAB2;SPRY2;ADORA2B;ERBB2;CDK20;CAMK1;MAP3K3;NRK;VANGL2
1078,GO:0002673,0.0824235436091315,0.981641294883248,3,26,regulation of acute inflammatory response,BP,ZP3;SERPING1;IL20RB
11464,GO:0045981,0.0824409560974636,0.976137124084227,4,41,positive regulation of nucleotide metabolic process,BP,APOE;INSR;PTHLH;ADORA2B
17463,GO:1900544,0.0824409560974636,0.976137124084227,4,41,positive regulation of purine nucleotide metabolic process,BP,APOE;INSR;PTHLH;ADORA2B
3929,GO:0008643,0.0826307325947582,0.965501724203521,7,91,carbohydrate transport,BP,INSR;RTN2;PIK3R1;SLC2A1;SLC2A9;SLC5A1;SORT1
7469,GO:0031657,0.0826809470190595,0.988935939756603,2,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;PKD2
7358,GO:0031430,0.0826896553377538,0.9889341069036,2,12,M band,CC,OBSL1;OBSCN
16213,GO:0090310,0.0827177509848722,0.998218464977479,1,2,negative regulation of methylation-dependent chromatin silencing,BP,TET1
18793,GO:1904426,0.0827288178226537,0.998217977701255,1,2,positive regulation of GTP binding,BP,EPHA4
5715,GO:0016880,0.0827319109017972,0.998217841499601,1,2,acid-ammonia (or amide) ligase activity,MF,GLUL
13706,GO:0060319,0.082732576354054,0.99821781219615,1,2,primitive erythrocyte differentiation,BP,ZFPM1
4494,GO:0010562,0.0828734884223293,0.941766946941974,36,691,positive regulation of phosphorus metabolic process,BP,APOE;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;INSR;VAV3;PKD2;DAB2IP;TBX1;SHC2;EPHA4;F2R;RPS6KA5;ACSL1;ERBB3;CSPG4;PTHLH;ACVR1B;CAMKK1;NAB2;TYRO3;ZP3;SPRY2;TNFRSF19;TRPV4;ADORA2B;IGFBP4;ERBB2;CDK20;ACKR3;CAMK1;MAP3K3;NRK;VANGL2
11444,GO:0045937,0.0828734884223293,0.941766946941974,36,691,positive regulation of phosphate metabolic process,BP,APOE;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;INSR;VAV3;PKD2;DAB2IP;TBX1;SHC2;EPHA4;F2R;RPS6KA5;ACSL1;ERBB3;CSPG4;PTHLH;ACVR1B;CAMKK1;NAB2;TYRO3;ZP3;SPRY2;TNFRSF19;TRPV4;ADORA2B;IGFBP4;ERBB2;CDK20;ACKR3;CAMK1;MAP3K3;NRK;VANGL2
7507,GO:0031749,0.0829038877791489,0.998210260061114,1,2,D2 dopamine receptor binding,MF,DNM1
19861,GO:2000393,0.0829581470033602,0.998207864606886,1,2,negative regulation of lamellipodium morphogenesis,BP,ARPIN
17752,GO:1901873,0.0829786810524554,0.998206957626487,1,2,regulation of post-translational protein modification,BP,CRTAP
17753,GO:1901874,0.0829786810524554,0.998206957626487,1,2,negative regulation of post-translational protein modification,BP,CRTAP
18528,GO:1903796,0.0829812349040642,0.99820684480717,1,2,negative regulation of inorganic anion transmembrane transport,BP,ANO9
10813,GO:0044342,0.0830374508475886,0.988860810864822,2,12,type B pancreatic cell proliferation,BP,SFRP1;IGFBP4
2234,GO:0005159,0.0830831844396678,0.988851158973556,2,12,insulin-like growth factor receptor binding,MF,INSR;PIK3R1
5044,GO:0015275,0.0831042633817538,0.998201405492816,1,2,stretch-activated, cation-selective, calcium channel activity,MF,TRPV4
17271,GO:0140135,0.0831042633817538,0.998201405492816,1,2,mechanosensitive cation channel activity,MF,TRPV4
1395,GO:0003340,0.0831126002029819,0.998201036595434,1,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,STAT1
20022,GO:2000697,0.0831126002029819,0.998201036595434,1,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,STAT1
4278,GO:0009726,0.0831768780485711,0.998198191027771,1,2,detection of endogenous stimulus,BP,PKD2
6293,GO:0019956,0.0833007114296743,0.988805206952044,2,12,chemokine binding,MF,CXCR1;ACKR3
12136,GO:0048294,0.0833063430246907,0.998192452508524,1,2,negative regulation of isotype switching to IgE isotypes,BP,BCL6
2580,GO:0005889,0.0833479369033676,0.998190606842168,1,2,potassium:proton exchanging ATPase complex,CC,ATP12A
1693,GO:0004197,0.0833564051703621,0.967969485277556,6,75,cysteine-type endopeptidase activity,MF,SFRP1;CTSB;CTSV;CTSL;CTSF;CAPNS2
4259,GO:0009637,0.0834065311764234,0.998188005139501,1,2,response to blue light,BP,CRY2
4291,GO:0009785,0.0834065311764234,0.998188005139501,1,2,blue light signaling pathway,BP,CRY2
4316,GO:0009882,0.0834065311764234,0.998188005139501,1,2,blue light photoreceptor activity,MF,CRY2
15257,GO:0071483,0.0834065311764234,0.998188005139501,1,2,cellular response to blue light,BP,CRY2
3734,GO:0008289,0.0834590693093519,0.945446539550222,25,455,lipid binding,MF,APOE;MVB12B;PSD4;LDLRAP1;SYT8;DAB2IP;CYP27C1;TUB;SEC14L2;IQSEC1;SYTL1;SNX29;UNC119B;SNX33;VAMP2;MICALL1;C2CD4C;HSD11B1;TULP3;NME4;WIPI2;PLCD1;RASA4;SMURF1;NISCH
8144,GO:0032902,0.0835092237273278,0.998183440675389,1,2,nerve growth factor production,BP,FURIN
10026,GO:0042539,0.0835842581448354,0.998180101763459,1,2,hypotonic salinity response,BP,TRPV4
15251,GO:0071477,0.0835842581448354,0.998180101763459,1,2,cellular hypotonic salinity response,BP,TRPV4
15608,GO:0072162,0.0836963732926703,0.998175106849847,1,2,metanephric mesenchymal cell differentiation,BP,STAT1
13957,GO:0060712,0.0837388233349918,0.988712437295393,2,12,spongiotrophoblast layer development,BP,GJB5;NRK
2278,GO:0005249,0.0837526487225817,0.981274733756145,3,25,voltage-gated potassium channel activity,MF,KCNJ15;PKD2;KCNC4
7951,GO:0032587,0.0837531812573707,0.96780750871626,6,73,ruffle membrane,CC,PSD4;ARHGEF4;EPS8L2;SPRY2;TRPV4;AIF1L
1324,GO:0003192,0.0837539522779538,0.998172538832039,1,2,mitral valve formation,BP,ZFPM1
15596,GO:0072135,0.0838087595062692,0.998170092681844,1,2,kidney mesenchymal cell proliferation,BP,STAT1
15597,GO:0072136,0.0838087595062692,0.998170092681844,1,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,STAT1
8365,GO:0033300,0.0838625002598365,0.99816769247056,1,2,dehydroascorbic acid transmembrane transporter activity,MF,SLC2A1
14905,GO:0070837,0.0838625002598365,0.99816769247056,1,2,dehydroascorbic acid transport,BP,SLC2A1
8850,GO:0034684,0.0839910125830218,0.998161946087964,1,2,integrin alphav-beta5 complex,CC,ITGB5
2634,GO:0005988,0.0840608333237635,0.998158820137148,1,2,lactose metabolic process,BP,SLC2A1
2635,GO:0005989,0.0840608333237635,0.998158820137148,1,2,lactose biosynthetic process,BP,SLC2A1
11602,GO:0046351,0.0840608333237635,0.998158820137148,1,2,disaccharide biosynthetic process,BP,SLC2A1
12,GO:0000023,0.0841761808582229,0.998153649821901,1,2,maltose metabolic process,BP,GAA
1867,GO:0004558,0.0841761808582229,0.998153649821901,1,2,alpha-1,4-glucosidase activity,MF,GAA
7861,GO:0032450,0.0841761808582229,0.998153649821901,1,2,maltose alpha-glucosidase activity,MF,GAA
8026,GO:0032703,0.0842426609424171,0.988605387890914,2,12,negative regulation of interleukin-2 production,BP,TNFAIP3;IL20RB
15240,GO:0071462,0.0842484672231868,0.998150405810451,1,2,cellular response to water stimulus,BP,PKD2
3521,GO:0007529,0.0842497479731388,0.998150348307119,1,2,establishment of synaptic specificity at neuromuscular junction,BP,F2R
823,GO:0002115,0.0842614895936556,0.988601379896829,2,12,store-operated calcium entry,BP,HOMER2;ORAI3
1246,GO:0003011,0.0842820033284117,0.998148899792599,1,2,involuntary skeletal muscle contraction,BP,GAA
18936,GO:1904761,0.0843355666784891,0.998146493075573,1,2,negative regulation of myofibroblast differentiation,BP,TP53INP1
3015,GO:0006577,0.0843790346578897,0.988576346240113,2,12,amino-acid betaine metabolic process,BP,CRAT;CPT1C
2609,GO:0005943,0.0844604207541066,0.998140876767974,1,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3R1
16658,GO:0097651,0.0844604207541066,0.998140876767974,1,2,phosphatidylinositol 3-kinase complex, class I,CC,PIK3R1
4812,GO:0014034,0.0844676683665849,0.99814055047611,1,2,neural crest cell fate commitment,BP,SFRP1
3494,GO:0007418,0.0844818011844973,0.998139914122091,1,2,ventral midline development,BP,GLI2
6515,GO:0021937,0.0844818011844973,0.998139914122091,1,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,GLI2
6516,GO:0021938,0.0844818011844973,0.998139914122091,1,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,GLI2
6517,GO:0021940,0.0844818011844973,0.998139914122091,1,2,positive regulation of cerebellar granule cell precursor proliferation,BP,GLI2
13971,GO:0060733,0.084502789756589,0.998138968866168,1,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,IMPACT
15111,GO:0071262,0.084502789756589,0.998138968866168,1,2,regulation of translational initiation in response to starvation,BP,IMPACT
15112,GO:0071264,0.084502789756589,0.998138968866168,1,2,positive regulation of translational initiation in response to starvation,BP,IMPACT
7883,GO:0032474,0.0845122794302537,0.998138541400236,1,2,otolith morphogenesis,BP,LRIG3
626,GO:0001819,0.0845155421965222,0.951653781617848,15,250,positive regulation of cytokine production,BP,POSTN;CYBA;ZFPM1;F2R;DDX60;PIK3R1;NFATC4;ZP3;TRPV4;ADORA2B;RNF135;STAT1;IFI16;IL20RB;CCDC88B
2758,GO:0006196,0.0845211829772725,0.998138140289948,1,2,AMP catabolic process,BP,NT5E
14511,GO:0070071,0.0846028474842223,0.988528622447941,2,12,proton-transporting two-sector ATPase complex assembly,BP,ATP6V0A2;TCIRG1
5003,GO:0015184,0.084627480562499,0.998133348029458,1,2,L-cystine transmembrane transporter activity,MF,SLC1A4
5194,GO:0015811,0.084627480562499,0.998133348029458,1,2,L-cystine transport,BP,SLC1A4
12448,GO:0050436,0.0846346600302177,0.998133024122259,1,2,microfibril binding,MF,LTBP1
152,GO:0000308,0.0846404184524384,0.99813276430539,1,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,CDK14
7009,GO:0030802,0.0846937226857439,0.980920044023354,3,26,regulation of cyclic nucleotide biosynthetic process,BP,APOE;PTHLH;ADORA2B
10510,GO:0043491,0.0846977345055448,0.958053869445037,10,148,protein kinase B signaling,BP,EGFR;FGFR4;INSR;FOXO1;ERBB3;PIK3R1;TYRO3;SPRY2;MC1R;ERBB2
502,GO:0001560,0.0847731902824912,0.998126768471765,1,2,regulation of cell growth by extracellular stimulus,BP,KIF26A
9144,GO:0035526,0.0848861358930305,0.998121660059684,1,2,retrograde transport, plasma membrane to Golgi,BP,RAB43
7006,GO:0030799,0.0849302366241015,0.975167054789715,4,41,regulation of cyclic nucleotide metabolic process,BP,APOE;PKD2;PTHLH;ADORA2B
15954,GO:0086006,0.0849573474334278,0.998118435497975,1,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,SCN4B
19673,GO:2000053,0.0850253457314623,0.998115353737953,1,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
17403,GO:1900220,0.08505271161843,0.998114112740855,1,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,PLXNB1
16925,GO:0098982,0.0850827762492718,0.99811274886794,1,2,GABA-ergic synapse,CC,NLGN2
16926,GO:0098983,0.0850827762492718,0.99811274886794,1,2,symmetric, GABA-ergic, inhibitory synapse,CC,NLGN2
18984,GO:1904862,0.0850957763268371,0.998112158963708,1,2,inhibitory synapse assembly,BP,NLGN2
20084,GO:2000809,0.0850957763268371,0.998112158963708,1,2,positive regulation of synaptic vesicle clustering,BP,NLGN2
13626,GO:0060187,0.0851004325290317,0.998111947655882,1,2,cell pole,CC,VANGL2
14901,GO:0070829,0.0851161563102256,0.998111233987671,1,2,heterochromatin maintenance,BP,MTHFR
12946,GO:0051389,0.0851593513073548,0.99810927273502,1,2,inactivation of MAPKK activity,BP,EPHB2
6528,GO:0021965,0.0851726201686005,0.998108670053697,1,2,spinal cord ventral commissure morphogenesis,BP,GLI2
15485,GO:0071910,0.0851864979668844,0.998108039606572,1,2,determination of liver left/right asymmetry,BP,PKD2
828,GO:0002133,0.0851913862051142,0.998107817515234,1,2,polycystin complex,CC,PKD2
15528,GO:0072021,0.0851913862051142,0.998107817515234,1,2,ascending thin limb development,BP,PKD2
15619,GO:0072177,0.0851913862051142,0.998107817515234,1,2,mesonephric duct development,BP,PKD2
15650,GO:0072218,0.0851913862051142,0.998107817515234,1,2,metanephric ascending thin limb development,BP,PKD2
14229,GO:0061341,0.0852159248543273,0.998106702424713,1,2,non-canonical Wnt signaling pathway involved in heart development,BP,VANGL2
14231,GO:0061346,0.0852159248543273,0.998106702424713,1,2,planar cell polarity pathway involved in heart morphogenesis,BP,VANGL2
13830,GO:0060488,0.0852159248543276,0.998106702424713,1,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,VANGL2
13831,GO:0060489,0.0852159248543276,0.998106702424713,1,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,VANGL2
13832,GO:0060490,0.0852159248543276,0.998106702424713,1,2,lateral sprouting involved in lung morphogenesis,BP,VANGL2
2415,GO:0005608,0.0852227073318368,0.998106394153339,1,2,laminin-3 complex,CC,LAMB2
2587,GO:0005899,0.0852227073318368,0.998106394153339,1,2,insulin receptor complex,CC,INSR
7099,GO:0030934,0.0852227073318368,0.998106394153339,1,2,anchoring collagen complex,CC,COL7A1
15565,GO:0072092,0.0852227073318368,0.998106394153339,1,2,ureteric bud invasion,BP,KIF26B
16431,GO:0097155,0.0852227073318368,0.998106394153339,1,2,fasciculation of sensory neuron axon,BP,EPHA4
18814,GO:1904475,0.0852227073318368,0.998106394153339,1,2,regulation of Ras GTPase binding,BP,EPHA4
20166,GO:2001106,0.0852227073318368,0.998106394153339,1,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,EPHA4
9518,GO:0036309,0.0852227073318368,0.998106394153339,1,2,protein localization to M-band,BP,OBSCN
12430,GO:0050321,0.0852777097798583,0.988384259413027,2,12,tau-protein kinase activity,MF,BRSK1;MARK4
7318,GO:0031348,0.0852954697485359,0.961624878991309,8,113,negative regulation of defense response,BP,TNFAIP3;APOE;HTRA1;NT5E;TYRO3;SERPING1;IFI16;IL20RB
5500,GO:0016485,0.0853904528217613,0.957628485398944,10,151,protein processing,BP,SERPINE2;RHBDF1;PRSS3;TYSND1;CTSV;SCG5;SERPING1;FURIN;IFI16;PCSK1
15552,GO:0072074,0.0854626012405073,0.988344587551029,2,12,kidney mesenchyme development,BP,PKD2;STAT1
1396,GO:0003341,0.0858071661650194,0.980563096105914,3,26,cilium movement,BP,GAS8;CABYR;MAFIP
3567,GO:0007628,0.0858517060335358,0.988260928409999,2,12,adult walking behavior,BP,EPHA4;EFNB3
11228,GO:0045540,0.0859092621557393,0.974782626831408,4,41,regulation of cholesterol biosynthetic process,BP,APOE;SEC14L2;SREBF1;MVD
19584,GO:1990778,0.0860972350598422,0.952858386397789,13,207,protein localization to cell periphery,BP,EPHB2;EGFR;EPB41L3;LDLRAP1;NSG1;RAB40B;TUB;VAMP3;PIK3R1;VAMP2;GOLGA7B;TULP3;SMURF1
7556,GO:0031941,0.0861406395123444,0.980455783831313,3,26,filamentous actin,CC,PKD2;ESPN;PDLIM4
17300,GO:1900025,0.0862885613830874,0.988166729077948,2,12,negative regulation of substrate adhesion-dependent cell spreading,BP,POSTN;DMTN
1899,GO:0004601,0.0863047839308196,0.980301935579982,3,28,peroxidase activity,MF,GPX7;GPX3;TXNDC17
1179,GO:0002833,0.0865492219379128,0.980324046133552,3,26,positive regulation of response to biotic stimulus,BP,CYBA;KLK5;DDX60
12489,GO:0050670,0.0867878865907377,0.960799285904203,8,114,regulation of lymphocyte proliferation,BP,GPNMB;BCL6;VAV3;NCK2;ZP3;ERBB2;IL20RB;CCDC88B
6292,GO:0019955,0.0868047023342645,0.969902944518522,5,58,cytokine binding,MF,LTBP1;CXCR1;LTBP4;ACKR3;IL20RB
15708,GO:0072337,0.0868270634856295,0.988050213893614,2,12,modified amino acid transport,BP,SLC1A4;ABCC1
6693,GO:0030122,0.0869734243092183,0.988018470132351,2,12,AP-2 adaptor complex,CC,EGFR;LDLRAP1
7482,GO:0031674,0.0870009771101552,0.966198054024193,6,75,I band,CC,OBSL1;FLNC;FHOD3;PARVB;OBSCN;SLC2A1
19715,GO:2000145,0.0870556821969129,0.940609617387165,30,562,regulation of cell motility,BP,POSTN;IFITM1;APOE;GPNMB;EGFR;SFRP1;INSR;CXCL14;SERPINE2;VEGFB;DAB2IP;F2R;ERBB3;PLXND1;DMTN;PIK3R1;ACVR1B;RHOD;HYAL1;ZP3;SPRY2;TP53INP1;TRPV4;ERBB2;ACKR3;ARPIN;PLXNB1;NISCH;MAP3K3;SP100
560,GO:0001701,0.0872082725232845,0.949893423380788,15,247,in utero embryonic development,BP,EGFR;GLI2;PKD2;TMEM231;TET1;PLCD3;GJB5;ENDOG;ACVR1B;RTF1;ZP3;PLCD1;MDFI;NRK;APBA1
14166,GO:0061138,0.0872264649610048,0.95844401068088,9,128,morphogenesis of a branching epithelium,BP,GLI2;SFRP1;PKD2;ETV5;RASIP1;PLXND1;NFATC4;SPRY2;VANGL2
4784,GO:0010996,0.0872672588559804,0.987954643513842,2,12,response to auditory stimulus,BP,SLITRK6;XPC
6737,GO:0030178,0.0876751323584447,0.95626788447839,10,153,negative regulation of Wnt signaling pathway,BP,APOE;APCDD1;SFRP1;WWTR1;FOXO1;DAB2IP;NFATC4;IGFBP4;KREMEN1;MDFI
3250,GO:0006936,0.0877563421325829,0.954585446173959,11,169,muscle contraction,BP,OBSL1;GAMT;GAA;VEGFB;SCN4B;F2R;ACTA2;SYNM;ITGB5;ADORA2B;MYL9
12306,GO:0048704,0.0879282731423869,0.96939855174845,5,58,embryonic skeletal system morphogenesis,BP,TBX1;WNT9A;HYAL1;TULP3;MDFI
7599,GO:0032011,0.0880912276748738,0.973953608836818,4,40,ARF protein signal transduction,BP,PSD4;APPL2;IQSEC1;ACAP3
7600,GO:0032012,0.0880912276748738,0.973953608836818,4,40,regulation of ARF protein signal transduction,BP,PSD4;APPL2;IQSEC1;ACAP3
19729,GO:2000177,0.0883165144272939,0.973830491825446,4,41,regulation of neural precursor cell proliferation,BP,GLI2;FOXO1;KCTD11;GJC2
10354,GO:0043217,0.0883921379968265,0.987709093995534,2,12,myelin maintenance,BP,EPB41L3;NDRG1
13926,GO:0060674,0.088491921686593,0.979693840046255,3,26,placenta blood vessel development,BP,PKD2;PLCD3;PLCD1
9316,GO:0035855,0.0884925329742353,0.987687086169529,2,12,megakaryocyte development,BP,ZFPM1;VPS33B
12688,GO:0050982,0.0886684440180436,0.987648487733234,2,12,detection of mechanical stimulus,BP,PKD2;SERPINE2
15245,GO:0071470,0.0891527279115947,0.979478041102121,3,26,cellular response to osmotic stress,BP,PKD2;SLC2A1;TRPV4
564,GO:0001706,0.0892138537864872,0.973473080630827,4,41,endoderm formation,BP,COL6A1;COL7A1;RTF1;ITGB5
5445,GO:0016358,0.0892268065761064,0.953705038452993,11,166,dendrite development,BP,APOE;PTPRS;OBSL1;EPHB2;MATN2;DAB2IP;EPHA4;NCK2;NFATC4;CRTC1;CAMK1
6713,GO:0030148,0.0893987459870505,0.965005573915134,6,76,sphingolipid biosynthetic process,BP,KDSR;ST3GAL5;CERS4;PLPP2;ALOXE3;ST6GALNAC6
16118,GO:0090179,0.0895567210827904,0.987452871801817,2,12,planar cell polarity pathway involved in neural tube closure,BP,SFRP1;VANGL2
13857,GO:0060541,0.0897619192402827,0.956982484848017,9,129,respiratory system development,BP,ALDH1A3;EGFR;THRA;GLI2;SREBF1;SPRY2;HSD11B1;TULP3;VANGL2
4749,GO:0010951,0.089770187969062,0.956933154292856,9,135,negative regulation of endopeptidase activity,BP,IFI6;LAMP3;SERPINE2;COL7A1;WNT9A;SPOCK1;SERPING1;FURIN;IFI16
12626,GO:0050870,0.0898045314860971,0.959137511264712,8,114,positive regulation of T cell activation,BP,MAP3K14;GLI2;BCL6;PIK3R1;NCK2;ZP3;EFNB3;CCDC88B
7084,GO:0030900,0.0900763119119848,0.949104661178352,14,227,forebrain development,BP,ALDH1A3;PTPRS;EPHB2;EGFR;GLI2;POU3F1;DAB2IP;DIXDC1;TYRO3;SLC2A1;MBOAT7;MDK;RTN4RL1;SUN1
11332,GO:0045730,0.0900837047076104,0.987202843687585,2,13,respiratory burst,BP,CYBA;INSR
8175,GO:0032944,0.0901802430174892,0.958920688689141,8,115,regulation of mononuclear cell proliferation,BP,GPNMB;BCL6;VAV3;NCK2;ZP3;ERBB2;IL20RB;CCDC88B
8033,GO:0032720,0.090243146412398,0.979064742391724,3,27,negative regulation of tumor necrosis factor production,BP,TNFAIP3;GPNMB;MC1R
15169,GO:0071356,0.0905187565237856,0.95134955446667,12,197,cellular response to tumor necrosis factor,BP,TNFAIP3;POSTN;MAP3K14;CYBA;SFRP1;DAB2IP;TXNDC17;HYAL1;RBCK1;TNFRSF19;STAT1;CCDC3
6828,GO:0030316,0.0909613625027609,0.968026612112534,5,58,osteoclast differentiation,BP,SFRP1;FAM20C;FAM213A;PIK3R1;GPR68
12533,GO:0050727,0.0910180971534358,0.952570886596899,11,173,regulation of inflammatory response,BP,TNFAIP3;APOE;EGFR;BCL6;NT5E;TYRO3;ZP3;TRPV4;ADORA2B;SERPING1;IL20RB
7768,GO:0032330,0.0911405704244428,0.978824510689525,3,26,regulation of chondrocyte differentiation,BP,GLI2;WNT9A;PTHLH
2259,GO:0005215,0.0911476107784272,0.935712077514778,35,678,transporter activity,MF,APOE;KCNJ15;SLC13A5;SHROOM2;ANO9;SLC16A5;SLC29A4;SV2A;PKD2;SCN4B;KCNC4;ANO8;ORAI3;S100A6;SLC38A4;ATP6V0A2;ATP12A;SLC2A1;LRRC8E;SLC2A9;TRPV4;PQLC2;NDUFA4L2;NIPAL4;SLC5A1;COX5B;SLC39A6;CLCN7;GJC2;SLC1A4;SLC13A3;ASIC1;TCIRG1;SLC47A1;ABCC1
14482,GO:0070011,0.0913681688385949,0.942743637694629,20,358,peptidase activity, acting on L-amino acid peptides,MF,TNFAIP3;HTRA1;ADAM19;SFRP1;NPEPL1;CTSB;RHBDF1;PRSS3;KLK5;RNPEPL1;TYSND1;CTSV;CTSL;ADAMTS15;KLK8;FURIN;PCSK1;CTSF;MMP1;CAPNS2
3865,GO:0008514,0.0914616312443492,0.955986989588377,9,131,organic anion transmembrane transporter activity,MF,SLC13A5;SLC16A5;SLC38A4;SLC2A1;SLC2A9;PQLC2;SLC1A4;SLC13A3;ABCC1
3367,GO:0007160,0.0918083097311757,0.953840837807107,10,148,cell-matrix adhesion,BP,POSTN;ITGB6;NINJ1;BCL6;SFRP1;DMTN;PIK3R1;RHOD;BCAM;ITGB5
6902,GO:0030514,0.091912739446279,0.978568892706734,3,26,negative regulation of BMP signaling pathway,BP,HTRA1;SFRP1;SMURF1
17904,GO:1902285,0.0922205331037026,0.98685916822306,2,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,PLXND1;PLXNB1
8570,GO:0034103,0.0922775747757892,0.972208941482849,4,42,regulation of tissue remodeling,BP,TNFAIP3;GPNMB;EGFR;SFRP1
6115,GO:0019395,0.0924105202338869,0.963482945567714,6,78,fatty acid oxidation,BP,CPT2;CRAT;TYSND1;CPT1C;AMACR;MLYCD
13110,GO:0051721,0.0925056509054437,0.978371951995441,3,26,protein phosphatase 2A binding,MF,FOXO1;DAB2IP;STAT1
6343,GO:0021543,0.0925180438228319,0.957649966548916,8,112,pallium development,BP,PTPRS;EGFR;DAB2IP;DIXDC1;SLC2A1;MBOAT7;MDK;SUN1
9762,GO:0040012,0.0927773232120104,0.935512619484794,32,609,regulation of locomotion,BP,POSTN;IFITM1;APOE;GPNMB;EGFR;SFRP1;INSR;CXCL14;SERPINE2;VEGFB;WNT3;DAB2IP;F2R;ERBB3;PLXND1;DMTN;PIK3R1;ACVR1B;RHOD;HYAL1;ZP3;SPRY2;TP53INP1;TRPV4;ERBB2;ACKR3;ARPIN;PLXNB1;NISCH;MAP3K3;ZSWIM8;SP100
19717,GO:2000147,0.0928100275807059,0.94330491471398,18,312,positive regulation of cell motility,BP,POSTN;GPNMB;EGFR;INSR;CXCL14;VEGFB;DAB2IP;F2R;DMTN;PIK3R1;ACVR1B;RHOD;HYAL1;ZP3;SPRY2;TRPV4;ACKR3;MAP3K3
8319,GO:0033194,0.0928181661974327,0.986584962472839,2,13,response to hydroperoxide,BP,GPX3;TP53INP1
10758,GO:0044262,0.0928882864078356,0.949890123727885,12,190,cellular carbohydrate metabolic process,BP,PGM1;INSR;GAA;FOXO1;PPP1R3E;B3GNT9;IMPA2;SLC2A1;IGFBP4;MLYCD;IDUA;ISYNA1
9900,GO:0042277,0.0929360739972465,0.951391642875673,11,173,peptide binding,MF,APOE;EPHB2;FBXO2;VIPR1;INSR;LDLRAP1;RNPEPL1;CTSV;PIK3R1;FURIN;APBA1
8407,GO:0033540,0.0930501903723159,0.986532017634608,2,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,CRAT;AMACR
17449,GO:1900424,0.0930581226501005,0.986530206169982,2,13,regulation of defense response to bacterium,BP,CYBA;KLK5
11821,GO:0046847,0.0930649804281629,0.971924016225013,4,41,filopodium assembly,BP,TENM2;ARHGEF4;ESPN;DMTN
9956,GO:0042383,0.0931148891888393,0.963162595917782,6,76,sarcolemma,CC,FLNC;COL6A1;RTN2;OBSCN;SLC2A1;SYNM
9256,GO:0035725,0.0932663891630429,0.963103124667643,6,75,sodium ion transmembrane transport,BP,SHROOM2;PKD2;SCN4B;ATP12A;STOM;ASIC1
3203,GO:0006865,0.0935940663385552,0.962923385339898,6,76,amino acid transport,BP,SV2A;SLC38A4;VAMP2;PQLC2;SLC1A4;APBA1
10768,GO:0044281,0.0936678871546897,0.926933452857456,70,1501,small molecule metabolic process,BP,APOE;ALDH1A3;LMF1;CPT2;KDSR;GAMT;TST;CRAT;FGFR4;PGM1;XYLT1;CYP4F22;DHTKD1;INSR;GAA;CES2;PKD2;LDLRAP1;NT5E;PDPR;FOXO1;BPHL;UROS;PRSS3;H6PD;TRERF1;CRTAP;CYP27C1;FAM20C;GLUL;TYSND1;SEC14L2;HEXB;PLCD3;PGLS;ACSL1;ATP6V0A2;SREBF1;CSPG4;RDH12;PTHLH;IMPA2;SLC2A1;CPT1C;HYAL1;CKMT1A;SLC2A9;MTHFR;RETSAT;SDHA;ALDH2;ADORA2B;NMRK1;AMACR;MVD;IGFBP4;NME4;PLCD1;COX5B;MLYCD;THNSL2;XYLT2;ALOXE3;TCIRG1;NISCH;NADK;ABCC1;IDUA;ISYNA1;CBR3
3438,GO:0007266,0.0937011135069563,0.952700695404207,10,149,Rho protein signal transduction,BP,APOE;BCL6;ARHGEF4;VAV3;OBSCN;F2R;ARHGEF19;EPS8L2;RHOD;VANGL2
9512,GO:0036295,0.0937021310030627,0.986382822528883,2,13,cellular response to increased oxygen levels,BP,FOXO1;ATP6V0A2
12069,GO:0048145,0.0937284447837722,0.966718187880903,5,60,regulation of fibroblast proliferation,BP,EGFR;SFRP1;DAB2IP;S100A6;TP53INP1
15105,GO:0071248,0.0938367878497444,0.95957639317319,7,96,cellular response to metal ion,BP,EGFR;PKD2;DMTN;ENDOG;NFATC4;RASA4;MT2A
705,GO:0001934,0.0939601067769622,0.934607237973195,32,612,positive regulation of protein phosphorylation,BP,GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;INSR;PKD2;DAB2IP;TBX1;SHC2;EPHA4;F2R;RPS6KA5;ACSL1;ERBB3;CSPG4;ACVR1B;CAMKK1;NAB2;TYRO3;SPRY2;TNFRSF19;TRPV4;ADORA2B;IGFBP4;ERBB2;CDK20;ACKR3;CAMK1;MAP3K3;NRK;VANGL2
16216,GO:0090313,0.0941157753667979,0.977775451695957,3,27,regulation of protein targeting to membrane,BP,DMTN;STOM;ERBB2
4450,GO:0010463,0.0942678886410836,0.977783219880287,3,26,mesenchymal cell proliferation,BP,TBX1;FBXW4;STAT1
8092,GO:0032802,0.0944395286600838,0.986213305928901,2,13,low-density lipoprotein particle receptor catabolic process,BP,APOE;FURIN
7476,GO:0031667,0.0945024339535346,0.942122000837488,18,316,response to nutrient levels,BP,POSTN;APOE;ULK2;EGFR;CYBA;SFRP1;FOXO1;GLUL;CTSV;ACSL1;SREBF1;UCN2;SLC2A1;TRPV4;MTHFR;IMPACT;STAT1;IFI16
10216,GO:0042982,0.0945215765946023,0.971263892794495,4,43,amyloid precursor protein metabolic process,BP,APOE;LDLRAP1;NSG1;EPHA4
3095,GO:0006688,0.0948017604029714,0.986129737433237,2,13,glycosphingolipid biosynthetic process,BP,ST3GAL5;ST6GALNAC6
6759,GO:0030214,0.0948977927611205,0.986107549571371,2,13,hyaluronan catabolic process,BP,HEXB;HYAL1
11816,GO:0046834,0.0950179072102463,0.962226954659253,6,75,lipid phosphorylation,BP,EGFR;FGFR4;ERBB3;PIK3R1;IMPA2;ERBB2
2369,GO:0005518,0.0951650644982745,0.971033967506151,4,42,collagen binding,MF,TGFBI;CTSB;CTSL;MRC2
10554,GO:0043551,0.0953247950873348,0.977427704629998,3,26,regulation of phosphatidylinositol 3-kinase activity,BP,VAV3;DAB2IP;PIK3R1
17336,GO:1900103,0.0955010069673121,0.985967865815818,2,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,DAB2IP;PIK3R1
4173,GO:0009267,0.0957407754130624,0.955828170466521,8,114,cellular response to starvation,BP,SFRP1;FOXO1;GLUL;CTSV;SREBF1;SLC2A1;IMPACT;IFI16
4453,GO:0010466,0.0957429690730398,0.953453743748793,9,137,negative regulation of peptidase activity,BP,IFI6;LAMP3;SERPINE2;COL7A1;WNT9A;SPOCK1;SERPING1;FURIN;IFI16
3128,GO:0006739,0.0957560530856025,0.977166336483497,3,28,NADP metabolic process,BP,H6PD;PGLS;NADK
12307,GO:0048705,0.0958563313464264,0.953425704457456,9,132,skeletal system morphogenesis,BP,THRA;SFRP1;TBX1;WNT9A;NAB2;HYAL1;TRPV4;TULP3;MDFI
10574,GO:0043586,0.0961914870656216,0.985807310734654,2,13,tongue development,BP,EGFR;TBX1
3436,GO:0007264,0.096200683857227,0.936123386469844,25,456,small GTPase mediated signal transduction,BP,APOE;EPHB2;RALGDS;RAPGEF5;BCL6;PSD4;ARHGEF4;VAV3;DAB2IP;OBSCN;SHC2;RAB40B;F2R;ARHGEF19;EPS8L2;APPL2;IQSEC1;ACAP3;ARHGAP40;RHOD;SPRY2;RASA4;NISCH;RAB43;VANGL2
11845,GO:0046889,0.0962515104501023,0.97055453214517,4,43,positive regulation of lipid biosynthetic process,BP,APOE;SREBF1;ZP3;CCDC3
10961,GO:0044794,0.0963249065107165,0.985776205600452,2,13,positive regulation by host of viral process,BP,APOE;STOM
4963,GO:0015103,0.0963279710773595,0.961551825894672,6,76,inorganic anion transmembrane transporter activity,MF,ANO9;ANO8;LRRC8E;CLCN7;SLC1A4;ABCC1
8740,GO:0034440,0.0965393492132981,0.961397702892305,6,79,lipid oxidation,BP,CPT2;CRAT;TYSND1;CPT1C;AMACR;MLYCD
5992,GO:0019058,0.0965663053582945,0.943650575726575,15,254,viral life cycle,BP,IFITM1;ITGB6;APOE;MVB12B;LAMP3;EGFR;OAS2;CTSB;TYRO3;STOM;EFNB3;ITGB5;FURIN;IFI16;RAB43
10392,GO:0043269,0.0972479026659894,0.941125506537097,17,295,regulation of ion transport,BP,APOE;KCNJ15;EPHB2;CYBA;NLGN2;ANO9;SV2A;PKD2;SERPINE2;SCN4B;KCNC4;F2R;HOMER2;STOM;VAMP2;CRY2;GJC2
16767,GO:0098656,0.0974368042602216,0.950435457879451,10,151,anion transmembrane transport,BP,CPT2;SLC13A5;ANO9;SLC38A4;LRRC8E;PQLC2;CLCN7;SLC1A4;SLC13A3;ABCC1
8053,GO:0032755,0.0974834062895374,0.970046451737251,4,43,positive regulation of interleukin-6 production,BP,CYBA;F2R;TRPV4;ADORA2B
1088,GO:0002684,0.0975362654267852,0.932259474570904,31,601,positive regulation of immune system process,BP,TNFAIP3;PTPRS;MAP3K14;CYBA;GLI2;BCL6;VAV3;CXCL14;CTSB;VEGFB;DAB2IP;KLK5;WIPF1;RPS6KA5;DDX60;PIK3R1;CTSL;NCK2;ACVR1B;FAM210B;TYRO3;ZP3;RBCK1;EFNB3;TRPV4;ADORA2B;SERPING1;GPR68;STAT1;IFI16;CCDC88B
4275,GO:0009719,0.097555358993553,0.926423981415065,52,1060,response to endogenous stimulus,BP,POSTN;APOE;HTRA1;SRSF5;MXRA5;COL6A1;EGFR;THRA;CYBA;FGFR4;SFRP1;TNFSF10;INSR;PKD2;RGMA;CTSB;FOXO1;UROS;DAB2IP;TBX1;FAM20C;EPHA4;CTSV;TUB;LTBP1;ACSL1;ATP6V0A2;SREBF1;DMTN;ENDOG;PIK3R1;CTSL;UCN2;FAM210B;SLC2A1;HYAL1;VAMP2;SPRY2;MDK;TRPV4;ITGB5;LTBP4;IMPACT;NEO1;MICALL1;ERBB2;STAT1;CRY2;FURIN;SMURF1;TCIRG1;SORT1
18422,GO:1903556,0.0976201095926833,0.97653064842704,3,28,negative regulation of tumor necrosis factor superfamily cytokine production,BP,TNFAIP3;GPNMB;MC1R
7030,GO:0030823,0.0977721027315839,0.985437115801024,2,13,regulation of cGMP metabolic process,BP,APOE;ADORA2B
6971,GO:0030670,0.0978779767268312,0.964753769287341,5,62,phagocytic vesicle membrane,CC,CYBA;ATP6V0A2;VAMP3;TCIRG1;RAB43
9698,GO:0038179,0.098127910002538,0.97641397437479,3,27,neurotrophin signaling pathway,BP,NDN;SPRY2;SORT1
3258,GO:0006952,0.0984240202643384,0.927448247860003,44,896,defense response,BP,TNFAIP3;IFITM1;ITGB6;APOE;IFI6;PTPRS;MAP3K14;HTRA1;EGFR;CYBA;OAS2;BCL6;CTSB;NT5E;DAB2IP;KLK5;RPL13A;F2R;RPS6KA5;DDX60;VAMP3;CTSL;TRIM22;NFATC4;TYRO3;HYAL1;ZP3;MDK;TRPV4;ADORA2B;SERPING1;IGFBP4;GPR68;RNF135;STAT1;WIPI2;IFI16;IL20RB;CCDC88B;HCP5;TCIRG1;MT2A;RAB43;SP100
15100,GO:0071241,0.0985579365650354,0.954220497810394,8,116,cellular response to inorganic substance,BP,EGFR;PKD2;FOXO1;DMTN;ENDOG;NFATC4;RASA4;MT2A
10591,GO:0043621,0.098717243453687,0.969535134763267,4,43,protein self-association,MF,TNFAIP3;DMTN;SLC2A1;VAMP2
5490,GO:0016460,0.099179256978848,0.985104442542551,2,13,myosin II complex,CC,OBSL1;MYL9
2315,GO:0005343,0.0992045747304812,0.985098430320064,2,13,organic acid:sodium symporter activity,MF,SLC13A5;SLC13A3
12068,GO:0048144,0.099247303983878,0.964134552522351,5,61,fibroblast proliferation,BP,EGFR;SFRP1;DAB2IP;S100A6;TP53INP1
16383,GO:0097062,0.0992818249680666,0.985080079829432,2,13,dendritic spine maintenance,BP,APOE;INSR
14896,GO:0070821,0.0992901891015607,0.969296874209425,4,43,tertiary granule membrane,CC,CYBA;GAA;HGSNAT;STOM
13716,GO:0060333,0.0993073893850982,0.964084909545493,5,62,interferon-gamma-mediated signaling pathway,BP,OAS2;TRIM22;STAT1;MT2A;SP100
6834,GO:0030323,0.0994262458818111,0.953758110260258,8,113,respiratory tube development,BP,EGFR;THRA;GLI2;SREBF1;SPRY2;HSD11B1;TULP3;VANGL2
16317,GO:0090659,0.0994421018312598,0.985041978694667,2,13,walking behavior,BP,EPHA4;EFNB3
6778,GO:0030239,0.0995790450331086,0.975915177124639,3,27,myofibril assembly,BP,OBSL1;FHOD3;OBSCN
3552,GO:0007611,0.0996573094086278,0.951187178447358,9,133,learning or memory,BP,APOE;EPHB2;EGFR;THRA;INSR;MDK;KLK8;CRTC1;ASIC1
5684,GO:0016831,0.0997494702790526,0.975797655646116,3,28,carboxy-lyase activity,MF,GLUL;MVD;MLYCD
7990,GO:0032642,0.0998135551695254,0.969045087513964,4,44,regulation of chemokine production,BP,POSTN;ZFPM1;TRPV4;ADORA2B
1900,GO:0004602,0.100091024619013,0.984639951211943,2,15,glutathione peroxidase activity,MF,GPX7;GPX3
4735,GO:0010927,0.100259419250862,0.963705129810344,5,59,cellular component assembly involved in morphogenesis,BP,OBSL1;EPB41L3;FHOD3;OBSCN;TENM4
12320,GO:0048732,0.100367951310964,0.938971795067616,17,294,gland development,BP,TNFAIP3;ALDH1A3;SRSF5;EGFR;THRA;OAS2;GLI2;SFRP1;INSR;PKD2;ETV5;SERPINE2;WNT3;TBX1;PLXND1;MDK;DBP
7056,GO:0030864,0.100462267155147,0.963609814299381,5,59,cortical actin cytoskeleton,CC,SHROOM2;WIPF1;SLC2A1;PLEKHH2;TRPV4
6699,GO:0030128,0.100578055777575,0.98477085736602,2,13,clathrin coat of endocytic vesicle,CC,EGFR;LDLRAP1
697,GO:0001921,0.100606917493139,0.984763944194192,2,13,positive regulation of receptor recycling,BP,NSG1;VAMP3
16269,GO:0090482,0.100683961488605,0.984745484065909,2,13,vitamin transmembrane transporter activity,MF,SLC2A1;ABCC1
10576,GO:0043588,0.100699726949181,0.942076189309674,14,236,skin development,BP,PRR9;EGFR;APCDD1;POU3F1;KLK5;CTSV;PPL;CTSL;ACVR1B;TNFRSF19;KLK8;FURIN;ALOXE3;VANGL2
9418,GO:0036035,0.100755768183216,0.984728270988837,2,13,osteoclast development,BP,FAM20C;GPR68
3179,GO:0006821,0.101034725442785,0.968568200694127,4,43,chloride transport,BP,ANO9;ANO8;CLCN7;SLC1A4
6895,GO:0030506,0.101110343140221,0.984643163633525,2,13,ankyrin binding,MF,FLNC;OBSCN
17811,GO:1902041,0.101283702563947,0.968429520804988,4,44,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,TNFAIP3;SFRP1;TNFSF10;SP100
14837,GO:0070664,0.101552291988775,0.968316691114447,4,44,negative regulation of leukocyte proliferation,BP,TNFAIP3;GPNMB;ERBB2;IL20RB
5830,GO:0017145,0.10167116732886,0.975190157138709,3,27,stem cell division,BP,ETV5;WWTR1;VANGL2
11824,GO:0046850,0.101733624397746,0.975168406235306,3,27,regulation of bone remodeling,BP,TNFAIP3;EGFR;SFRP1
16486,GO:0097242,0.101857108736696,0.984463318333963,2,13,amyloid-beta clearance,BP,APOE;INSR
10238,GO:0043010,0.102036570363062,0.944062563404284,12,191,camera-type eye development,BP,ALDH1A3;EPHB2;NINJ1;SLITRK6;SHROOM2;EGFR;SDK2;TMEM231;WNT9A;TUB;LAMB2;TULP3
14016,GO:0060831,0.102123396394141,0.984398990478194,2,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,GLI2;TULP3
3847,GO:0008484,0.102163742385105,0.98438923494927,2,13,sulfuric ester hydrolase activity,MF,ARSI;SGSH
6905,GO:0030517,0.102314027152717,0.974965984413572,3,27,negative regulation of axon extension,BP,PTPRS;WNT3;EPHA4
18389,GO:1903510,0.102353878562172,0.958454428224515,6,78,mucopolysaccharide metabolic process,BP,XYLT1;HEXB;CSPG4;HYAL1;XYLT2;IDUA
14475,GO:0065009,0.102425082001772,0.916709364917232,102,2228,regulation of molecular function,BP,TNFAIP3;APOE;IFI6;LAMP3;LMF1;GPNMB;MAP3K14;EPHB2;RALGDS;EGFR;THRA;CYBA;OAS2;FGFR4;PINLYP;NLGN2;RAPGEF5;BCL6;ANO9;PSD4;SFRP1;ARHGEF4;CKLF;TNFSF10;INSR;VAV3;PKD2;ZFPM1;PPP2R2C;CXCL14;LDLRAP1;CTSB;SERPINE2;VEGFB;WWTR1;WNT3;RASIP1;DAB2IP;COL7A1;OBSCN;SHC2;SCN4B;GAS8;EVI5L;EPHA4;WNT9A;TRAPPC2L;F2R;RPS6KA5;ARHGEF19;ACSL1;EPS8L2;ERBB3;SPOCK1;FRY;PLXND1;CSPG4;PIK3R1;PTHLH;IQSEC1;ACAP3;TRIM22;NCK2;CAMKK1;UCN2;ARHGAP40;NAB2;NFATC4;TYRO3;CLEC11A;ZP3;STOM;VAMP2;RBCK1;SPRY2;SCG5;MDK;PPP1R35;ADORA2B;SERPING1;RTN4RL1;TBC1D17;CRTC1;ERBB2;CDK20;CRY2;FURIN;IFI16;THNSL2;ALS2CL;NUAK1;PLXNB1;RASA4;CAMK1;ELFN2;MAP3K3;PPP1R14A;MDFI;SP100;NRK;SORT1;VANGL2
986,GO:0002455,0.102847592511943,0.984085045959867,2,14,humoral immune response mediated by circulating immunoglobulin,BP,ZP3;SERPING1
7839,GO:0032421,0.103058657933049,0.974644211212723,3,28,stereocilium bundle,CC,ESPN;HOMER2;EPS8L2
16116,GO:0090177,0.103274718245303,0.984119671580205,2,13,establishment of planar polarity involved in neural tube closure,BP,SFRP1;VANGL2
16117,GO:0090178,0.103274718245303,0.984119671580205,2,13,regulation of establishment of planar polarity involved in neural tube closure,BP,SFRP1;VANGL2
3293,GO:0007009,0.103474661070873,0.962162780098853,5,60,plasma membrane organization,BP,EPB41L3;ANO9;SNX33;NDRG1;MICALL1
1864,GO:0004553,0.103634407658988,0.962063548177764,5,61,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,GAA;HEXB;HYAL1;NAGLU;IDUA
6709,GO:0030140,0.104053379994747,0.974294114195351,3,28,trans-Golgi network transport vesicle,CC,LDLRAP1;FURIN;SORT1
12184,GO:0048471,0.104111492439048,0.929126525869648,27,510,perinuclear region of cytoplasm,CC,LAMP3;OBSL1;S100A4;EGFR;CYBA;OAS2;TMEM134;CTSB;RASIP1;RAB40B;TRAPPC2L;S100A6;VAMP3;DMTN;PIK3R1;STOM;VAMP2;NDRG1;PDLIM4;ERBB2;STAT1;ACKR3;ANGEL1;MT2A;VPS33B;SORT1;APBA1
11796,GO:0046777,0.104178639899134,0.94439438973866,11,171,protein autophosphorylation,BP,ULK2;GPNMB;EGFR;FGFR4;INSR;EPHA4;ACVR1B;TYRO3;IMPACT;ERBB2;MAP3K3
14086,GO:0060993,0.104336713751911,0.961752815819381,5,60,kidney morphogenesis,BP,PKD2;WWTR1;KIF26B;STAT1;VANGL2
5572,GO:0016616,0.104448396116532,0.95729629159861,6,83,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,KDSR;H6PD;SDR9C7;RDH12;HSD11B1;CBR3
10079,GO:0042627,0.104862378321558,0.996160381850417,1,3,chylomicron,CC,APOE
4468,GO:0010508,0.1049193782029,0.953571403956757,7,97,positive regulation of autophagy,BP,TP53INP2;FOXO1;TRIM65;TRIM22;TP53INP1;EPM2A;SMURF1
12250,GO:0048608,0.104943554251998,0.935781315850806,17,297,reproductive structure development,BP,HTRA1;EGFR;GLI2;SFRP1;TNFSF10;INSR;PKD2;CTSB;SERPINE2;CTSV;PLCD3;GJB5;TYRO3;ZP3;PLCD1;MDFI;NRK
4693,GO:0010873,0.105003363980422,0.99614978851633,1,3,positive regulation of cholesterol esterification,BP,APOE
18539,GO:1903825,0.105140255277781,0.957018797311829,6,78,organic acid transmembrane transport,BP,CPT2;SLC13A5;SLC38A4;PQLC2;SLC1A4;SLC13A3
19067,GO:1905039,0.105140255277781,0.957018797311829,6,78,carboxylic acid transmembrane transport,BP,CPT2;SLC13A5;SLC38A4;PQLC2;SLC1A4;SLC13A3
18359,GO:1903428,0.105234279954356,0.973876477134133,3,28,positive regulation of reactive oxygen species biosynthetic process,BP,CYBA;INSR;PKD2
17978,GO:1902512,0.105266249809181,0.996129994927578,1,3,positive regulation of apoptotic DNA fragmentation,BP,ENDOG
9913,GO:0042303,0.10537846221835,0.956878520378736,6,79,molting cycle,BP,EGFR;APCDD1;CTSV;ACVR1B;TNFRSF19;VANGL2
10084,GO:0042633,0.10537846221835,0.956878520378736,6,79,hair cycle,BP,EGFR;APCDD1;CTSV;ACVR1B;TNFRSF19;VANGL2
12691,GO:0050994,0.105580036658527,0.973753784315827,3,28,regulation of lipid catabolic process,BP,THRA;TYSND1;MLYCD
6844,GO:0030334,0.106005247480041,0.927178135619665,28,530,regulation of cell migration,BP,POSTN;IFITM1;APOE;GPNMB;EGFR;SFRP1;INSR;CXCL14;SERPINE2;VEGFB;DAB2IP;F2R;PLXND1;DMTN;PIK3R1;ACVR1B;RHOD;HYAL1;ZP3;SPRY2;TP53INP1;TRPV4;ACKR3;ARPIN;PLXNB1;NISCH;MAP3K3;SP100
15703,GO:0072329,0.10624540906612,0.952804613489307,7,100,monocarboxylic acid catabolic process,BP,CPT2;CRAT;TYSND1;CPT1C;AMACR;MLYCD;IDUA
10001,GO:0042476,0.106275943626589,0.956413222942185,6,79,odontogenesis,BP,HTRA1;GLI2;FOXO1;TBX1;KLK5;FAM20C
8510,GO:0033860,0.106288789922459,0.996052496886535,1,3,regulation of NAD(P)H oxidase activity,BP,CYBA
8512,GO:0033864,0.106288789922459,0.996052496886535,1,3,positive regulation of NAD(P)H oxidase activity,BP,CYBA
4152,GO:0009235,0.106357436485371,0.98321666095244,2,14,cobalamin metabolic process,BP,PRSS3;ABCC1
6727,GO:0030166,0.106398053245144,0.966298117962156,4,43,proteoglycan biosynthetic process,BP,XYLT1;CSPG4;XYLT2;VANGL2
10608,GO:0043651,0.106619195275744,0.983151177934668,2,14,linoleic acid metabolic process,BP,ACSL1;ALOXE3
12207,GO:0048518,0.106795231619557,0.910083722605473,171,3873,positive regulation of biological process,BP,TNFAIP3;POSTN;IFITM1;PEG3;SMOC2;APOE;ALDH1A3;MVB12B;LAMP3;PTPRS;OBSL1;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;NINJ1;ASH2L;HTRA1;SLITRK6;ADGRL1;SRSF5;EGFR;THRA;CITED4;CYBA;TCEA2;GLI2;FGFR4;NLGN2;IRF2BPL;VIPR1;BCL6;TENM2;ZNF318;SFRP1;ARHGEF4;POU3F1;TNFSF10;INSR;VAV3;PKD2;ESPN;ZFPM1;RGMA;DNM1;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;SERPINE2;SALL2;TP53INP2;VEGFB;WWTR1;FOXO1;WNT3;TRIM65;NSG1;BOC;SOX12;DDB2;DAB2IP;OBSCN;TBX1;KLK5;TRERF1;SHC2;SCN4B;SH3BP2;YEATS4;WIPF1;TET1;FAM20C;GLUL;EPHA4;WNT9A;MAGEF1;DIXDC1;TENM4;OLFM2;F2R;SMARCA1;KIF26B;RPS6KA5;TUB;SEC14L2;ARHGEF19;HEXB;ACSL1;EPS8L2;DDX60;ACTA2;ERBB3;S100A6;VAMP3;PLXND1;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;PTHLH;CTSL;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;NAB2;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CLEC11A;HYAL1;RTF1;ZP3;STOM;VAMP2;RBCK1;EFNB3;PCBP4;SPRY2;TP53INP1;TNFRSF19;MDK;TRPV4;NDRG1;ADORA2B;FBXW4;SERPING1;MARK4;MC1R;IMPACT;MVD;NEO1;CRTC1;IGFBP4;GPR68;ERBB2;RNF187;EPM2A;RNF135;STAT1;CDK20;ACKR3;MARCKSL1;FURIN;IFI16;IL20RB;CCDC88B;MLYCD;GJC2;ARPIN;DBP;MMP1;PLXNB1;SMURF1;CCDC3;CXXC5;CAMK1;TCIRG1;MAP3K3;SP100;NRK;SORT1;VANGL2
11001,GO:0045007,0.106994556193151,0.995998535673562,1,3,depurination,BP,MPG
6742,GO:0030194,0.107070266942973,0.983038101577902,2,14,positive regulation of blood coagulation,BP,F2R;DMTN
17317,GO:1900048,0.107070266942973,0.983038101577902,2,14,positive regulation of hemostasis,BP,F2R;DMTN
12561,GO:0050777,0.107263645656216,0.95586643083712,6,81,negative regulation of immune response,BP,TNFAIP3;BCL6;TYRO3;SERPING1;IFI16;IL20RB
3005,GO:0006566,0.107650150609008,0.995948065170152,1,3,threonine metabolic process,BP,THNSL2
4403,GO:0010224,0.107762251940465,0.982864057651669,2,14,response to UV-B,BP,XPC;HYAL1
2033,GO:0004792,0.107787744343578,0.995937430349992,1,3,thiosulfate sulfurtransferase activity,MF,TST
6076,GO:0019287,0.107894250214115,0.995929188285356,1,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,MVD
1098,GO:0002694,0.108471364906339,0.934382845974083,16,281,regulation of leukocyte activation,BP,TNFAIP3;GPNMB;MAP3K14;GLI2;BCL6;SFRP1;VAV3;PIK3R1;NCK2;TYRO3;ZP3;EFNB3;ADORA2B;ERBB2;IL20RB;CCDC88B
2193,GO:0005089,0.10848107052483,0.959791772141886,5,59,Rho guanyl-nucleotide exchange factor activity,MF,ARHGEF4;VAV3;OBSCN;ARHGEF19;EPS8L2
3778,GO:0008373,0.108514950940274,0.982673954626975,2,14,sialyltransferase activity,MF,ST3GAL5;ST6GALNAC6
16600,GO:0097503,0.108514950940274,0.982673954626975,2,14,sialylation,BP,ST3GAL5;ST6GALNAC6
5818,GO:0017124,0.10859118068999,0.951547021859944,7,97,SH3 domain binding,MF,ADAM19;CYBA;ESPN;DAB2IP;SH3BP2;WIPF1;CABYR
4004,GO:0009051,0.108613374654878,0.995873308010264,1,3,pentose-phosphate shunt, oxidative branch,BP,PGLS
5498,GO:0016480,0.108633774929568,0.995871716937477,1,3,negative regulation of transcription by RNA polymerase III,BP,NAB2
14262,GO:0061437,0.108769303732399,0.982609529283605,2,14,renal system vasculature development,BP,PKD2;ACTA2
14265,GO:0061440,0.108769303732399,0.982609529283605,2,14,kidney vasculature development,BP,PKD2;ACTA2
4487,GO:0010544,0.108803264827633,0.982600920147452,2,14,negative regulation of platelet activation,BP,APOE;SERPINE2
8593,GO:0034137,0.108971997849496,0.99584529096081,1,3,positive regulation of toll-like receptor 2 signaling pathway,BP,CYBA
1638,GO:0004096,0.108978267443775,0.995844800267913,1,3,catalase activity,MF,GPX7
6552,GO:0022037,0.10900610887144,0.95948805134832,5,61,metencephalon development,BP,PTPRS;GLI2;SERPINE2;MDK;NAGLU
624,GO:0001817,0.109190276348211,0.928427416812245,22,409,regulation of cytokine production,BP,TNFAIP3;POSTN;PTPRS;GPNMB;CYBA;BCL6;ZFPM1;F2R;RPS6KA5;DDX60;PIK3R1;NFATC4;ZP3;TRPV4;ADORA2B;MC1R;RNF135;STAT1;FURIN;IFI16;IL20RB;CCDC88B
10558,GO:0043558,0.109338459984937,0.982465027858316,2,14,regulation of translational initiation in response to stress,BP,NCK2;IMPACT
18194,GO:1903039,0.109479929347946,0.94792516515798,8,119,positive regulation of leukocyte cell-cell adhesion,BP,MAP3K14;GLI2;BCL6;PIK3R1;NCK2;ZP3;EFNB3;CCDC88B
625,GO:0001818,0.109548817276566,0.942949803253707,10,159,negative regulation of cytokine production,BP,TNFAIP3;PTPRS;GPNMB;BCL6;ZFPM1;RPS6KA5;MC1R;RNF135;FURIN;IL20RB
10870,GO:0044449,0.109589057810005,0.947871896528906,8,118,contractile fiber part,CC,OBSL1;FLNC;FHOD3;PARVB;OBSCN;SLC2A1;SYNM;MYL9
12623,GO:0050867,0.109682136519231,0.940856571283857,11,179,positive regulation of cell activation,BP,MAP3K14;GLI2;BCL6;VAV3;DMTN;PIK3R1;NCK2;ZP3;EFNB3;ADORA2B;CCDC88B
3495,GO:0007420,0.109732209809846,0.92666109517019,24,445,brain development,BP,ALDH1A3;PTPRS;EPHB2;SHROOM2;EGFR;THRA;GLI2;SFRP1;POU3F1;SERPINE2;WNT3;DAB2IP;GAS8;DIXDC1;SMARCA1;TYRO3;SLC2A1;MBOAT7;MDK;NAGLU;RTN4RL1;TULP3;SUN1;GJC2
9360,GO:0035928,0.109879068994114,0.99577398136341,1,3,rRNA import into mitochondrion,BP,TST
9238,GO:0035686,0.110021999229248,0.995762686575611,1,3,sperm fibrous sheath,CC,CABYR
660,GO:0001867,0.110218556174107,0.995747128103655,1,3,complement activation, lectin pathway,BP,SERPING1
16588,GO:0097487,0.110269670326806,0.995743077239592,1,3,multivesicular body, internal vesicle,CC,EGFR
8700,GO:0034374,0.11035113289329,0.99573661702438,1,3,low-density lipoprotein particle remodeling,BP,APOE
7804,GO:0032379,0.110360181679732,0.995735899111182,1,3,positive regulation of intracellular lipid transport,BP,LDLRAP1
7807,GO:0032382,0.110360181679732,0.995735899111182,1,3,positive regulation of intracellular sterol transport,BP,LDLRAP1
7810,GO:0032385,0.110360181679732,0.995735899111182,1,3,positive regulation of intracellular cholesterol transport,BP,LDLRAP1
7378,GO:0031461,0.110543770658507,0.942344766047158,10,157,cullin-RING ubiquitin ligase complex,CC,DCAF16;FBXO2;DDB2;KLHDC8B;CUL9;FBXW4;BTBD2;FBXW5;ZSWIM8;FBXO44
13073,GO:0051648,0.110690499833687,0.938432288220022,12,196,vesicle localization,BP,SHROOM2;NLGN2;DNM1;RIMS3;SYT8;COL7A1;TRAPPC2L;SYTL1;VAMP2;C2CD4C;BLOC1S4;VPS33B
14660,GO:0070326,0.110801682437085,0.995700793925914,1,3,very-low-density lipoprotein particle receptor binding,MF,APOE
1087,GO:0002683,0.110828829697066,0.933938518174052,15,263,negative regulation of immune system process,BP,TNFAIP3;PTPRS;GPNMB;HTRA1;BCL6;SFRP1;ZFPM1;DAB2IP;PIK3R1;TYRO3;SERPING1;GPR68;ERBB2;IFI16;IL20RB
12700,GO:0051005,0.11093509021209,0.995690156392118,1,3,negative regulation of lipoprotein lipase activity,BP,SORT1
20063,GO:2000773,0.111346440850991,0.98195149114942,2,14,negative regulation of cellular senescence,BP,BCL6;MAP3K3
6649,GO:0030027,0.111694792347937,0.941641765883163,10,155,lamellipodium,CC,PKD2;PARVB;ACTA2;PLXND1;CSPG4;PLEKHH2;TRPV4;PDLIM4;SLC39A6;ARPIN
4006,GO:0009055,0.111808369127806,0.953389631502764,6,87,electron transfer activity,MF,TXNRD3;CYBA;NDUFA4L2;SDHA;ALDH2;COX5B
595,GO:0001763,0.111906346762833,0.943849092175702,9,135,morphogenesis of a branching structure,BP,GLI2;SFRP1;PKD2;ETV5;RASIP1;PLXND1;NFATC4;SPRY2;VANGL2
14272,GO:0061458,0.111913909609453,0.930881469648115,17,300,reproductive system development,BP,HTRA1;EGFR;GLI2;SFRP1;TNFSF10;INSR;PKD2;CTSB;SERPINE2;CTSV;PLCD3;GJB5;TYRO3;ZP3;PLCD1;MDFI;NRK
9407,GO:0036015,0.111961051527364,0.995607886175082,1,3,response to interleukin-3,BP,MT2A
9408,GO:0036016,0.111961051527364,0.995607886175082,1,3,cellular response to interleukin-3,BP,MT2A
18650,GO:1904044,0.112105147854771,0.995596265625509,1,3,response to aldosterone,BP,CYBA
13669,GO:0060267,0.112158563704655,0.995591953827629,1,3,positive regulation of respiratory burst,BP,INSR
17086,GO:0102148,0.112281221427675,0.99558204431303,1,3,N-acetyl-beta-D-galactosaminidase activity,MF,HEXB
1595,GO:0004029,0.112349646802356,0.981692747964276,2,14,aldehyde dehydrogenase (NAD) activity,MF,ALDH1A3;ALDH2
1150,GO:0002765,0.112356969262807,0.995575918786179,1,3,immune response-inhibiting signal transduction,BP,IL20RB
1154,GO:0002775,0.112536557758443,0.995561378053736,1,3,antimicrobial peptide production,BP,KLK5
1155,GO:0002778,0.112536557758443,0.995561378053736,1,3,antibacterial peptide production,BP,KLK5
1156,GO:0002784,0.112536557758443,0.995561378053736,1,3,regulation of antimicrobial peptide production,BP,KLK5
1158,GO:0002786,0.112536557758443,0.995561378053736,1,3,regulation of antibacterial peptide production,BP,KLK5
19341,GO:1905867,0.112632505904208,0.995553599111277,1,3,epididymis development,BP,GJB5
14410,GO:0061771,0.112766312041319,0.995542738857279,1,3,response to caloric restriction,BP,APOE
8428,GO:0033590,0.112808955543671,0.995539274799517,1,3,response to cobalamin,BP,EGFR
2750,GO:0006182,0.112877939270563,0.981555911516374,2,14,cGMP biosynthetic process,BP,APOE;ADORA2B
9271,GO:0035747,0.112961609592372,0.995526862623082,1,3,natural killer cell chemotaxis,BP,CXCL14
7541,GO:0031905,0.113058276743626,0.995518993287015,1,3,early endosome lumen,CC,PDLIM4
521,GO:0001609,0.113110807185466,0.995514713906664,1,3,G-protein coupled adenosine receptor activity,MF,ADORA2B
3269,GO:0006972,0.113168110007446,0.981480582131033,2,14,hyperosmotic response,BP,SLC2A1;TRPV4
6873,GO:0030425,0.113185112573257,0.927098700656657,20,362,dendrite,CC,APOE;EPHB2;FBXO2;CYBA;TENM2;INSR;SV2A;DNM1;NSG1;DAB2IP;KCNC4;EPHA4;HOMER2;CPT1C;PDLIM4;CRTC1;STAT1;SLC1A4;SORT1;APBA1
16568,GO:0097447,0.113185112573257,0.927098700656657,20,362,dendritic tree,CC,APOE;EPHB2;FBXO2;CYBA;TENM2;INSR;SV2A;DNM1;NSG1;DAB2IP;KCNC4;EPHA4;HOMER2;CPT1C;PDLIM4;CRTC1;STAT1;SLC1A4;SORT1;APBA1
12317,GO:0048729,0.113234289344837,0.924036268426487,24,448,tissue morphogenesis,BP,ALDH1A3;PRICKLE2;EGFR;GLI2;SFRP1;PKD2;ZFPM1;ETV5;WNT3;RASIP1;TBX1;EPHA4;KIF26B;CTSV;ARHGEF19;ACTA2;PLXND1;NFATC4;SPRY2;GPC4;STAT1;TULP3;SMURF1;VANGL2
12964,GO:0051429,0.113286885737875,0.995500353988835,1,3,corticotropin-releasing hormone receptor binding,MF,UCN2
9809,GO:0042078,0.113490629229743,0.995483707656978,1,3,germ-line stem cell division,BP,ETV5
12066,GO:0048133,0.113490629229743,0.995483707656978,1,3,male germ-line stem cell asymmetric division,BP,ETV5
16790,GO:0098728,0.113490629229743,0.995483707656978,1,3,germline stem cell asymmetric division,BP,ETV5
6633,GO:0030001,0.113533641754335,0.923808412297247,24,450,metal ion transport,BP,KCNJ15;SLC13A5;SHROOM2;CYBA;PKD2;SERPINE2;SCN4B;KCNC4;F2R;HOMER2;ORAI3;SLC38A4;ATP6V0A2;ATP12A;STOM;VAMP2;TRPV4;NIPAL4;SLC5A1;SLC39A6;GJC2;SLC13A3;ASIC1;TCIRG1
7244,GO:0031232,0.113560867118596,0.995477961534851,1,3,extrinsic component of external side of plasma membrane,CC,SERPINE2
8258,GO:0033087,0.11358764354179,0.995475769955732,1,3,negative regulation of immature T cell proliferation,BP,ERBB2
838,GO:0002158,0.113840056748315,0.995455083064594,1,3,osteoclast proliferation,BP,TNFAIP3
5794,GO:0017075,0.113915675684951,0.981285955376644,2,14,syntaxin-1 binding,MF,VAMP3;VAMP2
18052,GO:1902722,0.11392264120891,0.995448303921248,1,3,positive regulation of prolactin secretion,BP,EGFR
15047,GO:0071073,0.113978252559947,0.995443735925651,1,3,positive regulation of phospholipid biosynthetic process,BP,ZP3
3590,GO:0008045,0.114054820186568,0.981249641121314,2,14,motor neuron axon guidance,BP,EPHA4;ERBB2
8484,GO:0033688,0.114062794736359,0.981247559065176,2,14,regulation of osteoblast proliferation,BP,SFRP1;PLXNB1
7847,GO:0032430,0.114280873477362,0.995418835820168,1,3,positive regulation of phospholipase A2 activity,BP,EGFR
13167,GO:0051835,0.114295402957918,0.995417638510327,1,3,positive regulation of synapse structural plasticity,BP,CAMK1
9927,GO:0042327,0.114331445427538,0.918421478177854,33,646,positive regulation of phosphorylation,BP,GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;INSR;VAV3;PKD2;DAB2IP;TBX1;SHC2;EPHA4;F2R;RPS6KA5;ACSL1;ERBB3;CSPG4;ACVR1B;CAMKK1;NAB2;TYRO3;SPRY2;TNFRSF19;TRPV4;ADORA2B;IGFBP4;ERBB2;CDK20;ACKR3;CAMK1;MAP3K3;NRK;VANGL2
16509,GO:0097320,0.11433437592064,0.981176598265245,2,14,plasma membrane tubulation,BP,SNX33;MICALL1
10297,GO:0043123,0.114354025600267,0.942318907667119,9,140,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,S100A4;MAP3K14;TNFSF10;F2R;TRIM22;RBCK1;TNFRSF19;CXXC5;MAP3K3
17674,GO:1901628,0.114422862515558,0.995407128055428,1,3,positive regulation of postsynaptic membrane organization,BP,APOE
3465,GO:0007341,0.114461208926054,0.995403963480854,1,3,penetration of zona pellucida,BP,HEXB
8084,GO:0032794,0.114646357743158,0.98109495107662,2,14,GTPase activating protein binding,MF,PLCD1;PLXNB1
4801,GO:0014013,0.114679482412086,0.956671688658405,5,63,regulation of gliogenesis,BP,ETV5;SERPINE2;EPHA4;TENM4;GJC2
10669,GO:0043988,0.1146942355387,0.99538470798882,1,3,histone H3-S28 phosphorylation,BP,RPS6KA5
6010,GO:0019087,0.114698515227509,0.995384353951421,1,3,transformation of host cell by virus,BP,INSR
13627,GO:0060191,0.114821290487545,0.962529446901076,4,46,regulation of lipase activity,BP,LMF1;EGFR;FURIN;SORT1
8703,GO:0034378,0.114854069056353,0.995371476023306,1,3,chylomicron assembly,BP,APOE
13953,GO:0060708,0.114983873850758,0.995360715294262,1,3,spongiotrophoblast differentiation,BP,GJB5
8009,GO:0032675,0.115030758107412,0.956498679826603,5,63,regulation of interleukin-6 production,BP,TNFAIP3;CYBA;F2R;TRPV4;ADORA2B
8867,GO:0034711,0.115152191923659,0.995346742190692,1,3,inhibin binding,MF,ACVR1B
2695,GO:0006084,0.115176692908251,0.970208941695087,3,29,acetyl-CoA metabolic process,BP,PDPR;MVD;MLYCD
12331,GO:0048752,0.115327052037493,0.995332202488217,1,3,semicircular canal morphogenesis,BP,TBX1
14517,GO:0070081,0.115414743866455,0.995324901850482,1,3,clathrin-sculpted monoamine transport vesicle,CC,VAMP2
14518,GO:0070083,0.115414743866455,0.995324901850482,1,3,clathrin-sculpted monoamine transport vesicle membrane,CC,VAMP2
14712,GO:0070427,0.115669981050273,0.99530361820214,1,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,TNFAIP3
10033,GO:0042554,0.115704001064278,0.980674884688638,2,15,superoxide anion generation,BP,EGFR;CYBA
18878,GO:1904636,0.115898034036529,0.995284558179082,1,3,response to ionomycin,BP,NFATC4
18879,GO:1904637,0.115898034036529,0.995284558179082,1,3,cellular response to ionomycin,BP,NFATC4
13622,GO:0060179,0.11597618087051,0.995278017505574,1,3,male mating behavior,BP,HEXB
9596,GO:0036493,0.115996036248805,0.995276354902321,1,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,NCK2
20214,GO:2001206,0.11600643580693,0.995275483965037,1,3,positive regulation of osteoclast development,BP,GPR68
1785,GO:0004435,0.116015511284913,0.98073499286589,2,14,phosphatidylinositol phospholipase C activity,MF,PLCD3;PLCD1
12454,GO:0050501,0.116076893823601,0.995269581045914,1,3,hyaluronan synthase activity,MF,HYAL1
17803,GO:1902022,0.116135965556623,0.995264629059813,1,3,L-lysine transport,BP,PQLC2
18347,GO:1903401,0.116135965556623,0.995264629059813,1,3,L-lysine transmembrane transport,BP,PQLC2
8057,GO:0032762,0.116167568659396,0.99526197864618,1,3,mast cell cytokine production,BP,BCL6
8058,GO:0032763,0.116167568659396,0.99526197864618,1,3,regulation of mast cell cytokine production,BP,BCL6
19278,GO:1905600,0.116191529808756,0.995259968607384,1,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,LDLRAP1
6728,GO:0030167,0.116196465549472,0.995259554504919,1,3,proteoglycan catabolic process,BP,SGSH
6746,GO:0030200,0.116196465549472,0.995259554504919,1,3,heparan sulfate proteoglycan catabolic process,BP,SGSH
6196,GO:0019740,0.11620885291744,0.995258515136076,1,3,nitrogen utilization,BP,GLUL
18328,GO:1903365,0.116229910941901,0.995256747974781,1,3,regulation of fear response,BP,APOE
20092,GO:2000822,0.116229910941901,0.995256747974781,1,3,regulation of behavioral fear response,BP,APOE
5664,GO:0016798,0.116269185824061,0.951083378179003,6,83,hydrolase activity, acting on glycosyl bonds,MF,GAA;HEXB;HYAL1;NAGLU;MPG;IDUA
18644,GO:1904031,0.116383153068693,0.969698648706564,3,30,positive regulation of cyclin-dependent protein kinase activity,BP,EGFR;PKD2;CDK20
15499,GO:0071942,0.116407376137682,0.995241841509475,1,3,XPC complex,CC,XPC
18084,GO:1902809,0.116440805392259,0.995239030800768,1,3,regulation of skeletal muscle fiber differentiation,BP,TBX1
3800,GO:0008410,0.116554967708359,0.995229425499037,1,3,CoA-transferase activity,MF,SUGCT
2502,GO:0005769,0.116555757757972,0.929997889591386,15,260,early endosome,CC,APOE;MVB12B;LAMP3;EGFR;LDLRAP1;NSG1;EPHA4;F2R;APPL2;RHOD;PDLIM4;ACKR3;NISCH;VPS33B;SORT1
10062,GO:0042594,0.116566365324847,0.940976683052807,9,139,response to starvation,BP,ULK2;SFRP1;FOXO1;GLUL;CTSV;SREBF1;SLC2A1;IMPACT;IFI16
6922,GO:0030550,0.116684110394942,0.995218547456947,1,3,acetylcholine receptor inhibitor activity,MF,LY6E
15519,GO:0072007,0.116717584668585,0.99521572569025,1,3,mesangial cell differentiation,BP,ACTA2
15520,GO:0072008,0.116717584668585,0.99521572569025,1,3,glomerular mesangial cell differentiation,BP,ACTA2
15602,GO:0072143,0.116717584668585,0.99521572569025,1,3,mesangial cell development,BP,ACTA2
15603,GO:0072144,0.116717584668585,0.99521572569025,1,3,glomerular mesangial cell development,BP,ACTA2
18717,GO:1904238,0.116717584668585,0.99521572569025,1,3,pericyte cell differentiation,BP,ACTA2
12381,GO:0048865,0.116722331299054,0.99521532549432,1,3,stem cell fate commitment,BP,SFRP1
1965,GO:0004693,0.11677012998684,0.969554147793191,3,30,cyclin-dependent protein serine/threonine kinase activity,MF,CDK18;CDK14;CDK20
14771,GO:0070541,0.116795863731037,0.995209123598569,1,3,response to platinum ion,BP,UROS
8253,GO:0033081,0.116983591391696,0.980334259764848,2,15,regulation of T cell differentiation in thymus,BP,GLI2;ERBB2
9453,GO:0036118,0.116994441166612,0.995192353898703,1,3,hyaluranon cable assembly,BP,HYAL1
17337,GO:1900104,0.116994441166612,0.995192353898703,1,3,regulation of hyaluranon cable assembly,BP,HYAL1
17338,GO:1900106,0.116994441166612,0.995192353898703,1,3,positive regulation of hyaluranon cable assembly,BP,HYAL1
14497,GO:0070050,0.117007174304801,0.995191277539008,1,3,neuron cellular homeostasis,BP,TYRO3
8494,GO:0033745,0.117146111514087,0.995179524598818,1,3,L-methionine-(R)-S-oxide reductase activity,MF,MSRB2
9783,GO:0042015,0.117158687978983,0.995178459985213,1,3,interleukin-20 binding,MF,IL20RB
837,GO:0002155,0.117260853226832,0.995169806962475,1,3,regulation of thyroid hormone mediated signaling pathway,BP,THRA
15406,GO:0071733,0.117267297837423,0.995169260852513,1,3,transcriptional activation by promoter-enhancer looping,BP,ZFPM1
16140,GO:0090202,0.117267297837423,0.995169260852513,1,3,gene looping,BP,ZFPM1
16298,GO:0090579,0.117267297837423,0.995169260852513,1,3,dsDNA loop formation,BP,ZFPM1
11275,GO:0045629,0.117284685560793,0.995167787271106,1,3,negative regulation of T-helper 2 cell differentiation,BP,BCL6
10464,GO:0043398,0.117285388318978,0.995167727708492,1,3,HLH domain binding,MF,PKD2
7747,GO:0032289,0.117413432795512,0.995156868757821,1,3,central nervous system myelin formation,BP,TENM4
13452,GO:0055038,0.117430546618,0.955287629664398,5,64,recycling endosome membrane,CC,NSG1;VAMP3;NDRG1;PDLIM4;MICALL1
9482,GO:0036166,0.117554233957409,0.995144913084961,1,3,phenotypic switching,BP,OLFM2
17412,GO:1900239,0.117554233957409,0.995144913084961,1,3,regulation of phenotypic switching,BP,OLFM2
9882,GO:0042249,0.117566270182634,0.980324062434932,2,14,establishment of planar polarity of embryonic epithelium,BP,SFRP1;VANGL2
9123,GO:0035502,0.117584618161966,0.995142331064436,1,3,metanephric part of ureteric bud development,BP,PKD2
11425,GO:0045916,0.117604258795856,0.995140661635975,1,3,negative regulation of complement activation,BP,SERPING1
19770,GO:2000258,0.117604258795856,0.995140661635975,1,3,negative regulation of protein activation cascade,BP,SERPING1
12282,GO:0048669,0.117624416474169,0.995138947944013,1,3,collateral sprouting in absence of injury,BP,WNT3
147,GO:0000302,0.117717405094864,0.937802959855614,10,163,response to reactive oxygen species,BP,TNFAIP3;APOE;TXNRD3;EGFR;PKD2;FOXO1;ENDOG;HYAL1;IMPACT;STAT1
6743,GO:0030195,0.117797605149333,0.969169384467341,3,30,negative regulation of blood coagulation,BP,APOE;SERPINE2;SERPING1
17316,GO:1900047,0.117797605149333,0.969169384467341,3,30,negative regulation of hemostasis,BP,APOE;SERPINE2;SERPING1
14120,GO:0061043,0.11780325054224,0.995123730489532,1,3,regulation of vascular wound healing,BP,TNFAIP3
2273,GO:0005244,0.117816315587083,0.955120460007359,5,63,voltage-gated ion channel activity,MF,KCNJ15;PKD2;SCN4B;KCNC4;CLCN7
6592,GO:0022832,0.117816315587083,0.955120460007359,5,63,voltage-gated channel activity,MF,KCNJ15;PKD2;SCN4B;KCNC4;CLCN7
18795,GO:1904428,0.117966632637955,0.995109805895708,1,3,negative regulation of tubulin deacetylation,BP,FRY
17665,GO:1901615,0.117975003754931,0.925500316457951,18,326,organic hydroxy compound metabolic process,BP,APOE;ALDH1A3;LMF1;FGFR4;LDLRAP1;TRERF1;CYP27C1;SEC14L2;PLCD3;SREBF1;RDH12;IMPA2;RETSAT;ALDH2;AMACR;MVD;PLCD1;ISYNA1
593,GO:0001758,0.118164535009457,0.995092911111331,1,3,retinal dehydrogenase activity,MF,ALDH1A3
14716,GO:0070432,0.118165137988811,0.995092859588321,1,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,TNFAIP3
11410,GO:0045893,0.118178868879235,0.909749054243822,51,1051,positive regulation of transcription, DNA-templated,BP,PEG3;NDN;ASH2L;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;ZNF318;SFRP1;POU3F1;INSR;PKD2;ZFPM1;RGMA;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;SOX12;DAB2IP;TBX1;TRERF1;YEATS4;TET1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;PLXND1;SREBF1;PIK3R1;NCK2;ACVR1B;NFATC4;RTF1;ZP3;TP53INP1;MDK;MC1R;CRTC1;ERBB2;RNF187;STAT1;IFI16;DBP;CAMK1;SP100
18387,GO:1903508,0.118178868879235,0.909749054243822,51,1051,positive regulation of nucleic acid-templated transcription,BP,PEG3;NDN;ASH2L;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;ZNF318;SFRP1;POU3F1;INSR;PKD2;ZFPM1;RGMA;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;SOX12;DAB2IP;TBX1;TRERF1;YEATS4;TET1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;PLXND1;SREBF1;PIK3R1;NCK2;ACVR1B;NFATC4;RTF1;ZP3;TP53INP1;MDK;MC1R;CRTC1;ERBB2;RNF187;STAT1;IFI16;DBP;CAMK1;SP100
10810,GO:0044339,0.118335473309912,0.995078293422649,1,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,WNT3
19601,GO:1990834,0.118363963342355,0.995075854878176,1,3,response to odorant,BP,CTSV
2401,GO:0005589,0.118375751265331,0.9950748457288,1,3,collagen type VI trimer,CC,COL6A1
16762,GO:0098647,0.118375751265331,0.9950748457288,1,3,collagen beaded filament,CC,COL6A1
3681,GO:0008203,0.11839747072711,0.945993772106273,7,101,cholesterol metabolic process,BP,APOE;LMF1;LDLRAP1;TRERF1;SEC14L2;SREBF1;MVD
13806,GO:0060448,0.118612632273811,0.995054543453617,1,3,dichotomous subdivision of terminal units involved in lung branching,BP,VANGL2
19985,GO:2000645,0.118640902364686,0.995052117568016,1,3,negative regulation of receptor catabolic process,BP,FURIN
2657,GO:0006024,0.118649846533278,0.949843796036668,6,81,glycosaminoglycan biosynthetic process,BP,XYLT1;CSPG4;SDC3;HYAL1;GPC4;XYLT2
5605,GO:0016684,0.118725647957328,0.968705484658897,3,32,oxidoreductase activity, acting on peroxide as acceptor,MF,GPX7;GPX3;TXNDC17
6277,GO:0019905,0.11872634899156,0.954667792052082,5,63,syntaxin binding,MF,SYT8;VAMP3;SYTL1;VAMP2;C2CD4C
11381,GO:0045829,0.118792700914808,0.995039080814428,1,3,negative regulation of isotype switching,BP,BCL6
18378,GO:1903463,0.118805971919242,0.995037940212135,1,3,regulation of mitotic cell cycle DNA replication,BP,BCL6
8252,GO:0033080,0.118855921780943,0.995033645930324,1,3,immature T cell proliferation in thymus,BP,ERBB2
4947,GO:0015057,0.118981792966761,0.995022815834771,1,3,thrombin-activated receptor activity,MF,F2R
11699,GO:0046548,0.11902478919262,0.995019113531805,1,3,retinal rod cell development,BP,NAGLU
6912,GO:0030534,0.119115733266126,0.954473744594455,5,63,adult behavior,BP,SLITRK6;DNM1;EPHA4;HOMER2;EFNB3
15479,GO:0071900,0.119185670431538,0.921831919257621,21,390,regulation of protein serine/threonine kinase activity,BP,TNFAIP3;APOE;MAP3K14;EPHB2;EGFR;SFRP1;INSR;PKD2;DAB2IP;SHC2;EPHA4;F2R;ACSL1;CSPG4;SPRY2;ADORA2B;ERBB2;CAMK1;MAP3K3;NRK;VANGL2
13,GO:0000026,0.119263912741064,0.994998496588927,1,3,alpha-1,2-mannosyltransferase activity,MF,PIGZ
3294,GO:0007010,0.119266359511113,0.909575778728856,48,977,cytoskeleton organization,BP,APOE;OBSL1;SHROOM2;EPB41L3;BCL6;BRSK1;SFRP1;FHOD3;PKD2;ESPN;TNXB;PARVB;OBSCN;GAS8;YEATS4;WIPF1;CORO6;DIXDC1;CTSV;ARHGEF19;EPS8L2;PPL;CUL9;FRY;DMTN;PIK3R1;IQSEC1;NCK2;ARHGAP40;RHOD;PLEKHH2;SPRY2;TRPV4;MSRB2;SYNM;ITGB5;MARK4;PDLIM4;CCDC69;ZMYM3;FBXW5;CCDC88B;SUN1;NINL;ARPIN;PLXNB1;NISCH;VANGL2
10556,GO:0043553,0.119277047036414,0.994997362860186,1,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,DAB2IP
16167,GO:0090244,0.119375827950186,0.994988831912025,1,3,Wnt signaling pathway involved in somitogenesis,BP,SFRP1
13623,GO:0060180,0.119418239473581,0.994985166794319,1,3,female mating behavior,BP,THRA
13729,GO:0060348,0.119437967189039,0.942083113546702,8,118,bone development,BP,ZFPM1;FAM20C;NAB2;TRPV4;GPR68;TULP3;PLXNB1;VPS33B
18040,GO:1902680,0.119534076641494,0.908630270182847,51,1052,positive regulation of RNA biosynthetic process,BP,PEG3;NDN;ASH2L;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;ZNF318;SFRP1;POU3F1;INSR;PKD2;ZFPM1;RGMA;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;SOX12;DAB2IP;TBX1;TRERF1;YEATS4;TET1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;PLXND1;SREBF1;PIK3R1;NCK2;ACVR1B;NFATC4;RTF1;ZP3;TP53INP1;MDK;MC1R;CRTC1;ERBB2;RNF187;STAT1;IFI16;DBP;CAMK1;SP100
11236,GO:0045578,0.119631999380962,0.994966672508113,1,3,negative regulation of B cell differentiation,BP,SFRP1
6723,GO:0030160,0.11982317022767,0.994950102077356,1,3,GKAP/Homer scaffold activity,MF,HOMER2
5115,GO:0015629,0.119936593628304,0.923092783696949,19,343,actin cytoskeleton,CC,OBSL1;SHROOM2;CYBA;H1F0;PGM1;FHOD3;PKD2;ESPN;PARVB;WIPF1;CORO6;DMTN;SLC2A1;PLEKHH2;TRPV4;MYL9;PDLIM4;AIF1L;VANGL2
141,GO:0000293,0.120165747332942,0.994920335823187,1,3,ferric-chelate reductase activity,MF,CYBRD1
16726,GO:0098563,0.120299353433147,0.97944072396716,2,15,intrinsic component of synaptic vesicle membrane,CC,PTPRS;SV2A
9286,GO:0035787,0.120428701759398,0.994897425080959,1,3,cell migration involved in kidney development,BP,VANGL2
2959,GO:0006516,0.120458657074956,0.979397400338195,2,15,glycoprotein catabolic process,BP,FBXO2;SGSH
5931,GO:0018298,0.120476660887546,0.994893240602414,1,3,protein-chromophore linkage,BP,CRY2
19532,GO:1990597,0.12048779561831,0.994892268826988,1,3,AIP1-IRE1 complex,CC,DAB2IP
680,GO:0001894,0.120508638850287,0.941413178407341,8,121,tissue homeostasis,BP,TNFAIP3;EGFR;TP53INP2;F2R;TUB;HOMER2;RDH12;IL20RB
12585,GO:0050810,0.120591174058905,0.953711400174814,5,64,regulation of steroid biosynthetic process,BP,APOE;FGFR4;SEC14L2;SREBF1;MVD
4429,GO:0010360,0.120640624804041,0.994878920876984,1,3,negative regulation of anion channel activity,BP,ANO9
8151,GO:0032911,0.120642815178147,0.994878729437778,1,3,negative regulation of transforming growth factor beta1 production,BP,FURIN
16969,GO:0099122,0.120660178953063,0.994877211705709,1,3,RNA polymerase II C-terminal domain binding,MF,RTF1
12619,GO:0050863,0.120689530423953,0.933745603910649,11,182,regulation of T cell activation,BP,GPNMB;MAP3K14;GLI2;BCL6;PIK3R1;NCK2;ZP3;EFNB3;ERBB2;IL20RB;CCDC88B
17359,GO:1900133,0.120692264208276,0.99487440657249,1,3,regulation of renin secretion into blood stream,BP,F2R
6681,GO:0030099,0.120699546554103,0.925803893915531,16,287,myeloid cell differentiation,BP,ASH2L;THRA;BCL6;SFRP1;ZFPM1;FAM20C;FAM213A;DMTN;PIK3R1;ACVR1B;FAM210B;MYL9;GPR68;STAT1;IFI16;VPS33B
16972,GO:0099132,0.120795223570482,0.968037808442421,3,30,ATP hydrolysis coupled cation transmembrane transport,BP,ATP6V0A2;ATP12A;TCIRG1
20261,GO:2001293,0.120830161221591,0.994862341324218,1,3,malonyl-CoA metabolic process,BP,MLYCD
3785,GO:0008381,0.120898063374845,0.994856394729806,1,3,mechanosensitive ion channel activity,MF,TRPV4
4806,GO:0014022,0.12117989955056,0.994831673714049,1,3,neural plate elongation,BP,VANGL2
6541,GO:0022007,0.12117989955056,0.994831673714049,1,3,convergent extension involved in neural plate elongation,BP,VANGL2
14690,GO:0070384,0.121244134113444,0.994826030649098,1,3,Harderian gland development,BP,ALDH1A3
4590,GO:0010724,0.121427097542033,0.994809939264399,1,3,regulation of definitive erythrocyte differentiation,BP,ZFPM1
12593,GO:0050820,0.121464582663868,0.979123000046132,2,15,positive regulation of coagulation,BP,F2R;DMTN
12601,GO:0050839,0.121528521312473,0.920094488371785,21,391,cell adhesion molecule binding,MF,POSTN;ITGB6;TGFBI;GPNMB;CADM4;ADGRL1;EGFR;NLGN2;TENM2;TNXB;DAB2IP;TENM4;EPS8L2;PPL;NDRG1;LTBP4;MICALL1;LAMB2;STAT1;H1FX;NISCH
3232,GO:0006906,0.121629290470393,0.940755691977335,8,120,vesicle fusion,BP,VAV3;SYT8;EVI5L;VAMP3;SYTL1;VAMP2;TBC1D17;C2CD4C
3545,GO:0007601,0.12175106970131,0.948153788309265,6,82,visual perception,BP,TGFBI;SLITRK6;OLFM2;RDH12;LAMB2;REEP6
12677,GO:0050953,0.12175106970131,0.948153788309265,6,82,sensory perception of light stimulus,BP,TGFBI;SLITRK6;OLFM2;RDH12;LAMB2;REEP6
2513,GO:0005783,0.121798803443372,0.904546261222174,62,1323,endoplasmic reticulum,CC,APOE;LMF1;KDSR;TXNRD3;GPX7;COL6A1;EGFR;FBXO2;CRAT;CYBA;OAS2;FGFR4;TENM2;XYLT1;CYP4F22;CERS4;CES2;SV2A;PKD2;RGMA;RTN2;ARSI;RHBDF1;TMEM129;WNT3;NSG1;COL7A1;H6PD;CRTAP;FKBP9;FAM20C;GLUL;ANO8;EPHA4;TRAPPC2L;B3GNT9;LTBP1;ACSL1;SREBF1;PIK3R1;NCK2;TYRO3;CPT1C;METTL7A;STOM;MBOAT7;LRRC8E;TMX4;ZDHHC1;RETSAT;IGFBP4;HSD11B1;LAMB2;SLC39A6;FURIN;CCDC88B;ANGEL1;XYLT2;CCDC3;REEP6;PIGZ;SORT1
13747,GO:0060374,0.121916207809809,0.994766792677142,1,3,mast cell differentiation,BP,ZFPM1
4610,GO:0010749,0.12201571374811,0.994757991643566,1,3,regulation of nitric oxide mediated signal transduction,BP,EGFR
18495,GO:1903725,0.122034693749437,0.959307052146821,4,46,regulation of phospholipid metabolic process,BP,VAV3;DAB2IP;PIK3R1;ZP3
48,GO:0000101,0.122071536413384,0.99475305084673,1,3,sulfur amino acid transport,BP,SLC1A4
10891,GO:0044539,0.122189075465336,0.994742639541183,1,3,long-chain fatty acid import,BP,ACSL1
17417,GO:1900245,0.122207727033989,0.994740986427853,1,3,positive regulation of MDA-5 signaling pathway,BP,DDX60
7866,GO:0032455,0.122232894736055,0.994738755344344,1,3,nerve growth factor processing,BP,FURIN
4789,GO:0012505,0.122278895723337,0.897386488533533,140,3156,endomembrane system,CC,POSTN;TGFBI;APOE;MVB12B;LAMP3;PTPRS;PHF7;OBSL1;LMF1;KDSR;PRICKLE2;TXNRD3;GPX7;ST3GAL5;COL6A1;EGFR;ADAM19;FBXO2;CRAT;CYBA;OAS2;H1F0;FGFR4;BCL6;PGM1;TENM2;XYLT1;CYP4F22;CERS4;BRSK1;INSR;GAA;CES2;SV2A;PKD2;RGMA;RTN2;ARSI;DNM1;CXCL14;LDLRAP1;CTSB;SYT8;SERPINE2;VEGFB;RHBDF1;TMEM129;WNT3;NSG1;RASIP1;COL7A1;PRSS3;H6PD;KLK5;CRTAP;GAS8;YEATS4;EVI5L;FKBP9;RAB40B;NRSN2;FAM20C;GLUL;ANO8;EPHA4;TRAPPC2L;B3GNT9;F2R;MPLKIP;CTSV;HEXB;LTBP1;ACSL1;HGSNAT;S100A6;ATP6V0A2;VAMP3;SREBF1;CSPG4;DMTN;PIK3R1;PTHLH;SDC3;APPL2;CTSL;TRIM22;NCK2;SYTL1;SNX33;TYRO3;RHOD;CXCR1;SLC2A1;CPT1C;METTL7A;STOM;VAMP2;MBOAT7;AVL9;SCG5;LRRC8E;SLC2A9;TMX4;ZDHHC1;GPC4;NDRG1;RETSAT;KLK8;SERPING1;PDLIM4;TBC1D17;GOLGA7B;NEO1;IGFBP4;ANKRD13D;MICALL1;ERBB2;C2CD4C;HSD11B1;LAMB2;ACKR3;MARCH9;SLC39A6;FURIN;CCDC88B;PCSK1;SUN1;ANGEL1;ASIC1;XYLT2;CCDC3;TCIRG1;NISCH;RAB43;VPS33B;ST6GALNAC6;REEP6;PIGZ;SORT1;APBA1
14392,GO:0061739,0.122301832963585,0.994732641493092,1,3,protein lipidation involved in autophagosome assembly,BP,WIPI2
8596,GO:0034140,0.122318684035747,0.994731146467588,1,3,negative regulation of toll-like receptor 3 signaling pathway,BP,TNFAIP3
2512,GO:0005782,0.122508410761592,0.967323148668907,3,31,peroxisomal matrix,CC,CRAT;AMACR;MLYCD
7543,GO:0031907,0.122508410761592,0.967323148668907,3,31,microbody lumen,CC,CRAT;AMACR;MLYCD
186,GO:0000404,0.122530329816306,0.994712350123366,1,3,heteroduplex DNA loop binding,MF,XPC
5839,GO:0017157,0.122574436977344,0.940179763184881,8,121,regulation of exocytosis,BP,RIMS3;SYT8;RAB40B;SYTL1;ZP3;VAMP2;ADORA2B;C2CD4C
10812,GO:0044341,0.122576696333486,0.994708227556808,1,3,sodium-dependent phosphate transport,BP,CRY2
8598,GO:0034142,0.12258091852167,0.978816801289856,2,15,toll-like receptor 4 signaling pathway,BP,TNFAIP3;DAB2IP
16386,GO:0097066,0.122646209332791,0.978798838086208,2,15,response to thyroid hormone,BP,CTSB;CTSL
718,GO:0001951,0.122698604179219,0.994697380289709,1,3,intestinal D-glucose absorption,BP,SLC5A1
17146,GO:0106001,0.122698604179219,0.994697380289709,1,3,intestinal hexose absorption,BP,SLC5A1
6662,GO:0030046,0.122729405857063,0.994694637716423,1,3,parallel actin filament bundle assembly,BP,ESPN
6782,GO:0030246,0.122746869547413,0.940076566911522,8,121,carbohydrate binding,MF,LGALS7B;ADGRL1;FBXO2;GAA;CLEC11A;ZP3;MRC2;LGALS9B
3186,GO:0006835,0.122860180830156,0.958933424990817,4,46,dicarboxylic acid transport,BP,SLC13A5;VAMP2;SLC13A3;APBA1
8141,GO:0032898,0.122870569435064,0.99468205892992,1,3,neurotrophin production,BP,FURIN
8610,GO:0034163,0.122976428202024,0.994672615717333,1,3,regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
12362,GO:0048840,0.122990292931106,0.994671378245627,1,3,otolith development,BP,LRIG3
8592,GO:0034136,0.123117221250929,0.994660042400676,1,3,negative regulation of toll-like receptor 2 signaling pathway,BP,TNFAIP3
413,GO:0001101,0.123129041685998,0.928426528648562,13,223,response to acid chemical,BP,COL6A1;EGFR;CYBA;SFRP1;PKD2;FOXO1;WNT3;TBX1;WNT9A;ACSL1;SREBF1;NFATC4;MTHFR
1323,GO:0003190,0.123670920096394,0.994610442656514,1,3,atrioventricular valve formation,BP,ZFPM1
3083,GO:0006672,0.123682190231832,0.952131205609187,5,65,ceramide metabolic process,BP,ST3GAL5;CERS4;HEXB;ALOXE3;ST6GALNAC6
7954,GO:0032590,0.123700421083414,0.978507962126925,2,15,dendrite membrane,CC,INSR;KCNC4
9637,GO:0038026,0.123719587992201,0.994606071409991,1,3,reelin-mediated signaling pathway,BP,DAB2IP
9839,GO:0042129,0.123721244193761,0.947031172562175,6,85,regulation of T cell proliferation,BP,GPNMB;NCK2;ZP3;ERBB2;IL20RB;CCDC88B
9563,GO:0036446,0.123758243275851,0.994602598135494,1,3,myofibroblast differentiation,BP,TP53INP1
18935,GO:1904760,0.123758243275851,0.994602598135494,1,3,regulation of myofibroblast differentiation,BP,TP53INP1
6458,GO:0021817,0.123816811335377,0.994597333388313,1,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,SUN1
10570,GO:0043578,0.123816811335377,0.994597333388313,1,3,nuclear matrix organization,BP,SUN1
16200,GO:0090292,0.123816811335377,0.994597333388313,1,3,nuclear matrix anchoring at nuclear membrane,BP,SUN1
2002,GO:0004741,0.124143400112679,0.994567926036371,1,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,PDPR
6514,GO:0021936,0.124209239620538,0.99456198732755,1,3,regulation of cerebellar granule cell precursor proliferation,BP,GLI2
10779,GO:0044300,0.124338991354607,0.994550273672057,1,3,cerebellar mossy fiber,CC,DAB2IP
15566,GO:0072093,0.124367121835464,0.99454773236009,1,3,metanephric renal vesicle formation,BP,KIF26B
698,GO:0001922,0.12440589254617,0.99454422877785,1,3,B-1 B cell homeostasis,BP,TNFAIP3
4827,GO:0014052,0.124438954005716,0.994541240178592,1,3,regulation of gamma-aminobutyric acid secretion,BP,SV2A
15657,GO:0072235,0.124465108067861,0.994538875360101,1,3,metanephric distal tubule development,BP,PKD2
7431,GO:0031587,0.124480628157346,0.994537471795543,1,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
15658,GO:0072236,0.124501154625766,0.994535615183462,1,3,metanephric loop of Henle development,BP,PKD2
4639,GO:0010801,0.124504135415663,0.978285147824359,2,15,negative regulation of peptidyl-threonine phosphorylation,BP,DMTN;SPRY2
11870,GO:0046935,0.12456047389002,0.994530247894475,1,3,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R1
6481,GO:0021869,0.124679128955071,0.994519503429579,1,3,forebrain ventricular zone progenitor cell division,BP,DIXDC1
4762,GO:0010966,0.124708628758508,0.994516830423796,1,3,regulation of phosphate transport,BP,CRY2
11418,GO:0045907,0.124736085372278,0.97822067464378,2,15,positive regulation of vasoconstriction,BP,EGFR;F2R
71,GO:0000147,0.124737790391972,0.994514187380088,1,3,actin cortical patch assembly,BP,WIPF1
10838,GO:0044396,0.124737790391972,0.994514187380088,1,3,actin cortical patch organization,BP,WIPF1
13085,GO:0051666,0.124737790391972,0.994514187380088,1,3,actin cortical patch localization,BP,WIPF1
15501,GO:0071947,0.124824463307987,0.99450632785241,1,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,TNFAIP3
12631,GO:0050878,0.124836653880382,0.921655552338305,17,308,regulation of body fluid levels,BP,APOE;EPHB2;CYBA;OAS2;VAV3;ZFPM1;SERPINE2;F2R;DMTN;PIK3R1;TYRO3;TRPV4;SERPING1;MYL9;BLOC1S4;ALOXE3;VPS33B
20082,GO:2000807,0.124953461330719,0.994494619211979,1,3,regulation of synaptic vesicle clustering,BP,NLGN2
11775,GO:0046697,0.124960148265042,0.978158321710247,2,15,decidualization,BP,CTSB;CTSV
6387,GO:0021631,0.125015196638027,0.994489011061173,1,3,optic nerve morphogenesis,BP,EPHB2
6327,GO:0021521,0.12502062292342,0.994488517982363,1,3,ventral spinal cord interneuron specification,BP,GLI2
6436,GO:0021775,0.12502062292342,0.994488517982363,1,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,GLI2
6437,GO:0021776,0.12502062292342,0.994488517982363,1,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,GLI2
13875,GO:0060573,0.12502062292342,0.994488517982363,1,3,cell fate specification involved in pattern specification,BP,GLI2
13881,GO:0060579,0.12502062292342,0.994488517982363,1,3,ventral spinal cord interneuron fate commitment,BP,GLI2
13882,GO:0060581,0.12502062292342,0.994488517982363,1,3,cell fate commitment involved in pattern specification,BP,GLI2
8400,GO:0033504,0.125033108087363,0.994487383384416,1,3,floor plate development,BP,GLI2
7064,GO:0030878,0.125046314052309,0.978134324376458,2,15,thyroid gland development,BP,THRA;TBX1
9172,GO:0035583,0.125058906656821,0.994485038528789,1,3,sequestering of TGFbeta in extracellular matrix,BP,LTBP1
2765,GO:0006211,0.125075813030509,0.994483501605911,1,3,5-methylcytosine catabolic process,BP,TET1
6246,GO:0019857,0.125075813030509,0.994483501605911,1,3,5-methylcytosine metabolic process,BP,TET1
10387,GO:0043260,0.125075813030509,0.994483501605911,1,3,laminin-11 complex,CC,LAMB2
15379,GO:0071688,0.125075813030509,0.994483501605911,1,3,striated muscle myosin thick filament assembly,BP,OBSL1
7163,GO:0031065,0.125100752476046,0.978119157778124,2,15,positive regulation of histone deacetylation,BP,BCL6;SREBF1
6676,GO:0030072,0.125159275836437,0.935654630292676,9,141,peptide hormone secretion,BP,EGFR;NLGN2;SFRP1;GLUL;SREBF1;SLC2A1;TRPV4;LTBP4;GPR68
12534,GO:0050728,0.125174202613579,0.951350835436047,5,66,negative regulation of inflammatory response,BP,TNFAIP3;APOE;NT5E;TYRO3;IL20RB
8192,GO:0032970,0.125734449728639,0.923581389771889,15,263,regulation of actin filament-based process,BP,SFRP1;FHOD3;WIPF1;DIXDC1;CTSV;ARHGEF19;EPS8L2;DMTN;PIK3R1;NCK2;ARHGAP40;RHOD;PLEKHH2;ARPIN;VANGL2
8122,GO:0032872,0.125796375611223,0.932682863149077,10,160,regulation of stress-activated MAPK cascade,BP,EGFR;SFRP1;FOXO1;DAB2IP;EPHA4;TNFRSF19;TRPV4;MAP3K3;NRK;VANGL2
16580,GO:0097472,0.125859591808331,0.966031559638068,3,31,cyclin-dependent protein kinase activity,MF,CDK18;CDK14;CDK20
1247,GO:0003012,0.125885014169476,0.9265549326002,13,222,muscle system process,BP,OBSL1;GAMT;CYBA;GAA;VEGFB;FOXO1;SCN4B;F2R;ACTA2;SYNM;ITGB5;ADORA2B;MYL9
12873,GO:0051259,0.126152596113119,0.917542186232037,20,378,protein complex oligomerization,BP,TNFAIP3;APOE;ALDH1A3;GPX3;COL6A1;INSR;PKD2;DNM1;KCNC4;GLUL;TRAPPC2L;TYSND1;HGSNAT;TRIM22;KCTD11;STOM;CRTC1;PEX11B;ASIC1;MMP1
13054,GO:0051604,0.126183162459642,0.928117924264627,12,207,protein maturation,BP,LMF1;SERPINE2;RHBDF1;PRSS3;MAGEF1;TYSND1;CTSV;SCG5;SERPING1;FURIN;IFI16;PCSK1
12734,GO:0051049,0.126205610937581,0.902637654518427,53,1107,regulation of transport,BP,POSTN;APOE;KCNJ15;EPHB2;EGFR;CYBA;OAS2;NLGN2;ANO9;SFRP1;INSR;SV2A;PKD2;RTN2;DNM1;LDLRAP1;RIMS3;SYT8;SERPINE2;RHBDF1;SCN4B;EVI5L;KCNC4;RAB40B;GLUL;F2R;TUB;HOMER2;ERBB3;VAMP3;SREBF1;DMTN;PIK3R1;SYTL1;SNX33;SLC2A1;ZP3;STOM;VAMP2;SCG5;TRPV4;ADORA2B;TBC1D17;STON1;GPR68;ERBB2;C2CD4C;CRY2;GJC2;ASIC1;CAMK1;REEP6;SP100
12031,GO:0048016,0.12655730428336,0.965825193480478,3,30,inositol phosphate-mediated signaling,BP,ADGRB2;ERBB3;NFATC4
16863,GO:0098862,0.126971367561023,0.945290995202186,6,83,cluster of actin-based cell projections,CC,RALGDS;CYBRD1;ESPN;HOMER2;SCART1;EPS8L2
94,GO:0000185,0.127102345153745,0.977558615006715,2,15,activation of MAPKKK activity,BP,DAB2IP;NRK
1241,GO:0003006,0.127390440383129,0.914874789728658,22,413,developmental process involved in reproduction,BP,HTRA1;EGFR;GLI2;IRF2BPL;SFRP1;TNFSF10;INSR;PKD2;CTSB;ETV5;SERPINE2;CTSV;HEXB;PLCD3;GJB5;ACVR1B;TYRO3;ZP3;CABYR;PLCD1;MDFI;NRK
865,GO:0002221,0.12742572239018,0.9372509596435,8,122,pattern recognition receptor signaling pathway,BP,TNFAIP3;PTPRS;CYBA;CTSB;DAB2IP;DDX60;CTSL;TYRO3
3698,GO:0008233,0.127974271309439,0.916199265094026,20,375,peptidase activity,MF,TNFAIP3;HTRA1;ADAM19;SFRP1;NPEPL1;CTSB;RHBDF1;PRSS3;KLK5;RNPEPL1;TYSND1;CTSV;CTSL;ADAMTS15;KLK8;FURIN;PCSK1;CTSF;MMP1;CAPNS2
6377,GO:0021602,0.128015786459355,0.977300935897512,2,15,cranial nerve morphogenesis,BP,EPHB2;TBX1
17646,GO:1901565,0.128159536510133,0.902503947681651,47,982,organonitrogen compound catabolic process,BP,TNFAIP3;APOE;MVB12B;LAMP3;TST;EGFR;FBXO2;CTSB;NT5E;SERPINE2;TP53INP2;WWTR1;RHBDF1;TMEM129;FOXO1;DAB2IP;SGSH;TET1;GLUL;EPHA4;RNPEPL1;MAGEF1;CTSV;HEXB;HGSNAT;CUL9;CSPG4;SDC3;CTSL;SNX33;HYAL1;RBCK1;SPATA18;GPC4;FBXW4;NAGLU;BTBD2;RNF187;RNF44;FURIN;FBXW5;THNSL2;CTSF;SMURF1;TCIRG1;IDUA;FBXO44
2841,GO:0006346,0.12838463412972,0.977196553253112,2,15,methylation-dependent chromatin silencing,BP,TET1;MBD1
5550,GO:0016581,0.128494110198478,0.977165535188074,2,15,NuRD complex,CC,SALL2;APPL2
16287,GO:0090545,0.128494110198478,0.977165535188074,2,15,CHD-type complex,CC,SALL2;APPL2
3780,GO:0008375,0.128766284401147,0.956153489917313,4,48,acetylglucosaminyltransferase activity,MF,XYLT1;B3GNT9;HEXB;XYLT2
12825,GO:0051186,0.129023587312847,0.913614150561027,22,428,cofactor metabolic process,BP,GAMT;GPX3;EGFR;CYBA;PGM1;DHTKD1;INSR;NT5E;PDPR;UROS;PRSS3;H6PD;PGLS;ACSL1;SLC2A1;MTHFR;NMRK1;MVD;MLYCD;NADK;ABCC1;CBR3
2190,GO:0005086,0.1291431693227,0.976981291106285,2,15,ARF guanyl-nucleotide exchange factor activity,MF,PSD4;IQSEC1
14270,GO:0061448,0.129154033707182,0.933158073375762,9,141,connective tissue development,BP,TGFBI;THRA;GLI2;WNT9A;ACTA2;PTHLH;HYAL1;TRPV4;FBXW4
12993,GO:0051489,0.129371870070031,0.964726680003887,3,30,regulation of filopodium assembly,BP,TENM2;ESPN;DMTN
14645,GO:0070302,0.129542750225912,0.93026491961467,10,161,regulation of stress-activated protein kinase signaling cascade,BP,EGFR;SFRP1;FOXO1;DAB2IP;EPHA4;TNFRSF19;TRPV4;MAP3K3;NRK;VANGL2
20062,GO:2000772,0.129659444305619,0.964547090401711,3,31,regulation of cellular senescence,BP,BCL6;NUAK1;MAP3K3
15779,GO:0072522,0.129747462643731,0.927777290945444,11,186,purine-containing compound biosynthetic process,BP,APOE;PGM1;DHTKD1;INSR;NT5E;ATP6V0A2;PTHLH;ADORA2B;NME4;COX5B;TCIRG1
7711,GO:0032228,0.12978341092608,0.97679897213829,2,15,regulation of synaptic transmission, GABAergic,BP,NLGN2;NISCH
6967,GO:0030665,0.129946179891772,0.948911749529598,5,66,clathrin-coated vesicle membrane,CC,APOE;EGFR;LDLRAP1;VAMP3;VAMP2
1918,GO:0004629,0.130064932298728,0.976718622949851,2,15,phospholipase C activity,MF,PLCD3;PLCD1
10237,GO:0043009,0.130254894947479,0.912718065086062,22,412,chordate embryonic development,BP,EGFR;GLI2;SFRP1;PKD2;SALL2;TMEM231;TBX1;TET1;WNT9A;PLCD3;GJB5;ENDOG;ACVR1B;HYAL1;RTF1;ZP3;TULP3;PLCD1;MDFI;NRK;VANGL2;APBA1
4128,GO:0009206,0.130375646354215,0.939043538049011,7,105,purine ribonucleoside triphosphate biosynthetic process,BP,PGM1;DHTKD1;INSR;ATP6V0A2;NME4;COX5B;TCIRG1
4644,GO:0010810,0.130375885325071,0.932400241256427,9,140,regulation of cell-substrate adhesion,BP,POSTN;SMOC2;NINJ1;BCL6;SFRP1;SPOCK1;DMTN;PIK3R1;RHOD
7964,GO:0032602,0.130694403633103,0.955222019950087,4,49,chemokine production,BP,POSTN;ZFPM1;TRPV4;ADORA2B
6275,GO:0019903,0.130880897458724,0.938791181253723,7,102,protein phosphatase binding,MF,EGFR;FOXO1;DAB2IP;PIK3R1;PDLIM4;ERBB2;STAT1
13192,GO:0051896,0.131198584027602,0.934961605114144,8,122,regulation of protein kinase B signaling,BP,EGFR;FGFR4;INSR;ERBB3;PIK3R1;SPRY2;MC1R;ERBB2
12925,GO:0051347,0.131427615234824,0.909504365723296,25,480,positive regulation of transferase activity,BP,MAP3K14;EPHB2;EGFR;FGFR4;INSR;VAV3;PKD2;DAB2IP;SHC2;EPHA4;F2R;ACSL1;ERBB3;CSPG4;CAMKK1;NAB2;TYRO3;SPRY2;ADORA2B;ERBB2;CDK20;CAMK1;MAP3K3;NRK;VANGL2
6710,GO:0030141,0.131476107578849,0.908110960618586,27,536,secretory granule,CC,LAMP3;CYBA;PGM1;GAA;CTSB;SYT8;SERPINE2;VEGFB;PRSS3;KLK5;RAB40B;CTSV;HEXB;HGSNAT;ATP6V0A2;VAMP3;CXCR1;METTL7A;STOM;VAMP2;SCG5;KLK8;SERPING1;PCSK1;SUN1;TCIRG1;VPS33B
3912,GO:0008610,0.1315588123729,0.90870733235508,26,507,lipid biosynthetic process,BP,APOE;ALDH1A3;KDSR;ST3GAL5;FGFR4;CERS4;TRERF1;SEC14L2;HEXB;ACSL1;SREBF1;PIK3R1;ZP3;MBOAT7;AMACR;MVD;HSD11B1;HINT2;PLPP2;MLYCD;THNSL2;ALOXE3;CCDC3;ST6GALNAC6;ISYNA1;PIGZ
5148,GO:0015711,0.131598348478783,0.919436212851884,15,265,organic anion transport,BP,APOE;CPT2;SLC13A5;SLC16A5;SV2A;ACSL1;SLC38A4;SLC2A1;VAMP2;SLC2A9;PQLC2;SLC1A4;SLC13A3;ABCC1;APBA1
12490,GO:0050671,0.132127564981243,0.947736523634724,5,68,positive regulation of lymphocyte proliferation,BP,BCL6;VAV3;NCK2;ZP3;CCDC88B
13720,GO:0060337,0.13219247645123,0.947702909083766,5,68,type I interferon signaling pathway,BP,IFITM1;IFI6;OAS2;STAT1;SP100
15170,GO:0071357,0.13219247645123,0.947702909083766,5,68,cellular response to type I interferon,BP,IFITM1;IFI6;OAS2;STAT1;SP100
12443,GO:0050431,0.132231814064759,0.976096467033079,2,15,transforming growth factor beta binding,MF,LTBP1;LTBP4
1657,GO:0004129,0.132713266661271,0.975554123567303,2,18,cytochrome-c oxidase activity,MF,NDUFA4L2;COX5B
4931,GO:0015002,0.132713266661271,0.975554123567303,2,18,heme-copper terminal oxidase activity,MF,NDUFA4L2;COX5B
5602,GO:0016676,0.132713266661271,0.975554123567303,2,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,NDUFA4L2;COX5B
6442,GO:0021782,0.132964902290857,0.947352688545034,5,66,glial cell development,BP,EGFR;POU3F1;TENM4;NDRG1;LAMB2
12783,GO:0051128,0.133044286894341,0.891991657247866,83,1799,regulation of cellular component organization,BP,POSTN;APOE;ULK2;PTPRS;OBSL1;ADGRB2;EPHB2;HTRA1;SLITRK6;ADGRL1;EGFR;THRA;CYBA;FGFR4;EPB41L3;NLGN2;BCL6;TENM2;SFRP1;FHOD3;TNFSF10;INSR;ESPN;RGMA;LDLRAP1;ETV5;SERPINE2;WNT3;PARVB;DDB2;DAB2IP;EVI5L;WIPF1;TET1;EPHA4;RPL13A;DIXDC1;CTSV;RPS6KA5;TUB;ARHGEF19;HEXB;EPS8L2;KIF26A;SPOCK1;CUL9;PLXND1;SREBF1;DMTN;ENDOG;PIK3R1;NCK2;ACVR1B;ARHGAP40;NFATC4;SNX33;RHOD;HYAL1;RTF1;PLEKHH2;EFNB3;SPRY2;TRPV4;MTHFR;KLK8;LTBP4;RTN4RL1;IMPACT;TBC1D17;CRTC1;IGFBP4;STON1;TOM1L2;ERBB2;ZMYM3;FBXW5;ARPIN;MMP1;PLXNB1;SMURF1;CAMK1;ZSWIM8;VANGL2
13040,GO:0051588,0.133127289498431,0.954123341391156,4,48,regulation of neurotransmitter transport,BP,SV2A;RIMS3;KCNC4;ASIC1
10695,GO:0044070,0.133311575362963,0.954036960884384,4,48,regulation of anion transport,BP,APOE;ANO9;SV2A;CRY2
10102,GO:0042692,0.133329758438068,0.923318942129218,12,203,muscle cell differentiation,BP,OBSL1;FLNC;THRA;FHOD3;BOC;OBSCN;TBX1;OLFM2;TMEM204;NFATC4;CAMK1;SORT1
884,GO:0002262,0.133342216504252,0.937320919766681,7,104,myeloid cell homeostasis,BP,THRA;BCL6;ZFPM1;DMTN;ACVR1B;FAM210B;STAT1
3425,GO:0007249,0.133347807996772,0.923289345843819,12,206,I-kappaB kinase/NF-kappaB signaling,BP,TNFAIP3;S100A4;MAP3K14;TNFSF10;DAB2IP;F2R;TRIM22;RBCK1;TNFRSF19;STAT1;CXXC5;MAP3K3
12265,GO:0048640,0.133413996400844,0.947146109693079,5,65,negative regulation of developmental growth,BP,ULK2;PTPRS;SFRP1;WNT3;EPHA4
8101,GO:0032813,0.133491690651089,0.962963918124031,3,32,tumor necrosis factor receptor superfamily binding,MF,TNFSF10;DAB2IP;STAT1
10614,GO:0043666,0.133707001861571,0.941528610221159,6,85,regulation of phosphoprotein phosphatase activity,BP,PPP2R2C;PPP1R35;CRY2;NUAK1;ELFN2;PPP1R14A
6706,GO:0030136,0.133914620210023,0.933291142937658,8,123,clathrin-coated vesicle,CC,APOE;EGFR;LDLRAP1;VAMP3;VAMP2;FURIN;VPS33B;SORT1
13707,GO:0060322,0.134113823524005,0.907436684213415,25,478,head development,BP,ALDH1A3;PTPRS;EPHB2;SHROOM2;EGFR;THRA;GLI2;SFRP1;POU3F1;SERPINE2;WNT3;DAB2IP;TBX1;GAS8;DIXDC1;SMARCA1;TYRO3;SLC2A1;MBOAT7;MDK;NAGLU;RTN4RL1;TULP3;SUN1;GJC2
7798,GO:0032373,0.134225345555222,0.975363783222489,2,16,positive regulation of sterol transport,BP,APOE;LDLRAP1
7801,GO:0032376,0.134225345555222,0.975363783222489,2,16,positive regulation of cholesterol transport,BP,APOE;LDLRAP1
3775,GO:0008360,0.134270747254533,0.93308466928987,8,122,regulation of cell shape,BP,EPB41L3;PARVB;WIPF1;HEXB;PLXND1;DMTN;RHOD;PLXNB1
12592,GO:0050819,0.13432252995749,0.962631401699418,3,32,negative regulation of coagulation,BP,APOE;SERPINE2;SERPING1
745,GO:0001990,0.134333609764611,0.97533203984563,2,16,regulation of systemic arterial blood pressure by hormone,BP,CYBA;F2R
15851,GO:0072659,0.134338604849874,0.924749662576507,11,183,protein localization to plasma membrane,BP,EPHB2;EGFR;EPB41L3;LDLRAP1;NSG1;RAB40B;VAMP3;PIK3R1;VAMP2;GOLGA7B;SMURF1
16447,GO:0097179,0.134463975943288,0.992822865432395,1,4,protease inhibitor complex,CC,KLK8
18664,GO:1904090,0.134463975943288,0.992822865432395,1,4,peptidase inhibitor complex,CC,KLK8
10153,GO:0042776,0.134731110502291,0.992793430264203,1,4,mitochondrial ATP synthesis coupled proton transport,BP,COX5B
1635,GO:0004090,0.13476807671242,0.992789351969351,1,4,carbonyl reductase (NADPH) activity,MF,CBR3
4074,GO:0009145,0.134873774331044,0.936391609491685,7,106,purine nucleoside triphosphate biosynthetic process,BP,PGM1;DHTKD1;INSR;ATP6V0A2;NME4;COX5B;TCIRG1
9409,GO:0036017,0.13498728815295,0.992765142287006,1,4,response to erythropoietin,BP,MT2A
9410,GO:0036018,0.13498728815295,0.992765142287006,1,4,cellular response to erythropoietin,BP,MT2A
13960,GO:0060716,0.135053211310792,0.975120635169849,2,16,labyrinthine layer blood vessel development,BP,PLCD3;PLCD1
16759,GO:0098644,0.135270050467218,0.975213114986257,2,15,complex of collagen trimers,CC,TNXB;COL7A1
20067,GO:2000778,0.135732900546398,0.974920293190267,2,16,positive regulation of interleukin-6 secretion,BP,F2R;TRPV4
11864,GO:0046928,0.135943557894511,0.962046111195443,3,31,regulation of neurotransmitter secretion,BP,RIMS3;KCNC4;ASIC1
10123,GO:0042733,0.135945774585846,0.952797027014924,4,48,embryonic digit morphogenesis,BP,GLI2;TMEM231;FBXW4;TULP3
7238,GO:0031225,0.136075000964991,0.945657362879516,5,69,anchored component of membrane,CC,RGMA;NT5E;LY6E;GPC4;RTN4RL1
3123,GO:0006732,0.136194168174508,0.914711076300772,16,295,coenzyme metabolic process,BP,GAMT;PGM1;DHTKD1;INSR;NT5E;PDPR;H6PD;PGLS;ACSL1;SLC2A1;MTHFR;NMRK1;MVD;MLYCD;NADK;CBR3
18031,GO:1902652,0.136659074246559,0.935351781962655,7,105,secondary alcohol metabolic process,BP,APOE;LMF1;LDLRAP1;TRERF1;SEC14L2;SREBF1;MVD
122,GO:0000253,0.137294537983742,0.992507711544076,1,4,3-keto sterol reductase activity,MF,CBR3
2598,GO:0005921,0.137417399285053,0.974421007344811,2,16,gap junction,CC,GJB5;GJC2
6659,GO:0030041,0.137499198458588,0.931064642228143,8,125,actin filament polymerization,BP,FHOD3;WIPF1;EPS8L2;DMTN;NCK2;ARHGAP40;MSRB2;ARPIN
7317,GO:0031347,0.137893644726197,0.906045527947424,23,447,regulation of defense response,BP,TNFAIP3;APOE;PTPRS;HTRA1;EGFR;CYBA;BCL6;CTSB;NT5E;DAB2IP;KLK5;RPS6KA5;DDX60;CTSL;TYRO3;ZP3;TRPV4;ADORA2B;SERPING1;RNF135;STAT1;IFI16;IL20RB
1195,GO:0002862,0.137982413284902,0.992430035170823,1,4,negative regulation of inflammatory response to antigenic stimulus,BP,IL20RB
7985,GO:0032635,0.138105636500345,0.944642735178265,5,67,interleukin-6 production,BP,TNFAIP3;CYBA;F2R;TRPV4;ADORA2B
9411,GO:0036019,0.138118614453857,0.974212004709984,2,16,endolysosome,CC,CTSB;CTSL
2704,GO:0006098,0.138118977641817,0.974070362831844,2,17,pentose-phosphate shunt,BP,H6PD;PGLS
8177,GO:0032946,0.138135402573142,0.944576235787082,5,69,positive regulation of mononuclear cell proliferation,BP,BCL6;VAV3;NCK2;ZP3;CCDC88B
11210,GO:0045444,0.138230235678372,0.927386735098449,9,144,fat cell differentiation,BP,SFRP1;ZFPM1;WWTR1;FOXO1;SREBF1;TRPV4;ALOXE3;CCDC3;SORT1
2081,GO:0004857,0.138260234439966,0.91797942115274,13,232,enzyme inhibitor activity,MF,PINLYP;SERPINE2;COL7A1;SPOCK1;FRY;SPRY2;SCG5;PPP1R35;SERPING1;RTN4RL1;FURIN;ELFN2;PPP1R14A
8034,GO:0032722,0.138315778651413,0.961019407928977,3,32,positive regulation of chemokine production,BP,POSTN;TRPV4;ADORA2B
19413,GO:1990126,0.138405192839483,0.974126391364945,2,16,retrograde transport, endosome to plasma membrane,BP,NSG1;MICALL1
486,GO:0001539,0.138706111076117,0.97403637148779,2,16,cilium or flagellum-dependent cell motility,BP,GAS8;MAFIP
13679,GO:0060285,0.138706111076117,0.97403637148779,2,16,cilium-dependent cell motility,BP,GAS8;MAFIP
3475,GO:0007369,0.138788607426828,0.930303969507875,8,122,gastrulation,BP,COL6A1;SFRP1;WNT3;COL7A1;TENM4;RTF1;ITGB5;VANGL2
4661,GO:0010827,0.138893741121734,0.951397932540801,4,48,regulation of glucose transmembrane transport,BP,INSR;RTN2;PIK3R1;SLC2A1
13873,GO:0060571,0.139064742512912,0.973928922710694,2,16,morphogenesis of an epithelial fold,BP,EGFR;GLI2
15647,GO:0072215,0.139149546621282,0.973903488680036,2,16,regulation of metanephros development,BP,WWTR1;STAT1
4867,GO:0014805,0.139746165033152,0.992228918682612,1,4,smooth muscle adaptation,BP,CYBA
16246,GO:0090382,0.139763718718328,0.960364844362808,3,33,phagosome maturation,BP,ATP6V0A2;TCIRG1;RAB43
15284,GO:0071542,0.140044686176535,0.973634415369845,2,16,dopaminergic neuron differentiation,BP,SFRP1;WNT3
19761,GO:2000243,0.140074519701701,0.960302216853085,3,32,positive regulation of reproductive process,BP,INSR;ACVR1B;ZP3
5078,GO:0015370,0.140206241550906,0.960317381594933,3,31,solute:sodium symporter activity,MF,SLC13A5;SLC5A1;SLC13A3
16948,GO:0099072,0.140285499210821,0.973561839156192,2,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,DNM1;NSG1
8548,GO:0034045,0.140619150173602,0.973461150882742,2,16,phagophore assembly site membrane,CC,ULK2;WIPI2
6239,GO:0019841,0.140623224113071,0.9921278636003,1,4,retinol binding,MF,CYP27C1
11435,GO:0045926,0.140760977321389,0.922911377738637,10,166,negative regulation of growth,BP,ULK2;PTPRS;BCL6;SFRP1;SERPINE2;WNT3;EPHA4;ACVR1B;HYAL1;MT2A
8743,GO:0034447,0.141027665649517,0.99208102925953,1,4,very-low-density lipoprotein particle clearance,BP,APOE
7277,GO:0031295,0.141400309654096,0.959758673530041,3,32,T cell costimulation,BP,MAP3K14;PIK3R1;EFNB3
8398,GO:0033500,0.141565033299969,0.92523314174103,9,146,carbohydrate homeostasis,BP,CYBA;FGFR4;INSR;FOXO1;ENDOG;PIK3R1;TRPV4;GPR68;CRY2
10061,GO:0042593,0.141565033299969,0.92523314174103,9,146,glucose homeostasis,BP,CYBA;FGFR4;INSR;FOXO1;ENDOG;PIK3R1;TRPV4;GPR68;CRY2
16214,GO:0090311,0.141822892410801,0.95958490107771,3,32,regulation of protein deacetylation,BP,BCL6;FRY;SREBF1
10859,GO:0044433,0.142112449160372,0.890350272979878,49,1036,cytoplasmic vesicle part,CC,APOE;MVB12B;LAMP3;ULK2;PTPRS;GPRC5C;EGFR;CYBA;PGM1;INSR;GAA;SV2A;PKD2;LDLRAP1;CTSB;SYT8;VEGFB;WNT3;NSG1;PRSS3;RAB40B;EPHA4;LRIG3;HEXB;HGSNAT;ATP6V0A2;VAMP3;SREBF1;APPL2;CTSL;SNX33;RHOD;CXCR1;METTL7A;STOM;VAMP2;NDRG1;SERPING1;PDLIM4;MICALL1;ERBB2;C2CD4C;FURIN;PCSK1;SUN1;TCIRG1;RAB43;VPS33B;SORT1
2950,GO:0006501,0.142330000569949,0.959310058858997,3,33,C-terminal protein lipidation,BP,LY6E;RTN4RL1;WIPI2
5150,GO:0015718,0.142657776489823,0.936466430401845,6,86,monocarboxylic acid transport,BP,APOE;CPT2;SLC16A5;SV2A;ACSL1;APBA1
15922,GO:0080008,0.142666183220733,0.959237372499172,3,32,Cul4-RING E3 ubiquitin ligase complex,CC,DCAF16;DDB2;FBXW5
4346,GO:0009967,0.142717302788318,0.889571474709389,50,1055,positive regulation of signal transduction,BP,GPNMB;S100A4;MAP3K14;EPHB2;EGFR;CYBA;FGFR4;NLGN2;SFRP1;TNFSF10;INSR;VAV3;PKD2;LDLRAP1;WNT3;DAB2IP;TBX1;KLK5;SHC2;SH3BP2;EPHA4;WNT9A;DIXDC1;F2R;DDX60;ERBB3;CSPG4;DMTN;PIK3R1;TRIM22;NCK2;ACVR1B;NFATC4;TYRO3;RBCK1;SPRY2;TP53INP1;TNFRSF19;TRPV4;ADORA2B;MC1R;NEO1;IGFBP4;ERBB2;ACKR3;PLXNB1;CXXC5;MAP3K3;NRK;VANGL2
16113,GO:0090174,0.143322073757007,0.927452511998205,8,125,organelle membrane fusion,BP,VAV3;SYT8;EVI5L;VAMP3;SYTL1;VAMP2;TBC1D17;C2CD4C
13582,GO:0060113,0.143350407508793,0.958954659091805,3,32,inner ear receptor cell differentiation,BP,SLITRK6;NAGLU;VANGL2
14731,GO:0070470,0.1434258578481,0.991800272955585,1,4,plasma membrane respiratory chain,CC,SDHA
13574,GO:0060087,0.143560113605952,0.991784401355532,1,4,relaxation of vascular smooth muscle,BP,ADORA2B
19150,GO:1905276,0.143663137816023,0.972535444684144,2,16,regulation of epithelial tube formation,BP,SFRP1;VANGL2
11581,GO:0046320,0.143706233104478,0.972522247255169,2,16,regulation of fatty acid oxidation,BP,TYSND1;MLYCD
2724,GO:0006121,0.143848158040434,0.991750293716939,1,4,mitochondrial electron transport, succinate to ubiquinone,BP,SDHA
7460,GO:0031644,0.144194590304907,0.958604943553709,3,32,regulation of neurological system process,BP,TENM4;F2R;KLK8
18456,GO:1903626,0.144247899459922,0.991702834942173,1,4,positive regulation of DNA catabolic process,BP,ENDOG
6097,GO:0019362,0.144585384013459,0.92663977146212,8,127,pyridine nucleotide metabolic process,BP,PGM1;DHTKD1;INSR;NT5E;H6PD;PGLS;NMRK1;NADK
11668,GO:0046496,0.144585384013459,0.92663977146212,8,127,nicotinamide nucleotide metabolic process,BP,PGM1;DHTKD1;INSR;NT5E;H6PD;PGLS;NMRK1;NADK
11311,GO:0045671,0.144763775323418,0.97219758613801,2,16,negative regulation of osteoclast differentiation,BP,SFRP1;PIK3R1
8091,GO:0032801,0.14488084304497,0.958319914063993,3,32,receptor catabolic process,BP,APOE;FURIN;SMURF1
545,GO:0001665,0.145016329689199,0.991611195724269,1,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,ST6GALNAC6
13756,GO:0060384,0.145035918237411,0.97211379045579,2,16,innervation,BP,SLITRK6;SERPINE2
16796,GO:0098742,0.145241794518474,0.930246137006365,7,104,cell-cell adhesion via plasma-membrane adhesion molecules,BP,LGALS7B;CADM4;ADGRL1;TENM2;SDK2;TENM4;PCDH1
17795,GO:1901998,0.145349345944536,0.958057139052484,3,33,toxin transport,BP,DNM1;RAB40B;RAB43
5241,GO:0015889,0.145545394162246,0.991547789560059,1,4,cobalamin transport,BP,ABCC1
19825,GO:2000344,0.145547815648268,0.991547498768775,1,4,positive regulation of acrosome reaction,BP,ZP3
10552,GO:0043549,0.145728603414344,0.893922372776119,32,643,regulation of kinase activity,BP,TNFAIP3;APOE;MAP3K14;EPHB2;EGFR;FGFR4;SFRP1;INSR;VAV3;PKD2;WWTR1;DAB2IP;SHC2;EPHA4;F2R;ACSL1;ERBB3;CSPG4;PIK3R1;NCK2;CAMKK1;NAB2;TYRO3;SPRY2;ADORA2B;RTN4RL1;ERBB2;CDK20;CAMK1;MAP3K3;NRK;VANGL2
2825,GO:0006309,0.145779004488625,0.971731049542792,2,17,apoptotic DNA fragmentation,BP,H1F0;ENDOG
19834,GO:2000354,0.145894420861017,0.991505820524447,1,4,regulation of ovarian follicle development,BP,ZP3
1144,GO:0002759,0.145971119884662,0.991496582894894,1,4,regulation of antimicrobial humoral response,BP,KLK5
1079,GO:0002674,0.146070935306346,0.991484553092816,1,4,negative regulation of acute inflammatory response,BP,IL20RB
3076,GO:0006665,0.146086313567044,0.925699836830317,8,127,sphingolipid metabolic process,BP,KDSR;ST3GAL5;CERS4;ARSI;HEXB;PLPP2;ALOXE3;ST6GALNAC6
1645,GO:0004111,0.146144637523631,0.991475664634507,1,4,creatine kinase activity,MF,CKMT1A
4013,GO:0009062,0.146249089287979,0.934355891907974,6,89,fatty acid catabolic process,BP,CPT2;CRAT;TYSND1;CPT1C;AMACR;MLYCD
5601,GO:0016675,0.146563053882687,0.971228340181262,2,19,oxidoreductase activity, acting on a heme group of donors,MF,NDUFA4L2;COX5B
7137,GO:0031017,0.146750599616553,0.991402397956118,1,4,exocrine pancreas development,BP,INSR
6288,GO:0019935,0.146858322943298,0.939963780501774,5,68,cyclic-nucleotide-mediated signaling,BP,APOE;PTHLH;UCN2;ADORA2B;MC1R
6705,GO:0030135,0.147014712096316,0.913900414841716,12,209,coated vesicle,CC,APOE;EGFR;LDLRAP1;COL7A1;VAMP3;SREBF1;VAMP2;FURIN;VPS33B;IDUA;SORT1;VANGL2
5310,GO:0016054,0.147162426397552,0.916055192009387,11,192,organic acid catabolic process,BP,CPT2;CRAT;GLUL;TYSND1;HEXB;CPT1C;HYAL1;AMACR;MLYCD;THNSL2;IDUA
11620,GO:0046395,0.147162426397552,0.916055192009387,11,192,carboxylic acid catabolic process,BP,CPT2;CRAT;GLUL;TYSND1;HEXB;CPT1C;HYAL1;AMACR;MLYCD;THNSL2;IDUA
12245,GO:0048593,0.147196367197667,0.939809798698715,5,67,camera-type eye morphogenesis,BP,ALDH1A3;EPHB2;SHROOM2;SDK2;WNT9A
623,GO:0001816,0.147365538090626,0.898747475891322,23,448,cytokine production,BP,TNFAIP3;POSTN;ITGB6;PTPRS;GPNMB;CYBA;BCL6;ZFPM1;F2R;RPS6KA5;DDX60;PIK3R1;NFATC4;ZP3;TRPV4;ADORA2B;MC1R;RNF135;STAT1;FURIN;IFI16;IL20RB;CCDC88B
3649,GO:0008154,0.147389774503185,0.92146482613877,9,147,actin polymerization or depolymerization,BP,FHOD3;WIPF1;EPS8L2;DMTN;NCK2;ARHGAP40;PLEKHH2;MSRB2;ARPIN
9359,GO:0035927,0.147516724759671,0.991309286115959,1,4,RNA import into mitochondrion,BP,TST
893,GO:0002278,0.147612353574061,0.991297626116564,1,4,eosinophil activation involved in immune response,BP,VAMP2
983,GO:0002447,0.147612353574061,0.991297626116564,1,4,eosinophil mediated immunity,BP,VAMP2
10417,GO:0043307,0.147612353574061,0.991297626116564,1,4,eosinophil activation,BP,VAMP2
10418,GO:0043308,0.147612353574061,0.991297626116564,1,4,eosinophil degranulation,BP,VAMP2
3417,GO:0007221,0.147620252436102,0.97131297672496,2,16,positive regulation of transcription of Notch receptor target,BP,PLXND1;STAT1
16954,GO:0099080,0.147922192243307,0.893290256322941,30,598,supramolecular complex,CC,OBSL1;FLNC;SHROOM2;COL6A1;FHOD3;PKD2;ESPN;DNM1;LDLRAP1;TNXB;PARVB;COL7A1;OBSCN;CLIP2;GAS8;WIPF1;KIF26B;LTBP1;KIF26A;DMTN;SLC2A1;SPRY2;TRPV4;SYNM;NDRG1;MYL9;PDLIM4;NINL;SLC1A4;AIF1L
11474,GO:0045995,0.147963915717506,0.933428646793796,6,86,regulation of embryonic development,BP,SFRP1;INSR;TENM4;TULP3;NRK;VANGL2
16832,GO:0098805,0.148206709218319,0.883427037775541,56,1195,whole membrane,CC,APOE;MVB12B;LAMP3;ULK2;PTPRS;COL6A1;EGFR;CYBA;SNN;INSR;CYBRD1;GAA;SV2A;LDLRAP1;SYT8;WNT3;NSG1;BPHL;RAB40B;MARVELD1;EPHA4;F2R;ACSL1;HGSNAT;ATP6V0A2;VAMP3;SREBF1;APPL2;FAM210B;RHOD;CXCR1;SLC2A1;CPT1C;STOM;VAMP2;PQLC2;SPATA18;NDRG1;RETSAT;RTN4RL1;PDLIM4;MICALL1;ERBB2;C2CD4C;WIPI2;MARCH9;FURIN;CLCN7;SUN1;PEX11B;TCIRG1;RAB43;VPS33B;DIRC2;ABCC1;SORT1
4471,GO:0010511,0.148339027952897,0.991208749669974,1,4,regulation of phosphatidylinositol biosynthetic process,BP,ZP3
12181,GO:0048408,0.148783836220664,0.991154108671165,1,4,epidermal growth factor binding,MF,EGFR
14528,GO:0070098,0.148812638937137,0.970782191996041,2,17,chemokine-mediated signaling pathway,BP,CXCR1;ACKR3
13470,GO:0055081,0.148831292215456,0.956666290737824,3,32,anion homeostasis,BP,APOE;FGFR4;PQLC2
12543,GO:0050750,0.148846465418694,0.970771540424658,2,17,low-density lipoprotein particle receptor binding,MF,APOE;LDLRAP1
14496,GO:0070044,0.148911641005241,0.991138375413369,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,VAMP2
2386,GO:0005544,0.148915138849896,0.956560979285166,3,33,calcium-dependent phospholipid binding,MF,SYT8;SYTL1;C2CD4C
10452,GO:0043380,0.148952341977924,0.991133361827343,1,4,regulation of memory T cell differentiation,BP,BCL6
8493,GO:0033743,0.149029266554549,0.991123882038041,1,4,peptide-methionine (R)-S-oxide reductase activity,MF,MSRB2
8255,GO:0033083,0.149324159791196,0.991087490685517,1,4,regulation of immature T cell proliferation,BP,ERBB2
10133,GO:0042749,0.149466882652185,0.991069849327816,1,4,regulation of circadian sleep/wake cycle,BP,PER3
11108,GO:0045187,0.149466882652185,0.991069849327816,1,4,regulation of circadian sleep/wake cycle, sleep,BP,PER3
12311,GO:0048710,0.149498603118608,0.970565882566785,2,17,regulation of astrocyte differentiation,BP,SERPINE2;EPHA4
16572,GO:0097452,0.149530838166044,0.991061938004452,1,4,GAIT complex,CC,RPL13A
9853,GO:0042158,0.149544755007135,0.9275540114483,7,110,lipoprotein biosynthetic process,BP,APOE;LY6E;ZDHHC1;RTN4RL1;GOLGA7B;WIPI2;PIGZ
8742,GO:0034446,0.149549981759809,0.938512716294493,5,68,substrate adhesion-dependent cell spreading,BP,POSTN;PARVB;VAMP3;DMTN;TYRO3
17260,GO:0140096,0.149573254069052,0.878288231924147,78,1695,catalytic activity, acting on a protein,MF,TNFAIP3;ULK2;PTPRS;FBXO41;MAP3K14;EPHB2;ASH2L;HTRA1;EGFR;ADAM19;FBXO2;FGFR4;CDK18;XYLT1;BRSK1;SFRP1;INSR;KMT5C;NPEPL1;PPP2R2C;CTSB;HR;PDPR;RHBDF1;TMEM129;DDB2;OBSCN;PRSS3;KLK5;FKBP9;FAM20C;EPHA4;RNPEPL1;HERC3;TYSND1;CTSV;RPS6KA5;KLHDC8B;LTBP1;ERBB3;CDK14;GRK6;CTSL;ACVR1B;CAMKK1;TYRO3;ADAMTS15;RBCK1;EFNB3;ADCK5;TMX4;ZDHHC1;KLK8;LTBP4;FBXW4;MARK4;GOLGA7B;ERBB2;RNF187;RNF135;FBXL8;CDK20;RNF44;FURIN;FBXW5;PCSK1;PLPP2;CTSF;MMP1;XYLT2;NUAK1;SMURF1;CAPNS2;CAMK1;RNF208;MAP3K3;NRK;FBXO44
2113,GO:0004920,0.149752934773579,0.991034435440101,1,4,interleukin-10 receptor activity,MF,IL20RB
7276,GO:0031294,0.149873585351306,0.956155799684629,3,33,lymphocyte costimulation,BP,MAP3K14;PIK3R1;EFNB3
10553,GO:0043550,0.149932200687902,0.956201578436192,3,32,regulation of lipid kinase activity,BP,VAV3;DAB2IP;PIK3R1
12701,GO:0051006,0.149938568255257,0.991011413457148,1,4,positive regulation of lipoprotein lipase activity,BP,LMF1
14243,GO:0061365,0.149938568255257,0.991011413457148,1,4,positive regulation of triglyceride lipase activity,BP,LMF1
10668,GO:0043987,0.150051380452992,0.990997407218369,1,4,histone H3-S10 phosphorylation,BP,RPS6KA5
6575,GO:0022612,0.150158398739503,0.932162067017669,6,86,gland morphogenesis,BP,TNFAIP3;EGFR;GLI2;SFRP1;ETV5;PLXND1
13144,GO:0051790,0.150160579859715,0.990983838406086,1,4,short-chain fatty acid biosynthetic process,BP,THNSL2
6274,GO:0019902,0.15024720902081,0.919627459307,9,145,phosphatase binding,MF,EGFR;FOXO1;DAB2IP;PIK3R1;PPP1R35;PDLIM4;ERBB2;STAT1;CRY2
3096,GO:0006689,0.150450306597505,0.990947784742145,1,4,ganglioside catabolic process,BP,HEXB
19034,GO:1904956,0.150583723200391,0.990931156438729,1,4,regulation of midbrain dopaminergic neuron differentiation,BP,SFRP1
577,GO:0001730,0.150731738644261,0.990912689493441,1,4,2'-5'-oligoadenylate synthetase activity,MF,OAS2
13162,GO:0051823,0.150747492682867,0.990910722777658,1,4,regulation of synapse structural plasticity,BP,CAMK1
17573,GO:1901300,0.150995325209541,0.990879753654499,1,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG
7270,GO:0031282,0.151066408067484,0.990870860736606,1,4,regulation of guanylate cyclase activity,BP,ADORA2B
7271,GO:0031284,0.151066408067484,0.990870860736606,1,4,positive regulation of guanylate cyclase activity,BP,ADORA2B
16466,GO:0097209,0.15120207391261,0.990853875189948,1,4,epidermal lamellar body,CC,KLK5
1688,GO:0004177,0.151271860967172,0.955562392045102,3,33,aminopeptidase activity,MF,NPEPL1;RNPEPL1;CTSV
2523,GO:0005794,0.151403316501258,0.881200258862555,54,1143,Golgi apparatus,CC,POSTN;TGFBI;APOE;PHF7;OBSL1;LMF1;ST3GAL5;EGFR;ADAM19;CYBA;H1F0;FGFR4;BCL6;TENM2;XYLT1;DNM1;CXCL14;LDLRAP1;RHBDF1;WNT3;NSG1;RASIP1;COL7A1;GAS8;FAM20C;EPHA4;TRAPPC2L;B3GNT9;F2R;MPLKIP;VAMP3;SREBF1;CSPG4;PIK3R1;PTHLH;SDC3;TRIM22;SLC2A1;VAMP2;ZDHHC1;GPC4;GOLGA7B;NEO1;MARCH9;FURIN;CCDC88B;ANGEL1;ASIC1;XYLT2;RAB43;VPS33B;ST6GALNAC6;SORT1;APBA1
16218,GO:0090315,0.151403772595107,0.990828590975288,1,4,negative regulation of protein targeting to membrane,BP,DMTN
19496,GO:1990441,0.151596105802426,0.990804445949413,1,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,NCK2
9767,GO:0040017,0.151621873728567,0.900738281982837,18,336,positive regulation of locomotion,BP,POSTN;GPNMB;EGFR;INSR;CXCL14;VEGFB;DAB2IP;F2R;DMTN;PIK3R1;ACVR1B;RHOD;HYAL1;ZP3;SPRY2;TRPV4;ACKR3;MAP3K3
13649,GO:0060232,0.15165329469249,0.990797260040043,1,4,delamination,BP,TRPV4
18139,GO:1902949,0.151657673070684,0.990796709763284,1,4,positive regulation of tau-protein kinase activity,BP,NAB2
4617,GO:0010757,0.151707173183242,0.990790487338094,1,4,negative regulation of plasminogen activation,BP,SERPINE2
16146,GO:0090209,0.151731844632103,0.99078738516541,1,4,negative regulation of triglyceride metabolic process,BP,APOE
10007,GO:0042490,0.15174864267824,0.955359432274113,3,33,mechanoreceptor differentiation,BP,SLITRK6;NAGLU;VANGL2
14211,GO:0061303,0.151789538042958,0.99078012864648,1,4,cornea development in camera-type eye,BP,WNT9A
3540,GO:0007596,0.151858447374652,0.910514764181203,12,212,blood coagulation,BP,APOE;VAV3;ZFPM1;SERPINE2;F2R;DMTN;PIK3R1;TYRO3;SERPING1;MYL9;BLOC1S4;VPS33B
4845,GO:0014704,0.15225525038191,0.955215455054562,3,32,intercalated disc,CC,OBSL1;SCN4B;SLC2A1
2411,GO:0005604,0.152312355482253,0.937042656643359,5,67,basement membrane,CC,TGFBI;SMOC2;MATN2;COL7A1;LAMB2
15418,GO:0071797,0.152448842489058,0.990696985677108,1,4,LUBAC complex,CC,RBCK1
13992,GO:0060762,0.152470550779943,0.990694241304202,1,4,regulation of branching involved in mammary gland duct morphogenesis,BP,ETV5
7235,GO:0031214,0.152593226667221,0.93686087220627,5,68,biomineral tissue development,BP,GPNMB;FOXO1;TBX1;FAM20C;PTHLH
15521,GO:0072009,0.152600217544517,0.936857063961674,5,68,nephron epithelium development,BP,PKD2;WWTR1;KIF26B;LAMB2;STAT1
12776,GO:0051121,0.152602521358085,0.990677548181196,1,4,hepoxilin metabolic process,BP,ALOXE3
12777,GO:0051122,0.152602521358085,0.990677548181196,1,4,hepoxilin biosynthetic process,BP,ALOXE3
1260,GO:0003062,0.152660928351988,0.990670155088012,1,4,regulation of heart rate by chemical signal,BP,SREBF1
14721,GO:0070444,0.152724526639595,0.990662101313503,1,4,oligodendrocyte progenitor proliferation,BP,GJC2
14722,GO:0070445,0.152724526639595,0.990662101313503,1,4,regulation of oligodendrocyte progenitor proliferation,BP,GJC2
15443,GO:0071838,0.152730032881314,0.99066140385489,1,4,cell proliferation in bone marrow,BP,MAP3K3
10636,GO:0043900,0.152833311964857,0.904118043579332,15,278,regulation of multi-organism process,BP,TNFAIP3;IFITM1;APOE;MVB12B;LAMP3;HTRA1;CYBA;OAS2;KLK5;DDX60;ACVR1B;ZP3;STOM;STAT1;IFI16
4007,GO:0009056,0.152877725842768,0.874008427877609,89,1989,catabolic process,BP,TNFAIP3;APOE;MVB12B;LAMP3;ULK2;CPT2;GPX3;TST;COL6A1;EGFR;FBXO2;CRAT;THRA;OAS2;H1F0;PGM1;DHTKD1;INSR;GAA;CES2;CTSB;NT5E;SERPINE2;TP53INP2;WWTR1;RHBDF1;TMEM129;FOXO1;TRIM65;RASIP1;DAB2IP;COL7A1;SGSH;TRERF1;TET1;GLUL;EPHA4;RPL13A;RNPEPL1;MAGEF1;TYSND1;CTSV;HEXB;PLCD3;ACSL1;HGSNAT;ATP6V0A2;CUL9;SREBF1;CSPG4;ENDOG;SDC3;CTSL;TRIM22;IMPA2;SNX33;CPT1C;HYAL1;RBCK1;PCBP4;TP53INP1;SPATA18;GPC4;ALDH2;FBXW4;NAGLU;MRC2;AMACR;BTBD2;TBC1D17;IAH1;RNF187;HSD11B1;EPM2A;RNF44;WIPI2;PLCD1;FURIN;FBXW5;IFI16;MLYCD;THNSL2;CTSF;MMP1;SMURF1;TCIRG1;IDUA;FBXO44;CBR3
19828,GO:2000347,0.152915179359527,0.990637935665344,1,4,positive regulation of hepatocyte proliferation,BP,TNFAIP3
19358,GO:1905908,0.15312262670325,0.990611603218264,1,4,positive regulation of amyloid fibril formation,BP,APOE
3130,GO:0006741,0.153124419913636,0.990611375423199,1,4,NADP biosynthetic process,BP,NADK
7894,GO:0032489,0.153124857143081,0.990611319880627,1,4,regulation of Cdc42 protein signal transduction,BP,APOE
13871,GO:0060563,0.153153701437659,0.954759485446472,3,33,neuroepithelial cell differentiation,BP,SLITRK6;TMEM231;FAM20C
18007,GO:1902576,0.153173369114894,0.990605156164703,1,4,negative regulation of nuclear cell cycle DNA replication,BP,BCL6
2097,GO:0004887,0.153183384078651,0.990603883437726,1,4,thyroid hormone receptor activity,MF,THRA
10121,GO:0042731,0.153283971780902,0.990591095370379,1,4,PH domain binding,MF,EPHA4
1117,GO:0002713,0.153299553749594,0.990589113545771,1,4,negative regulation of B cell mediated immunity,BP,BCL6
1212,GO:0002890,0.153299553749594,0.990589113545771,1,4,negative regulation of immunoglobulin mediated immune response,BP,BCL6
8896,GO:0034765,0.153404148514756,0.909453851177485,12,209,regulation of ion transmembrane transport,BP,KCNJ15;EPHB2;CYBA;NLGN2;ANO9;PKD2;SCN4B;KCNC4;F2R;STOM;VAMP2;GJC2
6702,GO:0030132,0.153438082196303,0.969311131741447,2,17,clathrin coat of coated pit,CC,EGFR;LDLRAP1
12107,GO:0048246,0.153737258149528,0.969068060705949,2,18,macrophage chemotaxis,BP,CKLF;TRPV4
2314,GO:0005342,0.153836915670494,0.929984105538995,6,88,organic acid transmembrane transporter activity,MF,SLC13A5;SLC16A5;SLC38A4;PQLC2;SLC1A4;SLC13A3
11874,GO:0046943,0.153836915670494,0.929984105538995,6,88,carboxylic acid transmembrane transporter activity,MF,SLC13A5;SLC16A5;SLC38A4;PQLC2;SLC1A4;SLC13A3
14033,GO:0060872,0.153871228283349,0.990516249166611,1,4,semicircular canal development,BP,TBX1
1908,GO:0004614,0.153974163429881,0.990503097252664,1,4,phosphoglucomutase activity,MF,PGM1
20134,GO:2001016,0.154012031301072,0.990498256455165,1,4,positive regulation of skeletal muscle cell differentiation,BP,TBX1
17797,GO:1902003,0.154021545028749,0.969123489574597,2,17,regulation of amyloid-beta formation,BP,APOE;EPHA4
10944,GO:0044769,0.154065468904313,0.968961963061173,2,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,ATP6V0A2;TCIRG1
11882,GO:0046961,0.154065468904313,0.968961963061173,2,18,proton-transporting ATPase activity, rotational mechanism,MF,ATP6V0A2;TCIRG1
974,GO:0002437,0.154088839093866,0.968954402768219,2,18,inflammatory response to antigenic stimulus,BP,ZP3;IL20RB
15328,GO:0071608,0.154279970297091,0.99046396695862,1,4,macrophage inflammatory protein-1 alpha production,BP,TRPV4
15350,GO:0071640,0.154279970297091,0.99046396695862,1,4,regulation of macrophage inflammatory protein 1 alpha production,BP,TRPV4
10293,GO:0043117,0.154387616340714,0.990450172294054,1,4,positive regulation of vascular permeability,BP,TRPV4
18179,GO:1903012,0.154388468264464,0.990450063078747,1,4,positive regulation of bone development,BP,GPR68
15607,GO:0072161,0.154391738724359,0.990449643804625,1,4,mesenchymal cell differentiation involved in kidney development,BP,STAT1
20130,GO:2001012,0.154391738724359,0.990449643804625,1,4,mesenchymal cell differentiation involved in renal system development,BP,STAT1
15174,GO:0071362,0.154417382006712,0.990446355984401,1,4,cellular response to ether,BP,NFATC4
3984,GO:0008934,0.154453313864006,0.990441748006384,1,4,inositol monophosphate 1-phosphatase activity,MF,IMPA2
13389,GO:0052832,0.154453313864006,0.990441748006384,1,4,inositol monophosphate 3-phosphatase activity,MF,IMPA2
13390,GO:0052833,0.154453313864006,0.990441748006384,1,4,inositol monophosphate 4-phosphatase activity,MF,IMPA2
13391,GO:0052834,0.154453313864006,0.990441748006384,1,4,inositol monophosphate phosphatase activity,MF,IMPA2
12733,GO:0051048,0.154477403196645,0.924557990470174,7,109,negative regulation of secretion,BP,SFRP1;RHBDF1;F2R;ERBB3;VAMP3;SREBF1;ASIC1
18584,GO:1903912,0.154500733163189,0.990435665029428,1,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,NCK2
8706,GO:0034381,0.154527072968399,0.954101501668353,3,34,plasma lipoprotein particle clearance,BP,APOE;LMF1;LDLRAP1
8483,GO:0033687,0.154554280904381,0.968951755212541,2,17,osteoblast proliferation,BP,SFRP1;PLXNB1
10322,GO:0043168,0.154567031105584,0.872308211457088,91,2000,anion binding,MF,POSTN;SMOC2;APOE;ALDH1A3;ULK2;PTPRS;GPNMB;MAP3K14;EPHB2;TXNRD3;EGFR;OAS2;FGFR4;CDK18;PSD4;BRSK1;SFRP1;DHTKD1;INSR;DHX32;NAT6;DNM1;LDLRAP1;SYT8;SERPINE2;TNXB;VEGFB;DAB2IP;OBSCN;RAB40B;CYP27C1;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;TUB;SEC14L2;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;ACVR1B;CAMKK1;SYTL1;SNX29;ATP12A;SNX33;TYRO3;RHOD;CKMT1A;VAMP2;ADAMTS15;SCG5;MDK;TRPV4;MTHFR;GPC4;SDHA;NMRK1;RTN4RL1;MARK4;MVD;MICALL1;ERBB2;C2CD4C;TULP3;NME4;CDK20;WIPI2;PLCD1;CRY2;CLCN7;THNSL2;NUAK1;RASA4;SMURF1;CAMK1;NISCH;NADK;RAB43;MAP3K3;ABCC1;DDX59;NRK;CBR3
12387,GO:0048872,0.154584474687441,0.913682520838814,10,169,homeostasis of number of cells,BP,TNFAIP3;THRA;BCL6;ZFPM1;F2R;DMTN;ACVR1B;FAM210B;STAT1;IL20RB
15799,GO:0072553,0.154596971197825,0.990423313171108,1,4,terminal button organization,BP,NLGN2
18540,GO:1903826,0.154644967430641,0.99041714980409,1,4,arginine transmembrane transport,BP,PQLC2
19594,GO:1990822,0.154644967430641,0.99041714980409,1,4,basic amino acid transmembrane transport,BP,PQLC2
18487,GO:1903715,0.154656765734946,0.990415634416048,1,4,regulation of aerobic respiration,BP,TRPV4
14263,GO:0061438,0.154662938760631,0.990414841494154,1,4,renal system vasculature morphogenesis,BP,PKD2
14264,GO:0061439,0.154662938760631,0.990414841494154,1,4,kidney vasculature morphogenesis,BP,PKD2
15263,GO:0071494,0.154693593493408,0.990410903388478,1,4,cellular response to UV-C,BP,IMPACT
17474,GO:1900747,0.154829642427276,0.990393415184815,1,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,DAB2IP
17993,GO:1902548,0.154829642427276,0.990393415184815,1,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,DAB2IP
16708,GO:0098528,0.154936551754132,0.990379660688532,1,4,skeletal muscle fiber differentiation,BP,TBX1
1146,GO:0002761,0.155001675793823,0.935516672738271,5,69,regulation of myeloid leukocyte differentiation,BP,SFRP1;ZFPM1;FAM213A;PIK3R1;GPR68
8124,GO:0032874,0.155285884968129,0.924092985411516,7,107,positive regulation of stress-activated MAPK cascade,BP,DAB2IP;EPHA4;TNFRSF19;TRPV4;MAP3K3;NRK;VANGL2
4297,GO:0009792,0.15529389913286,0.893530498989379,22,422,embryo development ending in birth or egg hatching,BP,EGFR;GLI2;SFRP1;PKD2;SALL2;TMEM231;TBX1;TET1;WNT9A;PLCD3;GJB5;ENDOG;ACVR1B;HYAL1;RTF1;ZP3;TULP3;PLCD1;MDFI;NRK;VANGL2;APBA1
4081,GO:0009152,0.155298136220204,0.913176740548508,10,172,purine ribonucleotide biosynthetic process,BP,APOE;PGM1;DHTKD1;INSR;ATP6V0A2;PTHLH;ADORA2B;NME4;COX5B;TCIRG1
18021,GO:1902617,0.155339580395708,0.990327713776997,1,4,response to fluoride,BP,FOXO1
15680,GO:0072284,0.155461569763105,0.990311960795364,1,4,metanephric S-shaped body morphogenesis,BP,PKD2
9241,GO:0035694,0.155465743442454,0.990311421587759,1,4,mitochondrial protein catabolic process,BP,SPATA18
16382,GO:0097061,0.155543517709136,0.943183331021187,4,50,dendritic spine organization,BP,APOE;EPHB2;INSR;EPHA4
1086,GO:0002682,0.155546507903306,0.881014121639891,43,910,regulation of immune system process,BP,TNFAIP3;IFITM1;PTPRS;GPNMB;MAP3K14;ASH2L;HTRA1;NCR3LG1;CYBA;GLI2;BCL6;SFRP1;VAV3;ZFPM1;CXCL14;CTSB;VEGFB;DAB2IP;KLK5;WIPF1;FAM213A;RPS6KA5;DDX60;PIK3R1;CTSL;NCK2;ACVR1B;FAM210B;TYRO3;ZP3;RBCK1;EFNB3;TRPV4;ADORA2B;SERPING1;MYL9;GPR68;ERBB2;RNF135;STAT1;IFI16;IL20RB;CCDC88B
1893,GO:0004591,0.155547689556033,0.990300831510206,1,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,DHTKD1
3205,GO:0006868,0.1556461710879,0.99028809630658,1,4,glutamine transport,BP,SLC1A4
5005,GO:0015186,0.1556461710879,0.99028809630658,1,4,L-glutamine transmembrane transporter activity,MF,SLC1A4
12132,GO:0048289,0.155685366559412,0.990283025222717,1,4,isotype switching to IgE isotypes,BP,BCL6
12135,GO:0048293,0.155685366559412,0.990283025222717,1,4,regulation of isotype switching to IgE isotypes,BP,BCL6
12590,GO:0050817,0.155706184430289,0.907816798956475,12,213,coagulation,BP,APOE;VAV3;ZFPM1;SERPINE2;F2R;DMTN;PIK3R1;TYRO3;SERPING1;MYL9;BLOC1S4;VPS33B
11584,GO:0046323,0.155761308237298,0.943074434772303,4,50,glucose import,BP,INSR;RTN2;PIK3R1;SORT1
417,GO:0001105,0.155813639360148,0.95361624890908,3,33,RNA polymerase II transcription coactivator activity,MF,CITED4;POU3F1;SOX12
12244,GO:0048592,0.155912912079678,0.928791356097489,6,87,eye morphogenesis,BP,ALDH1A3;EPHB2;SHROOM2;SDK2;WNT9A;NAGLU
17454,GO:1900451,0.155927064949541,0.990251723040248,1,4,positive regulation of glutamate receptor signaling pathway,BP,EPHB2
16923,GO:0098976,0.155956662949151,0.990247886109715,1,4,excitatory chemical synaptic transmission,BP,PDLIM4
3857,GO:0008504,0.156018698116635,0.990239841563192,1,4,monoamine transmembrane transporter activity,MF,SLC29A4
15082,GO:0071211,0.156061783637089,0.990234252257746,1,4,protein targeting to vacuole involved in autophagy,BP,SMURF1
16151,GO:0090219,0.156098195263554,0.990229527389164,1,4,negative regulation of lipid kinase activity,BP,DAB2IP
13519,GO:0060023,0.156098722223183,0.990229459000485,1,4,soft palate development,BP,TBX1
18511,GO:1903763,0.156214069620886,0.990214483059726,1,4,gap junction channel activity involved in cell communication by electrical coupling,MF,GJC2
14091,GO:0060998,0.156482731086773,0.942713271057854,4,50,regulation of dendritic spine development,BP,APOE;PTPRS;EPHA4;CAMK1
724,GO:0001957,0.156619079498364,0.990161801691227,1,4,intramembranous ossification,BP,MN1
9435,GO:0036072,0.156619079498364,0.990161801691227,1,4,direct ossification,BP,MN1
9530,GO:0036337,0.156628590554366,0.99016056272166,1,4,Fas signaling pathway,BP,SP100
19724,GO:2000171,0.156672646932773,0.968265042003364,2,17,negative regulation of dendrite development,BP,PTPRS;NFATC4
12651,GO:0050908,0.156728066522813,0.990147599338558,1,4,detection of light stimulus involved in visual perception,BP,REEP6
12683,GO:0050962,0.156728066522813,0.990147599338558,1,4,detection of light stimulus involved in sensory perception,BP,REEP6
19353,GO:1905898,0.156775241922666,0.95313032276205,3,34,positive regulation of response to endoplasmic reticulum stress,BP,DAB2IP;PIK3R1;NCK2
3487,GO:0007406,0.156790996900958,0.990139393722689,1,4,negative regulation of neuroblast proliferation,BP,KCTD11
8029,GO:0032713,0.156854584112813,0.990131098733677,1,4,negative regulation of interleukin-4 production,BP,ZFPM1
13911,GO:0060633,0.156892310471171,0.99012617553713,1,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,THRA
19713,GO:2000143,0.156892310471171,0.99012617553713,1,4,negative regulation of DNA-templated transcription, initiation,BP,THRA
19829,GO:2000348,0.156894363858727,0.990125907537278,1,4,regulation of CD40 signaling pathway,BP,TNFAIP3
12104,GO:0048243,0.157008379808452,0.990111020503279,1,4,norepinephrine secretion,BP,NISCH
10164,GO:0042799,0.157021626245677,0.990109290138036,1,4,histone methyltransferase activity (H4-K20 specific),MF,KMT5C
14838,GO:0070665,0.157058105615004,0.934305203668025,5,72,positive regulation of leukocyte proliferation,BP,BCL6;VAV3;NCK2;ZP3;CCDC88B
6234,GO:0019829,0.15707845656038,0.952998805973438,3,34,cation-transporting ATPase activity,MF,ATP6V0A2;ATP12A;TCIRG1
4315,GO:0009881,0.157088325237585,0.990100574862151,1,4,photoreceptor activity,MF,CRY2
16221,GO:0090322,0.157234637106367,0.967929911203437,2,18,regulation of superoxide metabolic process,BP,EGFR;CYBA
10604,GO:0043647,0.157236863399409,0.942334995618308,4,50,inositol phosphate metabolic process,BP,PLCD3;IMPA2;PLCD1;ISYNA1
12081,GO:0048170,0.157277685451803,0.99007580948572,1,4,positive regulation of long-term neuronal synaptic plasticity,BP,EPHB2
16414,GO:0097119,0.157292699705785,0.990073844431784,1,4,postsynaptic density protein 95 clustering,BP,NLGN2
14594,GO:0070206,0.15738794625958,0.952864437229119,3,34,protein trimerization,BP,COL6A1;TRIM22;ASIC1
14324,GO:0061588,0.157655619091283,0.990026282217618,1,4,calcium activated phospholipid scrambling,BP,ANO9
14325,GO:0061589,0.157655619091283,0.990026282217618,1,4,calcium activated phosphatidylserine scrambling,BP,ANO9
14326,GO:0061590,0.157655619091283,0.990026282217618,1,4,calcium activated phosphatidylcholine scrambling,BP,ANO9
14327,GO:0061591,0.157655619091283,0.990026282217618,1,4,calcium activated galactosylceramide scrambling,BP,ANO9
17297,GO:1900019,0.157825277965652,0.990004005747601,1,4,regulation of protein kinase C activity,BP,EGFR
17298,GO:1900020,0.157825277965652,0.990004005747601,1,4,positive regulation of protein kinase C activity,BP,EGFR
753,GO:0001999,0.15784795682793,0.990001025954324,1,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,F2R
754,GO:0002001,0.15784795682793,0.990001025954324,1,4,renin secretion into blood stream,BP,F2R
13050,GO:0051599,0.15788499099132,0.98999615898072,1,4,response to hydrostatic pressure,BP,PKD2
5570,GO:0016614,0.158009236468684,0.927441148845491,6,93,oxidoreductase activity, acting on CH-OH group of donors,MF,KDSR;H6PD;SDR9C7;RDH12;HSD11B1;CBR3
14915,GO:0070848,0.158086193531064,0.889515392706879,24,469,response to growth factor,BP,POSTN;NDN;HTRA1;MXRA5;EGFR;FGFR4;SFRP1;INSR;RGMA;DAB2IP;TBX1;FAM20C;LTBP1;TMEM204;HYAL1;SPRY2;ITGB5;LTBP4;NEO1;MICALL1;ERBB2;FURIN;SMURF1;SORT1
1295,GO:0003150,0.158218698975085,0.989952246160905,1,4,muscular septum morphogenesis,BP,VANGL2
9919,GO:0042311,0.158246764304838,0.967597416871075,2,18,vasodilation,BP,APOE;ADORA2B
18527,GO:1903795,0.158331621247258,0.989937363242085,1,4,regulation of inorganic anion transmembrane transport,BP,ANO9
1100,GO:0002696,0.158347556613862,0.911116213526791,10,172,positive regulation of leukocyte activation,BP,MAP3K14;GLI2;BCL6;VAV3;PIK3R1;NCK2;ZP3;EFNB3;ADORA2B;CCDC88B
10973,GO:0044821,0.158367365961039,0.9899326496961,1,4,meiotic telomere tethering at nuclear periphery,BP,SUN1
14587,GO:0070197,0.158367365961039,0.9899326496961,1,4,meiotic attachment of telomere to nuclear envelope,BP,SUN1
16484,GO:0097240,0.158367365961039,0.9899326496961,1,4,chromosome attachment to the nuclear envelope,BP,SUN1
548,GO:0001669,0.158481494809424,0.941624585100888,4,52,acrosomal vesicle,CC,SYT8;HEXB;ATP6V0A2;SUN1
14937,GO:0070887,0.158493080632568,0.868516645484123,94,2103,cellular response to chemical stimulus,BP,TNFAIP3;POSTN;IFITM1;APOE;IFI6;NDN;MAP3K14;HTRA1;TXNRD3;GPX7;SRSF5;GPX3;COL6A1;EGFR;THRA;CYBA;OAS2;GLI2;FGFR4;BCL6;SFRP1;CKLF;INSR;VAV3;CES2;PKD2;RGMA;CXCL14;CTSB;ETV5;VEGFB;FOXO1;WNT3;BPHL;UROS;DAB2IP;TBX1;FAM20C;FAM213A;EPHA4;WNT9A;RPL13A;RPS6KA5;TXNDC17;LTBP1;ACSL1;ATP6V0A2;VAMP3;SREBF1;DMTN;ENDOG;PIK3R1;TMEM204;CTSL;TRIM22;NCK2;UCN2;NFATC4;FAM210B;CXCR1;HYAL1;VAMP2;RBCK1;SPRY2;TP53INP1;TNFRSF19;TRPV4;ITGB5;NDRG1;LTBP4;RTN4RL1;IMPACT;NEO1;GPR68;MICALL1;ERBB2;STAT1;ACKR3;CRY2;FURIN;IL20RB;MMP1;RASA4;SMURF1;CCDC3;TCIRG1;MT2A;RAB43;MAP3K3;PPP1R14A;SP100;ABCC1;SORT1;CBR3
10255,GO:0043034,0.158774369300892,0.967577685002389,2,17,costamere,CC,FLNC;SYNM
4586,GO:0010719,0.158933107766738,0.967371150829607,2,18,negative regulation of epithelial to mesenchymal transition,BP,SFRP1;DAB2IP
3461,GO:0007320,0.158957835337243,0.989854614543307,1,4,insemination,BP,SERPINE2
5355,GO:0016185,0.159016213591783,0.98984688179812,1,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,DNM1
16856,GO:0098844,0.159016213591783,0.98984688179812,1,4,postsynaptic endocytic zone membrane,CC,DNM1
16874,GO:0098884,0.159016213591783,0.98984688179812,1,4,postsynaptic neurotransmitter receptor internalization,BP,DNM1
7625,GO:0032058,0.159059391211992,0.989841160480639,1,4,positive regulation of translational initiation in response to stress,BP,IMPACT
7652,GO:0032103,0.159085737586143,0.913753521145114,9,152,positive regulation of response to external stimulus,BP,EGFR;CYBA;CXCL14;VEGFB;KLK5;DDX60;ZP3;TRPV4;ADORA2B
16777,GO:0098693,0.159290440568942,0.952107259025203,3,33,regulation of synaptic vesicle cycle,BP,NLGN2;DNM1;RIMS3
18630,GO:1904016,0.159367489890822,0.98980028506839,1,4,response to Thyroglobulin triiodothyronine,BP,SLC2A1
10815,GO:0044344,0.159442143215342,0.921499187289799,7,109,cellular response to fibroblast growth factor stimulus,BP,POSTN;FGFR4;SFRP1;TBX1;FAM20C;HYAL1;SPRY2
13525,GO:0060029,0.159469572214391,0.989786722347175,1,4,convergent extension involved in organogenesis,BP,VANGL2
4123,GO:0009201,0.159674826998251,0.921324256500872,7,111,ribonucleoside triphosphate biosynthetic process,BP,PGM1;DHTKD1;INSR;ATP6V0A2;NME4;COX5B;TCIRG1
13705,GO:0060318,0.159706021044658,0.989755270371497,1,4,definitive erythrocyte differentiation,BP,ZFPM1
18919,GO:1904724,0.159710485176911,0.951720452163026,3,36,tertiary granule lumen,CC,PGM1;PRSS3;METTL7A
6358,GO:0021562,0.159712663611742,0.989754386038502,1,4,vestibulocochlear nerve development,BP,SLITRK6
19516,GO:1990535,0.159745909002186,0.989749959422355,1,4,neuron projection maintenance,BP,INSR
9648,GO:0038044,0.159785789132387,0.98974464803503,1,4,transforming growth factor-beta secretion,BP,ITGB6
13838,GO:0060509,0.159845837752608,0.989736647738953,1,4,Type I pneumocyte differentiation,BP,THRA
14899,GO:0070827,0.159940452432974,0.989724035385242,1,4,chromatin maintenance,BP,MTHFR
10869,GO:0044448,0.160009459416785,0.916858760443904,8,127,cell cortex part,CC,SHROOM2;PKD2;RIMS3;WIPF1;DMTN;SLC2A1;PLEKHH2;TRPV4
3601,GO:0008064,0.160111775933077,0.916754901588487,8,130,regulation of actin polymerization or depolymerization,BP,FHOD3;WIPF1;EPS8L2;DMTN;NCK2;ARHGAP40;PLEKHH2;ARPIN
10592,GO:0043622,0.16012691751875,0.989699154763896,1,4,cortical microtubule organization,BP,TRPV4
16168,GO:0090245,0.160171769814529,0.989693165150863,1,4,axis elongation involved in somitogenesis,BP,SFRP1
47,GO:0000099,0.160322437098478,0.989673031197939,1,4,sulfur amino acid transmembrane transporter activity,MF,SLC1A4
14799,GO:0070579,0.160338564768666,0.989670874774196,1,4,methylcytosine dioxygenase activity,MF,TET1
14647,GO:0070304,0.160588005305681,0.920805154350475,7,108,positive regulation of stress-activated protein kinase signaling cascade,BP,DAB2IP;EPHA4;TNFRSF19;TRPV4;MAP3K3;NRK;VANGL2
7566,GO:0031956,0.160647346972372,0.98962954090513,1,4,medium-chain fatty acid-CoA ligase activity,MF,ACSL1
17104,GO:0102391,0.160647346972372,0.98962954090513,1,4,decanoate-CoA ligase activity,MF,ACSL1
9236,GO:0035673,0.160753485611214,0.989615312570282,1,4,oligopeptide transmembrane transporter activity,MF,ABCC1
12874,GO:0051260,0.160796585006407,0.904220745324527,12,215,protein homooligomerization,BP,APOE;ALDH1A3;GPX3;PKD2;KCNC4;GLUL;TYSND1;KCTD11;STOM;CRTC1;PEX11B;ASIC1
5919,GO:0018230,0.160856518145363,0.96673364303629,2,18,peptidyl-L-cysteine S-palmitoylation,BP,ZDHHC1;GOLGA7B
5920,GO:0018231,0.160856518145363,0.96673364303629,2,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,ZDHHC1;GOLGA7B
3892,GO:0008559,0.160871569926049,0.989599470527009,1,4,xenobiotic transmembrane transporting ATPase activity,MF,ABCC1
12961,GO:0051425,0.160916413334649,0.989593450986096,1,4,PTB domain binding,MF,INSR
14278,GO:0061476,0.16091908507341,0.989593092286902,1,4,response to anticoagulant,BP,SFRP1
15271,GO:0071503,0.16091908507341,0.989593092286902,1,4,response to heparin,BP,SFRP1
15272,GO:0071504,0.16091908507341,0.989593092286902,1,4,cellular response to heparin,BP,SFRP1
1313,GO:0003175,0.160933851159658,0.989591109718842,1,4,tricuspid valve development,BP,ZFPM1
1321,GO:0003186,0.160933851159658,0.989591109718842,1,4,tricuspid valve morphogenesis,BP,ZFPM1
843,GO:0002175,0.160983756304564,0.9895844077017,1,4,protein localization to paranode region of axon,BP,EPB41L3
3502,GO:0007442,0.161021146163867,0.98957938490458,1,4,hindgut morphogenesis,BP,GLI2
18065,GO:1902744,0.161084115419437,0.989570922932028,1,4,negative regulation of lamellipodium organization,BP,ARPIN
10519,GO:0043506,0.161336669771402,0.93201964082891,5,69,regulation of JUN kinase activity,BP,SFRP1;DAB2IP;EPHA4;NRK;VANGL2
16395,GO:0097091,0.16165323464039,0.989494275428735,1,4,synaptic vesicle clustering,BP,NLGN2
12795,GO:0051145,0.161661379193572,0.950995666333553,3,34,smooth muscle cell differentiation,BP,OLFM2;TMEM204;NFATC4
16301,GO:0090599,0.161712761099404,0.989486241100107,1,4,alpha-glucosidase activity,MF,GAA
15904,GO:0075044,0.161799356152507,0.989474547398333,1,4,autophagy of host cells involved in interaction with symbiont,BP,ULK2
15905,GO:0075071,0.161799356152507,0.989474547398333,1,4,autophagy involved in symbiotic interaction,BP,ULK2
6748,GO:0030202,0.161850840853037,0.989467591642084,1,4,heparin metabolic process,BP,XYLT2
6756,GO:0030210,0.161850840853037,0.989467591642084,1,4,heparin biosynthetic process,BP,XYLT2
9686,GO:0038132,0.161927235967585,0.989457265844512,1,4,neuregulin binding,MF,ERBB3
10274,GO:0043083,0.162032960646106,0.989442966783746,1,4,synaptic cleft,CC,LAMB2
9679,GO:0038114,0.16225515939408,0.989412880802082,1,4,interleukin-21-mediated signaling pathway,BP,STAT1
16804,GO:0098756,0.16225515939408,0.989412880802082,1,4,response to interleukin-21,BP,STAT1
16805,GO:0098757,0.16225515939408,0.989412880802082,1,4,cellular response to interleukin-21,BP,STAT1
3543,GO:0007599,0.162298779317042,0.903158363609067,12,215,hemostasis,BP,APOE;VAV3;ZFPM1;SERPINE2;F2R;DMTN;PIK3R1;TYRO3;SERPING1;MYL9;BLOC1S4;VPS33B
6526,GO:0021957,0.162384070842897,0.989395404893613,1,4,corticospinal tract morphogenesis,BP,EPHA4
12064,GO:0048104,0.162432351847982,0.989388855672039,1,4,establishment of body hair or bristle planar orientation,BP,VANGL2
12065,GO:0048105,0.162432351847982,0.989388855672039,1,4,establishment of body hair planar orientation,BP,VANGL2
7144,GO:0031034,0.162467445148686,0.989384093969101,1,4,myosin filament assembly,BP,OBSL1
7430,GO:0031585,0.162626771398956,0.989362461001698,1,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
13846,GO:0060526,0.162636252212435,0.989361172969801,1,4,prostate glandular acinus morphogenesis,BP,SFRP1
13847,GO:0060527,0.162636252212435,0.989361172969801,1,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,SFRP1
9616,GO:0036515,0.16267055337951,0.989356512225042,1,4,serotonergic neuron axon guidance,BP,VANGL2
7742,GO:0032280,0.162710142456628,0.98935113160691,1,4,symmetric synapse,CC,NLGN2
19671,GO:2000051,0.162761232776392,0.98934418567004,1,4,negative regulation of non-canonical Wnt signaling pathway,BP,SFRP1
3591,GO:0008046,0.162841678774741,0.989333243762742,1,4,axon guidance receptor activity,MF,EPHB2
1169,GO:0002823,0.162875336157736,0.966059099519717,2,18,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,BCL6;IL20RB
15078,GO:0071205,0.163012881906741,0.989309937330623,1,4,protein localization to juxtaparanode region of axon,BP,EPB41L3
16403,GO:0097107,0.16307904373056,0.989300923165582,1,4,postsynaptic density assembly,BP,NLGN2
16778,GO:0098698,0.16307904373056,0.989300923165582,1,4,postsynaptic specialization assembly,BP,NLGN2
6837,GO:0030326,0.163110413984399,0.924501404069372,6,89,embryonic limb morphogenesis,BP,GLI2;WNT3;TMEM231;WNT9A;FBXW4;TULP3
8968,GO:0035113,0.163110413984399,0.924501404069372,6,89,embryonic appendage morphogenesis,BP,GLI2;WNT3;TMEM231;WNT9A;FBXW4;TULP3
6322,GO:0021514,0.163139154993299,0.989292729804566,1,4,ventral spinal cord interneuron differentiation,BP,GLI2
12346,GO:0048788,0.163192562360532,0.989285447370714,1,4,cytoskeleton of presynaptic active zone,CC,RIMS3
17030,GO:0099569,0.163192562360532,0.989285447370714,1,4,presynaptic cytoskeleton,CC,RIMS3
3058,GO:0006641,0.163216587219029,0.939221571886309,4,52,triglyceride metabolic process,BP,APOE;LMF1;ACSL1;SREBF1
566,GO:0001708,0.163383608153089,0.950235493478246,3,34,cell fate specification,BP,GLI2;TBX1;TENM4
3267,GO:0006970,0.163948845403254,0.938847338407782,4,52,response to osmotic stress,BP,EGFR;PKD2;SLC2A1;TRPV4
10759,GO:0044264,0.164014479821638,0.930496818425575,5,70,cellular polysaccharide metabolic process,BP,PGM1;INSR;GAA;PPP1R3E;B3GNT9
4513,GO:0010596,0.164198258131625,0.949874511981559,3,34,negative regulation of endothelial cell migration,BP,APOE;DAB2IP;SP100
14659,GO:0070325,0.164318534871016,0.965573493970825,2,18,lipoprotein particle receptor binding,MF,APOE;LDLRAP1
14834,GO:0070661,0.164402214626237,0.910201250209547,9,154,leukocyte proliferation,BP,TNFAIP3;GPNMB;BCL6;VAV3;NCK2;ZP3;ERBB2;IL20RB;CCDC88B
1244,GO:0003009,0.164539990709863,0.96549872878625,2,18,skeletal muscle contraction,BP,GAA;SYNM
3744,GO:0008305,0.164540771910571,0.965661023941893,2,17,integrin complex,CC,ITGB6;ITGB5
16754,GO:0098636,0.164540771910571,0.965661023941893,2,17,protein complex involved in cell adhesion,CC,ITGB6;ITGB5
8675,GO:0034340,0.164548078164082,0.930114335040537,5,73,response to type I interferon,BP,IFITM1;IFI6;OAS2;STAT1;SP100
14772,GO:0070542,0.164854430706165,0.938383556913068,4,52,response to fatty acid,BP,SFRP1;ACSL1;SREBF1;NFATC4
4665,GO:0010831,0.164892447819409,0.965379599465552,2,18,positive regulation of myotube differentiation,BP,THRA;TBX1
11835,GO:0046879,0.165232612613783,0.906437555863805,10,171,hormone secretion,BP,EGFR;NLGN2;SFRP1;GLUL;SREBF1;SLC2A1;SCG5;TRPV4;LTBP4;GPR68
7034,GO:0030832,0.165247277687544,0.91342497666204,8,131,regulation of actin filament length,BP,FHOD3;WIPF1;EPS8L2;DMTN;NCK2;ARHGAP40;PLEKHH2;ARPIN
12602,GO:0050840,0.165268718117748,0.949398809818575,3,34,extracellular matrix binding,MF,TGFBI;BCAM;ADAMTS15
543,GO:0001662,0.165354736877778,0.965223092101888,2,18,behavioral fear response,BP,APOE;MDK
862,GO:0002209,0.165354736877778,0.965223092101888,2,18,behavioral defense response,BP,APOE;MDK
10064,GO:0042596,0.165354736877778,0.965223092101888,2,18,fear response,BP,APOE;MDK
18127,GO:1902930,0.165413732920229,0.938096586069629,4,52,regulation of alcohol biosynthetic process,BP,APOE;SEC14L2;SREBF1;MVD
10404,GO:0043292,0.165782017021923,0.91307787098521,8,131,contractile fiber,CC,OBSL1;FLNC;FHOD3;PARVB;OBSCN;SLC2A1;SYNM;MYL9
12569,GO:0050789,0.165868386098178,0.856984025453981,316,7496,regulation of biological process,BP,TNFAIP3;POSTN;IFITM1;ITGB6;PEG3;TGFBI;SMOC2;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;KCNJ15;ULK2;PTPRS;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRF4;NINJ1;ASH2L;HTRA1;PRICKLE2;SLITRK6;GAMT;GPRC5C;TXNRD3;GIGYF1;ADGRL1;SRSF5;RALGDS;NCR3LG1;EGFR;FBXO2;THRA;CITED4;CYBA;OAS2;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;APCDD1;NLGN2;RAPGEF5;IRF2BPL;VIPR1;BCL6;ANO9;TENM2;PSD4;ZNF318;BRSK1;SFRP1;ARHGEF4;CKLF;FHOD3;UNK;POU3F1;TNFSF10;MN1;INSR;VAV3;KMT5C;GAA;SV2A;PKD2;ESPN;ZFPM1;RGMA;RTN2;DNM1;PPP2R2C;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;FOXO1;WNT3;TRIM65;LY6E;ZSCAN18;NSG1;PARVB;RASIP1;BOC;SOX12;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;TSC22D1;KLK5;TRERF1;SHC2;SCN4B;SH3BP2;CRTAP;GAS8;YEATS4;EVI5L;WIPF1;KCNC4;MNT;RAB40B;TET1;FAM20C;GLUL;FAM213A;EPHA4;ZNF266;WNT9A;RPL13A;MAGEF1;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;TCFL5;TYSND1;CTSV;NXPH4;RPS6KA5;TUB;HOMER2;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;ZNF362;ACSL1;EPS8L2;ZBTB42;DDX60;ACTA2;ERBB3;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;VAMP3;CUL9;FRY;PLXND1;CGREF1;SREBF1;CSPG4;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;IMPA2;XPC;ARHGAP40;NAB2;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;HYAL1;BCAM;RTF1;ZP3;STOM;VAMP2;PLEKHH2;RBCK1;EFNB3;PCBP4;ZNF554;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;TNFRSF19;TMX4;MDK;TRPV4;MTHFR;GPC4;MSRB2;ITGB5;NDRG1;KLK8;LTBP4;PPP1R35;ADORA2B;FBXW4;SERPING1;MRC2;MAFIP;MYL9;RTN4RL1;MARK4;BTBD2;MC1R;IMPACT;TBC1D17;MVD;NEO1;CRTC1;IGFBP4;STON1;GPR68;TOM1L2;GPR153;ERBB2;C2CD4C;RNF187;EPM2A;RNF135;H2AFJ;STAT1;TULP3;NME4;CDK20;HINT2;ACKR3;PLCD1;CRY2;MARCKSL1;ZMYM3;FURIN;FBXW5;RHPN1;IFI16;IL20RB;CCDC88B;PLPP2;MLYCD;THNSL2;NINL;PEX11B;FRAT1;GJC2;ARPIN;DBP;BEX2;ASIC1;MMP1;PER3;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;MT2A;RAB43;VPS33B;ELFN2;MAP3K3;PPP1R14A;MDFI;REEP6;SCMH1;ZSWIM8;SP100;NRK;SORT1;VANGL2;APBA1;TP53I11
16696,GO:0097755,0.16595310714136,0.949022746677584,3,35,positive regulation of blood vessel diameter,BP,APOE;EGFR;ADORA2B
16215,GO:0090312,0.165965831301671,0.965015762607179,2,18,positive regulation of protein deacetylation,BP,BCL6;SREBF1
5335,GO:0016125,0.166105941464307,0.917316947355867,7,111,sterol metabolic process,BP,APOE;LMF1;LDLRAP1;TRERF1;SEC14L2;SREBF1;MVD
10557,GO:0043555,0.16622895063289,0.964926336877081,2,18,regulation of translation in response to stress,BP,NCK2;IMPACT
9840,GO:0042130,0.166237996251518,0.948895461536511,3,35,negative regulation of T cell proliferation,BP,GPNMB;ERBB2;IL20RB
16830,GO:0098802,0.166461193752768,0.922502318972686,6,89,plasma membrane receptor complex,CC,ITGB6;INSR;OLFM2;ACVR1B;CPT1C;ITGB5
11589,GO:0046328,0.166497165688798,0.912638956862734,8,129,regulation of JNK cascade,BP,EGFR;SFRP1;DAB2IP;EPHA4;TNFRSF19;TRPV4;NRK;VANGL2
14643,GO:0070300,0.166666091970673,0.964777559541609,2,18,phosphatidic acid binding,MF,MICALL1;PLCD1
3411,GO:0007215,0.166831508710728,0.948701536041139,3,34,glutamate receptor signaling pathway,BP,EPHB2;NLGN2;HOMER2
3680,GO:0008202,0.16708678660649,0.902272135867867,11,196,steroid metabolic process,BP,APOE;LMF1;FGFR4;LDLRAP1;TRERF1;SEC14L2;SREBF1;AMACR;MVD;HSD11B1;HINT2
10957,GO:0044788,0.16718226334688,0.964601552104575,2,18,modulation by host of viral process,BP,APOE;STOM
5758,GO:0016999,0.167367885609403,0.921856578456686,6,94,antibiotic metabolic process,BP,GPX3;EGFR;CYBA;DHTKD1;SDHA;ALDH2
6605,GO:0022853,0.167698563792363,0.948241174240668,3,35,active ion transmembrane transporter activity,MF,ATP6V0A2;ATP12A;TCIRG1
10077,GO:0042625,0.167698563792363,0.948241174240668,3,35,ATPase coupled ion transmembrane transporter activity,MF,ATP6V0A2;ATP12A;TCIRG1
6898,GO:0030510,0.168005278336095,0.936761601055914,4,52,regulation of BMP signaling pathway,BP,HTRA1;SFRP1;NEO1;SMURF1
4417,GO:0010273,0.1680755722186,0.987885827927674,1,5,detoxification of copper ion,BP,MT2A
19427,GO:1990169,0.1680755722186,0.987885827927674,1,5,stress response to copper ion,BP,MT2A
15781,GO:0072524,0.16846055517153,0.911321804074146,8,132,pyridine-containing compound metabolic process,BP,PGM1;DHTKD1;INSR;NT5E;H6PD;PGLS;NMRK1;NADK
7480,GO:0031672,0.168496559611706,0.964151768403575,2,18,A band,CC,OBSL1;OBSCN
17706,GO:1901682,0.168840488772324,0.96403368225836,2,18,sulfur compound transmembrane transporter activity,MF,SLC1A4;ABCC1
4114,GO:0009190,0.168875374048678,0.947711907115117,3,35,cyclic nucleotide biosynthetic process,BP,APOE;PTHLH;ADORA2B
13342,GO:0052652,0.168875374048678,0.947711907115117,3,35,cyclic purine nucleotide metabolic process,BP,APOE;PTHLH;ADORA2B
3094,GO:0006687,0.168920081247909,0.936245406691151,4,53,glycosphingolipid metabolic process,BP,ST3GAL5;ARSI;HEXB;ST6GALNAC6
6835,GO:0030324,0.169560955669595,0.915177608580594,7,109,lung development,BP,EGFR;THRA;GLI2;SREBF1;SPRY2;HSD11B1;VANGL2
16186,GO:0090277,0.1695690900092,0.935908760129294,4,53,positive regulation of peptide hormone secretion,BP,EGFR;NLGN2;GLUL;GPR68
2251,GO:0005179,0.169651678408364,0.96360298162718,2,19,hormone activity,MF,PTHLH;UCN2
7182,GO:0031091,0.169746772247923,0.935816500133797,4,53,platelet alpha granule,CC,SERPINE2;VEGFB;SERPING1;VPS33B
3312,GO:0007035,0.169831240090195,0.963540831415614,2,19,vacuolar acidification,BP,ATP6V0A2;TCIRG1
10278,GO:0043087,0.170120825328048,0.885390549172147,19,358,regulation of GTPase activity,BP,BCL6;SFRP1;VAV3;RASIP1;DAB2IP;EVI5L;EPHA4;F2R;ARHGEF19;PLXND1;IQSEC1;ACAP3;ARHGAP40;SPRY2;TBC1D17;ERBB2;ALS2CL;PLXNB1;RASA4
6687,GO:0030111,0.170142989945051,0.893219583856301,14,259,regulation of Wnt signaling pathway,BP,APOE;APCDD1;SFRP1;WWTR1;FOXO1;WNT3;DAB2IP;DIXDC1;CDK14;NFATC4;IGFBP4;KREMEN1;MDFI;VANGL2
4347,GO:0009968,0.170391314701233,0.86894055048655,42,887,negative regulation of signal transduction,BP,TNFAIP3;APOE;IFI6;PTPRS;EPHB2;HTRA1;EGFR;FGFR4;APCDD1;BCL6;SFRP1;TNFSF10;INSR;PKD2;DNM1;SERPINE2;WWTR1;FOXO1;DAB2IP;MNT;EPHA4;LTBP1;ERBB3;KIF26A;NCK2;KCTD11;NFATC4;TYRO3;SPRY2;RTN4RL1;IGFBP4;ERBB2;EPM2A;STAT1;TULP3;ACKR3;CRY2;RASA4;SMURF1;KREMEN1;CCDC3;MDFI
2501,GO:0005768,0.170455550724262,0.873204695847012,33,679,endosome,CC,APOE;MVB12B;LAMP3;EGFR;CYBA;FGFR4;INSR;LDLRAP1;CTSB;NSG1;RAB40B;EPHA4;F2R;ATP6V0A2;VAMP3;APPL2;CTSL;SNX33;RHOD;AVL9;NDRG1;PDLIM4;TBC1D17;ANKRD13D;MICALL1;ERBB2;ACKR3;FURIN;TCIRG1;NISCH;RAB43;VPS33B;SORT1
9995,GO:0042470,0.170481076366343,0.920002000052722,6,93,melanosome,CC,GPNMB;CTSB;SYTL1;SLC2A1;STOM;SLC1A4
12342,GO:0048770,0.170481076366343,0.920002000052722,6,93,pigment granule,CC,GPNMB;CTSB;SYTL1;SLC2A1;STOM;SLC1A4
6505,GO:0021904,0.170762856330781,0.963370707484858,2,18,dorsal/ventral neural tube patterning,BP,GLI2;TULP3
18484,GO:1903707,0.170916742614589,0.919718785982429,6,94,negative regulation of hemopoiesis,BP,BCL6;SFRP1;ZFPM1;PIK3R1;GPR68;ERBB2
2696,GO:0006085,0.171122375933711,0.963246165142064,2,18,acetyl-CoA biosynthetic process,BP,PDPR;MLYCD
12108,GO:0048247,0.171248607832042,0.963048718756795,2,19,lymphocyte chemotaxis,BP,CKLF;CXCL14
2738,GO:0006164,0.171381186528802,0.902167049417697,10,176,purine nucleotide biosynthetic process,BP,APOE;PGM1;DHTKD1;INSR;ATP6V0A2;PTHLH;ADORA2B;NME4;COX5B;TCIRG1
15175,GO:0071363,0.171455483800322,0.87986793382247,23,452,cellular response to growth factor stimulus,BP,POSTN;NDN;HTRA1;EGFR;FGFR4;SFRP1;INSR;RGMA;DAB2IP;TBX1;FAM20C;LTBP1;TMEM204;HYAL1;SPRY2;ITGB5;LTBP4;NEO1;MICALL1;ERBB2;FURIN;SMURF1;SORT1
589,GO:0001754,0.171995793282062,0.962942876105241,2,18,eye photoreceptor cell differentiation,BP,SDK2;NAGLU
5735,GO:0016903,0.172009096213984,0.946293438841462,3,35,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,ALDH1A3;DHTKD1;ALDH2
12481,GO:0050661,0.172204851297577,0.946134102787968,3,36,NADP binding,MF,H6PD;MTHFR;CBR3
17157,GO:0106027,0.172255065249194,0.934553640644924,4,52,neuron projection organization,BP,APOE;EPHB2;INSR;EPHA4
4155,GO:0009240,0.173459663325182,0.987065529265406,1,5,isopentenyl diphosphate biosynthetic process,BP,MVD
11664,GO:0046490,0.173459663325182,0.987065529265406,1,5,isopentenyl diphosphate metabolic process,BP,MVD
16195,GO:0090287,0.173497209835951,0.900739020616031,10,172,regulation of cellular response to growth factor stimulus,BP,HTRA1;SFRP1;DAB2IP;FAM20C;LTBP1;TMEM204;SPRY2;LTBP4;NEO1;SMURF1
4838,GO:0014068,0.173710125602713,0.945517959678021,3,35,positive regulation of phosphatidylinositol 3-kinase signaling,BP,F2R;ERBB3;PLXNB1
4381,GO:0010107,0.174187039726954,0.962177457101479,2,18,potassium ion import,BP,KCNJ15;ATP12A
2185,GO:0005070,0.174390009750962,0.945206926223711,3,35,SH3/SH2 adaptor activity,MF,VAV3;SH3BP2;NCK2
10861,GO:0044438,0.174542369585678,0.924420158203856,5,74,microbody part,CC,CRAT;ACSL1;AMACR;MLYCD;PEX11B
10862,GO:0044439,0.174542369585678,0.924420158203856,5,74,peroxisomal part,CC,CRAT;ACSL1;AMACR;MLYCD;PEX11B
19849,GO:2000379,0.1746223670493,0.933226189330965,4,54,positive regulation of reactive oxygen species metabolic process,BP,EGFR;CYBA;INSR;PKD2
15264,GO:0071495,0.174634399201484,0.864964644917859,43,904,cellular response to endogenous stimulus,BP,POSTN;HTRA1;SRSF5;COL6A1;EGFR;THRA;CYBA;FGFR4;SFRP1;INSR;PKD2;RGMA;CTSB;FOXO1;UROS;DAB2IP;TBX1;FAM20C;EPHA4;LTBP1;ACSL1;ATP6V0A2;SREBF1;DMTN;PIK3R1;CTSL;UCN2;FAM210B;HYAL1;VAMP2;SPRY2;ITGB5;LTBP4;IMPACT;NEO1;MICALL1;ERBB2;STAT1;CRY2;FURIN;SMURF1;TCIRG1;SORT1
9990,GO:0042451,0.174858488353386,0.961641008530586,2,20,purine nucleoside biosynthetic process,BP,NT5E;NME4
11539,GO:0046129,0.174858488353386,0.961641008530586,2,20,purine ribonucleoside biosynthetic process,BP,NT5E;NME4
15411,GO:0071774,0.175526155499392,0.911346439463542,7,112,response to fibroblast growth factor,BP,POSTN;FGFR4;SFRP1;TBX1;FAM20C;HYAL1;SPRY2
5647,GO:0016775,0.175708056565244,0.986714373012687,1,5,phosphotransferase activity, nitrogenous group as acceptor,MF,CKMT1A
11924,GO:0047134,0.176220998689176,0.986633548582542,1,5,protein-disulfide reductase activity,MF,TXNDC17
9103,GO:0035455,0.176343332645826,0.961257423031014,2,19,response to interferon-alpha,BP,IFITM1;LAMP3
11591,GO:0046330,0.176372757607687,0.916467104248773,6,91,positive regulation of JNK cascade,BP,DAB2IP;EPHA4;TNFRSF19;TRPV4;NRK;VANGL2
15200,GO:0071398,0.17646850267176,0.944252232262071,3,35,cellular response to fatty acid,BP,SFRP1;SREBF1;NFATC4
5739,GO:0016918,0.176796942892814,0.986542480856967,1,5,retinal binding,MF,CYP27C1
4549,GO:0010648,0.176957860155256,0.862597810786956,44,936,negative regulation of cell communication,BP,TNFAIP3;APOE;IFI6;PTPRS;EPHB2;HTRA1;EGFR;FGFR4;APCDD1;BCL6;SFRP1;TNFSF10;INSR;PKD2;DNM1;SERPINE2;WWTR1;FOXO1;DAB2IP;MNT;EPHA4;LTBP1;ERBB3;KIF26A;SREBF1;NCK2;KCTD11;NFATC4;TYRO3;SPRY2;RTN4RL1;IGFBP4;ERBB2;EPM2A;STAT1;TULP3;ACKR3;CRY2;ASIC1;RASA4;SMURF1;KREMEN1;CCDC3;MDFI
12502,GO:0050688,0.1773037025872,0.931811503767316,4,54,regulation of defense response to virus,BP,TNFAIP3;HTRA1;DDX60;STAT1
4692,GO:0010872,0.177477497367065,0.986434440959876,1,5,regulation of cholesterol esterification,BP,APOE
1166,GO:0002820,0.177816688311135,0.960732874374157,2,19,negative regulation of adaptive immune response,BP,BCL6;IL20RB
12388,GO:0048873,0.178129504557754,0.96062112877523,2,19,homeostasis of number of cells within a tissue,BP,F2R;IL20RB
8257,GO:0033085,0.178450048072902,0.986279234076987,1,5,negative regulation of T cell differentiation in thymus,BP,ERBB2
8089,GO:0032799,0.178466575459432,0.960500571566969,2,19,low-density lipoprotein receptor particle metabolic process,BP,APOE;FURIN
4332,GO:0009914,0.178614349420115,0.897163673400968,10,174,hormone transport,BP,EGFR;NLGN2;SFRP1;GLUL;SREBF1;SLC2A1;SCG5;TRPV4;LTBP4;GPR68
10298,GO:0043124,0.178702294470083,0.943219795663098,3,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNFAIP3;DAB2IP;STAT1
12241,GO:0048585,0.178732425163255,0.858669294192601,51,1100,negative regulation of response to stimulus,BP,TNFAIP3;APOE;IFI6;PTPRS;EPHB2;HTRA1;EGFR;FGFR4;APCDD1;BCL6;SFRP1;TNFSF10;INSR;PKD2;RGMA;DNM1;NT5E;SERPINE2;WWTR1;FOXO1;WNT3;DAB2IP;MNT;EPHA4;MAGEF1;LTBP1;ERBB3;KIF26A;NCK2;KCTD11;NFATC4;TYRO3;SPRY2;KLK8;SERPING1;RTN4RL1;IGFBP4;ERBB2;EPM2A;STAT1;TULP3;ACKR3;CRY2;IFI16;IL20RB;RASA4;SMURF1;KREMEN1;CCDC3;MAP3K3;MDFI
737,GO:0001973,0.178863923010915,0.986212894812205,1,5,adenosine receptor signaling pathway,BP,ADORA2B
50,GO:0000104,0.179010704687511,0.986189325817668,1,5,succinate dehydrogenase activity,MF,SDHA
2486,GO:0005749,0.179010704687511,0.986189325817668,1,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,SDHA
3663,GO:0008177,0.179010704687511,0.986189325817668,1,5,succinate dehydrogenase (ubiquinone) activity,MF,SDHA
11143,GO:0045257,0.179010704687511,0.986189325817668,1,5,succinate dehydrogenase complex (ubiquinone),CC,SDHA
11148,GO:0045273,0.179010704687511,0.986189325817668,1,5,respiratory chain complex II,CC,SDHA
11152,GO:0045281,0.179010704687511,0.986189325817668,1,5,succinate dehydrogenase complex,CC,SDHA
11154,GO:0045283,0.179010704687511,0.986189325817668,1,5,fumarate reductase complex,CC,SDHA
12868,GO:0051254,0.179056253061048,0.858092502848449,52,1113,positive regulation of RNA metabolic process,BP,PEG3;NDN;ASH2L;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;ZNF318;SFRP1;POU3F1;INSR;PKD2;ZFPM1;RGMA;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;SOX12;DAB2IP;TBX1;TRERF1;YEATS4;TET1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;PLXND1;SREBF1;PIK3R1;NCK2;ACVR1B;NFATC4;RTF1;ZP3;TP53INP1;MDK;MC1R;CRTC1;ERBB2;RNF187;STAT1;IFI16;DBP;CAMK1;SP100
12854,GO:0051235,0.179173251293257,0.891064708626605,12,217,maintenance of location,BP,APOE;THRA;CYBA;EPB41L3;GAA;PKD2;F2R;HEXB;LTBP1;SUN1;MDFI;SP100
11229,GO:0045541,0.179240586836133,0.986152369418547,1,5,negative regulation of cholesterol biosynthetic process,BP,APOE
16143,GO:0090206,0.179240586836133,0.986152369418547,1,5,negative regulation of cholesterol metabolic process,BP,APOE
12820,GO:0051180,0.179272218652386,0.960211805552229,2,19,vitamin transport,BP,SLC2A1;ABCC1
7996,GO:0032651,0.179328486590151,0.942855123168652,3,36,regulation of interleukin-1 beta production,BP,TNFAIP3;F2R;IFI16
12865,GO:0051251,0.179627047082005,0.899900600447358,9,156,positive regulation of lymphocyte activation,BP,MAP3K14;GLI2;BCL6;VAV3;PIK3R1;NCK2;ZP3;EFNB3;CCDC88B
3563,GO:0007623,0.17971756242515,0.9038970617485,8,133,circadian rhythm,BP,EGFR;HEBP1;SREBF1;NAGLU;CRTC1;CRY2;DBP;PER3
12736,GO:0051051,0.179807902377572,0.886052448799981,14,262,negative regulation of transport,BP,EPHB2;ANO9;SFRP1;PKD2;SERPINE2;RHBDF1;F2R;ERBB3;VAMP3;SREBF1;DMTN;SNX33;ASIC1;SP100
3104,GO:0006699,0.179816156450181,0.960016349280494,2,19,bile acid biosynthetic process,BP,FGFR4;AMACR
15836,GO:0072604,0.179902970572195,0.959985117096819,2,19,interleukin-6 secretion,BP,F2R;TRPV4
3266,GO:0006968,0.180039981298121,0.959935805631625,2,19,cellular defense response,BP,ADORA2B;TCIRG1
8305,GO:0033176,0.18037689719117,0.95966563406176,2,20,proton-transporting V-type ATPase complex,CC,ATP6V0A2;TCIRG1
5053,GO:0015294,0.18073851926718,0.930030608141674,4,53,solute:cation symporter activity,MF,SLC13A5;SLC2A9;SLC5A1;SLC13A3
9851,GO:0042149,0.180769555981156,0.942183597122232,3,36,cellular response to glucose starvation,BP,SLC2A1;IMPACT;IFI16
11281,GO:0045637,0.180805588566584,0.895587549970156,10,179,regulation of myeloid cell differentiation,BP,ASH2L;SFRP1;ZFPM1;FAM213A;PIK3R1;ACVR1B;FAM210B;MYL9;GPR68;STAT1
10899,GO:0044557,0.180876643924392,0.985887806757042,1,5,relaxation of smooth muscle,BP,ADORA2B
8576,GO:0034112,0.180876679500502,0.985887800974611,1,5,positive regulation of homotypic cell-cell adhesion,BP,DMTN
4603,GO:0010739,0.181263084904724,0.985824920054373,1,5,positive regulation of protein kinase A signaling,BP,MC1R
7831,GO:0032413,0.181266767599621,0.941951262595129,3,36,negative regulation of ion transmembrane transporter activity,BP,EPHB2;ANO9;PKD2
16994,GO:0099512,0.181300504239075,0.86686907984084,29,591,supramolecular fiber,CC,OBSL1;FLNC;SHROOM2;COL6A1;FHOD3;PKD2;ESPN;DNM1;LDLRAP1;TNXB;PARVB;OBSCN;CLIP2;GAS8;WIPF1;KIF26B;LTBP1;KIF26A;DMTN;SLC2A1;SPRY2;TRPV4;SYNM;NDRG1;MYL9;PDLIM4;NINL;SLC1A4;AIF1L
18895,GO:1904688,0.181383071732024,0.985805363393456,1,5,regulation of cytoplasmic translational initiation,BP,RPL13A
8450,GO:0033619,0.181385201091043,0.92964057332847,4,54,membrane protein proteolysis,BP,APOE;ADAM19;SNX33;FURIN
7035,GO:0030833,0.181427635930858,0.907532558155213,7,114,regulation of actin filament polymerization,BP,FHOD3;WIPF1;EPS8L2;DMTN;NCK2;ARHGAP40;ARPIN
2285,GO:0005267,0.181590460327647,0.9417998333278,3,36,potassium channel activity,MF,KCNJ15;PKD2;KCNC4
10924,GO:0044706,0.181660440536764,0.902590926201963,8,134,multi-multicellular organism process,BP,CTSB;SERPINE2;CTSV;HEXB;PTHLH;ACVR1B;SLC2A1;NRK
8329,GO:0033218,0.181952111655883,0.891732356231439,11,199,amide binding,MF,APOE;EPHB2;FBXO2;VIPR1;INSR;LDLRAP1;RNPEPL1;CTSV;PIK3R1;FURIN;APBA1
14726,GO:0070459,0.181971841317519,0.985709187870416,1,5,prolactin secretion,BP,EGFR
11239,GO:0045581,0.182288101570274,0.959123087769788,2,19,negative regulation of T cell differentiation,BP,BCL6;ERBB2
6938,GO:0030595,0.182380213094394,0.91267200316634,6,96,leukocyte chemotaxis,BP,CKLF;VAV3;CXCL14;VEGFB;CXCR1;TRPV4
13988,GO:0060754,0.18239433762194,0.985639955982083,1,5,positive regulation of mast cell chemotaxis,BP,VEGFB
13538,GO:0060046,0.182471206224833,0.985627340477852,1,5,regulation of acrosome reaction,BP,ZP3
15349,GO:0071639,0.182512601108312,0.985620544351973,1,5,positive regulation of monocyte chemotactic protein-1 production,BP,TRPV4
8652,GO:0034260,0.182667189740397,0.941295123416876,3,36,negative regulation of GTPase activity,BP,DAB2IP;SPRY2;RASA4
6630,GO:0023057,0.182722841888056,0.857689231231409,44,939,negative regulation of signaling,BP,TNFAIP3;APOE;IFI6;PTPRS;EPHB2;HTRA1;EGFR;FGFR4;APCDD1;BCL6;SFRP1;TNFSF10;INSR;PKD2;DNM1;SERPINE2;WWTR1;FOXO1;DAB2IP;MNT;EPHA4;LTBP1;ERBB3;KIF26A;SREBF1;NCK2;KCTD11;NFATC4;TYRO3;SPRY2;RTN4RL1;IGFBP4;ERBB2;EPM2A;STAT1;TULP3;ACKR3;CRY2;ASIC1;RASA4;SMURF1;KREMEN1;CCDC3;MDFI
19244,GO:1905516,0.182747231357009,0.985581990304174,1,5,positive regulation of fertilization,BP,ZP3
9104,GO:0035456,0.183101156141886,0.958675339616865,2,20,response to interferon-beta,BP,IFITM1;STAT1
7302,GO:0031331,0.183106262970821,0.881632764111248,15,281,positive regulation of cellular catabolic process,BP,TNFAIP3;APOE;INSR;TP53INP2;FOXO1;TRIM65;DAB2IP;MAGEF1;ENDOG;TRIM22;SNX33;TP53INP1;EPM2A;FURIN;SMURF1
9868,GO:0042182,0.183157793922947,0.985514392573665,1,5,ketone catabolic process,BP,CBR3
16236,GO:0090344,0.183249713512477,0.958773385954011,2,19,negative regulation of cell aging,BP,BCL6;MAP3K3
13800,GO:0060441,0.183322196740466,0.958746976329926,2,19,epithelial tube branching involved in lung morphogenesis,BP,SPRY2;VANGL2
11170,GO:0045334,0.183587301609585,0.940862613930388,3,36,clathrin-coated endocytic vesicle,CC,APOE;EGFR;LDLRAP1
2396,GO:0005581,0.183873704917638,0.940804248409239,3,35,collagen trimer,CC,COL6A1;TNXB;COL7A1
4793,GO:0014002,0.183893148893034,0.958538701014971,2,19,astrocyte development,BP,EGFR;LAMB2
11220,GO:0045494,0.184077829236272,0.9584712387696,2,19,photoreceptor cell maintenance,BP,TUB;RDH12
4530,GO:0010628,0.184089138997225,0.85107659749338,62,1356,positive regulation of gene expression,BP,PEG3;LAMP3;NDN;EPHB2;ASH2L;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;ZNF318;SFRP1;POU3F1;INSR;PKD2;ZFPM1;RGMA;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;WNT3;SOX12;DAB2IP;TBX1;TRERF1;YEATS4;TET1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;ACTA2;ERBB3;PLXND1;SREBF1;PIK3R1;NCK2;ACVR1B;NFATC4;RTF1;ZP3;SPRY2;TP53INP1;MDK;TRPV4;MC1R;IMPACT;CRTC1;ERBB2;RNF187;STAT1;IFI16;GJC2;DBP;CAMK1;SP100
17529,GO:1901165,0.184089860729377,0.985360293712347,1,5,positive regulation of trophoblast cell migration,BP,ACVR1B
13076,GO:0051651,0.184206513627396,0.918824182453103,5,74,maintenance of location in cell,BP,APOE;EPB41L3;GAA;SUN1;SP100
2312,GO:0005337,0.184362759422581,0.985315007719514,1,5,nucleoside transmembrane transporter activity,MF,SLC29A4
5220,GO:0015858,0.184362759422581,0.985315007719514,1,5,nucleoside transport,BP,SLC29A4
17681,GO:1901642,0.184362759422581,0.985315007719514,1,5,nucleoside transmembrane transport,BP,SLC29A4
12892,GO:0051289,0.184370253390609,0.927953165805272,4,56,protein homotetramerization,BP,ALDH1A3;GPX3;PKD2;CRTC1
14106,GO:0061025,0.184463276917727,0.893047743571846,10,176,membrane fusion,BP,VAV3;DNM1;SYT8;EVI5L;VAMP3;SYTL1;VAMP2;TBC1D17;C2CD4C;VPS33B
7504,GO:0031730,0.184503247150911,0.985291664960981,1,5,CCR5 chemokine receptor binding,MF,STAT1
16927,GO:0098984,0.184528003913161,0.896597048037015,9,151,neuron to neuron synapse,CC,PTPRS;EPB41L3;NLGN2;DNM1;EPHA4;HOMER2;SPOCK1;DMTN;NCK2
1775,GO:0004415,0.184586536615155,0.985277816481317,1,5,hyalurononglucosaminidase activity,MF,HYAL1
2237,GO:0005164,0.184601667788564,0.958125631118392,2,20,tumor necrosis factor receptor binding,MF,TNFSF10;STAT1
16465,GO:0097208,0.184638142344763,0.985269232482282,1,5,alveolar lamellar body,CC,LAMP3
8015,GO:0032687,0.184667712959378,0.985264312537761,1,5,negative regulation of interferon-alpha production,BP,PTPRS
13198,GO:0051902,0.185299642895177,0.985158958999486,1,5,negative regulation of mitochondrial depolarization,BP,IFI6
18686,GO:1904180,0.185299642895177,0.985158958999486,1,5,negative regulation of membrane depolarization,BP,IFI6
334,GO:0000930,0.185605013366592,0.957911620759193,2,19,gamma-tubulin complex,CC,MZT2A;MZT2B
5888,GO:0018126,0.185612994098928,0.95790868811925,2,19,protein hydroxylation,BP,CRTAP;VPS33B
1111,GO:0002707,0.185795297334304,0.95768619058502,2,20,negative regulation of lymphocyte mediated immunity,BP,BCL6;IL20RB
8251,GO:0033079,0.185876864335691,0.985062369881603,1,5,immature T cell proliferation,BP,ERBB2
2627,GO:0005977,0.185912187773823,0.92720812829808,4,54,glycogen metabolic process,BP,PGM1;INSR;GAA;PPP1R3E
2691,GO:0006073,0.185912187773823,0.92720812829808,4,54,cellular glucan metabolic process,BP,PGM1;INSR;GAA;PPP1R3E
10687,GO:0044042,0.185912187773823,0.92720812829808,4,54,glucan metabolic process,BP,PGM1;INSR;GAA;PPP1R3E
9958,GO:0042392,0.185949067208053,0.98505026388231,1,5,sphingosine-1-phosphate phosphatase activity,MF,PLPP2
10025,GO:0042538,0.186006913045936,0.985040561230593,1,5,hyperosmotic salinity response,BP,TRPV4
10451,GO:0043379,0.186034382913986,0.985035952431133,1,5,memory T cell differentiation,BP,BCL6
16334,GO:0090713,0.186034382913986,0.985035952431133,1,5,immunological memory process,BP,BCL6
16335,GO:0090715,0.186034382913986,0.985035952431133,1,5,immunological memory formation process,BP,BCL6
715,GO:0001945,0.186096096269412,0.957731006293359,2,19,lymph vessel development,BP,TBX1;TMEM204
7104,GO:0030947,0.186097433150372,0.957730514164133,2,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,DAB2IP;TMEM204
6411,GO:0021696,0.186101956210807,0.957728849128919,2,19,cerebellar cortex morphogenesis,BP,GLI2;SERPINE2
11648,GO:0046467,0.186198546402478,0.90441463164406,7,116,membrane lipid biosynthetic process,BP,KDSR;ST3GAL5;CERS4;PLPP2;ALOXE3;ST6GALNAC6;PIGZ
19759,GO:2000241,0.186283836429587,0.917577305139122,5,75,regulation of reproductive process,BP,SFRP1;INSR;ACVR1B;ZP3;NRK
1972,GO:0004704,0.186316545240067,0.984988567541043,1,5,NF-kappaB-inducing kinase activity,MF,MAP3K14
15176,GO:0071364,0.186374467503733,0.939545666114836,3,36,cellular response to epidermal growth factor stimulus,BP,EGFR;DAB2IP;ERBB2
7382,GO:0031465,0.186416395009327,0.984971779777234,1,5,Cul4B-RING E3 ubiquitin ligase complex,CC,DDB2
6054,GO:0019221,0.186451668405268,0.865901483306179,25,519,cytokine-mediated signaling pathway,BP,TNFAIP3;IFITM1;IFI6;NDN;MAP3K14;OAS2;BCL6;FOXO1;RPS6KA5;TXNDC17;ACSL1;PIK3R1;TRIM22;CXCR1;RBCK1;TNFRSF19;RTN4RL1;STAT1;ACKR3;IL20RB;MMP1;CCDC3;MT2A;MAP3K3;SP100
3412,GO:0007216,0.186490093373479,0.984959382312483,1,5,G-protein coupled glutamate receptor signaling pathway,BP,HOMER2
14194,GO:0061200,0.186503174958416,0.984957181160669,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,VAMP2
14195,GO:0061202,0.186503174958416,0.984957181160669,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,VAMP2
876,GO:0002248,0.186606761753943,0.984939745112362,1,5,connective tissue replacement involved in inflammatory response wound healing,BP,F2R
831,GO:0002138,0.186719232120997,0.984920801320243,1,5,retinoic acid biosynthetic process,BP,ALDH1A3
5331,GO:0016102,0.186719232120997,0.984920801320243,1,5,diterpenoid biosynthetic process,BP,ALDH1A3
18574,GO:1903898,0.186797786573495,0.98490756242948,1,5,negative regulation of PERK-mediated unfolded protein response,BP,NCK2
11624,GO:0046415,0.186895991631302,0.984891002910411,1,5,urate metabolic process,BP,SLC2A9
7157,GO:0031058,0.186907000741147,0.917240506419471,5,74,positive regulation of histone modification,BP,BCL6;TET1;RPS6KA5;SREBF1;RTF1
8327,GO:0033211,0.186955625675565,0.984880942489093,1,5,adiponectin-activated signaling pathway,BP,ACSL1
1871,GO:0004563,0.187099033715281,0.984856734265603,1,5,beta-N-acetylhexosaminidase activity,MF,HEXB
3757,GO:0008328,0.187183971818385,0.957329750058549,2,19,ionotropic glutamate receptor complex,CC,OLFM2;CPT1C
16871,GO:0098878,0.187183971818385,0.957329750058549,2,19,neurotransmitter receptor complex,CC,OLFM2;CPT1C
15474,GO:0071895,0.187293518861538,0.984823870239477,1,5,odontoblast differentiation,BP,FAM20C
8260,GO:0033089,0.187332148176244,0.984817338060592,1,5,positive regulation of T cell differentiation in thymus,BP,GLI2
19125,GO:1905206,0.187446044117697,0.984798069470967,1,5,positive regulation of hydrogen peroxide-induced cell death,BP,ENDOG
14473,GO:0065007,0.187756487304002,0.837577122026547,331,7891,biological regulation,BP,TNFAIP3;POSTN;IFITM1;ITGB6;PEG3;TGFBI;SMOC2;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;KCNJ15;ULK2;PTPRS;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRF4;NINJ1;ASH2L;HTRA1;PRICKLE2;SLITRK6;GAMT;GPRC5C;TXNRD3;GIGYF1;ADGRL1;SRSF5;RALGDS;NCR3LG1;EGFR;FBXO2;THRA;CITED4;CYBA;OAS2;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;PINLYP;APCDD1;NLGN2;RAPGEF5;IRF2BPL;VIPR1;BCL6;ANO9;TENM2;PSD4;ZNF318;BRSK1;SFRP1;ARHGEF4;CKLF;FHOD3;UNK;POU3F1;TNFSF10;MN1;INSR;VAV3;KMT5C;CYBRD1;GAA;SV2A;PKD2;ESPN;ZFPM1;RGMA;RTN2;DNM1;PPP2R2C;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;FOXO1;WNT3;TRIM65;LY6E;ZSCAN18;NSG1;PARVB;RASIP1;BOC;SOX12;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;TSC22D1;KLK5;TRERF1;SHC2;SCN4B;SH3BP2;CRTAP;GAS8;YEATS4;EVI5L;WIPF1;KCNC4;MNT;RAB40B;TET1;CYP27C1;FAM20C;GLUL;FAM213A;EPHA4;ZNF266;WNT9A;TRAPPC2L;RPL13A;MAGEF1;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;TCFL5;TYSND1;CTSV;NXPH4;RPS6KA5;TUB;HOMER2;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;ZNF362;ACSL1;EPS8L2;ZBTB42;DDX60;ACTA2;ERBB3;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;VAMP3;CUL9;FRY;PLXND1;CGREF1;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;IMPA2;XPC;ARHGAP40;NAB2;NFATC4;ATP12A;SNX33;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;HYAL1;BCAM;RTF1;ZP3;STOM;VAMP2;PLEKHH2;RBCK1;EFNB3;PCBP4;ZNF554;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;TNFRSF19;TMX4;MDK;TRPV4;MTHFR;PQLC2;GPC4;MSRB2;ITGB5;NDRG1;RETSAT;KLK8;LTBP4;PPP1R35;ADORA2B;FBXW4;SERPING1;MRC2;MAFIP;MYL9;RTN4RL1;MARK4;BTBD2;MC1R;IMPACT;TBC1D17;MVD;NEO1;CRTC1;IGFBP4;STON1;GPR68;TOM1L2;GPR153;ERBB2;C2CD4C;RNF187;HSD11B1;EPM2A;RNF135;H2AFJ;STAT1;TULP3;NME4;CDK20;HINT2;ACKR3;PLCD1;CRY2;SLC39A6;BLOC1S4;MARCKSL1;ZMYM3;FURIN;FBXW5;RHPN1;IFI16;IL20RB;CCDC88B;PCSK1;PLPP2;MLYCD;SUN1;THNSL2;NINL;PEX11B;FRAT1;GJC2;ARPIN;DBP;BEX2;ASIC1;MMP1;ALS2CL;PER3;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;MT2A;RAB43;VPS33B;ELFN2;MAP3K3;PPP1R14A;MDFI;REEP6;SCMH1;ZSWIM8;SP100;ABCC1;NRK;SORT1;VANGL2;APBA1;TP53I11
3537,GO:0007588,0.187767033082327,0.956956103242464,2,20,excretion,BP,MDK;ADORA2B
3231,GO:0006904,0.18778768482628,0.938799833581291,3,37,vesicle docking involved in exocytosis,BP,RAB40B;VAMP3;VPS33B
20245,GO:2001258,0.18785081652525,0.956924964851396,2,20,negative regulation of cation channel activity,BP,EPHB2;PKD2
4823,GO:0014047,0.187953052223463,0.957045125001928,2,19,glutamate secretion,BP,VAMP2;APBA1
8627,GO:0034201,0.188017718222286,0.9847011544506,1,5,response to oleic acid,BP,ACSL1
5000,GO:0015181,0.18808753317215,0.984689295873199,1,5,arginine transmembrane transporter activity,MF,PQLC2
5007,GO:0015189,0.18808753317215,0.984689295873199,1,5,L-lysine transmembrane transporter activity,MF,PQLC2
20221,GO:2001225,0.188105497818061,0.98468624363871,1,5,regulation of chloride transport,BP,ANO9
11231,GO:0045545,0.188202892863588,0.984669690235527,1,5,syndecan binding,MF,GPNMB
8426,GO:0033578,0.188339682341351,0.984646424867535,1,5,protein glycosylation in Golgi,BP,LMF1
2334,GO:0005391,0.188364952777127,0.984642124731626,1,5,sodium:potassium-exchanging ATPase activity,MF,ATP12A
3891,GO:0008556,0.188364952777127,0.984642124731626,1,5,potassium-transporting ATPase activity,MF,ATP12A
1223,GO:0002921,0.188366093541723,0.984641930598314,1,5,negative regulation of humoral immune response,BP,SERPING1
15236,GO:0071458,0.188392958914102,0.984637358310525,1,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,PKD2
7545,GO:0031915,0.188469895458369,0.984624260182194,1,5,positive regulation of synaptic plasticity,BP,EPHB2
6932,GO:0030579,0.188484389099394,0.984621792019882,1,5,ubiquitin-dependent SMAD protein catabolic process,BP,SMURF1
7746,GO:0032288,0.188531738881676,0.956830440801866,2,19,myelin assembly,BP,EPB41L3;TENM4
18137,GO:1902947,0.188622067408074,0.984598335648577,1,5,regulation of tau-protein kinase activity,BP,NAB2
10620,GO:0043696,0.188752474938917,0.98457610006427,1,5,dedifferentiation,BP,OLFM2
10621,GO:0043697,0.188752474938917,0.98457610006427,1,5,cell dedifferentiation,BP,OLFM2
764,GO:0002024,0.18875811656973,0.984575137724662,1,5,diet induced thermogenesis,BP,TRPV4
14921,GO:0070857,0.188963780978278,0.984540033536799,1,5,regulation of bile acid biosynthetic process,BP,FGFR4
12687,GO:0050974,0.189002310022854,0.984533452309186,1,5,detection of mechanical stimulus involved in sensory perception,BP,SERPINE2
12238,GO:0048570,0.189058786295218,0.984523802722448,1,5,notochord morphogenesis,BP,GLI2
1394,GO:0003339,0.189172772407938,0.984504316974206,1,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,STAT1
20156,GO:2001046,0.189230477088383,0.984494447360581,1,5,positive regulation of integrin-mediated signaling pathway,BP,DMTN
15450,GO:0071863,0.189280585308994,0.984485874244824,1,5,regulation of cell proliferation in bone marrow,BP,MAP3K3
15451,GO:0071864,0.189280585308994,0.984485874244824,1,5,positive regulation of cell proliferation in bone marrow,BP,MAP3K3
4038,GO:0009100,0.189324142055799,0.875061563787881,16,306,glycoprotein metabolic process,BP,LMF1;ST3GAL5;FBXO2;XYLT1;VEGFB;SGSH;TET1;B3GNT9;HEXB;CSPG4;HYAL1;MVD;XYLT2;ST6GALNAC6;IDUA;VANGL2
16409,GO:0097113,0.189396608522777,0.984466013698971,1,5,AMPA glutamate receptor clustering,BP,APOE
16666,GO:0097688,0.189396608522777,0.984466013698971,1,5,glutamate receptor clustering,BP,APOE
5047,GO:0015279,0.18947195393777,0.984453108862706,1,5,store-operated calcium channel activity,MF,ORAI3
11296,GO:0045656,0.189590788351098,0.984432743561789,1,5,negative regulation of monocyte differentiation,BP,GPR68
14553,GO:0070141,0.189599792697913,0.984431199846249,1,5,response to UV-A,BP,EGFR
2088,GO:0004866,0.189723791723957,0.915491780526306,5,77,endopeptidase inhibitor activity,MF,SERPINE2;COL7A1;SPOCK1;SERPING1;FURIN
6868,GO:0030414,0.189723791723957,0.915491780526306,5,77,peptidase inhibitor activity,MF,SERPINE2;COL7A1;SPOCK1;SERPING1;FURIN
16234,GO:0090342,0.18977294361612,0.937850876326053,3,37,regulation of cell aging,BP,BCL6;NUAK1;MAP3K3
12425,GO:0050291,0.189791322300285,0.984398344050143,1,5,sphingosine N-acyltransferase activity,MF,CERS4
15381,GO:0071692,0.190010014070209,0.984360782620402,1,5,protein localization to extracellular region,BP,LTBP1
15382,GO:0071694,0.190010014070209,0.984360782620402,1,5,maintenance of protein location in extracellular region,BP,LTBP1
15849,GO:0072657,0.190025556498223,0.866061462077371,22,452,protein localization to membrane,BP,APOE;EPHB2;EGFR;EPB41L3;NLGN2;LDLRAP1;ETV5;NSG1;RAB40B;RPL13A;TUB;VAMP3;DMTN;PIK3R1;STOM;VAMP2;ZDHHC1;GOLGA7B;MICALL1;ERBB2;TULP3;SMURF1
11283,GO:0045639,0.190032494800215,0.924926311020016,4,55,positive regulation of myeloid cell differentiation,BP,ACVR1B;FAM210B;GPR68;STAT1
6401,GO:0021683,0.190136844674547,0.984338976280352,1,5,cerebellar granular layer morphogenesis,BP,SERPINE2
15228,GO:0071447,0.190146205169722,0.984337366248601,1,5,cellular response to hydroperoxide,BP,TP53INP1
13956,GO:0060711,0.190156419078736,0.937666979480324,3,37,labyrinthine layer development,BP,PLCD3;GJB5;PLCD1
9358,GO:0035926,0.190167056418699,0.984333779450543,1,5,chemokine (C-C motif) ligand 2 secretion,BP,POSTN
4432,GO:0010385,0.19018577972861,0.984330558315978,1,5,double-stranded methylated DNA binding,MF,MBD1
12366,GO:0048844,0.190307752127583,0.937669814617643,3,36,artery morphogenesis,BP,APOE;PKD2;TBX1
16837,GO:0098814,0.190349249632463,0.984302419839086,1,5,spontaneous synaptic transmission,BP,NSG1
15649,GO:0072217,0.190424598805125,0.984289440542297,1,5,negative regulation of metanephros development,BP,STAT1
13977,GO:0060740,0.190494272193292,0.95609904056899,2,19,prostate gland epithelium morphogenesis,BP,GLI2;SFRP1
2692,GO:0006081,0.190548644959374,0.924558058627378,4,57,cellular aldehyde metabolic process,BP,ALDH1A3;H6PD;CYP27C1;PGLS
7483,GO:0031681,0.190597101780163,0.984259703983149,1,5,G-protein beta-subunit binding,MF,F2R
7121,GO:0030976,0.190691115602049,0.984243484713915,1,5,thiamine pyrophosphate binding,MF,DHTKD1
6313,GO:0020037,0.190954550225212,0.924378572673714,4,56,heme binding,MF,CYBA;HEBP1;CYP4F22;CYP27C1
16877,GO:0098887,0.190955901537734,0.984197754920346,1,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,NSG1
13513,GO:0060017,0.191005915708637,0.984189109127325,1,5,parathyroid gland development,BP,TBX1
10637,GO:0043901,0.19102803481825,0.901249495246537,7,117,negative regulation of multi-organism process,BP,TNFAIP3;IFITM1;HTRA1;OAS2;ZP3;STAT1;IFI16
19986,GO:2000646,0.191131762724497,0.984167342949353,1,5,positive regulation of receptor catabolic process,BP,APOE
13454,GO:0055056,0.191227165347623,0.984150831482882,1,5,D-glucose transmembrane transporter activity,MF,SLC2A1
645,GO:0001839,0.191275915084687,0.984142390676816,1,5,neural plate morphogenesis,BP,VANGL2
16369,GO:0097039,0.19136294922161,0.98412731500357,1,5,protein linear polyubiquitination,BP,RBCK1
12190,GO:0048484,0.191444873954814,0.984113117226311,1,5,enteric nervous system development,BP,KIF26A
16084,GO:0090118,0.191520646999158,0.984099979395233,1,5,receptor-mediated endocytosis involved in cholesterol transport,BP,LDLRAP1
1370,GO:0003279,0.191607095030914,0.914494812428158,5,73,cardiac septum development,BP,ZFPM1;TBX1;LTBP1;PLXND1;VANGL2
17238,GO:0140029,0.191651157939972,0.923997228510334,4,56,exocytic process,BP,RAB40B;VAMP3;DMTN;VPS33B
3097,GO:0006690,0.191787681290143,0.923879655222651,4,57,icosanoid metabolic process,BP,CYP4F22;CES2;ALOXE3;ABCC1
2646,GO:0006006,0.191954629276461,0.895647519620905,8,136,glucose metabolic process,BP,PGM1;INSR;GAA;FOXO1;H6PD;IGFBP4;MLYCD;NISCH
6287,GO:0019934,0.191963953987174,0.984022998446282,1,5,cGMP-mediated signaling,BP,APOE
20158,GO:2001054,0.192039421331306,0.984009873236078,1,5,negative regulation of mesenchymal cell apoptotic process,BP,TBX1
1065,GO:0002638,0.192311515499838,0.983962502086899,1,5,negative regulation of immunoglobulin production,BP,BCL6
5230,GO:0015874,0.192315122375427,0.983961873622693,1,5,norepinephrine transport,BP,NISCH
836,GO:0002154,0.192508634795307,0.983928136214833,1,5,thyroid hormone mediated signaling pathway,BP,THRA
13641,GO:0060215,0.192572053542853,0.983917071231968,1,5,primitive hemopoiesis,BP,ZFPM1
15620,GO:0072178,0.192710173201141,0.983892958441093,1,5,nephric duct morphogenesis,BP,EPHA4
5761,GO:0017002,0.192728906465798,0.983889686489542,1,5,activin-activated receptor activity,MF,ACVR1B
12344,GO:0048786,0.192934259686216,0.955182537295179,2,19,presynaptic active zone,CC,SV2A;RIMS3
10565,GO:0043568,0.192979311763192,0.983845915904188,1,5,positive regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4
4999,GO:0015180,0.193090679756533,0.983826428085161,1,5,L-alanine transmembrane transporter activity,MF,SLC1A4
5191,GO:0015808,0.193090679756533,0.983826428085161,1,5,L-alanine transport,BP,SLC1A4
6607,GO:0022858,0.193090679756533,0.983826428085161,1,5,alanine transmembrane transporter activity,MF,SLC1A4
18794,GO:1904427,0.193315544552911,0.936144698130428,3,37,positive regulation of calcium ion transmembrane transport,BP,PKD2;F2R;GJC2
7061,GO:0030870,0.193330232348741,0.983784466347817,1,5,Mre11 complex,CC,SP100
494,GO:0001547,0.193432833715607,0.983766475820589,1,5,antral ovarian follicle growth,BP,ZP3
5953,GO:0018410,0.193572096458315,0.935947588010709,3,38,C-terminal protein amino acid modification,BP,LY6E;RTN4RL1;WIPI2
17670,GO:1901621,0.193766996237309,0.983707807001783,1,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,TULP3
13929,GO:0060677,0.1939795874367,0.983670422319157,1,5,ureteric bud elongation,BP,KIF26B
18356,GO:1903423,0.194039873489824,0.983659812359813,1,5,positive regulation of synaptic vesicle recycling,BP,DNM1
19471,GO:1990393,0.194103504407483,0.98364860964643,1,5,3M complex,CC,OBSL1
11230,GO:0045542,0.19429604391368,0.98361468606133,1,5,positive regulation of cholesterol biosynthetic process,BP,SREBF1
15964,GO:0086016,0.194303573534195,0.983613358635967,1,5,AV node cell action potential,BP,SCN4B
15973,GO:0086027,0.194303573534195,0.983613358635967,1,5,AV node cell to bundle of His cell signaling,BP,SCN4B
9371,GO:0035947,0.194336448387041,0.983607562315985,1,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,FOXO1
757,GO:0002009,0.194411875634081,0.865017623418037,20,394,morphogenesis of an epithelium,BP,ALDH1A3;PRICKLE2;EGFR;GLI2;SFRP1;PKD2;ETV5;RASIP1;EPHA4;KIF26B;CTSV;ARHGEF19;PLXND1;NFATC4;SPRY2;GPC4;STAT1;TULP3;SMURF1;VANGL2
3139,GO:0006754,0.194416044684963,0.905153304579465,6,96,ATP biosynthetic process,BP,PGM1;DHTKD1;INSR;ATP6V0A2;COX5B;TCIRG1
11044,GO:0045078,0.194430790082006,0.983590922275764,1,5,positive regulation of interferon-gamma biosynthetic process,BP,ZFPM1
5775,GO:0017034,0.194784812198396,0.983528397481389,1,5,Rap guanyl-nucleotide exchange factor activity,MF,RAPGEF5
7143,GO:0031033,0.194816572953348,0.983522781784356,1,5,myosin filament organization,BP,OBSL1
15357,GO:0071651,0.19481980257916,0.983522210687759,1,5,positive regulation of chemokine (C-C motif) ligand 5 production,BP,TRPV4
16247,GO:0090383,0.194829017519171,0.954148167267829,2,21,phagosome acidification,BP,ATP6V0A2;TCIRG1
13962,GO:0060718,0.194889815848741,0.983509827544731,1,5,chorionic trophoblast cell differentiation,BP,HTRA1
9025,GO:0035272,0.194957182902255,0.935348506016408,3,37,exocrine system development,BP,EGFR;INSR;PLXND1
8721,GO:0034398,0.195028237446734,0.98348533017621,1,5,telomere tethering at nuclear periphery,BP,SUN1
2593,GO:0005911,0.195263663386301,0.870504953508539,16,302,cell-cell junction,CC,OBSL1;CADM4;SHROOM2;FGFR4;EPB41L3;SV2A;PKD2;SCN4B;PPL;GJB5;PIK3R1;SLC2A1;NDRG1;PCDH1;GJC2;VANGL2
5010,GO:0015193,0.195324333616644,0.983432861449953,1,5,L-proline transmembrane transporter activity,MF,SLC1A4
9142,GO:0035524,0.195324333616644,0.983432861449953,1,5,proline transmembrane transport,BP,SLC1A4
1177,GO:0002831,0.195403150396657,0.904529479042077,6,96,regulation of response to biotic stimulus,BP,TNFAIP3;HTRA1;CYBA;KLK5;DDX60;STAT1
5042,GO:0015271,0.195592159250987,0.983385324022996,1,5,outward rectifier potassium channel activity,MF,PKD2
5246,GO:0015909,0.195691400058416,0.934991276763812,3,37,long-chain fatty acid transport,BP,APOE;CPT2;ACSL1
2160,GO:0005007,0.195842339797296,0.983340851291009,1,5,fibroblast growth factor-activated receptor activity,MF,FGFR4
6182,GO:0019682,0.19601360177356,0.953694508017644,2,21,glyceraldehyde-3-phosphate metabolic process,BP,H6PD;PGLS
3429,GO:0007254,0.19604805166067,0.888550204365882,9,156,JNK cascade,BP,EGFR;SFRP1;DAB2IP;EPHA4;TNFRSF19;TRPV4;ADORA2B;NRK;VANGL2
14251,GO:0061387,0.196063528326355,0.911806673663296,5,74,regulation of extent of cell growth,BP,APOE;ULK2;PTPRS;WNT3;EPHA4
13511,GO:0060013,0.196204542347137,0.98327635017415,1,5,righting reflex,BP,ALDH1A3
16401,GO:0097105,0.196240734937775,0.983269897506325,1,5,presynaptic membrane assembly,BP,NLGN2
16400,GO:0097104,0.196241598248016,0.983269743572741,1,5,postsynaptic membrane assembly,BP,NLGN2
7401,GO:0031514,0.196354483781661,0.911570884865009,5,76,motile cilium,CC,GLI2;PKD2;GAS8;CABYR;MAFIP
6456,GO:0021815,0.196540154573602,0.983216462716379,1,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,SUN1
8921,GO:0034992,0.196540154573602,0.983216462716379,1,5,microtubule organizing center attachment site,CC,SUN1
8922,GO:0034993,0.196540154573602,0.983216462716379,1,5,meiotic nuclear membrane microtubule tethering complex,CC,SUN1
16194,GO:0090286,0.196540154573602,0.983216462716379,1,5,cytoskeletal anchoring at nuclear membrane,BP,SUN1
17177,GO:0106083,0.196540154573602,0.983216462716379,1,5,nuclear membrane protein complex,CC,SUN1
17180,GO:0106094,0.196540154573602,0.983216462716379,1,5,nuclear membrane microtubule tethering complex,CC,SUN1
16955,GO:0099081,0.196555965451387,0.854270517765884,29,597,supramolecular polymer,CC,OBSL1;FLNC;SHROOM2;COL6A1;FHOD3;PKD2;ESPN;DNM1;LDLRAP1;TNXB;PARVB;OBSCN;CLIP2;GAS8;WIPF1;KIF26B;LTBP1;KIF26A;DMTN;SLC2A1;SPRY2;TRPV4;SYNM;NDRG1;MYL9;PDLIM4;NINL;SLC1A4;AIF1L
13919,GO:0060666,0.196625332860704,0.983201244686618,1,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,PLXND1
4525,GO:0010616,0.196704168370194,0.983187153147952,1,5,negative regulation of cardiac muscle adaptation,BP,FOXO1
18275,GO:1903243,0.196704168370194,0.983187153147952,1,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,FOXO1
633,GO:0001826,0.196781813310949,0.983173268107935,1,5,inner cell mass cell differentiation,BP,TET1
809,GO:0002087,0.196876076980954,0.983156402766351,1,5,regulation of respiratory gaseous exchange by neurological system process,BP,NLGN2
17418,GO:1900246,0.197030565957113,0.983128742147131,1,5,positive regulation of RIG-I signaling pathway,BP,DDX60
12567,GO:0050786,0.197144922793101,0.982446875328001,1,6,RAGE receptor binding,MF,S100A4
5361,GO:0016198,0.197244394960805,0.98309041600988,1,5,axon choice point recognition,BP,EFNB3
9615,GO:0036514,0.197307972850605,0.983079011311766,1,5,dopaminergic neuron axon guidance,BP,VANGL2
19025,GO:1904938,0.197307972850605,0.983079011311766,1,5,planar cell polarity pathway involved in axon guidance,BP,VANGL2
7619,GO:0032051,0.197532726667588,0.983038660938678,1,5,clathrin light chain binding,MF,NSG1
14295,GO:0061525,0.197574385670874,0.983031176067086,1,5,hindgut development,BP,GLI2
8346,GO:0033267,0.197873526851046,0.874779793295495,13,241,axon part,CC,ADGRL1;EPB41L3;TENM2;SV2A;DNM1;BOC;KCNC4;GLUL;EPHA4;SPOCK1;TRPV4;BLOC1S4;GJC2
6881,GO:0030473,0.197966104101719,0.982960707723595,1,5,nuclear migration along microtubule,BP,SUN1
10277,GO:0043086,0.198210407407717,0.85539184617172,26,539,negative regulation of catalytic activity,BP,TNFAIP3;APOE;IFI6;LAMP3;EPHB2;PINLYP;SFRP1;SERPINE2;WWTR1;DAB2IP;COL7A1;WNT9A;SPOCK1;FRY;SPRY2;SCG5;PPP1R35;SERPING1;RTN4RL1;CRY2;FURIN;IFI16;RASA4;ELFN2;PPP1R14A;SORT1
8120,GO:0032869,0.198294337692657,0.886965436633479,9,157,cellular response to insulin stimulus,BP,SRSF5;INSR;FOXO1;ATP6V0A2;SREBF1;PIK3R1;VAMP2;STAT1;TCIRG1
14388,GO:0061734,0.198354154467593,0.982890741781319,1,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,SMURF1
12263,GO:0048638,0.199053854801009,0.879393439830922,11,197,regulation of developmental growth,BP,APOE;ULK2;PTPRS;GAMT;SFRP1;INSR;WNT3;EPHA4;ZP3;SMURF1;NRK
9126,GO:0035507,0.199177473070532,0.98274177702793,1,5,regulation of myosin-light-chain-phosphatase activity,BP,NUAK1
6884,GO:0030479,0.199190142766587,0.982739479153677,1,5,actin cortical patch,CC,WIPF1
14354,GO:0061645,0.199190142766587,0.982739479153677,1,5,endocytic patch,CC,WIPF1
2467,GO:0005719,0.199388008531347,0.952391942825256,2,21,nuclear euchromatin,CC,ASH2L;H1F0
10805,GO:0044332,0.199466560108116,0.982689304296437,1,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
11102,GO:0045180,0.199629525861149,0.982659685655059,1,5,basal cortex,CC,PKD2
16847,GO:0098831,0.199655331258852,0.982654993043685,1,5,presynaptic active zone cytoplasmic component,CC,RIMS3
17972,GO:1902495,0.199744204614651,0.895538124567711,7,115,transmembrane transporter complex,CC,SCN4B;KCNC4;OLFM2;ATP12A;CPT1C;VAMP2;LRRC8E
19245,GO:1905517,0.199830352749548,0.952220065813947,2,21,macrophage migration,BP,CKLF;TRPV4
18661,GO:1904062,0.20007815244899,0.885701047564043,9,158,regulation of cation transmembrane transport,BP,EPHB2;CYBA;NLGN2;PKD2;SCN4B;F2R;STOM;VAMP2;GJC2
13560,GO:0060071,0.200115114444811,0.901471646103679,6,99,Wnt signaling pathway, planar cell polarity pathway,BP,PRICKLE2;SFRP1;ARHGEF19;GPC4;SMURF1;VANGL2
6561,GO:0022408,0.20061544418983,0.901195344184146,6,97,negative regulation of cell-cell adhesion,BP,GPNMB;BCL6;SERPINE2;TRPV4;ERBB2;IL20RB
16069,GO:0090092,0.201000972317526,0.889465359039727,8,137,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;SFRP1;WWTR1;LTBP1;ACVR1B;LTBP4;NEO1;SMURF1
6822,GO:0030307,0.201350050218594,0.894435935453618,7,117,positive regulation of cell growth,BP,EGFR;CYBA;SFRP1;WNT3;HYAL1;ERBB2;SMURF1
8567,GO:0034097,0.201370620119583,0.845024685715413,37,798,response to cytokine,BP,TNFAIP3;POSTN;IFITM1;IFI6;LAMP3;NDN;MAP3K14;CYBA;OAS2;BCL6;SFRP1;FOXO1;DAB2IP;RPL13A;RPS6KA5;TXNDC17;ACSL1;VAMP3;ENDOG;PIK3R1;TRIM22;CXCR1;HYAL1;RBCK1;SPRY2;TNFRSF19;MTHFR;RTN4RL1;STAT1;ACKR3;IL20RB;MMP1;CCDC3;MT2A;RAB43;MAP3K3;SP100
10638,GO:0043902,0.201467962830719,0.889103684382042,8,140,positive regulation of multi-organism process,BP,APOE;MVB12B;CYBA;KLK5;DDX60;ACVR1B;ZP3;STOM
4952,GO:0015079,0.201742791458617,0.918405572522043,4,56,potassium ion transmembrane transporter activity,MF,KCNJ15;PKD2;KCNC4;ATP12A
3213,GO:0006882,0.202049238251063,0.951353961107297,2,21,cellular zinc ion homeostasis,BP,SLC39A6;MT2A
13461,GO:0055069,0.202049238251063,0.951353961107297,2,21,zinc ion homeostasis,BP,SLC39A6;MT2A
695,GO:0001919,0.202057589562421,0.951509389398957,2,20,regulation of receptor recycling,BP,NSG1;VAMP3
9864,GO:0042177,0.202069682463965,0.900243883302928,6,98,negative regulation of protein catabolic process,BP,LAMP3;EGFR;SERPINE2;DAB2IP;EPHA4;FURIN
15129,GO:0071295,0.20212550972185,0.951482852533182,2,20,cellular response to vitamin,BP,POSTN;SFRP1
2630,GO:0005980,0.202230318198399,0.951441891118019,2,20,glycogen catabolic process,BP,PGM1;GAA
4160,GO:0009251,0.202230318198399,0.951441891118019,2,20,glucan catabolic process,BP,PGM1;GAA
8056,GO:0032760,0.202328427906131,0.931653177187792,3,38,positive regulation of tumor necrosis factor production,BP,CYBA;PIK3R1;NFATC4
12343,GO:0048771,0.202487775128767,0.90002060313499,6,96,tissue remodeling,BP,TNFAIP3;GPNMB;EGFR;SFRP1;F2R;CSPG4
708,GO:0001937,0.202637412948958,0.951282651182184,2,20,negative regulation of endothelial cell proliferation,BP,APOE;STAT1
3725,GO:0008277,0.202845228247379,0.907624706918317,5,77,regulation of G-protein coupled receptor protein signaling pathway,BP,DNM1;KLK5;HOMER2;GRK6;TULP3
2299,GO:0005310,0.203086282155372,0.951106815317739,2,20,dicarboxylic acid transmembrane transporter activity,MF,SLC13A5;SLC13A3
8860,GO:0034703,0.203635643155621,0.907175145617344,5,76,cation channel complex,CC,SCN4B;KCNC4;OLFM2;CPT1C;VAMP2
1256,GO:0003044,0.203886969624606,0.95063166776047,2,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,CYBA;F2R
17452,GO:1900449,0.20396196100056,0.950763014309131,2,20,regulation of glutamate receptor signaling pathway,BP,EPHB2;NLGN2
6545,GO:0022011,0.204363107814707,0.950605179467595,2,20,myelination in peripheral nervous system,BP,POU3F1;NDRG1
7750,GO:0032292,0.204363107814707,0.950605179467595,2,20,peripheral nervous system axon ensheathment,BP,POU3F1;NDRG1
16185,GO:0090276,0.204400150193998,0.892401157353774,7,117,regulation of peptide hormone secretion,BP,EGFR;NLGN2;SFRP1;GLUL;SREBF1;SLC2A1;GPR68
16196,GO:0090288,0.205156665543217,0.898307756042324,6,96,negative regulation of cellular response to growth factor stimulus,BP,HTRA1;SFRP1;DAB2IP;LTBP1;SPRY2;SMURF1
13840,GO:0060512,0.205432302714646,0.950183451045784,2,20,prostate gland morphogenesis,BP,GLI2;SFRP1
7319,GO:0031349,0.206030897610486,0.864038047291432,15,294,positive regulation of defense response,BP,TNFAIP3;PTPRS;EGFR;CYBA;CTSB;DAB2IP;KLK5;RPS6KA5;DDX60;CTSL;TYRO3;ZP3;TRPV4;ADORA2B;IFI16
13056,GO:0051607,0.206225824666924,0.881324798321661,9,161,defense response to virus,BP,TNFAIP3;IFITM1;MAP3K14;HTRA1;OAS2;DDX60;TRIM22;STAT1;IFI16
10775,GO:0044295,0.206353411338302,0.949818915995331,2,20,axonal growth cone,CC,BOC;EPHA4
4166,GO:0009260,0.206473184483996,0.87725812817578,10,184,ribonucleotide biosynthetic process,BP,APOE;PGM1;DHTKD1;INSR;ATP6V0A2;PTHLH;ADORA2B;NME4;COX5B;TCIRG1
4071,GO:0009142,0.206617246508325,0.890864332678121,7,120,nucleoside triphosphate biosynthetic process,BP,PGM1;DHTKD1;INSR;ATP6V0A2;NME4;COX5B;TCIRG1
18405,GO:1903531,0.206751216565388,0.89723527941718,6,98,negative regulation of secretion by cell,BP,SFRP1;RHBDF1;F2R;VAMP3;SREBF1;ASIC1
3562,GO:0007622,0.206755094813306,0.94949541145878,2,21,rhythmic behavior,BP,NAGLU;PER3
12203,GO:0048512,0.206755094813306,0.94949541145878,2,21,circadian behavior,BP,NAGLU;PER3
8226,GO:0033028,0.2075140866656,0.94919289330741,2,21,myeloid cell apoptotic process,BP,THRA;CTSL
14113,GO:0061035,0.207567392361715,0.929036417128301,3,38,regulation of cartilage development,BP,GLI2;WNT9A;PTHLH
9460,GO:0036126,0.20764580315577,0.928921460325249,3,39,sperm flagellum,CC,GAS8;CABYR;MAFIP
16683,GO:0097729,0.20764580315577,0.928921460325249,3,39,9+2 motile cilium,CC,GAS8;CABYR;MAFIP
15158,GO:0071345,0.207710136544194,0.841392069832232,34,732,cellular response to cytokine stimulus,BP,TNFAIP3;POSTN;IFITM1;IFI6;NDN;MAP3K14;CYBA;OAS2;BCL6;SFRP1;FOXO1;DAB2IP;RPL13A;RPS6KA5;TXNDC17;ACSL1;VAMP3;PIK3R1;TRIM22;CXCR1;HYAL1;RBCK1;SPRY2;TNFRSF19;RTN4RL1;STAT1;ACKR3;IL20RB;MMP1;CCDC3;MT2A;RAB43;MAP3K3;SP100
12624,GO:0050868,0.208026218398468,0.914768625664919,4,58,negative regulation of T cell activation,BP,GPNMB;BCL6;ERBB2;IL20RB
8969,GO:0035115,0.208368319870244,0.948851498063729,2,21,embryonic forelimb morphogenesis,BP,WNT3;WNT9A
14509,GO:0070069,0.208529984289241,0.948499019892955,2,23,cytochrome complex,CC,NDUFA4L2;COX5B
12720,GO:0051029,0.208650610517172,0.980234971904187,1,6,rRNA transport,BP,TST
6050,GO:0019217,0.208861190429657,0.914339132162144,4,57,regulation of fatty acid metabolic process,BP,PDPR;TYSND1;SREBF1;MLYCD
5827,GO:0017137,0.209339006948511,0.87915901931634,9,157,Rab GTPase binding,MF,RIMS3;GAS8;EVI5L;TRAPPC2L;SYTL1;NDRG1;TBC1D17;MICALL1;ALS2CL
6920,GO:0030548,0.20978653845887,0.980008786696456,1,6,acetylcholine receptor regulator activity,MF,LY6E
17039,GO:0099602,0.20978653845887,0.980008786696456,1,6,neurotransmitter receptor regulator activity,MF,LY6E
5580,GO:0016635,0.210606682668119,0.979844601896817,1,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,SDHA
18162,GO:1902991,0.210667496156691,0.947927813291802,2,21,regulation of amyloid precursor protein catabolic process,BP,APOE;EPHA4
10520,GO:0043507,0.210810554343137,0.913275018317338,4,56,positive regulation of JUN kinase activity,BP,DAB2IP;EPHA4;NRK;VANGL2
10485,GO:0043433,0.210839231110167,0.888038369033559,7,119,negative regulation of DNA binding transcription factor activity,BP,TNFAIP3;THRA;PKD2;DAB2IP;RBCK1;MDFI;SP100
2175,GO:0005044,0.211118653405402,0.947745738730445,2,21,scavenger receptor activity,MF,SCART1;ACKR3
15110,GO:0071260,0.2111281676351,0.912999506447797,4,58,cellular response to mechanical stimulus,BP,MAP3K14;EGFR;CYBA;SLC2A1
12308,GO:0048706,0.211173893515605,0.902527900786628,5,77,embryonic skeletal system development,BP,TBX1;WNT9A;HYAL1;TULP3;MDFI
14458,GO:0061951,0.211456661045012,0.92699370128568,3,39,establishment of protein localization to plasma membrane,BP,NSG1;VAMP3;VAMP2
13870,GO:0060562,0.211457502316738,0.86720495219127,12,221,epithelial tube morphogenesis,BP,GLI2;SFRP1;PKD2;ETV5;RASIP1;EPHA4;KIF26B;PLXND1;NFATC4;SPRY2;TULP3;VANGL2
13951,GO:0060706,0.211598445982714,0.947551811248717,2,21,cell differentiation involved in embryonic placenta development,BP,GJB5;MDFI
19824,GO:2000343,0.21162427246147,0.979639865186556,1,6,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN
7161,GO:0031063,0.211847258979154,0.947451123138569,2,21,regulation of histone deacetylation,BP,BCL6;SREBF1
12806,GO:0051156,0.211982614082992,0.947241978432111,2,22,glucose 6-phosphate metabolic process,BP,H6PD;PGLS
19660,GO:2000027,0.212079137583419,0.873182798340253,10,184,regulation of organ morphogenesis,BP,TNFAIP3;PRICKLE2;SFRP1;ETV5;TBX1;ARHGEF19;GPC4;STAT1;SMURF1;VANGL2
59,GO:0000122,0.212180015367446,0.841217607215397,29,603,negative regulation of transcription by RNA polymerase II,BP,PEG3;HES2;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZFPM1;SALL2;WWTR1;FOXO1;DAB2IP;MNT;TCFL5;ZBTB42;SREBF1;NCK2;NFATC4;RTF1;MBD1;TRPV4;IMPACT;STAT1;CRY2;IFI16;PER3;CXXC5;MDFI;SP100
13987,GO:0060753,0.212234510963542,0.979516541349055,1,6,regulation of mast cell chemotaxis,BP,VEGFB
12035,GO:0048020,0.212267424905827,0.979509878101448,1,6,CCR chemokine receptor binding,MF,STAT1
2032,GO:0004791,0.212415494158011,0.979479887563679,1,6,thioredoxin-disulfide reductase activity,MF,TXNRD3
7445,GO:0031623,0.212443322169318,0.912245931763237,4,58,receptor internalization,BP,DNM1;LDLRAP1;CXCR1;ACKR3
3555,GO:0007614,0.212658805808872,0.979430553904641,1,6,short-term memory,BP,MDK
3541,GO:0007597,0.21266777190051,0.979428734704076,1,6,blood coagulation, intrinsic pathway,BP,SERPING1
4408,GO:0010248,0.212889958616283,0.979383625257225,1,6,establishment or maintenance of transmembrane electrochemical gradient,BP,ATP12A
15715,GO:0072348,0.212959222932279,0.947000136320676,2,21,sulfur compound transport,BP,SLC1A4;ABCC1
8689,GO:0034362,0.212985111191385,0.979364290302377,1,6,low-density lipoprotein particle,CC,APOE
10702,GO:0044092,0.213023223382515,0.83625143815291,35,751,negative regulation of molecular function,BP,TNFAIP3;APOE;IFI6;LAMP3;EPHB2;THRA;PINLYP;ANO9;SFRP1;PKD2;ZFPM1;SERPINE2;WWTR1;DAB2IP;COL7A1;WNT9A;SPOCK1;FRY;NFATC4;RBCK1;SPRY2;SCG5;PPP1R35;SERPING1;RTN4RL1;CRY2;FURIN;IFI16;RASA4;CAMK1;ELFN2;PPP1R14A;MDFI;SP100;SORT1
3504,GO:0007492,0.213173336910158,0.911873403088513,4,57,endoderm development,BP,COL6A1;COL7A1;RTF1;ITGB5
18423,GO:1903557,0.213278894717605,0.926065333823295,3,39,positive regulation of tumor necrosis factor superfamily cytokine production,BP,CYBA;PIK3R1;NFATC4
20173,GO:2001138,0.213305506280529,0.979299112931514,1,6,regulation of phospholipid transport,BP,APOE
20174,GO:2001140,0.213305506280529,0.979299112931514,1,6,positive regulation of phospholipid transport,BP,APOE
11247,GO:0045591,0.21334859657123,0.979290338535271,1,6,positive regulation of regulatory T cell differentiation,BP,BCL6
16114,GO:0090175,0.213467596979572,0.89281060415927,6,101,regulation of establishment of planar polarity,BP,PRICKLE2;SFRP1;ARHGEF19;GPC4;SMURF1;VANGL2
11663,GO:0046488,0.213501259081133,0.87616277300856,9,159,phosphatidylinositol metabolic process,BP,EGFR;FGFR4;ERBB3;PIK3R1;IMPA2;ZP3;MBOAT7;ERBB2;PIGZ
1271,GO:0003084,0.213757731893879,0.979206925207036,1,6,positive regulation of systemic arterial blood pressure,BP,CYBA
7048,GO:0030855,0.213890092399125,0.848005251777613,21,427,epithelial cell differentiation,BP,TAGLN;PTPRS;PRR9;SLITRK6;TST;THRA;POU3F1;CTSB;WWTR1;TMEM231;TBX1;KLK5;FAM20C;CTSV;ACTA2;PPL;CTSL;KLK8;LAMB2;STAT1;FURIN
7992,GO:0032647,0.214122021193619,0.946526777493899,2,21,regulation of interferon-alpha production,BP,PTPRS;STAT1
19731,GO:2000179,0.21417460100263,0.946505330607658,2,21,positive regulation of neural precursor cell proliferation,BP,GLI2;GJC2
9560,GO:0036442,0.214253326149464,0.946316432724331,2,22,proton-exporting ATPase activity,MF,ATP6V0A2;TCIRG1
17653,GO:1901575,0.2144698965316,0.822008364197977,72,1630,organic substance catabolic process,BP,TNFAIP3;APOE;MVB12B;LAMP3;CPT2;TST;EGFR;FBXO2;CRAT;THRA;OAS2;H1F0;PGM1;DHTKD1;INSR;GAA;CES2;CTSB;NT5E;SERPINE2;TP53INP2;WWTR1;RHBDF1;TMEM129;FOXO1;DAB2IP;SGSH;TRERF1;TET1;GLUL;EPHA4;RPL13A;RNPEPL1;MAGEF1;TYSND1;CTSV;HEXB;PLCD3;HGSNAT;CUL9;CSPG4;ENDOG;SDC3;CTSL;IMPA2;SNX33;CPT1C;HYAL1;RBCK1;PCBP4;SPATA18;GPC4;ALDH2;FBXW4;NAGLU;AMACR;BTBD2;IAH1;RNF187;HSD11B1;RNF44;PLCD1;FURIN;FBXW5;MLYCD;THNSL2;CTSF;SMURF1;TCIRG1;IDUA;FBXO44;CBR3
3390,GO:0007187,0.214704725996632,0.900311585819461,5,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,VIPR1;PTHLH;UCN2;ADORA2B;MC1R
3124,GO:0006733,0.215106539019287,0.879612066212817,8,142,oxidoreduction coenzyme metabolic process,BP,PGM1;DHTKD1;INSR;NT5E;H6PD;PGLS;NMRK1;NADK
598,GO:0001766,0.215343686586195,0.978881841657377,1,6,membrane raft polarization,BP,MARVELD1
7426,GO:0031580,0.215343686586195,0.978881841657377,1,6,membrane raft distribution,BP,MARVELD1
15541,GO:0072050,0.215564551746526,0.9788363493168,1,6,S-shaped body morphogenesis,BP,PKD2
17664,GO:1901612,0.215604150828621,0.978828187265165,1,6,cardiolipin binding,MF,NME4
9998,GO:0042473,0.215835696994873,0.978780426942815,1,6,outer ear morphogenesis,BP,TBX1
7337,GO:0031399,0.215853526580736,0.824458547015682,57,1255,regulation of protein modification process,BP,TNFAIP3;APOE;GPNMB;MAP3K14;EPHB2;EGFR;FBXO2;FGFR4;BCL6;SFRP1;INSR;PKD2;PPP2R2C;WWTR1;FOXO1;DAB2IP;TBX1;SHC2;CRTAP;TET1;EPHA4;F2R;RPS6KA5;ACSL1;ERBB3;FRY;SREBF1;CSPG4;DMTN;NCK2;ACVR1B;CAMKK1;NAB2;TYRO3;RTF1;SPRY2;TNFRSF19;TRPV4;MTHFR;PPP1R35;ADORA2B;RTN4RL1;IMPACT;IGFBP4;ERBB2;CDK20;HINT2;ACKR3;CRY2;GJC2;NUAK1;CAMK1;ELFN2;MAP3K3;PPP1R14A;NRK;VANGL2
17497,GO:1901033,0.215960889231489,0.978754579249248,1,6,positive regulation of response to reactive oxygen species,BP,ENDOG
8129,GO:0032879,0.216016275211581,0.820042689885396,75,1675,regulation of localization,BP,POSTN;IFITM1;APOE;KCNJ15;GPNMB;EPHB2;EGFR;CYBA;OAS2;NLGN2;BCL6;ANO9;SFRP1;INSR;SV2A;PKD2;RTN2;DNM1;CXCL14;LDLRAP1;RIMS3;SYT8;SERPINE2;TP53INP2;VEGFB;RHBDF1;WNT3;DAB2IP;TMEM231;SCN4B;EVI5L;KCNC4;RAB40B;GLUL;F2R;TUB;HOMER2;ERBB3;VAMP3;PLXND1;SREBF1;DMTN;PIK3R1;TRIM22;ACVR1B;SYTL1;SNX33;RHOD;SLC2A1;HYAL1;ZP3;STOM;VAMP2;SPRY2;SCG5;TP53INP1;TRPV4;ADORA2B;TBC1D17;STON1;GPR68;ERBB2;C2CD4C;ACKR3;CRY2;GJC2;ARPIN;ASIC1;PLXNB1;CAMK1;NISCH;MAP3K3;REEP6;ZSWIM8;SP100
11670,GO:0046498,0.216056630869924,0.978734800356769,1,6,S-adenosylhomocysteine metabolic process,BP,GAMT
4189,GO:0009314,0.216059838781258,0.85235290067826,17,337,response to radiation,BP,EGFR;CYBA;BRSK1;SFRP1;DDB2;PIK3R1;XPC;NFATC4;HYAL1;TP53INP1;MC1R;IMPACT;CRTC1;CRY2;IFI16;PER3;REEP6
5883,GO:0018108,0.216072339578057,0.863694291728479,12,225,peptidyl-tyrosine phosphorylation,BP,EPHB2;EGFR;FGFR4;SFRP1;INSR;EPHA4;ERBB3;CSPG4;DMTN;NCK2;TYRO3;ERBB2
19504,GO:1990459,0.216110572630296,0.978723652276337,1,6,transferrin receptor binding,MF,RGMA
5192,GO:0015809,0.216323563255235,0.978679602328083,1,6,arginine transport,BP,PQLC2
16562,GO:0097435,0.216366903004894,0.843539602828144,23,466,supramolecular fiber organization,BP,APOE;OBSL1;SHROOM2;SFRP1;FHOD3;ESPN;TNXB;OBSCN;WIPF1;EPS8L2;FRY;DMTN;PIK3R1;NCK2;ARHGAP40;RHOD;PLEKHH2;TRPV4;MSRB2;ITGB5;CCDC88B;ARPIN;VPS33B
875,GO:0002246,0.216491799387994,0.978644772883532,1,6,wound healing involved in inflammatory response,BP,F2R
252,GO:0000717,0.216494510856326,0.945396205364447,2,22,nucleotide-excision repair, DNA duplex unwinding,BP,DDB2;XPC
8709,GO:0034384,0.216522149329374,0.978638486289342,1,6,high-density lipoprotein particle clearance,BP,APOE
16857,GO:0098845,0.216549527895141,0.978632814302746,1,6,postsynaptic endosome,CC,NSG1
11397,GO:0045859,0.216590633807513,0.838344761310355,28,585,regulation of protein kinase activity,BP,TNFAIP3;APOE;MAP3K14;EPHB2;EGFR;SFRP1;INSR;PKD2;WWTR1;DAB2IP;SHC2;EPHA4;F2R;ACSL1;ERBB3;CSPG4;NCK2;CAMKK1;NAB2;SPRY2;ADORA2B;RTN4RL1;ERBB2;CDK20;CAMK1;MAP3K3;NRK;VANGL2
12484,GO:0050664,0.216646815257272,0.978612652681737,1,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,CYBA
9754,GO:0039706,0.216659227129182,0.978610079719338,1,6,co-receptor binding,MF,NEO1
10124,GO:0042734,0.216963004831427,0.924255317996581,3,38,presynaptic membrane,CC,ADGRL1;NLGN2;RIMS3
11073,GO:0045124,0.217027043286526,0.94533634819659,2,21,regulation of bone resorption,BP,TNFAIP3;EGFR
10458,GO:0043392,0.217057268273085,0.924051093697629,3,40,negative regulation of DNA binding,BP,IFI16;MDFI;SP100
16135,GO:0090197,0.217093408545693,0.978519967285429,1,6,positive regulation of chemokine secretion,BP,POSTN
15262,GO:0071493,0.217100353144283,0.978518524269423,1,6,cellular response to UV-B,BP,HYAL1
11448,GO:0045944,0.217125844138365,0.831560880282137,37,787,positive regulation of transcription by RNA polymerase II,BP,PEG3;NDN;ASH2L;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;POU3F1;PKD2;ZFPM1;RGMA;ETV5;SALL2;WWTR1;FOXO1;SOX12;DAB2IP;TBX1;YEATS4;TET1;RPS6KA5;HEXB;PLXND1;SREBF1;PIK3R1;NCK2;ACVR1B;NFATC4;RTF1;MC1R;CRTC1;STAT1;IFI16;DBP;CAMK1
11757,GO:0046660,0.21725570700231,0.898724017112609,5,78,female sex differentiation,BP,SFRP1;INSR;ACVR1B;TYRO3;ZP3
3512,GO:0007507,0.217272437166478,0.849696957630325,18,353,heart development,BP,OBSL1;EGFR;ADAM19;GLI2;FHOD3;INSR;GAA;PKD2;ZFPM1;VEGFB;TBX1;TENM4;LTBP1;ERBB3;PLXND1;NFATC4;ERBB2;VANGL2
13631,GO:0060198,0.217336826261967,0.978469355728398,1,6,clathrin-sculpted vesicle,CC,VAMP2
10103,GO:0042693,0.217362723278806,0.978463967343817,1,6,muscle cell fate commitment,BP,TBX1
12588,GO:0050815,0.217612401366577,0.978411978795075,1,6,phosphoserine residue binding,MF,RTF1
3102,GO:0006695,0.217646277647674,0.909198142059821,4,59,cholesterol biosynthetic process,BP,APOE;SEC14L2;SREBF1;MVD
13497,GO:0055123,0.217786599808797,0.898424884594913,5,77,digestive system development,BP,EGFR;GLI2;SFRP1;INSR;VANGL2
9013,GO:0035256,0.217838350974831,0.978364871515971,1,6,G-protein coupled glutamate receptor binding,MF,HOMER2
131,GO:0000272,0.217897583868847,0.944977436897682,2,21,polysaccharide catabolic process,BP,PGM1;GAA
10751,GO:0044247,0.217897583868847,0.944977436897682,2,21,cellular polysaccharide catabolic process,BP,PGM1;GAA
16855,GO:0098843,0.217903583121037,0.97835126101711,1,6,postsynaptic endocytic zone,CC,DNM1
15941,GO:0080154,0.218066268578517,0.978317296617253,1,6,regulation of fertilization,BP,ZP3
1483,GO:0003836,0.218272847339662,0.978274126177386,1,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,ST3GAL5
3741,GO:0008299,0.218274296715031,0.944660676826582,2,22,isoprenoid biosynthetic process,BP,ALDH1A3;MVD
12781,GO:0051126,0.218307639367747,0.978266850748984,1,6,negative regulation of actin nucleation,BP,ARPIN
4258,GO:0009636,0.218507117771895,0.852250775512452,16,321,response to toxic substance,BP,TNFAIP3;APOE;TXNRD3;GPX7;GPX3;SNN;FOXO1;BPHL;FAM213A;TXNDC17;ENDOG;TP53INP1;IMPACT;STAT1;GJC2;MT2A
18140,GO:1902950,0.2186592943005,0.978193240137318,1,6,regulation of dendritic spine maintenance,BP,APOE
14916,GO:0070849,0.218665734219005,0.923296133465888,3,39,response to epidermal growth factor,BP,EGFR;DAB2IP;ERBB2
9665,GO:0038092,0.218667865152412,0.978191444320329,1,6,nodal signaling pathway,BP,ACVR1B
15242,GO:0071466,0.218778387298693,0.889306743465739,6,102,cellular response to xenobiotic stimulus,BP,EGFR;CES2;FOXO1;BPHL;ACSL1;CBR3
8491,GO:0033700,0.218824170197611,0.978158680038199,1,6,phospholipid efflux,BP,APOE
1438,GO:0003680,0.219027136133882,0.978116094347157,1,6,AT DNA binding,MF,H1F0
10105,GO:0042698,0.219036612648787,0.923104116960533,3,39,ovulation cycle,BP,EGFR;TYRO3;ZP3
1040,GO:0002573,0.219044535484284,0.88246101637688,7,119,myeloid leukocyte differentiation,BP,SFRP1;ZFPM1;FAM20C;FAM213A;PIK3R1;GPR68;IFI16
18723,GO:1904251,0.219313391474075,0.978055955387082,1,6,regulation of bile acid metabolic process,BP,FGFR4
12201,GO:0048505,0.219516756472602,0.978013175441841,1,6,regulation of timing of cell differentiation,BP,SERPINE2
266,GO:0000737,0.219602172920956,0.944109169915468,2,22,DNA catabolic process, endonucleolytic,BP,H1F0;ENDOG
12606,GO:0050850,0.219650481312492,0.944089061886784,2,22,positive regulation of calcium-mediated signaling,BP,PKD2;ERBB3
3274,GO:0006979,0.219764526595478,0.851256023770411,16,321,response to oxidative stress,BP,TNFAIP3;APOE;TXNRD3;GPX7;GPX3;EGFR;CYBA;PKD2;ETV5;FOXO1;ENDOG;HYAL1;TP53INP1;MSRB2;IMPACT;STAT1
7855,GO:0032438,0.219821918307121,0.944017677454503,2,22,melanosome organization,BP,SHROOM2;BLOC1S4
2476,GO:0005737,0.219840745287215,0.808901373809431,346,8347,cytoplasm,CC,TNFAIP3;POSTN;PEG3;TGFBI;TAGLN;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;LGALS7B;PTPRS;NOL4L;PHF7;FBXO41;OBSL1;LMF1;CPT2;GPNMB;NDN;S100A4;MAP3K14;EPHB2;KDSR;TNS1;HTRA1;PRICKLE2;PRR9;GAMT;GPRC5C;TXNRD3;GPX7;SRSF5;ST3GAL5;TST;FLNC;RALGDS;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;SNN;OAS2;H1F0;GLI2;HEBP1;FGFR4;EPB41L3;CDK18;BCL6;PGM1;TENM2;XYLT1;CYP4F22;ZNF318;CERS4;BRSK1;SFRP1;ARHGEF4;FHOD3;UNK;DHTKD1;INSR;VAV3;FAM185A;NPEPL1;CYBRD1;GAA;DHX32;CES2;SV2A;PKD2;ESPN;ZFPM1;RGMA;RTN2;NAT6;ARSI;DNM1;TMEM134;PPP2R2C;CXCL14;LDLRAP1;RIMS3;CTSB;NT5E;SYT8;SERPINE2;PDPR;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;NSG1;PARVB;RASIP1;BPHL;UROS;DAB2IP;COL7A1;OBSCN;PRSS3;H6PD;CLIP2;TSC22D1;SGSH;KLK5;TRERF1;SHC2;CRTAP;GAS8;WIPF1;FKBP9;SDR9C7;RAB40B;MARVELD1;NRSN2;FAM20C;GLUL;FAM213A;ANO8;EPHA4;MZT2A;TRAPPC2L;RPL13A;B3GNT9;RNPEPL1;DIXDC1;TENM4;ZNF687;OLFM2;F2R;KIF26B;HERC3;MPLKIP;TYSND1;CTSV;LRIG3;RPS6KA5;TUB;HOMER2;KLHDC8B;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;SCART1;PGLS;ACSL1;EPS8L2;ZBTB42;DDX60;ACTA2;ERBB3;HGSNAT;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;VAMP3;PPL;CUL9;FRY;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;SYTL1;IMPA2;UNC119B;XPC;ARHGAP40;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;CPT1C;METTL7A;HYAL1;STOM;CKMT1A;VAMP2;PLEKHH2;RBCK1;MBOAT7;AVL9;PCBP4;SPRY2;SCG5;LRRC8E;TP53INP1;CABYR;TMX4;MDK;TRPV4;ZDHHC1;MTHFR;PQLC2;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;RETSAT;NDUFA4L2;SDHA;KLK8;ALDH2;FBXW4;SERPING1;NAGLU;NMRK1;MAFIP;MYL9;RTN4RL1;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;IMPACT;LGALS9B;TBC1D17;MVD;GOLGA7B;MZT2B;NEO1;CRTC1;IGFBP4;STON1;ANKRD13D;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;RNF135;LAMB2;STAT1;FBXL8;TULP3;NME4;CDK20;HINT2;WIPI2;ACKR3;PLCD1;CRY2;MARCH9;COX5B;SLC39A6;BLOC1S4;MARCKSL1;ZMYM3;FURIN;FBXW5;CLCN7;RHPN1;IFI16;CCDC88B;PCSK1;MLYCD;SUN1;OXLD1;NINL;PEX11B;FRAT1;CTSF;ANGEL1;SLC1A4;BEX2;ASIC1;ALS2CL;PER3;XYLT2;NUAK1;ALOXE3;RASA4;SMURF1;CAPNS2;MEX3A;CCDC3;DOK4;CXXC5;CAMK1;TCIRG1;NISCH;RNF208;AIF1L;MT2A;NADK;RAB43;FAM117A;VPS33B;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;REEP6;DTNB;SP100;DIRC2;MPG;ABCC1;DDX59;MTMR11;IDUA;NRK;ISYNA1;PIGZ;FBXO44;SORT1;CBR3;VANGL2;APBA1
9803,GO:0042059,0.219851008677855,0.922604847851611,3,40,negative regulation of epidermal growth factor receptor signaling pathway,BP,EGFR;DAB2IP;SPRY2
11515,GO:0046085,0.219908191591535,0.977930703638518,1,6,adenosine metabolic process,BP,NT5E
5832,GO:0017147,0.219940264982067,0.944131327011383,2,21,Wnt-protein binding,MF,APCDD1;SFRP1
11419,GO:0045910,0.219964263970245,0.944121353414457,2,21,negative regulation of DNA recombination,BP,BCL6;MAGEF1
14619,GO:0070257,0.220185174400445,0.97787224298905,1,6,positive regulation of mucus secretion,BP,CYBA
11617,GO:0046390,0.22022202972783,0.867183290504637,10,187,ribose phosphate biosynthetic process,BP,APOE;PGM1;DHTKD1;INSR;ATP6V0A2;PTHLH;ADORA2B;NME4;COX5B;TCIRG1
7075,GO:0030890,0.220295477991391,0.943820289956035,2,22,positive regulation of B cell proliferation,BP,BCL6;VAV3
6601,GO:0022843,0.220464810966973,0.922363056651841,3,39,voltage-gated cation channel activity,MF,KCNJ15;PKD2;KCNC4
18214,GO:1903078,0.220500613483861,0.922344446228075,3,39,positive regulation of protein localization to plasma membrane,BP,EPHB2;EGFR;PIK3R1
17673,GO:1901626,0.220524813309745,0.977800441533698,1,6,regulation of postsynaptic membrane organization,BP,APOE
2626,GO:0005976,0.220567332470906,0.896652114196647,5,78,polysaccharide metabolic process,BP,PGM1;INSR;GAA;PPP1R3E;B3GNT9
14134,GO:0061072,0.220703486716636,0.977762617514963,1,6,iris morphogenesis,BP,WNT9A
5822,GO:0017128,0.220761537037509,0.977750320985983,1,6,phospholipid scramblase activity,MF,ANO9
20153,GO:2001040,0.220947071557545,0.977710994919125,1,6,positive regulation of cellular response to drug,BP,ENDOG
13827,GO:0060485,0.221210645855057,0.870589922455118,9,161,mesenchyme development,BP,S100A4;SFRP1;PKD2;WWTR1;DAB2IP;TBX1;ACTA2;ERBB3;STAT1
19370,GO:1905941,0.221267388567663,0.977643010021595,1,6,positive regulation of gonad development,BP,ZP3
13807,GO:0060449,0.221324570733459,0.977630861511828,1,6,bud elongation involved in lung branching,BP,SPRY2
11360,GO:0045779,0.221397716976261,0.977615316079472,1,6,negative regulation of bone resorption,BP,TNFAIP3
5683,GO:0016830,0.221422957629271,0.921712939220728,3,41,carbon-carbon lyase activity,MF,GLUL;MVD;MLYCD
602,GO:0001771,0.221446157349024,0.977605017990298,1,6,immunological synapse formation,BP,NCK2
2688,GO:0006069,0.221452748999601,0.977603616448752,1,6,ethanol oxidation,BP,ALDH2
10819,GO:0044351,0.221554090078728,0.977582062833071,1,6,macropinocytosis,BP,SNX33
20244,GO:2001257,0.221590331652752,0.896009584541647,5,78,regulation of cation channel activity,BP,EPHB2;NLGN2;PKD2;STOM;VAMP2
16035,GO:0090037,0.2216228827439,0.97756742521944,1,6,positive regulation of protein kinase C signaling,BP,MC1R
14119,GO:0061042,0.221663079656992,0.977558869731276,1,6,vascular wound healing,BP,TNFAIP3
2592,GO:0005905,0.221725171668896,0.906868405267659,4,58,clathrin-coated pit,CC,EGFR;LDLRAP1;ACKR3;SORT1
16675,GO:0097709,0.22194618291662,0.977498563179475,1,6,connective tissue replacement,BP,F2R
18151,GO:1902961,0.221949522254234,0.97749785130178,1,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,EPHA4
19140,GO:1905247,0.221949522254234,0.97749785130178,1,6,positive regulation of aspartic-type peptidase activity,BP,EPHA4
8165,GO:0032927,0.22202379685458,0.977482014279391,1,6,positive regulation of activin receptor signaling pathway,BP,ACVR1B
14275,GO:0061469,0.222076643821144,0.977470742366547,1,6,regulation of type B pancreatic cell proliferation,BP,SFRP1
10784,GO:0044306,0.22227787321413,0.895545044731608,5,79,neuron projection terminus,CC,SV2A;KCNC4;GLUL;EPHA4;VAMP2
8145,GO:0032905,0.222464396224828,0.977387942024253,1,6,transforming growth factor beta1 production,BP,FURIN
8148,GO:0032908,0.222464396224828,0.977387942024253,1,6,regulation of transforming growth factor beta1 production,BP,FURIN
710,GO:0001939,0.222715138600738,0.977334309370758,1,6,female pronucleus,CC,SLC2A1
10689,GO:0044057,0.222883065380491,0.855702251726166,13,248,regulation of system process,BP,EGFR;THRA;CYBA;NLGN2;GAA;FOXO1;SCN4B;TENM4;F2R;SREBF1;KLK8;ADORA2B;MYL9
15308,GO:0071578,0.22288703721663,0.977297500487471,1,6,zinc ion import across plasma membrane,BP,SLC39A6
14164,GO:0061135,0.222899658722527,0.895061800983407,5,82,endopeptidase regulator activity,MF,SERPINE2;COL7A1;SPOCK1;SERPING1;FURIN
6326,GO:0021520,0.222902507928964,0.977294186104576,1,6,spinal cord motor neuron cell fate specification,BP,GLI2
3310,GO:0007033,0.222952051087466,0.874084764216059,8,142,vacuole organization,BP,ULK2;GAA;TP53INP2;HEXB;TP53INP1;NAGLU;WIPI2;SMURF1
18756,GO:1904338,0.222996407326451,0.977274063742801,1,6,regulation of dopaminergic neuron differentiation,BP,SFRP1
15156,GO:0071340,0.223102802249481,0.977251251726835,1,6,skeletal muscle acetylcholine-gated channel clustering,BP,ETV5
10166,GO:0042802,0.223117555753899,0.819631944273572,52,1157,identical protein binding,MF,TNFAIP3;APOE;ALDH1A3;S100A4;EPHB2;HTRA1;CADM4;EGFR;APCDD1;NLGN2;BCL6;TENM2;ZNF318;SFRP1;TNFSF10;PKD2;DNM1;VEGFB;WWTR1;DAB2IP;COL7A1;TBX1;GLUL;EPHA4;TENM4;HOMER2;HEXB;ERBB3;S100A6;SDC3;KCTD11;IMPA2;NAB2;SNX33;SLC2A1;ZP3;STOM;PLEKHH2;TRPV4;PDLIM4;MVD;MICALL1;ERBB2;RNF135;STAT1;PCSK1;MLYCD;PEX11B;ALS2CL;NISCH;MDFI;SP100
4093,GO:0009165,0.223120456972446,0.858291606379382,12,232,nucleotide biosynthetic process,BP,APOE;PGM1;DHTKD1;INSR;ATP6V0A2;PTHLH;ADORA2B;NMRK1;NME4;COX5B;TCIRG1;NADK
11730,GO:0046624,0.223143651206492,0.977242489988636,1,6,sphingolipid transporter activity,MF,ABCC1
6625,GO:0023035,0.223186190795814,0.977233363643494,1,6,CD40 signaling pathway,BP,TNFAIP3
13558,GO:0060068,0.22324036739307,0.977221737794728,1,6,vagina development,BP,TYRO3
2978,GO:0006538,0.223272863329812,0.977214762862665,1,6,glutamate catabolic process,BP,GLUL
9738,GO:0039533,0.223381534023552,0.977191429200455,1,6,regulation of MDA-5 signaling pathway,BP,DDX60
20157,GO:2001053,0.223529041954926,0.977159735331088,1,6,regulation of mesenchymal cell apoptotic process,BP,TBX1
632,GO:0001825,0.223539240105848,0.942460241311469,2,22,blastocyst formation,BP,TET1;ZP3
12952,GO:0051403,0.223572308814967,0.861152743227034,11,205,stress-activated MAPK cascade,BP,EGFR;SFRP1;FOXO1;DAB2IP;EPHA4;TNFRSF19;TRPV4;ADORA2B;MAP3K3;NRK;VANGL2
3235,GO:0006910,0.223752837999879,0.977111603592794,1,6,phagocytosis, recognition,BP,TUB
15345,GO:0071635,0.223876269878587,0.977085033181705,1,6,negative regulation of transforming growth factor beta production,BP,FURIN
12982,GO:0051457,0.223945126031223,0.942289079064302,2,22,maintenance of protein location in nucleus,BP,SUN1;SP100
11968,GO:0047484,0.224037816261239,0.9770502323562,1,6,regulation of response to osmotic stress,BP,TRPV4
9170,GO:0035581,0.224059153292961,0.977045633683958,1,6,sequestering of extracellular ligand from receptor,BP,LTBP1
1381,GO:0003306,0.224062218281469,0.97704497305926,1,6,Wnt signaling pathway involved in heart development,BP,VANGL2
7664,GO:0032135,0.224093414449377,0.97703824846918,1,6,DNA insertion or deletion binding,MF,XPC
19605,GO:1990845,0.224109110656611,0.977034864611168,1,6,adaptive thermogenesis,BP,TRPV4
10208,GO:0042953,0.224139554718889,0.977028300559385,1,6,lipoprotein transport,BP,UNC119B
10993,GO:0044872,0.224139554718889,0.977028300559385,1,6,lipoprotein localization,BP,UNC119B
19773,GO:2000270,0.22418816549287,0.977017817428722,1,6,negative regulation of fibroblast apoptotic process,BP,SFRP1
9039,GO:0035304,0.224271185277116,0.885718722582324,6,100,regulation of protein dephosphorylation,BP,PPP2R2C;PPP1R35;CRY2;NUAK1;ELFN2;PPP1R14A
6692,GO:0030121,0.224378992613221,0.976976639144725,1,6,AP-1 adaptor complex,CC,LDLRAP1
574,GO:0001726,0.224436381768831,0.873076546460363,8,139,ruffle,CC,PSD4;ARHGEF4;WIPF1;EPS8L2;S100A6;SPRY2;TRPV4;AIF1L
15818,GO:0072578,0.224464969763872,0.9769580729539,1,6,neurotransmitter-gated ion channel clustering,BP,APOE
15234,GO:0071455,0.224519222081505,0.976946353270962,1,6,cellular response to hyperoxia,BP,FOXO1
8279,GO:0033137,0.224604747279033,0.942010450815552,2,22,negative regulation of peptidyl-serine phosphorylation,BP,DMTN;NCK2
9235,GO:0035672,0.224650829076745,0.976917909600755,1,6,oligopeptide transmembrane transport,BP,ABCC1
5460,GO:0016413,0.224662484750564,0.976915389573918,1,6,O-acetyltransferase activity,MF,CRAT
15118,GO:0071276,0.224878103152765,0.941741573460249,2,23,cellular response to cadmium ion,BP,EGFR;MT2A
17037,GO:0099590,0.224896731579282,0.97686471174902,1,6,neurotransmitter receptor internalization,BP,DNM1
17057,GO:0099638,0.225045359061707,0.976832525262945,1,6,endosome to plasma membrane protein transport,BP,NSG1
17058,GO:0099639,0.225045359061707,0.976832525262945,1,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,NSG1
7458,GO:0031642,0.225135057994474,0.976813088257684,1,6,negative regulation of myelination,BP,KLK8
19093,GO:1905097,0.225399910280599,0.976755644380294,1,6,regulation of guanyl-nucleotide exchange factor activity,BP,EPHA4
19173,GO:1905330,0.225431899530523,0.872296775882125,8,144,regulation of morphogenesis of an epithelium,BP,PRICKLE2;SFRP1;ETV5;ARHGEF19;GPC4;STAT1;SMURF1;VANGL2
629,GO:0001822,0.225444173276126,0.86337317310568,10,182,kidney development,BP,GLI2;SFRP1;PKD2;WWTR1;EPHA4;KIF26B;ACTA2;LAMB2;STAT1;VANGL2
7784,GO:0032355,0.225599149823409,0.89338520116621,5,81,response to estradiol,BP,POSTN;EGFR;SFRP1;ENDOG;FAM210B
11038,GO:0045072,0.225731275378154,0.97668366379396,1,6,regulation of interferon-gamma biosynthetic process,BP,ZFPM1
2019,GO:0004771,0.225804333507399,0.976667777219915,1,6,sterol esterase activity,MF,CES2
251,GO:0000715,0.225921897380712,0.94129806491836,2,23,nucleotide-excision repair, DNA damage recognition,BP,DDB2;XPC
18032,GO:1902653,0.225932539122962,0.904302254887924,4,60,secondary alcohol biosynthetic process,BP,APOE;SEC14L2;SREBF1;MVD
11320,GO:0045714,0.225987729312004,0.97662787121487,1,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,FURIN
6351,GO:0021554,0.226038511366209,0.976616814624851,1,6,optic nerve development,BP,EPHB2
15244,GO:0071468,0.226080941497447,0.976607574249618,1,6,cellular response to acidic pH,BP,IMPACT
19812,GO:2000323,0.226084804197334,0.976606732935867,1,6,negative regulation of glucocorticoid receptor signaling pathway,BP,CRY2
8900,GO:0034773,0.226093320060062,0.976604878082768,1,6,histone H4-K20 trimethylation,BP,KMT5C
4428,GO:0010359,0.226179025509814,0.97658620591685,1,6,regulation of anion channel activity,BP,ANO9
3732,GO:0008286,0.226255212956459,0.884398847811803,6,100,insulin receptor signaling pathway,BP,INSR;FOXO1;ATP6V0A2;SREBF1;PIK3R1;TCIRG1
14554,GO:0070142,0.226291788397244,0.976561626340973,1,6,synaptic vesicle budding,BP,DNM1
9595,GO:0036492,0.226475844903655,0.976521475823956,1,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,NCK2
5520,GO:0016528,0.226483171386426,0.919131864824109,3,40,sarcoplasm,CC,FLNC;RTN2;SPOCK1
3254,GO:0006941,0.226554830239093,0.892842087336328,5,79,striated muscle contraction,BP,OBSL1;GAA;VEGFB;SCN4B;SYNM
6768,GO:0030224,0.226626660389584,0.941152789771722,2,22,monocyte differentiation,BP,GPR68;IFI16
18227,GO:1903131,0.226626660389584,0.941152789771722,2,22,mononuclear cell differentiation,BP,GPR68;IFI16
15638,GO:0072203,0.227031855577732,0.976399955320046,1,6,cell proliferation involved in metanephros development,BP,STAT1
17965,GO:1902474,0.227157152637572,0.976372522711789,1,6,positive regulation of protein localization to synapse,BP,NLGN2
6777,GO:0030238,0.227295720856899,0.976342163962004,1,6,male sex determination,BP,INSR
14709,GO:0070424,0.227411617163893,0.976316755799414,1,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,TNFAIP3
15762,GO:0072497,0.227418301436341,0.976315289933371,1,6,mesenchymal stem cell differentiation,BP,WNT3
10742,GO:0044224,0.227545969054711,0.976287282684373,1,6,juxtaparanode region of axon,CC,EPB41L3
10374,GO:0043243,0.227699681805598,0.940695432788904,2,22,positive regulation of protein complex disassembly,BP,INSR;TRPV4
7967,GO:0032607,0.227723785966639,0.940685141290808,2,22,interferon-alpha production,BP,PTPRS;STAT1
8630,GO:0034205,0.227734244717643,0.940680675589408,2,22,amyloid-beta formation,BP,APOE;EPHA4
5559,GO:0016595,0.227885076381585,0.976212801566512,1,6,glutamate binding,MF,GLUL
4852,GO:0014731,0.227965872179435,0.976195036593395,1,6,spectrin-associated cytoskeleton,CC,DMTN
389,GO:0001042,0.228037867299513,0.976179200480013,1,6,RNA polymerase I core binding,MF,ERBB2
11834,GO:0046875,0.228056101737751,0.940543177519076,2,22,ephrin receptor binding,MF,EPHA4;EFNB3
7766,GO:0032328,0.228202677505084,0.976142926712795,1,6,alanine transport,BP,SLC1A4
4111,GO:0009187,0.228211457795171,0.903000740523996,4,59,cyclic nucleotide metabolic process,BP,APOE;PKD2;PTHLH;ADORA2B
12480,GO:0050660,0.228224335257834,0.902946056777777,4,60,flavin adenine dinucleotide binding,MF,TXNRD3;MTHFR;SDHA;CRY2
2212,GO:0005126,0.22850890701268,0.875852617767262,7,124,cytokine receptor binding,MF,CKLF;TNFSF10;CXCL14;VEGFB;DAB2IP;PIK3R1;STAT1
13457,GO:0055062,0.228675347486333,0.976038725184023,1,6,phosphate ion homeostasis,BP,FGFR4
15767,GO:0072505,0.228675347486333,0.976038725184023,1,6,divalent inorganic anion homeostasis,BP,FGFR4
15768,GO:0072506,0.228675347486333,0.976038725184023,1,6,trivalent inorganic anion homeostasis,BP,FGFR4
5915,GO:0018212,0.228696604609638,0.854057770779134,12,228,peptidyl-tyrosine modification,BP,EPHB2;EGFR;FGFR4;SFRP1;INSR;EPHA4;ERBB3;CSPG4;DMTN;NCK2;TYRO3;ERBB2
13936,GO:0060687,0.228751531902547,0.976021906552446,1,6,regulation of branching involved in prostate gland morphogenesis,BP,SFRP1
2717,GO:0006112,0.228900755107861,0.90259179768388,4,59,energy reserve metabolic process,BP,PGM1;INSR;GAA;PPP1R3E
12535,GO:0050729,0.22890537463476,0.902496235899212,4,61,positive regulation of inflammatory response,BP,EGFR;ZP3;TRPV4;ADORA2B
9092,GO:0035418,0.229147171322,0.940076049325453,2,22,protein localization to synapse,BP,NLGN2;NSG1
15995,GO:0086067,0.229413388685298,0.975875518421427,1,6,AV node cell to bundle of His cell communication,BP,SCN4B
19022,GO:1904929,0.22942708866593,0.975872483070805,1,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,GPC4
6272,GO:0019900,0.229483256780756,0.827472620514698,28,585,kinase binding,MF,TNFAIP3;EPHB2;SRSF5;EGFR;FGFR4;BRSK1;INSR;SV2A;DNM1;DAB2IP;SHC2;EPHA4;ACTA2;ERBB3;SREBF1;CSPG4;PIK3R1;TRIM22;TYRO3;RHOD;SLC2A1;SPRY2;TRPV4;TOM1L2;ERBB2;FBXW5;PER3;SP100
15654,GO:0072224,0.229493543401519,0.975857756438837,1,6,metanephric glomerulus development,BP,LAMB2
6801,GO:0030279,0.229603847544523,0.917478439701938,3,40,negative regulation of ossification,BP,SFRP1;SMURF1;KREMEN1
5203,GO:0015824,0.230179028634333,0.975705559437568,1,6,proline transport,BP,SLC1A4
13644,GO:0060219,0.230209808770562,0.975698712939974,1,6,camera-type eye photoreceptor cell differentiation,BP,SDK2
16019,GO:0089717,0.230295275118416,0.975679696851615,1,6,spanning component of membrane,CC,NLGN2
2954,GO:0006508,0.230642023268578,0.81163392024692,56,1253,proteolysis,BP,TNFAIP3;APOE;IFI6;MVB12B;LAMP3;HTRA1;ADAM19;FBXO2;FGFR4;TENM2;SFRP1;TNFSF10;NPEPL1;CTSB;SERPINE2;TP53INP2;WWTR1;RHBDF1;TMEM129;DDB2;DAB2IP;COL7A1;PRSS3;KLK5;EPHA4;WNT9A;RNPEPL1;MAGEF1;TENM4;F2R;TYSND1;CTSV;SPOCK1;CUL9;CTSL;SNX33;ADAMTS15;RBCK1;SCG5;KLK8;LTBP4;FBXW4;SERPING1;BTBD2;RNF187;RNF135;RNF44;FURIN;FBXW5;IFI16;PCSK1;CTSF;MMP1;SMURF1;CAPNS2;FBXO44
1094,GO:0002690,0.230664078533836,0.916762300620152,3,42,positive regulation of leukocyte chemotaxis,BP,CXCL14;VEGFB;TRPV4
11209,GO:0045429,0.230777049615348,0.939375300828726,2,22,positive regulation of nitric oxide biosynthetic process,BP,INSR;PKD2
18786,GO:1904407,0.230777049615348,0.939375300828726,2,22,positive regulation of nitric oxide metabolic process,BP,INSR;PKD2
1958,GO:0004683,0.230874497344121,0.939333292817841,2,22,calmodulin-dependent protein kinase activity,MF,CAMKK1;CAMK1
14521,GO:0070087,0.23104451266154,0.975512639798654,1,6,chromo shadow domain binding,MF,SP100
8078,GO:0032787,0.231062257255149,0.835333603170034,20,413,monocarboxylic acid metabolic process,BP,ALDH1A3;CPT2;CRAT;FGFR4;PGM1;DHTKD1;INSR;CES2;PDPR;CYP27C1;TYSND1;ACSL1;SREBF1;CSPG4;CPT1C;AMACR;MLYCD;THNSL2;ALOXE3;IDUA
7187,GO:0031098,0.231104940052394,0.852208654006294,12,228,stress-activated protein kinase signaling cascade,BP,MAP3K14;EGFR;SFRP1;FOXO1;DAB2IP;EPHA4;TNFRSF19;TRPV4;ADORA2B;MAP3K3;NRK;VANGL2
17044,GO:0099612,0.231118515310309,0.975496105046747,1,6,protein localization to axon,BP,EPB41L3
15336,GO:0071621,0.231228553161961,0.916460688393866,3,42,granulocyte chemotaxis,BP,CKLF;VAV3;TRPV4
8926,GO:0035014,0.231384059244664,0.975436722368053,1,6,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R1
6708,GO:0030139,0.231456104162032,0.855162878100988,11,209,endocytic vesicle,CC,APOE;EGFR;CYBA;LDLRAP1;WNT3;DAB2IP;ATP6V0A2;VAMP3;ITGB5;TCIRG1;RAB43
6643,GO:0030016,0.231482850429283,0.873820541280265,7,122,myofibril,CC,OBSL1;FLNC;FHOD3;PARVB;OBSCN;SLC2A1;SYNM
4521,GO:0010612,0.231605743145926,0.975387086873801,1,6,regulation of cardiac muscle adaptation,BP,FOXO1
18274,GO:1903242,0.231605743145926,0.975387086873801,1,6,regulation of cardiac muscle hypertrophy in response to stress,BP,FOXO1
7186,GO:0031095,0.231723662762735,0.975360661767759,1,6,platelet dense tubular network membrane,CC,DMTN
13132,GO:0051770,0.231828624254765,0.975337127265512,1,6,positive regulation of nitric-oxide synthase biosynthetic process,BP,STAT1
15531,GO:0072033,0.231991763983315,0.975300523265284,1,6,renal vesicle formation,BP,KIF26B
12780,GO:0051125,0.232040048677598,0.938829869760342,2,22,regulation of actin nucleation,BP,WIPF1;ARPIN
19146,GO:1905269,0.232167997777397,0.889230992811167,5,80,positive regulation of chromatin organization,BP,BCL6;TET1;RPS6KA5;SREBF1;RTF1
2241,GO:0005168,0.232178431949026,0.975258603221595,1,6,neurotrophin TRKA receptor binding,MF,PIK3R1
6266,GO:0019888,0.232365703665897,0.900433180084496,4,61,protein phosphatase regulator activity,MF,PPP2R2C;PPP1R35;ELFN2;PPP1R14A
11839,GO:0046883,0.232380602985414,0.867349063134118,8,143,regulation of hormone secretion,BP,EGFR;NLGN2;SFRP1;GLUL;SREBF1;SLC2A1;SCG5;GPR68
798,GO:0002072,0.23251283618928,0.975183407354669,1,6,optic cup morphogenesis involved in camera-type eye development,BP,ALDH1A3
3430,GO:0007256,0.232792582340077,0.975120404858703,1,6,activation of JNKK activity,BP,NRK
7236,GO:0031223,0.232813962814818,0.975115586047357,1,6,auditory behavior,BP,SLITRK6
11316,GO:0045685,0.233097651886929,0.915533990308859,3,41,regulation of glial cell differentiation,BP,SERPINE2;EPHA4;TENM4
1268,GO:0003073,0.233621009382126,0.915252969274023,3,41,regulation of systemic arterial blood pressure,BP,POSTN;CYBA;F2R
2082,GO:0004859,0.233731891241715,0.974245016662752,1,7,phospholipase inhibitor activity,MF,PINLYP
13569,GO:0060080,0.234052500601571,0.974835554780347,1,6,inhibitory postsynaptic potential,BP,NLGN2
16427,GO:0097151,0.234052500601571,0.974835554780347,1,6,positive regulation of inhibitory postsynaptic potential,BP,NLGN2
16844,GO:0098828,0.234052500601571,0.974835554780347,1,6,modulation of inhibitory postsynaptic potential,BP,NLGN2
19762,GO:2000249,0.234129379539197,0.937760355995395,2,23,regulation of actin cytoskeleton reorganization,BP,CTSV;RHOD
11338,GO:0045740,0.234182150486312,0.91495127710913,3,41,positive regulation of DNA replication,BP,EGFR;GLI2;INSR
474,GO:0001518,0.234313476065442,0.974776326563947,1,6,voltage-gated sodium channel complex,CC,SCN4B
16598,GO:0097501,0.234361463123921,0.974098623128722,1,7,stress response to metal ion,BP,MT2A
11503,GO:0046068,0.234436761576323,0.937789035763325,2,22,cGMP metabolic process,BP,APOE;ADORA2B
16592,GO:0097493,0.234535602405497,0.974725854172137,1,6,structural molecule activity conferring elasticity,MF,OBSL1
6712,GO:0030145,0.234706546422206,0.914668982576221,3,41,manganese ion binding,MF,NPEPL1;FAM20C;GLUL
6615,GO:0023014,0.234769370449758,0.822081856492572,29,615,signal transduction by protein phosphorylation,BP,APOE;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;SFRP1;INSR;FOXO1;DAB2IP;TBX1;SHC2;EPHA4;F2R;ERBB3;CSPG4;ACVR1B;TYRO3;SPRY2;TNFRSF19;TRPV4;ADORA2B;IGFBP4;ERBB2;ACKR3;RASA4;MAP3K3;NRK;VANGL2
14369,GO:0061687,0.234770649691758,0.974003228731928,1,7,detoxification of inorganic compound,BP,MT2A
17195,GO:0110053,0.235093830102685,0.856135909281791,10,186,regulation of actin filament organization,BP,SFRP1;FHOD3;WIPF1;EPS8L2;DMTN;PIK3R1;NCK2;ARHGAP40;PLEKHH2;ARPIN
17567,GO:1901293,0.235114632170391,0.84906667210678,12,235,nucleoside phosphate biosynthetic process,BP,APOE;PGM1;DHTKD1;INSR;ATP6V0A2;PTHLH;ADORA2B;NMRK1;NME4;COX5B;TCIRG1;NADK
11407,GO:0045880,0.235147252158346,0.93747902642109,2,22,positive regulation of smoothened signaling pathway,BP,SFRP1;WNT9A
562,GO:0001704,0.23541003359978,0.887181007465751,5,79,formation of primary germ layer,BP,COL6A1;WNT3;COL7A1;RTF1;ITGB5
10343,GO:0043197,0.235657508936904,0.878087669214492,6,100,dendritic spine,CC,FBXO2;TENM2;DNM1;EPHA4;PDLIM4;APBA1
5493,GO:0016469,0.235698741616442,0.936923663794957,2,24,proton-transporting two-sector ATPase complex,CC,ATP6V0A2;TCIRG1
949,GO:0002376,0.235796569554567,0.801251085868149,80,1830,immune system process,BP,TNFAIP3;IFITM1;IFI6;LAMP3;PTPRS;GPNMB;MAP3K14;ASH2L;HTRA1;NCR3LG1;THRA;CYBA;OAS2;GLI2;BCL6;PGM1;SFRP1;CKLF;TNFSF10;DHTKD1;VAV3;GAA;ZFPM1;CXCL14;CTSB;VEGFB;DAB2IP;TBX1;PRSS3;KLK5;WIPF1;FAM20C;FAM213A;RPL13A;CTSV;RPS6KA5;HEXB;SCART1;DDX60;HGSNAT;KIF26A;ATP6V0A2;VAMP3;DMTN;PIK3R1;SDC3;CTSL;TRIM22;NCK2;ACVR1B;FAM210B;TYRO3;CXCR1;METTL7A;ZP3;STOM;VAMP2;RBCK1;EFNB3;TRPV4;ITGB5;NDRG1;PTMS;ADORA2B;SERPING1;MYL9;GPR68;ERBB2;RNF135;STAT1;IFI16;IL20RB;CCDC88B;CTSF;MMP1;TCIRG1;MT2A;RAB43;VPS33B;SP100
11751,GO:0046651,0.235797013597666,0.86483476935051,8,147,lymphocyte proliferation,BP,GPNMB;BCL6;VAV3;NCK2;ZP3;ERBB2;IL20RB;CCDC88B
2087,GO:0004865,0.235850813509583,0.973750473212456,1,7,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R14A
12332,GO:0048753,0.235858079346472,0.937003843485443,2,23,pigment granule organization,BP,SHROOM2;BLOC1S4
6187,GO:0019706,0.236199652600133,0.936853895986526,2,23,protein-cysteine S-palmitoyltransferase activity,MF,ZDHHC1;GOLGA7B
6188,GO:0019707,0.236199652600133,0.936853895986526,2,23,protein-cysteine S-acyltransferase activity,MF,ZDHHC1;GOLGA7B
16716,GO:0098542,0.236787017479306,0.844827432264296,13,259,defense response to other organism,BP,TNFAIP3;IFITM1;MAP3K14;HTRA1;CYBA;OAS2;KLK5;DDX60;TRIM22;STAT1;WIPI2;IFI16;CCDC88B
6678,GO:0030091,0.236866374651669,0.973511596020514,1,7,protein repair,BP,MSRB2
7262,GO:0031267,0.236922600416179,0.827752531921885,22,443,small GTPase binding,MF,EGFR;FGFR4;RAPGEF5;ARHGEF4;VAV3;RIMS3;OBSCN;SHC2;GAS8;EVI5L;TRAPPC2L;ARHGEF19;EPS8L2;ERBB3;APPL2;ACAP3;SYTL1;NDRG1;TBC1D17;MICALL1;ERBB2;ALS2CL
4722,GO:0010907,0.236949124270641,0.936689818492588,2,22,positive regulation of glucose metabolic process,BP,INSR;FOXO1
12573,GO:0050794,0.237487627679391,0.790717220950991,298,7107,regulation of cellular process,BP,TNFAIP3;POSTN;IFITM1;ITGB6;PEG3;TGFBI;SMOC2;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;PTPRS;OBSL1;LMF1;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRF4;ASH2L;HTRA1;PRICKLE2;SLITRK6;GPRC5C;TXNRD3;GIGYF1;ADGRL1;SRSF5;RALGDS;EGFR;FBXO2;THRA;CITED4;CYBA;OAS2;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;APCDD1;NLGN2;RAPGEF5;IRF2BPL;VIPR1;BCL6;TENM2;PSD4;ZNF318;BRSK1;SFRP1;ARHGEF4;CKLF;FHOD3;UNK;POU3F1;TNFSF10;MN1;INSR;VAV3;KMT5C;PKD2;ESPN;ZFPM1;RGMA;DNM1;PPP2R2C;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;SYT8;SERPINE2;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;FOXO1;WNT3;TRIM65;LY6E;ZSCAN18;NSG1;PARVB;RASIP1;BOC;SOX12;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;TSC22D1;KLK5;TRERF1;SHC2;SH3BP2;CRTAP;GAS8;YEATS4;EVI5L;WIPF1;KCNC4;MNT;RAB40B;TET1;FAM20C;GLUL;FAM213A;EPHA4;ZNF266;WNT9A;RPL13A;MAGEF1;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;TCFL5;TYSND1;CTSV;NXPH4;RPS6KA5;TUB;HOMER2;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;ZNF362;ACSL1;EPS8L2;ZBTB42;DDX60;ERBB3;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;VAMP3;CUL9;FRY;PLXND1;CGREF1;SREBF1;CSPG4;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;IMPA2;XPC;ARHGAP40;NAB2;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;HYAL1;BCAM;RTF1;ZP3;VAMP2;PLEKHH2;RBCK1;EFNB3;PCBP4;ZNF554;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;TNFRSF19;TMX4;MDK;TRPV4;MTHFR;GPC4;MSRB2;ITGB5;NDRG1;KLK8;LTBP4;PPP1R35;ADORA2B;FBXW4;SERPING1;MRC2;MAFIP;MYL9;RTN4RL1;MARK4;MC1R;IMPACT;TBC1D17;MVD;NEO1;CRTC1;IGFBP4;STON1;GPR68;TOM1L2;GPR153;ERBB2;C2CD4C;RNF187;EPM2A;H2AFJ;STAT1;TULP3;NME4;CDK20;HINT2;ACKR3;PLCD1;CRY2;MARCKSL1;ZMYM3;FURIN;FBXW5;RHPN1;IFI16;IL20RB;CCDC88B;PLPP2;MLYCD;THNSL2;NINL;PEX11B;FRAT1;GJC2;ARPIN;DBP;BEX2;ASIC1;MMP1;PER3;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;MT2A;RAB43;VPS33B;ELFN2;MAP3K3;PPP1R14A;MDFI;SCMH1;ZSWIM8;SP100;NRK;SORT1;VANGL2;TP53I11
16217,GO:0090314,0.237654696771388,0.936213413591814,2,23,positive regulation of protein targeting to membrane,BP,STOM;ERBB2
7821,GO:0032400,0.237726180831118,0.936181875414692,2,23,melanosome localization,BP,SHROOM2;VPS33B
13176,GO:0051875,0.237726180831118,0.936181875414692,2,23,pigment granule localization,BP,SHROOM2;VPS33B
15558,GO:0072080,0.238122804092313,0.897017239703795,4,60,nephron tubule development,BP,PKD2;WWTR1;KIF26B;STAT1
5534,GO:0016559,0.238467210679865,0.973132610403655,1,7,peroxisome fission,BP,PEX11B
19028,GO:1904949,0.238524928874758,0.885102521419874,5,81,ATPase complex,CC,SALL2;YEATS4;SMARCA1;APPL2;ATP12A
2591,GO:0005903,0.238526226207571,0.896773159628592,4,60,brush border,CC,RALGDS;CYBRD1;ESPN;SCART1
17519,GO:1901137,0.238634562891573,0.821621798458815,26,552,carbohydrate derivative biosynthetic process,BP,APOE;LMF1;ST3GAL5;PGM1;XYLT1;DHTKD1;INSR;NT5E;VEGFB;TET1;B3GNT9;ATP6V0A2;CSPG4;PTHLH;SDC3;HYAL1;GPC4;ADORA2B;MVD;NME4;COX5B;XYLT2;TCIRG1;ST6GALNAC6;PIGZ;VANGL2
12995,GO:0051491,0.238776394234786,0.935885100386896,2,22,positive regulation of filopodium assembly,BP,TENM2;ESPN
15449,GO:0071855,0.23910829143301,0.972980000181337,1,7,neuropeptide receptor binding,MF,UCN2
17976,GO:1902510,0.239232077586066,0.972950477350232,1,7,regulation of apoptotic DNA fragmentation,BP,ENDOG
401,GO:0001078,0.239324936925985,0.875576359863675,6,101,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,HES2;ZFPM1;FOXO1;TCFL5;NFATC4;IFI16
10750,GO:0044242,0.239399817293997,0.862231577596605,8,147,cellular lipid catabolic process,BP,APOE;CPT2;CRAT;TYSND1;HEXB;CPT1C;AMACR;MLYCD
3155,GO:0006782,0.239400639261354,0.972910246793277,1,7,protoporphyrinogen IX biosynthetic process,BP,UROS
8895,GO:0034764,0.239812918671751,0.875244370745088,6,101,positive regulation of transmembrane transport,BP,EPHB2;INSR;PKD2;F2R;PIK3R1;GJC2
15297,GO:0071559,0.239969230560404,0.856808256745207,9,165,response to transforming growth factor beta,BP,POSTN;HTRA1;MXRA5;SFRP1;LTBP1;ITGB5;LTBP4;FURIN;SMURF1
13340,GO:0052650,0.240301155609356,0.972694757415464,1,7,NADP-retinol dehydrogenase activity,MF,RDH12
8735,GO:0034433,0.240787437128198,0.972577997508892,1,7,steroid esterification,BP,APOE
8736,GO:0034434,0.240787437128198,0.972577997508892,1,7,sterol esterification,BP,APOE
8737,GO:0034435,0.240787437128198,0.972577997508892,1,7,cholesterol esterification,BP,APOE
4284,GO:0009749,0.240900191626582,0.867178956566601,7,124,response to glucose,BP,CYBA;GLUL;CTSV;SREBF1;ENDOG;VAMP2;GPR68
6962,GO:0030658,0.241018944810712,0.867095097559476,7,124,transport vesicle membrane,CC,PTPRS;SV2A;LDLRAP1;SYT8;SREBF1;VAMP2;C2CD4C
8174,GO:0032943,0.241283662326118,0.860851275595609,8,148,mononuclear cell proliferation,BP,GPNMB;BCL6;VAV3;NCK2;ZP3;ERBB2;IL20RB;CCDC88B
12202,GO:0048511,0.241359484841828,0.851409019195607,10,187,rhythmic process,BP,EGFR;HEBP1;SREBF1;TYRO3;ZP3;NAGLU;CRTC1;CRY2;DBP;PER3
8887,GO:0034754,0.241377266687455,0.894902111112931,4,63,cellular hormone metabolic process,BP,ALDH1A3;CYP27C1;RDH12;RETSAT
11846,GO:0046890,0.241380893386095,0.866839417671947,7,124,regulation of lipid biosynthetic process,BP,APOE;FGFR4;SEC14L2;SREBF1;ZP3;MVD;CCDC3
6523,GO:0021954,0.241505809817166,0.910977512061454,3,41,central nervous system neuron development,BP,EPHB2;GLI2;EPHA4
12672,GO:0050930,0.241564564144364,0.972390827668392,1,7,induction of positive chemotaxis,BP,VEGFB
18193,GO:1903038,0.241785100116655,0.894698943059491,4,62,negative regulation of leukocyte cell-cell adhesion,BP,GPNMB;BCL6;ERBB2;IL20RB
8688,GO:0034361,0.241933116201643,0.97230181468428,1,7,very-low-density lipoprotein particle,CC,APOE
8710,GO:0034385,0.241933116201643,0.97230181468428,1,7,triglyceride-rich plasma lipoprotein particle,CC,APOE
8176,GO:0032945,0.242084648778433,0.910582036167424,3,42,negative regulation of mononuclear cell proliferation,BP,GPNMB;ERBB2;IL20RB
12491,GO:0050672,0.242084648778433,0.910582036167424,3,42,negative regulation of lymphocyte proliferation,BP,GPNMB;ERBB2;IL20RB
13607,GO:0060155,0.242274460779111,0.972219230561786,1,7,platelet dense granule organization,BP,F2R
12129,GO:0048284,0.242286828357614,0.860166060738403,8,145,organelle fusion,BP,VAV3;SYT8;EVI5L;VAMP3;SYTL1;VAMP2;TBC1D17;C2CD4C
2509,GO:0005777,0.242351659604933,0.873418645713521,6,105,peroxisome,CC,CRAT;TYSND1;ACSL1;AMACR;MLYCD;PEX11B
10049,GO:0042579,0.242351659604933,0.873418645713521,6,105,microbody,CC,CRAT;TYSND1;ACSL1;AMACR;MLYCD;PEX11B
2687,GO:0006068,0.242672163133784,0.972122838656833,1,7,ethanol catabolic process,BP,ALDH2
8662,GO:0034310,0.242672163133784,0.972122838656833,1,7,primary alcohol catabolic process,BP,ALDH2
10459,GO:0043393,0.242956229531056,0.854542919174332,9,169,regulation of protein binding,BP,APOE;ZFPM1;LDLRAP1;DAB2IP;GAS8;EPHA4;PLXND1;NFATC4;CAMK1
20058,GO:2000765,0.243064357420757,0.933807593526816,2,23,regulation of cytoplasmic translation,BP,UNK;RPL13A
4769,GO:0010976,0.243134409784564,0.850087993858592,10,185,positive regulation of neuron projection development,BP,APOE;OBSL1;WNT3;DAB2IP;EPHA4;PLXND1;CRTC1;PLXNB1;SMURF1;CAMK1
4022,GO:0009071,0.243185849044312,0.971998060313899,1,7,serine family amino acid catabolic process,BP,THNSL2
12240,GO:0048584,0.243208097291983,0.798328459345886,63,1419,positive regulation of response to stimulus,BP,TNFAIP3;PTPRS;GPNMB;S100A4;MAP3K14;EPHB2;EGFR;CYBA;FGFR4;NLGN2;SFRP1;TNFSF10;INSR;VAV3;PKD2;CXCL14;LDLRAP1;CTSB;VEGFB;WNT3;DAB2IP;TBX1;KLK5;SHC2;SH3BP2;WIPF1;EPHA4;WNT9A;DIXDC1;F2R;RPS6KA5;DDX60;ERBB3;CSPG4;DMTN;ENDOG;PIK3R1;CTSL;TRIM22;NCK2;ACVR1B;NFATC4;TYRO3;ZP3;RBCK1;SPRY2;TP53INP1;TNFRSF19;TRPV4;ADORA2B;SERPING1;MC1R;NEO1;IGFBP4;GPR68;ERBB2;ACKR3;IFI16;PLXNB1;CXXC5;MAP3K3;NRK;VANGL2
7971,GO:0032611,0.243253740665724,0.909940145593379,3,42,interleukin-1 beta production,BP,TNFAIP3;F2R;IFI16
1091,GO:0002687,0.243355302375608,0.893694667989626,4,63,positive regulation of leukocyte migration,BP,CXCL14;VEGFB;ZP3;TRPV4
12846,GO:0051224,0.243570714921646,0.872607568693625,6,104,negative regulation of protein transport,BP,SFRP1;RHBDF1;F2R;SREBF1;DMTN;SP100
2100,GO:0004896,0.243621665657092,0.909737782289656,3,42,cytokine receptor activity,MF,CXCR1;ACKR3;IL20RB
11811,GO:0046826,0.243633350801887,0.971889105537194,1,7,negative regulation of protein export from nucleus,BP,SP100
9821,GO:0042098,0.243756646188033,0.872457160314248,6,105,T cell proliferation,BP,GPNMB;NCK2;ZP3;ERBB2;IL20RB;CCDC88B
13780,GO:0060415,0.243778216015838,0.909730852906384,3,41,muscle tissue morphogenesis,BP,ZFPM1;TBX1;VANGL2
2374,GO:0005523,0.24384256912451,0.971838085549011,1,7,tropomyosin binding,MF,S100A6
4339,GO:0009952,0.244074572973251,0.864951230957311,7,123,anterior/posterior pattern specification,BP,GLI2;SFRP1;WNT3;TBX1;TULP3;SCMH1;VANGL2
3167,GO:0006805,0.244194016126505,0.893136871944567,4,64,xenobiotic metabolic process,BP,CES2;BPHL;ACSL1;CBR3
17471,GO:1900744,0.244301015789649,0.933252176683646,2,23,regulation of p38MAPK cascade,BP,DAB2IP;MAP3K3
19461,GO:1990351,0.24458044095043,0.864592372909884,7,123,transporter complex,CC,SCN4B;KCNC4;OLFM2;ATP12A;CPT1C;VAMP2;LRRC8E
13044,GO:0051592,0.244781810940715,0.880994078997912,5,82,response to calcium ion,BP,EGFR;PKD2;DMTN;ENDOG;RASA4
1160,GO:0002790,0.244791280332138,0.829180260079819,17,345,peptide secretion,BP,POSTN;ITGB6;LMF1;EGFR;NLGN2;SFRP1;RHBDF1;RAB40B;GLUL;OLFM2;F2R;SREBF1;DMTN;SLC2A1;TRPV4;LTBP4;GPR68
13665,GO:0060263,0.244938864780532,0.97156989948919,1,7,regulation of respiratory burst,BP,INSR
3423,GO:0007229,0.245183276995552,0.892717971686654,4,60,integrin-mediated signaling pathway,BP,ITGB6;VAV3;DMTN;ITGB5
15326,GO:0071605,0.245459696650642,0.971441991984332,1,7,monocyte chemotactic protein-1 production,BP,TRPV4
15347,GO:0071637,0.245459696650642,0.971441991984332,1,7,regulation of monocyte chemotactic protein-1 production,BP,TRPV4
9175,GO:0035586,0.245536592533434,0.971423080523076,1,7,purinergic receptor activity,MF,ADORA2B
2693,GO:0006082,0.245849580777812,0.80661337678824,37,819,organic acid metabolic process,BP,ALDH1A3;CPT2;GAMT;TST;CRAT;FGFR4;PGM1;XYLT1;CYP4F22;DHTKD1;INSR;CES2;PDPR;BPHL;UROS;CRTAP;CYP27C1;GLUL;TYSND1;HEXB;ACSL1;SREBF1;CSPG4;SLC2A1;CPT1C;HYAL1;CKMT1A;SLC2A9;MTHFR;SDHA;AMACR;MLYCD;THNSL2;XYLT2;ALOXE3;ABCC1;IDUA
18128,GO:1902931,0.246060630791007,0.971294014681638,1,7,negative regulation of alcohol biosynthetic process,BP,APOE
11585,GO:0046324,0.246072861641083,0.908465439530479,3,41,regulation of glucose import,BP,INSR;RTN2;PIK3R1
7057,GO:0030865,0.246362963526662,0.908304990425774,3,41,cortical cytoskeleton organization,BP,EPB41L3;WIPF1;TRPV4
6280,GO:0019911,0.246419261419849,0.971205500170991,1,7,structural constituent of myelin sheath,MF,MARVELD1
2504,GO:0005771,0.246432857922108,0.932129760904177,2,24,multivesicular body,CC,EGFR;NSG1
8859,GO:0034702,0.246685672308588,0.87051764805956,6,102,ion channel complex,CC,SCN4B;KCNC4;OLFM2;CPT1C;VAMP2;LRRC8E
8797,GO:0034599,0.247063332173786,0.843164995086931,11,215,cellular response to oxidative stress,BP,TNFAIP3;GPX7;GPX3;EGFR;CYBA;PKD2;ETV5;FOXO1;ENDOG;TP53INP1;IMPACT
11274,GO:0045628,0.247229946775114,0.971004852269923,1,7,regulation of T-helper 2 cell differentiation,BP,BCL6
18532,GO:1903800,0.247248866123419,0.971000160366293,1,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR
4615,GO:0010755,0.247359905892621,0.970972614515656,1,7,regulation of plasminogen activation,BP,SERPINE2
13084,GO:0051665,0.247478091548528,0.970943279929133,1,7,membrane raft localization,BP,MARVELD1
11171,GO:0045335,0.247483780416804,0.869896677649071,6,105,phagocytic vesicle,CC,CYBA;ATP6V0A2;VAMP3;ITGB5;TCIRG1;RAB43
3671,GO:0008191,0.247630769833489,0.970905359514465,1,7,metalloendopeptidase inhibitor activity,MF,SPOCK1
9776,GO:0040034,0.247632916312741,0.970904826200651,1,7,regulation of development, heterochronic,BP,SERPINE2
14225,GO:0061326,0.247656053323367,0.891148555502541,4,61,renal tubule development,BP,PKD2;WWTR1;KIF26B;STAT1
5011,GO:0015194,0.247817910611975,0.970858842042962,1,7,L-serine transmembrane transporter activity,MF,SLC1A4
5204,GO:0015825,0.247817910611975,0.970858842042962,1,7,L-serine transport,BP,SLC1A4
6609,GO:0022889,0.247817910611975,0.970858842042962,1,7,serine transmembrane transporter activity,MF,SLC1A4
7828,GO:0032410,0.247824146878347,0.907414359140507,3,42,negative regulation of transporter activity,BP,EPHB2;ANO9;PKD2
12103,GO:0048240,0.248051646929602,0.970800684052392,1,7,sperm capacitation,BP,CABYR
10058,GO:0042589,0.248199687209338,0.970763815346529,1,7,zymogen granule membrane,CC,VAMP2
6791,GO:0030262,0.248414446604237,0.931228072343231,2,24,apoptotic nuclear changes,BP,H1F0;ENDOG
5186,GO:0015802,0.248417917681962,0.970709418724082,1,7,basic amino acid transport,BP,PQLC2
2942,GO:0006489,0.248594684295935,0.970665316066411,1,7,dolichyl diphosphate biosynthetic process,BP,MVD
11646,GO:0046465,0.248594684295935,0.970665316066411,1,7,dolichyl diphosphate metabolic process,BP,MVD
9513,GO:0036296,0.248770727523153,0.931065400654946,2,24,response to increased oxygen levels,BP,FOXO1;ATP6V0A2
14617,GO:0070255,0.248810685819614,0.970611374102539,1,7,regulation of mucus secretion,BP,CYBA
6761,GO:0030216,0.248916631497407,0.855267540722322,8,149,keratinocyte differentiation,BP,PRR9;POU3F1;KLK5;CTSV;PPL;CTSL;KLK8;FURIN
16299,GO:0090594,0.248953694206753,0.970575630214359,1,7,inflammatory response to wounding,BP,F2R
13570,GO:0060081,0.249033111317661,0.970555770010185,1,7,membrane hyperpolarization,BP,CRTC1
506,GO:0001569,0.249123589102068,0.931066883412903,2,23,branching involved in blood vessel morphogenesis,BP,PLXND1;NFATC4
4619,GO:0010759,0.249145077887701,0.970527757290851,1,7,positive regulation of macrophage chemotaxis,BP,TRPV4
7846,GO:0032429,0.249169649887583,0.970521607673415,1,7,regulation of phospholipase A2 activity,BP,EGFR
11442,GO:0045935,0.249185369092723,0.794735334850518,57,1270,positive regulation of nucleobase-containing compound metabolic process,BP,PEG3;APOE;NDN;ASH2L;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;ZNF318;SFRP1;POU3F1;INSR;PKD2;ZFPM1;RGMA;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;SOX12;DAB2IP;TBX1;TRERF1;YEATS4;TET1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;PLXND1;SREBF1;ENDOG;PIK3R1;PTHLH;NCK2;ACVR1B;NFATC4;RTF1;ZP3;TP53INP1;MDK;ADORA2B;MC1R;CRTC1;ERBB2;RNF187;STAT1;IFI16;DBP;CAMK1;SP100
7802,GO:0032377,0.249230862382066,0.970506284946666,1,7,regulation of intracellular lipid transport,BP,LDLRAP1
7805,GO:0032380,0.249230862382066,0.970506284946666,1,7,regulation of intracellular sterol transport,BP,LDLRAP1
7808,GO:0032383,0.249230862382066,0.970506284946666,1,7,regulation of intracellular cholesterol transport,BP,LDLRAP1
16134,GO:0090196,0.24934716026892,0.970477160971377,1,7,regulation of chemokine secretion,BP,POSTN
81,GO:0000165,0.24952089211205,0.810357155341603,28,598,MAPK cascade,BP,APOE;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;SFRP1;INSR;FOXO1;DAB2IP;TBX1;SHC2;EPHA4;F2R;ERBB3;CSPG4;TYRO3;SPRY2;TNFRSF19;TRPV4;ADORA2B;IGFBP4;ERBB2;ACKR3;RASA4;MAP3K3;NRK;VANGL2
5519,GO:0016525,0.249688186227584,0.889894040447423,4,61,negative regulation of angiogenesis,BP,ADGRB2;DAB2IP;SPRY2;STAT1
12816,GO:0051174,0.249799986076395,0.795196127114856,54,1200,regulation of phosphorus metabolic process,BP,TNFAIP3;APOE;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;SFRP1;INSR;VAV3;PKD2;PPP2R2C;PDPR;WWTR1;FOXO1;DAB2IP;TBX1;SHC2;FAM20C;EPHA4;F2R;RPS6KA5;ACSL1;ERBB3;CSPG4;DMTN;PIK3R1;PTHLH;NCK2;ACVR1B;CAMKK1;NAB2;TYRO3;ZP3;SPRY2;TNFRSF19;TRPV4;PPP1R35;ADORA2B;RTN4RL1;IMPACT;IGFBP4;ERBB2;CDK20;ACKR3;CRY2;GJC2;NUAK1;CAMK1;ELFN2;MAP3K3;PPP1R14A;NRK;VANGL2
2810,GO:0006290,0.250044737382638,0.970302132457632,1,7,pyrimidine dimer repair,BP,DDB2
788,GO:0002062,0.250070864027595,0.889657261339623,4,61,chondrocyte differentiation,BP,TGFBI;GLI2;WNT9A;PTHLH
10787,GO:0044309,0.250148820848184,0.86812957665789,6,102,neuron spine,CC,FBXO2;TENM2;DNM1;EPHA4;PDLIM4;APBA1
9932,GO:0042340,0.25039983630126,0.970212812658085,1,7,keratan sulfate catabolic process,BP,HEXB
16038,GO:0090043,0.250653979374655,0.970148794679509,1,7,regulation of tubulin deacetylation,BP,FRY
8278,GO:0033135,0.250785956293715,0.877009124511929,5,83,regulation of peptidyl-serine phosphorylation,BP,EGFR;DMTN;NCK2;SPRY2;CAMK1
11695,GO:0046543,0.25099814304084,0.970061978196727,1,7,development of secondary female sexual characteristics,BP,IRF2BPL
5817,GO:0017121,0.250998693033883,0.970061839346198,1,7,phospholipid scrambling,BP,ANO9
12072,GO:0048148,0.251184573705187,0.970014891517167,1,7,behavioral response to cocaine,BP,HOMER2
11853,GO:0046906,0.251194707985876,0.888864421420415,4,63,tetrapyrrole binding,MF,CYBA;HEBP1;CYP4F22;CYP27C1
4788,GO:0012501,0.251214574115879,0.790557770044933,65,1478,programmed cell death,BP,TNFAIP3;PEG3;APOE;ALDH1A3;IFI6;LAMP3;LGALS7B;MAP3K14;EPHB2;EGFR;THRA;H1F0;GLI2;FGFR4;EPB41L3;BCL6;SFRP1;ARHGEF4;TNFSF10;INSR;VAV3;CTSB;FOXO1;NSG1;DAB2IP;OBSCN;TBX1;KLK5;MNT;EPHA4;WNT9A;F2R;CTSV;ARHGEF19;ERBB3;PPL;ENDOG;PIK3R1;CTSL;NCK2;ACVR1B;NFATC4;TYRO3;RBCK1;SPRY2;TP53INP1;TNFRSF19;MDK;NDRG1;KLK8;MARK4;ERBB2;STAT1;NME4;HINT2;ACKR3;FURIN;IFI16;BEX2;KREMEN1;NISCH;MAP3K3;SP100;NRK;SORT1
5768,GO:0017016,0.251322653459719,0.818601948511848,20,403,Ras GTPase binding,MF,EGFR;FGFR4;RAPGEF5;ARHGEF4;VAV3;RIMS3;OBSCN;SHC2;GAS8;EVI5L;TRAPPC2L;ARHGEF19;EPS8L2;ERBB3;SYTL1;NDRG1;TBC1D17;MICALL1;ERBB2;ALS2CL
11217,GO:0045472,0.252116224728767,0.96977896432567,1,7,response to ether,BP,NFATC4
2272,GO:0005243,0.25228938658733,0.969734999516,1,7,gap junction channel activity,MF,GJC2
15125,GO:0071285,0.252599403601667,0.969656198586078,1,7,cellular response to lithium ion,BP,NFATC4
11788,GO:0046719,0.252673623403216,0.969637316183811,1,7,regulation by virus of viral protein levels in host cell,BP,STAT1
7339,GO:0031401,0.252742327720537,0.801238247410884,36,781,positive regulation of protein modification process,BP,GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;BCL6;INSR;PKD2;DAB2IP;TBX1;SHC2;TET1;EPHA4;F2R;RPS6KA5;ACSL1;ERBB3;SREBF1;CSPG4;ACVR1B;CAMKK1;NAB2;TYRO3;RTF1;SPRY2;TNFRSF19;TRPV4;ADORA2B;IGFBP4;ERBB2;CDK20;ACKR3;CAMK1;MAP3K3;NRK;VANGL2
14045,GO:0060911,0.252756151609292,0.9696163123019,1,7,cardiac cell fate commitment,BP,TENM4
1392,GO:0003337,0.252972405988304,0.969561235794771,1,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,STAT1
8217,GO:0033013,0.253069018226483,0.904329337057266,3,44,tetrapyrrole metabolic process,BP,UROS;PRSS3;ABCC1
4996,GO:0015174,0.253198117049369,0.969503691244048,1,7,basic amino acid transmembrane transporter activity,MF,PQLC2
6775,GO:0030235,0.253228828789841,0.969495856647161,1,7,nitric-oxide synthase regulator activity,MF,EGFR
9819,GO:0042095,0.253311356772277,0.969474798089314,1,7,interferon-gamma biosynthetic process,BP,ZFPM1
18572,GO:1903896,0.253342269275801,0.969466908090628,1,7,positive regulation of IRE1-mediated unfolded protein response,BP,DAB2IP
9635,GO:0038024,0.253464998336183,0.904261058269233,3,42,cargo receptor activity,MF,LDLRAP1;SCART1;ACKR3
15248,GO:0071474,0.253533870878971,0.96941797889193,1,7,cellular hyperosmotic response,BP,SLC2A1
15247,GO:0071472,0.253587148735018,0.969404365556229,1,7,cellular response to salt stress,BP,TRPV4
4283,GO:0009746,0.253631462140818,0.858072306090353,7,126,response to hexose,BP,CYBA;GLUL;CTSV;SREBF1;ENDOG;VAMP2;GPR68
8350,GO:0033273,0.253745290210887,0.887277480113496,4,63,response to vitamin,BP,POSTN;EGFR;SFRP1;MTHFR
7461,GO:0031645,0.253795835245958,0.969351010165157,1,7,negative regulation of neurological system process,BP,KLK8
10047,GO:0042577,0.254077845814912,0.969278825077844,1,7,lipid phosphatase activity,MF,PLPP2
7142,GO:0031032,0.254174433320088,0.857739240765339,7,123,actomyosin structure organization,BP,OBSL1;EPB41L3;SFRP1;FHOD3;OBSCN;PIK3R1;ITGB5
10512,GO:0043495,0.254245556698686,0.969235851691936,1,7,protein membrane anchor,MF,SUN1
1594,GO:0004028,0.254264704275356,0.969230943273167,1,7,3-chloroallyl aldehyde dehydrogenase activity,MF,ALDH1A3
2271,GO:0005242,0.254265953840896,0.969230622935866,1,7,inward rectifier potassium channel activity,MF,KCNJ15
904,GO:0002295,0.254425664733722,0.969189664235306,1,7,T-helper cell lineage commitment,BP,ZFPM1
10447,GO:0043373,0.254425664733722,0.969189664235306,1,7,CD4-positive, alpha-beta T cell lineage commitment,BP,ZFPM1
10865,GO:0044444,0.254622698964617,0.774713109237376,297,7160,cytoplasmic part,CC,TNFAIP3;POSTN;PEG3;TGFBI;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;PTPRS;NOL4L;PHF7;FBXO41;OBSL1;LMF1;CPT2;GPNMB;NDN;S100A4;MAP3K14;EPHB2;KDSR;HTRA1;GAMT;GPRC5C;TXNRD3;GPX7;SRSF5;ST3GAL5;TST;FLNC;RALGDS;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CYBA;SNN;OAS2;H1F0;GLI2;FGFR4;EPB41L3;BCL6;PGM1;TENM2;XYLT1;CYP4F22;ZNF318;CERS4;BRSK1;SFRP1;ARHGEF4;FHOD3;DHTKD1;INSR;VAV3;FAM185A;CYBRD1;GAA;DHX32;CES2;SV2A;PKD2;RGMA;RTN2;ARSI;DNM1;TMEM134;PPP2R2C;CXCL14;LDLRAP1;RIMS3;CTSB;NT5E;SYT8;SERPINE2;PDPR;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;NSG1;PARVB;RASIP1;BPHL;UROS;DAB2IP;COL7A1;OBSCN;PRSS3;H6PD;CLIP2;SGSH;KLK5;TRERF1;SHC2;CRTAP;GAS8;WIPF1;FKBP9;SDR9C7;RAB40B;NRSN2;FAM20C;GLUL;ANO8;EPHA4;MZT2A;TRAPPC2L;RPL13A;B3GNT9;DIXDC1;ZNF687;F2R;HERC3;MPLKIP;TYSND1;CTSV;LRIG3;TUB;HOMER2;KLHDC8B;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;PGLS;ACSL1;EPS8L2;DDX60;ACTA2;HGSNAT;KIF26A;S100A6;CDK14;ATP6V0A2;VAMP3;PPL;CUL9;FRY;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;CTSL;ACAP3;TRIM22;NCK2;ACVR1B;CAMKK1;SYTL1;IMPA2;UNC119B;XPC;ARHGAP40;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CXCR1;SLC2A1;CPT1C;METTL7A;HYAL1;STOM;CKMT1A;VAMP2;PLEKHH2;RBCK1;MBOAT7;AVL9;PCBP4;SPRY2;SCG5;LRRC8E;TP53INP1;CABYR;TMX4;TRPV4;ZDHHC1;MTHFR;PQLC2;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;RETSAT;NDUFA4L2;SDHA;KLK8;ALDH2;FBXW4;SERPING1;NAGLU;NMRK1;MYL9;AMACR;MARK4;PDLIM4;BTBD2;LGALS9B;TBC1D17;MVD;GOLGA7B;MZT2B;NEO1;CRTC1;IGFBP4;ANKRD13D;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;RNF135;LAMB2;STAT1;FBXL8;TULP3;NME4;HINT2;WIPI2;ACKR3;PLCD1;CRY2;MARCH9;COX5B;SLC39A6;BLOC1S4;FURIN;FBXW5;CLCN7;RHPN1;IFI16;CCDC88B;PCSK1;MLYCD;SUN1;OXLD1;NINL;PEX11B;FRAT1;CTSF;ANGEL1;SLC1A4;ASIC1;ALS2CL;XYLT2;ALOXE3;RASA4;SMURF1;CAPNS2;MEX3A;CCDC3;DOK4;CXXC5;TCIRG1;NISCH;RNF208;MT2A;NADK;RAB43;VPS33B;MAP3K3;PPP1R14A;ST6GALNAC6;REEP6;DIRC2;MPG;ABCC1;IDUA;ISYNA1;PIGZ;FBXO44;SORT1;CBR3;VANGL2;APBA1
9471,GO:0036149,0.254684452526778,0.969123231910979,1,7,phosphatidylinositol acyl-chain remodeling,BP,MBOAT7
13043,GO:0051591,0.254712219744419,0.886722092831662,4,62,response to cAMP,BP,PKD2;SREBF1;DMTN;STAT1
16067,GO:0090090,0.254882486711104,0.85711779297277,7,129,negative regulation of canonical Wnt signaling pathway,BP,APOE;SFRP1;WWTR1;FOXO1;DAB2IP;IGFBP4;KREMEN1
9439,GO:0036089,0.254960114497922,0.969052379665155,1,7,cleavage furrow formation,BP,SNX33
815,GO:0002093,0.255027841548791,0.969034958133125,1,7,auditory receptor cell morphogenesis,BP,SLITRK6
5212,GO:0015844,0.255114023962261,0.928140994249439,2,24,monoamine transport,BP,SLC29A4;NISCH
11319,GO:0045713,0.255200038743502,0.968990638833628,1,7,low-density lipoprotein particle receptor biosynthetic process,BP,FURIN
13559,GO:0060070,0.255235508719427,0.833350075430408,12,237,canonical Wnt signaling pathway,BP,APOE;SFRP1;WWTR1;FOXO1;WNT3;DAB2IP;WNT9A;DIXDC1;CDK14;IGFBP4;FRAT1;KREMEN1
2388,GO:0005546,0.255349268867647,0.903118961060555,3,43,phosphatidylinositol-4,5-bisphosphate binding,MF,LDLRAP1;TULP3;PLCD1
3383,GO:0007178,0.255370950037095,0.836759153192305,11,211,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;SFRP1;RGMA;WWTR1;LTBP1;ACVR1B;ITGB5;LTBP4;NEO1;FURIN;SMURF1
10976,GO:0044829,0.255416138653913,0.968934969772906,1,7,positive regulation by host of viral genome replication,BP,STOM
5553,GO:0016589,0.255485785245538,0.968917016325694,1,7,NURF complex,CC,SMARCA1
3536,GO:0007586,0.25551177027117,0.903027088694593,3,43,digestion,BP,PRSS3;UCN2;SLC5A1
12278,GO:0048665,0.255675655646137,0.968868042128902,1,7,neuron fate specification,BP,GLI2
16787,GO:0098722,0.255740007034555,0.968851433851395,1,7,asymmetric stem cell division,BP,ETV5
19811,GO:2000322,0.255869853468915,0.968817907008254,1,7,regulation of glucocorticoid receptor signaling pathway,BP,CRY2
14747,GO:0070493,0.256273732650979,0.968713494533413,1,7,thrombin-activated receptor signaling pathway,BP,F2R
12390,GO:0048875,0.256517301972172,0.968650431355034,1,7,chemical homeostasis within a tissue,BP,HOMER2
16283,GO:0090533,0.256678814009561,0.968608574558858,1,7,cation-transporting ATPase complex,CC,ATP12A
12886,GO:0051281,0.256754985165252,0.927375788533885,2,24,positive regulation of release of sequestered calcium ion into cytosol,BP,PKD2;F2R
13075,GO:0051650,0.25678977815743,0.839617056224795,10,190,establishment of vesicle localization,BP,SHROOM2;DNM1;RIMS3;SYT8;COL7A1;TRAPPC2L;SYTL1;VAMP2;C2CD4C;BLOC1S4
11762,GO:0046676,0.256933890541598,0.92729214633332,2,24,negative regulation of insulin secretion,BP,SFRP1;SREBF1
16187,GO:0090278,0.256933890541598,0.92729214633332,2,24,negative regulation of peptide hormone secretion,BP,SFRP1;SREBF1
12943,GO:0051386,0.256946595004196,0.968539108483509,1,7,regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
17669,GO:1901620,0.256974485378062,0.968531868382038,1,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,TULP3
15936,GO:0080134,0.257064600012332,0.792858183465742,44,978,regulation of response to stress,BP,TNFAIP3;APOE;PTPRS;HTRA1;EGFR;CYBA;BCL6;SFRP1;RGMA;CTSB;NT5E;SERPINE2;FOXO1;DAB2IP;KLK5;EPHA4;MAGEF1;F2R;RPS6KA5;DDX60;DMTN;ENDOG;PIK3R1;CTSL;NCK2;TYRO3;ZP3;TNFRSF19;TRPV4;KLK8;ADORA2B;SERPING1;RTN4RL1;IMPACT;RNF135;STAT1;ACKR3;IFI16;IL20RB;NUAK1;VPS33B;MAP3K3;NRK;VANGL2
9594,GO:0036491,0.257113664297489,0.96849572475627,1,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,NCK2
6644,GO:0030017,0.25711712878743,0.863212700991832,6,105,sarcomere,CC,OBSL1;FLNC;FHOD3;PARVB;OBSCN;SLC2A1
19826,GO:2000345,0.257157370548996,0.968484369796492,1,7,regulation of hepatocyte proliferation,BP,TNFAIP3
11141,GO:0045252,0.257170207702541,0.968481034245482,1,7,oxoglutarate dehydrogenase complex,CC,DHTKD1
10471,GO:0043407,0.257213750335558,0.885060196665393,4,64,negative regulation of MAP kinase activity,BP,APOE;SFRP1;DAB2IP;SPRY2
6637,GO:0030007,0.257329397447881,0.968439654601169,1,7,cellular potassium ion homeostasis,BP,ATP12A
16428,GO:0097152,0.257367807781095,0.968429665689298,1,7,mesenchymal cell apoptotic process,BP,TBX1
9544,GO:0036376,0.25744073168618,0.968410696367331,1,7,sodium ion export across plasma membrane,BP,ATP12A
7093,GO:0030913,0.257757148102699,0.968328314492506,1,7,paranodal junction assembly,BP,EPB41L3
3378,GO:0007172,0.257851959278449,0.968303606090566,1,7,signal complex assembly,BP,NCK2
1322,GO:0003188,0.257852003048758,0.968303594681243,1,7,heart valve formation,BP,ZFPM1
2280,GO:0005251,0.257876832909476,0.968297122071094,1,7,delayed rectifier potassium channel activity,MF,KCNC4
13577,GO:0060090,0.257888556848697,0.848697413217647,8,146,molecular adaptor activity,MF,OBSL1;VAV3;LDLRAP1;DAB2IP;SH3BP2;PIK3R1;TRIM22;NCK2
15250,GO:0071476,0.257980703703834,0.968270037146304,1,7,cellular hypotonic response,BP,TRPV4
13841,GO:0060513,0.258333949688599,0.968177828966145,1,7,prostatic bud formation,BP,GLI2
14705,GO:0070417,0.258485052811313,0.968138340467948,1,7,cellular response to cold,BP,FOXO1
7713,GO:0032230,0.258551073438056,0.968121078349564,1,7,positive regulation of synaptic transmission, GABAergic,BP,NLGN2
6286,GO:0019933,0.258565527882916,0.88425781673325,4,63,cAMP-mediated signaling,BP,PTHLH;UCN2;ADORA2B;MC1R
16852,GO:0098839,0.258624570568356,0.968101855206166,1,7,postsynaptic density membrane,CC,PTPRS
17055,GO:0099634,0.258624570568356,0.968101855206166,1,7,postsynaptic specialization membrane,CC,PTPRS
13961,GO:0060717,0.258864763391127,0.968038987478017,1,7,chorion development,BP,HTRA1
9080,GO:0035384,0.258896374180291,0.901106093727467,3,43,thioester biosynthetic process,BP,PDPR;ACSL1;MLYCD
15333,GO:0071616,0.258896374180291,0.901106093727467,3,43,acyl-CoA biosynthetic process,BP,PDPR;ACSL1;MLYCD
14081,GO:0060982,0.2589149005234,0.968025855884288,1,7,coronary artery morphogenesis,BP,TBX1
1319,GO:0003183,0.25899176347231,0.968005718553672,1,7,mitral valve morphogenesis,BP,ZFPM1
2575,GO:0005883,0.259019715611974,0.967998393604147,1,7,neurofilament,CC,LDLRAP1
17964,GO:1902473,0.259024110521021,0.967997241818174,1,7,regulation of protein localization to synapse,BP,NLGN2
3670,GO:0008190,0.259109360703647,0.967974895459779,1,7,eukaryotic initiation factor 4E binding,MF,ANGEL1
2238,GO:0005165,0.259238771821102,0.967940956587475,1,7,neurotrophin receptor binding,MF,PIK3R1
2240,GO:0005167,0.259238771821102,0.967940956587475,1,7,neurotrophin TRK receptor binding,MF,PIK3R1
11619,GO:0046394,0.259314153387407,0.824177663474449,14,284,carboxylic acid biosynthetic process,BP,ALDH1A3;GAMT;FGFR4;PGM1;DHTKD1;INSR;UROS;GLUL;CSPG4;HYAL1;AMACR;MLYCD;THNSL2;ALOXE3
2276,GO:0005247,0.259503154969173,0.967871557671312,1,7,voltage-gated chloride channel activity,MF,CLCN7
20212,GO:2001204,0.259554480418576,0.967858075288787,1,7,regulation of osteoclast development,BP,GPR68
12304,GO:0048702,0.259565905282249,0.967855073725555,1,7,embryonic neurocranium morphogenesis,BP,TULP3
18497,GO:1903727,0.259587454517405,0.92604656352139,2,24,positive regulation of phospholipid metabolic process,BP,VAV3;ZP3
18983,GO:1904861,0.259605862327374,0.967844574891348,1,7,excitatory synapse assembly,BP,NLGN2
6696,GO:0030125,0.259793847679031,0.925949291192817,2,24,clathrin vesicle coat,CC,EGFR;LDLRAP1
16719,GO:0098552,0.259899106873691,0.826539237400618,13,258,side of membrane,CC,ITGB6;INSR;PKD2;LDLRAP1;SERPINE2;DAB2IP;CTSV;SCART1;S100A6;BCAM;GPC4;RTN4RL1;RASA4
11436,GO:0045927,0.259912491584875,0.841807256870248,9,169,positive regulation of growth,BP,EGFR;CYBA;SFRP1;INSR;WNT3;HYAL1;ZP3;ERBB2;SMURF1
5336,GO:0016126,0.260102908193591,0.883241308248199,4,64,sterol biosynthetic process,BP,APOE;SEC14L2;SREBF1;MVD
3776,GO:0008361,0.260108272766692,0.853436103120813,7,124,regulation of cell size,BP,APOE;ULK2;PTPRS;VAV3;WNT3;EPHA4;TRPV4
12305,GO:0048703,0.260224348718242,0.967681819935564,1,7,embryonic viscerocranium morphogenesis,BP,TBX1
23,GO:0000045,0.260492527162623,0.870502501875347,5,84,autophagosome assembly,BP,ULK2;TP53INP2;TP53INP1;WIPI2;SMURF1
19238,GO:1905475,0.260701141203979,0.852948485134252,7,127,regulation of protein localization to membrane,BP,EPHB2;EGFR;LDLRAP1;DMTN;PIK3R1;STOM;ERBB2
10646,GO:0043931,0.260735734652245,0.967546899566536,1,7,ossification involved in bone maturation,BP,PLXNB1
11218,GO:0045475,0.261152316102429,0.967436758082305,1,7,locomotor rhythm,BP,NAGLU
9777,GO:0040036,0.261193047431907,0.92528836378588,2,24,regulation of fibroblast growth factor receptor signaling pathway,BP,FAM20C;SPRY2
12712,GO:0051020,0.261358356406689,0.803374294533817,25,519,GTPase binding,MF,RALGDS;EGFR;FGFR4;RAPGEF5;PSD4;ARHGEF4;VAV3;RIMS3;OBSCN;SHC2;GAS8;EVI5L;TRAPPC2L;ARHGEF19;EPS8L2;ERBB3;APPL2;IQSEC1;ACAP3;SYTL1;NDRG1;TBC1D17;MICALL1;ERBB2;ALS2CL
2776,GO:0006228,0.261641850516358,0.966685119397783,1,8,UTP biosynthetic process,BP,NME4
2184,GO:0005068,0.262193891326498,0.967160453337788,1,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,PIK3R1
3505,GO:0007494,0.262279404390274,0.967137710429472,1,7,midgut development,BP,EGFR
187,GO:0000405,0.262297228048124,0.967132968964,1,7,bubble DNA binding,MF,XPC
6786,GO:0030252,0.262607482861611,0.967050373017751,1,7,growth hormone secretion,BP,LTBP4
2946,GO:0006497,0.26266330314462,0.859249863755204,6,108,protein lipidation,BP,LY6E;ZDHHC1;RTN4RL1;GOLGA7B;WIPI2;PIGZ
3365,GO:0007158,0.262691813273421,0.967027902431228,1,7,neuron cell-cell adhesion,BP,NLGN2
16402,GO:0097106,0.262728698211939,0.967018071401504,1,7,postsynaptic density organization,BP,NLGN2
16958,GO:0099084,0.262728698211939,0.967018071401504,1,7,postsynaptic specialization organization,BP,NLGN2
730,GO:0001964,0.262825278146495,0.966992321908124,1,7,startle response,BP,SLITRK6
15291,GO:0071549,0.262842806373876,0.924344259818259,2,25,cellular response to dexamethasone stimulus,BP,EGFR;FOXO1
1253,GO:0003018,0.263011322644853,0.868805778534367,5,84,vascular process in circulatory system,BP,APOE;EGFR;F2R;TRPV4;ADORA2B
6690,GO:0030119,0.263059922335499,0.89872347847643,3,43,AP-type membrane coat adaptor complex,CC,EGFR;LDLRAP1;VPS33B
7885,GO:0032480,0.263230789615649,0.898546106375957,3,44,negative regulation of type I interferon production,BP,TNFAIP3;PTPRS;RNF135
5506,GO:0016500,0.263257654365134,0.966876905954495,1,7,protein-hormone receptor activity,MF,INSR
5309,GO:0016053,0.263482070500055,0.820799542633087,14,285,organic acid biosynthetic process,BP,ALDH1A3;GAMT;FGFR4;PGM1;DHTKD1;INSR;UROS;GLUL;CSPG4;HYAL1;AMACR;MLYCD;THNSL2;ALOXE3
19774,GO:2000271,0.263509585089222,0.966809552454165,1,7,positive regulation of fibroblast apoptotic process,BP,SFRP1
17038,GO:0099601,0.26369648095085,0.924099359668554,2,24,regulation of neurotransmitter receptor activity,BP,EPHB2;NLGN2
5258,GO:0015926,0.263732954711355,0.966749770297493,1,7,glucosidase activity,MF,GAA
12180,GO:0048407,0.263760645561177,0.966742354957865,1,7,platelet-derived growth factor binding,MF,COL6A1
5633,GO:0016747,0.263817821431265,0.838800232021348,9,172,transferase activity, transferring acyl groups other than amino-acyl groups,MF,CPT2;CRAT;CERS4;NAT6;HGSNAT;CPT1C;MBOAT7;ZDHHC1;GOLGA7B
6370,GO:0021587,0.264195543768903,0.923861336147986,2,24,cerebellum morphogenesis,BP,GLI2;SERPINE2
11756,GO:0046658,0.264640525397275,0.923485729563101,2,25,anchored component of plasma membrane,CC,GPC4;RTN4RL1
7037,GO:0030835,0.264661585578172,0.923638763307229,2,24,negative regulation of actin filament depolymerization,BP,DMTN;PLEKHH2
4757,GO:0010960,0.264812524207419,0.966459982139307,1,7,magnesium ion homeostasis,BP,EGFR
573,GO:0001725,0.26488451020284,0.897672570715437,3,43,stress fiber,CC,CYBA;PDLIM4;VANGL2
16607,GO:0097517,0.26488451020284,0.897672570715437,3,43,contractile actin filament bundle,CC,CYBA;PDLIM4;VANGL2
13086,GO:0051668,0.264890679883134,0.867535350800763,5,84,localization within membrane,BP,APOE;DNM1;ETV5;NSG1;MARVELD1
12997,GO:0051493,0.264979484146176,0.808784541518757,19,393,regulation of cytoskeleton organization,BP,SFRP1;FHOD3;ESPN;WIPF1;DIXDC1;CTSV;ARHGEF19;EPS8L2;DMTN;PIK3R1;NCK2;ARHGAP40;RHOD;PLEKHH2;TRPV4;FBXW5;ARPIN;PLXNB1;VANGL2
7830,GO:0032412,0.265286380822572,0.849630802411916,7,126,regulation of ion transmembrane transporter activity,BP,EPHB2;NLGN2;ANO9;PKD2;SCN4B;STOM;VAMP2
14040,GO:0060900,0.265960849399204,0.966150181714583,1,7,embryonic camera-type eye formation,BP,ALDH1A3
12189,GO:0048483,0.266025728940514,0.922985617500933,2,24,autonomic nervous system development,BP,TBX1;KIF26A
18663,GO:1904064,0.266222392357998,0.879356974956895,4,64,positive regulation of cation transmembrane transport,BP,EPHB2;PKD2;F2R;GJC2
11037,GO:0045071,0.266279592619795,0.896709392912324,3,45,negative regulation of viral genome replication,BP,IFITM1;OAS2;IFI16
16290,GO:0090557,0.266309335132492,0.966055847919144,1,7,establishment of endothelial intestinal barrier,BP,PTPRS
13486,GO:0055102,0.266987874422164,0.965223946812799,1,8,lipase inhibitor activity,MF,PINLYP
10303,GO:0043130,0.267281058353524,0.878632927642489,4,65,ubiquitin binding,MF,TNFAIP3;TP53INP2;RBCK1;MARK4
12575,GO:0050796,0.267674178597864,0.855754506807256,6,106,regulation of insulin secretion,BP,NLGN2;SFRP1;GLUL;SREBF1;SLC2A1;GPR68
18326,GO:1903363,0.268091738550093,0.878113969358743,4,65,negative regulation of cellular protein catabolic process,BP,LAMP3;DAB2IP;EPHA4;FURIN
15130,GO:0071300,0.268203485915122,0.895669362517212,3,44,cellular response to retinoic acid,BP,WNT3;TBX1;WNT9A
10863,GO:0044440,0.26822472061954,0.806039753134614,19,398,endosomal part,CC,MVB12B;EGFR;INSR;CTSB;NSG1;EPHA4;ATP6V0A2;VAMP3;APPL2;CTSL;RHOD;NDRG1;PDLIM4;MICALL1;ERBB2;FURIN;TCIRG1;VPS33B;SORT1
13702,GO:0060315,0.268260185473745,0.964870992846772,1,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,PKD2
15425,GO:0071804,0.268265406524122,0.865244549731251,5,84,cellular potassium ion transport,BP,KCNJ15;PKD2;KCNC4;ATP12A;VAMP2
15426,GO:0071805,0.268265406524122,0.865244549731251,5,84,potassium ion transmembrane transport,BP,KCNJ15;PKD2;KCNC4;ATP12A;VAMP2
582,GO:0001736,0.268349763183566,0.855202977979268,6,109,establishment of planar polarity,BP,PRICKLE2;SFRP1;ARHGEF19;GPC4;SMURF1;VANGL2
3371,GO:0007164,0.268349763183566,0.855202977979268,6,109,establishment of tissue polarity,BP,PRICKLE2;SFRP1;ARHGEF19;GPC4;SMURF1;VANGL2
7316,GO:0031346,0.268426364209952,0.819700747106125,13,256,positive regulation of cell projection organization,BP,APOE;OBSL1;TENM2;ESPN;WNT3;DAB2IP;EPHA4;EPS8L2;PLXND1;CRTC1;PLXNB1;SMURF1;CAMK1
19732,GO:2000181,0.268889054743493,0.877700438679862,4,63,negative regulation of blood vessel morphogenesis,BP,ADGRB2;DAB2IP;SPRY2;STAT1
12550,GO:0050766,0.269205978032208,0.921286126931045,2,25,positive regulation of phagocytosis,BP,CYBA;TUB
14271,GO:0061450,0.269681602490463,0.964474297913773,1,8,trophoblast cell migration,BP,ACVR1B
17527,GO:1901163,0.269681602490463,0.964474297913773,1,8,regulation of trophoblast cell migration,BP,ACVR1B
12482,GO:0050662,0.269817341698458,0.825341884722433,11,220,coenzyme binding,MF,ALDH1A3;TXNRD3;DHTKD1;NAT6;H6PD;MTHFR;SDHA;ALDH2;CRY2;THNSL2;CBR3
15128,GO:0071294,0.270707726926905,0.964186360597425,1,8,cellular response to zinc ion,BP,MT2A
8244,GO:0033059,0.270866253161022,0.894038104599172,3,45,cellular pigmentation,BP,SHROOM2;BLOC1S4;VPS33B
9852,GO:0042157,0.271302898395623,0.845126897857251,7,131,lipoprotein metabolic process,BP,APOE;LY6E;ZDHHC1;RTN4RL1;GOLGA7B;WIPI2;PIGZ
19029,GO:1904950,0.271375318632189,0.853072531693822,6,108,negative regulation of establishment of protein localization,BP,SFRP1;RHBDF1;F2R;SREBF1;DMTN;SP100
8965,GO:0035107,0.271493731269095,0.853062252101442,6,105,appendage morphogenesis,BP,GLI2;WNT3;TMEM231;WNT9A;FBXW4;TULP3
8966,GO:0035108,0.271493731269095,0.853062252101442,6,105,limb morphogenesis,BP,GLI2;WNT3;TMEM231;WNT9A;FBXW4;TULP3
6757,GO:0030212,0.27207297328192,0.919890669507313,2,25,hyaluronan metabolic process,BP,HEXB;HYAL1
18454,GO:1903624,0.272387886082473,0.963712062329538,1,8,regulation of DNA catabolic process,BP,ENDOG
8701,GO:0034375,0.272511078308072,0.963677147255652,1,8,high-density lipoprotein particle remodeling,BP,APOE
2851,GO:0006359,0.272565114578052,0.919650029776961,2,25,regulation of transcription by RNA polymerase III,BP,NAB2;ERBB2
8267,GO:0033120,0.272960866582914,0.919456287370548,2,25,positive regulation of RNA splicing,BP,SRSF5;PIK3R1
2211,GO:0005125,0.27328082399172,0.874636528618549,4,68,cytokine activity,MF,CKLF;TNFSF10;CXCL14;THNSL2
1114,GO:0002710,0.273300814041196,0.963452870087233,1,8,negative regulation of T cell mediated immunity,BP,IL20RB
9036,GO:0035296,0.273341234783304,0.874735255274134,4,65,regulation of tube diameter,BP,APOE;EGFR;F2R;ADORA2B
16691,GO:0097746,0.273341234783304,0.874735255274134,4,65,regulation of blood vessel diameter,BP,APOE;EGFR;F2R;ADORA2B
9177,GO:0035588,0.273621935403584,0.963361451648425,1,8,G-protein coupled purinergic receptor signaling pathway,BP,ADORA2B
15470,GO:0071888,0.273949191486289,0.963268153921812,1,8,macrophage apoptotic process,BP,CTSL
19822,GO:2000341,0.274106575793803,0.963223237323325,1,8,regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN
16624,GO:0097546,0.274178222648391,0.918859018657578,2,25,ciliary base,CC,GLI2;TULP3
679,GO:0001893,0.274241642274498,0.918827849206429,2,25,maternal placenta development,BP,CTSB;CTSV
15734,GO:0072378,0.274254838178747,0.963180895682188,1,8,blood coagulation, fibrin clot formation,BP,SERPING1
2368,GO:0005516,0.274286691516111,0.843022994607776,7,126,calmodulin binding,MF,EGFR;OBSCN;CAMKK1;VAMP2;TRPV4;MARCKSL1;CAMK1
6112,GO:0019388,0.274716082764972,0.96304899456379,1,8,galactose catabolic process,BP,PGM1
14616,GO:0070254,0.274841251486097,0.963013154317219,1,8,mucus secretion,BP,CYBA
12802,GO:0051152,0.275942564451761,0.962696961762383,1,8,positive regulation of smooth muscle cell differentiation,BP,OLFM2
6563,GO:0022410,0.276164730398859,0.962632992148946,1,8,circadian sleep/wake cycle process,BP,PER3
12578,GO:0050802,0.276164730398859,0.962632992148946,1,8,circadian sleep/wake cycle, sleep,BP,PER3
17987,GO:1902531,0.276206606026093,0.769956039989956,58,1306,regulation of intracellular signal transduction,BP,TNFAIP3;APOE;GPNMB;S100A4;MAP3K14;EPHB2;EGFR;FGFR4;BCL6;PSD4;SFRP1;ARHGEF4;TNFSF10;INSR;VAV3;PKD2;SERPINE2;FOXO1;DAB2IP;OBSCN;TBX1;SHC2;EPHA4;F2R;ARHGEF19;EPS8L2;DDX60;ERBB3;CSPG4;PIK3R1;APPL2;IQSEC1;ACAP3;TRIM22;NCK2;ARHGAP40;TYRO3;RHOD;RBCK1;SPRY2;TP53INP1;TNFRSF19;TRPV4;ADORA2B;RTN4RL1;MC1R;IGFBP4;ERBB2;EPM2A;STAT1;ACKR3;NUAK1;PLXNB1;RASA4;CXXC5;MAP3K3;NRK;VANGL2
6824,GO:0030309,0.276262610313318,0.962604789294614,1,8,poly-N-acetyllactosamine metabolic process,BP,B3GNT9
6825,GO:0030311,0.276262610313318,0.962604789294614,1,8,poly-N-acetyllactosamine biosynthetic process,BP,B3GNT9
4058,GO:0009128,0.276305582962956,0.962592403466914,1,8,purine nucleoside monophosphate catabolic process,BP,NT5E
4087,GO:0009158,0.276305582962956,0.962592403466914,1,8,ribonucleoside monophosphate catabolic process,BP,NT5E
4097,GO:0009169,0.276305582962956,0.962592403466914,1,8,purine ribonucleoside monophosphate catabolic process,BP,NT5E
13045,GO:0051593,0.276309788418858,0.962591191221172,1,8,response to folic acid,BP,MTHFR
3057,GO:0006639,0.276328856374815,0.872798256822666,4,65,acylglycerol metabolic process,BP,APOE;LMF1;ACSL1;SREBF1
1031,GO:0002551,0.276378775652774,0.962571302098263,1,8,mast cell chemotaxis,BP,VEGFB
4839,GO:0014069,0.276427429131542,0.834780422994214,8,147,postsynaptic density,CC,PTPRS;EPB41L3;DNM1;EPHA4;HOMER2;SPOCK1;DMTN;NCK2
1101,GO:0002697,0.276504675464189,0.824220891679141,10,197,regulation of immune effector process,BP,TNFAIP3;HTRA1;BCL6;KLK5;DDX60;ZP3;ADORA2B;SERPING1;STAT1;IL20RB
13672,GO:0060272,0.276546441789808,0.962522938753524,1,8,embryonic skeletal joint morphogenesis,BP,HYAL1
12322,GO:0048736,0.276810368732037,0.841136294150464,7,127,appendage development,BP,GLI2;WNT3;TMEM231;WNT9A;FBXW4;TULP3;KREMEN1
13619,GO:0060173,0.276810368732037,0.841136294150464,7,127,limb development,BP,GLI2;WNT3;TMEM231;WNT9A;FBXW4;TULP3;KREMEN1
1108,GO:0002704,0.277010566973601,0.917301281595353,2,26,negative regulation of leukocyte mediated immunity,BP,BCL6;IL20RB
19356,GO:1905906,0.277018054628707,0.962386712277399,1,8,regulation of amyloid fibril formation,BP,APOE
19906,GO:2000484,0.277086321145656,0.962366970145292,1,8,positive regulation of interleukin-8 secretion,BP,F2R
7479,GO:0031670,0.277140284181968,0.890341942219652,3,45,cellular response to nutrient,BP,POSTN;CYBA;SFRP1
17812,GO:1902042,0.277486969261863,0.917064812542861,2,26,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,TNFAIP3;TNFSF10
3241,GO:0006921,0.277591222404996,0.917013024689394,2,26,cellular component disassembly involved in execution phase of apoptosis,BP,H1F0;ENDOG
4182,GO:0009306,0.277669911589636,0.804157626545684,16,331,protein secretion,BP,POSTN;ITGB6;LMF1;EGFR;NLGN2;SFRP1;RHBDF1;RAB40B;GLUL;OLFM2;F2R;SREBF1;DMTN;SLC2A1;TRPV4;GPR68
7086,GO:0030902,0.277836667250347,0.858646287080376,5,85,hindbrain development,BP,PTPRS;GLI2;SERPINE2;MDK;NAGLU
9399,GO:0035999,0.277853595435651,0.962144676915571,1,8,tetrahydrofolate interconversion,BP,MTHFR
15209,GO:0071417,0.277902554038039,0.799749347501335,18,373,cellular response to organonitrogen compound,BP,SRSF5;COL6A1;EGFR;CYBA;SFRP1;INSR;PKD2;FOXO1;UROS;EPHA4;ATP6V0A2;SREBF1;DMTN;PIK3R1;VAMP2;IMPACT;STAT1;TCIRG1
2625,GO:0005975,0.27802374963874,0.794416238551567,21,447,carbohydrate metabolic process,BP,ST3GAL5;PGM1;DHTKD1;INSR;GAA;FOXO1;PPP1R3E;H6PD;B3GNT9;HEXB;PGLS;IMPA2;SLC2A1;HYAL1;ALDH2;IGFBP4;MLYCD;NISCH;ST6GALNAC6;IDUA;ISYNA1
7767,GO:0032329,0.278132992928037,0.962063546188402,1,8,serine transport,BP,SLC1A4
15515,GO:0072001,0.27815795445534,0.82297574791843,10,192,renal system development,BP,GLI2;SFRP1;PKD2;WWTR1;EPHA4;KIF26B;ACTA2;LAMB2;STAT1;VANGL2
4045,GO:0009111,0.278176599386712,0.962050874978736,1,8,vitamin catabolic process,BP,CBR3
18212,GO:1903076,0.278333978598387,0.871492533277408,4,65,regulation of protein localization to plasma membrane,BP,EPHB2;EGFR;LDLRAP1;PIK3R1
15377,GO:0071682,0.278337871188527,0.962003991620885,1,8,endocytic vesicle lumen,CC,APOE
8658,GO:0034284,0.278419218759948,0.83988446837187,7,130,response to monosaccharide,BP,CYBA;GLUL;CTSV;SREBF1;ENDOG;VAMP2;GPR68
6974,GO:0030674,0.27844715392667,0.839902461934305,7,128,protein binding, bridging,MF,OBSL1;VAV3;LDLRAP1;SH3BP2;PIK3R1;TRIM22;NCK2
7457,GO:0031641,0.278473455684964,0.916735906485372,2,25,regulation of myelination,BP,TENM4;KLK8
703,GO:0001932,0.278486675716546,0.774764128026424,42,933,regulation of protein phosphorylation,BP,TNFAIP3;APOE;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;SFRP1;INSR;PKD2;WWTR1;FOXO1;DAB2IP;TBX1;SHC2;EPHA4;F2R;RPS6KA5;ACSL1;ERBB3;CSPG4;DMTN;NCK2;ACVR1B;CAMKK1;NAB2;TYRO3;SPRY2;TNFRSF19;TRPV4;ADORA2B;RTN4RL1;IMPACT;IGFBP4;ERBB2;CDK20;ACKR3;GJC2;CAMK1;MAP3K3;NRK;VANGL2
7603,GO:0032024,0.278669696752224,0.889433560892817,3,45,positive regulation of insulin secretion,BP,NLGN2;GLUL;GPR68
12269,GO:0048644,0.278813165063124,0.889429299823075,3,44,muscle organ morphogenesis,BP,ZFPM1;TBX1;VANGL2
8286,GO:0033144,0.2789108350975,0.916518334465668,2,25,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,SFRP1;CRY2
6969,GO:0030667,0.278968117092221,0.822294103051757,10,196,secretory granule membrane,CC,LAMP3;CYBA;GAA;RAB40B;HGSNAT;CXCR1;STOM;VAMP2;SUN1;TCIRG1
14465,GO:0062012,0.279142166976257,0.802915479026104,16,334,regulation of small molecule metabolic process,BP,APOE;LMF1;FGFR4;INSR;PKD2;LDLRAP1;PDPR;FOXO1;TYSND1;SEC14L2;SREBF1;PTHLH;ADORA2B;MVD;IGFBP4;MLYCD
20230,GO:2001238,0.279351575862161,0.888949992527588,3,46,positive regulation of extrinsic apoptotic signaling pathway,BP,SFRP1;TNFSF10;RBCK1
3642,GO:0008140,0.279682861470833,0.961611710908785,1,8,cAMP response element binding protein binding,MF,CRTC1
16158,GO:0090232,0.280248815248805,0.961445961322248,1,8,positive regulation of spindle checkpoint,BP,NDRG1
13189,GO:0051893,0.280388135699417,0.888491131181989,3,44,regulation of focal adhesion assembly,BP,SFRP1;DMTN;RHOD
16079,GO:0090109,0.280388135699417,0.888491131181989,3,44,regulation of cell-substrate junction assembly,BP,SFRP1;DMTN;RHOD
7474,GO:0031665,0.280464980029855,0.961382546725725,1,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,TNFAIP3
5576,GO:0016624,0.280472416278502,0.961380364158842,1,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,DHTKD1
5333,GO:0016114,0.280486921699949,0.961376106561841,1,8,terpenoid biosynthetic process,BP,ALDH1A3
8215,GO:0033008,0.280615473870046,0.961338362596239,1,8,positive regulation of mast cell activation involved in immune response,BP,ADORA2B
10416,GO:0043306,0.280615473870046,0.961338362596239,1,8,positive regulation of mast cell degranulation,BP,ADORA2B
14936,GO:0070886,0.280964902337364,0.96123566183802,1,8,positive regulation of calcineurin-NFAT signaling cascade,BP,ERBB3
17167,GO:0106058,0.280964902337364,0.96123566183802,1,8,positive regulation of calcineurin-mediated signaling,BP,ERBB3
7218,GO:0031146,0.281031226520291,0.869498871698934,4,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,FBXO2;WWTR1;FBXW4;FBXW5
19248,GO:1905523,0.281092374692714,0.961198157863022,1,8,positive regulation of macrophage migration,BP,TRPV4
7796,GO:0032371,0.281112796273763,0.915255171591552,2,26,regulation of sterol transport,BP,APOE;LDLRAP1
7799,GO:0032374,0.281112796273763,0.915255171591552,2,26,regulation of cholesterol transport,BP,APOE;LDLRAP1
8273,GO:0033129,0.281112866899637,0.961192126877043,1,8,positive regulation of histone phosphorylation,BP,RPS6KA5
12099,GO:0048227,0.281114433715487,0.961191665731349,1,8,plasma membrane to endosome transport,BP,SORT1
11282,GO:0045638,0.281452274970784,0.86931037372611,4,68,negative regulation of myeloid cell differentiation,BP,SFRP1;ZFPM1;PIK3R1;GPR68
7360,GO:0031432,0.281499542923935,0.96107822594625,1,8,titin binding,MF,OBSCN
9129,GO:0035510,0.281669566819064,0.914975736729168,2,26,DNA dealkylation,BP,TET1;MPG
6179,GO:0019674,0.2818310280625,0.887468267768374,3,46,NAD metabolic process,BP,NT5E;NMRK1;NADK
1175,GO:0002829,0.282047963009821,0.960916355980492,1,8,negative regulation of type 2 immune response,BP,BCL6
10575,GO:0043587,0.28241620152777,0.960807453768422,1,8,tongue morphogenesis,BP,TBX1
14715,GO:0070431,0.28249100977416,0.960785309078217,1,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,TNFAIP3
10619,GO:0043691,0.28265696451913,0.960736157897021,1,8,reverse cholesterol transport,BP,APOE
12927,GO:0051349,0.282685366329633,0.960727742566124,1,8,positive regulation of lyase activity,BP,ADORA2B
17032,GO:0099572,0.282700622218479,0.829989448611633,8,148,postsynaptic specialization,CC,PTPRS;EPB41L3;DNM1;EPHA4;HOMER2;SPOCK1;DMTN;NCK2
4752,GO:0010955,0.282784742547713,0.91441480339871,2,26,negative regulation of protein processing,BP,SERPINE2;SERPING1
18307,GO:1903318,0.282784742547713,0.91441480339871,2,26,negative regulation of protein maturation,BP,SERPINE2;SERPING1
17270,GO:0140131,0.282832087870419,0.960684253307689,1,8,positive regulation of lymphocyte chemotaxis,BP,CXCL14
3560,GO:0007620,0.282862266606565,0.960675304735795,1,8,copulation,BP,SERPINE2
15045,GO:0071071,0.282892690145347,0.960666282404318,1,8,regulation of phospholipid biosynthetic process,BP,ZP3
13426,GO:0055001,0.283126346975463,0.854941652550132,5,86,muscle cell development,BP,OBSL1;FLNC;FHOD3;OBSCN;NFATC4
18496,GO:1903726,0.283181495641823,0.960580576378802,1,8,negative regulation of phospholipid metabolic process,BP,DAB2IP
536,GO:0001655,0.283186314755382,0.814747670743525,11,215,urogenital system development,BP,EPHB2;GLI2;SFRP1;PKD2;WWTR1;EPHA4;KIF26B;ACTA2;LAMB2;STAT1;VANGL2
3683,GO:0008206,0.283227618657283,0.914191576573705,2,26,bile acid metabolic process,BP,FGFR4;AMACR
9824,GO:0042102,0.283919404186781,0.886138630373746,3,47,positive regulation of T cell proliferation,BP,NCK2;ZP3;CCDC88B
15355,GO:0071649,0.283937687060038,0.960355666506677,1,8,regulation of chemokine (C-C motif) ligand 5 production,BP,TRPV4
6612,GO:0022898,0.284030765816154,0.835721841323119,7,129,regulation of transmembrane transporter activity,BP,EPHB2;NLGN2;ANO9;PKD2;SCN4B;STOM;VAMP2
15224,GO:0071439,0.28435971602978,0.960229828471962,1,8,clathrin complex,CC,VPS33B
746,GO:0001991,0.284441162509098,0.960205517156339,1,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,F2R
3060,GO:0006643,0.284477881284948,0.822805616855856,9,177,membrane lipid metabolic process,BP,KDSR;ST3GAL5;CERS4;ARSI;HEXB;PLPP2;ALOXE3;ST6GALNAC6;PIGZ
9699,GO:0038180,0.284489716832786,0.960191019945416,1,8,nerve growth factor signaling pathway,BP,SORT1
6544,GO:0022010,0.28450219876476,0.960187292640844,1,8,central nervous system myelination,BP,TENM4
7749,GO:0032291,0.28450219876476,0.960187292640844,1,8,axon ensheathment in central nervous system,BP,TENM4
10615,GO:0043679,0.284716167893098,0.867256361486434,4,66,axon terminus,CC,SV2A;KCNC4;GLUL;EPHA4
3279,GO:0006987,0.284795648366234,0.96009960672465,1,8,activation of signaling protein activity involved in unfolded protein response,BP,DAB2IP
6689,GO:0030118,0.284825187497167,0.885748372738547,3,45,clathrin coat,CC,EGFR;LDLRAP1;VPS33B
3198,GO:0006857,0.284854524579325,0.960082000662687,1,8,oligopeptide transport,BP,ABCC1
19065,GO:1905037,0.284872721724107,0.853689159240762,5,87,autophagosome organization,BP,ULK2;TP53INP2;TP53INP1;WIPI2;SMURF1
631,GO:0001824,0.284940023700134,0.885599609636179,3,46,blastocyst development,BP,TET1;RTF1;ZP3
17801,GO:1902018,0.285006137617083,0.960036642690999,1,8,negative regulation of cilium assembly,BP,EVI5L
10378,GO:0043249,0.285020827934725,0.960032246241768,1,8,erythrocyte maturation,BP,FAM210B
13898,GO:0060603,0.285032152682583,0.913446577874351,2,25,mammary gland duct morphogenesis,BP,GLI2;ETV5
606,GO:0001775,0.285041980942675,0.771280458336565,38,851,cell activation,BP,TNFAIP3;APOE;GPNMB;MAP3K14;EGFR;CYBA;GLI2;BCL6;PGM1;SFRP1;VAV3;GAA;ZFPM1;CTSB;SERPINE2;PRSS3;F2R;HEXB;HGSNAT;DMTN;PIK3R1;NCK2;TYRO3;CXCR1;METTL7A;ZP3;STOM;VAMP2;EFNB3;NDRG1;ADORA2B;MYL9;ERBB2;BLOC1S4;IL20RB;CCDC88B;TCIRG1;VPS33B
16814,GO:0098779,0.285063613569992,0.960019439990806,1,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,SMURF1
17628,GO:1901526,0.285063613569992,0.960019439990806,1,8,positive regulation of mitophagy,BP,SMURF1
4250,GO:0009615,0.285129594855373,0.813123441199082,11,222,response to virus,BP,TNFAIP3;IFITM1;MAP3K14;HTRA1;OAS2;DDX60;ACTA2;TRIM22;HYAL1;STAT1;IFI16
3109,GO:0006704,0.285147207755344,0.959994412521209,1,8,glucocorticoid biosynthetic process,BP,HSD11B1
18149,GO:1902959,0.285177374015626,0.959985378782826,1,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,EPHA4
19138,GO:1905245,0.285177374015626,0.959985378782826,1,8,regulation of aspartic-type peptidase activity,BP,EPHA4
578,GO:0001731,0.28523263261193,0.9599688277598,1,8,formation of translation preinitiation complex,BP,RPL13A
20243,GO:2001256,0.285414352070125,0.959914371799089,1,8,regulation of store-operated calcium entry,BP,HOMER2
13793,GO:0060433,0.285717988799253,0.95982328685273,1,8,bronchus development,BP,TULP3
3056,GO:0006638,0.285753035058057,0.86657161726597,4,66,neutral lipid metabolic process,BP,APOE;LMF1;ACSL1;SREBF1
8595,GO:0034139,0.285865251922973,0.959779068504046,1,8,regulation of toll-like receptor 3 signaling pathway,BP,TNFAIP3
19031,GO:1904953,0.285936312867721,0.959757721303619,1,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3
11318,GO:0045687,0.286055661725964,0.912759961498469,2,26,positive regulation of glial cell differentiation,BP,SERPINE2;TENM4
596,GO:0001764,0.28613524320207,0.852875647347616,5,85,neuron migration,BP,NDN;UNK;MATN2;DAB2IP;SPOCK1
5435,GO:0016328,0.286175476330147,0.884933728263405,3,45,lateral plasma membrane,CC,NSG1;ERBB3;VANGL2
2321,GO:0005351,0.28623121401343,0.959669062074499,1,8,carbohydrate:proton symporter activity,MF,SLC2A9
1296,GO:0003151,0.286245490670449,0.884891426536091,3,45,outflow tract morphogenesis,BP,ZFPM1;TBX1;PLXND1
16869,GO:0098876,0.286270952122529,0.866229128244725,4,66,vesicle-mediated transport to the plasma membrane,BP,NSG1;VAMP3;VAMP2;MICALL1
6342,GO:0021542,0.286333803405236,0.959638193515234,1,8,dentate gyrus development,BP,MDK
1294,GO:0003149,0.286471491915252,0.959596742706365,1,8,membranous septum morphogenesis,BP,VANGL2
2751,GO:0006183,0.28650009427754,0.959009470789148,1,9,GTP biosynthetic process,BP,NME4
5557,GO:0016593,0.286513054010918,0.959584225775046,1,8,Cdc73/Paf1 complex,CC,RTF1
11865,GO:0046929,0.286533039147385,0.959578206222119,1,8,negative regulation of neurotransmitter secretion,BP,ASIC1
480,GO:0001527,0.286545260903997,0.959574524759356,1,8,microfibril,CC,LTBP1
13996,GO:0060766,0.286695496552993,0.959529254875213,1,8,negative regulation of androgen receptor signaling pathway,BP,SFRP1
6754,GO:0030208,0.286914994828482,0.959463062516555,1,8,dermatan sulfate biosynthetic process,BP,CSPG4
11587,GO:0046326,0.286926692916959,0.912485751209825,2,25,positive regulation of glucose import,BP,INSR;PIK3R1
12876,GO:0051262,0.28720996876475,0.841483277430635,6,115,protein tetramerization,BP,ALDH1A3;GPX3;INSR;PKD2;DNM1;CRTC1
11553,GO:0046165,0.287216881826757,0.841595037401752,6,110,alcohol biosynthetic process,BP,APOE;SEC14L2;SREBF1;IMPA2;MVD;ISYNA1
12559,GO:0050775,0.287830065687255,0.912025914726185,2,25,positive regulation of dendrite morphogenesis,BP,OBSL1;EPHA4
4322,GO:0009891,0.287881827729602,0.759294656064205,58,1314,positive regulation of biosynthetic process,BP,PEG3;APOE;NDN;ASH2L;EGFR;THRA;CITED4;CYBA;TCEA2;GLI2;FGFR4;IRF2BPL;ZNF318;SFRP1;POU3F1;INSR;PKD2;ZFPM1;RGMA;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;SOX12;DAB2IP;TBX1;TRERF1;YEATS4;TET1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;PLXND1;SREBF1;PIK3R1;PTHLH;NCK2;ACVR1B;NFATC4;RTF1;ZP3;TP53INP1;MDK;ADORA2B;MC1R;IMPACT;CRTC1;ERBB2;RNF187;STAT1;IFI16;DBP;CCDC3;CAMK1;SP100
7168,GO:0031076,0.288100079675186,0.911888260312428,2,25,embryonic camera-type eye development,BP,ALDH1A3;TULP3
5853,GO:0017185,0.288298100342633,0.95904455273181,1,8,peptidyl-lysine hydroxylation,BP,VPS33B
8974,GO:0035136,0.288441956733056,0.911543663538317,2,26,forelimb morphogenesis,BP,WNT3;WNT9A
4187,GO:0009312,0.288466590834383,0.911531067842545,2,26,oligosaccharide biosynthetic process,BP,SLC2A1;ST6GALNAC6
9593,GO:0036490,0.288664067517405,0.95893340601273,1,8,regulation of translation in response to endoplasmic reticulum stress,BP,NCK2
7741,GO:0032279,0.288698590774746,0.825374562204903,8,149,asymmetric synapse,CC,PTPRS;EPB41L3;DNM1;EPHA4;HOMER2;SPOCK1;DMTN;NCK2
16230,GO:0090335,0.288699658339802,0.958922587679651,1,8,regulation of brown fat cell differentiation,BP,TRPV4
13350,GO:0052689,0.288804436845099,0.850867053437645,5,89,carboxylic ester hydrolase activity,MF,NLGN2;CES2;BPHL;H6PD;PGLS
10800,GO:0044327,0.28882132996033,0.958885591607413,1,8,dendritic spine head,CC,DNM1
12110,GO:0048251,0.288901708529659,0.958861140892415,1,8,elastic fiber assembly,BP,TNXB
7994,GO:0032649,0.288923573127738,0.88311049780456,3,47,regulation of interferon-gamma production,BP,ZFPM1;ZP3;IL20RB
13659,GO:0060252,0.2889777505221,0.958838001713708,1,8,positive regulation of glial cell proliferation,BP,ETV5
11082,GO:0045141,0.28910187685732,0.958800214789344,1,8,meiotic telomere clustering,BP,SUN1
16152,GO:0090220,0.28910187685732,0.958800214789344,1,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,SUN1
18770,GO:1904377,0.289155182311194,0.883128087767448,3,45,positive regulation of protein localization to cell periphery,BP,EPHB2;EGFR;PIK3R1
9519,GO:0036310,0.289295804619285,0.958741139137117,1,8,annealing helicase activity,MF,SMARCA1
13727,GO:0060346,0.289458650070417,0.9586914947255,1,8,bone trabecula formation,BP,SFRP1
14464,GO:0062009,0.289611256592815,0.958644940819827,1,8,secondary palate development,BP,TBX1
3214,GO:0006883,0.289804506950259,0.958585945267025,1,8,cellular sodium ion homeostasis,BP,ATP12A
1312,GO:0003174,0.290027420125944,0.958517834670186,1,8,mitral valve development,BP,ZFPM1
14122,GO:0061045,0.290056499956292,0.882498416502823,3,46,negative regulation of wound healing,BP,APOE;SERPINE2;SERPING1
16771,GO:0098661,0.290149688980604,0.882523002472921,3,45,inorganic anion transmembrane transport,BP,ANO9;CLCN7;SLC1A4
7105,GO:0030948,0.290262818238417,0.958445840033601,1,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,DAB2IP
3268,GO:0006971,0.290320990890154,0.958428037419371,1,8,hypotonic response,BP,TRPV4
12067,GO:0048143,0.290465102120855,0.958383916232386,1,8,astrocyte activation,BP,EGFR
8325,GO:0033209,0.290483445511392,0.830707341169217,7,138,tumor necrosis factor-mediated signaling pathway,BP,TNFAIP3;MAP3K14;TXNDC17;RBCK1;TNFRSF19;STAT1;CCDC3
2425,GO:0005639,0.290489901871091,0.958376320832609,1,8,integral component of nuclear inner membrane,CC,SUN1
7242,GO:0031229,0.290489901871091,0.958376320832609,1,8,intrinsic component of nuclear inner membrane,CC,SUN1
10874,GO:0044453,0.290489901871091,0.958376320832609,1,8,nuclear membrane part,CC,SUN1
10693,GO:0044065,0.290545734663829,0.958359218073766,1,8,regulation of respiratory system process,BP,NLGN2
19137,GO:1905244,0.290708455951505,0.958309350257655,1,8,regulation of modification of synaptic structure,BP,EPHA4
7745,GO:0032287,0.290756608438677,0.958294586843612,1,8,peripheral nervous system myelin maintenance,BP,NDRG1
18559,GO:1903867,0.290806429105349,0.95827930883172,1,8,extraembryonic membrane development,BP,HTRA1
1440,GO:0003684,0.290914477488703,0.863095589684864,4,67,damaged DNA binding,MF,DDB2;XPC;CRY2;MPG
7537,GO:0031901,0.291041637353242,0.838822886486184,6,109,early endosome membrane,CC,EGFR;NSG1;EPHA4;APPL2;PDLIM4;VPS33B
14093,GO:0061000,0.291083771805665,0.958194200524189,1,8,negative regulation of dendritic spine development,BP,PTPRS
16555,GO:0097421,0.291202997064785,0.909967503031443,2,27,liver regeneration,BP,SRSF5;EGFR
7552,GO:0031936,0.29128799738643,0.958131466433412,1,8,negative regulation of chromatin silencing,BP,TET1
12632,GO:0050879,0.291392681640834,0.910029155944071,2,26,multicellular organismal movement,BP,GAA;SYNM
12634,GO:0050881,0.291392681640834,0.910029155944071,2,26,musculoskeletal movement,BP,GAA;SYNM
18485,GO:1903708,0.291402159206298,0.838533462958109,6,110,positive regulation of hemopoiesis,BP,GLI2;BCL6;ACVR1B;FAM210B;GPR68;STAT1
10078,GO:0042626,0.291510577456504,0.862747117633817,4,66,ATPase activity, coupled to transmembrane movement of substances,MF,ATP6V0A2;ATP12A;TCIRG1;ABCC1
11493,GO:0046051,0.29154501837745,0.957453126584238,1,9,UTP metabolic process,BP,NME4
646,GO:0001840,0.291571137125964,0.958044402645998,1,8,neural plate development,BP,VANGL2
11582,GO:0046321,0.291691436484787,0.958007380060517,1,8,positive regulation of fatty acid oxidation,BP,MLYCD
8113,GO:0032836,0.291880849443035,0.957949049720338,1,8,glomerular basement membrane development,BP,LAMB2
19619,GO:1990909,0.291916783860681,0.957937978382673,1,8,Wnt signalosome,CC,WNT3
9197,GO:0035612,0.292022974865797,0.957905251377131,1,8,AP-2 adaptor complex binding,MF,LDLRAP1
14809,GO:0070603,0.292136867596421,0.862279357895476,4,67,SWI/SNF superfamily-type complex,CC,SALL2;YEATS4;SMARCA1;APPL2
1617,GO:0004065,0.292151431623207,0.957865642867084,1,8,arylsulfatase activity,MF,ARSI
13620,GO:0060174,0.292238834242949,0.957838680879869,1,8,limb bud formation,BP,WNT3
7459,GO:0031643,0.292583071235715,0.957732394757729,1,8,positive regulation of myelination,BP,TENM4
14303,GO:0061548,0.292583343035207,0.957732310776928,1,8,ganglion development,BP,TULP3
14993,GO:0070977,0.292738220238166,0.957684441209855,1,8,bone maturation,BP,PLXNB1
12884,GO:0051279,0.292908452782523,0.880755794983316,3,46,regulation of release of sequestered calcium ion into cytosol,BP,CYBA;PKD2;F2R
17517,GO:1901135,0.292921321700926,0.762924601764245,40,909,carbohydrate derivative metabolic process,BP,APOE;LMF1;GAMT;ST3GAL5;FBXO2;PGM1;XYLT1;DHTKD1;INSR;PKD2;ARSI;NT5E;VEGFB;H6PD;SGSH;TET1;FAM20C;B3GNT9;HEXB;PGLS;HGSNAT;ATP6V0A2;CSPG4;PTHLH;SDC3;HYAL1;GPC4;SDHA;ADORA2B;NAGLU;MVD;NME4;COX5B;XYLT2;TCIRG1;NADK;ST6GALNAC6;IDUA;PIGZ;VANGL2
13065,GO:0051639,0.293071455257701,0.957581339731935,1,8,actin filament network formation,BP,FHOD3
15525,GO:0072015,0.293248343101518,0.957526553160661,1,8,glomerular visceral epithelial cell development,BP,LAMB2
15695,GO:0072310,0.293248343101518,0.957526553160661,1,8,glomerular epithelial cell development,BP,LAMB2
1411,GO:0003373,0.293389376571899,0.957482842634809,1,8,dynamin family protein polymerization involved in membrane fission,BP,DNM1
1412,GO:0003374,0.293389376571899,0.957482842634809,1,8,dynamin family protein polymerization involved in mitochondrial fission,BP,DNM1
9157,GO:0035562,0.293463317791591,0.95745991575659,1,8,negative regulation of chromatin binding,BP,NFATC4
12636,GO:0050884,0.293464940845778,0.957459412418637,1,8,neuromuscular process controlling posture,BP,GAA
5760,GO:0017001,0.293664283022774,0.908544526102576,2,28,antibiotic catabolic process,BP,GPX3;ALDH2
7997,GO:0032652,0.293822779804493,0.880115987924974,3,47,regulation of interleukin-1 production,BP,TNFAIP3;F2R;IFI16
6366,GO:0021575,0.294264854126082,0.908543786718616,2,26,hindbrain morphogenesis,BP,GLI2;SERPINE2
15374,GO:0071679,0.294269175164816,0.957209586317267,1,8,commissural neuron axon guidance,BP,EPHB2
12495,GO:0050680,0.294377201855585,0.847000686537761,5,87,negative regulation of epithelial cell proliferation,BP,APOE;SFRP1;DAB2IP;CTSV;STAT1
7126,GO:0030991,0.294778127446178,0.957051054039767,1,8,intraciliary transport particle A,CC,TULP3
16211,GO:0090308,0.294928485610198,0.957004155204486,1,8,regulation of methylation-dependent chromatin silencing,BP,TET1
10772,GO:0044291,0.29506960583341,0.879511672248426,3,45,cell-cell contact zone,CC,OBSL1;SCN4B;SLC2A1
18357,GO:1903426,0.295089064562621,0.879337197690232,3,47,regulation of reactive oxygen species biosynthetic process,BP,CYBA;INSR;PKD2
15497,GO:0071936,0.295113768194901,0.956946322690863,1,8,coreceptor activity involved in Wnt signaling pathway,MF,GPC4
17445,GO:1900402,0.295142901956514,0.956937225084216,1,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,FOXO1
3499,GO:0007435,0.295944264924229,0.907670150878941,2,26,salivary gland morphogenesis,BP,EGFR;PLXND1
2417,GO:0005614,0.295992214077352,0.956671526840851,1,8,interstitial matrix,CC,SMOC2
14626,GO:0070268,0.296182814906786,0.859423843799137,4,70,cornification,BP,KLK5;PPL;KLK8;FURIN
18130,GO:1902936,0.296260184960805,0.859513577816235,4,67,phosphatidylinositol bisphosphate binding,MF,LDLRAP1;TULP3;WIPI2;PLCD1
1162,GO:0002792,0.296279814943706,0.859451640457668,4,68,negative regulation of peptide secretion,BP,SFRP1;RHBDF1;F2R;SREBF1
12520,GO:0050709,0.296279814943706,0.859451640457668,4,68,negative regulation of protein secretion,BP,SFRP1;RHBDF1;F2R;SREBF1
14875,GO:0070757,0.296330416953069,0.956565463316538,1,8,interleukin-35-mediated signaling pathway,BP,STAT1
13845,GO:0060525,0.296407926136924,0.956541134823031,1,8,prostate glandular acinus development,BP,SFRP1
15173,GO:0071361,0.296409953093079,0.956540498499758,1,8,cellular response to ethanol,BP,TP53INP1
14535,GO:0070106,0.29644570012657,0.956529275540967,1,8,interleukin-27-mediated signaling pathway,BP,STAT1
2264,GO:0005225,0.29697206049185,0.956363830041691,1,8,volume-sensitive anion channel activity,MF,LRRC8E
18557,GO:1903861,0.296989442242272,0.956358360476314,1,8,positive regulation of dendrite extension,BP,SMURF1
1388,GO:0003333,0.297363393215321,0.878013664048434,3,46,amino acid transmembrane transport,BP,SLC38A4;PQLC2;SLC1A4
13711,GO:0060326,0.297363862224422,0.825549190353442,7,135,cell chemotaxis,BP,CKLF;VAV3;CXCL14;VEGFB;CXCR1;TRPV4;ABCC1
3297,GO:0007016,0.297409668762734,0.956226007126292,1,8,cytoskeletal anchoring at plasma membrane,BP,EPB41L3
11329,GO:0045725,0.298006700742681,0.956037572871834,1,8,positive regulation of glycogen biosynthetic process,BP,INSR
15704,GO:0072330,0.298042761807037,0.807068466233134,10,201,monocarboxylic acid biosynthetic process,BP,ALDH1A3;FGFR4;PGM1;DHTKD1;INSR;CSPG4;AMACR;MLYCD;THNSL2;ALOXE3
3572,GO:0007638,0.298229506471763,0.955967132484856,1,8,mechanosensory behavior,BP,SLITRK6
8863,GO:0034706,0.298266734281469,0.955955356554142,1,8,sodium channel complex,CC,SCN4B
10360,GO:0043225,0.298336137680492,0.955933397998621,1,8,ATPase-coupled anion transmembrane transporter activity,MF,ABCC1
16973,GO:0099133,0.298336137680492,0.955933397998621,1,8,ATP hydrolysis coupled anion transmembrane transport,BP,ABCC1
2397,GO:0005583,0.298509224510875,0.955878607700524,1,8,fibrillar collagen trimer,CC,TNXB
16758,GO:0098643,0.298509224510875,0.955878607700524,1,8,banded collagen fibril,CC,TNXB
5464,GO:0016417,0.298535853930852,0.906149398817597,2,27,S-acyltransferase activity,MF,ZDHHC1;GOLGA7B
5942,GO:0018345,0.298794736726988,0.906013285815067,2,27,protein palmitoylation,BP,ZDHHC1;GOLGA7B
15526,GO:0072017,0.299046045503961,0.955708429895753,1,8,distal tubule development,BP,PKD2
10384,GO:0043256,0.299453230443297,0.955579097599047,1,8,laminin complex,CC,LAMB2
18302,GO:1903307,0.299488730788591,0.905647960573598,2,27,positive regulation of regulated secretory pathway,BP,ZP3;ADORA2B
8695,GO:0034368,0.299826895901859,0.954826221993441,1,9,protein-lipid complex remodeling,BP,APOE
8696,GO:0034369,0.299826895901859,0.954826221993441,1,9,plasma lipoprotein particle remodeling,BP,APOE
14644,GO:0070301,0.299841544643815,0.8569984226821,4,69,cellular response to hydrogen peroxide,BP,TNFAIP3;FOXO1;ENDOG;IMPACT
6201,GO:0019752,0.299947392375313,0.761603464138966,33,746,carboxylic acid metabolic process,BP,ALDH1A3;CPT2;GAMT;CRAT;FGFR4;PGM1;CYP4F22;DHTKD1;INSR;CES2;PDPR;BPHL;UROS;CRTAP;CYP27C1;GLUL;TYSND1;HEXB;ACSL1;SREBF1;CSPG4;SLC2A1;CPT1C;HYAL1;CKMT1A;MTHFR;SDHA;AMACR;MLYCD;THNSL2;ALOXE3;ABCC1;IDUA
4331,GO:0009913,0.300062510641763,0.810505349481338,9,180,epidermal cell differentiation,BP,PRR9;SLITRK6;POU3F1;KLK5;CTSV;PPL;CTSL;KLK8;FURIN
15786,GO:0072529,0.300119089645917,0.905161360992786,2,28,pyrimidine-containing compound catabolic process,BP,NT5E;TET1
504,GO:0001562,0.300353669567324,0.954656088349136,1,9,response to protozoan,BP,CCDC88B
10181,GO:0042832,0.300353669567324,0.954656088349136,1,9,defense response to protozoan,BP,CCDC88B
4481,GO:0010524,0.301007150118164,0.904846396392775,2,27,positive regulation of calcium ion transport into cytosol,BP,PKD2;F2R
5708,GO:0016868,0.301389264697881,0.954320550840503,1,9,intramolecular transferase activity, phosphotransferases,MF,PGM1
4721,GO:0010906,0.301699248233506,0.855835782856288,4,67,regulation of glucose metabolic process,BP,INSR;FOXO1;IGFBP4;MLYCD
12212,GO:0048523,0.302258072364077,0.732615979225498,139,3280,negative regulation of cellular process,BP,TNFAIP3;POSTN;IFITM1;PEG3;TGFBI;HES2;APOE;IFI6;LAMP3;ULK2;PTPRS;GPNMB;NDN;MAP3K14;EPHB2;HTRA1;EGFR;FBXO2;THRA;CYBA;GLI2;FGFR4;APCDD1;IRF2BPL;BCL6;TENM2;ZNF318;BRSK1;SFRP1;FHOD3;UNK;TNFSF10;INSR;PKD2;ESPN;ZFPM1;RGMA;DNM1;CXCL14;SERPINE2;HR;SALL2;WWTR1;RHBDF1;FOXO1;WNT3;RASIP1;DAB2IP;COL7A1;TBX1;CRTAP;GAS8;EVI5L;MNT;TET1;EPHA4;WNT9A;RPL13A;MAGEF1;DIXDC1;F2R;TCFL5;CTSV;RPS6KA5;LTBP1;ZBTB42;ERBB3;KIF26A;SPOCK1;VAMP3;FRY;PLXND1;CGREF1;SREBF1;DMTN;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;KCTD11;XPC;NAB2;NFATC4;SNX33;TYRO3;HYAL1;RTF1;ZP3;PLEKHH2;RBCK1;EFNB3;PCBP4;SPRY2;MBD1;TP53INP1;MDK;TRPV4;NDRG1;KLK8;PPP1R35;SERPING1;RTN4RL1;IMPACT;IGFBP4;GPR68;TOM1L2;ERBB2;EPM2A;H2AFJ;STAT1;TULP3;HINT2;ACKR3;CRY2;FURIN;IFI16;IL20RB;GJC2;ARPIN;ASIC1;PER3;PLXNB1;RASA4;SMURF1;KREMEN1;MEX3A;CCDC3;CXXC5;NISCH;ELFN2;MAP3K3;PPP1R14A;MDFI;SCMH1;SP100;NRK;SORT1;TP53I11
6106,GO:0019372,0.302678881310862,0.953900726332565,1,9,lipoxygenase pathway,BP,ALOXE3
10125,GO:0042737,0.303604473034425,0.854348080208147,4,71,drug catabolic process,BP,GPX3;NT5E;ALDH2;IDUA
5644,GO:0016772,0.303696099486228,0.756674381780785,35,773,transferase activity, transferring phosphorus-containing groups,MF,ULK2;MAP3K14;EPHB2;EGFR;OAS2;FGFR4;CDK18;BRSK1;INSR;OBSCN;FAM20C;EPHA4;RPS6KA5;LTBP1;ERBB3;CDK14;GRK6;PIK3R1;ACVR1B;CAMKK1;TYRO3;CKMT1A;EFNB3;ADCK5;LTBP4;NMRK1;MARK4;ERBB2;NME4;CDK20;NUAK1;CAMK1;NADK;MAP3K3;NRK
4365,GO:0010033,0.30372874502935,0.736531224660452,92,2152,response to organic substance,BP,TNFAIP3;POSTN;IFITM1;APOE;IFI6;LAMP3;NDN;MAP3K14;HTRA1;SRSF5;GPX3;MXRA5;COL6A1;EGFR;FBXO2;THRA;CYBA;OAS2;GLI2;FGFR4;BCL6;SFRP1;TNFSF10;INSR;PKD2;RGMA;CTSB;TMEM129;FOXO1;WNT3;UROS;DAB2IP;TBX1;FAM20C;GLUL;EPHA4;WNT9A;RPL13A;F2R;CTSV;RPS6KA5;TUB;HOMER2;TXNDC17;LTBP1;ACSL1;ATP6V0A2;VAMP3;SREBF1;DMTN;ENDOG;PIK3R1;TMEM204;CTSL;TRIM22;NCK2;UCN2;NFATC4;FAM210B;CXCR1;SLC2A1;HYAL1;VAMP2;RBCK1;SPRY2;TP53INP1;TNFRSF19;MDK;TRPV4;MTHFR;ITGB5;LTBP4;RTN4RL1;IMPACT;NEO1;GPR68;MICALL1;ERBB2;STAT1;ACKR3;CRY2;FURIN;IL20RB;MMP1;SMURF1;CCDC3;TCIRG1;MT2A;RAB43;MAP3K3;SP100;SORT1
11673,GO:0046501,0.304107776676231,0.953432986930391,1,9,protoporphyrinogen IX metabolic process,BP,UROS
14780,GO:0070555,0.304130143655269,0.820324506330104,7,138,response to interleukin-1,BP,CYBA;SFRP1;DAB2IP;RPS6KA5;HYAL1;MTHFR;MAP3K3
12285,GO:0048672,0.304193264920269,0.953404917013921,1,9,positive regulation of collateral sprouting,BP,WNT3
2705,GO:0006099,0.304205821072886,0.902990464925916,2,28,tricarboxylic acid cycle,BP,DHTKD1;SDHA
14133,GO:0061061,0.304696263000154,0.776904778851936,18,380,muscle structure development,BP,TAGLN;OBSL1;FLNC;THRA;FHOD3;ZFPM1;CXCL14;BOC;OBSCN;TBX1;OLFM2;ZBTB42;ERBB3;TMEM204;NFATC4;CAMK1;SORT1;VANGL2
12649,GO:0050906,0.304749978308979,0.902699711942161,2,28,detection of stimulus involved in sensory perception,BP,SERPINE2;REEP6
6242,GO:0019852,0.304760658886608,0.953218368101355,1,9,L-ascorbic acid metabolic process,BP,SLC2A1
17663,GO:1901611,0.304765152423622,0.953216888999604,1,9,phosphatidylglycerol binding,MF,NME4
3144,GO:0006767,0.304985346156767,0.853498448703457,4,69,water-soluble vitamin metabolic process,BP,PRSS3;SLC2A1;MTHFR;ABCC1
13096,GO:0051701,0.305073647911854,0.812541241188347,8,156,interaction with host,BP,IFITM1;ITGB6;EGFR;INSR;CTSB;TYRO3;EFNB3;ITGB5
4993,GO:0015171,0.305122203969846,0.873096852899734,3,47,amino acid transmembrane transporter activity,MF,SLC38A4;PQLC2;SLC1A4
303,GO:0000813,0.305430276069175,0.952997659382289,1,9,ESCRT I complex,CC,MVB12B
5307,GO:0016051,0.305701138608454,0.812033264995572,8,157,carbohydrate biosynthetic process,BP,PGM1;INSR;FOXO1;B3GNT9;IMPA2;SLC2A1;ST6GALNAC6;ISYNA1
11032,GO:0045064,0.305852779033114,0.952858093559987,1,9,T-helper 2 cell differentiation,BP,BCL6
1080,GO:0002675,0.306077975872767,0.952783606945651,1,9,positive regulation of acute inflammatory response,BP,ZP3
14151,GO:0061098,0.306095919002494,0.902137493320075,2,27,positive regulation of protein tyrosine kinase activity,BP,EPHA4;ERBB3
3878,GO:0008532,0.306108733144241,0.952773428357508,1,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,B3GNT9
4055,GO:0009125,0.306149937131633,0.952759790633721,1,9,nucleoside monophosphate catabolic process,BP,NT5E
5574,GO:0016620,0.306291166366515,0.902032864100268,2,27,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,ALDH1A3;ALDH2
7026,GO:0030819,0.306347655700568,0.95269431813243,1,9,positive regulation of cAMP biosynthetic process,BP,PTHLH
4237,GO:0009581,0.306415878251495,0.872283207652864,3,47,detection of external stimulus,BP,PKD2;SERPINE2;REEP6
10514,GO:0043497,0.306505872450964,0.952641888728533,1,9,regulation of protein heterodimerization activity,BP,DAB2IP
6059,GO:0019229,0.307031374818437,0.901635735324155,2,27,regulation of vasoconstriction,BP,EGFR;F2R
286,GO:0000791,0.307070446242214,0.901455373359008,2,28,euchromatin,CC,ASH2L;H1F0
3264,GO:0006958,0.307279876521436,0.952384920378913,1,9,complement activation, classical pathway,BP,SERPING1
6333,GO:0021532,0.307601239189637,0.901329495609987,2,27,neural tube patterning,BP,GLI2;TULP3
4630,GO:0010770,0.307714353217175,0.826435818867942,6,110,positive regulation of cell morphogenesis involved in differentiation,BP,OBSL1;WNT3;EPHA4;PLXND1;DMTN;PLXNB1
16614,GO:0097531,0.307899066785011,0.952178774293807,1,9,mast cell migration,BP,VEGFB
12709,GO:0051017,0.308075611644545,0.826164935562711,6,110,actin filament bundle assembly,BP,SFRP1;ESPN;DMTN;PIK3R1;RHOD;ITGB5
10057,GO:0042588,0.308082974618161,0.952117447481869,1,9,zymogen granule,CC,VAMP2
11080,GO:0045136,0.308323238721503,0.952037259719759,1,9,development of secondary sexual characteristics,BP,IRF2BPL
12485,GO:0050665,0.308607043687471,0.95194244082472,1,9,hydrogen peroxide biosynthetic process,BP,CYBA
17756,GO:1901881,0.308628068003524,0.951935412340185,1,9,positive regulation of protein depolymerization,BP,TRPV4
17571,GO:1901298,0.308707258219362,0.951908933532861,1,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG
13947,GO:0060700,0.308765687687963,0.951889391110822,1,9,regulation of ribonuclease activity,BP,OAS2
15580,GO:0072109,0.30906389578534,0.951789580747615,1,9,glomerular mesangium development,BP,ACTA2
1102,GO:0002698,0.309149137773544,0.85059532460537,4,70,negative regulation of immune effector process,BP,HTRA1;BCL6;SERPING1;IL20RB
9086,GO:0035404,0.309258699650952,0.951724315538098,1,9,histone-serine phosphorylation,BP,RPS6KA5
6904,GO:0030516,0.309280190065933,0.850653883490294,4,67,regulation of axon extension,BP,APOE;PTPRS;WNT3;EPHA4
11335,GO:0045737,0.309288902623971,0.900258960898146,2,28,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR;PKD2
10140,GO:0042759,0.309358939600532,0.951690712310015,1,9,long-chain fatty acid biosynthetic process,BP,ALOXE3
5596,GO:0016667,0.309620019308301,0.87002723595528,3,50,oxidoreductase activity, acting on a sulfur group of donors,MF,TXNRD3;TXNDC17;MSRB2
7849,GO:0032432,0.309729193081475,0.870189938773083,3,47,actin filament bundle,CC,CYBA;PDLIM4;VANGL2
8212,GO:0033005,0.309740173547352,0.951562789113285,1,9,positive regulation of mast cell activation,BP,ADORA2B
16294,GO:0090568,0.309767033102934,0.900161631600662,2,27,nuclear transcriptional repressor complex,CC,SALL2;APPL2
17780,GO:1901978,0.309930873537442,0.951498726581248,1,9,positive regulation of cell cycle checkpoint,BP,NDRG1
5420,GO:0016303,0.310238902851859,0.900080936318091,2,26,1-phosphatidylinositol-3-kinase activity,MF,FGFR4;PIK3R1
16037,GO:0090042,0.310291316622422,0.951377508472547,1,9,tubulin deacetylation,BP,FRY
16365,GO:0097035,0.310335379732602,0.899854115150551,2,27,regulation of membrane lipid distribution,BP,ANO9;ABCC1
18156,GO:1902969,0.310426596382931,0.951331968505138,1,9,mitotic DNA replication,BP,BCL6
7269,GO:0031281,0.310515621179014,0.951301986204745,1,9,positive regulation of cyclase activity,BP,ADORA2B
15329,GO:0071609,0.3105434641298,0.951292606907052,1,9,chemokine (C-C motif) ligand 5 production,BP,TRPV4
8978,GO:0035150,0.310553693735814,0.849675907456461,4,69,regulation of tube size,BP,APOE;EGFR;F2R;ADORA2B
12633,GO:0050880,0.310553693735814,0.849675907456461,4,69,regulation of blood vessel size,BP,APOE;EGFR;F2R;ADORA2B
4687,GO:0010867,0.310762389076,0.951218822644925,1,9,positive regulation of triglyceride biosynthetic process,BP,SREBF1
20154,GO:2001044,0.3108102892201,0.95120267028439,1,9,regulation of integrin-mediated signaling pathway,BP,DMTN
9735,GO:0039530,0.311107011957616,0.951102544052538,1,9,MDA-5 signaling pathway,BP,DDX60
16133,GO:0090195,0.311235484071536,0.951059155692733,1,9,chemokine secretion,BP,POSTN
8705,GO:0034380,0.311283347380212,0.951042985344971,1,9,high-density lipoprotein particle assembly,BP,APOE
16559,GO:0097428,0.311532656109786,0.950412671003075,1,10,protein maturation by iron-sulfur cluster transfer,BP,MAGEF1
555,GO:0001678,0.31180762221927,0.834346070895942,5,91,cellular glucose homeostasis,BP,CYBA;FOXO1;ENDOG;PIK3R1;GPR68
997,GO:0002478,0.31182122876303,0.814359800057766,7,140,antigen processing and presentation of exogenous peptide antigen,BP,CYBA;CTSV;KIF26A;VAMP3;CTSL;ITGB5;CTSF
18827,GO:1904526,0.311983796757275,0.950805990260346,1,9,regulation of microtubule binding,BP,GAS8
17682,GO:1901652,0.31205726544012,0.775080516173057,16,338,response to peptide,BP,TNFAIP3;SRSF5;CYBA;TNFSF10;INSR;FOXO1;EPHA4;ATP6V0A2;SREBF1;PIK3R1;SLC2A1;VAMP2;TRPV4;STAT1;TCIRG1;SORT1
3529,GO:0007567,0.312314323147516,0.950693928456743,1,9,parturition,BP,NRK
18573,GO:1903897,0.312340522706286,0.950685039459793,1,9,regulation of PERK-mediated unfolded protein response,BP,NCK2
17672,GO:1901623,0.312407822664531,0.950662201668226,1,9,regulation of lymphocyte chemotaxis,BP,CXCL14
17830,GO:1902105,0.312437014239678,0.806726960910358,8,157,regulation of leukocyte differentiation,BP,GLI2;BCL6;SFRP1;ZFPM1;FAM213A;PIK3R1;GPR68;ERBB2
441,GO:0001190,0.312594954044422,0.868368532658743,3,47,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,CITED4;POU3F1;SOX12
13776,GO:0060411,0.31260856189056,0.868359859754174,3,47,cardiac septum morphogenesis,BP,ZFPM1;TBX1;VANGL2
15817,GO:0072577,0.312937620176947,0.898440557235809,2,27,endothelial cell apoptotic process,BP,TNFAIP3;DAB2IP
940,GO:0002363,0.313516780834538,0.950285005770701,1,9,alpha-beta T cell lineage commitment,BP,ZFPM1
3710,GO:0008253,0.313672405995531,0.950231939535636,1,9,5'-nucleotidase activity,MF,NT5E
16229,GO:0090331,0.313691693135049,0.950225360587259,1,9,negative regulation of platelet aggregation,BP,SERPINE2
12558,GO:0050774,0.313999475364766,0.950120306493532,1,9,negative regulation of dendrite morphogenesis,BP,NFATC4
17798,GO:1902004,0.314068751231845,0.950096643213129,1,9,positive regulation of amyloid-beta formation,BP,EPHA4
6829,GO:0030317,0.314198211036474,0.897587792399243,2,28,flagellated sperm motility,BP,GAS8;MAFIP
17953,GO:1902430,0.314268160769115,0.950028492660761,1,9,negative regulation of amyloid-beta formation,BP,APOE
15549,GO:0072070,0.314334462125048,0.950005821502477,1,9,loop of Henle development,BP,PKD2
3619,GO:0008097,0.314482166422054,0.949398848688326,1,10,5S rRNA binding,MF,TST
15814,GO:0072574,0.315088759814857,0.949747478105598,1,9,hepatocyte proliferation,BP,TNFAIP3
15815,GO:0072575,0.315088759814857,0.949747478105598,1,9,epithelial cell proliferation involved in liver morphogenesis,BP,TNFAIP3
16917,GO:0098969,0.315158225111677,0.949723647905963,1,9,neurotransmitter receptor transport to postsynaptic membrane,BP,NSG1
18410,GO:1903539,0.315158225111677,0.949723647905963,1,9,protein localization to postsynaptic membrane,BP,NSG1
18411,GO:1903540,0.315158225111677,0.949723647905963,1,9,establishment of protein localization to postsynaptic membrane,BP,NSG1
4254,GO:0009628,0.315172721486267,0.744087045841034,38,861,response to abiotic stimulus,BP,POSTN;MAP3K14;SLITRK6;EGFR;THRA;CYBA;GLI2;BRSK1;SFRP1;PKD2;SERPINE2;VEGFB;FOXO1;DDB2;ATP6V0A2;PPL;ENDOG;PIK3R1;XPC;NFATC4;SLC2A1;HYAL1;TP53INP1;TRPV4;MTHFR;NDRG1;MC1R;IMPACT;CRTC1;GPR68;STAT1;CRY2;CLCN7;IFI16;SUN1;ASIC1;PER3;REEP6
12973,GO:0051446,0.315230504965583,0.94969884524151,1,9,positive regulation of meiotic cell cycle,BP,INSR
16123,GO:0090185,0.315241635790824,0.949695025096946,1,9,negative regulation of kidney development,BP,STAT1
10211,GO:0042975,0.315247498036621,0.94969301308296,1,9,peroxisome proliferator activated receptor binding,MF,NFATC4
10532,GO:0043524,0.315266921788412,0.831823198923063,5,91,negative regulation of neuron apoptotic process,BP,APOE;F2R;ERBB3;TYRO3;MDK
6745,GO:0030199,0.315280753188843,0.897159935824271,2,27,collagen fibril organization,BP,TNXB;VPS33B
14316,GO:0061572,0.315360230801079,0.820648869299278,6,111,actin filament bundle organization,BP,SFRP1;ESPN;DMTN;PIK3R1;RHOD;ITGB5
4188,GO:0009313,0.315436446361828,0.949628138188579,1,9,oligosaccharide catabolic process,BP,HEXB
12571,GO:0050792,0.315474069248997,0.804274215454078,8,160,regulation of viral process,BP,IFITM1;APOE;MVB12B;LAMP3;OAS2;STOM;STAT1;IFI16
17592,GO:1901343,0.315474366492457,0.846319517325453,4,68,negative regulation of vasculature development,BP,ADGRB2;DAB2IP;SPRY2;STAT1
18342,GO:1903391,0.316303682354048,0.865996361492462,3,47,regulation of adherens junction organization,BP,SFRP1;DMTN;RHOD
7021,GO:0030814,0.316306236117169,0.896430828569451,2,28,regulation of cAMP metabolic process,BP,PKD2;PTHLH
13130,GO:0051767,0.316498505022636,0.949262584248222,1,9,nitric-oxide synthase biosynthetic process,BP,STAT1
13131,GO:0051769,0.316498505022636,0.949262584248222,1,9,regulation of nitric-oxide synthase biosynthetic process,BP,STAT1
3309,GO:0007032,0.316552324322419,0.845469500204927,4,70,endosome organization,BP,DNM1;SNX33;ALS2CL;VPS33B
17473,GO:1900746,0.316695599007577,0.94919457768371,1,9,regulation of vascular endothelial growth factor signaling pathway,BP,DAB2IP
17992,GO:1902547,0.316695599007577,0.94919457768371,1,9,regulation of cellular response to vascular endothelial growth factor stimulus,BP,DAB2IP
13861,GO:0060546,0.316716970492716,0.949187200366532,1,9,negative regulation of necroptotic process,BP,RBCK1
736,GO:0001972,0.317028716489004,0.949079517001835,1,9,retinoic acid binding,MF,CYP27C1
7296,GO:0031325,0.31709387435348,0.723837663490494,93,2166,positive regulation of cellular metabolic process,BP,TNFAIP3;PEG3;APOE;GPNMB;NDN;MAP3K14;EPHB2;ASH2L;SRSF5;EGFR;THRA;CITED4;CYBA;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;ZNF318;SFRP1;POU3F1;TNFSF10;INSR;VAV3;PKD2;ZFPM1;RGMA;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;TRIM65;NSG1;SOX12;DAB2IP;TBX1;TRERF1;SHC2;YEATS4;TET1;EPHA4;MAGEF1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;ACSL1;ERBB3;VAMP3;PLXND1;SREBF1;CSPG4;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;CAMKK1;NAB2;NFATC4;SNX33;TYRO3;RTF1;ZP3;SPRY2;TP53INP1;TNFRSF19;MDK;TRPV4;ADORA2B;MC1R;IMPACT;CRTC1;IGFBP4;ERBB2;RNF187;EPM2A;STAT1;CDK20;ACKR3;FURIN;IFI16;MLYCD;DBP;SMURF1;CAMK1;MAP3K3;SP100;NRK;VANGL2
1371,GO:0003281,0.317343766160182,0.865328066799554,3,47,ventricular septum development,BP,ZFPM1;LTBP1;VANGL2
2812,GO:0006294,0.317524981673157,0.89560383670173,2,29,nucleotide-excision repair, preincision complex assembly,BP,DDB2;XPC
17404,GO:1900221,0.317557386384377,0.948896602444175,1,9,regulation of amyloid-beta clearance,BP,APOE
10136,GO:0042754,0.317825185231743,0.948803801961862,1,9,negative regulation of circadian rhythm,BP,CRY2
6725,GO:0030163,0.31794688978804,0.745421201047413,33,742,protein catabolic process,BP,TNFAIP3;APOE;MVB12B;LAMP3;EGFR;FBXO2;CTSB;SERPINE2;TP53INP2;WWTR1;RHBDF1;TMEM129;FOXO1;DAB2IP;SGSH;EPHA4;MAGEF1;CTSV;CUL9;CTSL;SNX33;RBCK1;SPATA18;FBXW4;BTBD2;RNF187;RNF44;FURIN;FBXW5;CTSF;SMURF1;TCIRG1;FBXO44
265,GO:0000733,0.317958846420001,0.948757447847876,1,9,DNA strand renaturation,BP,SMARCA1
17269,GO:0140115,0.318003249583853,0.948742043324165,1,9,export across plasma membrane,BP,ATP12A
13566,GO:0060077,0.318022462791642,0.948735376970981,1,9,inhibitory synapse,CC,NLGN2
4662,GO:0010828,0.318231864837442,0.895536482105036,2,27,positive regulation of glucose transmembrane transport,BP,INSR;PIK3R1
11925,GO:0047144,0.318271752322455,0.948648836212159,1,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT7
19445,GO:1990253,0.318274621307929,0.948647839753564,1,9,cellular response to leucine starvation,BP,IMPACT
11269,GO:0045623,0.318318317632655,0.948632661724564,1,9,negative regulation of T-helper cell differentiation,BP,BCL6
4238,GO:0009582,0.3184701835271,0.86451936033956,3,48,detection of abiotic stimulus,BP,PKD2;SERPINE2;REEP6
1805,GO:0004467,0.318496869725563,0.948570614237361,1,9,long-chain fatty acid-CoA ligase activity,MF,ACSL1
11326,GO:0045722,0.318989633945289,0.948399152041948,1,9,positive regulation of gluconeogenesis,BP,FOXO1
18792,GO:1904424,0.319191840542718,0.948328696676182,1,9,regulation of GTP binding,BP,EPHA4
6734,GO:0030175,0.31928257197889,0.843664672655181,4,68,filopodium,CC,TENM2;EPHA4;ACTA2;TRPV4
4623,GO:0010763,0.319600170445296,0.948186251580193,1,9,positive regulation of fibroblast migration,BP,DMTN
6694,GO:0030123,0.31965944572348,0.948165554644777,1,9,AP-3 adaptor complex,CC,VPS33B
8423,GO:0033572,0.319793863332084,0.894346547464121,2,29,transferrin transport,BP,ATP6V0A2;TCIRG1
12620,GO:0050864,0.319866751420912,0.843154635241466,4,70,regulation of B cell activation,BP,TNFAIP3;BCL6;SFRP1;VAV3
17667,GO:1901617,0.319873062636445,0.800790831283248,8,159,organic hydroxy compound biosynthetic process,BP,APOE;FGFR4;SEC14L2;SREBF1;IMPA2;AMACR;MVD;ISYNA1
19688,GO:2000095,0.319963194629143,0.948059420633631,1,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,SFRP1
1168,GO:0002822,0.320053499842573,0.842975348688081,4,71,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,TNFAIP3;BCL6;ZP3;IL20RB
8720,GO:0034397,0.3200785130965,0.948019093866268,1,9,telomere localization,BP,SUN1
19800,GO:2000310,0.320174396720548,0.947985549647077,1,9,regulation of NMDA receptor activity,BP,EPHB2
3675,GO:0008195,0.32021951187713,0.947969762087913,1,9,phosphatidate phosphatase activity,MF,PLPP2
11843,GO:0046887,0.320277069115156,0.842867200087405,4,70,positive regulation of hormone secretion,BP,EGFR;NLGN2;GLUL;GPR68
19801,GO:2000311,0.320401493361983,0.947906051472596,1,9,regulation of AMPA receptor activity,BP,NLGN2
9658,GO:0038066,0.320534844901925,0.894091898282204,2,28,p38MAPK cascade,BP,DAB2IP;MAP3K3
10596,GO:0043627,0.320687815431601,0.863005622236185,3,49,response to estrogen,BP,ASH2L;CITED4;SFRP1
8899,GO:0034770,0.321275874308582,0.94759930600856,1,9,histone H4-K20 methylation,BP,KMT5C
2805,GO:0006285,0.32138430278057,0.946980014458181,1,10,base-excision repair, AP site formation,BP,MPG
14702,GO:0070411,0.321527594674384,0.947510805392597,1,9,I-SMAD binding,MF,SMURF1
7916,GO:0032526,0.321834590764252,0.841725617665248,4,71,response to retinoic acid,BP,WNT3;TBX1;WNT9A;SREBF1
19860,GO:2000392,0.321840784667738,0.947400572242996,1,9,regulation of lamellipodium morphogenesis,BP,ARPIN
13801,GO:0060442,0.321841932792526,0.947400167892131,1,9,branching involved in prostate gland morphogenesis,BP,SFRP1
3474,GO:0007368,0.321999211858859,0.84170901310924,4,69,determination of left/right symmetry,BP,PKD2;TBX1;GAS8;VANGL2
16613,GO:0097530,0.322140527522396,0.861985388912567,3,50,granulocyte migration,BP,CKLF;VAV3;TRPV4
667,GO:0001881,0.322214445139525,0.893156161772923,2,28,receptor recycling,BP,NSG1;VAMP3
19665,GO:2000042,0.322233240402632,0.947262250745884,1,9,negative regulation of double-strand break repair via homologous recombination,BP,MAGEF1
4466,GO:0010506,0.322303970761713,0.775035026569675,13,272,regulation of autophagy,BP,LAMP3;ULK2;TP53INP2;FOXO1;TRIM65;RASIP1;ATP6V0A2;SREBF1;TRIM22;TP53INP1;EPM2A;IFI16;SMURF1
12214,GO:0048525,0.32258732366158,0.841196376898731,4,71,negative regulation of viral process,BP,IFITM1;OAS2;STAT1;IFI16
11697,GO:0046545,0.322734097706226,0.841142039579261,4,70,development of primary female sexual characteristics,BP,SFRP1;INSR;ACVR1B;ZP3
2342,GO:0005451,0.32276171560688,0.947075656174621,1,9,monovalent cation:proton antiporter activity,MF,SLC47A1
12872,GO:0051258,0.322777251892669,0.786920633421553,10,204,protein polymerization,BP,FHOD3;DNM1;WIPF1;EPS8L2;DMTN;NCK2;ARHGAP40;TRPV4;MSRB2;ARPIN
8691,GO:0034364,0.322860870666632,0.946454062846381,1,10,high-density lipoprotein particle,CC,APOE
6973,GO:0030673,0.323297824576109,0.946885975628009,1,9,axolemma,CC,EPB41L3
8898,GO:0034767,0.323359782047729,0.840701640309679,4,70,positive regulation of ion transmembrane transport,BP,EPHB2;PKD2;F2R;GJC2
6053,GO:0019220,0.323518782303024,0.728808146155986,52,1187,regulation of phosphate metabolic process,BP,TNFAIP3;APOE;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;SFRP1;INSR;VAV3;PKD2;PPP2R2C;WWTR1;FOXO1;DAB2IP;TBX1;SHC2;EPHA4;F2R;RPS6KA5;ACSL1;ERBB3;CSPG4;DMTN;PIK3R1;PTHLH;NCK2;ACVR1B;CAMKK1;NAB2;TYRO3;ZP3;SPRY2;TNFRSF19;TRPV4;PPP1R35;ADORA2B;RTN4RL1;IMPACT;IGFBP4;ERBB2;CDK20;ACKR3;CRY2;GJC2;NUAK1;CAMK1;ELFN2;MAP3K3;PPP1R14A;NRK;VANGL2
7304,GO:0031333,0.323886592517335,0.82544783683468,5,92,negative regulation of protein complex assembly,BP,THRA;FHOD3;RPL13A;DMTN;IMPACT
3445,GO:0007274,0.323938320216151,0.946658845775963,1,9,neuromuscular synaptic transmission,BP,ETV5
14682,GO:0070373,0.324189842418083,0.860729054321069,3,49,negative regulation of ERK1 and ERK2 cascade,BP,EPHB2;DAB2IP;SPRY2
5882,GO:0018107,0.324535962006223,0.825001703102048,5,91,peptidyl-threonine phosphorylation,BP,DMTN;ACVR1B;CAMKK1;SPRY2;CAMK1
9329,GO:0035871,0.324689822395211,0.946391633831962,1,9,protein K11-linked deubiquitination,BP,TNFAIP3
9865,GO:0042178,0.32490320668356,0.945721624107694,1,10,xenobiotic catabolic process,BP,ACSL1
18116,GO:1902903,0.325235535587019,0.776173543392195,12,249,regulation of supramolecular fiber organization,BP,APOE;SFRP1;FHOD3;WIPF1;EPS8L2;DMTN;PIK3R1;NCK2;ARHGAP40;PLEKHH2;TRPV4;ARPIN
6701,GO:0030131,0.325463661559779,0.891335110025205,2,28,clathrin adaptor complex,CC,EGFR;LDLRAP1
16220,GO:0090317,0.325638601888508,0.891075588301833,2,29,negative regulation of intracellular protein transport,BP,DMTN;SP100
12505,GO:0050691,0.325764737087234,0.891004486892035,2,29,regulation of defense response to virus by host,BP,TNFAIP3;STAT1
3143,GO:0006766,0.325793248535684,0.823967144218243,5,94,vitamin metabolic process,BP,PRSS3;SLC2A1;MTHFR;ABCC1;CBR3
8347,GO:0033268,0.326031079766955,0.945912794462365,1,9,node of Ranvier,CC,SPOCK1
17063,GO:0099738,0.326085039230527,0.890985222114499,2,28,cell cortex region,CC,PKD2;RIMS3
8038,GO:0032729,0.326198181973856,0.890759992745101,2,29,positive regulation of interferon-gamma production,BP,ZFPM1;ZP3
3695,GO:0008219,0.326589521792833,0.720634510693271,67,1564,cell death,BP,TNFAIP3;PEG3;APOE;ALDH1A3;IFI6;LAMP3;LGALS7B;GPNMB;MAP3K14;EPHB2;EGFR;THRA;H1F0;GLI2;FGFR4;EPB41L3;BCL6;SFRP1;ARHGEF4;TNFSF10;INSR;VAV3;CTSB;FOXO1;NSG1;DAB2IP;OBSCN;TBX1;KLK5;MNT;EPHA4;WNT9A;F2R;CTSV;ARHGEF19;ERBB3;PPL;ENDOG;PIK3R1;CTSL;NCK2;ACVR1B;NFATC4;TYRO3;RBCK1;SPRY2;TP53INP1;TNFRSF19;MDK;NDRG1;KLK8;MARK4;IMPACT;ERBB2;STAT1;NME4;HINT2;ACKR3;FURIN;IFI16;BEX2;KREMEN1;NISCH;MAP3K3;SP100;NRK;SORT1
6897,GO:0030509,0.326816034184402,0.82330997503144,5,91,BMP signaling pathway,BP,HTRA1;SFRP1;RGMA;NEO1;SMURF1
12885,GO:0051280,0.327141911337127,0.944912125262537,1,10,negative regulation of release of sequestered calcium ion into cytosol,BP,PKD2
12889,GO:0051284,0.327141911337127,0.944912125262537,1,10,positive regulation of sequestering of calcium ion,BP,PKD2
4534,GO:0010633,0.327298890972438,0.858695300875925,3,49,negative regulation of epithelial cell migration,BP,APOE;DAB2IP;SP100
7628,GO:0032069,0.327338435523668,0.890115588704089,2,29,regulation of nuclease activity,BP,OAS2;DAB2IP
2590,GO:0005902,0.327381424217497,0.858641150422286,3,49,microvillus,CC,ESPN;CTSV;SYTL1
4057,GO:0009127,0.327555593646399,0.811211459614876,6,116,purine nucleoside monophosphate biosynthetic process,BP,PGM1;DHTKD1;INSR;ATP6V0A2;COX5B;TCIRG1
4096,GO:0009168,0.327555593646399,0.811211459614876,6,116,purine ribonucleoside monophosphate biosynthetic process,BP,PGM1;DHTKD1;INSR;ATP6V0A2;COX5B;TCIRG1
11688,GO:0046530,0.327561199332748,0.890151917704053,2,28,photoreceptor cell differentiation,BP,SDK2;NAGLU
2498,GO:0005765,0.32766612720268,0.767214736110265,14,297,lysosomal membrane,CC,LAMP3;COL6A1;CYBRD1;GAA;HGSNAT;ATP6V0A2;STOM;PQLC2;MARCH9;CLCN7;TCIRG1;VPS33B;DIRC2;SORT1
16859,GO:0098852,0.32766612720268,0.767214736110265,14,297,lytic vacuole membrane,CC,LAMP3;COL6A1;CYBRD1;GAA;HGSNAT;ATP6V0A2;STOM;PQLC2;MARCH9;CLCN7;TCIRG1;VPS33B;DIRC2;SORT1
10270,GO:0043067,0.328035850259793,0.726464087016773,48,1106,regulation of programmed cell death,BP,TNFAIP3;APOE;ALDH1A3;IFI6;LAMP3;MAP3K14;EPHB2;EGFR;THRA;GLI2;FGFR4;BCL6;SFRP1;ARHGEF4;TNFSF10;INSR;VAV3;CTSB;FOXO1;DAB2IP;OBSCN;TBX1;MNT;EPHA4;WNT9A;F2R;ARHGEF19;ERBB3;ENDOG;PIK3R1;NCK2;NFATC4;TYRO3;RBCK1;SPRY2;TP53INP1;MDK;NDRG1;MARK4;ERBB2;STAT1;NME4;ACKR3;BEX2;MAP3K3;SP100;NRK;SORT1
14929,GO:0070875,0.328203022714195,0.945132140578406,1,9,positive regulation of glycogen metabolic process,BP,INSR
6273,GO:0019901,0.328319545393331,0.745983148648871,24,525,protein kinase binding,MF,EPHB2;SRSF5;EGFR;FGFR4;BRSK1;INSR;SV2A;DNM1;DAB2IP;SHC2;EPHA4;ACTA2;ERBB3;SREBF1;CSPG4;PIK3R1;TRIM22;TYRO3;RHOD;SPRY2;TRPV4;TOM1L2;ERBB2;FBXW5
5821,GO:0017127,0.328739171606479,0.944330311371438,1,10,cholesterol transporter activity,MF,APOE
8694,GO:0034367,0.328950040104713,0.944253235493498,1,10,protein-containing complex remodeling,BP,APOE
11301,GO:0045661,0.329299558396742,0.88900314387713,2,29,regulation of myoblast differentiation,BP,CXCL14;BOC
5302,GO:0016043,0.329460307146994,0.704075213113611,192,4592,cellular component organization,BP,TNFAIP3;POSTN;ITGB6;TGFBI;SMOC2;APOE;ALDH1A3;IFI6;ULK2;PTPRS;OBSL1;NDN;ADGRB2;EPHB2;ASH2L;TNS1;HTRA1;SLITRK6;ADGRL1;SRSF5;GPX3;FLNC;SHROOM2;COL6A1;EGFR;ADAM19;THRA;CYBA;H1F0;GLI2;FGFR4;EPB41L3;NLGN2;BCL6;ANO9;TENM2;BRSK1;SFRP1;ARHGEF4;FHOD3;UNK;TNFSF10;INSR;VAV3;KMT5C;GAA;MATN2;PKD2;ESPN;ZFPM1;RGMA;DNM1;SDK2;LDLRAP1;ETV5;SYT8;SERPINE2;HR;TNXB;TP53INP2;WWTR1;WNT3;NSG1;PARVB;BOC;SOX12;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;KLK5;GAS8;YEATS4;EVI5L;WIPF1;KCNC4;TET1;MARVELD1;GLUL;EPHA4;TRAPPC2L;RPL13A;CORO6;DIXDC1;TENM4;F2R;SMARCA1;TYSND1;CTSV;RPS6KA5;TUB;ARHGEF19;HEXB;EPS8L2;HGSNAT;KIF26A;S100A6;SPOCK1;ATP6V0A2;VAMP3;PPL;CUL9;FRY;PLXND1;SREBF1;DMTN;ENDOG;PIK3R1;CTSL;IQSEC1;TRIM22;NCK2;ACVR1B;KCTD11;SYTL1;UNC119B;XPC;ARHGAP40;NFATC4;SNX33;TYRO3;RHOD;SLC2A1;HYAL1;RTF1;STOM;VAMP2;PLEKHH2;EFNB3;SPRY2;MBD1;TP53INP1;TRPV4;MTHFR;SPATA18;MSRB2;SYNM;ITGB5;NDRG1;KLK8;LTBP4;NAGLU;MAFIP;RTN4RL1;MARK4;PDLIM4;CCDC69;IMPACT;TBC1D17;NEO1;CRTC1;IGFBP4;STON1;TOM1L2;MICALL1;ERBB2;C2CD4C;H2AFJ;LAMB2;WIPI2;H1FX;BLOC1S4;ZMYM3;FURIN;FBXW5;CCDC88B;SUN1;NINL;PEX11B;FRAT1;ARPIN;ASIC1;MMP1;ALS2CL;PLXNB1;SMURF1;CAPNS2;DOK4;CAMK1;TCIRG1;NISCH;RAB43;VPS33B;SCMH1;ZSWIM8;SP100;ABCC1;NRK;SORT1;VANGL2;APBA1
12819,GO:0051179,0.329534341446722,0.704427098160663,180,4294,localization,BP,TNFAIP3;POSTN;IFITM1;ITGB6;APOE;MVB12B;KCNJ15;OBSL1;LMF1;CPT2;GPNMB;NDN;EPHB2;TNS1;SRSF5;TST;SLC13A5;SHROOM2;EGFR;THRA;CYBA;OAS2;FGFR4;EPB41L3;APCDD1;NLGN2;BCL6;PGM1;ANO9;BRSK1;SFRP1;CKLF;UNK;INSR;VAV3;SLC16A5;SLC29A4;GAA;MATN2;SV2A;PKD2;RTN2;DNM1;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;SYT8;SERPINE2;TP53INP2;VEGFB;RHBDF1;TMEM129;WNT3;NSG1;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;PRSS3;SCN4B;GAS8;EVI5L;WIPF1;KCNC4;RAB40B;MARVELD1;GLUL;ANO8;EPHA4;TRAPPC2L;RPL13A;DIXDC1;OLFM2;F2R;TUB;HOMER2;HEXB;LTBP1;SCART1;ACSL1;ORAI3;ERBB3;HGSNAT;KIF26A;S100A6;SPOCK1;SLC38A4;ATP6V0A2;VAMP3;PLXND1;SREBF1;CSPG4;DMTN;PIK3R1;SDC3;APPL2;ACAP3;TRIM22;NCK2;ACVR1B;SYTL1;UNC119B;ATP12A;SNX33;TYRO3;RHOD;CXCR1;SLC2A1;METTL7A;HYAL1;ZP3;STOM;VAMP2;MBOAT7;AVL9;SPRY2;SCG5;LRRC8E;TP53INP1;SLC2A9;MDK;TRPV4;ZDHHC1;PQLC2;NDUFA4L2;LTBP4;ADORA2B;SERPING1;MRC2;MAFIP;MARK4;TBC1D17;GOLGA7B;STON1;GPR68;TOM1L2;MICALL1;ERBB2;C2CD4C;TULP3;NME4;NIPAL4;WIPI2;ACKR3;SLC5A1;CRY2;COX5B;SLC39A6;BLOC1S4;FURIN;CLCN7;CCDC88B;SUN1;NINL;GJC2;SLC1A4;ARPIN;SLC13A3;ASIC1;MMP1;PLXNB1;SMURF1;CAMK1;TCIRG1;NISCH;RAB43;VPS33B;SLC47A1;MAP3K3;MDFI;REEP6;ZSWIM8;SP100;ABCC1;SORT1;VANGL2;APBA1
2823,GO:0006307,0.329864723525127,0.943918185898555,1,10,DNA dealkylation involved in DNA repair,BP,MPG
11234,GO:0045576,0.329961073568994,0.88862672018582,2,29,mast cell activation,BP,NDRG1;ADORA2B
16680,GO:0097722,0.330398695435815,0.888377371773426,2,29,sperm motility,BP,GAS8;MAFIP
3462,GO:0007338,0.330526214843251,0.856414528739712,3,51,single fertilization,BP,SYT8;HEXB;ZP3
15097,GO:0071230,0.330588906038268,0.856530209037001,3,49,cellular response to amino acid stimulus,BP,COL6A1;EGFR;CYBA
302,GO:0000812,0.330804563007632,0.943572704890336,1,10,Swr1 complex,CC,YEATS4
10130,GO:0042745,0.330979218416185,0.943508366268755,1,10,circadian sleep/wake cycle,BP,PER3
3051,GO:0006631,0.331111750369957,0.771163654200748,12,255,fatty acid metabolic process,BP,CPT2;CRAT;CES2;PDPR;TYSND1;ACSL1;SREBF1;CPT1C;AMACR;MLYCD;THNSL2;ALOXE3
16206,GO:0090303,0.331381642034335,0.887816357445631,2,29,positive regulation of wound healing,BP,F2R;DMTN
17883,GO:1902237,0.331443120860805,0.943337269176649,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,NCK2
3402,GO:0007202,0.331481331000919,0.94332316303926,1,10,activation of phospholipase C activity,BP,EGFR
12797,GO:0051147,0.331582242059962,0.81968591433144,5,93,regulation of muscle cell differentiation,BP,THRA;BOC;TBX1;OLFM2;CAMK1
6936,GO:0030593,0.331677744723904,0.887493087605676,2,30,neutrophil chemotaxis,BP,CKLF;VAV3
770,GO:0002031,0.331848965504779,0.943187337997564,1,10,G-protein coupled receptor internalization,BP,DNM1
9176,GO:0035587,0.331875373962099,0.943177573928712,1,10,purinergic receptor signaling pathway,BP,ADORA2B
12047,GO:0048037,0.332060051888105,0.757751942575445,16,352,cofactor binding,MF,ALDH1A3;TXNRD3;CYBA;HEBP1;CYP4F22;DHTKD1;NAT6;UROS;H6PD;CYP27C1;MTHFR;SDHA;ALDH2;CRY2;THNSL2;CBR3
15562,GO:0072088,0.332109899387508,0.855524767991172,3,49,nephron epithelium morphogenesis,BP,PKD2;KIF26B;STAT1
13628,GO:0060192,0.332254375582469,0.943037337020322,1,10,negative regulation of lipase activity,BP,SORT1
10394,GO:0043271,0.332427562584582,0.834219132883027,4,71,negative regulation of ion transport,BP,EPHB2;ANO9;PKD2;SERPINE2
13907,GO:0060627,0.332487396939615,0.75743331064229,16,342,regulation of vesicle-mediated transport,BP,APOE;CYBA;LDLRAP1;RIMS3;SYT8;EVI5L;RAB40B;TUB;SYTL1;SNX33;ZP3;VAMP2;ADORA2B;TBC1D17;STON1;C2CD4C
6262,GO:0019884,0.332759335845276,0.797887093839725,7,143,antigen processing and presentation of exogenous antigen,BP,CYBA;CTSV;KIF26A;VAMP3;CTSL;ITGB5;CTSF
3061,GO:0006644,0.332988169184196,0.756992413040297,16,343,phospholipid metabolic process,BP,EGFR;FGFR4;VAV3;DAB2IP;HEXB;ERBB3;PIK3R1;IMPA2;ZP3;MBOAT7;MVD;ERBB2;PLCD1;PLPP2;ISYNA1;PIGZ
5697,GO:0016853,0.333043937722383,0.806875939945664,6,120,isomerase activity,MF,PGM1;FKBP9;TMX4;AMACR;ALOXE3;ISYNA1
72,GO:0000149,0.333395632586479,0.818327207800223,5,93,SNARE binding,MF,SYT8;VAMP3;SYTL1;VAMP2;C2CD4C
17649,GO:1901568,0.333537081443668,0.818153501407199,5,95,fatty acid derivative metabolic process,BP,CYP4F22;CES2;ACSL1;ALOXE3;ABCC1
4640,GO:0010803,0.333543400169962,0.854415764245803,3,51,regulation of tumor necrosis factor-mediated signaling pathway,BP,TNFAIP3;RBCK1;CCDC3
15810,GO:0072567,0.333655607715515,0.942517108605499,1,10,chemokine (C-X-C motif) ligand 2 production,BP,POSTN
863,GO:0002218,0.333676385102378,0.777845416427216,10,209,activation of innate immune response,BP,TNFAIP3;PTPRS;CYBA;CTSB;DAB2IP;RPS6KA5;DDX60;CTSL;TYRO3;IFI16
7950,GO:0032585,0.333739524304984,0.942485865833404,1,10,multivesicular body membrane,CC,NSG1
551,GO:0001673,0.334233265911851,0.942301841730179,1,10,male germ cell nucleus,CC,TCFL5
10486,GO:0043434,0.334351042085667,0.761475231479186,14,297,response to peptide hormone,BP,SRSF5;CYBA;TNFSF10;INSR;FOXO1;ATP6V0A2;SREBF1;PIK3R1;SLC2A1;VAMP2;TRPV4;STAT1;TCIRG1;SORT1
20228,GO:2001236,0.334391998314319,0.805903048141682,6,117,regulation of extrinsic apoptotic signaling pathway,BP,TNFAIP3;IFI6;SFRP1;TNFSF10;RBCK1;SP100
7575,GO:0031968,0.334614587703269,0.788894196419867,8,162,organelle outer membrane,CC,SNN;BPHL;EPHA4;ACSL1;FAM210B;CPT1C;SPATA18;RETSAT
11482,GO:0046033,0.335177802153284,0.941948845006224,1,10,AMP metabolic process,BP,NT5E
11399,GO:0045861,0.335766346228817,0.776083108270643,10,211,negative regulation of proteolysis,BP,IFI6;LAMP3;SERPINE2;COL7A1;EPHA4;WNT9A;SPOCK1;SERPING1;FURIN;IFI16
7790,GO:0032365,0.336020666707688,0.885150873170975,2,29,intracellular lipid transport,BP,CPT2;LDLRAP1
12234,GO:0048565,0.336045626224054,0.831677479133265,4,70,digestive tract development,BP,EGFR;GLI2;SFRP1;VANGL2
2710,GO:0006105,0.33611069488403,0.941598966360901,1,10,succinate metabolic process,BP,SDHA
12570,GO:0050790,0.33650672446846,0.710779234407084,69,1607,regulation of catalytic activity,BP,TNFAIP3;APOE;IFI6;LAMP3;LMF1;MAP3K14;EPHB2;RALGDS;EGFR;CYBA;OAS2;FGFR4;PINLYP;BCL6;SFRP1;TNFSF10;INSR;VAV3;PKD2;PPP2R2C;CTSB;SERPINE2;WWTR1;RASIP1;DAB2IP;COL7A1;SHC2;EVI5L;EPHA4;WNT9A;F2R;ARHGEF19;ACSL1;ERBB3;SPOCK1;FRY;PLXND1;CSPG4;PIK3R1;IQSEC1;ACAP3;NCK2;CAMKK1;ARHGAP40;NAB2;TYRO3;SPRY2;SCG5;PPP1R35;ADORA2B;SERPING1;RTN4RL1;TBC1D17;ERBB2;CDK20;CRY2;FURIN;IFI16;ALS2CL;NUAK1;PLXNB1;RASA4;CAMK1;ELFN2;MAP3K3;PPP1R14A;NRK;SORT1;VANGL2
12447,GO:0050435,0.336590915946143,0.884821193596656,2,29,amyloid-beta metabolic process,BP,APOE;EPHA4
4218,GO:0009415,0.336710103152051,0.941373512381889,1,10,response to water,BP,PKD2
19240,GO:1905477,0.337057843040844,0.81553830812286,5,94,positive regulation of protein localization to membrane,BP,EPHB2;EGFR;PIK3R1;STOM;ERBB2
569,GO:0001711,0.337312660984748,0.941146362430816,1,10,endodermal cell fate commitment,BP,RTF1
11658,GO:0046479,0.337603501557451,0.941036538862077,1,10,glycosphingolipid catabolic process,BP,HEXB
6042,GO:0019208,0.337670307064211,0.830407365175224,4,72,phosphatase regulator activity,MF,PPP2R2C;PPP1R35;ELFN2;PPP1R14A
18036,GO:1902667,0.337769783757642,0.884307932934408,2,28,regulation of axon guidance,BP,WNT3;ZSWIM8
3314,GO:0007040,0.337883619420804,0.851520866066709,3,51,lysosome organization,BP,GAA;HEXB;NAGLU
15943,GO:0080171,0.337883619420804,0.851520866066709,3,51,lytic vacuole organization,BP,GAA;HEXB;NAGLU
15405,GO:0071732,0.338226620144403,0.940800841887672,1,10,cellular response to nitric oxide,BP,FOXO1
5528,GO:0016540,0.338288144120352,0.94077754040539,1,10,protein autoprocessing,BP,CTSV
52,GO:0000109,0.338350850042969,0.94075378576046,1,10,nucleotide-excision repair complex,CC,XPC
11465,GO:0045986,0.339133300345184,0.940456904758987,1,10,negative regulation of smooth muscle contraction,BP,ADORA2B
7869,GO:0032459,0.339336406190575,0.883068620548292,2,30,regulation of protein oligomerization,BP,APOE;MMP1
12079,GO:0048168,0.33959161038976,0.883079073600094,2,29,regulation of neuronal synaptic plasticity,BP,APOE;EPHB2
3265,GO:0006959,0.339670239309903,0.82873286397194,4,77,humoral immune response,BP,PRSS3;KLK5;ZP3;SERPING1
8804,GO:0034614,0.339891457036681,0.80156993376088,6,119,cellular response to reactive oxygen species,BP,TNFAIP3;EGFR;PKD2;FOXO1;ENDOG;IMPACT
15003,GO:0070989,0.340653838837737,0.939877491519946,1,10,oxidative demethylation,BP,TET1
2824,GO:0006308,0.340665853821831,0.882292421388668,2,30,DNA catabolic process,BP,H1F0;ENDOG
11786,GO:0046717,0.340782179392495,0.849654397434119,3,50,acid secretion,BP,SV2A;VAMP2;APBA1
6096,GO:0019359,0.340882430548583,0.812646545718709,5,94,nicotinamide nucleotide biosynthetic process,BP,PGM1;DHTKD1;INSR;NMRK1;NADK
6098,GO:0019363,0.340882430548583,0.812646545718709,5,94,pyridine nucleotide biosynthetic process,BP,PGM1;DHTKD1;INSR;NMRK1;NADK
19987,GO:2000647,0.341310978126165,0.939626066882371,1,10,negative regulation of stem cell proliferation,BP,KCTD11
6443,GO:0021783,0.341345021509657,0.939613024986124,1,10,preganglionic parasympathetic fiber development,BP,TBX1
10564,GO:0043567,0.341380800888684,0.93959931625885,1,10,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4
3443,GO:0007271,0.341414179579079,0.939586525703404,1,10,synaptic transmission, cholinergic,BP,APOE
13862,GO:0060547,0.341493280410808,0.93955620830962,1,10,negative regulation of necrotic cell death,BP,RBCK1
432,GO:0001161,0.341644316686681,0.939498295100132,1,10,intronic transcription regulatory region sequence-specific DNA binding,MF,BCL6
10734,GO:0044213,0.341644316686681,0.939498295100132,1,10,intronic transcription regulatory region DNA binding,MF,BCL6
17891,GO:1902259,0.341701804768568,0.939476243390409,1,10,regulation of delayed rectifier potassium channel activity,BP,VAMP2
19650,GO:2000009,0.342105423395457,0.939321287808359,1,10,negative regulation of protein localization to cell surface,BP,SNX33
20246,GO:2001259,0.342140616777661,0.881589514480284,2,29,positive regulation of cation channel activity,BP,EPHB2;PKD2
12471,GO:0050651,0.342296211946651,0.939247960281887,1,10,dermatan sulfate proteoglycan biosynthetic process,BP,CSPG4
16253,GO:0090398,0.34297150420522,0.848097701085419,3,51,cellular senescence,BP,BCL6;NUAK1;MAP3K3
12915,GO:0051336,0.343143666767962,0.7177718795225,39,890,regulation of hydrolase activity,BP,IFI6;LAMP3;LMF1;EGFR;OAS2;BCL6;SFRP1;TNFSF10;VAV3;PPP2R2C;SERPINE2;RASIP1;DAB2IP;COL7A1;EVI5L;EPHA4;WNT9A;F2R;ARHGEF19;SPOCK1;PLXND1;IQSEC1;ACAP3;ARHGAP40;SPRY2;PPP1R35;SERPING1;TBC1D17;ERBB2;CRY2;FURIN;IFI16;ALS2CL;NUAK1;PLXNB1;RASA4;ELFN2;PPP1R14A;SORT1
6144,GO:0019511,0.343166587331347,0.938912782430851,1,10,peptidyl-proline hydroxylation,BP,CRTAP
4712,GO:0010893,0.343236831656086,0.938885684507679,1,10,positive regulation of steroid biosynthetic process,BP,SREBF1
4808,GO:0014029,0.343293647974502,0.938863761509935,1,10,neural crest formation,BP,SFRP1
4360,GO:0010008,0.343321533225097,0.745446216788349,17,371,endosome membrane,CC,MVB12B;EGFR;INSR;NSG1;EPHA4;ATP6V0A2;VAMP3;APPL2;RHOD;NDRG1;PDLIM4;MICALL1;ERBB2;FURIN;TCIRG1;VPS33B;SORT1
12869,GO:0051255,0.343672765339504,0.938717358269526,1,10,spindle midzone assembly,BP,CCDC69
13777,GO:0060412,0.34370961048435,0.880668218119099,2,29,ventricular septum morphogenesis,BP,ZFPM1;VANGL2
4948,GO:0015074,0.343876668842154,0.938638532225093,1,10,DNA integration,BP,NYNRIN
16870,GO:0098877,0.344023997678763,0.938581540127687,1,10,neurotransmitter receptor transport to plasma membrane,BP,NSG1
15530,GO:0072028,0.344035396144571,0.847458570054204,3,50,nephron morphogenesis,BP,PKD2;KIF26B;STAT1
802,GO:0002080,0.344061800259511,0.938566911727234,1,10,acrosomal membrane,CC,SUN1
6989,GO:0030695,0.344248221435807,0.76004460525429,12,248,GTPase regulator activity,MF,RALGDS;VAV3;DAB2IP;EVI5L;ARHGEF19;APPL2;ACAP3;ARHGAP40;TBC1D17;ALS2CL;PLXNB1;RASA4
9880,GO:0042246,0.344828847967592,0.879846186550255,2,30,tissue regeneration,BP,POSTN;NINJ1
15816,GO:0072576,0.344944828548109,0.938224626326197,1,10,liver morphogenesis,BP,TNFAIP3
2199,GO:0005096,0.34501206549233,0.76362318295083,11,225,GTPase activator activity,MF,VAV3;DAB2IP;EVI5L;ARHGEF19;APPL2;ACAP3;ARHGAP40;TBC1D17;ALS2CL;PLXNB1;RASA4
12564,GO:0050780,0.345031291127311,0.938191051141068,1,10,dopamine receptor binding,MF,DNM1
5119,GO:0015645,0.345275786186086,0.938096050782538,1,10,fatty acid ligase activity,MF,ACSL1
6264,GO:0019886,0.3454176961398,0.824740839031957,4,73,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,CTSV;KIF26A;CTSL;CTSF
11303,GO:0045663,0.345589806599742,0.937973910218643,1,10,positive regulation of myoblast differentiation,BP,BOC
10443,GO:0043369,0.345794172668243,0.93789434461362,1,10,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,ZFPM1
2373,GO:0005522,0.345852130379853,0.937871769107318,1,10,profilin binding,MF,WIPF1
3253,GO:0006940,0.346011302865356,0.879147022491919,2,30,regulation of smooth muscle contraction,BP,F2R;ADORA2B
7131,GO:0031010,0.346049783769969,0.937794743555693,1,10,ISWI-type complex,CC,SMARCA1
5619,GO:0016723,0.3460585015877,0.937791344930935,1,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,CYBRD1
12696,GO:0050999,0.346095033647836,0.879097441185904,2,30,regulation of nitric-oxide synthase activity,BP,APOE;EGFR
10221,GO:0042987,0.346411365742776,0.878910037720595,2,30,amyloid precursor protein catabolic process,BP,APOE;EPHA4
16820,GO:0098792,0.346434036419266,0.937644839881354,1,10,xenophagy,BP,WIPI2
14289,GO:0061512,0.34652853015191,0.878840591538539,2,30,protein localization to cilium,BP,TUB;TULP3
19672,GO:2000052,0.346731319964821,0.937528718989027,1,10,positive regulation of non-canonical Wnt signaling pathway,BP,SFRP1
6915,GO:0030540,0.346919495779089,0.937455150705537,1,10,female genitalia development,BP,TYRO3
7564,GO:0031953,0.346955763005614,0.937440966004953,1,10,negative regulation of protein autophosphorylation,BP,IMPACT
11819,GO:0046838,0.347078402950721,0.937392985535251,1,10,phosphorylated carbohydrate dephosphorylation,BP,IMPA2
11828,GO:0046855,0.347078402950721,0.937392985535251,1,10,inositol phosphate dephosphorylation,BP,IMPA2
10445,GO:0043371,0.347204351316925,0.937343688218751,1,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,BCL6
4664,GO:0010830,0.347233879598205,0.878422115102135,2,30,regulation of myotube differentiation,BP,THRA;TBX1
3196,GO:0006853,0.347247502695033,0.937326793140784,1,10,carnitine shuttle,BP,CPT2
8897,GO:0034766,0.347279856525494,0.845174026568061,3,51,negative regulation of ion transmembrane transport,BP,EPHB2;ANO9;PKD2
12695,GO:0050998,0.347342725472083,0.93728950105657,1,10,nitric-oxide synthase binding,MF,DNM1
14596,GO:0070208,0.347775048545468,0.937120026480268,1,10,protein heterotrimerization,BP,COL6A1
6255,GO:0019867,0.347789286448154,0.778111960148123,8,164,outer membrane,CC,SNN;BPHL;EPHA4;ACSL1;FAM210B;CPT1C;SPATA18;RETSAT
4865,GO:0014745,0.348209322243051,0.936949516567621,1,10,negative regulation of muscle adaptation,BP,FOXO1
14085,GO:0060992,0.348367776127751,0.936887234853984,1,10,response to fungicide,BP,IMPACT
11449,GO:0045945,0.34864643653806,0.936777617192476,1,10,positive regulation of transcription by RNA polymerase III,BP,ERBB2
4157,GO:0009247,0.348692569098344,0.844055907770667,3,53,glycolipid biosynthetic process,BP,ST3GAL5;ST6GALNAC6;PIGZ
10231,GO:0043001,0.348820061420277,0.877478550635405,2,30,Golgi to plasma membrane protein transport,BP,VAMP3;VAMP2
11035,GO:0045069,0.34924131637478,0.821894384844538,4,74,regulation of viral genome replication,BP,IFITM1;OAS2;STOM;IFI16
15121,GO:0071280,0.349481962871179,0.935887549596726,1,11,cellular response to copper ion,BP,MT2A
18607,GO:1903960,0.35034151461217,0.936108406403321,1,10,negative regulation of anion transmembrane transport,BP,ANO9
2284,GO:0005262,0.350428634070807,0.843105236772372,3,50,calcium channel activity,MF,PKD2;ORAI3;TRPV4
13778,GO:0060413,0.35047819791897,0.936054263621914,1,10,atrial septum morphogenesis,BP,ZFPM1
15298,GO:0071560,0.350604399943384,0.775827879150315,8,162,cellular response to transforming growth factor beta stimulus,BP,POSTN;HTRA1;SFRP1;LTBP1;ITGB5;LTBP4;FURIN;SMURF1
9531,GO:0036342,0.350772997226378,0.935937396259312,1,10,post-anal tail morphogenesis,BP,VANGL2
11823,GO:0046849,0.35084423256577,0.842737883615239,3,51,bone remodeling,BP,TNFAIP3;EGFR;SFRP1
5089,GO:0015399,0.350878229159934,0.82074059869562,4,73,primary active transmembrane transporter activity,MF,ATP6V0A2;ATP12A;TCIRG1;ABCC1
5090,GO:0015405,0.350878229159934,0.82074059869562,4,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ATP6V0A2;ATP12A;TCIRG1;ABCC1
16349,GO:0097006,0.351134522893446,0.842459372931053,3,52,regulation of plasma lipoprotein particle levels,BP,APOE;LMF1;LDLRAP1
7827,GO:0032409,0.351474509921663,0.782951440267034,7,139,regulation of transporter activity,BP,EPHB2;NLGN2;ANO9;PKD2;SCN4B;STOM;VAMP2
8488,GO:0033692,0.351486559449261,0.84229720225738,3,51,cellular polysaccharide biosynthetic process,BP,PGM1;INSR;B3GNT9
14078,GO:0060977,0.351659833210666,0.935585069870469,1,10,coronary vasculature morphogenesis,BP,TBX1
18642,GO:1904029,0.351943919681345,0.819858760760809,4,75,regulation of cyclin-dependent protein kinase activity,BP,TNFAIP3;EGFR;PKD2;CDK20
13695,GO:0060307,0.351947473977851,0.935470550091498,1,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,SCN4B
10572,GO:0043584,0.352382448063293,0.9352971441118,1,10,nose development,BP,ALDH1A3
10488,GO:0043436,0.35240148455506,0.712233808546179,35,812,oxoacid metabolic process,BP,ALDH1A3;CPT2;GAMT;CRAT;FGFR4;PGM1;XYLT1;CYP4F22;DHTKD1;INSR;CES2;PDPR;BPHL;UROS;CRTAP;CYP27C1;GLUL;TYSND1;HEXB;ACSL1;SREBF1;CSPG4;SLC2A1;CPT1C;HYAL1;CKMT1A;MTHFR;SDHA;AMACR;MLYCD;THNSL2;XYLT2;ALOXE3;ABCC1;IDUA
2706,GO:0006101,0.352451454114558,0.875148569490944,2,31,citrate metabolic process,BP,DHTKD1;SDHA
16947,GO:0099068,0.352527969999587,0.935239069377656,1,10,postsynapse assembly,BP,NLGN2
3768,GO:0008349,0.352719153862708,0.935162725257567,1,10,MAP kinase kinase kinase kinase activity,MF,NRK
15276,GO:0071526,0.352754804341293,0.875291037975931,2,29,semaphorin-plexin signaling pathway,BP,PLXND1;PLXNB1
3391,GO:0007188,0.35287965278619,0.819266014272182,4,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,PTHLH;UCN2;ADORA2B;MC1R
2093,GO:0004879,0.353059135547686,0.874939869310745,2,30,nuclear receptor activity,MF,THRA;SREBF1
16710,GO:0098531,0.353059135547686,0.874939869310745,2,30,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,THRA;SREBF1
16074,GO:0090101,0.353424056132717,0.818864136234328,4,73,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;SFRP1;LTBP1;SMURF1
8669,GO:0034330,0.353488945616597,0.761266479399332,10,204,cell junction organization,BP,TNS1;FLNC;EPB41L3;NLGN2;SFRP1;SDK2;F2R;DMTN;RHOD;TRPV4
7155,GO:0031056,0.353662852341946,0.790765096463829,6,117,regulation of histone modification,BP,BCL6;TET1;RPS6KA5;SREBF1;RTF1;MTHFR
11377,GO:0045821,0.353722081998611,0.934761363946606,1,10,positive regulation of glycolytic process,BP,INSR
12834,GO:0051197,0.353722081998611,0.934761363946606,1,10,positive regulation of coenzyme metabolic process,BP,INSR
10290,GO:0043113,0.353839513483098,0.874469818452786,2,30,receptor clustering,BP,APOE;ETV5
10755,GO:0044257,0.353858893489402,0.717763159912242,28,635,cellular protein catabolic process,BP,TNFAIP3;APOE;MVB12B;LAMP3;FBXO2;CTSB;TP53INP2;WWTR1;RHBDF1;TMEM129;DAB2IP;EPHA4;MAGEF1;CTSV;CUL9;CTSL;RBCK1;SPATA18;FBXW4;BTBD2;RNF187;RNF44;FURIN;FBXW5;CTSF;SMURF1;TCIRG1;FBXO44
10499,GO:0043473,0.353894098307276,0.818467298674659,4,74,pigmentation,BP,SHROOM2;MC1R;BLOC1S4;VPS33B
5829,GO:0017144,0.353994044818488,0.724316474812301,23,529,drug metabolic process,BP,GAMT;GPX3;EGFR;CYBA;PGM1;DHTKD1;INSR;PKD2;NT5E;PRSS3;FAM20C;ACSL1;ATP6V0A2;CSPG4;CKMT1A;MTHFR;SDHA;ALDH2;COX5B;TCIRG1;NADK;ABCC1;IDUA
18555,GO:1903859,0.354047020521317,0.934631013604983,1,10,regulation of dendrite extension,BP,SMURF1
18111,GO:1902894,0.354050553462226,0.934629595508691,1,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4
5844,GO:0017166,0.354248490455197,0.934550116074846,1,10,vinculin binding,MF,SYNM
3498,GO:0007431,0.354513718526859,0.874063042459753,2,30,salivary gland development,BP,EGFR;PLXND1
9925,GO:0042325,0.354784565451295,0.703218590701016,45,1034,regulation of phosphorylation,BP,TNFAIP3;APOE;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;SFRP1;INSR;VAV3;PKD2;WWTR1;FOXO1;DAB2IP;TBX1;SHC2;EPHA4;F2R;RPS6KA5;ACSL1;ERBB3;CSPG4;DMTN;PIK3R1;NCK2;ACVR1B;CAMKK1;NAB2;TYRO3;SPRY2;TNFRSF19;TRPV4;ADORA2B;RTN4RL1;IMPACT;IGFBP4;ERBB2;CDK20;ACKR3;GJC2;CAMK1;MAP3K3;PPP1R14A;NRK;VANGL2
18768,GO:1904375,0.355015526440678,0.817687403106903,4,73,regulation of protein localization to cell periphery,BP,EPHB2;EGFR;LDLRAP1;PIK3R1
5117,GO:0015631,0.35525555844612,0.746732965038358,13,275,tubulin binding,MF,NDN;BRSK1;DNM1;CLIP2;GAS8;DIXDC1;KIF26B;KIF26A;TRPV4;NDRG1;MARK4;CCDC69;CCDC88B
6764,GO:0030219,0.35565973630343,0.816974194380298,4,78,megakaryocyte differentiation,BP,ASH2L;ZFPM1;MYL9;VPS33B
17350,GO:1900119,0.356161673970159,0.933196646234348,1,11,positive regulation of execution phase of apoptosis,BP,ENDOG
987,GO:0002456,0.356328792465958,0.838800176201377,3,53,T cell mediated immunity,BP,SCART1;ZP3;IL20RB
13731,GO:0060350,0.356581479157993,0.872811559058073,2,30,endochondral bone morphogenesis,BP,NAB2;TRPV4
14460,GO:0061971,0.356581479157993,0.872811559058073,2,30,replacement bone morphogenesis,BP,NAB2;TRPV4
17662,GO:1901607,0.356613549692916,0.838602792464432,3,53,alpha-amino acid biosynthetic process,BP,GAMT;GLUL;THNSL2
12931,GO:0051353,0.356906773142164,0.872454589342756,2,31,positive regulation of oxidoreductase activity,BP,APOE;CYBA
10215,GO:0042981,0.357103218564872,0.69994689718506,47,1094,regulation of apoptotic process,BP,TNFAIP3;APOE;ALDH1A3;IFI6;LAMP3;MAP3K14;EPHB2;EGFR;THRA;GLI2;FGFR4;BCL6;SFRP1;ARHGEF4;TNFSF10;INSR;VAV3;CTSB;FOXO1;DAB2IP;OBSCN;TBX1;MNT;EPHA4;WNT9A;F2R;ARHGEF19;ERBB3;ENDOG;PIK3R1;NCK2;NFATC4;TYRO3;RBCK1;SPRY2;TP53INP1;MDK;NDRG1;ERBB2;STAT1;NME4;ACKR3;BEX2;MAP3K3;SP100;NRK;SORT1
7969,GO:0032609,0.357496296790478,0.837990264784952,3,53,interferon-gamma production,BP,ZFPM1;ZP3;IL20RB
583,GO:0001738,0.357609784196271,0.787517784060691,6,121,morphogenesis of a polarized epithelium,BP,PRICKLE2;SFRP1;ARHGEF19;GPC4;SMURF1;VANGL2
15135,GO:0071310,0.357843420667995,0.688800425351974,76,1790,cellular response to organic substance,BP,TNFAIP3;POSTN;IFITM1;IFI6;NDN;MAP3K14;HTRA1;SRSF5;COL6A1;EGFR;THRA;CYBA;OAS2;GLI2;FGFR4;BCL6;SFRP1;INSR;PKD2;RGMA;CTSB;FOXO1;WNT3;UROS;DAB2IP;TBX1;FAM20C;EPHA4;WNT9A;RPL13A;RPS6KA5;TXNDC17;LTBP1;ACSL1;ATP6V0A2;VAMP3;SREBF1;DMTN;ENDOG;PIK3R1;TMEM204;CTSL;TRIM22;NCK2;UCN2;NFATC4;FAM210B;CXCR1;HYAL1;VAMP2;RBCK1;SPRY2;TP53INP1;TNFRSF19;ITGB5;LTBP4;RTN4RL1;IMPACT;NEO1;GPR68;MICALL1;ERBB2;STAT1;ACKR3;CRY2;FURIN;IL20RB;MMP1;SMURF1;CCDC3;TCIRG1;MT2A;RAB43;MAP3K3;SP100;SORT1
4756,GO:0010959,0.357851230480259,0.763160557091128,9,187,regulation of metal ion transport,BP,CYBA;PKD2;SERPINE2;SCN4B;F2R;HOMER2;STOM;VAMP2;GJC2
6813,GO:0030295,0.358069281530592,0.837670281297642,3,52,protein kinase activator activity,MF,ERBB3;SPRY2;CDK20
12992,GO:0051482,0.358094257275433,0.932405926600705,1,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,F2R
7160,GO:0031062,0.358150398612346,0.871858046516119,2,30,positive regulation of histone methylation,BP,TET1;RTF1
453,GO:0001227,0.358536245579152,0.769247757696131,8,163,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,HES2;BCL6;ZFPM1;FOXO1;MNT;TCFL5;NFATC4;IFI16
18400,GO:1903524,0.358556294644927,0.871450215213878,2,31,positive regulation of blood circulation,BP,EGFR;F2R
13629,GO:0060193,0.359193097295512,0.871061465181385,2,31,positive regulation of lipase activity,BP,LMF1;EGFR
4438,GO:0010421,0.359442906775522,0.931850866793839,1,11,hydrogen peroxide-mediated programmed cell death,BP,ENDOG
16578,GO:0097468,0.359442906775522,0.931850866793839,1,11,programmed cell death in response to reactive oxygen species,BP,ENDOG
2686,GO:0006067,0.359457351786495,0.931844907180169,1,11,ethanol metabolic process,BP,ALDH2
2649,GO:0006012,0.359946154865943,0.931643058876703,1,11,galactose metabolic process,BP,PGM1
7158,GO:0031060,0.360157796299086,0.836298141156679,3,51,regulation of histone methylation,BP,TET1;RTF1;MTHFR
4214,GO:0009409,0.360252990304946,0.870413183922555,2,31,response to cold,BP,THRA;FOXO1
11680,GO:0046514,0.360405639701097,0.93145299549161,1,11,ceramide catabolic process,BP,HEXB
17346,GO:1900115,0.360542906512958,0.931396155278295,1,11,extracellular regulation of signal transduction,BP,LTBP1
17347,GO:1900116,0.360542906512958,0.931396155278295,1,11,extracellular negative regulation of signal transduction,BP,LTBP1
8956,GO:0035091,0.360955849145027,0.760571283023207,9,185,phosphatidylinositol binding,MF,LDLRAP1;DAB2IP;TUB;SNX29;SNX33;TULP3;WIPI2;PLCD1;NISCH
8019,GO:0032691,0.361122175715345,0.931155981218902,1,11,negative regulation of interleukin-1 beta production,BP,TNFAIP3
10896,GO:0044548,0.361160196208828,0.931140199961267,1,11,S100 protein binding,MF,S100A6
10060,GO:0042592,0.361315064454289,0.696005517025606,47,1094,homeostatic process,BP,TNFAIP3;APOE;IFI6;NDN;TXNRD3;EGFR;THRA;CYBA;FGFR4;BCL6;INSR;CYBRD1;GAA;SV2A;PKD2;ZFPM1;LDLRAP1;TP53INP2;FOXO1;TRERF1;F2R;TUB;HOMER2;HEXB;ATP6V0A2;RDH12;DMTN;ENDOG;PIK3R1;ACVR1B;ATP12A;FAM210B;TYRO3;TMX4;TRPV4;PQLC2;NEO1;CRTC1;GPR68;STAT1;CRY2;SLC39A6;IL20RB;ALOXE3;TCIRG1;MT2A;SP100
18239,GO:1903169,0.361680910953055,0.812677323146821,4,74,regulation of calcium ion transmembrane transport,BP,CYBA;PKD2;F2R;GJC2
2563,GO:0005865,0.361776022283688,0.930884289383674,1,11,striated muscle thin filament,CC,FHOD3
13322,GO:0052548,0.361928706587026,0.744653611805193,12,265,regulation of endopeptidase activity,BP,IFI6;LAMP3;TNFSF10;SERPINE2;COL7A1;EPHA4;WNT9A;F2R;SPOCK1;SERPING1;FURIN;IFI16
14092,GO:0060999,0.362071501908259,0.869460079105898,2,30,positive regulation of dendritic spine development,BP,APOE;CAMK1
846,GO:0002178,0.362207290168992,0.930704738573634,1,11,palmitoyltransferase complex,CC,GOLGA7B
13466,GO:0055076,0.362346885861779,0.795962021407222,5,99,transition metal ion homeostasis,BP,CYBRD1;ATP6V0A2;NEO1;SLC39A6;MT2A
10393,GO:0043270,0.362427424365269,0.783682888719582,6,120,positive regulation of ion transport,BP,APOE;EPHB2;PKD2;SCN4B;F2R;GJC2
12312,GO:0048711,0.362438290511194,0.930608452199685,1,11,positive regulation of astrocyte differentiation,BP,SERPINE2
6880,GO:0030449,0.362445839290391,0.930605304355245,1,11,regulation of complement activation,BP,SERPING1
19769,GO:2000257,0.362445839290391,0.930605304355245,1,11,regulation of protein activation cascade,BP,SERPING1
4368,GO:0010038,0.362584217621066,0.753409297185471,10,214,response to metal ion,BP,EGFR;CYBRD1;PKD2;UROS;DMTN;ENDOG;NFATC4;NDRG1;RASA4;MT2A
7299,GO:0031328,0.362617500437849,0.690610427804967,56,1300,positive regulation of cellular biosynthetic process,BP,PEG3;APOE;NDN;ASH2L;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;ZNF318;SFRP1;POU3F1;INSR;PKD2;ZFPM1;RGMA;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;SOX12;DAB2IP;TBX1;TRERF1;YEATS4;TET1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;PLXND1;SREBF1;PIK3R1;PTHLH;NCK2;ACVR1B;NFATC4;RTF1;ZP3;TP53INP1;MDK;ADORA2B;MC1R;IMPACT;CRTC1;ERBB2;RNF187;STAT1;IFI16;DBP;CAMK1;SP100
959,GO:0002407,0.362900597187938,0.930415514087077,1,11,dendritic cell chemotaxis,BP,CXCR1
12019,GO:0048002,0.362946493786078,0.77341371378256,7,148,antigen processing and presentation of peptide antigen,BP,CYBA;CTSV;KIF26A;VAMP3;CTSL;ITGB5;CTSF
6111,GO:0019377,0.363224145643978,0.930280296276119,1,11,glycolipid catabolic process,BP,HEXB
11208,GO:0045428,0.363298131978299,0.868541955548342,2,31,regulation of nitric oxide biosynthetic process,BP,INSR;PKD2
1004,GO:0002495,0.363441990724291,0.811308793016759,4,75,antigen processing and presentation of peptide antigen via MHC class II,BP,CTSV;KIF26A;CTSL;CTSF
9446,GO:0036109,0.363546325918779,0.930145495707253,1,11,alpha-linolenic acid metabolic process,BP,ACSL1
1113,GO:0002709,0.363597869532268,0.868203807510215,2,32,regulation of T cell mediated immunity,BP,ZP3;IL20RB
14953,GO:0070911,0.363619177014607,0.868190647251427,2,32,global genome nucleotide-excision repair,BP,DDB2;XPC
1216,GO:0002903,0.363654013010024,0.930100404910274,1,11,negative regulation of B cell apoptotic process,BP,BCL6
6184,GO:0019693,0.364027121243524,0.727007449212759,17,386,ribose phosphate metabolic process,BP,APOE;PGM1;DHTKD1;INSR;PKD2;NT5E;H6PD;FAM20C;PGLS;ATP6V0A2;PTHLH;SDHA;ADORA2B;NME4;COX5B;TCIRG1;NADK
5245,GO:0015908,0.364029269673275,0.833506744716435,3,52,fatty acid transport,BP,APOE;CPT2;ACSL1
8004,GO:0032663,0.364057657413688,0.868073222512294,2,31,regulation of interleukin-2 production,BP,TNFAIP3;IL20RB
12192,GO:0048486,0.364086162476522,0.929919281584901,1,11,parasympathetic nervous system development,BP,TBX1
10481,GO:0043422,0.36437939879657,0.929796221567971,1,11,protein kinase B binding,MF,SRSF5
5131,GO:0015682,0.364782199479817,0.867471365104505,2,32,ferric iron transport,BP,ATP6V0A2;TCIRG1
15773,GO:0072512,0.364782199479817,0.867471365104505,2,32,trivalent inorganic cation transport,BP,ATP6V0A2;TCIRG1
5632,GO:0016746,0.364809764102023,0.7572435903204,9,190,transferase activity, transferring acyl groups,MF,CPT2;CRAT;CERS4;NAT6;HGSNAT;CPT1C;MBOAT7;ZDHHC1;GOLGA7B
17448,GO:1900409,0.364859687365901,0.929594386338496,1,11,positive regulation of cellular response to oxidative stress,BP,ENDOG
18106,GO:1902884,0.364859687365901,0.929594386338496,1,11,positive regulation of response to oxidative stress,BP,ENDOG
18262,GO:1903209,0.364859687365901,0.929594386338496,1,11,positive regulation of oxidative stress-induced cell death,BP,ENDOG
12074,GO:0048156,0.365052308874114,0.929513343027372,1,11,tau protein binding,MF,APOE
12766,GO:0051100,0.365106905800383,0.781475936586146,6,122,negative regulation of binding,BP,ZFPM1;NFATC4;IFI16;CAMK1;MDFI;SP100
17304,GO:1900029,0.36512625395452,0.929482216786639,1,11,positive regulation of ruffle assembly,BP,EPS8L2
8412,GO:0033555,0.365504367885093,0.86717818056756,2,31,multicellular organismal response to stress,BP,APOE;MDK
12487,GO:0050667,0.365511966405337,0.929319723873233,1,11,homocysteine metabolic process,BP,MTHFR
11456,GO:0045956,0.365689824403789,0.929244721120612,1,11,positive regulation of calcium ion-dependent exocytosis,BP,ZP3
5314,GO:0016064,0.365790281672895,0.832187982003602,3,53,immunoglobulin mediated immune response,BP,BCL6;ZP3;SERPING1
6191,GO:0019724,0.365790281672895,0.832187982003602,3,53,B cell mediated immunity,BP,BCL6;ZP3;SERPING1
15782,GO:0072525,0.365812269203606,0.793317928257602,5,97,pyridine-containing compound biosynthetic process,BP,PGM1;DHTKD1;INSR;NMRK1;NADK
4734,GO:0010923,0.365834660715596,0.809560849909708,4,74,negative regulation of phosphatase activity,BP,PPP1R35;CRY2;ELFN2;PPP1R14A
6129,GO:0019433,0.366150448230773,0.929050256516969,1,11,triglyceride catabolic process,BP,APOE
16145,GO:0090208,0.366199211352103,0.92902965132649,1,11,positive regulation of triglyceride metabolic process,BP,SREBF1
14185,GO:0061180,0.366646018544624,0.831664805320396,3,52,mammary gland epithelium development,BP,GLI2;ETV5;WNT3
4008,GO:0009057,0.36672000346208,0.690401437219373,48,1127,macromolecule catabolic process,BP,TNFAIP3;APOE;MVB12B;LAMP3;EGFR;FBXO2;OAS2;H1F0;PGM1;GAA;CTSB;SERPINE2;TP53INP2;WWTR1;RHBDF1;TMEM129;FOXO1;DAB2IP;SGSH;EPHA4;RPL13A;MAGEF1;CTSV;HEXB;HGSNAT;CUL9;CSPG4;ENDOG;SDC3;CTSL;SNX33;HYAL1;RBCK1;PCBP4;SPATA18;GPC4;FBXW4;NAGLU;BTBD2;RNF187;RNF44;FURIN;FBXW5;CTSF;SMURF1;TCIRG1;IDUA;FBXO44
15404,GO:0071731,0.367076074977519,0.928658520260504,1,11,response to nitric oxide,BP,FOXO1
3534,GO:0007584,0.367158148045544,0.770023057713939,7,144,response to nutrient,BP,POSTN;EGFR;CYBA;SFRP1;ACSL1;MTHFR;STAT1
19651,GO:2000010,0.367177325422601,0.928615592151052,1,11,positive regulation of protein localization to cell surface,BP,SNX33
18164,GO:1902993,0.367283491473643,0.928570563455111,1,11,positive regulation of amyloid precursor protein catabolic process,BP,EPHA4
5654,GO:0016783,0.367397996911593,0.928007032344054,1,12,sulfurtransferase activity,MF,TST
4313,GO:0009855,0.367716397147066,0.808142628148024,4,74,determination of bilateral symmetry,BP,PKD2;TBX1;GAS8;VANGL2
13708,GO:0060323,0.367793822161822,0.865755799342915,2,31,head morphogenesis,BP,WNT3;TBX1
15409,GO:0071772,0.367826461170229,0.791771507371976,5,96,response to BMP,BP,HTRA1;SFRP1;RGMA;NEO1;SMURF1
15410,GO:0071773,0.367826461170229,0.791771507371976,5,96,cellular response to BMP stimulus,BP,HTRA1;SFRP1;RGMA;NEO1;SMURF1
11859,GO:0046916,0.367893652901456,0.807862146787978,4,77,cellular transition metal ion homeostasis,BP,CYBRD1;ATP6V0A2;SLC39A6;MT2A
880,GO:0002252,0.3681015099354,0.700404155575141,32,740,immune effector process,BP,TNFAIP3;IFITM1;MAP3K14;HTRA1;CYBA;OAS2;BCL6;PGM1;VAV3;GAA;ZFPM1;CTSB;PRSS3;KLK5;WIPF1;HEXB;SCART1;DDX60;HGSNAT;PIK3R1;TRIM22;CXCR1;METTL7A;ZP3;STOM;VAMP2;ADORA2B;SERPING1;STAT1;IFI16;IL20RB;TCIRG1
7795,GO:0032370,0.368165855547881,0.865367998478528,2,32,positive regulation of lipid transport,BP,APOE;LDLRAP1
6700,GO:0030130,0.368228309611775,0.928169090180494,1,11,clathrin coat of trans-Golgi network vesicle,CC,LDLRAP1
2781,GO:0006241,0.368282083258216,0.927628785521442,1,12,CTP biosynthetic process,BP,NME4
11485,GO:0046036,0.368282083258216,0.927628785521442,1,12,CTP metabolic process,BP,NME4
707,GO:0001936,0.368383442629891,0.807588624170867,4,75,regulation of endothelial cell proliferation,BP,APOE;CYBA;VEGFB;STAT1
3621,GO:0008106,0.368797420549094,0.927407761077863,1,12,alcohol dehydrogenase (NADP+) activity,MF,RDH12
10550,GO:0043547,0.368955637042929,0.731269601202082,14,298,positive regulation of GTPase activity,BP,SFRP1;VAV3;DAB2IP;EVI5L;F2R;ARHGEF19;IQSEC1;ACAP3;ARHGAP40;TBC1D17;ERBB2;ALS2CL;PLXNB1;RASA4
8575,GO:0034111,0.368996756777339,0.927841574257831,1,11,negative regulation of homotypic cell-cell adhesion,BP,SERPINE2
6758,GO:0030213,0.369092908730365,0.927800531475745,1,11,hyaluronan biosynthetic process,BP,HYAL1
12773,GO:0051117,0.369110783252523,0.829763209602644,3,54,ATPase binding,MF,PKD2;ATP6V0A2;TCIRG1
11054,GO:0045088,0.36924452539692,0.734411480164256,13,286,regulation of innate immune response,BP,TNFAIP3;PTPRS;CYBA;CTSB;DAB2IP;RPS6KA5;DDX60;CTSL;TYRO3;SERPING1;RNF135;STAT1;IFI16
11138,GO:0045240,0.369265599319879,0.927726783079321,1,11,dihydrolipoyl dehydrogenase complex,CC,DHTKD1
17335,GO:1900102,0.369433805205131,0.927654906855127,1,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,NCK2
15290,GO:0071548,0.369461450185455,0.864558396542835,2,32,response to dexamethasone,BP,EGFR;FOXO1
19020,GO:1904925,0.369562025809787,0.927600088242066,1,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,SMURF1
3709,GO:0008252,0.36978830191685,0.92750328736159,1,11,nucleotidase activity,MF,NT5E
14507,GO:0070063,0.369868266667711,0.829303792747789,3,53,RNA polymerase binding,MF,RTF1;STOM;ERBB2
4281,GO:0009743,0.370034960003166,0.767645598199575,7,144,response to carbohydrate,BP,CYBA;GLUL;CTSV;SREBF1;ENDOG;VAMP2;GPR68
13477,GO:0055089,0.370193440468928,0.927329776935498,1,11,fatty acid homeostasis,BP,APOE
2529,GO:0005802,0.370234189022245,0.75941868729995,8,166,trans-Golgi network,CC,POSTN;TGFBI;NSG1;VAMP3;VAMP2;MARCH9;FURIN;RAB43
18163,GO:1902992,0.370249915184008,0.927305570669955,1,11,negative regulation of amyloid precursor protein catabolic process,BP,APOE
16543,GO:0097386,0.370530501541709,0.927185234257382,1,11,glial cell projection,CC,GLUL
7972,GO:0032612,0.370709678804954,0.82862784298903,3,54,interleukin-1 production,BP,TNFAIP3;F2R;IFI16
7087,GO:0030903,0.370872153755791,0.927038548299703,1,11,notochord development,BP,GLI2
7893,GO:0032488,0.371008846851932,0.926979810872781,1,11,Cdc42 protein signal transduction,BP,APOE
11344,GO:0045746,0.371170568060939,0.86348680229419,2,32,negative regulation of Notch signaling pathway,BP,EGFR;BCL6
14108,GO:0061029,0.371265660136584,0.926869381350727,1,11,eyelid development in camera-type eye,BP,EGFR
14321,GO:0061578,0.371413632520913,0.926805708218996,1,11,Lys63-specific deubiquitinase activity,MF,TNFAIP3
12916,GO:0051338,0.3715302312389,0.697238497334796,32,733,regulation of transferase activity,BP,TNFAIP3;APOE;MAP3K14;EPHB2;EGFR;FGFR4;SFRP1;INSR;VAV3;PKD2;WWTR1;DAB2IP;SHC2;EPHA4;F2R;ACSL1;ERBB3;CSPG4;PIK3R1;NCK2;CAMKK1;NAB2;TYRO3;SPRY2;ADORA2B;RTN4RL1;ERBB2;CDK20;CAMK1;MAP3K3;NRK;VANGL2
3522,GO:0007530,0.3716098766493,0.92672121265666,1,11,sex determination,BP,INSR
3075,GO:0006664,0.371626751104348,0.788638236199266,5,100,glycolipid metabolic process,BP,ST3GAL5;ARSI;HEXB;ST6GALNAC6;PIGZ
18388,GO:1903509,0.371626751104348,0.788638236199266,5,100,liposaccharide metabolic process,BP,ST3GAL5;ARSI;HEXB;ST6GALNAC6;PIGZ
2589,GO:0005901,0.371737254664762,0.828056673524435,3,52,caveola,CC,INSR;F2R;SLC2A1
4582,GO:0010715,0.371741045568029,0.926664703736928,1,11,regulation of extracellular matrix disassembly,BP,FGFR4
19704,GO:2000117,0.371803856059551,0.804899943768933,4,77,negative regulation of cysteine-type endopeptidase activity,BP,IFI6;LAMP3;WNT9A;IFI16
1092,GO:0002688,0.371932260225411,0.827681907698833,3,55,regulation of leukocyte chemotaxis,BP,CXCL14;VEGFB;TRPV4
681,GO:0001895,0.372098652729641,0.862903194549412,2,32,retina homeostasis,BP,TUB;RDH12
12998,GO:0051494,0.372181467276961,0.788302088317754,5,97,negative regulation of cytoskeleton organization,BP,FHOD3;ESPN;DMTN;PLEKHH2;ARPIN
463,GO:0001502,0.372188091543229,0.926471916821558,1,11,cartilage condensation,BP,THRA
16797,GO:0098743,0.372188091543229,0.926471916821558,1,11,cell aggregation,BP,THRA
9200,GO:0035615,0.372306839687095,0.926420656443923,1,11,clathrin adaptor activity,MF,LDLRAP1
16800,GO:0098748,0.372306839687095,0.926420656443923,1,11,endocytic adaptor activity,MF,LDLRAP1
2043,GO:0004806,0.37232988954968,0.926410703972276,1,11,triglyceride lipase activity,MF,CES2
7729,GO:0032266,0.372495016870458,0.862812134706196,2,31,phosphatidylinositol-3-phosphate binding,MF,DAB2IP;WIPI2
6814,GO:0030296,0.372531110973562,0.926323786508116,1,11,protein tyrosine kinase activator activity,MF,ERBB3
3239,GO:0006915,0.372564155824641,0.680025863103306,59,1391,apoptotic process,BP,TNFAIP3;PEG3;APOE;ALDH1A3;IFI6;LAMP3;LGALS7B;MAP3K14;EPHB2;EGFR;THRA;H1F0;GLI2;FGFR4;EPB41L3;BCL6;SFRP1;ARHGEF4;TNFSF10;INSR;VAV3;CTSB;FOXO1;NSG1;DAB2IP;OBSCN;TBX1;MNT;EPHA4;WNT9A;F2R;ARHGEF19;ERBB3;ENDOG;PIK3R1;CTSL;NCK2;ACVR1B;NFATC4;TYRO3;RBCK1;SPRY2;TP53INP1;TNFRSF19;MDK;NDRG1;ERBB2;STAT1;NME4;HINT2;ACKR3;IFI16;BEX2;KREMEN1;NISCH;MAP3K3;SP100;NRK;SORT1
10921,GO:0044666,0.372926632379911,0.926152763088483,1,11,MLL3/4 complex,CC,ASH2L
5184,GO:0015800,0.372941420528036,0.862531011843617,2,31,acidic amino acid transport,BP,VAMP2;APBA1
12805,GO:0051155,0.372955438192026,0.862363351959659,2,32,positive regulation of striated muscle cell differentiation,BP,THRA;TBX1
6048,GO:0019215,0.373223683144941,0.92602416295464,1,11,intermediate filament binding,MF,SYNM
12919,GO:0051341,0.37323546784937,0.826827811331633,3,54,regulation of oxidoreductase activity,BP,APOE;EGFR;CYBA
14754,GO:0070509,0.373270614922216,0.862323522857897,2,31,calcium ion import,BP,PKD2;TRPV4
4327,GO:0009896,0.373325659883392,0.724198009659664,15,328,positive regulation of catabolic process,BP,TNFAIP3;APOE;INSR;TP53INP2;FOXO1;TRIM65;DAB2IP;MAGEF1;ENDOG;TRIM22;SNX33;TP53INP1;EPM2A;FURIN;SMURF1
4626,GO:0010766,0.373333115881319,0.925976753378322,1,11,negative regulation of sodium ion transport,BP,SERPINE2
1862,GO:0004550,0.373356343488498,0.925434996569461,1,12,nucleoside diphosphate kinase activity,MF,NME4
14221,GO:0061318,0.373360190908932,0.925965020862228,1,11,renal filtration cell differentiation,BP,LAMB2
15583,GO:0072112,0.373360190908932,0.925965020862228,1,11,glomerular visceral epithelial cell differentiation,BP,LAMB2
15696,GO:0072311,0.373360190908932,0.925965020862228,1,11,glomerular epithelial cell differentiation,BP,LAMB2
1007,GO:0002504,0.373430553684035,0.803710870174945,4,76,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,CTSV;KIF26A;CTSL;CTSF
6846,GO:0030336,0.373675708572749,0.75651900675718,8,166,negative regulation of cell migration,BP,IFITM1;APOE;SFRP1;DAB2IP;TP53INP1;ARPIN;NISCH;SP100
11361,GO:0045780,0.373939724565758,0.92571362365565,1,11,positive regulation of bone resorption,BP,EGFR
11826,GO:0046852,0.373939724565758,0.92571362365565,1,11,positive regulation of bone remodeling,BP,EGFR
13173,GO:0051865,0.374607451553024,0.825925968175536,3,53,protein autoubiquitination,BP,DDB2;RNF187;RNF208
13874,GO:0060572,0.374779337000323,0.925348504412204,1,11,morphogenesis of an epithelial bud,BP,GLI2
7732,GO:0032270,0.374977577615108,0.683720952194272,46,1071,positive regulation of cellular protein metabolic process,BP,TNFAIP3;APOE;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;BCL6;TNFSF10;INSR;PKD2;DAB2IP;TBX1;SHC2;TET1;EPHA4;MAGEF1;F2R;RPS6KA5;ACSL1;ERBB3;SREBF1;CSPG4;NCK2;ACVR1B;CAMKK1;NAB2;SNX33;TYRO3;RTF1;SPRY2;TNFRSF19;TRPV4;ADORA2B;IMPACT;IGFBP4;ERBB2;CDK20;ACKR3;FURIN;IFI16;SMURF1;CAMK1;MAP3K3;NRK;VANGL2
16034,GO:0090036,0.375372101212427,0.925090087754209,1,11,regulation of protein kinase C signaling,BP,MC1R
13583,GO:0060117,0.375405632336096,0.925075453871058,1,11,auditory receptor cell development,BP,SLITRK6
11744,GO:0046639,0.375663191411555,0.924962991279474,1,11,negative regulation of alpha-beta T cell differentiation,BP,BCL6
4470,GO:0010510,0.375908954593873,0.924855585442484,1,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,PDPR
20132,GO:2001014,0.375931287471166,0.924845820763131,1,11,regulation of skeletal muscle cell differentiation,BP,TBX1
4324,GO:0009893,0.376180337319365,0.66673986458602,99,2349,positive regulation of metabolic process,BP,TNFAIP3;PEG3;APOE;LAMP3;GPNMB;NDN;MAP3K14;EPHB2;ASH2L;SRSF5;EGFR;THRA;CITED4;CYBA;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;ZNF318;SFRP1;POU3F1;TNFSF10;INSR;VAV3;PKD2;ZFPM1;RGMA;LDLRAP1;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;WNT3;TRIM65;NSG1;SOX12;DAB2IP;TBX1;TRERF1;SHC2;YEATS4;TET1;EPHA4;MAGEF1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;ACSL1;ACTA2;ERBB3;VAMP3;PLXND1;SREBF1;CSPG4;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;CAMKK1;NAB2;NFATC4;SNX33;TYRO3;RTF1;ZP3;SPRY2;TP53INP1;TNFRSF19;MDK;TRPV4;ADORA2B;MC1R;IMPACT;CRTC1;IGFBP4;ERBB2;RNF187;EPM2A;STAT1;CDK20;ACKR3;FURIN;IFI16;MLYCD;GJC2;DBP;SMURF1;CCDC3;CAMK1;MAP3K3;SP100;NRK;VANGL2
4300,GO:0009799,0.376309086549187,0.801564362653871,4,75,specification of symmetry,BP,PKD2;TBX1;GAS8;VANGL2
1017,GO:0002526,0.37644811508541,0.824450081044062,3,55,acute inflammatory response,BP,ZP3;SERPING1;IL20RB
15193,GO:0071391,0.376599850129405,0.924553151934709,1,11,cellular response to estrogen stimulus,BP,SFRP1
18177,GO:1903010,0.376695919005502,0.924511041157722,1,11,regulation of bone development,BP,GPR68
15143,GO:0071320,0.376820668476644,0.860076299174539,2,31,cellular response to cAMP,BP,PKD2;DMTN
10129,GO:0042744,0.377041624688135,0.92381721191674,1,12,hydrogen peroxide catabolic process,BP,GPX3
12536,GO:0050730,0.377193225897817,0.761677144732702,7,145,regulation of peptidyl-tyrosine phosphorylation,BP,EGFR;SFRP1;EPHA4;ERBB3;CSPG4;DMTN;NCK2
4943,GO:0015036,0.37728860105409,0.859323758787228,2,34,disulfide oxidoreductase activity,MF,TXNRD3;TXNDC17
3674,GO:0008194,0.377873891034829,0.783713565339727,5,99,UDP-glycosyltransferase activity,MF,XYLT1;B3GNT9;HEXB;HYAL1;XYLT2
200,GO:0000422,0.378039433101479,0.800140485253304,4,77,autophagy of mitochondrion,BP,SREBF1;SPATA18;WIPI2;SMURF1
14383,GO:0061726,0.378039433101479,0.800140485253304,4,77,mitochondrion disassembly,BP,SREBF1;SPATA18;WIPI2;SMURF1
2377,GO:0005527,0.378122937202022,0.923338597055293,1,12,macrolide binding,MF,FKBP9
2378,GO:0005528,0.378122937202022,0.923338597055293,1,12,FK506 binding,MF,FKBP9
5599,GO:0016671,0.378154274405298,0.923324699767046,1,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,MSRB2
13210,GO:0051928,0.37843908797477,0.823094333291396,3,54,positive regulation of calcium ion transport,BP,PKD2;F2R;GJC2
19585,GO:1990782,0.378579868450718,0.82307308779469,3,53,protein tyrosine kinase binding,MF,SHC2;EPHA4;PIK3R1
17049,GO:0099625,0.37868351950742,0.92363664457592,1,11,ventricular cardiac muscle cell membrane repolarization,BP,SCN4B
9992,GO:0042455,0.379000750677097,0.85822961520196,2,34,ribonucleoside biosynthetic process,BP,NT5E;NME4
12349,GO:0048799,0.379022081684164,0.923487101958432,1,11,animal organ maturation,BP,PLXNB1
9659,GO:0038083,0.379188360391215,0.858567690910595,2,31,peptidyl-tyrosine autophosphorylation,BP,EGFR;INSR
1143,GO:0002758,0.379205961225046,0.744905739568564,9,194,innate immune response-activating signal transduction,BP,TNFAIP3;PTPRS;CYBA;CTSB;DAB2IP;RPS6KA5;DDX60;CTSL;TYRO3
15960,GO:0086012,0.379476599591897,0.923286066535451,1,11,membrane depolarization during cardiac muscle cell action potential,BP,SCN4B
3606,GO:0008076,0.379620122938776,0.858128926900585,2,32,voltage-gated potassium channel complex,CC,KCNC4;VAMP2
15255,GO:0071481,0.380007259553695,0.923050953596099,1,11,cellular response to X-ray,BP,SFRP1
17047,GO:0099623,0.380199939914317,0.922965478509775,1,11,regulation of cardiac muscle cell membrane repolarization,BP,SCN4B
12525,GO:0050714,0.380228615299461,0.759140685139515,7,145,positive regulation of protein secretion,BP,POSTN;EGFR;NLGN2;GLUL;F2R;TRPV4;GPR68
6415,GO:0021700,0.381274672751624,0.758284987890688,7,144,developmental maturation,BP,ADGRL1;DAB2IP;FAM20C;NFATC4;FAM210B;CABYR;PLXNB1
16612,GO:0097529,0.381305559121013,0.797581955680342,4,78,myeloid leukocyte migration,BP,CKLF;VAV3;VEGFB;TRPV4
15717,GO:0072350,0.381554642601458,0.856734370445799,2,33,tricarboxylic acid metabolic process,BP,DHTKD1;SDHA
7020,GO:0030813,0.381897333646464,0.922210039407243,1,11,positive regulation of nucleotide catabolic process,BP,INSR
899,GO:0002287,0.381904183236123,0.856663376436875,2,32,alpha-beta T cell activation involved in immune response,BP,BCL6;ZFPM1
902,GO:0002293,0.381904183236123,0.856663376436875,2,32,alpha-beta T cell differentiation involved in immune response,BP,BCL6;ZFPM1
903,GO:0002294,0.381904183236123,0.856663376436875,2,32,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,BCL6;ZFPM1
9817,GO:0042093,0.381904183236123,0.856663376436875,2,32,T-helper cell differentiation,BP,BCL6;ZFPM1
4479,GO:0010522,0.382116282537042,0.82043565164965,3,54,regulation of calcium ion transport into cytosol,BP,CYBA;PKD2;F2R
769,GO:0002029,0.382152624161747,0.921539158521313,1,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,DNM1
6555,GO:0022401,0.382152624161747,0.921539158521313,1,12,negative adaptation of signaling pathway,BP,DNM1
12645,GO:0050900,0.382254889365449,0.736420898577479,10,216,leukocyte migration,BP,CKLF;VAV3;CXCL14;VEGFB;PIK3R1;SDC3;CXCR1;ZP3;TRPV4;MMP1
3174,GO:0006813,0.382283392236118,0.780224629376388,5,98,potassium ion transport,BP,KCNJ15;PKD2;KCNC4;ATP12A;VAMP2
7036,GO:0030834,0.383004602580868,0.855954675822637,2,32,regulation of actin filament depolymerization,BP,DMTN;PLEKHH2
3055,GO:0006637,0.383179794303909,0.796135670392316,4,78,acyl-CoA metabolic process,BP,PDPR;ACSL1;MVD;MLYCD
9079,GO:0035383,0.383179794303909,0.796135670392316,4,78,thioester metabolic process,BP,PDPR;ACSL1;MVD;MLYCD
20140,GO:2001025,0.383426776307591,0.920964987157825,1,12,positive regulation of response to drug,BP,ENDOG
3700,GO:0008235,0.383677609076622,0.855520398938122,2,32,metalloexopeptidase activity,MF,NPEPL1;RNPEPL1
4923,GO:0014902,0.384088497279952,0.819002739088358,3,54,myotube differentiation,BP,THRA;TBX1;SORT1
6900,GO:0030512,0.384098825619167,0.818995222225098,3,54,negative regulation of transforming growth factor beta receptor signaling pathway,BP,HTRA1;LTBP1;SMURF1
3098,GO:0006691,0.384253225466443,0.920591222471068,1,12,leukotriene metabolic process,BP,ABCC1
7570,GO:0031960,0.384290411161931,0.778510633001471,5,101,response to corticosteroid,BP,EGFR;CYBA;FOXO1;CTSV;MDK
12605,GO:0050849,0.384441939455512,0.920505727604375,1,12,negative regulation of calcium-mediated signaling,BP,PKD2
14695,GO:0070403,0.384514435609636,0.920472869327157,1,12,NAD+ binding,MF,ALDH1A3
4043,GO:0009109,0.384560796908732,0.920451852186817,1,12,coenzyme catabolic process,BP,CBR3
20255,GO:2001275,0.384573492598433,0.921010005084438,1,11,positive regulation of glucose import in response to insulin stimulus,BP,PIK3R1
16463,GO:0097202,0.384619030240631,0.920425448335302,1,12,activation of cysteine-type endopeptidase activity,BP,IFI16
2479,GO:0005741,0.384882317135023,0.755195554151308,7,147,mitochondrial outer membrane,CC,SNN;BPHL;EPHA4;ACSL1;FAM210B;CPT1C;SPATA18
189,GO:0000407,0.385004123703402,0.854662554285595,2,32,phagophore assembly site,CC,ULK2;WIPI2
7023,GO:0030816,0.385161953771925,0.920179025869625,1,12,positive regulation of cAMP metabolic process,BP,PTHLH
11714,GO:0046597,0.385530233671511,0.92001161055865,1,12,negative regulation of viral entry into host cell,BP,IFITM1
16502,GO:0097296,0.385709364590753,0.919930103861852,1,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TNFSF10
18542,GO:1903828,0.385929178249692,0.794055557315109,4,77,negative regulation of cellular protein localization,BP,TP53INP2;DMTN;SNX33;SP100
12303,GO:0048701,0.386031321801035,0.853996566379296,2,32,embryonic cranial skeleton morphogenesis,BP,TBX1;TULP3
20227,GO:2001235,0.386064395677792,0.754142110451226,7,150,positive regulation of apoptotic signaling pathway,BP,SFRP1;TNFSF10;DAB2IP;NCK2;NFATC4;RBCK1;TP53INP1
4299,GO:0009798,0.38617958761774,0.817478140760599,3,54,axis specification,BP,SFRP1;WNT3;MDFI
12274,GO:0048661,0.386183572619413,0.817475230098233,3,54,positive regulation of smooth muscle cell proliferation,BP,EGFR;CYBA;STAT1
17786,GO:1901985,0.386197377307468,0.853732388834825,2,33,positive regulation of protein acetylation,BP,RPS6KA5;CAMK1
19989,GO:2000649,0.386201445272866,0.85388612212526,2,32,regulation of sodium ion transmembrane transporter activity,BP,SCN4B;STOM
3702,GO:0008237,0.386484134705848,0.776813665444207,5,99,metallopeptidase activity,MF,ADAM19;NPEPL1;RNPEPL1;ADAMTS15;MMP1
12391,GO:0048878,0.38678057400897,0.687391426324015,28,644,chemical homeostasis,BP,APOE;IFI6;EGFR;CYBA;FGFR4;INSR;CYBRD1;SV2A;PKD2;LDLRAP1;FOXO1;F2R;HOMER2;HEXB;ATP6V0A2;ENDOG;PIK3R1;ATP12A;TRPV4;PQLC2;NEO1;GPR68;STAT1;CRY2;SLC39A6;ALOXE3;TCIRG1;MT2A
11215,GO:0045454,0.387038712605598,0.816621038559715,3,57,cell redox homeostasis,BP,TXNRD3;CYBA;TMX4
1210,GO:0002888,0.387188478995773,0.91925518390888,1,12,positive regulation of myeloid leukocyte mediated immunity,BP,ADORA2B
17500,GO:1901070,0.387357527154106,0.918694902968493,1,13,guanosine-containing compound biosynthetic process,BP,NME4
4266,GO:0009650,0.387369915478372,0.919172160139125,1,12,UV protection,BP,MC1R
10273,GO:0043073,0.387964443201538,0.918899750143105,1,12,germ cell nucleus,CC,TCFL5
3747,GO:0008308,0.388317806648087,0.918737579563217,1,12,voltage-gated anion channel activity,MF,CLCN7
12160,GO:0048365,0.388424349200485,0.815918069861338,3,53,Rac GTPase binding,MF,ARHGEF4;VAV3;EPS8L2
9854,GO:0042159,0.388726571438632,0.918549740465915,1,12,lipoprotein catabolic process,BP,APOE
17967,GO:1902476,0.388740794022233,0.852232705331057,2,32,chloride transmembrane transport,BP,CLCN7;SLC1A4
9546,GO:0036379,0.389085338511139,0.918384661864969,1,12,myofilament,CC,FHOD3
13600,GO:0060143,0.389160571426857,0.918350019638308,1,12,positive regulation of syncytium formation by plasma membrane fusion,BP,CAMK1
8271,GO:0033127,0.389221336933238,0.918322032712933,1,12,regulation of histone phosphorylation,BP,RPS6KA5
3318,GO:0007044,0.389516472806983,0.791367951018149,4,75,cell-substrate junction assembly,BP,TNS1;SFRP1;DMTN;RHOD
9106,GO:0035458,0.389563878322156,0.91816415962365,1,12,cellular response to interferon-beta,BP,STAT1
11681,GO:0046519,0.389576355402075,0.918158405630606,1,12,sphingoid metabolic process,BP,KDSR
11024,GO:0045055,0.389908392325212,0.693163000705429,22,507,regulated exocytosis,BP,CYBA;PGM1;GAA;RIMS3;CTSB;SYT8;VEGFB;PRSS3;HEXB;HGSNAT;VAMP3;DMTN;SYTL1;CXCR1;METTL7A;ZP3;STOM;VAMP2;ADORA2B;SERPING1;C2CD4C;TCIRG1
10521,GO:0043508,0.390244056469188,0.917850130154372,1,12,negative regulation of JUN kinase activity,BP,SFRP1
8933,GO:0035025,0.390476207588537,0.917742783293949,1,12,positive regulation of Rho protein signal transduction,BP,F2R
3313,GO:0007039,0.390813737871724,0.917586558492908,1,12,protein catabolic process in the vacuole,BP,TCIRG1
7455,GO:0031639,0.390874469268947,0.917558430219781,1,12,plasminogen activation,BP,SERPINE2
2359,GO:0005501,0.390875645272925,0.917557885486309,1,12,retinoid binding,MF,CYP27C1
10511,GO:0043492,0.390907126516592,0.790230798795565,4,76,ATPase activity, coupled to movement of substances,MF,ATP6V0A2;ATP12A;TCIRG1;ABCC1
15523,GO:0072012,0.391031301249051,0.917485765397808,1,12,glomerulus vasculature development,BP,ACTA2
5243,GO:0015893,0.391077633357341,0.773031715445696,5,101,drug transport,BP,SLC13A5;PQLC2;SLC13A3;SLC47A1;ABCC1
4686,GO:0010866,0.391148016454039,0.91743166282853,1,12,regulation of triglyceride biosynthetic process,BP,SREBF1
7107,GO:0030950,0.391384822913437,0.917321827127105,1,12,establishment or maintenance of actin cytoskeleton polarity,BP,RHOD
7379,GO:0031462,0.391839383040009,0.91711074635755,1,12,Cul2-RING ubiquitin ligase complex,CC,ZSWIM8
4695,GO:0010875,0.391896335314691,0.917084276990462,1,12,positive regulation of cholesterol efflux,BP,APOE
10501,GO:0043476,0.392034576620635,0.917020006230066,1,12,pigment accumulation,BP,SHROOM2
10502,GO:0043482,0.392034576620635,0.917020006230066,1,12,cellular pigment accumulation,BP,SHROOM2
2256,GO:0005200,0.392045502574504,0.789240479762157,4,78,structural constituent of cytoskeleton,MF,EPB41L3;YEATS4;PPL;SYNM
16477,GO:0097228,0.392431643096018,0.916835236319908,1,12,sperm principal piece,CC,CABYR
6803,GO:0030282,0.392852694622055,0.81257617097857,3,54,bone mineralization,BP,GPNMB;FAM20C;PTHLH
3577,GO:0008017,0.392886001164101,0.727173381124957,10,212,microtubule binding,MF,DNM1;CLIP2;GAS8;KIF26B;KIF26A;TRPV4;NDRG1;MARK4;CCDC69;CCDC88B
11844,GO:0046888,0.393091221656962,0.849218538485297,2,33,negative regulation of hormone secretion,BP,SFRP1;SREBF1
10090,GO:0042641,0.393805228457251,0.811871893153656,3,54,actomyosin,CC,CYBA;PDLIM4;VANGL2
14014,GO:0060828,0.393923317207981,0.732144647110896,9,196,regulation of canonical Wnt signaling pathway,BP,APOE;SFRP1;WWTR1;FOXO1;DAB2IP;DIXDC1;CDK14;IGFBP4;KREMEN1
2354,GO:0005484,0.394022860809985,0.848452272719276,2,34,SNAP receptor activity,MF,VAMP3;VAMP2
12086,GO:0048188,0.39428144039409,0.9159711885651,1,12,Set1C/COMPASS complex,CC,ASH2L
17848,GO:1902170,0.394330431343966,0.915948231457596,1,12,cellular response to reactive nitrogen species,BP,FOXO1
1165,GO:0002819,0.394401429860354,0.787344749893347,4,79,regulation of adaptive immune response,BP,TNFAIP3;BCL6;ZP3;IL20RB
4367,GO:0010035,0.394459628867255,0.705136683305107,15,339,response to inorganic substance,BP,TNFAIP3;TXNRD3;EGFR;CYBRD1;PKD2;FOXO1;UROS;DMTN;ENDOG;NFATC4;NDRG1;IMPACT;STAT1;RASA4;MT2A
11070,GO:0045120,0.394469431350707,0.915883075602972,1,12,pronucleus,CC,SLC2A1
8862,GO:0034705,0.394578930906721,0.848235578370112,2,33,potassium channel complex,CC,KCNC4;VAMP2
19018,GO:1904923,0.394601588850865,0.915821098900473,1,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,SMURF1
13427,GO:0055002,0.394817789797125,0.787115938473909,4,77,striated muscle cell development,BP,OBSL1;FLNC;FHOD3;OBSCN
9168,GO:0035579,0.395013430792838,0.810895808886715,3,55,specific granule membrane,CC,CYBA;HGSNAT;STOM
2071,GO:0004842,0.395096522361509,0.698982003245159,17,379,ubiquitin-protein transferase activity,MF,TNFAIP3;FBXO41;FBXO2;TMEM129;DDB2;HERC3;KLHDC8B;RBCK1;FBXW4;RNF187;RNF135;FBXL8;RNF44;FBXW5;SMURF1;RNF208;FBXO44
4131,GO:0009209,0.395823898628569,0.914742510168479,1,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,NME4
12315,GO:0048714,0.396175940014618,0.915080669207172,1,12,positive regulation of oligodendrocyte differentiation,BP,TENM4
9994,GO:0042462,0.396736804108585,0.91481594392314,1,12,eye photoreceptor cell development,BP,NAGLU
11295,GO:0045655,0.396876116308142,0.914750112003926,1,12,regulation of monocyte differentiation,BP,GPR68
13829,GO:0060487,0.396930631324062,0.914724342590431,1,12,lung epithelial cell differentiation,BP,THRA
4489,GO:0010557,0.397016946566975,0.659287063188452,53,1242,positive regulation of macromolecule biosynthetic process,BP,PEG3;NDN;ASH2L;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;ZNF318;SFRP1;POU3F1;INSR;PKD2;ZFPM1;RGMA;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;SOX12;DAB2IP;TBX1;TRERF1;YEATS4;TET1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;PLXND1;SREBF1;PIK3R1;NCK2;ACVR1B;NFATC4;RTF1;ZP3;TP53INP1;MDK;MC1R;IMPACT;CRTC1;ERBB2;RNF187;STAT1;IFI16;DBP;CAMK1;SP100
12697,GO:0051000,0.397262216291781,0.914567499968534,1,12,positive regulation of nitric-oxide synthase activity,BP,APOE
1008,GO:0002507,0.397459762264833,0.914473976157046,1,12,tolerance induction,BP,TNFAIP3
4744,GO:0010941,0.397562662036659,0.660195655101924,50,1183,regulation of cell death,BP,TNFAIP3;APOE;ALDH1A3;IFI6;LAMP3;GPNMB;MAP3K14;EPHB2;EGFR;THRA;GLI2;FGFR4;BCL6;SFRP1;ARHGEF4;TNFSF10;INSR;VAV3;CTSB;FOXO1;DAB2IP;OBSCN;TBX1;MNT;EPHA4;WNT9A;F2R;ARHGEF19;ERBB3;ENDOG;PIK3R1;NCK2;NFATC4;TYRO3;RBCK1;SPRY2;TP53INP1;MDK;NDRG1;MARK4;IMPACT;ERBB2;STAT1;NME4;ACKR3;BEX2;MAP3K3;SP100;NRK;SORT1
6677,GO:0030073,0.397712614425773,0.754622814666058,6,124,insulin secretion,BP,NLGN2;SFRP1;GLUL;SREBF1;SLC2A1;GPR68
8343,GO:0033262,0.397718874274734,0.914351211458636,1,12,regulation of nuclear cell cycle DNA replication,BP,BCL6
2274,GO:0005245,0.397730914699587,0.914345504236133,1,12,voltage-gated calcium channel activity,MF,PKD2
15287,GO:0071545,0.39787662408897,0.914276419015678,1,12,inositol phosphate catabolic process,BP,IMPA2
10974,GO:0044827,0.398046641033314,0.914195766267611,1,12,modulation by host of viral genome replication,BP,STOM
19918,GO:2000515,0.399029970524378,0.913728393418135,1,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,BCL6
11785,GO:0046716,0.399051165729205,0.913718302501321,1,12,muscle cell cellular homeostasis,BP,GAA
56,GO:0000118,0.399248530549923,0.807743224993338,3,55,histone deacetylase complex,CC,SALL2;TRERF1;APPL2
12127,GO:0048278,0.399582631396547,0.807414371913635,3,56,vesicle docking,BP,RAB40B;VAMP3;VPS33B
3177,GO:0006817,0.399883193867728,0.913321614011844,1,12,phosphate ion transport,BP,CRY2
8770,GO:0034497,0.399889788688172,0.913318465379089,1,12,protein localization to phagophore assembly site,BP,WIPI2
15522,GO:0072010,0.399937574978881,0.913295648211277,1,12,glomerular epithelium development,BP,LAMB2
16721,GO:0098554,0.400013271253918,0.912744812742588,1,13,cytoplasmic side of endoplasmic reticulum membrane,CC,PKD2
3161,GO:0006790,0.400137581282536,0.710869891777687,12,272,sulfur compound metabolic process,BP,GAMT;XYLT1;PDPR;HEXB;ACSL1;CSPG4;HYAL1;MTHFR;MVD;MLYCD;XYLT2;IDUA
3226,GO:0006897,0.40062863819267,0.687053531435477,20,452,endocytosis,BP,APOE;CYBA;NLGN2;VAV3;DNM1;LDLRAP1;SYT8;WIPF1;TUB;SCART1;PIK3R1;SNX33;TYRO3;CXCR1;MRC2;STON1;MICALL1;C2CD4C;ACKR3;SORT1
15429,GO:0071813,0.401127909241828,0.912726108626254,1,12,lipoprotein particle binding,MF,APOE
15430,GO:0071814,0.401127909241828,0.912726108626254,1,12,protein-lipid complex binding,MF,APOE
4637,GO:0010799,0.401142729600879,0.843861032430227,2,33,regulation of peptidyl-threonine phosphorylation,BP,DMTN;SPRY2
12660,GO:0050918,0.40117783361782,0.84368258257487,2,34,positive chemotaxis,BP,GPNMB;VEGFB
18129,GO:1902932,0.401588236495496,0.912505249781942,1,12,positive regulation of alcohol biosynthetic process,BP,SREBF1
16768,GO:0098657,0.401721661590203,0.682261197419886,22,499,import into cell,BP,APOE;CYBA;NLGN2;VAV3;DNM1;LDLRAP1;SYT8;WIPF1;GLUL;TUB;SCART1;PIK3R1;SNX33;TYRO3;CXCR1;MRC2;STON1;MICALL1;C2CD4C;ACKR3;SLC39A6;SORT1
17027,GO:0099563,0.401739211330082,0.912432740390256,1,12,modification of synaptic structure,BP,EPHA4
5682,GO:0016829,0.401764944642222,0.751094448963513,6,129,lyase activity,MF,UROS;GLUL;MVD;MLYCD;THNSL2;ALOXE3
17754,GO:1901879,0.401965654004369,0.805708708070053,3,55,regulation of protein depolymerization,BP,DMTN;PLEKHH2;TRPV4
12587,GO:0050812,0.402063303683468,0.912276964032067,1,12,regulation of acyl-CoA biosynthetic process,BP,PDPR
6638,GO:0030008,0.402069504131282,0.911754049112546,1,13,TRAPP complex,CC,TRAPPC2L
5058,GO:0015299,0.402125865494352,0.912246874101832,1,12,solute:proton antiporter activity,MF,SLC47A1
16096,GO:0090148,0.402135411300121,0.912242282370125,1,12,membrane fission,BP,DNM1
15778,GO:0072521,0.402436938758117,0.692186171976018,17,395,purine-containing compound metabolic process,BP,APOE;GAMT;PGM1;DHTKD1;INSR;PKD2;NT5E;FAM20C;ATP6V0A2;PTHLH;SLC2A9;SDHA;ADORA2B;NME4;COX5B;TCIRG1;NADK
10028,GO:0042542,0.402450361115854,0.763642227494365,5,104,response to hydrogen peroxide,BP,TNFAIP3;FOXO1;ENDOG;IMPACT;STAT1
10587,GO:0043616,0.402496563353743,0.842951079458862,2,33,keratinocyte proliferation,BP,CTSV;KLK8
6965,GO:0030662,0.402952323768506,0.750168191143171,6,126,coated vesicle membrane,CC,APOE;EGFR;LDLRAP1;VAMP3;SREBF1;VAMP2
7422,GO:0031572,0.403514788506524,0.842264966616573,2,33,G2 DNA damage checkpoint,BP,MAP3K14;BRSK1
2726,GO:0006123,0.40357148659582,0.910578023926705,1,14,mitochondrial electron transport, cytochrome c to oxygen,BP,COX5B
6173,GO:0019646,0.40357148659582,0.910578023926705,1,14,aerobic electron transport chain,BP,COX5B
7898,GO:0032495,0.403611665224536,0.911530418463859,1,12,response to muramyl dipeptide,BP,TNFAIP3
18191,GO:1903036,0.40384125084676,0.841888361800214,2,34,positive regulation of response to wounding,BP,F2R;DMTN
1275,GO:0003094,0.404137088935981,0.911276211551156,1,12,glomerular filtration,BP,F2R
7563,GO:0031952,0.404147839917798,0.841837645655681,2,33,regulation of protein autophosphorylation,BP,GPNMB;IMPACT
16943,GO:0099054,0.404244090082809,0.911224388708025,1,12,presynapse assembly,BP,NLGN2
4621,GO:0010761,0.404293664949462,0.841739129570426,2,33,fibroblast migration,BP,TNS1;DMTN
10346,GO:0043200,0.4043554336048,0.779469190108685,4,79,response to amino acid,BP,COL6A1;EGFR;CYBA;MTHFR
7073,GO:0030888,0.404532781717883,0.841420843712855,2,34,regulation of B cell proliferation,BP,BCL6;VAV3
6508,GO:0021915,0.40473765362819,0.748739875809601,6,123,neural tube development,BP,GLI2;SFRP1;PKD2;SALL2;TULP3;VANGL2
5561,GO:0016597,0.405015212477742,0.84109428326214,2,34,amino acid binding,MF,GLUL;THNSL2
10569,GO:0043576,0.405054439433996,0.910831323159546,1,12,regulation of respiratory gaseous exchange,BP,NLGN2
18549,GO:1903845,0.405174891536014,0.803213238117149,3,56,negative regulation of cellular response to transforming growth factor beta stimulus,BP,HTRA1;LTBP1;SMURF1
4085,GO:0009156,0.405299203334188,0.748161908479148,6,127,ribonucleoside monophosphate biosynthetic process,BP,PGM1;DHTKD1;INSR;ATP6V0A2;COX5B;TCIRG1
7174,GO:0031083,0.405595210519114,0.910039440353557,1,13,BLOC-1 complex,CC,BLOC1S4
9420,GO:0036038,0.405783898312733,0.909947113671115,1,13,MKS complex,CC,TMEM231
16092,GO:0090136,0.405889464843894,0.91042518413601,1,12,epithelial cell-cell adhesion,BP,ITGB5
14236,GO:0061351,0.406005597493887,0.778202637407957,4,78,neural precursor cell proliferation,BP,FOXO1;DIXDC1;KCTD11;GJC2
15186,GO:0071380,0.406024874759128,0.910359217842824,1,12,cellular response to prostaglandin E stimulus,BP,SFRP1
3166,GO:0006801,0.406255493473002,0.84010483654794,2,35,superoxide metabolic process,BP,EGFR;CYBA
10639,GO:0043903,0.406378085319528,0.728308601357173,8,175,regulation of symbiosis, encompassing mutualism through parasitism,BP,IFITM1;APOE;MVB12B;LAMP3;OAS2;STOM;STAT1;IFI16
4645,GO:0010811,0.40652128865567,0.777790654033146,4,78,positive regulation of cell-substrate adhesion,BP,SMOC2;NINJ1;SFRP1;DMTN
13196,GO:0051900,0.406713217498268,0.909491549684839,1,13,regulation of mitochondrial depolarization,BP,IFI6
6193,GO:0019730,0.40674221008362,0.83937617985848,2,38,antimicrobial humoral response,BP,PRSS3;KLK5
13191,GO:0051895,0.406852768416299,0.909955258842713,1,12,negative regulation of focal adhesion assembly,BP,DMTN
19604,GO:1990841,0.406852817629124,0.840005245947647,2,33,promoter-specific chromatin binding,MF,GLI2;STAT1
6631,GO:0023058,0.407030731756275,0.90933558003001,1,13,adaptation of signaling pathway,BP,DNM1
4277,GO:0009725,0.40723068909858,0.668260838524146,28,647,response to hormone,BP,POSTN;SRSF5;EGFR;THRA;CYBA;SFRP1;TNFSF10;INSR;CTSB;FOXO1;CTSV;TUB;ACSL1;ATP6V0A2;SREBF1;ENDOG;PIK3R1;CTSL;UCN2;FAM210B;SLC2A1;VAMP2;MDK;TRPV4;STAT1;CRY2;TCIRG1;SORT1
12782,GO:0051127,0.407662358222136,0.909559162055609,1,12,positive regulation of actin nucleation,BP,WIPF1
12328,GO:0048745,0.407696847911418,0.909542264266442,1,12,smooth muscle tissue development,BP,PKD2
11640,GO:0046459,0.407898333611856,0.908908563227465,1,13,short-chain fatty acid metabolic process,BP,THNSL2
8415,GO:0033559,0.407927385663095,0.800977393337235,3,58,unsaturated fatty acid metabolic process,BP,CES2;ACSL1;ALOXE3
7423,GO:0031573,0.408341799060092,0.908689826869308,1,13,intra-S DNA damage checkpoint,BP,XPC
10375,GO:0043244,0.408406467773061,0.776282015919297,4,78,regulation of protein complex disassembly,BP,INSR;DMTN;PLEKHH2;TRPV4
3210,GO:0006878,0.408455441454801,0.908633722158744,1,13,cellular copper ion homeostasis,BP,MT2A
17784,GO:1901983,0.408539113618909,0.800588557788858,3,57,regulation of protein acetylation,BP,RPS6KA5;HINT2;CAMK1
19904,GO:2000482,0.408562823299743,0.908580688989716,1,13,regulation of interleukin-8 secretion,BP,F2R
6591,GO:0022829,0.408648551825303,0.908538336407479,1,13,wide pore channel activity,MF,GJC2
1378,GO:0003299,0.408730199875339,0.90903509484077,1,12,muscle hypertrophy in response to stress,BP,FOXO1
4912,GO:0014887,0.408730199875339,0.90903509484077,1,12,cardiac muscle adaptation,BP,FOXO1
4920,GO:0014898,0.408730199875339,0.90903509484077,1,12,cardiac muscle hypertrophy in response to stress,BP,FOXO1
11409,GO:0045892,0.408750596727495,0.657043506573861,38,892,negative regulation of transcription, DNA-templated,BP,PEG3;HES2;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;ZFPM1;HR;SALL2;WWTR1;FOXO1;DAB2IP;MNT;TET1;TCFL5;RPS6KA5;ZBTB42;SREBF1;NCK2;NAB2;NFATC4;RTF1;ZP3;MBD1;TRPV4;IMPACT;H2AFJ;STAT1;CRY2;IFI16;PER3;CXXC5;MDFI;SCMH1;SP100
7058,GO:0030866,0.408877060770583,0.838627094034645,2,33,cortical actin cytoskeleton organization,BP,EPB41L3;WIPF1
14622,GO:0070262,0.409199893010342,0.908265671312348,1,13,peptidyl-serine dephosphorylation,BP,PPP2R2C
4407,GO:0010243,0.409237699959164,0.666370591972874,28,648,response to organonitrogen compound,BP,TNFAIP3;APOE;SRSF5;COL6A1;EGFR;FBXO2;CYBA;SFRP1;TNFSF10;INSR;PKD2;TMEM129;FOXO1;UROS;EPHA4;HOMER2;ATP6V0A2;SREBF1;DMTN;PIK3R1;SLC2A1;VAMP2;TRPV4;MTHFR;IMPACT;STAT1;TCIRG1;SORT1
12826,GO:0051187,0.409285813548171,0.837897652422758,2,36,cofactor catabolic process,BP,GPX3;CBR3
5698,GO:0016854,0.409388701879306,0.908172182575719,1,13,racemase and epimerase activity,MF,AMACR
11411,GO:0045898,0.409582456684692,0.908076184597508,1,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
14694,GO:0070402,0.409623118628906,0.908056030432853,1,13,NADPH binding,MF,CBR3
4480,GO:0010523,0.409788696868139,0.907973933509173,1,13,negative regulation of calcium ion transport into cytosol,BP,PKD2
7865,GO:0032454,0.409857803983006,0.908479694835887,1,12,histone demethylase activity (H3-K9 specific),MF,HR
12796,GO:0051146,0.409923839198635,0.733823397235126,7,148,striated muscle cell differentiation,BP,OBSL1;FLNC;THRA;FHOD3;OBSCN;TBX1;SORT1
11262,GO:0045616,0.409962829760632,0.837725862162366,2,34,regulation of keratinocyte differentiation,BP,CTSV;CTSL
6877,GO:0030431,0.4101564649488,0.907791427315795,1,13,sleep,BP,PER3
13937,GO:0060688,0.41021944545668,0.837550190450641,2,34,regulation of morphogenesis of a branching structure,BP,SFRP1;ETV5
9830,GO:0042110,0.410269799271106,0.701784083936516,12,268,T cell activation,BP,GPNMB;MAP3K14;GLI2;BCL6;ZFPM1;PIK3R1;NCK2;ZP3;EFNB3;ERBB2;IL20RB;CCDC88B
6080,GO:0019318,0.410476684703828,0.724758434065029,8,173,hexose metabolic process,BP,PGM1;INSR;GAA;FOXO1;H6PD;IGFBP4;MLYCD;NISCH
11358,GO:0045777,0.410748080726767,0.907497373778352,1,13,positive regulation of blood pressure,BP,CYBA
96,GO:0000187,0.410993439488234,0.756643176956079,5,102,activation of MAPK activity,BP,INSR;DAB2IP;SHC2;CSPG4;ADORA2B
3243,GO:0006925,0.412183610204627,0.906781493012735,1,13,inflammatory cell apoptotic process,BP,CTSL
675,GO:0001889,0.412264334348714,0.755550843261806,5,103,liver development,BP,TNFAIP3;SRSF5;EGFR;PKD2;DBP
901,GO:0002292,0.412398894777681,0.836054363357636,2,34,T cell differentiation involved in immune response,BP,BCL6;ZFPM1
13599,GO:0060142,0.412444680240895,0.906650938941404,1,13,regulation of syncytium formation by plasma membrane fusion,BP,CAMK1
8016,GO:0032688,0.412462516624135,0.90664201538169,1,13,negative regulation of interferon-beta production,BP,PTPRS
2637,GO:0005996,0.413043533027632,0.715309415691032,9,198,monosaccharide metabolic process,BP,PGM1;INSR;GAA;FOXO1;H6PD;SLC2A1;IGFBP4;MLYCD;NISCH
3687,GO:0008211,0.413114031727843,0.906315705076665,1,13,glucocorticoid metabolic process,BP,HSD11B1
11312,GO:0045672,0.41319772528343,0.906273736943095,1,13,positive regulation of osteoclast differentiation,BP,GPR68
9040,GO:0035305,0.413431380763933,0.772190130317769,4,79,negative regulation of dephosphorylation,BP,PPP1R35;CRY2;ELFN2;PPP1R14A
4792,GO:0012510,0.413722789704277,0.906010181641134,1,13,trans-Golgi network transport vesicle membrane,CC,LDLRAP1
18064,GO:1902743,0.413980416880743,0.834964607040588,2,34,regulation of lamellipodium organization,BP,DMTN;ARPIN
12669,GO:0050927,0.413996885987962,0.905872419948522,1,13,positive regulation of positive chemotaxis,BP,VEGFB
14150,GO:0061097,0.414221318435788,0.796253847899186,3,57,regulation of protein tyrosine kinase activity,BP,EPHA4;ERBB3;NCK2
3933,GO:0008652,0.414397686563306,0.79604190355683,3,58,cellular amino acid biosynthetic process,BP,GAMT;GLUL;THNSL2
1331,GO:0003205,0.414679861853654,0.753606092127353,5,101,cardiac chamber development,BP,ZFPM1;TBX1;LTBP1;PLXND1;VANGL2
8586,GO:0034123,0.414753391254147,0.905491558509202,1,13,positive regulation of toll-like receptor signaling pathway,BP,CYBA
18570,GO:1903894,0.415303324486626,0.905214105662422,1,13,regulation of IRE1-mediated unfolded protein response,BP,DAB2IP
6238,GO:0019840,0.41572182831162,0.905002628643361,1,13,isoprenoid binding,MF,CYP27C1
2506,GO:0005774,0.41593800160303,0.685521677138896,15,341,vacuolar membrane,CC,LAMP3;COL6A1;CYBRD1;GAA;HGSNAT;ATP6V0A2;STOM;PQLC2;MARCH9;CLCN7;TCIRG1;VPS33B;DIRC2;ABCC1;SORT1
12070,GO:0048146,0.416152670921909,0.833308551264237,2,35,positive regulation of fibroblast proliferation,BP,EGFR;S100A6
10412,GO:0043302,0.416174718710023,0.904773450913491,1,13,positive regulation of leukocyte degranulation,BP,ADORA2B
14141,GO:0061082,0.416621314435451,0.904547127826509,1,13,myeloid leukocyte cytokine production,BP,BCL6
11137,GO:0045239,0.41694391890512,0.904383435858582,1,13,tricarboxylic acid cycle enzyme complex,CC,DHTKD1
13364,GO:0052742,0.416982041608712,0.833049678525713,2,33,phosphatidylinositol kinase activity,MF,FGFR4;PIK3R1
7354,GO:0031424,0.417230173420415,0.768877828762791,4,84,keratinization,BP,KLK5;PPL;KLK8;FURIN
448,GO:0001222,0.417338507342376,0.904182985379936,1,13,transcription corepressor binding,MF,PER3
16981,GO:0099175,0.417727058839804,0.832368476700149,2,34,regulation of postsynapse organization,BP,APOE;EPHA4
11343,GO:0045745,0.418525997056805,0.903578191362638,1,13,positive regulation of G-protein coupled receptor protein signaling pathway,BP,KLK5
9058,GO:0035338,0.419159747031242,0.903254465627455,1,13,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSL1
4602,GO:0010738,0.419179790176269,0.903244216548734,1,13,regulation of protein kinase A signaling,BP,MC1R
4404,GO:0010225,0.419576889401976,0.903041022383219,1,13,response to UV-C,BP,IMPACT
7123,GO:0030983,0.419622991567194,0.903017415158155,1,13,mismatched DNA binding,MF,XPC
5759,GO:0017000,0.419641546257261,0.903007912989152,1,13,antibiotic biosynthetic process,BP,CYBA
4430,GO:0010369,0.419651799201899,0.903002662039009,1,13,chromocenter,CC,SCMH1
5767,GO:0017015,0.419849278631633,0.766935822862167,4,80,regulation of transforming growth factor beta receptor signaling pathway,BP,HTRA1;LTBP1;LTBP4;SMURF1
10770,GO:0044283,0.420080936294117,0.663330992866096,23,541,small molecule biosynthetic process,BP,APOE;ALDH1A3;GAMT;FGFR4;PGM1;DHTKD1;INSR;NT5E;FOXO1;UROS;GLUL;SEC14L2;SREBF1;CSPG4;IMPA2;HYAL1;AMACR;MVD;NME4;MLYCD;THNSL2;ALOXE3;ISYNA1
13648,GO:0060231,0.420089681405151,0.902778242125263,1,13,mesenchymal to epithelial transition,BP,STAT1
4568,GO:0010676,0.420168879031522,0.830665492841591,2,34,positive regulation of cellular carbohydrate metabolic process,BP,INSR;FOXO1
9442,GO:0036092,0.420279574752199,0.83075319179637,2,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGFR4;PIK3R1
4130,GO:0009208,0.420302615874096,0.902183575008835,1,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,NME4
1242,GO:0003007,0.420308047147055,0.724802228978909,7,148,heart morphogenesis,BP,INSR;GAA;PKD2;ZFPM1;TBX1;PLXND1;VANGL2
13041,GO:0051589,0.420347927996659,0.902645738584593,1,13,negative regulation of neurotransmitter transport,BP,ASIC1
19730,GO:2000178,0.42065156851381,0.902489802372048,1,13,negative regulation of neural precursor cell proliferation,BP,KCTD11
3427,GO:0007252,0.420741906227999,0.90244337941739,1,13,I-kappaB phosphorylation,BP,DAB2IP
768,GO:0002028,0.420894735612972,0.791110542927549,3,57,regulation of sodium ion transport,BP,SERPINE2;SCN4B;STOM
3415,GO:0007219,0.421160840694137,0.734632328459834,6,127,Notch signaling pathway,BP,POSTN;EGFR;BCL6;PLXND1;MDK;STAT1
13547,GO:0060055,0.42118761552884,0.902214138894395,1,13,angiogenesis involved in wound healing,BP,TNFAIP3
17054,GO:0099632,0.421749553031814,0.901924648517552,1,13,protein transport within plasma membrane,BP,NSG1
17056,GO:0099637,0.421749553031814,0.901924648517552,1,13,neurotransmitter receptor transport,BP,NSG1
16350,GO:0097009,0.421812919143805,0.901891971586306,1,13,energy homeostasis,BP,CRTC1
13227,GO:0051955,0.421824433663949,0.901886033007827,1,13,regulation of amino acid transport,BP,SV2A
8280,GO:0033138,0.422103644692478,0.7900943809412,3,58,positive regulation of peptidyl-serine phosphorylation,BP,EGFR;SPRY2;CAMK1
425,GO:0001133,0.422264708744321,0.901658796974162,1,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,THRA
13506,GO:0060008,0.422310901623811,0.901634937069408,1,13,Sertoli cell differentiation,BP,CTSV
13822,GO:0060479,0.422493739025751,0.901540461606045,1,13,lung cell differentiation,BP,THRA
10328,GO:0043175,0.422506799357958,0.828870273713038,2,35,RNA polymerase core enzyme binding,MF,RTF1;ERBB2
939,GO:0002360,0.42256676021615,0.901502714647959,1,13,T cell lineage commitment,BP,ZFPM1
11214,GO:0045453,0.422719758715884,0.8287205036651,2,35,bone resorption,BP,TNFAIP3;EGFR
3699,GO:0008234,0.423071863949716,0.722322718809606,7,151,cysteine-type peptidase activity,MF,TNFAIP3;SFRP1;CTSB;CTSV;CTSL;CTSF;CAPNS2
3743,GO:0008301,0.423099859394343,0.901226869615294,1,13,DNA binding, bending,MF,TRERF1
10766,GO:0044275,0.423904896675842,0.827885807564409,2,35,cellular carbohydrate catabolic process,BP,PGM1;GAA
2767,GO:0006213,0.424160649250956,0.827416813893781,2,37,pyrimidine nucleoside metabolic process,BP,NT5E;NME4
12235,GO:0048566,0.42424207591963,0.900634248744548,1,13,embryonic digestive tract development,BP,GLI2
4641,GO:0010804,0.424395660170058,0.900059621469149,1,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,CCDC3
18398,GO:1903522,0.424641642892339,0.731630657863759,6,127,regulation of blood circulation,BP,EGFR;THRA;GAA;SCN4B;F2R;SREBF1
9066,GO:0035357,0.424839093856509,0.900323628106738,1,13,peroxisome proliferator activated receptor signaling pathway,BP,ALOXE3
15099,GO:0071236,0.424883703892515,0.744886818776244,5,105,cellular response to antibiotic,BP,TNFAIP3;FOXO1;ENDOG;TP53INP1;IMPACT
6423,GO:0021756,0.424955655745128,0.900262912916831,1,13,striatum development,BP,ALDH1A3
12861,GO:0051247,0.425017976212981,0.63496038162124,48,1139,positive regulation of protein metabolic process,BP,TNFAIP3;APOE;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;BCL6;TNFSF10;INSR;PKD2;ZFPM1;FOXO1;DAB2IP;TBX1;SHC2;TET1;EPHA4;MAGEF1;F2R;RPS6KA5;ACSL1;ERBB3;SREBF1;CSPG4;NCK2;ACVR1B;CAMKK1;NAB2;SNX33;TYRO3;RTF1;SPRY2;TNFRSF19;TRPV4;ADORA2B;IMPACT;IGFBP4;ERBB2;CDK20;ACKR3;FURIN;IFI16;SMURF1;CAMK1;MAP3K3;NRK;VANGL2
11333,GO:0045732,0.425185872995582,0.711750684618062,8,175,positive regulation of protein catabolic process,BP,TNFAIP3;APOE;FOXO1;DAB2IP;MAGEF1;SNX33;FURIN;SMURF1
13468,GO:0055078,0.425293233192894,0.900086946024037,1,13,sodium ion homeostasis,BP,ATP12A
19127,GO:1905208,0.425307962778826,0.900079263680531,1,13,negative regulation of cardiocyte differentiation,BP,EGFR
989,GO:0002460,0.425500756848001,0.730836614113421,6,129,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,TNFAIP3;BCL6;SCART1;ZP3;SERPING1;IL20RB
5913,GO:0018210,0.425976974422402,0.744030206211914,5,103,peptidyl-threonine modification,BP,DMTN;ACVR1B;CAMKK1;SPRY2;CAMK1
9778,GO:0040037,0.426089114964536,0.89967132616986,1,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,SPRY2
7733,GO:0032271,0.42610564124018,0.71964048781203,7,152,regulation of protein polymerization,BP,FHOD3;WIPF1;EPS8L2;DMTN;NCK2;ARHGAP40;ARPIN
13732,GO:0060351,0.426133263780859,0.899648239998147,1,13,cartilage development involved in endochondral bone morphogenesis,BP,TRPV4
7462,GO:0031646,0.426162261092816,0.899633075028746,1,13,positive regulation of neurological system process,BP,TENM4
2697,GO:0006086,0.426337938064739,0.899541169599793,1,13,acetyl-CoA biosynthetic process from pyruvate,BP,PDPR
6043,GO:0019209,0.426668008323245,0.786535800371678,3,58,kinase activator activity,MF,ERBB3;SPRY2;CDK20
12641,GO:0050892,0.427129525311002,0.899126408049324,1,13,intestinal absorption,BP,SLC5A1
11545,GO:0046135,0.427130778278089,0.898624677318481,1,14,pyrimidine nucleoside catabolic process,BP,NT5E
16636,GO:0097617,0.427150128110397,0.899115598915468,1,13,annealing activity,MF,SMARCA1
416,GO:0001104,0.427202387500371,0.760864764552317,4,81,RNA polymerase II transcription cofactor activity,MF,CITED4;POU3F1;SOX12;TRERF1
16712,GO:0098533,0.427318976741921,0.899026986624765,1,13,ATPase dependent transmembrane transport complex,CC,ATP12A
18354,GO:1903421,0.42735858840951,0.899006191357958,1,13,regulation of synaptic vesicle recycling,BP,DNM1
447,GO:0001221,0.427424973872115,0.82539446873497,2,35,transcription cofactor binding,MF,FOXO1;PER3
12977,GO:0051452,0.427559679777128,0.825007022769471,2,37,intracellular pH reduction,BP,ATP6V0A2;TCIRG1
6875,GO:0030427,0.427898516884687,0.728837875685009,6,126,site of polarized growth,CC,ADGRL1;TENM2;BOC;EPHA4;FRY;TRPV4
9801,GO:0042056,0.42812568582562,0.898099588527146,1,14,chemoattractant activity,MF,GPNMB
12652,GO:0050909,0.42823269673654,0.898043011200433,1,14,sensory perception of taste,BP,ASIC1
16831,GO:0098803,0.428262799483437,0.784738101606143,3,66,respiratory chain complex,CC,NDUFA4L2;SDHA;COX5B
4672,GO:0010839,0.428387417758112,0.89846515372602,1,13,negative regulation of keratinocyte proliferation,BP,CTSV
19174,GO:1905331,0.428442717276415,0.898436022525954,1,13,negative regulation of morphogenesis of an epithelium,BP,STAT1
12881,GO:0051271,0.428495896146209,0.701507576386202,9,198,negative regulation of cellular component movement,BP,IFITM1;APOE;SFRP1;WNT3;DAB2IP;TP53INP1;ARPIN;NISCH;SP100
9740,GO:0039535,0.428616719660548,0.898344326306672,1,13,regulation of RIG-I signaling pathway,BP,DDX60
6660,GO:0030042,0.428666391925175,0.824511513007503,2,35,actin filament depolymerization,BP,DMTN;PLEKHH2
1541,GO:0003951,0.428753101764589,0.898272419654129,1,13,NAD+ kinase activity,MF,NADK
14099,GO:0061008,0.428817310660168,0.741549582078872,5,105,hepaticobiliary system development,BP,TNFAIP3;SRSF5;EGFR;PKD2;DBP
12831,GO:0051194,0.428857662018846,0.898217269651511,1,13,positive regulation of cofactor metabolic process,BP,INSR
811,GO:0002089,0.428924095634587,0.898182219858662,1,13,lens morphogenesis in camera-type eye,BP,SHROOM2
1318,GO:0003181,0.429214161747855,0.898029096334303,1,13,atrioventricular valve morphogenesis,BP,ZFPM1
130,GO:0000271,0.429403806751436,0.784390053019799,3,58,polysaccharide biosynthetic process,BP,PGM1;INSR;B3GNT9
8042,GO:0032733,0.429623595507928,0.897305873935315,1,14,positive regulation of interleukin-10 production,BP,IL20RB
11483,GO:0046034,0.429906795113012,0.700106024923661,9,208,ATP metabolic process,BP,PGM1;DHTKD1;INSR;FAM20C;ATP6V0A2;SDHA;COX5B;TCIRG1;NADK
16464,GO:0097205,0.430090755331702,0.897565486826864,1,13,renal filtration,BP,F2R
7681,GO:0032182,0.430251598093933,0.758300355895573,4,82,ubiquitin-like protein binding,MF,TNFAIP3;TP53INP2;RBCK1;MARK4
18525,GO:1903792,0.430587116839601,0.897302397390779,1,13,negative regulation of anion transport,BP,ANO9
5606,GO:0016701,0.430927034402423,0.896612115130616,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,ALOXE3
5607,GO:0016702,0.430927034402423,0.896612115130616,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,ALOXE3
14532,GO:0070102,0.431020723515767,0.897072229272826,1,13,interleukin-6-mediated signaling pathway,BP,STAT1
4127,GO:0009205,0.431103716045916,0.692790757481993,10,233,purine ribonucleoside triphosphate metabolic process,BP,PGM1;DHTKD1;INSR;FAM20C;ATP6V0A2;SDHA;NME4;COX5B;TCIRG1;NADK
12354,GO:0048814,0.431171698265812,0.783078593448903,3,57,regulation of dendrite morphogenesis,BP,OBSL1;EPHA4;NFATC4
17068,GO:0101003,0.431201973594968,0.822549267985012,2,36,ficolin-1-rich granule membrane,CC,GAA;TCIRG1
1178,GO:0002832,0.431314851442062,0.822468395792225,2,36,negative regulation of response to biotic stimulus,BP,TNFAIP3;HTRA1
10083,GO:0042632,0.431608322345869,0.822258048330883,2,36,cholesterol homeostasis,BP,APOE;LDLRAP1
13480,GO:0055092,0.431608322345869,0.822258048330883,2,36,sterol homeostasis,BP,APOE;LDLRAP1
17544,GO:1901215,0.431611667169841,0.725532672436147,6,129,negative regulation of neuron death,BP,APOE;GPNMB;F2R;ERBB3;TYRO3;MDK
3693,GO:0008217,0.432150526472929,0.756728217776624,4,82,regulation of blood pressure,BP,POSTN;CYBA;F2R;NISCH
3037,GO:0006612,0.432222441951844,0.71400507642264,7,165,protein targeting to membrane,BP,RPL13A;DMTN;STOM;ZDHHC1;GOLGA7B;MICALL1;ERBB2
15837,GO:0072606,0.432304254442503,0.895875952967101,1,14,interleukin-8 secretion,BP,F2R
6566,GO:0022414,0.432357405991587,0.637020749828614,35,824,reproductive process,BP,HTRA1;GAMT;TXNRD3;EGFR;THRA;GLI2;IRF2BPL;BCL6;ZNF318;SFRP1;TNFSF10;INSR;PKD2;CTSB;ETV5;SYT8;SERPINE2;WNT3;CRTAP;TCFL5;CTSV;HEXB;PLCD3;GJB5;PTHLH;ACVR1B;TYRO3;SLC2A1;ZP3;CABYR;PLCD1;SUN1;MDFI;SCMH1;NRK
13478,GO:0055090,0.432451178725115,0.895797227495499,1,14,acylglycerol homeostasis,BP,APOE
14662,GO:0070328,0.432451178725115,0.895797227495499,1,14,triglyceride homeostasis,BP,APOE
1163,GO:0002793,0.432565009892883,0.713924332650805,7,153,positive regulation of peptide secretion,BP,POSTN;EGFR;NLGN2;GLUL;F2R;TRPV4;GPR68
18039,GO:1902679,0.432565104647636,0.633508671167727,39,925,negative regulation of RNA biosynthetic process,BP,PEG3;HES2;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;ZFPM1;HR;SALL2;WWTR1;FOXO1;DAB2IP;MNT;TET1;TCFL5;RPS6KA5;ZBTB42;SREBF1;TRIM22;NCK2;NAB2;NFATC4;RTF1;ZP3;MBD1;TRPV4;IMPACT;H2AFJ;STAT1;CRY2;IFI16;PER3;CXXC5;MDFI;SCMH1;SP100
18386,GO:1903507,0.432565104647636,0.633508671167727,39,925,negative regulation of nucleic acid-templated transcription,BP,PEG3;HES2;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;ZFPM1;HR;SALL2;WWTR1;FOXO1;DAB2IP;MNT;TET1;TCFL5;RPS6KA5;ZBTB42;SREBF1;TRIM22;NCK2;NAB2;NFATC4;RTF1;ZP3;MBD1;TRPV4;IMPACT;H2AFJ;STAT1;CRY2;IFI16;PER3;CXXC5;MDFI;SCMH1;SP100
18343,GO:1903392,0.432602425697561,0.896229926517237,1,13,negative regulation of adherens junction organization,BP,DMTN
14248,GO:0061383,0.43300372385406,0.821408772214445,2,35,trabecula morphogenesis,BP,SFRP1;PLXNB1
973,GO:0002433,0.433145663071742,0.781439660732005,3,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,VAV3;WIPF1;PIK3R1
9669,GO:0038096,0.433145663071742,0.781439660732005,3,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,VAV3;WIPF1;PIK3R1
4618,GO:0010758,0.433200522604558,0.895395139687388,1,14,regulation of macrophage chemotaxis,BP,TRPV4
13802,GO:0060443,0.433316444096023,0.821183992287684,2,35,mammary gland morphogenesis,BP,GLI2;ETV5
14804,GO:0070588,0.433550026041868,0.71309304550209,7,151,calcium ion transmembrane transport,BP,CYBA;PKD2;F2R;ORAI3;TRPV4;GJC2;ASIC1
8302,GO:0033169,0.43362836795139,0.89568131189785,1,13,histone H3-K9 demethylation,BP,HR
5998,GO:0019068,0.433829491426278,0.820517343439589,2,37,virion assembly,BP,APOE;RAB43
3384,GO:0007179,0.433962915494379,0.723508134564822,6,128,transforming growth factor beta receptor signaling pathway,BP,HTRA1;LTBP1;ITGB5;LTBP4;FURIN;SMURF1
5489,GO:0016459,0.434065862415561,0.820644729895747,2,35,myosin complex,CC,OBSL1;MYL9
5627,GO:0016740,0.434227821756119,0.61464969190529,79,1891,transferase activity,MF,TNFAIP3;ULK2;FBXO41;CPT2;MAP3K14;EPHB2;ASH2L;GAMT;ST3GAL5;TST;EGFR;FBXO2;CRAT;OAS2;FGFR4;CDK18;XYLT1;NSUN7;CERS4;BRSK1;INSR;KMT5C;NAT6;TMEM129;DDB2;OBSCN;FAM20C;EPHA4;B3GNT9;HERC3;RPS6KA5;KLHDC8B;HEXB;LTBP1;ERBB3;HGSNAT;CDK14;GRK6;PIK3R1;SUGCT;TRIM22;ACVR1B;KCTD11;CAMKK1;TYRO3;CPT1C;METTL7A;HYAL1;CKMT1A;RBCK1;MBOAT7;EFNB3;ADCK5;ZDHHC1;LTBP4;FBXW4;NMRK1;MARK4;GOLGA7B;ERBB2;RNF187;RNF135;FBXL8;NME4;CDK20;RNF44;MARCH9;FBXW5;XYLT2;NUAK1;SMURF1;CAMK1;RNF208;NADK;MAP3K3;ST6GALNAC6;NRK;PIGZ;FBXO44
1123,GO:0002719,0.434391927057885,0.894753876939017,1,14,negative regulation of cytokine production involved in immune response,BP,BCL6
11371,GO:0045807,0.434512845295292,0.754766636646027,4,82,positive regulation of endocytosis,BP,APOE;CYBA;LDLRAP1;TUB
15181,GO:0071375,0.434613188372179,0.689709476319623,10,223,cellular response to peptide hormone stimulus,BP,SRSF5;CYBA;INSR;FOXO1;ATP6V0A2;SREBF1;PIK3R1;VAMP2;STAT1;TCIRG1
1695,GO:0004222,0.434800177187221,0.7801293565273,3,58,metalloendopeptidase activity,MF,ADAM19;ADAMTS15;MMP1
19716,GO:2000146,0.435024525665273,0.702951517562109,8,176,negative regulation of cell motility,BP,IFITM1;APOE;SFRP1;DAB2IP;TP53INP1;ARPIN;NISCH;SP100
10606,GO:0043649,0.43537366770451,0.894223641672566,1,14,dicarboxylic acid catabolic process,BP,GLUL
2,GO:0000003,0.435399896420082,0.634101642506395,35,825,reproduction,BP,HTRA1;GAMT;TXNRD3;EGFR;THRA;GLI2;IRF2BPL;BCL6;ZNF318;SFRP1;TNFSF10;INSR;PKD2;CTSB;ETV5;SYT8;SERPINE2;WNT3;CRTAP;TCFL5;CTSV;HEXB;PLCD3;GJB5;PTHLH;ACVR1B;TYRO3;SLC2A1;ZP3;CABYR;PLCD1;SUN1;MDFI;SCMH1;NRK
3262,GO:0006956,0.435407083186535,0.894205565054946,1,14,complement activation,BP,SERPING1
12702,GO:0051010,0.435524976837985,0.894662397769974,1,13,microtubule plus-end binding,MF,CLIP2
19453,GO:1990266,0.435661776665159,0.819194316235041,2,37,neutrophil migration,BP,CKLF;VAV3
16157,GO:0090231,0.435682361215481,0.894056576443591,1,14,regulation of spindle checkpoint,BP,NDRG1
18325,GO:1903362,0.435895637657106,0.694774509034801,9,202,regulation of cellular protein catabolic process,BP,TNFAIP3;APOE;LAMP3;RHBDF1;DAB2IP;EPHA4;MAGEF1;FURIN;SMURF1
3647,GO:0008150,0.43591735682538,0.63548351992573,456,11213,biological_process,BP,TNFAIP3;POSTN;IFITM1;ITGB6;PEG3;TGFBI;SMOC2;TAGLN;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;KCNJ15;ULK2;LGALS7B;PTPRS;FBXO41;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRF4;NINJ1;KDSR;ASH2L;TNS1;HTRA1;PRICKLE2;PRR9;SLITRK6;CADM4;GAMT;GPRC5C;TXNRD3;GIGYF1;ADGRL1;GPX7;SRSF5;ST3GAL5;GPX3;TST;DCAF16;MXRA5;FLNC;SLC13A5;RALGDS;NCR3LG1;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;NYNRIN;SNN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;PINLYP;APCDD1;NLGN2;CDK18;RAPGEF5;IRF2BPL;VIPR1;BCL6;PGM1;ANO9;TENM2;XYLT1;CYP4F22;PSD4;NSUN7;ZNF318;CERS4;BRSK1;SFRP1;ARHGEF4;CKLF;FHOD3;UNK;POU3F1;TNFSF10;MN1;DHRS4L2;DHTKD1;INSR;VAV3;SLC16A5;KMT5C;NPEPL1;CYBRD1;SLC29A4;GAA;DHX32;CES2;MATN2;SV2A;PKD2;ESPN;ZFPM1;RGMA;RTN2;NAT6;ARSI;DNM1;PPP2R2C;SDK2;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;TNXB;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;LY6E;ZSCAN18;NSG1;PARVB;RASIP1;BPHL;BOC;SOX12;UROS;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;PPP1R3E;PRSS3;H6PD;TSC22D1;SGSH;KLK5;TRERF1;SHC2;SCN4B;SH3BP2;CRTAP;GAS8;YEATS4;EVI5L;WIPF1;KRBA1;FKBP9;KCNC4;MNT;SDR9C7;RAB40B;TET1;MARVELD1;NRSN2;CYP27C1;FAM20C;GLUL;FAM213A;ANO8;EPHA4;ZNF266;WNT9A;TRAPPC2L;RPL13A;B3GNT9;RNPEPL1;CORO6;MAGEF1;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;HERC3;TCFL5;MPLKIP;TYSND1;CTSV;LRIG3;NXPH4;RPS6KA5;TUB;HOMER2;KLHDC8B;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;ZNF362;SCART1;PGLS;ACSL1;EPS8L2;ZBTB42;ORAI3;DDX60;ACTA2;ERBB3;HGSNAT;KIF26A;S100A6;SPOCK1;SLC38A4;CDK14;ATP6V0A2;VAMP3;PPL;CUL9;FRY;PLXND1;GJB5;CGREF1;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;IMPA2;UNC119B;XPC;ARHGAP40;NAB2;NFATC4;ATP12A;SNX33;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;CPT1C;METTL7A;HYAL1;BCAM;RTF1;ZP3;STOM;CKMT1A;VAMP2;PLEKHH2;ADAMTS15;RBCK1;MBOAT7;AVL9;EFNB3;PCBP4;ZNF554;ADCK5;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;TNFRSF19;CABYR;SLC2A9;TMX4;MDK;TRPV4;ZDHHC1;MTHFR;PQLC2;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;RETSAT;NDUFA4L2;SDHA;KLK8;PTMS;LTBP4;ALDH2;PPP1R35;ADORA2B;FBXW4;SERPING1;NAGLU;NMRK1;MRC2;MAFIP;MYL9;RTN4RL1;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;MC1R;IMPACT;TBC1D17;MVD;GOLGA7B;IAH1;NEO1;CRTC1;IGFBP4;STON1;GPR68;TOM1L2;GPR153;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;EPM2A;RNF135;H2AFJ;LAMB2;PCDH1;STAT1;TMEM54;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;NIPAL4;WIPI2;ACKR3;PLCD1;H1FX;SLC5A1;CRY2;MARCH9;COX5B;SLC39A6;BLOC1S4;MARCKSL1;ZMYM3;FURIN;FBXW5;CLCN7;RHPN1;IFI16;IL20RB;CCDC88B;PCSK1;PLPP2;MLYCD;SUN1;THNSL2;NINL;PEX11B;FRAT1;CTSF;GJC2;SLC1A4;ARPIN;SLC13A3;RPRD2;DBP;BEX2;ASIC1;MMP1;ALS2CL;PER3;XYLT2;NUAK1;PLXNB1;ALOXE3;RASA4;HCP5;SMURF1;KREMEN1;CAPNS2;MEX3A;CCDC3;DOK4;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;MT2A;NADK;RAB43;VPS33B;ELFN2;SLC47A1;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;REEP6;SCMH1;ZSWIM8;SP100;MPG;ABCC1;DDX59;IDUA;NRK;ISYNA1;PIGZ;FBXO44;SORT1;CBR3;VANGL2;APBA1;TP53I11
14163,GO:0061134,0.435925718045297,0.735344218288825,5,109,peptidase regulator activity,MF,SERPINE2;COL7A1;SPOCK1;SERPING1;FURIN
19379,GO:1990000,0.436965638421983,0.893360315109279,1,14,amyloid fibril formation,BP,APOE
14090,GO:0060997,0.437114998625185,0.818442071755635,2,35,dendritic spine morphogenesis,BP,EPHB2;EPHA4
6017,GO:0019104,0.437245251088291,0.892754413198,1,15,DNA N-glycosylase activity,MF,MPG
18548,GO:1903844,0.437284532906251,0.752456923776139,4,82,regulation of cellular response to transforming growth factor beta stimulus,BP,HTRA1;LTBP1;LTBP4;SMURF1
11439,GO:0045932,0.437482072177889,0.89307931877872,1,14,negative regulation of muscle contraction,BP,ADORA2B
10473,GO:0043409,0.437526122528151,0.720338962775496,6,130,negative regulation of MAPK cascade,BP,APOE;EPHB2;SFRP1;FOXO1;DAB2IP;SPRY2
717,GO:0001947,0.437936656512148,0.817846157205668,2,35,heart looping,BP,PKD2;VANGL2
6613,GO:0022900,0.438059085567321,0.719613746237688,6,141,electron transport chain,BP,TXNRD3;CYBA;NDUFA4L2;SDHA;ALDH2;COX5B
16121,GO:0090183,0.43827899174384,0.81744243138812,2,36,regulation of kidney development,BP,WWTR1;STAT1
1583,GO:0004012,0.439044542855632,0.892755293358998,1,13,phospholipid-translocating ATPase activity,MF,ABCC1
7884,GO:0032479,0.439063357030367,0.73271214487818,5,107,regulation of type I interferon production,BP,TNFAIP3;PTPRS;RNF135;STAT1;IFI16
18777,GO:1904385,0.439365220483425,0.892050794447132,1,14,cellular response to angiotensin,BP,CYBA
12668,GO:0050926,0.439542362093369,0.891953730141219,1,14,regulation of positive chemotaxis,BP,VEGFB
3084,GO:0006677,0.439643303345201,0.891898395419534,1,14,glycosylceramide metabolic process,BP,ST6GALNAC6
2209,GO:0005123,0.439683185710249,0.891876527564145,1,14,death receptor binding,MF,DAB2IP
4267,GO:0009651,0.439729479005519,0.891851141096431,1,14,response to salt stress,BP,TRPV4
13459,GO:0055065,0.440148773036102,0.666425437521514,14,322,metal ion homeostasis,BP,APOE;EGFR;CYBA;CYBRD1;SV2A;PKD2;F2R;HEXB;ATP6V0A2;ATP12A;TRPV4;NEO1;SLC39A6;MT2A
12560,GO:0050776,0.440539633813059,0.642326528403713,24,568,regulation of immune response,BP,TNFAIP3;IFITM1;PTPRS;NCR3LG1;CYBA;BCL6;VAV3;CTSB;DAB2IP;KLK5;WIPF1;RPS6KA5;DDX60;PIK3R1;CTSL;TYRO3;ZP3;RBCK1;ADORA2B;SERPING1;RNF135;STAT1;IFI16;IL20RB
6240,GO:0019842,0.440675644991309,0.74952240223447,4,84,vitamin binding,MF,DHTKD1;CYP27C1;SEC14L2;THNSL2
10441,GO:0043367,0.44077065639242,0.8156267320557,2,36,CD4-positive, alpha-beta T cell differentiation,BP,BCL6;ZFPM1
14934,GO:0070884,0.440774350753802,0.891277166434638,1,14,regulation of calcineurin-NFAT signaling cascade,BP,ERBB3
17165,GO:0106056,0.440774350753802,0.891277166434638,1,14,regulation of calcineurin-mediated signaling,BP,ERBB3
11395,GO:0045851,0.440865501566968,0.815269976299291,2,38,pH reduction,BP,ATP6V0A2;TCIRG1
4030,GO:0009084,0.440899279220077,0.891208413755725,1,14,glutamine family amino acid biosynthetic process,BP,GLUL
13211,GO:0051930,0.441022159174822,0.891140762110948,1,14,regulation of sensory perception of pain,BP,F2R
13212,GO:0051931,0.441022159174822,0.891140762110948,1,14,regulation of sensory perception,BP,F2R
9117,GO:0035493,0.441412926964327,0.890925450964079,1,14,SNARE complex assembly,BP,VAMP3
4895,GO:0014850,0.441420514552937,0.890921267623652,1,14,response to muscle activity,BP,POSTN
2628,GO:0005978,0.441829649649543,0.814852232865785,2,36,glycogen biosynthetic process,BP,PGM1;INSR
4159,GO:0009250,0.441829649649543,0.814852232865785,2,36,glucan biosynthetic process,BP,PGM1;INSR
4567,GO:0010675,0.442010643785376,0.748498067353747,4,82,regulation of cellular carbohydrate metabolic process,BP,INSR;FOXO1;IGFBP4;MLYCD
9159,GO:0035567,0.442060618235924,0.716302854879651,6,132,non-canonical Wnt signaling pathway,BP,PRICKLE2;SFRP1;ARHGEF19;GPC4;SMURF1;VANGL2
4694,GO:0010874,0.442239455134692,0.890469166683821,1,14,regulation of cholesterol efflux,BP,APOE
15582,GO:0072111,0.442967357212413,0.890066347810706,1,14,cell proliferation involved in kidney development,BP,STAT1
9667,GO:0038094,0.443101448153996,0.773421896415351,3,59,Fc-gamma receptor signaling pathway,BP,VAV3;WIPF1;PIK3R1
12444,GO:0050432,0.443511451714888,0.889764646620219,1,14,catecholamine secretion,BP,NISCH
18530,GO:1903798,0.443554407040778,0.889740805917168,1,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR
11034,GO:0045066,0.443715293237542,0.889651483704122,1,14,regulatory T cell differentiation,BP,BCL6
11245,GO:0045589,0.443715293237542,0.889651483704122,1,14,regulation of regulatory T cell differentiation,BP,BCL6
98,GO:0000209,0.44378444347565,0.671024873432762,12,276,protein polyubiquitination,BP,TNFAIP3;FBXO41;FBXO2;TMEM129;DDB2;RBCK1;FBXW4;RNF187;FBXL8;FBXW5;SMURF1;FBXO44
610,GO:0001779,0.444051854659879,0.8894644829711,1,14,natural killer cell differentiation,BP,TYRO3
2372,GO:0005521,0.444242638192987,0.889358392018353,1,14,lamin binding,MF,SUN1
11125,GO:0045216,0.444291944223601,0.694653558183563,8,173,cell-cell junction organization,BP,EPB41L3;NLGN2;SFRP1;SDK2;F2R;DMTN;RHOD;TRPV4
4523,GO:0010614,0.444406852998895,0.889267024665651,1,14,negative regulation of cardiac muscle hypertrophy,BP,FOXO1
6765,GO:0030220,0.444588853493842,0.889165706679135,1,14,platelet formation,BP,ZFPM1
9863,GO:0042176,0.445019496756444,0.665643847209575,13,300,regulation of protein catabolic process,BP,TNFAIP3;APOE;LAMP3;EGFR;SERPINE2;RHBDF1;FOXO1;DAB2IP;EPHA4;MAGEF1;SNX33;FURIN;SMURF1
6774,GO:0030234,0.445231990356557,0.628609558882049,31,735,enzyme regulator activity,MF,APOE;RALGDS;EGFR;PINLYP;VAV3;PPP2R2C;SERPINE2;DAB2IP;COL7A1;EVI5L;ARHGEF19;ERBB3;SPOCK1;FRY;PIK3R1;APPL2;ACAP3;ARHGAP40;SPRY2;SCG5;PPP1R35;SERPING1;RTN4RL1;TBC1D17;CDK20;FURIN;ALS2CL;PLXNB1;RASA4;ELFN2;PPP1R14A
2508,GO:0005776,0.445274487784259,0.745699617810089,4,83,autophagosome,CC,PEG3;TP53INP2;TP53INP1;TBC1D17
3463,GO:0007339,0.445548318019595,0.88815976080933,1,15,binding of sperm to zona pellucida,BP,ZP3
8942,GO:0035051,0.445647532143758,0.745433990692488,4,82,cardiocyte differentiation,BP,OBSL1;EGFR;FHOD3;TENM4
7184,GO:0031093,0.445676120704042,0.811875121631595,2,37,platelet alpha granule lumen,CC,VEGFB;SERPING1
2363,GO:0005506,0.445846748880361,0.745168059429255,4,84,iron ion binding,MF,CYP4F22;TET1;CYP27C1;ALOXE3
5618,GO:0016722,0.446081398369854,0.88833264190264,1,14,oxidoreductase activity, oxidizing metal ions,MF,CYBRD1
377,GO:0001010,0.446159880198848,0.88828872961407,1,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,THRA
13760,GO:0060390,0.446160358373779,0.888288462031836,1,14,regulation of SMAD protein signal transduction,BP,WWTR1
7966,GO:0032606,0.446247771987739,0.726462695950494,5,108,type I interferon production,BP,TNFAIP3;PTPRS;RNF135;STAT1;IFI16
4405,GO:0010226,0.446438456291491,0.888132773320457,1,14,response to lithium ion,BP,NFATC4
3773,GO:0008356,0.446463387363589,0.888118809451728,1,14,asymmetric cell division,BP,ETV5
10158,GO:0042789,0.446622584808287,0.888029617492772,1,14,mRNA transcription by RNA polymerase II,BP,SREBF1
16188,GO:0090279,0.447037203480797,0.887797115150204,1,14,regulation of calcium ion import,BP,PKD2
766,GO:0002026,0.447079163640631,0.88777356872943,1,14,regulation of the force of heart contraction,BP,GAA
7979,GO:0032623,0.447330985826571,0.810651200245494,2,37,interleukin-2 production,BP,TNFAIP3;IL20RB
3393,GO:0007190,0.447455692653445,0.887562137244225,1,14,activation of adenylate cyclase activity,BP,ADORA2B
19832,GO:2000352,0.447510528301037,0.88753132479253,1,14,negative regulation of endothelial cell apoptotic process,BP,TNFAIP3
5453,GO:0016405,0.447557509792978,0.887504921443666,1,14,CoA-ligase activity,MF,ACSL1
12548,GO:0050764,0.44786960015736,0.810251960813043,2,37,regulation of phagocytosis,BP,CYBA;TUB
17626,GO:1901524,0.447973595182252,0.887270914826323,1,14,regulation of mitophagy,BP,SMURF1
5904,GO:0018198,0.447974796707317,0.810031154666796,2,38,peptidyl-cysteine modification,BP,ZDHHC1;GOLGA7B
18577,GO:1903901,0.448098667105324,0.769234632854614,3,61,negative regulation of viral life cycle,BP,IFITM1;OAS2;IFI16
7407,GO:0031528,0.448147806776435,0.887172847992508,1,14,microvillus membrane,CC,SYTL1
8609,GO:0034162,0.448543069016841,0.886950150328798,1,14,toll-like receptor 9 signaling pathway,BP,PTPRS
638,GO:0001832,0.44857209983493,0.886933783048484,1,14,blastocyst growth,BP,RTF1
19772,GO:2000269,0.448608050699526,0.886913512265577,1,14,regulation of fibroblast apoptotic process,BP,SFRP1
10198,GO:0042921,0.448624812630546,0.886904060327399,1,14,glucocorticoid receptor signaling pathway,BP,CRY2
12208,GO:0048519,0.448688557331453,0.590729501911497,149,3628,negative regulation of biological process,BP,TNFAIP3;POSTN;IFITM1;PEG3;TGFBI;HES2;APOE;IFI6;LAMP3;ULK2;PTPRS;GPNMB;NDN;ADGRB2;MAP3K14;EPHB2;HTRA1;EGFR;FBXO2;THRA;CYBA;OAS2;GLI2;FGFR4;APCDD1;IRF2BPL;BCL6;ANO9;TENM2;ZNF318;BRSK1;SFRP1;FHOD3;UNK;TNFSF10;INSR;PKD2;ESPN;ZFPM1;RGMA;DNM1;CXCL14;NT5E;SERPINE2;HR;SALL2;TP53INP2;WWTR1;RHBDF1;FOXO1;WNT3;RASIP1;DAB2IP;COL7A1;TBX1;CRTAP;GAS8;EVI5L;MNT;TET1;EPHA4;WNT9A;RPL13A;MAGEF1;DIXDC1;F2R;TCFL5;CTSV;RPS6KA5;LTBP1;ZBTB42;ERBB3;KIF26A;SPOCK1;VAMP3;FRY;PLXND1;CGREF1;SREBF1;DMTN;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;KCTD11;XPC;NAB2;NFATC4;SNX33;TYRO3;HYAL1;RTF1;ZP3;PLEKHH2;RBCK1;EFNB3;PCBP4;SPRY2;MBD1;TP53INP1;MDK;TRPV4;NDRG1;KLK8;PPP1R35;ADORA2B;SERPING1;RTN4RL1;MC1R;IMPACT;CRTC1;IGFBP4;GPR68;TOM1L2;ERBB2;EPM2A;RNF135;H2AFJ;STAT1;TULP3;HINT2;ACKR3;CRY2;FURIN;IFI16;IL20RB;GJC2;ARPIN;ASIC1;PER3;PLXNB1;RASA4;SMURF1;KREMEN1;MEX3A;CCDC3;CXXC5;NISCH;MT2A;ELFN2;MAP3K3;PPP1R14A;MDFI;SCMH1;SP100;NRK;SORT1;TP53I11
5927,GO:0018279,0.448845459271074,0.809384358406422,2,38,protein N-linked glycosylation via asparagine,BP,ST3GAL5;ST6GALNAC6
13321,GO:0052547,0.448921691318662,0.666190228582606,12,283,regulation of peptidase activity,BP,IFI6;LAMP3;TNFSF10;SERPINE2;COL7A1;EPHA4;WNT9A;F2R;SPOCK1;SERPING1;FURIN;IFI16
15132,GO:0071305,0.449426884550079,0.886451200593557,1,14,cellular response to vitamin D,BP,SFRP1
7039,GO:0030837,0.450082081446015,0.808607418968292,2,37,negative regulation of actin filament polymerization,BP,FHOD3;DMTN
11292,GO:0045652,0.450201920515636,0.767247073602571,3,65,regulation of megakaryocyte differentiation,BP,ASH2L;ZFPM1;MYL9
16978,GO:0099172,0.450368037152353,0.885918371482032,1,14,presynapse organization,BP,NLGN2
19847,GO:2000377,0.450486292336375,0.722736421703826,5,109,regulation of reactive oxygen species metabolic process,BP,EGFR;CYBA;INSR;PKD2;FOXO1
18351,GO:1903409,0.450606930493909,0.767196748719618,3,61,reactive oxygen species biosynthetic process,BP,CYBA;INSR;PKD2
15769,GO:0072507,0.450681578276657,0.674923074026157,10,227,divalent inorganic cation homeostasis,BP,APOE;EGFR;CYBA;SV2A;PKD2;F2R;HEXB;TRPV4;SLC39A6;MT2A
13028,GO:0051571,0.451470576177182,0.88529218913273,1,14,positive regulation of histone H3-K4 methylation,BP,RTF1
7081,GO:0030897,0.451620165349962,0.885207065350045,1,14,HOPS complex,CC,VPS33B
12268,GO:0048643,0.451847403488895,0.885077679771042,1,14,positive regulation of skeletal muscle tissue development,BP,TBX1
8979,GO:0035162,0.45192541138974,0.885033242348605,1,14,embryonic hemopoiesis,BP,ZFPM1
18576,GO:1903900,0.452148798928114,0.721282609362988,5,109,regulation of viral life cycle,BP,IFITM1;LAMP3;OAS2;STOM;IFI16
8123,GO:0032873,0.452487577652915,0.80681104354124,2,37,negative regulation of stress-activated MAPK cascade,BP,SFRP1;FOXO1
14646,GO:0070303,0.452487577652915,0.80681104354124,2,37,negative regulation of stress-activated protein kinase signaling cascade,BP,SFRP1;FOXO1
5866,GO:0018023,0.452513692919671,0.806791493290127,2,37,peptidyl-lysine trimethylation,BP,KMT5C;RTF1
16098,GO:0090150,0.45269333694234,0.667417139927481,11,266,establishment of protein localization to membrane,BP,EGFR;NSG1;RPL13A;VAMP3;DMTN;STOM;VAMP2;ZDHHC1;GOLGA7B;MICALL1;ERBB2
13181,GO:0051882,0.452699653696609,0.884105837911204,1,15,mitochondrial depolarization,BP,IFI6
6919,GO:0030547,0.452705259169051,0.884102624885026,1,15,receptor inhibitor activity,MF,LY6E
15185,GO:0071379,0.452715980158349,0.884582285594315,1,14,cellular response to prostaglandin stimulus,BP,SFRP1
2261,GO:0005217,0.452867742084742,0.884495590953496,1,14,intracellular ligand-gated ion channel activity,MF,PKD2
5046,GO:0015278,0.452867742084742,0.884495590953496,1,14,calcium-release channel activity,MF,PKD2
2511,GO:0005779,0.452985226812605,0.883942078039792,1,15,integral component of peroxisomal membrane,CC,PEX11B
7243,GO:0031231,0.452985226812605,0.883942078039792,1,15,intrinsic component of peroxisomal membrane,CC,PEX11B
1372,GO:0003283,0.452994322619237,0.884423250101128,1,14,atrial septum development,BP,ZFPM1
4079,GO:0009150,0.453008390433031,0.650880222413867,15,358,purine ribonucleotide metabolic process,BP,APOE;PGM1;DHTKD1;INSR;PKD2;NT5E;FAM20C;ATP6V0A2;PTHLH;SDHA;ADORA2B;NME4;COX5B;TCIRG1;NADK
4998,GO:0015179,0.453092926006561,0.806357606554888,2,37,L-amino acid transmembrane transporter activity,MF,PQLC2;SLC1A4
8855,GO:0034695,0.453100095564404,0.884362779038013,1,14,response to prostaglandin E,BP,SFRP1
9866,GO:0042180,0.453799726600456,0.694772346270432,7,161,cellular ketone metabolic process,BP,KDSR;FGFR4;PDPR;TYSND1;SREBF1;MLYCD;CBR3
13642,GO:0060216,0.453882384686932,0.883914923860639,1,14,definitive hemopoiesis,BP,ZFPM1
11538,GO:0046128,0.453985689630932,0.764364664016256,3,62,purine ribonucleoside metabolic process,BP,GAMT;NT5E;NME4
12273,GO:0048660,0.454227408067779,0.738045129741664,4,84,regulation of smooth muscle cell proliferation,BP,TNFAIP3;EGFR;CYBA;STAT1
17489,GO:1901020,0.454274082361013,0.883201191094666,1,15,negative regulation of calcium ion transmembrane transporter activity,BP,PKD2
12785,GO:0051130,0.454384696417717,0.613231709219624,38,901,positive regulation of cellular component organization,BP,APOE;OBSL1;ADGRB2;EPHB2;SLITRK6;ADGRL1;CYBA;NLGN2;BCL6;TENM2;SFRP1;TNFSF10;INSR;ESPN;LDLRAP1;WNT3;DDB2;DAB2IP;WIPF1;TET1;EPHA4;RPS6KA5;TUB;EPS8L2;PLXND1;SREBF1;DMTN;ENDOG;NCK2;HYAL1;RTF1;TRPV4;CRTC1;ARPIN;MMP1;PLXNB1;SMURF1;CAMK1
13465,GO:0055075,0.454895957969238,0.883333045327344,1,14,potassium ion homeostasis,BP,ATP12A
16735,GO:0098588,0.455288826337917,0.598898730270755,63,1515,bounding membrane of organelle,CC,APOE;MVB12B;LAMP3;PTPRS;ST3GAL5;COL6A1;EGFR;CYBA;SNN;XYLT1;INSR;CYBRD1;GAA;SV2A;PKD2;LDLRAP1;SYT8;RHBDF1;WNT3;NSG1;BPHL;COL7A1;TMEM231;RAB40B;EPHA4;TRAPPC2L;B3GNT9;ACSL1;HGSNAT;ATP6V0A2;VAMP3;SREBF1;DMTN;APPL2;FAM210B;RHOD;CXCR1;SLC2A1;CPT1C;STOM;VAMP2;PQLC2;SPATA18;NDRG1;RETSAT;PDLIM4;GOLGA7B;MICALL1;ERBB2;C2CD4C;MARCH9;FURIN;CLCN7;SUN1;PEX11B;XYLT2;TCIRG1;RAB43;VPS33B;ST6GALNAC6;DIRC2;ABCC1;SORT1
9918,GO:0042310,0.455590916533003,0.804480622054873,2,37,vasoconstriction,BP,EGFR;F2R
18633,GO:1904019,0.455759698465001,0.763061340114184,3,60,epithelial cell apoptotic process,BP,TNFAIP3;DAB2IP;SORT1
998,GO:0002479,0.455828908841128,0.762579328439224,3,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,CYBA;VAMP3;ITGB5
7273,GO:0031290,0.455989344296746,0.882703299683387,1,14,retinal ganglion cell axon guidance,BP,EPHB2
20249,GO:2001269,0.456121071881217,0.882134311315183,1,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TNFSF10
11302,GO:0045662,0.456216403788383,0.882079079440169,1,15,negative regulation of myoblast differentiation,BP,CXCL14
6472,GO:0021846,0.456744621730916,0.88226704756429,1,14,cell proliferation in forebrain,BP,DIXDC1
7908,GO:0032507,0.457008019908067,0.761958812398019,3,61,maintenance of protein location in cell,BP,EPB41L3;SUN1;SP100
12732,GO:0051047,0.45710137539097,0.668954358260705,10,229,positive regulation of secretion,BP,POSTN;EGFR;CYBA;NLGN2;GLUL;F2R;ZP3;TRPV4;ADORA2B;GPR68
3531,GO:0007569,0.457166907902849,0.735479188757509,4,85,cell aging,BP,BCL6;MNT;NUAK1;MAP3K3
19246,GO:1905521,0.457330245825061,0.88143255589087,1,15,regulation of macrophage migration,BP,TRPV4
10120,GO:0042730,0.457679435630332,0.881229413565576,1,15,fibrinolysis,BP,SERPING1
8500,GO:0033764,0.458177697696483,0.880504805376337,1,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD11B1
12577,GO:0050801,0.458240380922809,0.63742190226228,18,423,ion homeostasis,BP,APOE;IFI6;EGFR;CYBA;FGFR4;CYBRD1;SV2A;PKD2;F2R;HEXB;ATP6V0A2;ATP12A;TRPV4;PQLC2;NEO1;SLC39A6;TCIRG1;MT2A
20220,GO:2001224,0.459202272614853,0.880840444472462,1,14,positive regulation of neuron migration,BP,DAB2IP
10830,GO:0044381,0.459288427330421,0.88079023774056,1,14,glucose import in response to insulin stimulus,BP,PIK3R1
20253,GO:2001273,0.459288427330421,0.88079023774056,1,14,regulation of glucose import in response to insulin stimulus,BP,PIK3R1
12196,GO:0048490,0.459414242245351,0.880216943185589,1,15,anterograde synaptic vesicle transport,BP,BLOC1S4
16996,GO:0099514,0.459414242245351,0.880216943185589,1,15,synaptic vesicle cytoskeletal transport,BP,BLOC1S4
16999,GO:0099517,0.459414242245351,0.880216943185589,1,15,synaptic vesicle transport along microtubule,BP,BLOC1S4
11004,GO:0045010,0.459461193383223,0.801406131999272,2,38,actin nucleation,BP,WIPF1;ARPIN
8062,GO:0032768,0.459695907501222,0.801227802540893,2,38,regulation of monooxygenase activity,BP,APOE;EGFR
5586,GO:0016646,0.460122157167476,0.879802235849619,1,15,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,MTHFR
7015,GO:0030808,0.460180306129898,0.732887350433074,4,85,regulation of nucleotide biosynthetic process,BP,APOE;INSR;PTHLH;ADORA2B
17437,GO:1900371,0.460180306129898,0.732887350433074,4,85,regulation of purine nucleotide biosynthetic process,BP,APOE;INSR;PTHLH;ADORA2B
15832,GO:0072595,0.460284842614778,0.800779976159475,2,38,maintenance of protein localization in organelle,BP,SUN1;SP100
7043,GO:0030850,0.460530972120327,0.800740806916037,2,37,prostate gland development,BP,GLI2;SFRP1
12764,GO:0051098,0.460590277742061,0.655287891313522,12,281,regulation of binding,BP,APOE;ZFPM1;LDLRAP1;DAB2IP;GAS8;EPHA4;PLXND1;NFATC4;IFI16;CAMK1;MDFI;SP100
4091,GO:0009163,0.460668990923166,0.800213948190234,2,40,nucleoside biosynthetic process,BP,NT5E;NME4
4581,GO:0010714,0.460899728608337,0.879345683116457,1,15,positive regulation of collagen metabolic process,BP,F2R
8190,GO:0032967,0.460899728608337,0.879345683116457,1,15,positive regulation of collagen biosynthetic process,BP,F2R
881,GO:0002253,0.460989236131404,0.643356674358124,15,353,activation of immune response,BP,TNFAIP3;PTPRS;CYBA;VAV3;CTSB;DAB2IP;WIPF1;RPS6KA5;DDX60;PIK3R1;CTSL;TYRO3;RBCK1;SERPING1;IFI16
11268,GO:0045622,0.461097414415358,0.879229437767151,1,15,regulation of T-helper cell differentiation,BP,BCL6
706,GO:0001935,0.461596762356567,0.731665374149661,4,85,endothelial cell proliferation,BP,APOE;CYBA;VEGFB;STAT1
13437,GO:0055013,0.461608421510817,0.799920201972277,2,37,cardiac muscle cell development,BP,OBSL1;FHOD3
10984,GO:0044853,0.461637321016572,0.758215126349431,3,60,plasma membrane raft,CC,INSR;F2R;SLC2A1
17472,GO:1900745,0.461662097319185,0.878896998543656,1,15,positive regulation of p38MAPK cascade,BP,MAP3K3
13586,GO:0060122,0.461749083128703,0.87884573724185,1,15,inner ear receptor cell stereocilium organization,BP,VANGL2
1599,GO:0004033,0.461764830692473,0.878395435451347,1,16,aldo-keto reductase (NADP) activity,MF,RDH12
4713,GO:0010894,0.462267347547406,0.878540037370949,1,15,negative regulation of steroid biosynthetic process,BP,APOE
14957,GO:0070920,0.462286016911897,0.878529016131823,1,15,regulation of production of small RNA involved in gene silencing by RNA,BP,EGFR
19666,GO:2000045,0.462313868453263,0.698178091839259,6,135,regulation of G1/S transition of mitotic cell cycle,BP,GPNMB;EGFR;PKD2;HYAL1;PCBP4;GJC2
11765,GO:0046683,0.463079198642479,0.730383956107611,4,85,response to organophosphorus,BP,PKD2;SREBF1;DMTN;STAT1
9529,GO:0036336,0.463209453282679,0.877983089594447,1,15,dendritic cell migration,BP,CXCR1
12272,GO:0048659,0.463231353440389,0.730252287492626,4,85,smooth muscle cell proliferation,BP,TNFAIP3;EGFR;CYBA;STAT1
3209,GO:0006875,0.463394146600293,0.652666621548028,12,279,cellular metal ion homeostasis,BP,APOE;CYBA;CYBRD1;SV2A;PKD2;F2R;HEXB;ATP6V0A2;ATP12A;TRPV4;SLC39A6;MT2A
5902,GO:0018196,0.463551152947775,0.798145089279904,2,39,peptidyl-asparagine modification,BP,ST3GAL5;ST6GALNAC6
4121,GO:0009199,0.46355227690819,0.662836785180988,10,239,ribonucleoside triphosphate metabolic process,BP,PGM1;DHTKD1;INSR;FAM20C;ATP6V0A2;SDHA;NME4;COX5B;TCIRG1;NADK
6171,GO:0019637,0.463679748577242,0.606750344241638,35,848,organophosphate metabolic process,BP,APOE;EGFR;FGFR4;PGM1;DHTKD1;INSR;VAV3;PKD2;NT5E;DAB2IP;H6PD;FAM20C;HEXB;PLCD3;PGLS;ERBB3;ATP6V0A2;PIK3R1;PTHLH;IMPA2;ZP3;MBOAT7;SDHA;ADORA2B;NMRK1;MVD;ERBB2;NME4;PLCD1;COX5B;PLPP2;TCIRG1;NADK;ISYNA1;PIGZ
7473,GO:0031664,0.464160072804289,0.877419479494087,1,15,regulation of lipopolysaccharide-mediated signaling pathway,BP,TNFAIP3
2332,GO:0005385,0.46426213514113,0.877358870632683,1,15,zinc ion transmembrane transporter activity,MF,SLC39A6
15307,GO:0071577,0.46426213514113,0.877358870632683,1,15,zinc ion transmembrane transport,BP,SLC39A6
6194,GO:0019731,0.464366080169988,0.876458476851535,1,17,antibacterial humoral response,BP,KLK5
8191,GO:0032968,0.464582219970862,0.87716866831974,1,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,RTF1
971,GO:0002431,0.464687927871122,0.755603454745645,3,61,Fc receptor mediated stimulatory signaling pathway,BP,VAV3;WIPF1;PIK3R1
9155,GO:0035556,0.464748299711655,0.584064326930947,82,1976,intracellular signal transduction,BP,TNFAIP3;APOE;GPNMB;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRL1;RALGDS;EGFR;FGFR4;RAPGEF5;BCL6;PSD4;BRSK1;SFRP1;ARHGEF4;TNFSF10;INSR;VAV3;PKD2;SERPINE2;WWTR1;FOXO1;DAB2IP;OBSCN;TBX1;SHC2;RAB40B;EPHA4;F2R;RPS6KA5;HOMER2;ARHGEF19;PLCD3;EPS8L2;DDX60;ERBB3;CSPG4;DMTN;PIK3R1;PTHLH;APPL2;IQSEC1;ACAP3;TRIM22;NCK2;CAMKK1;UCN2;ARHGAP40;NFATC4;TYRO3;RHOD;ZP3;RBCK1;PCBP4;SPRY2;TP53INP1;TNFRSF19;TRPV4;NDRG1;ADORA2B;RTN4RL1;MC1R;IGFBP4;ERBB2;EPM2A;STAT1;ACKR3;PLCD1;IFI16;NUAK1;PLXNB1;RASA4;CXXC5;CAMK1;NISCH;RAB43;MAP3K3;SP100;NRK;VANGL2
4685,GO:0010863,0.464830892707541,0.877020772426054,1,15,positive regulation of phospholipase C activity,BP,EGFR
14246,GO:0061371,0.465366874598993,0.797043812292697,2,37,determination of heart left/right asymmetry,BP,PKD2;VANGL2
9533,GO:0036344,0.465471726789208,0.876639124115098,1,15,platelet morphogenesis,BP,ZFPM1
17711,GO:1901700,0.46576309197684,0.599164795452573,42,1010,response to oxygen-containing compound,BP,TNFAIP3;POSTN;APOE;TXNRD3;SRSF5;GPX3;COL6A1;EGFR;CYBA;SFRP1;TNFSF10;INSR;PKD2;FOXO1;WNT3;DAB2IP;TBX1;GLUL;EPHA4;WNT9A;F2R;CTSV;HOMER2;ACSL1;ATP6V0A2;SREBF1;DMTN;ENDOG;PIK3R1;NFATC4;FAM210B;SLC2A1;HYAL1;VAMP2;TP53INP1;TRPV4;MTHFR;IMPACT;GPR68;STAT1;TCIRG1;SORT1
3319,GO:0007045,0.465949935099926,0.754630355979009,3,60,cell-substrate adherens junction assembly,BP,SFRP1;DMTN;RHOD
12051,GO:0048041,0.465949935099926,0.754630355979009,3,60,focal adhesion assembly,BP,SFRP1;DMTN;RHOD
15253,GO:0071479,0.466232759681376,0.754239535392244,3,62,cellular response to ionizing radiation,BP,CYBA;SFRP1;IFI16
17683,GO:1901653,0.46632276154776,0.654792162005965,11,253,cellular response to peptide,BP,SRSF5;CYBA;INSR;FOXO1;EPHA4;ATP6V0A2;SREBF1;PIK3R1;VAMP2;STAT1;TCIRG1
16042,GO:0090050,0.466562047373153,0.875988067069004,1,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,MAP3K3
2606,GO:0005938,0.466771895048592,0.65997209467764,10,226,cell cortex,CC,SHROOM2;PKD2;RIMS3;WIPF1;FRY;DMTN;RHOD;SLC2A1;PLEKHH2;TRPV4
4054,GO:0009124,0.46699690799222,0.69392201949481,6,136,nucleoside monophosphate biosynthetic process,BP,PGM1;DHTKD1;INSR;ATP6V0A2;COX5B;TCIRG1
7044,GO:0030851,0.467194442556578,0.875609455677024,1,15,granulocyte differentiation,BP,ZFPM1
15102,GO:0071243,0.467268421418988,0.87511380085493,1,16,cellular response to arsenic-containing substance,BP,UROS
17289,GO:0150034,0.467385708190892,0.673406578349154,8,180,distal axon,CC,ADGRL1;TENM2;SV2A;BOC;KCNC4;GLUL;EPHA4;TRPV4
4073,GO:0009144,0.467422585094272,0.659205900294041,10,240,purine nucleoside triphosphate metabolic process,BP,PGM1;DHTKD1;INSR;FAM20C;ATP6V0A2;SDHA;NME4;COX5B;TCIRG1;NADK
9050,GO:0035329,0.46793458411018,0.795066268264105,2,37,hippo signaling,BP,MAP3K14;WWTR1
4861,GO:0014741,0.4686359395406,0.874743709593288,1,15,negative regulation of muscle hypertrophy,BP,FOXO1
14900,GO:0070828,0.469157779778125,0.874429361245533,1,15,heterochromatin organization,BP,MTHFR
538,GO:0001657,0.469255323090822,0.751786884279072,3,61,ureteric bud development,BP,SFRP1;PKD2;KIF26B
721,GO:0001954,0.469442317977735,0.793748400229777,2,38,positive regulation of cell-matrix adhesion,BP,NINJ1;SFRP1
13787,GO:0060425,0.469564145375245,0.793653987342317,2,38,lung morphogenesis,BP,SPRY2;VANGL2
12899,GO:0051298,0.470151924178274,0.751034427891175,3,61,centrosome duplication,BP,BRSK1;PKD2;FBXW5
4732,GO:0010921,0.470283559131358,0.691014614303844,6,133,regulation of phosphatase activity,BP,PPP2R2C;PPP1R35;CRY2;NUAK1;ELFN2;PPP1R14A
6200,GO:0019751,0.470484655732025,0.723895650829985,4,86,polyol metabolic process,BP,PLCD3;IMPA2;PLCD1;ISYNA1
4039,GO:0009101,0.47052089571444,0.650827923370861,11,254,glycoprotein biosynthetic process,BP,LMF1;ST3GAL5;XYLT1;VEGFB;TET1;B3GNT9;CSPG4;MVD;XYLT2;ST6GALNAC6;VANGL2
15863,GO:0072676,0.470710427089442,0.792620054530575,2,39,lymphocyte migration,BP,CKLF;CXCL14
12123,GO:0048268,0.470770543793828,0.873454700712313,1,15,clathrin coat assembly,BP,NSG1
13897,GO:0060602,0.471192950288633,0.873198633186266,1,15,branch elongation of an epithelium,BP,SPRY2
11741,GO:0046636,0.471228168283805,0.873177268820061,1,15,negative regulation of alpha-beta T cell activation,BP,BCL6
14480,GO:0070006,0.471235112486835,0.873173055974224,1,15,metalloaminopeptidase activity,MF,RNPEPL1
17813,GO:1902043,0.471251156470151,0.873163322217152,1,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP1
17783,GO:1901981,0.472338433011286,0.703392343816322,5,109,phosphatidylinositol phosphate binding,MF,LDLRAP1;DAB2IP;TULP3;WIPI2;PLCD1
2739,GO:0006165,0.472437616698632,0.722138985047074,4,87,nucleoside diphosphate phosphorylation,BP,PGM1;DHTKD1;INSR;NME4
364,GO:0000983,0.472740180610775,0.87225787881561,1,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,STAT1
4584,GO:0010717,0.472757851673309,0.748764117780585,3,62,regulation of epithelial to mesenchymal transition,BP,SFRP1;WWTR1;DAB2IP
10167,GO:0042803,0.47276041417155,0.61483079473036,22,529,protein homodimerization activity,MF,APOE;ALDH1A3;CADM4;TENM2;ZNF318;PKD2;VEGFB;WWTR1;DAB2IP;TBX1;TENM4;HOMER2;HEXB;ERBB3;S100A6;IMPA2;STOM;PDLIM4;MVD;STAT1;PEX11B;SP100
10272,GO:0043069,0.472765576795073,0.608268870772553,26,625,negative regulation of programmed cell death,BP,TNFAIP3;APOE;IFI6;LAMP3;EPHB2;EGFR;GLI2;FGFR4;BCL6;SFRP1;TNFSF10;INSR;FOXO1;TBX1;MNT;EPHA4;WNT9A;F2R;ERBB3;PIK3R1;TYRO3;RBCK1;SPRY2;MDK;ERBB2;ACKR3
15860,GO:0072673,0.472900716136475,0.872160016433454,1,15,lamellipodium morphogenesis,BP,ARPIN
10143,GO:0042762,0.473004453245908,0.872096753028849,1,15,regulation of sulfur metabolic process,BP,PDPR
13462,GO:0055070,0.47362671581768,0.871253515333796,1,16,copper ion homeostasis,BP,MT2A
9901,GO:0042278,0.474108764176579,0.747475910634009,3,64,purine nucleoside metabolic process,BP,GAMT;NT5E;NME4
17796,GO:1902001,0.474151898430365,0.871395664275444,1,15,fatty acid transmembrane transport,BP,CPT2
10657,GO:0043968,0.474358060409708,0.87080471238333,1,16,histone H2A acetylation,BP,YEATS4
1311,GO:0003171,0.474524580432012,0.871167431538549,1,15,atrioventricular valve development,BP,ZFPM1
6398,GO:0021680,0.475005548116542,0.870872503628199,1,15,cerebellar Purkinje cell layer development,BP,NAGLU
11810,GO:0046825,0.475229518811777,0.789091860242679,2,39,regulation of protein export from nucleus,BP,CAMK1;SP100
2924,GO:0006465,0.475368589800942,0.870182949397616,1,16,signal peptide processing,BP,FURIN
8687,GO:0034358,0.475510564043004,0.870095442847888,1,16,plasma lipoprotein particle,CC,APOE
19583,GO:1990777,0.475510564043004,0.870095442847888,1,16,lipoprotein particle,CC,APOE
7886,GO:0032481,0.475595008460771,0.746290488157253,3,63,positive regulation of type I interferon production,BP,RNF135;STAT1;IFI16
15967,GO:0086019,0.476164403806228,0.870160134010559,1,15,cell-cell signaling involved in cardiac conduction,BP,SCN4B
10059,GO:0042590,0.476297472152837,0.745352262524787,3,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,CYBA;VAMP3;ITGB5
11223,GO:0045503,0.476659309297265,0.869855146271449,1,15,dynein light chain binding,MF,GLUL
731,GO:0001965,0.476727955259951,0.869343557670473,1,16,G-protein alpha-subunit binding,MF,F2R
9734,GO:0039529,0.476893646022917,0.869710576247111,1,15,RIG-I signaling pathway,BP,DDX60
3482,GO:0007398,0.477100372332314,0.869582955126089,1,15,ectoderm development,BP,SMURF1
13472,GO:0055083,0.477948537036536,0.869058512713843,1,15,monovalent inorganic anion homeostasis,BP,FGFR4
8020,GO:0032692,0.47800832838333,0.868549792447478,1,16,negative regulation of interleukin-1 production,BP,TNFAIP3
4673,GO:0010842,0.478216108972048,0.868892787614919,1,15,retina layer formation,BP,SDK2
7871,GO:0032461,0.47843084623143,0.868287181166956,1,16,positive regulation of protein oligomerization,BP,MMP1
13766,GO:0060396,0.478921559177908,0.86845521452312,1,15,growth hormone receptor signaling pathway,BP,PIK3R1
1694,GO:0004198,0.47905294963058,0.867899911754521,1,16,calcium-dependent cysteine-type endopeptidase activity,MF,CAPNS2
14703,GO:0070412,0.479207143944088,0.868277808982678,1,15,R-SMAD binding,MF,SMURF1
7637,GO:0032088,0.479650376314475,0.742769461046362,3,64,negative regulation of NF-kappaB transcription factor activity,BP,TNFAIP3;DAB2IP;RBCK1
3611,GO:0008083,0.479695693356035,0.742659651324037,3,65,growth factor activity,MF,VEGFB;CLEC11A;MDK
15784,GO:0072527,0.479871561490691,0.742440611594692,3,66,pyrimidine-containing compound metabolic process,BP,NT5E;TET1;NME4
16533,GO:0097367,0.479987575613833,0.573598400201993,66,1582,carbohydrate derivative binding,MF,POSTN;SMOC2;APOE;ULK2;PTPRS;GPNMB;MAP3K14;EPHB2;EGFR;OAS2;FGFR4;CDK18;BRSK1;SFRP1;INSR;DHX32;DNM1;CTSB;SERPINE2;TNXB;VEGFB;OBSCN;RAB40B;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;CTSL;ACVR1B;CAMKK1;ATP12A;TYRO3;RHOD;CKMT1A;ADAMTS15;SCG5;MDK;TRPV4;GPC4;LTBP4;NMRK1;RTN4RL1;MARK4;MVD;ERBB2;NME4;CDK20;CLCN7;NUAK1;CAMK1;NADK;RAB43;MAP3K3;ABCC1;DDX59;NRK
11752,GO:0046653,0.480232980259422,0.867163331202652,1,16,tetrahydrofolate metabolic process,BP,MTHFR
10492,GO:0043457,0.480494437493578,0.866999774782746,1,16,regulation of cellular respiration,BP,TRPV4
7633,GO:0032075,0.480495820613452,0.866998909220916,1,16,positive regulation of nuclease activity,BP,DAB2IP
15609,GO:0072163,0.480531151108968,0.742167306798917,3,62,mesonephric epithelium development,BP,SFRP1;PKD2;KIF26B
15610,GO:0072164,0.480531151108968,0.742167306798917,3,62,mesonephric tubule development,BP,SFRP1;PKD2;KIF26B
17758,GO:1901889,0.480803223115767,0.867283511715453,1,15,negative regulation of cell junction assembly,BP,DMTN
17685,GO:1901655,0.481149946626579,0.74156253682935,3,63,cellular response to ketone,BP,EGFR;SFRP1;FOXO1
11253,GO:0045600,0.481201498468177,0.784380717431602,2,39,positive regulation of fat cell differentiation,BP,SFRP1;CCDC3
5911,GO:0018208,0.481280835869215,0.784042556372936,2,41,peptidyl-proline modification,BP,CRTAP;FKBP9
10353,GO:0043209,0.481485253715217,0.680643352848672,6,138,myelin sheath,CC,DNM1;GLUL;NDRG1;SDHA;ERBB2;GJC2
2527,GO:0005798,0.481513137407769,0.680642132807724,6,137,Golgi-associated vesicle,CC,LDLRAP1;COL7A1;SREBF1;FURIN;SORT1;VANGL2
4077,GO:0009148,0.48153793021274,0.865924270365475,1,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,NME4
1215,GO:0002902,0.481554557799461,0.866335292286504,1,16,regulation of B cell apoptotic process,BP,BCL6
17912,GO:1902305,0.482784409465895,0.783122669044136,2,39,regulation of sodium ion transmembrane transport,BP,SCN4B;STOM
12246,GO:0048596,0.482827370944583,0.866015665939272,1,15,embryonic camera-type eye morphogenesis,BP,ALDH1A3
11808,GO:0046823,0.483076350696657,0.865377733841717,1,16,negative regulation of nucleocytoplasmic transport,BP,SP100
11445,GO:0045939,0.483537669226,0.865086594886466,1,16,negative regulation of steroid metabolic process,BP,APOE
16054,GO:0090075,0.483711363609691,0.864976871812016,1,16,relaxation of muscle,BP,ADORA2B
8718,GO:0034394,0.483954822513981,0.782189937621419,2,39,protein localization to cell surface,BP,SNX33;SMURF1
8939,GO:0035036,0.484347788791804,0.864148118486098,1,17,sperm-egg recognition,BP,ZP3
11168,GO:0045332,0.484402494630161,0.865023730880497,1,15,phospholipid translocation,BP,ABCC1
16697,GO:0097756,0.484507633976311,0.781748641286973,2,39,negative regulation of blood vessel diameter,BP,EGFR;F2R
2605,GO:0005930,0.48454958358008,0.73864861547017,3,63,axoneme,CC,GLI2;GAS8;TULP3
11642,GO:0046461,0.48470257100613,0.86434963178723,1,16,neutral lipid catabolic process,BP,APOE
11645,GO:0046464,0.48470257100613,0.86434963178723,1,16,acylglycerol catabolic process,BP,APOE
19405,GO:1990089,0.484729577395662,0.781571334136623,2,39,response to nerve growth factor,BP,MICALL1;SORT1
19406,GO:1990090,0.484729577395662,0.781571334136623,2,39,cellular response to nerve growth factor stimulus,BP,MICALL1;SORT1
8163,GO:0032925,0.484934601295185,0.864202533301212,1,16,regulation of activin receptor signaling pathway,BP,ACVR1B
8702,GO:0034377,0.484982227239062,0.864172327617997,1,16,plasma lipoprotein particle assembly,BP,APOE
5640,GO:0016763,0.485012969356425,0.781202270980039,2,40,transferase activity, transferring pentosyl groups,MF,XYLT1;XYLT2
12941,GO:0051384,0.485305570784365,0.71066846640767,4,89,response to glucocorticoid,BP,EGFR;FOXO1;CTSV;MDK
13927,GO:0060675,0.485663101896677,0.780824708676867,2,39,ureteric bud morphogenesis,BP,PKD2;KIF26B
15613,GO:0072171,0.485663101896677,0.780824708676867,2,39,mesonephric tubule morphogenesis,BP,PKD2;KIF26B
19867,GO:2000403,0.4858135905665,0.863644360966684,1,16,positive regulation of lymphocyte migration,BP,CXCL14
10165,GO:0042800,0.486381474917581,0.863282965121054,1,16,histone methyltransferase activity (H3-K4 specific),MF,ASH2L
12526,GO:0050715,0.486509339258639,0.736887217708782,3,64,positive regulation of cytokine secretion,BP,POSTN;F2R;TRPV4
3756,GO:0008327,0.486781499538995,0.863028025412442,1,16,methyl-CpG binding,MF,MBD1
3233,GO:0006907,0.486934522076591,0.862930422094769,1,16,pinocytosis,BP,SNX33
3261,GO:0006955,0.486992100288767,0.574002705311259,49,1201,immune response,BP,TNFAIP3;IFITM1;IFI6;LAMP3;PTPRS;MAP3K14;NCR3LG1;CYBA;OAS2;BCL6;PGM1;TNFSF10;VAV3;GAA;ZFPM1;CXCL14;CTSB;DAB2IP;PRSS3;KLK5;WIPF1;RPL13A;RPS6KA5;HEXB;SCART1;DDX60;HGSNAT;ATP6V0A2;VAMP3;PIK3R1;CTSL;TRIM22;TYRO3;CXCR1;METTL7A;ZP3;STOM;VAMP2;RBCK1;ADORA2B;SERPING1;RNF135;STAT1;IFI16;IL20RB;TCIRG1;MT2A;RAB43;SP100
1829,GO:0004497,0.487059795681893,0.779561748880451,2,40,monooxygenase activity,MF,CYP4F22;CYP27C1
19582,GO:1990776,0.487095336042431,0.862827801080613,1,16,response to angiotensin,BP,CYBA
465,GO:0001504,0.487257524543017,0.862724253044265,1,16,neurotransmitter uptake,BP,GLUL
7109,GO:0030952,0.487362943672914,0.862656922117827,1,16,establishment or maintenance of cytoskeleton polarity,BP,RHOD
4215,GO:0009410,0.487495311360467,0.663714095722636,7,164,response to xenobiotic stimulus,BP,EGFR;CES2;FOXO1;BPHL;HOMER2;ACSL1;CBR3
8075,GO:0032784,0.487601974331635,0.779126090359393,2,40,regulation of DNA-templated transcription, elongation,BP,TCEA2;RTF1
15944,GO:0080182,0.487735204519144,0.862418990627271,1,16,histone H3-K4 trimethylation,BP,RTF1
5540,GO:0016571,0.487786897278389,0.689338388535335,5,111,histone methylation,BP,ASH2L;KMT5C;TET1;RTF1;MTHFR
4954,GO:0015085,0.487911816373359,0.735828734830123,3,62,calcium ion transmembrane transporter activity,MF,PKD2;ORAI3;TRPV4
17689,GO:1901659,0.487936481719984,0.778590741119967,2,42,glycosyl compound biosynthetic process,BP,NT5E;NME4
12538,GO:0050732,0.488110810577539,0.778716802091988,2,40,negative regulation of peptidyl-tyrosine phosphorylation,BP,SFRP1;DMTN
2484,GO:0005746,0.488343590956315,0.734781206528766,3,72,mitochondrial respiratory chain,CC,NDUFA4L2;SDHA;COX5B
18662,GO:1904063,0.48847322398535,0.778425041713375,2,40,negative regulation of cation transmembrane transport,BP,EPHB2;PKD2
13463,GO:0055072,0.488720279339661,0.734905059198245,3,65,iron ion homeostasis,BP,CYBRD1;ATP6V0A2;NEO1
15266,GO:0071498,0.488868603616431,0.861692947667783,1,16,cellular response to fluid shear stress,BP,PKD2
14216,GO:0061311,0.488966593487674,0.861630061199013,1,16,cell surface receptor signaling pathway involved in heart development,BP,VANGL2
15294,GO:0071556,0.489323813246985,0.860965911026886,1,17,integral component of lumenal side of endoplasmic reticulum membrane,CC,PKD2
16720,GO:0098553,0.489323813246985,0.860965911026886,1,17,lumenal side of endoplasmic reticulum membrane,CC,PKD2
7952,GO:0032588,0.489661304198619,0.734162846900733,3,64,trans-Golgi network membrane,CC,NSG1;VAMP3;RAB43
12519,GO:0050708,0.489706749210908,0.632537237059136,11,259,regulation of protein secretion,BP,POSTN;EGFR;NLGN2;SFRP1;RHBDF1;GLUL;F2R;SREBF1;SLC2A1;TRPV4;GPR68
13726,GO:0060343,0.490208953842706,0.860831164759288,1,16,trabecula formation,BP,SFRP1
13482,GO:0055094,0.490372083687738,0.860726044983064,1,16,response to lipoprotein particle,BP,APOE
6328,GO:0021522,0.490793135015352,0.860454486476051,1,16,spinal cord motor neuron differentiation,BP,GLI2
4011,GO:0009060,0.490898114400028,0.732811770583835,3,68,aerobic respiration,BP,DHTKD1;SDHA;COX5B
725,GO:0001958,0.491080485495277,0.860268963481105,1,16,endochondral ossification,BP,NAB2
9436,GO:0036075,0.491080485495277,0.860268963481105,1,16,replacement ossification,BP,NAB2
4878,GO:0014823,0.491758089070063,0.775771100685866,2,40,response to activity,BP,POSTN;CYBA
17299,GO:1900024,0.491871818065917,0.775678909748991,2,40,regulation of substrate adhesion-dependent cell spreading,BP,POSTN;DMTN
5391,GO:0016254,0.492207352119061,0.859100184313623,1,17,preassembly of GPI anchor in ER membrane,BP,PIGZ
6344,GO:0021544,0.4924234204524,0.859399816497055,1,16,subpallium development,BP,ALDH1A3
15856,GO:0072666,0.493230061074676,0.774576306061999,2,40,establishment of protein localization to vacuole,BP,TNFAIP3;SMURF1
6217,GO:0019787,0.49348688268082,0.606080534405386,17,403,ubiquitin-like protein transferase activity,MF,TNFAIP3;FBXO41;FBXO2;TMEM129;DDB2;HERC3;KLHDC8B;RBCK1;FBXW4;RNF187;RNF135;FBXL8;RNF44;FBXW5;SMURF1;RNF208;FBXO44
10442,GO:0043368,0.493556493846198,0.858663790954475,1,16,positive T cell selection,BP,ZFPM1
6426,GO:0021761,0.493613445933988,0.730727855203244,3,64,limbic system development,BP,ALDH1A3;PTPRS;MDK
12638,GO:0050886,0.493848966105184,0.774072915859708,2,40,endocrine process,BP,CYBA;F2R
5568,GO:0016605,0.493943759733341,0.702965960137465,4,88,PML body,CC,TENM2;TP53INP2;TP53INP1;SP100
1293,GO:0003148,0.493980950126263,0.858387433504752,1,16,outflow tract septum morphogenesis,BP,TBX1
8036,GO:0032727,0.493982127147624,0.858386666679063,1,16,positive regulation of interferon-alpha production,BP,STAT1
12823,GO:0051184,0.494014476282635,0.858365590272617,1,16,cofactor transmembrane transporter activity,MF,ABCC1
4960,GO:0015095,0.494312469712646,0.858171343729795,1,16,magnesium ion transmembrane transporter activity,MF,NIPAL4
5137,GO:0015693,0.494312469712646,0.858171343729795,1,16,magnesium ion transport,BP,NIPAL4
18544,GO:1903830,0.494312469712646,0.858171343729795,1,16,magnesium ion transmembrane transport,BP,NIPAL4
17046,GO:0099622,0.494338679627202,0.858154250626089,1,16,cardiac muscle cell membrane repolarization,BP,SCN4B
13540,GO:0060048,0.494354181763893,0.730081688646395,3,64,cardiac muscle contraction,BP,GAA;VEGFB;SCN4B
449,GO:0001223,0.494369754433204,0.85813398310539,1,16,transcription coactivator binding,MF,FOXO1
7568,GO:0031958,0.494425553311081,0.858097585434954,1,16,corticosteroid receptor signaling pathway,BP,CRY2
12336,GO:0048762,0.49496616350635,0.668195091031212,6,136,mesenchymal cell differentiation,BP,S100A4;SFRP1;WWTR1;DAB2IP;TBX1;STAT1
7872,GO:0032462,0.494979266933246,0.857291573773104,1,17,regulation of protein homooligomerization,BP,APOE
13863,GO:0060548,0.495394276603964,0.583389347187083,28,681,negative regulation of cell death,BP,TNFAIP3;APOE;IFI6;LAMP3;GPNMB;EPHB2;EGFR;GLI2;FGFR4;BCL6;SFRP1;TNFSF10;INSR;FOXO1;TBX1;MNT;EPHA4;WNT9A;F2R;ERBB3;PIK3R1;TYRO3;RBCK1;SPRY2;MDK;IMPACT;ERBB2;ACKR3
11309,GO:0045669,0.495396929422189,0.772811203749328,2,40,positive regulation of osteoblast differentiation,BP,IFITM1;FAM20C
7136,GO:0031016,0.495396944814912,0.772811191184083,2,40,pancreas development,BP,INSR;FOXO1
16354,GO:0097014,0.495462090363021,0.729113833700161,3,64,ciliary plasm,CC,GLI2;GAS8;TULP3
12662,GO:0050920,0.495628130153472,0.682039691293151,5,114,regulation of chemotaxis,BP,CXCL14;VEGFB;WNT3;TRPV4;ZSWIM8
7363,GO:0031435,0.495688454931237,0.85727218164917,1,16,mitogen-activated protein kinase kinase kinase binding,MF,DAB2IP
10545,GO:0043542,0.495962928057053,0.667238437484262,6,137,endothelial cell migration,BP,APOE;DAB2IP;PRSS3;PLXND1;MAP3K3;SP100
4017,GO:0009066,0.495980994549957,0.772194744590226,2,41,aspartate family amino acid metabolic process,BP,MTHFR;THNSL2
9736,GO:0039531,0.496014875846204,0.85705833773295,1,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,DDX60
12839,GO:0051209,0.496056254968952,0.728594090917316,3,64,release of sequestered calcium ion into cytosol,BP,CYBA;PKD2;F2R
12888,GO:0051283,0.496056254968952,0.728594090917316,3,64,negative regulation of sequestering of calcium ion,BP,CYBA;PKD2;F2R
9455,GO:0036120,0.49613519247152,0.856979464118587,1,16,cellular response to platelet-derived growth factor stimulus,BP,HYAL1
18046,GO:1902692,0.496319388261644,0.856858660058605,1,16,regulation of neuroblast proliferation,BP,KCTD11
12827,GO:0051188,0.496417018101662,0.631719374032643,10,239,cofactor biosynthetic process,BP,CYBA;PGM1;DHTKD1;INSR;PDPR;UROS;ACSL1;NMRK1;MLYCD;NADK
19517,GO:1990542,0.496474483630332,0.728013478265583,3,67,mitochondrial transmembrane transport,BP,CPT2;TST;COX5B
17040,GO:0099604,0.496802450925343,0.856541532399502,1,16,ligand-gated calcium channel activity,MF,PKD2
4236,GO:0009566,0.49688766458645,0.727720674946914,3,66,fertilization,BP,SYT8;HEXB;ZP3
8894,GO:0034763,0.496947331642247,0.727739897907219,3,65,negative regulation of transmembrane transport,BP,EPHB2;ANO9;PKD2
6896,GO:0030507,0.497275244502319,0.85623070716952,1,16,spectrin binding,MF,DMTN
11841,GO:0046885,0.497485790511851,0.856092149516079,1,16,regulation of hormone biosynthetic process,BP,TRERF1
5867,GO:0018024,0.497571817047941,0.771032049283303,2,40,histone-lysine N-methyltransferase activity,MF,ASH2L;KMT5C
11713,GO:0046596,0.497782559927178,0.855447338659244,1,17,regulation of viral entry into host cell,BP,IFITM1
3574,GO:0008013,0.497873580079676,0.727077791819734,3,63,beta-catenin binding,MF,ASH2L;SHROOM2;FOXO1
19670,GO:2000050,0.49787607645513,0.855835079060322,1,16,regulation of non-canonical Wnt signaling pathway,BP,SFRP1
11497,GO:0046058,0.497909363778933,0.770755244316072,2,40,cAMP metabolic process,BP,PKD2;PTHLH
13694,GO:0060306,0.497928217521058,0.855800712732626,1,16,regulation of membrane repolarization,BP,SCN4B
11394,GO:0045844,0.498761031928225,0.770056024933515,2,40,positive regulation of striated muscle tissue development,BP,TBX1;ERBB3
12262,GO:0048636,0.498761031928225,0.770056024933515,2,40,positive regulation of muscle organ development,BP,TBX1;ERBB3
17751,GO:1901863,0.498761031928225,0.770056024933515,2,40,positive regulation of muscle tissue development,BP,TBX1;ERBB3
17208,GO:0120031,0.498810443440899,0.598225113549656,18,428,plasma membrane bounded cell projection assembly,BP,TENM2;ARHGEF4;VAV3;ESPN;WWTR1;PARVB;TMEM231;GAS8;EVI5L;EPS8L2;DMTN;NCK2;UNC119B;RHOD;MAFIP;MARK4;NINL;VANGL2
8017,GO:0032689,0.499089256162119,0.854582455658877,1,17,negative regulation of interferon-gamma production,BP,IL20RB
3370,GO:0007163,0.499685698112425,0.652337150288697,7,159,establishment or maintenance of cell polarity,BP,BRSK1;PARVB;KIF26B;RHOD;SPRY2;MARK4;VANGL2
2608,GO:0005942,0.499723298908101,0.854614335393163,1,16,phosphatidylinositol 3-kinase complex,CC,PIK3R1
15184,GO:0071378,0.500086941421604,0.854373235615353,1,16,cellular response to growth hormone stimulus,BP,PIK3R1
17645,GO:1901564,0.500088968729323,0.537400421651752,198,4897,organonitrogen compound metabolic process,BP,TNFAIP3;TGFBI;APOE;IFI6;MVB12B;LAMP3;ULK2;PTPRS;FBXO41;OBSL1;LMF1;GPNMB;MAP3K14;EPHB2;KDSR;ASH2L;HTRA1;PRR9;GAMT;ST3GAL5;TST;DCAF16;EGFR;ADAM19;FBXO2;CRAT;FGFR4;CDK18;BCL6;PGM1;TENM2;XYLT1;CERS4;BRSK1;SFRP1;UNK;TNFSF10;DHTKD1;INSR;KMT5C;NPEPL1;PKD2;ZFPM1;NAT6;ARSI;PPP2R2C;LDLRAP1;CTSB;NT5E;SERPINE2;HR;PDPR;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;LY6E;NSG1;BPHL;UROS;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;PRSS3;H6PD;SGSH;KLK5;SHC2;CRTAP;YEATS4;FKBP9;RAB40B;TET1;FAM20C;GLUL;ANO8;EPHA4;WNT9A;RPL13A;B3GNT9;RNPEPL1;MAGEF1;TENM4;F2R;HERC3;TYSND1;CTSV;RPS6KA5;KLHDC8B;HEXB;LTBP1;PGLS;ACSL1;ERBB3;HGSNAT;SPOCK1;CDK14;ATP6V0A2;CUL9;FRY;SREBF1;CSPG4;DMTN;GRK6;PIK3R1;PTHLH;SDC3;CTSL;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;NAB2;SNX33;TYRO3;CPT1C;HYAL1;RTF1;CKMT1A;ADAMTS15;RBCK1;ADCK5;SPRY2;SCG5;TNFRSF19;SLC2A9;TRPV4;ZDHHC1;MTHFR;SPATA18;GPC4;MSRB2;SDHA;KLK8;LTBP4;PPP1R35;ADORA2B;FBXW4;SERPING1;NAGLU;NMRK1;RTN4RL1;MARK4;BTBD2;IMPACT;MVD;GOLGA7B;IGFBP4;ERBB2;RNF187;RNF135;LAMB2;FBXL8;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;CRY2;MARCH9;COX5B;FURIN;FBXW5;IFI16;PCSK1;PLPP2;THNSL2;CTSF;GJC2;MMP1;XYLT2;NUAK1;ALOXE3;RASA4;SMURF1;CAPNS2;MEX3A;CAMK1;TCIRG1;RNF208;NADK;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;ABCC1;IDUA;NRK;PIGZ;FBXO44;VANGL2
630,GO:0001823,0.500176416392178,0.724976754958807,3,64,mesonephros development,BP,SFRP1;PKD2;KIF26B
9763,GO:0040013,0.500353006093183,0.634580921362549,9,210,negative regulation of locomotion,BP,IFITM1;APOE;SFRP1;WNT3;DAB2IP;TP53INP1;ARPIN;NISCH;SP100
3703,GO:0008238,0.500379769876919,0.724723267095427,3,65,exopeptidase activity,MF,NPEPL1;RNPEPL1;CTSV
4423,GO:0010324,0.500528956002428,0.768459798647676,2,41,membrane invagination,BP,SNX33;SMURF1
7388,GO:0031490,0.500887375326379,0.696488040303684,4,92,chromatin DNA binding,MF,THRA;H1F0;BCL6;HR
10171,GO:0042813,0.501284697870046,0.853577276123371,1,16,Wnt-activated receptor activity,MF,SFRP1
17461,GO:1900542,0.501341682389797,0.676751479695358,5,114,regulation of purine nucleotide metabolic process,BP,APOE;INSR;PKD2;PTHLH;ADORA2B
3170,GO:0006809,0.501382271085826,0.767755336671886,2,41,nitric oxide biosynthetic process,BP,INSR;PKD2
13208,GO:0051924,0.501528153933566,0.676578286832763,5,114,regulation of calcium ion transport,BP,CYBA;PKD2;F2R;HOMER2;GJC2
13804,GO:0060445,0.501616265692209,0.853356438201161,1,16,branching involved in salivary gland morphogenesis,BP,PLXND1
10382,GO:0043254,0.501809714596305,0.607568653165599,14,334,regulation of protein complex assembly,BP,APOE;THRA;FHOD3;DDB2;DAB2IP;WIPF1;RPL13A;EPS8L2;DMTN;NCK2;ARHGAP40;IMPACT;ARPIN;MMP1
2994,GO:0006555,0.502137712791569,0.85255172883772,1,17,methionine metabolic process,BP,MTHFR
1174,GO:0002828,0.502170977960045,0.85252946859599,1,17,regulation of type 2 immune response,BP,BCL6
9601,GO:0036499,0.50219864491599,0.85251095288264,1,17,PERK-mediated unfolded protein response,BP,NCK2
18117,GO:1902904,0.502320060279859,0.69531855312242,4,89,negative regulation of supramolecular fiber organization,BP,FHOD3;DMTN;PLEKHH2;ARPIN
12063,GO:0048103,0.502346218864069,0.852869498162425,1,16,somatic stem cell division,BP,VANGL2
7993,GO:0032648,0.502567622344465,0.766774818884923,2,41,regulation of interferon-beta production,BP,PTPRS;RNF135
1089,GO:0002685,0.502585469474982,0.694939440800038,4,92,regulation of leukocyte migration,BP,CXCL14;VEGFB;ZP3;TRPV4
2925,GO:0006468,0.502766246011418,0.555860103896726,54,1310,protein phosphorylation,BP,TNFAIP3;APOE;ULK2;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;CDK18;BRSK1;SFRP1;INSR;PKD2;WWTR1;FOXO1;DAB2IP;OBSCN;TBX1;SHC2;FAM20C;EPHA4;F2R;RPS6KA5;ACSL1;ERBB3;CDK14;CSPG4;DMTN;GRK6;PIK3R1;NCK2;ACVR1B;CAMKK1;NAB2;TYRO3;ADCK5;SPRY2;TNFRSF19;TRPV4;ADORA2B;RTN4RL1;MARK4;IMPACT;IGFBP4;ERBB2;CDK20;ACKR3;GJC2;NUAK1;RASA4;CAMK1;MAP3K3;NRK;VANGL2
3345,GO:0007097,0.502828250519969,0.852547368227613,1,16,nuclear migration,BP,SUN1
3924,GO:0008630,0.502861180042424,0.694687673056158,4,92,intrinsic apoptotic signaling pathway in response to DNA damage,BP,PIK3R1;NFATC4;ACKR3;IFI16
8064,GO:0032770,0.503245295474849,0.85180938941051,1,17,positive regulation of monooxygenase activity,BP,APOE
3182,GO:0006826,0.503282164610553,0.766047539324333,2,42,iron ion transport,BP,ATP6V0A2;TCIRG1
4042,GO:0009108,0.503592273497351,0.639177644635381,8,190,coenzyme biosynthetic process,BP,PGM1;DHTKD1;INSR;PDPR;ACSL1;NMRK1;MLYCD;NADK
13701,GO:0060314,0.503632549220596,0.85154926805064,1,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,PKD2
11768,GO:0046686,0.503693263595683,0.765577515282608,2,43,response to cadmium ion,BP,EGFR;MT2A
6260,GO:0019882,0.503695909607093,0.648337984241386,7,169,antigen processing and presentation,BP,CYBA;CTSV;KIF26A;VAMP3;CTSL;ITGB5;CTSF
13481,GO:0055093,0.50374496914058,0.851473699263108,1,17,response to hyperoxia,BP,FOXO1
15480,GO:0071901,0.503792331495414,0.67440743453655,5,116,negative regulation of protein serine/threonine kinase activity,BP,TNFAIP3;APOE;SFRP1;DAB2IP;SPRY2
17757,GO:1901888,0.504357813469245,0.721281912557201,3,64,regulation of cell junction assembly,BP,SFRP1;DMTN;RHOD
6724,GO:0030162,0.504814849878069,0.585462147014826,21,516,regulation of proteolysis,BP,APOE;IFI6;LAMP3;FGFR4;TNFSF10;SERPINE2;RHBDF1;DAB2IP;COL7A1;EPHA4;WNT9A;MAGEF1;F2R;SPOCK1;SNX33;LTBP4;SERPING1;BTBD2;FURIN;IFI16;SMURF1
1292,GO:0003143,0.505503864920478,0.764479082490573,2,40,embryonic heart tube morphogenesis,BP,PKD2;VANGL2
6373,GO:0021591,0.505740701709674,0.850128005144206,1,17,ventricular system development,BP,MBOAT7
11450,GO:0045947,0.505864350189953,0.850044371168129,1,17,negative regulation of translational initiation,BP,RPL13A
11313,GO:0045682,0.506246912079466,0.719456616970311,3,66,regulation of epidermis development,BP,CTSV;CTSL;NAB2
4141,GO:0009220,0.506371150956302,0.849289133739579,1,18,pyrimidine ribonucleotide biosynthetic process,BP,NME4
11542,GO:0046132,0.506371150956302,0.849289133739579,1,18,pyrimidine ribonucleoside biosynthetic process,BP,NME4
8594,GO:0034138,0.50644993289718,0.84964787966015,1,17,toll-like receptor 3 signaling pathway,BP,TNFAIP3
18448,GO:1903599,0.506676764492712,0.849494111519259,1,17,positive regulation of autophagy of mitochondrion,BP,SMURF1
878,GO:0002250,0.506681399709434,0.636232803934388,8,189,adaptive immune response,BP,TNFAIP3;LAMP3;BCL6;SCART1;CTSL;ZP3;SERPING1;IL20RB
12887,GO:0051282,0.506758924592396,0.719074025337599,3,65,regulation of sequestering of calcium ion,BP,CYBA;PKD2;F2R
8629,GO:0034204,0.506876462915007,0.849823949251406,1,16,lipid translocation,BP,ABCC1
16811,GO:0098771,0.506876939131909,0.595868601660619,16,386,inorganic ion homeostasis,BP,APOE;EGFR;CYBA;FGFR4;CYBRD1;SV2A;PKD2;F2R;HEXB;ATP6V0A2;ATP12A;TRPV4;NEO1;SLC39A6;TCIRG1;MT2A
7812,GO:0032387,0.507237551646498,0.762753369538129,2,42,negative regulation of intracellular transport,BP,DMTN;SP100
7791,GO:0032366,0.507358981827509,0.849031022864307,1,17,intracellular sterol transport,BP,LDLRAP1
7792,GO:0032367,0.507358981827509,0.849031022864307,1,17,intracellular cholesterol transport,BP,LDLRAP1
20054,GO:2000757,0.507876482298163,0.848679126064849,1,17,negative regulation of peptidyl-lysine acetylation,BP,HINT2
7213,GO:0031128,0.507906155306594,0.848658932449316,1,17,developmental induction,BP,WNT3
14005,GO:0060795,0.508374235266331,0.848340153929231,1,17,cell fate commitment involved in formation of primary germ layer,BP,RTF1
9239,GO:0035690,0.508974134633471,0.619603578985324,10,239,cellular response to drug,BP,TNFAIP3;EGFR;CYBA;SFRP1;FOXO1;ENDOG;TP53INP1;IMPACT;MT2A;PPP1R14A
4689,GO:0010869,0.509030217017053,0.847892672264085,1,17,regulation of receptor biosynthetic process,BP,FURIN
11055,GO:0045089,0.509039670726807,0.619517904858132,10,241,positive regulation of innate immune response,BP,TNFAIP3;PTPRS;CYBA;CTSB;DAB2IP;RPS6KA5;DDX60;CTSL;TYRO3;IFI16
11240,GO:0045582,0.509087761263255,0.761203772093441,2,42,positive regulation of T cell differentiation,BP,GLI2;BCL6
3184,GO:0006829,0.509212311780484,0.847768302907937,1,17,zinc ion transport,BP,SLC39A6
16815,GO:0098780,0.509553141113837,0.847535340918424,1,17,response to mitochondrial depolarisation,BP,SMURF1
2426,GO:0005640,0.509654038241621,0.847466331649458,1,17,nuclear outer membrane,CC,RETSAT
17428,GO:1900274,0.509885653685394,0.847307839671501,1,17,regulation of phospholipase C activity,BP,EGFR
11557,GO:0046173,0.509904177284264,0.760518237205684,2,42,polyol biosynthetic process,BP,IMPA2;ISYNA1
15189,GO:0071385,0.50993994896584,0.7604881753905,2,42,cellular response to glucocorticoid stimulus,BP,EGFR;FOXO1
1468,GO:0003756,0.510066302626379,0.847184149003104,1,17,protein disulfide isomerase activity,MF,TMX4
5706,GO:0016864,0.510066302626379,0.847184149003104,1,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,TMX4
12080,GO:0048169,0.51030582945047,0.847020043780022,1,17,regulation of long-term neuronal synaptic plasticity,BP,EPHB2
14450,GO:0061912,0.510492683079585,0.760160997831147,2,41,selective autophagy,BP,WIPI2;SMURF1
7338,GO:0031400,0.510831623290881,0.583929217326409,19,461,negative regulation of protein modification process,BP,TNFAIP3;APOE;EPHB2;SFRP1;WWTR1;FOXO1;DAB2IP;CRTAP;FRY;DMTN;NCK2;SPRY2;PPP1R35;RTN4RL1;IMPACT;HINT2;CRY2;ELFN2;PPP1R14A
11432,GO:0045923,0.5109190432735,0.846599393278111,1,17,positive regulation of fatty acid metabolic process,BP,MLYCD
8031,GO:0032715,0.510936333296187,0.846587521793546,1,17,negative regulation of interleukin-6 production,BP,TNFAIP3
18881,GO:1904646,0.51110256267509,0.846473356611257,1,17,cellular response to amyloid-beta,BP,EPHA4
12556,GO:0050772,0.511206727560239,0.715101994344756,3,65,positive regulation of axonogenesis,BP,WNT3;PLXND1;PLXNB1
9136,GO:0035518,0.511270366375632,0.846358053956272,1,17,histone H2A monoubiquitination,BP,DDB2
6533,GO:0021983,0.511455790040439,0.84623057838627,1,17,pituitary gland development,BP,GLI2
2574,GO:0005882,0.511718793659563,0.714497810245331,3,67,intermediate filament,CC,LDLRAP1;SYNM;SLC1A4
19894,GO:2000463,0.511775333782883,0.846010735538248,1,17,positive regulation of excitatory postsynaptic potential,BP,NLGN2
18399,GO:1903523,0.512243503093972,0.84568826921134,1,17,negative regulation of blood circulation,BP,F2R
10269,GO:0043066,0.512503179446975,0.570773435844523,25,612,negative regulation of apoptotic process,BP,TNFAIP3;APOE;IFI6;LAMP3;EPHB2;EGFR;GLI2;FGFR4;BCL6;SFRP1;TNFSF10;INSR;FOXO1;TBX1;MNT;EPHA4;WNT9A;F2R;ERBB3;PIK3R1;TYRO3;SPRY2;MDK;ERBB2;ACKR3
6325,GO:0021517,0.512522273687283,0.845496047792543,1,17,ventral spinal cord development,BP,GLI2
3227,GO:0006898,0.513126766116839,0.639421709575023,7,164,receptor-mediated endocytosis,BP,APOE;DNM1;LDLRAP1;SCART1;CXCR1;MICALL1;ACKR3
19352,GO:1905897,0.513143425012915,0.71321836388151,3,67,regulation of response to endoplasmic reticulum stress,BP,DAB2IP;PIK3R1;NCK2
20190,GO:2001171,0.513209048654803,0.845021826462162,1,17,positive regulation of ATP biosynthetic process,BP,INSR
10817,GO:0044346,0.51326178820757,0.844985370260336,1,17,fibroblast apoptotic process,BP,SFRP1
12562,GO:0050778,0.513283636394112,0.583954208367059,18,440,positive regulation of immune response,BP,TNFAIP3;PTPRS;CYBA;VAV3;CTSB;DAB2IP;KLK5;WIPF1;RPS6KA5;DDX60;PIK3R1;CTSL;TYRO3;ZP3;RBCK1;ADORA2B;SERPING1;IFI16
13529,GO:0060037,0.513439979049838,0.844862154402506,1,17,pharyngeal system development,BP,TBX1
4165,GO:0009259,0.513551580798298,0.592456914413819,15,372,ribonucleotide metabolic process,BP,APOE;PGM1;DHTKD1;INSR;PKD2;NT5E;FAM20C;ATP6V0A2;PTHLH;SDHA;ADORA2B;NME4;COX5B;TCIRG1;NADK
9660,GO:0038084,0.513625052997954,0.844734111197173,1,17,vascular endothelial growth factor signaling pathway,BP,DAB2IP
7672,GO:0032147,0.513663882659283,0.61508030909347,10,236,activation of protein kinase activity,BP,MAP3K14;EGFR;INSR;DAB2IP;SHC2;F2R;CSPG4;ADORA2B;MAP3K3;NRK
13886,GO:0060589,0.514611660453382,0.603433376442608,12,283,nucleoside-triphosphatase regulator activity,MF,RALGDS;VAV3;DAB2IP;EVI5L;ARHGEF19;APPL2;ACAP3;ARHGAP40;TBC1D17;ALS2CL;PLXNB1;RASA4
18647,GO:1904037,0.514805184872398,0.843916011684744,1,17,positive regulation of epithelial cell apoptotic process,BP,SORT1
18327,GO:1903364,0.5150544568267,0.663846999274351,5,116,positive regulation of cellular protein catabolic process,BP,TNFAIP3;APOE;DAB2IP;MAGEF1;SMURF1
1443,GO:0003690,0.515080446891235,0.56824620031031,25,602,double-stranded DNA binding,MF,HES2;ZNF704;NDN;EGFR;THRA;H1F0;GLI2;BCL6;ZFPM1;ETV5;HR;SALL2;SOX12;MNT;TCFL5;DDX60;SREBF1;XPC;NFATC4;MBD1;STAT1;CRY2;IFI16;DBP;PER3
7164,GO:0031069,0.51539085116775,0.843508966301303,1,17,hair follicle morphogenesis,BP,CTSV
13658,GO:0060251,0.51577840228005,0.843239231510346,1,17,regulation of glial cell proliferation,BP,ETV5
10134,GO:0042752,0.515787649789781,0.710908155018716,3,66,regulation of circadian rhythm,BP,CRTC1;CRY2;PER3
15344,GO:0071634,0.51602180894026,0.843069665310899,1,17,regulation of transforming growth factor beta production,BP,FURIN
8209,GO:0033002,0.51618972222878,0.662807413921012,5,115,muscle cell proliferation,BP,TNFAIP3;EGFR;CYBA;TENM4;STAT1
9986,GO:0042446,0.516602590893123,0.754719618340148,2,43,hormone biosynthetic process,BP,TRERF1;HSD11B1
4056,GO:0009126,0.516705865654972,0.611983359553048,10,248,purine nucleoside monophosphate metabolic process,BP,PGM1;DHTKD1;INSR;NT5E;FAM20C;ATP6V0A2;SDHA;COX5B;TCIRG1;NADK
4095,GO:0009167,0.516705865654972,0.611983359553048,10,248,purine ribonucleoside monophosphate metabolic process,BP,PGM1;DHTKD1;INSR;NT5E;FAM20C;ATP6V0A2;SDHA;COX5B;TCIRG1;NADK
8207,GO:0032994,0.516819828343492,0.842084315624083,1,18,protein-lipid complex,CC,APOE
8932,GO:0035024,0.516988310015709,0.842395177876385,1,17,negative regulation of Rho protein signal transduction,BP,BCL6
9454,GO:0036119,0.517024464364844,0.842369910198554,1,17,response to platelet-derived growth factor,BP,HYAL1
11857,GO:0046914,0.517397342809382,0.559137792642714,30,730,transition metal ion binding,MF,TNFAIP3;S100A4;PRICKLE2;THRA;TCEA2;GLI2;CYP4F22;ZNF318;TNFSF10;NPEPL1;TRIM65;TET1;CYP27C1;FAM20C;GLUL;RNPEPL1;S100A6;TRIM22;ADAMTS15;MBD1;MSRB2;MARCH9;ZMYM3;MMP1;ALOXE3;CXXC5;MT2A;ZCCHC24;ZSWIM8;DTNB
14595,GO:0070207,0.517429660556942,0.841656999623953,1,18,protein homotrimerization,BP,ASIC1
2980,GO:0006541,0.517548410462917,0.842003434536492,1,17,glutamine metabolic process,BP,GLUL
2170,GO:0005031,0.517729900886063,0.841446339783523,1,18,tumor necrosis factor-activated receptor activity,MF,TNFRSF19
2172,GO:0005035,0.517729900886063,0.841446339783523,1,18,death receptor activity,MF,TNFRSF19
3156,GO:0006783,0.51781519041852,0.841386463954881,1,18,heme biosynthetic process,BP,UROS
7227,GO:0031201,0.518378855093622,0.753204339358229,2,43,SNARE complex,CC,VAMP3;VAMP2
5190,GO:0015807,0.518389399284477,0.753328938470414,2,42,L-amino acid transport,BP,PQLC2;SLC1A4
10858,GO:0044432,0.518470009561545,0.549368793690784,39,959,endoplasmic reticulum part,CC,APOE;LMF1;KDSR;GPX7;COL6A1;EGFR;CYBA;XYLT1;CYP4F22;CERS4;CES2;PKD2;RTN2;ARSI;RHBDF1;TMEM129;WNT3;NSG1;COL7A1;H6PD;CRTAP;FAM20C;ANO8;LTBP1;ACSL1;SREBF1;PIK3R1;TYRO3;CPT1C;MBOAT7;LRRC8E;RETSAT;IGFBP4;HSD11B1;LAMB2;XYLT2;REEP6;PIGZ;SORT1
1335,GO:0003209,0.518629027373116,0.841245828703931,1,17,cardiac atrium morphogenesis,BP,ZFPM1
18606,GO:1903959,0.51863942791,0.841238525463851,1,17,regulation of anion transmembrane transport,BP,ANO9
15937,GO:0080135,0.519141017452334,0.569356405592209,22,536,regulation of cellular response to stress,BP,PTPRS;EGFR;BCL6;SFRP1;RGMA;FOXO1;DAB2IP;EPHA4;MAGEF1;ENDOG;PIK3R1;NCK2;TNFRSF19;TRPV4;KLK8;RTN4RL1;IMPACT;ACKR3;NUAK1;MAP3K3;NRK;VANGL2
2913,GO:0006446,0.519370079299104,0.707522836380496,3,68,regulation of translational initiation,BP,RPL13A;NCK2;IMPACT
14906,GO:0070838,0.519695695557855,0.609170058739471,10,238,divalent metal ion transport,BP,CYBA;PKD2;F2R;HOMER2;ORAI3;TRPV4;NIPAL4;SLC39A6;GJC2;ASIC1
4515,GO:0010604,0.519917108243341,0.527580400604457,90,2205,positive regulation of macromolecule metabolic process,BP,TNFAIP3;PEG3;APOE;LAMP3;GPNMB;NDN;MAP3K14;EPHB2;ASH2L;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;ZNF318;SFRP1;POU3F1;TNFSF10;INSR;PKD2;ZFPM1;RGMA;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;WNT3;NSG1;SOX12;DAB2IP;TBX1;TRERF1;SHC2;YEATS4;TET1;EPHA4;MAGEF1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;ACSL1;ACTA2;ERBB3;VAMP3;PLXND1;SREBF1;CSPG4;ENDOG;PIK3R1;NCK2;ACVR1B;CAMKK1;NAB2;NFATC4;SNX33;TYRO3;RTF1;ZP3;SPRY2;TP53INP1;TNFRSF19;MDK;TRPV4;ADORA2B;MC1R;IMPACT;CRTC1;IGFBP4;ERBB2;RNF187;STAT1;CDK20;ACKR3;FURIN;IFI16;GJC2;DBP;SMURF1;CAMK1;MAP3K3;SP100;NRK;VANGL2
10555,GO:0043552,0.520059685299018,0.840239148305021,1,17,positive regulation of phosphatidylinositol 3-kinase activity,BP,VAV3
18240,GO:1903170,0.520100039300992,0.839776902336276,1,18,negative regulation of calcium ion transmembrane transport,BP,PKD2
10764,GO:0044272,0.520195461495104,0.644137522549379,6,143,sulfur compound biosynthetic process,BP,XYLT1;PDPR;ACSL1;CSPG4;MLYCD;XYLT2
5373,GO:0016229,0.520286132585716,0.839257536490098,1,19,steroid dehydrogenase activity,MF,HSD11B1
14449,GO:0061900,0.520361193230775,0.840026458734787,1,17,glial cell activation,BP,EGFR
16426,GO:0097150,0.520471434774505,0.839948645731226,1,17,neuronal stem cell population maintenance,BP,FOXO1
2737,GO:0006163,0.520606159112053,0.585489978798858,15,374,purine nucleotide metabolic process,BP,APOE;PGM1;DHTKD1;INSR;PKD2;NT5E;FAM20C;ATP6V0A2;PTHLH;SDHA;ADORA2B;NME4;COX5B;TCIRG1;NADK
3273,GO:0006978,0.520692436866949,0.839357844010358,1,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,SP100
11750,GO:0046649,0.520826808163351,0.582111832732258,16,389,lymphocyte activation,BP,TNFAIP3;GPNMB;MAP3K14;GLI2;BCL6;SFRP1;VAV3;ZFPM1;PIK3R1;NCK2;TYRO3;ZP3;EFNB3;ERBB2;IL20RB;CCDC88B
7173,GO:0031082,0.521064296351512,0.83909442520166,1,18,BLOC complex,CC,BLOC1S4
19375,GO:1905954,0.52134523111258,0.7506622344091,2,43,positive regulation of lipid localization,BP,APOE;LDLRAP1
16585,GO:0097484,0.521366601408161,0.839315878120791,1,17,dendrite extension,BP,SMURF1
10319,GO:0043162,0.521616516807907,0.838702717876507,1,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,MVB12B
19708,GO:2000134,0.521694053019596,0.677225622589922,4,93,negative regulation of G1/S transition of mitotic cell cycle,BP,GPNMB;PKD2;PCBP4;GJC2
849,GO:0002183,0.52180542992288,0.838568571997611,1,18,cytoplasmic translational initiation,BP,RPL13A
11871,GO:0046939,0.522446523460589,0.676520615317283,4,93,nucleotide phosphorylation,BP,PGM1;DHTKD1;INSR;NME4
16010,GO:0086091,0.52301491514491,0.838146427788419,1,17,regulation of heart rate by cardiac conduction,BP,SCN4B
9793,GO:0042036,0.523263256060882,0.837530909036971,1,18,negative regulation of cytokine biosynthetic process,BP,ZFPM1
2233,GO:0005158,0.523300495189652,0.837943245395064,1,17,insulin receptor binding,MF,PIK3R1
6688,GO:0030117,0.523484721951363,0.675591918816711,4,92,membrane coat,CC,EGFR;DNM1;LDLRAP1;VPS33B
12185,GO:0048475,0.523484721951363,0.675591918816711,4,92,coated membrane,CC,EGFR;DNM1;LDLRAP1;VPS33B
18645,GO:1904035,0.523576522794414,0.748875791092792,2,42,regulation of epithelial cell apoptotic process,BP,TNFAIP3;SORT1
1689,GO:0004180,0.523650262238867,0.837254706797066,1,18,carboxypeptidase activity,MF,CTSV
15766,GO:0072503,0.5237239622649,0.611857752813585,9,216,cellular divalent inorganic cation homeostasis,BP,APOE;CYBA;SV2A;PKD2;F2R;HEXB;TRPV4;SLC39A6;MT2A
7267,GO:0031279,0.523997135014243,0.837006884521099,1,18,regulation of cyclase activity,BP,ADORA2B
2412,GO:0005605,0.524346864306175,0.837197345203328,1,17,basal lamina,CC,LAMB2
8230,GO:0033032,0.524378304313463,0.836734272441111,1,18,regulation of myeloid cell apoptotic process,BP,THRA
4395,GO:0010171,0.52466240435079,0.74793792693,2,42,body morphogenesis,BP,WNT3;TBX1
871,GO:0002230,0.524782311486493,0.836444998669395,1,18,positive regulation of defense response to virus by host,BP,STAT1
6760,GO:0030215,0.524969694243625,0.836752289675457,1,17,semaphorin receptor binding,MF,PLXNB1
8970,GO:0035116,0.525033171380777,0.836265210082515,1,18,embryonic hindlimb morphogenesis,BP,WNT3
17785,GO:1901984,0.525164001971661,0.836171393492825,1,18,negative regulation of protein acetylation,BP,HINT2
10444,GO:0043370,0.525231511896637,0.836122969300761,1,18,regulation of CD4-positive, alpha-beta T cell differentiation,BP,BCL6
11900,GO:0046983,0.525231786881509,0.546987190358682,34,850,protein dimerization activity,MF,HES2;APOE;ALDH1A3;CADM4;EGFR;CYBA;TENM2;ZNF318;PKD2;DNM1;VEGFB;WWTR1;DAB2IP;TBX1;MNT;TENM4;TCFL5;HOMER2;HEXB;ERBB3;S100A6;SREBF1;PIK3R1;IMPA2;TYRO3;STOM;CABYR;PDLIM4;MVD;ERBB2;H2AFJ;STAT1;PEX11B;SP100
11053,GO:0045087,0.525967325904326,0.562533452796822,22,546,innate immune response,BP,TNFAIP3;IFITM1;IFI6;PTPRS;CYBA;OAS2;CTSB;DAB2IP;RPL13A;RPS6KA5;DDX60;VAMP3;CTSL;TRIM22;TYRO3;SERPING1;RNF135;STAT1;IFI16;MT2A;RAB43;SP100
3899,GO:0008584,0.526087668090758,0.67314458928686,4,92,male gonad development,BP,SFRP1;TNFSF10;INSR;CTSV
10967,GO:0044804,0.52626904282048,0.835377569993659,1,18,autophagy of nucleus,BP,WIPI2
12604,GO:0050848,0.526365714373649,0.746326659411244,2,43,regulation of calcium-mediated signaling,BP,PKD2;ERBB3
3351,GO:0007129,0.526562756201736,0.835166149959453,1,18,synapsis,BP,SUN1
6800,GO:0030278,0.526628641604752,0.652847099144864,5,116,regulation of ossification,BP,IFITM1;SFRP1;FAM20C;SMURF1;KREMEN1
14472,GO:0065005,0.526695392772012,0.835070617074638,1,18,protein-lipid complex assembly,BP,APOE
14560,GO:0070161,0.526779083327593,0.568120475299288,19,463,anchoring junction,CC,ITGB6;TNS1;CADM4;FLNC;SHROOM2;EGFR;CYBA;PARVB;RPL13A;DIXDC1;PPL;CSPG4;TMEM204;TRPV4;SYNM;ITGB5;NDRG1;MRC2;AIF1L
12800,GO:0051150,0.526926253214148,0.834904250174063,1,18,regulation of smooth muscle cell differentiation,BP,OLFM2
13958,GO:0060713,0.526974177958167,0.834869699869176,1,18,labyrinthine layer morphogenesis,BP,GJB5
7049,GO:0030856,0.526998090268499,0.672286611152795,4,92,regulation of epithelial cell differentiation,BP,WWTR1;CTSV;CTSL;STAT1
8090,GO:0032800,0.527206959539015,0.834701813060067,1,18,receptor biosynthetic process,BP,FURIN
7643,GO:0032094,0.527219583609749,0.834692705100004,1,18,response to food,BP,SREBF1
2390,GO:0005548,0.527308166816919,0.745644607246628,2,42,phospholipid transporter activity,MF,ANO9;ABCC1
7968,GO:0032608,0.527599168900315,0.745255068391584,2,43,interferon-beta production,BP,PTPRS;RNF135
11466,GO:0045987,0.527738963224289,0.834317697663387,1,18,positive regulation of smooth muscle contraction,BP,F2R
13709,GO:0060324,0.527818959076968,0.745200515243442,2,42,face development,BP,ALDH1A3;TBX1
18406,GO:1903532,0.527893513674712,0.607756080309739,9,217,positive regulation of secretion by cell,BP,POSTN;EGFR;NLGN2;GLUL;F2R;ZP3;TRPV4;ADORA2B;GPR68
17210,GO:0120033,0.52802692997248,0.834109534960472,1,18,negative regulation of plasma membrane bounded cell projection assembly,BP,EVI5L
15160,GO:0071347,0.528061286722197,0.651287109856131,5,122,cellular response to interleukin-1,BP,SFRP1;DAB2IP;RPS6KA5;HYAL1;MAP3K3
12815,GO:0051173,0.528201199410392,0.520354959409238,85,2083,positive regulation of nitrogen compound metabolic process,BP,TNFAIP3;PEG3;APOE;GPNMB;NDN;MAP3K14;EPHB2;ASH2L;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;ZNF318;SFRP1;POU3F1;TNFSF10;INSR;PKD2;ZFPM1;RGMA;ETV5;SALL2;TP53INP2;WWTR1;FOXO1;SOX12;DAB2IP;TBX1;TRERF1;SHC2;YEATS4;TET1;EPHA4;MAGEF1;F2R;SMARCA1;RPS6KA5;SEC14L2;HEXB;ACSL1;ERBB3;PLXND1;SREBF1;CSPG4;ENDOG;PIK3R1;PTHLH;NCK2;ACVR1B;CAMKK1;NAB2;NFATC4;SNX33;TYRO3;RTF1;ZP3;SPRY2;TP53INP1;TNFRSF19;MDK;TRPV4;ADORA2B;MC1R;IMPACT;CRTC1;IGFBP4;ERBB2;RNF187;STAT1;CDK20;ACKR3;FURIN;IFI16;DBP;SMURF1;CAMK1;MAP3K3;SP100;NRK;VANGL2
17755,GO:1901880,0.528236363374584,0.744837293234744,2,42,negative regulation of protein depolymerization,BP,DMTN;PLEKHH2
11754,GO:0046655,0.52890115947404,0.833476520351244,1,18,folic acid metabolic process,BP,MTHFR
18118,GO:1902905,0.529078655298473,0.635571786399685,6,143,positive regulation of supramolecular fiber organization,BP,APOE;SFRP1;WIPF1;NCK2;TRPV4;ARPIN
3216,GO:0006885,0.52927386405915,0.698393019386041,3,69,regulation of pH,BP,ATP6V0A2;ATP12A;TCIRG1
5713,GO:0016878,0.529598065235493,0.832970759146825,1,18,acid-thiol ligase activity,MF,ACSL1
65,GO:0000132,0.529957057287974,0.832709833508468,1,18,establishment of mitotic spindle orientation,BP,SPRY2
13430,GO:0055006,0.530227642170345,0.743100490809843,2,42,cardiac cell development,BP,OBSL1;FHOD3
15772,GO:0072511,0.530385054585681,0.598641455158425,10,240,divalent inorganic cation transport,BP,CYBA;PKD2;F2R;HOMER2;ORAI3;TRPV4;NIPAL4;SLC39A6;GJC2;ASIC1
15770,GO:0072509,0.53062655380421,0.832222503194765,1,18,divalent inorganic cation transmembrane transporter activity,MF,SLC39A6
5054,GO:0015295,0.530761752857063,0.832123976988273,1,18,solute:proton symporter activity,MF,SLC2A9
5436,GO:0016331,0.531183046639816,0.648477507640264,5,116,morphogenesis of embryonic epithelium,BP,ALDH1A3;GLI2;SFRP1;TULP3;VANGL2
18483,GO:1903706,0.531750871715329,0.581951867278293,13,325,regulation of hemopoiesis,BP,ASH2L;GLI2;BCL6;SFRP1;ZFPM1;FAM213A;PIK3R1;ACVR1B;FAM210B;MYL9;GPR68;ERBB2;STAT1
9248,GO:0035710,0.531793892409717,0.741591794554251,2,43,CD4-positive, alpha-beta T cell activation,BP,BCL6;ZFPM1
3218,GO:0006887,0.53204609972649,0.552907476385628,24,595,exocytosis,BP,CYBA;PGM1;GAA;RIMS3;CTSB;SYT8;VEGFB;PRSS3;RAB40B;HEXB;HGSNAT;VAMP3;DMTN;SYTL1;CXCR1;METTL7A;ZP3;STOM;VAMP2;ADORA2B;SERPING1;C2CD4C;TCIRG1;VPS33B
3900,GO:0008585,0.532211199624824,0.695748754507053,3,68,female gonad development,BP,SFRP1;INSR;ZP3
15203,GO:0071402,0.532343325174917,0.830968555921915,1,18,cellular response to lipoprotein particle stimulus,BP,APOE
11558,GO:0046174,0.532542324814575,0.830822803655508,1,18,polyol catabolic process,BP,IMPA2
6704,GO:0030134,0.532952135045949,0.694992296056393,3,69,COPII-coated ER to Golgi transport vesicle,CC,COL7A1;SREBF1;VANGL2
7906,GO:0032504,0.533029202713757,0.561882320780284,19,464,multicellular organism reproduction,BP,GAMT;TXNRD3;EGFR;THRA;BCL6;SFRP1;CTSB;ETV5;SERPINE2;WNT3;CRTAP;TCFL5;CTSV;HEXB;TYRO3;ZP3;CABYR;SUN1;SCMH1
17900,GO:1902275,0.533092264369684,0.631723983933381,6,141,regulation of chromatin organization,BP,BCL6;TET1;RPS6KA5;SREBF1;RTF1;MTHFR
2469,GO:0005721,0.533121176185812,0.830398364190627,1,18,pericentric heterochromatin,CC,KMT5C
9993,GO:0042461,0.533742951778087,0.829941663444801,1,18,photoreceptor cell development,BP,NAGLU
791,GO:0002065,0.53380229241251,0.694273646185567,3,68,columnar/cuboidal epithelial cell differentiation,BP,SLITRK6;TMEM231;FAM20C
9021,GO:0035267,0.534188471335833,0.829206169244766,1,19,NuA4 histone acetyltransferase complex,CC,YEATS4
10338,GO:0043189,0.534188471335833,0.829206169244766,1,19,H4/H2A histone acetyltransferase complex,CC,YEATS4
6323,GO:0021515,0.53424644932641,0.829571240849951,1,18,cell differentiation in spinal cord,BP,GLI2
4842,GO:0014074,0.534746602350575,0.664896660171119,4,93,response to purine-containing compound,BP,PKD2;SREBF1;DMTN;STAT1
3215,GO:0006884,0.534925550660513,0.829070777473574,1,18,cell volume homeostasis,BP,TRPV4
8854,GO:0034694,0.53511881804164,0.828928170699351,1,18,response to prostaglandin,BP,SFRP1
74,GO:0000151,0.535170314711889,0.588109768700218,11,267,ubiquitin ligase complex,CC,DCAF16;FBXO2;DDB2;KLHDC8B;CUL9;RBCK1;FBXW4;BTBD2;FBXW5;ZSWIM8;FBXO44
11698,GO:0046546,0.53518712899864,0.664476845323199,4,93,development of primary male sexual characteristics,BP,SFRP1;TNFSF10;INSR;CTSV
9822,GO:0042100,0.535260438637775,0.738409578159611,2,44,B cell proliferation,BP,BCL6;VAV3
19001,GO:1904886,0.535306325213585,0.82878973858621,1,18,beta-catenin destruction complex disassembly,BP,FRAT1
18407,GO:1903533,0.535529499715073,0.664061345080843,4,95,regulation of protein targeting,BP,SREBF1;DMTN;STOM;ERBB2
13053,GO:0051603,0.535754642167588,0.549201422504295,24,592,proteolysis involved in cellular protein catabolic process,BP,TNFAIP3;MVB12B;LAMP3;FBXO2;CTSB;TP53INP2;WWTR1;RHBDF1;TMEM129;DAB2IP;EPHA4;MAGEF1;CTSV;CUL9;CTSL;RBCK1;FBXW4;BTBD2;RNF187;RNF44;FBXW5;CTSF;SMURF1;FBXO44
733,GO:0001968,0.535791785983977,0.828430988029214,1,18,fibronectin binding,MF,CTSL
4497,GO:0010565,0.536245295838697,0.643403119856962,5,122,regulation of cellular ketone metabolic process,BP,FGFR4;PDPR;TYSND1;SREBF1;MLYCD
13595,GO:0060135,0.536292384194587,0.73763041417601,2,43,maternal process involved in female pregnancy,BP,CTSB;CTSV
14105,GO:0061024,0.536552664819705,0.543831100043068,27,665,membrane organization,BP,APOE;EGFR;EPB41L3;NLGN2;ANO9;VAV3;DNM1;LDLRAP1;ETV5;SYT8;NSG1;COL7A1;EVI5L;MARVELD1;TRAPPC2L;VAMP3;SYTL1;SNX33;VAMP2;NDRG1;TBC1D17;MICALL1;C2CD4C;SUN1;SMURF1;VPS33B;ABCC1
12838,GO:0051208,0.536966853878917,0.691329053854842,3,68,sequestering of calcium ion,BP,CYBA;PKD2;F2R
15275,GO:0071514,0.536990879017104,0.827542726063518,1,18,genetic imprinting,BP,NDN
15325,GO:0071604,0.537058129420884,0.827492817899174,1,18,transforming growth factor beta production,BP,FURIN
16150,GO:0090218,0.537640090769228,0.827060527988311,1,18,positive regulation of lipid kinase activity,BP,VAV3
10149,GO:0042772,0.537773108062939,0.826548664124318,1,19,DNA damage response, signal transduction resulting in transcription,BP,SP100
4942,GO:0015035,0.53788492798164,0.826094053179441,1,20,protein disulfide oxidoreductase activity,MF,TXNRD3
16506,GO:0097306,0.538077863914061,0.736188606901148,2,42,cellular response to alcohol,BP,SFRP1;TP53INP1
2729,GO:0006140,0.538078069646911,0.641719952838582,5,119,regulation of nucleotide metabolic process,BP,APOE;INSR;PKD2;PTHLH;ADORA2B
6564,GO:0022411,0.538332061295507,0.556529686354748,19,475,cellular component disassembly,BP,HTRA1;H1F0;FGFR4;INSR;KLK5;CTSV;SREBF1;DMTN;ENDOG;CTSL;PLEKHH2;TRPV4;SPATA18;WIPI2;FURIN;FRAT1;MMP1;SMURF1;CAPNS2
4076,GO:0009147,0.538397480168488,0.825711040794754,1,20,pyrimidine nucleoside triphosphate metabolic process,BP,NME4
18081,GO:1902806,0.53848899951297,0.626337122350774,6,146,regulation of cell cycle G1/S phase transition,BP,GPNMB;EGFR;PKD2;HYAL1;PCBP4;GJC2
12663,GO:0050921,0.538587098523693,0.689676576302197,3,70,positive regulation of chemotaxis,BP,CXCL14;VEGFB;TRPV4
7040,GO:0030838,0.538692626691499,0.689577866368617,3,70,positive regulation of actin filament polymerization,BP,WIPF1;NCK2;ARPIN
11661,GO:0046486,0.538698402274685,0.575096861249792,13,316,glycerolipid metabolic process,BP,APOE;LMF1;EGFR;FGFR4;ACSL1;ERBB3;SREBF1;PIK3R1;IMPA2;ZP3;MBOAT7;ERBB2;PIGZ
6282,GO:0019915,0.538870017084545,0.735211460151728,2,44,lipid storage,BP,APOE;HEXB
3363,GO:0007156,0.539453081842559,0.689153840209482,3,66,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CADM4;SDK2;PCDH1
13859,GO:0060544,0.5395261639945,0.825239050968387,1,19,regulation of necroptotic process,BP,RBCK1
6652,GO:0030031,0.539560514975618,0.557825668246396,18,438,cell projection assembly,BP,TENM2;ARHGEF4;VAV3;ESPN;WWTR1;PARVB;TMEM231;GAS8;EVI5L;EPS8L2;DMTN;NCK2;UNC119B;RHOD;MAFIP;MARK4;NINL;VANGL2
6714,GO:0030149,0.539592723660092,0.825189198295397,1,19,sphingolipid catabolic process,BP,HEXB
15370,GO:0071675,0.539665453403103,0.825134713430342,1,19,regulation of mononuclear cell migration,BP,TRPV4
10291,GO:0043114,0.540035368365328,0.82527366934442,1,18,regulation of vascular permeability,BP,TRPV4
5105,GO:0015491,0.540352926175344,0.825035852119524,1,18,cation:cation antiporter activity,MF,SLC47A1
9349,GO:0035909,0.540370612276713,0.825022600743717,1,18,aorta morphogenesis,BP,TBX1
17660,GO:1901605,0.540426595176115,0.624415586091483,6,147,alpha-amino acid metabolic process,BP,GAMT;CRTAP;GLUL;CKMT1A;MTHFR;THNSL2
11567,GO:0046209,0.54062412596552,0.733649329411294,2,44,nitric oxide metabolic process,BP,INSR;PKD2
9285,GO:0035774,0.54066855225721,0.824382093475296,1,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,GPR68
7024,GO:0030817,0.540779220783221,0.824298927172239,1,19,regulation of cAMP biosynthetic process,BP,PTHLH
9406,GO:0036010,0.540876920833906,0.824642962637865,1,18,protein localization to endosome,BP,MICALL1
13072,GO:0051647,0.540953525477782,0.824585475353082,1,18,nucleus localization,BP,SUN1
7425,GO:0031579,0.541071100712037,0.824079456068374,1,19,membrane raft organization,BP,MARVELD1
6658,GO:0030038,0.541087189648272,0.687473669552181,3,68,contractile actin filament bundle assembly,BP,SFRP1;PIK3R1;ITGB5
10314,GO:0043149,0.541087189648272,0.687473669552181,3,68,stress fiber assembly,BP,SFRP1;PIK3R1;ITGB5
18234,GO:1903146,0.541557712254167,0.732815785326041,2,44,regulation of autophagy of mitochondrion,BP,SREBF1;SMURF1
2629,GO:0005979,0.542537581050839,0.823393907013815,1,18,regulation of glycogen biosynthetic process,BP,INSR
4759,GO:0010962,0.542537581050839,0.823393907013815,1,18,regulation of glucan biosynthetic process,BP,INSR
9073,GO:0035371,0.542543794853557,0.823389222191958,1,18,microtubule plus-end,CC,CLIP2
12365,GO:0048843,0.542580177660512,0.823361790142074,1,18,negative regulation of axon extension involved in axon guidance,BP,WNT3
12917,GO:0051339,0.542658990589794,0.822882274363668,1,19,regulation of lyase activity,BP,ADORA2B
1105,GO:0002701,0.543365187100955,0.82234809446748,1,19,negative regulation of production of molecular mediator of immune response,BP,BCL6
561,GO:0001702,0.543703463808872,0.82251344542898,1,18,gastrulation with mouth forming second,BP,TENM4
767,GO:0002027,0.543774824935084,0.730830299824381,2,44,regulation of heart rate,BP,SCN4B;SREBF1
3527,GO:0007565,0.544678947372857,0.635261057334276,5,120,female pregnancy,BP,CTSB;CTSV;PTHLH;ACVR1B;SLC2A1
5665,GO:0016799,0.544728817147756,0.820933323022865,1,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,MPG
18082,GO:1902807,0.54494474270597,0.654981322589138,4,96,negative regulation of cell cycle G1/S phase transition,BP,GPNMB;PKD2;PCBP4;GJC2
8572,GO:0034105,0.545049744467981,0.821069509568865,1,19,positive regulation of tissue remodeling,BP,EGFR
8213,GO:0033006,0.5452186313482,0.820940984679922,1,19,regulation of mast cell activation involved in immune response,BP,ADORA2B
10414,GO:0043304,0.5452186313482,0.820940984679922,1,19,regulation of mast cell degranulation,BP,ADORA2B
482,GO:0001533,0.545238059341297,0.729262180918782,2,46,cornified envelope,CC,PRR9;PPL
15188,GO:0071384,0.545606082826512,0.729054459490389,2,45,cellular response to corticosteroid stimulus,BP,EGFR;FOXO1
9056,GO:0035336,0.545674975898956,0.820593391448331,1,19,long-chain fatty-acyl-CoA metabolic process,BP,ACSL1
643,GO:0001837,0.545679721790466,0.65435962638568,4,94,epithelial to mesenchymal transition,BP,S100A4;SFRP1;WWTR1;DAB2IP
1161,GO:0002791,0.54570806553157,0.577572414300665,11,270,regulation of peptide secretion,BP,POSTN;EGFR;NLGN2;SFRP1;RHBDF1;GLUL;F2R;SREBF1;SLC2A1;TRPV4;GPR68
4139,GO:0009218,0.54597713805489,0.819981098556247,1,20,pyrimidine ribonucleotide metabolic process,BP,NME4
1110,GO:0002706,0.546103038082062,0.682538720966686,3,71,regulation of lymphocyte mediated immunity,BP,BCL6;ZP3;IL20RB
11770,GO:0046688,0.546199898576099,0.819810819680004,1,20,response to copper ion,BP,MT2A
17029,GO:0099568,0.546404019626654,0.563403435687696,14,340,cytoplasmic region,CC,SHROOM2;GLI2;PKD2;RIMS3;GAS8;WIPF1;FRY;DMTN;RHOD;SLC2A1;PLEKHH2;TRPV4;TULP3;BLOC1S4
4601,GO:0010737,0.546439641374822,0.820009938628216,1,19,protein kinase A signaling,BP,MC1R
16995,GO:0099513,0.54645135418478,0.548406942981059,19,466,polymeric cytoskeletal fiber,CC,SHROOM2;PKD2;ESPN;DNM1;LDLRAP1;CLIP2;GAS8;WIPF1;KIF26B;KIF26A;DMTN;SPRY2;TRPV4;SYNM;NDRG1;PDLIM4;NINL;SLC1A4;AIF1L
10316,GO:0043154,0.546878944089234,0.681804089642085,3,71,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,IFI6;LAMP3;WNT9A
14730,GO:0070469,0.546966024190903,0.681297893937063,3,78,respiratory chain,CC,NDUFA4L2;SDHA;COX5B
5825,GO:0017134,0.547076444367084,0.819523075922801,1,19,fibroblast growth factor binding,MF,FGFR4
18176,GO:1903008,0.547155965935023,0.652842690199803,4,96,organelle disassembly,BP,SREBF1;SPATA18;WIPI2;SMURF1
5653,GO:0016782,0.54790956826522,0.72685038204128,2,46,transferase activity, transferring sulfur-containing groups,MF,TST;SUGCT
3525,GO:0007548,0.548034794764921,0.605231247826557,7,169,sex differentiation,BP,SFRP1;TNFSF10;INSR;CTSV;ACVR1B;TYRO3;ZP3
4604,GO:0010742,0.548202050238546,0.818660339913727,1,19,macrophage derived foam cell differentiation,BP,STAT1
16055,GO:0090077,0.548202050238546,0.818660339913727,1,19,foam cell differentiation,BP,STAT1
18880,GO:1904645,0.548216481086591,0.818649261230871,1,19,response to amyloid-beta,BP,EPHA4
363,GO:0000982,0.548418829665424,0.574883778866322,11,267,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,HES2;NDN;GLI2;ZFPM1;FOXO1;SOX12;TCFL5;SREBF1;NFATC4;IFI16;DBP
4545,GO:0010644,0.548521318110133,0.8184151289161,1,19,cell communication by electrical coupling,BP,GJC2
78,GO:0000159,0.548897018184071,0.818126290098737,1,19,protein phosphatase type 2A complex,CC,PPP2R2C
15394,GO:0071709,0.549296386146709,0.817818916567244,1,19,membrane assembly,BP,NLGN2
20225,GO:2001233,0.54950023519225,0.568650756336232,12,302,regulation of apoptotic signaling pathway,BP,TNFAIP3;IFI6;SFRP1;TNFSF10;DAB2IP;MNT;NCK2;NFATC4;RBCK1;TP53INP1;ACKR3;SP100
9581,GO:0036475,0.550044580484787,0.817242127938669,1,19,neuron death in response to oxidative stress,BP,ENDOG
19978,GO:2000637,0.550455550666859,0.816924785263585,1,19,positive regulation of gene silencing by miRNA,BP,EGFR
20247,GO:2001267,0.550766408370693,0.816296280157648,1,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TNFSF10
19692,GO:2000104,0.550910469705735,0.816573073453815,1,19,negative regulation of DNA-dependent DNA replication,BP,BCL6
547,GO:0001667,0.551663849664392,0.571613503908054,11,268,ameboidal-type cell migration,BP,APOE;TNS1;DAB2IP;TBX1;PRSS3;PLXND1;DMTN;ACVR1B;HYAL1;MAP3K3;SP100
14762,GO:0070528,0.551895771231161,0.815809745551511,1,19,protein kinase C signaling,BP,MC1R
14430,GO:0061844,0.551954134337829,0.814702681658684,1,22,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,KLK5
20069,GO:2000780,0.552704319077652,0.815181752877536,1,19,negative regulation of double-strand break repair,BP,MAGEF1
201,GO:0000423,0.552808775906729,0.815100516826455,1,19,mitophagy,BP,SMURF1
1103,GO:0002699,0.553007075213066,0.647110339589424,4,97,positive regulation of immune effector process,BP,KLK5;DDX60;ZP3;ADORA2B
1485,GO:0003841,0.553153025703545,0.81483262318056,1,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT7
16258,GO:0090407,0.553575563253468,0.538895851516131,20,498,organophosphate biosynthetic process,BP,APOE;FGFR4;PGM1;DHTKD1;INSR;HEXB;ATP6V0A2;PIK3R1;PTHLH;ZP3;MBOAT7;ADORA2B;NMRK1;MVD;NME4;COX5B;TCIRG1;NADK;ISYNA1;PIGZ
2594,GO:0005912,0.553678147434733,0.543570372366635,18,446,adherens junction,CC,ITGB6;TNS1;CADM4;FLNC;SHROOM2;EGFR;CYBA;PARVB;RPL13A;DIXDC1;CSPG4;TMEM204;TRPV4;SYNM;ITGB5;NDRG1;MRC2;AIF1L
4504,GO:0010575,0.553972221120908,0.814194074927196,1,19,positive regulation of vascular endothelial growth factor production,BP,ADORA2B
3211,GO:0006879,0.554030114229503,0.721278440105674,2,46,cellular iron ion homeostasis,BP,CYBRD1;ATP6V0A2
1149,GO:0002764,0.554063359798405,0.555625899864869,14,349,immune response-regulating signaling pathway,BP,TNFAIP3;PTPRS;CYBA;VAV3;CTSB;DAB2IP;WIPF1;RPS6KA5;DDX60;PIK3R1;CTSL;TYRO3;RBCK1;IL20RB
39,GO:0000079,0.554265995864174,0.674699705951383,3,72,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,TNFAIP3;EGFR;PKD2
898,GO:0002286,0.554667946662847,0.720820332426613,2,45,T cell activation involved in immune response,BP,BCL6;ZFPM1
12318,GO:0048730,0.554733098871109,0.813599652633688,1,19,epidermis morphogenesis,BP,CTSV
810,GO:0002088,0.554789776620987,0.720840867234321,2,44,lens development in camera-type eye,BP,SLITRK6;SHROOM2
4070,GO:0009141,0.554827249142889,0.574084947678861,10,257,nucleoside triphosphate metabolic process,BP,PGM1;DHTKD1;INSR;FAM20C;ATP6V0A2;SDHA;NME4;COX5B;TCIRG1;NADK
3343,GO:0007095,0.554849675576881,0.813508465692203,1,19,mitotic G2 DNA damage checkpoint,BP,BRSK1
3257,GO:0006950,0.555191501727181,0.489285822001299,106,2640,response to stress,BP,TNFAIP3;POSTN;IFITM1;ITGB6;APOE;IFI6;ULK2;PTPRS;MAP3K14;NINJ1;ASH2L;HTRA1;TXNRD3;GPX7;GPX3;EGFR;FBXO2;THRA;CYBA;OAS2;BCL6;BRSK1;SFRP1;VAV3;MATN2;PKD2;ZFPM1;RGMA;CTSB;ETV5;NT5E;SERPINE2;VEGFB;TMEM129;FOXO1;DDB2;DAB2IP;KLK5;GLUL;EPHA4;RPL13A;MAGEF1;F2R;CTSV;RPS6KA5;ARHGEF19;DDX60;ERBB3;VAMP3;SREBF1;DMTN;ENDOG;PIK3R1;CTSL;TRIM22;NCK2;UCN2;XPC;NFATC4;TYRO3;SLC2A1;HYAL1;ZP3;PCBP4;TP53INP1;TNFRSF19;TMX4;MDK;TRPV4;MTHFR;SPATA18;MSRB2;NDRG1;KLK8;ADORA2B;SERPING1;MYL9;RTN4RL1;BTBD2;MC1R;IMPACT;IGFBP4;GPR68;ERBB2;RNF135;LAMB2;STAT1;WIPI2;ACKR3;BLOC1S4;IFI16;IL20RB;CCDC88B;MLYCD;NUAK1;HCP5;SMURF1;TCIRG1;MT2A;RAB43;VPS33B;MAP3K3;SP100;MPG;NRK;VANGL2
14763,GO:0070530,0.555723614168649,0.812823904690692,1,19,K63-linked polyubiquitin modification-dependent protein binding,MF,TNFAIP3
1115,GO:0002711,0.555965938451777,0.812238658093467,1,20,positive regulation of T cell mediated immunity,BP,ZP3
9769,GO:0040019,0.556055772088787,0.812563278126563,1,19,positive regulation of embryonic development,BP,TENM4
11081,GO:0045137,0.556114145789198,0.608924085799822,6,146,development of primary sexual characteristics,BP,SFRP1;TNFSF10;INSR;CTSV;ACVR1B;ZP3
6232,GO:0019827,0.556379197648441,0.623745504974295,5,120,stem cell population maintenance,BP,SFRP1;FOXO1;TET1;RTF1;VANGL2
10857,GO:0044431,0.556411052388933,0.521152694995801,29,716,Golgi apparatus part,CC,POSTN;TGFBI;ST3GAL5;EGFR;XYLT1;LDLRAP1;RHBDF1;WNT3;NSG1;RASIP1;COL7A1;TRAPPC2L;B3GNT9;VAMP3;SREBF1;CSPG4;PIK3R1;SDC3;SLC2A1;VAMP2;GPC4;GOLGA7B;MARCH9;FURIN;ANGEL1;XYLT2;RAB43;ST6GALNAC6;SORT1
19793,GO:2000300,0.556498372210422,0.812215611728921,1,19,regulation of synaptic vesicle exocytosis,BP,RIMS3
13713,GO:0060330,0.556518571246143,0.811803866049378,1,20,regulation of response to interferon-gamma,BP,STAT1
13717,GO:0060334,0.556518571246143,0.811803866049378,1,20,regulation of interferon-gamma-mediated signaling pathway,BP,STAT1
17516,GO:1901099,0.556769941364924,0.811605871574703,1,20,negative regulation of signal transduction in absence of ligand,BP,IFI6
20232,GO:2001240,0.556769941364924,0.811605871574703,1,20,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IFI6
17348,GO:1900117,0.557488687893417,0.811038964600813,1,20,regulation of execution phase of apoptosis,BP,ENDOG
6003,GO:0019079,0.557652749094154,0.642561816715049,4,97,viral genome replication,BP,IFITM1;OAS2;STOM;IFI16
1142,GO:0002757,0.557779250651788,0.555844532196188,13,325,immune response-activating signal transduction,BP,TNFAIP3;PTPRS;CYBA;VAV3;CTSB;DAB2IP;WIPF1;RPS6KA5;DDX60;PIK3R1;CTSL;TYRO3;RBCK1
13367,GO:0052745,0.557894765588651,0.81111586840231,1,19,inositol phosphate phosphatase activity,MF,IMPA2
10546,GO:0043543,0.557901749199799,0.585751237967642,8,198,protein acylation,BP,NAT6;FOXO1;YEATS4;RPS6KA5;ZDHHC1;GOLGA7B;HINT2;CAMK1
16626,GO:0097553,0.557904433520859,0.671339399900879,3,70,calcium ion transmembrane import into cytosol,BP,CYBA;PKD2;F2R
13025,GO:0051568,0.558055215392659,0.717705873024941,2,45,histone H3-K4 methylation,BP,ASH2L;RTF1
5585,GO:0016645,0.558182410763596,0.810490699760032,1,20,oxidoreductase activity, acting on the CH-NH group of donors,MF,MTHFR
2941,GO:0006488,0.558406011340676,0.810313753637934,1,20,dolichol-linked oligosaccharide biosynthetic process,BP,MVD
15733,GO:0072376,0.558499731348472,0.810239555083874,1,20,protein activation cascade,BP,SERPING1
399,GO:0001076,0.559035922393986,0.606005722455086,6,146,transcription factor activity, RNA polymerase II transcription factor binding,MF,THRA;CITED4;POU3F1;SOX12;TRERF1;RTF1
18258,GO:1903205,0.559182634882085,0.809698302803207,1,20,regulation of hydrogen peroxide-induced cell death,BP,ENDOG
11265,GO:0045619,0.559364553153915,0.640878807318256,4,97,regulation of lymphocyte differentiation,BP,GLI2;BCL6;SFRP1;ERBB2
12942,GO:0051385,0.559473045076896,0.809467813843,1,20,response to mineralocorticoid,BP,CYBA
8188,GO:0032965,0.559542275915592,0.809412839662998,1,20,regulation of collagen biosynthetic process,BP,F2R
1460,GO:0003727,0.559952712933548,0.669294017947522,3,71,single-stranded RNA binding,MF,THRA;DDX60;MEX3A
277,GO:0000780,0.56005289880528,0.809007036328711,1,20,condensed nuclear chromosome, centromeric region,CC,KMT5C
12627,GO:0050871,0.560151373235589,0.715640694585711,2,46,positive regulation of B cell activation,BP,BCL6;VAV3
10923,GO:0044703,0.560618977751137,0.52765832786179,22,547,multi-organism reproductive process,BP,GAMT;TXNRD3;THRA;BCL6;CTSB;ETV5;SYT8;SERPINE2;WNT3;CRTAP;TCFL5;CTSV;HEXB;PTHLH;ACVR1B;TYRO3;SLC2A1;ZP3;CABYR;SUN1;SCMH1;NRK
8672,GO:0034333,0.561084713130276,0.668339609475997,3,69,adherens junction assembly,BP,SFRP1;DMTN;RHOD
7119,GO:0030971,0.5610875045101,0.714900763743038,2,45,receptor tyrosine kinase binding,MF,SHC2;PIK3R1
7001,GO:0030742,0.561092829872832,0.808178766045537,1,20,GTP-dependent protein binding,MF,RAPGEF5
3224,GO:0006895,0.561117543891266,0.808561069685661,1,19,Golgi to endosome transport,BP,SORT1
5035,GO:0015248,0.561165772368546,0.808120578349706,1,20,sterol transporter activity,MF,APOE
12640,GO:0050891,0.561358545447026,0.714649242535815,2,45,multicellular organismal water homeostasis,BP,TRPV4;ALOXE3
2566,GO:0005871,0.561381322733553,0.71476218951452,2,44,kinesin complex,CC,KIF26B;KIF26A
513,GO:0001578,0.561709244175689,0.714323608310166,2,45,microtubule bundle formation,BP,GAS8;MARK4
17323,GO:1900078,0.562183908320821,0.807710584328422,1,19,positive regulation of cellular response to insulin stimulus,BP,PIK3R1
13217,GO:0051937,0.562395768960915,0.807137576699377,1,20,catecholamine transport,BP,NISCH
18037,GO:1902668,0.562514808641793,0.807446150825366,1,19,negative regulation of axon guidance,BP,WNT3
20229,GO:2001237,0.562698766172419,0.666567046805037,3,72,negative regulation of extrinsic apoptotic signaling pathway,BP,TNFAIP3;IFI6;TNFSF10
15931,GO:0080111,0.562778621608105,0.806830906678633,1,20,DNA demethylation,BP,TET1
15958,GO:0086010,0.562882861729585,0.807151736475107,1,19,membrane depolarization during action potential,BP,SCN4B
4016,GO:0009065,0.563027324695201,0.806631514459225,1,20,glutamine family amino acid catabolic process,BP,GLUL
8173,GO:0032941,0.563295578858351,0.806416290533741,1,20,secretion by tissue,BP,CYBA
4092,GO:0009164,0.563443118889387,0.805931804611869,1,21,nucleoside catabolic process,BP,NT5E
1240,GO:0003002,0.563455924885685,0.580162787825953,8,197,regionalization,BP,GLI2;SFRP1;WNT3;TBX1;TULP3;MDFI;SCMH1;VANGL2
11812,GO:0046827,0.563485784152393,0.806263587447672,1,20,positive regulation of protein export from nucleus,BP,CAMK1
16789,GO:0098727,0.563667256299567,0.616460474729794,5,121,maintenance of cell number,BP,SFRP1;FOXO1;TET1;RTF1;VANGL2
540,GO:0001659,0.564057067073647,0.805804449279466,1,20,temperature homeostasis,BP,FOXO1
2799,GO:0006275,0.566227984781444,0.634092737992124,4,97,regulation of DNA replication,BP,EGFR;GLI2;BCL6;INSR
13617,GO:0060170,0.566762502928323,0.709607382879842,2,45,ciliary membrane,CC,PKD2;TMEM231
12187,GO:0048477,0.566884812543102,0.709363054314595,2,46,oogenesis,BP,HEXB;ZP3
15337,GO:0071622,0.566899104943106,0.803139039201579,1,21,regulation of granulocyte chemotaxis,BP,TRPV4
17209,GO:0120032,0.567040819710457,0.61305046142941,5,122,regulation of plasma membrane bounded cell projection assembly,BP,TENM2;ESPN;EVI5L;EPS8L2;DMTN
3404,GO:0007205,0.567849254604299,0.802737844769962,1,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,F2R
15926,GO:0080025,0.568265327891412,0.802399380524943,1,20,phosphatidylinositol-3,5-bisphosphate binding,MF,WIPI2
8161,GO:0032922,0.568452452265876,0.708020038073398,2,45,circadian regulation of gene expression,BP,CRY2;PER3
642,GO:0001836,0.568605480909355,0.707388290763887,2,49,release of cytochrome c from mitochondria,BP,IFI6;TNFSF10
3223,GO:0006893,0.568820294649026,0.70754371669536,2,46,Golgi to plasma membrane transport,BP,VAMP3;VAMP2
11235,GO:0045577,0.569130707042609,0.801694145794084,1,20,regulation of B cell differentiation,BP,SFRP1
4352,GO:0009987,0.569518096792606,0.484807108902486,424,10474,cellular process,BP,TNFAIP3;POSTN;IFITM1;ITGB6;PEG3;TGFBI;SMOC2;TAGLN;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;KCNJ15;ULK2;LGALS7B;PTPRS;FBXO41;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRF4;KDSR;ASH2L;TNS1;HTRA1;PRICKLE2;PRR9;SLITRK6;CADM4;GAMT;GPRC5C;TXNRD3;GIGYF1;ADGRL1;GPX7;SRSF5;ST3GAL5;GPX3;TST;DCAF16;FLNC;RALGDS;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;NYNRIN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;APCDD1;NLGN2;CDK18;RAPGEF5;IRF2BPL;VIPR1;BCL6;PGM1;ANO9;TENM2;XYLT1;CYP4F22;PSD4;ZNF318;CERS4;BRSK1;SFRP1;ARHGEF4;CKLF;FHOD3;UNK;POU3F1;TNFSF10;MN1;DHTKD1;INSR;VAV3;KMT5C;CYBRD1;GAA;DHX32;CES2;MATN2;SV2A;PKD2;ESPN;ZFPM1;RGMA;NAT6;ARSI;DNM1;PPP2R2C;SDK2;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;TNXB;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;LY6E;ZSCAN18;NSG1;PARVB;RASIP1;BPHL;BOC;SOX12;UROS;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;PPP1R3E;PRSS3;H6PD;TSC22D1;SGSH;KLK5;TRERF1;SHC2;SCN4B;SH3BP2;CRTAP;GAS8;YEATS4;EVI5L;WIPF1;FKBP9;KCNC4;MNT;RAB40B;TET1;MARVELD1;CYP27C1;FAM20C;GLUL;FAM213A;ANO8;EPHA4;ZNF266;WNT9A;TRAPPC2L;RPL13A;B3GNT9;RNPEPL1;CORO6;MAGEF1;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;HERC3;TCFL5;MPLKIP;TYSND1;CTSV;NXPH4;RPS6KA5;TUB;HOMER2;KLHDC8B;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;ZNF362;PGLS;ACSL1;EPS8L2;ZBTB42;DDX60;ACTA2;ERBB3;HGSNAT;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;VAMP3;PPL;CUL9;FRY;PLXND1;GJB5;CGREF1;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;SDC3;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;IMPA2;UNC119B;XPC;ARHGAP40;NAB2;NFATC4;ATP12A;SNX33;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;CPT1C;METTL7A;HYAL1;BCAM;RTF1;ZP3;STOM;CKMT1A;VAMP2;PLEKHH2;RBCK1;MBOAT7;AVL9;EFNB3;PCBP4;ZNF554;ADCK5;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;TNFRSF19;CABYR;SLC2A9;TMX4;MDK;TRPV4;ZDHHC1;MTHFR;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;RETSAT;NDUFA4L2;SDHA;KLK8;PTMS;LTBP4;ALDH2;PPP1R35;ADORA2B;FBXW4;SERPING1;NAGLU;NMRK1;MRC2;MAFIP;MYL9;RTN4RL1;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;MC1R;IMPACT;TBC1D17;MVD;GOLGA7B;NEO1;CRTC1;IGFBP4;STON1;GPR68;TOM1L2;GPR153;MICALL1;ERBB2;C2CD4C;RNF187;EPM2A;RNF135;H2AFJ;LAMB2;PCDH1;STAT1;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;PLCD1;H1FX;CRY2;MARCH9;COX5B;SLC39A6;BLOC1S4;MARCKSL1;ZMYM3;FURIN;FBXW5;RHPN1;IFI16;IL20RB;CCDC88B;PCSK1;PLPP2;MLYCD;SUN1;THNSL2;NINL;PEX11B;FRAT1;CTSF;GJC2;SLC1A4;ARPIN;RPRD2;DBP;BEX2;ASIC1;MMP1;ALS2CL;PER3;XYLT2;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;CAPNS2;MEX3A;CCDC3;DOK4;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;MT2A;NADK;RAB43;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;SCMH1;ZSWIM8;SP100;MPG;ABCC1;DDX59;IDUA;NRK;ISYNA1;PIGZ;FBXO44;SORT1;CBR3;VANGL2;APBA1;TP53I11
9166,GO:0035577,0.569709099290923,0.70658130876615,2,47,azurophil granule membrane,CC,GAA;STOM
11422,GO:0045913,0.569780527559935,0.706769023952128,2,45,positive regulation of carbohydrate metabolic process,BP,INSR;FOXO1
13602,GO:0060148,0.570065887147978,0.800930091654852,1,20,positive regulation of posttranscriptional gene silencing,BP,EGFR
3581,GO:0008023,0.570135222610251,0.706303884464554,2,46,transcription elongation factor complex,CC,TCEA2;RTF1
13169,GO:0051851,0.570403419251329,0.705925745230982,2,47,modification by host of symbiont morphology or physiology,BP,APOE;STOM
10691,GO:0044060,0.570569235819428,0.800518015429951,1,20,regulation of endocrine process,BP,F2R
18890,GO:1904680,0.570573879001273,0.800139494541707,1,21,peptide transmembrane transporter activity,MF,ABCC1
10008,GO:0042491,0.570786621382736,0.800339867806215,1,20,inner ear auditory receptor cell differentiation,BP,SLITRK6
9861,GO:0042171,0.571495558484096,0.799758135131216,1,20,lysophosphatidic acid acyltransferase activity,MF,MBOAT7
15334,GO:0071617,0.571495558484096,0.799758135131216,1,20,lysophospholipid acyltransferase activity,MF,MBOAT7
16415,GO:0097120,0.57176713514057,0.799534979666232,1,20,receptor localization to synapse,BP,NSG1
4177,GO:0009299,0.572059775556714,0.799294325016894,1,20,mRNA transcription,BP,SREBF1
11400,GO:0045862,0.572432320864301,0.550443466302114,11,279,positive regulation of proteolysis,BP,APOE;FGFR4;TNFSF10;DAB2IP;EPHA4;MAGEF1;F2R;SNX33;FURIN;IFI16;SMURF1
6636,GO:0030004,0.572435821161941,0.65697894795595,3,73,cellular monovalent inorganic cation homeostasis,BP,ATP6V0A2;ATP12A;TCIRG1
4089,GO:0009161,0.572457061275168,0.556174086174354,10,259,ribonucleoside monophosphate metabolic process,BP,PGM1;DHTKD1;INSR;NT5E;FAM20C;ATP6V0A2;SDHA;COX5B;TCIRG1;NADK
8857,GO:0034698,0.572991041062176,0.798527172844359,1,20,response to gonadotropin,BP,CTSV
17710,GO:1901699,0.573136596187906,0.523762610324654,18,447,cellular response to nitrogen compound,BP,SRSF5;COL6A1;EGFR;CYBA;SFRP1;INSR;PKD2;FOXO1;UROS;EPHA4;ATP6V0A2;SREBF1;DMTN;PIK3R1;VAMP2;IMPACT;STAT1;TCIRG1
11471,GO:0045992,0.573172868449755,0.798377153490581,1,20,negative regulation of embryonic development,BP,TULP3
13190,GO:0051894,0.57354645524514,0.798068679304081,1,20,positive regulation of focal adhesion assembly,BP,SFRP1
3152,GO:0006779,0.573610284784689,0.797637514124067,1,21,porphyrin-containing compound biosynthetic process,BP,UROS
7641,GO:0032092,0.574343700780218,0.65509649024712,3,73,positive regulation of protein binding,BP,APOE;EPHA4;PLXND1
18078,GO:1902803,0.574506616531826,0.797274376199141,1,20,regulation of synaptic vesicle transport,BP,RIMS3
9816,GO:0042092,0.574846566056023,0.796612693002305,1,21,type 2 immune response,BP,BCL6
11257,GO:0045604,0.574995469495281,0.701568262000955,2,47,regulation of epidermal cell differentiation,BP,CTSV;CTSL
7565,GO:0031954,0.575170861167781,0.796723616684059,1,20,positive regulation of protein autophosphorylation,BP,GPNMB
10010,GO:0042493,0.575247724597978,0.50914260399696,24,605,response to drug,BP,TNFAIP3;SLC13A5;EGFR;CYBA;SFRP1;VAV3;VEGFB;FOXO1;HOMER2;ACSL1;SREBF1;ENDOG;XPC;TP53INP1;MDK;MTHFR;PQLC2;IMPACT;STAT1;SLC13A3;MT2A;SLC47A1;PPP1R14A;ABCC1
7065,GO:0030879,0.575333124891357,0.624995391199666,4,97,mammary gland development,BP,OAS2;GLI2;ETV5;WNT3
3449,GO:0007283,0.575390460019187,0.547441878794436,11,276,spermatogenesis,BP,GAMT;TXNRD3;BCL6;ETV5;CRTAP;TCFL5;CTSV;TYRO3;CABYR;SUN1;SCMH1
13803,GO:0060444,0.575525476919991,0.796429165052436,1,20,branching involved in mammary gland duct morphogenesis,BP,ETV5
7910,GO:0032509,0.575730841767866,0.795877482250194,1,21,endosome transport via multivesicular body sorting pathway,BP,SORT1
5057,GO:0015298,0.575747922509564,0.796244309717459,1,20,solute:cation antiporter activity,MF,SLC47A1
3234,GO:0006909,0.575748186788349,0.58906573100012,6,149,phagocytosis,BP,CYBA;VAV3;WIPF1;TUB;PIK3R1;TYRO3
3238,GO:0006914,0.575827730931946,0.523674558241587,17,428,autophagy,BP,LAMP3;ULK2;TP53INP2;FOXO1;TRIM65;RASIP1;ATP6V0A2;SREBF1;TRIM22;TP53INP1;SPATA18;TBC1D17;EPM2A;WIPI2;IFI16;SMURF1;TCIRG1
14451,GO:0061919,0.575827730931946,0.523674558241587,17,428,process utilizing autophagic mechanism,BP,LAMP3;ULK2;TP53INP2;FOXO1;TRIM65;RASIP1;ATP6V0A2;SREBF1;TRIM22;TP53INP1;SPATA18;TBC1D17;EPM2A;WIPI2;IFI16;SMURF1;TCIRG1
14872,GO:0070741,0.575861090767013,0.796150220974186,1,20,response to interleukin-6,BP,STAT1
15167,GO:0071354,0.575861090767013,0.796150220974186,1,20,cellular response to interleukin-6,BP,STAT1
2943,GO:0006490,0.576153283112546,0.795525608137664,1,21,oligosaccharide-lipid intermediate biosynthetic process,BP,MVD
3481,GO:0007389,0.576430898525798,0.552209236371002,10,249,pattern specification process,BP,GLI2;SFRP1;PKD2;WNT3;TBX1;GAS8;TULP3;MDFI;SCMH1;VANGL2
2528,GO:0005801,0.576440432142505,0.700189259516756,2,47,cis-Golgi network,CC,PIK3R1;ANGEL1
20161,GO:2001057,0.576509912677144,0.700122855613766,2,47,reactive nitrogen species metabolic process,BP,INSR;PKD2
19002,GO:1904888,0.576526769848652,0.700233193139433,2,46,cranial skeletal system development,BP,TBX1;TULP3
6874,GO:0030426,0.576653948295087,0.603349382078123,5,122,growth cone,CC,ADGRL1;TENM2;BOC;EPHA4;TRPV4
11065,GO:0045111,0.576822888281589,0.623409972770531,4,99,intermediate filament cytoskeleton,CC,LDLRAP1;DDX60;SYNM;SLC1A4
18526,GO:1903793,0.576992578671132,0.79482527428136,1,21,positive regulation of anion transport,BP,APOE
17211,GO:0120034,0.577165787309037,0.652369025759993,3,72,positive regulation of plasma membrane bounded cell projection assembly,BP,TENM2;ESPN;EPS8L2
8121,GO:0032870,0.577262394065026,0.517044259383177,19,474,cellular response to hormone stimulus,BP,SRSF5;EGFR;THRA;CYBA;SFRP1;INSR;CTSB;FOXO1;ACSL1;ATP6V0A2;SREBF1;PIK3R1;CTSL;UCN2;FAM210B;VAMP2;STAT1;CRY2;TCIRG1
7551,GO:0031935,0.577312867306472,0.794940547522328,1,20,regulation of chromatin silencing,BP,TET1
7734,GO:0032272,0.577313430084889,0.699354283878637,2,47,negative regulation of protein polymerization,BP,FHOD3;DMTN
11163,GO:0045321,0.577335205266046,0.498577327331634,30,758,leukocyte activation,BP,TNFAIP3;GPNMB;MAP3K14;CYBA;GLI2;BCL6;PGM1;SFRP1;VAV3;GAA;ZFPM1;CTSB;PRSS3;HEXB;HGSNAT;PIK3R1;NCK2;TYRO3;CXCR1;METTL7A;ZP3;STOM;VAMP2;EFNB3;NDRG1;ADORA2B;ERBB2;IL20RB;CCDC88B;TCIRG1
1107,GO:0002703,0.577377322963461,0.622809369721657,4,100,regulation of leukocyte mediated immunity,BP,BCL6;ZP3;ADORA2B;IL20RB
13469,GO:0055080,0.577434753112089,0.528210525855861,15,378,cation homeostasis,BP,APOE;EGFR;CYBA;CYBRD1;SV2A;PKD2;F2R;HEXB;ATP6V0A2;ATP12A;TRPV4;NEO1;SLC39A6;TCIRG1;MT2A
14927,GO:0070873,0.577597369736627,0.794702910856167,1,20,regulation of glycogen metabolic process,BP,INSR
283,GO:0000786,0.577967328499743,0.65087525893973,3,84,nucleosome,CC,H1F0;H2AFJ;H1FX
3718,GO:0008270,0.57886820393978,0.507170544784561,23,574,zinc ion binding,MF,TNFAIP3;PRICKLE2;THRA;TCEA2;GLI2;ZNF318;TNFSF10;TRIM65;TET1;RNPEPL1;S100A6;TRIM22;ADAMTS15;MBD1;MSRB2;MARCH9;ZMYM3;MMP1;CXXC5;MT2A;ZCCHC24;ZSWIM8;DTNB
2811,GO:0006293,0.578997965652696,0.793145223089406,1,21,nucleotide-excision repair, preincision complex stabilization,BP,DDB2
2813,GO:0006295,0.578997965652696,0.793145223089406,1,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,DDB2
4018,GO:0009067,0.579051906054985,0.793099902810449,1,21,aspartate family amino acid biosynthetic process,BP,THNSL2
17684,GO:1901654,0.579113556126257,0.600757081720662,5,125,response to ketone,BP,EGFR;CYBA;SFRP1;FOXO1;SREBF1
13471,GO:0055082,0.579205571697285,0.520201310188572,17,429,cellular chemical homeostasis,BP,APOE;CYBA;CYBRD1;SV2A;PKD2;FOXO1;F2R;HEXB;ATP6V0A2;ENDOG;PIK3R1;ATP12A;TRPV4;GPR68;SLC39A6;TCIRG1;MT2A
7822,GO:0032401,0.579813878141885,0.79245896707802,1,21,establishment of melanosome localization,BP,SHROOM2
13201,GO:0051905,0.579813878141885,0.79245896707802,1,21,establishment of pigment granule localization,BP,SHROOM2
19776,GO:2000273,0.579936990872659,0.792355281743895,1,21,positive regulation of signaling receptor activity,BP,EPHB2
7958,GO:0032594,0.580144523453063,0.792180417102875,1,21,protein transport within lipid bilayer,BP,NSG1
357,GO:0000976,0.580249796802887,0.511694256395518,20,497,transcription regulatory region sequence-specific DNA binding,MF,HES2;ZNF704;NDN;THRA;GLI2;BCL6;ZFPM1;ETV5;HR;SALL2;SOX12;MNT;TCFL5;SREBF1;NFATC4;STAT1;CRY2;IFI16;DBP;PER3
12501,GO:0050687,0.580250046781876,0.792091465287172,1,21,negative regulation of defense response to virus,BP,HTRA1
12169,GO:0048384,0.580279855458061,0.792066333034062,1,21,retinoic acid receptor signaling pathway,BP,TBX1
3904,GO:0008593,0.580410023589387,0.649074504536627,3,73,regulation of Notch signaling pathway,BP,POSTN;EGFR;BCL6
5639,GO:0016758,0.580530856238701,0.584136209088561,6,151,transferase activity, transferring hexosyl groups,MF,XYLT1;B3GNT9;HEXB;HYAL1;XYLT2;PIGZ
614,GO:0001783,0.580563101599716,0.791827418066221,1,21,B cell apoptotic process,BP,BCL6
8210,GO:0033003,0.580689448784342,0.791720784411772,1,21,regulation of mast cell activation,BP,ADORA2B
8249,GO:0033077,0.580879123438372,0.695929536354407,2,47,T cell differentiation in thymus,BP,GLI2;ERBB2
22,GO:0000041,0.580968915261342,0.648387506427178,3,75,transition metal ion transport,BP,ATP6V0A2;SLC39A6;TCIRG1
4843,GO:0014075,0.581306130346166,0.791199779185813,1,21,response to amine,BP,UROS
5249,GO:0015914,0.582073849549352,0.694776860109263,2,47,phospholipid transport,BP,APOE;ABCC1
13833,GO:0060491,0.582291247964539,0.597547041765838,5,124,regulation of cell projection assembly,BP,TENM2;ESPN;EVI5L;EPS8L2;DMTN
5577,GO:0016627,0.582879147671514,0.693758340418458,2,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,RETSAT;SDHA
15502,GO:0071949,0.583260037821058,0.789543055417913,1,21,FAD binding,MF,CRY2
12735,GO:0051050,0.583638832203642,0.500534100327262,24,603,positive regulation of transport,BP,POSTN;APOE;EPHB2;EGFR;CYBA;NLGN2;INSR;PKD2;DNM1;LDLRAP1;SCN4B;GLUL;F2R;TUB;PIK3R1;ZP3;STOM;VAMP2;TRPV4;ADORA2B;GPR68;ERBB2;GJC2;CAMK1
5407,GO:0016279,0.583962711924504,0.692949156479148,2,47,protein-lysine N-methyltransferase activity,MF,ASH2L;KMT5C
18438,GO:1903580,0.584300188604609,0.788657402369655,1,21,positive regulation of ATP metabolic process,BP,INSR
13539,GO:0060047,0.58433367472051,0.59542741916296,5,125,heart contraction,BP,THRA;GAA;VEGFB;SCN4B;SREBF1
7836,GO:0032418,0.584506502232511,0.6922987626321,2,48,lysosome localization,BP,ADORA2B;VPS33B
4341,GO:0009954,0.584568437044861,0.788428579105611,1,21,proximal/distal pattern formation,BP,GLI2
11071,GO:0045121,0.584872415344392,0.558238503806188,8,200,membrane raft,CC,EGFR;INSR;MARVELD1;F2R;SLC2A1;STOM;RTN4RL1;FURIN
15556,GO:0072078,0.585371775037912,0.691581458856764,2,47,nephron tubule morphogenesis,BP,PKD2;KIF26B
149,GO:0000305,0.585648695546997,0.787148336812493,1,22,response to oxygen radical,BP,TXNRD3
14261,GO:0061436,0.585821886273761,0.787357071545482,1,21,establishment of skin barrier,BP,ALOXE3
11336,GO:0045738,0.58615128852849,0.787074858434137,1,21,negative regulation of DNA repair,BP,MAGEF1
8040,GO:0032731,0.586897223407097,0.786434821197855,1,21,positive regulation of interleukin-1 beta production,BP,IFI16
613,GO:0001782,0.587231162596369,0.786147856830277,1,21,B cell homeostasis,BP,TNFAIP3
8178,GO:0032947,0.587265980743809,0.642269387944045,3,72,protein-containing complex scaffold activity,MF,LDLRAP1;HOMER2;NCK2
17490,GO:1901021,0.587553642485764,0.785870485143238,1,21,positive regulation of calcium ion transmembrane transporter activity,BP,PKD2
10331,GO:0043178,0.588487030635521,0.688420732523981,2,48,alcohol binding,MF,APOE;CYP27C1
10370,GO:0043236,0.588675006595143,0.784904025767447,1,21,laminin binding,MF,BCAM
7998,GO:0032653,0.58936470554693,0.783946911406816,1,22,regulation of interleukin-10 production,BP,IL20RB
4412,GO:0010259,0.589465696531154,0.784220736428877,1,21,multicellular organism aging,BP,CTSV
13093,GO:0051693,0.589692562283893,0.784024407024456,1,21,actin filament capping,BP,DMTN
10373,GO:0043242,0.589773655145469,0.687285252454604,2,47,negative regulation of protein complex disassembly,BP,DMTN;PLEKHH2
11447,GO:0045943,0.589903966884532,0.783841345523763,1,21,positive regulation of transcription by RNA polymerase I,BP,ERBB2
14503,GO:0070059,0.589946082871352,0.686872808174295,2,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,DAB2IP;NCK2
13026,GO:0051569,0.59034454565046,0.783459487332614,1,21,regulation of histone H3-K4 methylation,BP,RTF1
15957,GO:0086009,0.590440400505625,0.783376345730247,1,21,membrane repolarization,BP,SCN4B
3556,GO:0007616,0.590469364043529,0.783351219248806,1,21,long-term memory,BP,APOE
9733,GO:0039528,0.590778154300279,0.783083210632835,1,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,DDX60
13099,GO:0051704,0.590794784024271,0.463614507763575,62,1570,multi-organism process,BP,TNFAIP3;IFITM1;ITGB6;APOE;MVB12B;LAMP3;ULK2;MAP3K14;HTRA1;GAMT;TXNRD3;EGFR;THRA;CYBA;OAS2;BCL6;INSR;CTSB;ETV5;SYT8;SERPINE2;WNT3;DAB2IP;TBX1;PRSS3;KLK5;CRTAP;WIPF1;RAB40B;RPL13A;F2R;TCFL5;CTSV;HEXB;DDX60;ACTA2;PIK3R1;PTHLH;TRIM22;ACVR1B;TYRO3;SLC2A1;HYAL1;ZP3;STOM;RBCK1;EFNB3;CABYR;ITGB5;CRTC1;STAT1;WIPI2;ACKR3;FURIN;IFI16;CCDC88B;SUN1;MMP1;RAB43;SCMH1;SP100;NRK
9156,GO:0035561,0.590798320615112,0.783065699613129,1,21,regulation of chromatin binding,BP,NFATC4
4625,GO:0010765,0.590816396354358,0.783050003064098,1,21,positive regulation of sodium ion transport,BP,SCN4B
16861,GO:0098857,0.590824018991951,0.552065882638381,8,201,membrane microdomain,CC,EGFR;INSR;MARVELD1;F2R;SLC2A1;STOM;RTN4RL1;FURIN
16088,GO:0090130,0.590835913727743,0.552053542101834,8,201,tissue migration,BP,APOE;DAB2IP;PRSS3;ACTA2;PLXND1;HYAL1;MAP3K3;SP100
6155,GO:0019538,0.590891774584177,0.447220642467716,168,4200,protein metabolic process,BP,TNFAIP3;TGFBI;APOE;IFI6;MVB12B;LAMP3;ULK2;PTPRS;FBXO41;OBSL1;LMF1;GPNMB;MAP3K14;EPHB2;ASH2L;HTRA1;PRR9;ST3GAL5;DCAF16;EGFR;ADAM19;FBXO2;FGFR4;CDK18;BCL6;TENM2;XYLT1;BRSK1;SFRP1;UNK;TNFSF10;INSR;KMT5C;NPEPL1;PKD2;ZFPM1;NAT6;ARSI;PPP2R2C;LDLRAP1;CTSB;SERPINE2;HR;PDPR;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;LY6E;NSG1;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;PRSS3;SGSH;KLK5;SHC2;CRTAP;YEATS4;FKBP9;RAB40B;TET1;FAM20C;ANO8;EPHA4;WNT9A;RPL13A;B3GNT9;RNPEPL1;MAGEF1;TENM4;F2R;HERC3;TYSND1;CTSV;RPS6KA5;KLHDC8B;HEXB;LTBP1;ACSL1;ERBB3;SPOCK1;CDK14;CUL9;FRY;SREBF1;CSPG4;DMTN;GRK6;PIK3R1;CTSL;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;NAB2;SNX33;TYRO3;HYAL1;RTF1;ADAMTS15;RBCK1;ADCK5;SPRY2;SCG5;TNFRSF19;TRPV4;ZDHHC1;MTHFR;SPATA18;MSRB2;KLK8;LTBP4;PPP1R35;ADORA2B;FBXW4;SERPING1;RTN4RL1;MARK4;BTBD2;IMPACT;MVD;GOLGA7B;IGFBP4;ERBB2;RNF187;RNF135;LAMB2;FBXL8;CDK20;HINT2;RNF44;WIPI2;ACKR3;CRY2;MARCH9;FURIN;FBXW5;IFI16;PCSK1;PLPP2;CTSF;GJC2;MMP1;XYLT2;NUAK1;RASA4;SMURF1;CAPNS2;MEX3A;CAMK1;TCIRG1;RNF208;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;IDUA;NRK;PIGZ;FBXO44;VANGL2
5360,GO:0016197,0.591248309227025,0.561211645614187,7,177,endosomal transport,BP,MVB12B;NSG1;VAMP3;SNX33;TBC1D17;MICALL1;SORT1
17691,GO:1901661,0.591319935903517,0.781917667420246,1,23,quinone metabolic process,BP,CBR3
11647,GO:0046466,0.591454823533488,0.78213156452063,1,22,membrane lipid catabolic process,BP,HEXB
9580,GO:0036474,0.591564072503645,0.782036385839914,1,22,cell death in response to hydrogen peroxide,BP,ENDOG
985,GO:0002449,0.591909420840327,0.587545164340401,5,128,lymphocyte mediated immunity,BP,BCL6;SCART1;ZP3;SERPING1;IL20RB
2926,GO:0006469,0.59255160398744,0.550213307555413,8,205,negative regulation of protein kinase activity,BP,TNFAIP3;APOE;EPHB2;SFRP1;WWTR1;DAB2IP;SPRY2;RTN4RL1
16,GO:0000030,0.592564898071901,0.781163104743898,1,22,mannosyltransferase activity,MF,PIGZ
3612,GO:0008088,0.592876355907494,0.684110468865242,2,48,axo-dendritic transport,BP,BLOC1S4;APBA1
8941,GO:0035050,0.593156667774046,0.683959064542524,2,47,embryonic heart tube development,BP,PKD2;VANGL2
12629,GO:0050873,0.593584042655599,0.780271327719641,1,22,brown fat cell differentiation,BP,TRPV4
11307,GO:0045667,0.594300437368384,0.63500717074475,3,74,regulation of osteoblast differentiation,BP,IFITM1;SFRP1;FAM20C
1348,GO:0003230,0.594648080518858,0.779704690549948,1,21,cardiac atrium development,BP,ZFPM1
8558,GO:0034067,0.594979187446013,0.779413927479657,1,21,protein localization to Golgi apparatus,BP,OBSL1
4928,GO:0014911,0.595217010601037,0.779204915952761,1,21,positive regulation of smooth muscle cell migration,BP,POSTN
6818,GO:0030301,0.595466055518299,0.681430210233954,2,49,cholesterol transport,BP,APOE;LDLRAP1
5406,GO:0016278,0.595478358507454,0.681538399035359,2,48,lysine N-methyltransferase activity,MF,ASH2L;KMT5C
17302,GO:1900027,0.596009319406831,0.778138919647113,1,22,regulation of ruffle assembly,BP,EPS8L2
14812,GO:0070613,0.596264331171747,0.680638415154769,2,49,regulation of protein processing,BP,SERPINE2;SERPING1
9327,GO:0035869,0.59628427976463,0.680618613207152,2,49,ciliary transition zone,CC,TMEM231;UNC119B
6685,GO:0030104,0.596651486001802,0.680374622355044,2,48,water homeostasis,BP,TRPV4;ALOXE3
3553,GO:0007612,0.597643397689806,0.631592885107596,3,74,learning,BP,EPHB2;INSR;ASIC1
2702,GO:0006096,0.59819029596343,0.630967255004176,3,75,glycolytic process,BP,PGM1;DHTKD1;INSR
11383,GO:0045833,0.598357623043718,0.678556435036412,2,49,negative regulation of lipid metabolic process,BP,APOE;DAB2IP
8668,GO:0034329,0.598373326358865,0.553851439981389,7,174,cell junction assembly,BP,TNS1;FLNC;EPB41L3;SFRP1;DMTN;RHOD;TRPV4
15440,GO:0071827,0.598466923942065,0.775963316717309,1,22,plasma lipoprotein particle organization,BP,APOE
13657,GO:0060249,0.598550694474035,0.523408217176884,11,284,anatomical structure homeostasis,BP,TNFAIP3;EGFR;GAA;TP53INP2;F2R;TUB;HOMER2;RDH12;TYRO3;IL20RB;SP100
16532,GO:0097366,0.599032584939908,0.77546044841551,1,22,response to bronchodilator,BP,FOXO1
11451,GO:0045948,0.599040530974982,0.775453378799432,1,22,positive regulation of translational initiation,BP,IMPACT
19775,GO:2000272,0.599331056475614,0.775194789611033,1,22,negative regulation of signaling receptor activity,BP,EPHB2
1250,GO:0003015,0.599345958680692,0.579856502826709,5,127,heart process,BP,THRA;GAA;VEGFB;SCN4B;SREBF1
6635,GO:0030003,0.599371028836346,0.513031550891678,13,333,cellular cation homeostasis,BP,APOE;CYBA;CYBRD1;SV2A;PKD2;F2R;HEXB;ATP6V0A2;ATP12A;TRPV4;SLC39A6;TCIRG1;MT2A
5638,GO:0016757,0.599389546057104,0.543070470801003,8,206,transferase activity, transferring glycosyl groups,MF,ST3GAL5;XYLT1;B3GNT9;HEXB;HYAL1;XYLT2;ST6GALNAC6;PIGZ
8379,GO:0033344,0.599530405586913,0.775017232920476,1,22,cholesterol efflux,BP,APOE
5782,GO:0017053,0.599769328004856,0.629412514417578,3,74,transcriptional repressor complex,CC,ZFPM1;SALL2;APPL2
10699,GO:0044089,0.600222087550522,0.504618878538147,15,379,positive regulation of cellular component biogenesis,BP,ADGRB2;EPHB2;SLITRK6;ADGRL1;NLGN2;TENM2;SFRP1;ESPN;DDB2;WIPF1;EPS8L2;NCK2;HYAL1;ARPIN;MMP1
8927,GO:0035019,0.600275945588787,0.676641231971379,2,49,somatic stem cell population maintenance,BP,SFRP1;VANGL2
3122,GO:0006730,0.600684651885142,0.77398722398905,1,22,one-carbon metabolic process,BP,MTHFR
13995,GO:0060765,0.600695934249109,0.773977139635258,1,22,regulation of androgen receptor signaling pathway,BP,SFRP1
16522,GO:0097346,0.600757691566797,0.773580851585879,1,23,INO80-type complex,CC,YEATS4
8162,GO:0032924,0.600889159316482,0.77380438279692,1,22,activin receptor signaling pathway,BP,ACVR1B
5796,GO:0017080,0.601339209105541,0.773401645560869,1,22,sodium channel regulator activity,MF,SCN4B
14966,GO:0070936,0.601646017905188,0.675269130008416,2,49,protein K48-linked ubiquitination,BP,TNFAIP3;RNF187
12323,GO:0048738,0.601797551663074,0.577357862811721,5,125,cardiac muscle tissue development,BP,OBSL1;FHOD3;ZFPM1;TENM4;ERBB3
6573,GO:0022607,0.601838360193644,0.445012451178191,88,2212,cellular component assembly,BP,TNFAIP3;APOE;ALDH1A3;ULK2;OBSL1;ADGRB2;EPHB2;ASH2L;TNS1;SLITRK6;ADGRL1;SRSF5;GPX3;FLNC;COL6A1;THRA;CYBA;H1F0;EPB41L3;NLGN2;TENM2;SFRP1;ARHGEF4;FHOD3;INSR;VAV3;PKD2;ESPN;DNM1;SDK2;TNXB;TP53INP2;WWTR1;NSG1;PARVB;SOX12;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;GAS8;EVI5L;WIPF1;KCNC4;GLUL;TRAPPC2L;RPL13A;TENM4;TYSND1;EPS8L2;HGSNAT;ATP6V0A2;VAMP3;PLXND1;DMTN;PIK3R1;TRIM22;NCK2;KCTD11;UNC119B;XPC;ARHGAP40;RHOD;SLC2A1;HYAL1;STOM;VAMP2;TP53INP1;TRPV4;MSRB2;ITGB5;MAFIP;MARK4;CCDC69;IMPACT;CRTC1;WIPI2;H1FX;NINL;PEX11B;ARPIN;ASIC1;MMP1;SMURF1;TCIRG1;VANGL2;APBA1
4503,GO:0010574,0.601874967820471,0.772921550519616,1,22,regulation of vascular endothelial growth factor production,BP,ADORA2B
1041,GO:0002576,0.601923927358082,0.627065799743515,3,76,platelet degranulation,BP,VEGFB;DMTN;SERPING1
13159,GO:0051817,0.602045211921609,0.626940763530998,3,76,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,APOE;INSR;STOM
14519,GO:0070085,0.602150193866446,0.540194064940366,8,205,glycosylation,BP,LMF1;ST3GAL5;VEGFB;TET1;B3GNT9;MVD;ST6GALNAC6;PIGZ
8975,GO:0035137,0.602269930878143,0.772567163514348,1,22,hindlimb morphogenesis,BP,WNT3
13922,GO:0060669,0.602426978595344,0.772426141462753,1,22,embryonic placenta morphogenesis,BP,GJB5
15067,GO:0071158,0.602617920487496,0.626287705459735,3,77,positive regulation of cell cycle arrest,BP,PKD2;DAB2IP;PCBP4
14073,GO:0060969,0.602647390419125,0.772228117046486,1,22,negative regulation of gene silencing,BP,TET1
7308,GO:0031338,0.602884347374643,0.674147960863616,2,48,regulation of vesicle fusion,BP,EVI5L;TBC1D17
19239,GO:1905476,0.602886613002561,0.772013054785726,1,22,negative regulation of protein localization to membrane,BP,DMTN
5774,GO:0017025,0.603336355946653,0.7712645992372,1,23,TBP-class protein binding,MF,THRA
5278,GO:0015980,0.603529137883769,0.538622449495997,8,214,energy derivation by oxidation of organic compounds,BP,PGM1;DHTKD1;INSR;GAA;PPP1R3E;NFATC4;SDHA;COX5B
4240,GO:0009584,0.603619074960725,0.77135367563454,1,22,detection of visible light,BP,REEP6
6430,GO:0021766,0.603715928888205,0.673189399875643,2,49,hippocampus development,BP,PTPRS;MDK
2699,GO:0006090,0.604351818130851,0.59504781962329,4,102,pyruvate metabolic process,BP,PGM1;DHTKD1;INSR;PDPR
1349,GO:0003231,0.604476313055917,0.624559724954757,3,74,cardiac ventricle development,BP,ZFPM1;LTBP1;VANGL2
9757,GO:0040001,0.605056644165669,0.770055623277863,1,22,establishment of mitotic spindle localization,BP,SPRY2
2595,GO:0005913,0.605329127838485,0.623610708351409,3,75,cell-cell adherens junction,CC,CADM4;SHROOM2;NDRG1
7832,GO:0032414,0.605360719055418,0.67153099323576,2,49,positive regulation of ion transmembrane transporter activity,BP,EPHB2;PKD2
13789,GO:0060428,0.60547365619643,0.769678108593665,1,22,lung epithelium development,BP,THRA
10752,GO:0044248,0.605531135313435,0.445460260260846,71,1803,cellular catabolic process,BP,TNFAIP3;APOE;MVB12B;LAMP3;ULK2;CPT2;GPX3;TST;FBXO2;CRAT;OAS2;H1F0;PGM1;DHTKD1;INSR;GAA;CTSB;NT5E;TP53INP2;WWTR1;RHBDF1;TMEM129;FOXO1;TRIM65;RASIP1;DAB2IP;SGSH;TET1;GLUL;EPHA4;RPL13A;RNPEPL1;MAGEF1;TYSND1;CTSV;HEXB;ACSL1;ATP6V0A2;CUL9;SREBF1;CSPG4;ENDOG;CTSL;TRIM22;SNX33;CPT1C;HYAL1;RBCK1;PCBP4;TP53INP1;SPATA18;ALDH2;FBXW4;AMACR;BTBD2;TBC1D17;RNF187;EPM2A;RNF44;WIPI2;FURIN;FBXW5;IFI16;MLYCD;THNSL2;CTSF;SMURF1;TCIRG1;IDUA;FBXO44;CBR3
7779,GO:0032350,0.605597608629208,0.769565811744984,1,22,regulation of hormone metabolic process,BP,TRERF1
18646,GO:1904036,0.60597737554756,0.769221513832244,1,22,negative regulation of epithelial cell apoptotic process,BP,TNFAIP3
5813,GO:0017112,0.605992544043991,0.670892564918911,2,49,Rab guanyl-nucleotide exchange factor activity,MF,TRAPPC2L;ALS2CL
2716,GO:0006111,0.606392704827968,0.768844557718927,1,22,regulation of gluconeogenesis,BP,FOXO1
6891,GO:0030501,0.606853654941864,0.76842568484767,1,22,positive regulation of bone mineralization,BP,FAM20C
14568,GO:0070169,0.606853654941864,0.76842568484767,1,22,positive regulation of biomineral tissue development,BP,FAM20C
8356,GO:0033280,0.606968097055552,0.768321606068515,1,22,response to vitamin D,BP,SFRP1
5589,GO:0016651,0.606989729341479,0.621417171723953,3,83,oxidoreductase activity, acting on NAD(P)H,MF,TXNRD3;CYBA;TXNDC17
5123,GO:0015662,0.6070067979596,0.768286402226965,1,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,ATP12A
3141,GO:0006757,0.607280116189884,0.621521789716649,3,76,ATP generation from ADP,BP,PGM1;DHTKD1;INSR
2940,GO:0006487,0.607559312487386,0.621107734465939,3,78,protein N-linked glycosylation,BP,ST3GAL5;MVD;ST6GALNAC6
1332,GO:0003206,0.607606299248317,0.621247156245647,3,75,cardiac chamber morphogenesis,BP,ZFPM1;TBX1;VANGL2
7640,GO:0032091,0.607743451760408,0.620916218095356,3,78,negative regulation of protein binding,BP,ZFPM1;NFATC4;CAMK1
10344,GO:0043198,0.607837786061907,0.767529586987637,1,22,dendritic shaft,CC,EPHA4
5424,GO:0016310,0.607991338362737,0.444866833239541,65,1636,phosphorylation,BP,TNFAIP3;APOE;ULK2;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;CDK18;PGM1;BRSK1;SFRP1;DHTKD1;INSR;VAV3;PKD2;WWTR1;FOXO1;DAB2IP;OBSCN;TBX1;SHC2;FAM20C;EPHA4;F2R;RPS6KA5;ACSL1;ERBB3;CDK14;CSPG4;DMTN;GRK6;PIK3R1;NCK2;ACVR1B;CAMKK1;IMPA2;NAB2;TYRO3;CKMT1A;ADCK5;SPRY2;TNFRSF19;TRPV4;SDHA;ADORA2B;NMRK1;RTN4RL1;MARK4;IMPACT;IGFBP4;ERBB2;NME4;CDK20;ACKR3;COX5B;GJC2;NUAK1;RASA4;CAMK1;NADK;MAP3K3;PPP1R14A;NRK;VANGL2
18306,GO:1903317,0.608143884302689,0.668594819225347,2,50,regulation of protein maturation,BP,SERPINE2;SERPING1
12875,GO:0051261,0.608828709060452,0.619974976876927,3,75,protein depolymerization,BP,DMTN;PLEKHH2;TRPV4
19831,GO:2000351,0.609199526478279,0.766285600450607,1,22,regulation of endothelial cell apoptotic process,BP,TNFAIP3
20053,GO:2000756,0.609311608361641,0.667407812044585,2,50,regulation of peptidyl-lysine acetylation,BP,RPS6KA5;HINT2
14226,GO:0061333,0.609374467717885,0.667462292368612,2,49,renal tubule morphogenesis,BP,PKD2;KIF26B
649,GO:0001843,0.609506670158021,0.61926838671497,3,75,neural tube closure,BP,SFRP1;TULP3;VANGL2
13900,GO:0060606,0.609506670158021,0.61926838671497,3,75,tube closure,BP,SFRP1;TULP3;VANGL2
18344,GO:1903393,0.609740817218632,0.765789804998324,1,22,positive regulation of adherens junction organization,BP,SFRP1
4579,GO:0010712,0.609782897479017,0.765400808863634,1,23,regulation of collagen metabolic process,BP,F2R
12251,GO:0048609,0.610279941012435,0.485235447281979,18,459,multicellular organismal reproductive process,BP,GAMT;TXNRD3;EGFR;THRA;BCL6;CTSB;ETV5;SERPINE2;WNT3;CRTAP;TCFL5;CTSV;HEXB;TYRO3;ZP3;CABYR;SUN1;SCMH1
19602,GO:1990837,0.610567579374369,0.478110054795355,21,530,sequence-specific double-stranded DNA binding,MF,HES2;ZNF704;NDN;THRA;H1F0;GLI2;BCL6;ZFPM1;ETV5;HR;SALL2;SOX12;MNT;TCFL5;SREBF1;NFATC4;STAT1;CRY2;IFI16;DBP;PER3
7200,GO:0031114,0.61065190200691,0.764953607214274,1,22,regulation of microtubule depolymerization,BP,TRPV4
2866,GO:0006383,0.61070747450688,0.665871475844321,2,51,transcription by RNA polymerase III,BP,NAB2;ERBB2
3176,GO:0006816,0.610773436555101,0.531116201879197,8,205,calcium ion transport,BP,CYBA;PKD2;F2R;HOMER2;ORAI3;TRPV4;GJC2;ASIC1
11238,GO:0045580,0.610991446756188,0.617590585408075,3,77,regulation of T cell differentiation,BP,GLI2;BCL6;ERBB2
11544,GO:0046134,0.611417402867502,0.763574880180107,1,24,pyrimidine nucleoside biosynthetic process,BP,NME4
13068,GO:0051642,0.611436183467277,0.764232089181668,1,22,centrosome localization,BP,SUN1
7673,GO:0032148,0.611909570985807,0.76344319367057,1,23,activation of protein kinase B activity,BP,INSR
12350,GO:0048806,0.612044175081537,0.763671668009338,1,22,genitalia development,BP,TYRO3
6103,GO:0019369,0.612049692396762,0.76331380400779,1,23,arachidonic acid metabolic process,BP,ALOXE3
20151,GO:2001038,0.612436760679648,0.762956118705971,1,23,regulation of cellular response to drug,BP,ENDOG
13663,GO:0060260,0.612518493922931,0.762880540711725,1,23,regulation of transcription initiation from RNA polymerase II promoter,BP,THRA
12867,GO:0051253,0.612650704016708,0.453490859710433,39,990,negative regulation of RNA metabolic process,BP,PEG3;HES2;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;ZFPM1;HR;SALL2;WWTR1;FOXO1;DAB2IP;MNT;TET1;TCFL5;RPS6KA5;ZBTB42;SREBF1;TRIM22;NCK2;NAB2;NFATC4;RTF1;ZP3;MBD1;TRPV4;IMPACT;H2AFJ;STAT1;CRY2;IFI16;PER3;CXXC5;MDFI;SCMH1;SP100
3142,GO:0006760,0.612960696383708,0.762471342013833,1,23,folic acid-containing compound metabolic process,BP,MTHFR
9800,GO:0042054,0.613929500952626,0.662687887381626,2,50,histone methyltransferase activity,MF,ASH2L;KMT5C
15710,GO:0072341,0.614472854075084,0.662015073902257,2,51,modified amino acid binding,MF,MTHFR;PLCD1
17329,GO:1900087,0.614594401091887,0.760955197240453,1,23,positive regulation of G1/S transition of mitotic cell cycle,BP,HYAL1
507,GO:0001570,0.614670563051302,0.662046175004063,2,49,vasculogenesis,BP,RASIP1;ACKR3
12052,GO:0048048,0.614771084610608,0.761146416458198,1,22,embryonic eye morphogenesis,BP,ALDH1A3
13195,GO:0051899,0.614982129536777,0.661606215584103,2,50,membrane depolarization,BP,IFI6;SCN4B
13097,GO:0051702,0.615239170679879,0.661226862433977,2,51,interaction with symbiont,BP,APOE;STOM
8951,GO:0035082,0.615502166340709,0.760109772143926,1,23,axoneme assembly,BP,GAS8
10188,GO:0042866,0.615955286476958,0.612382083336887,3,77,pyruvate biosynthetic process,BP,PGM1;DHTKD1;INSR
12891,GO:0051287,0.616176621942946,0.66015051330225,2,52,NAD binding,MF,ALDH1A3;ALDH2
2976,GO:0006536,0.616525777305106,0.759153893496417,1,23,glutamate metabolic process,BP,GLUL
11111,GO:0045191,0.61654469386715,0.759136203026251,1,23,regulation of isotype switching,BP,BCL6
3382,GO:0007176,0.616835364537211,0.758864255372935,1,23,regulation of epidermal growth factor-activated receptor activity,BP,NCK2
1139,GO:0002753,0.616912467448723,0.659617006981026,2,50,cytoplasmic pattern recognition receptor signaling pathway,BP,TNFAIP3;DDX60
12314,GO:0048713,0.617206720140787,0.758516500029223,1,23,regulation of oligodendrocyte differentiation,BP,TENM4
9019,GO:0035264,0.617314450797776,0.581392114416372,4,102,multicellular organism growth,BP,SLITRK6;GAMT;WWTR1;APBA1
14628,GO:0070273,0.617406769296122,0.758329015456374,1,23,phosphatidylinositol-4-phosphate binding,MF,DAB2IP
4050,GO:0009117,0.61749455300148,0.477587662334771,18,476,nucleotide metabolic process,BP,APOE;PGM1;DHTKD1;INSR;PKD2;NT5E;H6PD;FAM20C;PGLS;ATP6V0A2;PTHLH;SDHA;ADORA2B;NMRK1;NME4;COX5B;TCIRG1;NADK
4742,GO:0010939,0.617763879493449,0.75766565325163,1,24,regulation of necrotic cell death,BP,RBCK1
2510,GO:0005778,0.618059620007629,0.658315960350043,2,51,peroxisomal membrane,CC,ACSL1;PEX11B
7539,GO:0031903,0.618059620007629,0.658315960350043,2,51,microbody membrane,CC,ACSL1;PEX11B
5417,GO:0016298,0.618269993342023,0.609939714260825,3,77,lipase activity,MF,CES2;PLCD3;PLCD1
4502,GO:0010573,0.618312883655119,0.757478504733252,1,23,vascular endothelial growth factor production,BP,ADORA2B
10541,GO:0043537,0.618315728435705,0.757475831146831,1,23,negative regulation of blood vessel endothelial cell migration,BP,APOE
12276,GO:0048663,0.618423148580959,0.757374859891141,1,23,neuron fate commitment,BP,GLI2
12353,GO:0048813,0.618472174170327,0.580203234869327,4,101,dendrite morphogenesis,BP,OBSL1;EPHB2;EPHA4;NFATC4
6901,GO:0030513,0.618488141002939,0.757313754597609,1,23,positive regulation of BMP signaling pathway,BP,NEO1
10325,GO:0043171,0.618519121586747,0.757284623043586,1,23,peptide catabolic process,BP,RNPEPL1
6682,GO:0030100,0.619500641737523,0.543283690589815,6,156,regulation of endocytosis,BP,APOE;CYBA;LDLRAP1;TUB;SNX33;STON1
8417,GO:0033561,0.619525266287691,0.756337163263594,1,23,regulation of water loss via skin,BP,ALOXE3
3251,GO:0006937,0.620048246071956,0.607995417107101,3,78,regulation of muscle contraction,BP,F2R;ADORA2B;MYL9
11758,GO:0046661,0.62032322280186,0.578147448666341,4,103,male sex differentiation,BP,SFRP1;TNFSF10;INSR;CTSV
2701,GO:0006094,0.620524520741884,0.655647854312517,2,52,gluconeogenesis,BP,PGM1;FOXO1
11211,GO:0045445,0.620856963529503,0.655413507130284,2,51,myoblast differentiation,BP,CXCL14;BOC
7538,GO:0031902,0.6212666876142,0.577020820701391,4,106,late endosome membrane,CC,MVB12B;NSG1;MICALL1;VPS33B
18470,GO:1903672,0.621383378867604,0.754580445942189,1,23,positive regulation of sprouting angiogenesis,BP,MAP3K3
5459,GO:0016411,0.621407864534033,0.754557235799067,1,23,acylglycerol O-acyltransferase activity,MF,MBOAT7
104,GO:0000217,0.621702380154789,0.754277938450822,1,23,DNA secondary structure binding,MF,XPC
7907,GO:0032506,0.621814644913604,0.75417141444692,1,23,cytokinetic process,BP,SNX33
10605,GO:0043648,0.621944817108232,0.605921540229783,3,79,dicarboxylic acid metabolic process,BP,GLUL;MTHFR;SDHA
10240,GO:0043014,0.622264014456846,0.753744690768311,1,23,alpha-tubulin binding,MF,TRPV4
7973,GO:0032613,0.622447606621952,0.753237311794269,1,24,interleukin-10 production,BP,IL20RB
15471,GO:0071889,0.622491019901075,0.753528922451909,1,23,14-3-3 protein binding,MF,DAB2IP
4918,GO:0014896,0.622633332621156,0.653678759325172,2,50,muscle hypertrophy,BP,CYBA;FOXO1
13231,GO:0051959,0.622670414645435,0.753358311680393,1,23,dynein light intermediate chain binding,MF,CCDC88B
993,GO:0002474,0.622687840370812,0.604903469367775,3,83,antigen processing and presentation of peptide antigen via MHC class I,BP,CYBA;VAMP3;ITGB5
12897,GO:0051294,0.62310825265617,0.752941554757078,1,23,establishment of spindle orientation,BP,SPRY2
5687,GO:0016835,0.623284501048099,0.652662733731873,2,53,carbon-oxygen lyase activity,MF,UROS;THNSL2
12100,GO:0048232,0.623359024633522,0.497228725436892,11,286,male gamete generation,BP,GAMT;TXNRD3;BCL6;ETV5;CRTAP;TCFL5;CTSV;TYRO3;CABYR;SUN1;SCMH1
4457,GO:0010470,0.623413474466626,0.752650728591852,1,23,regulation of gastrulation,BP,TENM4
9643,GO:0038034,0.623467861715728,0.652578634807222,2,52,signal transduction in absence of ligand,BP,IFI6;ERBB3
16453,GO:0097192,0.623467861715728,0.652578634807222,2,52,extrinsic apoptotic signaling pathway in absence of ligand,BP,IFI6;ERBB3
426,GO:0001134,0.623663734080914,0.752412088170075,1,23,transcription factor activity, transcription factor recruiting,MF,THRA
15369,GO:0071674,0.62374210862914,0.752003197837656,1,24,mononuclear cell migration,BP,TRPV4
15830,GO:0072593,0.624268747801637,0.538094587744997,6,160,reactive oxygen species metabolic process,BP,GPX3;EGFR;CYBA;INSR;PKD2;FOXO1
11899,GO:0046982,0.624545602963013,0.486411473013083,13,348,protein heterodimerization activity,MF,EGFR;CYBA;TENM2;VEGFB;TENM4;HOMER2;HEXB;ERBB3;PIK3R1;TYRO3;CABYR;ERBB2;H2AFJ
15445,GO:0071840,0.624683857532422,0.411647823428513,192,4800,cellular component organization or biogenesis,BP,TNFAIP3;POSTN;ITGB6;TGFBI;SMOC2;APOE;ALDH1A3;IFI6;ULK2;PTPRS;OBSL1;NDN;ADGRB2;EPHB2;ASH2L;TNS1;HTRA1;SLITRK6;ADGRL1;SRSF5;GPX3;FLNC;SHROOM2;COL6A1;EGFR;ADAM19;THRA;CYBA;H1F0;GLI2;FGFR4;EPB41L3;NLGN2;BCL6;ANO9;TENM2;BRSK1;SFRP1;ARHGEF4;FHOD3;UNK;TNFSF10;INSR;VAV3;KMT5C;GAA;MATN2;PKD2;ESPN;ZFPM1;RGMA;DNM1;SDK2;LDLRAP1;ETV5;SYT8;SERPINE2;HR;TNXB;TP53INP2;WWTR1;WNT3;NSG1;PARVB;BOC;SOX12;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;KLK5;GAS8;YEATS4;EVI5L;WIPF1;KCNC4;TET1;MARVELD1;GLUL;EPHA4;TRAPPC2L;RPL13A;CORO6;DIXDC1;TENM4;F2R;SMARCA1;TYSND1;CTSV;RPS6KA5;TUB;ARHGEF19;HEXB;EPS8L2;HGSNAT;KIF26A;S100A6;SPOCK1;ATP6V0A2;VAMP3;PPL;CUL9;FRY;PLXND1;SREBF1;DMTN;ENDOG;PIK3R1;CTSL;IQSEC1;TRIM22;NCK2;ACVR1B;KCTD11;SYTL1;UNC119B;XPC;ARHGAP40;NFATC4;SNX33;TYRO3;RHOD;SLC2A1;HYAL1;RTF1;STOM;VAMP2;PLEKHH2;EFNB3;SPRY2;MBD1;TP53INP1;TRPV4;MTHFR;SPATA18;MSRB2;SYNM;ITGB5;NDRG1;KLK8;LTBP4;NAGLU;MAFIP;RTN4RL1;MARK4;PDLIM4;CCDC69;IMPACT;TBC1D17;NEO1;CRTC1;IGFBP4;STON1;TOM1L2;MICALL1;ERBB2;C2CD4C;H2AFJ;LAMB2;WIPI2;H1FX;BLOC1S4;ZMYM3;FURIN;FBXW5;CCDC88B;SUN1;NINL;PEX11B;FRAT1;ARPIN;ASIC1;MMP1;ALS2CL;PLXNB1;SMURF1;CAPNS2;DOK4;CAMK1;TCIRG1;NISCH;RAB43;VPS33B;SCMH1;ZSWIM8;SP100;ABCC1;NRK;SORT1;VANGL2;APBA1
4797,GO:0014009,0.624733967314165,0.751389669043554,1,23,glial cell proliferation,BP,ETV5
6291,GO:0019953,0.625203686954019,0.472163793339272,17,439,sexual reproduction,BP,GAMT;TXNRD3;THRA;BCL6;ETV5;SYT8;SERPINE2;WNT3;CRTAP;TCFL5;CTSV;HEXB;TYRO3;ZP3;CABYR;SUN1;SCMH1
2573,GO:0005881,0.625204235563787,0.650872239036951,2,51,cytoplasmic microtubule,CC,CLIP2;TRPV4
18202,GO:1903053,0.625368317795719,0.750782221593488,1,23,regulation of extracellular matrix organization,BP,FGFR4
1327,GO:0003197,0.625446346277543,0.750707428312246,1,23,endocardial cushion development,BP,ERBB3
11267,GO:0045621,0.625799182314967,0.650135429746781,2,52,positive regulation of lymphocyte differentiation,BP,GLI2;BCL6
13724,GO:0060341,0.625804327838447,0.456611844056398,24,615,regulation of cellular localization,BP,EPHB2;EGFR;CYBA;NLGN2;PKD2;DNM1;LDLRAP1;RIMS3;TP53INP2;KCNC4;F2R;SREBF1;DMTN;PIK3R1;SNX33;STOM;VAMP2;ADORA2B;GPR68;ERBB2;ASIC1;CAMK1;REEP6;SP100
8218,GO:0033014,0.625906686175872,0.749929657818602,1,24,tetrapyrrole biosynthetic process,BP,UROS
6192,GO:0019725,0.626239830098766,0.461590434736126,21,545,cellular homeostasis,BP,APOE;TXNRD3;CYBA;CYBRD1;GAA;SV2A;PKD2;FOXO1;F2R;HEXB;ATP6V0A2;ENDOG;PIK3R1;ATP12A;TYRO3;TMX4;TRPV4;GPR68;SLC39A6;TCIRG1;MT2A
6739,GO:0030183,0.627642799418745,0.599898159790742,3,78,B cell differentiation,BP,BCL6;SFRP1;PIK3R1
3530,GO:0007568,0.628171689794475,0.512490598914429,8,211,aging,BP,BCL6;MNT;CTSV;SREBF1;ENDOG;SERPING1;NUAK1;MAP3K3
4913,GO:0014888,0.628267600441692,0.747992220897443,1,23,striated muscle adaptation,BP,FOXO1
10271,GO:0043068,0.628805497462844,0.465661244900583,18,470,positive regulation of programmed cell death,BP,ALDH1A3;BCL6;SFRP1;ARHGEF4;TNFSF10;VAV3;FOXO1;DAB2IP;OBSCN;F2R;ARHGEF19;ENDOG;NCK2;NFATC4;RBCK1;TP53INP1;MARK4;SORT1
4053,GO:0009123,0.628933519247985,0.496948354558099,10,271,nucleoside monophosphate metabolic process,BP,PGM1;DHTKD1;INSR;NT5E;FAM20C;ATP6V0A2;SDHA;COX5B;TCIRG1;NADK
8077,GO:0032786,0.629006014933809,0.746938891074457,1,24,positive regulation of DNA-templated transcription, elongation,BP,RTF1
7731,GO:0032269,0.629449402114175,0.441238947140912,33,852,negative regulation of cellular protein metabolic process,BP,TNFAIP3;APOE;IFI6;LAMP3;EPHB2;EGFR;SFRP1;UNK;SERPINE2;WWTR1;FOXO1;DAB2IP;COL7A1;CRTAP;EPHA4;WNT9A;RPL13A;SPOCK1;FRY;DMTN;NCK2;SPRY2;PPP1R35;SERPING1;RTN4RL1;IMPACT;HINT2;CRY2;FURIN;IFI16;MEX3A;ELFN2;PPP1R14A
19917,GO:2000514,0.62997206408655,0.74600140448759,1,24,regulation of CD4-positive, alpha-beta T cell activation,BP,BCL6
13772,GO:0060402,0.630076933203472,0.597282838133164,3,78,calcium ion transport into cytosol,BP,CYBA;PKD2;F2R
16736,GO:0098589,0.630317211354517,0.51022522437137,8,208,membrane region,CC,EGFR;INSR;MARVELD1;F2R;SLC2A1;STOM;RTN4RL1;FURIN
5056,GO:0015297,0.630543615514451,0.645243096616535,2,51,antiporter activity,MF,CLCN7;SLC47A1
17877,GO:1902230,0.630574261442906,0.745102705887389,1,25,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,ACKR3
4083,GO:0009154,0.630827509704412,0.745169148424164,1,24,purine ribonucleotide catabolic process,BP,NT5E
10276,GO:0043085,0.630983942238212,0.433615522900977,40,1016,positive regulation of catalytic activity,BP,APOE;LMF1;MAP3K14;EPHB2;EGFR;CYBA;FGFR4;SFRP1;TNFSF10;INSR;VAV3;PKD2;DAB2IP;SHC2;EVI5L;EPHA4;F2R;ARHGEF19;ACSL1;ERBB3;CSPG4;IQSEC1;ACAP3;CAMKK1;ARHGAP40;NAB2;TYRO3;SPRY2;ADORA2B;TBC1D17;ERBB2;CDK20;IFI16;ALS2CL;PLXNB1;RASA4;CAMK1;MAP3K3;NRK;VANGL2
15438,GO:0071825,0.631004448621453,0.744996759008993,1,24,protein-lipid complex subunit organization,BP,APOE
9844,GO:0042136,0.631482933111567,0.644133423810892,2,52,neurotransmitter biosynthetic process,BP,INSR;PKD2
16824,GO:0098796,0.631537814194371,0.444718751181238,28,730,membrane protein complex,CC,ITGB6;MVB12B;EGFR;CYBA;INSR;DNM1;LDLRAP1;SCN4B;KCNC4;OLFM2;ATP6V0A2;VAMP3;GJB5;PIK3R1;ACVR1B;ATP12A;CPT1C;VAMP2;LRRC8E;ITGB5;NDUFA4L2;SDHA;NEO1;COX5B;SUN1;GJC2;TCIRG1;VPS33B
6843,GO:0030332,0.631547695636806,0.744466950330772,1,24,cyclin binding,MF,CDK14
4369,GO:0010039,0.631772988096355,0.744246996278151,1,24,response to iron ion,BP,CYBRD1
13533,GO:0060041,0.631801981028937,0.595486396876676,3,77,retina development in camera-type eye,BP,SDK2;TUB;LAMB2
10701,GO:0044091,0.631968237283161,0.744056262222562,1,24,membrane biogenesis,BP,NLGN2
9859,GO:0042168,0.632050730970198,0.743661317207502,1,25,heme metabolic process,BP,UROS
4997,GO:0015175,0.632365238292251,0.743668122645611,1,24,neutral amino acid transmembrane transporter activity,MF,SLC1A4
12264,GO:0048639,0.632870948787483,0.564608268678901,4,104,positive regulation of developmental growth,BP,INSR;WNT3;ZP3;SMURF1
20218,GO:2001222,0.632912075263938,0.743475673054736,1,23,regulation of neuron migration,BP,DAB2IP
7207,GO:0031122,0.633745870630265,0.641839569966382,2,51,cytoplasmic microtubule organization,BP,TRPV4;CCDC88B
3207,GO:0006873,0.6339028110135,0.476472820304558,13,341,cellular ion homeostasis,BP,APOE;CYBA;CYBRD1;SV2A;PKD2;F2R;HEXB;ATP6V0A2;ATP12A;TRPV4;SLC39A6;TCIRG1;MT2A
14917,GO:0070851,0.634022808739892,0.592960887419022,3,79,growth factor receptor binding,MF,VAV3;VEGFB;DAB2IP
5707,GO:0016866,0.634053041537445,0.741697119155431,1,25,intramolecular transferase activity,MF,PGM1
10697,GO:0044087,0.634199682912909,0.444680256136764,26,663,regulation of cellular component biogenesis,BP,APOE;ADGRB2;EPHB2;SLITRK6;ADGRL1;THRA;NLGN2;TENM2;SFRP1;FHOD3;ESPN;DDB2;DAB2IP;EVI5L;WIPF1;RPL13A;EPS8L2;DMTN;PIK3R1;NCK2;ARHGAP40;RHOD;HYAL1;IMPACT;ARPIN;MMP1
6691,GO:0030120,0.634205677504929,0.641235191559758,2,52,vesicle coat,CC,EGFR;LDLRAP1
9038,GO:0035303,0.634327702268643,0.527304895587906,6,157,regulation of dephosphorylation,BP,PPP2R2C;PPP1R35;CRY2;NUAK1;ELFN2;PPP1R14A
3138,GO:0006753,0.634669859554655,0.459387670215642,18,481,nucleoside phosphate metabolic process,BP,APOE;PGM1;DHTKD1;INSR;PKD2;NT5E;H6PD;FAM20C;PGLS;ATP6V0A2;PTHLH;SDHA;ADORA2B;NMRK1;NME4;COX5B;TCIRG1;NADK
13447,GO:0055025,0.634917629365292,0.741162452816416,1,24,positive regulation of cardiac muscle tissue development,BP,ERBB3
15855,GO:0072665,0.635020680998307,0.640364738061736,2,52,protein localization to vacuole,BP,TNFAIP3;SMURF1
8938,GO:0035035,0.635535781086541,0.740552938572484,1,24,histone acetyltransferase binding,MF,STAT1
6128,GO:0019432,0.635930090814486,0.740163591260442,1,24,triglyceride biosynthetic process,BP,SREBF1
7198,GO:0031112,0.636369253362433,0.739729453112343,1,24,positive regulation of microtubule polymerization or depolymerization,BP,TRPV4
16838,GO:0098815,0.637180615626029,0.738925978442762,1,24,modulation of excitatory postsynaptic potential,BP,NLGN2
3099,GO:0006692,0.637229774879826,0.738558361611987,1,25,prostanoid metabolic process,BP,CES2
3100,GO:0006693,0.637229774879826,0.738558361611987,1,25,prostaglandin metabolic process,BP,CES2
17881,GO:1902235,0.637353345381607,0.738435707992632,1,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,NCK2
17988,GO:1902532,0.637986176626701,0.464636452915992,15,392,negative regulation of intracellular signal transduction,BP,TNFAIP3;APOE;EPHB2;BCL6;SFRP1;PKD2;SERPINE2;FOXO1;DAB2IP;SPRY2;RTN4RL1;EPM2A;STAT1;ACKR3;RASA4
12483,GO:0050663,0.638155528060569,0.558736419415297,4,107,cytokine secretion,BP,POSTN;ITGB6;F2R;TRPV4
5458,GO:0016410,0.638666755080787,0.58785282068394,3,80,N-acyltransferase activity,MF,CERS4;NAT6;HGSNAT
2850,GO:0006357,0.638782045046938,0.413657754131306,63,1593,regulation of transcription by RNA polymerase II,BP,PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;BCL6;TENM2;SFRP1;POU3F1;PKD2;ZFPM1;RGMA;ETV5;SALL2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;TCFL5;RPS6KA5;HEXB;ZBTB42;PLXND1;SREBF1;PIK3R1;NCK2;ACVR1B;NFATC4;RTF1;MBD1;TRPV4;MC1R;IMPACT;NEO1;CRTC1;ERBB2;STAT1;CRY2;ZMYM3;IFI16;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;MDFI;SP100
4622,GO:0010762,0.639477927325254,0.736641146854814,1,24,regulation of fibroblast migration,BP,DMTN
11480,GO:0046031,0.640152338853607,0.586230273521968,3,80,ADP metabolic process,BP,PGM1;DHTKD1;INSR
14603,GO:0070229,0.640829844447121,0.734967696433646,1,25,negative regulation of lymphocyte apoptotic process,BP,BCL6
6639,GO:0030010,0.640905716143153,0.555845390886723,4,104,establishment of cell polarity,BP,BRSK1;KIF26B;SPRY2;MARK4
10531,GO:0043523,0.641708571327902,0.534370231769374,5,134,regulation of neuron apoptotic process,BP,APOE;F2R;ERBB3;TYRO3;MDK
14429,GO:0061842,0.641720496171971,0.73439664175502,1,24,microtubule organizing center localization,BP,SUN1
10798,GO:0044325,0.641788151623606,0.584439331774088,3,80,ion channel binding,MF,PKD2;RIMS3;SCN4B
4670,GO:0010837,0.641915679585498,0.734200626942668,1,24,regulation of keratinocyte proliferation,BP,CTSV
13730,GO:0060349,0.643334901337169,0.631407267210283,2,52,bone morphogenesis,BP,NAB2;TRPV4
1316,GO:0003179,0.643515773275682,0.732589699817276,1,24,heart valve morphogenesis,BP,ZFPM1
5308,GO:0016052,0.643799991318863,0.532074670448292,5,134,carbohydrate catabolic process,BP,PGM1;DHTKD1;INSR;GAA;HEXB
10970,GO:0044815,0.643908544509922,0.581534677263187,3,91,DNA packaging complex,CC,H1F0;H2AFJ;H1FX
11440,GO:0045933,0.644145369034265,0.731628916176223,1,25,positive regulation of muscle contraction,BP,F2R
8708,GO:0034383,0.644426588756215,0.731344306115039,1,25,low-density lipoprotein particle clearance,BP,LDLRAP1
7118,GO:0030970,0.644615402541503,0.73115309116029,1,25,retrograde protein transport, ER to cytosol,BP,TMEM129
18390,GO:1903513,0.644615402541503,0.73115309116029,1,25,endoplasmic reticulum to cytosol transport,BP,TMEM129
14094,GO:0061001,0.644690664462064,0.731402280858301,1,24,regulation of dendritic spine morphogenesis,BP,EPHA4
13224,GO:0051952,0.644737812977856,0.731029070384472,1,25,regulation of amine transport,BP,SV2A
11877,GO:0046949,0.645003769618929,0.730759469534501,1,25,fatty-acyl-CoA biosynthetic process,BP,ACSL1
3584,GO:0008028,0.645190115688045,0.730570451318632,1,25,monocarboxylic acid transmembrane transporter activity,MF,SLC16A5
11763,GO:0046677,0.645262285563569,0.49391119659655,8,216,response to antibiotic,BP,TNFAIP3;FOXO1;UROS;ENDOG;HYAL1;TP53INP1;IMPACT;STAT1
3576,GO:0008016,0.645695085759622,0.550457326578571,4,107,regulation of heart contraction,BP,THRA;GAA;SCN4B;SREBF1
2304,GO:0005319,0.64573418606618,0.580100378445126,3,80,lipid transporter activity,MF,APOE;ANO9;ABCC1
2744,GO:0006171,0.645919909518302,0.729829249119727,1,25,cAMP biosynthetic process,BP,PTHLH
13781,GO:0060416,0.645935752299525,0.730139673709,1,24,response to growth hormone,BP,PIK3R1
4167,GO:0009261,0.646111191574261,0.72963472802546,1,25,ribonucleotide catabolic process,BP,NT5E
8132,GO:0032885,0.646288016067128,0.729781658791742,1,24,regulation of polysaccharide biosynthetic process,BP,INSR
13534,GO:0060042,0.646507937793193,0.729557968564285,1,24,retina morphogenesis in camera-type eye,BP,SDK2
1116,GO:0002712,0.646520931999474,0.729217701044774,1,25,regulation of B cell mediated immunity,BP,BCL6
1211,GO:0002889,0.646520931999474,0.729217701044774,1,25,regulation of immunoglobulin mediated immune response,BP,BCL6
9860,GO:0042169,0.646621754859605,0.729442147400171,1,24,SH2 domain binding,MF,TRPV4
2862,GO:0006376,0.647303939081124,0.72841944680866,1,25,mRNA splice site selection,BP,SRSF5
4475,GO:0010518,0.648148487537316,0.727556502229966,1,25,positive regulation of phospholipase activity,BP,EGFR
2929,GO:0006473,0.648375763285411,0.511840057655967,6,162,protein acetylation,BP,NAT6;FOXO1;YEATS4;RPS6KA5;HINT2;CAMK1
4373,GO:0010043,0.648746121091052,0.726641270590389,1,26,response to zinc ion,BP,MT2A
8645,GO:0034243,0.649520304689613,0.726150476448606,1,25,regulation of transcription elongation from RNA polymerase II promoter,BP,RTF1
12363,GO:0048841,0.649620287295976,0.726377562869589,1,24,regulation of axon extension involved in axon guidance,BP,WNT3
4684,GO:0010862,0.65012829932311,0.72552560239394,1,25,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,ACVR1B
7138,GO:0031018,0.650174630758489,0.725477941328512,1,25,endocrine pancreas development,BP,FOXO1
4508,GO:0010591,0.650257965145577,0.725392199927457,1,25,regulation of lamellipodium assembly,BP,DMTN
15950,GO:0086002,0.650297040837689,0.725682356091959,1,24,cardiac muscle cell action potential involved in contraction,BP,SCN4B
14787,GO:0070566,0.650673015745011,0.724964864880618,1,25,adenylyltransferase activity,MF,OAS2
17561,GO:1901264,0.650836088206867,0.622878076698161,2,55,carbohydrate derivative transport,BP,CYBA;SLC29A4
6081,GO:0019319,0.651066068438961,0.622624562403014,2,55,hexose biosynthetic process,BP,PGM1;FOXO1
6670,GO:0030057,0.651136045214057,0.724818653345634,1,24,desmosome,CC,PPL
7793,GO:0032368,0.651335637082428,0.622431529487547,2,54,regulation of lipid transport,BP,APOE;LDLRAP1
9046,GO:0035315,0.651538912649341,0.724071749179091,1,25,hair cell differentiation,BP,SLITRK6
4805,GO:0014020,0.651952878444361,0.57320835249596,3,80,primary neural tube formation,BP,SFRP1;TULP3;VANGL2
8403,GO:0033522,0.653264727317009,0.722285252033211,1,25,histone H2A ubiquitination,BP,DDB2
4511,GO:0010594,0.653500331128644,0.541759203088132,4,108,regulation of endothelial cell migration,BP,APOE;DAB2IP;MAP3K3;SP100
3538,GO:0007589,0.653730106213123,0.619784406919392,2,54,body fluid secretion,BP,CYBA;OAS2
19439,GO:1990204,0.653877603693547,0.570623345117872,3,88,oxidoreductase complex,CC,CYBA;DHTKD1;SDHA
7816,GO:0032392,0.654095340641832,0.570758783959436,3,81,DNA geometric change,BP,DDB2;SMARCA1;XPC
17759,GO:1901890,0.654107068300345,0.721410171042585,1,25,positive regulation of cell junction assembly,BP,SFRP1
11541,GO:0046131,0.654971555171726,0.719916300047789,1,27,pyrimidine ribonucleoside metabolic process,BP,NME4
13136,GO:0051781,0.655043086292345,0.618327727672619,2,54,positive regulation of cell division,BP,VEGFB;MDK
4051,GO:0009119,0.655067562377809,0.569501166431221,3,84,ribonucleoside metabolic process,BP,GAMT;NT5E;NME4
16138,GO:0090200,0.655128321169933,0.719752576957376,1,27,positive regulation of release of cytochrome c from mitochondria,BP,TNFSF10
11026,GO:0045058,0.655160340765053,0.72031306824159,1,25,T cell selection,BP,ZFPM1
8054,GO:0032757,0.655212433498753,0.719950133105559,1,26,positive regulation of interleukin-8 production,BP,F2R
7050,GO:0030857,0.655254746110674,0.720214577116935,1,25,negative regulation of epithelial cell differentiation,BP,STAT1
11437,GO:0045930,0.655262759402849,0.468396894912037,10,273,negative regulation of mitotic cell cycle,BP,GPNMB;EGFR;BCL6;BRSK1;PKD2;WNT9A;XPC;PCBP4;TOM1L2;GJC2
3408,GO:0007212,0.655456748448531,0.719694956419865,1,26,dopamine receptor signaling pathway,BP,NSG1
4061,GO:0009132,0.656108995512983,0.538769401647898,4,110,nucleoside diphosphate metabolic process,BP,PGM1;DHTKD1;INSR;NME4
8948,GO:0035066,0.656128497920902,0.718992447264733,1,26,positive regulation of histone acetylation,BP,RPS6KA5
15254,GO:0071480,0.657015331092209,0.718062991467087,1,26,cellular response to gamma radiation,BP,CYBA
8471,GO:0033673,0.657047166373655,0.480956447121483,8,217,negative regulation of kinase activity,BP,TNFAIP3;APOE;EPHB2;SFRP1;WWTR1;DAB2IP;SPRY2;RTN4RL1
14767,GO:0070536,0.657749183979787,0.717602775642002,1,25,protein K63-linked deubiquitination,BP,TNFAIP3
18200,GO:1903051,0.657911401483745,0.615027429249137,2,55,negative regulation of proteolysis involved in cellular protein catabolic process,BP,LAMP3;EPHA4
4794,GO:0014003,0.657998488136172,0.717029896338931,1,26,oligodendrocyte development,BP,TENM4
3782,GO:0008378,0.658235779521978,0.716780128067841,1,26,galactosyltransferase activity,MF,B3GNT9
15151,GO:0071333,0.658281271520055,0.565950686555089,3,83,cellular response to glucose stimulus,BP,CYBA;ENDOG;GPR68
15947,GO:0085029,0.658355567019462,0.716965114437555,1,25,extracellular matrix assembly,BP,TNXB
2356,GO:0005496,0.658486573396722,0.614384538578887,2,55,steroid binding,MF,APOE;HSD11B1
2503,GO:0005770,0.658511582243014,0.488823456254036,7,190,late endosome,CC,MVB12B;EGFR;NSG1;F2R;ANKRD13D;MICALL1;VPS33B
10383,GO:0043255,0.658673198355747,0.614390651568994,2,53,regulation of carbohydrate biosynthetic process,BP,INSR;FOXO1
11359,GO:0045778,0.65868962349528,0.614262812843616,2,54,positive regulation of ossification,BP,IFITM1;FAM20C
9931,GO:0042339,0.659318608493794,0.7156382657185,1,26,keratan sulfate metabolic process,BP,HEXB
894,GO:0002279,0.659506624774975,0.715439648032127,1,26,mast cell activation involved in immune response,BP,ADORA2B
10413,GO:0043303,0.659506624774975,0.715439648032127,1,26,mast cell degranulation,BP,ADORA2B
11737,GO:0046632,0.659562530261487,0.613285528934054,2,54,alpha-beta T cell differentiation,BP,BCL6;ZFPM1
11430,GO:0045921,0.659850603867664,0.612857072234186,2,55,positive regulation of exocytosis,BP,ZP3;ADORA2B
11334,GO:0045736,0.660270535933599,0.71463159229789,1,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,TNFAIP3
1208,GO:0002886,0.660530803386998,0.71435589154043,1,26,regulation of myeloid leukocyte mediated immunity,BP,ADORA2B
7730,GO:0032268,0.66065803204496,0.387371439238802,74,1893,regulation of cellular protein metabolic process,BP,TNFAIP3;APOE;IFI6;LAMP3;GPNMB;MAP3K14;EPHB2;EGFR;FBXO2;FGFR4;BCL6;SFRP1;UNK;TNFSF10;INSR;PKD2;PPP2R2C;SERPINE2;WWTR1;RHBDF1;FOXO1;DAB2IP;COL7A1;TBX1;SHC2;CRTAP;TET1;EPHA4;WNT9A;RPL13A;MAGEF1;F2R;RPS6KA5;ACSL1;ERBB3;SPOCK1;FRY;SREBF1;CSPG4;DMTN;NCK2;ACVR1B;CAMKK1;NAB2;SNX33;TYRO3;RTF1;SPRY2;TNFRSF19;TRPV4;MTHFR;PPP1R35;ADORA2B;SERPING1;RTN4RL1;IMPACT;IGFBP4;ERBB2;CDK20;HINT2;ACKR3;CRY2;FURIN;IFI16;GJC2;NUAK1;SMURF1;MEX3A;CAMK1;ELFN2;MAP3K3;PPP1R14A;NRK;VANGL2
3592,GO:0008047,0.660981854683505,0.439807892439075,15,393,enzyme activator activity,MF,APOE;VAV3;DAB2IP;EVI5L;ARHGEF19;ERBB3;APPL2;ACAP3;ARHGAP40;SPRY2;TBC1D17;CDK20;ALS2CL;PLXNB1;RASA4
15055,GO:0071108,0.661585480619082,0.713550372503448,1,25,protein K48-linked deubiquitination,BP,TNFAIP3
19865,GO:2000401,0.661592707961013,0.713228943463363,1,26,regulation of lymphocyte migration,BP,CXCL14
5188,GO:0015804,0.662393222596666,0.712377187910293,1,26,neutral amino acid transport,BP,SLC1A4
12862,GO:0051248,0.662496862819844,0.405308603249468,34,890,negative regulation of protein metabolic process,BP,TNFAIP3;APOE;IFI6;LAMP3;EPHB2;EGFR;SFRP1;UNK;ZFPM1;SERPINE2;WWTR1;FOXO1;DAB2IP;COL7A1;CRTAP;EPHA4;WNT9A;RPL13A;SPOCK1;FRY;DMTN;NCK2;SPRY2;PPP1R35;SERPING1;RTN4RL1;IMPACT;HINT2;CRY2;FURIN;IFI16;MEX3A;ELFN2;PPP1R14A
10398,GO:0043277,0.662903543873169,0.711833207864433,1,26,apoptotic cell clearance,BP,TYRO3
10351,GO:0043207,0.663421947923856,0.426095782355721,19,510,response to external biotic stimulus,BP,TNFAIP3;IFITM1;MAP3K14;HTRA1;CYBA;OAS2;DAB2IP;PRSS3;KLK5;WIPF1;F2R;DDX60;ACTA2;TRIM22;HYAL1;STAT1;WIPI2;IFI16;CCDC88B
13101,GO:0051707,0.663421947923856,0.426095782355721,19,510,response to other organism,BP,TNFAIP3;IFITM1;MAP3K14;HTRA1;CYBA;OAS2;DAB2IP;PRSS3;KLK5;WIPF1;F2R;DDX60;ACTA2;TRIM22;HYAL1;STAT1;WIPI2;IFI16;CCDC88B
5139,GO:0015695,0.663471972706676,0.711226375610761,1,26,organic cation transport,BP,SLC47A1
19571,GO:1990752,0.66361382384103,0.711390178317906,1,25,microtubule end,CC,CLIP2
11488,GO:0046039,0.663738301866513,0.710649919138796,1,27,GTP metabolic process,BP,NME4
8037,GO:0032728,0.663835740638872,0.710837526125259,1,26,positive regulation of interferon-beta production,BP,RNF135
2772,GO:0006221,0.663896743608237,0.710209559540513,1,28,pyrimidine nucleotide biosynthetic process,BP,NME4
11641,GO:0046460,0.664096587635778,0.710558450893026,1,26,neutral lipid biosynthetic process,BP,SREBF1
11644,GO:0046463,0.664096587635778,0.710558450893026,1,26,acylglycerol biosynthetic process,BP,SREBF1
2231,GO:0005154,0.66426432880337,0.71037888049812,1,26,epidermal growth factor receptor binding,MF,VAV3
9566,GO:0036452,0.664380533628653,0.709962149293799,1,27,ESCRT complex,CC,MVB12B
4499,GO:0010569,0.664472238516583,0.710156192181462,1,26,regulation of double-strand break repair via homologous recombination,BP,MAGEF1
8137,GO:0032890,0.665077642828253,0.70950701839332,1,26,regulation of organic acid transport,BP,SV2A
10971,GO:0044818,0.66550381258794,0.709049379257137,1,26,mitotic G2/M transition checkpoint,BP,BRSK1
14513,GO:0070076,0.666257237998351,0.708556509114267,1,25,histone lysine demethylation,BP,HR
15147,GO:0071326,0.666264460064073,0.556858587366968,3,84,cellular response to monosaccharide stimulus,BP,CYBA;ENDOG;GPR68
15149,GO:0071331,0.666264460064073,0.556858587366968,3,84,cellular response to hexose stimulus,BP,CYBA;ENDOG;GPR68
7282,GO:0031301,0.666279529317911,0.506872493172178,5,140,integral component of organelle membrane,CC,PTPRS;SV2A;PQLC2;SUN1;PEX11B
3054,GO:0006636,0.666420510595858,0.707769338809903,1,27,unsaturated fatty acid biosynthetic process,BP,ALOXE3
11308,GO:0045668,0.667161590107215,0.707264000858181,1,26,negative regulation of osteoblast differentiation,BP,SFRP1
7829,GO:0032411,0.667356458587959,0.604379850268359,2,55,positive regulation of transporter activity,BP,EPHB2;PKD2
5270,GO:0015949,0.668140214491201,0.705637346258397,1,28,nucleobase-containing small molecule interconversion,BP,NME4
7863,GO:0032452,0.668177412734107,0.706484971795359,1,25,histone demethylase activity,MF,HR
6270,GO:0019898,0.668294675183503,0.477926820477494,7,189,extrinsic component of membrane,CC,SERPINE2;S100A6;PIK3R1;SYTL1;SNX33;MICALL1;WIPI2
17712,GO:1901701,0.668656356636089,0.406527774121032,27,706,cellular response to oxygen-containing compound,BP,TNFAIP3;SRSF5;COL6A1;EGFR;CYBA;SFRP1;INSR;PKD2;FOXO1;WNT3;DAB2IP;TBX1;EPHA4;WNT9A;ATP6V0A2;SREBF1;DMTN;ENDOG;PIK3R1;NFATC4;FAM210B;VAMP2;TP53INP1;IMPACT;GPR68;STAT1;TCIRG1
11342,GO:0045744,0.668660006981468,0.705347647896504,1,27,negative regulation of G-protein coupled receptor protein signaling pathway,BP,DNM1
13710,GO:0060325,0.66906097621512,0.705208231195198,1,26,face morphogenesis,BP,TBX1
9871,GO:0042220,0.669068455607997,0.705200114414544,1,26,response to cocaine,BP,HOMER2
17832,GO:1902107,0.669322373227472,0.55336716162381,3,84,positive regulation of leukocyte differentiation,BP,GLI2;BCL6;GPR68
3252,GO:0006939,0.669849346511543,0.601537123760599,2,55,smooth muscle contraction,BP,F2R;ADORA2B
15593,GO:0072132,0.6710282988747,0.703067396883097,1,26,mesenchyme morphogenesis,BP,ACTA2
20055,GO:2000758,0.671115699334477,0.702674710343957,1,27,positive regulation of peptidyl-lysine acetylation,BP,RPS6KA5
1014,GO:0002521,0.67126989082559,0.445114619889569,11,295,leukocyte differentiation,BP,GLI2;BCL6;SFRP1;ZFPM1;FAM20C;FAM213A;PIK3R1;TYRO3;GPR68;ERBB2;IFI16
17688,GO:1901658,0.671833556467793,0.701613596311362,1,28,glycosyl compound catabolic process,BP,NT5E
5252,GO:0015918,0.671973471252381,0.599000628146637,2,56,sterol transport,BP,APOE;LDLRAP1
10543,GO:0043539,0.672079572412826,0.701620545799881,1,27,protein serine/threonine kinase activator activity,MF,SPRY2
8187,GO:0032964,0.672126870020583,0.701568744427401,1,27,collagen biosynthetic process,BP,F2R
7322,GO:0031369,0.672277166458103,0.701404091022779,1,27,translation initiation factor binding,MF,ANGEL1
6569,GO:0022602,0.673145924449495,0.700749803994159,1,26,ovulation cycle process,BP,ZP3
12844,GO:0051222,0.673251681756995,0.442893118676413,11,298,positive regulation of protein transport,BP,POSTN;EGFR;NLGN2;GLUL;F2R;STOM;VAMP2;TRPV4;GPR68;ERBB2;CAMK1
7189,GO:0031100,0.673407342378757,0.5972524262155,2,57,animal organ regeneration,BP,SRSF5;EGFR
8131,GO:0032881,0.673410135235982,0.700459679128139,1,26,regulation of polysaccharide metabolic process,BP,INSR
15002,GO:0070988,0.673784827776528,0.597021402432086,2,55,demethylation,BP,HR;TET1
1109,GO:0002705,0.674025740625716,0.59654007385494,2,57,positive regulation of leukocyte mediated immunity,BP,ZP3;ADORA2B
17301,GO:1900026,0.674053377193903,0.699452959272119,1,27,positive regulation of substrate adhesion-dependent cell spreading,BP,DMTN
984,GO:0002448,0.674234169698233,0.699253818332175,1,27,mast cell mediated immunity,BP,ADORA2B
371,GO:0000993,0.675198597205452,0.698189808619402,1,27,RNA polymerase II core binding,MF,RTF1
19649,GO:2000008,0.675307211973693,0.698069798807146,1,27,regulation of protein localization to cell surface,BP,SNX33
11084,GO:0045143,0.675441080437623,0.697921835673947,1,27,homologous chromosome segregation,BP,SUN1
17709,GO:1901698,0.675485617450772,0.397880523937219,28,733,response to nitrogen compound,BP,TNFAIP3;APOE;SRSF5;COL6A1;EGFR;FBXO2;CYBA;SFRP1;TNFSF10;INSR;PKD2;TMEM129;FOXO1;UROS;EPHA4;HOMER2;ATP6V0A2;SREBF1;DMTN;PIK3R1;SLC2A1;VAMP2;TRPV4;MTHFR;IMPACT;STAT1;TCIRG1;SORT1
1358,GO:0003254,0.675590369115678,0.697756763374539,1,27,regulation of membrane depolarization,BP,IFI6
2927,GO:0006470,0.675598127898265,0.45250330913901,9,244,protein dephosphorylation,BP,PTPRS;PPP2R2C;PDPR;PPP1R35;CRY2;PLPP2;NUAK1;ELFN2;PPP1R14A
8041,GO:0032732,0.675649330859826,0.697691548867175,1,27,positive regulation of interleukin-1 production,BP,IFI16
12972,GO:0051445,0.67568931637459,0.697647316851882,1,27,regulation of meiotic cell cycle,BP,INSR
3338,GO:0007088,0.675725307282956,0.496143463621664,5,140,regulation of mitotic nuclear division,BP,OBSL1;INSR;CUL9;TOM1L2;FBXW5
1228,GO:0002931,0.675855832301317,0.697463063526776,1,27,response to ischemia,BP,MLYCD
12778,GO:0051123,0.676363353568736,0.696621548297572,1,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
10410,GO:0043300,0.676842609570223,0.696369409553398,1,27,regulation of leukocyte degranulation,BP,ADORA2B
2602,GO:0005925,0.677128845894985,0.429347461951184,13,353,focal adhesion,CC,ITGB6;TNS1;FLNC;EGFR;CYBA;PARVB;RPL13A;DIXDC1;CSPG4;TRPV4;ITGB5;MRC2;AIF1L
13079,GO:0051656,0.67761931764113,0.428829621874708,13,349,establishment of organelle localization,BP,SHROOM2;DNM1;RIMS3;SYT8;COL7A1;TRAPPC2L;SYTL1;VAMP2;SPRY2;ADORA2B;C2CD4C;BLOC1S4;SUN1
11706,GO:0046579,0.678244668009871,0.694810288680098,1,27,positive regulation of Ras protein signal transduction,BP,F2R
7085,GO:0030901,0.678527817773197,0.591328199818005,2,57,midbrain development,BP,SFRP1;WNT3
12093,GO:0048207,0.679532900882809,0.590158429980146,2,57,vesicle targeting, rough ER to cis-Golgi,BP,COL7A1;TRAPPC2L
12094,GO:0048208,0.679532900882809,0.590158429980146,2,57,COPII vesicle coating,BP,COL7A1;TRAPPC2L
3447,GO:0007276,0.680575294562202,0.421719152708208,14,376,gamete generation,BP,GAMT;TXNRD3;BCL6;ETV5;WNT3;CRTAP;TCFL5;CTSV;HEXB;TYRO3;ZP3;CABYR;SUN1;SCMH1
709,GO:0001938,0.680614677318568,0.588896846581294,2,57,positive regulation of endothelial cell proliferation,BP,CYBA;VEGFB
2601,GO:0005924,0.680662135832415,0.42542626703338,13,354,cell-substrate adherens junction,CC,ITGB6;TNS1;FLNC;EGFR;CYBA;PARVB;RPL13A;DIXDC1;CSPG4;TRPV4;ITGB5;MRC2;AIF1L
12329,GO:0048747,0.681646398688832,0.69100192237421,1,27,muscle fiber development,BP,FLNC
616,GO:0001786,0.681684600180713,0.690958947698304,1,27,phosphatidylserine binding,MF,PLCD1
7405,GO:0031526,0.683506240987817,0.688904338748545,1,27,brush border membrane,CC,CYBRD1
12275,GO:0048662,0.683532303490429,0.68859054085625,1,28,negative regulation of smooth muscle cell proliferation,BP,TNFAIP3
3308,GO:0007031,0.683539192822239,0.688582745197333,1,28,peroxisome organization,BP,PEX11B
16725,GO:0098562,0.683674547211432,0.487043254755011,5,139,cytoplasmic side of membrane,CC,PKD2;LDLRAP1;DAB2IP;S100A6;RASA4
16451,GO:0097190,0.68382358719383,0.408757348395423,17,464,apoptotic signaling pathway,BP,TNFAIP3;IFI6;SFRP1;TNFSF10;DAB2IP;MNT;ERBB3;PIK3R1;NCK2;ACVR1B;NFATC4;RBCK1;TP53INP1;ACKR3;IFI16;SP100;SORT1
10321,GO:0043167,0.68438682583266,0.350548228648854,175,4374,ion binding,MF,TNFAIP3;POSTN;PEG3;SMOC2;APOE;ALDH1A3;ULK2;PTPRS;PHF7;ZNF704;GPNMB;S100A4;MAP3K14;EPHB2;LENG9;ASH2L;PRICKLE2;TXNRD3;EGFR;ADAM19;THRA;CYBA;SNN;OAS2;TCEA2;GLI2;FGFR4;CDK18;IRF2BPL;CALML3;BCL6;PGM1;TENM2;CYP4F22;PSD4;ZNF318;BRSK1;SFRP1;UNK;TNFSF10;DHTKD1;INSR;VAV3;NPEPL1;CYBRD1;DHX32;MATN2;PKD2;ZFPM1;NAT6;ARSI;DNM1;LDLRAP1;NT5E;SYT8;SERPINE2;HR;TNXB;SALL2;VEGFB;TMEM129;TRIM65;ZSCAN18;DAB2IP;OBSCN;PRSS3;SGSH;TRERF1;FKBP9;RAB40B;TET1;CYP27C1;FAM20C;GLUL;EPHA4;ZNF266;RNPEPL1;ZNF687;SMARCA1;KIF26B;RPS6KA5;TUB;SEC14L2;LTBP1;PLCD3;ZNF362;ACSL1;ZBTB42;DDX60;ACTA2;ERBB3;KIF26A;S100A6;SPOCK1;CDK14;CUL9;CGREF1;ENDOG;GRK6;ACAP3;TRIM22;ACVR1B;CAMKK1;SYTL1;SNX29;IMPA2;ATP12A;SNX33;TYRO3;RHOD;CKMT1A;VAMP2;ADAMTS15;RBCK1;ZNF554;SCG5;MBD1;CABYR;MDK;TRPV4;MTHFR;GPC4;MSRB2;SDHA;LTBP4;NMRK1;MYL9;RTN4RL1;MARK4;PDLIM4;MVD;MICALL1;ERBB2;C2CD4C;RNF187;RNF135;PCDH1;TULP3;NME4;CDK20;RNF44;WIPI2;PLCD1;CRY2;MARCH9;COX5B;ZMYM3;FURIN;CLCN7;THNSL2;NINL;MMP1;NUAK1;ALOXE3;RASA4;SMURF1;CAPNS2;MEX3A;CXXC5;CAMK1;ZNF446;NISCH;RNF208;AIF1L;MT2A;NADK;RAB43;ZCCHC24;MAP3K3;ZSWIM8;DTNB;ABCC1;DDX59;NRK;CBR3
17495,GO:1901031,0.684608674762715,0.687370737294975,1,28,regulation of response to reactive oxygen species,BP,ENDOG
13460,GO:0055067,0.685137510660609,0.534929123820878,3,86,monovalent inorganic cation homeostasis,BP,ATP6V0A2;ATP12A;TCIRG1
7887,GO:0032482,0.685558418592729,0.582904952852716,2,59,Rab protein signal transduction,BP,RAB40B;RAB43
7943,GO:0032570,0.685680907275004,0.686151952836402,1,28,response to progesterone,BP,SREBF1
1310,GO:0003170,0.68593556181832,0.686147923774155,1,27,heart valve development,BP,ZFPM1
18643,GO:1904030,0.685937173840363,0.685860115996775,1,28,negative regulation of cyclin-dependent protein kinase activity,BP,TNFAIP3
16599,GO:0097502,0.686326254940677,0.685416627779592,1,28,mannosylation,BP,PIGZ
11593,GO:0046332,0.686635419436989,0.581928315518333,2,56,SMAD binding,MF,ACVR1B;SMURF1
5297,GO:0016032,0.687038320922217,0.389391605285485,25,677,viral process,BP,IFITM1;ITGB6;APOE;MVB12B;LAMP3;EGFR;OAS2;INSR;CTSB;RPL13A;PIK3R1;TRIM22;TYRO3;STOM;RBCK1;EFNB3;ITGB5;CRTC1;STAT1;ACKR3;FURIN;IFI16;MMP1;RAB43;SP100
18110,GO:1902893,0.687525229755255,0.684333998435759,1,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4
2375,GO:0005524,0.687727262218765,0.370232179630751,45,1149,ATP binding,MF,ULK2;MAP3K14;EPHB2;EGFR;OAS2;FGFR4;CDK18;BRSK1;INSR;DHX32;OBSCN;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;ACVR1B;CAMKK1;ATP12A;TYRO3;CKMT1A;TRPV4;NMRK1;MARK4;MVD;ERBB2;NME4;CDK20;CLCN7;NUAK1;CAMK1;NADK;MAP3K3;ABCC1;DDX59;NRK
5891,GO:0018149,0.688227615056882,0.682725579777528,1,30,peptide cross-linking,BP,PRR9
12249,GO:0048599,0.688280742133999,0.6831814817464,1,28,oocyte development,BP,ZP3
11858,GO:0046915,0.688342686534441,0.683110441250579,1,28,transition metal ion transmembrane transporter activity,MF,SLC39A6
12310,GO:0048709,0.689497710956511,0.578337774009432,2,58,oligodendrocyte differentiation,BP,TENM4;ERBB2
980,GO:0002443,0.690323118398282,0.399028405528091,18,492,leukocyte mediated immunity,BP,CYBA;BCL6;PGM1;GAA;CTSB;PRSS3;HEXB;SCART1;HGSNAT;CXCR1;METTL7A;ZP3;STOM;VAMP2;ADORA2B;SERPING1;IL20RB;TCIRG1
12803,GO:0051153,0.690395396906764,0.577270425687483,2,58,regulation of striated muscle cell differentiation,BP,THRA;TBX1
6859,GO:0030374,0.690476530752494,0.577272415968423,2,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,THRA;TRERF1
10942,GO:0044764,0.690597406036941,0.680516184408354,1,28,multi-organism cellular process,BP,DDX60
7300,GO:0031329,0.690656149753843,0.384048903809543,26,691,regulation of cellular catabolic process,BP,TNFAIP3;APOE;LAMP3;ULK2;INSR;TP53INP2;RHBDF1;FOXO1;TRIM65;RASIP1;DAB2IP;EPHA4;MAGEF1;TYSND1;ATP6V0A2;SREBF1;ENDOG;TRIM22;SNX33;PCBP4;TP53INP1;EPM2A;FURIN;IFI16;MLYCD;SMURF1
5712,GO:0016877,0.690675168289296,0.680426417842699,1,28,ligase activity, forming carbon-sulfur bonds,MF,ACSL1
4811,GO:0014033,0.690908950930482,0.57675756880274,2,57,neural crest cell differentiation,BP,SFRP1;TBX1
4337,GO:0009948,0.691052337269675,0.679990745450083,1,28,anterior/posterior axis specification,BP,WNT3
4239,GO:0009583,0.691080352369912,0.679958366400277,1,28,detection of light stimulus,BP,REEP6
2945,GO:0006493,0.691250419311466,0.527720125422432,3,86,protein O-linked glycosylation,BP,VEGFB;TET1;B3GNT9
16041,GO:0090049,0.69160340709098,0.67935336517812,1,28,regulation of cell migration involved in sprouting angiogenesis,BP,MAP3K3
269,GO:0000768,0.691624856868417,0.679328535844657,1,28,syncytium formation by plasma membrane fusion,BP,CAMK1
11767,GO:0046685,0.691670113554077,0.679006522110595,1,29,response to arsenic-containing substance,BP,UROS
11590,GO:0046329,0.691730790941302,0.679205889135786,1,28,negative regulation of JNK cascade,BP,SFRP1
8725,GO:0034405,0.691932611805967,0.678972126742157,1,28,response to fluid shear stress,BP,PKD2
194,GO:0000413,0.691994401184268,0.678379102938727,1,30,protein peptidyl-prolyl isomerization,BP,FKBP9
1467,GO:0003755,0.691994401184268,0.678379102938727,1,30,peptidyl-prolyl cis-trans isomerase activity,MF,FKBP9
19126,GO:1905207,0.692102234123936,0.678775555979175,1,28,regulation of cardiocyte differentiation,BP,EGFR
2090,GO:0004869,0.692104819317899,0.678502662794692,1,29,cysteine-type endopeptidase inhibitor activity,MF,SPOCK1
554,GO:0001676,0.692355396800783,0.574838103024764,2,59,long-chain fatty acid metabolic process,BP,ACSL1;ALOXE3
4325,GO:0009894,0.69265010376766,0.378070874249129,29,769,regulation of catabolic process,BP,TNFAIP3;APOE;LAMP3;ULK2;EGFR;THRA;INSR;SERPINE2;TP53INP2;RHBDF1;FOXO1;TRIM65;RASIP1;DAB2IP;EPHA4;MAGEF1;TYSND1;ATP6V0A2;SREBF1;ENDOG;TRIM22;SNX33;PCBP4;TP53INP1;EPM2A;FURIN;IFI16;MLYCD;SMURF1
762,GO:0002020,0.692660133562,0.525994408030034,3,87,protease binding,MF,TNFAIP3;TYSND1;FURIN
10035,GO:0042558,0.69306142278743,0.677391706228543,1,29,pteridine-containing compound metabolic process,BP,MTHFR
9356,GO:0035924,0.693312946841754,0.677369759843676,1,28,cellular response to vascular endothelial growth factor stimulus,BP,DAB2IP
12609,GO:0050853,0.693743625506353,0.676868526807389,1,28,B cell receptor signaling pathway,BP,VAV3
3228,GO:0006900,0.693747726642423,0.524701456261134,3,87,vesicle budding from membrane,BP,DNM1;COL7A1;TRAPPC2L
19760,GO:2000242,0.694119779487177,0.676159082772916,1,29,negative regulation of reproductive process,BP,ZP3
10190,GO:0042887,0.694295248807379,0.675954365332262,1,29,amide transmembrane transporter activity,MF,ABCC1
5546,GO:0016577,0.694465670162913,0.676318614248422,1,27,histone demethylation,BP,HR
11608,GO:0046364,0.695066424233857,0.571498112341605,2,60,monosaccharide biosynthetic process,BP,PGM1;FOXO1
8977,GO:0035148,0.695255387795416,0.493652845139786,4,113,tube formation,BP,SFRP1;DAB2IP;TULP3;VANGL2
6909,GO:0030522,0.695313925391393,0.437848098574376,8,221,intracellular receptor signaling pathway,BP,TNFAIP3;THRA;SFRP1;TBX1;DDX60;SREBF1;CRY2;ALOXE3
17661,GO:1901606,0.695966802607682,0.570415608322067,2,60,alpha-amino acid catabolic process,BP,GLUL;THNSL2
13517,GO:0060021,0.695970662646434,0.570698426879309,2,57,roof of mouth development,BP,EPHB2;TBX1
9306,GO:0035821,0.696110883349643,0.521781289301397,3,89,modification of morphology or physiology of other organism,BP,APOE;INSR;STOM
704,GO:0001933,0.696185994726689,0.412329470285862,12,330,negative regulation of protein phosphorylation,BP,TNFAIP3;APOE;EPHB2;SFRP1;WWTR1;FOXO1;DAB2IP;DMTN;NCK2;SPRY2;RTN4RL1;IMPACT
15510,GO:0071985,0.696364497095367,0.673532543891783,1,29,multivesicular body sorting pathway,BP,SORT1
3208,GO:0006874,0.696763689573588,0.445419354566532,7,196,cellular calcium ion homeostasis,BP,APOE;CYBA;SV2A;PKD2;F2R;HEXB;TRPV4
5208,GO:0015837,0.696900927257418,0.672902400497152,1,29,amine transport,BP,SV2A
6668,GO:0030055,0.697130213134287,0.407011342001554,13,358,cell-substrate junction,CC,ITGB6;TNS1;FLNC;EGFR;CYBA;PARVB;RPL13A;DIXDC1;CSPG4;TRPV4;ITGB5;MRC2;AIF1L
5382,GO:0016239,0.697335248860152,0.568955250562329,2,58,positive regulation of macroautophagy,BP,EPM2A;SMURF1
3886,GO:0008543,0.698060982437871,0.519551503459559,3,87,fibroblast growth factor receptor signaling pathway,BP,FGFR4;FAM20C;SPRY2
3610,GO:0008081,0.698337851878828,0.567744552007183,2,58,phosphoric diester hydrolase activity,MF,PLCD3;PLCD1
5455,GO:0016407,0.698584661537005,0.518871611253745,3,88,acetyltransferase activity,MF,CRAT;NAT6;HGSNAT
13209,GO:0051926,0.698857699880168,0.670595670493389,1,29,negative regulation of calcium ion transport,BP,PKD2
10920,GO:0044665,0.69902049799025,0.670403181298673,1,29,MLL1/2 complex,CC,ASH2L
15155,GO:0071339,0.69902049799025,0.670403181298673,1,29,MLL1 complex,CC,ASH2L
360,GO:0000979,0.699558950450677,0.669765894221465,1,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,STAT1
5541,GO:0016572,0.699857968571995,0.669411570923031,1,29,histone phosphorylation,BP,RPS6KA5
17837,GO:1902116,0.700304757510533,0.668881586720369,1,29,negative regulation of organelle assembly,BP,EVI5L
4356,GO:0009994,0.701157428460698,0.667868280206737,1,29,oocyte differentiation,BP,ZP3
3151,GO:0006778,0.701379430741231,0.667346948857185,1,30,porphyrin-containing compound metabolic process,BP,UROS
10515,GO:0043500,0.703143236853218,0.561811884257391,2,59,muscle adaptation,BP,CYBA;FOXO1
5701,GO:0016859,0.703143876131985,0.664998696308398,1,31,cis-trans isomerase activity,MF,FKBP9
3797,GO:0008406,0.703205099244662,0.464133910979181,5,143,gonad development,BP,SFRP1;TNFSF10;INSR;CTSV;ZP3
9,GO:0000018,0.703358054630869,0.561549669803083,2,59,regulation of DNA recombination,BP,BCL6;MAGEF1
12767,GO:0051101,0.70336870254993,0.513011413165004,3,90,regulation of DNA binding,BP,IFI16;MDFI;SP100
6810,GO:0030291,0.703407071932334,0.664924760713551,1,30,protein serine/threonine kinase inhibitor activity,MF,SPRY2
9831,GO:0042113,0.703809126351758,0.463419576105855,5,143,B cell activation,BP,TNFAIP3;BCL6;SFRP1;VAV3;PIK3R1
15145,GO:0071322,0.70464954882685,0.511511899695528,3,89,cellular response to carbohydrate stimulus,BP,CYBA;ENDOG;GPR68
3431,GO:0007257,0.704655975223566,0.663962694067948,1,28,activation of JUN kinase activity,BP,DAB2IP
13721,GO:0060338,0.705653022784211,0.662485074452572,1,29,regulation of type I interferon-mediated signaling pathway,BP,STAT1
4696,GO:0010876,0.705899682475263,0.425621870395584,8,223,lipid localization,BP,APOE;CPT2;ANO9;LDLRAP1;HEXB;ACSL1;NME4;ABCC1
12821,GO:0051181,0.706164695293944,0.661608124776172,1,30,cofactor transport,BP,ABCC1
12368,GO:0048846,0.706865636472084,0.661300399815318,1,28,axon extension involved in axon guidance,BP,WNT3
17903,GO:1902284,0.706865636472084,0.661300399815318,1,28,neuron projection extension involved in neuron projection guidance,BP,WNT3
647,GO:0001841,0.706982829115852,0.50878467577547,3,87,neural tube formation,BP,SFRP1;TULP3;VANGL2
10268,GO:0043065,0.707470102480917,0.382487967987302,17,467,positive regulation of apoptotic process,BP,ALDH1A3;BCL6;SFRP1;ARHGEF4;TNFSF10;VAV3;FOXO1;DAB2IP;OBSCN;F2R;ARHGEF19;ENDOG;NCK2;NFATC4;RBCK1;TP53INP1;SORT1
4435,GO:0010390,0.707664719911695,0.660053846861945,1,29,histone monoubiquitination,BP,DDB2
18121,GO:1902911,0.707896297067546,0.507569715826123,3,89,protein kinase complex,CC,INSR;CDK14;ACVR1B
11113,GO:0045197,0.708091931524963,0.659535749513546,1,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,VANGL2
2939,GO:0006486,0.708601526286001,0.431613068788936,7,199,protein glycosylation,BP,LMF1;ST3GAL5;VEGFB;TET1;B3GNT9;MVD;ST6GALNAC6
10476,GO:0043413,0.708601526286001,0.431613068788936,7,199,macromolecule glycosylation,BP,LMF1;ST3GAL5;VEGFB;TET1;B3GNT9;MVD;ST6GALNAC6
3433,GO:0007259,0.709090490890797,0.506064338668513,3,90,JAK-STAT cascade,BP,PKD2;RTN4RL1;STAT1
1476,GO:0003824,0.709180062761654,0.324776212539935,171,4346,catalytic activity,MF,TNFAIP3;ALDH1A3;ULK2;PTPRS;FBXO41;CPT2;MAP3K14;EPHB2;KDSR;ASH2L;HTRA1;GAMT;TXNRD3;GPX7;ST3GAL5;GPX3;TST;EGFR;ADAM19;FBXO2;CRAT;CYBA;OAS2;FGFR4;NLGN2;CDK18;PGM1;XYLT1;CYP4F22;NSUN7;CERS4;BRSK1;SFRP1;DHRS4L2;DHTKD1;INSR;KMT5C;NPEPL1;CYBRD1;GAA;DHX32;CES2;NAT6;ARSI;DNM1;PPP2R2C;CTSB;NT5E;HR;PDPR;RHBDF1;TMEM129;BPHL;UROS;DDB2;OBSCN;PRSS3;H6PD;SGSH;KLK5;FKBP9;SDR9C7;RAB40B;TET1;CYP27C1;FAM20C;GLUL;EPHA4;B3GNT9;RNPEPL1;SMARCA1;KIF26B;HERC3;TYSND1;CTSV;RPS6KA5;KLHDC8B;TXNDC17;HEXB;LTBP1;PLCD3;PGLS;ACSL1;DDX60;ERBB3;HGSNAT;KIF26A;CDK14;ATP6V0A2;RDH12;ENDOG;GRK6;PIK3R1;SUGCT;CTSL;TRIM22;ACVR1B;KCTD11;CAMKK1;IMPA2;ATP12A;TYRO3;RHOD;CPT1C;METTL7A;HYAL1;CKMT1A;ADAMTS15;RBCK1;MBOAT7;EFNB3;ADCK5;TMX4;ZDHHC1;MTHFR;MSRB2;RETSAT;NDUFA4L2;SDHA;KLK8;LTBP4;ALDH2;FBXW4;NAGLU;NMRK1;AMACR;MARK4;MVD;GOLGA7B;IAH1;ERBB2;RNF187;HSD11B1;RNF135;FBXL8;NME4;CDK20;HINT2;RNF44;PLCD1;MARCH9;COX5B;FURIN;FBXW5;PCSK1;PLPP2;MLYCD;THNSL2;CTSF;MMP1;XYLT2;NUAK1;ALOXE3;SMURF1;CAPNS2;CAMK1;TCIRG1;RNF208;NADK;RAB43;MAP3K3;ST6GALNAC6;MPG;ABCC1;DDX59;IDUA;NRK;ISYNA1;PIGZ;FBXO44;CBR3
17778,GO:1901976,0.709325893267008,0.657774013267324,1,30,regulation of cell cycle checkpoint,BP,NDRG1
12183,GO:0048469,0.709356142729165,0.505790394209402,3,89,cell maturation,BP,FAM20C;FAM210B;CABYR
12996,GO:0051492,0.709687925365544,0.553772869309957,2,59,regulation of stress fiber assembly,BP,SFRP1;PIK3R1
20136,GO:2001021,0.709970226123197,0.553238995153838,2,61,negative regulation of response to DNA damage stimulus,BP,MAGEF1;ACKR3
12266,GO:0048641,0.710168791239082,0.657008059431563,1,29,regulation of skeletal muscle tissue development,BP,TBX1
18083,GO:1902808,0.710295334205494,0.656591286830436,1,30,positive regulation of cell cycle G1/S phase transition,BP,HYAL1
13771,GO:0060401,0.710441478729166,0.504516163121249,3,88,cytosolic calcium ion transport,BP,CYBA;PKD2;F2R
12978,GO:0051453,0.710470150205462,0.552620173159144,2,61,regulation of intracellular pH,BP,ATP6V0A2;TCIRG1
44,GO:0000096,0.710740645451315,0.656046907965216,1,30,sulfur amino acid metabolic process,BP,MTHFR
14624,GO:0070266,0.710763320938543,0.656019169421793,1,30,necroptotic process,BP,RBCK1
5103,GO:0015485,0.71134408828493,0.655308115389965,1,30,cholesterol binding,MF,APOE
10839,GO:0044403,0.711567187107793,0.36107961190698,26,712,symbiont process,BP,IFITM1;ITGB6;APOE;MVB12B;LAMP3;ULK2;EGFR;OAS2;INSR;CTSB;RPL13A;PIK3R1;TRIM22;TYRO3;STOM;RBCK1;EFNB3;ITGB5;CRTC1;STAT1;ACKR3;FURIN;IFI16;MMP1;RAB43;SP100
1581,GO:0004004,0.712170011954746,0.550696600165139,2,59,ATP-dependent RNA helicase activity,MF,DHX32;DDX59
11675,GO:0046503,0.712669367720541,0.653681114180074,1,30,glycerolipid catabolic process,BP,APOE
5779,GO:0017048,0.712794800993215,0.452803765394072,5,140,Rho GTPase binding,MF,ARHGEF4;VAV3;OBSCN;ARHGEF19;EPS8L2
3052,GO:0006633,0.712942949629828,0.501301232483846,3,91,fatty acid biosynthetic process,BP,MLYCD;THNSL2;ALOXE3
19712,GO:2000142,0.713518397002861,0.652635552407607,1,30,regulation of DNA-templated transcription, initiation,BP,THRA
11742,GO:0046637,0.713815932332362,0.652268543930222,1,30,regulation of alpha-beta T cell differentiation,BP,BCL6
2524,GO:0005795,0.714123108503718,0.470933095881681,4,117,Golgi stack,CC,NSG1;RASIP1;MARCH9;SORT1
1249,GO:0003014,0.71439084728291,0.547836796981859,2,60,renal system process,BP,CYBA;F2R
11820,GO:0046839,0.714595637244433,0.651570050093919,1,29,phospholipid dephosphorylation,BP,PLPP2
3229,GO:0006901,0.715001939985968,0.546982360153133,2,61,vesicle coating,BP,COL7A1;TRAPPC2L
2849,GO:0006356,0.715236360771356,0.650512147051623,1,30,regulation of transcription by RNA polymerase I,BP,ERBB2
16670,GO:0097696,0.71564619047012,0.497975654475192,3,91,STAT cascade,BP,PKD2;RTN4RL1;STAT1
17966,GO:1902475,0.716200288206451,0.64931615788729,1,30,L-alpha-amino acid transmembrane transport,BP,PQLC2
16828,GO:0098800,0.716224015003704,0.496905707138879,3,99,inner mitochondrial membrane protein complex,CC,NDUFA4L2;SDHA;COX5B
5988,GO:0019048,0.716371992491325,0.649102770295755,1,30,modulation by virus of host morphology or physiology,BP,INSR
7125,GO:0030990,0.716404921879686,0.649061834917268,1,30,intraciliary transport particle,CC,TULP3
15951,GO:0086003,0.716425242586376,0.649302368040494,1,29,cardiac muscle cell contraction,BP,SCN4B
4020,GO:0009069,0.716733421811853,0.648404677819043,1,31,serine family amino acid metabolic process,BP,THNSL2
3256,GO:0006949,0.716855941785939,0.648500771986254,1,30,syncytium formation,BP,CAMK1
4745,GO:0010942,0.717094409598094,0.369189740160492,18,496,positive regulation of cell death,BP,ALDH1A3;BCL6;SFRP1;ARHGEF4;TNFSF10;VAV3;FOXO1;DAB2IP;OBSCN;F2R;ARHGEF19;ENDOG;NCK2;NFATC4;RBCK1;TP53INP1;MARK4;SORT1
12852,GO:0051233,0.717195472165201,0.648077922520222,1,30,spindle midzone,CC,CCDC69
3645,GO:0008144,0.717432932293786,0.336091062057944,49,1266,drug binding,MF,ULK2;MAP3K14;EPHB2;EGFR;OAS2;FGFR4;CDK18;BRSK1;SFRP1;INSR;DHX32;OBSCN;FKBP9;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;ACVR1B;CAMKK1;ATP12A;TYRO3;CKMT1A;TRPV4;NMRK1;MARK4;MVD;ERBB2;NME4;CDK20;CLCN7;THNSL2;NUAK1;CAMK1;MT2A;NADK;MAP3K3;ABCC1;DDX59;NRK
18199,GO:1903050,0.717672640396213,0.432196616096452,6,175,regulation of proteolysis involved in cellular protein catabolic process,BP,LAMP3;RHBDF1;DAB2IP;EPHA4;MAGEF1;SMURF1
2938,GO:0006482,0.717974799153194,0.647372477153742,1,29,protein demethylation,BP,HR
3690,GO:0008214,0.717974799153194,0.647372477153742,1,29,protein dealkylation,BP,HR
4532,GO:0010631,0.718228982018773,0.420290838694038,7,199,epithelial cell migration,BP,APOE;DAB2IP;PRSS3;PLXND1;HYAL1;MAP3K3;SP100
9828,GO:0042108,0.718254613670476,0.646756228482596,1,30,positive regulation of cytokine biosynthetic process,BP,ZFPM1
17876,GO:1902229,0.71888150101648,0.645488419682359,1,32,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,ACKR3
3401,GO:0007200,0.719420277346313,0.645046953954708,1,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,F2R
5608,GO:0016705,0.719486568085852,0.493275037979853,3,90,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,CYP4F22;TET1;CYP27C1
8908,GO:0034968,0.719643653916862,0.493130550196351,3,89,histone lysine methylation,BP,ASH2L;KMT5C;RTF1
20241,GO:2001252,0.720572129136638,0.443302509700091,5,146,positive regulation of chromosome organization,BP,BCL6;TET1;RPS6KA5;SREBF1;RTF1
1914,GO:0004620,0.72064489160824,0.539890371697109,2,61,phospholipase activity,MF,PLCD3;PLCD1
1457,GO:0003724,0.720829202164699,0.539749179975554,2,60,RNA helicase activity,MF,DHX32;DDX59
3667,GO:0008186,0.721117959664666,0.539383997581459,2,60,RNA-dependent ATPase activity,MF,DHX32;DDX59
2932,GO:0006476,0.722484385811636,0.489546384394391,3,90,protein deacetylation,BP,BCL6;FRY;SREBF1
19695,GO:2000107,0.722551926356901,0.641100602807597,1,31,negative regulation of leukocyte apoptotic process,BP,BCL6
12896,GO:0051293,0.722600311059313,0.641291043519981,1,30,establishment of spindle localization,BP,SPRY2
2952,GO:0006506,0.722644169732069,0.640748051955488,1,32,GPI anchor biosynthetic process,BP,PIGZ
9011,GO:0035254,0.722720462952512,0.641138968286064,1,30,glutamate receptor binding,MF,HOMER2
6680,GO:0030098,0.723275711151532,0.414278948604387,7,201,lymphocyte differentiation,BP,GLI2;BCL6;SFRP1;ZFPM1;PIK3R1;TYRO3;ERBB2
16090,GO:0090132,0.723317490542258,0.414243722600806,7,200,epithelium migration,BP,APOE;DAB2IP;PRSS3;PLXND1;HYAL1;MAP3K3;SP100
3222,GO:0006892,0.723684762508119,0.488048186343802,3,90,post-Golgi vesicle-mediated transport,BP,VAMP3;VAMP2;SORT1
16446,GO:0097178,0.724308511064263,0.638871450567013,1,31,ruffle assembly,BP,EPS8L2
2816,GO:0006298,0.724547955260855,0.638566716280698,1,31,mismatch repair,BP,XPC
6827,GO:0030315,0.724551292091345,0.638815187417222,1,30,T-tubule,CC,RTN2
16173,GO:0090257,0.724865355563981,0.457737639434217,4,119,regulation of muscle system process,BP,FOXO1;F2R;ADORA2B;MYL9
4410,GO:0010256,0.725660000900082,0.374561413634723,13,360,endomembrane system organization,BP,OBSL1;EPB41L3;ANO9;DNM1;SERPINE2;F2R;SNX33;NDRG1;MICALL1;SUN1;ALS2CL;RAB43;VPS33B
11036,GO:0045070,0.726470790751557,0.636111940094112,1,31,positive regulation of viral genome replication,BP,STOM
8499,GO:0033762,0.726723789104423,0.635787937424047,1,31,response to glucagon,BP,SREBF1
20231,GO:2001239,0.726950971476585,0.635258905460368,1,32,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IFI6
11443,GO:0045936,0.72794709543743,0.362056471056356,16,443,negative regulation of phosphate metabolic process,BP,TNFAIP3;APOE;EPHB2;SFRP1;WWTR1;FOXO1;DAB2IP;DMTN;NCK2;SPRY2;PPP1R35;RTN4RL1;IMPACT;CRY2;ELFN2;PPP1R14A
14708,GO:0070423,0.728063136215818,0.634068755391766,1,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,TNFAIP3
1148,GO:0002763,0.728094843320396,0.6340279756582,1,31,positive regulation of myeloid leukocyte differentiation,BP,GPR68
12860,GO:0051246,0.728748287258611,0.314424408606013,77,2007,regulation of protein metabolic process,BP,TNFAIP3;APOE;IFI6;LAMP3;GPNMB;MAP3K14;EPHB2;EGFR;FBXO2;FGFR4;BCL6;SFRP1;UNK;TNFSF10;INSR;PKD2;ZFPM1;PPP2R2C;SERPINE2;WWTR1;RHBDF1;FOXO1;DAB2IP;COL7A1;TBX1;SHC2;CRTAP;TET1;EPHA4;WNT9A;RPL13A;MAGEF1;F2R;RPS6KA5;ACSL1;ERBB3;SPOCK1;FRY;SREBF1;CSPG4;DMTN;NCK2;ACVR1B;CAMKK1;NAB2;SNX33;TYRO3;RTF1;SPRY2;TNFRSF19;TRPV4;MTHFR;LTBP4;PPP1R35;ADORA2B;SERPING1;RTN4RL1;BTBD2;IMPACT;IGFBP4;ERBB2;CDK20;HINT2;ACKR3;CRY2;FURIN;IFI16;GJC2;NUAK1;SMURF1;MEX3A;CAMK1;ELFN2;MAP3K3;PPP1R14A;NRK;VANGL2
9431,GO:0036064,0.729289324827579,0.480963990071055,3,91,ciliary basal body,CC,PKD2;GAS8;MARK4
3549,GO:0007606,0.729527550501369,0.631942265105767,1,32,sensory perception of chemical stimulus,BP,ASIC1
5262,GO:0015932,0.729759090371967,0.631643010774047,1,32,nucleobase-containing compound transmembrane transporter activity,MF,SLC29A4
7424,GO:0031577,0.729913796090659,0.631442949317487,1,32,spindle checkpoint,BP,NDRG1
8651,GO:0034250,0.730402078622337,0.45079599330428,4,122,positive regulation of cellular amide metabolic process,BP,EPHA4;NCK2;IMPACT;ERBB2
17485,GO:1901016,0.730422522041062,0.631024029462163,1,31,regulation of potassium ion transmembrane transporter activity,BP,VAMP2
8285,GO:0033143,0.730726391119438,0.526927974389084,2,62,regulation of intracellular steroid hormone receptor signaling pathway,BP,SFRP1;CRY2
12742,GO:0051057,0.730731255656215,0.630624077415876,1,31,positive regulation of small GTPase mediated signal transduction,BP,F2R
3206,GO:0006869,0.730734505830784,0.40537545178294,7,201,lipid transport,BP,APOE;CPT2;ANO9;LDLRAP1;ACSL1;NME4;ABCC1
3539,GO:0007595,0.730855795854637,0.630462639373801,1,31,lactation,BP,OAS2
4495,GO:0010563,0.731024412663801,0.358540777440305,16,444,negative regulation of phosphorus metabolic process,BP,TNFAIP3;APOE;EPHB2;SFRP1;WWTR1;FOXO1;DAB2IP;DMTN;NCK2;SPRY2;PPP1R35;RTN4RL1;IMPACT;CRY2;ELFN2;PPP1R14A
7938,GO:0032559,0.731224870377696,0.323194050988343,45,1169,adenyl ribonucleotide binding,MF,ULK2;MAP3K14;EPHB2;EGFR;OAS2;FGFR4;CDK18;BRSK1;INSR;DHX32;OBSCN;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;ACVR1B;CAMKK1;ATP12A;TYRO3;CKMT1A;TRPV4;NMRK1;MARK4;MVD;ERBB2;NME4;CDK20;CLCN7;NUAK1;CAMK1;NADK;MAP3K3;ABCC1;DDX59;NRK
13464,GO:0055074,0.731251085186738,0.404727714626736,7,203,calcium ion homeostasis,BP,APOE;CYBA;SV2A;PKD2;F2R;HEXB;TRPV4
17622,GO:1901505,0.73129111633203,0.629657883282503,1,32,carbohydrate derivative transmembrane transporter activity,MF,SLC29A4
19701,GO:2000113,0.731540150141247,0.324586433033359,42,1115,negative regulation of cellular macromolecule biosynthetic process,BP,PEG3;HES2;EGFR;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;ZFPM1;HR;SALL2;WWTR1;FOXO1;DAB2IP;MNT;TET1;RPL13A;TCFL5;RPS6KA5;ZBTB42;SREBF1;NCK2;NAB2;NFATC4;RTF1;ZP3;MBD1;TRPV4;IMPACT;H2AFJ;STAT1;CRY2;IFI16;PER3;MEX3A;CXXC5;MDFI;SCMH1;SP100
4220,GO:0009435,0.73194099294306,0.628813141715066,1,32,NAD biosynthetic process,BP,NMRK1
8953,GO:0035088,0.732219571351885,0.628690999237923,1,31,establishment or maintenance of apical/basal cell polarity,BP,VANGL2
14203,GO:0061245,0.732219571351885,0.628690999237923,1,31,establishment or maintenance of bipolar cell polarity,BP,VANGL2
15993,GO:0086065,0.732391444003743,0.628467227402176,1,31,cell communication involved in cardiac conduction,BP,SCN4B
12193,GO:0048487,0.732748254100278,0.627761607297492,1,32,beta-tubulin binding,MF,TRPV4
7735,GO:0032273,0.732833775988894,0.476385141141531,3,93,positive regulation of protein polymerization,BP,WIPF1;NCK2;ARPIN
2951,GO:0006505,0.733562796884139,0.626471795663178,1,33,GPI anchor metabolic process,BP,PIGZ
9057,GO:0035337,0.733703863256755,0.626513651029542,1,32,fatty-acyl-CoA metabolic process,BP,ACSL1
3072,GO:0006661,0.734384742366246,0.445931387472888,4,119,phosphatidylinositol biosynthetic process,BP,FGFR4;PIK3R1;ZP3;PIGZ
10409,GO:0043299,0.734424260169692,0.364371463260333,13,373,leukocyte degranulation,BP,CYBA;PGM1;GAA;CTSB;PRSS3;HEXB;HGSNAT;CXCR1;METTL7A;STOM;VAMP2;ADORA2B;TCIRG1
8984,GO:0035176,0.734538323536273,0.625662647519242,1,31,social behavior,BP,TBX1
13098,GO:0051703,0.734538323536273,0.625662647519242,1,31,intraspecies interaction between organisms,BP,TBX1
12213,GO:0048524,0.734798425508386,0.473842333567749,3,94,positive regulation of viral process,BP,APOE;MVB12B;STOM
1421,GO:0003407,0.735301593503342,0.624661327462361,1,31,neural retina development,BP,SDK2
3171,GO:0006810,0.735478365919236,0.299633462328305,130,3339,transport,BP,POSTN;ITGB6;APOE;MVB12B;KCNJ15;LMF1;CPT2;EPHB2;SRSF5;TST;SLC13A5;SHROOM2;EGFR;CYBA;OAS2;NLGN2;BCL6;PGM1;ANO9;BRSK1;SFRP1;CKLF;INSR;VAV3;SLC16A5;SLC29A4;GAA;SV2A;PKD2;RTN2;DNM1;LDLRAP1;RIMS3;CTSB;SYT8;SERPINE2;VEGFB;RHBDF1;TMEM129;NSG1;COL7A1;PRSS3;SCN4B;EVI5L;WIPF1;KCNC4;RAB40B;GLUL;ANO8;TRAPPC2L;RPL13A;OLFM2;F2R;TUB;HOMER2;HEXB;SCART1;ACSL1;ORAI3;ERBB3;HGSNAT;KIF26A;S100A6;SLC38A4;ATP6V0A2;VAMP3;SREBF1;DMTN;PIK3R1;APPL2;ACAP3;SYTL1;UNC119B;ATP12A;SNX33;TYRO3;RHOD;CXCR1;SLC2A1;METTL7A;ZP3;STOM;VAMP2;SCG5;LRRC8E;SLC2A9;TRPV4;ZDHHC1;PQLC2;NDUFA4L2;LTBP4;ADORA2B;SERPING1;MRC2;TBC1D17;GOLGA7B;STON1;GPR68;TOM1L2;MICALL1;ERBB2;C2CD4C;NME4;NIPAL4;ACKR3;SLC5A1;CRY2;COX5B;SLC39A6;BLOC1S4;FURIN;CLCN7;CCDC88B;SUN1;GJC2;SLC1A4;SLC13A3;ASIC1;SMURF1;CAMK1;TCIRG1;NISCH;RAB43;VPS33B;SLC47A1;REEP6;SP100;ABCC1;SORT1;APBA1
6956,GO:0030641,0.73576075854302,0.520228621807612,2,64,regulation of cellular pH,BP,ATP6V0A2;TCIRG1
16769,GO:0098659,0.73595315432519,0.623804796713309,1,31,inorganic cation import across plasma membrane,BP,SLC39A6
17035,GO:0099587,0.73595315432519,0.623804796713309,1,31,inorganic ion import across plasma membrane,BP,SLC39A6
14107,GO:0061028,0.735987195309099,0.623760002376401,1,31,establishment of endothelial barrier,BP,PTPRS
13530,GO:0060038,0.736047900408156,0.623680109870412,1,31,cardiac muscle cell proliferation,BP,TENM4
1434,GO:0003674,0.736117955005778,0.328201881411152,455,11295,molecular_function,MF,TNFAIP3;POSTN;IFITM1;ITGB6;PEG3;TGFBI;SMOC2;TAGLN;HES2;APOE;ALDH1A3;IFI6;MVB12B;KCNJ15;ULK2;LGALS7B;PTPRS;NOL4L;PHF7;FBXO41;OBSL1;CPT2;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;ADGRF4;NINJ1;LENG9;KDSR;ASH2L;TNS1;HTRA1;PRICKLE2;PRR9;CADM4;GAMT;GPRC5C;TXNRD3;GIGYF1;ADGRL1;GPX7;SRSF5;ST3GAL5;GPX3;TST;DCAF16;MXRA5;FLNC;SLC13A5;RALGDS;NCR3LG1;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;NYNRIN;SNN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;PINLYP;APCDD1;NLGN2;CDK18;RAPGEF5;IRF2BPL;VIPR1;CALML3;BCL6;PGM1;ANO9;TENM2;XYLT1;CYP4F22;PSD4;NSUN7;ZNF318;CERS4;BRSK1;SFRP1;ARHGEF4;CKLF;FHOD3;UNK;POU3F1;TNFSF10;MN1;DHRS4L2;DHTKD1;INSR;VAV3;SLC16A5;KMT5C;NPEPL1;CYBRD1;SLC29A4;GAA;DHX32;CES2;MATN2;SV2A;PKD2;ESPN;ZFPM1;RGMA;RTN2;NAT6;ARSI;DNM1;TMEM134;PPP2R2C;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;TNXB;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TYMSOS;TMEM129;FOXO1;WNT3;TRIM65;LY6E;ZSCAN18;NSG1;PARVB;BPHL;BOC;SOX12;UROS;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;PRSS3;H6PD;CLIP2;TSC22D1;SGSH;KLK5;TRERF1;SHC2;SCN4B;SH3BP2;CRTAP;GAS8;YEATS4;EVI5L;WIPF1;KRBA1;FKBP9;KCNC4;MNT;SDR9C7;RAB40B;TET1;MARVELD1;NRSN2;CYP27C1;FAM20C;GLUL;FAM213A;ANO8;EPHA4;ZNF266;WNT9A;TRAPPC2L;RPL13A;B3GNT9;RNPEPL1;CORO6;MAGEF1;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;HERC3;TCFL5;MPLKIP;TYSND1;CTSV;NXPH4;RPS6KA5;TUB;HOMER2;KLHDC8B;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;ZNF362;SCART1;PGLS;ACSL1;EPS8L2;ZBTB42;ORAI3;DDX60;ACTA2;ERBB3;HGSNAT;KIF26A;S100A6;SPOCK1;SLC38A4;CDK14;ATP6V0A2;VAMP3;PPL;CUL9;FRY;PLXND1;CGREF1;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;SNX29;IMPA2;UNC119B;XPC;ARHGAP40;NAB2;NFATC4;ATP12A;SNX33;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;CPT1C;METTL7A;HYAL1;BCAM;RTF1;ZP3;STOM;CKMT1A;VAMP2;PLEKHH2;ADAMTS15;RBCK1;MBOAT7;EFNB3;PCBP4;ZNF554;ADCK5;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;TNFRSF19;CABYR;SLC2A9;TMX4;MDK;TRPV4;ZDHHC1;MTHFR;PQLC2;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;RETSAT;NDUFA4L2;SDHA;KLK8;LTBP4;ALDH2;PPP1R35;ADORA2B;FBXW4;WDR90;SERPING1;PLEKHN1;NAGLU;NMRK1;MRC2;MYL9;RTN4RL1;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;MC1R;IMPACT;LGALS9B;TBC1D17;MVD;GOLGA7B;IAH1;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;GPR68;TOM1L2;GPR153;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;EPM2A;RNF135;H2AFJ;LAMB2;PCDH1;STAT1;TMEM54;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;NIPAL4;WIPI2;ACKR3;PLCD1;H1FX;SLC5A1;CRY2;MARCH9;COX5B;SLC39A6;BLOC1S4;MARCKSL1;ZMYM3;FURIN;FBXW5;CLCN7;RHPN1;IFI16;IL20RB;CCDC88B;PCSK1;PLPP2;MLYCD;SUN1;THNSL2;NINL;PEX11B;FRAT1;CTSF;GJC2;ANGEL1;SLC1A4;ARPIN;SLC13A3;DBP;BEX2;ASIC1;MMP1;ALS2CL;PER3;XYLT2;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;CAPNS2;MEX3A;DOK4;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;AIF1L;MT2A;NADK;RAB43;VPS33B;ZCCHC24;ELFN2;SLC47A1;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;REEP6;SCMH1;ZSWIM8;DTNB;SP100;MPG;ABCC1;DDX59;IDUA;NRK;ISYNA1;PIGZ;FBXO44;SORT1;CBR3;VANGL2;APBA1
9960,GO:0042398,0.73708675589258,0.621840025752681,1,33,cellular modified amino acid biosynthetic process,BP,GAMT
3934,GO:0008654,0.737113969462092,0.38877297577643,8,231,phospholipid biosynthetic process,BP,FGFR4;HEXB;PIK3R1;ZP3;MBOAT7;MVD;ISYNA1;PIGZ
3299,GO:0007018,0.737288327929625,0.388587356947027,8,229,microtubule-based movement,BP,GAS8;KIF26B;KIF26A;CABYR;MAFIP;BLOC1S4;SUN1;APBA1
2935,GO:0006479,0.737574453270179,0.422454922337965,5,149,protein methylation,BP,ASH2L;KMT5C;TET1;RTF1;MTHFR
3689,GO:0008213,0.737574453270179,0.422454922337965,5,149,protein alkylation,BP,ASH2L;KMT5C;TET1;RTF1;MTHFR
10847,GO:0044419,0.738329390653473,0.331304305824597,26,723,interspecies interaction between organisms,BP,IFITM1;ITGB6;APOE;MVB12B;LAMP3;ULK2;EGFR;OAS2;INSR;CTSB;RPL13A;PIK3R1;TRIM22;TYRO3;STOM;RBCK1;EFNB3;ITGB5;CRTC1;STAT1;ACKR3;FURIN;IFI16;MMP1;RAB43;SP100
9330,GO:0035872,0.738526981698839,0.620161869588821,1,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,TNFAIP3
11061,GO:0045104,0.738726106110174,0.619897712130855,1,32,intermediate filament cytoskeleton organization,BP,SYNM
5537,GO:0016567,0.73875253559588,0.330854921346134,26,710,protein ubiquitination,BP,TNFAIP3;FBXO41;DCAF16;FBXO2;WWTR1;TMEM129;DDB2;RAB40B;MAGEF1;HERC3;KLHDC8B;CUL9;TRIM22;KCTD11;RTF1;RBCK1;FBXW4;RNF187;RNF135;FBXL8;RNF44;MARCH9;FBXW5;SMURF1;RNF208;FBXO44
4329,GO:0009898,0.740237898594097,0.438558163201376,4,120,cytoplasmic side of plasma membrane,CC,LDLRAP1;DAB2IP;S100A6;RASA4
13066,GO:0051640,0.740330242864581,0.340644142542197,19,523,organelle localization,BP,SHROOM2;NLGN2;DNM1;RIMS3;SYT8;COL7A1;RAB40B;TRAPPC2L;VAMP3;SYTL1;VAMP2;SPRY2;ADORA2B;MARK4;C2CD4C;BLOC1S4;SUN1;NINL;VPS33B
6337,GO:0021536,0.740532044652102,0.617494942666048,1,32,diencephalon development,BP,GLI2
12518,GO:0050707,0.740585316166233,0.466440980277566,3,94,regulation of cytokine secretion,BP,POSTN;F2R;TRPV4
1458,GO:0003725,0.740927743082551,0.513542209537108,2,63,double-stranded RNA binding,MF,OAS2;DDX60
5648,GO:0016776,0.741237199160909,0.616323565486561,1,33,phosphotransferase activity, phosphate group as acceptor,MF,NME4
2604,GO:0005929,0.74170430546107,0.359977215630731,12,339,cilium,CC,GLI2;PKD2;TMEM231;GAS8;TUB;UNC119B;CABYR;TRPV4;MAFIP;MARK4;TULP3;CDK20
12845,GO:0051223,0.742069653540046,0.343231201178164,17,475,regulation of protein transport,BP,POSTN;EGFR;NLGN2;SFRP1;RHBDF1;GLUL;F2R;SREBF1;DMTN;SLC2A1;STOM;VAMP2;TRPV4;GPR68;ERBB2;CAMK1;SP100
16082,GO:0090114,0.742321194107816,0.511619188732583,2,64,COPII-coated vesicle budding,BP,COL7A1;TRAPPC2L
1453,GO:0003714,0.742826682433847,0.401712285267497,6,178,transcription corepressor activity,MF,HR;WWTR1;MNT;TRIM22;NAB2;SP100
10539,GO:0043535,0.743763194569586,0.509711169308587,2,64,regulation of blood vessel endothelial cell migration,BP,APOE;MAP3K3
17187,GO:0110020,0.743807868477627,0.509736781089972,2,63,regulation of actomyosin structure organization,BP,SFRP1;PIK3R1
1064,GO:0002637,0.744041798869031,0.612557862519478,1,33,regulation of immunoglobulin production,BP,BCL6
15065,GO:0071156,0.744817810038164,0.46089155092766,3,96,regulation of cell cycle arrest,BP,PKD2;DAB2IP;PCBP4
6731,GO:0030170,0.744912823555485,0.611382039363165,1,33,pyridoxal phosphate binding,MF,THNSL2
14631,GO:0070279,0.744912823555485,0.611382039363165,1,33,vitamin B6 binding,MF,THNSL2
7281,GO:0031300,0.745100769813088,0.412998701444305,5,154,intrinsic component of organelle membrane,CC,PTPRS;SV2A;PQLC2;SUN1;PEX11B
3300,GO:0007019,0.74523373068437,0.611179580073243,1,32,microtubule depolymerization,BP,TRPV4
2468,GO:0005720,0.745379860952582,0.610750332875959,1,33,nuclear heterochromatin,CC,KMT5C
1452,GO:0003713,0.745898371551953,0.370931417021273,9,261,transcription coactivator activity,MF,THRA;CITED4;POU3F1;WWTR1;SOX12;TRERF1;MNT;NFATC4;SP100
8170,GO:0032934,0.745912567703165,0.610028745252822,1,33,sterol binding,MF,APOE
4064,GO:0009135,0.74594847308669,0.459516592675818,3,94,purine nucleoside diphosphate metabolic process,BP,PGM1;DHTKD1;INSR
4103,GO:0009179,0.74594847308669,0.459516592675818,3,94,purine ribonucleoside diphosphate metabolic process,BP,PGM1;DHTKD1;INSR
13763,GO:0060393,0.746077304011228,0.609805370095384,1,33,regulation of pathway-restricted SMAD protein phosphorylation,BP,ACVR1B
5763,GO:0017004,0.746215817034959,0.609399364562686,1,34,cytochrome complex assembly,BP,CYBA
16938,GO:0099024,0.74638323995474,0.609390247585815,1,33,plasma membrane invagination,BP,SNX33
11627,GO:0046426,0.746613543270142,0.609077504222652,1,33,negative regulation of JAK-STAT cascade,BP,RTN4RL1
19006,GO:1904893,0.746613543270142,0.609077504222652,1,33,negative regulation of STAT cascade,BP,RTN4RL1
12089,GO:0048199,0.747553390915562,0.504586451361436,2,65,vesicle targeting, to, from or within Golgi,BP,COL7A1;TRAPPC2L
4474,GO:0010517,0.747899316867767,0.607327574353917,1,33,regulation of phospholipase activity,BP,EGFR
890,GO:0002275,0.748487063701556,0.347960318419621,13,377,myeloid cell activation involved in immune response,BP,CYBA;PGM1;GAA;CTSB;PRSS3;HEXB;HGSNAT;CXCR1;METTL7A;STOM;VAMP2;ADORA2B;TCIRG1
4326,GO:0009895,0.748731576035494,0.383487643836132,7,208,negative regulation of catabolic process,BP,LAMP3;EGFR;SERPINE2;RASIP1;DAB2IP;EPHA4;FURIN
8363,GO:0033293,0.748930502729264,0.605700127634082,1,34,monocarboxylic acid binding,MF,CYP27C1
4245,GO:0009607,0.748979766865122,0.330711610197806,19,537,response to biotic stimulus,BP,TNFAIP3;IFITM1;MAP3K14;HTRA1;CYBA;OAS2;DAB2IP;PRSS3;KLK5;WIPF1;F2R;DDX60;ACTA2;TRIM22;HYAL1;STAT1;WIPI2;IFI16;CCDC88B
8114,GO:0032838,0.748986971532212,0.427372895990886,4,123,plasma membrane bounded cell projection cytoplasm,CC,GLI2;GAS8;TULP3;BLOC1S4
13138,GO:0051783,0.749648434209595,0.407326647662567,5,153,regulation of nuclear division,BP,OBSL1;INSR;CUL9;TOM1L2;FBXW5
11060,GO:0045103,0.749830795164625,0.604686363032721,1,33,intermediate filament-based process,BP,SYNM
860,GO:0002204,0.750455488001031,0.603828898904904,1,33,somatic recombination of immunoglobulin genes involved in immune response,BP,BCL6
861,GO:0002208,0.750455488001031,0.603828898904904,1,33,somatic diversification of immunoglobulins involved in immune response,BP,BCL6
11110,GO:0045190,0.750455488001031,0.603828898904904,1,33,isotype switching,BP,BCL6
10563,GO:0043565,0.750496020594815,0.315248059979165,28,755,sequence-specific DNA binding,MF,HES2;ZNF704;NDN;THRA;H1F0;GLI2;BCL6;POU3F1;ZFPM1;ETV5;HR;SALL2;FOXO1;SOX12;TBX1;MNT;ZNF266;TCFL5;SREBF1;NFATC4;ZNF554;MBD1;STAT1;CRY2;IFI16;DBP;PER3;CXXC5
3650,GO:0008156,0.750690938464475,0.603505305055434,1,33,negative regulation of DNA replication,BP,BCL6
12116,GO:0048260,0.750739941274883,0.603437929232837,1,33,positive regulation of receptor-mediated endocytosis,BP,LDLRAP1
12664,GO:0050922,0.751419877083035,0.602502052493316,1,33,negative regulation of chemotaxis,BP,WNT3
8671,GO:0034332,0.751738957864115,0.452063260390425,3,92,adherens junction organization,BP,SFRP1;DMTN;RHOD
127,GO:0000266,0.752018119945691,0.601677062718127,1,33,mitochondrial fission,BP,DNM1
4393,GO:0010165,0.753034723783504,0.600271791242572,1,33,response to X-ray,BP,SFRP1
2547,GO:0005844,0.753235696205307,0.49664535259982,2,69,polysome,CC,UNK;IMPACT
3528,GO:0007566,0.753274776000224,0.599718368636496,1,34,embryo implantation,BP,ACVR1B
590,GO:0001755,0.75363183625939,0.599444416872238,1,33,neural crest cell migration,BP,TBX1
3781,GO:0008376,0.753862082068009,0.599124991100702,1,33,acetylgalactosaminyltransferase activity,MF,B3GNT9
16937,GO:0099023,0.754064550634229,0.495830436543234,2,65,tethering complex,CC,TRAPPC2L;VPS33B
14138,GO:0061077,0.754469800220492,0.495123558419887,2,67,chaperone-mediated protein folding,BP,CRTAP;FKBP9
1446,GO:0003697,0.754527813486613,0.448216763486685,3,96,single-stranded DNA binding,MF,XPC;RTF1;CRY2
6926,GO:0030554,0.754528356130961,0.297596669473169,45,1181,adenyl nucleotide binding,MF,ULK2;MAP3K14;EPHB2;EGFR;OAS2;FGFR4;CDK18;BRSK1;INSR;DHX32;OBSCN;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;ACVR1B;CAMKK1;ATP12A;TYRO3;CKMT1A;TRPV4;NMRK1;MARK4;MVD;ERBB2;NME4;CDK20;CLCN7;NUAK1;CAMK1;NADK;MAP3K3;ABCC1;DDX59;NRK
981,GO:0002444,0.755047833594075,0.340236048201182,13,379,myeloid leukocyte mediated immunity,BP,CYBA;PGM1;GAA;CTSB;PRSS3;HEXB;HGSNAT;CXCR1;METTL7A;STOM;VAMP2;ADORA2B;TCIRG1
7811,GO:0032386,0.755417593358183,0.348262625392016,11,318,regulation of intracellular transport,BP,LDLRAP1;RIMS3;SREBF1;DMTN;STOM;VAMP2;ADORA2B;ERBB2;CAMK1;REEP6;SP100
726,GO:0001959,0.756435353165805,0.41772648455474,4,126,regulation of cytokine-mediated signaling pathway,BP,TNFAIP3;RBCK1;STAT1;CCDC3
14334,GO:0061614,0.757105015806619,0.594602721216823,1,33,pri-miRNA transcription by RNA polymerase II,BP,NFATC4
3637,GO:0008134,0.757346752390397,0.32324313322837,18,505,transcription factor binding,MF,HES2;GPX3;THRA;GLI2;ZFPM1;FOXO1;TRERF1;SMARCA1;PIK3R1;NAB2;NFATC4;HYAL1;CRTC1;STAT1;IFI16;PER3;CXXC5;MDFI
12926,GO:0051348,0.757416218932496,0.364115365684009,8,240,negative regulation of transferase activity,BP,TNFAIP3;APOE;EPHB2;SFRP1;WWTR1;DAB2IP;SPRY2;RTN4RL1
15383,GO:0071695,0.757526792959385,0.444303733788404,3,95,anatomical structure maturation,BP,FAM20C;FAM210B;PLXNB1
7917,GO:0032527,0.757884904931177,0.593285830574115,1,34,protein exit from endoplasmic reticulum,BP,TMEM129
4109,GO:0009185,0.757933298817608,0.443721031656495,3,96,ribonucleoside diphosphate metabolic process,BP,PGM1;DHTKD1;INSR
15785,GO:0072528,0.758073612300086,0.592612501562751,1,36,pyrimidine-containing compound biosynthetic process,BP,NME4
3613,GO:0008089,0.758348227540039,0.592634466153798,1,34,anterograde axonal transport,BP,BLOC1S4
13474,GO:0055086,0.758355586440809,0.319893156589493,19,547,nucleobase-containing small molecule metabolic process,BP,APOE;GAMT;PGM1;DHTKD1;INSR;PKD2;NT5E;H6PD;FAM20C;PGLS;ATP6V0A2;PTHLH;SDHA;ADORA2B;NMRK1;NME4;COX5B;TCIRG1;NADK
13431,GO:0055007,0.758507092619462,0.489787272492445,2,65,cardiac muscle cell differentiation,BP,OBSL1;FHOD3
5865,GO:0018022,0.759146114324911,0.442158178480724,3,95,peptidyl-lysine methylation,BP,ASH2L;KMT5C;RTF1
3486,GO:0007405,0.759623631124538,0.591060282585398,1,33,neuroblast proliferation,BP,KCTD11
11736,GO:0046631,0.76008174356731,0.487551177120151,2,66,alpha-beta T cell activation,BP,BCL6;ZFPM1
16073,GO:0090100,0.760168242341386,0.48743255214333,2,66,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,ACVR1B;NEO1
8295,GO:0033157,0.760241267144127,0.369276024067276,7,211,regulation of intracellular protein transport,BP,SREBF1;DMTN;STOM;VAMP2;ERBB2;CAMK1;SP100
10676,GO:0044003,0.760431331338021,0.589694781875052,1,34,modification by symbiont of host morphology or physiology,BP,INSR
5521,GO:0016529,0.760558537281379,0.589514675486267,1,34,sarcoplasmic reticulum,CC,RTN2
16504,GO:0097300,0.760880516595838,0.588847470310634,1,35,programmed necrotic cell death,BP,RBCK1
11354,GO:0045766,0.761084844897586,0.439536769661183,3,96,positive regulation of angiogenesis,BP,VEGFB;HYAL1;MAP3K3
5880,GO:0018105,0.761090229973046,0.368261960814839,7,208,peptidyl-serine phosphorylation,BP,EGFR;RPS6KA5;DMTN;NCK2;CAMKK1;SPRY2;CAMK1
8833,GO:0034656,0.761740111304393,0.587427675532764,1,36,nucleobase-containing small molecule catabolic process,BP,NT5E
4094,GO:0009166,0.762251160657362,0.410159928060753,4,127,nucleotide catabolic process,BP,PGM1;DHTKD1;INSR;NT5E
10948,GO:0044773,0.762529616797518,0.43752430664048,3,98,mitotic DNA damage checkpoint,BP,BRSK1;XPC;PCBP4
4049,GO:0009116,0.763742500845141,0.435820720645876,3,100,nucleoside metabolic process,BP,GAMT;NT5E;NME4
2422,GO:0005635,0.763970179449118,0.329694845718476,13,375,nuclear envelope,CC,PRICKLE2;EGFR;CERS4;INSR;YEATS4;RAB40B;S100A6;SREBF1;TYRO3;SLC2A9;RETSAT;SUN1;SORT1
3045,GO:0006623,0.764243544785481,0.584267330034048,1,34,protein targeting to vacuole,BP,SMURF1
32,GO:0000060,0.764464295473474,0.583738812807513,1,35,protein import into nucleus, translocation,BP,BCL6
5564,GO:0016601,0.764560445898381,0.583813358819687,1,34,Rac protein signal transduction,BP,NISCH
3163,GO:0006796,0.764651858684758,0.273684352006306,87,2279,phosphate-containing compound metabolic process,BP,TNFAIP3;APOE;ULK2;PTPRS;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;CDK18;PGM1;BRSK1;SFRP1;DHTKD1;INSR;VAV3;PKD2;PPP2R2C;NT5E;PDPR;WWTR1;FOXO1;DAB2IP;OBSCN;TBX1;H6PD;SHC2;FAM20C;EPHA4;F2R;RPS6KA5;HEXB;PLCD3;PGLS;ACSL1;ERBB3;CDK14;ATP6V0A2;CSPG4;DMTN;GRK6;PIK3R1;PTHLH;NCK2;ACVR1B;CAMKK1;IMPA2;NAB2;TYRO3;ZP3;CKMT1A;MBOAT7;ADCK5;SPRY2;TNFRSF19;TRPV4;SDHA;PPP1R35;ADORA2B;NMRK1;RTN4RL1;MARK4;IMPACT;MVD;IGFBP4;ERBB2;NME4;CDK20;ACKR3;PLCD1;CRY2;COX5B;PLPP2;THNSL2;GJC2;NUAK1;RASA4;CAMK1;TCIRG1;NADK;ELFN2;MAP3K3;PPP1R14A;NRK;ISYNA1;PIGZ;VANGL2
12224,GO:0048545,0.76470829263966,0.3481307381544,9,266,response to steroid hormone,BP,EGFR;THRA;CYBA;SFRP1;FOXO1;CTSV;SREBF1;MDK;CRY2
17248,GO:0140056,0.764708633920232,0.388178352251248,5,155,organelle localization by membrane tethering,BP,RAB40B;VAMP3;MARK4;NINL;VPS33B
15469,GO:0071887,0.76479777214863,0.4808975909118,2,68,leukocyte apoptotic process,BP,BCL6;CTSL
5167,GO:0015748,0.765123451125979,0.480522202580349,2,67,organophosphate ester transport,BP,APOE;ABCC1
7867,GO:0032456,0.765280390787502,0.58278040628435,1,34,endocytic recycling,BP,MICALL1
11370,GO:0045806,0.76579520190721,0.581827588312897,1,35,negative regulation of endocytosis,BP,SNX33
16750,GO:0098631,0.765817492477503,0.581795513196186,1,35,cell adhesion mediator activity,MF,BCAM
5688,GO:0016836,0.766834481570223,0.58012863935517,1,36,hydro-lyase activity,MF,UROS
13077,GO:0051653,0.76709165925489,0.580171742748679,1,34,spindle localization,BP,SPRY2
7714,GO:0032231,0.767128086446607,0.477815935852504,2,66,regulation of actin filament bundle assembly,BP,SFRP1;PIK3R1
12999,GO:0051495,0.767146758560004,0.385027421732181,5,156,positive regulation of cytoskeleton organization,BP,SFRP1;WIPF1;NCK2;TRPV4;ARPIN
12740,GO:0051055,0.767942379978682,0.578727993259585,1,35,negative regulation of lipid biosynthetic process,BP,APOE
414,GO:0001102,0.767952079356929,0.578713946005589,1,35,RNA polymerase II activating transcription factor binding,MF,ZFPM1
12537,GO:0050731,0.768668081433078,0.429286890367197,3,98,positive regulation of peptidyl-tyrosine phosphorylation,BP,EPHA4;ERBB3;CSPG4
10050,GO:0042581,0.76914571376326,0.428600255209532,3,99,specific granule,CC,CYBA;HGSNAT;STOM
6879,GO:0030433,0.769572876468527,0.474249339131708,2,68,ubiquitin-dependent ERAD pathway,BP,FBXO2;TMEM129
19703,GO:2000116,0.769577859907314,0.368130271727163,6,189,regulation of cysteine-type endopeptidase activity,BP,IFI6;LAMP3;TNFSF10;WNT9A;F2R;IFI16
953,GO:0002381,0.769878851775169,0.575915298482232,1,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,BCL6
7862,GO:0032451,0.770272339266955,0.575556161228237,1,34,demethylase activity,MF,HR
9494,GO:0036230,0.770336437708652,0.325899276542505,12,357,granulocyte activation,BP,CYBA;PGM1;GAA;CTSB;PRSS3;HEXB;HGSNAT;CXCR1;METTL7A;STOM;VAMP2;TCIRG1
2188,GO:0005080,0.770663943910192,0.574770264862485,1,35,protein kinase C binding,MF,TRPV4
6916,GO:0030544,0.770819907967429,0.574339951561494,1,36,Hsp70 protein binding,MF,MVD
362,GO:0000981,0.771202609355099,0.294100335406265,26,712,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,PEG3;HES2;NDN;THRA;GLI2;BCL6;POU3F1;ZFPM1;ETV5;SALL2;FOXO1;ZSCAN18;SOX12;TBX1;TSC22D1;TRERF1;MNT;TCFL5;SREBF1;NFATC4;STAT1;ZMYM3;IFI16;DBP;ZNF446;SP100
10733,GO:0044212,0.771426105290872,0.299428084269871,22,608,transcription regulatory region DNA binding,MF,HES2;ZNF704;NDN;ASH2L;THRA;GLI2;BCL6;ZFPM1;ETV5;HR;SALL2;SOX12;TRERF1;MNT;TCFL5;SREBF1;NFATC4;STAT1;CRY2;IFI16;DBP;PER3
12951,GO:0051402,0.771581133183632,0.379286517930443,5,157,neuron apoptotic process,BP,APOE;F2R;ERBB3;TYRO3;MDK
4490,GO:0010558,0.771885682162854,0.279388858367714,43,1161,negative regulation of macromolecule biosynthetic process,BP,PEG3;HES2;EGFR;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;ZFPM1;HR;SALL2;WWTR1;FOXO1;DAB2IP;MNT;TET1;RPL13A;TCFL5;RPS6KA5;ZBTB42;SREBF1;TRIM22;NCK2;NAB2;NFATC4;RTF1;ZP3;MBD1;TRPV4;IMPACT;H2AFJ;STAT1;CRY2;IFI16;PER3;MEX3A;CXXC5;MDFI;SCMH1;SP100
14183,GO:0061178,0.772641935360552,0.57167019341186,1,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,GPR68
2757,GO:0006195,0.772769466406146,0.571482773219659,1,36,purine nucleotide catabolic process,BP,NT5E
4520,GO:0010611,0.772914035609672,0.571473439154658,1,35,regulation of cardiac muscle hypertrophy,BP,FOXO1
18201,GO:1903052,0.773079485665547,0.423269682470343,3,99,positive regulation of proteolysis involved in cellular protein catabolic process,BP,DAB2IP;MAGEF1;SMURF1
539,GO:0001658,0.77392648425725,0.56998263895001,1,35,branching involved in ureteric bud morphogenesis,BP,PKD2
395,GO:0001067,0.774109524237368,0.29632184295492,22,609,regulatory region nucleic acid binding,MF,HES2;ZNF704;NDN;ASH2L;THRA;GLI2;BCL6;ZFPM1;ETV5;HR;SALL2;SOX12;TRERF1;MNT;TCFL5;SREBF1;NFATC4;STAT1;CRY2;IFI16;DBP;PER3
18433,GO:1903573,0.774121274887221,0.56949167891251,1,36,negative regulation of response to endoplasmic reticulum stress,BP,NCK2
10943,GO:0044766,0.774180336571388,0.46769550943812,2,69,multi-organism transport,BP,MVB12B;RAB40B
18008,GO:1902579,0.774180336571388,0.46769550943812,2,69,multi-organism localization,BP,MVB12B;RAB40B
7472,GO:0031663,0.774511183600671,0.568915855400335,1,36,lipopolysaccharide-mediated signaling pathway,BP,TNFAIP3
12270,GO:0048645,0.775027953548431,0.568151627139787,1,36,animal organ formation,BP,GLI2
6841,GO:0030330,0.775272022333719,0.420241298356434,3,100,DNA damage response, signal transduction by p53 class mediator,BP,PCBP4;NDRG1;SP100
4533,GO:0010632,0.775849609939655,0.37376638140677,5,156,regulation of epithelial cell migration,BP,APOE;DAB2IP;HYAL1;MAP3K3;SP100
2814,GO:0006296,0.775886180056662,0.566686773564177,1,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,DDB2
13432,GO:0055008,0.775900700672254,0.567062414091484,1,35,cardiac muscle tissue morphogenesis,BP,ZFPM1
9849,GO:0042147,0.775987772972378,0.465209821334009,2,68,retrograde transport, endosome to Golgi,BP,VAMP3;TBC1D17
7947,GO:0032580,0.77628694707852,0.464785167400804,2,68,Golgi cisterna membrane,CC,NSG1;SORT1
17800,GO:1902017,0.776350113039951,0.566190855710519,1,36,regulation of cilium assembly,BP,EVI5L
151,GO:0000307,0.776519031336262,0.565746586464329,1,37,cyclin-dependent protein kinase holoenzyme complex,CC,CDK14
13759,GO:0060389,0.777858815617581,0.563943749578277,1,36,pathway-restricted SMAD protein phosphorylation,BP,ACVR1B
12833,GO:0051196,0.778119210557735,0.462178369119291,2,68,regulation of coenzyme metabolic process,BP,INSR;PDPR
20226,GO:2001234,0.778335915510405,0.370425789649285,5,161,negative regulation of apoptotic signaling pathway,BP,TNFAIP3;IFI6;TNFSF10;MNT;ACKR3
15738,GO:0072384,0.778382012382501,0.461803620593245,2,68,organelle transport along microtubule,BP,BLOC1S4;SUN1
9186,GO:0035601,0.778435579391054,0.415951264202505,3,99,protein deacylation,BP,BCL6;FRY;SREBF1
2700,GO:0006091,0.77899589613201,0.315411113201543,12,364,generation of precursor metabolites and energy,BP,TXNRD3;CYBA;PGM1;DHTKD1;INSR;GAA;PPP1R3E;NFATC4;NDUFA4L2;SDHA;ALDH2;COX5B
12853,GO:0051234,0.779067937677141,0.252819943920215,132,3423,establishment of localization,BP,TNFAIP3;POSTN;ITGB6;APOE;MVB12B;KCNJ15;LMF1;CPT2;EPHB2;SRSF5;TST;SLC13A5;SHROOM2;EGFR;CYBA;OAS2;NLGN2;BCL6;PGM1;ANO9;BRSK1;SFRP1;CKLF;INSR;VAV3;SLC16A5;SLC29A4;GAA;SV2A;PKD2;RTN2;DNM1;LDLRAP1;RIMS3;CTSB;SYT8;SERPINE2;VEGFB;RHBDF1;TMEM129;NSG1;COL7A1;PRSS3;SCN4B;EVI5L;WIPF1;KCNC4;RAB40B;GLUL;ANO8;TRAPPC2L;RPL13A;OLFM2;F2R;TUB;HOMER2;HEXB;SCART1;ACSL1;ORAI3;ERBB3;HGSNAT;KIF26A;S100A6;SLC38A4;ATP6V0A2;VAMP3;SREBF1;DMTN;PIK3R1;APPL2;ACAP3;SYTL1;UNC119B;ATP12A;SNX33;TYRO3;RHOD;CXCR1;SLC2A1;METTL7A;ZP3;STOM;VAMP2;SPRY2;SCG5;LRRC8E;SLC2A9;TRPV4;ZDHHC1;PQLC2;NDUFA4L2;LTBP4;ADORA2B;SERPING1;MRC2;TBC1D17;GOLGA7B;STON1;GPR68;TOM1L2;MICALL1;ERBB2;C2CD4C;NME4;NIPAL4;ACKR3;SLC5A1;CRY2;COX5B;SLC39A6;BLOC1S4;FURIN;CLCN7;CCDC88B;SUN1;GJC2;SLC1A4;SLC13A3;ASIC1;SMURF1;CAMK1;TCIRG1;NISCH;RAB43;VPS33B;SLC47A1;REEP6;SP100;ABCC1;SORT1;APBA1
16455,GO:0097194,0.779197804410154,0.460492900196176,2,70,execution phase of apoptosis,BP,H1F0;ENDOG
16064,GO:0090087,0.779415957447613,0.29968668835197,17,488,regulation of peptide transport,BP,POSTN;EGFR;NLGN2;SFRP1;RHBDF1;GLUL;F2R;SREBF1;DMTN;SLC2A1;STOM;VAMP2;TRPV4;GPR68;ERBB2;CAMK1;SP100
12581,GO:0050805,0.779841412105779,0.560974990371403,1,36,negative regulation of synaptic transmission,BP,ASIC1
7595,GO:0032007,0.780227541678381,0.560394692990229,1,36,negative regulation of TOR signaling,BP,EPM2A
4748,GO:0010950,0.780602072325127,0.385766695315713,4,133,positive regulation of endopeptidase activity,BP,TNFSF10;EPHA4;F2R;IFI16
1104,GO:0002700,0.781116466462211,0.457745402116712,2,70,regulation of production of molecular mediator of immune response,BP,BCL6;KLK5
14583,GO:0070192,0.781160237403284,0.558990141921966,1,36,chromosome organization involved in meiotic cell cycle,BP,SUN1
3013,GO:0006575,0.781498099615206,0.384565635953636,4,133,cellular modified amino acid metabolic process,BP,GAMT;CRTAP;CKMT1A;MTHFR
11971,GO:0047496,0.781855739505503,0.557940156193122,1,36,vesicle transport along microtubule,BP,BLOC1S4
19470,GO:1990391,0.781902971169491,0.557868769932372,1,36,DNA repair complex,CC,XPC
1449,GO:0003707,0.782032105678383,0.557673542131011,1,36,steroid hormone receptor activity,MF,THRA
9926,GO:0042326,0.782045896178859,0.311762853588967,12,354,negative regulation of phosphorylation,BP,TNFAIP3;APOE;EPHB2;SFRP1;WWTR1;FOXO1;DAB2IP;DMTN;NCK2;SPRY2;RTN4RL1;IMPACT
2838,GO:0006342,0.782394351451166,0.410190356601609,3,107,chromatin silencing,BP,TET1;MBD1;H2AFJ
4863,GO:0014743,0.782834857082557,0.556458184388787,1,36,regulation of muscle hypertrophy,BP,FOXO1
16734,GO:0098586,0.783653107913547,0.555216259554986,1,36,cellular response to virus,BP,DDX60
16791,GO:0098732,0.783686155020581,0.408667075661299,3,100,macromolecule deacylation,BP,BCL6;FRY;SREBF1
644,GO:0001838,0.784015565951334,0.408251344934226,3,99,embryonic epithelial tube formation,BP,SFRP1;TULP3;VANGL2
13476,GO:0055088,0.784281907563319,0.453187149185252,2,70,lipid homeostasis,BP,APOE;LDLRAP1
3403,GO:0007204,0.784430122644203,0.380701774011068,4,130,positive regulation of cytosolic calcium ion concentration,BP,CYBA;PKD2;F2R;TRPV4
12756,GO:0051090,0.78486618440442,0.317469300459516,10,300,regulation of DNA binding transcription factor activity,BP,TNFAIP3;THRA;PKD2;DAB2IP;RPS6KA5;TRIM22;RBCK1;CRTC1;MDFI;SP100
13765,GO:0060395,0.785213007677355,0.552839957591166,1,36,SMAD protein signal transduction,BP,WWTR1
7408,GO:0031529,0.785432900599086,0.552308209621796,1,37,ruffle organization,BP,EPS8L2
16998,GO:0099516,0.786004411487603,0.551629963284872,1,36,ion antiporter activity,MF,SLC47A1
17548,GO:1901224,0.786153022260832,0.551206362825836,1,37,positive regulation of NIK/NF-kappaB signaling,BP,EGFR
18668,GO:1904115,0.786385455338479,0.550850195344791,1,37,axon cytoplasm,CC,BLOC1S4
16137,GO:0090199,0.786423937686705,0.550429510118004,1,39,regulation of release of cytochrome c from mitochondria,BP,TNFSF10
727,GO:0001960,0.787038191763569,0.549662767103545,1,38,negative regulation of cytokine-mediated signaling pathway,BP,CCDC3
15821,GO:0072583,0.787252469078735,0.54971573500865,1,36,clathrin-dependent endocytosis,BP,DNM1
17566,GO:1901292,0.787394820004456,0.376644293141328,4,132,nucleoside phosphate catabolic process,BP,PGM1;DHTKD1;INSR;NT5E
8010,GO:0032677,0.788115558425375,0.548004862990115,1,38,regulation of interleukin-8 production,BP,F2R
8455,GO:0033627,0.788733761862018,0.547237326336774,1,37,cell adhesion mediated by integrin,BP,ITGB6
15949,GO:0086001,0.789176883789628,0.546749538256331,1,36,cardiac muscle cell action potential,BP,SCN4B
14655,GO:0070317,0.789270485066413,0.546407865802077,1,37,negative regulation of G0 to G1 transition,BP,DAB2IP
3063,GO:0006650,0.78939974094675,0.317524599402713,9,271,glycerophospholipid metabolic process,BP,EGFR;FGFR4;ERBB3;PIK3R1;IMPA2;ZP3;MBOAT7;ERBB2;PIGZ
6082,GO:0019320,0.789503916750935,0.545860182874713,1,38,hexose catabolic process,BP,PGM1
5485,GO:0016447,0.789516209424051,0.546027656240369,1,37,somatic recombination of immunoglobulin gene segments,BP,BCL6
5702,GO:0016860,0.78963924917663,0.545473787479787,1,39,intramolecular oxidoreductase activity,MF,TMX4
4658,GO:0010824,0.789787791678243,0.545607097643882,1,37,regulation of centrosome duplication,BP,FBXW5
13000,GO:0051496,0.7899191804949,0.545403507618631,1,37,positive regulation of stress fiber assembly,BP,SFRP1
15198,GO:0071396,0.789945906209867,0.298432264129903,13,381,cellular response to lipid,BP,TNFAIP3;EGFR;THRA;SFRP1;FOXO1;WNT3;DAB2IP;TBX1;WNT9A;SREBF1;NFATC4;FAM210B;CRY2
19373,GO:1905952,0.790251825166075,0.444432979291621,2,71,regulation of lipid localization,BP,APOE;LDLRAP1
12594,GO:0050821,0.790302332190604,0.372672482547768,4,133,protein stabilization,BP,CRTAP;EPHA4;PIK3R1;PER3
6568,GO:0022600,0.790457952915687,0.544567793515814,1,37,digestive system process,BP,SLC5A1
4287,GO:0009755,0.79065650890961,0.354225367241895,5,159,hormone-mediated signaling pathway,BP,THRA;SFRP1;ACSL1;UCN2;CRY2
358,GO:0000977,0.790759001511724,0.291253485555292,15,433,RNA polymerase II regulatory region sequence-specific DNA binding,MF,HES2;NDN;THRA;GLI2;BCL6;ZFPM1;ETV5;SALL2;MNT;TCFL5;SREBF1;NFATC4;STAT1;IFI16;DBP
19030,GO:1904951,0.790963983012293,0.30505337147255,11,330,positive regulation of establishment of protein localization,BP,POSTN;EGFR;NLGN2;GLUL;F2R;STOM;VAMP2;TRPV4;GPR68;ERBB2;CAMK1
779,GO:0002042,0.791628407722704,0.542747392829398,1,37,cell migration involved in sprouting angiogenesis,BP,MAP3K3
7437,GO:0031593,0.791688101849648,0.542654372196337,1,37,polyubiquitin modification-dependent protein binding,MF,TNFAIP3
10152,GO:0042775,0.791791310634413,0.441678860197055,2,79,mitochondrial ATP synthesis coupled electron transport,BP,SDHA;COX5B
5609,GO:0016706,0.791883151047483,0.542350308167834,1,37,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,TET1
12893,GO:0051290,0.792192120528134,0.541022477586437,1,42,protein heterotetramerization,BP,INSR
2714,GO:0006109,0.792390120827066,0.36990530167948,4,130,regulation of carbohydrate metabolic process,BP,INSR;FOXO1;IGFBP4;MLYCD
7674,GO:0032153,0.792413528835973,0.441329971381683,2,70,cell division site,CC,PLCD3;RHOD
2083,GO:0004860,0.792589236831436,0.440933102463347,2,72,protein kinase inhibitor activity,MF,SPRY2;RTN4RL1
11441,GO:0045934,0.792689161474831,0.257707499206132,40,1095,negative regulation of nucleobase-containing compound metabolic process,BP,PEG3;HES2;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;ZFPM1;HR;SALL2;WWTR1;FOXO1;DAB2IP;MNT;TET1;MAGEF1;TCFL5;RPS6KA5;ZBTB42;SREBF1;TRIM22;NCK2;NAB2;NFATC4;RTF1;ZP3;MBD1;TRPV4;IMPACT;H2AFJ;STAT1;CRY2;IFI16;PER3;CXXC5;MDFI;SCMH1;SP100
12221,GO:0048538,0.79305865913773,0.540513857342984,1,37,thymus development,BP,TBX1
14739,GO:0070482,0.79309825519937,0.312811391931145,9,279,response to oxygen levels,BP,POSTN;CYBA;SFRP1;VEGFB;FOXO1;ATP6V0A2;ENDOG;MTHFR;NDRG1
8480,GO:0033683,0.79332255552719,0.539735383050458,1,39,nucleotide-excision repair, DNA incision,BP,DDB2
6664,GO:0030048,0.793553706019401,0.439722344737473,2,69,actin filament-based movement,BP,SCN4B;WIPF1
11390,GO:0045840,0.793810185489463,0.539148589235878,1,38,positive regulation of mitotic nuclear division,BP,INSR
5216,GO:0015850,0.793812108080028,0.394421086721608,3,102,organic hydroxy compound transport,BP,APOE;LDLRAP1;NISCH
6890,GO:0030500,0.79407238694876,0.538924700497914,1,37,regulation of bone mineralization,BP,FAM20C
16310,GO:0090630,0.794353809666955,0.438540970210152,2,69,activation of GTPase activity,BP,EVI5L;TBC1D17
14602,GO:0070228,0.794835437798229,0.537359140225273,1,39,regulation of lymphocyte apoptotic process,BP,BCL6
11331,GO:0045727,0.794888087673043,0.392823956809532,3,104,positive regulation of translation,BP,NCK2;IMPACT;ERBB2
12840,GO:0051213,0.795586906040229,0.436573683737929,2,71,dioxygenase activity,MF,TET1;ALOXE3
4899,GO:0014855,0.79590534948553,0.536038383663948,1,37,striated muscle cell proliferation,BP,TENM4
7909,GO:0032508,0.795928541856024,0.436067184047463,2,71,DNA duplex unwinding,BP,DDB2;XPC
40,GO:0000082,0.796381122817983,0.323373454531992,7,221,G1/S transition of mitotic cell cycle,BP,GPNMB;EGFR;PKD2;ACVR1B;HYAL1;PCBP4;GJC2
14944,GO:0070897,0.796465107169147,0.534786780291717,1,39,DNA-templated transcriptional preinitiation complex assembly,BP,THRA
6683,GO:0030101,0.796686858222683,0.534435733745448,1,39,natural killer cell activation,BP,TYRO3
6559,GO:0022406,0.796743801879432,0.346037746737223,5,162,membrane docking,BP,RAB40B;VAMP3;MARK4;NINL;VPS33B
3609,GO:0008080,0.796872138677999,0.434598009802306,2,72,N-acetyltransferase activity,MF,NAT6;HGSNAT
10949,GO:0044774,0.797193863612965,0.389554314574083,3,104,mitotic DNA integrity checkpoint,BP,BRSK1;XPC;PCBP4
4463,GO:0010498,0.79727185955311,0.286230897144392,14,416,proteasomal protein catabolic process,BP,LAMP3;FBXO2;WWTR1;RHBDF1;TMEM129;DAB2IP;RBCK1;FBXW4;BTBD2;RNF187;RNF44;FBXW5;SMURF1;FBXO44
13989,GO:0060759,0.797325215811583,0.363038605662978,4,134,regulation of response to cytokine stimulus,BP,TNFAIP3;RBCK1;STAT1;CCDC3
9352,GO:0035914,0.797543567671946,0.533255977213283,1,38,skeletal muscle cell differentiation,BP,TBX1
10881,GO:0044464,0.79764978314161,0.252220593328276,445,11082,cell part,CC,TNFAIP3;POSTN;IFITM1;ITGB6;PEG3;TGFBI;TAGLN;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;KCNJ15;ULK2;LGALS7B;PTPRS;NOL4L;PHF7;FBXO41;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;KDSR;ASH2L;TNS1;HTRA1;PRICKLE2;PRR9;SLITRK6;CADM4;GAMT;GPRC5C;TXNRD3;ADGRL1;GPX7;SRSF5;ST3GAL5;TST;DCAF16;FLNC;SLC13A5;RALGDS;NCR3LG1;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;SNN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;APCDD1;NLGN2;CDK18;RAPGEF5;IRF2BPL;VIPR1;BCL6;PGM1;ANO9;TENM2;XYLT1;CYP4F22;PSD4;ZNF318;CERS4;BRSK1;SFRP1;ARHGEF4;FHOD3;UNK;POU3F1;TNFSF10;DHTKD1;INSR;VAV3;FAM185A;SLC16A5;KMT5C;NPEPL1;CYBRD1;SLC29A4;GAA;DHX32;CES2;SV2A;PKD2;ESPN;SIRPB2;ZFPM1;RGMA;RTN2;NAT6;ARSI;DNM1;TMEM134;PPP2R2C;SDK2;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;TNXB;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;LY6E;ZSCAN18;NSG1;PARVB;RASIP1;BPHL;BOC;SOX12;UROS;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;PRSS3;H6PD;CLIP2;TSC22D1;SGSH;KLK5;TRERF1;SHC2;SCN4B;CRTAP;GAS8;YEATS4;EVI5L;WIPF1;FKBP9;KCNC4;MNT;SDR9C7;RAB40B;TET1;MARVELD1;NRSN2;CYP27C1;FAM20C;GLUL;FAM213A;ANO8;EPHA4;ZNF266;MZT2A;TRAPPC2L;RPL13A;B3GNT9;RNPEPL1;CORO6;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;HERC3;CSMD2;TCFL5;MPLKIP;TYSND1;CTSV;LRIG3;RPS6KA5;TUB;HOMER2;KLHDC8B;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;ZNF362;SCART1;PGLS;ACSL1;EPS8L2;ZBTB42;DDX60;ACTA2;ERBB3;HGSNAT;KIF26A;S100A6;SPOCK1;SLC38A4;CDK14;ATP6V0A2;VAMP3;PPL;CUL9;FRY;PLXND1;GJB5;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;IMPA2;UNC119B;XPC;ARHGAP40;NAB2;NFATC4;ATP12A;SNX33;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;CPT1C;METTL7A;HYAL1;BCAM;RTF1;ZP3;STOM;CKMT1A;VAMP2;PLEKHH2;ADAMTS15;RBCK1;MBOAT7;AVL9;EFNB3;PCBP4;ZNF554;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;TNFRSF19;CABYR;SLC2A9;TMX4;MDK;TRPV4;ZDHHC1;MTHFR;PQLC2;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;RETSAT;CA11;NDUFA4L2;SDHA;KLK8;PTMS;ALDH2;ADORA2B;FBXW4;SERPING1;PLEKHN1;NAGLU;NMRK1;MRC2;MAFIP;MYL9;RTN4RL1;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;MC1R;IMPACT;LGALS9B;TBC1D17;MVD;GOLGA7B;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;STON1;GPR68;TOM1L2;GPR153;ANKRD13D;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;EPM2A;RNF135;H2AFJ;LAMB2;PCDH1;STAT1;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;PLCD1;H1FX;SLC5A1;CRY2;MARCH9;COX5B;SLC39A6;BLOC1S4;MARCKSL1;ZMYM3;FURIN;FBXW5;CLCN7;RHPN1;IFI16;IL20RB;CCDC88B;PCSK1;PLPP2;MLYCD;SUN1;OXLD1;NINL;PEX11B;FRAT1;CTSF;GJC2;ANGEL1;SLC1A4;ARPIN;SLC13A3;RPRD2;DBP;BEX2;ASIC1;ALS2CL;PER3;XYLT2;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;CAPNS2;MEX3A;CCDC3;DOK4;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;AIF1L;MT2A;NADK;RAB43;FAM117A;VPS33B;SLC47A1;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;REEP6;SCMH1;ZSWIM8;DTNB;SP100;DIRC2;MPG;ABCC1;DDX59;MTMR11;IDUA;NRK;ISYNA1;PIGZ;FBXO44;SORT1;CBR3;VANGL2;APBA1
792,GO:0002066,0.797820243870637,0.532816513505326,1,38,columnar/cuboidal epithelial cell development,BP,SLITRK6
10150,GO:0042773,0.798267576476765,0.432037544573258,2,80,ATP synthesis coupled electron transport,BP,SDHA;COX5B
2771,GO:0006220,0.798384808652018,0.531408170464445,1,41,pyrimidine nucleotide metabolic process,BP,NME4
3724,GO:0008276,0.799066807020861,0.431327883771976,2,72,protein methyltransferase activity,MF,ASH2L;KMT5C
6041,GO:0019207,0.799068118654275,0.342877425564261,5,164,kinase regulator activity,MF,ERBB3;PIK3R1;SPRY2;RTN4RL1;CDK20
12088,GO:0048194,0.799472108149457,0.430722185076565,2,72,Golgi vesicle budding,BP,COL7A1;TRAPPC2L
379,GO:0001012,0.799542386273379,0.280624109687998,15,436,RNA polymerase II regulatory region DNA binding,MF,HES2;NDN;THRA;GLI2;BCL6;ZFPM1;ETV5;SALL2;MNT;TCFL5;SREBF1;NFATC4;STAT1;IFI16;DBP
3508,GO:0007498,0.799648945251364,0.430525944507542,2,71,mesoderm development,BP,WNT3;TBX1
8990,GO:0035196,0.799963641468862,0.529398923987128,1,38,production of miRNAs involved in gene silencing by miRNA,BP,EGFR
1122,GO:0002718,0.800678786502627,0.52807394096739,1,39,regulation of cytokine production involved in immune response,BP,BCL6
6269,GO:0019897,0.800717976321186,0.384605559660626,3,102,extrinsic component of plasma membrane,CC,SERPINE2;S100A6;SYTL1
8625,GO:0034198,0.801323302415262,0.527039220668631,1,39,cellular response to amino acid starvation,BP,IMPACT
15617,GO:0072175,0.801514918865654,0.383464599029013,3,102,epithelial tube formation,BP,SFRP1;TULP3;VANGL2
4014,GO:0009063,0.801617564918864,0.427375785531593,2,74,cellular amino acid catabolic process,BP,GLUL;THNSL2
4585,GO:0010718,0.80184098747569,0.526386365493631,1,38,positive regulation of epithelial to mesenchymal transition,BP,WWTR1
14623,GO:0070265,0.802316442194687,0.525269867694763,1,40,necrotic cell death,BP,RBCK1
14566,GO:0070167,0.802341535364262,0.525580093155186,1,38,regulation of biomineral tissue development,BP,FAM20C
12837,GO:0051205,0.802367144793233,0.525188109090238,1,40,protein insertion into membrane,BP,EGFR
15563,GO:0072089,0.803131841128614,0.425295680443984,2,71,stem cell proliferation,BP,WNT3;KCTD11
13100,GO:0051705,0.80329317072685,0.524043658835218,1,38,multi-organism behavior,BP,TBX1
3240,GO:0006919,0.80332990292295,0.424735237337994,2,75,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNFSF10;F2R
16512,GO:0097327,0.803625137878816,0.424416976940664,2,73,response to antineoplastic agent,BP,EGFR;FOXO1
18973,GO:1904837,0.80384086065032,0.522643280910691,1,41,beta-catenin-TCF complex assembly,BP,ASH2L
889,GO:0002274,0.804173720999101,0.277775180284303,14,422,myeloid leukocyte activation,BP,CYBA;PGM1;GAA;CTSB;PRSS3;HEXB;HGSNAT;CXCR1;METTL7A;STOM;VAMP2;NDRG1;ADORA2B;TCIRG1
3277,GO:0006984,0.804223072089926,0.522357460986111,1,39,ER-nucleus signaling pathway,BP,NCK2
7813,GO:0032388,0.80439229529283,0.322836674881452,6,193,positive regulation of intracellular transport,BP,LDLRAP1;STOM;VAMP2;ADORA2B;ERBB2;CAMK1
7344,GO:0031406,0.804555705864807,0.37894657791361,3,106,carboxylic acid binding,MF,CYP27C1;GLUL;THNSL2
3448,GO:0007281,0.805434567088167,0.35180445128261,4,134,germ cell development,BP,ETV5;HEXB;ZP3;CABYR
7986,GO:0032637,0.805486467703108,0.520132590919916,1,40,interleukin-8 production,BP,F2R
6044,GO:0019210,0.805595341510939,0.42137187010676,2,74,kinase inhibitor activity,MF,SPRY2;RTN4RL1
15714,GO:0072347,0.806618015082398,0.518457841528916,1,39,response to anesthetic,BP,HOMER2
17603,GO:1901379,0.806685167127144,0.518348066477833,1,39,regulation of potassium ion transmembrane transport,BP,VAMP2
4175,GO:0009295,0.80702176309183,0.517625690761112,1,40,nucleoid,CC,MPG
10092,GO:0042645,0.80702176309183,0.517625690761112,1,40,mitochondrial nucleoid,CC,MPG
82,GO:0000166,0.807205645007007,0.232711337789709,61,1628,nucleotide binding,MF,ALDH1A3;ULK2;MAP3K14;EPHB2;TXNRD3;EGFR;OAS2;FGFR4;CDK18;BRSK1;INSR;DHX32;DNM1;NT5E;OBSCN;H6PD;RAB40B;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;ACVR1B;CAMKK1;ATP12A;TYRO3;RHOD;CKMT1A;SCG5;MBD1;TRPV4;MTHFR;SDHA;ALDH2;NMRK1;MARK4;MVD;ERBB2;NME4;CDK20;HINT2;CRY2;CLCN7;NUAK1;CAMK1;NADK;RAB43;MAP3K3;ABCC1;DDX59;NRK;CBR3
2420,GO:0005623,0.807212230176348,0.241403746136494,445,11087,cell,CC,TNFAIP3;POSTN;IFITM1;ITGB6;PEG3;TGFBI;TAGLN;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;KCNJ15;ULK2;LGALS7B;PTPRS;NOL4L;PHF7;FBXO41;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;KDSR;ASH2L;TNS1;HTRA1;PRICKLE2;PRR9;SLITRK6;CADM4;GAMT;GPRC5C;TXNRD3;ADGRL1;GPX7;SRSF5;ST3GAL5;TST;DCAF16;FLNC;SLC13A5;RALGDS;NCR3LG1;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;SNN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;APCDD1;NLGN2;CDK18;RAPGEF5;IRF2BPL;VIPR1;BCL6;PGM1;ANO9;TENM2;XYLT1;CYP4F22;PSD4;ZNF318;CERS4;BRSK1;SFRP1;ARHGEF4;FHOD3;UNK;POU3F1;TNFSF10;DHTKD1;INSR;VAV3;FAM185A;SLC16A5;KMT5C;NPEPL1;CYBRD1;SLC29A4;GAA;DHX32;CES2;SV2A;PKD2;ESPN;SIRPB2;ZFPM1;RGMA;RTN2;NAT6;ARSI;DNM1;TMEM134;PPP2R2C;SDK2;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;TNXB;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;LY6E;ZSCAN18;NSG1;PARVB;RASIP1;BPHL;BOC;SOX12;UROS;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;PRSS3;H6PD;CLIP2;TSC22D1;SGSH;KLK5;TRERF1;SHC2;SCN4B;CRTAP;GAS8;YEATS4;EVI5L;WIPF1;FKBP9;KCNC4;MNT;SDR9C7;RAB40B;TET1;MARVELD1;NRSN2;CYP27C1;FAM20C;GLUL;FAM213A;ANO8;EPHA4;ZNF266;MZT2A;TRAPPC2L;RPL13A;B3GNT9;RNPEPL1;CORO6;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;HERC3;CSMD2;TCFL5;MPLKIP;TYSND1;CTSV;LRIG3;RPS6KA5;TUB;HOMER2;KLHDC8B;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;ZNF362;SCART1;PGLS;ACSL1;EPS8L2;ZBTB42;DDX60;ACTA2;ERBB3;HGSNAT;KIF26A;S100A6;SPOCK1;SLC38A4;CDK14;ATP6V0A2;VAMP3;PPL;CUL9;FRY;PLXND1;GJB5;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;TMEM204;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;IMPA2;UNC119B;XPC;ARHGAP40;NAB2;NFATC4;ATP12A;SNX33;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;CPT1C;METTL7A;HYAL1;BCAM;RTF1;ZP3;STOM;CKMT1A;VAMP2;PLEKHH2;ADAMTS15;RBCK1;MBOAT7;AVL9;EFNB3;PCBP4;ZNF554;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;TNFRSF19;CABYR;SLC2A9;TMX4;MDK;TRPV4;ZDHHC1;MTHFR;PQLC2;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;RETSAT;CA11;NDUFA4L2;SDHA;KLK8;PTMS;ALDH2;ADORA2B;FBXW4;SERPING1;PLEKHN1;NAGLU;NMRK1;MRC2;MAFIP;MYL9;RTN4RL1;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;MC1R;IMPACT;LGALS9B;TBC1D17;MVD;GOLGA7B;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;STON1;GPR68;TOM1L2;GPR153;ANKRD13D;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;EPM2A;RNF135;H2AFJ;LAMB2;PCDH1;STAT1;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;PLCD1;H1FX;SLC5A1;CRY2;MARCH9;COX5B;SLC39A6;BLOC1S4;MARCKSL1;ZMYM3;FURIN;FBXW5;CLCN7;RHPN1;IFI16;IL20RB;CCDC88B;PCSK1;PLPP2;MLYCD;SUN1;OXLD1;NINL;PEX11B;FRAT1;CTSF;GJC2;ANGEL1;SLC1A4;ARPIN;SLC13A3;RPRD2;DBP;BEX2;ASIC1;ALS2CL;PER3;XYLT2;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;CAPNS2;MEX3A;CCDC3;DOK4;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;AIF1L;MT2A;NADK;RAB43;FAM117A;VPS33B;SLC47A1;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;REEP6;SCMH1;ZSWIM8;DTNB;SP100;DIRC2;MPG;ABCC1;DDX59;MTMR11;IDUA;NRK;ISYNA1;PIGZ;FBXO44;SORT1;CBR3;VANGL2;APBA1
11549,GO:0046148,0.807314593441168,0.517146136150655,1,40,pigment biosynthetic process,BP,UROS
8534,GO:0033993,0.807902642368644,0.259809062493997,20,579,response to lipid,BP,TNFAIP3;POSTN;EGFR;THRA;CYBA;SFRP1;FOXO1;WNT3;DAB2IP;TBX1;WNT9A;F2R;CTSV;ACSL1;SREBF1;ENDOG;NFATC4;FAM210B;MDK;CRY2
15780,GO:0072523,0.808069444544216,0.515907862266034,1,40,purine-containing compound catabolic process,BP,NT5E
9284,GO:0035773,0.808185157705649,0.515717777224872,1,40,insulin secretion involved in cellular response to glucose stimulus,BP,GPR68
17562,GO:1901265,0.808481948548553,0.231282682227361,61,1629,nucleoside phosphate binding,MF,ALDH1A3;ULK2;MAP3K14;EPHB2;TXNRD3;EGFR;OAS2;FGFR4;CDK18;BRSK1;INSR;DHX32;DNM1;NT5E;OBSCN;H6PD;RAB40B;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;ACVR1B;CAMKK1;ATP12A;TYRO3;RHOD;CKMT1A;SCG5;MBD1;TRPV4;MTHFR;SDHA;ALDH2;NMRK1;MARK4;MVD;ERBB2;NME4;CDK20;HINT2;CRY2;CLCN7;NUAK1;CAMK1;NADK;RAB43;MAP3K3;ABCC1;DDX59;NRK;CBR3
12375,GO:0048857,0.808668831949213,0.51492246348854,1,40,neural nucleus development,BP,ALDH1A3
8724,GO:0034404,0.808977998731729,0.329366516116312,5,168,nucleobase-containing small molecule biosynthetic process,BP,PGM1;DHTKD1;INSR;NT5E;NME4
10330,GO:0043177,0.809922089634475,0.371138425510623,3,107,organic acid binding,MF,CYP27C1;GLUL;THNSL2
15232,GO:0071453,0.810289290841134,0.327556042215766,5,169,cellular response to oxygen levels,BP,SFRP1;FOXO1;ATP6V0A2;ENDOG;NDRG1
11337,GO:0045739,0.81070593964553,0.511559120229776,1,40,positive regulation of DNA repair,BP,EGFR
11739,GO:0046634,0.810812310535738,0.511382886949063,1,40,regulation of alpha-beta T cell activation,BP,BCL6
565,GO:0001707,0.811183343724038,0.510940309203489,1,39,mesoderm formation,BP,WNT3
6679,GO:0030097,0.81249457844676,0.254295936257511,20,585,hemopoiesis,BP,ASH2L;THRA;GLI2;BCL6;SFRP1;DHTKD1;ZFPM1;FAM20C;FAM213A;DMTN;PIK3R1;ACVR1B;FAM210B;TYRO3;MYL9;GPR68;ERBB2;STAT1;IFI16;VPS33B
591,GO:0001756,0.812736311581016,0.508357620139368,1,39,somitogenesis,BP,SFRP1
10760,GO:0044265,0.813065753214423,0.238289909737203,34,962,cellular macromolecule catabolic process,BP,TNFAIP3;APOE;MVB12B;LAMP3;FBXO2;OAS2;H1F0;CTSB;TP53INP2;WWTR1;RHBDF1;TMEM129;DAB2IP;SGSH;EPHA4;RPL13A;MAGEF1;CTSV;CUL9;ENDOG;CTSL;RBCK1;PCBP4;SPATA18;FBXW4;BTBD2;RNF187;RNF44;FURIN;FBXW5;CTSF;SMURF1;TCIRG1;FBXO44
10540,GO:0043536,0.81389513344679,0.506248733374525,1,40,positive regulation of blood vessel endothelial cell migration,BP,MAP3K3
5425,GO:0016311,0.814565226706674,0.271566797146097,12,361,dephosphorylation,BP,PTPRS;PPP2R2C;NT5E;PDPR;IMPA2;PPP1R35;CRY2;PLPP2;THNSL2;NUAK1;ELFN2;PPP1R14A
336,GO:0000932,0.814875748726334,0.407084329165222,2,75,P-body,CC,BTBD2;MEX3A
9957,GO:0042391,0.814984767051447,0.308615833989491,6,195,regulation of membrane potential,BP,IFI6;NLGN2;RIMS3;SCN4B;CRTC1;ASIC1
10833,GO:0044389,0.815530298785554,0.284161928699924,9,283,ubiquitin-like protein ligase binding,MF,EGFR;FOXO1;ERBB3;CUL9;ACVR1B;BTBD2;MC1R;STAT1;PER3
17998,GO:1902562,0.815571228179151,0.503270699490187,1,41,H4 histone acetyltransferase complex,CC,YEATS4
3745,GO:0008306,0.816047540784318,0.502633324125271,1,40,associative learning,BP,ASIC1
3656,GO:0008170,0.816112232808512,0.405165571863215,2,75,N-methyltransferase activity,MF,ASH2L;KMT5C
488,GO:0001541,0.816148264347156,0.502298520844534,1,41,ovarian follicle development,BP,ZP3
6762,GO:0030217,0.816271591006617,0.336502194759818,4,136,T cell differentiation,BP,GLI2;BCL6;ZFPM1;ERBB2
15564,GO:0072091,0.816394205826653,0.502048638562923,1,40,regulation of stem cell proliferation,BP,KCTD11
2804,GO:0006284,0.816771967658651,0.501088511177085,1,42,base-excision repair,BP,MPG
10148,GO:0042771,0.817162327361669,0.500428378661607,1,42,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,IFI16
9841,GO:0042133,0.817386818917448,0.403181791827241,2,75,neurotransmitter metabolic process,BP,INSR;PKD2
12217,GO:0048534,0.818017335276556,0.246062416120804,21,614,hematopoietic or lymphoid organ development,BP,ASH2L;THRA;GLI2;BCL6;SFRP1;DHTKD1;ZFPM1;TBX1;FAM20C;FAM213A;DMTN;PIK3R1;ACVR1B;FAM210B;TYRO3;MYL9;GPR68;ERBB2;STAT1;IFI16;VPS33B
3455,GO:0007292,0.819031794278816,0.400612624132571,2,75,female gamete generation,BP,HEXB;ZP3
6039,GO:0019205,0.819056329174688,0.497213377179395,1,42,nucleobase-containing compound kinase activity,MF,NME4
13991,GO:0060761,0.819068058886255,0.49719340373359,1,42,negative regulation of response to cytokine stimulus,BP,CCDC3
19145,GO:1905268,0.819602105556314,0.496606390632812,1,40,negative regulation of chromatin organization,BP,TET1
11389,GO:0045839,0.820080987273516,0.495465655213836,1,42,negative regulation of mitotic nuclear division,BP,TOM1L2
11732,GO:0046626,0.820488459340603,0.494926733894529,1,41,regulation of insulin receptor signaling pathway,BP,PIK3R1
10341,GO:0043195,0.820643261839562,0.494661843977063,1,41,terminal bouton,CC,SV2A
16622,GO:0097542,0.82089003487357,0.49423929738314,1,41,ciliary tip,CC,GLI2
16905,GO:0098930,0.820928435688343,0.494173512979183,1,41,axonal transport,BP,BLOC1S4
8130,GO:0032880,0.820985205951691,0.238411931266583,24,690,regulation of protein localization,BP,POSTN;EPHB2;EGFR;NLGN2;SFRP1;LDLRAP1;TP53INP2;RHBDF1;TMEM231;GLUL;F2R;SREBF1;DMTN;PIK3R1;TRIM22;SNX33;SLC2A1;STOM;VAMP2;TRPV4;GPR68;ERBB2;CAMK1;SP100
14654,GO:0070316,0.82120732594197,0.493695494451289,1,41,regulation of G0 to G1 transition,BP,DAB2IP
20138,GO:2001023,0.821855111529615,0.49242552347066,1,42,regulation of response to drug,BP,ENDOG
7150,GO:0031050,0.82243707572276,0.491582404296886,1,41,dsRNA fragmentation,BP,EGFR
14956,GO:0070918,0.82243707572276,0.491582404296886,1,41,production of small RNA involved in gene silencing by RNA,BP,EGFR
4465,GO:0010501,0.822584726042147,0.491328112993941,1,41,RNA secondary structure unwinding,BP,DDX59
4321,GO:0009890,0.8239046973408,0.219996632826131,44,1218,negative regulation of biosynthetic process,BP,PEG3;HES2;APOE;EGFR;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;ZFPM1;HR;SALL2;WWTR1;FOXO1;DAB2IP;MNT;TET1;RPL13A;TCFL5;RPS6KA5;ZBTB42;SREBF1;TRIM22;NCK2;NAB2;NFATC4;RTF1;ZP3;MBD1;TRPV4;IMPACT;H2AFJ;STAT1;CRY2;IFI16;PER3;MEX3A;CXXC5;MDFI;SCMH1;SP100
10421,GO:0043312,0.824275560342956,0.263103943159986,11,347,neutrophil degranulation,BP,CYBA;PGM1;GAA;CTSB;PRSS3;HEXB;HGSNAT;CXCR1;METTL7A;STOM;TCIRG1
411,GO:0001098,0.824393805259646,0.488043878924543,1,42,basal transcription machinery binding,MF,RTF1
412,GO:0001099,0.824393805259646,0.488043878924543,1,42,basal RNA polymerase II transcription machinery binding,MF,RTF1
12923,GO:0051345,0.824458029060766,0.2415632324542,19,555,positive regulation of hydrolase activity,BP,LMF1;EGFR;SFRP1;TNFSF10;VAV3;DAB2IP;EVI5L;EPHA4;F2R;ARHGEF19;IQSEC1;ACAP3;ARHGAP40;TBC1D17;ERBB2;IFI16;ALS2CL;PLXNB1;RASA4
883,GO:0002260,0.824557103606655,0.487760760722984,1,42,lymphocyte homeostasis,BP,TNFAIP3
20236,GO:2001244,0.824932445510398,0.486814472472825,1,44,positive regulation of intrinsic apoptotic signaling pathway,BP,NCK2
4927,GO:0014910,0.825052046263922,0.487060146644893,1,41,regulation of smooth muscle cell migration,BP,POSTN
3162,GO:0006793,0.825335114249665,0.206935244276519,88,2351,phosphorus metabolic process,BP,TNFAIP3;APOE;ULK2;PTPRS;GPNMB;MAP3K14;EPHB2;EGFR;FGFR4;CDK18;PGM1;BRSK1;SFRP1;DHTKD1;INSR;VAV3;PKD2;PPP2R2C;NT5E;PDPR;WWTR1;FOXO1;DAB2IP;OBSCN;TBX1;H6PD;SHC2;FAM20C;EPHA4;F2R;RPS6KA5;HEXB;PLCD3;PGLS;ACSL1;ERBB3;CDK14;ATP6V0A2;CSPG4;DMTN;GRK6;PIK3R1;PTHLH;NCK2;ACVR1B;CAMKK1;IMPA2;NAB2;TYRO3;ZP3;CKMT1A;MBOAT7;ADCK5;SPRY2;TNFRSF19;TRPV4;SDHA;PPP1R35;ADORA2B;NMRK1;RTN4RL1;MARK4;IMPACT;MVD;IGFBP4;ERBB2;NME4;CDK20;ACKR3;PLCD1;CRY2;COX5B;PLPP2;MLYCD;THNSL2;GJC2;NUAK1;RASA4;CAMK1;TCIRG1;NADK;ELFN2;MAP3K3;PPP1R14A;NRK;ISYNA1;PIGZ;VANGL2
18632,GO:1904018,0.826485033351598,0.346593308489225,3,108,positive regulation of vasculature development,BP,VEGFB;HYAL1;MAP3K3
12830,GO:0051193,0.826782965046243,0.388308224802527,2,76,regulation of cofactor metabolic process,BP,INSR;PDPR
896,GO:0002283,0.827134505739736,0.25943612741608,11,348,neutrophil activation involved in immune response,BP,CYBA;PGM1;GAA;CTSB;PRSS3;HEXB;HGSNAT;CXCR1;METTL7A;STOM;TCIRG1
12152,GO:0048332,0.827309750766731,0.483123701176043,1,41,mesoderm morphogenesis,BP,WNT3
2923,GO:0006464,0.827467096213085,0.201325553423795,117,3073,cellular protein modification process,BP,TNFAIP3;APOE;ULK2;PTPRS;FBXO41;OBSL1;LMF1;GPNMB;MAP3K14;EPHB2;ASH2L;PRR9;ST3GAL5;DCAF16;EGFR;FBXO2;FGFR4;CDK18;BCL6;BRSK1;SFRP1;INSR;KMT5C;PKD2;NAT6;ARSI;PPP2R2C;HR;PDPR;VEGFB;WWTR1;TMEM129;FOXO1;LY6E;DDB2;DAB2IP;OBSCN;TBX1;SHC2;CRTAP;YEATS4;FKBP9;RAB40B;TET1;FAM20C;ANO8;EPHA4;B3GNT9;MAGEF1;F2R;HERC3;RPS6KA5;KLHDC8B;LTBP1;ACSL1;ERBB3;CDK14;CUL9;FRY;SREBF1;CSPG4;DMTN;GRK6;PIK3R1;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;NAB2;TYRO3;RTF1;RBCK1;ADCK5;SPRY2;TNFRSF19;TRPV4;ZDHHC1;MTHFR;PPP1R35;ADORA2B;FBXW4;RTN4RL1;MARK4;IMPACT;MVD;GOLGA7B;IGFBP4;ERBB2;RNF187;RNF135;LAMB2;FBXL8;CDK20;HINT2;RNF44;WIPI2;ACKR3;CRY2;MARCH9;FBXW5;PLPP2;GJC2;NUAK1;RASA4;SMURF1;CAMK1;RNF208;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;NRK;PIGZ;FBXO44;VANGL2
9486,GO:0036211,0.827467096213085,0.201325553423795,117,3073,protein modification process,BP,TNFAIP3;APOE;ULK2;PTPRS;FBXO41;OBSL1;LMF1;GPNMB;MAP3K14;EPHB2;ASH2L;PRR9;ST3GAL5;DCAF16;EGFR;FBXO2;FGFR4;CDK18;BCL6;BRSK1;SFRP1;INSR;KMT5C;PKD2;NAT6;ARSI;PPP2R2C;HR;PDPR;VEGFB;WWTR1;TMEM129;FOXO1;LY6E;DDB2;DAB2IP;OBSCN;TBX1;SHC2;CRTAP;YEATS4;FKBP9;RAB40B;TET1;FAM20C;ANO8;EPHA4;B3GNT9;MAGEF1;F2R;HERC3;RPS6KA5;KLHDC8B;LTBP1;ACSL1;ERBB3;CDK14;CUL9;FRY;SREBF1;CSPG4;DMTN;GRK6;PIK3R1;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;NAB2;TYRO3;RTF1;RBCK1;ADCK5;SPRY2;TNFRSF19;TRPV4;ZDHHC1;MTHFR;PPP1R35;ADORA2B;FBXW4;RTN4RL1;MARK4;IMPACT;MVD;GOLGA7B;IGFBP4;ERBB2;RNF187;RNF135;LAMB2;FBXL8;CDK20;HINT2;RNF44;WIPI2;ACKR3;CRY2;MARCH9;FBXW5;PLPP2;GJC2;NUAK1;RASA4;SMURF1;CAMK1;RNF208;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;NRK;PIGZ;FBXO44;VANGL2
3298,GO:0007017,0.827773358172581,0.23431741938415,21,606,microtubule-based process,BP,OBSL1;BRSK1;PKD2;GAS8;DIXDC1;KIF26B;KIF26A;CUL9;SPRY2;CABYR;TRPV4;MAFIP;MARK4;CCDC69;ERBB2;BLOC1S4;FBXW5;CCDC88B;SUN1;NINL;APBA1
10402,GO:0043281,0.828581550038041,0.302069982732393,5,174,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,IFI6;LAMP3;TNFSF10;WNT9A;F2R
11009,GO:0045023,0.829022075108869,0.47995909986341,1,42,G0 to G1 transition,BP,DAB2IP
400,GO:0001077,0.829125713831114,0.301398147153506,5,168,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NDN;GLI2;SOX12;SREBF1;DBP
3346,GO:0007098,0.82975696117263,0.341654520432991,3,108,centrosome cycle,BP,BRSK1;PKD2;FBXW5
5912,GO:0018209,0.829934774436585,0.278897337540331,7,226,peptidyl-serine modification,BP,EGFR;RPS6KA5;DMTN;NCK2;CAMKK1;SPRY2;CAMK1
17994,GO:1902554,0.830183782331699,0.38274648985062,2,78,serine/threonine protein kinase complex,CC,CDK14;ACVR1B
2857,GO:0006366,0.831036328520079,0.20486468854107,65,1759,transcription by RNA polymerase II,BP,PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;BCL6;TENM2;SFRP1;POU3F1;PKD2;ZFPM1;RGMA;ETV5;SALL2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;TCFL5;RPS6KA5;HEXB;ZBTB42;PLXND1;SREBF1;PIK3R1;NCK2;ACVR1B;NFATC4;RTF1;MBD1;TRPV4;MC1R;IMPACT;NEO1;CRTC1;ERBB2;STAT1;CRY2;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;MDFI;SP100
17067,GO:0101002,0.831828236397858,0.313901637818668,4,145,ficolin-1-rich granule,CC,PGM1;GAA;CTSB;TCIRG1
17731,GO:1901799,0.832291694204273,0.47401891809453,1,43,negative regulation of proteasomal protein catabolic process,BP,LAMP3
1766,GO:0004386,0.832313703262858,0.3133656456844,4,137,helicase activity,MF,DHX32;SMARCA1;DDX60;DDX59
7181,GO:0031090,0.832465305434455,0.199903518779099,82,2220,organelle membrane,CC,APOE;MVB12B;LAMP3;ULK2;PTPRS;CPT2;PRICKLE2;GPRC5C;ST3GAL5;TST;COL6A1;EGFR;FBXO2;CRAT;CYBA;SNN;XYLT1;CYP4F22;CERS4;INSR;CYBRD1;GAA;SV2A;PKD2;DNM1;LDLRAP1;SYT8;RHBDF1;WNT3;NSG1;BPHL;COL7A1;TMEM231;YEATS4;RAB40B;EPHA4;TRAPPC2L;B3GNT9;LRIG3;ACSL1;HGSNAT;ATP6V0A2;VAMP3;SREBF1;DMTN;APPL2;NCK2;SNX33;FAM210B;RHOD;CXCR1;SLC2A1;CPT1C;STOM;CKMT1A;VAMP2;PQLC2;SPATA18;NDRG1;RETSAT;NDUFA4L2;SDHA;PDLIM4;GOLGA7B;MICALL1;ERBB2;C2CD4C;NME4;MARCH9;COX5B;FURIN;CLCN7;SUN1;PEX11B;XYLT2;TCIRG1;RAB43;VPS33B;ST6GALNAC6;DIRC2;ABCC1;SORT1
17000,GO:0099518,0.832519681320812,0.473764823710165,1,42,vesicle cytoskeletal trafficking,BP,BLOC1S4
3230,GO:0006903,0.832852707757445,0.37844136594913,2,78,vesicle targeting,BP,COL7A1;TRAPPC2L
671,GO:0001885,0.833788974811436,0.471498552538216,1,42,endothelial cell development,BP,PTPRS
16227,GO:0090329,0.834089019877455,0.470809249540555,1,43,regulation of DNA-dependent DNA replication,BP,BCL6
12738,GO:0051053,0.834594702996232,0.334257958603406,3,109,negative regulation of DNA metabolic process,BP,BCL6;TET1;MAGEF1
13854,GO:0060537,0.834715551853371,0.272402022963189,7,226,muscle tissue development,BP,OBSL1;FHOD3;PKD2;ZFPM1;TBX1;TENM4;ERBB3
1170,GO:0002824,0.835151893291681,0.468756585528059,1,44,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ZP3
12990,GO:0051480,0.835341999611845,0.308839000822902,4,141,regulation of cytosolic calcium ion concentration,BP,CYBA;PKD2;F2R;TRPV4
5714,GO:0016879,0.83544183654743,0.468380297313845,1,43,ligase activity, forming carbon-nitrogen bonds,MF,GLUL
1112,GO:0002708,0.83608227121719,0.467081107764644,1,44,positive regulation of lymphocyte mediated immunity,BP,ZP3
13671,GO:0060271,0.836227566196362,0.25704956296368,9,286,cilium assembly,BP,WWTR1;TMEM231;GAS8;EVI5L;UNC119B;MAFIP;MARK4;NINL;VANGL2
17488,GO:1901019,0.836291093857783,0.466849683200173,1,43,regulation of calcium ion transmembrane transporter activity,BP,PKD2
7716,GO:0032233,0.836425534490511,0.466606969669559,1,43,positive regulation of actin filament bundle assembly,BP,SFRP1
13568,GO:0060079,0.836843273700457,0.465852080742482,1,43,excitatory postsynaptic potential,BP,NLGN2
12758,GO:0051092,0.837412569825064,0.329839091495587,3,112,positive regulation of NF-kappaB transcription factor activity,BP,RPS6KA5;TRIM22;RBCK1
10980,GO:0044843,0.837591012519998,0.268406189689356,7,233,cell cycle G1/S phase transition,BP,GPNMB;EGFR;PKD2;ACVR1B;HYAL1;PCBP4;GJC2
790,GO:0002064,0.837651742720836,0.305459402822453,4,140,epithelial cell development,BP,PTPRS;SLITRK6;ACTA2;LAMB2
9764,GO:0040014,0.837747287989095,0.464214712298373,1,43,regulation of multicellular organism growth,BP,GAMT
6276,GO:0019904,0.83797045382756,0.225006364647293,19,561,protein domain specific binding,MF,ADAM19;THRA;CYBA;ARHGEF4;INSR;PKD2;ESPN;WNT3;DAB2IP;SH3BP2;WIPF1;EPHA4;DIXDC1;HOMER2;PLXND1;CABYR;TRPV4;ANGEL1;SP100
14471,GO:0065004,0.838240919368644,0.276468345672457,6,213,protein-DNA complex assembly,BP,THRA;H1F0;SOX12;DDB2;XPC;H1FX
15389,GO:0071702,0.838300787574476,0.195335756725958,71,1932,organic substance transport,BP,POSTN;ITGB6;APOE;MVB12B;LMF1;CPT2;SRSF5;TST;SLC13A5;EGFR;CYBA;NLGN2;BCL6;ANO9;SFRP1;INSR;SLC16A5;SLC29A4;SV2A;RTN2;LDLRAP1;RHBDF1;TMEM129;NSG1;EVI5L;RAB40B;GLUL;RPL13A;OLFM2;F2R;ACSL1;SLC38A4;ATP6V0A2;VAMP3;SREBF1;DMTN;PIK3R1;SYTL1;UNC119B;SNX33;RHOD;SLC2A1;STOM;VAMP2;SCG5;SLC2A9;TRPV4;ZDHHC1;PQLC2;LTBP4;TBC1D17;GOLGA7B;GPR68;TOM1L2;MICALL1;ERBB2;NME4;SLC5A1;SLC1A4;SLC13A3;SMURF1;CAMK1;TCIRG1;NISCH;RAB43;VPS33B;SLC47A1;SP100;ABCC1;SORT1;APBA1
847,GO:0002181,0.838814081734443,0.3683585467295,2,85,cytoplasmic translation,BP,UNK;RPL13A
941,GO:0002366,0.838824671214741,0.231974924502394,15,463,leukocyte activation involved in immune response,BP,CYBA;BCL6;PGM1;GAA;ZFPM1;CTSB;PRSS3;HEXB;HGSNAT;CXCR1;METTL7A;STOM;VAMP2;ADORA2B;TCIRG1
359,GO:0000978,0.839123134734337,0.253203430906968,9,286,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,HES2;NDN;GLI2;ZFPM1;TCFL5;SREBF1;NFATC4;STAT1;IFI16
18468,GO:1903670,0.839315665515483,0.461361822772966,1,43,regulation of sprouting angiogenesis,BP,MAP3K3
13140,GO:0051785,0.8398902175476,0.460167063058648,1,44,positive regulation of nuclear division,BP,INSR
1013,GO:0002520,0.840050428637798,0.217969281086693,22,651,immune system development,BP,TNFAIP3;ASH2L;THRA;GLI2;BCL6;SFRP1;DHTKD1;ZFPM1;TBX1;FAM20C;FAM213A;DMTN;PIK3R1;ACVR1B;FAM210B;TYRO3;MYL9;GPR68;ERBB2;STAT1;IFI16;VPS33B
9835,GO:0042119,0.840180559457155,0.242545814730757,11,353,neutrophil activation,BP,CYBA;PGM1;GAA;CTSB;PRSS3;HEXB;HGSNAT;CXCR1;METTL7A;STOM;TCIRG1
17543,GO:1901214,0.840555146591469,0.273341046248716,6,203,regulation of neuron death,BP,APOE;GPNMB;F2R;ERBB3;TYRO3;MDK
7298,GO:0031327,0.840657644816888,0.201111815536604,43,1202,negative regulation of cellular biosynthetic process,BP,PEG3;HES2;EGFR;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;ZFPM1;HR;SALL2;WWTR1;FOXO1;DAB2IP;MNT;TET1;RPL13A;TCFL5;RPS6KA5;ZBTB42;SREBF1;TRIM22;NCK2;NAB2;NFATC4;RTF1;ZP3;MBD1;TRPV4;IMPACT;H2AFJ;STAT1;CRY2;IFI16;PER3;MEX3A;CXXC5;MDFI;SCMH1;SP100
5359,GO:0016192,0.840820873677535,0.197409700325828,52,1433,vesicle-mediated transport,BP,APOE;MVB12B;LMF1;CYBA;NLGN2;PGM1;VAV3;GAA;DNM1;LDLRAP1;RIMS3;CTSB;SYT8;VEGFB;NSG1;COL7A1;PRSS3;EVI5L;WIPF1;RAB40B;TRAPPC2L;TUB;HEXB;SCART1;HGSNAT;KIF26A;VAMP3;DMTN;PIK3R1;APPL2;ACAP3;SYTL1;SNX33;TYRO3;CXCR1;METTL7A;ZP3;STOM;VAMP2;ADORA2B;SERPING1;MRC2;TBC1D17;STON1;MICALL1;C2CD4C;ACKR3;BLOC1S4;TCIRG1;RAB43;VPS33B;SORT1
10703,GO:0044093,0.84101079510116,0.199827745230864,45,1248,positive regulation of molecular function,BP,APOE;LMF1;MAP3K14;EPHB2;EGFR;CYBA;FGFR4;SFRP1;TNFSF10;INSR;VAV3;PKD2;DAB2IP;SHC2;EVI5L;EPHA4;F2R;RPS6KA5;ARHGEF19;ACSL1;ERBB3;PLXND1;CSPG4;IQSEC1;ACAP3;TRIM22;CAMKK1;ARHGAP40;NAB2;TYRO3;RBCK1;SPRY2;ADORA2B;TBC1D17;CRTC1;ERBB2;CDK20;IFI16;ALS2CL;PLXNB1;RASA4;CAMK1;MAP3K3;NRK;VANGL2
11629,GO:0046434,0.841173207162433,0.284142456508048,5,174,organophosphate catabolic process,BP,PGM1;DHTKD1;INSR;NT5E;IMPA2
16795,GO:0098739,0.841375475948906,0.45759124722242,1,43,import across plasma membrane,BP,SLC39A6
11169,GO:0045333,0.841506788879083,0.299493315833543,4,153,cellular respiration,BP,DHTKD1;NFATC4;SDHA;COX5B
2820,GO:0006304,0.841673908521786,0.363896166965905,2,80,DNA modification,BP,TET1;MPG
5544,GO:0016575,0.841828060644283,0.363695351496461,2,79,histone deacetylation,BP,BCL6;SREBF1
1106,GO:0002702,0.842023281088138,0.456114468309952,1,45,positive regulation of production of molecular mediator of immune response,BP,KLK5
15009,GO:0070997,0.842834460336343,0.261202387741313,7,233,neuron death,BP,APOE;GPNMB;F2R;ERBB3;ENDOG;TYRO3;MDK
14591,GO:0070201,0.842929553911658,0.222468539277489,17,514,regulation of establishment of protein localization,BP,POSTN;EGFR;NLGN2;SFRP1;RHBDF1;GLUL;F2R;SREBF1;DMTN;SLC2A1;STOM;VAMP2;TRPV4;GPR68;ERBB2;CAMK1;SP100
19678,GO:2000060,0.843095042185971,0.361540384243348,2,80,positive regulation of ubiquitin-dependent protein catabolic process,BP,MAGEF1;SMURF1
2423,GO:0005637,0.843416690395111,0.453681696718456,1,44,nuclear inner membrane,CC,SUN1
17687,GO:1901657,0.843697629266603,0.319985695569413,3,116,glycosyl compound metabolic process,BP,GAMT;NT5E;NME4
10389,GO:0043266,0.843731589442329,0.453098664176813,1,44,regulation of potassium ion transport,BP,VAMP2
12814,GO:0051172,0.844165077945443,0.18998423189594,65,1777,negative regulation of nitrogen compound metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;IFI6;LAMP3;EPHB2;EGFR;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;ZFPM1;SERPINE2;HR;SALL2;WWTR1;FOXO1;DAB2IP;COL7A1;CRTAP;MNT;TET1;EPHA4;WNT9A;RPL13A;MAGEF1;TCFL5;RPS6KA5;ZBTB42;SPOCK1;FRY;SREBF1;DMTN;TRIM22;NCK2;NAB2;NFATC4;RTF1;ZP3;SPRY2;MBD1;TRPV4;PPP1R35;SERPING1;RTN4RL1;IMPACT;H2AFJ;STAT1;HINT2;CRY2;FURIN;IFI16;PER3;MEX3A;CXXC5;ELFN2;PPP1R14A;MDFI;SCMH1;SP100
11609,GO:0046365,0.845378222127056,0.449766216887066,1,46,monosaccharide catabolic process,BP,PGM1
4791,GO:0012507,0.845522520483836,0.449630752611767,1,45,ER to Golgi transport vesicle membrane,CC,SREBF1
2254,GO:0005198,0.845641059139616,0.221069239456955,16,504,structural molecule activity,MF,APOE;OBSL1;PRR9;NCR3LG1;EPB41L3;LDLRAP1;OBSCN;YEATS4;MARVELD1;RPL13A;HOMER2;PPL;NCK2;SYNM;MYL9;LAMB2
982,GO:0002446,0.845644079566632,0.235396716901882,11,355,neutrophil mediated immunity,BP,CYBA;PGM1;GAA;CTSB;PRSS3;HEXB;HGSNAT;CXCR1;METTL7A;STOM;TCIRG1
3654,GO:0008168,0.845902635622471,0.277281286435106,5,176,methyltransferase activity,MF,ASH2L;GAMT;NSUN7;KMT5C;METTL7A
885,GO:0002263,0.846060974430456,0.222815372495793,15,466,cell activation involved in immune response,BP,CYBA;BCL6;PGM1;GAA;ZFPM1;CTSB;PRSS3;HEXB;HGSNAT;CXCR1;METTL7A;STOM;VAMP2;ADORA2B;TCIRG1
10538,GO:0043534,0.846743780399993,0.355452378412881,2,80,blood vessel endothelial cell migration,BP,APOE;MAP3K3
17498,GO:1901068,0.847431752442035,0.445925503666307,1,46,guanosine-containing compound metabolic process,BP,NME4
758,GO:0002011,0.848106504999296,0.444930908674031,1,44,morphogenesis of an epithelial sheet,BP,VANGL2
16406,GO:0097110,0.848133778437838,0.444739739885068,1,45,scaffold protein binding,MF,NCK2
3468,GO:0007346,0.848206602610916,0.212310214615519,19,574,regulation of mitotic cell cycle,BP,OBSL1;GPNMB;MAP3K14;EGFR;BCL6;BRSK1;INSR;PKD2;WNT9A;CUL9;XPC;HYAL1;PCBP4;TOM1L2;FBXW5;NINL;GJC2;MAP3K3;NRK
1986,GO:0004721,0.848661692369062,0.288960572136003,4,144,phosphoprotein phosphatase activity,MF,PTPRS;PPP2R2C;PDPR;PLPP2
109,GO:0000226,0.848721174316462,0.221944651651936,14,427,microtubule cytoskeleton organization,BP,OBSL1;BRSK1;PKD2;GAS8;DIXDC1;CUL9;SPRY2;TRPV4;MARK4;CCDC69;FBXW5;CCDC88B;SUN1;NINL
5483,GO:0016445,0.849421329477747,0.442311262069787,1,45,somatic diversification of immunoglobulins,BP,BCL6
3733,GO:0008287,0.849644224113378,0.441889716296021,1,45,protein serine/threonine phosphatase complex,CC,PPP2R2C
18292,GO:1903293,0.849644224113378,0.441889716296021,1,45,phosphatase complex,CC,PPP2R2C
36,GO:0000075,0.850468644739145,0.25928637210163,6,207,cell cycle checkpoint,BP,MAP3K14;BRSK1;WNT9A;XPC;PCBP4;NDRG1
1036,GO:0002562,0.850827327408742,0.439646527792302,1,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,BCL6
5482,GO:0016444,0.850827327408742,0.439646527792302,1,45,somatic cell DNA recombination,BP,BCL6
20160,GO:2001056,0.850866844651316,0.308693489912537,3,117,positive regulation of cysteine-type endopeptidase activity,BP,TNFSF10;F2R;IFI16
38,GO:0000077,0.850972656173805,0.285431882602134,4,146,DNA damage checkpoint,BP,MAP3K14;BRSK1;XPC;PCBP4
5363,GO:0016202,0.851174504996579,0.347981557142021,2,80,regulation of striated muscle tissue development,BP,TBX1;ERBB3
13055,GO:0051606,0.851528271153074,0.307673540000999,3,116,detection of stimulus,BP,PKD2;SERPINE2;REEP6
5543,GO:0016574,0.851789583898606,0.437815002019375,1,45,histone ubiquitination,BP,DDB2
13180,GO:0051881,0.85183111469744,0.437351029670066,1,48,regulation of mitochondrial membrane potential,BP,IFI6
11373,GO:0045814,0.852580715191602,0.30586696381069,3,121,negative regulation of gene expression, epigenetic,BP,TET1;MBD1;H2AFJ
4750,GO:0010952,0.852804844721723,0.282578978229874,4,150,positive regulation of peptidase activity,BP,TNFSF10;EPHA4;F2R;IFI16
8947,GO:0035065,0.852879137481607,0.435599501362346,1,46,regulation of histone acetylation,BP,RPS6KA5
10952,GO:0044782,0.853358638661988,0.234043423475883,9,292,cilium organization,BP,WWTR1;TMEM231;GAS8;EVI5L;UNC119B;MAFIP;MARK4;NINL;VANGL2
6265,GO:0019887,0.853565758133848,0.281460073663634,4,148,protein kinase regulator activity,MF,ERBB3;SPRY2;RTN4RL1;CDK20
13139,GO:0051784,0.854895857942065,0.431596472830045,1,47,negative regulation of nuclear division,BP,TOM1L2
3317,GO:0007043,0.85556143327543,0.34049804889977,2,80,cell-cell junction assembly,BP,EPB41L3;TRPV4
14470,GO:0065003,0.855690995231788,0.180890495073659,50,1416,protein-containing complex assembly,BP,TNFAIP3;APOE;ALDH1A3;OBSL1;ASH2L;SRSF5;GPX3;COL6A1;THRA;CYBA;H1F0;FHOD3;INSR;PKD2;DNM1;NSG1;SOX12;DDB2;DAB2IP;COL7A1;WIPF1;KCNC4;GLUL;TRAPPC2L;RPL13A;TYSND1;EPS8L2;HGSNAT;ATP6V0A2;VAMP3;DMTN;TRIM22;NCK2;KCTD11;XPC;ARHGAP40;SLC2A1;STOM;VAMP2;TRPV4;MSRB2;IMPACT;CRTC1;H1FX;PEX11B;ARPIN;ASIC1;MMP1;TCIRG1;APBA1
7116,GO:0030968,0.855946846510129,0.300632259741051,3,116,endoplasmic reticulum unfolded protein response,BP,DAB2IP;PIK3R1;NCK2
6271,GO:0019899,0.855978019393655,0.176085572298004,67,1820,enzyme binding,MF,TNFAIP3;EPHB2;SRSF5;RALGDS;EGFR;FGFR4;RAPGEF5;PSD4;BRSK1;ARHGEF4;INSR;VAV3;SV2A;PKD2;DNM1;RIMS3;FOXO1;DAB2IP;OBSCN;SHC2;GAS8;EVI5L;EPHA4;TRAPPC2L;TYSND1;ARHGEF19;EPS8L2;ACTA2;ERBB3;ATP6V0A2;CUL9;SREBF1;CSPG4;PIK3R1;APPL2;IQSEC1;ACAP3;TRIM22;ACVR1B;SYTL1;TYRO3;RHOD;SLC2A1;RTF1;ZP3;STOM;SPRY2;TRPV4;NDRG1;PPP1R35;PDLIM4;BTBD2;MC1R;TBC1D17;TOM1L2;MICALL1;ERBB2;STAT1;TULP3;CRY2;FURIN;FBXW5;ALS2CL;PER3;TCIRG1;SP100;SORT1
12260,GO:0048634,0.856132381654677,0.339465337299377,2,81,regulation of muscle organ development,BP,TBX1;ERBB3
17749,GO:1901861,0.856238591481847,0.339282796136253,2,81,regulation of muscle tissue development,BP,TBX1;ERBB3
10244,GO:0043022,0.857563176957932,0.426427551471921,1,47,ribosome binding,MF,IMPACT
13446,GO:0055024,0.857593914552721,0.426496088664667,1,46,regulation of cardiac muscle tissue development,BP,ERBB3
4926,GO:0014909,0.857769471431077,0.426154069453792,1,46,smooth muscle cell migration,BP,POSTN
12739,GO:0051054,0.858659145488557,0.258531147673898,5,179,positive regulation of DNA metabolic process,BP,EGFR;GLI2;FGFR4;INSR;ENDOG
285,GO:0000790,0.858974925833775,0.226333514047572,9,303,nuclear chromatin,CC,ASH2L;H1F0;KMT5C;SALL2;YEATS4;SMARCA1;APPL2;H2AFJ;STAT1
17546,GO:1901222,0.858991345211365,0.423639019618345,1,47,regulation of NIK/NF-kappaB signaling,BP,EGFR
365,GO:0000987,0.859075430124522,0.226255269933153,9,293,proximal promoter sequence-specific DNA binding,MF,HES2;NDN;GLI2;ZFPM1;TCFL5;SREBF1;NFATC4;STAT1;IFI16
4840,GO:0014070,0.85916514256902,0.195746564654287,21,629,response to organic cyclic compound,BP,POSTN;EGFR;THRA;CYBA;GLI2;SFRP1;PKD2;FOXO1;CTSV;HOMER2;ACSL1;SREBF1;DMTN;ENDOG;NFATC4;FAM210B;MDK;MTHFR;IMPACT;STAT1;CRY2
9983,GO:0042440,0.859367715331975,0.422778659526914,1,48,pigment metabolic process,BP,UROS
13440,GO:0055017,0.859817394701389,0.422147869891247,1,46,cardiac muscle tissue growth,BP,TENM4
1167,GO:0002821,0.860569769653512,0.420416832270976,1,48,positive regulation of adaptive immune response,BP,ZP3
7141,GO:0031023,0.860769119939911,0.292895810485986,3,115,microtubule organizing center organization,BP,BRSK1;PKD2;FBXW5
19243,GO:1905515,0.860884463779267,0.419919841132646,1,47,non-motile cilium assembly,BP,VANGL2
7447,GO:0031625,0.861544384387004,0.228306011110264,8,270,ubiquitin protein ligase binding,MF,EGFR;FOXO1;ERBB3;CUL9;ACVR1B;BTBD2;MC1R;PER3
5660,GO:0016791,0.861753327312585,0.243053996972114,6,208,phosphatase activity,MF,PTPRS;PPP2R2C;NT5E;PDPR;IMPA2;PLPP2
11096,GO:0045171,0.862364926072211,0.416869910477945,1,48,intercellular bridge,CC,NINL
2802,GO:0006282,0.862946356660058,0.327499045014495,2,84,regulation of DNA repair,BP,EGFR;MAGEF1
5380,GO:0016236,0.863200613427973,0.225989633717861,8,271,macroautophagy,BP,ULK2;TP53INP2;ATP6V0A2;TP53INP1;EPM2A;WIPI2;SMURF1;TCIRG1
4015,GO:0009064,0.8632156301597,0.415180723159901,1,48,glutamine family amino acid metabolic process,BP,GLUL
18254,GO:1903201,0.863347709563958,0.414917977368879,1,48,regulation of oxidative stress-induced cell death,BP,ENDOG
8342,GO:0033260,0.86400625170915,0.413487945826598,1,49,nuclear DNA replication,BP,BCL6
531,GO:0001650,0.864281427199661,0.287103641950201,3,118,fibrillar center,CC,MAP3K14;B3GNT9;NUAK1
14469,GO:0065002,0.864518384883701,0.412352117391744,1,50,intracellular protein transmembrane transport,BP,RTN2
1470,GO:0003777,0.867037964253827,0.320393195703081,2,82,microtubule motor activity,MF,KIF26B;KIF26A
3761,GO:0008333,0.867556669355688,0.40647600958861,1,48,endosome to lysosome transport,BP,SORT1
7301,GO:0031330,0.867640173331924,0.245074388481437,5,181,negative regulation of cellular catabolic process,BP,LAMP3;RASIP1;DAB2IP;EPHA4;FURIN
7675,GO:0032154,0.867679556378628,0.406227497994783,1,48,cleavage furrow,CC,PLCD3
1439,GO:0003682,0.867733851903846,0.197273329991068,14,438,chromatin binding,MF,ASH2L;EGFR;THRA;H1F0;GLI2;BCL6;HR;FOXO1;MNT;SMARCA1;SREBF1;NFATC4;STAT1;SP100
2499,GO:0005766,0.868157619002504,0.280671083198242,3,121,primary lysosome,CC,GAA;HEXB;STOM
10051,GO:0042582,0.868157619002504,0.280671083198242,3,121,azurophil granule,CC,GAA;HEXB;STOM
10864,GO:0044441,0.868475407142483,0.218609236391674,8,269,ciliary part,CC,GLI2;PKD2;TMEM231;GAS8;UNC119B;CABYR;MARK4;TULP3
3341,GO:0007093,0.869179796317875,0.257254191975787,4,153,mitotic cell cycle checkpoint,BP,BRSK1;WNT9A;XPC;PCBP4
17028,GO:0099565,0.869227633633466,0.403086816232704,1,48,chemical synaptic transmission, postsynaptic,BP,NLGN2
6614,GO:0022904,0.869245006751051,0.315955893289034,2,94,respiratory electron transport chain,BP,SDHA;COX5B
16819,GO:0098791,0.869303811326004,0.181837937860156,22,659,Golgi subcompartment,CC,POSTN;TGFBI;ST3GAL5;EGFR;XYLT1;RHBDF1;NSG1;RASIP1;COL7A1;TRAPPC2L;B3GNT9;VAMP3;SREBF1;SLC2A1;VAMP2;GOLGA7B;MARCH9;FURIN;XYLT2;RAB43;ST6GALNAC6;SORT1
10048,GO:0042578,0.869363473489642,0.217358518099359,8,269,phosphoric ester hydrolase activity,MF,PTPRS;PPP2R2C;NT5E;PDPR;PLCD3;IMPA2;PLCD1;PLPP2
8206,GO:0032993,0.869532481541888,0.256540825277965,4,163,protein-DNA complex,CC,H1F0;SOX12;H2AFJ;H1FX
9605,GO:0036503,0.869607210234019,0.315638914562709,2,86,ERAD pathway,BP,FBXO2;TMEM129
10147,GO:0042770,0.869868619433835,0.277873220384636,3,120,signal transduction in response to DNA damage,BP,PCBP4;NDRG1;SP100
10127,GO:0042742,0.86988651062562,0.314969111077694,2,90,defense response to bacterium,BP,CYBA;KLK5
10323,GO:0043169,0.871364500560583,0.152878910130901,112,2972,cation binding,MF,TNFAIP3;POSTN;PEG3;SMOC2;APOE;PHF7;ZNF704;S100A4;LENG9;ASH2L;PRICKLE2;ADAM19;THRA;CYBA;SNN;OAS2;TCEA2;GLI2;IRF2BPL;CALML3;BCL6;PGM1;TENM2;CYP4F22;ZNF318;BRSK1;UNK;TNFSF10;DHTKD1;VAV3;NPEPL1;CYBRD1;MATN2;PKD2;ZFPM1;ARSI;NT5E;SYT8;HR;SALL2;TMEM129;TRIM65;ZSCAN18;OBSCN;PRSS3;SGSH;TRERF1;FKBP9;TET1;CYP27C1;FAM20C;GLUL;ZNF266;RNPEPL1;ZNF687;RPS6KA5;LTBP1;PLCD3;ZNF362;ZBTB42;S100A6;SPOCK1;CUL9;CGREF1;ENDOG;ACAP3;TRIM22;ACVR1B;SYTL1;IMPA2;ATP12A;ADAMTS15;RBCK1;ZNF554;MBD1;CABYR;MSRB2;LTBP4;NMRK1;MYL9;PDLIM4;MICALL1;C2CD4C;RNF187;RNF135;PCDH1;NME4;RNF44;PLCD1;MARCH9;COX5B;ZMYM3;FURIN;THNSL2;NINL;MMP1;NUAK1;ALOXE3;RASA4;CAPNS2;MEX3A;CXXC5;ZNF446;RNF208;AIF1L;MT2A;NADK;ZCCHC24;MAP3K3;ZSWIM8;DTNB;DDX59
3311,GO:0007034,0.871580825086169,0.275062108150063,3,119,vacuolar transport,BP,HGSNAT;SMURF1;SORT1
1379,GO:0003300,0.871583471788293,0.398271303472789,1,48,cardiac muscle hypertrophy,BP,FOXO1
11078,GO:0045132,0.871699869273479,0.397914182764031,1,49,meiotic chromosome segregation,BP,SUN1
18541,GO:1903827,0.872085727326138,0.194056654454947,13,415,regulation of cellular protein localization,BP,EPHB2;EGFR;LDLRAP1;TP53INP2;SREBF1;DMTN;PIK3R1;SNX33;STOM;VAMP2;ERBB2;CAMK1;SP100
6964,GO:0030660,0.872151444733735,0.311041341879848,2,87,Golgi-associated vesicle membrane,CC,LDLRAP1;SREBF1
942,GO:0002367,0.872638618677679,0.39586890172243,1,50,cytokine production involved in immune response,BP,BCL6
9444,GO:0036094,0.873568027157237,0.156068220540918,66,1811,small molecule binding,MF,APOE;ALDH1A3;ULK2;MAP3K14;EPHB2;TXNRD3;EGFR;OAS2;FGFR4;CDK18;BRSK1;DHTKD1;INSR;DHX32;DNM1;NT5E;OBSCN;H6PD;RAB40B;CYP27C1;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;SEC14L2;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;ACVR1B;CAMKK1;ATP12A;TYRO3;RHOD;CKMT1A;SCG5;MBD1;TRPV4;MTHFR;SDHA;ALDH2;NMRK1;MARK4;MVD;ERBB2;NME4;CDK20;HINT2;CRY2;CLCN7;THNSL2;NUAK1;CAMK1;NADK;RAB43;MAP3K3;ABCC1;DDX59;NRK;CBR3
18578,GO:1903902,0.874221028439104,0.392596131686137,1,50,positive regulation of viral life cycle,BP,STOM
13567,GO:0060078,0.874947063437354,0.391200941120201,1,49,regulation of postsynaptic membrane potential,BP,NLGN2
2569,GO:0005875,0.8750393451853,0.269295987179894,3,119,microtubule associated complex,CC,CLIP2;KIF26B;KIF26A
5628,GO:0016741,0.875225977657537,0.233503430504319,5,185,transferase activity, transferring one-carbon groups,MF,ASH2L;GAMT;NSUN7;KMT5C;METTL7A
4940,GO:0015030,0.875308899538354,0.390225664206379,1,51,Cajal body,CC,TRIM22
14601,GO:0070227,0.875521582966154,0.389782352020532,1,51,lymphocyte apoptotic process,BP,BCL6
4424,GO:0010332,0.876120441624991,0.388640791222481,1,50,response to gamma radiation,BP,CYBA
911,GO:0002312,0.876164038005769,0.388549657706141,1,50,B cell activation involved in immune response,BP,BCL6
4919,GO:0014897,0.877200067314593,0.386492467811658,1,49,striated muscle hypertrophy,BP,FOXO1
20068,GO:2000779,0.877592482563411,0.385554921137989,1,50,regulation of double-strand break repair,BP,MAGEF1
6993,GO:0030705,0.877819970470291,0.24358864218944,4,152,cytoskeleton-dependent intracellular transport,BP,BLOC1S4;CCDC88B;SUN1;APBA1
2722,GO:0006119,0.877862476638196,0.30034589474142,2,96,oxidative phosphorylation,BP,SDHA;COX5B
7583,GO:0031985,0.877911477141491,0.300609101222686,2,87,Golgi cisterna,CC,NSG1;SORT1
11721,GO:0046605,0.878549221402754,0.38353958053605,1,50,regulation of centrosome cycle,BP,FBXW5
11831,GO:0046872,0.878898906203438,0.144533291479311,110,2929,metal ion binding,MF,TNFAIP3;POSTN;PEG3;SMOC2;APOE;PHF7;ZNF704;S100A4;LENG9;ASH2L;PRICKLE2;ADAM19;THRA;CYBA;SNN;OAS2;TCEA2;GLI2;IRF2BPL;CALML3;BCL6;PGM1;TENM2;CYP4F22;ZNF318;BRSK1;UNK;TNFSF10;VAV3;NPEPL1;CYBRD1;MATN2;PKD2;ZFPM1;ARSI;NT5E;SYT8;HR;SALL2;TMEM129;TRIM65;ZSCAN18;OBSCN;PRSS3;SGSH;TRERF1;FKBP9;TET1;CYP27C1;FAM20C;GLUL;ZNF266;RNPEPL1;ZNF687;RPS6KA5;LTBP1;PLCD3;ZNF362;ZBTB42;S100A6;SPOCK1;CUL9;CGREF1;ENDOG;ACAP3;TRIM22;ACVR1B;SYTL1;IMPA2;ATP12A;ADAMTS15;RBCK1;ZNF554;MBD1;CABYR;MSRB2;LTBP4;NMRK1;MYL9;PDLIM4;MICALL1;C2CD4C;RNF187;RNF135;PCDH1;NME4;RNF44;PLCD1;MARCH9;COX5B;ZMYM3;FURIN;NINL;MMP1;NUAK1;ALOXE3;RASA4;CAPNS2;MEX3A;CXXC5;ZNF446;RNF208;AIF1L;MT2A;NADK;ZCCHC24;MAP3K3;ZSWIM8;DTNB;DDX59
16219,GO:0090316,0.880155351746981,0.239797005017538,4,155,positive regulation of intracellular protein transport,BP,STOM;VAMP2;ERBB2;CAMK1
15206,GO:0071407,0.880818752845094,0.182385156041265,13,417,cellular response to organic cyclic compound,BP,EGFR;THRA;CYBA;GLI2;SFRP1;PKD2;FOXO1;DMTN;NFATC4;FAM210B;IMPACT;STAT1;CRY2
136,GO:0000287,0.880971361871285,0.238501191360642,4,154,magnesium ion binding,MF,PGM1;BRSK1;GLUL;RPS6KA5
546,GO:0001666,0.881011459574532,0.206835234235676,7,251,response to hypoxia,BP,POSTN;CYBA;SFRP1;VEGFB;ENDOG;MTHFR;NDRG1
2568,GO:0005874,0.881362548301005,0.191053835409308,10,331,microtubule,CC,SHROOM2;DNM1;CLIP2;GAS8;KIF26B;KIF26A;SPRY2;TRPV4;NDRG1;NINL
13782,GO:0060419,0.881374092417272,0.37754378062924,1,50,heart growth,BP,TENM4
14615,GO:0070252,0.881396426929378,0.377496102976564,1,50,actin-mediated cell contraction,BP,SCN4B
6047,GO:0019213,0.881425499941899,0.377325533515681,1,51,deacetylase activity,MF,CES2
6888,GO:0030496,0.882003653320201,0.236837990639616,4,154,midbody,CC,MPLKIP;KLHDC8B;SLC2A1;CCDC69
14750,GO:0070498,0.883136113822359,0.290751974635815,2,93,interleukin-1-mediated signaling pathway,BP,RPS6KA5;MAP3K3
11809,GO:0046824,0.883304089202677,0.373299394467235,1,51,positive regulation of nucleocytoplasmic transport,BP,CAMK1
3583,GO:0008026,0.883855837637512,0.289655877190018,2,87,ATP-dependent helicase activity,MF,DHX32;DDX59
14492,GO:0070035,0.883855837637512,0.289655877190018,2,87,purine NTP-dependent helicase activity,MF,DHX32;DDX59
6241,GO:0019843,0.883893473703089,0.371546790513566,1,56,rRNA binding,MF,TST
15427,GO:0071806,0.88457663302364,0.370253909640911,1,54,protein transmembrane transport,BP,RTN2
7420,GO:0031570,0.884599190798342,0.232607350526117,4,156,DNA integrity checkpoint,BP,MAP3K14;BRSK1;XPC;PCBP4
2715,GO:0006110,0.884783194023503,0.370107633119027,1,51,regulation of glycolytic process,BP,INSR
3278,GO:0006986,0.884860979431994,0.232166929375548,4,157,response to unfolded protein,BP,TMEM129;DAB2IP;PIK3R1;NCK2
7380,GO:0031463,0.885658016090845,0.368210707922439,1,51,Cul3-RING ubiquitin ligase complex,CC,KLHDC8B
116,GO:0000245,0.886558265801904,0.366047458572561,1,53,spliceosomal complex assembly,BP,SRSF5
9217,GO:0035639,0.886917490282372,0.144234397841793,50,1402,purine ribonucleoside triphosphate binding,MF,ULK2;MAP3K14;EPHB2;EGFR;OAS2;FGFR4;CDK18;BRSK1;INSR;DHX32;DNM1;OBSCN;RAB40B;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;ACVR1B;CAMKK1;ATP12A;TYRO3;RHOD;CKMT1A;SCG5;TRPV4;NMRK1;MARK4;MVD;ERBB2;NME4;CDK20;CLCN7;NUAK1;CAMK1;NADK;RAB43;MAP3K3;ABCC1;DDX59;NRK
6565,GO:0022412,0.887247664159672,0.214868748415841,5,187,cellular process involved in reproduction in multicellular organism,BP,SFRP1;ETV5;HEXB;ZP3;CABYR
4540,GO:0010639,0.889343353577774,0.188687242712463,8,279,negative regulation of organelle organization,BP,FHOD3;ESPN;EVI5L;TET1;DMTN;PLEKHH2;TOM1L2;ARPIN
15921,GO:0075733,0.889596855057473,0.359380483173914,1,53,intracellular transport of virus,BP,MVB12B
7581,GO:0031983,0.889809309773435,0.201151450596608,6,227,vesicle lumen,CC,APOE;EGFR;VEGFB;HEXB;SERPING1;PCSK1
10517,GO:0043502,0.889994207046679,0.358602155524285,1,52,regulation of muscle adaptation,BP,FOXO1
19694,GO:2000106,0.891294736974637,0.355522014991089,1,54,regulation of leukocyte apoptotic process,BP,BCL6
4846,GO:0014706,0.891685217961946,0.198367944878125,6,217,striated muscle tissue development,BP,OBSL1;FHOD3;ZFPM1;TBX1;TENM4;ERBB3
3315,GO:0007041,0.892356414686812,0.273522095397619,2,90,lysosomal transport,BP,HGSNAT;SORT1
11807,GO:0046822,0.892521693328375,0.273167795803205,2,91,regulation of nucleocytoplasmic transport,BP,CAMK1;SP100
14129,GO:0061053,0.893858334696824,0.349984809692838,1,52,somite development,BP,SFRP1
17446,GO:1900407,0.894026125449197,0.349412199022168,1,54,regulation of cellular response to oxidative stress,BP,ENDOG
7858,GO:0032446,0.894031943136435,0.146855274101966,26,790,protein modification by small protein conjugation,BP,TNFAIP3;FBXO41;DCAF16;FBXO2;WWTR1;TMEM129;DDB2;RAB40B;MAGEF1;HERC3;KLHDC8B;CUL9;TRIM22;KCTD11;RTF1;RBCK1;FBXW4;RNF187;RNF135;FBXL8;RNF44;MARCH9;FBXW5;SMURF1;RNF208;FBXO44
7572,GO:0031965,0.894054920532149,0.187509221741176,7,251,nuclear membrane,CC,PRICKLE2;EGFR;CERS4;YEATS4;RETSAT;SUN1;SORT1
7724,GO:0032259,0.894578390578728,0.181010821091002,8,283,methylation,BP,ASH2L;GAMT;NSUN7;KMT5C;TET1;METTL7A;RTF1;MTHFR
8447,GO:0033613,0.895622114870726,0.345808840332832,1,54,activating transcription factor binding,MF,ZFPM1
16438,GO:0097164,0.896032536255581,0.232977333587563,3,129,ammonium ion metabolic process,BP,KDSR;CRAT;CPT1C
9792,GO:0042035,0.896737975202074,0.343274646492748,1,54,regulation of cytokine biosynthetic process,BP,ZFPM1
17792,GO:1901992,0.896858083951946,0.342909192145837,1,55,positive regulation of mitotic cell cycle phase transition,BP,HYAL1
10496,GO:0043467,0.897111401824077,0.264302236875036,2,92,regulation of generation of precursor metabolites and energy,BP,INSR;TRPV4
4873,GO:0014812,0.897618205459481,0.341266859750974,1,54,muscle cell migration,BP,POSTN
15187,GO:0071383,0.89778023132138,0.198134896726911,5,191,cellular response to steroid hormone stimulus,BP,EGFR;THRA;SFRP1;FOXO1;CRY2
859,GO:0002200,0.897976252295995,0.340447943709484,1,54,somatic diversification of immune receptors,BP,BCL6
17321,GO:1900076,0.898068724201539,0.340236234804843,1,54,regulation of cellular response to insulin stimulus,BP,PIK3R1
4810,GO:0014032,0.898419709162001,0.33943189125177,1,54,neural crest cell development,BP,TBX1
1462,GO:0003730,0.898759595125952,0.338651796424153,1,54,mRNA 3'-UTR binding,MF,PCBP4
5538,GO:0016569,0.898780945746368,0.160396699269782,12,397,covalent chromatin modification,BP,ASH2L;BCL6;KMT5C;HR;DDB2;YEATS4;TET1;RPS6KA5;SREBF1;RTF1;MBD1;MTHFR
7018,GO:0030811,0.899006583422002,0.338084182429376,1,54,regulation of nucleotide catabolic process,BP,INSR
607,GO:0001776,0.89955568699791,0.336728369928225,1,55,leukocyte homeostasis,BP,TNFAIP3
9510,GO:0036293,0.89991377202059,0.178624935896478,7,259,response to decreased oxygen levels,BP,POSTN;CYBA;SFRP1;VEGFB;ENDOG;MTHFR;NDRG1
19944,GO:2000573,0.900681353137695,0.334039105537468,1,56,positive regulation of DNA biosynthetic process,BP,FGFR4
8265,GO:0033116,0.900731192083773,0.333923648373601,1,56,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,COL7A1
18543,GO:1903829,0.901119222101677,0.171337410379369,8,285,positive regulation of cellular protein localization,BP,EPHB2;EGFR;PIK3R1;SNX33;STOM;VAMP2;ERBB2;CAMK1
3580,GO:0008022,0.901673652531818,0.204263699014864,4,162,protein C-terminus binding,MF,DNM1;YEATS4;BCAM;ERBB2
6584,GO:0022625,0.901683306875423,0.33117547119459,1,63,cytosolic large ribosomal subunit,CC,RPL13A
16676,GO:0097711,0.902043060352115,0.25459698935639,2,94,ciliary basal body-plasma membrane docking,BP,MARK4;NINL
11803,GO:0046794,0.902987564274773,0.32866942103988,1,56,transport of virus,BP,MVB12B
9020,GO:0035265,0.90311048346415,0.252562517267941,2,92,organ growth,BP,TENM4;SPRY2
367,GO:0000989,0.903136435707075,0.146195577679277,16,517,transcription factor activity, transcription factor binding,MF,THRA;CITED4;POU3F1;HR;WWTR1;FOXO1;SOX12;TRERF1;MNT;TRIM22;NAB2;NFATC4;RTF1;CRY2;PER3;SP100
17651,GO:1901570,0.903270801740049,0.3279212795958,1,57,fatty acid derivative biosynthetic process,BP,ACSL1
7305,GO:0031334,0.903498847536617,0.18887083393654,5,195,positive regulation of protein complex assembly,BP,DDB2;WIPF1;NCK2;ARPIN;MMP1
5448,GO:0016363,0.903637339684292,0.251448974318575,2,94,nuclear matrix,CC,YEATS4;MBD1
15437,GO:0071824,0.903894969000261,0.179279905098197,6,237,protein-DNA complex subunit organization,BP,THRA;H1F0;SOX12;DDB2;XPC;H1FX
12894,GO:0051291,0.904207174633225,0.250154666695569,2,99,protein heterooligomerization,BP,COL6A1;INSR
10956,GO:0044786,0.904321540634986,0.325453151046036,1,57,cell cycle DNA replication,BP,BCL6
3950,GO:0008757,0.90474095238963,0.217368731814606,3,131,S-adenosylmethionine-dependent methyltransferase activity,MF,ASH2L;GAMT;KMT5C
14745,GO:0070491,0.904810029662687,0.324386317301792,1,56,repressing transcription factor binding,MF,STAT1
12115,GO:0048259,0.905397065945375,0.322999084361563,1,56,regulation of receptor-mediated endocytosis,BP,LDLRAP1
8808,GO:0034620,0.906514309198782,0.214151148718982,3,131,cellular response to unfolded protein,BP,DAB2IP;PIK3R1;NCK2
4809,GO:0014031,0.907051091920407,0.319070231695255,1,56,mesenchymal cell development,BP,TBX1
17791,GO:1901991,0.907713471874932,0.181930646976677,5,202,negative regulation of mitotic cell cycle phase transition,BP,GPNMB;BRSK1;PKD2;PCBP4;GJC2
7934,GO:0032555,0.907717149388605,0.119326179216133,50,1422,purine ribonucleotide binding,MF,ULK2;MAP3K14;EPHB2;EGFR;OAS2;FGFR4;CDK18;BRSK1;INSR;DHX32;DNM1;OBSCN;RAB40B;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;ACVR1B;CAMKK1;ATP12A;TYRO3;RHOD;CKMT1A;SCG5;TRPV4;NMRK1;MARK4;MVD;ERBB2;NME4;CDK20;CLCN7;NUAK1;CAMK1;NADK;RAB43;MAP3K3;ABCC1;DDX59;NRK
7335,GO:0031397,0.90785305496448,0.31698893314162,1,58,negative regulation of protein ubiquitination,BP,TNFAIP3
4747,GO:0010948,0.908664264037718,0.159996336704089,8,295,negative regulation of cell cycle process,BP,GPNMB;BCL6;BRSK1;PKD2;DAB2IP;PCBP4;TOM1L2;GJC2
1469,GO:0003774,0.909104659554298,0.240522105830484,2,94,motor activity,MF,KIF26B;KIF26A
10588,GO:0043618,0.909485330208716,0.239530998180025,2,101,regulation of transcription from RNA polymerase II promoter in response to stress,BP,NCK2;IMPACT
4765,GO:0010970,0.909833901079947,0.20808305643442,3,131,transport along microtubule,BP,BLOC1S4;SUN1;APBA1
16966,GO:0099111,0.909833901079947,0.20808305643442,3,131,microtubule-based transport,BP,BLOC1S4;SUN1;APBA1
3272,GO:0006977,0.910044340957867,0.311639892248982,1,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,PCBP4
12380,GO:0048864,0.910046200173801,0.311794588886716,1,57,stem cell development,BP,TBX1
366,GO:0000988,0.910375913067491,0.136375201717838,16,522,transcription factor activity, protein binding,MF,THRA;CITED4;POU3F1;HR;WWTR1;FOXO1;SOX12;TRERF1;MNT;TRIM22;NAB2;NFATC4;RTF1;CRY2;PER3;SP100
7196,GO:0031110,0.910405100847467,0.310926052920786,1,57,regulation of microtubule polymerization or depolymerization,BP,TRPV4
897,GO:0002285,0.911009680479419,0.23656668220929,2,97,lymphocyte activation involved in immune response,BP,BCL6;ZFPM1
2852,GO:0006360,0.911549454868882,0.307988069865399,1,59,transcription by RNA polymerase I,BP,ERBB2
15171,GO:0071359,0.911929308048772,0.307140237998821,1,58,cellular response to dsRNA,BP,EGFR
3515,GO:0007517,0.912160170186058,0.166257883385978,6,227,muscle organ development,BP,TAGLN;ZFPM1;TBX1;ZBTB42;ERBB3;VANGL2
5499,GO:0016482,0.912163083742424,0.203789480160967,3,131,cytosolic transport,BP,VAMP3;TBC1D17;SORT1
454,GO:0001228,0.912271602294177,0.159665346829177,7,258,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,NDN;GLI2;ETV5;SALL2;SOX12;SREBF1;DBP
10761,GO:0044267,0.912321640410742,0.104741845507801,145,3911,cellular protein metabolic process,BP,TNFAIP3;TGFBI;APOE;IFI6;MVB12B;LAMP3;ULK2;PTPRS;FBXO41;OBSL1;LMF1;GPNMB;MAP3K14;EPHB2;ASH2L;PRR9;ST3GAL5;DCAF16;EGFR;FBXO2;FGFR4;CDK18;BCL6;BRSK1;SFRP1;UNK;TNFSF10;INSR;KMT5C;PKD2;NAT6;ARSI;PPP2R2C;CTSB;SERPINE2;HR;PDPR;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;LY6E;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;SHC2;CRTAP;YEATS4;FKBP9;RAB40B;TET1;FAM20C;ANO8;EPHA4;WNT9A;RPL13A;B3GNT9;MAGEF1;F2R;HERC3;CTSV;RPS6KA5;KLHDC8B;HEXB;LTBP1;ACSL1;ERBB3;SPOCK1;CDK14;CUL9;FRY;SREBF1;CSPG4;DMTN;GRK6;PIK3R1;CTSL;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;NAB2;SNX33;TYRO3;RTF1;RBCK1;ADCK5;SPRY2;TNFRSF19;TRPV4;ZDHHC1;MTHFR;SPATA18;MSRB2;PPP1R35;ADORA2B;FBXW4;SERPING1;RTN4RL1;MARK4;BTBD2;IMPACT;MVD;GOLGA7B;IGFBP4;ERBB2;RNF187;RNF135;LAMB2;FBXL8;CDK20;HINT2;RNF44;WIPI2;ACKR3;CRY2;MARCH9;FURIN;FBXW5;IFI16;PLPP2;CTSF;GJC2;MMP1;NUAK1;RASA4;SMURF1;MEX3A;CAMK1;TCIRG1;RNF208;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;NRK;PIGZ;FBXO44;VANGL2
3032,GO:0006605,0.912547455551654,0.146453833853002,10,367,protein targeting,BP,RPL13A;SREBF1;DMTN;RHOD;STOM;ZDHHC1;GOLGA7B;MICALL1;ERBB2;SMURF1
6908,GO:0030521,0.913212844333337,0.303999345723527,1,58,androgen receptor signaling pathway,BP,SFRP1
10497,GO:0043470,0.913488529573208,0.303322190880561,1,58,regulation of carbohydrate catabolic process,BP,INSR
7676,GO:0032155,0.913897334473371,0.302316395764989,1,58,cell division site part,CC,PLCD3
6736,GO:0030177,0.913943796343728,0.200396693967876,3,136,positive regulation of Wnt signaling pathway,BP,SFRP1;WNT3;DIXDC1
15756,GO:0072431,0.913981580922757,0.301956243775259,1,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,PCBP4
17942,GO:1902400,0.913981580922757,0.301956243775259,1,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,PCBP4
10656,GO:0043967,0.914286842609454,0.301278641884875,1,59,histone H4 acetylation,BP,YEATS4
17232,GO:0120111,0.915485774449203,0.298311890641592,1,59,neuron projection cytoplasm,CC,BLOC1S4
4401,GO:0010212,0.915666624469715,0.197219289712679,3,134,response to ionizing radiation,BP,CYBA;SFRP1;IFI16
11363,GO:0045786,0.916272627901659,0.128290215457516,16,532,negative regulation of cell cycle,BP,TNFAIP3;GPNMB;MAP3K14;EGFR;BCL6;BRSK1;PKD2;DAB2IP;WNT9A;CGREF1;XPC;PCBP4;TP53INP1;NDRG1;TOM1L2;GJC2
8133,GO:0032886,0.916541300157187,0.178614817538478,4,166,regulation of microtubule-based process,BP,DIXDC1;TRPV4;ERBB2;FBXW5
15090,GO:0071222,0.916783671365338,0.224626131453999,2,100,cellular response to lipopolysaccharide,BP,TNFAIP3;DAB2IP
20188,GO:2001169,0.916809717116202,0.29501547191302,1,59,regulation of ATP biosynthetic process,BP,INSR
10475,GO:0043412,0.917061838572925,0.100397232852577,119,3232,macromolecule modification,BP,TNFAIP3;APOE;ULK2;PTPRS;FBXO41;OBSL1;LMF1;GPNMB;MAP3K14;EPHB2;ASH2L;PRR9;ST3GAL5;DCAF16;EGFR;FBXO2;FGFR4;CDK18;BCL6;BRSK1;SFRP1;INSR;KMT5C;PKD2;NAT6;ARSI;PPP2R2C;HR;PDPR;VEGFB;WWTR1;TMEM129;FOXO1;LY6E;DDB2;DAB2IP;OBSCN;TBX1;SHC2;CRTAP;YEATS4;FKBP9;RAB40B;TET1;FAM20C;ANO8;EPHA4;B3GNT9;MAGEF1;F2R;HERC3;RPS6KA5;KLHDC8B;LTBP1;ACSL1;ERBB3;CDK14;CUL9;FRY;SREBF1;CSPG4;DMTN;GRK6;PIK3R1;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;NAB2;TYRO3;RTF1;RBCK1;ADCK5;SPRY2;MBD1;TNFRSF19;TRPV4;ZDHHC1;MTHFR;PPP1R35;ADORA2B;FBXW4;RTN4RL1;MARK4;IMPACT;MVD;GOLGA7B;IGFBP4;ERBB2;RNF187;RNF135;LAMB2;FBXL8;CDK20;HINT2;RNF44;WIPI2;ACKR3;CRY2;MARCH9;FBXW5;PLPP2;GJC2;NUAK1;RASA4;SMURF1;CAMK1;RNF208;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;MPG;NRK;PIGZ;FBXO44;VANGL2
18104,GO:1902882,0.917385466087834,0.293500742549353,1,60,regulation of response to oxidative stress,BP,ENDOG
7932,GO:0032553,0.917538295649328,0.107410308075639,50,1433,ribonucleotide binding,MF,ULK2;MAP3K14;EPHB2;EGFR;OAS2;FGFR4;CDK18;BRSK1;INSR;DHX32;DNM1;OBSCN;RAB40B;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;ACVR1B;CAMKK1;ATP12A;TYRO3;RHOD;CKMT1A;SCG5;TRPV4;NMRK1;MARK4;MVD;ERBB2;NME4;CDK20;CLCN7;NUAK1;CAMK1;NADK;RAB43;MAP3K3;ABCC1;DDX59;NRK
15749,GO:0072413,0.917564926629017,0.292979043482896,1,61,signal transduction involved in mitotic cell cycle checkpoint,BP,PCBP4
17943,GO:1902402,0.917564926629017,0.292979043482896,1,61,signal transduction involved in mitotic DNA damage checkpoint,BP,PCBP4
17944,GO:1902403,0.917564926629017,0.292979043482896,1,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,PCBP4
11800,GO:0046785,0.918116015738228,0.291741745699518,1,59,microtubule polymerization,BP,TRPV4
1859,GO:0004536,0.918560889825174,0.290475916920537,1,61,deoxyribonuclease activity,MF,ENDOG
3036,GO:0006611,0.918589205729666,0.174961358151792,4,170,protein export from nucleus,BP,SRSF5;SMURF1;CAMK1;SP100
68,GO:0000139,0.918769822566672,0.122248363566712,18,582,Golgi membrane,CC,ST3GAL5;EGFR;XYLT1;RHBDF1;NSG1;COL7A1;TRAPPC2L;B3GNT9;VAMP3;SREBF1;SLC2A1;GOLGA7B;MARCH9;FURIN;XYLT2;RAB43;ST6GALNAC6;SORT1
9813,GO:0042089,0.919291992128035,0.28870216255122,1,60,cytokine biosynthetic process,BP,ZFPM1
5795,GO:0017076,0.919842357032369,0.104598940208347,50,1436,purine nucleotide binding,MF,ULK2;MAP3K14;EPHB2;EGFR;OAS2;FGFR4;CDK18;BRSK1;INSR;DHX32;DNM1;OBSCN;RAB40B;FAM20C;GLUL;EPHA4;SMARCA1;KIF26B;RPS6KA5;ACSL1;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;GRK6;ACVR1B;CAMKK1;ATP12A;TYRO3;RHOD;CKMT1A;SCG5;TRPV4;NMRK1;MARK4;MVD;ERBB2;NME4;CDK20;CLCN7;NUAK1;CAMK1;NADK;RAB43;MAP3K3;ABCC1;DDX59;NRK
10503,GO:0043484,0.920174147623002,0.217550459291684,2,100,regulation of RNA splicing,BP,SRSF5;PIK3R1
3927,GO:0008637,0.920384999864744,0.216996243158683,2,104,apoptotic mitochondrial changes,BP,IFI6;TNFSF10
4467,GO:0010507,0.920525787972648,0.28557217002014,1,60,negative regulation of autophagy,BP,RASIP1
134,GO:0000281,0.920834054145677,0.284787070407656,1,60,mitotic cytokinesis,BP,SNX33
2521,GO:0005791,0.920875985291016,0.284539746435678,1,62,rough endoplasmic reticulum,CC,GLUL
5555,GO:0016591,0.921335504859741,0.215021918497142,2,103,DNA-directed RNA polymerase II, holoenzyme,CC,RTF1;RPRD2
1987,GO:0004722,0.921484934722164,0.283054054249625,1,61,protein serine/threonine phosphatase activity,MF,PPP2R2C
17647,GO:1901566,0.921498077032585,0.102337522859524,51,1520,organonitrogen compound biosynthetic process,BP,APOE;LMF1;KDSR;GAMT;ST3GAL5;EGFR;PGM1;XYLT1;CERS4;UNK;DHTKD1;INSR;ZFPM1;NT5E;VEGFB;LY6E;UROS;TET1;GLUL;RPL13A;B3GNT9;ATP6V0A2;CSPG4;PTHLH;SDC3;NCK2;HYAL1;ZDHHC1;GPC4;ADORA2B;NMRK1;RTN4RL1;IMPACT;MVD;GOLGA7B;ERBB2;NME4;WIPI2;COX5B;FURIN;PCSK1;PLPP2;THNSL2;XYLT2;ALOXE3;MEX3A;TCIRG1;NADK;ST6GALNAC6;PIGZ;VANGL2
2962,GO:0006520,0.921886357094634,0.144480727534359,7,274,cellular amino acid metabolic process,BP,GAMT;BPHL;CRTAP;GLUL;CKMT1A;MTHFR;THNSL2
11159,GO:0045296,0.922208755615245,0.139288656731449,8,298,cadherin binding,MF,EGFR;DAB2IP;EPS8L2;PPL;NDRG1;MICALL1;STAT1;H1FX
9031,GO:0035282,0.922364212087017,0.280871648425175,1,60,segmentation,BP,SFRP1
9827,GO:0042107,0.922389631603951,0.280735237813936,1,61,cytokine metabolic process,BP,ZFPM1
10696,GO:0044085,0.923643168240764,0.0947644954838728,88,2474,cellular component biogenesis,BP,TNFAIP3;APOE;ALDH1A3;ULK2;OBSL1;ADGRB2;EPHB2;ASH2L;TNS1;SLITRK6;ADGRL1;SRSF5;GPX3;FLNC;COL6A1;THRA;CYBA;H1F0;EPB41L3;NLGN2;TENM2;SFRP1;ARHGEF4;FHOD3;INSR;VAV3;PKD2;ESPN;DNM1;SDK2;TNXB;TP53INP2;WWTR1;NSG1;PARVB;SOX12;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;GAS8;EVI5L;WIPF1;KCNC4;GLUL;TRAPPC2L;RPL13A;TENM4;TYSND1;EPS8L2;HGSNAT;ATP6V0A2;VAMP3;PLXND1;DMTN;PIK3R1;TRIM22;NCK2;KCTD11;UNC119B;XPC;ARHGAP40;RHOD;SLC2A1;HYAL1;STOM;VAMP2;TP53INP1;TRPV4;MSRB2;ITGB5;MAFIP;MARK4;CCDC69;IMPACT;CRTC1;WIPI2;H1FX;NINL;PEX11B;ARPIN;ASIC1;MMP1;SMURF1;TCIRG1;VANGL2;APBA1
10590,GO:0043620,0.923865339994701,0.209581183619587,2,106,regulation of DNA-templated transcription in response to stress,BP,NCK2;IMPACT
12765,GO:0051099,0.92420507394228,0.180954696945611,3,139,positive regulation of binding,BP,APOE;EPHA4;PLXND1
776,GO:0002039,0.924437189832882,0.275446892612343,1,61,p53 binding,MF,NUAK1
4535,GO:0010634,0.924490720631763,0.208380028928595,2,101,positive regulation of epithelial cell migration,BP,HYAL1;MAP3K3
5976,GO:0018995,0.925266148895682,0.273221505866519,1,62,host,CC,MVB12B
10613,GO:0043657,0.925266148895682,0.273221505866519,1,62,host cell,CC,MVB12B
10736,GO:0044215,0.925266148895682,0.273221505866519,1,62,other organism,CC,MVB12B
10737,GO:0044216,0.925266148895682,0.273221505866519,1,62,other organism cell,CC,MVB12B
10738,GO:0044217,0.925266148895682,0.273221505866519,1,62,other organism part,CC,MVB12B
2557,GO:0005856,0.925750086410163,0.0965498080645367,54,1555,cytoskeleton,CC,ITGB6;OBSL1;NDN;ADGRB2;TNS1;FLNC;SHROOM2;CYBA;H1F0;GLI2;EPB41L3;PGM1;BRSK1;FHOD3;PKD2;ESPN;DNM1;LDLRAP1;RIMS3;PARVB;CLIP2;GAS8;WIPF1;MARVELD1;MZT2A;CORO6;KIF26B;MPLKIP;DDX60;ACTA2;KIF26A;PPL;FRY;DMTN;SLC2A1;STOM;PLEKHH2;SPRY2;CABYR;TRPV4;SYNM;NDRG1;MYL9;MARK4;PDLIM4;CCDC69;MZT2B;TULP3;CCDC88B;NINL;SLC1A4;NUAK1;AIF1L;VANGL2
9377,GO:0035966,0.926612440597304,0.160584707964919,4,174,response to topologically incorrect protein,BP,TMEM129;DAB2IP;PIK3R1;NCK2
14371,GO:0061695,0.927042704792632,0.141958499998808,6,240,transferase complex, transferring phosphorus-containing groups,CC,INSR;CDK14;PIK3R1;ACVR1B;RTF1;RPRD2
10933,GO:0044728,0.927198564532533,0.268156331422056,1,62,DNA methylation or demethylation,BP,TET1
950,GO:0002377,0.927736536579232,0.266671339199463,1,63,immunoglobulin production,BP,BCL6
16454,GO:0097193,0.928425035889611,0.139646957052962,6,243,intrinsic apoptotic signaling pathway,BP,DAB2IP;PIK3R1;NCK2;NFATC4;ACKR3;IFI16
5948,GO:0018394,0.928793271525169,0.172054782112927,3,140,peptidyl-lysine acetylation,BP,YEATS4;RPS6KA5;HINT2
7389,GO:0031491,0.929134617042743,0.262779684891191,1,66,nucleosome binding,MF,SMARCA1
15087,GO:0071219,0.92989079752967,0.196616380765445,2,105,cellular response to molecule of bacterial origin,BP,TNFAIP3;DAB2IP
9579,GO:0036473,0.92999495690804,0.260604560385974,1,64,cell death in response to oxidative stress,BP,ENDOG
10401,GO:0043280,0.93012175294816,0.196063021766608,2,107,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNFSF10;F2R
2530,GO:0005811,0.93035992158665,0.259627436912555,1,64,lipid droplet,CC,METTL7A
7295,GO:0031324,0.930416007235154,0.088996474313392,66,1892,negative regulation of cellular metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;IFI6;LAMP3;EPHB2;EGFR;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;ZFPM1;SERPINE2;HR;SALL2;WWTR1;FOXO1;RASIP1;DAB2IP;COL7A1;CRTAP;MNT;TET1;EPHA4;WNT9A;RPL13A;MAGEF1;TCFL5;RPS6KA5;ZBTB42;SPOCK1;FRY;SREBF1;DMTN;TRIM22;NCK2;NAB2;NFATC4;RTF1;ZP3;SPRY2;MBD1;TRPV4;PPP1R35;SERPING1;RTN4RL1;IMPACT;H2AFJ;STAT1;HINT2;CRY2;FURIN;IFI16;PER3;MEX3A;CXXC5;ELFN2;PPP1R14A;MDFI;SCMH1;SP100
14467,GO:0062014,0.930454821938235,0.259373037055198,1,64,negative regulation of small molecule metabolic process,BP,APOE
8913,GO:0034976,0.930517216883336,0.136170637664795,6,241,response to endoplasmic reticulum stress,BP,FBXO2;TMEM129;DAB2IP;PIK3R1;NCK2;TMX4
16684,GO:0097730,0.930689492653271,0.258806228998471,1,63,non-motile cilium,CC,PKD2
5539,GO:0016570,0.931017449633659,0.116432861286961,11,389,histone modification,BP,ASH2L;BCL6;KMT5C;HR;DDB2;YEATS4;TET1;RPS6KA5;SREBF1;RTF1;MTHFR
10400,GO:0043279,0.931037683844378,0.257807624498133,1,64,response to alkaloid,BP,HOMER2
8411,GO:0033554,0.931766536091043,0.0890002189981661,55,1613,cellular response to stress,BP,TNFAIP3;APOE;PTPRS;MAP3K14;ASH2L;GPX7;GPX3;EGFR;FBXO2;CYBA;BCL6;BRSK1;SFRP1;VAV3;MATN2;PKD2;RGMA;ETV5;TMEM129;FOXO1;DDB2;DAB2IP;GLUL;EPHA4;MAGEF1;CTSV;SREBF1;ENDOG;PIK3R1;NCK2;XPC;NFATC4;SLC2A1;PCBP4;TP53INP1;TNFRSF19;TMX4;TRPV4;SPATA18;NDRG1;KLK8;ADORA2B;RTN4RL1;MC1R;IMPACT;LAMB2;ACKR3;IFI16;NUAK1;SMURF1;MAP3K3;SP100;MPG;NRK;VANGL2
18962,GO:1904813,0.932053233915458,0.191780133945098,2,109,ficolin-1-rich granule lumen,CC,PGM1;CTSB
5567,GO:0016604,0.93255940453364,0.101380042881479,20,652,nuclear body,CC,PHF7;SRSF5;H1F0;GLI2;RAPGEF5;TENM2;HR;TP53INP2;WWTR1;OBSCN;TRIM22;NFATC4;PLEKHH2;MBD1;TP53INP1;FNBP4;CRTC1;CRY2;IFI16;SP100
12904,GO:0051303,0.932749814474989,0.253119349381959,1,65,establishment of chromosome localization,BP,SUN1
17788,GO:1901988,0.932963837199431,0.139102365676088,5,215,negative regulation of cell cycle phase transition,BP,GPNMB;BRSK1;PKD2;PCBP4;GJC2
4172,GO:0009266,0.933083280409749,0.14874059739757,4,177,response to temperature stimulus,BP,THRA;FOXO1;TP53INP1;TRPV4
9653,GO:0038061,0.933527072620635,0.188502143972204,2,110,NIK/NF-kappaB signaling,BP,MAP3K14;EGFR
13074,GO:0051649,0.933738529879865,0.0862495035259216,57,1669,establishment of localization in cell,BP,APOE;MVB12B;LMF1;CPT2;SRSF5;SHROOM2;CYBA;NLGN2;BCL6;BRSK1;PKD2;RTN2;DNM1;LDLRAP1;RIMS3;SYT8;TMEM129;NSG1;COL7A1;EVI5L;KCNC4;RAB40B;TRAPPC2L;RPL13A;F2R;VAMP3;SREBF1;DMTN;SYTL1;SNX33;RHOD;STOM;VAMP2;SPRY2;SCG5;ZDHHC1;ADORA2B;TBC1D17;GOLGA7B;GPR68;TOM1L2;MICALL1;ERBB2;C2CD4C;COX5B;BLOC1S4;CCDC88B;SUN1;ASIC1;SMURF1;CAMK1;RAB43;VPS33B;REEP6;SP100;SORT1;APBA1
8237,GO:0033043,0.933767567139175,0.092182757689875,33,1011,regulation of organelle organization,BP,OBSL1;BCL6;SFRP1;FHOD3;TNFSF10;INSR;ESPN;EVI5L;WIPF1;TET1;DIXDC1;CTSV;RPS6KA5;ARHGEF19;EPS8L2;CUL9;SREBF1;DMTN;PIK3R1;NCK2;ARHGAP40;RHOD;RTF1;PLEKHH2;TRPV4;MTHFR;TBC1D17;TOM1L2;FBXW5;ARPIN;PLXNB1;SMURF1;VANGL2
430,GO:0001158,0.933903857198916,0.249975000462055,1,65,enhancer sequence-specific DNA binding,MF,ZNF704
12962,GO:0051427,0.933915834861991,0.16193717372591,3,142,hormone receptor binding,MF,PTHLH;UCN2;STAT1
7463,GO:0031647,0.9341297616723,0.137078375580215,5,212,regulation of protein stability,BP,CRTAP;EPHA4;SREBF1;PIK3R1;PER3
15705,GO:0072331,0.934170857038971,0.130010687248925,6,245,signal transduction by p53 class mediator,BP,PCBP4;TP53INP1;NDRG1;IFI16;NUAK1;SP100
17789,GO:1901989,0.934510337559798,0.248256070281742,1,66,positive regulation of cell cycle phase transition,BP,HYAL1
289,GO:0000794,0.934670351492345,0.247875130349376,1,65,condensed nuclear chromosome,CC,KMT5C
2956,GO:0006511,0.935086320835644,0.103319122826783,15,515,ubiquitin-dependent protein catabolic process,BP,TNFAIP3;MVB12B;FBXO2;TP53INP2;WWTR1;TMEM129;MAGEF1;CUL9;RBCK1;FBXW4;BTBD2;RNF187;RNF44;FBXW5;SMURF1
9668,GO:0038095,0.935088109410574,0.18505399657067,2,109,Fc-epsilon receptor signaling pathway,BP,VAV3;PIK3R1
4178,GO:0009301,0.93518223018114,0.246353325462449,1,67,snRNA transcription,BP,RPRD2
10161,GO:0042795,0.93518223018114,0.246353325462449,1,67,snRNA transcription by RNA polymerase II,BP,RPRD2
2957,GO:0006513,0.935457147563429,0.245710002260949,1,65,protein monoubiquitination,BP,DDB2
12396,GO:0050000,0.935694032569008,0.244998286131306,1,66,chromosome localization,BP,SUN1
15391,GO:0071705,0.93584416211294,0.0835115917225969,58,1702,nitrogen compound transport,BP,POSTN;ITGB6;APOE;MVB12B;LMF1;SRSF5;TST;EGFR;CYBA;NLGN2;BCL6;SFRP1;SLC29A4;SV2A;RTN2;RHBDF1;TMEM129;NSG1;EVI5L;RAB40B;GLUL;RPL13A;OLFM2;F2R;SLC38A4;ATP6V0A2;VAMP3;SREBF1;DMTN;SYTL1;UNC119B;SNX33;RHOD;SLC2A1;STOM;VAMP2;SCG5;SLC2A9;TRPV4;ZDHHC1;PQLC2;LTBP4;TBC1D17;GOLGA7B;GPR68;TOM1L2;MICALL1;ERBB2;SLC1A4;SMURF1;CAMK1;TCIRG1;NISCH;RAB43;VPS33B;SP100;ABCC1;APBA1
10261,GO:0043044,0.935938443121043,0.244159447313466,1,69,ATP-dependent chromatin remodeling,BP,SMARCA1
18263,GO:1903214,0.93641450375892,0.242948429803194,1,67,regulation of protein targeting to mitochondrion,BP,SREBF1
16178,GO:0090263,0.936486458355938,0.18190271622232,2,110,positive regulation of canonical Wnt signaling pathway,BP,SFRP1;DIXDC1
2833,GO:0006334,0.93649909622195,0.18174970580636,2,116,nucleosome assembly,BP,H1F0;H1FX
10318,GO:0043161,0.936537445906808,0.110504070931825,10,371,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,FBXO2;WWTR1;TMEM129;RBCK1;FBXW4;BTBD2;RNF187;RNF44;FBXW5;SMURF1
287,GO:0000792,0.936589505410444,0.242518858043152,1,66,heterochromatin,CC,KMT5C
18310,GO:1903321,0.936751342628289,0.242013449055322,1,67,negative regulation of protein modification by small protein conjugation or removal,BP,TNFAIP3
14227,GO:0061337,0.937401424342763,0.240317025302588,1,65,cardiac conduction,BP,SCN4B
9167,GO:0035578,0.937551110019724,0.239732002398695,1,68,azurophil granule lumen,CC,HEXB
15235,GO:0071456,0.937690951798984,0.15430159628123,3,148,cellular response to hypoxia,BP,SFRP1;ENDOG;NDRG1
11212,GO:0045446,0.937842771902594,0.239084225578901,1,65,endothelial cell differentiation,BP,PTPRS
3350,GO:0007127,0.938018189873715,0.238480367459426,1,67,meiosis I,BP,SUN1
3321,GO:0007050,0.938074117078734,0.130094264302918,5,214,cell cycle arrest,BP,PKD2;DAB2IP;CGREF1;PCBP4;TP53INP1
20137,GO:2001022,0.938085394470273,0.23829220157798,1,67,positive regulation of response to DNA damage stimulus,BP,EGFR
9862,GO:0042175,0.938086345315266,0.0902986710111917,25,806,nuclear outer membrane-endoplasmic reticulum membrane network,CC,LMF1;KDSR;EGFR;CYBA;XYLT1;CYP4F22;CERS4;PKD2;RTN2;RHBDF1;TMEM129;NSG1;ACSL1;SREBF1;PIK3R1;TYRO3;CPT1C;MBOAT7;LRRC8E;RETSAT;HSD11B1;XYLT2;REEP6;PIGZ;SORT1
9600,GO:0036498,0.938310721734454,0.237660759601149,1,67,IRE1-mediated unfolded protein response,BP,DAB2IP
7421,GO:0031571,0.938691502702895,0.236537954769961,1,68,mitotic G1 DNA damage checkpoint,BP,PCBP4
10972,GO:0044819,0.938691502702895,0.236537954769961,1,68,mitotic G1/S transition checkpoint,BP,PCBP4
12757,GO:0051091,0.938894803815885,0.137891222017257,4,180,positive regulation of DNA binding transcription factor activity,BP,RPS6KA5;TRIM22;RBCK1;CRTC1
2491,GO:0005758,0.938956136950049,0.235641642114369,1,71,mitochondrial intermembrane space,CC,NME4
11006,GO:0045017,0.939191270684492,0.128124515277109,5,211,glycerolipid biosynthetic process,BP,FGFR4;SREBF1;PIK3R1;ZP3;PIGZ
13736,GO:0060359,0.939254410106041,0.235006978476058,1,67,response to ammonium ion,BP,HOMER2
5569,GO:0016607,0.939567881797413,0.108551078892409,9,340,nuclear speck,CC,PHF7;SRSF5;GLI2;TRIM22;NFATC4;MBD1;FNBP4;CRY2;IFI16
9378,GO:0035967,0.940332675446498,0.148975744201097,3,146,cellular response to topologically incorrect protein,BP,DAB2IP;PIK3R1;NCK2
2434,GO:0005657,0.940420547630436,0.23165336023051,1,68,replication fork,CC,BCL6
2860,GO:0006369,0.940618839192333,0.231038145661074,1,69,termination of RNA polymerase II transcription,BP,SRSF5
10243,GO:0043021,0.940755009119084,0.172229043284867,2,110,ribonucleoprotein complex binding,MF,IMPACT;RNF135
10953,GO:0044783,0.941302001858543,0.229091828942367,1,69,G1 DNA damage checkpoint,BP,PCBP4
977,GO:0002440,0.941346377812324,0.170873828333151,2,110,production of molecular mediator of immune response,BP,BCL6;KLK5
2809,GO:0006289,0.941365398760823,0.170768182065824,2,113,nucleotide-excision repair,BP,DDB2;XPC
7246,GO:0031234,0.942372202643801,0.226130523372363,1,67,extrinsic component of cytoplasmic side of plasma membrane,CC,S100A6
467,GO:0001508,0.942893132876558,0.224630700501989,1,67,action potential,BP,SCN4B
14462,GO:0061982,0.943228800484885,0.223557942385495,1,69,meiosis I cell cycle process,BP,SUN1
6289,GO:0019941,0.943297029876836,0.0914573431168738,15,523,modification-dependent protein catabolic process,BP,TNFAIP3;MVB12B;FBXO2;TP53INP2;WWTR1;TMEM129;MAGEF1;CUL9;RBCK1;FBXW4;BTBD2;RNF187;RNF44;FBXW5;SMURF1
7573,GO:0031966,0.943322703305649,0.090212236678526,16,577,mitochondrial membrane,CC,CPT2;TST;CRAT;SNN;DNM1;BPHL;EPHA4;ACSL1;FAM210B;CPT1C;CKMT1A;SPATA18;NDUFA4L2;SDHA;NME4;COX5B
14959,GO:0070925,0.943653885888612,0.0868584926138336,19,636,organelle assembly,BP,ULK2;OBSL1;NLGN2;FHOD3;TP53INP2;WWTR1;TMEM231;OBSCN;GAS8;EVI5L;UNC119B;TP53INP1;MAFIP;MARK4;CCDC69;WIPI2;NINL;SMURF1;VANGL2
3451,GO:0007286,0.944078374858058,0.221096622152251,1,69,spermatid development,BP,CABYR
11216,GO:0045471,0.944256295920912,0.220530137197786,1,70,response to ethanol,BP,TP53INP1
10856,GO:0044430,0.944901026786526,0.0759141290599396,39,1185,cytoskeletal part,CC,ITGB6;OBSL1;NDN;ADGRB2;SHROOM2;CYBA;GLI2;BRSK1;FHOD3;PKD2;ESPN;DNM1;LDLRAP1;CLIP2;GAS8;WIPF1;MZT2A;KIF26B;MPLKIP;KIF26A;FRY;DMTN;SLC2A1;PLEKHH2;SPRY2;TRPV4;SYNM;NDRG1;MYL9;MARK4;PDLIM4;CCDC69;MZT2B;TULP3;CCDC88B;NINL;SLC1A4;AIF1L;VANGL2
14350,GO:0061640,0.945208013110725,0.217803265714645,1,69,cytoskeleton-dependent cytokinesis,BP,SNX33
16048,GO:0090068,0.945770332994088,0.11621655013236,5,218,positive regulation of cell cycle process,BP,INSR;PKD2;DAB2IP;HYAL1;PCBP4
4512,GO:0010595,0.946886671268794,0.212816116907785,1,70,positive regulation of endothelial cell migration,BP,MAP3K3
15706,GO:0072332,0.946931557411605,0.212590208020411,1,72,intrinsic apoptotic signaling pathway by p53 class mediator,BP,IFI16
10466,GO:0043401,0.947260502411165,0.134645276679576,3,148,steroid hormone mediated signaling pathway,BP,THRA;SFRP1;CRY2
16505,GO:0097305,0.94743400138762,0.156657558402065,2,112,response to alcohol,BP,SFRP1;TP53INP1
13636,GO:0060205,0.947702905138649,0.112637116143364,5,226,cytoplasmic vesicle lumen,CC,APOE;VEGFB;HEXB;SERPING1;PCSK1
8961,GO:0035097,0.947799653199608,0.210107548695419,1,70,histone methyltransferase complex,CC,ASH2L
14752,GO:0070507,0.947890574870747,0.133323548483535,3,148,regulation of microtubule cytoskeleton organization,BP,DIXDC1;TRPV4;FBXW5
4531,GO:0010629,0.948194722320204,0.0699503298740512,47,1429,negative regulation of gene expression,BP,PEG3;HES2;EGFR;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;ZFPM1;SERPINE2;HR;SALL2;WWTR1;FOXO1;DAB2IP;MNT;TET1;RPL13A;TCFL5;RPS6KA5;ZBTB42;SREBF1;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;PCBP4;MBD1;TP53INP1;TRPV4;SERPING1;IMPACT;H2AFJ;STAT1;CRY2;IFI16;PER3;MEX3A;CXXC5;MDFI;SCMH1;SP100
15747,GO:0072401,0.948395424994392,0.208238872373169,1,72,signal transduction involved in DNA integrity checkpoint,BP,PCBP4
15751,GO:0072422,0.948395424994392,0.208238872373169,1,72,signal transduction involved in DNA damage checkpoint,BP,PCBP4
2519,GO:0005789,0.948477244924347,0.0767652378739939,24,791,endoplasmic reticulum membrane,CC,LMF1;KDSR;EGFR;CYBA;XYLT1;CYP4F22;CERS4;PKD2;RTN2;RHBDF1;TMEM129;NSG1;ACSL1;SREBF1;TYRO3;CPT1C;MBOAT7;LRRC8E;RETSAT;HSD11B1;XYLT2;REEP6;PIGZ;SORT1
5384,GO:0016241,0.949046000965272,0.130856446377635,3,151,regulation of macroautophagy,BP,ATP6V0A2;EPM2A;SMURF1
12810,GO:0051168,0.949442104362692,0.117623347718174,4,187,nuclear export,BP,SRSF5;SMURF1;CAMK1;SP100
777,GO:0002040,0.949917090253717,0.203761733474264,1,70,sprouting angiogenesis,BP,MAP3K3
9511,GO:0036294,0.950049171472327,0.128691444114438,3,155,cellular response to decreased oxygen levels,BP,SFRP1;ENDOG;NDRG1
390,GO:0001046,0.950191460744405,0.20288648970372,1,71,core promoter sequence-specific DNA binding,MF,STAT1
9666,GO:0038093,0.95030736602491,0.128154211703696,3,154,Fc receptor signaling pathway,BP,VAV3;WIPF1;PIK3R1
2837,GO:0006338,0.950360340176479,0.128031334951653,3,155,chromatin remodeling,BP,SMARCA1;SCMH1;SP100
11438,GO:0045931,0.950457808470565,0.149417581508418,2,114,positive regulation of mitotic cell cycle,BP,INSR;HYAL1
11374,GO:0045815,0.950601472040474,0.201393456085831,1,77,positive regulation of gene expression, epigenetic,BP,TET1
15745,GO:0072395,0.950656600511083,0.201389282277893,1,73,signal transduction involved in cell cycle checkpoint,BP,PCBP4
5658,GO:0016788,0.951027602971249,0.0790438694640666,16,559,hydrolase activity, acting on ester bonds,MF,PTPRS;NLGN2;CES2;ARSI;PPP2R2C;NT5E;PDPR;BPHL;H6PD;SGSH;PLCD3;PGLS;ENDOG;IMPA2;PLCD1;PLPP2
10601,GO:0043632,0.951364669808116,0.0796028270611617,15,532,modification-dependent macromolecule catabolic process,BP,TNFAIP3;MVB12B;FBXO2;TP53INP2;WWTR1;TMEM129;MAGEF1;CUL9;RBCK1;FBXW4;BTBD2;RNF187;RNF44;FBXW5;SMURF1
16843,GO:0098827,0.951471136635212,0.0726443739002583,24,795,endoplasmic reticulum subcompartment,CC,LMF1;KDSR;EGFR;CYBA;XYLT1;CYP4F22;CERS4;PKD2;RTN2;RHBDF1;TMEM129;NSG1;ACSL1;SREBF1;TYRO3;CPT1C;MBOAT7;LRRC8E;RETSAT;HSD11B1;XYLT2;REEP6;PIGZ;SORT1
3217,GO:0006886,0.951554663917974,0.0706921105734297,28,917,intracellular protein transport,BP,SRSF5;BCL6;RTN2;TMEM129;NSG1;EVI5L;RAB40B;RPL13A;SREBF1;DMTN;SYTL1;SNX33;RHOD;STOM;VAMP2;SCG5;ZDHHC1;TBC1D17;GOLGA7B;TOM1L2;MICALL1;ERBB2;SMURF1;CAMK1;RAB43;VPS33B;SP100;APBA1
14165,GO:0061136,0.951834658746143,0.124901374819596,3,154,regulation of proteasomal protein catabolic process,BP,LAMP3;RHBDF1;DAB2IP
2072,GO:0004843,0.951845763189663,0.197855454400177,1,71,thiol-dependent ubiquitin-specific protease activity,MF,TNFAIP3
6906,GO:0030518,0.952237173614017,0.145126151371257,2,114,intracellular steroid hormone receptor signaling pathway,BP,SFRP1;CRY2
10435,GO:0043331,0.952517963102818,0.195707172707822,1,73,response to dsRNA,BP,EGFR
17790,GO:1901990,0.952610979564812,0.0875741984423719,9,357,regulation of mitotic cell cycle phase transition,BP,GPNMB;EGFR;BRSK1;PKD2;XPC;HYAL1;PCBP4;NINL;GJC2
12206,GO:0048515,0.952673365285807,0.195229415017355,1,73,spermatid differentiation,BP,CABYR
2531,GO:0005813,0.952991102151301,0.0810866410858269,12,440,centrosome,CC,ITGB6;OBSL1;NDN;ADGRB2;BRSK1;MZT2A;MPLKIP;NDRG1;MARK4;MZT2B;CCDC88B;SLC1A4
18436,GO:1903578,0.953082028541574,0.193970529448477,1,73,regulation of ATP metabolic process,BP,INSR
19595,GO:1990823,0.953499644410347,0.192680266906355,1,73,response to leukemia inhibitory factor,BP,SPRY2
19598,GO:1990830,0.953499644410347,0.192680266906355,1,73,cellular response to leukemia inhibitory factor,BP,SPRY2
12914,GO:0051321,0.953658782192539,0.120996523997668,3,153,meiotic cell cycle,BP,ZNF318;INSR;SUN1
12903,GO:0051302,0.95402593546157,0.140735263488639,2,116,regulation of cell division,BP,VEGFB;MDK
7576,GO:0031970,0.954598902747427,0.189069905049142,1,78,organelle envelope lumen,CC,NME4
5388,GO:0016247,0.954862089619814,0.188362537330215,1,75,channel regulator activity,MF,SCN4B
10876,GO:0044455,0.954990673432572,0.11799531588322,3,166,mitochondrial membrane part,CC,NDUFA4L2;SDHA;COX5B
3307,GO:0007030,0.955018486916812,0.138317043222477,2,115,Golgi organization,BP,OBSL1;RAB43
969,GO:0002429,0.955134149233558,0.0988067380578675,5,228,immune response-activating cell surface receptor signaling pathway,BP,VAV3;WIPF1;RPS6KA5;PIK3R1;RBCK1
2441,GO:0005667,0.955972774991381,0.0919034724946412,6,260,transcription factor complex,CC,THRA;POU3F1;ZFPM1;WWTR1;TRERF1;NFATC4
391,GO:0001047,0.956210890761233,0.135356042697111,2,116,core promoter binding,MF,STAT1;IFI16
19441,GO:1990234,0.956559947946439,0.0671854567964236,21,714,transferase complex,CC,ASH2L;DCAF16;FBXO2;DHTKD1;INSR;DDB2;YEATS4;KLHDC8B;CDK14;CUL9;PIK3R1;ACVR1B;RTF1;RBCK1;FBXW4;BTBD2;GOLGA7B;FBXW5;RPRD2;ZSWIM8;FBXO44
5899,GO:0018193,0.956764021943353,0.0632591449229187,29,935,peptidyl-amino acid modification,BP,EPHB2;ASH2L;ST3GAL5;EGFR;FGFR4;SFRP1;INSR;KMT5C;CRTAP;YEATS4;FKBP9;EPHA4;RPS6KA5;ERBB3;CSPG4;DMTN;NCK2;ACVR1B;CAMKK1;TYRO3;RTF1;SPRY2;ZDHHC1;GOLGA7B;ERBB2;HINT2;CAMK1;VPS33B;ST6GALNAC6
12737,GO:0051052,0.957056277091598,0.0828273884893045,8,323,regulation of DNA metabolic process,BP,EGFR;GLI2;FGFR4;BCL6;INSR;TET1;MAGEF1;ENDOG
2847,GO:0006354,0.957060572623137,0.133166289466856,2,121,DNA-templated transcription, elongation,BP,TCEA2;RTF1
1299,GO:0003158,0.957396410910277,0.180408833760664,1,74,endothelium development,BP,PTPRS
5721,GO:0016887,0.957451589805971,0.0796236236540715,9,349,ATPase activity,MF,DHX32;SMARCA1;KIF26B;KIF26A;ATP6V0A2;ATP12A;TCIRG1;ABCC1;DDX59
2367,GO:0005515,0.957609661681107,0.0520191333764794,319,8286,protein binding,MF,TNFAIP3;POSTN;IFITM1;ITGB6;TGFBI;TAGLN;HES2;APOE;ALDH1A3;IFI6;MVB12B;KCNJ15;ULK2;PTPRS;NOL4L;PHF7;OBSL1;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;NINJ1;ASH2L;TNS1;HTRA1;CADM4;GIGYF1;ADGRL1;GPX7;SRSF5;GPX3;DCAF16;FLNC;RALGDS;NCR3LG1;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CYBA;OAS2;H1F0;TCEA2;GLI2;FGFR4;EPB41L3;APCDD1;NLGN2;CDK18;RAPGEF5;VIPR1;CALML3;BCL6;PGM1;ANO9;TENM2;PSD4;ZNF318;BRSK1;SFRP1;ARHGEF4;CKLF;FHOD3;TNFSF10;INSR;VAV3;KMT5C;CYBRD1;DHX32;MATN2;SV2A;PKD2;ESPN;ZFPM1;RGMA;RTN2;ARSI;DNM1;TMEM134;PPP2R2C;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;SYT8;SERPINE2;TNXB;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TYMSOS;FOXO1;WNT3;NSG1;PARVB;BOC;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;PRSS3;CLIP2;TSC22D1;KLK5;TRERF1;SHC2;SCN4B;SH3BP2;GAS8;YEATS4;EVI5L;WIPF1;MNT;FAM20C;GLUL;EPHA4;ZNF266;WNT9A;TRAPPC2L;CORO6;MAGEF1;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;TCFL5;MPLKIP;TYSND1;CTSV;NXPH4;RPS6KA5;HOMER2;TXNDC17;ARHGEF19;HEXB;LTBP1;PGLS;EPS8L2;ORAI3;DDX60;ACTA2;ERBB3;KIF26A;S100A6;CDK14;ATP6V0A2;VAMP3;PPL;CUL9;PLXND1;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;SDC3;APPL2;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;IMPA2;UNC119B;XPC;NAB2;NFATC4;SNX33;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;CPT1C;HYAL1;BCAM;RTF1;ZP3;STOM;VAMP2;PLEKHH2;RBCK1;MBOAT7;EFNB3;ADCK5;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;CABYR;MDK;TRPV4;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;SDHA;KLK8;LTBP4;PPP1R35;FBXW4;WDR90;SERPING1;PLEKHN1;NMRK1;MRC2;RTN4RL1;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;MC1R;IMPACT;LGALS9B;TBC1D17;MVD;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;TOM1L2;MICALL1;ERBB2;C2CD4C;RNF187;EPM2A;RNF135;H2AFJ;LAMB2;STAT1;FBXL8;TULP3;NME4;CDK20;WIPI2;ACKR3;PLCD1;H1FX;SLC5A1;CRY2;COX5B;BLOC1S4;MARCKSL1;FURIN;FBXW5;RHPN1;IFI16;IL20RB;CCDC88B;PCSK1;PLPP2;MLYCD;SUN1;THNSL2;NINL;PEX11B;FRAT1;ANGEL1;ARPIN;BEX2;ASIC1;ALS2CL;PER3;NUAK1;PLXNB1;ALOXE3;SMURF1;KREMEN1;DOK4;CXXC5;CAMK1;TCIRG1;NISCH;RNF208;AIF1L;MT2A;NADK;RAB43;VPS33B;MAP3K3;MDFI;REEP6;SCMH1;DTNB;SP100;MPG;IDUA;ISYNA1;FBXO44;SORT1;CBR3;VANGL2;APBA1
9055,GO:0035335,0.95807671448504,0.178197847338062,1,75,peptidyl-tyrosine dephosphorylation,BP,PTPRS
4296,GO:0009791,0.958106064013981,0.178142903291243,1,74,post-embryonic development,BP,NDN
13067,GO:0051641,0.958449215316657,0.0539154757048981,75,2183,cellular localization,BP,TNFAIP3;APOE;MVB12B;OBSL1;LMF1;CPT2;EPHB2;SRSF5;SHROOM2;EGFR;CYBA;EPB41L3;NLGN2;BCL6;BRSK1;GAA;PKD2;RTN2;DNM1;LDLRAP1;RIMS3;ETV5;SYT8;TP53INP2;TMEM129;NSG1;COL7A1;OBSCN;GAS8;EVI5L;WIPF1;KCNC4;RAB40B;MARVELD1;TRAPPC2L;RPL13A;F2R;TUB;VAMP3;SREBF1;DMTN;PIK3R1;SYTL1;SNX33;RHOD;STOM;VAMP2;SPRY2;SCG5;ZDHHC1;ADORA2B;MARK4;TBC1D17;GOLGA7B;GPR68;TOM1L2;MICALL1;ERBB2;C2CD4C;TULP3;WIPI2;COX5B;BLOC1S4;CCDC88B;SUN1;NINL;ASIC1;SMURF1;CAMK1;RAB43;VPS33B;REEP6;SP100;SORT1;APBA1
20235,GO:2001243,0.958618401743949,0.17635001764345,1,78,negative regulation of intrinsic apoptotic signaling pathway,BP,ACKR3
2831,GO:0006325,0.959163271315459,0.0647018625946691,19,661,chromatin organization,BP,ASH2L;H1F0;BCL6;KMT5C;ZFPM1;HR;DDB2;YEATS4;TET1;SMARCA1;RPS6KA5;SREBF1;RTF1;MBD1;MTHFR;H2AFJ;H1FX;SCMH1;SP100
9048,GO:0035326,0.959216837756965,0.174494925607299,1,76,enhancer binding,MF,ZNF704
12607,GO:0050851,0.959278242378161,0.108634739686054,3,162,antigen receptor-mediated signaling pathway,BP,VAV3;PIK3R1;RBCK1
11626,GO:0046425,0.959462801649908,0.173627882159841,1,78,regulation of JAK-STAT cascade,BP,RTN4RL1
8650,GO:0034249,0.959501308396349,0.0904792944590323,5,232,negative regulation of cellular amide metabolic process,BP,APOE;EGFR;UNK;RPL13A;MEX3A
1989,GO:0004725,0.959777410268689,0.172680926631841,1,76,protein tyrosine phosphatase activity,MF,PTPRS
3220,GO:0006890,0.959857093974647,0.172386026534806,1,77,retrograde vesicle-mediated transport, Golgi to ER,BP,KIF26A
8722,GO:0034399,0.959981773479171,0.12586320302549,2,119,nuclear periphery,CC,YEATS4;MBD1
10075,GO:0042623,0.959988677031276,0.0808115134859058,7,290,ATPase activity, coupled,MF,DHX32;SMARCA1;ATP6V0A2;ATP12A;TCIRG1;ABCC1;DDX59
6735,GO:0030176,0.960428725922759,0.124685123738965,2,122,integral component of endoplasmic reticulum membrane,CC,PKD2;RTN2
3620,GO:0008104,0.9605916656387,0.0516269744311633,70,2059,protein localization,BP,TNFAIP3;POSTN;ITGB6;APOE;MVB12B;OBSL1;LMF1;EPHB2;SRSF5;SHROOM2;EGFR;THRA;EPB41L3;NLGN2;BCL6;SFRP1;PKD2;RTN2;LDLRAP1;ETV5;TP53INP2;RHBDF1;TMEM129;NSG1;TMEM231;OBSCN;GAS8;EVI5L;RAB40B;MARVELD1;GLUL;RPL13A;OLFM2;F2R;TUB;LTBP1;ATP6V0A2;VAMP3;SREBF1;DMTN;PIK3R1;TRIM22;SYTL1;UNC119B;SNX33;RHOD;SLC2A1;STOM;VAMP2;SCG5;TRPV4;ZDHHC1;TBC1D17;GOLGA7B;GPR68;TOM1L2;MICALL1;ERBB2;TULP3;WIPI2;SUN1;SMURF1;CAMK1;TCIRG1;RAB43;VPS33B;MDFI;SP100;VANGL2;APBA1
7594,GO:0032006,0.960681542159556,0.16970199054987,1,77,regulation of TOR signaling,BP,EPM2A
7574,GO:0031967,0.960736284583013,0.0578256203081306,29,972,organelle envelope,CC,CPT2;PRICKLE2;TST;EGFR;CRAT;SNN;CERS4;INSR;DNM1;BPHL;YEATS4;RAB40B;EPHA4;ACSL1;S100A6;SREBF1;FAM210B;TYRO3;CPT1C;CKMT1A;SLC2A9;SPATA18;RETSAT;NDUFA4L2;SDHA;NME4;COX5B;SUN1;SORT1
7578,GO:0031975,0.960736284583013,0.0578256203081306,29,972,envelope,CC,CPT2;PRICKLE2;TST;EGFR;CRAT;SNN;CERS4;INSR;DNM1;BPHL;YEATS4;RAB40B;EPHA4;ACSL1;S100A6;SREBF1;FAM210B;TYRO3;CPT1C;CKMT1A;SLC2A9;SPATA18;RETSAT;NDUFA4L2;SDHA;NME4;COX5B;SUN1;SORT1
19005,GO:1904892,0.96099453176141,0.168609136169216,1,79,regulation of STAT cascade,BP,RTN4RL1
4516,GO:0010605,0.961408354789936,0.0507627136380038,68,2017,negative regulation of macromolecule metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;IFI6;LAMP3;EPHB2;EGFR;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;ZFPM1;SERPINE2;HR;SALL2;WWTR1;FOXO1;DAB2IP;COL7A1;CRTAP;MNT;TET1;EPHA4;WNT9A;RPL13A;MAGEF1;TCFL5;RPS6KA5;ZBTB42;SPOCK1;FRY;SREBF1;DMTN;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;PCBP4;SPRY2;MBD1;TP53INP1;TRPV4;PPP1R35;SERPING1;RTN4RL1;IMPACT;H2AFJ;STAT1;HINT2;CRY2;FURIN;IFI16;PER3;MEX3A;CXXC5;ELFN2;PPP1R14A;MDFI;SCMH1;SP100
11653,GO:0046474,0.961781462903766,0.092827795060808,4,194,glycerophospholipid biosynthetic process,BP,FGFR4;PIK3R1;ZP3;PIGZ
5488,GO:0016458,0.961801731567453,0.0860202038619024,5,237,gene silencing,BP,EGFR;TET1;MBD1;H2AFJ;SCMH1
10873,GO:0044452,0.962340914378008,0.101786904502005,3,163,nucleolar part,CC,MAP3K14;B3GNT9;NUAK1
60,GO:0000123,0.962369714183929,0.164081541629117,1,79,histone acetyltransferase complex,CC,YEATS4
20135,GO:2001020,0.962521841334161,0.101387469119926,3,162,regulation of response to DNA damage stimulus,BP,EGFR;MAGEF1;ACKR3
15085,GO:0071216,0.962939712642617,0.118244507902672,2,123,cellular response to biotic stimulus,BP,TNFAIP3;DAB2IP
14072,GO:0060968,0.963046721243715,0.117915113195497,2,127,regulation of gene silencing,BP,EGFR;TET1
20234,GO:2001242,0.963508354294267,0.116721876929691,2,127,regulation of intrinsic apoptotic signaling pathway,BP,NCK2;ACKR3
3039,GO:0006614,0.963543045530809,0.15983567648925,1,91,SRP-dependent cotranslational protein targeting to membrane,BP,RPL13A
11854,GO:0046907,0.964213304917592,0.049377571736356,47,1458,intracellular transport,BP,APOE;MVB12B;LMF1;CPT2;SRSF5;BCL6;RTN2;DNM1;LDLRAP1;RIMS3;SYT8;TMEM129;NSG1;COL7A1;EVI5L;RAB40B;TRAPPC2L;RPL13A;VAMP3;SREBF1;DMTN;SYTL1;SNX33;RHOD;STOM;VAMP2;SCG5;ZDHHC1;ADORA2B;TBC1D17;GOLGA7B;TOM1L2;MICALL1;ERBB2;C2CD4C;COX5B;BLOC1S4;CCDC88B;SUN1;SMURF1;CAMK1;RAB43;VPS33B;REEP6;SP100;SORT1;APBA1
1451,GO:0003712,0.964276896640044,0.0633248339705388,12,457,transcription cofactor activity,MF,THRA;CITED4;POU3F1;HR;WWTR1;SOX12;TRERF1;MNT;TRIM22;NAB2;NFATC4;SP100
7240,GO:0031227,0.964548329674016,0.114046063507118,2,125,intrinsic component of endoplasmic reticulum membrane,CC,PKD2;RTN2
3285,GO:0006998,0.964659253448865,0.156395208750656,1,80,nuclear envelope organization,BP,SUN1
10648,GO:0043933,0.964827123067243,0.0477255190411728,54,1665,protein-containing complex subunit organization,BP,TNFAIP3;APOE;ALDH1A3;OBSL1;ASH2L;SRSF5;GPX3;COL6A1;THRA;CYBA;H1F0;FHOD3;INSR;PKD2;DNM1;TNXB;NSG1;SOX12;DDB2;DAB2IP;COL7A1;WIPF1;KCNC4;GLUL;TRAPPC2L;RPL13A;TYSND1;EPS8L2;HGSNAT;ATP6V0A2;VAMP3;DMTN;TRIM22;NCK2;KCTD11;XPC;ARHGAP40;SLC2A1;STOM;VAMP2;PLEKHH2;TRPV4;MSRB2;IMPACT;CRTC1;H1FX;PEX11B;FRAT1;ARPIN;ASIC1;MMP1;TCIRG1;VPS33B;APBA1
3618,GO:0008094,0.965160256495982,0.154732213007255,1,79,DNA-dependent ATPase activity,MF,SMARCA1
13450,GO:0055029,0.965237037582656,0.112221036249281,2,127,nuclear DNA-directed RNA polymerase complex,CC,RTF1;RPRD2
19676,GO:2000058,0.965248142489578,0.112217359228407,2,125,regulation of ubiquitin-dependent protein catabolic process,BP,MAGEF1;SMURF1
10477,GO:0043414,0.965296086654327,0.0792033599521,5,234,macromolecule methylation,BP,ASH2L;KMT5C;TET1;RTF1;MTHFR
14347,GO:0061630,0.965797495135147,0.0844422754491198,4,198,ubiquitin protein ligase activity,MF,TMEM129;HERC3;RNF44;SMURF1
7392,GO:0031497,0.966115590450652,0.109831572745113,2,134,chromatin assembly,BP,H1F0;H1FX
5776,GO:0017038,0.96617541041753,0.0930440764845641,3,165,protein import,BP,APOE;BCL6;SNX33
5318,GO:0016073,0.966385082733067,0.150407012308956,1,84,snRNA metabolic process,BP,RPRD2
5207,GO:0015833,0.966457163174587,0.0461966339209975,49,1520,peptide transport,BP,POSTN;ITGB6;APOE;MVB12B;LMF1;SRSF5;EGFR;NLGN2;BCL6;SFRP1;RTN2;RHBDF1;TMEM129;NSG1;EVI5L;RAB40B;GLUL;RPL13A;OLFM2;F2R;ATP6V0A2;VAMP3;SREBF1;DMTN;SYTL1;UNC119B;SNX33;RHOD;SLC2A1;STOM;VAMP2;SCG5;TRPV4;ZDHHC1;LTBP4;TBC1D17;GOLGA7B;GPR68;TOM1L2;MICALL1;ERBB2;SMURF1;CAMK1;TCIRG1;RAB43;VPS33B;SP100;ABCC1;APBA1
202,GO:0000428,0.966502884740989,0.108879471961797,2,128,DNA-directed RNA polymerase complex,CC,RTF1;RPRD2
4767,GO:0010972,0.968148117738499,0.144238551075947,1,87,negative regulation of G2/M transition of mitotic cell cycle,BP,BRSK1
15050,GO:0071103,0.968337280814625,0.0731268506777005,5,245,DNA conformation change,BP,H1F0;DDB2;SMARCA1;XPC;H1FX
7066,GO:0030880,0.968628172836956,0.103199911301911,2,130,RNA polymerase complex,CC,RTF1;RPRD2
2920,GO:0006457,0.96889866478746,0.0778104416291357,4,209,protein folding,BP,CRTAP;FKBP9;TMX4;LTBP4
3270,GO:0006974,0.969051666794787,0.0491512459286387,21,738,cellular response to DNA damage stimulus,BP,MAP3K14;ASH2L;EGFR;BCL6;BRSK1;VAV3;FOXO1;DDB2;MAGEF1;PIK3R1;XPC;NFATC4;PCBP4;SPATA18;NDRG1;MC1R;ACKR3;IFI16;NUAK1;SP100;MPG
17237,GO:0140014,0.969234286341482,0.0713498422785558,5,239,mitotic nuclear division,BP,OBSL1;INSR;CUL9;TOM1L2;FBXW5
19780,GO:2000278,0.969782610364963,0.138583148740843,1,84,regulation of DNA biosynthetic process,BP,FGFR4
2376,GO:0005525,0.96992154366798,0.065899837180539,6,277,GTP binding,MF,INSR;DNM1;RAB40B;RHOD;SCG5;RAB43
8233,GO:0033036,0.970275787528738,0.0390820359016986,77,2268,macromolecule localization,BP,TNFAIP3;POSTN;ITGB6;APOE;MVB12B;OBSL1;LMF1;CPT2;EPHB2;SRSF5;TST;SHROOM2;EGFR;THRA;EPB41L3;NLGN2;BCL6;ANO9;SFRP1;PKD2;RTN2;LDLRAP1;ETV5;TP53INP2;RHBDF1;TMEM129;NSG1;TMEM231;OBSCN;GAS8;EVI5L;RAB40B;MARVELD1;GLUL;RPL13A;OLFM2;F2R;TUB;HEXB;LTBP1;ACSL1;ATP6V0A2;VAMP3;SREBF1;DMTN;PIK3R1;TRIM22;SYTL1;UNC119B;SNX33;RHOD;SLC2A1;STOM;VAMP2;SCG5;TRPV4;ZDHHC1;TBC1D17;GOLGA7B;GPR68;TOM1L2;MICALL1;ERBB2;TULP3;NME4;WIPI2;SUN1;SMURF1;CAMK1;TCIRG1;RAB43;VPS33B;MDFI;SP100;ABCC1;VANGL2;APBA1
14360,GO:0061659,0.970347574584414,0.0747259412403429,4,203,ubiquitin-like protein ligase activity,MF,TMEM129;HERC3;RNF44;SMURF1
3038,GO:0006613,0.970428106099217,0.136013883582249,1,96,cotranslational protein targeting to membrane,BP,RPL13A
17787,GO:1901987,0.970874413086193,0.0567719928103256,9,379,regulation of cell cycle phase transition,BP,GPNMB;EGFR;BRSK1;PKD2;XPC;HYAL1;PCBP4;NINL;GJC2
2478,GO:0005740,0.971161033263792,0.0487398752740305,16,617,mitochondrial envelope,CC,CPT2;TST;CRAT;SNN;DNM1;BPHL;EPHA4;ACSL1;FAM210B;CPT1C;CKMT1A;SPATA18;NDUFA4L2;SDHA;NME4;COX5B
2472,GO:0005730,0.971206943109409,0.0448078826385176,24,835,nucleolus,CC,CPT2;MAP3K14;SRSF5;GLI2;CTSB;TRERF1;SDR9C7;RPL13A;B3GNT9;CTSV;IQSEC1;XPC;RTF1;ZNF554;SDHA;MAFIP;PCDH1;STAT1;TULP3;HINT2;H1FX;IFI16;NUAK1;DDX59
4496,GO:0010564,0.971362622601761,0.0478029507067568,17,622,regulation of cell cycle process,BP,OBSL1;GPNMB;EGFR;BCL6;BRSK1;SFRP1;INSR;PKD2;DAB2IP;CUL9;XPC;HYAL1;PCBP4;TOM1L2;FBXW5;NINL;GJC2
8879,GO:0034728,0.97154333430185,0.0952058263361926,2,139,nucleosome organization,BP,H1F0;H1FX
10189,GO:0042886,0.971823656291954,0.0391760425082158,49,1534,amide transport,BP,POSTN;ITGB6;APOE;MVB12B;LMF1;SRSF5;EGFR;NLGN2;BCL6;SFRP1;RTN2;RHBDF1;TMEM129;NSG1;EVI5L;RAB40B;GLUL;RPL13A;OLFM2;F2R;ATP6V0A2;VAMP3;SREBF1;DMTN;SYTL1;UNC119B;SNX33;RHOD;SLC2A1;STOM;VAMP2;SCG5;TRPV4;ZDHHC1;LTBP4;TBC1D17;GOLGA7B;GPR68;TOM1L2;MICALL1;ERBB2;SMURF1;CAMK1;TCIRG1;RAB43;VPS33B;SP100;ABCC1;APBA1
7929,GO:0032550,0.972150162785669,0.0615925995159793,6,280,purine ribonucleoside binding,MF,INSR;DNM1;RAB40B;RHOD;SCG5;RAB43
5542,GO:0016573,0.97255878651956,0.0924904984143611,2,131,histone acetylation,BP,YEATS4;RPS6KA5
13115,GO:0051726,0.972628212895154,0.0410734511282347,30,999,regulation of cell cycle,BP,TNFAIP3;OBSL1;GPNMB;MAP3K14;SRSF5;EGFR;BCL6;BRSK1;SFRP1;INSR;PKD2;DAB2IP;MNT;WNT9A;CDK14;CUL9;CGREF1;XPC;HYAL1;PCBP4;TP53INP1;NDRG1;TOM1L2;CDK20;FBXW5;NINL;GJC2;BEX2;MAP3K3;NRK
10593,GO:0043624,0.973114981392225,0.0766362239888245,3,179,cellular protein complex disassembly,BP,DMTN;PLEKHH2;TRPV4
2888,GO:0006413,0.97312486388069,0.0765854325549697,3,184,translational initiation,BP,RPL13A;NCK2;IMPACT
3219,GO:0006888,0.973418269655841,0.0759462168563927,3,172,ER to Golgi vesicle-mediated transport,BP,LMF1;COL7A1;TRAPPC2L
669,GO:0001883,0.973499688487721,0.0589599202781989,6,282,purine nucleoside binding,MF,INSR;DNM1;RAB40B;RHOD;SCG5;RAB43
12087,GO:0048193,0.973901121974887,0.0554196669564887,7,311,Golgi vesicle transport,BP,LMF1;COL7A1;TRAPPC2L;KIF26A;VAMP3;VAMP2;SORT1
7195,GO:0031109,0.973994563427614,0.123320022821784,1,86,microtubule polymerization or depolymerization,BP,TRPV4
7249,GO:0031248,0.974149743142612,0.122699930015456,1,88,protein acetyltransferase complex,CC,YEATS4
17970,GO:1902493,0.974149743142612,0.122699930015456,1,88,acetyltransferase complex,CC,YEATS4
7209,GO:0031124,0.974593871188055,0.121054278376653,1,88,mRNA 3'-end processing,BP,SRSF5
9959,GO:0042393,0.974818170573396,0.0725476675420205,3,173,histone binding,MF,CTSV;CTSL;STAT1
15872,GO:0072686,0.97487783429998,0.120020740808309,1,87,mitotic spindle,CC,PKD2
7940,GO:0032561,0.974968046293587,0.0560740452242384,6,284,guanyl ribonucleotide binding,MF,INSR;DNM1;RAB40B;RHOD;SCG5;RAB43
7928,GO:0032549,0.975070852855483,0.0558714236407119,6,284,ribonucleoside binding,MF,INSR;DNM1;RAB40B;RHOD;SCG5;RAB43
8901,GO:0034774,0.975293213910127,0.0638339986139833,4,218,secretory granule lumen,CC,VEGFB;HEXB;SERPING1;PCSK1
5947,GO:0018393,0.975342356678328,0.0846784823517411,2,134,internal peptidyl-lysine acetylation,BP,YEATS4;RPS6KA5
8238,GO:0033044,0.975355033905111,0.0553220441691392,6,279,regulation of chromosome organization,BP,BCL6;TET1;RPS6KA5;SREBF1;RTF1;MTHFR
11020,GO:0045047,0.975567276207358,0.117166889382481,1,101,protein targeting to ER,BP,RPL13A
5977,GO:0019001,0.975633859011793,0.0547574540175238,6,285,guanyl nucleotide binding,MF,INSR;DNM1;RAB40B;RHOD;SCG5;RAB43
8865,GO:0034708,0.97572462994689,0.116784266587797,1,90,methyltransferase complex,CC,ASH2L
8803,GO:0034613,0.975798617423177,0.0342224361069862,46,1459,cellular protein localization,BP,TNFAIP3;APOE;OBSL1;EPHB2;SRSF5;EGFR;EPB41L3;NLGN2;BCL6;RTN2;LDLRAP1;ETV5;TP53INP2;TMEM129;NSG1;OBSCN;GAS8;EVI5L;RAB40B;RPL13A;TUB;VAMP3;SREBF1;DMTN;PIK3R1;SYTL1;SNX33;RHOD;STOM;VAMP2;SCG5;ZDHHC1;TBC1D17;GOLGA7B;TOM1L2;MICALL1;ERBB2;TULP3;WIPI2;SUN1;SMURF1;CAMK1;RAB43;VPS33B;SP100;APBA1
17732,GO:1901800,0.976183303287794,0.115054792605295,1,90,positive regulation of proteasomal protein catabolic process,BP,DAB2IP
1152,GO:0002768,0.976186777184602,0.0570713406163962,5,251,immune response-regulating cell surface receptor signaling pathway,BP,VAV3;WIPF1;RPS6KA5;PIK3R1;RBCK1
5710,GO:0016874,0.976270902372809,0.0820317439506859,2,135,ligase activity,MF,GLUL;ACSL1
5833,GO:0017148,0.976449323733872,0.0612594355931698,4,216,negative regulation of translation,BP,EGFR;UNK;RPL13A;MEX3A
9571,GO:0036459,0.976641766102875,0.113359687490316,1,88,thiol-dependent ubiquitinyl hydrolase activity,MF,TNFAIP3
17069,GO:0101005,0.976641766102875,0.113359687490316,1,88,ubiquitinyl hydrolase activity,MF,TNFAIP3
12902,GO:0051301,0.97668106402497,0.0421624491937777,13,508,cell division,BP,ETV5;VEGFB;WWTR1;DIXDC1;MPLKIP;KLHDC8B;CDK14;SNX33;RHOD;MDK;MARK4;CDK20;VANGL2
4539,GO:0010638,0.976935137810195,0.0417428056749519,13,509,positive regulation of organelle organization,BP,BCL6;SFRP1;TNFSF10;INSR;WIPF1;TET1;RPS6KA5;SREBF1;NCK2;RTF1;TRPV4;ARPIN;SMURF1
864,GO:0002220,0.977293711910185,0.110750721313477,1,94,innate immune response activating cell surface receptor signaling pathway,BP,RPS6KA5
866,GO:0002223,0.977293711910185,0.110750721313477,1,94,stimulatory C-type lectin receptor signaling pathway,BP,RPS6KA5
3517,GO:0007519,0.977497682021104,0.110047442640553,1,90,skeletal muscle tissue development,BP,TBX1
282,GO:0000785,0.977531425565232,0.0425460107802071,11,457,chromatin,CC,ASH2L;H1F0;KMT5C;HR;SALL2;YEATS4;SMARCA1;APPL2;H2AFJ;STAT1;H1FX
4656,GO:0010822,0.977562882547587,0.078290734124682,2,139,positive regulation of mitochondrion organization,BP,TNFSF10;SMURF1
9215,GO:0035637,0.977682897268663,0.109356214726787,1,89,multicellular organismal signaling,BP,SCN4B
12608,GO:0050852,0.977769333202364,0.0776781932428476,2,141,T cell receptor signaling pathway,BP,PIK3R1;RBCK1
17261,GO:0140097,0.978044695295978,0.0645637746919461,3,178,catalytic activity, acting on DNA,MF,SMARCA1;ENDOG;MPG
13643,GO:0060218,0.978247256454697,0.106974884173061,1,100,hematopoietic stem cell differentiation,BP,SFRP1
2600,GO:0005923,0.978499811551868,0.106196693716912,1,89,bicellular tight junction,CC,SHROOM2
2931,GO:0006475,0.978522938754674,0.0755157579867278,2,138,internal protein amino acid acetylation,BP,YEATS4;RPS6KA5
15833,GO:0072599,0.978627542892721,0.105437278421624,1,104,establishment of protein localization to endoplasmic reticulum,BP,RPL13A
668,GO:0001882,0.978640428719676,0.0487464432344576,6,290,nucleoside binding,MF,INSR;DNM1;RAB40B;RHOD;SCG5;RAB43
14864,GO:0070727,0.978712975767331,0.0303081680502599,46,1469,cellular macromolecule localization,BP,TNFAIP3;APOE;OBSL1;EPHB2;SRSF5;EGFR;EPB41L3;NLGN2;BCL6;RTN2;LDLRAP1;ETV5;TP53INP2;TMEM129;NSG1;OBSCN;GAS8;EVI5L;RAB40B;RPL13A;TUB;VAMP3;SREBF1;DMTN;PIK3R1;SYTL1;SNX33;RHOD;STOM;VAMP2;SCG5;ZDHHC1;TBC1D17;GOLGA7B;TOM1L2;MICALL1;ERBB2;TULP3;WIPI2;SUN1;SMURF1;CAMK1;RAB43;VPS33B;SP100;APBA1
16816,GO:0098781,0.978778080854249,0.105016534832021,1,94,ncRNA transcription,BP,RPRD2
12130,GO:0048285,0.97886457048661,0.0440847612987354,8,354,organelle fission,BP,OBSL1;INSR;DNM1;CUL9;TOM1L2;FBXW5;SUN1;PEX11B
4941,GO:0015031,0.978874746204088,0.0299968225529646,47,1502,protein transport,BP,POSTN;ITGB6;APOE;MVB12B;LMF1;SRSF5;EGFR;NLGN2;BCL6;SFRP1;RTN2;RHBDF1;TMEM129;NSG1;EVI5L;RAB40B;GLUL;RPL13A;OLFM2;F2R;ATP6V0A2;VAMP3;SREBF1;DMTN;SYTL1;UNC119B;SNX33;RHOD;SLC2A1;STOM;VAMP2;SCG5;TRPV4;ZDHHC1;TBC1D17;GOLGA7B;GPR68;TOM1L2;MICALL1;ERBB2;SMURF1;CAMK1;TCIRG1;RAB43;VPS33B;SP100;APBA1
18069,GO:1902750,0.979078941187506,0.1037886481451,1,97,negative regulation of cell cycle G2/M phase transition,BP,BRSK1
1461,GO:0003729,0.979115557926648,0.0618674231671542,3,180,mRNA binding,MF,UNK;RPL13A;PCBP4
7582,GO:0031984,0.97990952348225,0.0294186452788386,39,1272,organelle subcompartment,CC,POSTN;TGFBI;LMF1;KDSR;ST3GAL5;EGFR;CYBA;XYLT1;CYP4F22;CERS4;PKD2;RTN2;RHBDF1;TMEM129;NSG1;RASIP1;COL7A1;TRAPPC2L;B3GNT9;ACSL1;VAMP3;SREBF1;TYRO3;SLC2A1;CPT1C;VAMP2;MBOAT7;LRRC8E;RETSAT;GOLGA7B;HSD11B1;MARCH9;FURIN;XYLT2;RAB43;ST6GALNAC6;REEP6;PIGZ;SORT1
4213,GO:0009408,0.980082447139962,0.0709226911074999,2,140,response to heat,BP,TP53INP1;TRPV4
14559,GO:0070160,0.980252061886469,0.0992706491535275,1,91,occluding junction,CC,SHROOM2
7546,GO:0031929,0.9807192284574,0.0973539868267492,1,94,TOR signaling,BP,EPM2A
13855,GO:0060538,0.980995732500737,0.0962464567065272,1,94,skeletal muscle organ development,BP,TBX1
324,GO:0000910,0.981037471905533,0.0680834295303335,2,140,cytokinesis,BP,SNX33;RHOD
2859,GO:0006368,0.981105784800573,0.0957542506619231,1,97,transcription elongation from RNA polymerase II promoter,BP,RTF1
2787,GO:0006260,0.981748932799,0.0452047760837994,5,257,DNA replication,BP,EGFR;GLI2;BCL6;INSR;PTMS
18499,GO:1903747,0.982138611178454,0.0915591902338498,1,98,regulation of establishment of protein localization to mitochondrion,BP,SREBF1
2533,GO:0005815,0.982548849825227,0.0307253881913499,16,610,microtubule organizing center,CC,ITGB6;OBSL1;NDN;ADGRB2;BRSK1;PKD2;GAS8;MZT2A;MPLKIP;FRY;NDRG1;MARK4;MZT2B;CCDC88B;NINL;SLC1A4
4655,GO:0010821,0.982624597407103,0.0528502664645425,3,188,regulation of mitochondrion organization,BP,TNFSF10;SREBF1;SMURF1
1528,GO:0003924,0.982802312733641,0.0466337664091456,4,227,GTPase activity,MF,DNM1;RAB40B;RHOD;RAB43
6585,GO:0022626,0.982934391275924,0.0881359749992817,1,110,cytosolic ribosome,CC,RPL13A
14068,GO:0060964,0.98342869367161,0.0861809806365118,1,103,regulation of gene silencing by miRNA,BP,EGFR
12748,GO:0051082,0.983471128791379,0.0860321775492624,1,101,unfolded protein binding,MF,SCG5
10872,GO:0044451,0.984576483542972,0.0242972582585562,28,975,nucleoplasm part,CC,PHF7;ASH2L;SRSF5;H1F0;TCEA2;GLI2;RAPGEF5;TENM2;HR;SALL2;TP53INP2;WWTR1;OBSCN;TRERF1;YEATS4;APPL2;TRIM22;NFATC4;RTF1;PLEKHH2;MBD1;TP53INP1;FNBP4;CRTC1;CRY2;IFI16;RPRD2;SP100
6214,GO:0019783,0.984599017973754,0.0813468648399054,1,98,ubiquitin-like protein-specific protease activity,MF,TNFAIP3
8809,GO:0034622,0.984630762927181,0.0249601462781809,24,881,cellular protein-containing complex assembly,BP,OBSL1;SRSF5;THRA;CYBA;H1F0;FHOD3;DNM1;NSG1;SOX12;DDB2;WIPF1;RPL13A;EPS8L2;ATP6V0A2;VAMP3;DMTN;NCK2;XPC;ARHGAP40;TRPV4;MSRB2;H1FX;ARPIN;TCIRG1
2858,GO:0006367,0.984729578106272,0.0567558408322102,2,150,transcription initiation from RNA polymerase II promoter,BP,THRA;WWTR1
2832,GO:0006333,0.984789144700095,0.0565373808869742,2,156,chromatin assembly or disassembly,BP,H1F0;H1FX
3283,GO:0006996,0.98481977459175,0.0199032509889992,106,3091,organelle organization,BP,APOE;IFI6;ULK2;OBSL1;ASH2L;SHROOM2;H1F0;EPB41L3;NLGN2;BCL6;BRSK1;SFRP1;FHOD3;TNFSF10;INSR;VAV3;KMT5C;GAA;PKD2;ESPN;ZFPM1;DNM1;SYT8;SERPINE2;HR;TNXB;TP53INP2;WWTR1;PARVB;DDB2;COL7A1;TMEM231;OBSCN;GAS8;YEATS4;EVI5L;WIPF1;TET1;TRAPPC2L;CORO6;DIXDC1;F2R;SMARCA1;CTSV;RPS6KA5;ARHGEF19;HEXB;EPS8L2;ATP6V0A2;VAMP3;PPL;CUL9;FRY;SREBF1;DMTN;PIK3R1;IQSEC1;NCK2;SYTL1;UNC119B;XPC;ARHGAP40;SNX33;RHOD;RTF1;VAMP2;PLEKHH2;SPRY2;MBD1;TP53INP1;TRPV4;MTHFR;SPATA18;MSRB2;SYNM;ITGB5;NAGLU;MAFIP;MARK4;PDLIM4;CCDC69;TBC1D17;TOM1L2;C2CD4C;H2AFJ;WIPI2;H1FX;BLOC1S4;ZMYM3;FBXW5;CCDC88B;SUN1;NINL;PEX11B;ARPIN;ALS2CL;PLXNB1;SMURF1;TCIRG1;NISCH;RAB43;VPS33B;SCMH1;SP100;SORT1;VANGL2
11364,GO:0045787,0.984971109980978,0.0356853878552434,6,301,positive regulation of cell cycle,BP,EGFR;INSR;PKD2;DAB2IP;HYAL1;PCBP4
13601,GO:0060147,0.985365900604721,0.0779799303945923,1,106,regulation of posttranscriptional gene silencing,BP,EGFR
14070,GO:0060966,0.985365900604721,0.0779799303945923,1,106,regulation of gene silencing by RNA,BP,EGFR
12847,GO:0051225,0.98541151463711,0.0778603576367,1,100,spindle assembly,BP,CCDC69
8200,GO:0032984,0.985521661589035,0.0368401120263371,5,274,protein-containing complex disassembly,BP,INSR;DMTN;PLEKHH2;TRPV4;FRAT1
5657,GO:0016787,0.985762291550671,0.0200211847703826,58,1822,hydrolase activity,MF,TNFAIP3;PTPRS;HTRA1;ADAM19;NLGN2;SFRP1;NPEPL1;GAA;DHX32;CES2;ARSI;DNM1;PPP2R2C;CTSB;NT5E;PDPR;RHBDF1;BPHL;PRSS3;H6PD;SGSH;KLK5;RAB40B;RNPEPL1;SMARCA1;KIF26B;TYSND1;CTSV;HEXB;PLCD3;PGLS;DDX60;KIF26A;ATP6V0A2;ENDOG;CTSL;IMPA2;ATP12A;RHOD;HYAL1;ADAMTS15;KLK8;NAGLU;IAH1;HINT2;PLCD1;FURIN;PCSK1;PLPP2;CTSF;MMP1;CAPNS2;TCIRG1;RAB43;MPG;ABCC1;DDX59;IDUA
5263,GO:0015934,0.985929889224364,0.0754585027544356,1,115,large ribosomal subunit,CC,RPL13A
7899,GO:0032496,0.986018424880203,0.0438401045331815,3,194,response to lipopolysaccharide,BP,TNFAIP3;DAB2IP;F2R
874,GO:0002244,0.986150801128285,0.0522433950733667,2,158,hematopoietic progenitor cell differentiation,BP,SFRP1;DHTKD1
5909,GO:0018205,0.986174001009312,0.0314319443121261,7,337,peptidyl-lysine modification,BP,ASH2L;KMT5C;YEATS4;RPS6KA5;RTF1;HINT2;VPS33B
10871,GO:0044450,0.986200175090419,0.0521380666121957,2,148,microtubule organizing center part,CC,MZT2A;MZT2B
12379,GO:0048863,0.986284323795227,0.0431061395431359,3,199,stem cell differentiation,BP,SFRP1;WNT3;TBX1
276,GO:0000779,0.986387690832293,0.073593142113877,1,104,condensed chromosome, centromeric region,CC,KMT5C
7166,GO:0031072,0.986387758820918,0.0736048811066246,1,103,heat shock protein binding,MF,MVD
257,GO:0000724,0.986434724796369,0.073412487293955,1,102,double-strand break repair via homologous recombination,BP,MAGEF1
2883,GO:0006406,0.986552726668055,0.072885316051997,1,103,mRNA export from nucleus,BP,SRSF5
15218,GO:0071427,0.986552726668055,0.072885316051997,1,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,SRSF5
17236,GO:0140013,0.986692165306026,0.0722754658284867,1,103,meiotic nuclear division,BP,SUN1
2522,GO:0005793,0.986790388359208,0.071833120306414,1,104,endoplasmic reticulum-Golgi intermediate compartment,CC,COL7A1
258,GO:0000725,0.986998620291095,0.0709297901517215,1,103,recombinational repair,BP,MAGEF1
1447,GO:0003700,0.987174106688989,0.0199241243281007,32,1089,DNA binding transcription factor activity,MF,PEG3;HES2;NDN;THRA;GLI2;BCL6;POU3F1;ZFPM1;ETV5;HR;SALL2;FOXO1;ZSCAN18;SOX12;TBX1;TSC22D1;TRERF1;YEATS4;MNT;ZNF266;TCFL5;SREBF1;TRIM22;NFATC4;ZNF554;MSRB2;STAT1;ZMYM3;IFI16;DBP;ZNF446;SP100
2846,GO:0006353,0.987243503104586,0.0698039069098283,1,107,DNA-templated transcription, termination,BP,SRSF5
18198,GO:1903047,0.987676546315448,0.0211249194941043,20,758,mitotic cell cycle process,BP,OBSL1;GPNMB;EGFR;BCL6;BRSK1;INSR;PKD2;WNT9A;CDK14;CUL9;ACVR1B;XPC;SNX33;HYAL1;PCBP4;SPRY2;TOM1L2;FBXW5;NINL;GJC2
1844,GO:0004519,0.988123930380598,0.0658687197504427,1,108,endonuclease activity,MF,ENDOG
132,GO:0000278,0.98821958471231,0.0192977186790924,25,907,mitotic cell cycle,BP,OBSL1;GPNMB;MAP3K14;EGFR;BCL6;BRSK1;INSR;PKD2;PPP2R2C;YEATS4;WNT9A;CDK14;CUL9;ACVR1B;XPC;SNX33;HYAL1;PCBP4;SPRY2;TOM1L2;FBXW5;NINL;GJC2;MAP3K3;NRK
10407,GO:0043296,0.988377583749805,0.0647789175092928,1,103,apical junction complex,CC,SHROOM2
10947,GO:0044772,0.98851150223961,0.0230863626662231,11,484,mitotic cell cycle phase transition,BP,GPNMB;EGFR;BRSK1;PKD2;CDK14;ACVR1B;XPC;HYAL1;PCBP4;NINL;GJC2
404,GO:0001085,0.988659010055468,0.0634609081878048,1,107,RNA polymerase II transcription factor binding,MF,ZFPM1
10964,GO:0044798,0.988791924743822,0.0437004670114699,2,157,nuclear transcription factor complex,CC,THRA;NFATC4
16826,GO:0098798,0.989057753994885,0.0354213748807951,3,218,mitochondrial protein complex,CC,NDUFA4L2;SDHA;COX5B
2481,GO:0005743,0.989148766314154,0.0241567783474111,8,407,mitochondrial inner membrane,CC,CPT2;TST;CRAT;CKMT1A;NDUFA4L2;SDHA;NME4;COX5B
93,GO:0000184,0.989186135500487,0.0609459582082789,1,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,RPL13A
2830,GO:0006323,0.989525007904067,0.0412297348258572,2,166,DNA packaging,BP,H1F0;H1FX
872,GO:0002237,0.989640428731105,0.033813773759744,3,203,response to molecule of bacterial origin,BP,TNFAIP3;DAB2IP;F2R
17728,GO:1901796,0.989781399629012,0.0403938073693984,2,160,regulation of signal transduction by p53 class mediator,BP,TP53INP1;NUAK1
11105,GO:0045184,0.989810190761734,0.0149566667905576,48,1583,establishment of protein localization,BP,TNFAIP3;POSTN;ITGB6;APOE;MVB12B;LMF1;SRSF5;EGFR;NLGN2;BCL6;SFRP1;RTN2;RHBDF1;TMEM129;NSG1;EVI5L;RAB40B;GLUL;RPL13A;OLFM2;F2R;ATP6V0A2;VAMP3;SREBF1;DMTN;SYTL1;UNC119B;SNX33;RHOD;SLC2A1;STOM;VAMP2;SCG5;TRPV4;ZDHHC1;TBC1D17;GOLGA7B;GPR68;TOM1L2;MICALL1;ERBB2;SMURF1;CAMK1;TCIRG1;RAB43;VPS33B;SP100;APBA1
3320,GO:0007049,0.990068466243473,0.0146440273273963,47,1543,cell cycle,BP,TNFAIP3;OBSL1;GPNMB;MAP3K14;SRSF5;EGFR;BCL6;ZNF318;BRSK1;SFRP1;INSR;PKD2;PPP2R2C;DAB2IP;YEATS4;MNT;MARVELD1;WNT9A;DIXDC1;MPLKIP;KLHDC8B;CDK14;CUL9;CGREF1;APPL2;ACVR1B;KCTD11;XPC;SNX33;RHOD;HYAL1;PCBP4;SPRY2;TP53INP1;NDRG1;MARK4;CCDC69;TOM1L2;CDK20;FBXW5;SUN1;NINL;GJC2;BEX2;CAMK1;MAP3K3;NRK
8649,GO:0034248,0.990274836141073,0.0210676475813778,9,425,regulation of cellular amide metabolic process,BP,APOE;EGFR;UNK;EPHA4;RPL13A;NCK2;IMPACT;ERBB2;MEX3A
3189,GO:0006839,0.990407823105788,0.0279432637771611,4,249,mitochondrial transport,BP,CPT2;TST;SREBF1;COX5B
4251,GO:0009617,0.990488383759168,0.0253754127903378,5,286,response to bacterium,BP,TNFAIP3;CYBA;DAB2IP;KLK5;F2R
9574,GO:0036464,0.990537820023064,0.0378333814676143,2,161,cytoplasmic ribonucleoprotein granule,CC,BTBD2;MEX3A
3648,GO:0008152,0.990564934082332,0.0121974035667589,311,8264,metabolic process,BP,TNFAIP3;PEG3;TGFBI;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;PTPRS;FBXO41;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;MAP3K14;EPHB2;KDSR;ASH2L;HTRA1;PRR9;GAMT;TXNRD3;GPX7;SRSF5;ST3GAL5;GPX3;TST;DCAF16;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;CDK18;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;CYP4F22;NSUN7;ZNF318;CERS4;BRSK1;SFRP1;UNK;POU3F1;TNFSF10;MN1;DHRS4L2;DHTKD1;INSR;VAV3;KMT5C;NPEPL1;CYBRD1;GAA;DHX32;CES2;PKD2;ZFPM1;RGMA;NAT6;ARSI;DNM1;PPP2R2C;LDLRAP1;CTSB;ETV5;NT5E;SERPINE2;HR;PDPR;TNXB;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;LY6E;ZSCAN18;NSG1;RASIP1;BPHL;SOX12;UROS;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;PPP1R3E;PRSS3;H6PD;TSC22D1;SGSH;KLK5;TRERF1;SHC2;CRTAP;YEATS4;FKBP9;MNT;SDR9C7;RAB40B;TET1;CYP27C1;FAM20C;GLUL;FAM213A;ANO8;EPHA4;ZNF266;WNT9A;RPL13A;B3GNT9;RNPEPL1;MAGEF1;TENM4;ZNF687;F2R;SMARCA1;HERC3;TCFL5;TYSND1;CTSV;RPS6KA5;KLHDC8B;SEC14L2;TXNDC17;HEXB;LTBP1;PLCD3;ZNF362;PGLS;ACSL1;ZBTB42;ACTA2;ERBB3;HGSNAT;SPOCK1;CDK14;ATP6V0A2;VAMP3;CUL9;FRY;PLXND1;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;SUGCT;PTHLH;SDC3;CTSL;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;IMPA2;XPC;NAB2;NFATC4;SNX33;TYRO3;CXCR1;SLC2A1;CPT1C;METTL7A;HYAL1;RTF1;ZP3;CKMT1A;ADAMTS15;RBCK1;MBOAT7;PCBP4;ZNF554;ADCK5;SPRY2;SCG5;MBD1;TP53INP1;TNFRSF19;SLC2A9;TMX4;MDK;TRPV4;ZDHHC1;MTHFR;SPATA18;GPC4;MSRB2;RETSAT;NDUFA4L2;SDHA;KLK8;PTMS;LTBP4;ALDH2;PPP1R35;ADORA2B;FBXW4;SERPING1;NAGLU;NMRK1;MRC2;MAFIP;RTN4RL1;AMACR;MARK4;BTBD2;MC1R;IMPACT;TBC1D17;MVD;GOLGA7B;IAH1;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;HSD11B1;EPM2A;RNF135;H2AFJ;LAMB2;STAT1;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;PLCD1;CRY2;MARCH9;COX5B;ZMYM3;FURIN;FBXW5;IFI16;PCSK1;PLPP2;MLYCD;THNSL2;CTSF;GJC2;RPRD2;DBP;MMP1;PER3;XYLT2;NUAK1;ALOXE3;RASA4;SMURF1;CAPNS2;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;NADK;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;SCMH1;SP100;MPG;ABCC1;DDX59;IDUA;NRK;ISYNA1;PIGZ;FBXO44;SORT1;CBR3;VANGL2;APBA1
7334,GO:0031396,0.990625142407032,0.0375323358131496,2,162,regulation of protein ubiquitination,BP,TNFAIP3;FBXO2
133,GO:0000280,0.990644578789944,0.0233555059323475,6,317,nuclear division,BP,OBSL1;INSR;CUL9;TOM1L2;FBXW5;SUN1
281,GO:0000784,0.990676848909547,0.0540338764343776,1,114,nuclear chromosome, telomeric region,CC,SP100
2355,GO:0005488,0.990755142927262,0.0126763973321127,392,10118,binding,MF,TNFAIP3;POSTN;IFITM1;ITGB6;PEG3;TGFBI;SMOC2;TAGLN;HES2;APOE;ALDH1A3;IFI6;MVB12B;KCNJ15;ULK2;LGALS7B;PTPRS;NOL4L;PHF7;OBSL1;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;NINJ1;LENG9;ASH2L;TNS1;HTRA1;PRICKLE2;CADM4;TXNRD3;GIGYF1;ADGRL1;GPX7;SRSF5;GPX3;TST;DCAF16;FLNC;RALGDS;NCR3LG1;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CYBA;NYNRIN;SNN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;APCDD1;NLGN2;CDK18;RAPGEF5;IRF2BPL;VIPR1;CALML3;BCL6;PGM1;ANO9;TENM2;CYP4F22;PSD4;NSUN7;ZNF318;CERS4;BRSK1;SFRP1;ARHGEF4;CKLF;FHOD3;UNK;POU3F1;TNFSF10;DHTKD1;INSR;VAV3;KMT5C;NPEPL1;CYBRD1;GAA;DHX32;MATN2;SV2A;PKD2;ESPN;ZFPM1;RGMA;RTN2;NAT6;ARSI;DNM1;TMEM134;PPP2R2C;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;TNXB;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TYMSOS;TMEM129;FOXO1;WNT3;TRIM65;ZSCAN18;NSG1;PARVB;BOC;SOX12;UROS;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;PRSS3;H6PD;CLIP2;TSC22D1;SGSH;KLK5;TRERF1;SHC2;SCN4B;SH3BP2;CRTAP;GAS8;YEATS4;EVI5L;WIPF1;FKBP9;MNT;RAB40B;TET1;CYP27C1;FAM20C;GLUL;EPHA4;ZNF266;WNT9A;TRAPPC2L;RPL13A;RNPEPL1;CORO6;MAGEF1;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;TCFL5;MPLKIP;TYSND1;CTSV;NXPH4;RPS6KA5;TUB;HOMER2;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;ZNF362;PGLS;ACSL1;EPS8L2;ZBTB42;ORAI3;DDX60;ACTA2;ERBB3;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;VAMP3;PPL;CUL9;PLXND1;CGREF1;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;SDC3;APPL2;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;SNX29;IMPA2;UNC119B;XPC;NAB2;NFATC4;ATP12A;SNX33;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;CPT1C;HYAL1;BCAM;RTF1;ZP3;STOM;CKMT1A;VAMP2;PLEKHH2;ADAMTS15;RBCK1;MBOAT7;EFNB3;PCBP4;ZNF554;ADCK5;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;CABYR;MDK;TRPV4;ZDHHC1;MTHFR;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;SDHA;KLK8;LTBP4;ALDH2;PPP1R35;FBXW4;WDR90;SERPING1;PLEKHN1;NMRK1;MRC2;MYL9;RTN4RL1;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;MC1R;IMPACT;LGALS9B;TBC1D17;MVD;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;TOM1L2;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;EPM2A;RNF135;H2AFJ;LAMB2;PCDH1;STAT1;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;PLCD1;H1FX;SLC5A1;CRY2;MARCH9;COX5B;BLOC1S4;MARCKSL1;ZMYM3;FURIN;FBXW5;CLCN7;RHPN1;IFI16;IL20RB;CCDC88B;PCSK1;PLPP2;MLYCD;SUN1;THNSL2;NINL;PEX11B;FRAT1;ANGEL1;ARPIN;DBP;BEX2;ASIC1;MMP1;ALS2CL;PER3;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;KREMEN1;CAPNS2;MEX3A;DOK4;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;AIF1L;MT2A;NADK;RAB43;VPS33B;ZCCHC24;MAP3K3;MDFI;REEP6;SCMH1;ZSWIM8;DTNB;SP100;MPG;ABCC1;DDX59;IDUA;NRK;ISYNA1;FBXO44;SORT1;CBR3;VANGL2;APBA1
4323,GO:0009892,0.990820243667342,0.0128600669810327,69,2166,negative regulation of metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;IFI6;LAMP3;EPHB2;EGFR;THRA;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;ZFPM1;SERPINE2;HR;SALL2;WWTR1;FOXO1;RASIP1;DAB2IP;COL7A1;CRTAP;MNT;TET1;EPHA4;WNT9A;RPL13A;MAGEF1;TCFL5;RPS6KA5;ZBTB42;SPOCK1;FRY;SREBF1;DMTN;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;PCBP4;SPRY2;MBD1;TP53INP1;TRPV4;PPP1R35;SERPING1;RTN4RL1;IMPACT;H2AFJ;STAT1;HINT2;CRY2;FURIN;IFI16;PER3;MEX3A;CXXC5;ELFN2;PPP1R14A;MDFI;SCMH1;SP100
2477,GO:0005739,0.990825034792737,0.0138836220800609,41,1425,mitochondrion,CC,IFI6;CPT2;TXNRD3;TST;CRAT;CYBA;SNN;OAS2;DHTKD1;DHX32;DNM1;CTSB;PDPR;FOXO1;BPHL;UROS;GLUL;EPHA4;ACSL1;PPL;ENDOG;SUGCT;XPC;FAM210B;CPT1C;STOM;CKMT1A;SPATA18;MSRB2;NDUFA4L2;SDHA;ALDH2;AMACR;NME4;HINT2;COX5B;MLYCD;OXLD1;SMURF1;TCIRG1;MPG
20240,GO:2001251,0.990870497650576,0.0531376190153898,1,111,negative regulation of chromosome organization,BP,TET1
10875,GO:0044454,0.990957990903588,0.0190747577468228,10,462,nuclear chromosome part,CC,ASH2L;H1F0;KMT5C;SALL2;YEATS4;SMARCA1;APPL2;H2AFJ;STAT1;SP100
8775,GO:0034504,0.991058629057759,0.0297526324125695,3,204,protein localization to nucleus,BP,BCL6;SUN1;SP100
14829,GO:0070647,0.99112815817873,0.0146634365277667,26,951,protein modification by small protein conjugation or removal,BP,TNFAIP3;FBXO41;DCAF16;FBXO2;WWTR1;TMEM129;DDB2;RAB40B;MAGEF1;HERC3;KLHDC8B;CUL9;TRIM22;KCTD11;RTF1;RBCK1;FBXW4;RNF187;RNF135;FBXL8;RNF44;MARCH9;FBXW5;SMURF1;RNF208;FBXO44
14989,GO:0070972,0.991161954761662,0.051641079334307,1,125,protein localization to endoplasmic reticulum,BP,RPL13A
17597,GO:1901361,0.991321092455567,0.0170063370344706,13,573,organic cyclic compound catabolic process,BP,APOE;OAS2;H1F0;PGM1;DHTKD1;INSR;NT5E;TRERF1;TET1;RPL13A;ENDOG;PCBP4;HSD11B1
5261,GO:0015931,0.991458638119241,0.0285844111007688,3,207,nucleobase-containing compound transport,BP,SRSF5;TST;SLC29A4
3033,GO:0006606,0.99149415476974,0.0501259684989254,1,113,protein import into nucleus,BP,BCL6
6254,GO:0019866,0.991508762590051,0.0186063611727896,9,450,organelle inner membrane,CC,CPT2;TST;CRAT;CKMT1A;NDUFA4L2;SDHA;NME4;COX5B;SUN1
9771,GO:0040029,0.991596970343613,0.0227200546494471,5,290,regulation of gene expression, epigenetic,BP,EGFR;TET1;MBD1;H2AFJ;IFI16
8801,GO:0034605,0.991694002186883,0.0491486692050695,1,114,cellular response to heat,BP,TRPV4
3048,GO:0006626,0.992144476129918,0.0469030253057125,1,120,protein targeting to mitochondrion,BP,SREBF1
17239,GO:0140030,0.992278232504999,0.046284962635549,1,114,modification-dependent protein binding,MF,TNFAIP3
18197,GO:1903046,0.992359551291564,0.0458686960451679,1,116,meiotic cell cycle process,BP,SUN1
2540,GO:0005829,0.992544241969169,0.00978627682616807,142,4102,cytosol,CC,TNFAIP3;ALDH1A3;MVB12B;ULK2;NOL4L;PHF7;FBXO41;OBSL1;NDN;MAP3K14;EPHB2;HTRA1;GAMT;SRSF5;FLNC;RALGDS;FBXO2;THRA;OAS2;GLI2;EPB41L3;PGM1;ZNF318;SFRP1;ARHGEF4;DHTKD1;VAV3;FAM185A;PPP2R2C;LDLRAP1;NT5E;SERPINE2;TP53INP2;WWTR1;FOXO1;TRIM65;PARVB;UROS;DAB2IP;OBSCN;KLK5;TRERF1;SHC2;WIPF1;SDR9C7;GLUL;MZT2A;TRAPPC2L;RPL13A;DIXDC1;ZNF687;HERC3;TUB;HOMER2;KLHDC8B;SEC14L2;TXNDC17;ARHGEF19;PLCD3;PGLS;EPS8L2;DDX60;ACTA2;KIF26A;S100A6;CDK14;VAMP3;PPL;CUL9;SREBF1;DMTN;ENDOG;PIK3R1;PTHLH;APPL2;ACAP3;TRIM22;NCK2;ACVR1B;CAMKK1;IMPA2;UNC119B;ARHGAP40;NFATC4;SNX33;RHOD;SLC2A1;VAMP2;PLEKHH2;RBCK1;PCBP4;SPRY2;TP53INP1;CABYR;MTHFR;MSRB2;NDRG1;FBXW4;NMRK1;MYL9;MARK4;BTBD2;LGALS9B;TBC1D17;MVD;MZT2B;CRTC1;ERBB2;RNF187;RNF135;STAT1;FBXL8;WIPI2;PLCD1;CRY2;BLOC1S4;FBXW5;RHPN1;IFI16;MLYCD;NINL;FRAT1;ANGEL1;ALS2CL;ALOXE3;RASA4;SMURF1;CAPNS2;MEX3A;DOK4;CXXC5;NISCH;RNF208;MT2A;NADK;MAP3K3;PPP1R14A;ISYNA1;FBXO44;SORT1;CBR3;APBA1
7208,GO:0031123,0.992747480931722,0.0439183293826332,1,119,RNA 3'-end processing,BP,SRSF5
9282,GO:0035770,0.993216290644586,0.0284406081832623,2,170,ribonucleoprotein granule,CC,BTBD2;MEX3A
10855,GO:0044429,0.993369431416728,0.0116936010334764,21,851,mitochondrial part,CC,CPT2;TST;CRAT;SNN;DHTKD1;DNM1;PDPR;BPHL;EPHA4;ACSL1;FAM210B;CPT1C;CKMT1A;SPATA18;NDUFA4L2;SDHA;ALDH2;NME4;COX5B;MLYCD;MPG
15217,GO:0071426,0.993466414658297,0.0402714049147385,1,121,ribonucleoprotein complex export from nucleus,BP,SRSF5
15071,GO:0071166,0.993723248449985,0.0389478918156645,1,122,ribonucleoprotein complex localization,BP,SRSF5
6004,GO:0019080,0.993821476940425,0.0262130755695851,2,184,viral gene expression,BP,RPL13A;FURIN
2826,GO:0006310,0.993827026494169,0.0215076555325034,3,216,DNA recombination,BP,BCL6;MAGEF1;ENDOG
10945,GO:0044770,0.993889975320167,0.0129212692615283,11,511,cell cycle phase transition,BP,GPNMB;EGFR;BRSK1;PKD2;CDK14;ACVR1B;XPC;HYAL1;PCBP4;NINL;GJC2
12477,GO:0050657,0.99400798060095,0.0255546533824463,2,173,nucleic acid transport,BP,SRSF5;TST
12478,GO:0050658,0.99400798060095,0.0255546533824463,2,173,RNA transport,BP,SRSF5;TST
18094,GO:1902850,0.994178706228549,0.0365837724289147,1,122,microtubule cytoskeleton organization involved in mitosis,BP,SPRY2
7395,GO:0031503,0.994499817956811,0.019431397999644,3,219,protein-containing complex localization,BP,SRSF5;DNM1;NSG1
3284,GO:0006997,0.994504122225341,0.0348619363241928,1,124,nucleus organization,BP,SUN1
5650,GO:0016779,0.994537052861394,0.0346731623302382,1,127,nucleotidyltransferase activity,MF,OAS2
2536,GO:0005819,0.99464397671363,0.0151791974036599,5,298,spindle,CC,PKD2;MZT2A;FRY;CCDC69;MZT2B
4434,GO:0010389,0.994644661713593,0.0231804035056166,2,180,regulation of G2/M transition of mitotic cell cycle,BP,BRSK1;NINL
12855,GO:0051236,0.994669774663847,0.0230947483833313,2,176,establishment of RNA localization,BP,SRSF5;TST
2492,GO:0005759,0.994751115088747,0.0130813572808428,7,393,mitochondrial matrix,CC,TST;DHTKD1;PDPR;ALDH2;NME4;MLYCD;MPG
3237,GO:0006913,0.994764562352707,0.0148699408277764,5,301,nucleocytoplasmic transport,BP,SRSF5;BCL6;SMURF1;CAMK1;SP100
42,GO:0000086,0.994798031788473,0.0184943755415089,3,225,G2/M transition of mitotic cell cycle,BP,BRSK1;CDK14;NINL
12811,GO:0051169,0.995195845706462,0.0137624598383689,5,304,nuclear transport,BP,SRSF5;BCL6;SMURF1;CAMK1;SP100
16296,GO:0090575,0.995583155515771,0.0290071879552409,1,131,RNA polymerase II transcription factor complex,CC,THRA
8989,GO:0035195,0.995588855738087,0.0289643845315026,1,134,gene silencing by miRNA,BP,EGFR
2891,GO:0006417,0.995654740777182,0.011016607151113,7,386,regulation of translation,BP,EGFR;UNK;RPL13A;NCK2;IMPACT;ERBB2;MEX3A
9014,GO:0035257,0.995789441559615,0.027868501092584,1,130,nuclear hormone receptor binding,MF,STAT1
110,GO:0000228,0.995843043284227,0.00933547966814928,10,493,nuclear chromosome,CC,ASH2L;H1F0;KMT5C;SALL2;YEATS4;SMARCA1;APPL2;H2AFJ;STAT1;SP100
2882,GO:0006405,0.996078015439879,0.0262415553685056,1,133,RNA export from nucleus,BP,SRSF5
12812,GO:0051170,0.996132731711891,0.0259327452262716,1,133,import into nucleus,BP,BCL6
18309,GO:1903320,0.996414963318224,0.0163543115287808,2,188,regulation of protein modification by small protein conjugation or removal,BP,TNFAIP3;FBXO2
1463,GO:0003735,0.996428637916702,0.0241888221901009,1,154,structural constituent of ribosome,MF,RPL13A
5116,GO:0015630,0.996538966844703,0.00608377825068717,25,964,microtubule cytoskeleton,CC,ITGB6;OBSL1;NDN;ADGRB2;SHROOM2;BRSK1;PKD2;DNM1;CLIP2;GAS8;MZT2A;KIF26B;MPLKIP;KIF26A;FRY;SPRY2;TRPV4;NDRG1;MARK4;CCDC69;MZT2B;CCDC88B;NINL;SLC1A4;NUAK1
8988,GO:0035194,0.996551224475469,0.0235218164215895,1,140,posttranscriptional gene silencing by RNA,BP,EGFR
6581,GO:0022618,0.996576643931205,0.015702990904033,2,193,ribonucleoprotein complex assembly,BP,SRSF5;RPL13A
12719,GO:0051028,0.996601272796515,0.0232477127478136,1,135,mRNA transport,BP,SRSF5
2788,GO:0006261,0.996688758102762,0.0227344324225824,1,137,DNA-dependent DNA replication,BP,BCL6
5480,GO:0016441,0.996703161815893,0.0226392646347537,1,141,posttranscriptional gene silencing,BP,EGFR
10762,GO:0044270,0.996743038114166,0.00721793827091968,11,548,cellular nitrogen compound catabolic process,BP,TST;OAS2;H1F0;PGM1;DHTKD1;INSR;NT5E;TET1;RPL13A;ENDOG;PCBP4
10866,GO:0044445,0.996778817376716,0.0148789707001023,2,203,cytosolic part,CC,RPL13A;BLOC1S4
10979,GO:0044839,0.996779167491767,0.012096665984928,3,239,cell cycle G2/M phase transition,BP,BRSK1;CDK14;NINL
10507,GO:0043488,0.996807071086841,0.0220334701840678,1,141,regulation of mRNA stability,BP,PCBP4
18068,GO:1902749,0.99694102410136,0.0142313382012198,2,195,regulation of cell cycle G2/M phase transition,BP,BRSK1;NINL
17836,GO:1902115,0.997392313043284,0.0185542278131196,1,140,regulation of organelle assembly,BP,EVI5L
331,GO:0000922,0.997455590717555,0.0181653237043455,1,142,spindle pole,CC,FRY
5548,GO:0016579,0.997464363785754,0.0097764198549087,3,244,protein deubiquitination,BP,TNFAIP3;DDB2;RNF135
278,GO:0000781,0.997523625388775,0.017741641583089,1,146,chromosome, telomeric region,CC,SP100
10506,GO:0043487,0.997639214222236,0.0170284758437318,1,148,regulation of RNA stability,BP,PCBP4
2786,GO:0006259,0.997694208876201,0.00438084712556035,20,844,DNA metabolic process,BP,EGFR;NYNRIN;H1F0;GLI2;FGFR4;BCL6;INSR;NT5E;DDB2;TET1;MAGEF1;SMARCA1;ENDOG;XPC;MBD1;PTMS;MC1R;IGFBP4;SP100;MPG
16208,GO:0090305,0.997696311221336,0.00897300849276468,3,248,nucleic acid phosphodiester bond hydrolysis,BP,H1F0;DDB2;ENDOG
15439,GO:0071826,0.997710909530472,0.0110305416775544,2,204,ribonucleoprotein complex subunit organization,BP,SRSF5;RPL13A
2845,GO:0006352,0.997812694242268,0.0105974242567698,2,205,DNA-templated transcription, initiation,BP,THRA;WWTR1
5812,GO:0017111,0.998049811619117,0.00414605021926625,14,647,nucleoside-triphosphatase activity,MF,DHX32;DNM1;RAB40B;SMARCA1;KIF26B;DDX60;KIF26A;ATP6V0A2;ATP12A;RHOD;TCIRG1;RAB43;ABCC1;DDX59
256,GO:0000723,0.998124040316008,0.013978272389434,1,153,telomere maintenance,BP,SP100
7147,GO:0031047,0.998197309294591,0.013505017508104,1,155,gene silencing by RNA,BP,EGFR
15847,GO:0072655,0.998290397841111,0.0129003710305727,1,157,establishment of protein localization to mitochondrion,BP,SREBF1
15390,GO:0071704,0.998311023760775,0.00228434011450937,290,7906,organic substance metabolic process,BP,TNFAIP3;PEG3;TGFBI;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;PTPRS;FBXO41;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;MAP3K14;EPHB2;KDSR;ASH2L;HTRA1;PRR9;GAMT;SRSF5;ST3GAL5;TST;DCAF16;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;CDK18;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;CYP4F22;ZNF318;CERS4;BRSK1;SFRP1;UNK;POU3F1;TNFSF10;MN1;DHTKD1;INSR;VAV3;KMT5C;NPEPL1;GAA;DHX32;CES2;PKD2;ZFPM1;RGMA;NAT6;ARSI;DNM1;PPP2R2C;LDLRAP1;CTSB;ETV5;NT5E;SERPINE2;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;LY6E;ZSCAN18;NSG1;BPHL;SOX12;UROS;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;PPP1R3E;PRSS3;H6PD;TSC22D1;SGSH;KLK5;TRERF1;SHC2;CRTAP;YEATS4;FKBP9;MNT;RAB40B;TET1;CYP27C1;FAM20C;GLUL;ANO8;EPHA4;ZNF266;WNT9A;RPL13A;B3GNT9;RNPEPL1;MAGEF1;TENM4;ZNF687;F2R;SMARCA1;HERC3;TCFL5;TYSND1;CTSV;RPS6KA5;KLHDC8B;SEC14L2;HEXB;LTBP1;PLCD3;ZNF362;PGLS;ACSL1;ZBTB42;ACTA2;ERBB3;HGSNAT;SPOCK1;CDK14;ATP6V0A2;VAMP3;CUL9;FRY;PLXND1;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;SDC3;CTSL;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;IMPA2;XPC;NAB2;NFATC4;SNX33;TYRO3;CXCR1;SLC2A1;CPT1C;HYAL1;RTF1;ZP3;CKMT1A;ADAMTS15;RBCK1;MBOAT7;PCBP4;ZNF554;ADCK5;SPRY2;SCG5;MBD1;TP53INP1;TNFRSF19;SLC2A9;MDK;TRPV4;ZDHHC1;MTHFR;SPATA18;GPC4;MSRB2;RETSAT;SDHA;KLK8;PTMS;LTBP4;ALDH2;PPP1R35;ADORA2B;FBXW4;SERPING1;NAGLU;NMRK1;MAFIP;RTN4RL1;AMACR;MARK4;BTBD2;MC1R;IMPACT;MVD;GOLGA7B;IAH1;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;HSD11B1;RNF135;H2AFJ;LAMB2;STAT1;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;PLCD1;CRY2;MARCH9;COX5B;ZMYM3;FURIN;FBXW5;IFI16;PCSK1;PLPP2;MLYCD;THNSL2;CTSF;GJC2;RPRD2;DBP;MMP1;PER3;XYLT2;NUAK1;ALOXE3;RASA4;SMURF1;CAPNS2;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;NADK;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;SCMH1;SP100;MPG;ABCC1;DDX59;IDUA;NRK;ISYNA1;PIGZ;FBXO44;SORT1;CBR3;VANGL2;APBA1
2880,GO:0006403,0.99838238023515,0.00811993893574312,2,209,RNA localization,BP,SRSF5;TST
14828,GO:0070646,0.998488576068992,0.00615036561719822,3,259,protein modification by small protein removal,BP,TNFAIP3;DDB2;RNF135
14801,GO:0070585,0.998500748767874,0.0115170067439327,1,160,protein localization to mitochondrion,BP,SREBF1
10757,GO:0044260,0.998561444504392,0.00193851033015237,221,6226,cellular macromolecule metabolic process,BP,TNFAIP3;PEG3;TGFBI;HES2;APOE;IFI6;MVB12B;LAMP3;ULK2;PTPRS;FBXO41;OBSL1;LMF1;ZNF704;GPNMB;NDN;MAP3K14;EPHB2;ASH2L;HTRA1;PRR9;SRSF5;ST3GAL5;DCAF16;EGFR;FBXO2;THRA;CITED4;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;CDK18;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;ZNF318;BRSK1;SFRP1;UNK;POU3F1;TNFSF10;MN1;INSR;KMT5C;GAA;PKD2;ZFPM1;RGMA;NAT6;ARSI;DNM1;PPP2R2C;LDLRAP1;CTSB;ETV5;NT5E;SERPINE2;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;LY6E;ZSCAN18;NSG1;SOX12;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;PPP1R3E;TSC22D1;SGSH;TRERF1;SHC2;CRTAP;YEATS4;FKBP9;MNT;RAB40B;TET1;FAM20C;ANO8;EPHA4;ZNF266;WNT9A;RPL13A;B3GNT9;MAGEF1;ZNF687;F2R;SMARCA1;HERC3;TCFL5;CTSV;RPS6KA5;KLHDC8B;SEC14L2;HEXB;LTBP1;ZNF362;ACSL1;ZBTB42;ERBB3;SPOCK1;CDK14;VAMP3;CUL9;FRY;PLXND1;SREBF1;CSPG4;DMTN;ENDOG;GRK6;PIK3R1;CTSL;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;XPC;NAB2;NFATC4;SNX33;TYRO3;CXCR1;HYAL1;RTF1;ZP3;RBCK1;PCBP4;ZNF554;ADCK5;SPRY2;MBD1;TP53INP1;TNFRSF19;MDK;TRPV4;ZDHHC1;MTHFR;SPATA18;MSRB2;PTMS;PPP1R35;ADORA2B;FBXW4;SERPING1;MAFIP;RTN4RL1;MARK4;BTBD2;MC1R;IMPACT;MVD;GOLGA7B;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;RNF135;H2AFJ;LAMB2;STAT1;FBXL8;TULP3;CDK20;HINT2;RNF44;WIPI2;ACKR3;CRY2;MARCH9;ZMYM3;FURIN;FBXW5;IFI16;PLPP2;CTSF;GJC2;RPRD2;DBP;MMP1;PER3;XYLT2;NUAK1;RASA4;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;TCIRG1;RNF208;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;SCMH1;SP100;MPG;IDUA;NRK;PIGZ;FBXO44;VANGL2
14102,GO:0061013,0.998596882836919,0.0108766804850312,1,160,regulation of mRNA catabolic process,BP,PCBP4
3322,GO:0007051,0.998639167190291,0.0105977502060829,1,156,spindle organization,BP,CCDC69
15929,GO:0080090,0.998651873579322,0.00185105931146241,153,4503,regulation of primary metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;IFI6;LAMP3;LMF1;CPT2;ZNF704;GPNMB;NDN;MAP3K14;EPHB2;ASH2L;HTRA1;SRSF5;EGFR;FBXO2;THRA;CITED4;OAS2;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;POU3F1;TNFSF10;MN1;INSR;VAV3;KMT5C;PKD2;ZFPM1;RGMA;PPP2R2C;LDLRAP1;ETV5;SERPINE2;HR;PDPR;SALL2;TP53INP2;WWTR1;RHBDF1;FOXO1;ZSCAN18;SOX12;DAB2IP;COL7A1;TBX1;TSC22D1;TRERF1;SHC2;CRTAP;YEATS4;MNT;TET1;EPHA4;ZNF266;WNT9A;RPL13A;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;TYSND1;RPS6KA5;SEC14L2;HEXB;ZNF362;ACSL1;ZBTB42;ERBB3;SPOCK1;FRY;PLXND1;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;CAMKK1;NAB2;NFATC4;SNX33;TYRO3;RTF1;ZP3;RBCK1;PCBP4;ZNF554;SPRY2;MBD1;TP53INP1;TNFRSF19;MDK;TRPV4;MTHFR;MSRB2;LTBP4;PPP1R35;ADORA2B;SERPING1;MAFIP;RTN4RL1;BTBD2;MC1R;IMPACT;MVD;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CDK20;HINT2;ACKR3;CRY2;ZMYM3;FURIN;IFI16;MLYCD;GJC2;DBP;PER3;NUAK1;SMURF1;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;ELFN2;MAP3K3;PPP1R14A;MDFI;SCMH1;SP100;NRK;VANGL2
2848,GO:0006355,0.998673836210623,0.00192608809430017,89,2828,regulation of transcription, DNA-templated,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;PIK3R1;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100
11776,GO:0046700,0.998674697840838,0.00323120143121063,10,548,heterocycle catabolic process,BP,OAS2;H1F0;PGM1;DHTKD1;INSR;NT5E;TET1;RPL13A;ENDOG;PCBP4
6007,GO:0019083,0.998679651015538,0.0103089339242671,1,170,viral transcription,BP,RPL13A
7689,GO:0032200,0.998834061251948,0.00926010879917798,1,166,telomere organization,BP,SP100
10835,GO:0044391,0.998834429696978,0.00924315124177169,1,182,ribosomal subunit,CC,RPL13A
17267,GO:0140110,0.998916944397659,0.00183127799370732,38,1408,transcription regulator activity,MF,PEG3;HES2;NDN;THRA;CITED4;GLI2;BCL6;POU3F1;ZFPM1;ETV5;HR;SALL2;WWTR1;FOXO1;ZSCAN18;SOX12;TBX1;TSC22D1;TRERF1;YEATS4;MNT;ZNF266;TCFL5;SREBF1;TRIM22;NAB2;NFATC4;RTF1;ZNF554;MSRB2;STAT1;CRY2;ZMYM3;IFI16;DBP;PER3;ZNF446;SP100
6131,GO:0019439,0.998939287143984,0.00262503638901969,10,557,aromatic compound catabolic process,BP,OAS2;H1F0;PGM1;DHTKD1;INSR;NT5E;TET1;RPL13A;ENDOG;PCBP4
18385,GO:1903506,0.998953975178021,0.00153042963198567,89,2845,regulation of nucleic acid-templated transcription,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;PIK3R1;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100
20175,GO:2001141,0.99898186814162,0.00149085410901413,89,2847,regulation of RNA biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;PIK3R1;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100
8832,GO:0034655,0.998999781451868,0.00258422421444516,9,522,nucleobase-containing compound catabolic process,BP,OAS2;H1F0;PGM1;DHTKD1;INSR;NT5E;RPL13A;ENDOG;PCBP4
10324,GO:0043170,0.999014826332352,0.0013407841559931,245,6848,macromolecule metabolic process,BP,TNFAIP3;PEG3;TGFBI;HES2;APOE;IFI6;MVB12B;LAMP3;ULK2;PTPRS;FBXO41;OBSL1;LMF1;ZNF704;GPNMB;NDN;MAP3K14;EPHB2;ASH2L;HTRA1;PRR9;SRSF5;ST3GAL5;DCAF16;EGFR;ADAM19;FBXO2;THRA;CITED4;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;CDK18;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;ZNF318;BRSK1;SFRP1;UNK;POU3F1;TNFSF10;MN1;INSR;KMT5C;NPEPL1;GAA;DHX32;PKD2;ZFPM1;RGMA;NAT6;ARSI;DNM1;PPP2R2C;LDLRAP1;CTSB;ETV5;NT5E;SERPINE2;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;LY6E;ZSCAN18;NSG1;SOX12;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;PPP1R3E;PRSS3;TSC22D1;SGSH;KLK5;TRERF1;SHC2;CRTAP;YEATS4;FKBP9;MNT;RAB40B;TET1;FAM20C;ANO8;EPHA4;ZNF266;WNT9A;RPL13A;B3GNT9;RNPEPL1;MAGEF1;TENM4;ZNF687;F2R;SMARCA1;HERC3;TCFL5;TYSND1;CTSV;RPS6KA5;KLHDC8B;SEC14L2;HEXB;LTBP1;ZNF362;ACSL1;ZBTB42;ACTA2;ERBB3;HGSNAT;SPOCK1;CDK14;VAMP3;CUL9;FRY;PLXND1;SREBF1;CSPG4;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;SDC3;CTSL;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;XPC;NAB2;NFATC4;SNX33;TYRO3;CXCR1;HYAL1;RTF1;ZP3;ADAMTS15;RBCK1;PCBP4;ZNF554;ADCK5;SPRY2;SCG5;MBD1;TP53INP1;TNFRSF19;MDK;TRPV4;ZDHHC1;MTHFR;SPATA18;GPC4;MSRB2;KLK8;PTMS;LTBP4;PPP1R35;ADORA2B;FBXW4;SERPING1;NAGLU;MAFIP;RTN4RL1;MARK4;BTBD2;MC1R;IMPACT;MVD;GOLGA7B;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;RNF135;H2AFJ;LAMB2;STAT1;FBXL8;TULP3;CDK20;HINT2;RNF44;WIPI2;ACKR3;CRY2;MARCH9;ZMYM3;FURIN;FBXW5;IFI16;PCSK1;PLPP2;CTSF;GJC2;RPRD2;DBP;MMP1;PER3;XYLT2;NUAK1;RASA4;SMURF1;CAPNS2;MEX3A;CXXC5;CAMK1;ZNF446;TCIRG1;RNF208;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;SCMH1;SP100;MPG;DDX59;IDUA;NRK;PIGZ;FBXO44;SORT1;VANGL2;APBA1
2419,GO:0005622,0.999028493502996,0.00148198890804927,403,10508,intracellular,CC,TNFAIP3;POSTN;ITGB6;PEG3;TGFBI;TAGLN;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;LGALS7B;PTPRS;NOL4L;PHF7;FBXO41;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;KDSR;ASH2L;TNS1;HTRA1;PRICKLE2;PRR9;GAMT;GPRC5C;TXNRD3;ADGRL1;GPX7;SRSF5;ST3GAL5;TST;DCAF16;FLNC;RALGDS;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;SNN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;CDK18;RAPGEF5;IRF2BPL;BCL6;PGM1;ANO9;TENM2;XYLT1;CYP4F22;ZNF318;CERS4;BRSK1;SFRP1;ARHGEF4;FHOD3;UNK;POU3F1;DHTKD1;INSR;VAV3;FAM185A;KMT5C;NPEPL1;CYBRD1;GAA;DHX32;CES2;SV2A;PKD2;ESPN;ZFPM1;RGMA;RTN2;NAT6;ARSI;DNM1;TMEM134;PPP2R2C;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;TNXB;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;ZSCAN18;NSG1;PARVB;RASIP1;BPHL;BOC;SOX12;UROS;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;PRSS3;H6PD;CLIP2;TSC22D1;SGSH;KLK5;TRERF1;SHC2;CRTAP;GAS8;YEATS4;EVI5L;WIPF1;FKBP9;MNT;SDR9C7;RAB40B;TET1;MARVELD1;NRSN2;CYP27C1;FAM20C;GLUL;FAM213A;ANO8;EPHA4;ZNF266;MZT2A;TRAPPC2L;RPL13A;B3GNT9;RNPEPL1;CORO6;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;HERC3;TCFL5;MPLKIP;TYSND1;CTSV;LRIG3;RPS6KA5;TUB;HOMER2;KLHDC8B;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;ZNF362;SCART1;PGLS;ACSL1;EPS8L2;ZBTB42;DDX60;ACTA2;ERBB3;HGSNAT;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;VAMP3;PPL;CUL9;FRY;SREBF1;CSPG4;RDH12;DMTN;ENDOG;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;UCN2;SYTL1;IMPA2;UNC119B;XPC;ARHGAP40;NAB2;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;CPT1C;METTL7A;HYAL1;RTF1;ZP3;STOM;CKMT1A;VAMP2;PLEKHH2;RBCK1;MBOAT7;AVL9;PCBP4;ZNF554;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;TNFRSF19;CABYR;SLC2A9;TMX4;MDK;TRPV4;ZDHHC1;MTHFR;PQLC2;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;RETSAT;NDUFA4L2;SDHA;KLK8;PTMS;ALDH2;ADORA2B;FBXW4;SERPING1;NAGLU;NMRK1;MAFIP;MYL9;RTN4RL1;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;MC1R;IMPACT;LGALS9B;TBC1D17;MVD;GOLGA7B;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;STON1;TOM1L2;ANKRD13D;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;EPM2A;RNF135;H2AFJ;LAMB2;PCDH1;STAT1;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;PLCD1;H1FX;CRY2;MARCH9;COX5B;SLC39A6;BLOC1S4;MARCKSL1;ZMYM3;FURIN;FBXW5;CLCN7;RHPN1;IFI16;CCDC88B;PCSK1;MLYCD;SUN1;OXLD1;NINL;PEX11B;FRAT1;CTSF;ANGEL1;SLC1A4;RPRD2;DBP;BEX2;ASIC1;ALS2CL;PER3;XYLT2;NUAK1;PLXNB1;ALOXE3;RASA4;SMURF1;CAPNS2;MEX3A;CCDC3;DOK4;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;AIF1L;MT2A;NADK;RAB43;FAM117A;VPS33B;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;REEP6;SCMH1;ZSWIM8;DTNB;SP100;DIRC2;MPG;ABCC1;DDX59;MTMR11;IDUA;NRK;ISYNA1;PIGZ;FBXO44;SORT1;CBR3;VANGL2;APBA1
7294,GO:0031323,0.999110029400039,0.00123385095984733,156,4612,regulation of cellular metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;IFI6;LAMP3;ULK2;LMF1;ZNF704;GPNMB;NDN;MAP3K14;EPHB2;ASH2L;HTRA1;SRSF5;EGFR;FBXO2;THRA;CITED4;CYBA;OAS2;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;POU3F1;TNFSF10;MN1;INSR;VAV3;KMT5C;PKD2;ZFPM1;RGMA;PPP2R2C;ETV5;SERPINE2;HR;PDPR;SALL2;TP53INP2;WWTR1;RHBDF1;FOXO1;TRIM65;ZSCAN18;NSG1;RASIP1;SOX12;DAB2IP;COL7A1;TBX1;TSC22D1;TRERF1;SHC2;CRTAP;YEATS4;MNT;TET1;FAM20C;EPHA4;ZNF266;WNT9A;RPL13A;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;TYSND1;RPS6KA5;SEC14L2;HEXB;ZNF362;ACSL1;ZBTB42;ERBB3;SPOCK1;ATP6V0A2;VAMP3;FRY;PLXND1;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;CAMKK1;NAB2;NFATC4;SNX33;TYRO3;RTF1;ZP3;RBCK1;PCBP4;ZNF554;SPRY2;MBD1;TP53INP1;TNFRSF19;MDK;TRPV4;MTHFR;MSRB2;PPP1R35;ADORA2B;SERPING1;MAFIP;RTN4RL1;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;EPM2A;H2AFJ;STAT1;TULP3;CDK20;HINT2;ACKR3;CRY2;ZMYM3;FURIN;IFI16;MLYCD;GJC2;DBP;PER3;NUAK1;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;ELFN2;MAP3K3;PPP1R14A;MDFI;SCMH1;SP100;NRK;VANGL2
5492,GO:0016462,0.999199751831472,0.00179470690050465,14,685,pyrophosphatase activity,MF,DHX32;DNM1;RAB40B;SMARCA1;KIF26B;DDX60;KIF26A;ATP6V0A2;ATP12A;RHOD;TCIRG1;RAB43;ABCC1;DDX59
5677,GO:0016817,0.999233439719084,0.00172340173772395,14,687,hydrolase activity, acting on acid anhydrides,MF,DHX32;DNM1;RAB40B;SMARCA1;KIF26B;DDX60;KIF26A;ATP6V0A2;ATP12A;RHOD;TCIRG1;RAB43;ABCC1;DDX59
5678,GO:0016818,0.999233439719084,0.00172340173772395,14,687,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,DHX32;DNM1;RAB40B;SMARCA1;KIF26B;DDX60;KIF26A;ATP6V0A2;ATP12A;RHOD;TCIRG1;RAB43;ABCC1;DDX59
272,GO:0000775,0.999291254393838,0.00599762065061491,1,173,chromosome, centromeric region,CC,KMT5C
288,GO:0000793,0.999308672423155,0.00586780746908236,1,174,condensed chromosome,CC,KMT5C
1843,GO:0004518,0.999329452509098,0.00571189183388967,1,176,nuclease activity,MF,ENDOG
2451,GO:0005681,0.999390818143986,0.00524835983163307,1,181,spliceosomal complex,CC,DHX32
6055,GO:0019222,0.999391935075063,0.000847637850843987,166,4904,regulation of metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;IFI6;LAMP3;ULK2;LMF1;CPT2;ZNF704;GPNMB;NDN;MAP3K14;EPHB2;ASH2L;HTRA1;SRSF5;EGFR;FBXO2;THRA;CITED4;CYBA;OAS2;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;POU3F1;TNFSF10;MN1;INSR;VAV3;KMT5C;PKD2;ZFPM1;RGMA;PPP2R2C;LDLRAP1;ETV5;SERPINE2;HR;PDPR;SALL2;TP53INP2;WWTR1;RHBDF1;FOXO1;WNT3;TRIM65;ZSCAN18;NSG1;RASIP1;SOX12;DAB2IP;COL7A1;TBX1;TSC22D1;TRERF1;SHC2;CRTAP;YEATS4;MNT;TET1;FAM20C;EPHA4;ZNF266;WNT9A;RPL13A;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;TYSND1;RPS6KA5;SEC14L2;HEXB;ZNF362;ACSL1;ZBTB42;ACTA2;ERBB3;SPOCK1;ATP6V0A2;VAMP3;FRY;PLXND1;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;CAMKK1;NAB2;NFATC4;SNX33;TYRO3;RTF1;ZP3;RBCK1;PCBP4;ZNF554;SPRY2;MBD1;TP53INP1;TNFRSF19;MDK;TRPV4;MTHFR;MSRB2;LTBP4;PPP1R35;ADORA2B;SERPING1;MAFIP;RTN4RL1;BTBD2;MC1R;IMPACT;MVD;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;EPM2A;H2AFJ;STAT1;TULP3;CDK20;HINT2;ACKR3;CRY2;ZMYM3;FURIN;IFI16;MLYCD;GJC2;DBP;PER3;NUAK1;SMURF1;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;ELFN2;MAP3K3;PPP1R14A;MDFI;SCMH1;SP100;NRK;SORT1;VANGL2;APBA1
15476,GO:0071897,0.999410711808948,0.00509921879929189,1,178,DNA biosynthetic process,BP,FGFR4
10581,GO:0043603,0.999525987961818,0.000992634421173432,19,907,cellular amide metabolic process,BP,APOE;ST3GAL5;EGFR;CERS4;UNK;EPHA4;RPL13A;RNPEPL1;HEXB;NCK2;SCG5;MTHFR;IMPACT;ERBB2;FURIN;PCSK1;ALOXE3;MEX3A;ST6GALNAC6
4518,GO:0010608,0.999528728763023,0.00134207596036728,8,505,posttranscriptional regulation of gene expression,BP,EGFR;UNK;RPL13A;NCK2;PCBP4;IMPACT;ERBB2;MEX3A
6556,GO:0022402,0.999577883394689,0.000805233738779186,27,1138,cell cycle process,BP,OBSL1;GPNMB;EGFR;BCL6;BRSK1;SFRP1;INSR;PKD2;DAB2IP;WNT9A;CDK14;CUL9;CGREF1;ACVR1B;XPC;SNX33;RHOD;HYAL1;PCBP4;SPRY2;TP53INP1;CCDC69;TOM1L2;FBXW5;SUN1;NINL;GJC2
342,GO:0000956,0.999634584941483,0.00333993662265466,1,200,nuclear-transcribed mRNA catabolic process,BP,RPL13A
2844,GO:0006351,0.999641353104613,0.000539871502033484,91,2974,transcription, DNA-templated,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;PIK3R1;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100
1436,GO:0003677,0.99968206661847,0.000525678836104136,53,1918,DNA binding,MF,TNFAIP3;HES2;ZNF704;NDN;ASH2L;EGFR;THRA;H1F0;TCEA2;GLI2;BCL6;CERS4;POU3F1;ZFPM1;ETV5;HR;SALL2;FOXO1;ZSCAN18;SOX12;DDB2;TBX1;TRERF1;YEATS4;MNT;TET1;ZNF266;ZNF687;SMARCA1;TCFL5;ZNF362;ZBTB42;DDX60;SREBF1;XPC;NFATC4;RTF1;PCBP4;ZNF554;MBD1;ZDHHC1;H2AFJ;STAT1;H1FX;CRY2;ZMYM3;IFI16;DBP;PER3;CXXC5;ZNF446;SP100;MPG
17971,GO:1902494,0.999693118041869,0.000582304483365428,29,1230,catalytic complex,CC,ASH2L;DCAF16;FBXO2;CYBA;DHTKD1;INSR;PPP2R2C;SALL2;DDB2;TRERF1;YEATS4;SMARCA1;KLHDC8B;CDK14;CUL9;PIK3R1;APPL2;ACVR1B;ATP12A;RTF1;RBCK1;SDHA;FBXW4;BTBD2;GOLGA7B;FBXW5;RPRD2;ZSWIM8;FBXO44
3289,GO:0007005,0.999693537440456,0.000950302239922978,7,485,mitochondrion organization,BP,IFI6;TNFSF10;DNM1;SREBF1;SPATA18;WIPI2;SMURF1
2818,GO:0006302,0.999703390173668,0.00277780822855139,1,195,double-strand break repair,BP,MAGEF1
12813,GO:0051171,0.999703636924134,0.000425284508967932,144,4386,regulation of nitrogen compound metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;IFI6;LAMP3;ZNF704;GPNMB;NDN;MAP3K14;EPHB2;ASH2L;HTRA1;SRSF5;EGFR;FBXO2;THRA;CITED4;OAS2;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;POU3F1;TNFSF10;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;PPP2R2C;ETV5;SERPINE2;HR;SALL2;TP53INP2;WWTR1;RHBDF1;FOXO1;ZSCAN18;SOX12;DAB2IP;COL7A1;TBX1;TSC22D1;TRERF1;SHC2;CRTAP;YEATS4;MNT;TET1;EPHA4;ZNF266;WNT9A;RPL13A;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ACSL1;ZBTB42;ERBB3;SPOCK1;FRY;PLXND1;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;CAMKK1;NAB2;NFATC4;SNX33;TYRO3;RTF1;ZP3;RBCK1;PCBP4;ZNF554;SPRY2;MBD1;TP53INP1;TNFRSF19;MDK;TRPV4;MTHFR;MSRB2;LTBP4;PPP1R35;ADORA2B;SERPING1;MAFIP;RTN4RL1;BTBD2;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CDK20;HINT2;ACKR3;CRY2;ZMYM3;FURIN;IFI16;GJC2;DBP;PER3;NUAK1;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;ELFN2;MAP3K3;PPP1R14A;MDFI;SCMH1;SP100;NRK;VANGL2
16660,GO:0097659,0.999709170393622,0.000440360544605153,91,2988,nucleic acid-templated transcription,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;PIK3R1;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100
8067,GO:0032774,0.999750127115178,0.000379936274861456,91,2998,RNA biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;PIK3R1;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100
12866,GO:0051252,0.999755935065225,0.000370773422173263,92,3022,regulation of RNA metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;OAS2;TCEA2;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;PIK3R1;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;PCBP4;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100
16776,GO:0098687,0.9997750277655,0.00108971538105881,3,312,chromosomal region,CC,KMT5C;SCMH1;SP100
7577,GO:0031974,0.999776508554891,0.000324207792908604,138,4301,membrane-enclosed lumen,CC,ITGB6;APOE;NOL4L;PHF7;CPT2;NDN;MAP3K14;ASH2L;GPX7;SRSF5;TST;DCAF16;COL6A1;EGFR;CRAT;THRA;CITED4;OAS2;H1F0;TCEA2;GLI2;RAPGEF5;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;BRSK1;POU3F1;DHTKD1;INSR;KMT5C;GAA;CES2;ZFPM1;ARSI;DNM1;CTSB;ETV5;NT5E;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;FOXO1;WNT3;TRIM65;NSG1;BOC;SOX12;DDB2;COL7A1;OBSCN;PRSS3;H6PD;SGSH;TRERF1;CRTAP;YEATS4;MNT;SDR9C7;FAM20C;ANO8;MZT2A;RPL13A;B3GNT9;ZNF687;OLFM2;SMARCA1;MPLKIP;CTSV;RPS6KA5;HEXB;LTBP1;ZBTB42;SREBF1;CSPG4;PTHLH;SDC3;APPL2;CTSL;IQSEC1;TRIM22;XPC;NFATC4;METTL7A;HYAL1;RTF1;PLEKHH2;ZNF554;MBD1;TP53INP1;GPC4;SDHA;ALDH2;SERPING1;NAGLU;MAFIP;AMACR;PDLIM4;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;RNF187;H2AFJ;LAMB2;PCDH1;STAT1;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;H1FX;CRY2;ZMYM3;FURIN;CLCN7;IFI16;PCSK1;MLYCD;CTSF;RPRD2;NUAK1;SMURF1;CXXC5;RNF208;SCMH1;SP100;MPG;DDX59;IDUA;CBR3
10368,GO:0043233,0.999776508554891,0.000324207792908604,138,4301,organelle lumen,CC,ITGB6;APOE;NOL4L;PHF7;CPT2;NDN;MAP3K14;ASH2L;GPX7;SRSF5;TST;DCAF16;COL6A1;EGFR;CRAT;THRA;CITED4;OAS2;H1F0;TCEA2;GLI2;RAPGEF5;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;BRSK1;POU3F1;DHTKD1;INSR;KMT5C;GAA;CES2;ZFPM1;ARSI;DNM1;CTSB;ETV5;NT5E;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;FOXO1;WNT3;TRIM65;NSG1;BOC;SOX12;DDB2;COL7A1;OBSCN;PRSS3;H6PD;SGSH;TRERF1;CRTAP;YEATS4;MNT;SDR9C7;FAM20C;ANO8;MZT2A;RPL13A;B3GNT9;ZNF687;OLFM2;SMARCA1;MPLKIP;CTSV;RPS6KA5;HEXB;LTBP1;ZBTB42;SREBF1;CSPG4;PTHLH;SDC3;APPL2;CTSL;IQSEC1;TRIM22;XPC;NFATC4;METTL7A;HYAL1;RTF1;PLEKHH2;ZNF554;MBD1;TP53INP1;GPC4;SDHA;ALDH2;SERPING1;NAGLU;MAFIP;AMACR;PDLIM4;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;RNF187;H2AFJ;LAMB2;PCDH1;STAT1;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;H1FX;CRY2;ZMYM3;FURIN;CLCN7;IFI16;PCSK1;MLYCD;CTSF;RPRD2;NUAK1;SMURF1;CXXC5;RNF208;SCMH1;SP100;MPG;DDX59;IDUA;CBR3
14484,GO:0070013,0.999776508554891,0.000324207792908604,138,4301,intracellular organelle lumen,CC,ITGB6;APOE;NOL4L;PHF7;CPT2;NDN;MAP3K14;ASH2L;GPX7;SRSF5;TST;DCAF16;COL6A1;EGFR;CRAT;THRA;CITED4;OAS2;H1F0;TCEA2;GLI2;RAPGEF5;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;BRSK1;POU3F1;DHTKD1;INSR;KMT5C;GAA;CES2;ZFPM1;ARSI;DNM1;CTSB;ETV5;NT5E;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;FOXO1;WNT3;TRIM65;NSG1;BOC;SOX12;DDB2;COL7A1;OBSCN;PRSS3;H6PD;SGSH;TRERF1;CRTAP;YEATS4;MNT;SDR9C7;FAM20C;ANO8;MZT2A;RPL13A;B3GNT9;ZNF687;OLFM2;SMARCA1;MPLKIP;CTSV;RPS6KA5;HEXB;LTBP1;ZBTB42;SREBF1;CSPG4;PTHLH;SDC3;APPL2;CTSL;IQSEC1;TRIM22;XPC;NFATC4;METTL7A;HYAL1;RTF1;PLEKHH2;ZNF554;MBD1;TP53INP1;GPC4;SDHA;ALDH2;SERPING1;NAGLU;MAFIP;AMACR;PDLIM4;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;RNF187;H2AFJ;LAMB2;PCDH1;STAT1;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;H1FX;CRY2;ZMYM3;FURIN;CLCN7;IFI16;PCSK1;MLYCD;CTSF;RPRD2;NUAK1;SMURF1;CXXC5;RNF208;SCMH1;SP100;MPG;DDX59;IDUA;CBR3
10748,GO:0044238,0.999779209271094,0.000313294779778919,275,7694,primary metabolic process,BP,TNFAIP3;PEG3;TGFBI;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;PTPRS;FBXO41;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;MAP3K14;EPHB2;KDSR;ASH2L;HTRA1;PRR9;GAMT;SRSF5;ST3GAL5;DCAF16;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;CDK18;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;ZNF318;CERS4;BRSK1;SFRP1;UNK;POU3F1;TNFSF10;MN1;DHTKD1;INSR;VAV3;KMT5C;NPEPL1;GAA;DHX32;CES2;PKD2;ZFPM1;RGMA;NAT6;ARSI;PPP2R2C;LDLRAP1;CTSB;ETV5;NT5E;SERPINE2;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;LY6E;ZSCAN18;NSG1;BPHL;SOX12;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;PPP1R3E;PRSS3;H6PD;TSC22D1;SGSH;KLK5;TRERF1;SHC2;CRTAP;YEATS4;FKBP9;MNT;RAB40B;TET1;CYP27C1;FAM20C;GLUL;ANO8;EPHA4;ZNF266;WNT9A;RPL13A;B3GNT9;RNPEPL1;MAGEF1;TENM4;ZNF687;F2R;SMARCA1;HERC3;TCFL5;TYSND1;CTSV;RPS6KA5;KLHDC8B;SEC14L2;HEXB;LTBP1;PLCD3;ZNF362;PGLS;ACSL1;ZBTB42;ERBB3;SPOCK1;CDK14;ATP6V0A2;CUL9;FRY;PLXND1;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;SDC3;CTSL;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;IMPA2;XPC;NAB2;NFATC4;SNX33;TYRO3;SLC2A1;CPT1C;HYAL1;RTF1;ZP3;CKMT1A;ADAMTS15;RBCK1;MBOAT7;PCBP4;ZNF554;ADCK5;SPRY2;SCG5;MBD1;TP53INP1;TNFRSF19;MDK;TRPV4;ZDHHC1;MTHFR;SPATA18;GPC4;MSRB2;RETSAT;SDHA;KLK8;PTMS;LTBP4;ALDH2;PPP1R35;ADORA2B;FBXW4;SERPING1;NMRK1;MAFIP;RTN4RL1;AMACR;MARK4;BTBD2;MC1R;IMPACT;MVD;GOLGA7B;IAH1;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;HSD11B1;RNF135;H2AFJ;LAMB2;STAT1;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;PLCD1;CRY2;MARCH9;COX5B;ZMYM3;FURIN;FBXW5;IFI16;PCSK1;PLPP2;MLYCD;THNSL2;CTSF;GJC2;RPRD2;DBP;MMP1;PER3;XYLT2;NUAK1;ALOXE3;RASA4;SMURF1;CAPNS2;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;NADK;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;SCMH1;SP100;MPG;DDX59;IDUA;NRK;ISYNA1;PIGZ;FBXO44;VANGL2
13661,GO:0060255,0.99978166581909,0.000314533786585493,150,4568,regulation of macromolecule metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;IFI6;LAMP3;ZNF704;GPNMB;NDN;MAP3K14;EPHB2;ASH2L;HTRA1;SRSF5;EGFR;FBXO2;THRA;CITED4;OAS2;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;POU3F1;TNFSF10;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;PPP2R2C;ETV5;SERPINE2;HR;SALL2;TP53INP2;WWTR1;RHBDF1;FOXO1;WNT3;ZSCAN18;NSG1;SOX12;DAB2IP;COL7A1;TBX1;TSC22D1;TRERF1;SHC2;CRTAP;YEATS4;MNT;TET1;EPHA4;ZNF266;WNT9A;RPL13A;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ACSL1;ZBTB42;ACTA2;ERBB3;SPOCK1;VAMP3;FRY;PLXND1;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;CAMKK1;NAB2;NFATC4;SNX33;TYRO3;RTF1;ZP3;RBCK1;PCBP4;ZNF554;SPRY2;MBD1;TP53INP1;TNFRSF19;MDK;TRPV4;MTHFR;MSRB2;LTBP4;PPP1R35;ADORA2B;SERPING1;MAFIP;RTN4RL1;BTBD2;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CDK20;HINT2;ACKR3;CRY2;ZMYM3;FURIN;IFI16;GJC2;DBP;PER3;NUAK1;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;ELFN2;MAP3K3;PPP1R14A;MDFI;SCMH1;SP100;NRK;SORT1;VANGL2;APBA1
10582,GO:0043604,0.999781937838752,0.000538759917945176,13,733,amide biosynthetic process,BP,ST3GAL5;EGFR;CERS4;UNK;RPL13A;NCK2;IMPACT;ERBB2;FURIN;PCSK1;ALOXE3;MEX3A;ST6GALNAC6
2546,GO:0005840,0.999808068925354,0.00188123250432604,1,225,ribosome,CC,RPL13A
10853,GO:0044427,0.99987949396494,0.000298873459523275,14,771,chromosomal part,CC,ASH2L;H1F0;BCL6;KMT5C;HR;SALL2;YEATS4;SMARCA1;APPL2;H2AFJ;STAT1;H1FX;SCMH1;SP100
8831,GO:0034654,0.999894675577087,0.000161031930033305,103,3384,nucleobase-containing compound biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;SFRP1;POU3F1;MN1;DHTKD1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;ATP6V0A2;PLXND1;SREBF1;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;ADORA2B;NMRK1;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;NME4;CRY2;COX5B;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;MDFI;SCMH1;SP100
2878,GO:0006401,0.999899467280254,0.000519135018731841,3,346,RNA catabolic process,BP,OAS2;RPL13A;PCBP4
17598,GO:1901362,0.999901602758326,0.000149750446815657,108,3526,organic cyclic compound biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;SFRP1;POU3F1;MN1;DHTKD1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;UROS;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;ATP6V0A2;PLXND1;SREBF1;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;ADORA2B;NMRK1;MAFIP;AMACR;MC1R;IMPACT;MVD;NEO1;CRTC1;ERBB2;RNF187;HSD11B1;H2AFJ;STAT1;TULP3;NME4;HINT2;CRY2;COX5B;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;MDFI;SCMH1;SP100
3168,GO:0006807,0.999918816192343,0.000117461475401508,259,7379,nitrogen compound metabolic process,BP,TNFAIP3;PEG3;TGFBI;HES2;APOE;IFI6;MVB12B;LAMP3;ULK2;PTPRS;FBXO41;OBSL1;LMF1;ZNF704;GPNMB;NDN;MAP3K14;EPHB2;KDSR;ASH2L;HTRA1;PRR9;GAMT;SRSF5;ST3GAL5;TST;DCAF16;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;CDK18;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;ZNF318;CERS4;BRSK1;SFRP1;UNK;POU3F1;TNFSF10;MN1;DHTKD1;INSR;KMT5C;NPEPL1;DHX32;PKD2;ZFPM1;RGMA;NAT6;ARSI;PPP2R2C;LDLRAP1;CTSB;ETV5;NT5E;SERPINE2;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;LY6E;ZSCAN18;NSG1;BPHL;SOX12;UROS;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;PRSS3;H6PD;TSC22D1;SGSH;KLK5;TRERF1;SHC2;CRTAP;YEATS4;FKBP9;MNT;RAB40B;TET1;FAM20C;GLUL;ANO8;EPHA4;ZNF266;WNT9A;RPL13A;B3GNT9;RNPEPL1;MAGEF1;TENM4;ZNF687;F2R;SMARCA1;HERC3;TCFL5;TYSND1;CTSV;RPS6KA5;KLHDC8B;SEC14L2;HEXB;LTBP1;ZNF362;PGLS;ACSL1;ZBTB42;ERBB3;HGSNAT;SPOCK1;CDK14;ATP6V0A2;CUL9;FRY;PLXND1;SREBF1;CSPG4;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;SDC3;CTSL;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;XPC;NAB2;NFATC4;SNX33;TYRO3;CPT1C;HYAL1;RTF1;ZP3;CKMT1A;ADAMTS15;RBCK1;PCBP4;ZNF554;ADCK5;SPRY2;SCG5;MBD1;TP53INP1;TNFRSF19;SLC2A9;MDK;TRPV4;ZDHHC1;MTHFR;SPATA18;GPC4;MSRB2;SDHA;KLK8;PTMS;LTBP4;PPP1R35;ADORA2B;FBXW4;SERPING1;NAGLU;NMRK1;MAFIP;RTN4RL1;MARK4;BTBD2;MC1R;IMPACT;MVD;GOLGA7B;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;RNF135;H2AFJ;LAMB2;STAT1;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;CRY2;MARCH9;COX5B;ZMYM3;FURIN;FBXW5;IFI16;PCSK1;PLPP2;THNSL2;CTSF;GJC2;RPRD2;DBP;MMP1;PER3;XYLT2;NUAK1;ALOXE3;RASA4;SMURF1;CAPNS2;MEX3A;CXXC5;CAMK1;ZNF446;TCIRG1;RNF208;NADK;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;SCMH1;SP100;MPG;ABCC1;DDX59;IDUA;NRK;PIGZ;FBXO44;VANGL2
4455,GO:0010468,0.999920963024874,0.000121085313127543,107,3507,regulation of gene expression,BP,TNFAIP3;PEG3;HES2;APOE;LAMP3;ZNF704;NDN;EPHB2;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;SERPINE2;HR;SALL2;TP53INP2;WWTR1;FOXO1;WNT3;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;RPL13A;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;ACTA2;ERBB3;PLXND1;SREBF1;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;PCBP4;ZNF554;SPRY2;MBD1;TP53INP1;MDK;TRPV4;MSRB2;SERPING1;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;GJC2;DBP;PER3;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100;SORT1;APBA1
6130,GO:0019438,0.999921364273676,0.000120946579050958,104,3430,aromatic compound biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;SFRP1;POU3F1;MN1;DHTKD1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;UROS;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;ATP6V0A2;PLXND1;SREBF1;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;ADORA2B;NMRK1;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;NME4;CRY2;COX5B;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;MDFI;SCMH1;SP100
5889,GO:0018130,0.999924376744712,0.000116425089893245,104,3433,heterocycle biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;SFRP1;POU3F1;MN1;DHTKD1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;UROS;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;ATP6V0A2;PLXND1;SREBF1;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;ADORA2B;NMRK1;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;NME4;CRY2;COX5B;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;MDFI;SCMH1;SP100
10747,GO:0044237,0.999929447190896,0.000102948249370751,280,7890,cellular metabolic process,BP,TNFAIP3;PEG3;TGFBI;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;PTPRS;FBXO41;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;MAP3K14;EPHB2;KDSR;ASH2L;HTRA1;PRR9;GAMT;TXNRD3;SRSF5;ST3GAL5;GPX3;TST;DCAF16;EGFR;FBXO2;CRAT;THRA;CITED4;CYBA;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;CDK18;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;CYP4F22;ZNF318;CERS4;BRSK1;SFRP1;UNK;POU3F1;TNFSF10;MN1;DHTKD1;INSR;VAV3;KMT5C;GAA;DHX32;CES2;PKD2;ZFPM1;RGMA;NAT6;ARSI;DNM1;PPP2R2C;LDLRAP1;CTSB;ETV5;NT5E;SERPINE2;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;TRIM65;LY6E;ZSCAN18;NSG1;RASIP1;BPHL;SOX12;UROS;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;PPP1R3E;PRSS3;H6PD;TSC22D1;SGSH;TRERF1;SHC2;CRTAP;YEATS4;FKBP9;MNT;RAB40B;TET1;CYP27C1;FAM20C;GLUL;ANO8;EPHA4;ZNF266;WNT9A;RPL13A;B3GNT9;RNPEPL1;MAGEF1;ZNF687;F2R;SMARCA1;HERC3;TCFL5;TYSND1;CTSV;RPS6KA5;KLHDC8B;SEC14L2;HEXB;LTBP1;PLCD3;ZNF362;PGLS;ACSL1;ZBTB42;ERBB3;SPOCK1;CDK14;ATP6V0A2;VAMP3;CUL9;FRY;PLXND1;SREBF1;CSPG4;RDH12;DMTN;ENDOG;GRK6;PIK3R1;PTHLH;SDC3;CTSL;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;IMPA2;XPC;NAB2;NFATC4;SNX33;TYRO3;CXCR1;SLC2A1;CPT1C;HYAL1;RTF1;ZP3;CKMT1A;RBCK1;MBOAT7;PCBP4;ZNF554;ADCK5;SPRY2;SCG5;MBD1;TP53INP1;TNFRSF19;SLC2A9;MDK;TRPV4;ZDHHC1;MTHFR;SPATA18;GPC4;MSRB2;RETSAT;NDUFA4L2;SDHA;PTMS;ALDH2;PPP1R35;ADORA2B;FBXW4;SERPING1;NMRK1;MAFIP;RTN4RL1;AMACR;MARK4;BTBD2;MC1R;IMPACT;TBC1D17;MVD;GOLGA7B;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;EPM2A;RNF135;H2AFJ;LAMB2;STAT1;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;PLCD1;CRY2;MARCH9;COX5B;ZMYM3;FURIN;FBXW5;IFI16;PCSK1;PLPP2;MLYCD;THNSL2;CTSF;GJC2;RPRD2;DBP;MMP1;PER3;XYLT2;NUAK1;ALOXE3;RASA4;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;TCIRG1;RNF208;NADK;VPS33B;ELFN2;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;SCMH1;SP100;MPG;ABCC1;DDX59;IDUA;NRK;ISYNA1;PIGZ;FBXO44;CBR3;VANGL2
2801,GO:0006281,0.999935650931357,0.000236936542779108,6,485,DNA repair,BP,EGFR;DDB2;MAGEF1;XPC;MC1R;MPG
171,GO:0000377,0.999938011879349,0.000425752370156867,2,298,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,SRSF5;DHX32
183,GO:0000398,0.999938011879349,0.000425752370156867,2,298,mRNA splicing, via spliceosome,BP,SRSF5;DHX32
2961,GO:0006518,0.999942768229929,0.000151273947676497,13,783,peptide metabolic process,BP,APOE;EGFR;UNK;EPHA4;RPL13A;RNPEPL1;NCK2;SCG5;IMPACT;ERBB2;FURIN;PCSK1;MEX3A
8383,GO:0033365,0.999943109136805,0.000155227703804284,12,729,protein localization to organelle,BP,TNFAIP3;OBSL1;BCL6;OBSCN;RPL13A;TUB;SREBF1;MICALL1;TULP3;SUN1;SMURF1;SP100
170,GO:0000375,0.999944645466768,0.000383714834333194,2,301,RNA splicing, via transesterification reactions,BP,SRSF5;DHX32
15831,GO:0072594,0.999949437151037,0.00020714494508155,5,459,establishment of protein localization to organelle,BP,TNFAIP3;BCL6;RPL13A;SREBF1;SMURF1
10851,GO:0044424,0.999951887361384,7.9003234145257e-05,391,10390,intracellular part,CC,TNFAIP3;POSTN;ITGB6;PEG3;TGFBI;TAGLN;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;LGALS7B;PTPRS;NOL4L;PHF7;FBXO41;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;KDSR;ASH2L;TNS1;HTRA1;PRICKLE2;PRR9;GAMT;GPRC5C;TXNRD3;GPX7;SRSF5;ST3GAL5;TST;DCAF16;FLNC;RALGDS;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;SNN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;CDK18;RAPGEF5;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;CYP4F22;ZNF318;CERS4;BRSK1;SFRP1;ARHGEF4;FHOD3;UNK;POU3F1;DHTKD1;INSR;VAV3;FAM185A;KMT5C;NPEPL1;CYBRD1;GAA;DHX32;CES2;SV2A;PKD2;ESPN;ZFPM1;RGMA;RTN2;NAT6;ARSI;DNM1;TMEM134;PPP2R2C;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;ZSCAN18;NSG1;PARVB;RASIP1;BPHL;BOC;SOX12;UROS;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;PRSS3;H6PD;CLIP2;TSC22D1;SGSH;KLK5;TRERF1;SHC2;CRTAP;GAS8;YEATS4;WIPF1;FKBP9;MNT;SDR9C7;RAB40B;TET1;MARVELD1;NRSN2;CYP27C1;FAM20C;GLUL;FAM213A;ANO8;EPHA4;ZNF266;MZT2A;TRAPPC2L;RPL13A;B3GNT9;RNPEPL1;CORO6;DIXDC1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;HERC3;TCFL5;MPLKIP;TYSND1;CTSV;LRIG3;RPS6KA5;TUB;HOMER2;KLHDC8B;SEC14L2;TXNDC17;ARHGEF19;HEXB;LTBP1;PLCD3;ZNF362;SCART1;PGLS;ACSL1;EPS8L2;ZBTB42;DDX60;ACTA2;ERBB3;HGSNAT;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;VAMP3;PPL;CUL9;FRY;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;KCTD11;CAMKK1;SYTL1;IMPA2;UNC119B;XPC;ARHGAP40;NAB2;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CXCR1;CLEC11A;SLC2A1;CPT1C;METTL7A;HYAL1;RTF1;STOM;CKMT1A;VAMP2;PLEKHH2;RBCK1;MBOAT7;AVL9;PCBP4;ZNF554;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;CABYR;SLC2A9;TMX4;MDK;TRPV4;ZDHHC1;MTHFR;PQLC2;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;RETSAT;NDUFA4L2;SDHA;KLK8;PTMS;ALDH2;FBXW4;SERPING1;NAGLU;NMRK1;MAFIP;MYL9;RTN4RL1;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;IMPACT;LGALS9B;TBC1D17;MVD;GOLGA7B;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;STON1;ANKRD13D;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;EPM2A;RNF135;H2AFJ;LAMB2;PCDH1;STAT1;FBXL8;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;PLCD1;H1FX;CRY2;MARCH9;COX5B;SLC39A6;BLOC1S4;MARCKSL1;ZMYM3;FURIN;FBXW5;CLCN7;RHPN1;IFI16;CCDC88B;PCSK1;MLYCD;SUN1;OXLD1;NINL;PEX11B;FRAT1;CTSF;ANGEL1;SLC1A4;RPRD2;DBP;BEX2;ASIC1;ALS2CL;PER3;XYLT2;NUAK1;ALOXE3;RASA4;SMURF1;CAPNS2;MEX3A;CCDC3;DOK4;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;AIF1L;MT2A;NADK;RAB43;FAM117A;VPS33B;MAP3K3;PPP1R14A;ST6GALNAC6;MDFI;REEP6;SCMH1;ZSWIM8;DTNB;SP100;DIRC2;MPG;ABCC1;DDX59;MTMR11;IDUA;NRK;ISYNA1;PIGZ;FBXO44;SORT1;CBR3;VANGL2;APBA1
2856,GO:0006364,0.999956662384762,0.000492107362030343,1,255,rRNA processing,BP,RPL13A
6052,GO:0019219,0.999958567295131,6.53785079957299e-05,97,3267,regulation of nucleobase-containing compound metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;OAS2;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;PCBP4;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;ADORA2B;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100
12883,GO:0051276,0.999959037686885,9.2701517831176e-05,21,1048,chromosome organization,BP,ASH2L;H1F0;BCL6;KMT5C;ZFPM1;HR;DDB2;YEATS4;TET1;SMARCA1;RPS6KA5;SREBF1;XPC;RTF1;MBD1;MTHFR;H2AFJ;H1FX;SUN1;SCMH1;SP100
2879,GO:0006402,0.999966639405282,0.000240645957618601,2,322,mRNA catabolic process,BP,RPL13A;PCBP4
18303,GO:1903311,0.999969453746752,0.000358348019391301,1,250,regulation of mRNA metabolic process,BP,PCBP4
10362,GO:0043227,0.999969791183661,4.64514069238067e-05,336,9232,membrane-bounded organelle,CC,TNFAIP3;POSTN;ITGB6;PEG3;TGFBI;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;LGALS7B;PTPRS;NOL4L;PHF7;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;S100A4;MAP3K14;EPHB2;KDSR;ASH2L;HTRA1;PRICKLE2;CADM4;GAMT;GPRC5C;TXNRD3;GPX7;SRSF5;ST3GAL5;GPX3;TST;DCAF16;MXRA5;RALGDS;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;SNN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;CDK18;RAPGEF5;IRF2BPL;CALML3;BCL6;PGM1;TENM2;XYLT1;CYP4F22;ZNF318;CERS4;BRSK1;SFRP1;POU3F1;GAREM2;TNFSF10;DHTKD1;INSR;VAV3;KMT5C;NPEPL1;CYBRD1;GAA;DHX32;CES2;SV2A;PKD2;ZFPM1;RGMA;RTN2;ARSI;DNM1;CXCL14;LDLRAP1;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;TNXB;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;ZSCAN18;NSG1;RASIP1;BPHL;BOC;SOX12;UROS;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;PRSS3;H6PD;TSC22D1;SGSH;KLK5;TRERF1;CRTAP;GAS8;YEATS4;WIPF1;FKBP9;MNT;SDR9C7;RAB40B;TET1;MARVELD1;NRSN2;CYP27C1;FAM20C;GLUL;FAM213A;ANO8;EPHA4;ZNF266;WNT9A;MZT2A;TRAPPC2L;RPL13A;B3GNT9;MAGEF1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;HERC3;TCFL5;MPLKIP;TYSND1;CTSV;LRIG3;RPS6KA5;TUB;SEC14L2;TXNDC17;HEXB;LTBP1;ZNF362;PGLS;ACSL1;EPS8L2;ZBTB42;ACTA2;HGSNAT;S100A6;CDK14;ATP6V0A2;VAMP3;PPL;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;CAMKK1;SYTL1;SNX29;XPC;NAB2;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CXCR1;SLC2A1;CPT1C;METTL7A;HYAL1;BCAM;RTF1;STOM;CKMT1A;VAMP2;PLEKHH2;MBOAT7;AVL9;ZNF554;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;CABYR;SLC2A9;TMX4;TRPV4;ZDHHC1;PQLC2;SPATA18;GPC4;MSRB2;ITGB5;NDRG1;RETSAT;NDUFA4L2;SDHA;KLK8;PTMS;LTBP4;ALDH2;SERPING1;NAGLU;MAFIP;RTN4RL1;AMACR;PDLIM4;CCDC69;TBC1D17;GOLGA7B;IAH1;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;TOM1L2;ANKRD13D;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;EPM2A;H2AFJ;LAMB2;PCDH1;STAT1;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;PLCD1;H1FX;SLC5A1;CRY2;MARCH9;COX5B;SLC39A6;MARCKSL1;ZMYM3;FURIN;CLCN7;IFI16;CCDC88B;PCSK1;MLYCD;SUN1;OXLD1;PEX11B;FRAT1;CTSF;ANGEL1;SLC1A4;SLC13A3;RPRD2;DBP;BEX2;ASIC1;PER3;XYLT2;NUAK1;SMURF1;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;AIF1L;MT2A;RAB43;VPS33B;SLC47A1;ST6GALNAC6;MDFI;REEP6;SCMH1;SP100;DIRC2;MPG;ABCC1;DDX59;MTMR11;IDUA;PIGZ;SORT1;CBR3;VANGL2;APBA1
16836,GO:0098813,0.999974042029748,0.000308975351394037,1,252,nuclear chromosome segregation,BP,SUN1
4320,GO:0009889,0.999981375938817,2.98128733895216e-05,100,3397,regulation of biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;EGFR;THRA;CITED4;CYBA;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;PDPR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;RPL13A;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;ADORA2B;MAFIP;MC1R;IMPACT;MVD;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;FURIN;IFI16;DBP;PER3;SMURF1;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100
19700,GO:2000112,0.999981875168567,2.93595229218127e-05,93,3206,regulation of cellular macromolecule biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;RPL13A;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;PIK3R1;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;DBP;PER3;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100
10260,GO:0043043,0.999983592715104,5.37860691274243e-05,9,672,peptide biosynthetic process,BP,EGFR;UNK;RPL13A;NCK2;IMPACT;ERBB2;FURIN;PCSK1;MEX3A
17262,GO:0140098,0.999983925766938,0.000122599634983004,2,331,catalytic activity, acting on RNA,MF,DHX32;DDX59
10850,GO:0044422,0.999984249031499,2.35496497588906e-05,245,7154,organelle part,CC,POSTN;ITGB6;TGFBI;APOE;MVB12B;LAMP3;ULK2;PTPRS;NOL4L;PHF7;OBSL1;LMF1;CPT2;NDN;ADGRB2;MAP3K14;KDSR;ASH2L;PRICKLE2;GPRC5C;GPX7;SRSF5;ST3GAL5;TST;DCAF16;FLNC;SHROOM2;COL6A1;EGFR;FBXO2;CRAT;THRA;CITED4;CYBA;SNN;OAS2;H1F0;TCEA2;GLI2;RAPGEF5;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;CYP4F22;ZNF318;CERS4;BRSK1;FHOD3;POU3F1;DHTKD1;INSR;KMT5C;CYBRD1;GAA;DHX32;CES2;SV2A;PKD2;ESPN;ZFPM1;RTN2;ARSI;DNM1;LDLRAP1;CTSB;ETV5;NT5E;SYT8;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;NSG1;PARVB;RASIP1;BPHL;BOC;SOX12;DDB2;COL7A1;TMEM231;OBSCN;PRSS3;H6PD;CLIP2;SGSH;TRERF1;CRTAP;GAS8;YEATS4;WIPF1;MNT;SDR9C7;RAB40B;FAM20C;ANO8;EPHA4;MZT2A;TRAPPC2L;RPL13A;B3GNT9;ZNF687;OLFM2;SMARCA1;KIF26B;MPLKIP;CTSV;LRIG3;RPS6KA5;HOMER2;HEXB;LTBP1;ACSL1;EPS8L2;ZBTB42;HGSNAT;KIF26A;S100A6;ATP6V0A2;VAMP3;FRY;SREBF1;CSPG4;DMTN;PIK3R1;PTHLH;SDC3;APPL2;CTSL;IQSEC1;TRIM22;NCK2;UNC119B;XPC;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CXCR1;SLC2A1;CPT1C;METTL7A;HYAL1;RTF1;STOM;CKMT1A;VAMP2;PLEKHH2;MBOAT7;ZNF554;SPRY2;MBD1;LRRC8E;TP53INP1;CABYR;SLC2A9;TRPV4;PQLC2;SPATA18;GPC4;SYNM;NDRG1;RETSAT;NDUFA4L2;SDHA;ALDH2;SERPING1;NAGLU;MAFIP;MYL9;AMACR;MARK4;PDLIM4;CCDC69;GOLGA7B;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;H2AFJ;LAMB2;PCDH1;STAT1;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;H1FX;CRY2;MARCH9;COX5B;ZMYM3;FURIN;CLCN7;IFI16;CCDC88B;PCSK1;MLYCD;SUN1;NINL;PEX11B;CTSF;ANGEL1;SLC1A4;RPRD2;XYLT2;NUAK1;SMURF1;CXXC5;TCIRG1;RNF208;AIF1L;RAB43;VPS33B;ST6GALNAC6;REEP6;SCMH1;SP100;DIRC2;MPG;ABCC1;DDX59;IDUA;PIGZ;SORT1;CBR3;VANGL2
2462,GO:0005694,0.999985540586588,3.84924987066361e-05,15,882,chromosome,CC,ASH2L;H1F0;BCL6;KMT5C;HR;SALL2;YEATS4;SMARCA1;APPL2;MBD1;H2AFJ;STAT1;H1FX;SCMH1;SP100
3784,GO:0008380,0.999985697998472,8.49540672725425e-05,3,391,RNA splicing,BP,SRSF5;DHX32;PIK3R1
5317,GO:0016072,0.999987393359102,0.000159410165554471,1,284,rRNA metabolic process,BP,RPL13A
4488,GO:0010556,0.999987479189261,2.04222301433666e-05,94,3254,regulation of macromolecule biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;RPL13A;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;PIK3R1;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;FURIN;IFI16;DBP;PER3;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100
10361,GO:0043226,0.999991146800408,1.43720640228031e-05,358,9764,organelle,CC,TNFAIP3;POSTN;ITGB6;PEG3;TGFBI;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;LGALS7B;PTPRS;NOL4L;PHF7;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;KDSR;ASH2L;TNS1;HTRA1;PRICKLE2;CADM4;GAMT;GPRC5C;TXNRD3;GPX7;SRSF5;ST3GAL5;GPX3;TST;DCAF16;MXRA5;FLNC;RALGDS;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;SNN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;EPB41L3;CDK18;RAPGEF5;IRF2BPL;CALML3;BCL6;PGM1;TENM2;XYLT1;CYP4F22;ZNF318;CERS4;BRSK1;SFRP1;FHOD3;POU3F1;GAREM2;TNFSF10;DHTKD1;INSR;VAV3;KMT5C;NPEPL1;CYBRD1;GAA;DHX32;CES2;SV2A;PKD2;ESPN;ZFPM1;RGMA;RTN2;ARSI;DNM1;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;TNXB;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;ZSCAN18;NSG1;PARVB;RASIP1;BPHL;BOC;SOX12;UROS;DDB2;DAB2IP;COL7A1;TMEM231;OBSCN;TBX1;PRSS3;H6PD;CLIP2;TSC22D1;SGSH;KLK5;TRERF1;CRTAP;GAS8;YEATS4;WIPF1;FKBP9;MNT;SDR9C7;RAB40B;TET1;MARVELD1;NRSN2;CYP27C1;FAM20C;GLUL;FAM213A;ANO8;EPHA4;ZNF266;WNT9A;MZT2A;TRAPPC2L;RPL13A;B3GNT9;CORO6;MAGEF1;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;HERC3;TCFL5;MPLKIP;TYSND1;CTSV;LRIG3;RPS6KA5;TUB;HOMER2;SEC14L2;TXNDC17;HEXB;LTBP1;ZNF362;PGLS;ACSL1;EPS8L2;ZBTB42;DDX60;ACTA2;HGSNAT;KIF26A;S100A6;SPOCK1;CDK14;ATP6V0A2;VAMP3;PPL;FRY;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;ACVR1B;CAMKK1;SYTL1;SNX29;UNC119B;XPC;NAB2;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CXCR1;SLC2A1;CPT1C;METTL7A;HYAL1;BCAM;RTF1;STOM;CKMT1A;VAMP2;PLEKHH2;MBOAT7;AVL9;ZNF554;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;CABYR;SLC2A9;TMX4;TRPV4;ZDHHC1;PQLC2;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;RETSAT;NDUFA4L2;SDHA;KLK8;PTMS;LTBP4;ALDH2;SERPING1;NAGLU;MAFIP;MYL9;RTN4RL1;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;TBC1D17;GOLGA7B;IAH1;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;TOM1L2;ANKRD13D;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;EPM2A;H2AFJ;LAMB2;PCDH1;STAT1;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;PLCD1;H1FX;SLC5A1;CRY2;MARCH9;COX5B;SLC39A6;MARCKSL1;ZMYM3;FURIN;CLCN7;IFI16;CCDC88B;PCSK1;MLYCD;SUN1;OXLD1;NINL;PEX11B;FRAT1;CTSF;ANGEL1;SLC1A4;SLC13A3;RPRD2;DBP;BEX2;ASIC1;PER3;XYLT2;NUAK1;SMURF1;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;AIF1L;MT2A;RAB43;VPS33B;SLC47A1;ST6GALNAC6;MDFI;REEP6;SCMH1;SP100;DIRC2;MPG;ABCC1;DDX59;MTMR11;IDUA;PIGZ;SORT1;CBR3;VANGL2;APBA1
7297,GO:0031326,0.999993691106794,1.04153104680936e-05,96,3347,regulation of cellular biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;PDPR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;RPL13A;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;ADORA2B;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;DBP;PER3;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100
10363,GO:0043228,0.999993749629317,1.03927821093102e-05,92,3265,non-membrane-bounded organelle,CC,ITGB6;OBSL1;CPT2;NDN;ADGRB2;MAP3K14;ASH2L;TNS1;SRSF5;FLNC;SHROOM2;CYBA;H1F0;GLI2;EPB41L3;BCL6;PGM1;BRSK1;FHOD3;KMT5C;PKD2;ESPN;DNM1;LDLRAP1;RIMS3;CTSB;HR;SALL2;PARVB;OBSCN;CLIP2;TRERF1;GAS8;YEATS4;WIPF1;SDR9C7;MARVELD1;MZT2A;RPL13A;B3GNT9;CORO6;SMARCA1;KIF26B;MPLKIP;CTSV;DDX60;ACTA2;KIF26A;PPL;FRY;DMTN;APPL2;IQSEC1;XPC;SLC2A1;METTL7A;RTF1;STOM;PLEKHH2;ZNF554;SPRY2;MBD1;CABYR;TRPV4;SYNM;NDRG1;SDHA;MAFIP;MYL9;MARK4;PDLIM4;BTBD2;CCDC69;MZT2B;H2AFJ;PCDH1;STAT1;TULP3;HINT2;H1FX;IFI16;CCDC88B;NINL;SLC1A4;NUAK1;MEX3A;AIF1L;SCMH1;SP100;MPG;DDX59;VANGL2
10367,GO:0043232,0.999993749629317,1.03927821093102e-05,92,3265,intracellular non-membrane-bounded organelle,CC,ITGB6;OBSL1;CPT2;NDN;ADGRB2;MAP3K14;ASH2L;TNS1;SRSF5;FLNC;SHROOM2;CYBA;H1F0;GLI2;EPB41L3;BCL6;PGM1;BRSK1;FHOD3;KMT5C;PKD2;ESPN;DNM1;LDLRAP1;RIMS3;CTSB;HR;SALL2;PARVB;OBSCN;CLIP2;TRERF1;GAS8;YEATS4;WIPF1;SDR9C7;MARVELD1;MZT2A;RPL13A;B3GNT9;CORO6;SMARCA1;KIF26B;MPLKIP;CTSV;DDX60;ACTA2;KIF26A;PPL;FRY;DMTN;APPL2;IQSEC1;XPC;SLC2A1;METTL7A;RTF1;STOM;PLEKHH2;ZNF554;SPRY2;MBD1;CABYR;TRPV4;SYNM;NDRG1;SDHA;MAFIP;MYL9;MARK4;PDLIM4;BTBD2;CCDC69;MZT2B;H2AFJ;PCDH1;STAT1;TULP3;HINT2;H1FX;IFI16;CCDC88B;NINL;SLC1A4;NUAK1;MEX3A;AIF1L;SCMH1;SP100;MPG;DDX59;VANGL2
9884,GO:0042254,0.999996509140508,4.88308746296369e-05,1,316,ribosome biogenesis,BP,RPL13A
3326,GO:0007059,0.99999667516534,4.67272509932664e-05,1,300,chromosome segregation,BP,SUN1
2887,GO:0006412,0.999997995020715,8.22601335452552e-06,7,653,translation,BP,EGFR;UNK;RPL13A;NCK2;IMPACT;ERBB2;MEX3A
10867,GO:0044446,0.99999816104212,2.86429784733078e-06,236,7059,intracellular organelle part,CC,POSTN;ITGB6;TGFBI;APOE;MVB12B;LAMP3;ULK2;PTPRS;NOL4L;PHF7;OBSL1;LMF1;CPT2;NDN;ADGRB2;MAP3K14;KDSR;ASH2L;PRICKLE2;GPRC5C;GPX7;SRSF5;ST3GAL5;TST;DCAF16;SHROOM2;COL6A1;EGFR;CRAT;THRA;CITED4;CYBA;SNN;OAS2;H1F0;TCEA2;GLI2;RAPGEF5;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;CYP4F22;ZNF318;CERS4;BRSK1;FHOD3;POU3F1;DHTKD1;INSR;KMT5C;CYBRD1;GAA;DHX32;CES2;SV2A;PKD2;ESPN;ZFPM1;RTN2;ARSI;DNM1;LDLRAP1;CTSB;ETV5;NT5E;SYT8;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;NSG1;RASIP1;BPHL;BOC;SOX12;DDB2;COL7A1;OBSCN;PRSS3;H6PD;CLIP2;SGSH;TRERF1;CRTAP;GAS8;YEATS4;WIPF1;MNT;SDR9C7;RAB40B;FAM20C;ANO8;EPHA4;MZT2A;TRAPPC2L;RPL13A;B3GNT9;ZNF687;OLFM2;SMARCA1;KIF26B;MPLKIP;CTSV;LRIG3;RPS6KA5;HEXB;LTBP1;ACSL1;ZBTB42;HGSNAT;KIF26A;S100A6;ATP6V0A2;VAMP3;FRY;SREBF1;CSPG4;DMTN;PIK3R1;PTHLH;SDC3;APPL2;CTSL;IQSEC1;TRIM22;XPC;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CXCR1;SLC2A1;CPT1C;METTL7A;HYAL1;RTF1;STOM;CKMT1A;VAMP2;PLEKHH2;MBOAT7;ZNF554;SPRY2;MBD1;LRRC8E;TP53INP1;SLC2A9;TRPV4;PQLC2;SPATA18;GPC4;SYNM;NDRG1;RETSAT;NDUFA4L2;SDHA;ALDH2;SERPING1;NAGLU;MAFIP;MYL9;AMACR;MARK4;PDLIM4;CCDC69;GOLGA7B;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;H2AFJ;LAMB2;PCDH1;STAT1;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;H1FX;CRY2;MARCH9;COX5B;ZMYM3;FURIN;CLCN7;IFI16;CCDC88B;PCSK1;MLYCD;SUN1;NINL;PEX11B;CTSF;ANGEL1;SLC1A4;RPRD2;XYLT2;NUAK1;SMURF1;CXXC5;TCIRG1;RNF208;AIF1L;RAB43;VPS33B;ST6GALNAC6;REEP6;SCMH1;SP100;DIRC2;MPG;ABCC1;DDX59;IDUA;PIGZ;SORT1;CBR3;VANGL2
10763,GO:0044271,0.999999135176134,1.45041066435205e-06,113,3949,cellular nitrogen compound biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;ST3GAL5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;CERS4;SFRP1;UNK;POU3F1;MN1;DHTKD1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;UROS;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;RPL13A;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;ATP6V0A2;PLXND1;SREBF1;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;ADORA2B;NMRK1;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;NME4;CRY2;COX5B;ZMYM3;FURIN;IFI16;PCSK1;RPRD2;DBP;PER3;ALOXE3;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;ST6GALNAC6;MDFI;SCMH1;SP100
17654,GO:1901576,0.999999332669774,1.08588647473809e-06,148,4892,organic substance biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ALDH1A3;LMF1;ZNF704;NDN;KDSR;ASH2L;HTRA1;GAMT;SRSF5;ST3GAL5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;ZNF318;CERS4;SFRP1;UNK;POU3F1;MN1;DHTKD1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;FOXO1;LY6E;ZSCAN18;SOX12;UROS;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;GLUL;ZNF266;RPL13A;B3GNT9;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ACSL1;ZBTB42;ATP6V0A2;PLXND1;SREBF1;CSPG4;PIK3R1;PTHLH;SDC3;TRIM22;NCK2;ACVR1B;IMPA2;NAB2;NFATC4;SLC2A1;HYAL1;RTF1;ZP3;RBCK1;MBOAT7;ZNF554;MBD1;TP53INP1;MDK;TRPV4;ZDHHC1;GPC4;MSRB2;PTMS;ADORA2B;NMRK1;MAFIP;RTN4RL1;AMACR;MC1R;IMPACT;MVD;GOLGA7B;NEO1;CRTC1;ERBB2;RNF187;HSD11B1;H2AFJ;STAT1;TULP3;NME4;HINT2;WIPI2;CRY2;COX5B;ZMYM3;FURIN;IFI16;PCSK1;PLPP2;MLYCD;THNSL2;RPRD2;DBP;PER3;XYLT2;ALOXE3;SMURF1;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;ST6GALNAC6;MDFI;SCMH1;SP100;ISYNA1;PIGZ;VANGL2
4009,GO:0009058,0.999999479747444,8.49817757509458e-07,149,4932,biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ALDH1A3;LMF1;ZNF704;NDN;KDSR;ASH2L;HTRA1;GAMT;SRSF5;ST3GAL5;EGFR;THRA;CITED4;CYBA;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;ZNF318;CERS4;SFRP1;UNK;POU3F1;MN1;DHTKD1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;FOXO1;LY6E;ZSCAN18;SOX12;UROS;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;GLUL;ZNF266;RPL13A;B3GNT9;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ACSL1;ZBTB42;ATP6V0A2;PLXND1;SREBF1;CSPG4;PIK3R1;PTHLH;SDC3;TRIM22;NCK2;ACVR1B;IMPA2;NAB2;NFATC4;SLC2A1;HYAL1;RTF1;ZP3;RBCK1;MBOAT7;ZNF554;MBD1;TP53INP1;MDK;TRPV4;ZDHHC1;GPC4;MSRB2;PTMS;ADORA2B;NMRK1;MAFIP;RTN4RL1;AMACR;MC1R;IMPACT;MVD;GOLGA7B;NEO1;CRTC1;ERBB2;RNF187;HSD11B1;H2AFJ;STAT1;TULP3;NME4;HINT2;WIPI2;CRY2;COX5B;ZMYM3;FURIN;IFI16;PCSK1;PLPP2;MLYCD;THNSL2;RPRD2;DBP;PER3;XYLT2;ALOXE3;SMURF1;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;ST6GALNAC6;MDFI;SCMH1;SP100;ISYNA1;PIGZ;VANGL2
10854,GO:0044428,0.999999579506528,7.22365677126965e-07,106,3794,nuclear part,CC,ITGB6;NOL4L;PHF7;CPT2;NDN;MAP3K14;ASH2L;PRICKLE2;SRSF5;DCAF16;EGFR;THRA;CITED4;OAS2;H1F0;TCEA2;GLI2;RAPGEF5;IRF2BPL;BCL6;TENM2;ZNF318;CERS4;BRSK1;POU3F1;INSR;KMT5C;DHX32;ZFPM1;DNM1;CTSB;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;TRIM65;BOC;SOX12;DDB2;OBSCN;TRERF1;YEATS4;MNT;SDR9C7;RAB40B;MZT2A;RPL13A;B3GNT9;ZNF687;OLFM2;SMARCA1;MPLKIP;CTSV;RPS6KA5;ZBTB42;S100A6;SREBF1;PTHLH;APPL2;IQSEC1;TRIM22;XPC;NFATC4;TYRO3;RTF1;PLEKHH2;ZNF554;MBD1;TP53INP1;SLC2A9;RETSAT;SDHA;MAFIP;MZT2B;FNBP4;NEO1;CRTC1;RNF187;H2AFJ;PCDH1;STAT1;TULP3;CDK20;HINT2;RNF44;WIPI2;H1FX;CRY2;ZMYM3;CLCN7;IFI16;SUN1;RPRD2;NUAK1;SMURF1;CXXC5;RNF208;SCMH1;SP100;MPG;DDX59;SORT1;CBR3
8205,GO:0032991,0.999999619477736,6.53942802232615e-07,107,3844,protein-containing complex,CC,ITGB6;APOE;MVB12B;OBSL1;EPHB2;ASH2L;GPRC5C;GIGYF1;DCAF16;COL6A1;EGFR;FBXO2;THRA;CYBA;H1F0;TCEA2;FGFR4;VIPR1;UNK;POU3F1;DHTKD1;INSR;DHX32;PKD2;ESPN;ZFPM1;DNM1;PPP2R2C;LDLRAP1;TNXB;SALL2;WWTR1;WNT3;SOX12;DDB2;DAB2IP;COL7A1;TMEM231;CLIP2;TRERF1;SCN4B;CRTAP;YEATS4;KCNC4;EPHA4;MZT2A;TRAPPC2L;RPL13A;OLFM2;SMARCA1;KIF26B;KLHDC8B;LTBP1;EPS8L2;ERBB3;KIF26A;CDK14;ATP6V0A2;VAMP3;CUL9;PLXND1;GJB5;PIK3R1;APPL2;ACVR1B;XPC;NFATC4;ATP12A;TYRO3;CPT1C;RTF1;VAMP2;RBCK1;LRRC8E;ITGB5;NDUFA4L2;SDHA;KLK8;FBXW4;MYL9;PDLIM4;BTBD2;IMPACT;GOLGA7B;MZT2B;NEO1;ERBB2;H2AFJ;LAMB2;STAT1;TULP3;WIPI2;H1FX;COX5B;BLOC1S4;FBXW5;SUN1;PEX11B;GJC2;RPRD2;PLXNB1;MEX3A;TCIRG1;VPS33B;ZSWIM8;SP100;FBXO44
10753,GO:0044249,0.999999683073235,5.24349229421904e-07,144,4826,cellular biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;ALDH1A3;LMF1;ZNF704;NDN;KDSR;ASH2L;HTRA1;GAMT;SRSF5;ST3GAL5;EGFR;THRA;CITED4;CYBA;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;ZNF318;CERS4;SFRP1;UNK;POU3F1;MN1;DHTKD1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;FOXO1;LY6E;ZSCAN18;SOX12;UROS;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;GLUL;ZNF266;RPL13A;B3GNT9;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ACSL1;ZBTB42;ATP6V0A2;PLXND1;SREBF1;CSPG4;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;IMPA2;NAB2;NFATC4;SLC2A1;HYAL1;RTF1;ZP3;RBCK1;MBOAT7;ZNF554;MBD1;TP53INP1;MDK;TRPV4;ZDHHC1;MSRB2;PTMS;ADORA2B;NMRK1;MAFIP;RTN4RL1;AMACR;MC1R;IMPACT;MVD;GOLGA7B;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;NME4;WIPI2;CRY2;COX5B;ZMYM3;FURIN;IFI16;PCSK1;PLPP2;MLYCD;THNSL2;RPRD2;DBP;PER3;XYLT2;ALOXE3;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;ST6GALNAC6;MDFI;SCMH1;SP100;ISYNA1;PIGZ;VANGL2
6576,GO:0022613,0.999999734913901,2.62868284830113e-06,2,446,ribonucleoprotein complex biogenesis,BP,SRSF5;RPL13A
4010,GO:0009059,0.999999740344294,4.43272898164354e-07,117,4109,macromolecule biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;LMF1;ZNF704;NDN;ASH2L;HTRA1;SRSF5;ST3GAL5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;ZNF318;SFRP1;UNK;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;VEGFB;WWTR1;FOXO1;LY6E;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;RPL13A;B3GNT9;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;CSPG4;PIK3R1;SDC3;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;HYAL1;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;ZDHHC1;GPC4;MSRB2;PTMS;MAFIP;RTN4RL1;MC1R;IMPACT;MVD;GOLGA7B;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;WIPI2;CRY2;ZMYM3;FURIN;IFI16;RPRD2;DBP;PER3;XYLT2;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;ST6GALNAC6;MDFI;SCMH1;SP100;PIGZ;VANGL2
7579,GO:0031981,0.999999750477457,4.41249095431166e-07,95,3515,nuclear lumen,CC,ITGB6;NOL4L;PHF7;CPT2;NDN;MAP3K14;ASH2L;SRSF5;DCAF16;THRA;CITED4;OAS2;H1F0;TCEA2;GLI2;RAPGEF5;IRF2BPL;BCL6;TENM2;ZNF318;BRSK1;POU3F1;INSR;KMT5C;ZFPM1;DNM1;CTSB;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;TRIM65;BOC;SOX12;DDB2;OBSCN;TRERF1;YEATS4;MNT;SDR9C7;MZT2A;RPL13A;B3GNT9;ZNF687;OLFM2;SMARCA1;MPLKIP;CTSV;RPS6KA5;ZBTB42;SREBF1;PTHLH;APPL2;IQSEC1;TRIM22;XPC;NFATC4;RTF1;PLEKHH2;ZNF554;MBD1;TP53INP1;SDHA;MAFIP;MZT2B;FNBP4;NEO1;CRTC1;RNF187;H2AFJ;PCDH1;STAT1;TULP3;CDK20;HINT2;RNF44;WIPI2;H1FX;CRY2;ZMYM3;CLCN7;IFI16;RPRD2;NUAK1;SMURF1;CXXC5;RNF208;SCMH1;SP100;MPG;DDX59;CBR3
2874,GO:0006397,0.999999784128965,2.16644803221462e-06,2,439,mRNA processing,BP,SRSF5;DHX32
2431,GO:0005654,0.999999818658023,3.35423642011634e-07,78,3041,nucleoplasm,CC,ITGB6;NOL4L;PHF7;CPT2;NDN;ASH2L;SRSF5;DCAF16;THRA;CITED4;OAS2;H1F0;TCEA2;GLI2;RAPGEF5;IRF2BPL;BCL6;TENM2;ZNF318;BRSK1;POU3F1;KMT5C;ZFPM1;DNM1;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;TRIM65;BOC;SOX12;DDB2;OBSCN;TRERF1;YEATS4;MNT;MZT2A;ZNF687;OLFM2;SMARCA1;MPLKIP;RPS6KA5;ZBTB42;SREBF1;PTHLH;APPL2;TRIM22;XPC;NFATC4;RTF1;PLEKHH2;MBD1;TP53INP1;MZT2B;FNBP4;NEO1;CRTC1;RNF187;STAT1;CDK20;RNF44;WIPI2;CRY2;ZMYM3;CLCN7;IFI16;RPRD2;NUAK1;SMURF1;CXXC5;RNF208;SCMH1;SP100;MPG;CBR3
8824,GO:0034645,0.999999880291296,2.08419286435675e-07,113,4039,cellular macromolecule biosynthetic process,BP,TNFAIP3;PEG3;HES2;APOE;LMF1;ZNF704;NDN;ASH2L;HTRA1;SRSF5;ST3GAL5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;ZNF318;SFRP1;UNK;POU3F1;MN1;INSR;KMT5C;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;VEGFB;WWTR1;FOXO1;LY6E;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;RPL13A;B3GNT9;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;CSPG4;PIK3R1;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;ZNF554;MBD1;TP53INP1;MDK;TRPV4;ZDHHC1;MSRB2;PTMS;MAFIP;RTN4RL1;MC1R;IMPACT;MVD;GOLGA7B;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;WIPI2;CRY2;ZMYM3;IFI16;RPRD2;DBP;PER3;XYLT2;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;ST6GALNAC6;MDFI;SCMH1;SP100;PIGZ;VANGL2
8759,GO:0034470,0.999999883032709,2.05418880657218e-06,1,396,ncRNA processing,BP,RPL13A
19617,GO:1990904,0.999999924957065,3.88159065398191e-07,6,701,ribonucleoprotein complex,CC,UNK;DHX32;RPL13A;BTBD2;IMPACT;MEX3A
16435,GO:0097159,0.999999976720375,4.08047447420527e-08,132,4616,organic cyclic compound binding,MF,TNFAIP3;PEG3;HES2;APOE;ALDH1A3;ULK2;ZNF704;NDN;S100A4;MAP3K14;EPHB2;ASH2L;TNS1;TXNRD3;SRSF5;TST;EGFR;THRA;CYBA;NYNRIN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;CDK18;BCL6;CYP4F22;NSUN7;ZNF318;CERS4;BRSK1;UNK;POU3F1;DHTKD1;INSR;DHX32;ZFPM1;DNM1;ETV5;NT5E;HR;SALL2;FOXO1;ZSCAN18;SOX12;DDB2;OBSCN;TBX1;H6PD;TRERF1;YEATS4;FKBP9;MNT;RAB40B;TET1;CYP27C1;FAM20C;GLUL;EPHA4;ZNF266;RPL13A;ZNF687;SMARCA1;KIF26B;TCFL5;RPS6KA5;SEC14L2;ZNF362;ACSL1;ZBTB42;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;SREBF1;ENDOG;GRK6;ACVR1B;CAMKK1;XPC;NFATC4;ATP12A;TYRO3;RHOD;RTF1;CKMT1A;PCBP4;ZNF554;SCG5;MBD1;TRPV4;ZDHHC1;MTHFR;SDHA;ALDH2;NMRK1;MARK4;MVD;ERBB2;HSD11B1;H2AFJ;STAT1;NME4;CDK20;HINT2;H1FX;CRY2;ZMYM3;CLCN7;IFI16;THNSL2;DBP;PER3;NUAK1;MEX3A;CXXC5;CAMK1;ZNF446;NADK;RAB43;ZCCHC24;MAP3K3;SP100;MPG;ABCC1;DDX59;NRK;CBR3
4454,GO:0010467,0.999999977286691,4.04878321445976e-08,118,4261,gene expression,BP,TNFAIP3;PEG3;HES2;APOE;LAMP3;LMF1;ZNF704;NDN;EPHB2;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;UNK;POU3F1;MN1;INSR;KMT5C;DHX32;PKD2;ZFPM1;RGMA;ETV5;SERPINE2;HR;SALL2;TP53INP2;WWTR1;RHBDF1;FOXO1;WNT3;ZSCAN18;SOX12;DAB2IP;TBX1;PRSS3;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;RPL13A;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;TYSND1;CTSV;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;ACTA2;ERBB3;PLXND1;SREBF1;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;PCBP4;ZNF554;SPRY2;SCG5;MBD1;TP53INP1;MDK;TRPV4;MSRB2;SERPING1;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;FURIN;IFI16;PCSK1;GJC2;RPRD2;DBP;PER3;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100;SORT1;APBA1
17599,GO:1901363,0.999999983336897,2.94303764686503e-08,130,4578,heterocyclic compound binding,MF,TNFAIP3;PEG3;HES2;ALDH1A3;ULK2;ZNF704;NDN;S100A4;MAP3K14;EPHB2;ASH2L;TNS1;TXNRD3;SRSF5;TST;EGFR;THRA;CYBA;NYNRIN;OAS2;H1F0;TCEA2;GLI2;HEBP1;FGFR4;CDK18;BCL6;CYP4F22;NSUN7;ZNF318;CERS4;BRSK1;UNK;POU3F1;DHTKD1;INSR;DHX32;ZFPM1;DNM1;ETV5;NT5E;HR;SALL2;FOXO1;ZSCAN18;SOX12;DDB2;OBSCN;TBX1;H6PD;TRERF1;YEATS4;FKBP9;MNT;RAB40B;TET1;CYP27C1;FAM20C;GLUL;EPHA4;ZNF266;RPL13A;ZNF687;SMARCA1;KIF26B;TCFL5;RPS6KA5;SEC14L2;ZNF362;ACSL1;ZBTB42;DDX60;ACTA2;ERBB3;KIF26A;CDK14;CUL9;SREBF1;ENDOG;GRK6;ACVR1B;CAMKK1;XPC;NFATC4;ATP12A;TYRO3;RHOD;RTF1;CKMT1A;PCBP4;ZNF554;SCG5;MBD1;TRPV4;ZDHHC1;MTHFR;SDHA;ALDH2;NMRK1;MARK4;MVD;ERBB2;H2AFJ;STAT1;NME4;CDK20;HINT2;H1FX;CRY2;ZMYM3;CLCN7;IFI16;THNSL2;DBP;PER3;NUAK1;MEX3A;CXXC5;CAMK1;ZNF446;NADK;RAB43;ZCCHC24;MAP3K3;SP100;MPG;ABCC1;DDX59;NRK;CBR3
10364,GO:0043229,0.99999998645128,2.4191761923954e-08,324,9288,intracellular organelle,CC,TNFAIP3;POSTN;ITGB6;PEG3;TGFBI;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;ULK2;LGALS7B;PTPRS;NOL4L;PHF7;OBSL1;LMF1;CPT2;ZNF704;GPNMB;NDN;S100A4;ADGRB2;MAP3K14;EPHB2;KDSR;ASH2L;TNS1;PRICKLE2;GAMT;GPRC5C;TXNRD3;GPX7;SRSF5;ST3GAL5;TST;DCAF16;FLNC;RALGDS;SHROOM2;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;SNN;OAS2;H1F0;TCEA2;GLI2;FGFR4;EPB41L3;CDK18;RAPGEF5;IRF2BPL;BCL6;PGM1;TENM2;XYLT1;CYP4F22;ZNF318;CERS4;BRSK1;FHOD3;POU3F1;DHTKD1;INSR;KMT5C;NPEPL1;CYBRD1;GAA;DHX32;CES2;SV2A;PKD2;ESPN;ZFPM1;RGMA;RTN2;ARSI;DNM1;CXCL14;LDLRAP1;RIMS3;CTSB;ETV5;NT5E;SYT8;SERPINE2;HR;PDPR;SALL2;TP53INP2;VEGFB;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;ZSCAN18;NSG1;PARVB;RASIP1;BPHL;BOC;SOX12;UROS;DDB2;DAB2IP;COL7A1;OBSCN;TBX1;PRSS3;H6PD;CLIP2;TSC22D1;SGSH;KLK5;TRERF1;CRTAP;GAS8;YEATS4;WIPF1;FKBP9;MNT;SDR9C7;RAB40B;TET1;MARVELD1;NRSN2;CYP27C1;FAM20C;GLUL;ANO8;EPHA4;ZNF266;MZT2A;TRAPPC2L;RPL13A;B3GNT9;CORO6;TENM4;ZNF687;OLFM2;F2R;SMARCA1;KIF26B;HERC3;TCFL5;MPLKIP;TYSND1;CTSV;LRIG3;RPS6KA5;TUB;SEC14L2;HEXB;LTBP1;ZNF362;ACSL1;ZBTB42;DDX60;ACTA2;HGSNAT;KIF26A;S100A6;CDK14;ATP6V0A2;VAMP3;PPL;FRY;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;CAMKK1;SYTL1;XPC;NAB2;NFATC4;SNX33;FAM210B;TYRO3;RHOD;CXCR1;SLC2A1;CPT1C;METTL7A;HYAL1;RTF1;STOM;CKMT1A;VAMP2;PLEKHH2;MBOAT7;AVL9;ZNF554;SPRY2;SCG5;MBD1;LRRC8E;TP53INP1;CABYR;SLC2A9;TMX4;TRPV4;ZDHHC1;PQLC2;SPATA18;GPC4;MSRB2;SYNM;ITGB5;NDRG1;RETSAT;NDUFA4L2;SDHA;KLK8;PTMS;ALDH2;SERPING1;NAGLU;MAFIP;MYL9;AMACR;MARK4;PDLIM4;BTBD2;CCDC69;TBC1D17;GOLGA7B;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;ANKRD13D;MICALL1;ERBB2;C2CD4C;RNF187;HSD11B1;EPM2A;H2AFJ;LAMB2;PCDH1;STAT1;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;H1FX;CRY2;MARCH9;COX5B;SLC39A6;ZMYM3;FURIN;CLCN7;IFI16;CCDC88B;PCSK1;MLYCD;SUN1;OXLD1;NINL;PEX11B;FRAT1;CTSF;ANGEL1;SLC1A4;RPRD2;DBP;BEX2;ASIC1;PER3;XYLT2;NUAK1;SMURF1;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;TCIRG1;NISCH;RNF208;AIF1L;MT2A;RAB43;VPS33B;ST6GALNAC6;MDFI;REEP6;SCMH1;SP100;DIRC2;MPG;ABCC1;DDX59;IDUA;PIGZ;SORT1;CBR3;VANGL2;APBA1
8835,GO:0034660,0.999999995506833,5.86448746053542e-08,2,546,ncRNA metabolic process,BP,RPL13A;RPRD2
5316,GO:0016071,0.999999997808945,1.46651627232497e-08,5,737,mRNA metabolic process,BP,SRSF5;DHX32;RPL13A;SREBF1;PCBP4
5315,GO:0016070,0.999999998344905,3.24213483795238e-09,96,3759,RNA metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;OAS2;TCEA2;GLI2;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;POU3F1;MN1;INSR;KMT5C;DHX32;PKD2;ZFPM1;RGMA;ETV5;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;RPL13A;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;PIK3R1;TRIM22;NCK2;ACVR1B;NAB2;NFATC4;RTF1;ZP3;RBCK1;PCBP4;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;MAFIP;MC1R;IMPACT;NEO1;CRTC1;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100;DDX59
17596,GO:1901360,0.999999999770737,5.0515805579904e-10,133,4863,organic cyclic compound metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;LMF1;ZNF704;NDN;ASH2L;HTRA1;GAMT;SRSF5;EGFR;THRA;CITED4;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;SFRP1;POU3F1;MN1;DHTKD1;INSR;KMT5C;DHX32;PKD2;ZFPM1;RGMA;LDLRAP1;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;UROS;DDB2;DAB2IP;TBX1;PRSS3;H6PD;TSC22D1;TRERF1;YEATS4;MNT;TET1;FAM20C;ZNF266;RPL13A;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;PGLS;ZBTB42;ATP6V0A2;PLXND1;SREBF1;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;XPC;NAB2;NFATC4;RTF1;ZP3;RBCK1;PCBP4;ZNF554;MBD1;TP53INP1;SLC2A9;MDK;TRPV4;MTHFR;MSRB2;SDHA;PTMS;ADORA2B;NMRK1;MAFIP;AMACR;MC1R;IMPACT;MVD;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;HSD11B1;H2AFJ;STAT1;TULP3;NME4;HINT2;CRY2;COX5B;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;MDFI;SCMH1;SP100;MPG;ABCC1;DDX59
11659,GO:0046483,0.99999999983889,3.58298265457322e-10,127,4715,heterocycle metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;GAMT;SRSF5;EGFR;THRA;CITED4;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;SFRP1;POU3F1;MN1;DHTKD1;INSR;KMT5C;DHX32;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;UROS;DDB2;DAB2IP;TBX1;PRSS3;H6PD;TSC22D1;TRERF1;YEATS4;MNT;TET1;FAM20C;ZNF266;RPL13A;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;PGLS;ZBTB42;ATP6V0A2;PLXND1;SREBF1;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;XPC;NAB2;NFATC4;RTF1;ZP3;RBCK1;PCBP4;ZNF554;MBD1;TP53INP1;SLC2A9;MDK;TRPV4;MTHFR;MSRB2;SDHA;PTMS;ADORA2B;NMRK1;MAFIP;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;H2AFJ;STAT1;TULP3;NME4;CRY2;COX5B;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;MDFI;SCMH1;SP100;MPG;ABCC1;DDX59
3119,GO:0006725,0.999999999921984,2.24656199740252e-10,127,4728,cellular aromatic compound metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;GAMT;SRSF5;EGFR;THRA;CITED4;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;SFRP1;POU3F1;MN1;DHTKD1;INSR;KMT5C;DHX32;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;UROS;DDB2;DAB2IP;TBX1;PRSS3;H6PD;TSC22D1;TRERF1;YEATS4;MNT;TET1;FAM20C;ZNF266;RPL13A;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;PGLS;ZBTB42;ATP6V0A2;PLXND1;SREBF1;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;XPC;NAB2;NFATC4;RTF1;ZP3;RBCK1;PCBP4;ZNF554;MBD1;TP53INP1;SLC2A9;MDK;TRPV4;MTHFR;MSRB2;SDHA;PTMS;ADORA2B;NMRK1;MAFIP;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;H2AFJ;STAT1;TULP3;NME4;CRY2;COX5B;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;MDFI;SCMH1;SP100;MPG;ABCC1;DDX59
16207,GO:0090304,0.999999999933778,1.94835340919106e-10,107,4174,nucleic acid metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;SRSF5;EGFR;THRA;CITED4;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;TENM2;ZNF318;SFRP1;POU3F1;MN1;INSR;KMT5C;DHX32;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DDB2;DAB2IP;TBX1;TSC22D1;TRERF1;YEATS4;MNT;TET1;ZNF266;RPL13A;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;ZBTB42;PLXND1;SREBF1;ENDOG;PIK3R1;TRIM22;NCK2;ACVR1B;XPC;NAB2;NFATC4;RTF1;ZP3;RBCK1;PCBP4;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;PTMS;MAFIP;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;H2AFJ;STAT1;TULP3;CRY2;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;MDFI;SCMH1;SP100;MPG;DDX59
10366,GO:0043231,0.999999999936312,1.79516283606436e-10,271,8297,intracellular membrane-bounded organelle,CC,TNFAIP3;POSTN;ITGB6;PEG3;TGFBI;HES2;APOE;ALDH1A3;IFI6;MVB12B;LAMP3;LGALS7B;NOL4L;PHF7;OBSL1;LMF1;CPT2;ZNF704;NDN;S100A4;MAP3K14;EPHB2;KDSR;ASH2L;PRICKLE2;GAMT;TXNRD3;GPX7;SRSF5;ST3GAL5;TST;DCAF16;RALGDS;COL6A1;EGFR;ADAM19;FBXO2;CRAT;THRA;CITED4;CYBA;SNN;OAS2;H1F0;TCEA2;GLI2;FGFR4;CDK18;RAPGEF5;IRF2BPL;BCL6;TENM2;XYLT1;CYP4F22;ZNF318;CERS4;BRSK1;POU3F1;DHTKD1;INSR;KMT5C;NPEPL1;CYBRD1;GAA;DHX32;CES2;SV2A;PKD2;ZFPM1;RGMA;RTN2;ARSI;DNM1;CXCL14;LDLRAP1;CTSB;ETV5;NT5E;HR;PDPR;SALL2;TP53INP2;WWTR1;RHBDF1;TMEM129;FOXO1;WNT3;TRIM65;ZSCAN18;NSG1;RASIP1;BPHL;BOC;SOX12;UROS;DDB2;COL7A1;OBSCN;TBX1;H6PD;TSC22D1;SGSH;TRERF1;CRTAP;GAS8;YEATS4;FKBP9;MNT;SDR9C7;RAB40B;TET1;MARVELD1;CYP27C1;FAM20C;GLUL;ANO8;EPHA4;ZNF266;MZT2A;TRAPPC2L;RPL13A;B3GNT9;TENM4;ZNF687;OLFM2;F2R;SMARCA1;TCFL5;MPLKIP;TYSND1;CTSV;RPS6KA5;TUB;SEC14L2;HEXB;LTBP1;ZNF362;ACSL1;ZBTB42;HGSNAT;S100A6;CDK14;ATP6V0A2;VAMP3;PPL;SREBF1;CSPG4;DMTN;ENDOG;PIK3R1;SUGCT;PTHLH;SDC3;APPL2;CTSL;IQSEC1;ACAP3;TRIM22;NCK2;CAMKK1;XPC;NAB2;NFATC4;FAM210B;TYRO3;RHOD;SLC2A1;CPT1C;METTL7A;HYAL1;RTF1;STOM;CKMT1A;VAMP2;PLEKHH2;MBOAT7;ZNF554;SPRY2;MBD1;LRRC8E;TP53INP1;CABYR;SLC2A9;TMX4;ZDHHC1;PQLC2;SPATA18;GPC4;MSRB2;NDRG1;RETSAT;NDUFA4L2;SDHA;PTMS;ALDH2;NAGLU;MAFIP;AMACR;PDLIM4;CCDC69;TBC1D17;GOLGA7B;MZT2B;FNBP4;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;HSD11B1;EPM2A;H2AFJ;LAMB2;PCDH1;STAT1;TULP3;NME4;CDK20;HINT2;RNF44;WIPI2;ACKR3;H1FX;CRY2;MARCH9;COX5B;SLC39A6;ZMYM3;FURIN;CLCN7;IFI16;CCDC88B;MLYCD;SUN1;OXLD1;PEX11B;FRAT1;CTSF;ANGEL1;RPRD2;DBP;BEX2;ASIC1;PER3;XYLT2;NUAK1;SMURF1;MEX3A;CCDC3;CXXC5;CAMK1;ZNF446;TCIRG1;RNF208;MT2A;RAB43;VPS33B;ST6GALNAC6;MDFI;REEP6;SCMH1;SP100;DIRC2;MPG;ABCC1;DDX59;IDUA;PIGZ;SORT1;CBR3;APBA1
1456,GO:0003723,0.999999999939529,2.62979675076063e-10,20,1483,RNA binding,MF,S100A4;TNS1;SRSF5;TST;THRA;OAS2;H1F0;NSUN7;UNK;DHX32;DNM1;RPL13A;DDX60;RTF1;PCBP4;H1FX;IFI16;MEX3A;ZCCHC24;DDX59
2421,GO:0005634,0.999999999944801,1.56019955406027e-10,164,5706,nucleus,CC,TNFAIP3;ITGB6;PEG3;HES2;APOE;ALDH1A3;MVB12B;LGALS7B;NOL4L;PHF7;CPT2;ZNF704;NDN;S100A4;MAP3K14;EPHB2;ASH2L;PRICKLE2;GAMT;TXNRD3;SRSF5;DCAF16;RALGDS;EGFR;THRA;CITED4;CYBA;OAS2;H1F0;TCEA2;GLI2;CDK18;RAPGEF5;IRF2BPL;BCL6;TENM2;ZNF318;CERS4;BRSK1;POU3F1;INSR;KMT5C;NPEPL1;DHX32;ZFPM1;DNM1;CTSB;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;TRIM65;ZSCAN18;NSG1;BOC;SOX12;DDB2;OBSCN;TBX1;TSC22D1;TRERF1;YEATS4;MNT;SDR9C7;RAB40B;TET1;MARVELD1;GLUL;ZNF266;MZT2A;RPL13A;B3GNT9;TENM4;ZNF687;OLFM2;SMARCA1;TCFL5;MPLKIP;CTSV;RPS6KA5;TUB;SEC14L2;ZNF362;ZBTB42;S100A6;CDK14;PPL;SREBF1;ENDOG;PIK3R1;PTHLH;APPL2;CTSL;IQSEC1;TRIM22;CAMKK1;XPC;NAB2;NFATC4;TYRO3;SLC2A1;RTF1;PLEKHH2;ZNF554;SPRY2;MBD1;TP53INP1;CABYR;SLC2A9;GPC4;NDRG1;RETSAT;SDHA;PTMS;MAFIP;PDLIM4;CCDC69;MZT2B;FNBP4;NEO1;CRTC1;ERBB2;RNF187;EPM2A;H2AFJ;PCDH1;STAT1;TULP3;CDK20;HINT2;RNF44;WIPI2;ACKR3;H1FX;CRY2;ZMYM3;CLCN7;IFI16;SUN1;ANGEL1;RPRD2;DBP;BEX2;PER3;NUAK1;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;RNF208;MT2A;MDFI;REEP6;SCMH1;SP100;MPG;DDX59;SORT1;CBR3;APBA1
1,GO:0000002,1,0.366138692539737,0,24,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.960426449315397,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.922076399120138,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.958787867083198,0,1,vacuole inheritance,BP,
6,GO:0000012,1,0.68622435900883,0,9,single strand break repair,BP,
7,GO:0000014,1,0.742418228079017,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8,GO:0000015,1,0.962409894753983,0,1,phosphopyruvate hydratase complex,CC,
10,GO:0000019,1,0.880410221419935,0,3,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.654263378856468,0,10,mitotic spindle elongation,BP,
14,GO:0000027,1,0.369238014281986,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.517205977870534,0,18,ribosomal small subunit assembly,BP,
17,GO:0000032,1,0.962561648789528,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.889225638427403,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.932291866263446,0,2,acyl binding,MF,
20,GO:0000036,1,0.932291866263446,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.373236737078923,0,24,very long-chain fatty acid metabolic process,BP,
24,GO:0000048,1,0.960463589704419,0,1,peptidyltransferase activity,MF,
25,GO:0000049,1,0.10790251911192,0,54,tRNA binding,MF,
26,GO:0000050,1,0.667806359183264,0,10,urea cycle,BP,
27,GO:0000052,1,0.74368843748186,0,7,citrulline metabolic process,BP,
28,GO:0000053,1,0.962384348259453,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.599916817044739,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.729900553292529,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.760712726685039,0,7,ribosomal small subunit export from nucleus,BP,
33,GO:0000062,1,0.505344562805454,0,17,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.84230643756098,0,4,L-ornithine transmembrane transporter activity,MF,
35,GO:0000070,1,0.00269636495085464,0,142,mitotic sister chromatid segregation,BP,
37,GO:0000076,1,0.539333860008171,0,15,DNA replication checkpoint,BP,
41,GO:0000083,1,0.367959906195968,0,24,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.960955849389069,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
45,GO:0000097,1,0.565164014058531,0,14,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.746672573067186,0,7,sulfur amino acid catabolic process,BP,
49,GO:0000103,1,0.885739979768197,0,3,sulfate assimilation,BP,
51,GO:0000105,1,0.919735962688424,0,2,histidine biosynthetic process,BP,
53,GO:0000110,1,0.882372744980128,0,3,nucleotide-excision repair factor 1 complex,CC,
55,GO:0000117,1,0.956442067451943,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
57,GO:0000120,1,0.81725340260802,0,5,RNA polymerase I transcription factor complex,CC,
58,GO:0000121,1,0.958207088018547,0,1,glycerol-1-phosphatase activity,MF,
61,GO:0000124,1,0.594245752161612,0,13,SAGA complex,CC,
62,GO:0000125,1,0.820014081014867,0,5,PCAF complex,CC,
63,GO:0000126,1,0.915656570322519,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.778081332727334,0,6,transcription factor TFIIIC complex,CC,
66,GO:0000137,1,0.627104596177742,0,11,Golgi cis cisterna,CC,
67,GO:0000138,1,0.78836513958913,0,6,Golgi trans cisterna,CC,
69,GO:0000145,1,0.506996111467954,0,16,exocyst,CC,
70,GO:0000146,1,0.536406093527739,0,14,microfilament motor activity,MF,
73,GO:0000150,1,0.723314945626597,0,8,recombinase activity,MF,
75,GO:0000152,1,0.195536466389703,0,40,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.634337263336226,0,11,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.259572121147989,0,34,rRNA modification,BP,
79,GO:0000160,1,0.957254343969317,0,1,phosphorelay signal transduction system,BP,
80,GO:0000164,1,0.631404850720691,0,11,protein phosphatase type 1 complex,CC,
83,GO:0000171,1,0.918341240974948,0,2,ribonuclease MRP activity,MF,
84,GO:0000172,1,0.787086620781577,0,6,ribonuclease MRP complex,CC,
85,GO:0000173,1,0.962963231340897,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
86,GO:0000175,1,0.289951000805009,0,30,3'-5'-exoribonuclease activity,MF,
87,GO:0000176,1,0.61167270601484,0,13,nuclear exosome (RNase complex),CC,
88,GO:0000177,1,0.548876309901915,0,15,cytoplasmic exosome (RNase complex),CC,
89,GO:0000178,1,0.414711268699491,0,22,exosome (RNase complex),CC,
90,GO:0000179,1,0.85298277672034,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
91,GO:0000182,1,0.652949326031258,0,10,rDNA binding,MF,
92,GO:0000183,1,0.237948373473705,0,39,chromatin silencing at rDNA,BP,
97,GO:0000188,1,0.390982314153806,0,23,inactivation of MAPK activity,BP,
99,GO:0000210,1,0.957555241268031,0,1,NAD+ diphosphatase activity,MF,
100,GO:0000212,1,0.65737778136625,0,10,meiotic spindle organization,BP,
101,GO:0000213,1,0.854672506155791,0,4,tRNA-intron endonuclease activity,MF,
102,GO:0000214,1,0.855307098786845,0,4,tRNA-intron endonuclease complex,CC,
103,GO:0000215,1,0.924983360490973,0,2,tRNA 2'-phosphotransferase activity,MF,
106,GO:0000221,1,0.881005828365144,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
107,GO:0000224,1,0.959866728138754,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
108,GO:0000225,1,0.964379624832299,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
111,GO:0000229,1,0.963136610540099,0,1,cytoplasmic chromosome,CC,
112,GO:0000235,1,0.708911108875253,0,8,astral microtubule,CC,
113,GO:0000242,1,0.443385455962124,0,19,pericentriolar material,CC,
114,GO:0000243,1,0.731775617627599,0,8,commitment complex,CC,
115,GO:0000244,1,0.62667052158501,0,11,spliceosomal tri-snRNP complex assembly,BP,
117,GO:0000246,1,0.956742549546252,0,1,delta24(24-1) sterol reductase activity,MF,
118,GO:0000247,1,0.964374490092341,0,1,C-8 sterol isomerase activity,MF,
119,GO:0000248,1,0.917239804830104,0,2,C-5 sterol desaturase activity,MF,
120,GO:0000250,1,0.956762118939854,0,1,lanosterol synthase activity,MF,
121,GO:0000252,1,0.963121164903035,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
123,GO:0000254,1,0.919270839167849,0,2,C-4 methylsterol oxidase activity,MF,
124,GO:0000255,1,0.915050065820572,0,2,allantoin metabolic process,BP,
125,GO:0000257,1,0.963814807334626,0,1,nitrilase activity,MF,
126,GO:0000262,1,0.963136610540099,0,1,mitochondrial chromosome,CC,
128,GO:0000268,1,0.846097878145866,0,4,peroxisome targeting sequence binding,MF,
129,GO:0000270,1,0.964322923966933,0,1,peptidoglycan metabolic process,BP,
135,GO:0000285,1,0.882339190289622,0,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
137,GO:0000288,1,0.0510443956094222,0,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
138,GO:0000289,1,0.226977995917208,0,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,
139,GO:0000290,1,0.689211921778959,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
140,GO:0000291,1,0.248985887015935,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
142,GO:0000294,1,0.917513772825851,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
143,GO:0000295,1,0.637586219113025,0,11,adenine nucleotide transmembrane transporter activity,MF,
144,GO:0000296,1,0.960732770483758,0,1,spermine transport,BP,
145,GO:0000298,1,0.851608970642098,0,4,endopolyphosphatase activity,MF,
146,GO:0000301,1,0.881387700816259,0,3,retrograde transport, vesicle recycling within Golgi,BP,
148,GO:0000303,1,0.469487184851678,0,19,response to superoxide,BP,
150,GO:0000306,1,0.842463638275204,0,4,extrinsic component of vacuolar membrane,CC,
153,GO:0000309,1,0.91547768952439,0,2,nicotinamide-nucleotide adenylyltransferase activity,MF,
154,GO:0000313,1,0.0439279193175917,0,84,organellar ribosome,CC,
155,GO:0000314,1,0.355388756495885,0,28,organellar small ribosomal subunit,CC,
156,GO:0000315,1,0.149993148757882,0,51,organellar large ribosomal subunit,CC,
157,GO:0000320,1,0.915348606469417,0,2,re-entry into mitotic cell cycle,BP,
158,GO:0000322,1,0.885966738395174,0,3,storage vacuole,CC,
160,GO:0000332,1,0.965995416961728,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
161,GO:0000333,1,0.923915512577768,0,2,telomerase catalytic core complex,CC,
162,GO:0000338,1,0.676658793241871,0,10,protein deneddylation,BP,
163,GO:0000339,1,0.495152529150574,0,17,RNA cap binding,MF,
164,GO:0000340,1,0.681991522114706,0,9,RNA 7-methylguanosine cap binding,MF,
165,GO:0000346,1,0.588853304642447,0,13,transcription export complex,CC,
166,GO:0000347,1,0.789615696125702,0,6,THO complex,CC,
167,GO:0000349,1,0.921559203152604,0,2,generation of catalytic spliceosome for first transesterification step,BP,
168,GO:0000350,1,0.890891808236841,0,3,generation of catalytic spliceosome for second transesterification step,BP,
169,GO:0000354,1,0.916185615533018,0,2,cis assembly of pre-catalytic spliceosome,BP,
172,GO:0000379,1,0.888499255511829,0,3,tRNA-type intron splice site recognition and cleavage,BP,
173,GO:0000380,1,0.15055344836017,0,45,alternative mRNA splicing, via spliceosome,BP,
174,GO:0000381,1,0.249503903754649,0,33,regulation of alternative mRNA splicing, via spliceosome,BP,
175,GO:0000384,1,0.927303872862873,0,2,first spliceosomal transesterification activity,MF,
176,GO:0000386,1,0.881635537154583,0,3,second spliceosomal transesterification activity,MF,
177,GO:0000387,1,0.236650879645799,0,36,spliceosomal snRNP assembly,BP,
178,GO:0000389,1,0.780204546737731,0,6,mRNA 3'-splice site recognition,BP,
179,GO:0000390,1,0.92450295540981,0,2,spliceosomal complex disassembly,BP,
180,GO:0000393,1,0.820993633387505,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
181,GO:0000394,1,0.511020682086419,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
182,GO:0000395,1,0.813979844200357,0,5,mRNA 5'-splice site recognition,BP,
184,GO:0000400,1,0.513457020039805,0,16,four-way junction DNA binding,MF,
185,GO:0000403,1,0.769234719762133,0,6,Y-form DNA binding,MF,
188,GO:0000406,1,0.916547969472476,0,2,double-strand/single-strand DNA junction binding,MF,
190,GO:0000408,1,0.823355392073408,0,5,EKC/KEOPS complex,CC,
191,GO:0000409,1,0.956441843839217,0,1,regulation of transcription by galactose,BP,
192,GO:0000411,1,0.956441843839217,0,1,positive regulation of transcription by galactose,BP,
193,GO:0000412,1,0.958798569417721,0,1,histone peptidyl-prolyl isomerization,BP,
195,GO:0000414,1,0.839291580945667,0,4,regulation of histone H3-K36 methylation,BP,
196,GO:0000415,1,0.956441843839217,0,1,negative regulation of histone H3-K36 methylation,BP,
197,GO:0000416,1,0.957234033670307,0,1,positive regulation of histone H3-K36 methylation,BP,
198,GO:0000417,1,0.956927530270733,0,1,HIR complex,CC,
199,GO:0000421,1,0.356821862230668,0,25,autophagosome membrane,CC,
203,GO:0000429,1,0.886597862252176,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
204,GO:0000430,1,0.926981611041012,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
205,GO:0000431,1,0.956441843839217,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
206,GO:0000432,1,0.926981611041012,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
207,GO:0000435,1,0.956441843839217,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
208,GO:0000436,1,0.886597862252176,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
209,GO:0000438,1,0.892150142415192,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
210,GO:0000439,1,0.694340481717959,0,9,core TFIIH complex,CC,
211,GO:0000444,1,0.850973375416548,0,4,MIS12/MIND type complex,CC,
212,GO:0000445,1,0.789615696125702,0,6,THO complex part of transcription export complex,CC,
213,GO:0000447,1,0.699173367212268,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
214,GO:0000448,1,0.918561648716637,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
215,GO:0000451,1,0.920464543528033,0,2,rRNA 2'-O-methylation,BP,
216,GO:0000453,1,0.920464543528033,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
217,GO:0000454,1,0.896579361688438,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
218,GO:0000455,1,0.92538985115148,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
219,GO:0000459,1,0.761756153176725,0,7,exonucleolytic trimming involved in rRNA processing,BP,
220,GO:0000460,1,0.267493694129045,0,33,maturation of 5.8S rRNA,BP,
221,GO:0000461,1,0.931767134824827,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
222,GO:0000462,1,0.229810688501161,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
223,GO:0000463,1,0.675697062680194,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000466,1,0.413295521549309,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000467,1,0.761756153176725,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000469,1,0.352960882841675,0,26,cleavage involved in rRNA processing,BP,
227,GO:0000470,1,0.38746990037411,0,24,maturation of LSU-rRNA,BP,
228,GO:0000472,1,0.881043851160284,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000478,1,0.539920225394673,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
230,GO:0000479,1,0.56233570746579,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000480,1,0.778446338039109,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000481,1,0.957375045454888,0,1,maturation of 5S rRNA,BP,
233,GO:0000491,1,0.698666544485605,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
234,GO:0000492,1,0.756986182437326,0,7,box C/D snoRNP assembly,BP,
235,GO:0000493,1,0.9230003973984,0,2,box H/ACA snoRNP assembly,BP,
236,GO:0000494,1,0.964341017540768,0,1,box C/D snoRNA 3'-end processing,BP,
237,GO:0000495,1,0.959731749686441,0,1,box H/ACA snoRNA 3'-end processing,BP,
238,GO:0000496,1,0.965995416961728,0,1,base pairing,MF,
239,GO:0000497,1,0.965995416961728,0,1,base pairing with DNA,MF,
240,GO:0000502,1,0.0870282808331537,0,63,proteasome complex,CC,
241,GO:0000506,1,0.70625851670825,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
242,GO:0000578,1,0.3912244451594,0,22,embryonic axis specification,BP,
243,GO:0000700,1,0.853108451654738,0,4,mismatch base pair DNA N-glycosylase activity,MF,
244,GO:0000701,1,0.927572387314226,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000702,1,0.830193678780252,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
246,GO:0000703,1,0.929110433014104,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
247,GO:0000706,1,0.917172198947032,0,2,meiotic DNA double-strand break processing,BP,
248,GO:0000707,1,0.722033600151412,0,8,meiotic DNA recombinase assembly,BP,
249,GO:0000710,1,0.839902308706756,0,4,meiotic mismatch repair,BP,
250,GO:0000712,1,0.684837806848453,0,9,resolution of meiotic recombination intermediates,BP,
253,GO:0000718,1,0.962717105863326,0,1,nucleotide-excision repair, DNA damage removal,BP,
254,GO:0000720,1,0.883742259559969,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
255,GO:0000722,1,0.558235089458812,0,14,telomere maintenance via recombination,BP,
259,GO:0000726,1,0.0472021560669484,0,75,non-recombinational repair,BP,
260,GO:0000727,1,0.816856422104126,0,5,double-strand break repair via break-induced replication,BP,
261,GO:0000729,1,0.393227763302331,0,22,DNA double-strand break processing,BP,
262,GO:0000730,1,0.664134504879595,0,10,DNA recombinase assembly,BP,
263,GO:0000731,1,0.0582349671718223,0,68,DNA synthesis involved in DNA repair,BP,
264,GO:0000732,1,0.343227276961153,0,25,strand displacement,BP,
267,GO:0000738,1,0.848483010276613,0,4,DNA catabolic process, exonucleolytic,BP,
268,GO:0000741,1,0.962651352838346,0,1,karyogamy,BP,
270,GO:0000773,1,0.964778188240337,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
271,GO:0000774,1,0.640182008308372,0,11,adenyl-nucleotide exchange factor activity,MF,
273,GO:0000776,1,0.0065596328075009,0,121,kinetochore,CC,
274,GO:0000777,1,0.0225323052108439,0,92,condensed chromosome kinetochore,CC,
275,GO:0000778,1,0.614721535064728,0,12,condensed nuclear chromosome kinetochore,CC,
279,GO:0000782,1,0.661568016194535,0,10,telomere cap complex,CC,
280,GO:0000783,1,0.661568016194535,0,10,nuclear telomere cap complex,CC,
284,GO:0000788,1,0.333050458789948,0,31,nuclear nucleosome,CC,
290,GO:0000795,1,0.491263406300602,0,17,synaptonemal complex,CC,
291,GO:0000796,1,0.73283574136022,0,7,condensin complex,CC,
292,GO:0000797,1,0.95651844827831,0,1,condensin core heterodimer,CC,
293,GO:0000798,1,0.879905212651394,0,3,nuclear cohesin complex,CC,
294,GO:0000799,1,0.875165282955152,0,3,nuclear condensin complex,CC,
295,GO:0000800,1,0.739566696393496,0,7,lateral element,CC,
296,GO:0000801,1,0.956833452289196,0,1,central element,CC,
297,GO:0000803,1,0.350560978760423,0,25,sex chromosome,CC,
298,GO:0000805,1,0.743479283596301,0,7,X chromosome,CC,
299,GO:0000806,1,0.919067103493111,0,2,Y chromosome,CC,
300,GO:0000808,1,0.685083313653993,0,9,origin recognition complex,CC,
301,GO:0000811,1,0.884074892432412,0,3,GINS complex,CC,
304,GO:0000814,1,0.889692911651033,0,3,ESCRT II complex,CC,
305,GO:0000815,1,0.618420457227316,0,12,ESCRT III complex,CC,
306,GO:0000818,1,0.922429982975105,0,2,nuclear MIS12/MIND complex,CC,
307,GO:0000819,1,0.00012078381428965,0,216,sister chromatid segregation,BP,
308,GO:0000820,1,0.914811764735861,0,2,regulation of glutamine family amino acid metabolic process,BP,
309,GO:0000821,1,0.956441843839217,0,1,regulation of arginine metabolic process,BP,
310,GO:0000822,1,0.877283323985697,0,3,inositol hexakisphosphate binding,MF,
311,GO:0000823,1,0.962494535129895,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
312,GO:0000824,1,0.962494535129895,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
313,GO:0000825,1,0.962494535129895,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
314,GO:0000827,1,0.843602754871012,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
315,GO:0000828,1,0.843602754871012,0,4,inositol hexakisphosphate kinase activity,MF,
316,GO:0000829,1,0.843602754871012,0,4,inositol heptakisphosphate kinase activity,MF,
317,GO:0000832,1,0.843602754871012,0,4,inositol hexakisphosphate 5-kinase activity,MF,
318,GO:0000835,1,0.774651818661921,0,6,ER ubiquitin ligase complex,CC,
319,GO:0000836,1,0.809830456425389,0,5,Hrd1p ubiquitin ligase complex,CC,
320,GO:0000839,1,0.882789482990071,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
321,GO:0000900,1,0.651068584846579,0,10,translation repressor activity, mRNA regulatory element binding,MF,
325,GO:0000912,1,0.771255354408555,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
326,GO:0000915,1,0.771255354408555,0,6,actomyosin contractile ring assembly,BP,
327,GO:0000916,1,0.961125608718277,0,1,actomyosin contractile ring contraction,BP,
328,GO:0000917,1,0.962307303735668,0,1,division septum assembly,BP,
329,GO:0000920,1,0.505869176682583,0,17,cell separation after cytokinesis,BP,
330,GO:0000921,1,0.647948181341496,0,10,septin ring assembly,BP,
332,GO:0000923,1,0.771328790576231,0,6,equatorial microtubule organizing center,CC,
333,GO:0000928,1,0.958787867083198,0,1,gamma-tubulin small complex, spindle pole body,CC,
337,GO:0000938,1,0.841206529949338,0,4,GARP complex,CC,
338,GO:0000939,1,0.887858819262937,0,3,condensed chromosome inner kinetochore,CC,
339,GO:0000940,1,0.579202827775962,0,13,condensed chromosome outer kinetochore,CC,
340,GO:0000941,1,0.960862140081554,0,1,condensed nuclear chromosome inner kinetochore,CC,
341,GO:0000942,1,0.850412172940321,0,4,condensed nuclear chromosome outer kinetochore,CC,
343,GO:0000957,1,0.805897945918871,0,5,mitochondrial RNA catabolic process,BP,
344,GO:0000958,1,0.878841505590808,0,3,mitochondrial mRNA catabolic process,BP,
345,GO:0000959,1,0.183514833082832,0,41,mitochondrial RNA metabolic process,BP,
346,GO:0000960,1,0.842152928516724,0,4,regulation of mitochondrial RNA catabolic process,BP,
347,GO:0000961,1,0.917021318947511,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
348,GO:0000962,1,0.918370844595587,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
349,GO:0000963,1,0.522261639655618,0,16,mitochondrial RNA processing,BP,
350,GO:0000964,1,0.849208791226245,0,4,mitochondrial RNA 5'-end processing,BP,
351,GO:0000965,1,0.816255825510054,0,5,mitochondrial RNA 3'-end processing,BP,
352,GO:0000966,1,0.43025941258405,0,21,RNA 5'-end processing,BP,
353,GO:0000967,1,0.881043851160284,0,3,rRNA 5'-end processing,BP,
354,GO:0000972,1,0.746961708315949,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
355,GO:0000973,1,0.882320318369604,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
356,GO:0000974,1,0.591663730533009,0,13,Prp19 complex,CC,
361,GO:0000980,1,0.114226929117214,0,52,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
368,GO:0000990,1,0.684425980103264,0,9,transcription factor activity, core RNA polymerase binding,MF,
369,GO:0000991,1,0.921584592472158,0,2,transcription factor activity, core RNA polymerase II binding,MF,
370,GO:0000992,1,0.918390665717829,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
372,GO:0000994,1,0.962548270217091,0,1,RNA polymerase III core binding,MF,
373,GO:0000995,1,0.839539996678767,0,4,transcription factor activity, core RNA polymerase III binding,MF,
374,GO:0001002,1,0.918390665717829,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
375,GO:0001003,1,0.918390665717829,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
376,GO:0001007,1,0.842360240297292,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
378,GO:0001011,1,0.956441843839217,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
380,GO:0001013,1,0.714891745360066,0,8,RNA polymerase I regulatory region DNA binding,MF,
381,GO:0001016,1,0.750814768580338,0,7,RNA polymerase III regulatory region DNA binding,MF,
382,GO:0001018,1,0.921813764786161,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
383,GO:0001025,1,0.874924186969474,0,3,RNA polymerase III transcription factor binding,MF,
384,GO:0001026,1,0.915656570322519,0,2,TFIIIB-type transcription factor activity,MF,
385,GO:0001030,1,0.808635294335298,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
386,GO:0001031,1,0.808635294335298,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
387,GO:0001032,1,0.846925499830377,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
388,GO:0001034,1,0.962459084629583,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
392,GO:0001054,1,0.649492666449954,0,11,RNA polymerase I activity,MF,
393,GO:0001055,1,0.652768597437183,0,11,RNA polymerase II activity,MF,
394,GO:0001056,1,0.552799476528116,0,15,RNA polymerase III activity,MF,
396,GO:0001069,1,0.914922384284886,0,2,regulatory region RNA binding,MF,
397,GO:0001074,1,0.959697146982428,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
398,GO:0001075,1,0.774301664857765,0,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
402,GO:0001083,1,0.808151090062365,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
403,GO:0001084,1,0.959697146982428,0,1,transcription factor activity, TFIID-class binding,MF,
405,GO:0001087,1,0.956441843839217,0,1,transcription factor activity, TFIIB-class binding,MF,
406,GO:0001091,1,0.514700343445036,0,16,RNA polymerase II basal transcription factor binding,MF,
407,GO:0001093,1,0.880429563631035,0,3,TFIIB-class transcription factor binding,MF,
408,GO:0001094,1,0.691753313720656,0,9,TFIID-class transcription factor binding,MF,
409,GO:0001096,1,0.957296118345447,0,1,TFIIF-class transcription factor binding,MF,
410,GO:0001097,1,0.883045553936892,0,3,TFIIH-class transcription factor binding,MF,
415,GO:0001103,1,0.299529394691271,0,29,RNA polymerase II repressing transcription factor binding,MF,
418,GO:0001106,1,0.413165882904198,0,21,RNA polymerase II transcription corepressor activity,MF,
419,GO:0001112,1,0.958435540056003,0,1,DNA-templated transcriptional open complex formation,BP,
420,GO:0001113,1,0.958435540056003,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
421,GO:0001120,1,0.958435540056003,0,1,protein-DNA complex remodeling,BP,
422,GO:0001128,1,0.96386490469618,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
423,GO:0001129,1,0.88046301685,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
424,GO:0001132,1,0.88046301685,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
427,GO:0001135,1,0.739529548919537,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
428,GO:0001147,1,0.915885262646538,0,2,transcription termination site sequence-specific DNA binding,MF,
429,GO:0001156,1,0.874924186969474,0,3,TFIIIC-class transcription factor binding,MF,
431,GO:0001160,1,0.915885262646538,0,2,transcription termination site DNA binding,MF,
433,GO:0001162,1,0.718935183571819,0,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
434,GO:0001163,1,0.714891745360066,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
435,GO:0001164,1,0.714891745360066,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
436,GO:0001165,1,0.956596058191214,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
437,GO:0001172,1,0.924280434660259,0,2,transcription, RNA-templated,BP,
438,GO:0001179,1,0.962265975424353,0,1,RNA polymerase I transcription factor binding,MF,
439,GO:0001181,1,0.921848076785828,0,2,transcription factor activity, core RNA polymerase I binding,MF,
440,GO:0001188,1,0.714891745360066,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
442,GO:0001191,1,0.243658055637699,0,34,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
443,GO:0001192,1,0.965064943804811,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
444,GO:0001193,1,0.965064943804811,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
445,GO:0001205,1,0.429856694358971,0,20,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
446,GO:0001206,1,0.768891703380646,0,6,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
450,GO:0001224,1,0.876519614181223,0,3,RNA polymerase II transcription cofactor binding,MF,
451,GO:0001225,1,0.91505799954222,0,2,RNA polymerase II transcription coactivator binding,MF,
452,GO:0001226,1,0.957891697329934,0,1,RNA polymerase II transcription corepressor binding,MF,
455,GO:0001300,1,0.918090938915397,0,2,chronological cell aging,BP,
456,GO:0001302,1,0.779695036812353,0,6,replicative cell aging,BP,
457,GO:0001306,1,0.964705222565708,0,1,age-dependent response to oxidative stress,BP,
458,GO:0001315,1,0.964705222565708,0,1,age-dependent response to reactive oxygen species,BP,
459,GO:0001325,1,0.52407071079781,0,15,formation of extrachromosomal circular DNA,BP,
460,GO:0001401,1,0.922030530482321,0,2,mitochondrial sorting and assembly machinery complex,CC,
461,GO:0001405,1,0.816906055532369,0,5,presequence translocase-associated import motor,CC,
468,GO:0001510,1,0.0819815717867775,0,61,RNA methylation,BP,
469,GO:0001512,1,0.964410350568492,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
470,GO:0001514,1,0.750502139972741,0,7,selenocysteine incorporation,BP,
471,GO:0001515,1,0.961859288274502,0,1,opioid peptide activity,MF,
472,GO:0001516,1,0.547550934655588,0,15,prostaglandin biosynthetic process,BP,
473,GO:0001517,1,0.806838662034373,0,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
475,GO:0001519,1,0.957231078804825,0,1,peptide amidation,BP,
476,GO:0001520,1,0.9167345854017,0,2,outer dense fiber,CC,
477,GO:0001522,1,0.495678400414257,0,18,pseudouridine synthesis,BP,
481,GO:0001530,1,0.66755950835868,0,10,lipopolysaccharide binding,MF,
483,GO:0001534,1,0.957185460433089,0,1,radial spoke,CC,
484,GO:0001536,1,0.957185460433089,0,1,radial spoke stalk,CC,
485,GO:0001537,1,0.919219396016207,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
489,GO:0001542,1,0.77025931102665,0,6,ovulation from ovarian follicle,BP,
490,GO:0001543,1,0.956441843839217,0,1,ovarian follicle rupture,BP,
491,GO:0001544,1,0.956441843839217,0,1,initiation of primordial ovarian follicle growth,BP,
492,GO:0001545,1,0.956908931262264,0,1,primary ovarian follicle growth,BP,
493,GO:0001546,1,0.962961649857946,0,1,preantral ovarian follicle growth,BP,
495,GO:0001550,1,0.914910563901317,0,2,ovarian cumulus expansion,BP,
496,GO:0001552,1,0.961986733978888,0,1,ovarian follicle atresia,BP,
497,GO:0001553,1,0.804980161156868,0,5,luteinization,BP,
498,GO:0001554,1,0.802063873837641,0,5,luteolysis,BP,
499,GO:0001555,1,0.919220047357995,0,2,oocyte growth,BP,
500,GO:0001556,1,0.497046503739253,0,17,oocyte maturation,BP,
503,GO:0001561,1,0.783846499849601,0,6,fatty acid alpha-oxidation,BP,
508,GO:0001572,1,0.9565224254008,0,1,lactosylceramide biosynthetic process,BP,
511,GO:0001575,1,0.925030151243812,0,2,globoside metabolic process,BP,
512,GO:0001576,1,0.96145798091186,0,1,globoside biosynthetic process,BP,
514,GO:0001579,1,0.91784004172213,0,2,medium-chain fatty acid transport,BP,
515,GO:0001580,1,0.769058408051745,0,7,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
516,GO:0001582,1,0.959796447129613,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
517,GO:0001588,1,0.929456054798056,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
518,GO:0001595,1,0.964304781093423,0,1,angiotensin receptor activity,MF,
519,GO:0001605,1,0.956483797008087,0,1,adrenomedullin receptor activity,MF,
520,GO:0001608,1,0.815398803427329,0,5,G-protein coupled nucleotide receptor activity,MF,
522,GO:0001614,1,0.784123056033189,0,6,purinergic nucleotide receptor activity,MF,
524,GO:0001631,1,0.922500762465884,0,2,cysteinyl leukotriene receptor activity,MF,
525,GO:0001632,1,0.922500762465884,0,2,leukotriene B4 receptor activity,MF,
526,GO:0001635,1,0.885459693491824,0,3,calcitonin gene-related peptide receptor activity,MF,
528,GO:0001640,1,0.956441843839217,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
529,GO:0001642,1,0.956441843839217,0,1,group III metabotropic glutamate receptor activity,MF,
532,GO:0001651,1,0.924595564148869,0,2,dense fibrillar component,CC,
533,GO:0001652,1,0.850990199459411,0,4,granular component,CC,
541,GO:0001660,1,0.779722102548085,0,6,fever generation,BP,
542,GO:0001661,1,0.919347349812988,0,2,conditioned taste aversion,BP,
549,GO:0001671,1,0.412163827688448,0,22,ATPase activator activity,MF,
550,GO:0001672,1,0.739095681965959,0,7,regulation of chromatin assembly or disassembly,BP,
552,GO:0001674,1,0.919358768892196,0,2,female germ cell nucleus,CC,
553,GO:0001675,1,0.708882269445367,0,8,acrosome assembly,BP,
556,GO:0001680,1,0.960783019309075,0,1,tRNA 3'-terminal CCA addition,BP,
557,GO:0001681,1,0.958921484820709,0,1,sialate O-acetylesterase activity,MF,
558,GO:0001682,1,0.625370768396718,0,12,tRNA 5'-leader removal,BP,
559,GO:0001696,1,0.776234400114691,0,6,gastric acid secretion,BP,
563,GO:0001705,1,0.916227955217286,0,2,ectoderm formation,BP,
567,GO:0001709,1,0.49625705605903,0,17,cell fate determination,BP,
568,GO:0001710,1,0.779516799351837,0,6,mesodermal cell fate commitment,BP,
570,GO:0001712,1,0.916227955217286,0,2,ectodermal cell fate commitment,BP,
571,GO:0001714,1,0.855785109859203,0,4,endodermal cell fate specification,BP,
572,GO:0001715,1,0.957101073089762,0,1,ectodermal cell fate specification,BP,
575,GO:0001727,1,0.809086371800288,0,5,lipid kinase activity,MF,
576,GO:0001729,1,0.917114755870566,0,2,ceramide kinase activity,MF,
579,GO:0001732,1,0.920031863215015,0,2,formation of cytoplasmic translation initiation complex,BP,
580,GO:0001733,1,0.959866728138754,0,1,galactosylceramide sulfotransferase activity,MF,
581,GO:0001735,1,0.918013899788035,0,2,prenylcysteine oxidase activity,MF,
584,GO:0001739,1,0.782297440494034,0,6,sex chromatin,CC,
585,GO:0001740,1,0.884365666796314,0,3,Barr body,CC,
586,GO:0001741,1,0.634363434282786,0,11,XY body,CC,
587,GO:0001743,1,0.91597912418791,0,2,optic placode formation,BP,
588,GO:0001750,1,0.226446983382901,0,35,photoreceptor outer segment,CC,
592,GO:0001757,1,0.916130234846583,0,2,somite specification,BP,
594,GO:0001759,1,0.637562133634727,0,11,organ induction,BP,
597,GO:0001765,1,0.694851415782506,0,9,membrane raft assembly,BP,
599,GO:0001767,1,0.770331776388856,0,6,establishment of lymphocyte polarity,BP,
600,GO:0001768,1,0.805430004426971,0,5,establishment of T cell polarity,BP,
601,GO:0001770,1,0.956441843839217,0,1,establishment of natural killer cell polarity,BP,
603,GO:0001772,1,0.446896444116091,0,19,immunological synapse,CC,
604,GO:0001773,1,0.593554582239809,0,13,myeloid dendritic cell activation,BP,
605,GO:0001774,1,0.57083310712923,0,13,microglial cell activation,BP,
608,GO:0001777,1,0.965207538270858,0,1,T cell homeostatic proliferation,BP,
609,GO:0001778,1,0.83696947091366,0,4,plasma membrane repair,BP,
611,GO:0001780,1,0.679880699244141,0,9,neutrophil homeostasis,BP,
612,GO:0001781,1,0.809720006967518,0,5,neutrophil apoptotic process,BP,
617,GO:0001787,1,0.819699807079328,0,5,natural killer cell proliferation,BP,
618,GO:0001792,1,0.956749289912141,0,1,polymeric immunoglobulin receptor activity,MF,
627,GO:0001820,1,0.88234238583067,0,3,serotonin secretion,BP,
628,GO:0001821,1,0.758438331891061,0,7,histamine secretion,BP,
634,GO:0001827,1,0.914870612107981,0,2,inner cell mass cell fate commitment,BP,
635,GO:0001828,1,0.914870612107981,0,2,inner cell mass cellular morphogenesis,BP,
636,GO:0001829,1,0.660761751147239,0,10,trophectodermal cell differentiation,BP,
637,GO:0001831,1,0.956441843839217,0,1,trophectodermal cellular morphogenesis,BP,
639,GO:0001833,1,0.654294563308363,0,10,inner cell mass cell proliferation,BP,
640,GO:0001834,1,0.958787867083198,0,1,trophectodermal cell proliferation,BP,
641,GO:0001835,1,0.957965721664968,0,1,blastocyst hatching,BP,
648,GO:0001842,1,0.81336538335088,0,5,neural fold formation,BP,
650,GO:0001844,1,0.297360347583561,0,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
651,GO:0001845,1,0.696743498374691,0,9,phagolysosome assembly,BP,
652,GO:0001846,1,0.822506431309712,0,5,opsonin binding,MF,
653,GO:0001848,1,0.822506431309712,0,5,complement binding,MF,
654,GO:0001849,1,0.927778659228101,0,2,complement component C1q binding,MF,
655,GO:0001850,1,0.962379230688068,0,1,complement component C3a binding,MF,
656,GO:0001851,1,0.962379230688068,0,1,complement component C3b binding,MF,
657,GO:0001855,1,0.963168935665411,0,1,complement component C4b binding,MF,
658,GO:0001865,1,0.804467167747012,0,5,NK T cell differentiation,BP,
659,GO:0001866,1,0.857018113971991,0,4,NK T cell proliferation,BP,
663,GO:0001871,1,0.773832989814169,0,6,pattern binding,MF,
664,GO:0001875,1,0.879146990695265,0,3,lipopolysaccharide receptor activity,MF,
665,GO:0001878,1,0.960668298710852,0,1,response to yeast,BP,
666,GO:0001880,1,0.915659735623657,0,2,Mullerian duct regression,BP,
670,GO:0001884,1,0.918031102339929,0,2,pyrimidine nucleoside binding,MF,
672,GO:0001886,1,0.741893758487053,0,7,endothelial cell morphogenesis,BP,
673,GO:0001887,1,0.847338042021631,0,4,selenium compound metabolic process,BP,
674,GO:0001888,1,0.917080656414922,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
677,GO:0001891,1,0.533022702043076,0,15,phagocytic cup,CC,
682,GO:0001905,1,0.956441843839217,0,1,activation of membrane attack complex,BP,
683,GO:0001906,1,0.0754106926777304,0,65,cell killing,BP,
684,GO:0001907,1,0.889306249679851,0,3,killing by symbiont of host cells,BP,
685,GO:0001909,1,0.123106570555279,0,52,leukocyte mediated cytotoxicity,BP,
686,GO:0001910,1,0.309761770002562,0,29,regulation of leukocyte mediated cytotoxicity,BP,
687,GO:0001911,1,0.670168195778271,0,10,negative regulation of leukocyte mediated cytotoxicity,BP,
688,GO:0001912,1,0.50122290193453,0,17,positive regulation of leukocyte mediated cytotoxicity,BP,
689,GO:0001913,1,0.4505826773715,0,20,T cell mediated cytotoxicity,BP,
690,GO:0001914,1,0.597161722527848,0,13,regulation of T cell mediated cytotoxicity,BP,
691,GO:0001915,1,0.883059559950881,0,3,negative regulation of T cell mediated cytotoxicity,BP,
692,GO:0001916,1,0.729375148875182,0,8,positive regulation of T cell mediated cytotoxicity,BP,
694,GO:0001918,1,0.959072263298757,0,1,farnesylated protein binding,MF,
696,GO:0001920,1,0.878888730540624,0,3,negative regulation of receptor recycling,BP,
699,GO:0001923,1,0.882297648699944,0,3,B-1 B cell differentiation,BP,
700,GO:0001927,1,0.879172165206272,0,3,exocyst assembly,BP,
701,GO:0001928,1,0.960847741478687,0,1,regulation of exocyst assembly,BP,
702,GO:0001931,1,0.712831397209553,0,8,uropod,CC,
711,GO:0001940,1,0.811085126817253,0,5,male pronucleus,CC,
716,GO:0001946,1,0.652170172181188,0,10,lymphangiogenesis,BP,
722,GO:0001955,1,0.810316000515108,0,5,blood vessel maturation,BP,
723,GO:0001956,1,0.681744779780417,0,9,positive regulation of neurotransmitter secretion,BP,
728,GO:0001961,1,0.251792840635657,0,33,positive regulation of cytokine-mediated signaling pathway,BP,
729,GO:0001963,1,0.571496356370832,0,14,synaptic transmission, dopaminergic,BP,
732,GO:0001967,1,0.740871044627928,0,7,suckling behavior,BP,
734,GO:0001969,1,0.956441843839217,0,1,regulation of activation of membrane attack complex,BP,
735,GO:0001971,1,0.956441843839217,0,1,negative regulation of activation of membrane attack complex,BP,
738,GO:0001974,1,0.347228261558549,0,25,blood vessel remodeling,BP,
739,GO:0001975,1,0.633787082143724,0,11,response to amphetamine,BP,
740,GO:0001976,1,0.848165169305347,0,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,
742,GO:0001978,1,0.961120186609872,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
743,GO:0001983,1,0.961120186609872,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
744,GO:0001985,1,0.961120186609872,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
747,GO:0001992,1,0.956703611372165,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
748,GO:0001993,1,0.850837647441795,0,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
749,GO:0001994,1,0.961120186609872,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
750,GO:0001996,1,0.884781791680084,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,
751,GO:0001997,1,0.961120186609872,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
752,GO:0001998,1,0.962064116170112,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
755,GO:0002002,1,0.84972763177964,0,4,regulation of angiotensin levels in blood,BP,
756,GO:0002003,1,0.84972763177964,0,4,angiotensin maturation,BP,
760,GO:0002017,1,0.962200219543573,0,1,regulation of blood volume by renal aldosterone,BP,
765,GO:0002025,1,0.961645026588241,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
771,GO:0002032,1,0.925208443479937,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
772,GO:0002034,1,0.962064116170112,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
773,GO:0002036,1,0.845972678112155,0,4,regulation of L-glutamate import across plasma membrane,BP,
774,GO:0002037,1,0.961331647935178,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
775,GO:0002038,1,0.960822557325351,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
778,GO:0002041,1,0.960729184614524,0,1,intussusceptive angiogenesis,BP,
780,GO:0002043,1,0.692298231142333,0,9,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
781,GO:0002046,1,0.964821598476581,0,1,opsin binding,MF,
782,GO:0002051,1,0.838692434797194,0,4,osteoblast fate commitment,BP,
783,GO:0002052,1,0.597445282709458,0,12,positive regulation of neuroblast proliferation,BP,
785,GO:0002054,1,0.889038209313083,0,3,nucleobase binding,MF,
786,GO:0002055,1,0.965369793085691,0,1,adenine binding,MF,
787,GO:0002060,1,0.889038209313083,0,3,purine nucleobase binding,MF,
789,GO:0002063,1,0.456860433435106,0,18,chondrocyte development,BP,
793,GO:0002067,1,0.30715921890695,0,28,glandular epithelial cell differentiation,BP,
794,GO:0002068,1,0.487363736468254,0,17,glandular epithelial cell development,BP,
795,GO:0002069,1,0.784404251310157,0,6,columnar/cuboidal epithelial cell maturation,BP,
796,GO:0002070,1,0.638111341090685,0,11,epithelial cell maturation,BP,
797,GO:0002071,1,0.918726410323987,0,2,glandular epithelial cell maturation,BP,
799,GO:0002074,1,0.881138921341286,0,3,extraocular skeletal muscle development,BP,
801,GO:0002079,1,0.916249771973658,0,2,inner acrosomal membrane,CC,
803,GO:0002081,1,0.956441843839217,0,1,outer acrosomal membrane,CC,
804,GO:0002082,1,0.563352018585898,0,14,regulation of oxidative phosphorylation,BP,
805,GO:0002083,1,0.962993212713458,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
806,GO:0002084,1,0.693010498790441,0,9,protein depalmitoylation,BP,
807,GO:0002085,1,0.882736464515157,0,3,inhibition of neuroepithelial cell differentiation,BP,
812,GO:0002090,1,0.349705706154786,0,25,regulation of receptor internalization,BP,
813,GO:0002091,1,0.742526699298538,0,7,negative regulation of receptor internalization,BP,
814,GO:0002092,1,0.528970275689048,0,15,positive regulation of receptor internalization,BP,
816,GO:0002094,1,0.922423169220146,0,2,polyprenyltransferase activity,MF,
817,GO:0002097,1,0.52134344905218,0,16,tRNA wobble base modification,BP,
818,GO:0002098,1,0.616022380855461,0,12,tRNA wobble uridine modification,BP,
819,GO:0002100,1,0.956441843839217,0,1,tRNA wobble adenosine to inosine editing,BP,
820,GO:0002101,1,0.885004871512586,0,3,tRNA wobble cytosine modification,BP,
821,GO:0002102,1,0.325851171036078,0,26,podosome,CC,
822,GO:0002114,1,0.957140723293023,0,1,interleukin-33 receptor activity,MF,
825,GO:0002118,1,0.957646460058749,0,1,aggressive behavior,BP,
826,GO:0002121,1,0.957646460058749,0,1,inter-male aggressive behavior,BP,
827,GO:0002127,1,0.963610588646058,0,1,tRNA wobble base cytosine methylation,BP,
829,GO:0002134,1,0.918031102339929,0,2,UTP binding,MF,
830,GO:0002135,1,0.959843233179047,0,1,CTP binding,MF,
832,GO:0002143,1,0.854868910710031,0,4,tRNA wobble position uridine thiolation,BP,
833,GO:0002144,1,0.961403869121993,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
834,GO:0002151,1,0.775180966035053,0,6,G-quadruplex RNA binding,MF,
839,GO:0002159,1,0.840407663086408,0,4,desmosome assembly,BP,
840,GO:0002161,1,0.601876939980044,0,12,aminoacyl-tRNA editing activity,MF,
841,GO:0002162,1,0.732108198684866,0,7,dystroglycan binding,MF,
842,GO:0002169,1,0.918836042647092,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
844,GO:0002176,1,0.893450751441367,0,3,male germ cell proliferation,BP,
845,GO:0002177,1,0.889095477856889,0,3,manchette,CC,
848,GO:0002182,1,0.629903331938201,0,11,cytoplasmic translational elongation,BP,
850,GO:0002184,1,0.917157123989653,0,2,cytoplasmic translational termination,BP,
851,GO:0002188,1,0.876689917233567,0,3,translation reinitiation,BP,
852,GO:0002189,1,0.959868408902231,0,1,ribose phosphate diphosphokinase complex,CC,
853,GO:0002190,1,0.824781388251579,0,5,cap-independent translational initiation,BP,
854,GO:0002191,1,0.885151847494421,0,3,cap-dependent translational initiation,BP,
855,GO:0002192,1,0.929378037577743,0,2,IRES-dependent translational initiation of linear mRNA,BP,
856,GO:0002193,1,0.878626524749857,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
857,GO:0002196,1,0.962135838670923,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
858,GO:0002199,1,0.756329286492185,0,7,zona pellucida receptor complex,CC,
869,GO:0002227,1,0.703331340807687,0,10,innate immune response in mucosa,BP,
870,GO:0002228,1,0.230954256411881,0,36,natural killer cell mediated immunity,BP,
873,GO:0002238,1,0.956479002849494,0,1,response to molecule of fungal origin,BP,
877,GO:0002249,1,0.914777292668164,0,2,lymphocyte anergy,BP,
879,GO:0002251,1,0.567931202351706,0,15,organ or tissue specific immune response,BP,
882,GO:0002254,1,0.924196654416313,0,2,kinin cascade,BP,
886,GO:0002265,1,0.875961148762618,0,3,astrocyte activation involved in immune response,BP,
887,GO:0002266,1,0.922170705585802,0,2,follicular dendritic cell activation,BP,
888,GO:0002268,1,0.922170705585802,0,2,follicular dendritic cell differentiation,BP,
891,GO:0002276,1,0.919853436248898,0,2,basophil activation involved in immune response,BP,
892,GO:0002277,1,0.965013665213141,0,1,myeloid dendritic cell activation involved in immune response,BP,
895,GO:0002281,1,0.806386488667853,0,5,macrophage activation involved in immune response,BP,
900,GO:0002291,1,0.925741575029812,0,2,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
905,GO:0002296,1,0.915275487403768,0,2,T-helper 1 cell lineage commitment,BP,
906,GO:0002299,1,0.963239223116218,0,1,alpha-beta intraepithelial T cell differentiation,BP,
907,GO:0002300,1,0.963239223116218,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
908,GO:0002304,1,0.963239223116218,0,1,gamma-delta intraepithelial T cell differentiation,BP,
909,GO:0002305,1,0.963239223116218,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
910,GO:0002309,1,0.965161841747877,0,1,T cell proliferation involved in immune response,BP,
912,GO:0002313,1,0.543354343720669,0,15,mature B cell differentiation involved in immune response,BP,
913,GO:0002314,1,0.92521308469592,0,2,germinal center B cell differentiation,BP,
914,GO:0002315,1,0.712916845106421,0,8,marginal zone B cell differentiation,BP,
915,GO:0002316,1,0.956756130289669,0,1,follicular B cell differentiation,BP,
916,GO:0002317,1,0.894722294992173,0,3,plasma cell differentiation,BP,
917,GO:0002318,1,0.881774590270042,0,3,myeloid progenitor cell differentiation,BP,
918,GO:0002320,1,0.576459571134032,0,13,lymphoid progenitor cell differentiation,BP,
919,GO:0002322,1,0.915226639274399,0,2,B cell proliferation involved in immune response,BP,
920,GO:0002323,1,0.697476053805072,0,9,natural killer cell activation involved in immune response,BP,
921,GO:0002325,1,0.964322923966933,0,1,natural killer cell differentiation involved in immune response,BP,
922,GO:0002326,1,0.875812417678567,0,3,B cell lineage commitment,BP,
923,GO:0002327,1,0.765676850671477,0,6,immature B cell differentiation,BP,
924,GO:0002328,1,0.682394250835201,0,9,pro-B cell differentiation,BP,
925,GO:0002329,1,0.83703593431309,0,4,pre-B cell differentiation,BP,
926,GO:0002331,1,0.914777292668164,0,2,pre-B cell allelic exclusion,BP,
927,GO:0002332,1,0.956442075022866,0,1,transitional stage B cell differentiation,BP,
928,GO:0002333,1,0.956442075022866,0,1,transitional one stage B cell differentiation,BP,
929,GO:0002335,1,0.458507383306301,0,19,mature B cell differentiation,BP,
930,GO:0002337,1,0.922448536280427,0,2,B-1a B cell differentiation,BP,
931,GO:0002339,1,0.927641135904047,0,2,B cell selection,BP,
932,GO:0002347,1,0.659781668679641,0,10,response to tumor cell,BP,
933,GO:0002349,1,0.818940960816152,0,5,histamine production involved in inflammatory response,BP,
934,GO:0002351,1,0.956479002849494,0,1,serotonin production involved in inflammatory response,BP,
935,GO:0002352,1,0.927641135904047,0,2,B cell negative selection,BP,
936,GO:0002353,1,0.924196654416313,0,2,plasma kallikrein-kinin cascade,BP,
937,GO:0002357,1,0.959145611667106,0,1,defense response to tumor cell,BP,
938,GO:0002358,1,0.965207538270858,0,1,B cell homeostatic proliferation,BP,
943,GO:0002368,1,0.960639697930963,0,1,B cell cytokine production,BP,
944,GO:0002369,1,0.459351851319278,0,19,T cell cytokine production,BP,
945,GO:0002370,1,0.885344092257384,0,3,natural killer cell cytokine production,BP,
946,GO:0002371,1,0.846134639178342,0,4,dendritic cell cytokine production,BP,
947,GO:0002373,1,0.964909985697755,0,1,plasmacytoid dendritic cell cytokine production,BP,
948,GO:0002374,1,0.628771368428142,0,11,cytokine secretion involved in immune response,BP,
951,GO:0002378,1,0.956645819375332,0,1,immunoglobulin biosynthetic process,BP,
952,GO:0002380,1,0.956632503670716,0,1,immunoglobulin secretion involved in immune response,BP,
954,GO:0002384,1,0.956848140134744,0,1,hepatic immune response,BP,
955,GO:0002385,1,0.593571750629075,0,14,mucosal immune response,BP,
956,GO:0002386,1,0.920435820839069,0,2,immune response in mucosal-associated lymphoid tissue,BP,
957,GO:0002396,1,0.962078140903472,0,1,MHC protein complex assembly,BP,
958,GO:0002397,1,0.962078140903472,0,1,MHC class I protein complex assembly,BP,
960,GO:0002408,1,0.956443788810866,0,1,myeloid dendritic cell chemotaxis,BP,
961,GO:0002414,1,0.886005759061348,0,3,immunoglobulin transcytosis in epithelial cells,BP,
962,GO:0002415,1,0.920435820839069,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
963,GO:0002416,1,0.962599985792854,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
964,GO:0002418,1,0.717566941157742,0,8,immune response to tumor cell,BP,
965,GO:0002420,1,0.844186639765197,0,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
966,GO:0002423,1,0.844186639765197,0,4,natural killer cell mediated immune response to tumor cell,BP,
967,GO:0002424,1,0.919960861607589,0,2,T cell mediated immune response to tumor cell,BP,
968,GO:0002428,1,0.888959182377079,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
970,GO:0002430,1,0.960734563591107,0,1,complement receptor mediated signaling pathway,BP,
972,GO:0002432,1,0.956672239583708,0,1,granuloma formation,BP,
976,GO:0002439,1,0.925205571835954,0,2,chronic inflammatory response to antigenic stimulus,BP,
978,GO:0002441,1,0.818940960816152,0,5,histamine secretion involved in inflammatory response,BP,
979,GO:0002442,1,0.956479002849494,0,1,serotonin secretion involved in inflammatory response,BP,
988,GO:0002457,1,0.881874724124301,0,3,T cell antigen processing and presentation,BP,
990,GO:0002461,1,0.960618270503813,0,1,tolerance induction dependent upon immune response,BP,
992,GO:0002468,1,0.875273949120997,0,3,dendritic cell antigen processing and presentation,BP,
994,GO:0002475,1,0.778815992287684,0,6,antigen processing and presentation via MHC class Ib,BP,
995,GO:0002476,1,0.921400119414519,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
996,GO:0002477,1,0.964797515428989,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
999,GO:0002480,1,0.709818496835546,0,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1000,GO:0002481,1,0.964797515428989,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1001,GO:0002483,1,0.718001500524302,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1002,GO:0002488,1,0.956931729370711,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1003,GO:0002489,1,0.956931729370711,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1005,GO:0002501,1,0.962078140903472,0,1,peptide antigen assembly with MHC protein complex,BP,
1006,GO:0002502,1,0.962078140903472,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1009,GO:0002513,1,0.881021827157982,0,3,tolerance induction to self antigen,BP,
1010,GO:0002514,1,0.956566939031699,0,1,B cell tolerance induction,BP,
1011,GO:0002517,1,0.811790746124152,0,5,T cell tolerance induction,BP,
1012,GO:0002519,1,0.960618270503813,0,1,natural killer cell tolerance induction,BP,
1015,GO:0002523,1,0.819634727595127,0,5,leukocyte migration involved in inflammatory response,BP,
1018,GO:0002528,1,0.916808285856407,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1019,GO:0002532,1,0.23274457601224,0,35,production of molecular mediator involved in inflammatory response,BP,
1020,GO:0002534,1,0.38103154817209,0,23,cytokine production involved in inflammatory response,BP,
1021,GO:0002536,1,0.927386738231283,0,2,respiratory burst involved in inflammatory response,BP,
1022,GO:0002537,1,0.956441843839217,0,1,nitric oxide production involved in inflammatory response,BP,
1023,GO:0002538,1,0.958145282645265,0,1,arachidonic acid metabolite production involved in inflammatory response,BP,
1024,GO:0002540,1,0.958145282645265,0,1,leukotriene production involved in inflammatory response,BP,
1025,GO:0002541,1,0.923595634068977,0,2,activation of plasma proteins involved in acute inflammatory response,BP,
1026,GO:0002542,1,0.961569608228912,0,1,Factor XII activation,BP,
1027,GO:0002543,1,0.918755155359485,0,2,activation of blood coagulation via clotting cascade,BP,
1030,GO:0002548,1,0.502949034255796,0,17,monocyte chemotaxis,BP,
1032,GO:0002553,1,0.818940960816152,0,5,histamine secretion by mast cell,BP,
1033,GO:0002554,1,0.956479002849494,0,1,serotonin secretion by platelet,BP,
1034,GO:0002560,1,0.956808261360976,0,1,basophil mediated immunity,BP,
1035,GO:0002561,1,0.956808261360976,0,1,basophil degranulation,BP,
1037,GO:0002566,1,0.533572965294199,0,15,somatic diversification of immune receptors via somatic mutation,BP,
1038,GO:0002568,1,0.803731077712775,0,5,somatic diversification of T cell receptor genes,BP,
1039,GO:0002572,1,0.917118855404089,0,2,pro-T cell differentiation,BP,
1042,GO:0002577,1,0.753630470286817,0,7,regulation of antigen processing and presentation,BP,
1043,GO:0002578,1,0.853407430337021,0,4,negative regulation of antigen processing and presentation,BP,
1044,GO:0002579,1,0.883119728633621,0,3,positive regulation of antigen processing and presentation,BP,
1045,GO:0002580,1,0.889552293970737,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1046,GO:0002581,1,0.921808293643804,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1047,GO:0002582,1,0.965013665213141,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1048,GO:0002583,1,0.861057598225125,0,4,regulation of antigen processing and presentation of peptide antigen,BP,
1049,GO:0002584,1,0.892282492974669,0,3,negative regulation of antigen processing and presentation of peptide antigen,BP,
1050,GO:0002585,1,0.965013665213141,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1051,GO:0002586,1,0.930070338270343,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1052,GO:0002587,1,0.963792420807342,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1053,GO:0002588,1,0.965013665213141,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1054,GO:0002589,1,0.925809016548141,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1055,GO:0002590,1,0.925809016548141,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1056,GO:0002604,1,0.875273949120997,0,3,regulation of dendritic cell antigen processing and presentation,BP,
1057,GO:0002605,1,0.956441843839217,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1058,GO:0002606,1,0.915142953952982,0,2,positive regulation of dendritic cell antigen processing and presentation,BP,
1059,GO:0002625,1,0.961969091550826,0,1,regulation of T cell antigen processing and presentation,BP,
1060,GO:0002626,1,0.961969091550826,0,1,negative regulation of T cell antigen processing and presentation,BP,
1062,GO:0002635,1,0.956441843839217,0,1,negative regulation of germinal center formation,BP,
1063,GO:0002636,1,0.963310309890086,0,1,positive regulation of germinal center formation,BP,
1066,GO:0002639,1,0.425015140981891,0,21,positive regulation of immunoglobulin production,BP,
1067,GO:0002643,1,0.683908527504592,0,9,regulation of tolerance induction,BP,
1068,GO:0002645,1,0.811790746124152,0,5,positive regulation of tolerance induction,BP,
1069,GO:0002649,1,0.956566939031699,0,1,regulation of tolerance induction to self antigen,BP,
1070,GO:0002651,1,0.956566939031699,0,1,positive regulation of tolerance induction to self antigen,BP,
1071,GO:0002652,1,0.960618270503813,0,1,regulation of tolerance induction dependent upon immune response,BP,
1072,GO:0002661,1,0.956566939031699,0,1,regulation of B cell tolerance induction,BP,
1073,GO:0002663,1,0.956566939031699,0,1,positive regulation of B cell tolerance induction,BP,
1074,GO:0002664,1,0.811790746124152,0,5,regulation of T cell tolerance induction,BP,
1075,GO:0002666,1,0.848773908685221,0,4,positive regulation of T cell tolerance induction,BP,
1076,GO:0002667,1,0.914777292668164,0,2,regulation of T cell anergy,BP,
1077,GO:0002669,1,0.956441843839217,0,1,positive regulation of T cell anergy,BP,
1084,GO:0002679,1,0.886988864668579,0,3,respiratory burst involved in defense response,BP,
1085,GO:0002681,1,0.803731077712775,0,5,somatic recombination of T cell receptor gene segments,BP,
1090,GO:0002686,1,0.503385936201537,0,17,negative regulation of leukocyte migration,BP,
1093,GO:0002689,1,0.760663310819252,0,7,negative regulation of leukocyte chemotaxis,BP,
1095,GO:0002691,1,0.604369065043572,0,12,regulation of cellular extravasation,BP,
1096,GO:0002692,1,0.845571042289337,0,4,negative regulation of cellular extravasation,BP,
1097,GO:0002693,1,0.743049899827542,0,7,positive regulation of cellular extravasation,BP,
1118,GO:0002714,1,0.494638765333787,0,17,positive regulation of B cell mediated immunity,BP,
1119,GO:0002715,1,0.477011626832663,0,18,regulation of natural killer cell mediated immunity,BP,
1120,GO:0002716,1,0.695229676542263,0,9,negative regulation of natural killer cell mediated immunity,BP,
1121,GO:0002717,1,0.660813142848717,0,10,positive regulation of natural killer cell mediated immunity,BP,
1124,GO:0002720,1,0.401700647640081,0,22,positive regulation of cytokine production involved in immune response,BP,
1125,GO:0002724,1,0.585059878811725,0,13,regulation of T cell cytokine production,BP,
1126,GO:0002725,1,0.888275531702102,0,3,negative regulation of T cell cytokine production,BP,
1127,GO:0002726,1,0.688409943931398,0,9,positive regulation of T cell cytokine production,BP,
1128,GO:0002727,1,0.885344092257384,0,3,regulation of natural killer cell cytokine production,BP,
1129,GO:0002728,1,0.956647939587746,0,1,negative regulation of natural killer cell cytokine production,BP,
1130,GO:0002729,1,0.925471414446117,0,2,positive regulation of natural killer cell cytokine production,BP,
1131,GO:0002730,1,0.846134639178342,0,4,regulation of dendritic cell cytokine production,BP,
1132,GO:0002731,1,0.922880249875649,0,2,negative regulation of dendritic cell cytokine production,BP,
1133,GO:0002732,1,0.956635663036805,0,1,positive regulation of dendritic cell cytokine production,BP,
1134,GO:0002736,1,0.964909985697755,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1135,GO:0002737,1,0.964909985697755,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1136,GO:0002739,1,0.686352692523536,0,9,regulation of cytokine secretion involved in immune response,BP,
1137,GO:0002740,1,0.963030903296506,0,1,negative regulation of cytokine secretion involved in immune response,BP,
1138,GO:0002741,1,0.744002750498235,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1140,GO:0002755,1,0.364858071367048,0,24,MyD88-dependent toll-like receptor signaling pathway,BP,
1141,GO:0002756,1,0.32760703574979,0,27,MyD88-independent toll-like receptor signaling pathway,BP,
1151,GO:0002767,1,0.923069610329736,0,2,immune response-inhibiting cell surface receptor signaling pathway,BP,
1153,GO:0002774,1,0.958359748824633,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
1157,GO:0002785,1,0.957307438174566,0,1,negative regulation of antimicrobial peptide production,BP,
1159,GO:0002787,1,0.957307438174566,0,1,negative regulation of antibacterial peptide production,BP,
1171,GO:0002825,1,0.667220488253083,0,10,regulation of T-helper 1 type immune response,BP,
1172,GO:0002826,1,0.882367581412942,0,3,negative regulation of T-helper 1 type immune response,BP,
1173,GO:0002827,1,0.75622492098596,0,7,positive regulation of T-helper 1 type immune response,BP,
1176,GO:0002830,1,0.721049967501078,0,8,positive regulation of type 2 immune response,BP,
1180,GO:0002834,1,0.776596186443777,0,6,regulation of response to tumor cell,BP,
1181,GO:0002835,1,0.919865432366809,0,2,negative regulation of response to tumor cell,BP,
1182,GO:0002836,1,0.881613058586797,0,3,positive regulation of response to tumor cell,BP,
1183,GO:0002837,1,0.776596186443777,0,6,regulation of immune response to tumor cell,BP,
1184,GO:0002838,1,0.919865432366809,0,2,negative regulation of immune response to tumor cell,BP,
1185,GO:0002839,1,0.881613058586797,0,3,positive regulation of immune response to tumor cell,BP,
1186,GO:0002840,1,0.919960861607589,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1187,GO:0002842,1,0.960639697930963,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1188,GO:0002855,1,0.844186639765197,0,4,regulation of natural killer cell mediated immune response to tumor cell,BP,
1189,GO:0002856,1,0.919865432366809,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1190,GO:0002857,1,0.917741884516907,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1191,GO:0002858,1,0.844186639765197,0,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1192,GO:0002859,1,0.919865432366809,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1193,GO:0002860,1,0.917741884516907,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1200,GO:0002870,1,0.914777292668164,0,2,T cell anergy,BP,
1201,GO:0002874,1,0.963030903296506,0,1,regulation of chronic inflammatory response to antigenic stimulus,BP,
1202,GO:0002875,1,0.963030903296506,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1209,GO:0002887,1,0.844111408888332,0,4,negative regulation of myeloid leukocyte mediated immunity,BP,
1213,GO:0002891,1,0.494638765333787,0,17,positive regulation of immunoglobulin mediated immune response,BP,
1214,GO:0002901,1,0.891502386358861,0,3,mature B cell apoptotic process,BP,
1217,GO:0002904,1,0.889027923358637,0,3,positive regulation of B cell apoptotic process,BP,
1218,GO:0002905,1,0.891502386358861,0,3,regulation of mature B cell apoptotic process,BP,
1219,GO:0002906,1,0.891502386358861,0,3,negative regulation of mature B cell apoptotic process,BP,
1220,GO:0002911,1,0.914777292668164,0,2,regulation of lymphocyte anergy,BP,
1221,GO:0002913,1,0.956441843839217,0,1,positive regulation of lymphocyte anergy,BP,
1225,GO:0002923,1,0.960851340621743,0,1,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1226,GO:0002924,1,0.960851340621743,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1227,GO:0002930,1,0.95646405199533,0,1,trabecular meshwork development,BP,
1229,GO:0002933,1,0.923891605232603,0,2,lipid hydroxylation,BP,
1230,GO:0002934,1,0.676940555261031,0,9,desmosome organization,BP,
1231,GO:0002940,1,0.921488157975069,0,2,tRNA N2-guanine methylation,BP,
1232,GO:0002943,1,0.853330723997192,0,4,tRNA dihydrouridine synthesis,BP,
1233,GO:0002944,1,0.918938320492967,0,2,cyclin K-CDK12 complex,CC,
1234,GO:0002945,1,0.918938320492967,0,2,cyclin K-CDK13 complex,CC,
1235,GO:0002946,1,0.963610588646058,0,1,tRNA C5-cytosine methylation,BP,
1236,GO:0002947,1,0.956853741398637,0,1,tumor necrosis factor receptor superfamily complex,CC,
1237,GO:0002949,1,0.890494269638355,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1238,GO:0002950,1,0.882000853135811,0,3,ceramide phosphoethanolamine synthase activity,MF,
1239,GO:0002951,1,0.960463589704419,0,1,leukotriene-C(4) hydrolase,MF,
1252,GO:0003017,1,0.956441843839217,0,1,lymph circulation,BP,
1254,GO:0003025,1,0.919252237784679,0,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1255,GO:0003032,1,0.920589425098897,0,2,detection of oxygen,BP,
1257,GO:0003050,1,0.958083071201817,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1258,GO:0003056,1,0.809360598244204,0,5,regulation of vascular smooth muscle contraction,BP,
1259,GO:0003057,1,0.88534131830244,0,3,regulation of the force of heart contraction by chemical signal,BP,
1261,GO:0003064,1,0.962327906909524,0,1,regulation of heart rate by hormone,BP,
1262,GO:0003065,1,0.962508001556062,0,1,positive regulation of heart rate by epinephrine,BP,
1263,GO:0003068,1,0.964705222565708,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1264,GO:0003069,1,0.964705222565708,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1265,GO:0003070,1,0.964705222565708,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1267,GO:0003072,1,0.962064116170112,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1272,GO:0003085,1,0.692562995960018,0,9,negative regulation of systemic arterial blood pressure,BP,
1273,GO:0003091,1,0.426561489765836,0,20,renal water homeostasis,BP,
1276,GO:0003096,1,0.812265221183493,0,5,renal sodium ion transport,BP,
1277,GO:0003097,1,0.848771641586467,0,4,renal water transport,BP,
1278,GO:0003099,1,0.961120186609872,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
1279,GO:0003100,1,0.849385339259423,0,4,regulation of systemic arterial blood pressure by endothelin,BP,
1280,GO:0003104,1,0.845653684617604,0,4,positive regulation of glomerular filtration,BP,
1284,GO:0003128,1,0.821840843238705,0,5,heart field specification,BP,
1285,GO:0003129,1,0.887646620981185,0,3,heart induction,BP,
1286,GO:0003130,1,0.922270464030282,0,2,BMP signaling pathway involved in heart induction,BP,
1287,GO:0003131,1,0.958962085136742,0,1,mesodermal-endodermal cell signaling,BP,
1288,GO:0003133,1,0.922270464030282,0,2,endodermal-mesodermal cell signaling,BP,
1289,GO:0003134,1,0.922270464030282,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1290,GO:0003139,1,0.853903018742968,0,4,secondary heart field specification,BP,
1291,GO:0003140,1,0.848323101127802,0,4,determination of left/right asymmetry in lateral mesoderm,BP,
1297,GO:0003156,1,0.421278682344084,0,21,regulation of animal organ formation,BP,
1298,GO:0003157,1,0.714602827346857,0,8,endocardium development,BP,
1300,GO:0003159,1,0.637405814308858,0,11,morphogenesis of an endothelium,BP,
1301,GO:0003160,1,0.884892847706728,0,3,endocardium morphogenesis,BP,
1302,GO:0003161,1,0.677708820495077,0,9,cardiac conduction system development,BP,
1303,GO:0003162,1,0.914777305344354,0,2,atrioventricular node development,BP,
1304,GO:0003163,1,0.914872629980002,0,2,sinoatrial node development,BP,
1305,GO:0003164,1,0.914870339285718,0,2,His-Purkinje system development,BP,
1306,GO:0003165,1,0.956441971176086,0,1,Purkinje myocyte development,BP,
1307,GO:0003166,1,0.956538992333406,0,1,bundle of His development,BP,
1308,GO:0003167,1,0.956538992333406,0,1,atrioventricular bundle cell differentiation,BP,
1309,GO:0003169,1,0.915797034529551,0,2,coronary vein morphogenesis,BP,
1314,GO:0003176,1,0.849897435336082,0,4,aortic valve development,BP,
1315,GO:0003177,1,0.771724544448362,0,6,pulmonary valve development,BP,
1317,GO:0003180,1,0.849897435336082,0,4,aortic valve morphogenesis,BP,
1320,GO:0003184,1,0.771724544448362,0,6,pulmonary valve morphogenesis,BP,
1325,GO:0003193,1,0.958142130655448,0,1,pulmonary valve formation,BP,
1328,GO:0003198,1,0.627732382454253,0,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1329,GO:0003199,1,0.963332843891388,0,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1330,GO:0003203,1,0.483705907505967,0,17,endocardial cushion morphogenesis,BP,
1333,GO:0003207,1,0.842460247276996,0,4,cardiac chamber formation,BP,
1334,GO:0003208,1,0.180201920448561,0,40,cardiac ventricle morphogenesis,BP,
1336,GO:0003211,1,0.842460247276996,0,4,cardiac ventricle formation,BP,
1337,GO:0003213,1,0.914777292668164,0,2,cardiac right atrium morphogenesis,BP,
1338,GO:0003214,1,0.775623818101479,0,6,cardiac left ventricle morphogenesis,BP,
1339,GO:0003215,1,0.595794926510925,0,12,cardiac right ventricle morphogenesis,BP,
1340,GO:0003219,1,0.920894602352379,0,2,cardiac right ventricle formation,BP,
1341,GO:0003220,1,0.956441843839217,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1342,GO:0003221,1,0.956441843839217,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1343,GO:0003222,1,0.619450882894893,0,11,ventricular trabecula myocardium morphogenesis,BP,
1344,GO:0003223,1,0.770795867057789,0,6,ventricular compact myocardium morphogenesis,BP,
1345,GO:0003226,1,0.956441843839217,0,1,right ventricular compact myocardium morphogenesis,BP,
1346,GO:0003228,1,0.885924135823027,0,3,atrial cardiac muscle tissue development,BP,
1347,GO:0003229,1,0.263927707381182,0,31,ventricular cardiac muscle tissue development,BP,
1350,GO:0003241,1,0.88273100787408,0,3,growth involved in heart morphogenesis,BP,
1351,GO:0003245,1,0.92293898503275,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1352,GO:0003247,1,0.96300265421436,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1353,GO:0003249,1,0.914777292668164,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1354,GO:0003250,1,0.914777292668164,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1355,GO:0003251,1,0.956441843839217,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1356,GO:0003252,1,0.956441843839217,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1357,GO:0003253,1,0.846532871672805,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1359,GO:0003256,1,0.878886908519005,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1360,GO:0003257,1,0.956725253418938,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1361,GO:0003263,1,0.819637529751005,0,5,cardioblast proliferation,BP,
1362,GO:0003264,1,0.783921404532267,0,6,regulation of cardioblast proliferation,BP,
1363,GO:0003266,1,0.817179526701476,0,5,regulation of secondary heart field cardioblast proliferation,BP,
1364,GO:0003270,1,0.956441843839217,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1365,GO:0003272,1,0.575033148401035,0,13,endocardial cushion formation,BP,
1366,GO:0003273,1,0.881107074055058,0,3,cell migration involved in endocardial cushion formation,BP,
1367,GO:0003274,1,0.877038881458401,0,3,endocardial cushion fusion,BP,
1368,GO:0003275,1,0.915927906554526,0,2,apoptotic process involved in outflow tract morphogenesis,BP,
1369,GO:0003278,1,0.879952328398569,0,3,apoptotic process involved in heart morphogenesis,BP,
1373,GO:0003284,1,0.84026761471789,0,4,septum primum development,BP,
1374,GO:0003289,1,0.876986031696984,0,3,atrial septum primum morphogenesis,BP,
1375,GO:0003292,1,0.95644185709155,0,1,cardiac septum cell differentiation,BP,
1376,GO:0003294,1,0.918109683970876,0,2,atrial ventricular junction remodeling,BP,
1377,GO:0003298,1,0.602761834515186,0,12,physiological muscle hypertrophy,BP,
1380,GO:0003301,1,0.602761834515186,0,12,physiological cardiac muscle hypertrophy,BP,
1382,GO:0003307,1,0.885762148876758,0,3,regulation of Wnt signaling pathway involved in heart development,BP,
1383,GO:0003308,1,0.922205918155875,0,2,negative regulation of Wnt signaling pathway involved in heart development,BP,
1384,GO:0003309,1,0.530845276764426,0,15,type B pancreatic cell differentiation,BP,
1385,GO:0003310,1,0.96356435360397,0,1,pancreatic A cell differentiation,BP,
1386,GO:0003321,1,0.884781791680084,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1387,GO:0003323,1,0.553498035563254,0,14,type B pancreatic cell development,BP,
1389,GO:0003334,1,0.630173991408668,0,11,keratinocyte development,BP,
1390,GO:0003335,1,0.959849939186192,0,1,corneocyte development,BP,
1391,GO:0003336,1,0.959849939186192,0,1,corneocyte desquamation,BP,
1397,GO:0003342,1,0.958466475086436,0,1,proepicardium development,BP,
1398,GO:0003343,1,0.958466475086436,0,1,septum transversum development,BP,
1399,GO:0003344,1,0.766360535114938,0,6,pericardium morphogenesis,BP,
1400,GO:0003345,1,0.957075053295403,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1401,GO:0003348,1,0.842181031714018,0,4,cardiac endothelial cell differentiation,BP,
1402,GO:0003350,1,0.919088835542731,0,2,pulmonary myocardium development,BP,
1404,GO:0003352,1,0.812119059584258,0,5,regulation of cilium movement,BP,
1405,GO:0003356,1,0.812119059584258,0,5,regulation of cilium beat frequency,BP,
1406,GO:0003357,1,0.914841822754689,0,2,noradrenergic neuron differentiation,BP,
1407,GO:0003360,1,0.880568887670861,0,3,brainstem development,BP,
1408,GO:0003363,1,0.956441843839217,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1409,GO:0003365,1,0.874964860413911,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1410,GO:0003366,1,0.956441843839217,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
1413,GO:0003376,1,0.685456581604371,0,9,sphingosine-1-phosphate signaling pathway,BP,
1414,GO:0003382,1,0.391512799574124,0,22,epithelial cell morphogenesis,BP,
1415,GO:0003383,1,0.874973232976283,0,3,apical constriction,BP,
1416,GO:0003400,1,0.961172605270695,0,1,regulation of COPII vesicle coating,BP,
1419,GO:0003404,1,0.957871317478817,0,1,optic vesicle morphogenesis,BP,
1420,GO:0003406,1,0.879367963571881,0,3,retinal pigment epithelium development,BP,
1422,GO:0003408,1,0.914777292668164,0,2,optic cup formation involved in camera-type eye development,BP,
1423,GO:0003409,1,0.957871317478817,0,1,optic cup structural organization,BP,
1424,GO:0003413,1,0.741668005003699,0,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1425,GO:0003415,1,0.839971751555877,0,4,chondrocyte hypertrophy,BP,
1426,GO:0003416,1,0.572922429602151,0,13,endochondral bone growth,BP,
1427,GO:0003417,1,0.711984993235267,0,8,growth plate cartilage development,BP,
1428,GO:0003418,1,0.843152761895364,0,4,growth plate cartilage chondrocyte differentiation,BP,
1429,GO:0003419,1,0.920186692634362,0,2,growth plate cartilage chondrocyte proliferation,BP,
1430,GO:0003420,1,0.920186692634362,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1431,GO:0003430,1,0.917293146237953,0,2,growth plate cartilage chondrocyte growth,BP,
1432,GO:0003431,1,0.843152761895364,0,4,growth plate cartilage chondrocyte development,BP,
1433,GO:0003433,1,0.810300462984931,0,5,chondrocyte development involved in endochondral bone morphogenesis,BP,
1437,GO:0003678,1,0.13937007358922,0,46,DNA helicase activity,MF,
1441,GO:0003688,1,0.55467796409772,0,14,DNA replication origin binding,MF,
1442,GO:0003689,1,0.724342789776859,0,8,DNA clamp loader activity,MF,
1444,GO:0003691,1,0.688447164175525,0,9,double-stranded telomeric DNA binding,MF,
1445,GO:0003696,1,0.846987046033046,0,4,satellite DNA binding,MF,
1448,GO:0003705,1,0.0936003052421057,0,56,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
1450,GO:0003708,1,0.842313986129708,0,4,retinoic acid receptor activity,MF,
1454,GO:0003720,1,0.723382350235418,0,8,telomerase activity,MF,
1455,GO:0003721,1,0.965995416961728,0,1,telomerase RNA reverse transcriptase activity,MF,
1459,GO:0003726,1,0.914827379831438,0,2,double-stranded RNA adenosine deaminase activity,MF,
1464,GO:0003743,1,0.136874653655482,0,49,translation initiation factor activity,MF,
1465,GO:0003746,1,0.521141731092018,0,16,translation elongation factor activity,MF,
1466,GO:0003747,1,0.777812262590453,0,6,translation release factor activity,MF,
1472,GO:0003785,1,0.478270222619153,0,18,actin monomer binding,MF,
1473,GO:0003796,1,0.963379181486961,0,1,lysozyme activity,MF,
1474,GO:0003810,1,0.881356854115972,0,3,protein-glutamine gamma-glutamyltransferase activity,MF,
1475,GO:0003823,1,0.377162742776457,0,24,antigen binding,MF,
1477,GO:0003826,1,0.923611288536685,0,2,alpha-ketoacid dehydrogenase activity,MF,
1478,GO:0003827,1,0.919300332134083,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1479,GO:0003828,1,0.915204466392495,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1480,GO:0003829,1,0.915930054190222,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1481,GO:0003831,1,0.716215154708908,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1482,GO:0003835,1,0.915070192688512,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1484,GO:0003839,1,0.858791447362574,0,4,gamma-glutamylcyclotransferase activity,MF,
1486,GO:0003842,1,0.957965721664968,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1487,GO:0003844,1,0.958257290505709,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1489,GO:0003846,1,0.919096363887145,0,2,2-acylglycerol O-acyltransferase activity,MF,
1490,GO:0003847,1,0.857079037479125,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1491,GO:0003854,1,0.887814539782758,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1492,GO:0003857,1,0.700315039149833,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1493,GO:0003858,1,0.918152560297517,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1494,GO:0003860,1,0.962027234666323,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1495,GO:0003863,1,0.923611288536685,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1496,GO:0003865,1,0.92188555446637,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1497,GO:0003867,1,0.956499496521757,0,1,4-aminobutyrate transaminase activity,MF,
1498,GO:0003868,1,0.962487793884042,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1499,GO:0003870,1,0.96055767454098,0,1,5-aminolevulinate synthase activity,MF,
1500,GO:0003872,1,0.88078422711923,0,3,6-phosphofructokinase activity,MF,
1501,GO:0003873,1,0.876171344669917,0,3,6-phosphofructo-2-kinase activity,MF,
1502,GO:0003874,1,0.96492184451589,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1503,GO:0003875,1,0.95763516218882,0,1,ADP-ribosylarginine hydrolase activity,MF,
1504,GO:0003876,1,0.915772416397962,0,2,AMP deaminase activity,MF,
1505,GO:0003877,1,0.961380405141031,0,1,ATP adenylyltransferase activity,MF,
1506,GO:0003878,1,0.956702227540248,0,1,ATP citrate synthase activity,MF,
1507,GO:0003880,1,0.884040024477363,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1508,GO:0003881,1,0.962221025674372,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1509,GO:0003882,1,0.960163878368359,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1510,GO:0003883,1,0.917558708748795,0,2,CTP synthase activity,MF,
1511,GO:0003886,1,0.875711800021663,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1512,GO:0003887,1,0.33906165041161,0,26,DNA-directed DNA polymerase activity,MF,
1513,GO:0003896,1,0.887532551197033,0,3,DNA primase activity,MF,
1514,GO:0003899,1,0.194209150969318,0,41,DNA-directed 5'-3' RNA polymerase activity,MF,
1516,GO:0003906,1,0.602029372756379,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1517,GO:0003908,1,0.964085797949569,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1518,GO:0003909,1,0.74661131490748,0,7,DNA ligase activity,MF,
1519,GO:0003910,1,0.776629500905655,0,6,DNA ligase (ATP) activity,MF,
1520,GO:0003916,1,0.77238667539785,0,6,DNA topoisomerase activity,MF,
1521,GO:0003917,1,0.844356191738038,0,4,DNA topoisomerase type I activity,MF,
1522,GO:0003918,1,0.914792234565335,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1523,GO:0003919,1,0.961875270092358,0,1,FMN adenylyltransferase activity,MF,
1524,GO:0003920,1,0.962193275935904,0,1,GMP reductase activity,MF,
1525,GO:0003921,1,0.96011546759398,0,1,GMP synthase activity,MF,
1526,GO:0003922,1,0.96011546759398,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1527,GO:0003923,1,0.815497727069396,0,5,GPI-anchor transamidase activity,MF,
1529,GO:0003933,1,0.961942591276251,0,1,GTP cyclohydrolase activity,MF,
1530,GO:0003934,1,0.961942591276251,0,1,GTP cyclohydrolase I activity,MF,
1531,GO:0003937,1,0.961425520249245,0,1,IMP cyclohydrolase activity,MF,
1532,GO:0003938,1,0.924258291081542,0,2,IMP dehydrogenase activity,MF,
1533,GO:0003939,1,0.959897033209647,0,1,L-iditol 2-dehydrogenase activity,MF,
1535,GO:0003941,1,0.925223590258252,0,2,L-serine ammonia-lyase activity,MF,
1536,GO:0003943,1,0.919003369725621,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1537,GO:0003944,1,0.961031657186628,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1538,GO:0003945,1,0.850079883680056,0,4,N-acetyllactosamine synthase activity,MF,
1539,GO:0003948,1,0.96145798091186,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1540,GO:0003950,1,0.485653310932701,0,17,NAD+ ADP-ribosyltransferase activity,MF,
1542,GO:0003952,1,0.960188160832726,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1543,GO:0003953,1,0.96344146594306,0,1,NAD+ nucleosidase activity,MF,
1544,GO:0003954,1,0.23269798836991,0,40,NADH dehydrogenase activity,MF,
1545,GO:0003955,1,0.886613826407558,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1546,GO:0003956,1,0.96300265421436,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1547,GO:0003957,1,0.956563247926027,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1548,GO:0003958,1,0.807656608374316,0,5,NADPH-hemoprotein reductase activity,MF,
1549,GO:0003960,1,0.891529503132918,0,3,NADPH:quinone reductase activity,MF,
1550,GO:0003962,1,0.96265960442676,0,1,cystathionine gamma-synthase activity,MF,
1551,GO:0003963,1,0.921540149423773,0,2,RNA-3'-phosphate cyclase activity,MF,
1552,GO:0003964,1,0.723382350235418,0,8,RNA-directed DNA polymerase activity,MF,
1553,GO:0003968,1,0.924280434660259,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1554,GO:0003972,1,0.958787867083198,0,1,RNA ligase (ATP) activity,MF,
1555,GO:0003973,1,0.956441843839217,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
1556,GO:0003974,1,0.963080846127032,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1557,GO:0003975,1,0.961255756037948,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1558,GO:0003976,1,0.886394584001196,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1559,GO:0003977,1,0.919999867988528,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1560,GO:0003978,1,0.963080846127032,0,1,UDP-glucose 4-epimerase activity,MF,
1561,GO:0003979,1,0.958074907260221,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1562,GO:0003980,1,0.914824533249632,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1563,GO:0003983,1,0.961259370841159,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1564,GO:0003985,1,0.88742777881645,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1565,GO:0003986,1,0.895676175676846,0,3,acetyl-CoA hydrolase activity,MF,
1566,GO:0003987,1,0.916967074364878,0,2,acetate-CoA ligase activity,MF,
1567,GO:0003988,1,0.78957541949464,0,6,acetyl-CoA C-acyltransferase activity,MF,
1568,GO:0003989,1,0.914777292668164,0,2,acetyl-CoA carboxylase activity,MF,
1569,GO:0003990,1,0.960188160832726,0,1,acetylcholinesterase activity,MF,
1570,GO:0003991,1,0.961515633785377,0,1,acetylglutamate kinase activity,MF,
1571,GO:0003993,1,0.790977798318101,0,6,acid phosphatase activity,MF,
1572,GO:0003994,1,0.918362755804494,0,2,aconitate hydratase activity,MF,
1573,GO:0003995,1,0.583752587745213,0,13,acyl-CoA dehydrogenase activity,MF,
1574,GO:0003996,1,0.960876543965003,0,1,acyl-CoA ligase activity,MF,
1575,GO:0003997,1,0.88262695147256,0,3,acyl-CoA oxidase activity,MF,
1576,GO:0003998,1,0.931016504966308,0,2,acylphosphatase activity,MF,
1577,GO:0003999,1,0.965369793085691,0,1,adenine phosphoribosyltransferase activity,MF,
1578,GO:0004000,1,0.775947615625184,0,6,adenosine deaminase activity,MF,
1579,GO:0004001,1,0.961580393285619,0,1,adenosine kinase activity,MF,
1580,GO:0004003,1,0.242487042065926,0,33,ATP-dependent DNA helicase activity,MF,
1582,GO:0004008,1,0.914777292668164,0,2,copper-exporting ATPase activity,MF,
1584,GO:0004013,1,0.879320324431143,0,3,adenosylhomocysteinase activity,MF,
1585,GO:0004014,1,0.957939783253298,0,1,adenosylmethionine decarboxylase activity,MF,
1586,GO:0004016,1,0.76659676873433,0,6,adenylate cyclase activity,MF,
1587,GO:0004017,1,0.811596944176707,0,5,adenylate kinase activity,MF,
1588,GO:0004018,1,0.963482675636237,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1589,GO:0004019,1,0.959148574166656,0,1,adenylosuccinate synthase activity,MF,
1590,GO:0004020,1,0.9186450919705,0,2,adenylylsulfate kinase activity,MF,
1591,GO:0004021,1,0.957026642911005,0,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1592,GO:0004022,1,0.959515561955651,0,1,alcohol dehydrogenase (NAD) activity,MF,
1593,GO:0004027,1,0.964186951617662,0,1,alcohol sulfotransferase activity,MF,
1597,GO:0004031,1,0.956491231636102,0,1,aldehyde oxidase activity,MF,
1598,GO:0004032,1,0.830945960457869,0,5,alditol:NADP+ 1-oxidoreductase activity,MF,
1600,GO:0004034,1,0.960050111061931,0,1,aldose 1-epimerase activity,MF,
1601,GO:0004040,1,0.919919055211749,0,2,amidase activity,MF,
1602,GO:0004042,1,0.961515633785377,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1603,GO:0004043,1,0.957445113851019,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1604,GO:0004044,1,0.957208308783455,0,1,amidophosphoribosyltransferase activity,MF,
1605,GO:0004045,1,0.860246537707095,0,4,aminoacyl-tRNA hydrolase activity,MF,
1606,GO:0004046,1,0.889244499365586,0,3,aminoacylase activity,MF,
1607,GO:0004047,1,0.926331985942464,0,2,aminomethyltransferase activity,MF,
1608,GO:0004052,1,0.921996590712921,0,2,arachidonate 12-lipoxygenase activity,MF,
1609,GO:0004053,1,0.926802447031919,0,2,arginase activity,MF,
1610,GO:0004055,1,0.962384348259453,0,1,argininosuccinate synthase activity,MF,
1611,GO:0004056,1,0.961802356086505,0,1,argininosuccinate lyase activity,MF,
1612,GO:0004057,1,0.961002767874492,0,1,arginyltransferase activity,MF,
1613,GO:0004060,1,0.961716667669917,0,1,arylamine N-acetyltransferase activity,MF,
1614,GO:0004061,1,0.962814632476997,0,1,arylformamidase activity,MF,
1615,GO:0004062,1,0.861364135304538,0,4,aryl sulfotransferase activity,MF,
1616,GO:0004064,1,0.889056034476586,0,3,arylesterase activity,MF,
1618,GO:0004066,1,0.922260941947027,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1619,GO:0004069,1,0.923008738817873,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1620,GO:0004070,1,0.914777293311417,0,2,aspartate carbamoyltransferase activity,MF,
1621,GO:0004074,1,0.930902984143311,0,2,biliverdin reductase activity,MF,
1622,GO:0004075,1,0.87803010159859,0,3,biotin carboxylase activity,MF,
1623,GO:0004077,1,0.956441843839217,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1624,GO:0004078,1,0.956441843839217,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1625,GO:0004079,1,0.956441843839217,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1626,GO:0004080,1,0.956441843839217,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1627,GO:0004081,1,0.925388694857522,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1628,GO:0004082,1,0.891770568486764,0,3,bisphosphoglycerate mutase activity,MF,
1629,GO:0004083,1,0.958787867083198,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
1630,GO:0004084,1,0.921105304694621,0,2,branched-chain-amino-acid transaminase activity,MF,
1631,GO:0004085,1,0.962057098494237,0,1,butyryl-CoA dehydrogenase activity,MF,
1632,GO:0004087,1,0.914777293311417,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1633,GO:0004088,1,0.914777293311417,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1634,GO:0004089,1,0.808741279163709,0,5,carbonate dehydratase activity,MF,
1639,GO:0004098,1,0.962116634221409,0,1,cerebroside-sulfatase activity,MF,
1640,GO:0004103,1,0.92387189231635,0,2,choline kinase activity,MF,
1641,GO:0004104,1,0.921162518810214,0,2,cholinesterase activity,MF,
1642,GO:0004105,1,0.921218255736746,0,2,choline-phosphate cytidylyltransferase activity,MF,
1643,GO:0004108,1,0.958556484743289,0,1,citrate (Si)-synthase activity,MF,
1644,GO:0004109,1,0.920924730300138,0,2,coproporphyrinogen oxidase activity,MF,
1646,GO:0004112,1,0.570027854237415,0,13,cyclic-nucleotide phosphodiesterase activity,MF,
1647,GO:0004113,1,0.956457369970198,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1648,GO:0004114,1,0.596006410763025,0,12,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1649,GO:0004115,1,0.735422635617614,0,7,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1650,GO:0004117,1,0.959323986822767,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1651,GO:0004118,1,0.956797270288564,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1652,GO:0004122,1,0.959654540720847,0,1,cystathionine beta-synthase activity,MF,
1653,GO:0004123,1,0.96265960442676,0,1,cystathionine gamma-lyase activity,MF,
1654,GO:0004126,1,0.729832894589021,0,8,cytidine deaminase activity,MF,
1655,GO:0004127,1,0.919130739198895,0,2,cytidylate kinase activity,MF,
1656,GO:0004128,1,0.754293909857142,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1658,GO:0004132,1,0.961668331293021,0,1,dCMP deaminase activity,MF,
1659,GO:0004133,1,0.956441843839217,0,1,glycogen debranching enzyme activity,MF,
1660,GO:0004134,1,0.956441843839217,0,1,4-alpha-glucanotransferase activity,MF,
1661,GO:0004135,1,0.956441843839217,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1662,GO:0004137,1,0.917874063006844,0,2,deoxycytidine kinase activity,MF,
1663,GO:0004138,1,0.964734502232411,0,1,deoxyguanosine kinase activity,MF,
1664,GO:0004139,1,0.962717105863326,0,1,deoxyribose-phosphate aldolase activity,MF,
1665,GO:0004140,1,0.923832657606599,0,2,dephospho-CoA kinase activity,MF,
1666,GO:0004142,1,0.88541032976604,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1667,GO:0004143,1,0.704914204679486,0,8,diacylglycerol kinase activity,MF,
1668,GO:0004144,1,0.919096363887145,0,2,diacylglycerol O-acyltransferase activity,MF,
1669,GO:0004145,1,0.930562127826944,0,2,diamine N-acetyltransferase activity,MF,
1670,GO:0004146,1,0.923133585373016,0,2,dihydrofolate reductase activity,MF,
1671,GO:0004148,1,0.957413043485265,0,1,dihydrolipoyl dehydrogenase activity,MF,
1672,GO:0004149,1,0.958896529823705,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1673,GO:0004151,1,0.914777293311417,0,2,dihydroorotase activity,MF,
1674,GO:0004152,1,0.961530034609931,0,1,dihydroorotate dehydrogenase activity,MF,
1675,GO:0004155,1,0.962961649857946,0,1,6,7-dihydropteridine reductase activity,MF,
1676,GO:0004157,1,0.956610929582769,0,1,dihydropyrimidinase activity,MF,
1677,GO:0004161,1,0.923968509693509,0,2,dimethylallyltranstransferase activity,MF,
1679,GO:0004164,1,0.962501271030242,0,1,diphthine synthase activity,MF,
1680,GO:0004165,1,0.879769261330587,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1681,GO:0004167,1,0.932514779934249,0,2,dopachrome isomerase activity,MF,
1682,GO:0004168,1,0.961060556757563,0,1,dolichol kinase activity,MF,
1683,GO:0004169,1,0.823063957502079,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1684,GO:0004170,1,0.962224489723766,0,1,dUTP diphosphatase activity,MF,
1685,GO:0004174,1,0.920140035796251,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1687,GO:0004176,1,0.842635814722548,0,4,ATP-dependent peptidase activity,MF,
1690,GO:0004181,1,0.684995380023838,0,9,metallocarboxypeptidase activity,MF,
1691,GO:0004185,1,0.718777478122953,0,8,serine-type carboxypeptidase activity,MF,
1692,GO:0004190,1,0.560170804509964,0,14,aspartic-type endopeptidase activity,MF,
1697,GO:0004298,1,0.520699831114343,0,18,threonine-type endopeptidase activity,MF,
1698,GO:0004300,1,0.727342778454102,0,8,enoyl-CoA hydratase activity,MF,
1699,GO:0004301,1,0.759838026020522,0,7,epoxide hydrolase activity,MF,
1700,GO:0004303,1,0.76595713972136,0,7,estradiol 17-beta-dehydrogenase activity,MF,
1701,GO:0004304,1,0.96253486933222,0,1,estrone sulfotransferase activity,MF,
1702,GO:0004305,1,0.848387702174333,0,4,ethanolamine kinase activity,MF,
1703,GO:0004306,1,0.962276322502539,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1704,GO:0004307,1,0.92687082451618,0,2,ethanolaminephosphotransferase activity,MF,
1705,GO:0004308,1,0.850720407450492,0,4,exo-alpha-sialidase activity,MF,
1706,GO:0004309,1,0.843651849211678,0,4,exopolyphosphatase activity,MF,
1707,GO:0004310,1,0.961389430746383,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1708,GO:0004311,1,0.883723571882758,0,3,farnesyltranstransferase activity,MF,
1709,GO:0004312,1,0.692783648791108,0,9,fatty acid synthase activity,MF,
1710,GO:0004313,1,0.956441843839217,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1711,GO:0004314,1,0.920055790811718,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1712,GO:0004315,1,0.922060630532282,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1713,GO:0004316,1,0.956441843839217,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1714,GO:0004317,1,0.956441843839217,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1715,GO:0004319,1,0.956441843839217,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1716,GO:0004320,1,0.920682000546707,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1717,GO:0004322,1,0.882012865157379,0,3,ferroxidase activity,MF,
1718,GO:0004324,1,0.962137583103709,0,1,ferredoxin-NADP+ reductase activity,MF,
1719,GO:0004325,1,0.956441843839217,0,1,ferrochelatase activity,MF,
1720,GO:0004326,1,0.960026136503136,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1721,GO:0004329,1,0.916755692252297,0,2,formate-tetrahydrofolate ligase activity,MF,
1722,GO:0004331,1,0.840052890014645,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1723,GO:0004332,1,0.927621940887142,0,2,fructose-bisphosphate aldolase activity,MF,
1724,GO:0004333,1,0.962501271030242,0,1,fumarate hydratase activity,MF,
1725,GO:0004334,1,0.963552745332219,0,1,fumarylacetoacetase activity,MF,
1726,GO:0004335,1,0.923459150607274,0,2,galactokinase activity,MF,
1727,GO:0004336,1,0.958740152998096,0,1,galactosylceramidase activity,MF,
1728,GO:0004337,1,0.923968509693509,0,2,geranyltranstransferase activity,MF,
1729,GO:0004340,1,0.876297488862277,0,3,glucokinase activity,MF,
1730,GO:0004342,1,0.924266336616419,0,2,glucosamine-6-phosphate deaminase activity,MF,
1731,GO:0004343,1,0.957020958121669,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1734,GO:0004346,1,0.963005798583478,0,1,glucose-6-phosphatase activity,MF,
1735,GO:0004347,1,0.961461586368301,0,1,glucose-6-phosphate isomerase activity,MF,
1736,GO:0004348,1,0.919381629564915,0,2,glucosylceramidase activity,MF,
1737,GO:0004349,1,0.95758141865191,0,1,glutamate 5-kinase activity,MF,
1738,GO:0004350,1,0.95758141865191,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1740,GO:0004352,1,0.957562892968896,0,1,glutamate dehydrogenase (NAD+) activity,MF,
1741,GO:0004353,1,0.957562892968896,0,1,glutamate dehydrogenase [NAD(P)+] activity,MF,
1743,GO:0004357,1,0.917345906062125,0,2,glutamate-cysteine ligase activity,MF,
1744,GO:0004359,1,0.881448788932848,0,3,glutaminase activity,MF,
1745,GO:0004360,1,0.956441843839217,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1746,GO:0004361,1,0.962766033503394,0,1,glutaryl-CoA dehydrogenase activity,MF,
1747,GO:0004362,1,0.960804579664695,0,1,glutathione-disulfide reductase activity,MF,
1748,GO:0004363,1,0.962106147083215,0,1,glutathione synthase activity,MF,
1749,GO:0004364,1,0.512044140750601,0,18,glutathione transferase activity,MF,
1750,GO:0004365,1,0.963953048764493,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1751,GO:0004366,1,0.808839227234973,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
1752,GO:0004367,1,0.95703524330473,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1753,GO:0004368,1,0.956441843839217,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
1754,GO:0004370,1,0.915623536867314,0,2,glycerol kinase activity,MF,
1755,GO:0004371,1,0.958787867083198,0,1,glycerone kinase activity,MF,
1756,GO:0004372,1,0.922600406772291,0,2,glycine hydroxymethyltransferase activity,MF,
1757,GO:0004373,1,0.957623944391169,0,1,glycogen (starch) synthase activity,MF,
1758,GO:0004375,1,0.95712201154618,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1759,GO:0004376,1,0.849457075954628,0,4,glycolipid mannosyltransferase activity,MF,
1760,GO:0004377,1,0.959876817778746,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1761,GO:0004378,1,0.958750693191651,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1762,GO:0004379,1,0.914877286441943,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1763,GO:0004382,1,0.920771007497056,0,2,guanosine-diphosphatase activity,MF,
1764,GO:0004383,1,0.76659676873433,0,6,guanylate cyclase activity,MF,
1765,GO:0004385,1,0.623666328581387,0,11,guanylate kinase activity,MF,
1767,GO:0004392,1,0.92731028872354,0,2,heme oxygenase (decyclizing) activity,MF,
1768,GO:0004394,1,0.956823028005688,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1769,GO:0004395,1,0.964083115104504,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1770,GO:0004396,1,0.876297488862277,0,3,hexokinase activity,MF,
1771,GO:0004397,1,0.958160049997458,0,1,histidine ammonia-lyase activity,MF,
1772,GO:0004402,1,0.117181769724703,0,51,histone acetyltransferase activity,MF,
1773,GO:0004407,1,0.171033542081431,0,42,histone deacetylase activity,MF,
1774,GO:0004408,1,0.9607399435986,0,1,holocytochrome-c synthase activity,MF,
1776,GO:0004416,1,0.923288462087707,0,2,hydroxyacylglutathione hydrolase activity,MF,
1777,GO:0004418,1,0.963514880645511,0,1,hydroxymethylbilane synthase activity,MF,
1778,GO:0004419,1,0.963413359851575,0,1,hydroxymethylglutaryl-CoA lyase activity,MF,
1779,GO:0004420,1,0.956625411611973,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1780,GO:0004421,1,0.95756135946994,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
1781,GO:0004422,1,0.927067628945206,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1782,GO:0004423,1,0.956441843839217,0,1,iduronate-2-sulfatase activity,MF,
1783,GO:0004427,1,0.894084039238841,0,3,inorganic diphosphatase activity,MF,
1784,GO:0004430,1,0.77416641397165,0,6,1-phosphatidylinositol 4-kinase activity,MF,
1786,GO:0004438,1,0.541917836015402,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1787,GO:0004439,1,0.708160593785797,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1788,GO:0004441,1,0.961448966112996,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1789,GO:0004445,1,0.808417599464048,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1790,GO:0004446,1,0.958910370595393,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1791,GO:0004448,1,0.823159377754079,0,5,isocitrate dehydrogenase activity,MF,
1792,GO:0004449,1,0.890171031708132,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1793,GO:0004450,1,0.924737773035969,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1794,GO:0004452,1,0.92652149337218,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
1795,GO:0004454,1,0.960278778522984,0,1,ketohexokinase activity,MF,
1796,GO:0004457,1,0.856159692112746,0,4,lactate dehydrogenase activity,MF,
1797,GO:0004458,1,0.959690575072104,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
1798,GO:0004459,1,0.892129163312383,0,3,L-lactate dehydrogenase activity,MF,
1799,GO:0004461,1,0.91987205383705,0,2,lactose synthase activity,MF,
1800,GO:0004462,1,0.961616317607833,0,1,lactoylglutathione lyase activity,MF,
1801,GO:0004463,1,0.96151203275936,0,1,leukotriene-A4 hydrolase activity,MF,
1802,GO:0004464,1,0.931972251775837,0,2,leukotriene-C4 synthase activity,MF,
1803,GO:0004465,1,0.882293001964088,0,3,lipoprotein lipase activity,MF,
1804,GO:0004466,1,0.851343936352057,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
1806,GO:0004468,1,0.840082241383957,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1807,GO:0004470,1,0.848715528291681,0,4,malic enzyme activity,MF,
1808,GO:0004471,1,0.880357550218592,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1809,GO:0004473,1,0.880357550218592,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1810,GO:0004475,1,0.963105685108655,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1811,GO:0004476,1,0.962561648789528,0,1,mannose-6-phosphate isomerase activity,MF,
1812,GO:0004477,1,0.846103804641258,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1813,GO:0004478,1,0.958983277574597,0,1,methionine adenosyltransferase activity,MF,
1814,GO:0004479,1,0.959193269451407,0,1,methionyl-tRNA formyltransferase activity,MF,
1815,GO:0004482,1,0.956441843839217,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1816,GO:0004483,1,0.919270839167849,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
1817,GO:0004484,1,0.95664394699563,0,1,mRNA guanylyltransferase activity,MF,
1818,GO:0004485,1,0.918836042647092,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
1819,GO:0004486,1,0.957579866097818,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1820,GO:0004487,1,0.883788096243287,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
1821,GO:0004488,1,0.846103804641258,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
1823,GO:0004490,1,0.963148942527419,0,1,methylglutaconyl-CoA hydratase activity,MF,
1824,GO:0004491,1,0.961111150127444,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
1825,GO:0004492,1,0.961360544739415,0,1,methylmalonyl-CoA decarboxylase activity,MF,
1826,GO:0004493,1,0.965074228027059,0,1,methylmalonyl-CoA epimerase activity,MF,
1827,GO:0004494,1,0.958603849440705,0,1,methylmalonyl-CoA mutase activity,MF,
1828,GO:0004496,1,0.961513833312638,0,1,mevalonate kinase activity,MF,
1830,GO:0004498,1,0.960026136503136,0,1,calcidiol 1-monooxygenase activity,MF,
1831,GO:0004499,1,0.961262985576921,0,1,N,N-dimethylaniline monooxygenase activity,MF,
1832,GO:0004500,1,0.958404959737927,0,1,dopamine beta-monooxygenase activity,MF,
1833,GO:0004504,1,0.957231078804825,0,1,peptidylglycine monooxygenase activity,MF,
1834,GO:0004505,1,0.92656778604614,0,2,phenylalanine 4-monooxygenase activity,MF,
1835,GO:0004506,1,0.958529419385071,0,1,squalene monooxygenase activity,MF,
1836,GO:0004511,1,0.962109643726768,0,1,tyrosine 3-monooxygenase activity,MF,
1839,GO:0004514,1,0.883485369211199,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
1840,GO:0004515,1,0.875594341914608,0,3,nicotinate-nucleotide adenylyltransferase activity,MF,
1841,GO:0004516,1,0.958787867083198,0,1,nicotinate phosphoribosyltransferase activity,MF,
1842,GO:0004517,1,0.918291200203417,0,2,nitric-oxide synthase activity,MF,
1845,GO:0004520,1,0.15704571188472,0,45,endodeoxyribonuclease activity,MF,
1846,GO:0004521,1,0.150573526336009,0,47,endoribonuclease activity,MF,
1847,GO:0004522,1,0.963228572969555,0,1,ribonuclease A activity,MF,
1848,GO:0004523,1,0.793389479467038,0,6,RNA-DNA hybrid ribonuclease activity,MF,
1849,GO:0004525,1,0.844499768059363,0,4,ribonuclease III activity,MF,
1850,GO:0004526,1,0.64943121399611,0,11,ribonuclease P activity,MF,
1851,GO:0004527,1,0.0581257133294762,0,68,exonuclease activity,MF,
1852,GO:0004528,1,0.84979296362986,0,4,phosphodiesterase I activity,MF,
1853,GO:0004529,1,0.495926596706977,0,17,exodeoxyribonuclease activity,MF,
1854,GO:0004530,1,0.916532876365381,0,2,deoxyribonuclease I activity,MF,
1855,GO:0004531,1,0.961745266686015,0,1,deoxyribonuclease II activity,MF,
1856,GO:0004532,1,0.24504463163025,0,34,exoribonuclease activity,MF,
1857,GO:0004534,1,0.875983981904282,0,3,5'-3' exoribonuclease activity,MF,
1858,GO:0004535,1,0.597017962250215,0,12,poly(A)-specific ribonuclease activity,MF,
1860,GO:0004540,1,0.0298696371152712,0,86,ribonuclease activity,MF,
1861,GO:0004549,1,0.531154142511202,0,16,tRNA-specific ribonuclease activity,MF,
1863,GO:0004551,1,0.622695333771986,0,12,nucleotide diphosphatase activity,MF,
1865,GO:0004556,1,0.961114764662936,0,1,alpha-amylase activity,MF,
1866,GO:0004557,1,0.922439465575029,0,2,alpha-galactosidase activity,MF,
1868,GO:0004559,1,0.568971604705908,0,13,alpha-mannosidase activity,MF,
1869,GO:0004560,1,0.92427361086417,0,2,alpha-L-fucosidase activity,MF,
1872,GO:0004565,1,0.846683374031645,0,4,beta-galactosidase activity,MF,
1873,GO:0004566,1,0.924745617950853,0,2,beta-glucuronidase activity,MF,
1874,GO:0004567,1,0.957833010849434,0,1,beta-mannosidase activity,MF,
1875,GO:0004568,1,0.917720781119006,0,2,chitinase activity,MF,
1876,GO:0004569,1,0.956600781516942,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
1877,GO:0004571,1,0.740686563390196,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
1878,GO:0004572,1,0.914799155580171,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
1879,GO:0004573,1,0.959249046543361,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
1881,GO:0004576,1,0.675477305857502,0,10,oligosaccharyl transferase activity,MF,
1882,GO:0004577,1,0.924490805725821,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
1883,GO:0004578,1,0.957009704575427,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
1884,GO:0004579,1,0.700478139475954,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
1885,GO:0004581,1,0.964334561191138,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
1886,GO:0004582,1,0.897621685054924,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
1887,GO:0004583,1,0.845044949761599,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
1888,GO:0004584,1,0.96047244470973,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
1889,GO:0004586,1,0.882019455835234,0,3,ornithine decarboxylase activity,MF,
1890,GO:0004587,1,0.961839736491861,0,1,ornithine-oxo-acid transaminase activity,MF,
1891,GO:0004588,1,0.959477338425506,0,1,orotate phosphoribosyltransferase activity,MF,
1892,GO:0004590,1,0.959477338425506,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
1894,GO:0004594,1,0.848588884363418,0,4,pantothenate kinase activity,MF,
1895,GO:0004595,1,0.96070409671246,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
1896,GO:0004596,1,0.661223542488278,0,10,peptide alpha-N-acetyltransferase activity,MF,
1897,GO:0004597,1,0.957351868553723,0,1,peptide-aspartate beta-dioxygenase activity,MF,
1898,GO:0004598,1,0.957231078804825,0,1,peptidylamidoglycolate lyase activity,MF,
1901,GO:0004605,1,0.879859846116488,0,3,phosphatidate cytidylyltransferase activity,MF,
1902,GO:0004607,1,0.963839902953951,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
1903,GO:0004608,1,0.964778188240337,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
1904,GO:0004609,1,0.922273276267045,0,2,phosphatidylserine decarboxylase activity,MF,
1905,GO:0004610,1,0.961777397943035,0,1,phosphoacetylglucosamine mutase activity,MF,
1906,GO:0004611,1,0.961893011303364,0,1,phosphoenolpyruvate carboxykinase activity,MF,
1907,GO:0004613,1,0.961893011303364,0,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
1909,GO:0004615,1,0.926050966746125,0,2,phosphomannomutase activity,MF,
1910,GO:0004616,1,0.885683211521501,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
1911,GO:0004617,1,0.961702355394599,0,1,phosphoglycerate dehydrogenase activity,MF,
1912,GO:0004618,1,0.960247337156865,0,1,phosphoglycerate kinase activity,MF,
1913,GO:0004619,1,0.891770568486764,0,3,phosphoglycerate mutase activity,MF,
1915,GO:0004621,1,0.960734563591107,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
1916,GO:0004622,1,0.513106963251524,0,16,lysophospholipase activity,MF,
1917,GO:0004623,1,0.437486978237532,0,20,phospholipase A2 activity,MF,
1919,GO:0004630,1,0.814228209561783,0,5,phospholipase D activity,MF,
1920,GO:0004631,1,0.96399668736991,0,1,phosphomevalonate kinase activity,MF,
1921,GO:0004632,1,0.964089820187488,0,1,phosphopantothenate--cysteine ligase activity,MF,
1922,GO:0004633,1,0.960988327643468,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
1923,GO:0004634,1,0.962409894753983,0,1,phosphopyruvate hydratase activity,MF,
1924,GO:0004637,1,0.957621550957317,0,1,phosphoribosylamine-glycine ligase activity,MF,
1925,GO:0004638,1,0.957793715511202,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1926,GO:0004639,1,0.957793715511202,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
1927,GO:0004641,1,0.957621550957317,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1928,GO:0004642,1,0.956446374547937,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
1929,GO:0004643,1,0.961425520249245,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
1930,GO:0004644,1,0.957621550957317,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
1931,GO:0004645,1,0.845154233278337,0,4,phosphorylase activity,MF,
1932,GO:0004647,1,0.924594643447958,0,2,phosphoserine phosphatase activity,MF,
1933,GO:0004648,1,0.961344291496941,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
1934,GO:0004649,1,0.921196569523867,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
1935,GO:0004651,1,0.921235456348659,0,2,polynucleotide 5'-phosphatase activity,MF,
1936,GO:0004652,1,0.70713444378766,0,8,polynucleotide adenylyltransferase activity,MF,
1937,GO:0004653,1,0.595114734262955,0,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,
1938,GO:0004654,1,0.956589907309842,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
1939,GO:0004655,1,0.958089214265029,0,1,porphobilinogen synthase activity,MF,
1940,GO:0004656,1,0.884267717208582,0,3,procollagen-proline 4-dioxygenase activity,MF,
1941,GO:0004657,1,0.960988327643468,0,1,proline dehydrogenase activity,MF,
1942,GO:0004658,1,0.923987072293495,0,2,propionyl-CoA carboxylase activity,MF,
1943,GO:0004659,1,0.539953605503524,0,15,prenyltransferase activity,MF,
1944,GO:0004660,1,0.923594300836803,0,2,protein farnesyltransferase activity,MF,
1945,GO:0004661,1,0.81882361494942,0,5,protein geranylgeranyltransferase activity,MF,
1946,GO:0004662,1,0.923862648307824,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
1947,GO:0004663,1,0.853619176276528,0,4,Rab geranylgeranyltransferase activity,MF,
1948,GO:0004666,1,0.914994790560034,0,2,prostaglandin-endoperoxide synthase activity,MF,
1949,GO:0004668,1,0.958072871054507,0,1,protein-arginine deiminase activity,MF,
1950,GO:0004671,1,0.956523440739523,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
1952,GO:0004673,1,0.965387612865884,0,1,protein histidine kinase activity,MF,
1955,GO:0004676,1,0.956441843839217,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
1956,GO:0004677,1,0.877230040033475,0,3,DNA-dependent protein kinase activity,MF,
1957,GO:0004679,1,0.744175781764337,0,7,AMP-activated protein kinase activity,MF,
1959,GO:0004686,1,0.956441843839217,0,1,elongation factor-2 kinase activity,MF,
1960,GO:0004687,1,0.914777292668164,0,2,myosin light chain kinase activity,MF,
1961,GO:0004689,1,0.806832279234927,0,5,phosphorylase kinase activity,MF,
1962,GO:0004690,1,0.740166773781129,0,7,cyclic nucleotide-dependent protein kinase activity,MF,
1963,GO:0004691,1,0.773338085041652,0,6,cAMP-dependent protein kinase activity,MF,
1964,GO:0004692,1,0.957128385594068,0,1,cGMP-dependent protein kinase activity,MF,
1966,GO:0004694,1,0.839612439039681,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
1967,GO:0004697,1,0.595049887086363,0,12,protein kinase C activity,MF,
1968,GO:0004698,1,0.956441843839217,0,1,calcium-dependent protein kinase C activity,MF,
1969,GO:0004699,1,0.878320402552919,0,3,calcium-independent protein kinase C activity,MF,
1973,GO:0004705,1,0.882279401396369,0,3,JUN kinase activity,MF,
1974,GO:0004706,1,0.876915822044665,0,3,JUN kinase kinase kinase activity,MF,
1975,GO:0004707,1,0.607265652688839,0,12,MAP kinase activity,MF,
1976,GO:0004708,1,0.605951557471718,0,12,MAP kinase kinase activity,MF,
1978,GO:0004711,1,0.739434553765418,0,7,ribosomal protein S6 kinase activity,MF,
1979,GO:0004712,1,0.221646699576101,0,36,protein serine/threonine/tyrosine kinase activity,MF,
1982,GO:0004715,1,0.264419024743822,0,31,non-membrane spanning protein tyrosine kinase activity,MF,
1984,GO:0004719,1,0.881562257140425,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
1985,GO:0004720,1,0.808268791885512,0,5,protein-lysine 6-oxidase activity,MF,
1988,GO:0004723,1,0.739290570337234,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
1990,GO:0004726,1,0.716764593199559,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
1991,GO:0004727,1,0.961580393285619,0,1,prenylated protein tyrosine phosphatase activity,MF,
1992,GO:0004728,1,0.959690575072104,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
1993,GO:0004729,1,0.962656304908182,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
1994,GO:0004730,1,0.962910855798239,0,1,pseudouridylate synthase activity,MF,
1995,GO:0004731,1,0.918515395078076,0,2,purine-nucleoside phosphorylase activity,MF,
1996,GO:0004733,1,0.957590767519006,0,1,pyridoxamine-phosphate oxidase activity,MF,
1997,GO:0004735,1,0.92639351543291,0,2,pyrroline-5-carboxylate reductase activity,MF,
1998,GO:0004736,1,0.956937648692346,0,1,pyruvate carboxylase activity,MF,
1999,GO:0004738,1,0.810776464118921,0,5,pyruvate dehydrogenase activity,MF,
2000,GO:0004739,1,0.922598812487433,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2001,GO:0004740,1,0.878977584593375,0,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2003,GO:0004742,1,0.956705835689818,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2004,GO:0004743,1,0.958787867083198,0,1,pyruvate kinase activity,MF,
2006,GO:0004747,1,0.964260512789494,0,1,ribokinase activity,MF,
2007,GO:0004748,1,0.87767461540119,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2008,GO:0004749,1,0.852598598365157,0,4,ribose phosphate diphosphokinase activity,MF,
2009,GO:0004750,1,0.96070051465296,0,1,ribulose-phosphate 3-epimerase activity,MF,
2010,GO:0004751,1,0.962348468382813,0,1,ribose-5-phosphate isomerase activity,MF,
2011,GO:0004753,1,0.956441843839217,0,1,saccharopine dehydrogenase activity,MF,
2012,GO:0004756,1,0.922068113727459,0,2,selenide, water dikinase activity,MF,
2013,GO:0004757,1,0.963549840155055,0,1,sepiapterin reductase activity,MF,
2014,GO:0004758,1,0.809672665029021,0,5,serine C-palmitoyltransferase activity,MF,
2015,GO:0004766,1,0.96405622692437,0,1,spermidine synthase activity,MF,
2016,GO:0004767,1,0.814601832055952,0,5,sphingomyelin phosphodiesterase activity,MF,
2017,GO:0004768,1,0.879475910595112,0,3,stearoyl-CoA 9-desaturase activity,MF,
2018,GO:0004769,1,0.964374490092341,0,1,steroid delta-isomerase activity,MF,
2020,GO:0004772,1,0.957692460089517,0,1,sterol O-acyltransferase activity,MF,
2021,GO:0004773,1,0.956441843839217,0,1,steryl-sulfatase activity,MF,
2022,GO:0004774,1,0.889530306730648,0,3,succinate-CoA ligase activity,MF,
2023,GO:0004775,1,0.926120243744573,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2024,GO:0004776,1,0.925472962381371,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2025,GO:0004777,1,0.956463626558617,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2026,GO:0004778,1,0.963034035118357,0,1,succinyl-CoA hydrolase activity,MF,
2027,GO:0004779,1,0.9186450919705,0,2,sulfate adenylyltransferase activity,MF,
2028,GO:0004781,1,0.9186450919705,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2029,GO:0004782,1,0.959323986822767,0,1,sulfinoalanine decarboxylase activity,MF,
2030,GO:0004784,1,0.862020152754689,0,4,superoxide dismutase activity,MF,
2031,GO:0004790,1,0.959803113935219,0,1,thioether S-methyltransferase activity,MF,
2034,GO:0004793,1,0.922600406772291,0,2,threonine aldolase activity,MF,
2035,GO:0004794,1,0.963713473724914,0,1,L-threonine ammonia-lyase activity,MF,
2037,GO:0004797,1,0.921208328668625,0,2,thymidine kinase activity,MF,
2038,GO:0004798,1,0.924436773665056,0,2,thymidylate kinase activity,MF,
2039,GO:0004799,1,0.963167399764482,0,1,thymidylate synthase activity,MF,
2040,GO:0004801,1,0.964139228634114,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2041,GO:0004802,1,0.961382210358185,0,1,transketolase activity,MF,
2042,GO:0004803,1,0.915416916804465,0,2,transposase activity,MF,
2044,GO:0004807,1,0.963541117147673,0,1,triose-phosphate isomerase activity,MF,
2045,GO:0004809,1,0.886401521913408,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2046,GO:0004810,1,0.960783019309075,0,1,tRNA adenylyltransferase activity,MF,
2047,GO:0004812,1,0.162927724829209,0,44,aminoacyl-tRNA ligase activity,MF,
2048,GO:0004813,1,0.88143076294885,0,3,alanine-tRNA ligase activity,MF,
2049,GO:0004814,1,0.888844217405885,0,3,arginine-tRNA ligase activity,MF,
2050,GO:0004815,1,0.920006354501105,0,2,aspartate-tRNA ligase activity,MF,
2051,GO:0004816,1,0.921225305261991,0,2,asparagine-tRNA ligase activity,MF,
2052,GO:0004817,1,0.923251257205493,0,2,cysteine-tRNA ligase activity,MF,
2053,GO:0004818,1,0.915373892657344,0,2,glutamate-tRNA ligase activity,MF,
2054,GO:0004819,1,0.918411377493976,0,2,glutamine-tRNA ligase activity,MF,
2055,GO:0004820,1,0.923802433510588,0,2,glycine-tRNA ligase activity,MF,
2056,GO:0004821,1,0.923407781662589,0,2,histidine-tRNA ligase activity,MF,
2057,GO:0004822,1,0.915930124478699,0,2,isoleucine-tRNA ligase activity,MF,
2058,GO:0004823,1,0.915171300962259,0,2,leucine-tRNA ligase activity,MF,
2059,GO:0004824,1,0.961380405141031,0,1,lysine-tRNA ligase activity,MF,
2060,GO:0004825,1,0.919170833869042,0,2,methionine-tRNA ligase activity,MF,
2061,GO:0004826,1,0.81824438605196,0,5,phenylalanine-tRNA ligase activity,MF,
2062,GO:0004827,1,0.886061182014848,0,3,proline-tRNA ligase activity,MF,
2063,GO:0004828,1,0.925095648014791,0,2,serine-tRNA ligase activity,MF,
2064,GO:0004829,1,0.882080319054784,0,3,threonine-tRNA ligase activity,MF,
2065,GO:0004830,1,0.920019535055147,0,2,tryptophan-tRNA ligase activity,MF,
2066,GO:0004831,1,0.921047062533359,0,2,tyrosine-tRNA ligase activity,MF,
2067,GO:0004832,1,0.876082482004189,0,3,valine-tRNA ligase activity,MF,
2068,GO:0004833,1,0.963207223515115,0,1,tryptophan 2,3-dioxygenase activity,MF,
2069,GO:0004835,1,0.956462998645709,0,1,tubulin-tyrosine ligase activity,MF,
2070,GO:0004839,1,0.805436016946091,0,5,ubiquitin activating enzyme activity,MF,
2073,GO:0004844,1,0.823750303373382,0,5,uracil DNA N-glycosylase activity,MF,
2074,GO:0004849,1,0.820895800907073,0,5,uridine kinase activity,MF,
2075,GO:0004850,1,0.962437067087896,0,1,uridine phosphorylase activity,MF,
2077,GO:0004853,1,0.963747422027828,0,1,uroporphyrinogen decarboxylase activity,MF,
2078,GO:0004854,1,0.914824534693486,0,2,xanthine dehydrogenase activity,MF,
2079,GO:0004855,1,0.956441845348625,0,1,xanthine oxidase activity,MF,
2080,GO:0004856,1,0.957270133322202,0,1,xylulokinase activity,MF,
2084,GO:0004861,1,0.644083642775225,0,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2085,GO:0004862,1,0.754003007201383,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
2092,GO:0004874,1,0.914859813420824,0,2,aryl hydrocarbon receptor activity,MF,
2094,GO:0004882,1,0.957916064022112,0,1,androgen receptor activity,MF,
2095,GO:0004883,1,0.956441843839217,0,1,glucocorticoid receptor activity,MF,
2096,GO:0004886,1,0.917056037419659,0,2,9-cis retinoic acid receptor activity,MF,
2099,GO:0004890,1,0.958160049997458,0,1,GABA-A receptor activity,MF,
2101,GO:0004897,1,0.876788834987021,0,3,ciliary neurotrophic factor receptor activity,MF,
2102,GO:0004900,1,0.96230042687993,0,1,erythropoietin receptor activity,MF,
2103,GO:0004904,1,0.816585911809981,0,5,interferon receptor activity,MF,
2104,GO:0004905,1,0.921694685934057,0,2,type I interferon receptor activity,MF,
2105,GO:0004906,1,0.923822049406696,0,2,interferon-gamma receptor activity,MF,
2106,GO:0004908,1,0.8124849446496,0,5,interleukin-1 receptor activity,MF,
2107,GO:0004909,1,0.92003961474094,0,2,interleukin-1, Type I, activating receptor activity,MF,
2108,GO:0004910,1,0.963622098166324,0,1,interleukin-1, Type II, blocking receptor activity,MF,
2109,GO:0004913,1,0.960380584070096,0,1,interleukin-4 receptor activity,MF,
2110,GO:0004915,1,0.916726701814491,0,2,interleukin-6 receptor activity,MF,
2111,GO:0004917,1,0.962457392907156,0,1,interleukin-7 receptor activity,MF,
2114,GO:0004921,1,0.958072871054507,0,1,interleukin-11 receptor activity,MF,
2115,GO:0004923,1,0.916337408417727,0,2,leukemia inhibitory factor receptor activity,MF,
2116,GO:0004924,1,0.877234382384436,0,3,oncostatin-M receptor activity,MF,
2118,GO:0004931,1,0.961659370281862,0,1,extracellularly ATP-gated cation channel activity,MF,
2119,GO:0004935,1,0.924253503264185,0,2,adrenergic receptor activity,MF,
2120,GO:0004936,1,0.961120186609872,0,1,alpha-adrenergic receptor activity,MF,
2121,GO:0004937,1,0.961120186609872,0,1,alpha1-adrenergic receptor activity,MF,
2122,GO:0004939,1,0.961645026588241,0,1,beta-adrenergic receptor activity,MF,
2123,GO:0004941,1,0.961645026588241,0,1,beta2-adrenergic receptor activity,MF,
2124,GO:0004945,1,0.964304781093423,0,1,angiotensin type II receptor activity,MF,
2125,GO:0004947,1,0.92238665812939,0,2,bradykinin receptor activity,MF,
2126,GO:0004948,1,0.956483797008087,0,1,calcitonin receptor activity,MF,
2128,GO:0004952,1,0.929456054798056,0,2,dopamine neurotransmitter receptor activity,MF,
2129,GO:0004953,1,0.816787999193005,0,5,icosanoid receptor activity,MF,
2130,GO:0004954,1,0.885424146619465,0,3,prostanoid receptor activity,MF,
2131,GO:0004955,1,0.921548921765071,0,2,prostaglandin receptor activity,MF,
2132,GO:0004957,1,0.957677532435855,0,1,prostaglandin E receptor activity,MF,
2133,GO:0004960,1,0.960806377001927,0,1,thromboxane receptor activity,MF,
2134,GO:0004961,1,0.960806377001927,0,1,thromboxane A2 receptor activity,MF,
2135,GO:0004962,1,0.957125193193742,0,1,endothelin receptor activity,MF,
2136,GO:0004965,1,0.915371667231112,0,2,G-protein coupled GABA receptor activity,MF,
2137,GO:0004966,1,0.890466383591682,0,3,galanin receptor activity,MF,
2138,GO:0004968,1,0.914777292741325,0,2,gonadotropin-releasing hormone receptor activity,MF,
2139,GO:0004969,1,0.917133735471384,0,2,histamine receptor activity,MF,
2140,GO:0004970,1,0.875192997287286,0,3,ionotropic glutamate receptor activity,MF,
2141,GO:0004972,1,0.875192997287286,0,3,NMDA glutamate receptor activity,MF,
2142,GO:0004974,1,0.922500762465884,0,2,leukotriene receptor activity,MF,
2144,GO:0004979,1,0.962252164035365,0,1,beta-endorphin receptor activity,MF,
2146,GO:0004984,1,0.892007715190121,0,3,olfactory receptor activity,MF,
2147,GO:0004985,1,0.889915128606543,0,3,opioid receptor activity,MF,
2148,GO:0004990,1,0.956703611372165,0,1,oxytocin receptor activity,MF,
2149,GO:0004992,1,0.956842221697132,0,1,platelet activating factor receptor activity,MF,
2150,GO:0004993,1,0.887725713534676,0,3,G-protein coupled serotonin receptor activity,MF,
2151,GO:0004996,1,0.957076563173688,0,1,thyroid-stimulating hormone receptor activity,MF,
2152,GO:0004998,1,0.956462433765706,0,1,transferrin receptor activity,MF,
2154,GO:0005000,1,0.916543914576028,0,2,vasopressin receptor activity,MF,
2155,GO:0005001,1,0.6443773851613,0,10,transmembrane receptor protein tyrosine phosphatase activity,MF,
2161,GO:0005008,1,0.956441843839217,0,1,hepatocyte growth factor-activated receptor activity,MF,
2163,GO:0005010,1,0.8749246654594,0,3,insulin-like growth factor-activated receptor activity,MF,
2164,GO:0005011,1,0.956531058175876,0,1,macrophage colony-stimulating factor receptor activity,MF,
2165,GO:0005021,1,0.918230831211416,0,2,vascular endothelial growth factor-activated receptor activity,MF,
2167,GO:0005025,1,0.87690886602126,0,3,transforming growth factor beta receptor activity, type I,MF,
2168,GO:0005026,1,0.956566939031699,0,1,transforming growth factor beta receptor activity, type II,MF,
2173,GO:0005041,1,0.675977619981162,0,9,low-density lipoprotein particle receptor activity,MF,
2174,GO:0005042,1,0.956482823133062,0,1,netrin receptor activity,MF,
2176,GO:0005046,1,0.923992080422723,0,2,KDEL sequence binding,MF,
2177,GO:0005047,1,0.813618966218799,0,5,signal recognition particle binding,MF,
2178,GO:0005048,1,0.184965217874474,0,40,signal sequence binding,MF,
2179,GO:0005049,1,0.705601948343551,0,8,nuclear export signal receptor activity,MF,
2180,GO:0005052,1,0.917299379418353,0,2,peroxisome matrix targeting signal-1 binding,MF,
2181,GO:0005053,1,0.963465044831287,0,1,peroxisome matrix targeting signal-2 binding,MF,
2186,GO:0005072,1,0.707288085860082,0,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2187,GO:0005078,1,0.734883728505722,0,7,MAP-kinase scaffold activity,MF,
2191,GO:0005087,1,0.855270678865807,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2194,GO:0005090,1,0.961172605270695,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2195,GO:0005092,1,0.58875413884083,0,13,GDP-dissociation inhibitor activity,MF,
2196,GO:0005093,1,0.922142963118277,0,2,Rab GDP-dissociation inhibitor activity,MF,
2197,GO:0005094,1,0.927823662866467,0,2,Rho GDP-dissociation inhibitor activity,MF,
2198,GO:0005095,1,0.635970543912851,0,11,GTPase inhibitor activity,MF,
2201,GO:0005104,1,0.648516987686312,0,10,fibroblast growth factor receptor binding,MF,
2202,GO:0005105,1,0.960781223267318,0,1,type 1 fibroblast growth factor receptor binding,MF,
2204,GO:0005112,1,0.525334419158159,0,15,Notch binding,MF,
2205,GO:0005113,1,0.808790100435485,0,5,patched binding,MF,
2206,GO:0005114,1,0.743137733948243,0,7,type II transforming growth factor beta receptor binding,MF,
2207,GO:0005115,1,0.956441843839217,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2208,GO:0005119,1,0.916007359029005,0,2,smoothened binding,MF,
2210,GO:0005124,1,0.923232139887825,0,2,scavenger receptor binding,MF,
2213,GO:0005127,1,0.88195289124387,0,3,ciliary neurotrophic factor receptor binding,MF,
2214,GO:0005128,1,0.957929311651211,0,1,erythropoietin receptor binding,MF,
2215,GO:0005131,1,0.84113066557384,0,4,growth hormone receptor binding,MF,
2216,GO:0005132,1,0.929238714192212,0,2,type I interferon receptor binding,MF,
2217,GO:0005134,1,0.884729226636061,0,3,interleukin-2 receptor binding,MF,
2218,GO:0005135,1,0.957929311651211,0,1,interleukin-3 receptor binding,MF,
2219,GO:0005136,1,0.958226606773588,0,1,interleukin-4 receptor binding,MF,
2220,GO:0005137,1,0.961176220626819,0,1,interleukin-5 receptor binding,MF,
2221,GO:0005138,1,0.810091944733817,0,5,interleukin-6 receptor binding,MF,
2222,GO:0005141,1,0.963030903296506,0,1,interleukin-10 receptor binding,MF,
2223,GO:0005142,1,0.960504359753247,0,1,interleukin-11 receptor binding,MF,
2224,GO:0005143,1,0.919936054668529,0,2,interleukin-12 receptor binding,MF,
2225,GO:0005146,1,0.921555628251402,0,2,leukemia inhibitory factor receptor binding,MF,
2226,GO:0005149,1,0.718833664530818,0,8,interleukin-1 receptor binding,MF,
2227,GO:0005150,1,0.921517959837066,0,2,interleukin-1, Type I receptor binding,MF,
2228,GO:0005151,1,0.920612265231795,0,2,interleukin-1, Type II receptor binding,MF,
2229,GO:0005152,1,0.882659006228427,0,3,interleukin-1 receptor antagonist activity,MF,
2230,GO:0005153,1,0.958224430065193,0,1,interleukin-8 receptor binding,MF,
2232,GO:0005157,1,0.960240360586506,0,1,macrophage colony-stimulating factor receptor binding,MF,
2235,GO:0005160,1,0.363370901837213,0,24,transforming growth factor beta receptor binding,MF,
2236,GO:0005161,1,0.647866253250429,0,10,platelet-derived growth factor receptor binding,MF,
2239,GO:0005166,1,0.964775768520543,0,1,neurotrophin p75 receptor binding,MF,
2242,GO:0005169,1,0.922756428789441,0,2,neurotrophin TRKB receptor binding,MF,
2243,GO:0005170,1,0.956449657969446,0,1,neurotrophin TRKC receptor binding,MF,
2244,GO:0005171,1,0.961619907758403,0,1,hepatocyte growth factor receptor binding,MF,
2246,GO:0005173,1,0.875217759017978,0,3,stem cell factor receptor binding,MF,
2247,GO:0005174,1,0.960761473693852,0,1,CD40 receptor binding,MF,
2248,GO:0005175,1,0.965517824034273,0,1,CD27 receptor binding,MF,
2249,GO:0005176,1,0.926204502236304,0,2,ErbB-2 class receptor binding,MF,
2252,GO:0005183,1,0.962766033503394,0,1,gonadotropin hormone-releasing hormone activity,MF,
2253,GO:0005184,1,0.893579445801093,0,3,neuropeptide hormone activity,MF,
2255,GO:0005199,1,0.957750084148186,0,1,structural constituent of cell wall,MF,
2257,GO:0005201,1,0.229571922366053,0,34,extracellular matrix structural constituent,MF,
2258,GO:0005212,1,0.890317941961111,0,3,structural constituent of eye lens,MF,
2262,GO:0005219,1,0.964832408529058,0,1,ryanodine-sensitive calcium-release channel activity,MF,
2263,GO:0005220,1,0.874924186969474,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2265,GO:0005227,1,0.582013435803403,0,13,calcium activated cation channel activity,MF,
2267,GO:0005230,1,0.653963612913238,0,10,extracellular ligand-gated ion channel activity,MF,
2268,GO:0005231,1,0.713450985981507,0,8,excitatory extracellular ligand-gated ion channel activity,MF,
2269,GO:0005234,1,0.914804196863567,0,2,extracellularly glutamate-gated ion channel activity,MF,
2270,GO:0005237,1,0.958160049997458,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
2275,GO:0005246,1,0.481780635112345,0,18,calcium channel regulator activity,MF,
2279,GO:0005250,1,0.918553866422492,0,2,A-type (transient outward) potassium channel activity,MF,
2287,GO:0005275,1,0.958459304617754,0,1,amine transmembrane transporter activity,MF,
2288,GO:0005280,1,0.878531191125918,0,3,amino acid:proton symporter activity,MF,
2289,GO:0005283,1,0.741202648884376,0,7,amino acid:sodium symporter activity,MF,
2290,GO:0005287,1,0.918619107337285,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2291,GO:0005289,1,0.918619107337285,0,2,high-affinity arginine transmembrane transporter activity,MF,
2292,GO:0005290,1,0.919838726087908,0,2,L-histidine transmembrane transporter activity,MF,
2293,GO:0005292,1,0.918619107337285,0,2,high-affinity lysine transmembrane transporter activity,MF,
2294,GO:0005294,1,0.956441843839217,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2295,GO:0005295,1,0.958026563055971,0,1,neutral amino acid:sodium symporter activity,MF,
2296,GO:0005298,1,0.956703611372165,0,1,proline:sodium symporter activity,MF,
2297,GO:0005308,1,0.957475083746267,0,1,creatine transmembrane transporter activity,MF,
2298,GO:0005309,1,0.957475083746267,0,1,creatine:sodium symporter activity,MF,
2300,GO:0005313,1,0.772206254370932,0,6,L-glutamate transmembrane transporter activity,MF,
2301,GO:0005314,1,0.918228348780826,0,2,high-affinity glutamate transmembrane transporter activity,MF,
2302,GO:0005315,1,0.877055418468287,0,3,inorganic phosphate transmembrane transporter activity,MF,
2303,GO:0005316,1,0.957895426154051,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2305,GO:0005324,1,0.919671454972756,0,2,long-chain fatty acid transporter activity,MF,
2306,GO:0005326,1,0.374397777574731,0,23,neurotransmitter transporter activity,MF,
2307,GO:0005328,1,0.648679956538313,0,10,neurotransmitter:sodium symporter activity,MF,
2308,GO:0005329,1,0.914942483729233,0,2,dopamine transmembrane transporter activity,MF,
2309,GO:0005330,1,0.956614265908789,0,1,dopamine:sodium symporter activity,MF,
2310,GO:0005332,1,0.961784531839262,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
2311,GO:0005335,1,0.956614265908789,0,1,serotonin:sodium symporter activity,MF,
2313,GO:0005338,1,0.639124809805448,0,11,nucleotide-sugar transmembrane transporter activity,MF,
2316,GO:0005344,1,0.961954963465342,0,1,oxygen carrier activity,MF,
2317,GO:0005345,1,0.818252346199502,0,5,purine nucleobase transmembrane transporter activity,MF,
2318,GO:0005346,1,0.637586219113025,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2319,GO:0005347,1,0.718461507216229,0,8,ATP transmembrane transporter activity,MF,
2320,GO:0005350,1,0.921051177574091,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
2323,GO:0005365,1,0.914777292668164,0,2,myo-inositol transmembrane transporter activity,MF,
2324,GO:0005366,1,0.956441843839217,0,1,myo-inositol:proton symporter activity,MF,
2325,GO:0005367,1,0.956441843839217,0,1,myo-inositol:sodium symporter activity,MF,
2326,GO:0005368,1,0.956441843839217,0,1,taurine transmembrane transporter activity,MF,
2327,GO:0005369,1,0.956441843839217,0,1,taurine:sodium symporter activity,MF,
2328,GO:0005372,1,0.852820760456033,0,4,water transmembrane transporter activity,MF,
2329,GO:0005375,1,0.778382220653057,0,6,copper ion transmembrane transporter activity,MF,
2330,GO:0005381,1,0.780057894958634,0,6,iron ion transmembrane transporter activity,MF,
2331,GO:0005384,1,0.839732862964614,0,4,manganese ion transmembrane transporter activity,MF,
2333,GO:0005388,1,0.702743944489243,0,8,calcium-transporting ATPase activity,MF,
2337,GO:0005415,1,0.922606417102907,0,2,nucleoside:sodium symporter activity,MF,
2338,GO:0005416,1,0.678859776156402,0,9,amino acid:cation symporter activity,MF,
2339,GO:0005427,1,0.958185588856806,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2340,GO:0005432,1,0.881091816429122,0,3,calcium:sodium antiporter activity,MF,
2341,GO:0005436,1,0.917005403325718,0,2,sodium:phosphate symporter activity,MF,
2343,GO:0005452,1,0.596066596496712,0,12,inorganic anion exchanger activity,MF,
2344,GO:0005456,1,0.962426886922234,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2345,GO:0005457,1,0.916310332209799,0,2,GDP-fucose transmembrane transporter activity,MF,
2346,GO:0005459,1,0.928339508525673,0,2,UDP-galactose transmembrane transporter activity,MF,
2347,GO:0005461,1,0.956441843839217,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2348,GO:0005462,1,0.919357708134558,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2349,GO:0005464,1,0.956441843839217,0,1,UDP-xylose transmembrane transporter activity,MF,
2350,GO:0005471,1,0.888407405316192,0,3,ATP:ADP antiporter activity,MF,
2351,GO:0005476,1,0.920791451635959,0,2,carnitine:acyl carnitine antiporter activity,MF,
2352,GO:0005477,1,0.957479419432803,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2353,GO:0005483,1,0.881613078169458,0,3,soluble NSF attachment protein activity,MF,
2357,GO:0005497,1,0.928068082592441,0,2,androgen binding,MF,
2358,GO:0005499,1,0.919786401223033,0,2,vitamin D binding,MF,
2362,GO:0005504,1,0.579614073303229,0,14,fatty acid binding,MF,
2364,GO:0005507,1,0.216254444897495,0,38,copper ion binding,MF,
2366,GO:0005513,1,0.722266777621,0,8,detection of calcium ion,BP,
2370,GO:0005519,1,0.956975068871395,0,1,cytoskeletal regulatory protein binding,MF,
2379,GO:0005534,1,0.884851966311302,0,3,galactose binding,MF,
2380,GO:0005536,1,0.683570779973072,0,9,glucose binding,MF,
2381,GO:0005537,1,0.718176855174873,0,8,mannose binding,MF,
2383,GO:0005540,1,0.720552991222274,0,8,hyaluronic acid binding,MF,
2384,GO:0005542,1,0.787378808865303,0,6,folic acid binding,MF,
2387,GO:0005545,1,0.591296047353527,0,12,1-phosphatidylinositol binding,MF,
2389,GO:0005547,1,0.288551636843334,0,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
2393,GO:0005577,1,0.87791913719831,0,3,fibrinogen complex,CC,
2395,GO:0005579,1,0.956443767776723,0,1,membrane attack complex,CC,
2398,GO:0005584,1,0.914780056935387,0,2,collagen type I trimer,CC,
2399,GO:0005587,1,0.80034130881904,0,5,collagen type IV trimer,CC,
2400,GO:0005588,1,0.874924186969474,0,3,collagen type V trimer,CC,
2403,GO:0005591,1,0.959574977993315,0,1,collagen type VIII trimer,CC,
2404,GO:0005592,1,0.956441843839217,0,1,collagen type XI trimer,CC,
2405,GO:0005593,1,0.842022778377401,0,4,FACIT collagen trimer,CC,
2406,GO:0005594,1,0.920481250236332,0,2,collagen type IX trimer,CC,
2407,GO:0005595,1,0.956441843839217,0,1,collagen type XII trimer,CC,
2408,GO:0005597,1,0.956442016918176,0,1,collagen type XVI trimer,CC,
2409,GO:0005598,1,0.959574977993315,0,1,short-chain collagen trimer,CC,
2410,GO:0005600,1,0.958370112224775,0,1,collagen type XIII trimer,CC,
2413,GO:0005606,1,0.874924186969474,0,3,laminin-1 complex,CC,
2414,GO:0005607,1,0.914805910034403,0,2,laminin-2 complex,CC,
2416,GO:0005610,1,0.87533569169235,0,3,laminin-5 complex,CC,
2424,GO:0005638,1,0.846126450304428,0,4,lamin filament,CC,
2427,GO:0005641,1,0.745006126113755,0,7,nuclear envelope lumen,CC,
2428,GO:0005642,1,0.807877442948338,0,5,annulate lamellae,CC,
2429,GO:0005643,1,0.0407235769037266,0,76,nuclear pore,CC,
2430,GO:0005652,1,0.687297099030374,0,9,nuclear lamina,CC,
2432,GO:0005655,1,0.735679371911419,0,8,nucleolar ribonuclease P complex,CC,
2433,GO:0005656,1,0.888500646288565,0,3,nuclear pre-replicative complex,CC,
2435,GO:0005658,1,0.780021418532228,0,6,alpha DNA polymerase:primase complex,CC,
2436,GO:0005662,1,0.563759276409794,0,14,DNA replication factor A complex,CC,
2437,GO:0005663,1,0.790964070320723,0,6,DNA replication factor C complex,CC,
2438,GO:0005664,1,0.685083313653993,0,9,nuclear origin of replication recognition complex,CC,
2439,GO:0005665,1,0.514392894730352,0,17,DNA-directed RNA polymerase II, core complex,CC,
2440,GO:0005666,1,0.510592820476511,0,17,DNA-directed RNA polymerase III complex,CC,
2442,GO:0005668,1,0.926151836542044,0,2,RNA polymerase transcription factor SL1 complex,CC,
2443,GO:0005669,1,0.245067872281976,0,35,transcription factor TFIID complex,CC,
2444,GO:0005671,1,0.555628781142872,0,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2445,GO:0005672,1,0.860759183258893,0,4,transcription factor TFIIA complex,CC,
2446,GO:0005673,1,0.923267829151982,0,2,transcription factor TFIIE complex,CC,
2447,GO:0005674,1,0.924817180104787,0,2,transcription factor TFIIF complex,CC,
2448,GO:0005675,1,0.594943411756183,0,13,holo TFIIH complex,CC,
2449,GO:0005677,1,0.68113662336418,0,9,chromatin silencing complex,CC,
2450,GO:0005680,1,0.430158230059106,0,21,anaphase-promoting complex,CC,
2452,GO:0005682,1,0.410025796606048,0,22,U5 snRNP,CC,
2453,GO:0005683,1,0.773187133840297,0,7,U7 snRNP,CC,
2454,GO:0005684,1,0.0983301981098938,0,58,U2-type spliceosomal complex,CC,
2455,GO:0005685,1,0.458868635733382,0,20,U1 snRNP,CC,
2456,GO:0005686,1,0.460932713945462,0,20,U2 snRNP,CC,
2457,GO:0005687,1,0.658530687042704,0,11,U4 snRNP,CC,
2458,GO:0005688,1,0.739701879703274,0,8,U6 snRNP,CC,
2459,GO:0005689,1,0.368156443716003,0,26,U12-type spliceosomal complex,CC,
2460,GO:0005690,1,0.921474296444937,0,2,U4atac snRNP,CC,
2461,GO:0005691,1,0.956688923264148,0,1,U6atac snRNP,CC,
2463,GO:0005697,1,0.411523035668891,0,22,telomerase holoenzyme complex,CC,
2464,GO:0005712,1,0.918278007046537,0,2,chiasma,CC,
2465,GO:0005713,1,0.960101674776263,0,1,recombination nodule,CC,
2466,GO:0005715,1,0.960101674776263,0,1,late recombination nodule,CC,
2470,GO:0005724,1,0.96300265421436,0,1,nuclear telomeric heterochromatin,CC,
2471,GO:0005726,1,0.838373720668172,0,4,perichromatin fibrils,CC,
2473,GO:0005731,1,0.962746502046533,0,1,nucleolus organizer region,CC,
2474,GO:0005732,1,0.403235580417118,0,24,small nucleolar ribonucleoprotein complex,CC,
2475,GO:0005736,1,0.621329584306664,0,12,DNA-directed RNA polymerase I complex,CC,
2480,GO:0005742,1,0.735557330693953,0,8,mitochondrial outer membrane translocase complex,CC,
2482,GO:0005744,1,0.600475050153506,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2483,GO:0005745,1,0.919598822996815,0,2,m-AAA complex,CC,
2485,GO:0005747,1,0.216744236706144,0,42,mitochondrial respiratory chain complex I,CC,
2487,GO:0005750,1,0.654215899594119,0,11,mitochondrial respiratory chain complex III,CC,
2489,GO:0005753,1,0.961071396363931,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2490,GO:0005757,1,0.856478761077345,0,4,mitochondrial permeability transition pore complex,CC,
2493,GO:0005760,1,0.915190581316752,0,2,gamma DNA polymerase complex,CC,
2494,GO:0005761,1,0.0439279193175917,0,84,mitochondrial ribosome,CC,
2495,GO:0005762,1,0.149993148757882,0,51,mitochondrial large ribosomal subunit,CC,
2496,GO:0005763,1,0.355388756495885,0,28,mitochondrial small ribosomal subunit,CC,
2500,GO:0005767,1,0.667560888197287,0,10,secondary lysosome,CC,
2514,GO:0005784,1,0.863124297606178,0,4,Sec61 translocon complex,CC,
2515,GO:0005785,1,0.756406750491718,0,7,signal recognition particle receptor complex,CC,
2516,GO:0005786,1,0.791393929463581,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2517,GO:0005787,1,0.823428652468298,0,5,signal peptidase complex,CC,
2520,GO:0005790,1,0.404174195228165,0,22,smooth endoplasmic reticulum,CC,
2526,GO:0005797,1,0.755242411920313,0,7,Golgi medial cisterna,CC,
2532,GO:0005814,1,0.0086703269167336,0,112,centriole,CC,
2534,GO:0005816,1,0.739524139894978,0,7,spindle pole body,CC,
2535,GO:0005818,1,0.708911108875253,0,8,aster,CC,
2537,GO:0005826,1,0.808373991103079,0,5,actomyosin contractile ring,CC,
2538,GO:0005827,1,0.808407654325868,0,5,polar microtubule,CC,
2539,GO:0005828,1,0.73778970586416,0,7,kinetochore microtubule,CC,
2541,GO:0005832,1,0.664971053815147,0,10,chaperonin-containing T-complex,CC,
2542,GO:0005833,1,0.958544150054087,0,1,hemoglobin complex,CC,
2543,GO:0005834,1,0.440363401985197,0,20,heterotrimeric G-protein complex,CC,
2544,GO:0005838,1,0.446105446545049,0,21,proteasome regulatory particle,CC,
2545,GO:0005839,1,0.475492721267413,0,20,proteasome core complex,CC,
2548,GO:0005845,1,0.632923621043728,0,11,mRNA cap binding complex,CC,
2549,GO:0005846,1,0.919578382289125,0,2,nuclear cap binding complex,CC,
2550,GO:0005847,1,0.509253497386248,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2551,GO:0005849,1,0.468824683798896,0,18,mRNA cleavage factor complex,CC,
2552,GO:0005850,1,0.841521764381716,0,4,eukaryotic translation initiation factor 2 complex,CC,
2553,GO:0005851,1,0.787775505487366,0,6,eukaryotic translation initiation factor 2B complex,CC,
2554,GO:0005852,1,0.510123295453793,0,17,eukaryotic translation initiation factor 3 complex,CC,
2555,GO:0005853,1,0.890437037264688,0,3,eukaryotic translation elongation factor 1 complex,CC,
2556,GO:0005854,1,0.922595228670577,0,2,nascent polypeptide-associated complex,CC,
2558,GO:0005858,1,0.708740887404322,0,8,axonemal dynein complex,CC,
2560,GO:0005861,1,0.89076762563307,0,3,troponin complex,CC,
2561,GO:0005862,1,0.851922129188183,0,4,muscle thin filament tropomyosin,CC,
2562,GO:0005863,1,0.957248930696226,0,1,striated muscle myosin thick filament,CC,
2564,GO:0005868,1,0.442543198491403,0,20,cytoplasmic dynein complex,CC,
2565,GO:0005869,1,0.725850895409086,0,8,dynactin complex,CC,
2567,GO:0005873,1,0.877133970283176,0,3,plus-end kinesin complex,CC,
2570,GO:0005876,1,0.0938483688583895,0,56,spindle microtubule,CC,
2571,GO:0005879,1,0.810452334802704,0,5,axonemal microtubule,CC,
2572,GO:0005880,1,0.963545480053835,0,1,nuclear microtubule,CC,
2577,GO:0005885,1,0.680622486782019,0,10,Arp2/3 protein complex,CC,
2581,GO:0005890,1,0.847743975611598,0,4,sodium:potassium-exchanging ATPase complex,CC,
2582,GO:0005891,1,0.689069227945247,0,9,voltage-gated calcium channel complex,CC,
2583,GO:0005892,1,0.810696945601403,0,5,acetylcholine-gated channel complex,CC,
2584,GO:0005895,1,0.961176220626819,0,1,interleukin-5 receptor complex,CC,
2585,GO:0005896,1,0.916726701814491,0,2,interleukin-6 receptor complex,CC,
2586,GO:0005898,1,0.95694618751992,0,1,interleukin-13 receptor complex,CC,
2588,GO:0005900,1,0.917192502363145,0,2,oncostatin-M receptor complex,CC,
2596,GO:0005915,1,0.770090885869508,0,6,zonula adherens,CC,
2597,GO:0005916,1,0.769542289478887,0,6,fascia adherens,CC,
2603,GO:0005927,1,0.963280149525521,0,1,muscle tendon junction,CC,
2607,GO:0005940,1,0.677418330253467,0,9,septin ring,CC,
2610,GO:0005945,1,0.917913552336195,0,2,6-phosphofructokinase complex,CC,
2611,GO:0005947,1,0.818532935835377,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2612,GO:0005952,1,0.810304118201031,0,5,cAMP-dependent protein kinase complex,CC,
2613,GO:0005953,1,0.923862648307824,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2614,GO:0005954,1,0.960074142414195,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2615,GO:0005955,1,0.840210892060158,0,4,calcineurin complex,CC,
2616,GO:0005956,1,0.925143998052294,0,2,protein kinase CK2 complex,CC,
2617,GO:0005958,1,0.881299714305864,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2618,GO:0005960,1,0.922095364377755,0,2,glycine cleavage complex,CC,
2619,GO:0005964,1,0.806832279234927,0,5,phosphorylase kinase complex,CC,
2620,GO:0005965,1,0.923594300836803,0,2,protein farnesyltransferase complex,CC,
2621,GO:0005967,1,0.879220236308992,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2622,GO:0005968,1,0.847706003100567,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2623,GO:0005969,1,0.956441843839217,0,1,serine-pyruvate aminotransferase complex,CC,
2624,GO:0005971,1,0.87767461540119,0,3,ribonucleoside-diphosphate reductase complex,CC,
2631,GO:0005981,1,0.844521438305227,0,4,regulation of glycogen catabolic process,BP,
2636,GO:0005991,1,0.958618969707619,0,1,trehalose metabolic process,BP,
2638,GO:0005997,1,0.856369965867811,0,4,xylulose metabolic process,BP,
2639,GO:0005998,1,0.957270133322202,0,1,xylulose catabolic process,BP,
2640,GO:0005999,1,0.926903560040761,0,2,xylulose biosynthetic process,BP,
2641,GO:0006000,1,0.637443961929693,0,11,fructose metabolic process,BP,
2642,GO:0006001,1,0.84796849899504,0,4,fructose catabolic process,BP,
2643,GO:0006002,1,0.781769488840828,0,6,fructose 6-phosphate metabolic process,BP,
2644,GO:0006003,1,0.840052890014645,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2645,GO:0006004,1,0.575487810406223,0,13,fucose metabolic process,BP,
2647,GO:0006007,1,0.425376130015715,0,21,glucose catabolic process,BP,
2648,GO:0006011,1,0.780470717275852,0,6,UDP-glucose metabolic process,BP,
2650,GO:0006013,1,0.715884130556801,0,8,mannose metabolic process,BP,
2651,GO:0006014,1,0.894760554221118,0,3,D-ribose metabolic process,BP,
2652,GO:0006015,1,0.884817634110099,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2661,GO:0006030,1,0.917720781119006,0,2,chitin metabolic process,BP,
2662,GO:0006032,1,0.917720781119006,0,2,chitin catabolic process,BP,
2663,GO:0006040,1,0.326926809687142,0,27,amino sugar metabolic process,BP,
2664,GO:0006041,1,0.850718365759252,0,4,glucosamine metabolic process,BP,
2665,GO:0006043,1,0.924266336616419,0,2,glucosamine catabolic process,BP,
2666,GO:0006044,1,0.580573573315971,0,13,N-acetylglucosamine metabolic process,BP,
2667,GO:0006045,1,0.915471231064941,0,2,N-acetylglucosamine biosynthetic process,BP,
2668,GO:0006046,1,0.889465514110199,0,3,N-acetylglucosamine catabolic process,BP,
2669,GO:0006047,1,0.587748086073,0,13,UDP-N-acetylglucosamine metabolic process,BP,
2670,GO:0006048,1,0.693804403197098,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2671,GO:0006049,1,0.95871135198431,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2672,GO:0006050,1,0.963191933642196,0,1,mannosamine metabolic process,BP,
2673,GO:0006051,1,0.963191933642196,0,1,N-acetylmannosamine metabolic process,BP,
2674,GO:0006054,1,0.665418291293331,0,10,N-acetylneuraminate metabolic process,BP,
2675,GO:0006055,1,0.964152519439114,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2676,GO:0006056,1,0.962561648789528,0,1,mannoprotein metabolic process,BP,
2677,GO:0006057,1,0.962561648789528,0,1,mannoprotein biosynthetic process,BP,
2678,GO:0006059,1,0.891578691493253,0,3,hexitol metabolic process,BP,
2679,GO:0006060,1,0.925054655162642,0,2,sorbitol metabolic process,BP,
2680,GO:0006061,1,0.963704959771134,0,1,sorbitol biosynthetic process,BP,
2681,GO:0006062,1,0.959897033209647,0,1,sorbitol catabolic process,BP,
2682,GO:0006063,1,0.618115316447602,0,12,uronic acid metabolic process,BP,
2683,GO:0006064,1,0.82321251037947,0,5,glucuronate catabolic process,BP,
2684,GO:0006065,1,0.880833561131838,0,3,UDP-glucuronate biosynthetic process,BP,
2689,GO:0006071,1,0.638873984817951,0,11,glycerol metabolic process,BP,
2690,GO:0006072,1,0.737399782842746,0,7,glycerol-3-phosphate metabolic process,BP,
2694,GO:0006083,1,0.877038733414222,0,3,acetate metabolic process,BP,
2698,GO:0006089,1,0.636680261128455,0,11,lactate metabolic process,BP,
2703,GO:0006097,1,0.924737773035969,0,2,glyoxylate cycle,BP,
2707,GO:0006102,1,0.822940602738346,0,5,isocitrate metabolic process,BP,
2708,GO:0006103,1,0.537313996399006,0,15,2-oxoglutarate metabolic process,BP,
2709,GO:0006104,1,0.785863485441184,0,6,succinyl-CoA metabolic process,BP,
2711,GO:0006106,1,0.888391495272628,0,3,fumarate metabolic process,BP,
2712,GO:0006107,1,0.696275060533531,0,9,oxaloacetate metabolic process,BP,
2713,GO:0006108,1,0.787436857661651,0,6,malate metabolic process,BP,
2718,GO:0006113,1,0.958787867083198,0,1,fermentation,BP,
2719,GO:0006114,1,0.886023516985255,0,3,glycerol biosynthetic process,BP,
2720,GO:0006116,1,0.919991463004561,0,2,NADH oxidation,BP,
2721,GO:0006117,1,0.959731749686441,0,1,acetaldehyde metabolic process,BP,
2723,GO:0006120,1,0.19104226802598,0,45,mitochondrial electron transport, NADH to ubiquinone,BP,
2725,GO:0006122,1,0.598827083712036,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2727,GO:0006127,1,0.956441843839217,0,1,glycerophosphate shuttle,BP,
2728,GO:0006139,1,9.12494337217402e-11,122,4611,nucleobase-containing compound metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;GAMT;SRSF5;EGFR;THRA;CITED4;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;SFRP1;POU3F1;MN1;DHTKD1;INSR;KMT5C;DHX32;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;DDB2;DAB2IP;TBX1;H6PD;TSC22D1;TRERF1;YEATS4;MNT;TET1;FAM20C;ZNF266;RPL13A;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;PGLS;ZBTB42;ATP6V0A2;PLXND1;SREBF1;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;XPC;NAB2;NFATC4;RTF1;ZP3;RBCK1;PCBP4;ZNF554;MBD1;TP53INP1;MDK;TRPV4;MSRB2;SDHA;PTMS;ADORA2B;NMRK1;MAFIP;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;H2AFJ;STAT1;TULP3;NME4;CRY2;COX5B;ZMYM3;IFI16;RPRD2;DBP;PER3;SMURF1;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;MDFI;SCMH1;SP100;MPG;DDX59
2730,GO:0006144,1,0.455945868350198,0,19,purine nucleobase metabolic process,BP,
2731,GO:0006145,1,0.83840839924665,0,4,purine nucleobase catabolic process,BP,
2732,GO:0006147,1,0.95644531911026,0,1,guanine catabolic process,BP,
2733,GO:0006148,1,0.96029277657686,0,1,inosine catabolic process,BP,
2734,GO:0006152,1,0.791825677871975,0,6,purine nucleoside catabolic process,BP,
2735,GO:0006154,1,0.92454367387257,0,2,adenosine catabolic process,BP,
2736,GO:0006157,1,0.963310309890086,0,1,deoxyadenosine catabolic process,BP,
2740,GO:0006166,1,0.823119478591486,0,5,purine ribonucleoside salvage,BP,
2741,GO:0006167,1,0.823393307072769,0,5,AMP biosynthetic process,BP,
2742,GO:0006168,1,0.894958162400753,0,3,adenine salvage,BP,
2743,GO:0006169,1,0.961580393285619,0,1,adenosine salvage,BP,
2745,GO:0006172,1,0.960750706657499,0,1,ADP biosynthetic process,BP,
2746,GO:0006174,1,0.958787867083198,0,1,dADP phosphorylation,BP,
2747,GO:0006175,1,0.961580393285619,0,1,dATP biosynthetic process,BP,
2748,GO:0006177,1,0.822654171566404,0,5,GMP biosynthetic process,BP,
2749,GO:0006178,1,0.927067628945206,0,2,guanine salvage,BP,
2752,GO:0006185,1,0.964785442296245,0,1,dGDP biosynthetic process,BP,
2753,GO:0006186,1,0.958787867083198,0,1,dGDP phosphorylation,BP,
2754,GO:0006188,1,0.660276065741137,0,10,IMP biosynthetic process,BP,
2755,GO:0006189,1,0.777802169329916,0,6,'de novo' IMP biosynthetic process,BP,
2756,GO:0006193,1,0.964513019642941,0,1,ITP catabolic process,BP,
2759,GO:0006198,1,0.64495723605424,0,10,cAMP catabolic process,BP,
2760,GO:0006203,1,0.889513835498202,0,3,dGTP catabolic process,BP,
2761,GO:0006206,1,0.500609469876189,0,17,pyrimidine nucleobase metabolic process,BP,
2762,GO:0006207,1,0.773955026283952,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2763,GO:0006208,1,0.920954897856584,0,2,pyrimidine nucleobase catabolic process,BP,
2764,GO:0006210,1,0.920954897856584,0,2,thymine catabolic process,BP,
2766,GO:0006212,1,0.958222255349026,0,1,uracil catabolic process,BP,
2768,GO:0006214,1,0.958222255349026,0,1,thymidine catabolic process,BP,
2769,GO:0006216,1,0.760274509366157,0,7,cytidine catabolic process,BP,
2770,GO:0006218,1,0.962437067087896,0,1,uridine catabolic process,BP,
2773,GO:0006222,1,0.697073948922502,0,9,UMP biosynthetic process,BP,
2774,GO:0006226,1,0.891161271006267,0,3,dUMP biosynthetic process,BP,
2775,GO:0006227,1,0.924436773665056,0,2,dUDP biosynthetic process,BP,
2777,GO:0006231,1,0.889315452638255,0,3,dTMP biosynthetic process,BP,
2778,GO:0006233,1,0.924436773665056,0,2,dTDP biosynthetic process,BP,
2779,GO:0006235,1,0.858266683340569,0,4,dTTP biosynthetic process,BP,
2780,GO:0006238,1,0.964136567279706,0,1,CMP salvage,BP,
2782,GO:0006244,1,0.627588867261126,0,12,pyrimidine nucleotide catabolic process,BP,
2783,GO:0006253,1,0.964473912272003,0,1,dCTP catabolic process,BP,
2784,GO:0006256,1,0.958682820389596,0,1,UDP catabolic process,BP,
2785,GO:0006258,1,0.926399811659741,0,2,UDP-glucose catabolic process,BP,
2789,GO:0006264,1,0.653994356153712,0,10,mitochondrial DNA replication,BP,
2790,GO:0006265,1,0.683541624551614,0,9,DNA topological change,BP,
2791,GO:0006266,1,0.394441619041545,0,23,DNA ligation,BP,
2792,GO:0006267,1,0.888500646288565,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
2793,GO:0006268,1,0.7464205472245,0,7,DNA unwinding involved in DNA replication,BP,
2794,GO:0006269,1,0.81298272437259,0,5,DNA replication, synthesis of RNA primer,BP,
2795,GO:0006270,1,0.183398521325931,0,41,DNA replication initiation,BP,
2796,GO:0006271,1,0.443003640749936,0,20,DNA strand elongation involved in DNA replication,BP,
2797,GO:0006272,1,0.881739717943706,0,3,leading strand elongation,BP,
2798,GO:0006273,1,0.634073636401871,0,11,lagging strand elongation,BP,
2800,GO:0006278,1,0.0646278196200468,0,66,RNA-dependent DNA biosynthetic process,BP,
2803,GO:0006283,1,0.0538160389911681,0,73,transcription-coupled nucleotide-excision repair,BP,
2806,GO:0006286,1,0.928838404621004,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
2807,GO:0006287,1,0.810605151640373,0,5,base-excision repair, gap-filling,BP,
2808,GO:0006288,1,0.887626584325424,0,3,base-excision repair, DNA ligation,BP,
2815,GO:0006297,1,0.395577276807283,0,23,nucleotide-excision repair, DNA gap filling,BP,
2817,GO:0006301,1,0.133459153456646,0,49,postreplication repair,BP,
2819,GO:0006303,1,0.0633318632929575,0,68,double-strand break repair via nonhomologous end joining,BP,
2821,GO:0006305,1,0.153076256474587,0,44,DNA alkylation,BP,
2822,GO:0006306,1,0.153076256474587,0,44,DNA methylation,BP,
2827,GO:0006311,1,0.95815793451167,0,1,meiotic gene conversion,BP,
2828,GO:0006312,1,0.39876348859187,0,22,mitotic recombination,BP,
2829,GO:0006313,1,0.95692335524707,0,1,transposition, DNA-mediated,BP,
2834,GO:0006335,1,0.313054408885366,0,32,DNA replication-dependent nucleosome assembly,BP,
2835,GO:0006336,1,0.143045407848232,0,50,DNA replication-independent nucleosome assembly,BP,
2836,GO:0006337,1,0.511958937356009,0,16,nucleosome disassembly,BP,
2839,GO:0006343,1,0.957104703318769,0,1,establishment of chromatin silencing,BP,
2840,GO:0006344,1,0.840115175499804,0,4,maintenance of chromatin silencing,BP,
2842,GO:0006348,1,0.731485801917254,0,8,chromatin silencing at telomere,BP,
2843,GO:0006349,1,0.569863035514067,0,13,regulation of gene expression by genetic imprinting,BP,
2853,GO:0006361,1,0.246153904585374,0,35,transcription initiation from RNA polymerase I promoter,BP,
2854,GO:0006362,1,0.314752888631405,0,29,transcription elongation from RNA polymerase I promoter,BP,
2855,GO:0006363,1,0.301730657005394,0,30,termination of RNA polymerase I transcription,BP,
2861,GO:0006370,1,0.278451972581959,0,32,7-methylguanosine mRNA capping,BP,
2863,GO:0006378,1,0.192973763769825,0,39,mRNA polyadenylation,BP,
2864,GO:0006379,1,0.330046186813158,0,27,mRNA cleavage,BP,
2865,GO:0006382,1,0.80497075971028,0,5,adenosine to inosine editing,BP,
2867,GO:0006384,1,0.742507293966537,0,7,transcription initiation from RNA polymerase III promoter,BP,
2868,GO:0006386,1,0.965243895011195,0,1,termination of RNA polymerase III transcription,BP,
2869,GO:0006388,1,0.580381458878659,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
2870,GO:0006390,1,0.583889481075368,0,13,mitochondrial transcription,BP,
2871,GO:0006391,1,0.886251924759222,0,3,transcription initiation from mitochondrial promoter,BP,
2872,GO:0006393,1,0.919270839167849,0,2,termination of mitochondrial transcription,BP,
2873,GO:0006396,1,7.44680062856643e-11,5,876,RNA processing,BP,SRSF5;EGFR;DHX32;RPL13A;PIK3R1
2875,GO:0006398,1,0.81251355146353,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
2876,GO:0006399,1,0.000558793898674039,0,184,tRNA metabolic process,BP,
2877,GO:0006400,1,0.0495364934425687,0,74,tRNA modification,BP,
2881,GO:0006404,1,0.888247607434194,0,3,RNA import into nucleus,BP,
2884,GO:0006407,1,0.889060824784857,0,3,rRNA export from nucleus,BP,
2885,GO:0006408,1,0.925531530920165,0,2,snRNA export from nucleus,BP,
2886,GO:0006409,1,0.259593233035309,0,32,tRNA export from nucleus,BP,
2889,GO:0006414,1,0.00807817977256146,0,125,translational elongation,BP,
2890,GO:0006415,1,0.0224184051128024,0,100,translational termination,BP,
2892,GO:0006418,1,0.135000143174631,0,49,tRNA aminoacylation for protein translation,BP,
2893,GO:0006419,1,0.88143076294885,0,3,alanyl-tRNA aminoacylation,BP,
2894,GO:0006420,1,0.888844217405885,0,3,arginyl-tRNA aminoacylation,BP,
2895,GO:0006421,1,0.882311570131966,0,3,asparaginyl-tRNA aminoacylation,BP,
2896,GO:0006422,1,0.960579041251633,0,1,aspartyl-tRNA aminoacylation,BP,
2897,GO:0006423,1,0.923251257205493,0,2,cysteinyl-tRNA aminoacylation,BP,
2898,GO:0006424,1,0.915373892657344,0,2,glutamyl-tRNA aminoacylation,BP,
2899,GO:0006425,1,0.918411377493976,0,2,glutaminyl-tRNA aminoacylation,BP,
2900,GO:0006426,1,0.923802433510588,0,2,glycyl-tRNA aminoacylation,BP,
2901,GO:0006427,1,0.923407781662589,0,2,histidyl-tRNA aminoacylation,BP,
2902,GO:0006428,1,0.915930124478699,0,2,isoleucyl-tRNA aminoacylation,BP,
2903,GO:0006429,1,0.915171300962259,0,2,leucyl-tRNA aminoacylation,BP,
2904,GO:0006430,1,0.961380405141031,0,1,lysyl-tRNA aminoacylation,BP,
2905,GO:0006431,1,0.919170833869042,0,2,methionyl-tRNA aminoacylation,BP,
2906,GO:0006432,1,0.81824438605196,0,5,phenylalanyl-tRNA aminoacylation,BP,
2907,GO:0006433,1,0.886061182014848,0,3,prolyl-tRNA aminoacylation,BP,
2908,GO:0006434,1,0.925095648014791,0,2,seryl-tRNA aminoacylation,BP,
2909,GO:0006435,1,0.882080319054784,0,3,threonyl-tRNA aminoacylation,BP,
2910,GO:0006436,1,0.920019535055147,0,2,tryptophanyl-tRNA aminoacylation,BP,
2911,GO:0006437,1,0.921047062533359,0,2,tyrosyl-tRNA aminoacylation,BP,
2912,GO:0006438,1,0.876082482004189,0,3,valyl-tRNA aminoacylation,BP,
2914,GO:0006447,1,0.914973045412226,0,2,regulation of translational initiation by iron,BP,
2915,GO:0006448,1,0.495280194600248,0,17,regulation of translational elongation,BP,
2916,GO:0006449,1,0.74570379851853,0,7,regulation of translational termination,BP,
2917,GO:0006450,1,0.465239702406823,0,19,regulation of translational fidelity,BP,
2918,GO:0006451,1,0.750502139972741,0,7,translational readthrough,BP,
2919,GO:0006452,1,0.921970973559921,0,2,translational frameshifting,BP,
2921,GO:0006458,1,0.150732649804288,0,46,'de novo' protein folding,BP,
2922,GO:0006463,1,0.957214100514588,0,1,steroid hormone receptor complex assembly,BP,
2928,GO:0006471,1,0.367785577961747,0,24,protein ADP-ribosylation,BP,
2930,GO:0006474,1,0.553314100918046,0,14,N-terminal protein amino acid acetylation,BP,
2933,GO:0006477,1,0.810804023710883,0,5,protein sulfation,BP,
2934,GO:0006478,1,0.925014767387519,0,2,peptidyl-tyrosine sulfation,BP,
2936,GO:0006480,1,0.958787867083198,0,1,N-terminal protein amino acid methylation,BP,
2937,GO:0006481,1,0.884040024477363,0,3,C-terminal protein methylation,BP,
2944,GO:0006491,1,0.504726960206118,0,16,N-glycan processing,BP,
2947,GO:0006498,1,0.807134673186904,0,5,N-terminal protein lipidation,BP,
2948,GO:0006499,1,0.839650394067642,0,4,N-terminal protein myristoylation,BP,
2949,GO:0006500,1,0.961288286535632,0,1,N-terminal protein palmitoylation,BP,
2953,GO:0006507,1,0.960734563591107,0,1,GPI anchor release,BP,
2958,GO:0006515,1,0.365000132306162,0,24,protein quality control for misfolded or incompletely synthesized proteins,BP,
2960,GO:0006517,1,0.258427651133877,0,32,protein deglycosylation,BP,
2963,GO:0006521,1,0.142028390458,0,51,regulation of cellular amino acid metabolic process,BP,
2964,GO:0006522,1,0.957026642911005,0,1,alanine metabolic process,BP,
2965,GO:0006524,1,0.957026642911005,0,1,alanine catabolic process,BP,
2966,GO:0006525,1,0.54429994430124,0,15,arginine metabolic process,BP,
2967,GO:0006526,1,0.814128265725751,0,5,arginine biosynthetic process,BP,
2968,GO:0006527,1,0.695792388177136,0,9,arginine catabolic process,BP,
2969,GO:0006528,1,0.889108473039837,0,3,asparagine metabolic process,BP,
2970,GO:0006529,1,0.922260941947027,0,2,asparagine biosynthetic process,BP,
2971,GO:0006531,1,0.779952735170125,0,6,aspartate metabolic process,BP,
2972,GO:0006532,1,0.923008738817873,0,2,aspartate biosynthetic process,BP,
2973,GO:0006533,1,0.923008738817873,0,2,aspartate catabolic process,BP,
2974,GO:0006534,1,0.63242722720348,0,11,cysteine metabolic process,BP,
2975,GO:0006535,1,0.959654540720847,0,1,cysteine biosynthetic process from serine,BP,
2977,GO:0006537,1,0.841513727470278,0,4,glutamate biosynthetic process,BP,
2979,GO:0006540,1,0.91862987506129,0,2,glutamate decarboxylation to succinate,BP,
2982,GO:0006543,1,0.878712828144361,0,3,glutamine catabolic process,BP,
2983,GO:0006544,1,0.72306428993991,0,8,glycine metabolic process,BP,
2984,GO:0006545,1,0.922600406772291,0,2,glycine biosynthetic process,BP,
2985,GO:0006546,1,0.886606636172765,0,3,glycine catabolic process,BP,
2986,GO:0006547,1,0.844920492874359,0,4,histidine metabolic process,BP,
2987,GO:0006548,1,0.918668847120462,0,2,histidine catabolic process,BP,
2988,GO:0006549,1,0.847107238590593,0,4,isoleucine metabolic process,BP,
2989,GO:0006550,1,0.925762602933124,0,2,isoleucine catabolic process,BP,
2990,GO:0006551,1,0.75118509877482,0,7,leucine metabolic process,BP,
2991,GO:0006552,1,0.815553781080588,0,5,leucine catabolic process,BP,
2992,GO:0006553,1,0.684051410584819,0,9,lysine metabolic process,BP,
2993,GO:0006554,1,0.713414735057302,0,8,lysine catabolic process,BP,
2995,GO:0006556,1,0.922031113681919,0,2,S-adenosylmethionine biosynthetic process,BP,
2996,GO:0006557,1,0.957939783253298,0,1,S-adenosylmethioninamine biosynthetic process,BP,
2997,GO:0006558,1,0.862815042308572,0,4,L-phenylalanine metabolic process,BP,
2998,GO:0006559,1,0.862815042308572,0,4,L-phenylalanine catabolic process,BP,
2999,GO:0006560,1,0.785455671349296,0,6,proline metabolic process,BP,
3000,GO:0006561,1,0.853231383839427,0,4,proline biosynthetic process,BP,
3001,GO:0006562,1,0.920590652223798,0,2,proline catabolic process,BP,
3002,GO:0006563,1,0.67311740408112,0,10,L-serine metabolic process,BP,
3003,GO:0006564,1,0.789654558760692,0,6,L-serine biosynthetic process,BP,
3004,GO:0006565,1,0.887956110675459,0,3,L-serine catabolic process,BP,
3006,GO:0006567,1,0.928217709923809,0,2,threonine catabolic process,BP,
3007,GO:0006568,1,0.820610284431821,0,5,tryptophan metabolic process,BP,
3008,GO:0006569,1,0.891184462161528,0,3,tryptophan catabolic process,BP,
3009,GO:0006570,1,0.860030432253594,0,4,tyrosine metabolic process,BP,
3010,GO:0006572,1,0.893908612823941,0,3,tyrosine catabolic process,BP,
3011,GO:0006573,1,0.720320483733561,0,8,valine metabolic process,BP,
3012,GO:0006574,1,0.854677020062616,0,4,valine catabolic process,BP,
3014,GO:0006576,1,0.310511700117326,0,29,cellular biogenic amine metabolic process,BP,
3016,GO:0006578,1,0.811993751397082,0,5,amino-acid betaine biosynthetic process,BP,
3017,GO:0006580,1,0.959359571164546,0,1,ethanolamine metabolic process,BP,
3018,GO:0006582,1,0.678974514511597,0,9,melanin metabolic process,BP,
3019,GO:0006584,1,0.356391560426666,0,25,catecholamine metabolic process,BP,
3020,GO:0006585,1,0.962109643726768,0,1,dopamine biosynthetic process from tyrosine,BP,
3021,GO:0006586,1,0.820610284431821,0,5,indolalkylamine metabolic process,BP,
3022,GO:0006589,1,0.958404959737927,0,1,octopamine biosynthetic process,BP,
3023,GO:0006590,1,0.678682800022392,0,9,thyroid hormone generation,BP,
3024,GO:0006591,1,0.752838971056629,0,7,ornithine metabolic process,BP,
3025,GO:0006592,1,0.95758141865191,0,1,ornithine biosynthetic process,BP,
3026,GO:0006595,1,0.580792874524739,0,14,polyamine metabolic process,BP,
3027,GO:0006596,1,0.624288700377327,0,12,polyamine biosynthetic process,BP,
3028,GO:0006597,1,0.922327721523865,0,2,spermine biosynthetic process,BP,
3029,GO:0006598,1,0.830693702345241,0,5,polyamine catabolic process,BP,
3034,GO:0006607,1,0.421625487159538,0,20,NLS-bearing protein import into nucleus,BP,
3035,GO:0006610,1,0.708871596227552,0,8,ribosomal protein import into nucleus,BP,
3040,GO:0006616,1,0.795861611268677,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3041,GO:0006617,1,0.927299084127009,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3042,GO:0006620,1,0.750549968548623,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3043,GO:0006621,1,0.721456213556262,0,8,protein retention in ER lumen,BP,
3044,GO:0006622,1,0.410709173965418,0,21,protein targeting to lysosome,BP,
3046,GO:0006624,1,0.928048789905313,0,2,vacuolar protein processing,BP,
3047,GO:0006625,1,0.491097772785831,0,17,protein targeting to peroxisome,BP,
3049,GO:0006627,1,0.791096711253579,0,6,protein processing involved in protein targeting to mitochondrion,BP,
3059,GO:0006642,1,0.879203853067252,0,3,triglyceride mobilization,BP,
3062,GO:0006646,1,0.630547685342114,0,11,phosphatidylethanolamine biosynthetic process,BP,
3064,GO:0006651,1,0.922788126062363,0,2,diacylglycerol biosynthetic process,BP,
3065,GO:0006654,1,0.278101594070249,0,30,phosphatidic acid biosynthetic process,BP,
3066,GO:0006655,1,0.659397261846382,0,10,phosphatidylglycerol biosynthetic process,BP,
3067,GO:0006656,1,0.31630628155439,0,28,phosphatidylcholine biosynthetic process,BP,
3068,GO:0006657,1,0.753521406695656,0,7,CDP-choline pathway,BP,
3069,GO:0006658,1,0.417278165072995,0,21,phosphatidylserine metabolic process,BP,
3070,GO:0006659,1,0.84807684559476,0,4,phosphatidylserine biosynthetic process,BP,
3071,GO:0006660,1,0.96253486933222,0,1,phosphatidylserine catabolic process,BP,
3073,GO:0006662,1,0.699185501387287,0,9,glycerol ether metabolic process,BP,
3074,GO:0006663,1,0.883186678110904,0,3,platelet activating factor biosynthetic process,BP,
3078,GO:0006667,1,0.920286974835962,0,2,sphinganine metabolic process,BP,
3079,GO:0006668,1,0.918208012607128,0,2,sphinganine-1-phosphate metabolic process,BP,
3080,GO:0006669,1,0.958601337026769,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3081,GO:0006670,1,0.666872956221515,0,10,sphingosine metabolic process,BP,
3082,GO:0006671,1,0.956684152238897,0,1,phytosphingosine metabolic process,BP,
3085,GO:0006678,1,0.747336898946484,0,7,glucosylceramide metabolic process,BP,
3086,GO:0006679,1,0.921093670822869,0,2,glucosylceramide biosynthetic process,BP,
3087,GO:0006680,1,0.881745739437921,0,3,glucosylceramide catabolic process,BP,
3088,GO:0006681,1,0.77904306637162,0,6,galactosylceramide metabolic process,BP,
3089,GO:0006682,1,0.883046702784664,0,3,galactosylceramide biosynthetic process,BP,
3090,GO:0006683,1,0.958740152998096,0,1,galactosylceramide catabolic process,BP,
3091,GO:0006684,1,0.588502676047395,0,13,sphingomyelin metabolic process,BP,
3092,GO:0006685,1,0.811397976865358,0,5,sphingomyelin catabolic process,BP,
3093,GO:0006686,1,0.783075782793935,0,6,sphingomyelin biosynthetic process,BP,
3103,GO:0006696,1,0.924159023005585,0,2,ergosterol biosynthetic process,BP,
3105,GO:0006700,1,0.545159524456606,0,15,C21-steroid hormone biosynthetic process,BP,
3106,GO:0006701,1,0.846906187402412,0,4,progesterone biosynthetic process,BP,
3107,GO:0006702,1,0.809561258310159,0,5,androgen biosynthetic process,BP,
3108,GO:0006703,1,0.73486915162918,0,8,estrogen biosynthetic process,BP,
3110,GO:0006705,1,0.842036628105556,0,4,mineralocorticoid biosynthetic process,BP,
3113,GO:0006710,1,0.96221756057917,0,1,androgen catabolic process,BP,
3114,GO:0006711,1,0.96253486933222,0,1,estrogen catabolic process,BP,
3115,GO:0006713,1,0.962511364794423,0,1,glucocorticoid catabolic process,BP,
3118,GO:0006722,1,0.960319061862212,0,1,triterpenoid metabolic process,BP,
3120,GO:0006726,1,0.956519923983069,0,1,eye pigment biosynthetic process,BP,
3121,GO:0006729,1,0.763661551750362,0,7,tetrahydrobiopterin biosynthetic process,BP,
3125,GO:0006734,1,0.34573189950021,0,26,NADH metabolic process,BP,
3126,GO:0006735,1,0.50293936199934,0,17,NADH regeneration,BP,
3127,GO:0006738,1,0.96029277657686,0,1,nicotinamide riboside catabolic process,BP,
3129,GO:0006740,1,0.88259854904634,0,3,NADPH regeneration,BP,
3131,GO:0006742,1,0.957555241268031,0,1,NADP catabolic process,BP,
3132,GO:0006743,1,0.556468748621093,0,15,ubiquinone metabolic process,BP,
3133,GO:0006744,1,0.581728394349116,0,14,ubiquinone biosynthetic process,BP,
3134,GO:0006747,1,0.961875270092358,0,1,FAD biosynthetic process,BP,
3135,GO:0006749,1,0.195718938162888,0,42,glutathione metabolic process,BP,
3136,GO:0006750,1,0.57057957642051,0,14,glutathione biosynthetic process,BP,
3137,GO:0006751,1,0.821482945374422,0,5,glutathione catabolic process,BP,
3140,GO:0006756,1,0.958787867083198,0,1,AMP phosphorylation,BP,
3145,GO:0006768,1,0.631093391469349,0,11,biotin metabolic process,BP,
3146,GO:0006771,1,0.749176852352299,0,7,riboflavin metabolic process,BP,
3147,GO:0006772,1,0.962491165173348,0,1,thiamine metabolic process,BP,
3148,GO:0006775,1,0.397854303885712,0,23,fat-soluble vitamin metabolic process,BP,
3149,GO:0006776,1,0.885116569822675,0,3,vitamin A metabolic process,BP,
3150,GO:0006777,1,0.780283236017305,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3154,GO:0006781,1,0.961168989933982,0,1,succinyl-CoA pathway,BP,
3157,GO:0006784,1,0.916757762314565,0,2,heme a biosynthetic process,BP,
3158,GO:0006787,1,0.79629585260409,0,6,porphyrin-containing compound catabolic process,BP,
3159,GO:0006788,1,0.92731028872354,0,2,heme oxidation,BP,
3160,GO:0006789,1,0.922487277091813,0,2,bilirubin conjugation,BP,
3164,GO:0006797,1,0.808974687564589,0,5,polyphosphate metabolic process,BP,
3165,GO:0006798,1,0.843651849211678,0,4,polyphosphate catabolic process,BP,
3169,GO:0006808,1,0.923798723707797,0,2,regulation of nitrogen utilization,BP,
3180,GO:0006824,1,0.884684706676613,0,3,cobalt ion transport,BP,
3181,GO:0006825,1,0.480852537961149,0,18,copper ion transport,BP,
3183,GO:0006828,1,0.876254516283014,0,3,manganese ion transport,BP,
3185,GO:0006833,1,0.780532918265388,0,6,water transport,BP,
3188,GO:0006837,1,0.77790815024017,0,6,serotonin transport,BP,
3191,GO:0006843,1,0.963111881132099,0,1,mitochondrial citrate transmembrane transport,BP,
3192,GO:0006844,1,0.924180180127158,0,2,acyl carnitine transport,BP,
3193,GO:0006848,1,0.880176319609871,0,3,pyruvate transport,BP,
3194,GO:0006850,1,0.919270839167849,0,2,mitochondrial pyruvate transmembrane transport,BP,
3195,GO:0006851,1,0.437909199715745,0,20,mitochondrial calcium ion transmembrane transport,BP,
3199,GO:0006858,1,0.888159953266678,0,3,extracellular transport,BP,
3200,GO:0006862,1,0.519614688679737,0,16,nucleotide transport,BP,
3201,GO:0006863,1,0.788468105634319,0,6,purine nucleobase transport,BP,
3202,GO:0006864,1,0.921684364992934,0,2,pyrimidine nucleotide transport,BP,
3204,GO:0006867,1,0.959101436414188,0,1,asparagine transport,BP,
3212,GO:0006880,1,0.894924840711735,0,3,intracellular sequestering of iron ion,BP,
3221,GO:0006891,1,0.285522438771129,0,30,intra-Golgi vesicle-mediated transport,BP,
3225,GO:0006896,1,0.553768818228096,0,14,Golgi to vacuole transport,BP,
3236,GO:0006911,1,0.368347612859771,0,24,phagocytosis, engulfment,BP,
3242,GO:0006924,1,0.726341669158771,0,8,activation-induced cell death of T cells,BP,
3245,GO:0006929,1,0.410764759187372,0,21,substrate-dependent cell migration,BP,
3246,GO:0006930,1,0.713415995392966,0,8,substrate-dependent cell migration, cell extension,BP,
3247,GO:0006931,1,0.882471194881111,0,3,substrate-dependent cell migration, cell attachment to substrate,BP,
3248,GO:0006933,1,0.925199129274646,0,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3255,GO:0006942,1,0.158205164829667,0,44,regulation of striated muscle contraction,BP,
3259,GO:0006953,1,0.497486141730453,0,17,acute-phase response,BP,
3263,GO:0006957,1,0.956443767776723,0,1,complement activation, alternative pathway,BP,
3271,GO:0006975,1,0.749233842624064,0,7,DNA damage induced protein phosphorylation,BP,
3276,GO:0006983,1,0.653207418009091,0,10,ER overload response,BP,
3280,GO:0006990,1,0.885807705122024,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3281,GO:0006991,1,0.682081883337156,0,9,response to sterol depletion,BP,
3282,GO:0006995,1,0.67618490044855,0,10,cellular response to nitrogen starvation,BP,
3286,GO:0006999,1,0.530279968590036,0,15,nuclear pore organization,BP,
3287,GO:0007000,1,0.745801209096286,0,7,nucleolus organization,BP,
3288,GO:0007004,1,0.0703616102737331,0,64,telomere maintenance via telomerase,BP,
3290,GO:0007006,1,0.0182885151076084,0,99,mitochondrial membrane organization,BP,
3291,GO:0007007,1,0.420811423999983,0,22,inner mitochondrial membrane organization,BP,
3292,GO:0007008,1,0.957726119347696,0,1,outer mitochondrial membrane organization,BP,
3295,GO:0007014,1,0.957248930696226,0,1,actin ubiquitination,BP,
3301,GO:0007020,1,0.331180703574625,0,26,microtubule nucleation,BP,
3302,GO:0007021,1,0.766172503343034,0,7,tubulin complex assembly,BP,
3303,GO:0007023,1,0.85560827381156,0,4,post-chaperonin tubulin folding pathway,BP,
3304,GO:0007026,1,0.463861455297746,0,18,negative regulation of microtubule depolymerization,BP,
3305,GO:0007028,1,0.70793673801176,0,8,cytoplasm organization,BP,
3306,GO:0007029,1,0.164040144046266,0,43,endoplasmic reticulum organization,BP,
3316,GO:0007042,1,0.735223784361836,0,8,lysosomal lumen acidification,BP,
3323,GO:0007052,1,0.0119604864280686,0,105,mitotic spindle organization,BP,
3324,GO:0007056,1,0.923603288031155,0,2,spindle assembly involved in female meiosis,BP,
3325,GO:0007057,1,0.923603288031155,0,2,spindle assembly involved in female meiosis I,BP,
3327,GO:0007060,1,0.920530603943903,0,2,male meiosis chromosome segregation,BP,
3328,GO:0007062,1,0.00681360737907684,0,120,sister chromatid cohesion,BP,
3329,GO:0007063,1,0.41267436273833,0,21,regulation of sister chromatid cohesion,BP,
3330,GO:0007064,1,0.397135441355317,0,22,mitotic sister chromatid cohesion,BP,
3331,GO:0007066,1,0.964914731631763,0,1,female meiosis sister chromatid cohesion,BP,
3332,GO:0007072,1,0.962746502046533,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3333,GO:0007076,1,0.502733003668756,0,16,mitotic chromosome condensation,BP,
3334,GO:0007077,1,0.17292147382654,0,42,mitotic nuclear envelope disassembly,BP,
3335,GO:0007079,1,0.877025318558285,0,3,mitotic chromosome movement towards spindle pole,BP,
3336,GO:0007080,1,0.172500893569704,0,43,mitotic metaphase plate congression,BP,
3337,GO:0007084,1,0.671596628520055,0,10,mitotic nuclear envelope reassembly,BP,
3339,GO:0007089,1,0.845626428109168,0,4,traversing start control point of mitotic cell cycle,BP,
3340,GO:0007091,1,0.132160301977235,0,49,metaphase/anaphase transition of mitotic cell cycle,BP,
3342,GO:0007094,1,0.305105538683262,0,29,mitotic spindle assembly checkpoint,BP,
3344,GO:0007096,1,0.540459783758694,0,15,regulation of exit from mitosis,BP,
3347,GO:0007099,1,0.289880955932299,0,29,centriole replication,BP,
3348,GO:0007100,1,0.578641088777779,0,13,mitotic centrosome separation,BP,
3349,GO:0007113,1,0.890871778828746,0,3,endomitotic cell cycle,BP,
3352,GO:0007130,1,0.746929901400455,0,7,synaptonemal complex assembly,BP,
3353,GO:0007131,1,0.22419831512533,0,36,reciprocal meiotic recombination,BP,
3354,GO:0007135,1,0.781287214461288,0,6,meiosis II,BP,
3355,GO:0007140,1,0.384983411108737,0,23,male meiotic nuclear division,BP,
3356,GO:0007141,1,0.616370500490006,0,12,male meiosis I,BP,
3357,GO:0007143,1,0.474861988028143,0,18,female meiotic nuclear division,BP,
3358,GO:0007144,1,0.784898320052599,0,6,female meiosis I,BP,
3359,GO:0007146,1,0.958787867083198,0,1,meiotic recombination nodule assembly,BP,
3360,GO:0007147,1,0.957355152912972,0,1,female meiosis II,BP,
3368,GO:0007161,1,0.839374325628882,0,4,calcium-independent cell-matrix adhesion,BP,
3375,GO:0007168,1,0.920091559240088,0,2,receptor guanylyl cyclase signaling pathway,BP,
3377,GO:0007171,1,0.776336884990477,0,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3380,GO:0007174,1,0.960937814011146,0,1,epidermal growth factor catabolic process,BP,
3381,GO:0007175,1,0.560584381186609,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3385,GO:0007181,1,0.921770647359114,0,2,transforming growth factor beta receptor complex assembly,BP,
3386,GO:0007182,1,0.775976228616844,0,6,common-partner SMAD protein phosphorylation,BP,
3387,GO:0007183,1,0.627112010095712,0,11,SMAD protein complex assembly,BP,
3388,GO:0007185,1,0.836804296355554,0,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3394,GO:0007191,1,0.781560367082945,0,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3395,GO:0007193,1,0.266803472392577,0,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,
3396,GO:0007194,1,0.751270673067138,0,7,negative regulation of adenylate cyclase activity,BP,
3397,GO:0007195,1,0.918375689689295,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3398,GO:0007196,1,0.956441843839217,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3399,GO:0007197,1,0.91767372982214,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3400,GO:0007198,1,0.923803940182497,0,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3405,GO:0007206,1,0.95678917286191,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3406,GO:0007207,1,0.922082392820585,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3407,GO:0007210,1,0.887725713534676,0,3,serotonin receptor signaling pathway,BP,
3409,GO:0007213,1,0.664334291290299,0,10,G-protein coupled acetylcholine receptor signaling pathway,BP,
3410,GO:0007214,1,0.7762852506611,0,6,gamma-aminobutyric acid signaling pathway,BP,
3413,GO:0007217,1,0.959766517645851,0,1,tachykinin receptor signaling pathway,BP,
3416,GO:0007220,1,0.531759664897013,0,15,Notch receptor processing,BP,
3418,GO:0007223,1,0.249954320893548,0,32,Wnt signaling pathway, calcium modulating pathway,BP,
3420,GO:0007225,1,0.956541737984803,0,1,patched ligand maturation,BP,
3421,GO:0007227,1,0.876192697238895,0,3,signal transduction downstream of smoothened,BP,
3422,GO:0007228,1,0.915568690421816,0,2,positive regulation of hh target transcription factor activity,BP,
3426,GO:0007250,1,0.511725351949541,0,16,activation of NF-kappaB-inducing kinase activity,BP,
3428,GO:0007253,1,0.759972511911299,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3432,GO:0007258,1,0.845549145734295,0,4,JUN phosphorylation,BP,
3434,GO:0007260,1,0.173217661224968,0,43,tyrosine phosphorylation of STAT protein,BP,
3442,GO:0007270,1,0.776047544725304,0,6,neuron-neuron synaptic transmission,BP,
3450,GO:0007284,1,0.915372709077706,0,2,spermatogonial cell division,BP,
3452,GO:0007288,1,0.66144740448441,0,10,sperm axoneme assembly,BP,
3453,GO:0007289,1,0.628349445139531,0,11,spermatid nucleus differentiation,BP,
3454,GO:0007290,1,0.956533377435599,0,1,spermatid nucleus elongation,BP,
3456,GO:0007296,1,0.84246527248091,0,4,vitellogenesis,BP,
3457,GO:0007308,1,0.959753253487819,0,1,oocyte construction,BP,
3458,GO:0007309,1,0.959753253487819,0,1,oocyte axis specification,BP,
3459,GO:0007314,1,0.959753253487819,0,1,oocyte anterior/posterior axis specification,BP,
3460,GO:0007315,1,0.959753253487819,0,1,pole plasm assembly,BP,
3466,GO:0007342,1,0.859805805654867,0,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3467,GO:0007344,1,0.962651352838346,0,1,pronuclear fusion,BP,
3469,GO:0007350,1,0.600349607939686,0,12,blastoderm segmentation,BP,
3470,GO:0007351,1,0.682912609479119,0,9,tripartite regional subdivision,BP,
3471,GO:0007352,1,0.956441843839217,0,1,zygotic specification of dorsal/ventral axis,BP,
3472,GO:0007354,1,0.883700774111288,0,3,zygotic determination of anterior/posterior axis, embryo,BP,
3473,GO:0007356,1,0.922577424169566,0,2,thorax and anterior abdomen determination,BP,
3476,GO:0007371,1,0.957216426198729,0,1,ventral midline determination,BP,
3477,GO:0007379,1,0.63074151268306,0,11,segment specification,BP,
3478,GO:0007386,1,0.811748521429539,0,5,compartment pattern specification,BP,
3479,GO:0007387,1,0.959307059372719,0,1,anterior compartment pattern formation,BP,
3480,GO:0007388,1,0.959307059372719,0,1,posterior compartment specification,BP,
3484,GO:0007402,1,0.964775768520543,0,1,ganglion mother cell fate determination,BP,
3485,GO:0007403,1,0.957654579206527,0,1,glial cell fate determination,BP,
3490,GO:0007412,1,0.923000738725049,0,2,axon target recognition,BP,
3500,GO:0007439,1,0.958598826789882,0,1,ectodermal digestive tract development,BP,
3501,GO:0007440,1,0.766435413832057,0,6,foregut morphogenesis,BP,
3503,GO:0007468,1,0.961594767891253,0,1,regulation of rhodopsin gene expression,BP,
3506,GO:0007495,1,0.958097431883921,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3507,GO:0007497,1,0.956503107942366,0,1,posterior midgut development,BP,
3509,GO:0007499,1,0.956576492492707,0,1,ectoderm and mesoderm interaction,BP,
3510,GO:0007500,1,0.922761862655228,0,2,mesodermal cell fate determination,BP,
3511,GO:0007501,1,0.881283777041002,0,3,mesodermal cell fate specification,BP,
3513,GO:0007509,1,0.956441843839217,0,1,mesoderm migration involved in gastrulation,BP,
3514,GO:0007512,1,0.811947419365517,0,5,adult heart development,BP,
3516,GO:0007518,1,0.960449431238827,0,1,myoblast fate determination,BP,
3518,GO:0007520,1,0.433920498700251,0,20,myoblast fusion,BP,
3519,GO:0007525,1,0.91788478045023,0,2,somatic muscle development,BP,
3523,GO:0007538,1,0.915338435527532,0,2,primary sex determination,BP,
3524,GO:0007542,1,0.915338435527532,0,2,primary sex determination, germ-line,BP,
3526,GO:0007549,1,0.599291463074606,0,12,dosage compensation,BP,
3532,GO:0007571,1,0.964705222565708,0,1,age-dependent general metabolic decline,BP,
3533,GO:0007576,1,0.959839882241408,0,1,nucleolar fragmentation,BP,
3542,GO:0007598,1,0.9605114596766,0,1,blood coagulation, extrinsic pathway,BP,
3546,GO:0007602,1,0.382408101358667,0,23,phototransduction,BP,
3547,GO:0007603,1,0.511325967026728,0,16,phototransduction, visible light,BP,
3550,GO:0007608,1,0.533575119386623,0,15,sensory perception of smell,BP,
3561,GO:0007621,1,0.956441843839217,0,1,negative regulation of female receptivity,BP,
3564,GO:0007624,1,0.956838917985689,0,1,ultradian rhythm,BP,
3565,GO:0007625,1,0.786530904722926,0,6,grooming behavior,BP,
3568,GO:0007631,1,0.233124868804027,0,35,feeding behavior,BP,
3569,GO:0007632,1,0.226423422855296,0,35,visual behavior,BP,
3570,GO:0007634,1,0.960198582901171,0,1,optokinetic behavior,BP,
3571,GO:0007635,1,0.7413156134012,0,7,chemosensory behavior,BP,
3578,GO:0008020,1,0.919627179858157,0,2,G-protein coupled photoreceptor activity,MF,
3582,GO:0008024,1,0.712259718021177,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3585,GO:0008033,1,0.00777577599152509,0,120,tRNA processing,BP,
3586,GO:0008035,1,0.846168569651497,0,4,high-density lipoprotein particle binding,MF,
3589,GO:0008043,1,0.930509802352436,0,2,intracellular ferritin complex,CC,
3593,GO:0008048,1,0.960811769590848,0,1,calcium sensitive guanylate cyclase activator activity,MF,
3596,GO:0008052,1,0.964775768520543,0,1,sensory organ boundary specification,BP,
3597,GO:0008053,1,0.445979181380251,0,20,mitochondrial fusion,BP,
3599,GO:0008061,1,0.917720781119006,0,2,chitin binding,MF,
3600,GO:0008063,1,0.844463343600425,0,4,Toll signaling pathway,BP,
3602,GO:0008065,1,0.916368868439007,0,2,establishment of blood-nerve barrier,BP,
3603,GO:0008066,1,0.837061046227753,0,4,glutamate receptor activity,MF,
3604,GO:0008073,1,0.927822221895377,0,2,ornithine decarboxylase inhibitor activity,MF,
3605,GO:0008074,1,0.76659676873433,0,6,guanylate cyclase complex, soluble,CC,
3607,GO:0008078,1,0.956441843839217,0,1,mesodermal cell migration,BP,
3608,GO:0008079,1,0.777812262590453,0,6,translation termination factor activity,MF,
3614,GO:0008090,1,0.749229068222097,0,7,retrograde axonal transport,BP,
3615,GO:0008091,1,0.766379325465704,0,6,spectrin,CC,
3622,GO:0008107,1,0.916872857669193,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3623,GO:0008108,1,0.963887050156494,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3624,GO:0008109,1,0.916103256391546,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3626,GO:0008112,1,0.963194994307159,0,1,nicotinamide N-methyltransferase activity,MF,
3627,GO:0008113,1,0.928685348389915,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3628,GO:0008117,1,0.956441843839217,0,1,sphinganine-1-phosphate aldolase activity,MF,
3629,GO:0008118,1,0.960968477693179,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3630,GO:0008119,1,0.95796765639063,0,1,thiopurine S-methyltransferase activity,MF,
3631,GO:0008120,1,0.963018362093173,0,1,ceramide glucosyltransferase activity,MF,
3632,GO:0008121,1,0.768553546088541,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3633,GO:0008124,1,0.92656778604614,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3634,GO:0008126,1,0.958921484820709,0,1,acetylesterase activity,MF,
3635,GO:0008127,1,0.963993968322759,0,1,quercetin 2,3-dioxygenase activity,MF,
3636,GO:0008131,1,0.878669347872415,0,3,primary amine oxidase activity,MF,
3638,GO:0008135,1,0.0359844074977674,0,81,translation factor activity, RNA binding,MF,
3639,GO:0008137,1,0.251433154461222,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3640,GO:0008138,1,0.235908980091505,0,35,protein tyrosine/serine/threonine phosphatase activity,MF,
3641,GO:0008139,1,0.36879871891241,0,23,nuclear localization sequence binding,MF,
3643,GO:0008142,1,0.84289218551936,0,4,oxysterol binding,MF,
3644,GO:0008143,1,0.552415649492662,0,14,poly(A) binding,MF,
3646,GO:0008146,1,0.314525598973672,0,28,sulfotransferase activity,MF,
3651,GO:0008157,1,0.559322839037036,0,14,protein phosphatase 1 binding,MF,
3652,GO:0008158,1,0.922897675414813,0,2,hedgehog receptor activity,MF,
3653,GO:0008160,1,0.959608956538029,0,1,protein tyrosine phosphatase activator activity,MF,
3655,GO:0008169,1,0.884776820495575,0,3,C-methyltransferase activity,MF,
3657,GO:0008171,1,0.42217576086407,0,21,O-methyltransferase activity,MF,
3658,GO:0008172,1,0.815411188013732,0,5,S-methyltransferase activity,MF,
3659,GO:0008173,1,0.104284274042088,0,55,RNA methyltransferase activity,MF,
3660,GO:0008174,1,0.688987828899967,0,9,mRNA methyltransferase activity,MF,
3661,GO:0008175,1,0.313140568565222,0,28,tRNA methyltransferase activity,MF,
3662,GO:0008176,1,0.927947083944993,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3664,GO:0008179,1,0.656455762688642,0,10,adenylate cyclase binding,MF,
3665,GO:0008180,1,0.317192362439615,0,28,COP9 signalosome,CC,
3666,GO:0008184,1,0.917623833581945,0,2,glycogen phosphorylase activity,MF,
3668,GO:0008187,1,0.430426551774263,0,20,poly-pyrimidine tract binding,MF,
3669,GO:0008188,1,0.819861650326369,0,5,neuropeptide receptor activity,MF,
3672,GO:0008192,1,0.882393565969654,0,3,RNA guanylyltransferase activity,MF,
3673,GO:0008193,1,0.922391282052038,0,2,tRNA guanylyltransferase activity,MF,
3676,GO:0008198,1,0.503525916769343,0,17,ferrous iron binding,MF,
3677,GO:0008199,1,0.824703684717936,0,5,ferric iron binding,MF,
3678,GO:0008200,1,0.359017938162403,0,25,ion channel inhibitor activity,MF,
3682,GO:0008204,1,0.924159023005585,0,2,ergosterol metabolic process,BP,
3684,GO:0008207,1,0.465098093427444,0,19,C21-steroid hormone metabolic process,BP,
3685,GO:0008209,1,0.58212713682675,0,13,androgen metabolic process,BP,
3686,GO:0008210,1,0.505849831871325,0,17,estrogen metabolic process,BP,
3688,GO:0008212,1,0.842036628105556,0,4,mineralocorticoid metabolic process,BP,
3691,GO:0008215,1,0.794532740805372,0,6,spermine metabolic process,BP,
3692,GO:0008216,1,0.766767439078357,0,7,spermidine metabolic process,BP,
3694,GO:0008218,1,0.95756135946994,0,1,bioluminescence,BP,
3696,GO:0008227,1,0.721743191388571,0,8,G-protein coupled amine receptor activity,MF,
3697,GO:0008228,1,0.914785613664869,0,2,opsonization,BP,
3704,GO:0008239,1,0.781317484046565,0,6,dipeptidyl-peptidase activity,MF,
3705,GO:0008240,1,0.91586799264806,0,2,tripeptidyl-peptidase activity,MF,
3706,GO:0008242,1,0.720992800612844,0,8,omega peptidase activity,MF,
3707,GO:0008250,1,0.626473288142446,0,12,oligosaccharyltransferase complex,CC,
3708,GO:0008251,1,0.91745519863714,0,2,tRNA-specific adenosine deaminase activity,MF,
3711,GO:0008254,1,0.956441843839217,0,1,3'-nucleotidase activity,MF,
3712,GO:0008260,1,0.957438075438589,0,1,3-oxoacid CoA-transferase activity,MF,
3713,GO:0008263,1,0.919733580088239,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3714,GO:0008265,1,0.95923239003662,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3715,GO:0008266,1,0.511474241628474,0,16,poly(U) RNA binding,MF,
3716,GO:0008267,1,0.956441843839217,0,1,poly-glutamine tract binding,MF,
3717,GO:0008269,1,0.961028045423662,0,1,JAK pathway signal transduction adaptor activity,MF,
3719,GO:0008271,1,0.805946740556967,0,5,secondary active sulfate transmembrane transporter activity,MF,
3720,GO:0008272,1,0.742716440889693,0,7,sulfate transport,BP,
3721,GO:0008273,1,0.91499187768862,0,2,calcium, potassium:sodium antiporter activity,MF,
3723,GO:0008275,1,0.840806299764669,0,4,gamma-tubulin small complex,CC,
3726,GO:0008278,1,0.708358264279183,0,8,cohesin complex,CC,
3727,GO:0008281,1,0.956554813705885,0,1,sulfonylurea receptor activity,MF,
3728,GO:0008282,1,0.916690585548125,0,2,inward rectifying potassium channel,CC,
3735,GO:0008290,1,0.782731800396796,0,6,F-actin capping protein complex,CC,
3736,GO:0008294,1,0.956441843839217,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
3737,GO:0008295,1,0.854530141359998,0,4,spermidine biosynthetic process,BP,
3738,GO:0008296,1,0.724991280761319,0,8,3'-5'-exodeoxyribonuclease activity,MF,
3739,GO:0008297,1,0.77936295422473,0,6,single-stranded DNA exodeoxyribonuclease activity,MF,
3740,GO:0008298,1,0.614991954515546,0,12,intracellular mRNA localization,BP,
3742,GO:0008300,1,0.917842039345893,0,2,isoprenoid catabolic process,BP,
3748,GO:0008309,1,0.853112462325633,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3749,GO:0008310,1,0.848469807171506,0,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3750,GO:0008311,1,0.926700876695124,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3751,GO:0008312,1,0.760565831938339,0,7,7S RNA binding,MF,
3752,GO:0008318,1,0.750996300907217,0,7,protein prenyltransferase activity,MF,
3753,GO:0008320,1,0.607659409484123,0,13,protein transmembrane transporter activity,MF,
3754,GO:0008321,1,0.914801199280943,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
3758,GO:0008329,1,0.779615754671755,0,6,signaling pattern recognition receptor activity,MF,
3759,GO:0008330,1,0.852990815146914,0,4,protein tyrosine/threonine phosphatase activity,MF,
3760,GO:0008331,1,0.883302865568333,0,3,high voltage-gated calcium channel activity,MF,
3762,GO:0008334,1,0.379276612525154,0,24,histone mRNA metabolic process,BP,
3763,GO:0008340,1,0.675133962559929,0,9,determination of adult lifespan,BP,
3764,GO:0008343,1,0.956441843839217,0,1,adult feeding behavior,BP,
3767,GO:0008348,1,0.957307438174566,0,1,negative regulation of antimicrobial humoral response,BP,
3769,GO:0008352,1,0.959464653932691,0,1,katanin complex,CC,
3770,GO:0008353,1,0.527353494458255,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3771,GO:0008354,1,0.74357506854419,0,7,germ cell migration,BP,
3772,GO:0008355,1,0.956675308678278,0,1,olfactory learning,BP,
3774,GO:0008358,1,0.959753253487819,0,1,maternal determination of anterior/posterior axis, embryo,BP,
3783,GO:0008379,1,0.834943531419369,0,5,thioredoxin peroxidase activity,MF,
3786,GO:0008384,1,0.877746845146585,0,3,IkappaB kinase activity,MF,
3787,GO:0008385,1,0.6879911008642,0,9,IkappaB kinase complex,CC,
3788,GO:0008391,1,0.923374423909688,0,2,arachidonic acid monooxygenase activity,MF,
3789,GO:0008392,1,0.923374423909688,0,2,arachidonic acid epoxygenase activity,MF,
3790,GO:0008395,1,0.754684790114095,0,7,steroid hydroxylase activity,MF,
3791,GO:0008396,1,0.960355944082266,0,1,oxysterol 7-alpha-hydroxylase activity,MF,
3792,GO:0008398,1,0.95833572972433,0,1,sterol 14-demethylase activity,MF,
3793,GO:0008401,1,0.917952279209516,0,2,retinoic acid 4-hydroxylase activity,MF,
3794,GO:0008403,1,0.958121229211977,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
3795,GO:0008404,1,0.962269425548233,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3796,GO:0008405,1,0.962269425548233,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
3798,GO:0008408,1,0.154238495053181,0,45,3'-5' exonuclease activity,MF,
3799,GO:0008409,1,0.505889553862105,0,16,5'-3' exonuclease activity,MF,
3801,GO:0008413,1,0.928452658429404,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
3802,GO:0008417,1,0.653660787969856,0,10,fucosyltransferase activity,MF,
3803,GO:0008418,1,0.96447897122233,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
3804,GO:0008419,1,0.95949323408596,0,1,RNA lariat debranching enzyme activity,MF,
3805,GO:0008420,1,0.718491544210815,0,8,CTD phosphatase activity,MF,
3806,GO:0008422,1,0.915661004125682,0,2,beta-glucosidase activity,MF,
3807,GO:0008424,1,0.957891697329934,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
3808,GO:0008425,1,0.964083115104504,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3809,GO:0008426,1,0.890426624862692,0,3,protein kinase C inhibitor activity,MF,
3810,GO:0008427,1,0.926729657322993,0,2,calcium-dependent protein kinase inhibitor activity,MF,
3811,GO:0008428,1,0.882211871638586,0,3,ribonuclease inhibitor activity,MF,
3812,GO:0008429,1,0.729459754402703,0,8,phosphatidylethanolamine binding,MF,
3815,GO:0008432,1,0.717183605530785,0,8,JUN kinase binding,MF,
3816,GO:0008434,1,0.956550284375981,0,1,calcitriol receptor activity,MF,
3817,GO:0008440,1,0.84352016620603,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
3818,GO:0008441,1,0.918297803055121,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
3819,GO:0008442,1,0.961852180856042,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
3820,GO:0008443,1,0.771691398445403,0,6,phosphofructokinase activity,MF,
3821,GO:0008444,1,0.961078623376909,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
3822,GO:0008446,1,0.962878924763691,0,1,GDP-mannose 4,6-dehydratase activity,MF,
3823,GO:0008448,1,0.962353602143447,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
3824,GO:0008449,1,0.875247808400479,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
3825,GO:0008452,1,0.958787867083198,0,1,RNA ligase activity,MF,
3826,GO:0008453,1,0.958787867083198,0,1,alanine-glyoxylate transaminase activity,MF,
3827,GO:0008454,1,0.917580063505697,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
3828,GO:0008455,1,0.959323986822767,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3829,GO:0008456,1,0.957231669126271,0,1,alpha-N-acetylgalactosaminidase activity,MF,
3830,GO:0008457,1,0.956859015494478,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
3831,GO:0008458,1,0.957963788787012,0,1,carnitine O-octanoyltransferase activity,MF,
3832,GO:0008459,1,0.918823418235952,0,2,chondroitin 6-sulfotransferase activity,MF,
3833,GO:0008460,1,0.962102649513654,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
3834,GO:0008465,1,0.964155174412667,0,1,glycerate dehydrogenase activity,MF,
3835,GO:0008466,1,0.962450622780884,0,1,glycogenin glucosyltransferase activity,MF,
3836,GO:0008467,1,0.889857337809224,0,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
3837,GO:0008469,1,0.722669377800659,0,8,histone-arginine N-methyltransferase activity,MF,
3838,GO:0008470,1,0.956580809297161,0,1,isovaleryl-CoA dehydrogenase activity,MF,
3839,GO:0008474,1,0.667083106055988,0,10,palmitoyl-(protein) hydrolase activity,MF,
3840,GO:0008475,1,0.879141151351951,0,3,procollagen-lysine 5-dioxygenase activity,MF,
3841,GO:0008476,1,0.925014767387519,0,2,protein-tyrosine sulfotransferase activity,MF,
3842,GO:0008478,1,0.956441843839217,0,1,pyridoxal kinase activity,MF,
3843,GO:0008479,1,0.859111504864029,0,4,queuine tRNA-ribosyltransferase activity,MF,
3844,GO:0008481,1,0.922413131820914,0,2,sphinganine kinase activity,MF,
3845,GO:0008482,1,0.960575478574431,0,1,sulfite oxidase activity,MF,
3846,GO:0008483,1,0.609616612007067,0,12,transaminase activity,MF,
3848,GO:0008486,1,0.851608970642098,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
3849,GO:0008488,1,0.958126436373152,0,1,gamma-glutamyl carboxylase activity,MF,
3850,GO:0008489,1,0.958759945309585,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
3851,GO:0008493,1,0.96225734534078,0,1,tetracycline transmembrane transporter activity,MF,
3852,GO:0008494,1,0.756433767447548,0,7,translation activator activity,MF,
3853,GO:0008495,1,0.958512331126642,0,1,protoheme IX farnesyltransferase activity,MF,
3854,GO:0008496,1,0.956763707449669,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
3855,GO:0008499,1,0.663529478420099,0,10,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
3856,GO:0008503,1,0.924933045188567,0,2,benzodiazepine receptor activity,MF,
3858,GO:0008506,1,0.917243972761644,0,2,sucrose:proton symporter activity,MF,
3859,GO:0008507,1,0.957415801263181,0,1,sodium:iodide symporter activity,MF,
3860,GO:0008508,1,0.926961744335302,0,2,bile acid:sodium symporter activity,MF,
3862,GO:0008510,1,0.801103859182189,0,5,sodium:bicarbonate symporter activity,MF,
3863,GO:0008511,1,0.956441843839217,0,1,sodium:potassium:chloride symporter activity,MF,
3864,GO:0008513,1,0.961075009811943,0,1,secondary active organic cation transmembrane transporter activity,MF,
3866,GO:0008515,1,0.917243972761644,0,2,sucrose transmembrane transporter activity,MF,
3867,GO:0008517,1,0.841544902003261,0,4,folic acid transmembrane transporter activity,MF,
3868,GO:0008518,1,0.958932636110817,0,1,reduced folate carrier activity,MF,
3869,GO:0008519,1,0.491772194814124,0,17,ammonium transmembrane transporter activity,MF,
3870,GO:0008520,1,0.956441843839217,0,1,L-ascorbate:sodium symporter activity,MF,
3871,GO:0008521,1,0.9594678223719,0,1,acetyl-CoA transmembrane transporter activity,MF,
3872,GO:0008523,1,0.957864878489591,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
3873,GO:0008525,1,0.777003159240792,0,6,phosphatidylcholine transporter activity,MF,
3874,GO:0008526,1,0.710786152694519,0,8,phosphatidylinositol transporter activity,MF,
3875,GO:0008527,1,0.771508866092879,0,7,taste receptor activity,MF,
3877,GO:0008531,1,0.959323986822767,0,1,riboflavin kinase activity,MF,
3879,GO:0008534,1,0.861907267237759,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
3880,GO:0008535,1,0.380835405306274,0,24,respiratory chain complex IV assembly,BP,
3881,GO:0008536,1,0.255139783367113,0,32,Ran GTPase binding,MF,
3882,GO:0008537,1,0.89189655284333,0,3,proteasome activator complex,CC,
3883,GO:0008540,1,0.627149183756654,0,12,proteasome regulatory particle, base subcomplex,CC,
3884,GO:0008541,1,0.766610328198543,0,7,proteasome regulatory particle, lid subcomplex,CC,
3885,GO:0008542,1,0.266274662349651,0,31,visual learning,BP,
3888,GO:0008545,1,0.916750756321715,0,2,JUN kinase kinase activity,MF,
3889,GO:0008553,1,0.690955774069586,0,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,
3890,GO:0008555,1,0.956447581051959,0,1,chloride-transporting ATPase activity,MF,
3893,GO:0008565,1,0.0538965805497517,0,71,protein transporter activity,MF,
3894,GO:0008568,1,0.65509763503849,0,10,microtubule-severing ATPase activity,MF,
3895,GO:0008569,1,0.621501302062803,0,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,
3896,GO:0008574,1,0.375021733030335,0,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,
3897,GO:0008579,1,0.956452574540766,0,1,JUN kinase phosphatase activity,MF,
3898,GO:0008582,1,0.914777292668164,0,2,regulation of synaptic growth at neuromuscular junction,BP,
3902,GO:0008591,1,0.962464157847848,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
3903,GO:0008592,1,0.957989060654006,0,1,regulation of Toll signaling pathway,BP,
3905,GO:0008594,1,0.915690490361788,0,2,photoreceptor cell morphogenesis,BP,
3906,GO:0008595,1,0.682912609479119,0,9,anterior/posterior axis specification, embryo,BP,
3907,GO:0008597,1,0.924618157726591,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
3908,GO:0008603,1,0.814140124290939,0,5,cAMP-dependent protein kinase regulator activity,MF,
3909,GO:0008607,1,0.884168438590189,0,3,phosphorylase kinase regulator activity,MF,
3910,GO:0008608,1,0.314331752789155,0,28,attachment of spindle microtubules to kinetochore,BP,
3911,GO:0008609,1,0.956441843839217,0,1,alkylglycerone-phosphate synthase activity,MF,
3913,GO:0008611,1,0.814909580629098,0,5,ether lipid biosynthetic process,BP,
3914,GO:0008612,1,0.855409939132249,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
3915,GO:0008614,1,0.920571194251529,0,2,pyridoxine metabolic process,BP,
3916,GO:0008615,1,0.920571194251529,0,2,pyridoxine biosynthetic process,BP,
3917,GO:0008616,1,0.891306703277484,0,3,queuosine biosynthetic process,BP,
3918,GO:0008617,1,0.964734502232411,0,1,guanosine metabolic process,BP,
3919,GO:0008622,1,0.82003658691779,0,5,epsilon DNA polymerase complex,CC,
3920,GO:0008623,1,0.918417336564551,0,2,CHRAC,CC,
3922,GO:0008626,1,0.884354112160116,0,3,granzyme-mediated apoptotic signaling pathway,BP,
3923,GO:0008627,1,0.743338275743576,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
3925,GO:0008631,1,0.199916436088197,0,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
3926,GO:0008635,1,0.693791296770038,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
3928,GO:0008641,1,0.658001443313795,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3931,GO:0008649,1,0.525279028018017,0,16,rRNA methyltransferase activity,MF,
3932,GO:0008650,1,0.957432471441811,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
3935,GO:0008655,1,0.62478444813715,0,12,pyrimidine-containing compound salvage,BP,
3936,GO:0008656,1,0.563242692695429,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
3937,GO:0008670,1,0.928593634694017,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
3938,GO:0008689,1,0.964083115104504,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
3939,GO:0008700,1,0.958787867083198,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
3940,GO:0008705,1,0.956441843839217,0,1,methionine synthase activity,MF,
3941,GO:0008709,1,0.964880250454939,0,1,cholate 7-alpha-dehydrogenase activity,MF,
3942,GO:0008721,1,0.960063836388062,0,1,D-serine ammonia-lyase activity,MF,
3944,GO:0008732,1,0.922600406772291,0,2,L-allo-threonine aldolase activity,MF,
3945,GO:0008745,1,0.964322923966933,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
3946,GO:0008746,1,0.956563247926027,0,1,NAD(P)+ transhydrogenase activity,MF,
3947,GO:0008747,1,0.963246820358345,0,1,N-acetylneuraminate lyase activity,MF,
3948,GO:0008750,1,0.956563247926027,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
3949,GO:0008753,1,0.957611221596689,0,1,NADPH dehydrogenase (quinone) activity,MF,
3951,GO:0008761,1,0.956451554093075,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
3952,GO:0008768,1,0.965083500337225,0,1,UDP-sugar diphosphatase activity,MF,
3953,GO:0008775,1,0.962389463089632,0,1,acetate CoA-transferase activity,MF,
3954,GO:0008781,1,0.928152797708291,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
3955,GO:0008783,1,0.961064169833123,0,1,agmatinase activity,MF,
3956,GO:0008785,1,0.963228572969555,0,1,alkyl hydroperoxide reductase activity,MF,
3957,GO:0008792,1,0.958787867083198,0,1,arginine decarboxylase activity,MF,
3958,GO:0008794,1,0.964976139134778,0,1,arsenate reductase (glutaredoxin) activity,MF,
3959,GO:0008796,1,0.925388694857522,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
3960,GO:0008798,1,0.956441850141088,0,1,beta-aspartyl-peptidase activity,MF,
3961,GO:0008802,1,0.957445113851019,0,1,betaine-aldehyde dehydrogenase activity,MF,
3962,GO:0008803,1,0.964790274089157,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
3963,GO:0008808,1,0.957149400412029,0,1,cardiolipin synthase activity,MF,
3964,GO:0008817,1,0.956843326994385,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
3965,GO:0008821,1,0.693960142212106,0,9,crossover junction endodeoxyribonuclease activity,MF,
3966,GO:0008823,1,0.809277597205763,0,5,cupric reductase activity,MF,
3967,GO:0008829,1,0.962403089142594,0,1,dCTP deaminase activity,MF,
3968,GO:0008832,1,0.958066773890521,0,1,dGTPase activity,MF,
3969,GO:0008841,1,0.960026136503136,0,1,dihydrofolate synthase activity,MF,
3970,GO:0008852,1,0.958949432704085,0,1,exodeoxyribonuclease I activity,MF,
3971,GO:0008853,1,0.885519136221069,0,3,exodeoxyribonuclease III activity,MF,
3972,GO:0008859,1,0.964869514684434,0,1,exoribonuclease II activity,MF,
3973,GO:0008865,1,0.876297488862277,0,3,fructokinase activity,MF,
3974,GO:0008887,1,0.957991017642359,0,1,glycerate kinase activity,MF,
3975,GO:0008889,1,0.878485672597526,0,3,glycerophosphodiester phosphodiesterase activity,MF,
3976,GO:0008890,1,0.963170471227968,0,1,glycine C-acetyltransferase activity,MF,
3977,GO:0008892,1,0.95644531911026,0,1,guanine deaminase activity,MF,
3978,GO:0008893,1,0.96465860431468,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
3979,GO:0008894,1,0.95922936827312,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
3980,GO:0008897,1,0.958869021098298,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
3982,GO:0008903,1,0.964491601914096,0,1,hydroxypyruvate isomerase activity,MF,
3983,GO:0008905,1,0.963105685108655,0,1,mannose-phosphate guanylyltransferase activity,MF,
3985,GO:0008940,1,0.87951131368205,0,3,nitrate reductase activity,MF,
3986,GO:0008941,1,0.923439858345075,0,2,nitric oxide dioxygenase activity,MF,
3987,GO:0008948,1,0.847660884358564,0,4,oxaloacetate decarboxylase activity,MF,
3988,GO:0008962,1,0.92301304818223,0,2,phosphatidylglycerophosphatase activity,MF,
3989,GO:0008963,1,0.961255756037948,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
3990,GO:0008967,1,0.92150686290421,0,2,phosphoglycolate phosphatase activity,MF,
3991,GO:0008970,1,0.744453106019092,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
3992,GO:0008973,1,0.957973471665783,0,1,phosphopentomutase activity,MF,
3993,GO:0008988,1,0.919270839167849,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
3994,GO:0008995,1,0.959690575072104,0,1,ribonuclease E activity,MF,
3995,GO:0009000,1,0.960112017744568,0,1,selenocysteine lyase activity,MF,
3996,GO:0009007,1,0.95729486741685,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
3997,GO:0009008,1,0.808186742782789,0,5,DNA-methyltransferase activity,MF,
3998,GO:0009013,1,0.956463626558617,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
3999,GO:0009019,1,0.842988186816426,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4000,GO:0009020,1,0.961923130581001,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4001,GO:0009032,1,0.962929946069701,0,1,thymidine phosphorylase activity,MF,
4002,GO:0009041,1,0.886423018584015,0,3,uridylate kinase activity,MF,
4003,GO:0009048,1,0.648174494372142,0,10,dosage compensation by inactivation of X chromosome,BP,
4005,GO:0009052,1,0.820168940260984,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4019,GO:0009068,1,0.611147253878264,0,12,aspartate family amino acid catabolic process,BP,
4021,GO:0009070,1,0.570122632760933,0,14,serine family amino acid biosynthetic process,BP,
4023,GO:0009072,1,0.655576486486802,0,11,aromatic amino acid family metabolic process,BP,
4024,GO:0009074,1,0.740042000975092,0,8,aromatic amino acid family catabolic process,BP,
4025,GO:0009078,1,0.957026642911005,0,1,pyruvate family amino acid metabolic process,BP,
4026,GO:0009080,1,0.957026642911005,0,1,pyruvate family amino acid catabolic process,BP,
4027,GO:0009081,1,0.405319928684673,0,22,branched-chain amino acid metabolic process,BP,
4028,GO:0009082,1,0.921105304694621,0,2,branched-chain amino acid biosynthetic process,BP,
4029,GO:0009083,1,0.443013974188924,0,20,branched-chain amino acid catabolic process,BP,
4031,GO:0009085,1,0.917098944675905,0,2,lysine biosynthetic process,BP,
4032,GO:0009086,1,0.638311032796353,0,11,methionine biosynthetic process,BP,
4034,GO:0009092,1,0.852325201850483,0,4,homoserine metabolic process,BP,
4035,GO:0009093,1,0.959654540720847,0,1,cysteine catabolic process,BP,
4036,GO:0009098,1,0.921105304694621,0,2,leucine biosynthetic process,BP,
4037,GO:0009099,1,0.921105304694621,0,2,valine biosynthetic process,BP,
4040,GO:0009106,1,0.921874323196946,0,2,lipoate metabolic process,BP,
4041,GO:0009107,1,0.962883723522496,0,1,lipoate biosynthetic process,BP,
4044,GO:0009110,1,0.515822812693387,0,16,vitamin biosynthetic process,BP,
4046,GO:0009112,1,0.23796663721507,0,35,nucleobase metabolic process,BP,
4047,GO:0009113,1,0.589962082114374,0,13,purine nucleobase biosynthetic process,BP,
4048,GO:0009115,1,0.914824534693486,0,2,xanthine catabolic process,BP,
4052,GO:0009120,1,0.789728155645931,0,6,deoxyribonucleoside metabolic process,BP,
4059,GO:0009129,1,0.574378348003138,0,14,pyrimidine nucleoside monophosphate metabolic process,BP,
4060,GO:0009130,1,0.574378348003138,0,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4062,GO:0009133,1,0.856864323718036,0,4,nucleoside diphosphate biosynthetic process,BP,
4063,GO:0009134,1,0.756577280287708,0,7,nucleoside diphosphate catabolic process,BP,
4065,GO:0009136,1,0.926915557926603,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4066,GO:0009137,1,0.853444060271063,0,4,purine nucleoside diphosphate catabolic process,BP,
4067,GO:0009138,1,0.886235626959524,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4068,GO:0009139,1,0.924436773665056,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4069,GO:0009140,1,0.958682820389596,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4072,GO:0009143,1,0.646600793524741,0,11,nucleoside triphosphate catabolic process,BP,
4075,GO:0009146,1,0.79044038035104,0,6,purine nucleoside triphosphate catabolic process,BP,
4078,GO:0009149,1,0.928037756749047,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4080,GO:0009151,1,0.677421933615201,0,10,purine deoxyribonucleotide metabolic process,BP,
4082,GO:0009153,1,0.927716082966944,0,2,purine deoxyribonucleotide biosynthetic process,BP,
4084,GO:0009155,1,0.789501023412231,0,6,purine deoxyribonucleotide catabolic process,BP,
4086,GO:0009157,1,0.702786197527728,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4088,GO:0009159,1,0.958787867083198,0,1,deoxyribonucleoside monophosphate catabolic process,BP,
4090,GO:0009162,1,0.65005576045053,0,11,deoxyribonucleoside monophosphate metabolic process,BP,
4098,GO:0009170,1,0.964785442296245,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4099,GO:0009173,1,0.697073948922502,0,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4100,GO:0009174,1,0.697073948922502,0,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4101,GO:0009176,1,0.824103029498594,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4102,GO:0009177,1,0.824103029498594,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4104,GO:0009180,1,0.926915557926603,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4105,GO:0009181,1,0.853444060271063,0,4,purine ribonucleoside diphosphate catabolic process,BP,
4106,GO:0009182,1,0.891130290515516,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4107,GO:0009183,1,0.964785442296245,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4108,GO:0009184,1,0.963367253297087,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4110,GO:0009186,1,0.823778276774982,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4112,GO:0009188,1,0.926915557926603,0,2,ribonucleoside diphosphate biosynthetic process,BP,
4113,GO:0009189,1,0.891877970470572,0,3,deoxyribonucleoside diphosphate biosynthetic process,BP,
4115,GO:0009191,1,0.788898795428711,0,6,ribonucleoside diphosphate catabolic process,BP,
4116,GO:0009192,1,0.963367253297087,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
4117,GO:0009193,1,0.958682820389596,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4118,GO:0009195,1,0.958682820389596,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4119,GO:0009196,1,0.924436773665056,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4120,GO:0009197,1,0.924436773665056,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4122,GO:0009200,1,0.535608065430961,0,16,deoxyribonucleoside triphosphate metabolic process,BP,
4124,GO:0009202,1,0.791257489098066,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4125,GO:0009203,1,0.964513019642941,0,1,ribonucleoside triphosphate catabolic process,BP,
4126,GO:0009204,1,0.760536081550724,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4129,GO:0009207,1,0.964513019642941,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4132,GO:0009211,1,0.796485177267724,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4133,GO:0009212,1,0.858266683340569,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4134,GO:0009213,1,0.928037756749047,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4135,GO:0009214,1,0.589954683372136,0,12,cyclic nucleotide catabolic process,BP,
4136,GO:0009215,1,0.703200410352607,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4137,GO:0009216,1,0.921948496174275,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4138,GO:0009217,1,0.819534895194475,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4140,GO:0009219,1,0.499496849961084,0,18,pyrimidine deoxyribonucleotide metabolic process,BP,
4142,GO:0009221,1,0.734320979630423,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4143,GO:0009222,1,0.958682820389596,0,1,pyrimidine ribonucleotide catabolic process,BP,
4144,GO:0009223,1,0.654660627120453,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4145,GO:0009224,1,0.964136567279706,0,1,CMP biosynthetic process,BP,
4146,GO:0009225,1,0.262524468203971,0,33,nucleotide-sugar metabolic process,BP,
4147,GO:0009226,1,0.431703439224777,0,21,nucleotide-sugar biosynthetic process,BP,
4148,GO:0009227,1,0.888144140059112,0,3,nucleotide-sugar catabolic process,BP,
4149,GO:0009231,1,0.959323986822767,0,1,riboflavin biosynthetic process,BP,
4150,GO:0009233,1,0.917198302260916,0,2,menaquinone metabolic process,BP,
4151,GO:0009234,1,0.957329124230061,0,1,menaquinone biosynthetic process,BP,
4153,GO:0009236,1,0.877551001318091,0,3,cobalamin biosynthetic process,BP,
4154,GO:0009237,1,0.958703543985504,0,1,siderophore metabolic process,BP,
4156,GO:0009245,1,0.932291866263446,0,2,lipid A biosynthetic process,BP,
4158,GO:0009249,1,0.774680260302375,0,7,protein lipoylation,BP,
4161,GO:0009253,1,0.964322923966933,0,1,peptidoglycan catabolic process,BP,
4162,GO:0009256,1,0.806931852547452,0,5,10-formyltetrahydrofolate metabolic process,BP,
4163,GO:0009257,1,0.916755692252297,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4164,GO:0009258,1,0.916445225645492,0,2,10-formyltetrahydrofolate catabolic process,BP,
4168,GO:0009262,1,0.285637536545875,0,32,deoxyribonucleotide metabolic process,BP,
4169,GO:0009263,1,0.597818322069602,0,13,deoxyribonucleotide biosynthetic process,BP,
4170,GO:0009264,1,0.497457270915668,0,18,deoxyribonucleotide catabolic process,BP,
4171,GO:0009265,1,0.681208905610955,0,10,2'-deoxyribonucleotide biosynthetic process,BP,
4176,GO:0009298,1,0.858481438600384,0,4,GDP-mannose biosynthetic process,BP,
4179,GO:0009303,1,0.329462932504397,0,27,rRNA transcription,BP,
4180,GO:0009304,1,0.744888114271947,0,7,tRNA transcription,BP,
4181,GO:0009305,1,0.956441843839217,0,1,protein biotinylation,BP,
4183,GO:0009308,1,0.0297417132530518,0,89,amine metabolic process,BP,
4184,GO:0009309,1,0.598296815342479,0,13,amine biosynthetic process,BP,
4185,GO:0009310,1,0.648420216411063,0,11,amine catabolic process,BP,
4190,GO:0009328,1,0.850286941774639,0,4,phenylalanine-tRNA ligase complex,CC,
4191,GO:0009330,1,0.91551265660479,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4192,GO:0009331,1,0.91534489313396,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
4193,GO:0009346,1,0.956702227540248,0,1,citrate lyase complex,CC,
4194,GO:0009353,1,0.963920131135718,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4195,GO:0009360,1,0.959342520623393,0,1,DNA polymerase III complex,CC,
4196,GO:0009368,1,0.9262734073931,0,2,endopeptidase Clp complex,CC,
4197,GO:0009372,1,0.957908533970339,0,1,quorum sensing,BP,
4198,GO:0009374,1,0.806671182979804,0,5,biotin binding,MF,
4199,GO:0009378,1,0.802443813584627,0,5,four-way junction helicase activity,MF,
4200,GO:0009383,1,0.917745069573135,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4201,GO:0009384,1,0.956451554093075,0,1,N-acylmannosamine kinase activity,MF,
4202,GO:0009386,1,0.960668298710852,0,1,translational attenuation,BP,
4203,GO:0009394,1,0.338181961720362,0,28,2'-deoxyribonucleotide metabolic process,BP,
4204,GO:0009395,1,0.309877340790984,0,28,phospholipid catabolic process,BP,
4205,GO:0009396,1,0.694314834891158,0,9,folic acid-containing compound biosynthetic process,BP,
4206,GO:0009397,1,0.845968059695972,0,4,folic acid-containing compound catabolic process,BP,
4207,GO:0009398,1,0.959323986822767,0,1,FMN biosynthetic process,BP,
4208,GO:0009400,1,0.958913145680909,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4209,GO:0009403,1,0.851312031023448,0,4,toxin biosynthetic process,BP,
4210,GO:0009404,1,0.525868934704549,0,16,toxin metabolic process,BP,
4211,GO:0009405,1,0.914781591009984,0,2,pathogenesis,BP,
4212,GO:0009407,1,0.85849167499681,0,4,toxin catabolic process,BP,
4217,GO:0009414,1,0.787713863638009,0,6,response to water deprivation,BP,
4221,GO:0009436,1,0.958787867083198,0,1,glyoxylate catabolic process,BP,
4223,GO:0009438,1,0.823666304603233,0,5,methylglyoxal metabolic process,BP,
4226,GO:0009441,1,0.96492184451589,0,1,glycolate metabolic process,BP,
4227,GO:0009443,1,0.956441843839217,0,1,pyridoxal 5'-phosphate salvage,BP,
4228,GO:0009445,1,0.759443582907302,0,7,putrescine metabolic process,BP,
4229,GO:0009446,1,0.816137260746818,0,5,putrescine biosynthetic process,BP,
4230,GO:0009447,1,0.895953800118513,0,3,putrescine catabolic process,BP,
4231,GO:0009448,1,0.841153590932505,0,4,gamma-aminobutyric acid metabolic process,BP,
4232,GO:0009449,1,0.879451560424573,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4233,GO:0009450,1,0.914853275739432,0,2,gamma-aminobutyric acid catabolic process,BP,
4234,GO:0009451,1,0.00460849881662227,0,132,RNA modification,BP,
4235,GO:0009452,1,0.266522885323898,0,33,7-methylguanosine RNA capping,BP,
4241,GO:0009593,1,0.33722820303341,0,27,detection of chemical stimulus,BP,
4242,GO:0009595,1,0.710479460834979,0,8,detection of biotic stimulus,BP,
4243,GO:0009597,1,0.811747259181088,0,5,detection of virus,BP,
4246,GO:0009608,1,0.923032490717533,0,2,response to symbiont,BP,
4247,GO:0009609,1,0.923032490717533,0,2,response to symbiotic bacterium,BP,
4252,GO:0009620,1,0.452091516279257,0,20,response to fungus,BP,
4253,GO:0009624,1,0.959631709220558,0,1,response to nematode,BP,
4255,GO:0009629,1,0.782181577589948,0,6,response to gravity,BP,
4256,GO:0009631,1,0.956468614910803,0,1,cold acclimation,BP,
4257,GO:0009635,1,0.615917664304566,0,12,response to herbicide,BP,
4260,GO:0009642,1,0.743786730667341,0,7,response to light intensity,BP,
4261,GO:0009644,1,0.919596922401192,0,2,response to high light intensity,BP,
4262,GO:0009645,1,0.95756135946994,0,1,response to low light intensity stimulus,BP,
4263,GO:0009646,1,0.957886117614705,0,1,response to absence of light,BP,
4269,GO:0009669,1,0.917243972761644,0,2,sucrose:cation symporter activity,MF,
4270,GO:0009674,1,0.956441843839217,0,1,potassium:sodium symporter activity,MF,
4271,GO:0009692,1,0.959631709220558,0,1,ethylene metabolic process,BP,
4272,GO:0009698,1,0.959631709220558,0,1,phenylpropanoid metabolic process,BP,
4273,GO:0009712,1,0.356391560426666,0,25,catechol-containing compound metabolic process,BP,
4274,GO:0009713,1,0.690145288658231,0,9,catechol-containing compound biosynthetic process,BP,
4276,GO:0009720,1,0.958547844808964,0,1,detection of hormone stimulus,BP,
4279,GO:0009737,1,0.956704721962182,0,1,response to abscisic acid,BP,
4280,GO:0009738,1,0.956704721962182,0,1,abscisic acid-activated signaling pathway,BP,
4282,GO:0009744,1,0.879764564168312,0,3,response to sucrose,BP,
4285,GO:0009750,1,0.848300932647094,0,4,response to fructose,BP,
4286,GO:0009753,1,0.928527892364252,0,2,response to jasmonic acid,BP,
4288,GO:0009756,1,0.787185671389381,0,6,carbohydrate mediated signaling,BP,
4289,GO:0009757,1,0.819778485408868,0,5,hexose mediated signaling,BP,
4290,GO:0009758,1,0.956441843839217,0,1,carbohydrate utilization,BP,
4292,GO:0009786,1,0.921732778864014,0,2,regulation of asymmetric cell division,BP,
4293,GO:0009787,1,0.956704721962182,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4294,GO:0009789,1,0.956704721962182,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4298,GO:0009794,1,0.847528968334313,0,4,regulation of mitotic cell cycle, embryonic,BP,
4301,GO:0009804,1,0.959631709220558,0,1,coumarin metabolic process,BP,
4302,GO:0009810,1,0.961028045423662,0,1,stilbene metabolic process,BP,
4303,GO:0009812,1,0.70011230549926,0,9,flavonoid metabolic process,BP,
4304,GO:0009814,1,0.961053331004262,0,1,defense response, incompatible interaction,BP,
4305,GO:0009817,1,0.961053331004262,0,1,defense response to fungus, incompatible interaction,BP,
4306,GO:0009820,1,0.889394943489513,0,3,alkaloid metabolic process,BP,
4307,GO:0009822,1,0.962759528869784,0,1,alkaloid catabolic process,BP,
4308,GO:0009826,1,0.920387743601943,0,2,unidimensional cell growth,BP,
4309,GO:0009838,1,0.821446624452552,0,5,abscission,BP,
4310,GO:0009841,1,0.96048662209716,0,1,mitochondrial endopeptidase Clp complex,CC,
4311,GO:0009850,1,0.962389463089632,0,1,auxin metabolic process,BP,
4312,GO:0009852,1,0.962389463089632,0,1,auxin catabolic process,BP,
4314,GO:0009880,1,0.203369739990081,0,37,embryonic pattern specification,BP,
4317,GO:0009886,1,0.666109579773903,0,10,post-embryonic animal morphogenesis,BP,
4330,GO:0009912,1,0.816133575657651,0,5,auditory receptor cell fate commitment,BP,
4333,GO:0009918,1,0.959482102469118,0,1,sterol delta7 reductase activity,MF,
4334,GO:0009922,1,0.811455539240222,0,5,fatty acid elongase activity,MF,
4336,GO:0009931,1,0.748042402398842,0,7,calcium-dependent protein serine/threonine kinase activity,MF,
4342,GO:0009955,1,0.961042493422886,0,1,adaxial/abaxial pattern specification,BP,
4343,GO:0009956,1,0.957036685293961,0,1,radial pattern formation,BP,
4344,GO:0009957,1,0.918647914176205,0,2,epidermal cell fate specification,BP,
4348,GO:0009972,1,0.760274509366157,0,7,cytidine deamination,BP,
4349,GO:0009975,1,0.67728499223267,0,9,cyclase activity,MF,
4350,GO:0009982,1,0.594398289674164,0,13,pseudouridine synthase activity,MF,
4355,GO:0009992,1,0.961131030975855,0,1,cellular water homeostasis,BP,
4357,GO:0009996,1,0.921172309451772,0,2,negative regulation of cell fate specification,BP,
4359,GO:0010002,1,0.70930239434472,0,8,cardioblast differentiation,BP,
4361,GO:0010009,1,0.812700814609214,0,5,cytoplasmic side of endosome membrane,CC,
4362,GO:0010015,1,0.965280077340104,0,1,root morphogenesis,BP,
4363,GO:0010025,1,0.919544580289203,0,2,wax biosynthetic process,BP,
4364,GO:0010032,1,0.800575105279117,0,5,meiotic chromosome condensation,BP,
4366,GO:0010034,1,0.957480867695754,0,1,response to acetate,BP,
4370,GO:0010040,1,0.850824815263831,0,4,response to iron(II) ion,BP,
4371,GO:0010041,1,0.817773459146326,0,5,response to iron(III) ion,BP,
4372,GO:0010042,1,0.606690854430245,0,12,response to manganese ion,BP,
4374,GO:0010044,1,0.849779208665387,0,4,response to aluminum ion,BP,
4375,GO:0010046,1,0.849817063640524,0,4,response to mycotoxin,BP,
4376,GO:0010053,1,0.965280077340104,0,1,root epidermal cell differentiation,BP,
4377,GO:0010054,1,0.965280077340104,0,1,trichoblast differentiation,BP,
4378,GO:0010070,1,0.960289275693844,0,1,zygote asymmetric cell division,BP,
4379,GO:0010092,1,0.516940489051258,0,16,specification of animal organ identity,BP,
4380,GO:0010106,1,0.961969091550826,0,1,cellular response to iron ion starvation,BP,
4382,GO:0010121,1,0.961839736491861,0,1,arginine catabolic process to proline via ornithine,BP,
4383,GO:0010124,1,0.962389463089632,0,1,phenylacetate catabolic process,BP,
4384,GO:0010133,1,0.920590652223798,0,2,proline catabolic process to glutamate,BP,
4385,GO:0010138,1,0.858408652564516,0,4,pyrimidine ribonucleotide salvage,BP,
4386,GO:0010139,1,0.963071508807238,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4387,GO:0010142,1,0.95756135946994,0,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4388,GO:0010155,1,0.701851150362078,0,9,regulation of proton transport,BP,
4389,GO:0010157,1,0.956441843839217,0,1,response to chlorate,BP,
4390,GO:0010159,1,0.881983198206845,0,3,specification of animal organ position,BP,
4391,GO:0010160,1,0.964775768520543,0,1,formation of animal organ boundary,BP,
4392,GO:0010164,1,0.963071508807238,0,1,response to cesium ion,BP,
4394,GO:0010166,1,0.919544580289203,0,2,wax metabolic process,BP,
4396,GO:0010172,1,0.647763288056609,0,10,embryonic body morphogenesis,BP,
4397,GO:0010181,1,0.658696843222103,0,10,FMN binding,MF,
4398,GO:0010182,1,0.819778485408868,0,5,sugar mediated signaling pathway,BP,
4399,GO:0010189,1,0.96287732446197,0,1,vitamin E biosynthetic process,BP,
4400,GO:0010193,1,0.923613198484139,0,2,response to ozone,BP,
4402,GO:0010216,1,0.76864194513926,0,6,maintenance of DNA methylation,BP,
4406,GO:0010232,1,0.958222255349026,0,1,vascular transport,BP,
4409,GO:0010255,1,0.819778485408868,0,5,glucose mediated signaling pathway,BP,
4411,GO:0010257,1,0.128451689788437,0,55,NADH dehydrogenase complex assembly,BP,
4413,GO:0010260,1,0.958787867083198,0,1,animal organ senescence,BP,
4414,GO:0010265,1,0.77787191177366,0,6,SCF complex assembly,BP,
4415,GO:0010266,1,0.884572956124493,0,3,response to vitamin B1,BP,
4416,GO:0010269,1,0.890560392513474,0,3,response to selenium ion,BP,
4418,GO:0010286,1,0.823358957964512,0,5,heat acclimation,BP,
4419,GO:0010288,1,0.438621092735041,0,20,response to lead ion,BP,
4420,GO:0010309,1,0.96288851906386,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4421,GO:0010310,1,0.688225834531441,0,9,regulation of hydrogen peroxide metabolic process,BP,
4422,GO:0010314,1,0.658626238124644,0,10,phosphatidylinositol-5-phosphate binding,MF,
4425,GO:0010335,1,0.956633402815242,0,1,response to non-ionic osmotic stress,BP,
4426,GO:0010340,1,0.747178344915372,0,7,carboxyl-O-methyltransferase activity,MF,
4427,GO:0010348,1,0.958787867083198,0,1,lithium:proton antiporter activity,MF,
4431,GO:0010370,1,0.920479628065061,0,2,perinucleolar chromocenter,CC,
4433,GO:0010387,1,0.960725599208896,0,1,COP9 signalosome assembly,BP,
4436,GO:0010412,1,0.957833010849434,0,1,mannan metabolic process,BP,
4437,GO:0010420,1,0.964083115104504,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4439,GO:0010428,1,0.956441843839217,0,1,methyl-CpNpG binding,MF,
4440,GO:0010430,1,0.956552924507682,0,1,fatty acid omega-oxidation,BP,
4442,GO:0010452,1,0.682909675867028,0,9,histone H3-K36 methylation,BP,
4443,GO:0010453,1,0.582233752768203,0,13,regulation of cell fate commitment,BP,
4444,GO:0010454,1,0.882673475146152,0,3,negative regulation of cell fate commitment,BP,
4445,GO:0010455,1,0.85234284883269,0,4,positive regulation of cell fate commitment,BP,
4446,GO:0010457,1,0.617970250813516,0,11,centriole-centriole cohesion,BP,
4447,GO:0010458,1,0.344122904144636,0,26,exit from mitosis,BP,
4448,GO:0010459,1,0.856796601565587,0,4,negative regulation of heart rate,BP,
4449,GO:0010460,1,0.670863071128143,0,10,positive regulation of heart rate,BP,
4458,GO:0010481,1,0.884091714200176,0,3,epidermal cell division,BP,
4459,GO:0010482,1,0.884091714200176,0,3,regulation of epidermal cell division,BP,
4460,GO:0010484,1,0.839834165719731,0,4,H3 histone acetyltransferase activity,MF,
4461,GO:0010485,1,0.464536859890071,0,18,H4 histone acetyltransferase activity,MF,
4462,GO:0010494,1,0.180150474845248,0,40,cytoplasmic stress granule,CC,
4464,GO:0010499,1,0.43693525500142,0,22,proteasomal ubiquitin-independent protein catabolic process,BP,
4469,GO:0010509,1,0.956443076209304,0,1,polyamine homeostasis,BP,
4472,GO:0010512,1,0.919628828173175,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4476,GO:0010519,1,0.782458346257951,0,6,negative regulation of phospholipase activity,BP,
4477,GO:0010520,1,0.919407156898679,0,2,regulation of reciprocal meiotic recombination,BP,
4478,GO:0010521,1,0.885609983821282,0,3,telomerase inhibitor activity,MF,
4482,GO:0010528,1,0.607887193907556,0,12,regulation of transposition,BP,
4483,GO:0010529,1,0.607887193907556,0,12,negative regulation of transposition,BP,
4484,GO:0010533,1,0.896837609000343,0,3,regulation of activation of Janus kinase activity,BP,
4485,GO:0010536,1,0.930118564382199,0,2,positive regulation of activation of Janus kinase activity,BP,
4491,GO:0010559,1,0.326770068910586,0,27,regulation of glycoprotein biosynthetic process,BP,
4492,GO:0010560,1,0.578303727301783,0,13,positive regulation of glycoprotein biosynthetic process,BP,
4493,GO:0010561,1,0.642272786478951,0,11,negative regulation of glycoprotein biosynthetic process,BP,
4498,GO:0010566,1,0.712901375445387,0,8,regulation of ketone biosynthetic process,BP,
4500,GO:0010571,1,0.76909076153109,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4505,GO:0010585,1,0.962036024577607,0,1,glutamine secretion,BP,
4506,GO:0010586,1,0.414167271596743,0,21,miRNA metabolic process,BP,
4507,GO:0010587,1,0.805726823948035,0,5,miRNA catabolic process,BP,
4509,GO:0010592,1,0.556351599369677,0,14,positive regulation of lamellipodium assembly,BP,
4510,GO:0010593,1,0.914820963632538,0,2,negative regulation of lamellipodium assembly,BP,
4514,GO:0010603,1,0.733837924340092,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4517,GO:0010606,1,0.801555125626822,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4519,GO:0010609,1,0.921345794254462,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4522,GO:0010613,1,0.444442323663832,0,19,positive regulation of cardiac muscle hypertrophy,BP,
4524,GO:0010615,1,0.9565710502021,0,1,positive regulation of cardiac muscle adaptation,BP,
4526,GO:0010621,1,0.964516792156834,0,1,negative regulation of transcription by transcription factor localization,BP,
4527,GO:0010623,1,0.74686923578448,0,7,programmed cell death involved in cell development,BP,
4528,GO:0010624,1,0.839425473798775,0,4,regulation of Schwann cell proliferation,BP,
4529,GO:0010626,1,0.839425473798775,0,4,negative regulation of Schwann cell proliferation,BP,
4536,GO:0010635,1,0.718923267220258,0,8,regulation of mitochondrial fusion,BP,
4537,GO:0010636,1,0.917944733837283,0,2,positive regulation of mitochondrial fusion,BP,
4538,GO:0010637,1,0.816465732997287,0,5,negative regulation of mitochondrial fusion,BP,
4541,GO:0010640,1,0.505547177694812,0,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,
4542,GO:0010641,1,0.840943201438573,0,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4543,GO:0010642,1,0.628363048042509,0,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4544,GO:0010643,1,0.879991788641963,0,3,cell communication by chemical coupling,BP,
4546,GO:0010645,1,0.918109683970876,0,2,regulation of cell communication by chemical coupling,BP,
4550,GO:0010649,1,0.684498560709139,0,9,regulation of cell communication by electrical coupling,BP,
4551,GO:0010650,1,0.956441843839217,0,1,positive regulation of cell communication by electrical coupling,BP,
4552,GO:0010652,1,0.918109683970876,0,2,positive regulation of cell communication by chemical coupling,BP,
4553,GO:0010656,1,0.398919963943951,0,22,negative regulation of muscle cell apoptotic process,BP,
4554,GO:0010657,1,0.18563499697122,0,40,muscle cell apoptotic process,BP,
4555,GO:0010658,1,0.393447852942777,0,22,striated muscle cell apoptotic process,BP,
4556,GO:0010659,1,0.428455106994894,0,20,cardiac muscle cell apoptotic process,BP,
4557,GO:0010660,1,0.211336390453198,0,37,regulation of muscle cell apoptotic process,BP,
4558,GO:0010661,1,0.530139198139714,0,15,positive regulation of muscle cell apoptotic process,BP,
4559,GO:0010662,1,0.429375744177322,0,20,regulation of striated muscle cell apoptotic process,BP,
4560,GO:0010663,1,0.77334924787482,0,6,positive regulation of striated muscle cell apoptotic process,BP,
4561,GO:0010664,1,0.531269745560554,0,15,negative regulation of striated muscle cell apoptotic process,BP,
4562,GO:0010665,1,0.467572578692788,0,18,regulation of cardiac muscle cell apoptotic process,BP,
4563,GO:0010666,1,0.77334924787482,0,6,positive regulation of cardiac muscle cell apoptotic process,BP,
4564,GO:0010667,1,0.60476743403411,0,12,negative regulation of cardiac muscle cell apoptotic process,BP,
4565,GO:0010668,1,0.80451860202089,0,5,ectodermal cell differentiation,BP,
4566,GO:0010669,1,0.580652047824926,0,13,epithelial structure maintenance,BP,
4569,GO:0010677,1,0.431429189272018,0,20,negative regulation of cellular carbohydrate metabolic process,BP,
4570,GO:0010692,1,0.735659696346199,0,7,regulation of alkaline phosphatase activity,BP,
4571,GO:0010693,1,0.914964119774619,0,2,negative regulation of alkaline phosphatase activity,BP,
4572,GO:0010694,1,0.804063064836898,0,5,positive regulation of alkaline phosphatase activity,BP,
4573,GO:0010698,1,0.924604269068211,0,2,acetyltransferase activator activity,MF,
4574,GO:0010700,1,0.958275000686016,0,1,negative regulation of norepinephrine secretion,BP,
4575,GO:0010701,1,0.919764909657937,0,2,positive regulation of norepinephrine secretion,BP,
4576,GO:0010705,1,0.956599196512343,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4577,GO:0010710,1,0.886115758129409,0,3,regulation of collagen catabolic process,BP,
4578,GO:0010711,1,0.965291349103236,0,1,negative regulation of collagen catabolic process,BP,
4580,GO:0010713,1,0.788856260323221,0,6,negative regulation of collagen metabolic process,BP,
4583,GO:0010716,1,0.88969279078645,0,3,negative regulation of extracellular matrix disassembly,BP,
4589,GO:0010722,1,0.956441843839217,0,1,regulation of ferrochelatase activity,BP,
4591,GO:0010726,1,0.921417160232942,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4592,GO:0010727,1,0.841312684800429,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
4593,GO:0010728,1,0.8455591898257,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4594,GO:0010729,1,0.961684453543003,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4595,GO:0010730,1,0.879257124802906,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4596,GO:0010731,1,0.96055233641454,0,1,protein glutathionylation,BP,
4597,GO:0010732,1,0.96055233641454,0,1,regulation of protein glutathionylation,BP,
4598,GO:0010734,1,0.96055233641454,0,1,negative regulation of protein glutathionylation,BP,
4599,GO:0010735,1,0.875889413463854,0,3,positive regulation of transcription via serum response element binding,BP,
4600,GO:0010736,1,0.956725253418938,0,1,serum response element binding,MF,
4605,GO:0010743,1,0.536176734369881,0,15,regulation of macrophage derived foam cell differentiation,BP,
4606,GO:0010744,1,0.778887959108342,0,6,positive regulation of macrophage derived foam cell differentiation,BP,
4607,GO:0010745,1,0.688519148286164,0,9,negative regulation of macrophage derived foam cell differentiation,BP,
4608,GO:0010746,1,0.838931129477262,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4609,GO:0010748,1,0.838931129477262,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4612,GO:0010751,1,0.914777292668164,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
4613,GO:0010752,1,0.915031410639541,0,2,regulation of cGMP-mediated signaling,BP,
4614,GO:0010754,1,0.956441843839217,0,1,negative regulation of cGMP-mediated signaling,BP,
4616,GO:0010756,1,0.887276727577845,0,3,positive regulation of plasminogen activation,BP,
4620,GO:0010760,1,0.858586832192622,0,4,negative regulation of macrophage chemotaxis,BP,
4624,GO:0010764,1,0.781769410346322,0,6,negative regulation of fibroblast migration,BP,
4627,GO:0010767,1,0.877620783612084,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4628,GO:0010768,1,0.914777292668164,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4632,GO:0010792,1,0.77599245025815,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4633,GO:0010793,1,0.807393135168004,0,5,regulation of mRNA export from nucleus,BP,
4634,GO:0010795,1,0.964083115104504,0,1,regulation of ubiquinone biosynthetic process,BP,
4635,GO:0010796,1,0.891276887441085,0,3,regulation of multivesicular body size,BP,
4636,GO:0010797,1,0.964221206292426,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4638,GO:0010800,1,0.409543637849828,0,21,positive regulation of peptidyl-threonine phosphorylation,BP,
4642,GO:0010807,1,0.775275701280669,0,6,regulation of synaptic vesicle priming,BP,
4643,GO:0010808,1,0.956441843839217,0,1,positive regulation of synaptic vesicle priming,BP,
4647,GO:0010813,1,0.921551074647862,0,2,neuropeptide catabolic process,BP,
4648,GO:0010814,1,0.956466376657804,0,1,substance P catabolic process,BP,
4649,GO:0010815,1,0.846203722411947,0,4,bradykinin catabolic process,BP,
4650,GO:0010816,1,0.956466376657804,0,1,calcitonin catabolic process,BP,
4652,GO:0010818,1,0.690305144735088,0,9,T cell chemotaxis,BP,
4653,GO:0010819,1,0.779361373310262,0,6,regulation of T cell chemotaxis,BP,
4654,GO:0010820,1,0.779361373310262,0,6,positive regulation of T cell chemotaxis,BP,
4657,GO:0010823,1,0.196483533732563,0,40,negative regulation of mitochondrion organization,BP,
4659,GO:0010825,1,0.771965268959376,0,6,positive regulation of centrosome duplication,BP,
4660,GO:0010826,1,0.604138470575289,0,12,negative regulation of centrosome duplication,BP,
4663,GO:0010829,1,0.636344674130617,0,11,negative regulation of glucose transmembrane transport,BP,
4666,GO:0010832,1,0.780581567128622,0,6,negative regulation of myotube differentiation,BP,
4667,GO:0010833,1,0.0458142559531121,0,74,telomere maintenance via telomere lengthening,BP,
4668,GO:0010835,1,0.749085892127401,0,7,regulation of protein ADP-ribosylation,BP,
4669,GO:0010836,1,0.890094671837176,0,3,negative regulation of protein ADP-ribosylation,BP,
4671,GO:0010838,1,0.804165184708834,0,5,positive regulation of keratinocyte proliferation,BP,
4674,GO:0010845,1,0.959560471927079,0,1,positive regulation of reciprocal meiotic recombination,BP,
4675,GO:0010847,1,0.843481741991488,0,4,regulation of chromatin assembly,BP,
4676,GO:0010848,1,0.957914178785012,0,1,regulation of chromatin disassembly,BP,
4677,GO:0010849,1,0.961071396363931,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4678,GO:0010851,1,0.960811769590848,0,1,cyclase regulator activity,MF,
4679,GO:0010853,1,0.960811769590848,0,1,cyclase activator activity,MF,
4680,GO:0010856,1,0.95790103293402,0,1,adenylate cyclase activator activity,MF,
4681,GO:0010857,1,0.71770020022576,0,8,calcium-dependent protein kinase activity,MF,
4682,GO:0010858,1,0.926729657322993,0,2,calcium-dependent protein kinase regulator activity,MF,
4683,GO:0010859,1,0.95669213849836,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
4688,GO:0010868,1,0.915625869062561,0,2,negative regulation of triglyceride biosynthetic process,BP,
4690,GO:0010870,1,0.664601431782286,0,10,positive regulation of receptor biosynthetic process,BP,
4691,GO:0010871,1,0.84428166643565,0,4,negative regulation of receptor biosynthetic process,BP,
4698,GO:0010878,1,0.631948268320607,0,11,cholesterol storage,BP,
4699,GO:0010879,1,0.960822557325351,0,1,cholesterol transport involved in cholesterol storage,BP,
4700,GO:0010880,1,0.537658365433051,0,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4701,GO:0010881,1,0.639059511773687,0,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
4702,GO:0010882,1,0.537992571555683,0,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,
4703,GO:0010883,1,0.311827555715581,0,28,regulation of lipid storage,BP,
4704,GO:0010884,1,0.606412172517054,0,12,positive regulation of lipid storage,BP,
4705,GO:0010885,1,0.686817942663625,0,9,regulation of cholesterol storage,BP,
4706,GO:0010886,1,0.878951989530222,0,3,positive regulation of cholesterol storage,BP,
4707,GO:0010887,1,0.781456469489055,0,6,negative regulation of cholesterol storage,BP,
4708,GO:0010888,1,0.609560423657833,0,12,negative regulation of lipid storage,BP,
4709,GO:0010889,1,0.720470843889727,0,8,regulation of sequestering of triglyceride,BP,
4710,GO:0010890,1,0.890068390361619,0,3,positive regulation of sequestering of triglyceride,BP,
4711,GO:0010891,1,0.809496483898441,0,5,negative regulation of sequestering of triglyceride,BP,
4714,GO:0010896,1,0.883511067938303,0,3,regulation of triglyceride catabolic process,BP,
4715,GO:0010897,1,0.960734563591107,0,1,negative regulation of triglyceride catabolic process,BP,
4716,GO:0010898,1,0.919626691957042,0,2,positive regulation of triglyceride catabolic process,BP,
4717,GO:0010899,1,0.886377147617602,0,3,regulation of phosphatidylcholine catabolic process,BP,
4718,GO:0010900,1,0.965968319363988,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
4719,GO:0010904,1,0.961111150127444,0,1,regulation of UDP-glucose catabolic process,BP,
4720,GO:0010905,1,0.961111150127444,0,1,negative regulation of UDP-glucose catabolic process,BP,
4723,GO:0010908,1,0.878667712618599,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4724,GO:0010909,1,0.878667712618599,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4725,GO:0010911,1,0.740085421336281,0,7,regulation of isomerase activity,BP,
4726,GO:0010912,1,0.740085421336281,0,7,positive regulation of isomerase activity,BP,
4727,GO:0010915,1,0.930422221039525,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4728,GO:0010916,1,0.930422221039525,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
4729,GO:0010917,1,0.727013641259859,0,8,negative regulation of mitochondrial membrane potential,BP,
4730,GO:0010918,1,0.750427528997382,0,7,positive regulation of mitochondrial membrane potential,BP,
4731,GO:0010919,1,0.73763583348896,0,7,regulation of inositol phosphate biosynthetic process,BP,
4733,GO:0010922,1,0.374280438413445,0,23,positive regulation of phosphatase activity,BP,
4736,GO:0010931,1,0.956441843839217,0,1,macrophage tolerance induction,BP,
4737,GO:0010932,1,0.956441843839217,0,1,regulation of macrophage tolerance induction,BP,
4738,GO:0010933,1,0.956441843839217,0,1,positive regulation of macrophage tolerance induction,BP,
4739,GO:0010934,1,0.683548123506734,0,9,macrophage cytokine production,BP,
4740,GO:0010935,1,0.744003799751916,0,7,regulation of macrophage cytokine production,BP,
4741,GO:0010936,1,0.812194631723717,0,5,negative regulation of macrophage cytokine production,BP,
4743,GO:0010940,1,0.825410597417369,0,5,positive regulation of necrotic cell death,BP,
4746,GO:0010944,1,0.786130207313176,0,6,negative regulation of transcription by competitive promoter binding,BP,
4751,GO:0010954,1,0.632639521362904,0,11,positive regulation of protein processing,BP,
4753,GO:0010956,1,0.91861912787464,0,2,negative regulation of calcidiol 1-monooxygenase activity,BP,
4754,GO:0010957,1,0.883184453943546,0,3,negative regulation of vitamin D biosynthetic process,BP,
4755,GO:0010958,1,0.845972678112155,0,4,regulation of amino acid import across plasma membrane,BP,
4758,GO:0010961,1,0.914844434506283,0,2,cellular magnesium ion homeostasis,BP,
4760,GO:0010963,1,0.96357015028942,0,1,regulation of L-arginine import,BP,
4761,GO:0010965,1,0.127572471828569,0,50,regulation of mitotic sister chromatid separation,BP,
4763,GO:0010967,1,0.962814632476997,0,1,regulation of polyamine biosynthetic process,BP,
4764,GO:0010968,1,0.782188211686452,0,6,regulation of microtubule nucleation,BP,
4766,GO:0010971,1,0.453132078441445,0,19,positive regulation of G2/M transition of mitotic cell cycle,BP,
4771,GO:0010979,1,0.918309866791442,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
4772,GO:0010980,1,0.918309866791442,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
4773,GO:0010982,1,0.919266300981115,0,2,regulation of high-density lipoprotein particle clearance,BP,
4774,GO:0010983,1,0.919266300981115,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
4775,GO:0010984,1,0.641269255494342,0,11,regulation of lipoprotein particle clearance,BP,
4776,GO:0010985,1,0.819483985331525,0,5,negative regulation of lipoprotein particle clearance,BP,
4777,GO:0010986,1,0.846692326332667,0,4,positive regulation of lipoprotein particle clearance,BP,
4778,GO:0010988,1,0.78398985235105,0,6,regulation of low-density lipoprotein particle clearance,BP,
4779,GO:0010989,1,0.880782278336712,0,3,negative regulation of low-density lipoprotein particle clearance,BP,
4780,GO:0010990,1,0.87554904277629,0,3,regulation of SMAD protein complex assembly,BP,
4781,GO:0010991,1,0.914940617572581,0,2,negative regulation of SMAD protein complex assembly,BP,
4782,GO:0010992,1,0.74845071193106,0,7,ubiquitin recycling,BP,
4783,GO:0010994,1,0.818151282279601,0,5,free ubiquitin chain polymerization,BP,
4785,GO:0010997,1,0.810888927430553,0,5,anaphase-promoting complex binding,MF,
4787,GO:0010999,1,0.956645115883487,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
4795,GO:0014004,1,0.917067048208303,0,2,microglia differentiation,BP,
4796,GO:0014005,1,0.917067048208303,0,2,microglia development,BP,
4798,GO:0014010,1,0.802848851429832,0,5,Schwann cell proliferation,BP,
4799,GO:0014011,1,0.958787867083198,0,1,Schwann cell proliferation involved in axon regeneration,BP,
4800,GO:0014012,1,0.847511366695711,0,4,peripheral nervous system axon regeneration,BP,
4802,GO:0014014,1,0.419992945058265,0,21,negative regulation of gliogenesis,BP,
4804,GO:0014016,1,0.960188160832726,0,1,neuroblast differentiation,BP,
4807,GO:0014028,1,0.963332843891388,0,1,notochord formation,BP,
4813,GO:0014036,1,0.957024743659525,0,1,neural crest cell fate specification,BP,
4815,GO:0014038,1,0.883635028541677,0,3,regulation of Schwann cell differentiation,BP,
4816,GO:0014040,1,0.917924164942648,0,2,positive regulation of Schwann cell differentiation,BP,
4817,GO:0014041,1,0.744002093837488,0,7,regulation of neuron maturation,BP,
4818,GO:0014042,1,0.837434953284645,0,4,positive regulation of neuron maturation,BP,
4819,GO:0014043,1,0.921066033945551,0,2,negative regulation of neuron maturation,BP,
4821,GO:0014045,1,0.84548042455162,0,4,establishment of endothelial blood-brain barrier,BP,
4822,GO:0014046,1,0.690322757487034,0,9,dopamine secretion,BP,
4824,GO:0014048,1,0.809376764275353,0,5,regulation of glutamate secretion,BP,
4825,GO:0014049,1,0.844757313436133,0,4,positive regulation of glutamate secretion,BP,
4828,GO:0014053,1,0.956499496521757,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
4829,GO:0014054,1,0.956850747692907,0,1,positive regulation of gamma-aminobutyric acid secretion,BP,
4830,GO:0014059,1,0.690322757487034,0,9,regulation of dopamine secretion,BP,
4831,GO:0014061,1,0.881381284813261,0,3,regulation of norepinephrine secretion,BP,
4832,GO:0014062,1,0.922496854897752,0,2,regulation of serotonin secretion,BP,
4833,GO:0014063,1,0.964338435751775,0,1,negative regulation of serotonin secretion,BP,
4834,GO:0014064,1,0.956614265908789,0,1,positive regulation of serotonin secretion,BP,
4841,GO:0014072,1,0.49549117234043,0,17,response to isoquinoline alkaloid,BP,
4844,GO:0014701,1,0.876034933178153,0,3,junctional sarcoplasmic reticulum membrane,CC,
4847,GO:0014717,1,0.923237088216994,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4848,GO:0014718,1,0.923237088216994,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4849,GO:0014719,1,0.888852771160671,0,3,skeletal muscle satellite cell activation,BP,
4851,GO:0014722,1,0.85324370055039,0,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,
4853,GO:0014732,1,0.885771863697193,0,3,skeletal muscle atrophy,BP,
4854,GO:0014733,1,0.677350453724482,0,9,regulation of skeletal muscle adaptation,BP,
4855,GO:0014734,1,0.914777292668164,0,2,skeletal muscle hypertrophy,BP,
4856,GO:0014735,1,0.921784117854095,0,2,regulation of muscle atrophy,BP,
4857,GO:0014736,1,0.921784117854095,0,2,negative regulation of muscle atrophy,BP,
4858,GO:0014738,1,0.88231891283107,0,3,regulation of muscle hyperplasia,BP,
4859,GO:0014739,1,0.958585059351351,0,1,positive regulation of muscle hyperplasia,BP,
4860,GO:0014740,1,0.920445444428696,0,2,negative regulation of muscle hyperplasia,BP,
4862,GO:0014742,1,0.444442323663832,0,19,positive regulation of muscle hypertrophy,BP,
4864,GO:0014744,1,0.877003566084514,0,3,positive regulation of muscle adaptation,BP,
4868,GO:0014806,1,0.924851470360958,0,2,smooth muscle hyperplasia,BP,
4869,GO:0014807,1,0.780796185607975,0,6,regulation of somitogenesis,BP,
4870,GO:0014808,1,0.518153071296029,0,16,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4871,GO:0014809,1,0.889866750626071,0,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
4872,GO:0014810,1,0.965271047917488,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
4874,GO:0014816,1,0.914777292668164,0,2,skeletal muscle satellite cell differentiation,BP,
4875,GO:0014819,1,0.82405341187752,0,5,regulation of skeletal muscle contraction,BP,
4876,GO:0014820,1,0.781739223059347,0,6,tonic smooth muscle contraction,BP,
4877,GO:0014821,1,0.853177967815761,0,4,phasic smooth muscle contraction,BP,
4879,GO:0014824,1,0.846837304295255,0,4,artery smooth muscle contraction,BP,
4880,GO:0014825,1,0.965198421423852,0,1,stomach fundus smooth muscle contraction,BP,
4881,GO:0014826,1,0.961427324140695,0,1,vein smooth muscle contraction,BP,
4882,GO:0014827,1,0.960952241826681,0,1,intestine smooth muscle contraction,BP,
4883,GO:0014829,1,0.600087431074905,0,12,vascular smooth muscle contraction,BP,
4884,GO:0014831,1,0.81210125635817,0,5,gastro-intestinal system smooth muscle contraction,BP,
4885,GO:0014832,1,0.876868820643052,0,3,urinary bladder smooth muscle contraction,BP,
4886,GO:0014834,1,0.884181279554648,0,3,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
4887,GO:0014835,1,0.956725253418938,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
4888,GO:0014839,1,0.927366669620824,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
4889,GO:0014841,1,0.740046599500206,0,7,skeletal muscle satellite cell proliferation,BP,
4890,GO:0014842,1,0.740046599500206,0,7,regulation of skeletal muscle satellite cell proliferation,BP,
4891,GO:0014843,1,0.956441843839217,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
4892,GO:0014846,1,0.915092693701667,0,2,esophagus smooth muscle contraction,BP,
4893,GO:0014847,1,0.965198421423852,0,1,proximal stomach smooth muscle contraction,BP,
4894,GO:0014848,1,0.876868820643052,0,3,urinary tract smooth muscle contraction,BP,
4896,GO:0014852,1,0.958853989181565,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4897,GO:0014853,1,0.958853989181565,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
4898,GO:0014854,1,0.715369227579064,0,8,response to inactivity,BP,
4900,GO:0014856,1,0.740046599500206,0,7,skeletal muscle cell proliferation,BP,
4901,GO:0014857,1,0.740046599500206,0,7,regulation of skeletal muscle cell proliferation,BP,
4902,GO:0014858,1,0.914832606956516,0,2,positive regulation of skeletal muscle cell proliferation,BP,
4903,GO:0014859,1,0.957822209654798,0,1,negative regulation of skeletal muscle cell proliferation,BP,
4904,GO:0014866,1,0.879935961407959,0,3,skeletal myofibril assembly,BP,
4905,GO:0014870,1,0.773275273984552,0,6,response to muscle inactivity,BP,
4906,GO:0014874,1,0.743424766651564,0,7,response to stimulus involved in regulation of muscle adaptation,BP,
4907,GO:0014876,1,0.96376714617817,0,1,response to injury involved in regulation of muscle adaptation,BP,
4908,GO:0014877,1,0.806528356527176,0,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,
4909,GO:0014878,1,0.956450092596557,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
4910,GO:0014883,1,0.844181679339204,0,4,transition between fast and slow fiber,BP,
4911,GO:0014886,1,0.91639626817299,0,2,transition between slow and fast fiber,BP,
4914,GO:0014889,1,0.753376330275312,0,7,muscle atrophy,BP,
4915,GO:0014891,1,0.849653605292953,0,4,striated muscle atrophy,BP,
4916,GO:0014894,1,0.806528356527176,0,5,response to denervation involved in regulation of muscle adaptation,BP,
4921,GO:0014900,1,0.849906780391409,0,4,muscle hyperplasia,BP,
4922,GO:0014901,1,0.923237088216994,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
4924,GO:0014904,1,0.530321623131161,0,15,myotube cell development,BP,
4925,GO:0014908,1,0.956441843839217,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
4929,GO:0014912,1,0.514098743955586,0,16,negative regulation of smooth muscle cell migration,BP,
4930,GO:0014916,1,0.879957006190798,0,3,regulation of lung blood pressure,BP,
4933,GO:0015014,1,0.838985197769247,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
4934,GO:0015015,1,0.842376130498496,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
4935,GO:0015016,1,0.915263828157752,0,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
4936,GO:0015018,1,0.963596174117928,0,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
4938,GO:0015020,1,0.558210775836999,0,14,glucuronosyltransferase activity,MF,
4944,GO:0015037,1,0.630064492360571,0,12,peptide disulfide oxidoreductase activity,MF,
4945,GO:0015038,1,0.831019657533434,0,5,glutathione disulfide oxidoreductase activity,MF,
4946,GO:0015039,1,0.962137583103709,0,1,NADPH-adrenodoxin reductase activity,MF,
4955,GO:0015086,1,0.956819476805938,0,1,cadmium ion transmembrane transporter activity,MF,
4956,GO:0015087,1,0.956819476805938,0,1,cobalt ion transmembrane transporter activity,MF,
4957,GO:0015091,1,0.956462433765706,0,1,ferric iron transmembrane transporter activity,MF,
4958,GO:0015093,1,0.915249358247852,0,2,ferrous iron transmembrane transporter activity,MF,
4959,GO:0015094,1,0.956819476805938,0,1,lead ion transmembrane transporter activity,MF,
4961,GO:0015098,1,0.962135838670923,0,1,molybdate ion transmembrane transporter activity,MF,
4962,GO:0015101,1,0.512480101770943,0,16,organic cation transmembrane transporter activity,MF,
4964,GO:0015105,1,0.96403734027842,0,1,arsenite transmembrane transporter activity,MF,
4965,GO:0015106,1,0.618603277846955,0,11,bicarbonate transmembrane transporter activity,MF,
4967,GO:0015111,1,0.87618067249613,0,3,iodide transmembrane transporter activity,MF,
4968,GO:0015112,1,0.959490051413541,0,1,nitrate transmembrane transporter activity,MF,
4969,GO:0015114,1,0.739380283926402,0,7,phosphate ion transmembrane transporter activity,MF,
4970,GO:0015116,1,0.775440881494352,0,6,sulfate transmembrane transporter activity,MF,
4971,GO:0015117,1,0.962165461126179,0,1,thiosulfate transmembrane transporter activity,MF,
4972,GO:0015119,1,0.881469235379402,0,3,hexose phosphate transmembrane transporter activity,MF,
4973,GO:0015125,1,0.849881542862047,0,4,bile acid transmembrane transporter activity,MF,
4974,GO:0015127,1,0.95647281873084,0,1,bilirubin transmembrane transporter activity,MF,
4975,GO:0015129,1,0.88101778689584,0,3,lactate transmembrane transporter activity,MF,
4976,GO:0015130,1,0.956842221697132,0,1,mevalonate transmembrane transporter activity,MF,
4977,GO:0015131,1,0.962165461126179,0,1,oxaloacetate transmembrane transporter activity,MF,
4978,GO:0015136,1,0.957838435280282,0,1,sialic acid transmembrane transporter activity,MF,
4980,GO:0015140,1,0.926121451980989,0,2,malate transmembrane transporter activity,MF,
4987,GO:0015152,1,0.961393040645808,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
4988,GO:0015154,1,0.917243972761644,0,2,disaccharide transmembrane transporter activity,MF,
4989,GO:0015157,1,0.917243972761644,0,2,oligosaccharide transmembrane transporter activity,MF,
4990,GO:0015165,1,0.69583532561313,0,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
4991,GO:0015166,1,0.843797463494466,0,4,polyol transmembrane transporter activity,MF,
4992,GO:0015168,1,0.922421118115538,0,2,glycerol transmembrane transporter activity,MF,
4994,GO:0015172,1,0.772206254370932,0,6,acidic amino acid transmembrane transporter activity,MF,
4995,GO:0015173,1,0.960101674776263,0,1,aromatic amino acid transmembrane transporter activity,MF,
5001,GO:0015182,1,0.959101436414188,0,1,L-asparagine transmembrane transporter activity,MF,
5002,GO:0015183,1,0.87931052225495,0,3,L-aspartate transmembrane transporter activity,MF,
5004,GO:0015185,1,0.961784531839262,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
5006,GO:0015187,1,0.811287410639103,0,5,glycine transmembrane transporter activity,MF,
5008,GO:0015190,1,0.959101436414188,0,1,L-leucine transmembrane transporter activity,MF,
5009,GO:0015191,1,0.959101436414188,0,1,L-methionine transmembrane transporter activity,MF,
5013,GO:0015196,1,0.960101674776263,0,1,L-tryptophan transmembrane transporter activity,MF,
5014,GO:0015203,1,0.958787867083198,0,1,polyamine transmembrane transporter activity,MF,
5015,GO:0015204,1,0.882587324480348,0,3,urea transmembrane transporter activity,MF,
5016,GO:0015205,1,0.782596462844369,0,6,nucleobase transmembrane transporter activity,MF,
5017,GO:0015207,1,0.888407405316192,0,3,adenine transmembrane transporter activity,MF,
5018,GO:0015211,1,0.960077580028746,0,1,purine nucleoside transmembrane transporter activity,MF,
5019,GO:0015215,1,0.542298518506879,0,15,nucleotide transmembrane transporter activity,MF,
5020,GO:0015216,1,0.637586219113025,0,11,purine nucleotide transmembrane transporter activity,MF,
5021,GO:0015217,1,0.689588842964173,0,9,ADP transmembrane transporter activity,MF,
5022,GO:0015218,1,0.921684364992934,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5023,GO:0015220,1,0.842914689790269,0,4,choline transmembrane transporter activity,MF,
5024,GO:0015222,1,0.920367922656645,0,2,serotonin transmembrane transporter activity,MF,
5025,GO:0015226,1,0.847685997966686,0,4,carnitine transmembrane transporter activity,MF,
5026,GO:0015227,1,0.924180180127158,0,2,acyl carnitine transmembrane transporter activity,MF,
5027,GO:0015228,1,0.883679680693187,0,3,coenzyme A transmembrane transporter activity,MF,
5028,GO:0015229,1,0.956441843839217,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5029,GO:0015230,1,0.920899247048679,0,2,FAD transmembrane transporter activity,MF,
5030,GO:0015232,1,0.740028739962495,0,7,heme transporter activity,MF,
5031,GO:0015234,1,0.921908036876841,0,2,thiamine transmembrane transporter activity,MF,
5033,GO:0015245,1,0.812686970928391,0,5,fatty acid transmembrane transporter activity,MF,
5034,GO:0015247,1,0.875303381731356,0,3,aminophospholipid transmembrane transporter activity,MF,
5036,GO:0015250,1,0.852820760456033,0,4,water channel activity,MF,
5037,GO:0015252,1,0.958244092294393,0,1,proton channel activity,MF,
5038,GO:0015254,1,0.922421118115538,0,2,glycerol channel activity,MF,
5039,GO:0015265,1,0.958459304617754,0,1,urea channel activity,MF,
5041,GO:0015269,1,0.724530599268313,0,8,calcium-activated potassium channel activity,MF,
5043,GO:0015272,1,0.95832890868468,0,1,ATP-activated inward rectifier potassium channel activity,MF,
5049,GO:0015288,1,0.790993464999249,0,6,porin activity,MF,
5051,GO:0015292,1,0.958787867083198,0,1,uniporter activity,MF,
5055,GO:0015296,1,0.73486433981928,0,7,anion:cation symporter activity,MF,
5059,GO:0015301,1,0.466131581161724,0,18,anion:anion antiporter activity,MF,
5061,GO:0015315,1,0.881469235379402,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5062,GO:0015317,1,0.962859697496962,0,1,phosphate:proton symporter activity,MF,
5064,GO:0015319,1,0.917005403325718,0,2,sodium:inorganic phosphate symporter activity,MF,
5065,GO:0015321,1,0.917005403325718,0,2,sodium-dependent phosphate transmembrane transporter activity,MF,
5066,GO:0015322,1,0.958185588856806,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5067,GO:0015327,1,0.956441843839217,0,1,cystine:glutamate antiporter activity,MF,
5068,GO:0015328,1,0.956441843839217,0,1,cystine secondary active transmembrane transporter activity,MF,
5069,GO:0015333,1,0.878927179238719,0,3,peptide:proton symporter activity,MF,
5070,GO:0015347,1,0.71049239266929,0,8,sodium-independent organic anion transmembrane transporter activity,MF,
5071,GO:0015349,1,0.917555526795946,0,2,thyroid hormone transmembrane transporter activity,MF,
5072,GO:0015350,1,0.917159793935246,0,2,methotrexate transmembrane transporter activity,MF,
5073,GO:0015355,1,0.853614854701147,0,4,secondary active monocarboxylate transmembrane transporter activity,MF,
5075,GO:0015367,1,0.962541572549126,0,1,oxoglutarate:malate antiporter activity,MF,
5076,GO:0015368,1,0.771044843007354,0,6,calcium:cation antiporter activity,MF,
5077,GO:0015369,1,0.956444441803967,0,1,calcium:proton antiporter activity,MF,
5079,GO:0015373,1,0.915708905737398,0,2,anion:sodium symporter activity,MF,
5080,GO:0015375,1,0.958026563055971,0,1,glycine:sodium symporter activity,MF,
5081,GO:0015377,1,0.767567907788909,0,6,cation:chloride symporter activity,MF,
5082,GO:0015378,1,0.956441843839217,0,1,sodium:chloride symporter activity,MF,
5083,GO:0015379,1,0.767567907788909,0,6,potassium:chloride symporter activity,MF,
5084,GO:0015385,1,0.707032201379875,0,8,sodium:proton antiporter activity,MF,
5085,GO:0015386,1,0.73744232785767,0,7,potassium:proton antiporter activity,MF,
5086,GO:0015389,1,0.960973890670753,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5087,GO:0015390,1,0.960973890670753,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5088,GO:0015391,1,0.960973890670753,0,1,nucleobase:cation symporter activity,MF,
5091,GO:0015410,1,0.877639698428565,0,3,manganese-transporting ATPase activity,MF,
5093,GO:0015421,1,0.957485221603084,0,1,oligopeptide-transporting ATPase activity,MF,
5095,GO:0015432,1,0.957478695870549,0,1,bile acid-exporting ATPase activity,MF,
5096,GO:0015433,1,0.916289672164121,0,2,peptide antigen-transporting ATPase activity,MF,
5097,GO:0015439,1,0.958546612686084,0,1,heme-transporting ATPase activity,MF,
5098,GO:0015440,1,0.841012787674639,0,4,peptide-transporting ATPase activity,MF,
5099,GO:0015450,1,0.767337706048925,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5100,GO:0015459,1,0.323974752865713,0,27,potassium channel regulator activity,MF,
5101,GO:0015464,1,0.748535012060579,0,7,acetylcholine receptor activity,MF,
5104,GO:0015489,1,0.958787867083198,0,1,putrescine transmembrane transporter activity,MF,
5106,GO:0015499,1,0.959482102469118,0,1,formate transmembrane transporter activity,MF,
5107,GO:0015501,1,0.918228348780826,0,2,glutamate:sodium symporter activity,MF,
5108,GO:0015526,1,0.881469235379402,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5109,GO:0015538,1,0.957838435280282,0,1,sialic acid:proton symporter activity,MF,
5111,GO:0015562,1,0.842543619975645,0,4,efflux transmembrane transporter activity,MF,
5112,GO:0015578,1,0.960150025481178,0,1,mannose transmembrane transporter activity,MF,
5113,GO:0015605,1,0.418261534577789,0,21,organophosphate ester transmembrane transporter activity,MF,
5114,GO:0015616,1,0.838824012206479,0,4,DNA translocase activity,MF,
5118,GO:0015643,1,0.751698562313092,0,7,toxic substance binding,MF,
5120,GO:0015651,1,0.778678400766452,0,6,quaternary ammonium group transmembrane transporter activity,MF,
5121,GO:0015658,1,0.959101436414188,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5122,GO:0015660,1,0.959482102469118,0,1,formate efflux transmembrane transporter activity,MF,
5124,GO:0015669,1,0.889655427876673,0,3,gas transport,BP,
5125,GO:0015670,1,0.962907669111412,0,1,carbon dioxide transport,BP,
5126,GO:0015671,1,0.923931676227115,0,2,oxygen transport,BP,
5128,GO:0015677,1,0.708083071965843,0,8,copper ion import,BP,
5129,GO:0015679,1,0.914864452443845,0,2,plasma membrane copper ion transport,BP,
5130,GO:0015680,1,0.891198861022508,0,3,intracellular copper ion transport,BP,
5132,GO:0015684,1,0.915249358247852,0,2,ferrous iron transport,BP,
5133,GO:0015688,1,0.927664495821798,0,2,iron chelate transport,BP,
5134,GO:0015689,1,0.962135838670923,0,1,molybdate ion transport,BP,
5135,GO:0015691,1,0.881536342490456,0,3,cadmium ion transport,BP,
5136,GO:0015692,1,0.956819476805938,0,1,lead ion transport,BP,
5138,GO:0015694,1,0.95647281873084,0,1,mercury ion transport,BP,
5140,GO:0015696,1,0.155219224476645,0,45,ammonium transport,BP,
5141,GO:0015697,1,0.68480291529502,0,9,quaternary ammonium group transport,BP,
5143,GO:0015700,1,0.96403734027842,0,1,arsenite transport,BP,
5144,GO:0015701,1,0.445398702943713,0,19,bicarbonate transport,BP,
5145,GO:0015705,1,0.838005773063945,0,4,iodide transport,BP,
5146,GO:0015706,1,0.959490051413541,0,1,nitrate transport,BP,
5147,GO:0015709,1,0.962165461126179,0,1,thiosulfate transport,BP,
5149,GO:0015712,1,0.848851695927285,0,4,hexose phosphate transport,BP,
5151,GO:0015721,1,0.581611868799539,0,13,bile acid and bile salt transport,BP,
5152,GO:0015722,1,0.877749107512871,0,3,canalicular bile acid transport,BP,
5153,GO:0015723,1,0.95647281873084,0,1,bilirubin transport,BP,
5154,GO:0015724,1,0.959482102469118,0,1,formate transport,BP,
5155,GO:0015727,1,0.842886444364106,0,4,lactate transport,BP,
5156,GO:0015728,1,0.956842221697132,0,1,mevalonate transport,BP,
5157,GO:0015729,1,0.962165461126179,0,1,oxaloacetate transport,BP,
5158,GO:0015732,1,0.721716926478581,0,8,prostaglandin transport,BP,
5159,GO:0015734,1,0.956441843839217,0,1,taurine transport,BP,
5160,GO:0015739,1,0.957838435280282,0,1,sialic acid transport,BP,
5162,GO:0015742,1,0.962541572549126,0,1,alpha-ketoglutarate transport,BP,
5163,GO:0015743,1,0.962165461126179,0,1,malate transport,BP,
5169,GO:0015760,1,0.848851695927285,0,4,glucose-6-phosphate transport,BP,
5170,GO:0015761,1,0.960150025481178,0,1,mannose transmembrane transport,BP,
5171,GO:0015766,1,0.917243972761644,0,2,disaccharide transport,BP,
5172,GO:0015770,1,0.917243972761644,0,2,sucrose transport,BP,
5173,GO:0015772,1,0.917243972761644,0,2,oligosaccharide transport,BP,
5174,GO:0015780,1,0.614051483004244,0,12,nucleotide-sugar transmembrane transport,BP,
5175,GO:0015782,1,0.962426886922234,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5176,GO:0015783,1,0.916310332209799,0,2,GDP-fucose transmembrane transport,BP,
5177,GO:0015786,1,0.960804579664695,0,1,UDP-glucose transmembrane transport,BP,
5178,GO:0015787,1,0.956441843839217,0,1,UDP-glucuronic acid transmembrane transport,BP,
5179,GO:0015790,1,0.956441843839217,0,1,UDP-xylose transmembrane transport,BP,
5180,GO:0015791,1,0.774317459156704,0,6,polyol transport,BP,
5181,GO:0015793,1,0.922421118115538,0,2,glycerol transport,BP,
5182,GO:0015797,1,0.959482102469118,0,1,mannitol transport,BP,
5183,GO:0015798,1,0.874924186969474,0,3,myo-inositol transport,BP,
5185,GO:0015801,1,0.922487719931854,0,2,aromatic amino acid transport,BP,
5187,GO:0015803,1,0.881621287865726,0,3,branched-chain amino acid transport,BP,
5189,GO:0015805,1,0.960955849389069,0,1,S-adenosyl-L-methionine transport,BP,
5193,GO:0015810,1,0.916813402664139,0,2,aspartate transmembrane transport,BP,
5196,GO:0015813,1,0.576268391323181,0,13,L-glutamate transmembrane transport,BP,
5197,GO:0015816,1,0.77593895338035,0,6,glycine transport,BP,
5198,GO:0015817,1,0.959066455660129,0,1,histidine transport,BP,
5200,GO:0015820,1,0.919222520960561,0,2,leucine transport,BP,
5201,GO:0015821,1,0.959101436414188,0,1,methionine transport,BP,
5202,GO:0015822,1,0.840753877678645,0,4,ornithine transport,BP,
5206,GO:0015827,1,0.922487719931854,0,2,tryptophan transport,BP,
5209,GO:0015838,1,0.745507779679676,0,7,amino-acid betaine transport,BP,
5210,GO:0015840,1,0.882587324480348,0,3,urea transport,BP,
5211,GO:0015842,1,0.92565549106895,0,2,aminergic neurotransmitter loading into synaptic vesicle,BP,
5213,GO:0015846,1,0.782449219467923,0,6,polyamine transport,BP,
5214,GO:0015847,1,0.958787867083198,0,1,putrescine transport,BP,
5217,GO:0015851,1,0.754107534356571,0,7,nucleobase transport,BP,
5218,GO:0015853,1,0.856074897542232,0,4,adenine transport,BP,
5219,GO:0015855,1,0.921051177574091,0,2,pyrimidine nucleobase transport,BP,
5221,GO:0015860,1,0.922606417102907,0,2,purine nucleoside transmembrane transport,BP,
5222,GO:0015862,1,0.960586168447709,0,1,uridine transport,BP,
5223,GO:0015864,1,0.923095194771853,0,2,pyrimidine nucleoside transport,BP,
5224,GO:0015865,1,0.610925253406237,0,12,purine nucleotide transport,BP,
5225,GO:0015866,1,0.689588842964173,0,9,ADP transport,BP,
5226,GO:0015867,1,0.688425901531456,0,9,ATP transport,BP,
5227,GO:0015868,1,0.610925253406237,0,12,purine ribonucleotide transport,BP,
5228,GO:0015871,1,0.771056708827796,0,6,choline transport,BP,
5229,GO:0015872,1,0.5429046591514,0,15,dopamine transport,BP,
5231,GO:0015876,1,0.9594678223719,0,1,acetyl-CoA transport,BP,
5232,GO:0015878,1,0.957864878489591,0,1,biotin transport,BP,
5233,GO:0015879,1,0.814933231867478,0,5,carnitine transport,BP,
5234,GO:0015880,1,0.883679680693187,0,3,coenzyme A transport,BP,
5235,GO:0015881,1,0.957475083746267,0,1,creatine transmembrane transport,BP,
5236,GO:0015882,1,0.956441843839217,0,1,L-ascorbic acid transmembrane transport,BP,
5237,GO:0015884,1,0.812187807618274,0,5,folic acid transport,BP,
5238,GO:0015886,1,0.740028739962495,0,7,heme transport,BP,
5239,GO:0015887,1,0.957864878489591,0,1,pantothenate transmembrane transport,BP,
5240,GO:0015888,1,0.917885658822718,0,2,thiamine transport,BP,
5242,GO:0015891,1,0.927664495821798,0,2,siderophore transport,BP,
5244,GO:0015904,1,0.96225734534078,0,1,tetracycline transport,BP,
5247,GO:0015910,1,0.919671454972756,0,2,peroxisomal long-chain fatty acid import,BP,
5248,GO:0015911,1,0.805737743355293,0,5,plasma membrane long-chain fatty acid transport,BP,
5250,GO:0015916,1,0.9594678223719,0,1,fatty-acyl-CoA transport,BP,
5251,GO:0015917,1,0.837166630676,0,4,aminophospholipid transport,BP,
5253,GO:0015919,1,0.510381937779301,0,16,peroxisomal membrane transport,BP,
5254,GO:0015920,1,0.959392282604984,0,1,lipopolysaccharide transport,BP,
5255,GO:0015923,1,0.544952681321844,0,14,mannosidase activity,MF,
5256,GO:0015924,1,0.677542388865365,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5257,GO:0015925,1,0.780992638339007,0,6,galactosidase activity,MF,
5259,GO:0015928,1,0.92427361086417,0,2,fucosidase activity,MF,
5264,GO:0015935,1,0.0814099242613539,0,68,small ribosomal subunit,CC,
5265,GO:0015936,1,0.544410017100192,0,15,coenzyme A metabolic process,BP,
5266,GO:0015937,1,0.672509841802855,0,10,coenzyme A biosynthetic process,BP,
5267,GO:0015938,1,0.964734502232411,0,1,coenzyme A catabolic process,BP,
5268,GO:0015939,1,0.81524288699174,0,5,pantothenate metabolic process,BP,
5269,GO:0015942,1,0.885237945975309,0,3,formate metabolic process,BP,
5271,GO:0015950,1,0.962193275935904,0,1,purine nucleotide interconversion,BP,
5272,GO:0015951,1,0.962193275935904,0,1,purine ribonucleotide interconversion,BP,
5273,GO:0015959,1,0.751681868881594,0,7,diadenosine polyphosphate metabolic process,BP,
5274,GO:0015960,1,0.8826971016308,0,3,diadenosine polyphosphate biosynthetic process,BP,
5275,GO:0015961,1,0.851608970642098,0,4,diadenosine polyphosphate catabolic process,BP,
5276,GO:0015965,1,0.8826971016308,0,3,diadenosine tetraphosphate metabolic process,BP,
5277,GO:0015966,1,0.8826971016308,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5282,GO:0015990,1,0.965257483635333,0,1,electron transport coupled proton transport,BP,
5284,GO:0016004,1,0.719252161200008,0,8,phospholipase activator activity,MF,
5285,GO:0016005,1,0.917935148881249,0,2,phospholipase A2 activator activity,MF,
5286,GO:0016010,1,0.629297427962076,0,11,dystrophin-associated glycoprotein complex,CC,
5287,GO:0016011,1,0.880987063152396,0,3,dystroglycan complex,CC,
5288,GO:0016012,1,0.921115732008874,0,2,sarcoglycan complex,CC,
5289,GO:0016013,1,0.918700568588894,0,2,syntrophin complex,CC,
5290,GO:0016015,1,0.925784717302693,0,2,morphogen activity,MF,
5291,GO:0016018,1,0.670546304584292,0,10,cyclosporin A binding,MF,
5292,GO:0016019,1,0.964322923966933,0,1,peptidoglycan receptor activity,MF,
5295,GO:0016024,1,0.574842179095152,0,13,CDP-diacylglycerol biosynthetic process,BP,
5296,GO:0016031,1,0.957726119347696,0,1,tRNA import into mitochondrion,BP,
5298,GO:0016034,1,0.963887050156494,0,1,maleylacetoacetate isomerase activity,MF,
5299,GO:0016035,1,0.922405464223593,0,2,zeta DNA polymerase complex,CC,
5300,GO:0016036,1,0.960806377001927,0,1,cellular response to phosphate starvation,BP,
5303,GO:0016045,1,0.773688626676506,0,6,detection of bacterium,BP,
5304,GO:0016048,1,0.748436164579678,0,7,detection of temperature stimulus,BP,
5312,GO:0016056,1,0.575990978921201,0,13,rhodopsin mediated signaling pathway,BP,
5313,GO:0016062,1,0.959773158506325,0,1,adaptation of rhodopsin mediated signaling,BP,
5319,GO:0016074,1,0.635551903793845,0,12,snoRNA metabolic process,BP,
5320,GO:0016075,1,0.552157258433581,0,15,rRNA catabolic process,BP,
5321,GO:0016077,1,0.956441843839217,0,1,snoRNA catabolic process,BP,
5322,GO:0016078,1,0.793480142338017,0,6,tRNA catabolic process,BP,
5324,GO:0016080,1,0.875899066346654,0,3,synaptic vesicle targeting,BP,
5325,GO:0016081,1,0.773270085143361,0,6,synaptic vesicle docking,BP,
5326,GO:0016082,1,0.626168599270128,0,11,synaptic vesicle priming,BP,
5327,GO:0016093,1,0.78518681924431,0,6,polyprenol metabolic process,BP,
5328,GO:0016094,1,0.879084192043854,0,3,polyprenol biosynthetic process,BP,
5329,GO:0016095,1,0.9594678223719,0,1,polyprenol catabolic process,BP,
5332,GO:0016103,1,0.956619352253465,0,1,diterpenoid catabolic process,BP,
5334,GO:0016115,1,0.956619352253465,0,1,terpenoid catabolic process,BP,
5338,GO:0016128,1,0.886708107282018,0,3,phytosteroid metabolic process,BP,
5339,GO:0016129,1,0.886708107282018,0,3,phytosteroid biosynthetic process,BP,
5340,GO:0016131,1,0.959482102469118,0,1,brassinosteroid metabolic process,BP,
5341,GO:0016132,1,0.959482102469118,0,1,brassinosteroid biosynthetic process,BP,
5342,GO:0016137,1,0.59749405179819,0,13,glycoside metabolic process,BP,
5343,GO:0016139,1,0.752080006800343,0,7,glycoside catabolic process,BP,
5344,GO:0016149,1,0.957277496893921,0,1,translation release factor activity, codon specific,MF,
5345,GO:0016150,1,0.963062159069305,0,1,translation release factor activity, codon nonspecific,MF,
5346,GO:0016154,1,0.962929946069701,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5347,GO:0016155,1,0.916445225645492,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5348,GO:0016160,1,0.961114764662936,0,1,amylase activity,MF,
5349,GO:0016165,1,0.92163043289847,0,2,linoleate 13S-lipoxygenase activity,MF,
5350,GO:0016174,1,0.84468896070042,0,4,NAD(P)H oxidase activity,MF,
5352,GO:0016176,1,0.842512194954648,0,4,superoxide-generating NADPH oxidase activator activity,MF,
5353,GO:0016180,1,0.409903255851184,0,22,snRNA processing,BP,
5354,GO:0016182,1,0.956519923983069,0,1,synaptic vesicle budding from endosome,BP,
5356,GO:0016188,1,0.808848061487923,0,5,synaptic vesicle maturation,BP,
5357,GO:0016189,1,0.956441843839217,0,1,synaptic vesicle to endosome fusion,BP,
5358,GO:0016191,1,0.840220496192364,0,4,synaptic vesicle uncoating,BP,
5362,GO:0016199,1,0.837934011251572,0,4,axon midline choice point recognition,BP,
5364,GO:0016206,1,0.920816017819461,0,2,catechol O-methyltransferase activity,MF,
5365,GO:0016208,1,0.695424997374129,0,9,AMP binding,MF,
5368,GO:0016212,1,0.922680826348854,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5369,GO:0016213,1,0.95815793451167,0,1,linoleoyl-CoA desaturase activity,MF,
5370,GO:0016215,1,0.879475910595112,0,3,acyl-CoA desaturase activity,MF,
5371,GO:0016222,1,0.920257491044203,0,2,procollagen-proline 4-dioxygenase complex,CC,
5372,GO:0016226,1,0.458914156435269,0,20,iron-sulfur cluster assembly,BP,
5374,GO:0016230,1,0.922725468603348,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5375,GO:0016231,1,0.956466035081377,0,1,beta-N-acetylglucosaminidase activity,MF,
5376,GO:0016232,1,0.958997479022436,0,1,HNK-1 sulfotransferase activity,MF,
5377,GO:0016233,1,0.128986821230373,0,51,telomere capping,BP,
5378,GO:0016234,1,0.0552678808553103,0,68,inclusion body,CC,
5379,GO:0016235,1,0.234717593131464,0,34,aggresome,CC,
5381,GO:0016237,1,0.956488546109679,0,1,lysosomal microautophagy,BP,
5383,GO:0016240,1,0.846970815877755,0,4,autophagosome membrane docking,BP,
5385,GO:0016242,1,0.297752128701619,0,29,negative regulation of macroautophagy,BP,
5386,GO:0016243,1,0.956951357901455,0,1,regulation of autophagosome size,BP,
5387,GO:0016246,1,0.538278606129443,0,15,RNA interference,BP,
5389,GO:0016248,1,0.343585005979763,0,26,channel inhibitor activity,MF,
5392,GO:0016255,1,0.751558325291301,0,7,attachment of GPI anchor to protein,BP,
5393,GO:0016256,1,0.922127547091234,0,2,N-glycan processing to lysosome,BP,
5394,GO:0016259,1,0.848489682432861,0,4,selenocysteine metabolic process,BP,
5395,GO:0016260,1,0.922068113727459,0,2,selenocysteine biosynthetic process,BP,
5396,GO:0016262,1,0.882382745355381,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5397,GO:0016263,1,0.925877371586589,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5398,GO:0016264,1,0.74122437726352,0,7,gap junction assembly,BP,
5399,GO:0016266,1,0.19401428208413,0,39,O-glycan processing,BP,
5400,GO:0016267,1,0.925877371586589,0,2,O-glycan processing, core 1,BP,
5401,GO:0016269,1,0.960019297233385,0,1,O-glycan processing, core 3,BP,
5402,GO:0016272,1,0.776433249679399,0,7,prefoldin complex,CC,
5403,GO:0016273,1,0.63852702858197,0,11,arginine N-methyltransferase activity,MF,
5404,GO:0016274,1,0.63852702858197,0,11,protein-arginine N-methyltransferase activity,MF,
5405,GO:0016277,1,0.96032783469921,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5408,GO:0016281,1,0.712163195515735,0,8,eukaryotic translation initiation factor 4F complex,CC,
5409,GO:0016282,1,0.956634756826496,0,1,eukaryotic 43S preinitiation complex,CC,
5410,GO:0016286,1,0.922433836338153,0,2,small conductance calcium-activated potassium channel activity,MF,
5411,GO:0016287,1,0.959373564735114,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5412,GO:0016289,1,0.577674307507813,0,14,CoA hydrolase activity,MF,
5413,GO:0016290,1,0.734472752863897,0,8,palmitoyl-CoA hydrolase activity,MF,
5414,GO:0016295,1,0.920682000546707,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5415,GO:0016296,1,0.920682000546707,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5416,GO:0016297,1,0.920682000546707,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5418,GO:0016300,1,0.879048203044015,0,3,tRNA (uracil) methyltransferase activity,MF,
5421,GO:0016307,1,0.547457929109729,0,14,phosphatidylinositol phosphate kinase activity,MF,
5422,GO:0016308,1,0.772647350692084,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5423,GO:0016309,1,0.877171944425106,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5426,GO:0016312,1,0.842965223970867,0,4,inositol bisphosphate phosphatase activity,MF,
5427,GO:0016314,1,0.914847308892458,0,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5428,GO:0016316,1,0.915195441957175,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5429,GO:0016320,1,0.922074788960402,0,2,endoplasmic reticulum membrane fusion,BP,
5430,GO:0016321,1,0.884438790108483,0,3,female meiosis chromosome segregation,BP,
5431,GO:0016322,1,0.771775762414814,0,6,neuron remodeling,BP,
5434,GO:0016327,1,0.582711114320811,0,13,apicolateral plasma membrane,CC,
5437,GO:0016332,1,0.957037166504587,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5438,GO:0016333,1,0.958660956807448,0,1,morphogenesis of follicular epithelium,BP,
5439,GO:0016334,1,0.958660956807448,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5440,GO:0016338,1,0.726333408538575,0,8,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5441,GO:0016339,1,0.503350337466515,0,16,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5442,GO:0016340,1,0.914777327508532,0,2,calcium-dependent cell-matrix adhesion,BP,
5443,GO:0016342,1,0.544438613010226,0,14,catenin complex,CC,
5444,GO:0016344,1,0.91805062561352,0,2,meiotic chromosome movement towards spindle pole,BP,
5447,GO:0016362,1,0.914777292668164,0,2,activin receptor activity, type II,MF,
5449,GO:0016401,1,0.920466330986291,0,2,palmitoyl-CoA oxidase activity,MF,
5450,GO:0016402,1,0.958897911304066,0,1,pristanoyl-CoA oxidase activity,MF,
5451,GO:0016403,1,0.922407893860435,0,2,dimethylargininase activity,MF,
5452,GO:0016404,1,0.956644180413678,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5456,GO:0016408,1,0.593269131769027,0,13,C-acyltransferase activity,MF,
5461,GO:0016414,1,0.957963788787012,0,1,O-octanoyltransferase activity,MF,
5462,GO:0016415,1,0.957963788787012,0,1,octanoyltransferase activity,MF,
5465,GO:0016418,1,0.915029807043052,0,2,S-acetyltransferase activity,MF,
5466,GO:0016419,1,0.920055790811718,0,2,S-malonyltransferase activity,MF,
5467,GO:0016420,1,0.920055790811718,0,2,malonyltransferase activity,MF,
5468,GO:0016421,1,0.776605327739939,0,6,CoA carboxylase activity,MF,
5469,GO:0016422,1,0.886648436435115,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5470,GO:0016423,1,0.586445086348565,0,13,tRNA (guanine) methyltransferase activity,MF,
5471,GO:0016426,1,0.847462401005175,0,4,tRNA (adenine) methyltransferase activity,MF,
5472,GO:0016427,1,0.719822837612872,0,8,tRNA (cytosine) methyltransferase activity,MF,
5473,GO:0016428,1,0.848110177671433,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5474,GO:0016429,1,0.883898775260789,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5475,GO:0016430,1,0.958787867083198,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5476,GO:0016433,1,0.786996898322885,0,6,rRNA (adenine) methyltransferase activity,MF,
5477,GO:0016434,1,0.87991632949066,0,3,rRNA (cytosine) methyltransferase activity,MF,
5478,GO:0016435,1,0.851059339079397,0,4,rRNA (guanine) methyltransferase activity,MF,
5479,GO:0016436,1,0.917624794189463,0,2,rRNA (uridine) methyltransferase activity,MF,
5481,GO:0016442,1,0.623966361352522,0,11,RISC complex,CC,
5484,GO:0016446,1,0.557902566421724,0,14,somatic hypermutation of immunoglobulin genes,BP,
5486,GO:0016453,1,0.854736357268263,0,4,C-acetyltransferase activity,MF,
5487,GO:0016454,1,0.809672665029021,0,5,C-palmitoyltransferase activity,MF,
5491,GO:0016461,1,0.751092282109314,0,7,unconventional myosin complex,CC,
5495,GO:0016476,1,0.880253618932511,0,3,regulation of embryonic cell shape,BP,
5497,GO:0016479,1,0.884365666796314,0,3,negative regulation of transcription by RNA polymerase I,BP,
5503,GO:0016492,1,0.956850747692907,0,1,G-protein coupled neurotensin receptor activity,MF,
5504,GO:0016493,1,0.920796566040029,0,2,C-C chemokine receptor activity,MF,
5507,GO:0016502,1,0.784123056033189,0,6,nucleotide receptor activity,MF,
5508,GO:0016503,1,0.96397217586163,0,1,pheromone receptor activity,MF,
5509,GO:0016504,1,0.260787615696398,0,33,peptidase activator activity,MF,
5510,GO:0016505,1,0.518855281665211,0,16,peptidase activator activity involved in apoptotic process,MF,
5511,GO:0016507,1,0.958390964683053,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5512,GO:0016508,1,0.879939449047427,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5513,GO:0016509,1,0.884087914925184,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5514,GO:0016514,1,0.57605719946506,0,13,SWI/SNF complex,CC,
5515,GO:0016517,1,0.961825504587889,0,1,interleukin-12 receptor activity,MF,
5516,GO:0016519,1,0.961659370281862,0,1,gastric inhibitory peptide receptor activity,MF,
5517,GO:0016520,1,0.956591811544085,0,1,growth hormone-releasing hormone receptor activity,MF,
5522,GO:0016530,1,0.79452755877172,0,6,metallochaperone activity,MF,
5523,GO:0016531,1,0.830725912437089,0,5,copper chaperone activity,MF,
5524,GO:0016532,1,0.890285308427559,0,3,superoxide dismutase copper chaperone activity,MF,
5525,GO:0016533,1,0.923011361920487,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5526,GO:0016534,1,0.957097972860728,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
5527,GO:0016538,1,0.326391387041428,0,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5529,GO:0016553,1,0.608080025235405,0,12,base conversion or substitution editing,BP,
5530,GO:0016554,1,0.755500551652359,0,7,cytidine to uridine editing,BP,
5531,GO:0016556,1,0.545216991678244,0,15,mRNA modification,BP,
5532,GO:0016557,1,0.890078400226807,0,3,peroxisome membrane biogenesis,BP,
5533,GO:0016558,1,0.607146527698457,0,12,protein import into peroxisome matrix,BP,
5535,GO:0016560,1,0.844180380963563,0,4,protein import into peroxisome matrix, docking,BP,
5536,GO:0016561,1,0.921168470215277,0,2,protein import into peroxisome matrix, translocation,BP,
5545,GO:0016576,1,0.884319573738521,0,3,histone dephosphorylation,BP,
5547,GO:0016578,1,0.395182765978025,0,22,histone deubiquitination,BP,
5549,GO:0016580,1,0.627097318151884,0,11,Sin3 complex,CC,
5551,GO:0016584,1,0.757591972465162,0,7,nucleosome positioning,BP,
5552,GO:0016586,1,0.914964427019436,0,2,RSC-type complex,CC,
5554,GO:0016590,1,0.956441843839217,0,1,ACF complex,CC,
5556,GO:0016592,1,0.240507396727471,0,35,mediator complex,CC,
5558,GO:0016594,1,0.810691914183618,0,5,glycine binding,MF,
5560,GO:0016596,1,0.958787867083198,0,1,thienylcyclohexylpiperidine binding,MF,
5562,GO:0016598,1,0.924826506318954,0,2,protein arginylation,BP,
5563,GO:0016600,1,0.708823060366742,0,8,flotillin complex,CC,
5565,GO:0016602,1,0.849250100892765,0,4,CCAAT-binding factor complex,CC,
5566,GO:0016603,1,0.92542209783738,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5571,GO:0016615,1,0.786782989173414,0,6,malate dehydrogenase activity,MF,
5573,GO:0016618,1,0.886704070811076,0,3,hydroxypyruvate reductase activity,MF,
5575,GO:0016623,1,0.956491231636102,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5578,GO:0016628,1,0.433681755366924,0,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5579,GO:0016634,1,0.782449629364053,0,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5581,GO:0016638,1,0.598684131428245,0,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5582,GO:0016639,1,0.957562892968896,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5583,GO:0016641,1,0.65327769187796,0,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5584,GO:0016642,1,0.95712201154618,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5587,GO:0016647,1,0.925756757679149,0,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5588,GO:0016649,1,0.920140035796251,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5590,GO:0016652,1,0.956563247926027,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5591,GO:0016653,1,0.606897762952155,0,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5592,GO:0016655,1,0.165329036212479,0,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5593,GO:0016657,1,0.962193275935904,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5594,GO:0016661,1,0.813969304414792,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5595,GO:0016662,1,0.959654540720847,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5598,GO:0016670,1,0.742772820872127,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5600,GO:0016672,1,0.929976778999366,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5603,GO:0016679,1,0.73751191707565,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5604,GO:0016681,1,0.768553546088541,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5610,GO:0016708,1,0.923439858345075,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
5611,GO:0016709,1,0.433630808525493,0,20,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
5612,GO:0016711,1,0.959631709220558,0,1,flavonoid 3'-monooxygenase activity,MF,
5613,GO:0016712,1,0.722439462993705,0,8,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
5614,GO:0016714,1,0.89145440231957,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
5615,GO:0016715,1,0.91741152734243,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
5616,GO:0016717,1,0.806671994873843,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5617,GO:0016721,1,0.862020152754689,0,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
5620,GO:0016724,1,0.882012865157379,0,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
5621,GO:0016725,1,0.80289920016425,0,5,oxidoreductase activity, acting on CH or CH2 groups,MF,
5622,GO:0016726,1,0.914824534693486,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
5623,GO:0016727,1,0.956441845348625,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
5624,GO:0016728,1,0.87767461540119,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
5625,GO:0016730,1,0.962137583103709,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5626,GO:0016731,1,0.962137583103709,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
5629,GO:0016742,1,0.746631708165211,0,7,hydroxymethyl-, formyl- and related transferase activity,MF,
5630,GO:0016743,1,0.914777293311417,0,2,carboxyl- or carbamoyltransferase activity,MF,
5631,GO:0016744,1,0.926903560040761,0,2,transferase activity, transferring aldehyde or ketonic groups,MF,
5634,GO:0016748,1,0.921072231292734,0,2,succinyltransferase activity,MF,
5635,GO:0016749,1,0.96055767454098,0,1,N-succinyltransferase activity,MF,
5636,GO:0016751,1,0.958896529823705,0,1,S-succinyltransferase activity,MF,
5637,GO:0016755,1,0.693180322627428,0,9,transferase activity, transferring amino-acyl groups,MF,
5641,GO:0016765,1,0.158619183976237,0,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
5642,GO:0016768,1,0.962827537057955,0,1,spermine synthase activity,MF,
5643,GO:0016769,1,0.587619838544773,0,13,transferase activity, transferring nitrogenous groups,MF,
5646,GO:0016774,1,0.884118897888536,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
5649,GO:0016778,1,0.852598598365157,0,4,diphosphotransferase activity,MF,
5651,GO:0016780,1,0.477376230870336,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
5652,GO:0016781,1,0.922068113727459,0,2,phosphotransferase activity, paired acceptors,MF,
5655,GO:0016784,1,0.963498797201556,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
5656,GO:0016785,1,0.956442016918176,0,1,transferase activity, transferring selenium-containing groups,MF,
5659,GO:0016790,1,0.315569259001393,0,29,thiolester hydrolase activity,MF,
5661,GO:0016793,1,0.958066773890521,0,1,triphosphoric monoester hydrolase activity,MF,
5662,GO:0016794,1,0.96465860431468,0,1,diphosphoric monoester hydrolase activity,MF,
5663,GO:0016796,1,0.136058019399274,0,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
5666,GO:0016801,1,0.591343461574842,0,13,hydrolase activity, acting on ether bonds,MF,
5667,GO:0016802,1,0.879320324431143,0,3,trialkylsulfonium hydrolase activity,MF,
5668,GO:0016803,1,0.672570978890226,0,10,ether hydrolase activity,MF,
5669,GO:0016805,1,0.746165368729323,0,7,dipeptidase activity,MF,
5671,GO:0016810,1,0.0104947429896169,0,110,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
5672,GO:0016811,1,0.0578344550293829,0,69,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
5673,GO:0016812,1,0.801745360237462,0,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
5674,GO:0016813,1,0.787122962827963,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
5675,GO:0016814,1,0.372971966208051,0,24,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
5676,GO:0016815,1,0.963814807334626,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
5679,GO:0016822,1,0.927772691569014,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5680,GO:0016823,1,0.927772691569014,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
5685,GO:0016832,1,0.755504651979027,0,7,aldehyde-lyase activity,MF,
5686,GO:0016833,1,0.81842454330875,0,5,oxo-acid-lyase activity,MF,
5690,GO:0016840,1,0.647402026552034,0,11,carbon-nitrogen lyase activity,MF,
5691,GO:0016841,1,0.886506241486171,0,3,ammonia-lyase activity,MF,
5692,GO:0016842,1,0.761752173055845,0,7,amidine-lyase activity,MF,
5693,GO:0016843,1,0.958787867083198,0,1,amine-lyase activity,MF,
5694,GO:0016844,1,0.958787867083198,0,1,strictosidine synthase activity,MF,
5695,GO:0016846,1,0.767389831522028,0,7,carbon-sulfur lyase activity,MF,
5696,GO:0016849,1,0.677507433304137,0,9,phosphorus-oxygen lyase activity,MF,
5699,GO:0016855,1,0.960063836388062,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
5700,GO:0016857,1,0.662783332586839,0,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
5703,GO:0016861,1,0.733006890571781,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
5704,GO:0016862,1,0.932514779934249,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
5705,GO:0016863,1,0.681764638752477,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
5711,GO:0016875,1,0.162927724829209,0,44,ligase activity, forming carbon-oxygen bonds,MF,
5716,GO:0016881,1,0.512394741744745,0,16,acid-amino acid ligase activity,MF,
5717,GO:0016882,1,0.924141785365738,0,2,cyclo-ligase activity,MF,
5718,GO:0016884,1,0.65920931416298,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
5719,GO:0016885,1,0.714352259648953,0,8,ligase activity, forming carbon-carbon bonds,MF,
5720,GO:0016886,1,0.65962345267819,0,10,ligase activity, forming phosphoric ester bonds,MF,
5722,GO:0016888,1,0.629756732548442,0,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5723,GO:0016889,1,0.451728979256344,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
5724,GO:0016890,1,0.921695775256389,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
5725,GO:0016891,1,0.337542661552277,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
5726,GO:0016892,1,0.793690603222875,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
5727,GO:0016893,1,0.241078646794169,0,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
5728,GO:0016894,1,0.358397683390807,0,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
5729,GO:0016895,1,0.495926596706977,0,17,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5730,GO:0016896,1,0.265180652432889,0,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
5731,GO:0016898,1,0.959690575072104,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
5732,GO:0016899,1,0.915490201664894,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
5733,GO:0016900,1,0.930558326319754,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
5734,GO:0016901,1,0.956441843839217,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
5736,GO:0016907,1,0.91767372982214,0,2,G-protein coupled acetylcholine receptor activity,MF,
5737,GO:0016909,1,0.882279401396369,0,3,SAP kinase activity,MF,
5738,GO:0016917,1,0.877065781522589,0,3,GABA receptor activity,MF,
5740,GO:0016920,1,0.956441843839217,0,1,pyroglutamyl-peptidase activity,MF,
5741,GO:0016922,1,0.46568026775987,0,18,ligand-dependent nuclear receptor binding,MF,
5742,GO:0016925,1,0.0278674024575454,0,85,protein sumoylation,BP,
5743,GO:0016926,1,0.741599798003206,0,7,protein desumoylation,BP,
5744,GO:0016929,1,0.770203130850861,0,6,SUMO-specific protease activity,MF,
5745,GO:0016936,1,0.925066862480023,0,2,galactoside binding,MF,
5746,GO:0016938,1,0.958630361518247,0,1,kinesin I complex,CC,
5747,GO:0016939,1,0.87679637579324,0,3,kinesin II complex,CC,
5748,GO:0016941,1,0.957622348362285,0,1,natriuretic peptide receptor activity,MF,
5749,GO:0016942,1,0.8855361791881,0,3,insulin-like growth factor binding protein complex,CC,
5750,GO:0016964,1,0.956441843839217,0,1,alpha-2 macroglobulin receptor activity,MF,
5751,GO:0016971,1,0.880642517286975,0,3,flavin-linked sulfhydryl oxidase activity,MF,
5752,GO:0016972,1,0.842359551620385,0,4,thiol oxidase activity,MF,
5753,GO:0016973,1,0.65887909300352,0,10,poly(A)+ mRNA export from nucleus,BP,
5754,GO:0016979,1,0.963676501818385,0,1,lipoate-protein ligase activity,MF,
5755,GO:0016992,1,0.962883723522496,0,1,lipoate synthase activity,MF,
5756,GO:0016997,1,0.850720407450492,0,4,alpha-sialidase activity,MF,
5757,GO:0016998,1,0.922753337775968,0,2,cell wall macromolecule catabolic process,BP,
5762,GO:0017003,1,0.9607399435986,0,1,protein-heme linkage,BP,
5764,GO:0017005,1,0.957335578823384,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
5765,GO:0017006,1,0.9607399435986,0,1,protein-tetrapyrrole linkage,BP,
5766,GO:0017014,1,0.663445619703653,0,10,protein nitrosylation,BP,
5769,GO:0017017,1,0.612430238138259,0,12,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
5770,GO:0017018,1,0.914838862385282,0,2,myosin phosphatase activity,MF,
5771,GO:0017020,1,0.958853989181565,0,1,myosin phosphatase regulator activity,MF,
5772,GO:0017022,1,0.166587165788437,0,43,myosin binding,MF,
5773,GO:0017024,1,0.965013665213141,0,1,myosin I binding,MF,
5777,GO:0017040,1,0.850173199907525,0,4,N-acylsphingosine amidohydrolase activity,MF,
5780,GO:0017049,1,0.413437927033549,0,21,GTP-Rho binding,MF,
5781,GO:0017050,1,0.922413131820914,0,2,D-erythro-sphingosine kinase activity,MF,
5784,GO:0017056,1,0.345202648431415,0,25,structural constituent of nuclear pore,MF,
5786,GO:0017059,1,0.721250704321659,0,8,serine C-palmitoyltransferase complex,CC,
5787,GO:0017060,1,0.920976880158589,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
5788,GO:0017061,1,0.956498691491919,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
5789,GO:0017062,1,0.692586474155569,0,9,respiratory chain complex III assembly,BP,
5790,GO:0017064,1,0.961400259837265,0,1,fatty acid amide hydrolase activity,MF,
5791,GO:0017065,1,0.963216381320259,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
5792,GO:0017069,1,0.218429185958363,0,38,snRNA binding,MF,
5793,GO:0017070,1,0.643777925363702,0,11,U6 snRNA binding,MF,
5797,GO:0017081,1,0.587036587877555,0,13,chloride channel regulator activity,MF,
5798,GO:0017082,1,0.958787867083198,0,1,mineralocorticoid receptor activity,MF,
5799,GO:0017084,1,0.95758141865191,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
5800,GO:0017085,1,0.537629531306514,0,15,response to insecticide,BP,
5801,GO:0017087,1,0.957022848732762,0,1,mitochondrial processing peptidase complex,CC,
5802,GO:0017089,1,0.923846580418386,0,2,glycolipid transporter activity,MF,
5803,GO:0017091,1,0.419257474160604,0,21,AU-rich element binding,MF,
5804,GO:0017095,1,0.91549243197245,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
5805,GO:0017098,1,0.959843233179047,0,1,sulfonylurea receptor binding,MF,
5806,GO:0017099,1,0.851343936352057,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
5807,GO:0017101,1,0.612096881844037,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5808,GO:0017102,1,0.919617714993743,0,2,methionyl glutamyl tRNA synthetase complex,CC,
5809,GO:0017108,1,0.776792840849352,0,6,5'-flap endonuclease activity,MF,
5810,GO:0017109,1,0.917345906062125,0,2,glutamate-cysteine ligase complex,CC,
5811,GO:0017110,1,0.588845936583966,0,13,nucleoside-diphosphatase activity,MF,
5814,GO:0017113,1,0.958222255349026,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
5815,GO:0017116,1,0.879001880743819,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
5816,GO:0017119,1,0.603280989690094,0,12,Golgi transport complex,CC,
5819,GO:0017125,1,0.956540720490852,0,1,deoxycytidyl transferase activity,MF,
5820,GO:0017126,1,0.956449631324241,0,1,nucleologenesis,BP,
5823,GO:0017130,1,0.956441843839217,0,1,poly(C) RNA binding,MF,
5824,GO:0017133,1,0.960504359753247,0,1,mitochondrial electron transfer flavoprotein complex,CC,
5826,GO:0017136,1,0.513300583851666,0,16,NAD-dependent histone deacetylase activity,MF,
5828,GO:0017143,1,0.920700686821241,0,2,insecticide metabolic process,BP,
5831,GO:0017146,1,0.837441012162514,0,4,NMDA selective glutamate receptor complex,CC,
5834,GO:0017150,1,0.853330723997192,0,4,tRNA dihydrouridine synthase activity,MF,
5835,GO:0017151,1,0.744568887860363,0,7,DEAD/H-box RNA helicase binding,MF,
5841,GO:0017160,1,0.548216409123294,0,14,Ral GTPase binding,MF,
5842,GO:0017161,1,0.915195441957175,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
5843,GO:0017162,1,0.714844842362023,0,8,aryl hydrocarbon receptor binding,MF,
5845,GO:0017168,1,0.956927530270733,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
5846,GO:0017169,1,0.75827887583924,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5848,GO:0017176,1,0.764724330563571,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
5849,GO:0017177,1,0.95704199370308,0,1,glucosidase II complex,CC,
5850,GO:0017178,1,0.958787867083198,0,1,diphthine-ammonia ligase activity,MF,
5851,GO:0017182,1,0.688632962544821,0,9,peptidyl-diphthamide metabolic process,BP,
5852,GO:0017183,1,0.688632962544821,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
5854,GO:0017186,1,0.92542209783738,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
5855,GO:0017187,1,0.853605723044514,0,4,peptidyl-glutamic acid carboxylation,BP,
5856,GO:0017196,1,0.778854725291,0,6,N-terminal peptidyl-methionine acetylation,BP,
5857,GO:0017198,1,0.965034687154615,0,1,N-terminal peptidyl-serine acetylation,BP,
5858,GO:0018002,1,0.965034687154615,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
5859,GO:0018008,1,0.914877286441943,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
5860,GO:0018009,1,0.961288286535632,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
5861,GO:0018011,1,0.958787867083198,0,1,N-terminal peptidyl-alanine methylation,BP,
5862,GO:0018012,1,0.958787867083198,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5863,GO:0018013,1,0.958787867083198,0,1,N-terminal peptidyl-glycine methylation,BP,
5864,GO:0018016,1,0.958787867083198,0,1,N-terminal peptidyl-proline dimethylation,BP,
5868,GO:0018025,1,0.958787867083198,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5869,GO:0018026,1,0.686493242949286,0,9,peptidyl-lysine monomethylation,BP,
5870,GO:0018027,1,0.557747060760189,0,14,peptidyl-lysine dimethylation,BP,
5871,GO:0018032,1,0.957231078804825,0,1,protein amidation,BP,
5872,GO:0018057,1,0.879328431674921,0,3,peptidyl-lysine oxidation,BP,
5873,GO:0018063,1,0.9607399435986,0,1,cytochrome c-heme linkage,BP,
5874,GO:0018065,1,0.665382003296809,0,11,protein-cofactor linkage,BP,
5875,GO:0018076,1,0.836929583265714,0,4,N-terminal peptidyl-lysine acetylation,BP,
5876,GO:0018094,1,0.957682493305144,0,1,protein polyglycylation,BP,
5877,GO:0018095,1,0.712798891062763,0,8,protein polyglutamylation,BP,
5878,GO:0018101,1,0.958072871054507,0,1,protein citrullination,BP,
5879,GO:0018103,1,0.773920802063993,0,6,protein C-linked glycosylation,BP,
5881,GO:0018106,1,0.965387612865884,0,1,peptidyl-histidine phosphorylation,BP,
5884,GO:0018114,1,0.960063836388062,0,1,threonine racemase activity,MF,
5885,GO:0018117,1,0.962967973676731,0,1,protein adenylylation,BP,
5886,GO:0018119,1,0.663445619703653,0,10,peptidyl-cysteine S-nitrosylation,BP,
5887,GO:0018125,1,0.887653883684102,0,3,peptidyl-cysteine methylation,BP,
5890,GO:0018146,1,0.418362399061165,0,21,keratan sulfate biosynthetic process,BP,
5892,GO:0018153,1,0.921653801692201,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
5893,GO:0018158,1,0.696505368400529,0,9,protein oxidation,BP,
5894,GO:0018160,1,0.963514880645511,0,1,peptidyl-pyrromethane cofactor linkage,BP,
5895,GO:0018166,1,0.956462998645709,0,1,C-terminal protein-tyrosinylation,BP,
5896,GO:0018171,1,0.856468895676415,0,4,peptidyl-cysteine oxidation,BP,
5897,GO:0018175,1,0.962967973676731,0,1,protein nucleotidylation,BP,
5898,GO:0018192,1,0.960153487129964,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
5900,GO:0018194,1,0.958787867083198,0,1,peptidyl-alanine modification,BP,
5901,GO:0018195,1,0.501304777616795,0,17,peptidyl-arginine modification,BP,
5903,GO:0018197,1,0.876223413021518,0,3,peptidyl-aspartic acid modification,BP,
5905,GO:0018199,1,0.852907721049721,0,4,peptidyl-glutamine modification,BP,
5906,GO:0018200,1,0.515702530961888,0,16,peptidyl-glutamic acid modification,BP,
5907,GO:0018201,1,0.877166522254848,0,3,peptidyl-glycine modification,BP,
5908,GO:0018202,1,0.635799498796638,0,11,peptidyl-histidine modification,BP,
5910,GO:0018206,1,0.661304359310201,0,10,peptidyl-methionine modification,BP,
5914,GO:0018211,1,0.773920802063993,0,6,peptidyl-tryptophan modification,BP,
5916,GO:0018214,1,0.853605723044514,0,4,protein carboxylation,BP,
5917,GO:0018216,1,0.58571910122192,0,13,peptidyl-arginine methylation,BP,
5918,GO:0018217,1,0.956951357901455,0,1,peptidyl-aspartic acid phosphorylation,BP,
5921,GO:0018242,1,0.570563261600107,0,13,protein O-linked glycosylation via serine,BP,
5922,GO:0018243,1,0.595114734262955,0,12,protein O-linked glycosylation via threonine,BP,
5923,GO:0018262,1,0.921653801692201,0,2,isopeptide cross-linking,BP,
5924,GO:0018271,1,0.956441843839217,0,1,biotin-protein ligase activity,MF,
5925,GO:0018272,1,0.96265960442676,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
5926,GO:0018277,1,0.96047244470973,0,1,protein deamination,BP,
5928,GO:0018282,1,0.918578526143056,0,2,metal incorporation into metallo-sulfur cluster,BP,
5929,GO:0018283,1,0.918578526143056,0,2,iron incorporation into metallo-sulfur cluster,BP,
5930,GO:0018293,1,0.964242198674625,0,1,protein-FAD linkage,BP,
5932,GO:0018307,1,0.926470306701199,0,2,enzyme active site formation,BP,
5933,GO:0018312,1,0.920786407400097,0,2,peptidyl-serine ADP-ribosylation,BP,
5934,GO:0018315,1,0.956756130289669,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
5935,GO:0018317,1,0.773920802063993,0,6,protein C-linked glycosylation via tryptophan,BP,
5936,GO:0018322,1,0.956462998645709,0,1,protein tyrosinylation,BP,
5937,GO:0018323,1,0.96492184451589,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
5938,GO:0018335,1,0.841625470272086,0,4,protein succinylation,BP,
5939,GO:0018342,1,0.688849020873532,0,9,protein prenylation,BP,
5940,GO:0018343,1,0.885787642095979,0,3,protein farnesylation,BP,
5941,GO:0018344,1,0.783142886996887,0,6,protein geranylgeranylation,BP,
5943,GO:0018350,1,0.960377061592084,0,1,protein esterification,BP,
5944,GO:0018352,1,0.924581249598696,0,2,protein-pyridoxal-5-phosphate linkage,BP,
5945,GO:0018364,1,0.931282138849604,0,2,peptidyl-glutamine methylation,BP,
5946,GO:0018377,1,0.839650394067642,0,4,protein myristoylation,BP,
5949,GO:0018395,1,0.957364396235892,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
5951,GO:0018401,1,0.846145058365672,0,4,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
5952,GO:0018406,1,0.773920802063993,0,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
5954,GO:0018423,1,0.924228650292593,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
5955,GO:0018444,1,0.877967094398681,0,3,translation release factor complex,CC,
5956,GO:0018455,1,0.964048139216157,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
5957,GO:0018467,1,0.959515561955651,0,1,formaldehyde dehydrogenase activity,MF,
5958,GO:0018478,1,0.961111150127444,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
5959,GO:0018479,1,0.961407478194606,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
5960,GO:0018585,1,0.961192489871639,0,1,fluorene oxygenase activity,MF,
5961,GO:0018636,1,0.928527892364252,0,2,phenanthrene 9,10-monooxygenase activity,MF,
5962,GO:0018738,1,0.964268346280998,0,1,S-formylglutathione hydrolase activity,MF,
5963,GO:0018773,1,0.962869317582296,0,1,acetylpyruvate hydrolase activity,MF,
5964,GO:0018812,1,0.845046611043729,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
5965,GO:0018872,1,0.960098229325435,0,1,arsonoacetate metabolic process,BP,
5966,GO:0018879,1,0.885759712297031,0,3,biphenyl metabolic process,BP,
5967,GO:0018894,1,0.920700686821241,0,2,dibenzo-p-dioxin metabolic process,BP,
5968,GO:0018904,1,0.597885194091577,0,13,ether metabolic process,BP,
5969,GO:0018916,1,0.857281595259926,0,4,nitrobenzene metabolic process,BP,
5970,GO:0018917,1,0.961192489871639,0,1,fluorene metabolic process,BP,
5971,GO:0018931,1,0.963704959771134,0,1,naphthalene metabolic process,BP,
5972,GO:0018958,1,0.144342631588502,0,46,phenol-containing compound metabolic process,BP,
5973,GO:0018963,1,0.92307829262714,0,2,phthalate metabolic process,BP,
5974,GO:0018992,1,0.915338435527532,0,2,germ-line sex determination,BP,
5975,GO:0018993,1,0.958734896341551,0,1,somatic sex determination,BP,
5978,GO:0019002,1,0.921092164029583,0,2,GMP binding,MF,
5979,GO:0019003,1,0.120103207441184,0,52,GDP binding,MF,
5981,GO:0019008,1,0.922037443710163,0,2,molybdopterin synthase complex,CC,
5982,GO:0019034,1,0.915074582605229,0,2,viral replication complex,CC,
5983,GO:0019035,1,0.956441854282437,0,1,viral integration complex,CC,
5984,GO:0019042,1,0.636976440251951,0,11,viral latency,BP,
5985,GO:0019043,1,0.696364580647074,0,9,establishment of viral latency,BP,
5986,GO:0019045,1,0.914777292668164,0,2,latent virus replication,BP,
5987,GO:0019046,1,0.914777292668164,0,2,release from viral latency,BP,
5989,GO:0019049,1,0.843383059472811,0,4,evasion or tolerance of host defenses by virus,BP,
5990,GO:0019050,1,0.888241634474252,0,3,suppression by virus of host apoptotic process,BP,
5991,GO:0019054,1,0.433287696376223,0,20,modulation by virus of host process,BP,
5993,GO:0019060,1,0.929051608343514,0,2,intracellular transport of viral protein in host cell,BP,
5994,GO:0019061,1,0.960786611699082,0,1,uncoating of virus,BP,
5995,GO:0019062,1,0.887711404040572,0,3,virion attachment to host cell,BP,
5996,GO:0019064,1,0.886372417110425,0,3,fusion of virus membrane with host plasma membrane,BP,
5997,GO:0019065,1,0.879222574585183,0,3,receptor-mediated endocytosis of virus by host cell,BP,
5999,GO:0019072,1,0.915251541602811,0,2,viral genome packaging,BP,
6000,GO:0019074,1,0.915251541602811,0,2,viral RNA genome packaging,BP,
6002,GO:0019076,1,0.250976952365199,0,33,viral release from host cell,BP,
6005,GO:0019081,1,0.560331210362658,0,14,viral translation,BP,
6008,GO:0019085,1,0.916290641342982,0,2,early viral transcription,BP,
6009,GO:0019086,1,0.849373025419353,0,4,late viral transcription,BP,
6011,GO:0019088,1,0.963167399764482,0,1,immortalization of host cell by virus,BP,
6012,GO:0019089,1,0.956441843839217,0,1,transmission of virus,BP,
6014,GO:0019100,1,0.915338435527532,0,2,male germ-line sex determination,BP,
6015,GO:0019101,1,0.958734896341551,0,1,female somatic sex determination,BP,
6016,GO:0019103,1,0.790188259339383,0,6,pyrimidine nucleotide binding,MF,
6018,GO:0019107,1,0.914877286441943,0,2,myristoyltransferase activity,MF,
6019,GO:0019118,1,0.963814807334626,0,1,phenanthrene-epoxide hydrolase activity,MF,
6020,GO:0019119,1,0.963814807334626,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6021,GO:0019135,1,0.962177637993178,0,1,deoxyhypusine monooxygenase activity,MF,
6022,GO:0019136,1,0.852843205272989,0,4,deoxynucleoside kinase activity,MF,
6023,GO:0019144,1,0.928866946457773,0,2,ADP-sugar diphosphatase activity,MF,
6024,GO:0019145,1,0.959974959431182,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6025,GO:0019150,1,0.961564214416647,0,1,D-ribulokinase activity,MF,
6026,GO:0019153,1,0.963127347250878,0,1,protein-disulfide reductase (glutathione) activity,MF,
6027,GO:0019158,1,0.876297488862277,0,3,mannokinase activity,MF,
6028,GO:0019166,1,0.890084867025265,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6029,GO:0019171,1,0.956441843839217,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6030,GO:0019184,1,0.523680986203961,0,16,nonribosomal peptide biosynthetic process,BP,
6031,GO:0019185,1,0.917791421651216,0,2,snRNA-activating protein complex,CC,
6032,GO:0019187,1,0.957009704575427,0,1,beta-1,4-mannosyltransferase activity,MF,
6033,GO:0019198,1,0.6443773851613,0,10,transmembrane receptor protein phosphatase activity,MF,
6035,GO:0019200,1,0.451821593026883,0,19,carbohydrate kinase activity,MF,
6036,GO:0019201,1,0.431761963183983,0,20,nucleotide kinase activity,MF,
6037,GO:0019202,1,0.95758141865191,0,1,amino acid kinase activity,MF,
6038,GO:0019203,1,0.808964898521961,0,5,carbohydrate phosphatase activity,MF,
6040,GO:0019206,1,0.645371862401095,0,11,nucleoside kinase activity,MF,
6045,GO:0019211,1,0.661989156427991,0,10,phosphatase activator activity,MF,
6056,GO:0019226,1,0.333365797661395,0,26,transmission of nerve impulse,BP,
6057,GO:0019227,1,0.882603327029523,0,3,neuronal action potential propagation,BP,
6058,GO:0019228,1,0.601203375248823,0,12,neuronal action potential,BP,
6060,GO:0019230,1,0.914777292668164,0,2,proprioception,BP,
6062,GO:0019236,1,0.922542172511934,0,2,response to pheromone,BP,
6063,GO:0019237,1,0.77451509418108,0,6,centromeric DNA binding,MF,
6064,GO:0019238,1,0.782483968254848,0,6,cyclohydrolase activity,MF,
6065,GO:0019239,1,0.363498932676938,0,25,deaminase activity,MF,
6066,GO:0019240,1,0.837801222241933,0,4,citrulline biosynthetic process,BP,
6067,GO:0019242,1,0.961461586368301,0,1,methylglyoxal biosynthetic process,BP,
6068,GO:0019243,1,0.923288462087707,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6069,GO:0019249,1,0.884848279319813,0,3,lactate biosynthetic process,BP,
6071,GO:0019255,1,0.924514612090334,0,2,glucose 1-phosphate metabolic process,BP,
6072,GO:0019262,1,0.825221317080873,0,5,N-acetylneuraminate catabolic process,BP,
6073,GO:0019264,1,0.922600406772291,0,2,glycine biosynthetic process from serine,BP,
6074,GO:0019276,1,0.958849901589406,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
6075,GO:0019285,1,0.957445113851019,0,1,glycine betaine biosynthetic process from choline,BP,
6077,GO:0019290,1,0.958703543985504,0,1,siderophore biosynthetic process,BP,
6078,GO:0019303,1,0.929773082503538,0,2,D-ribose catabolic process,BP,
6079,GO:0019317,1,0.770742267876858,0,6,fucose catabolic process,BP,
6083,GO:0019321,1,0.653970983920674,0,11,pentose metabolic process,BP,
6084,GO:0019322,1,0.856471946516911,0,4,pentose biosynthetic process,BP,
6085,GO:0019323,1,0.855051946721235,0,4,pentose catabolic process,BP,
6086,GO:0019336,1,0.813538068099303,0,5,phenol-containing compound catabolic process,BP,
6087,GO:0019341,1,0.959631709220558,0,1,dibenzo-p-dioxin catabolic process,BP,
6088,GO:0019343,1,0.923817687517983,0,2,cysteine biosynthetic process via cystathionine,BP,
6089,GO:0019344,1,0.887287430622779,0,3,cysteine biosynthetic process,BP,
6090,GO:0019346,1,0.852325201850483,0,4,transsulfuration,BP,
6091,GO:0019348,1,0.819732576253279,0,5,dolichol metabolic process,BP,
6092,GO:0019353,1,0.959314746291732,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6093,GO:0019355,1,0.91547768952439,0,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6094,GO:0019357,1,0.958787867083198,0,1,nicotinate nucleotide biosynthetic process,BP,
6095,GO:0019358,1,0.958787867083198,0,1,nicotinate nucleotide salvage,BP,
6099,GO:0019364,1,0.957555241268031,0,1,pyridine nucleotide catabolic process,BP,
6100,GO:0019365,1,0.958787867083198,0,1,pyridine nucleotide salvage,BP,
6101,GO:0019367,1,0.811455539240222,0,5,fatty acid elongation, saturated fatty acid,BP,
6102,GO:0019368,1,0.811455539240222,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6104,GO:0019370,1,0.758022279077117,0,7,leukotriene biosynthetic process,BP,
6105,GO:0019371,1,0.786791100518091,0,6,cyclooxygenase pathway,BP,
6107,GO:0019373,1,0.814467145507103,0,5,epoxygenase P450 pathway,BP,
6108,GO:0019374,1,0.77904306637162,0,6,galactolipid metabolic process,BP,
6109,GO:0019375,1,0.883046702784664,0,3,galactolipid biosynthetic process,BP,
6110,GO:0019376,1,0.958740152998096,0,1,galactolipid catabolic process,BP,
6113,GO:0019389,1,0.959525157182243,0,1,glucuronoside metabolic process,BP,
6114,GO:0019391,1,0.959525157182243,0,1,glucuronoside catabolic process,BP,
6116,GO:0019400,1,0.569546254028758,0,14,alditol metabolic process,BP,
6117,GO:0019401,1,0.853857404304293,0,4,alditol biosynthetic process,BP,
6118,GO:0019402,1,0.963817600391932,0,1,galactitol metabolic process,BP,
6119,GO:0019405,1,0.776552802221144,0,6,alditol catabolic process,BP,
6120,GO:0019406,1,0.963704959771134,0,1,hexitol biosynthetic process,BP,
6121,GO:0019407,1,0.959897033209647,0,1,hexitol catabolic process,BP,
6122,GO:0019408,1,0.917751981045301,0,2,dolichol biosynthetic process,BP,
6123,GO:0019413,1,0.916967074364878,0,2,acetate biosynthetic process,BP,
6124,GO:0019417,1,0.916336536048016,0,2,sulfur oxidation,BP,
6125,GO:0019418,1,0.861149723631466,0,4,sulfide oxidation,BP,
6126,GO:0019427,1,0.916967074364878,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6127,GO:0019430,1,0.528406959335357,0,16,removal of superoxide radicals,BP,
6132,GO:0019441,1,0.891184462161528,0,3,tryptophan catabolic process to kynurenine,BP,
6133,GO:0019448,1,0.959654540720847,0,1,L-cysteine catabolic process,BP,
6134,GO:0019464,1,0.886606636172765,0,3,glycine decarboxylation via glycine cleavage system,BP,
6135,GO:0019470,1,0.847471826110643,0,4,4-hydroxyproline catabolic process,BP,
6136,GO:0019471,1,0.635996323783722,0,11,4-hydroxyproline metabolic process,BP,
6137,GO:0019474,1,0.881322240942626,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6138,GO:0019477,1,0.881322240942626,0,3,L-lysine catabolic process,BP,
6139,GO:0019482,1,0.91743498736803,0,2,beta-alanine metabolic process,BP,
6140,GO:0019483,1,0.958222255349026,0,1,beta-alanine biosynthetic process,BP,
6141,GO:0019493,1,0.961839736491861,0,1,arginine catabolic process to proline,BP,
6142,GO:0019509,1,0.818286557291246,0,5,L-methionine salvage from methylthioadenosine,BP,
6143,GO:0019510,1,0.960725599208896,0,1,S-adenosylhomocysteine catabolic process,BP,
6145,GO:0019516,1,0.959690575072104,0,1,lactate oxidation,BP,
6146,GO:0019518,1,0.963170471227968,0,1,L-threonine catabolic process to glycine,BP,
6147,GO:0019519,1,0.959897033209647,0,1,pentitol metabolic process,BP,
6148,GO:0019520,1,0.922327974547388,0,2,aldonic acid metabolic process,BP,
6149,GO:0019521,1,0.922327974547388,0,2,D-gluconate metabolic process,BP,
6150,GO:0019527,1,0.959897033209647,0,1,pentitol catabolic process,BP,
6151,GO:0019530,1,0.877822853747608,0,3,taurine metabolic process,BP,
6152,GO:0019531,1,0.805946740556967,0,5,oxalate transmembrane transporter activity,MF,
6153,GO:0019532,1,0.805946740556967,0,5,oxalate transport,BP,
6154,GO:0019534,1,0.839399239501727,0,4,toxin transmembrane transporter activity,MF,
6156,GO:0019541,1,0.882018129285306,0,3,propionate metabolic process,BP,
6157,GO:0019542,1,0.916967074364878,0,2,propionate biosynthetic process,BP,
6158,GO:0019543,1,0.961893011303364,0,1,propionate catabolic process,BP,
6159,GO:0019544,1,0.961839736491861,0,1,arginine catabolic process to glutamate,BP,
6160,GO:0019547,1,0.926802447031919,0,2,arginine catabolic process to ornithine,BP,
6161,GO:0019550,1,0.923008738817873,0,2,glutamate catabolic process to aspartate,BP,
6162,GO:0019551,1,0.923008738817873,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6163,GO:0019556,1,0.958160049997458,0,1,histidine catabolic process to glutamate and formamide,BP,
6164,GO:0019557,1,0.958160049997458,0,1,histidine catabolic process to glutamate and formate,BP,
6165,GO:0019563,1,0.809010322214128,0,5,glycerol catabolic process,BP,
6166,GO:0019585,1,0.618115316447602,0,12,glucuronate metabolic process,BP,
6167,GO:0019605,1,0.962057098494237,0,1,butyrate metabolic process,BP,
6168,GO:0019614,1,0.813538068099303,0,5,catechol-containing compound catabolic process,BP,
6169,GO:0019626,1,0.756525623501171,0,7,short-chain fatty acid catabolic process,BP,
6170,GO:0019627,1,0.667806359183264,0,10,urea metabolic process,BP,
6172,GO:0019640,1,0.82321251037947,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6174,GO:0019659,1,0.958787867083198,0,1,glucose catabolic process to lactate,BP,
6175,GO:0019660,1,0.958787867083198,0,1,glycolytic fermentation,BP,
6176,GO:0019661,1,0.958787867083198,0,1,glucose catabolic process to lactate via pyruvate,BP,
6177,GO:0019666,1,0.958787867083198,0,1,nitrogenous compound fermentation,BP,
6178,GO:0019673,1,0.768613844183362,0,7,GDP-mannose metabolic process,BP,
6181,GO:0019677,1,0.957555241268031,0,1,NAD catabolic process,BP,
6183,GO:0019692,1,0.311833532646647,0,30,deoxyribose phosphate metabolic process,BP,
6185,GO:0019694,1,0.877822853747608,0,3,alkanesulfonate metabolic process,BP,
6186,GO:0019695,1,0.843679226398168,0,4,choline metabolic process,BP,
6189,GO:0019720,1,0.780283236017305,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6195,GO:0019732,1,0.919180032082163,0,2,antifungal humoral response,BP,
6197,GO:0019742,1,0.960319061862212,0,1,pentacyclic triterpenoid metabolic process,BP,
6198,GO:0019747,1,0.965008985258825,0,1,regulation of isoprenoid metabolic process,BP,
6199,GO:0019748,1,0.230830193881335,0,36,secondary metabolic process,BP,
6202,GO:0019755,1,0.849841864714526,0,4,one-carbon compound transport,BP,
6203,GO:0019763,1,0.920963670230645,0,2,immunoglobulin receptor activity,MF,
6204,GO:0019770,1,0.962599985792854,0,1,IgG receptor activity,MF,
6205,GO:0019773,1,0.776271435853856,0,7,proteasome core complex, alpha-subunit complex,CC,
6206,GO:0019774,1,0.698531492194799,0,10,proteasome core complex, beta-subunit complex,CC,
6207,GO:0019776,1,0.883575571547428,0,3,Atg8 ligase activity,MF,
6208,GO:0019777,1,0.926039194134486,0,2,Atg12 transferase activity,MF,
6209,GO:0019778,1,0.956488546109679,0,1,Atg12 activating enzyme activity,MF,
6210,GO:0019779,1,0.956488546109679,0,1,Atg8 activating enzyme activity,MF,
6211,GO:0019780,1,0.956441843839217,0,1,FAT10 activating enzyme activity,MF,
6212,GO:0019781,1,0.925216418421438,0,2,NEDD8 activating enzyme activity,MF,
6213,GO:0019782,1,0.95781683282922,0,1,ISG15 activating enzyme activity,MF,
6215,GO:0019784,1,0.761021078777031,0,7,NEDD8-specific protease activity,MF,
6216,GO:0019785,1,0.92018070587933,0,2,ISG15-specific protease activity,MF,
6218,GO:0019788,1,0.794199049227261,0,6,NEDD8 transferase activity,MF,
6219,GO:0019789,1,0.516634046788432,0,16,SUMO transferase activity,MF,
6220,GO:0019797,1,0.881379331721532,0,3,procollagen-proline 3-dioxygenase activity,MF,
6221,GO:0019798,1,0.779350481172561,0,6,procollagen-proline dioxygenase activity,MF,
6222,GO:0019799,1,0.958787867083198,0,1,tubulin N-acetyltransferase activity,MF,
6223,GO:0019800,1,0.963439989554014,0,1,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6224,GO:0019808,1,0.891416819688312,0,3,polyamine binding,MF,
6225,GO:0019809,1,0.930562127826944,0,2,spermidine binding,MF,
6226,GO:0019810,1,0.957939783253298,0,1,putrescine binding,MF,
6227,GO:0019811,1,0.956614265908789,0,1,cocaine binding,MF,
6228,GO:0019814,1,0.956479002849494,0,1,immunoglobulin complex,CC,
6229,GO:0019815,1,0.956479002849494,0,1,B cell receptor complex,CC,
6230,GO:0019825,1,0.663399070542303,0,10,oxygen binding,MF,
6231,GO:0019826,1,0.919478691521097,0,2,oxygen sensor activity,MF,
6233,GO:0019828,1,0.963953048764493,0,1,aspartic-type endopeptidase inhibitor activity,MF,
6235,GO:0019834,1,0.893741845252913,0,3,phospholipase A2 inhibitor activity,MF,
6236,GO:0019835,1,0.559352739871024,0,15,cytolysis,BP,
6243,GO:0019853,1,0.963498797201556,0,1,L-ascorbic acid biosynthetic process,BP,
6244,GO:0019855,1,0.730127006075527,0,8,calcium channel inhibitor activity,MF,
6245,GO:0019856,1,0.773955026283952,0,6,pyrimidine nucleobase biosynthetic process,BP,
6247,GO:0019858,1,0.92362261413091,0,2,cytosine metabolic process,BP,
6248,GO:0019859,1,0.920954897856584,0,2,thymine metabolic process,BP,
6249,GO:0019860,1,0.922925404073385,0,2,uracil metabolic process,BP,
6250,GO:0019862,1,0.963219431240646,0,1,IgA binding,MF,
6251,GO:0019863,1,0.963696435020339,0,1,IgE binding,MF,
6252,GO:0019864,1,0.962599985792854,0,1,IgG binding,MF,
6253,GO:0019865,1,0.89352675828542,0,3,immunoglobulin binding,MF,
6256,GO:0019869,1,0.722743771815493,0,8,chloride channel inhibitor activity,MF,
6257,GO:0019870,1,0.809686287663078,0,5,potassium channel inhibitor activity,MF,
6258,GO:0019871,1,0.806344267681797,0,5,sodium channel inhibitor activity,MF,
6259,GO:0019878,1,0.917098944675905,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6261,GO:0019883,1,0.65832802691476,0,10,antigen processing and presentation of endogenous antigen,BP,
6263,GO:0019885,1,0.74570397792133,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6267,GO:0019894,1,0.231506805613147,0,34,kinesin binding,MF,
6268,GO:0019896,1,0.624751879854183,0,11,axonal transport of mitochondrion,BP,
6278,GO:0019907,1,0.758978799598047,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6279,GO:0019908,1,0.520778224197372,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6283,GO:0019918,1,0.847654512236257,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6284,GO:0019919,1,0.752638649069104,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6290,GO:0019948,1,0.921151559140662,0,2,SUMO activating enzyme activity,MF,
6294,GO:0019957,1,0.922034960851496,0,2,C-C chemokine binding,MF,
6297,GO:0019960,1,0.875608690420256,0,3,C-X3-C chemokine binding,MF,
6298,GO:0019961,1,0.915871786977713,0,2,interferon binding,MF,
6299,GO:0019962,1,0.956441843839217,0,1,type I interferon binding,MF,
6300,GO:0019964,1,0.957586085891017,0,1,interferon-gamma binding,MF,
6301,GO:0019966,1,0.752267099521318,0,7,interleukin-1 binding,MF,
6302,GO:0019970,1,0.958072871054507,0,1,interleukin-11 binding,MF,
6303,GO:0019981,1,0.916726701814491,0,2,interleukin-6 binding,MF,
6304,GO:0019985,1,0.201272080690014,0,39,translesion synthesis,BP,
6305,GO:0019988,1,0.959193269451407,0,1,charged-tRNA amino acid modification,BP,
6306,GO:0019992,1,0.715735087600412,0,8,diacylglycerol binding,MF,
6307,GO:0020003,1,0.958787867083198,0,1,symbiont-containing vacuole,CC,
6308,GO:0020012,1,0.917543871402858,0,2,evasion or tolerance of host immune response,BP,
6309,GO:0020016,1,0.876831347719954,0,3,ciliary pocket,CC,
6310,GO:0020018,1,0.876831347719954,0,3,ciliary pocket membrane,CC,
6311,GO:0020021,1,0.963167399764482,0,1,immortalization of host cell,BP,
6312,GO:0020027,1,0.718107397758434,0,8,hemoglobin metabolic process,BP,
6314,GO:0021501,1,0.961468796467614,0,1,prechordal plate formation,BP,
6315,GO:0021502,1,0.915729472230286,0,2,neural fold elevation formation,BP,
6316,GO:0021503,1,0.956441843839217,0,1,neural fold bending,BP,
6320,GO:0021512,1,0.956763071416755,0,1,spinal cord anterior/posterior patterning,BP,
6324,GO:0021516,1,0.877549998822077,0,3,dorsal spinal cord development,BP,
6329,GO:0021523,1,0.925456437168237,0,2,somatic motor neuron differentiation,BP,
6330,GO:0021524,1,0.92330713536137,0,2,visceral motor neuron differentiation,BP,
6331,GO:0021526,1,0.962231414670732,0,1,medial motor column neuron differentiation,BP,
6332,GO:0021527,1,0.914781806247378,0,2,spinal cord association neuron differentiation,BP,
6334,GO:0021533,1,0.68200959821258,0,9,cell differentiation in hindbrain,BP,
6335,GO:0021534,1,0.810980994222086,0,5,cell proliferation in hindbrain,BP,
6336,GO:0021535,1,0.648090566074981,0,10,cell migration in hindbrain,BP,
6339,GO:0021539,1,0.925540085651688,0,2,subthalamus development,BP,
6340,GO:0021540,1,0.849620376009263,0,4,corpus callosum morphogenesis,BP,
6341,GO:0021541,1,0.956783512249054,0,1,ammon gyrus development,BP,
6346,GO:0021546,1,0.922460277294167,0,2,rhombomere development,BP,
6347,GO:0021547,1,0.961468796467614,0,1,midbrain-hindbrain boundary initiation,BP,
6348,GO:0021548,1,0.807221859599218,0,5,pons development,BP,
6350,GO:0021553,1,0.956441843839217,0,1,olfactory nerve development,BP,
6352,GO:0021555,1,0.921600738501741,0,2,midbrain-hindbrain boundary morphogenesis,BP,
6353,GO:0021557,1,0.922967630025577,0,2,oculomotor nerve development,BP,
6354,GO:0021558,1,0.96356435360397,0,1,trochlear nerve development,BP,
6355,GO:0021559,1,0.772655216105864,0,6,trigeminal nerve development,BP,
6356,GO:0021560,1,0.919651984708432,0,2,abducens nerve development,BP,
6357,GO:0021561,1,0.7746215310162,0,6,facial nerve development,BP,
6359,GO:0021563,1,0.916229376277192,0,2,glossopharyngeal nerve development,BP,
6361,GO:0021566,1,0.956494207602847,0,1,hypoglossal nerve development,BP,
6362,GO:0021569,1,0.963130436377395,0,1,rhombomere 3 development,BP,
6363,GO:0021570,1,0.963130436377395,0,1,rhombomere 4 development,BP,
6364,GO:0021571,1,0.957776133356968,0,1,rhombomere 5 development,BP,
6365,GO:0021572,1,0.957776133356968,0,1,rhombomere 6 development,BP,
6367,GO:0021577,1,0.956984038203023,0,1,hindbrain structural organization,BP,
6368,GO:0021578,1,0.876092359695945,0,3,hindbrain maturation,BP,
6369,GO:0021586,1,0.957097972860728,0,1,pons maturation,BP,
6371,GO:0021589,1,0.956984038203023,0,1,cerebellum structural organization,BP,
6372,GO:0021590,1,0.915370557978179,0,2,cerebellum maturation,BP,
6374,GO:0021592,1,0.956452840361057,0,1,fourth ventricle development,BP,
6375,GO:0021598,1,0.919651984708432,0,2,abducens nerve morphogenesis,BP,
6376,GO:0021599,1,0.919651984708432,0,2,abducens nerve formation,BP,
6378,GO:0021603,1,0.842521564294236,0,4,cranial nerve formation,BP,
6379,GO:0021604,1,0.809870455258253,0,5,cranial nerve structural organization,BP,
6380,GO:0021610,1,0.7746215310162,0,6,facial nerve morphogenesis,BP,
6381,GO:0021612,1,0.809870455258253,0,5,facial nerve structural organization,BP,
6382,GO:0021615,1,0.957959928570021,0,1,glossopharyngeal nerve morphogenesis,BP,
6383,GO:0021618,1,0.956494207602847,0,1,hypoglossal nerve morphogenesis,BP,
6384,GO:0021622,1,0.957871317478817,0,1,oculomotor nerve morphogenesis,BP,
6385,GO:0021623,1,0.957871317478817,0,1,oculomotor nerve formation,BP,
6386,GO:0021626,1,0.876092359695945,0,3,central nervous system maturation,BP,
6388,GO:0021636,1,0.840884313633851,0,4,trigeminal nerve morphogenesis,BP,
6389,GO:0021637,1,0.840884313633851,0,4,trigeminal nerve structural organization,BP,
6391,GO:0021648,1,0.918225405745854,0,2,vestibulocochlear nerve morphogenesis,BP,
6392,GO:0021649,1,0.960046682619021,0,1,vestibulocochlear nerve structural organization,BP,
6393,GO:0021650,1,0.956441843839217,0,1,vestibulocochlear nerve formation,BP,
6394,GO:0021670,1,0.714974959851774,0,8,lateral ventricle development,BP,
6396,GO:0021678,1,0.891618026802207,0,3,third ventricle development,BP,
6397,GO:0021679,1,0.917975626704212,0,2,cerebellar molecular layer development,BP,
6400,GO:0021682,1,0.956441880263142,0,1,nerve maturation,BP,
6402,GO:0021684,1,0.881282757721402,0,3,cerebellar granular layer formation,BP,
6403,GO:0021685,1,0.956441843839217,0,1,cerebellar granular layer structural organization,BP,
6404,GO:0021687,1,0.917975626704212,0,2,cerebellar molecular layer morphogenesis,BP,
6405,GO:0021688,1,0.957847511414,0,1,cerebellar molecular layer formation,BP,
6406,GO:0021691,1,0.915370557978179,0,2,cerebellar Purkinje cell layer maturation,BP,
6407,GO:0021692,1,0.70476021951356,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
6408,GO:0021693,1,0.916121846626856,0,2,cerebellar Purkinje cell layer structural organization,BP,
6409,GO:0021694,1,0.804375056445456,0,5,cerebellar Purkinje cell layer formation,BP,
6412,GO:0021697,1,0.600935744075068,0,12,cerebellar cortex formation,BP,
6413,GO:0021698,1,0.916121846626856,0,2,cerebellar cortex structural organization,BP,
6414,GO:0021699,1,0.915370557978179,0,2,cerebellar cortex maturation,BP,
6416,GO:0021702,1,0.804375056445456,0,5,cerebellar Purkinje cell differentiation,BP,
6417,GO:0021707,1,0.881282757721402,0,3,cerebellar granule cell differentiation,BP,
6418,GO:0021718,1,0.957097972860728,0,1,superior olivary nucleus development,BP,
6419,GO:0021722,1,0.957097972860728,0,1,superior olivary nucleus maturation,BP,
6420,GO:0021730,1,0.956441843839217,0,1,trigeminal sensory nucleus development,BP,
6421,GO:0021740,1,0.956441843839217,0,1,principal sensory nucleus of trigeminal nerve development,BP,
6422,GO:0021747,1,0.875675195619031,0,3,cochlear nucleus development,BP,
6424,GO:0021757,1,0.957335578823384,0,1,caudate nucleus development,BP,
6425,GO:0021758,1,0.957335578823384,0,1,putamen development,BP,
6427,GO:0021762,1,0.29451655570994,0,30,substantia nigra development,BP,
6428,GO:0021763,1,0.960930601614166,0,1,subthalamic nucleus development,BP,
6429,GO:0021764,1,0.914777292668164,0,2,amygdala development,BP,
6432,GO:0021769,1,0.880269870993595,0,3,orbitofrontal cortex development,BP,
6433,GO:0021771,1,0.956441860364028,0,1,lateral geniculate nucleus development,BP,
6434,GO:0021772,1,0.499455459814817,0,16,olfactory bulb development,BP,
6435,GO:0021773,1,0.879242596416638,0,3,striatal medium spiny neuron differentiation,BP,
6438,GO:0021778,1,0.956441843839217,0,1,oligodendrocyte cell fate specification,BP,
6439,GO:0021779,1,0.956441843839217,0,1,oligodendrocyte cell fate commitment,BP,
6440,GO:0021780,1,0.956441843839217,0,1,glial cell fate specification,BP,
6441,GO:0021781,1,0.811522677527958,0,5,glial cell fate commitment,BP,
6444,GO:0021784,1,0.965502483530677,0,1,postganglionic parasympathetic fiber development,BP,
6445,GO:0021785,1,0.76919759176927,0,6,branchiomotor neuron axon guidance,BP,
6446,GO:0021794,1,0.741472169803386,0,7,thalamus development,BP,
6448,GO:0021796,1,0.87973319188857,0,3,cerebral cortex regionalization,BP,
6449,GO:0021797,1,0.957698301862685,0,1,forebrain anterior/posterior pattern specification,BP,
6450,GO:0021798,1,0.914832245621355,0,2,forebrain dorsal/ventral pattern formation,BP,
6452,GO:0021800,1,0.803397349981512,0,5,cerebral cortex tangential migration,BP,
6454,GO:0021812,1,0.956441843839217,0,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6457,GO:0021816,1,0.917021318947511,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6460,GO:0021822,1,0.96127202209764,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6461,GO:0021823,1,0.914820963632538,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6462,GO:0021824,1,0.918225518391051,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6463,GO:0021825,1,0.839998902833628,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6464,GO:0021826,1,0.919855016869388,0,2,substrate-independent telencephalic tangential migration,BP,
6465,GO:0021827,1,0.914820963632538,0,2,postnatal olfactory bulb interneuron migration,BP,
6466,GO:0021828,1,0.918225518391051,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6467,GO:0021830,1,0.919855016869388,0,2,interneuron migration from the subpallium to the cortex,BP,
6468,GO:0021836,1,0.914820963632538,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6469,GO:0021840,1,0.960408793001707,0,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6470,GO:0021842,1,0.960408793001707,0,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6471,GO:0021843,1,0.919855016869388,0,2,substrate-independent telencephalic tangential interneuron migration,BP,
6473,GO:0021847,1,0.9151919195996,0,2,ventricular zone neuroblast division,BP,
6474,GO:0021849,1,0.916702334466109,0,2,neuroblast division in subventricular zone,BP,
6475,GO:0021854,1,0.637432666897891,0,11,hypothalamus development,BP,
6476,GO:0021855,1,0.882344849737755,0,3,hypothalamus cell migration,BP,
6477,GO:0021856,1,0.918225518391051,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
6478,GO:0021859,1,0.806586556957627,0,5,pyramidal neuron differentiation,BP,
6479,GO:0021860,1,0.806586556957627,0,5,pyramidal neuron development,BP,
6480,GO:0021861,1,0.756781506785378,0,7,forebrain radial glial cell differentiation,BP,
6482,GO:0021870,1,0.956441843839217,0,1,Cajal-Retzius cell differentiation,BP,
6483,GO:0021871,1,0.625123131250087,0,11,forebrain regionalization,BP,
6484,GO:0021872,1,0.231186750172561,0,35,forebrain generation of neurons,BP,
6485,GO:0021873,1,0.768300332242565,0,6,forebrain neuroblast division,BP,
6486,GO:0021877,1,0.808613671046132,0,5,forebrain neuron fate commitment,BP,
6487,GO:0021879,1,0.324267099847163,0,27,forebrain neuron differentiation,BP,
6488,GO:0021881,1,0.957698301862685,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6489,GO:0021882,1,0.923009643824649,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6490,GO:0021884,1,0.50935125864982,0,16,forebrain neuron development,BP,
6492,GO:0021886,1,0.88593588882204,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6493,GO:0021888,1,0.88593588882204,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6494,GO:0021889,1,0.774832362701144,0,6,olfactory bulb interneuron differentiation,BP,
6495,GO:0021891,1,0.804067835357815,0,5,olfactory bulb interneuron development,BP,
6496,GO:0021892,1,0.890342869051393,0,3,cerebral cortex GABAergic interneuron differentiation,BP,
6497,GO:0021893,1,0.923009643824649,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6498,GO:0021894,1,0.964614142412615,0,1,cerebral cortex GABAergic interneuron development,BP,
6499,GO:0021895,1,0.657981178483246,0,10,cerebral cortex neuron differentiation,BP,
6500,GO:0021896,1,0.914783539819918,0,2,forebrain astrocyte differentiation,BP,
6501,GO:0021897,1,0.914783539819918,0,2,forebrain astrocyte development,BP,
6502,GO:0021898,1,0.88395849563414,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6503,GO:0021902,1,0.914784869594754,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
6504,GO:0021903,1,0.814960062973308,0,5,rostrocaudal neural tube patterning,BP,
6509,GO:0021924,1,0.810980994222086,0,5,cell proliferation in external granule layer,BP,
6510,GO:0021930,1,0.810980994222086,0,5,cerebellar granule cell precursor proliferation,BP,
6511,GO:0021932,1,0.740019746137081,0,7,hindbrain radial glia guided cell migration,BP,
6512,GO:0021934,1,0.914777526230396,0,2,hindbrain tangential cell migration,BP,
6513,GO:0021935,1,0.914777526230396,0,2,cerebellar granule cell precursor tangential migration,BP,
6518,GO:0021941,1,0.956614265908789,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
6519,GO:0021942,1,0.881449363767029,0,3,radial glia guided migration of Purkinje cell,BP,
6520,GO:0021943,1,0.83958671018413,0,4,formation of radial glial scaffolds,BP,
6525,GO:0021956,1,0.961784531839262,0,1,central nervous system interneuron axonogenesis,BP,
6527,GO:0021960,1,0.877561163478666,0,3,anterior commissure morphogenesis,BP,
6529,GO:0021966,1,0.956487499770039,0,1,corticospinal neuron axon guidance,BP,
6530,GO:0021972,1,0.956487499770039,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6531,GO:0021978,1,0.81133469775049,0,5,telencephalon regionalization,BP,
6532,GO:0021979,1,0.847884215744792,0,4,hypothalamus cell differentiation,BP,
6534,GO:0021984,1,0.812069167033697,0,5,adenohypophysis development,BP,
6536,GO:0021988,1,0.478348635360958,0,17,olfactory lobe development,BP,
6537,GO:0021993,1,0.956452840361057,0,1,initiation of neural tube closure,BP,
6538,GO:0021997,1,0.914777292668164,0,2,neural plate axis specification,BP,
6539,GO:0021998,1,0.957364396235892,0,1,neural plate mediolateral regionalization,BP,
6540,GO:0021999,1,0.815929212694079,0,5,neural plate anterior/posterior regionalization,BP,
6543,GO:0022009,1,0.84548042455162,0,4,central nervous system vasculogenesis,BP,
6546,GO:0022012,1,0.956441843839217,0,1,subpallium cell proliferation in forebrain,BP,
6547,GO:0022018,1,0.956441843839217,0,1,lateral ganglionic eminence cell proliferation,BP,
6548,GO:0022027,1,0.836907862561667,0,4,interkinetic nuclear migration,BP,
6549,GO:0022028,1,0.837346221393421,0,4,tangential migration from the subventricular zone to the olfactory bulb,BP,
6554,GO:0022400,1,0.626361575932495,0,11,regulation of rhodopsin mediated signaling pathway,BP,
6567,GO:0022417,1,0.705825944224408,0,9,protein maturation by protein folding,BP,
6572,GO:0022605,1,0.850316834039694,0,4,mammalian oogenesis stage,BP,
6577,GO:0022614,1,0.877016036454971,0,3,membrane to membrane docking,BP,
6578,GO:0022615,1,0.855448351162415,0,4,protein to membrane docking,BP,
6579,GO:0022616,1,0.354965606252448,0,25,DNA strand elongation,BP,
6582,GO:0022622,1,0.965280077340104,0,1,root system development,BP,
6583,GO:0022624,1,0.397804290780599,0,24,proteasome accessory complex,CC,
6586,GO:0022627,1,0.205649595845326,0,43,cytosolic small ribosomal subunit,CC,
6589,GO:0022821,1,0.674716398710342,0,9,potassium ion antiporter activity,MF,
6590,GO:0022824,1,0.710750971019536,0,8,transmitter-gated ion channel activity,MF,
6594,GO:0022835,1,0.710750971019536,0,8,transmitter-gated channel activity,MF,
6598,GO:0022840,1,0.851462100458518,0,4,leak channel activity,MF,
6599,GO:0022841,1,0.887741541744187,0,3,potassium ion leak channel activity,MF,
6600,GO:0022842,1,0.851462100458518,0,4,narrow pore channel activity,MF,
6602,GO:0022848,1,0.847630379389463,0,4,acetylcholine-gated cation-selective channel activity,MF,
6603,GO:0022849,1,0.956469970904914,0,1,glutamate-gated calcium ion channel activity,MF,
6604,GO:0022851,1,0.958160049997458,0,1,GABA-gated chloride ion channel activity,MF,
6608,GO:0022884,1,0.581509838104575,0,14,macromolecule transmembrane transporter activity,MF,
6611,GO:0022894,1,0.960905366649566,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
6616,GO:0023016,1,0.916171251816775,0,2,signal transduction by trans-phosphorylation,BP,
6617,GO:0023019,1,0.687757702781278,0,9,signal transduction involved in regulation of gene expression,BP,
6618,GO:0023021,1,0.884728724211126,0,3,termination of signal transduction,BP,
6619,GO:0023023,1,0.64368011992593,0,11,MHC protein complex binding,MF,
6620,GO:0023024,1,0.958074907260221,0,1,MHC class I protein complex binding,MF,
6621,GO:0023025,1,0.920747485481208,0,2,MHC class Ib protein complex binding,MF,
6622,GO:0023026,1,0.699126709587352,0,9,MHC class II protein complex binding,MF,
6623,GO:0023029,1,0.844616427867284,0,4,MHC class Ib protein binding,MF,
6624,GO:0023030,1,0.920747485481208,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
6626,GO:0023041,1,0.887376911991982,0,3,neuronal signal transduction,BP,
6634,GO:0030002,1,0.775528627993754,0,6,cellular anion homeostasis,BP,
6640,GO:0030011,1,0.681761661744161,0,9,maintenance of cell polarity,BP,
6641,GO:0030014,1,0.529546110388029,0,15,CCR4-NOT complex,CC,
6642,GO:0030015,1,0.810212018617325,0,5,CCR4-NOT core complex,CC,
6646,GO:0030020,1,0.880380135060731,0,3,extracellular matrix structural constituent conferring tensile strength,MF,
6647,GO:0030021,1,0.958324371557144,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
6648,GO:0030023,1,0.874924186969474,0,3,extracellular matrix constituent conferring elasticity,MF,
6654,GO:0030033,1,0.525377931433151,0,15,microvillus assembly,BP,
6655,GO:0030035,1,0.877405201300666,0,3,microspike assembly,BP,
6657,GO:0030037,1,0.956488722038956,0,1,actin filament reorganization involved in cell cycle,BP,
6661,GO:0030043,1,0.852754944792168,0,4,actin filament fragmentation,BP,
6663,GO:0030047,1,0.877547364482167,0,3,actin modification,BP,
6665,GO:0030049,1,0.568566355768023,0,14,muscle filament sliding,BP,
6666,GO:0030050,1,0.768381898611248,0,6,vesicle transport along actin filament,BP,
6669,GO:0030056,1,0.765464510331182,0,6,hemidesmosome,CC,
6671,GO:0030060,1,0.893734729233528,0,3,L-malate dehydrogenase activity,MF,
6672,GO:0030061,1,0.81191401583046,0,5,mitochondrial crista,CC,
6673,GO:0030062,1,0.78618562122098,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
6674,GO:0030070,1,0.8805481466924,0,3,insulin processing,BP,
6675,GO:0030071,1,0.150715117796268,0,46,regulation of mitotic metaphase/anaphase transition,BP,
6686,GO:0030108,1,0.963498797201556,0,1,HLA-A specific activating MHC class I receptor activity,MF,
6695,GO:0030124,1,0.851190300522837,0,4,AP-4 adaptor complex,CC,
6697,GO:0030126,1,0.54079484895656,0,15,COPI vesicle coat,CC,
6698,GO:0030127,1,0.552181185069693,0,14,COPII vesicle coat,CC,
6707,GO:0030137,1,0.392081000806005,0,23,COPI-coated vesicle,CC,
6711,GO:0030144,1,0.882102506271495,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
6715,GO:0030150,1,0.49320463697618,0,18,protein import into mitochondrial matrix,BP,
6716,GO:0030151,1,0.847015175190326,0,4,molybdenum ion binding,MF,
6719,GO:0030156,1,0.965372022766248,0,1,benzodiazepine receptor binding,MF,
6720,GO:0030157,1,0.713204803833543,0,8,pancreatic juice secretion,BP,
6726,GO:0030165,1,0.0762175061303998,0,60,PDZ domain binding,MF,
6730,GO:0030169,1,0.769097518598453,0,6,low-density lipoprotein particle binding,MF,
6732,GO:0030173,1,0.225233124691721,0,36,integral component of Golgi membrane,CC,
6733,GO:0030174,1,0.781520882056351,0,6,regulation of DNA-dependent DNA replication initiation,BP,
6740,GO:0030185,1,0.961427324140695,0,1,nitric oxide transport,BP,
6766,GO:0030222,1,0.957357786768584,0,1,eosinophil differentiation,BP,
6767,GO:0030223,1,0.812078484530822,0,5,neutrophil differentiation,BP,
6769,GO:0030225,1,0.379266296433169,0,23,macrophage differentiation,BP,
6770,GO:0030226,1,0.874924186969474,0,3,apolipoprotein receptor activity,MF,
6771,GO:0030228,1,0.648506148440077,0,10,lipoprotein particle receptor activity,MF,
6772,GO:0030229,1,0.876110573661963,0,3,very-low-density lipoprotein particle receptor activity,MF,
6773,GO:0030233,1,0.962983758604616,0,1,deoxynucleotide transmembrane transporter activity,MF,
6776,GO:0030237,1,0.917548871963642,0,2,female sex determination,BP,
6779,GO:0030240,1,0.956441843839217,0,1,skeletal muscle thin filament assembly,BP,
6780,GO:0030241,1,0.914777292668164,0,2,skeletal muscle myosin thick filament assembly,BP,
6781,GO:0030242,1,0.80444138324658,0,5,autophagy of peroxisome,BP,
6783,GO:0030247,1,0.773832989814169,0,6,polysaccharide binding,MF,
6784,GO:0030249,1,0.960811769590848,0,1,guanylate cyclase regulator activity,MF,
6785,GO:0030250,1,0.960811769590848,0,1,guanylate cyclase activator activity,MF,
6788,GO:0030259,1,0.84870579347935,0,4,lipid glycosylation,BP,
6790,GO:0030261,1,0.304562448834252,0,28,chromosome condensation,BP,
6792,GO:0030263,1,0.84068076405562,0,4,apoptotic chromosome condensation,BP,
6793,GO:0030264,1,0.958787867083198,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6794,GO:0030267,1,0.886704070811076,0,3,glyoxylate reductase (NADP) activity,MF,
6795,GO:0030272,1,0.965041680775463,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
6796,GO:0030274,1,0.846563419198176,0,4,LIM domain binding,MF,
6797,GO:0030275,1,0.517888946976425,0,16,LRR domain binding,MF,
6799,GO:0030277,1,0.716269812862597,0,8,maintenance of gastrointestinal epithelium,BP,
6802,GO:0030280,1,0.639248669301361,0,11,structural constituent of epidermis,MF,
6804,GO:0030283,1,0.964880250454939,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
6805,GO:0030284,1,0.807571411875567,0,5,estrogen receptor activity,MF,
6807,GO:0030286,1,0.2429036123886,0,34,dynein complex,CC,
6808,GO:0030289,1,0.852167143900685,0,4,protein phosphatase 4 complex,CC,
6809,GO:0030290,1,0.957422721392941,0,1,sphingolipid activator protein activity,MF,
6811,GO:0030292,1,0.884471208465144,0,3,protein tyrosine kinase inhibitor activity,MF,
6812,GO:0030294,1,0.961026239603393,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
6815,GO:0030297,1,0.878679884981606,0,3,transmembrane receptor protein tyrosine kinase activator activity,MF,
6816,GO:0030298,1,0.964192233074412,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
6817,GO:0030299,1,0.885262313879302,0,3,intestinal cholesterol absorption,BP,
6819,GO:0030302,1,0.962983758604616,0,1,deoxynucleotide transport,BP,
6820,GO:0030305,1,0.962591667793119,0,1,heparanase activity,MF,
6821,GO:0030306,1,0.767956206911223,0,6,ADP-ribosylation factor binding,MF,
6826,GO:0030314,1,0.915938530006892,0,2,junctional membrane complex,CC,
6830,GO:0030318,1,0.57202051151339,0,13,melanocyte differentiation,BP,
6831,GO:0030320,1,0.775528627993754,0,6,cellular monovalent inorganic anion homeostasis,BP,
6832,GO:0030321,1,0.917685371477383,0,2,transepithelial chloride transport,BP,
6833,GO:0030322,1,0.88621991187989,0,3,stabilization of membrane potential,BP,
6838,GO:0030327,1,0.87959183935414,0,3,prenylated protein catabolic process,BP,
6839,GO:0030328,1,0.918013899788035,0,2,prenylcysteine catabolic process,BP,
6840,GO:0030329,1,0.918013899788035,0,2,prenylcysteine metabolic process,BP,
6842,GO:0030331,1,0.250323975909738,0,33,estrogen receptor binding,MF,
6847,GO:0030337,1,0.924161595161746,0,2,DNA polymerase processivity factor activity,MF,
6848,GO:0030342,1,0.958121229211977,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
6849,GO:0030343,1,0.963071508807238,0,1,vitamin D3 25-hydroxylase activity,MF,
6850,GO:0030345,1,0.958324371557144,0,1,structural constituent of tooth enamel,MF,
6851,GO:0030346,1,0.780256279303918,0,6,protein phosphatase 2B binding,MF,
6852,GO:0030348,1,0.920301756790465,0,2,syntaxin-3 binding,MF,
6853,GO:0030350,1,0.915739646849769,0,2,iron-responsive element binding,MF,
6854,GO:0030351,1,0.958910370595393,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
6855,GO:0030366,1,0.92795208960632,0,2,molybdopterin synthase activity,MF,
6856,GO:0030368,1,0.77426690556353,0,6,interleukin-17 receptor activity,MF,
6857,GO:0030371,1,0.444157834566953,0,19,translation repressor activity,MF,
6858,GO:0030372,1,0.956526537861544,0,1,high molecular weight B cell growth factor receptor binding,MF,
6860,GO:0030375,1,0.876967454505236,0,3,thyroid hormone receptor coactivator activity,MF,
6861,GO:0030377,1,0.963601943618745,0,1,urokinase plasminogen activator receptor activity,MF,
6862,GO:0030378,1,0.960063836388062,0,1,serine racemase activity,MF,
6864,GO:0030388,1,0.85212984431495,0,4,fructose 1,6-bisphosphate metabolic process,BP,
6865,GO:0030389,1,0.965493704741023,0,1,fructosamine metabolic process,BP,
6866,GO:0030395,1,0.965768149912146,0,1,lactose binding,MF,
6867,GO:0030397,1,0.145997330768499,0,46,membrane disassembly,BP,
6870,GO:0030422,1,0.696904000559239,0,9,production of siRNA involved in RNA interference,BP,
6871,GO:0030423,1,0.848642956516766,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
6876,GO:0030430,1,0.845403513033032,0,4,host cell cytoplasm,CC,
6878,GO:0030432,1,0.923481892160513,0,2,peristalsis,BP,
6882,GO:0030474,1,0.958787867083198,0,1,spindle pole body duplication,BP,
6883,GO:0030478,1,0.840130757010895,0,4,actin cap,CC,
6885,GO:0030485,1,0.921395593129425,0,2,smooth muscle contractile fiber,CC,
6886,GO:0030488,1,0.269014113809803,0,32,tRNA methylation,BP,
6887,GO:0030490,1,0.118875095929686,0,53,maturation of SSU-rRNA,BP,
6889,GO:0030497,1,0.661195926572327,0,10,fatty acid elongation,BP,
6892,GO:0030502,1,0.77130970726736,0,6,negative regulation of bone mineralization,BP,
6893,GO:0030504,1,0.956441843839217,0,1,inorganic diphosphate transmembrane transporter activity,MF,
6894,GO:0030505,1,0.914777292668164,0,2,inorganic diphosphate transport,BP,
6899,GO:0030511,1,0.415146251149958,0,21,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
6903,GO:0030515,1,0.302298685076224,0,30,snoRNA binding,MF,
6907,GO:0030520,1,0.141705217092232,0,46,intracellular estrogen receptor signaling pathway,BP,
6910,GO:0030523,1,0.956705835689818,0,1,dihydrolipoamide S-acyltransferase activity,MF,
6911,GO:0030532,1,0.0620242470280933,0,69,small nuclear ribonucleoprotein complex,CC,
6913,GO:0030538,1,0.917572194560766,0,2,embryonic genitalia morphogenesis,BP,
6914,GO:0030539,1,0.706449034811283,0,8,male genitalia development,BP,
6918,GO:0030546,1,0.775161466789276,0,6,receptor activator activity,MF,
6921,GO:0030549,1,0.964388601127591,0,1,acetylcholine receptor activator activity,MF,
6923,GO:0030551,1,0.482593677541097,0,17,cyclic nucleotide binding,MF,
6924,GO:0030552,1,0.593462913349083,0,12,cAMP binding,MF,
6925,GO:0030553,1,0.875877751367865,0,3,cGMP binding,MF,
6927,GO:0030572,1,0.957149400412029,0,1,phosphatidyltransferase activity,MF,
6929,GO:0030575,1,0.684003170488493,0,9,nuclear body organization,BP,
6930,GO:0030576,1,0.882206303631895,0,3,Cajal body organization,BP,
6931,GO:0030578,1,0.845039957257009,0,4,PML body organization,BP,
6933,GO:0030580,1,0.964083115104504,0,1,quinone cofactor methyltransferase activity,MF,
6934,GO:0030581,1,0.929051608343514,0,2,symbiont intracellular protein transport in host,BP,
6935,GO:0030586,1,0.957886117614705,0,1,[methionine synthase] reductase activity,MF,
6937,GO:0030594,1,0.405789124843757,0,22,neurotransmitter receptor activity,MF,
6939,GO:0030611,1,0.964976139134778,0,1,arsenate reductase activity,MF,
6940,GO:0030613,1,0.897400611702513,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6941,GO:0030614,1,0.897400611702513,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
6942,GO:0030616,1,0.956441843839217,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
6943,GO:0030617,1,0.958313064483935,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
6944,GO:0030618,1,0.83869160468712,0,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
6945,GO:0030619,1,0.75575251605626,0,7,U1 snRNA binding,MF,
6946,GO:0030620,1,0.794746541127407,0,6,U2 snRNA binding,MF,
6947,GO:0030621,1,0.775407456307128,0,6,U4 snRNA binding,MF,
6948,GO:0030622,1,0.881333532139337,0,3,U4atac snRNA binding,MF,
6949,GO:0030623,1,0.956441843839217,0,1,U5 snRNA binding,MF,
6950,GO:0030624,1,0.956688923264148,0,1,U6atac snRNA binding,MF,
6951,GO:0030626,1,0.920893499103636,0,2,U12 snRNA binding,MF,
6952,GO:0030627,1,0.924572488502379,0,2,pre-mRNA 5'-splice site binding,MF,
6953,GO:0030628,1,0.789231282811126,0,6,pre-mRNA 3'-splice site binding,MF,
6954,GO:0030629,1,0.958787867083198,0,1,U6 snRNA 3'-end binding,MF,
6955,GO:0030638,1,0.825866856983119,0,5,polyketide metabolic process,BP,
6957,GO:0030643,1,0.841463032233077,0,4,cellular phosphate ion homeostasis,BP,
6958,GO:0030644,1,0.921669723765443,0,2,cellular chloride ion homeostasis,BP,
6959,GO:0030647,1,0.825866856983119,0,5,aminoglycoside antibiotic metabolic process,BP,
6960,GO:0030653,1,0.95647281873084,0,1,beta-lactam antibiotic metabolic process,BP,
6961,GO:0030656,1,0.784814913058108,0,6,regulation of vitamin metabolic process,BP,
6966,GO:0030663,1,0.48247425678244,0,18,COPI-coated vesicle membrane,CC,
6976,GO:0030677,1,0.600755516942159,0,13,ribonuclease P complex,CC,
6977,GO:0030678,1,0.887755534273355,0,3,mitochondrial ribonuclease P complex,CC,
6978,GO:0030681,1,0.676777420049003,0,10,multimeric ribonuclease P complex,CC,
6979,GO:0030682,1,0.917543871402858,0,2,evasion or tolerance of host defense response,BP,
6980,GO:0030683,1,0.917543871402858,0,2,evasion or tolerance by virus of host immune response,BP,
6981,GO:0030684,1,0.0512611583415495,0,73,preribosome,CC,
6982,GO:0030686,1,0.267076099945366,0,32,90S preribosome,CC,
6983,GO:0030687,1,0.399049780388373,0,23,preribosome, large subunit precursor,CC,
6984,GO:0030688,1,0.610612536412369,0,12,preribosome, small subunit precursor,CC,
6985,GO:0030689,1,0.885349731600479,0,3,Noc complex,CC,
6986,GO:0030690,1,0.959006028046282,0,1,Noc1p-Noc2p complex,CC,
6987,GO:0030691,1,0.959006028046282,0,1,Noc2p-Noc3p complex,CC,
6988,GO:0030692,1,0.923201500838957,0,2,Noc4p-Nop14p complex,CC,
6990,GO:0030696,1,0.958144231494751,0,1,tRNA (m5U54) methyltransferase activity,MF,
6991,GO:0030697,1,0.958144231494751,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
6992,GO:0030702,1,0.956927530270733,0,1,chromatin silencing at centromere,BP,
6994,GO:0030718,1,0.957114104269117,0,1,germ-line stem cell population maintenance,BP,
6995,GO:0030719,1,0.959753253487819,0,1,P granule organization,BP,
6996,GO:0030728,1,0.600864239387876,0,12,ovulation,BP,
6997,GO:0030729,1,0.957809688311412,0,1,acetoacetate-CoA ligase activity,MF,
6998,GO:0030730,1,0.663845396168141,0,10,sequestering of triglyceride,BP,
7000,GO:0030735,1,0.958787867083198,0,1,carnosine N-methyltransferase activity,MF,
7002,GO:0030748,1,0.959803113935219,0,1,amine N-methyltransferase activity,MF,
7003,GO:0030760,1,0.963194994307159,0,1,pyridine N-methyltransferase activity,MF,
7004,GO:0030791,1,0.960098229325435,0,1,arsenite methyltransferase activity,MF,
7005,GO:0030792,1,0.960098229325435,0,1,methylarsonite methyltransferase activity,MF,
7007,GO:0030800,1,0.660625216128367,0,10,negative regulation of cyclic nucleotide metabolic process,BP,
7010,GO:0030803,1,0.720453278139915,0,8,negative regulation of cyclic nucleotide biosynthetic process,BP,
7012,GO:0030805,1,0.87706088323269,0,3,regulation of cyclic nucleotide catabolic process,BP,
7013,GO:0030806,1,0.917011116500683,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7014,GO:0030807,1,0.956441843839217,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7016,GO:0030809,1,0.493224491365486,0,17,negative regulation of nucleotide biosynthetic process,BP,
7019,GO:0030812,1,0.713089453695441,0,8,negative regulation of nucleotide catabolic process,BP,
7022,GO:0030815,1,0.660625216128367,0,10,negative regulation of cAMP metabolic process,BP,
7025,GO:0030818,1,0.720453278139915,0,8,negative regulation of cAMP biosynthetic process,BP,
7027,GO:0030820,1,0.87706088323269,0,3,regulation of cAMP catabolic process,BP,
7028,GO:0030821,1,0.917011116500683,0,2,negative regulation of cAMP catabolic process,BP,
7029,GO:0030822,1,0.956441843839217,0,1,positive regulation of cAMP catabolic process,BP,
7038,GO:0030836,1,0.752090348594871,0,7,positive regulation of actin filament depolymerization,BP,
7041,GO:0030846,1,0.956441843839217,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7042,GO:0030849,1,0.956464809774559,0,1,autosome,CC,
7045,GO:0030852,1,0.682929856871693,0,9,regulation of granulocyte differentiation,BP,
7046,GO:0030853,1,0.803916840745718,0,5,negative regulation of granulocyte differentiation,BP,
7047,GO:0030854,1,0.813325870910519,0,5,positive regulation of granulocyte differentiation,BP,
7051,GO:0030858,1,0.242184851762914,0,34,positive regulation of epithelial cell differentiation,BP,
7052,GO:0030859,1,0.526969299350654,0,15,polarized epithelial cell differentiation,BP,
7053,GO:0030860,1,0.918187094053815,0,2,regulation of polarized epithelial cell differentiation,BP,
7054,GO:0030862,1,0.956442836694781,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7059,GO:0030867,1,0.371932899495334,0,25,rough endoplasmic reticulum membrane,CC,
7060,GO:0030868,1,0.886816116250923,0,3,smooth endoplasmic reticulum membrane,CC,
7062,GO:0030874,1,0.962746502046533,0,1,nucleolar chromatin,CC,
7063,GO:0030877,1,0.652549867892537,0,10,beta-catenin destruction complex,CC,
7067,GO:0030881,1,0.791130873196583,0,6,beta-2-microglobulin binding,MF,
7068,GO:0030882,1,0.957169766353492,0,1,lipid antigen binding,MF,
7069,GO:0030883,1,0.957169766353492,0,1,endogenous lipid antigen binding,MF,
7070,GO:0030884,1,0.957169766353492,0,1,exogenous lipid antigen binding,MF,
7071,GO:0030885,1,0.89240948450825,0,3,regulation of myeloid dendritic cell activation,BP,
7072,GO:0030886,1,0.925102203464026,0,2,negative regulation of myeloid dendritic cell activation,BP,
7074,GO:0030889,1,0.654202359161109,0,10,negative regulation of B cell proliferation,BP,
7076,GO:0030891,1,0.849431315261267,0,4,VCB complex,CC,
7077,GO:0030893,1,0.879210030821849,0,3,meiotic cohesin complex,CC,
7078,GO:0030894,1,0.347195149184146,0,26,replisome,CC,
7079,GO:0030895,1,0.923136199087514,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7080,GO:0030896,1,0.848502501870166,0,4,checkpoint clamp complex,CC,
7082,GO:0030898,1,0.706864015146276,0,8,actin-dependent ATPase activity,MF,
7083,GO:0030899,1,0.964741802595523,0,1,calcium-dependent ATPase activity,MF,
7088,GO:0030904,1,0.434138462710556,0,20,retromer complex,CC,
7089,GO:0030905,1,0.847331108010011,0,4,retromer, tubulation complex,CC,
7090,GO:0030906,1,0.848677026876148,0,4,retromer, cargo-selective complex,CC,
7091,GO:0030910,1,0.91597912418791,0,2,olfactory placode formation,BP,
7092,GO:0030911,1,0.709087243719822,0,8,TPR domain binding,MF,
7094,GO:0030914,1,0.615525913437875,0,12,STAGA complex,CC,
7095,GO:0030915,1,0.757522632961878,0,7,Smc5-Smc6 complex,CC,
7096,GO:0030916,1,0.875854150041817,0,3,otic vesicle formation,BP,
7097,GO:0030917,1,0.847478962363703,0,4,midbrain-hindbrain boundary development,BP,
7098,GO:0030920,1,0.965034687154615,0,1,peptidyl-serine acetylation,BP,
7100,GO:0030935,1,0.959574977993315,0,1,sheet-forming collagen trimer,CC,
7101,GO:0030936,1,0.958370112224775,0,1,transmembrane collagen trimer,CC,
7102,GO:0030942,1,0.889574670305364,0,3,endoplasmic reticulum signal peptide binding,MF,
7103,GO:0030943,1,0.884747053436753,0,3,mitochondrion targeting sequence binding,MF,
7106,GO:0030949,1,0.74020391047473,0,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7108,GO:0030951,1,0.84244778280038,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7110,GO:0030953,1,0.736848329110857,0,7,astral microtubule organization,BP,
7111,GO:0030955,1,0.678238348946618,0,9,potassium ion binding,MF,
7112,GO:0030956,1,0.886289612020985,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7113,GO:0030957,1,0.664648648293024,0,10,Tat protein binding,MF,
7114,GO:0030961,1,0.958787867083198,0,1,peptidyl-arginine hydroxylation,BP,
7115,GO:0030964,1,0.216744236706144,0,42,NADH dehydrogenase complex,CC,
7117,GO:0030969,1,0.880616073154928,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7120,GO:0030974,1,0.962983758604616,0,1,thiamine pyrophosphate transmembrane transport,BP,
7122,GO:0030981,1,0.877798183155465,0,3,cortical microtubule cytoskeleton,CC,
7127,GO:0030992,1,0.455570236865802,0,19,intraciliary transport particle B,CC,
7128,GO:0030997,1,0.880483476951124,0,3,regulation of centriole-centriole cohesion,BP,
7129,GO:0031000,1,0.635052766406122,0,11,response to caffeine,BP,
7130,GO:0031005,1,0.651437729912344,0,10,filamin binding,MF,
7132,GO:0031011,1,0.553455343261186,0,15,Ino80 complex,CC,
7134,GO:0031013,1,0.962814632476997,0,1,troponin I binding,MF,
7135,GO:0031014,1,0.931340913315311,0,2,troponin T binding,MF,
7139,GO:0031021,1,0.886056629766342,0,3,interphase microtubule organizing center,CC,
7140,GO:0031022,1,0.915337576549257,0,2,nuclear migration along microfilament,BP,
7145,GO:0031038,1,0.961389430746383,0,1,myosin II filament organization,BP,
7146,GO:0031045,1,0.773846211696499,0,6,dense core granule,CC,
7148,GO:0031048,1,0.91719733569348,0,2,chromatin silencing by small RNA,BP,
7149,GO:0031049,1,0.958962085136742,0,1,programmed DNA elimination,BP,
7151,GO:0031052,1,0.958962085136742,0,1,chromosome breakage,BP,
7152,GO:0031053,1,0.653500189245824,0,10,primary miRNA processing,BP,
7153,GO:0031054,1,0.5810962530419,0,13,pre-miRNA processing,BP,
7154,GO:0031055,1,0.200473856784163,0,42,chromatin remodeling at centromere,BP,
7156,GO:0031057,1,0.254789097568578,0,32,negative regulation of histone modification,BP,
7159,GO:0031061,1,0.503655593128839,0,16,negative regulation of histone methylation,BP,
7162,GO:0031064,1,0.914777317313074,0,2,negative regulation of histone deacetylation,BP,
7165,GO:0031071,1,0.960415853187976,0,1,cysteine desulfurase activity,MF,
7167,GO:0031074,1,0.882622635007585,0,3,nucleocytoplasmic transport complex,CC,
7169,GO:0031077,1,0.750861631840634,0,7,post-embryonic camera-type eye development,BP,
7170,GO:0031078,1,0.627207597174492,0,11,histone deacetylase activity (H3-K14 specific),MF,
7171,GO:0031080,1,0.657230394196307,0,10,nuclear pore outer ring,CC,
7172,GO:0031081,1,0.917371998989092,0,2,nuclear pore distribution,BP,
7175,GO:0031084,1,0.878028797914562,0,3,BLOC-2 complex,CC,
7176,GO:0031085,1,0.917901374097738,0,2,BLOC-3 complex,CC,
7177,GO:0031086,1,0.717001191017439,0,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7178,GO:0031087,1,0.748090098063724,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7179,GO:0031088,1,0.814127932843762,0,5,platelet dense granule membrane,CC,
7180,GO:0031089,1,0.816969111016275,0,5,platelet dense granule lumen,CC,
7183,GO:0031092,1,0.625211323207936,0,11,platelet alpha granule membrane,CC,
7193,GO:0031105,1,0.677418330253467,0,9,septin complex,CC,
7194,GO:0031106,1,0.595544024205421,0,12,septin ring organization,BP,
7197,GO:0031111,1,0.317875857907867,0,27,negative regulation of microtubule polymerization or depolymerization,BP,
7199,GO:0031113,1,0.219159720673427,0,36,regulation of microtubule polymerization,BP,
7201,GO:0031115,1,0.685689225771714,0,9,negative regulation of microtubule polymerization,BP,
7202,GO:0031116,1,0.395609753000066,0,22,positive regulation of microtubule polymerization,BP,
7204,GO:0031118,1,0.740728960113482,0,8,rRNA pseudouridine synthesis,BP,
7205,GO:0031119,1,0.761191705257374,0,7,tRNA pseudouridine synthesis,BP,
7206,GO:0031120,1,0.862310453575775,0,4,snRNA pseudouridine synthesis,BP,
7210,GO:0031125,1,0.636176054009107,0,12,rRNA 3'-end processing,BP,
7211,GO:0031126,1,0.768906810120326,0,7,snoRNA 3'-end processing,BP,
7212,GO:0031127,1,0.916872857669193,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
7214,GO:0031133,1,0.921759849345865,0,2,regulation of axon diameter,BP,
7215,GO:0031134,1,0.882577807932695,0,3,sister chromatid biorientation,BP,
7216,GO:0031143,1,0.604215568511698,0,12,pseudopodium,CC,
7217,GO:0031145,1,0.0507504615817337,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7219,GO:0031151,1,0.956441843839217,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7220,GO:0031161,1,0.958179177604344,0,1,phosphatidylinositol catabolic process,BP,
7221,GO:0031163,1,0.458914156435269,0,20,metallo-sulfur cluster assembly,BP,
7222,GO:0031166,1,0.877854479495926,0,3,integral component of vacuolar membrane,CC,
7223,GO:0031167,1,0.432031044108569,0,21,rRNA methylation,BP,
7225,GO:0031177,1,0.891677232157038,0,3,phosphopantetheine binding,MF,
7226,GO:0031179,1,0.957231078804825,0,1,peptide modification,BP,
7228,GO:0031204,1,0.883599057433643,0,3,posttranslational protein targeting to membrane, translocation,BP,
7229,GO:0031205,1,0.92368851721466,0,2,endoplasmic reticulum Sec complex,CC,
7230,GO:0031208,1,0.917960596691159,0,2,POZ domain binding,MF,
7231,GO:0031209,1,0.704748784564781,0,8,SCAR complex,CC,
7232,GO:0031210,1,0.611996259055963,0,12,phosphatidylcholine binding,MF,
7233,GO:0031211,1,0.721250704321659,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7234,GO:0031213,1,0.91540832807388,0,2,RSF complex,CC,
7241,GO:0031228,1,0.190644927814507,0,40,intrinsic component of Golgi membrane,CC,
7245,GO:0031233,1,0.615118611221703,0,12,intrinsic component of external side of plasma membrane,CC,
7248,GO:0031247,1,0.92239572301628,0,2,actin rod assembly,BP,
7250,GO:0031249,1,0.960261301714898,0,1,denatured protein binding,MF,
7251,GO:0031251,1,0.914785741151782,0,2,PAN complex,CC,
7254,GO:0031254,1,0.712831397209553,0,8,cell trailing edge,CC,
7257,GO:0031260,1,0.964556901077911,0,1,pseudopodium membrane,CC,
7258,GO:0031261,1,0.815453024846849,0,5,DNA replication preinitiation complex,CC,
7259,GO:0031262,1,0.860509658747504,0,4,Ndc80 complex,CC,
7260,GO:0031264,1,0.692046599275197,0,9,death-inducing signaling complex,CC,
7261,GO:0031265,1,0.782067136556729,0,6,CD95 death-inducing signaling complex,CC,
7263,GO:0031268,1,0.612329473374813,0,12,pseudopodium organization,BP,
7264,GO:0031269,1,0.634851217883341,0,11,pseudopodium assembly,BP,
7265,GO:0031272,1,0.692342302308993,0,9,regulation of pseudopodium assembly,BP,
7266,GO:0031274,1,0.692342302308993,0,9,positive regulation of pseudopodium assembly,BP,
7268,GO:0031280,1,0.751270673067138,0,7,negative regulation of cyclase activity,BP,
7272,GO:0031289,1,0.95840028639604,0,1,actin phosphorylation,BP,
7274,GO:0031291,1,0.885046280046452,0,3,Ran protein signal transduction,BP,
7275,GO:0031293,1,0.378140816520423,0,23,membrane protein intracellular domain proteolysis,BP,
7278,GO:0031296,1,0.964290491203397,0,1,B cell costimulation,BP,
7279,GO:0031297,1,0.333741050139751,0,26,replication fork processing,BP,
7280,GO:0031298,1,0.689840428402578,0,9,replication fork protection complex,CC,
7283,GO:0031302,1,0.956466376657804,0,1,intrinsic component of endosome membrane,CC,
7284,GO:0031304,1,0.23713306052013,0,36,intrinsic component of mitochondrial inner membrane,CC,
7285,GO:0031305,1,0.23713306052013,0,36,integral component of mitochondrial inner membrane,CC,
7286,GO:0031306,1,0.405803312007741,0,22,intrinsic component of mitochondrial outer membrane,CC,
7287,GO:0031307,1,0.424254258641051,0,21,integral component of mitochondrial outer membrane,CC,
7288,GO:0031310,1,0.877854479495926,0,3,intrinsic component of vacuolar membrane,CC,
7289,GO:0031312,1,0.310282683096698,0,28,extrinsic component of organelle membrane,CC,
7290,GO:0031313,1,0.74616923147303,0,7,extrinsic component of endosome membrane,CC,
7291,GO:0031314,1,0.808225538333052,0,5,extrinsic component of mitochondrial inner membrane,CC,
7292,GO:0031315,1,0.956441843839217,0,1,extrinsic component of mitochondrial outer membrane,CC,
7293,GO:0031320,1,0.959897033209647,0,1,hexitol dehydrogenase activity,MF,
7303,GO:0031332,1,0.623966361352522,0,11,RNAi effector complex,CC,
7306,GO:0031335,1,0.960806377001927,0,1,regulation of sulfur amino acid metabolic process,BP,
7307,GO:0031337,1,0.960806377001927,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7309,GO:0031339,1,0.881149092343255,0,3,negative regulation of vesicle fusion,BP,
7310,GO:0031340,1,0.778546070428305,0,6,positive regulation of vesicle fusion,BP,
7311,GO:0031341,1,0.254852465730521,0,34,regulation of cell killing,BP,
7312,GO:0031342,1,0.643234753992212,0,11,negative regulation of cell killing,BP,
7313,GO:0031343,1,0.429740419276281,0,21,positive regulation of cell killing,BP,
7320,GO:0031362,1,0.693787110536211,0,9,anchored component of external side of plasma membrane,CC,
7321,GO:0031365,1,0.363374927488856,0,24,N-terminal protein amino acid modification,BP,
7323,GO:0031370,1,0.956540286545912,0,1,eukaryotic initiation factor 4G binding,MF,
7324,GO:0031371,1,0.723376002168784,0,8,ubiquitin conjugating enzyme complex,CC,
7325,GO:0031372,1,0.924659995070474,0,2,UBC13-MMS2 complex,CC,
7326,GO:0031379,1,0.925676239471927,0,2,RNA-directed RNA polymerase complex,CC,
7327,GO:0031380,1,0.957886117614705,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7328,GO:0031386,1,0.631048413331539,0,12,protein tag,MF,
7329,GO:0031389,1,0.958771881359281,0,1,Rad17 RFC-like complex,CC,
7330,GO:0031390,1,0.724746434680717,0,8,Ctf18 RFC-like complex,CC,
7331,GO:0031392,1,0.845478960126206,0,4,regulation of prostaglandin biosynthetic process,BP,
7332,GO:0031393,1,0.917119681768258,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7333,GO:0031394,1,0.921898377868058,0,2,positive regulation of prostaglandin biosynthetic process,BP,
7336,GO:0031398,1,0.0228492814977001,0,91,positive regulation of protein ubiquitination,BP,
7340,GO:0031402,1,0.707401436896805,0,8,sodium ion binding,MF,
7341,GO:0031403,1,0.915978324728997,0,2,lithium ion binding,MF,
7342,GO:0031404,1,0.883626045563337,0,3,chloride ion binding,MF,
7343,GO:0031405,1,0.956441843839217,0,1,lipoic acid binding,MF,
7345,GO:0031407,1,0.960461819250754,0,1,oxylipin metabolic process,BP,
7347,GO:0031414,1,0.688684402094169,0,9,N-terminal protein acetyltransferase complex,CC,
7348,GO:0031415,1,0.85043470888083,0,4,NatA complex,CC,
7349,GO:0031416,1,0.922582426791907,0,2,NatB complex,CC,
7350,GO:0031417,1,0.877836953063847,0,3,NatC complex,CC,
7351,GO:0031418,1,0.494684785690565,0,17,L-ascorbic acid binding,MF,
7352,GO:0031419,1,0.749460520552268,0,7,cobalamin binding,MF,
7353,GO:0031420,1,0.570042342321036,0,13,alkali metal ion binding,MF,
7355,GO:0031427,1,0.879295109396775,0,3,response to methotrexate,BP,
7356,GO:0031428,1,0.823805679096702,0,5,box C/D snoRNP complex,CC,
7357,GO:0031429,1,0.831619633930703,0,5,box H/ACA snoRNP complex,CC,
7359,GO:0031431,1,0.917802292459577,0,2,Dbf4-dependent protein kinase complex,CC,
7361,GO:0031433,1,0.956441843839217,0,1,telethonin binding,MF,
7364,GO:0031436,1,0.917856566100554,0,2,BRCA1-BARD1 complex,CC,
7365,GO:0031437,1,0.880376343979174,0,3,regulation of mRNA cleavage,BP,
7366,GO:0031438,1,0.958338007501677,0,1,negative regulation of mRNA cleavage,BP,
7367,GO:0031439,1,0.918655886918706,0,2,positive regulation of mRNA cleavage,BP,
7368,GO:0031440,1,0.394760215940986,0,22,regulation of mRNA 3'-end processing,BP,
7369,GO:0031441,1,0.68026676611083,0,9,negative regulation of mRNA 3'-end processing,BP,
7370,GO:0031442,1,0.687125776290815,0,9,positive regulation of mRNA 3'-end processing,BP,
7372,GO:0031444,1,0.964741802595523,0,1,slow-twitch skeletal muscle fiber contraction,BP,
7373,GO:0031445,1,0.921052862961409,0,2,regulation of heterochromatin assembly,BP,
7374,GO:0031453,1,0.921052862961409,0,2,positive regulation of heterochromatin assembly,BP,
7375,GO:0031455,1,0.957445113851019,0,1,glycine betaine metabolic process,BP,
7376,GO:0031456,1,0.957445113851019,0,1,glycine betaine biosynthetic process,BP,
7377,GO:0031460,1,0.956504486802855,0,1,glycine betaine transport,BP,
7381,GO:0031464,1,0.610175326955215,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7383,GO:0031466,1,0.85136037170974,0,4,Cul5-RING ubiquitin ligase complex,CC,
7384,GO:0031467,1,0.817417082596254,0,5,Cul7-RING ubiquitin ligase complex,CC,
7385,GO:0031468,1,0.483940449537031,0,18,nuclear envelope reassembly,BP,
7386,GO:0031475,1,0.963364268007045,0,1,myosin V complex,CC,
7387,GO:0031489,1,0.589237092341019,0,13,myosin V binding,MF,
7390,GO:0031492,1,0.196301509939273,0,42,nucleosomal DNA binding,MF,
7391,GO:0031493,1,0.883357435578287,0,3,nucleosomal histone binding,MF,
7393,GO:0031498,1,0.490383800283304,0,17,chromatin disassembly,BP,
7394,GO:0031501,1,0.862133168954041,0,4,mannosyltransferase complex,CC,
7396,GO:0031506,1,0.962561648789528,0,1,cell wall glycoprotein biosynthetic process,BP,
7397,GO:0031507,1,0.662438303275067,0,10,heterochromatin assembly,BP,
7398,GO:0031508,1,0.924085616317623,0,2,pericentric heterochromatin assembly,BP,
7399,GO:0031509,1,0.96300265421436,0,1,telomeric heterochromatin assembly,BP,
7400,GO:0031510,1,0.887585917703996,0,3,SUMO activating enzyme complex,CC,
7402,GO:0031515,1,0.885602948112308,0,3,tRNA (m1A) methyltransferase complex,CC,
7403,GO:0031519,1,0.138119231211757,0,47,PcG protein complex,CC,
7404,GO:0031523,1,0.917487186862173,0,2,Myb complex,CC,
7406,GO:0031527,1,0.620152965943934,0,11,filopodium membrane,CC,
7409,GO:0031530,1,0.962766033503394,0,1,gonadotropin-releasing hormone receptor binding,MF,
7410,GO:0031531,1,0.963920131135718,0,1,thyrotropin-releasing hormone receptor binding,MF,
7412,GO:0031533,1,0.956441843839217,0,1,mRNA cap methyltransferase complex,CC,
7413,GO:0031536,1,0.857920651052108,0,4,positive regulation of exit from mitosis,BP,
7414,GO:0031543,1,0.686770363659503,0,9,peptidyl-proline dioxygenase activity,MF,
7415,GO:0031544,1,0.84474645412128,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7416,GO:0031545,1,0.813048116456708,0,5,peptidyl-proline 4-dioxygenase activity,MF,
7417,GO:0031547,1,0.914889958036468,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
7418,GO:0031554,1,0.956441843839217,0,1,regulation of DNA-templated transcription, termination,BP,
7419,GO:0031559,1,0.956762118939854,0,1,oxidosqualene cyclase activity,MF,
7427,GO:0031581,1,0.624304586218181,0,11,hemidesmosome assembly,BP,
7428,GO:0031583,1,0.961427324140695,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7429,GO:0031584,1,0.817653485407355,0,5,activation of phospholipase D activity,BP,
7432,GO:0031588,1,0.682303143373042,0,9,nucleotide-activated protein kinase complex,CC,
7434,GO:0031590,1,0.919220047357995,0,2,wybutosine metabolic process,BP,
7435,GO:0031591,1,0.919220047357995,0,2,wybutosine biosynthetic process,BP,
7436,GO:0031592,1,0.956441843839217,0,1,centrosomal corona,CC,
7439,GO:0031595,1,0.736866688732205,0,8,nuclear proteasome complex,CC,
7440,GO:0031597,1,0.623192333191442,0,12,cytosolic proteasome complex,CC,
7441,GO:0031616,1,0.697917061439769,0,9,spindle pole centrosome,CC,
7442,GO:0031618,1,0.714519674000735,0,8,nuclear pericentric heterochromatin,CC,
7443,GO:0031620,1,0.883123842837493,0,3,regulation of fever generation,BP,
7444,GO:0031622,1,0.883123842837493,0,3,positive regulation of fever generation,BP,
7446,GO:0031624,1,0.300055509749218,0,28,ubiquitin conjugating enzyme binding,MF,
7448,GO:0031626,1,0.956458937738547,0,1,beta-endorphin binding,MF,
7449,GO:0031627,1,0.879921039194296,0,3,telomeric loop formation,BP,
7450,GO:0031628,1,0.845250661113479,0,4,opioid receptor binding,MF,
7451,GO:0031629,1,0.663302268518514,0,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7452,GO:0031630,1,0.957029977034742,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7453,GO:0031635,1,0.962252164035365,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7456,GO:0031640,1,0.568880042665647,0,15,killing of cells of other organism,BP,
7464,GO:0031648,1,0.203412548505618,0,38,protein destabilization,BP,
7465,GO:0031649,1,0.607447051076051,0,12,heat generation,BP,
7466,GO:0031650,1,0.71550841252821,0,8,regulation of heat generation,BP,
7467,GO:0031651,1,0.956825884947973,0,1,negative regulation of heat generation,BP,
7468,GO:0031652,1,0.747813382044712,0,7,positive regulation of heat generation,BP,
7470,GO:0031658,1,0.75515048384132,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7475,GO:0031666,1,0.848008609977413,0,4,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7481,GO:0031673,1,0.956441843839217,0,1,H zone,CC,
7484,GO:0031682,1,0.958420205715724,0,1,G-protein gamma-subunit binding,MF,
7485,GO:0031683,1,0.609137576075375,0,12,G-protein beta/gamma-subunit complex binding,MF,
7486,GO:0031685,1,0.916970225043438,0,2,adenosine receptor binding,MF,
7487,GO:0031686,1,0.958275000686016,0,1,A1 adenosine receptor binding,MF,
7488,GO:0031690,1,0.585375024075498,0,13,adrenergic receptor binding,MF,
7489,GO:0031691,1,0.924633908921312,0,2,alpha-1A adrenergic receptor binding,MF,
7490,GO:0031692,1,0.924633908921312,0,2,alpha-1B adrenergic receptor binding,MF,
7491,GO:0031694,1,0.964446019514661,0,1,alpha-2A adrenergic receptor binding,MF,
7492,GO:0031697,1,0.840607928630909,0,4,beta-1 adrenergic receptor binding,MF,
7493,GO:0031698,1,0.846490010762737,0,4,beta-2 adrenergic receptor binding,MF,
7494,GO:0031699,1,0.956825884947973,0,1,beta-3 adrenergic receptor binding,MF,
7495,GO:0031700,1,0.963575942017026,0,1,adrenomedullin receptor binding,MF,
7496,GO:0031701,1,0.709593671890647,0,8,angiotensin receptor binding,MF,
7497,GO:0031702,1,0.738372346670637,0,7,type 1 angiotensin receptor binding,MF,
7498,GO:0031704,1,0.958026563055971,0,1,apelin receptor binding,MF,
7499,GO:0031705,1,0.961427324140695,0,1,bombesin receptor binding,MF,
7500,GO:0031707,1,0.961427324140695,0,1,endothelin A receptor binding,MF,
7501,GO:0031708,1,0.961427324140695,0,1,endothelin B receptor binding,MF,
7502,GO:0031726,1,0.964192233074412,0,1,CCR1 chemokine receptor binding,MF,
7503,GO:0031729,1,0.964192233074412,0,1,CCR4 chemokine receptor binding,MF,
7505,GO:0031731,1,0.965968319363988,0,1,CCR6 chemokine receptor binding,MF,
7506,GO:0031748,1,0.811637314591719,0,5,D1 dopamine receptor binding,MF,
7508,GO:0031752,1,0.915015164321376,0,2,D5 dopamine receptor binding,MF,
7509,GO:0031753,1,0.959066455660129,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7510,GO:0031755,1,0.959066455660129,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
7511,GO:0031762,1,0.924633908921312,0,2,follicle-stimulating hormone receptor binding,MF,
7512,GO:0031763,1,0.965280077340104,0,1,galanin receptor binding,MF,
7513,GO:0031764,1,0.965280077340104,0,1,type 1 galanin receptor binding,MF,
7514,GO:0031765,1,0.965280077340104,0,1,type 2 galanin receptor binding,MF,
7515,GO:0031766,1,0.965280077340104,0,1,type 3 galanin receptor binding,MF,
7516,GO:0031775,1,0.956441843839217,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7517,GO:0031798,1,0.956441843839217,0,1,type 1 metabotropic glutamate receptor binding,MF,
7518,GO:0031802,1,0.882133758236257,0,3,type 5 metabotropic glutamate receptor binding,MF,
7519,GO:0031811,1,0.957050263221873,0,1,G-protein coupled nucleotide receptor binding,MF,
7520,GO:0031812,1,0.957050263221873,0,1,P2Y1 nucleotide receptor binding,MF,
7521,GO:0031821,1,0.780536783112462,0,6,G-protein coupled serotonin receptor binding,MF,
7522,GO:0031826,1,0.890667620430722,0,3,type 2A serotonin receptor binding,MF,
7523,GO:0031839,1,0.965198421423852,0,1,type 1 neuromedin U receptor binding,MF,
7524,GO:0031840,1,0.965198421423852,0,1,type 2 neuromedin U receptor binding,MF,
7525,GO:0031848,1,0.655970104826095,0,10,protection from non-homologous end joining at telomere,BP,
7526,GO:0031849,1,0.95719796421066,0,1,olfactory receptor binding,MF,
7527,GO:0031852,1,0.845250661113479,0,4,mu-type opioid receptor binding,MF,
7528,GO:0031859,1,0.962113139440756,0,1,platelet activating factor receptor binding,MF,
7529,GO:0031860,1,0.875863787697756,0,3,telomeric 3' overhang formation,BP,
7530,GO:0031862,1,0.915416817668967,0,2,prostanoid receptor binding,MF,
7531,GO:0031867,1,0.957110437004909,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
7532,GO:0031870,1,0.956441843839217,0,1,thromboxane A2 receptor binding,MF,
7533,GO:0031871,1,0.881451681582835,0,3,proteinase activated receptor binding,MF,
7534,GO:0031883,1,0.961414695689025,0,1,taste receptor binding,MF,
7535,GO:0031893,1,0.961047912051555,0,1,vasopressin receptor binding,MF,
7536,GO:0031896,1,0.961047912051555,0,1,V2 vasopressin receptor binding,MF,
7542,GO:0031906,1,0.922980020781177,0,2,late endosome lumen,CC,
7544,GO:0031914,1,0.885744284330138,0,3,negative regulation of synaptic plasticity,BP,
7547,GO:0031930,1,0.963535295571133,0,1,mitochondria-nucleus signaling pathway,BP,
7548,GO:0031931,1,0.744058142630937,0,7,TORC1 complex,CC,
7549,GO:0031932,1,0.583623953413809,0,13,TORC2 complex,CC,
7550,GO:0031933,1,0.885158350199797,0,3,telomeric heterochromatin,CC,
7553,GO:0031937,1,0.707497409046779,0,8,positive regulation of chromatin silencing,BP,
7554,GO:0031938,1,0.926453998895315,0,2,regulation of chromatin silencing at telomere,BP,
7555,GO:0031940,1,0.96300265421436,0,1,positive regulation of chromatin silencing at telomere,BP,
7557,GO:0031943,1,0.716716567404043,0,8,regulation of glucocorticoid metabolic process,BP,
7558,GO:0031944,1,0.842172337361811,0,4,negative regulation of glucocorticoid metabolic process,BP,
7559,GO:0031945,1,0.957044903232465,0,1,positive regulation of glucocorticoid metabolic process,BP,
7560,GO:0031946,1,0.770966432176286,0,6,regulation of glucocorticoid biosynthetic process,BP,
7561,GO:0031947,1,0.842172337361811,0,4,negative regulation of glucocorticoid biosynthetic process,BP,
7562,GO:0031948,1,0.957044903232465,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
7567,GO:0031957,1,0.746121645347965,0,7,very long-chain fatty acid-CoA ligase activity,MF,
7569,GO:0031959,1,0.917030453508492,0,2,mineralocorticoid receptor signaling pathway,BP,
7571,GO:0031962,1,0.956441843839217,0,1,mineralocorticoid receptor binding,MF,
7584,GO:0031987,1,0.709425217183097,0,8,locomotion involved in locomotory behavior,BP,
7585,GO:0031990,1,0.918768729039817,0,2,mRNA export from nucleus in response to heat stress,BP,
7588,GO:0031996,1,0.66048369563883,0,10,thioesterase binding,MF,
7589,GO:0031997,1,0.886189328051168,0,3,N-terminal myristoylation domain binding,MF,
7591,GO:0031999,1,0.917091093702635,0,2,negative regulation of fatty acid beta-oxidation,BP,
7592,GO:0032000,1,0.800813698090875,0,5,positive regulation of fatty acid beta-oxidation,BP,
7593,GO:0032002,1,0.922351641839089,0,2,interleukin-28 receptor complex,CC,
7596,GO:0032008,1,0.288080108491521,0,30,positive regulation of TOR signaling,BP,
7597,GO:0032009,1,0.741079314304921,0,7,early phagosome,CC,
7598,GO:0032010,1,0.883425680390788,0,3,phagolysosome,CC,
7601,GO:0032020,1,0.791849915956016,0,6,ISG15-protein conjugation,BP,
7602,GO:0032021,1,0.845046611043729,0,4,NELF complex,CC,
7604,GO:0032025,1,0.665593534777826,0,10,response to cobalt ion,BP,
7605,GO:0032026,1,0.735823468921132,0,7,response to magnesium ion,BP,
7606,GO:0032027,1,0.881240636765134,0,3,myosin light chain binding,MF,
7607,GO:0032028,1,0.961393040645808,0,1,myosin head/neck binding,MF,
7608,GO:0032029,1,0.956441843839217,0,1,myosin tail binding,MF,
7609,GO:0032036,1,0.817224617702458,0,5,myosin heavy chain binding,MF,
7610,GO:0032039,1,0.571343495303047,0,13,integrator complex,CC,
7611,GO:0032040,1,0.260839998805002,0,33,small-subunit processome,CC,
7612,GO:0032041,1,0.627207597174492,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
7613,GO:0032042,1,0.552984906559475,0,14,mitochondrial DNA metabolic process,BP,
7614,GO:0032044,1,0.922248287762153,0,2,DSIF complex,CC,
7615,GO:0032045,1,0.716799447937739,0,8,guanyl-nucleotide exchange factor complex,CC,
7616,GO:0032048,1,0.559487142473492,0,14,cardiolipin metabolic process,BP,
7617,GO:0032049,1,0.718585112775148,0,8,cardiolipin biosynthetic process,BP,
7618,GO:0032050,1,0.746683322108141,0,7,clathrin heavy chain binding,MF,
7620,GO:0032052,1,0.82106608809219,0,5,bile acid binding,MF,
7621,GO:0032053,1,0.917021318947511,0,2,ciliary basal body organization,BP,
7622,GO:0032055,1,0.777107269583062,0,6,negative regulation of translation in response to stress,BP,
7624,GO:0032057,1,0.842772883504533,0,4,negative regulation of translational initiation in response to stress,BP,
7626,GO:0032059,1,0.743706841976034,0,7,bleb,CC,
7627,GO:0032060,1,0.657833121761506,0,10,bleb assembly,BP,
7629,GO:0032070,1,0.693744667288185,0,9,regulation of deoxyribonuclease activity,BP,
7630,GO:0032071,1,0.750308991701837,0,7,regulation of endodeoxyribonuclease activity,BP,
7631,GO:0032072,1,0.957657838392433,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7632,GO:0032074,1,0.777853101285401,0,6,negative regulation of nuclease activity,BP,
7634,GO:0032076,1,0.959299384807479,0,1,negative regulation of deoxyribonuclease activity,BP,
7635,GO:0032077,1,0.818697073865301,0,5,positive regulation of deoxyribonuclease activity,BP,
7636,GO:0032079,1,0.849379608770134,0,4,positive regulation of endodeoxyribonuclease activity,BP,
7638,GO:0032089,1,0.917004445576597,0,2,NACHT domain binding,MF,
7639,GO:0032090,1,0.923989009168847,0,2,Pyrin domain binding,MF,
7642,GO:0032093,1,0.958787867083198,0,1,SAM domain binding,MF,
7644,GO:0032095,1,0.723695700726096,0,8,regulation of response to food,BP,
7645,GO:0032096,1,0.786371614427249,0,6,negative regulation of response to food,BP,
7646,GO:0032097,1,0.962252164035365,0,1,positive regulation of response to food,BP,
7647,GO:0032098,1,0.723695910688282,0,8,regulation of appetite,BP,
7648,GO:0032099,1,0.786371614427249,0,6,negative regulation of appetite,BP,
7649,GO:0032100,1,0.962252164035365,0,1,positive regulation of appetite,BP,
7653,GO:0032104,1,0.562028612845502,0,14,regulation of response to extracellular stimulus,BP,
7654,GO:0032105,1,0.723101797997703,0,8,negative regulation of response to extracellular stimulus,BP,
7655,GO:0032106,1,0.888030626816604,0,3,positive regulation of response to extracellular stimulus,BP,
7656,GO:0032107,1,0.562028612845502,0,14,regulation of response to nutrient levels,BP,
7657,GO:0032108,1,0.723101797997703,0,8,negative regulation of response to nutrient levels,BP,
7658,GO:0032109,1,0.888030626816604,0,3,positive regulation of response to nutrient levels,BP,
7659,GO:0032116,1,0.917021318947511,0,2,SMC loading complex,CC,
7660,GO:0032119,1,0.724811993412978,0,8,sequestering of zinc ion,BP,
7661,GO:0032127,1,0.958170656814958,0,1,dense core granule membrane,CC,
7662,GO:0032129,1,0.921691244631685,0,2,histone deacetylase activity (H3-K9 specific),MF,
7663,GO:0032133,1,0.854042245124062,0,4,chromosome passenger complex,CC,
7665,GO:0032137,1,0.880106338077921,0,3,guanine/thymine mispair binding,MF,
7666,GO:0032138,1,0.840845506781821,0,4,single base insertion or deletion binding,MF,
7667,GO:0032139,1,0.883444172412623,0,3,dinucleotide insertion or deletion binding,MF,
7668,GO:0032142,1,0.876874473217227,0,3,single guanine insertion binding,MF,
7669,GO:0032143,1,0.916686999286711,0,2,single thymine insertion binding,MF,
7670,GO:0032144,1,0.956499496521757,0,1,4-aminobutyrate transaminase complex,CC,
7671,GO:0032145,1,0.956499496521757,0,1,succinate-semialdehyde dehydrogenase binding,MF,
7677,GO:0032156,1,0.648120099049447,0,10,septin cytoskeleton,CC,
7678,GO:0032160,1,0.677418330253467,0,9,septin filament array,CC,
7679,GO:0032173,1,0.958511114545818,0,1,septin collar,CC,
7680,GO:0032181,1,0.916547969472476,0,2,dinucleotide repeat insertion binding,MF,
7682,GO:0032183,1,0.571657698852399,0,13,SUMO binding,MF,
7683,GO:0032184,1,0.840790255628858,0,4,SUMO polymer binding,MF,
7684,GO:0032185,1,0.57097487598568,0,13,septin cytoskeleton organization,BP,
7686,GO:0032194,1,0.957329124230061,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
7687,GO:0032196,1,0.533028743919163,0,15,transposition,BP,
7688,GO:0032197,1,0.95701813027708,0,1,transposition, RNA-mediated,BP,
7690,GO:0032201,1,0.335063045340502,0,27,telomere maintenance via semi-conservative replication,BP,
7691,GO:0032202,1,0.851476875024627,0,4,telomere assembly,BP,
7692,GO:0032203,1,0.962278046052311,0,1,telomere formation via telomerase,BP,
7693,GO:0032204,1,0.0409103056120285,0,76,regulation of telomere maintenance,BP,
7694,GO:0032205,1,0.224123497511016,0,35,negative regulation of telomere maintenance,BP,
7695,GO:0032206,1,0.12985748043375,0,49,positive regulation of telomere maintenance,BP,
7696,GO:0032207,1,0.958769224964552,0,1,regulation of telomere maintenance via recombination,BP,
7697,GO:0032208,1,0.958769224964552,0,1,negative regulation of telomere maintenance via recombination,BP,
7698,GO:0032210,1,0.11866896916029,0,51,regulation of telomere maintenance via telomerase,BP,
7699,GO:0032211,1,0.448176472355167,0,19,negative regulation of telomere maintenance via telomerase,BP,
7700,GO:0032212,1,0.256773523405507,0,33,positive regulation of telomere maintenance via telomerase,BP,
7701,GO:0032213,1,0.91914605848228,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7702,GO:0032214,1,0.91914605848228,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
7703,GO:0032216,1,0.960869341377633,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
7704,GO:0032217,1,0.881379331721532,0,3,riboflavin transmembrane transporter activity,MF,
7705,GO:0032218,1,0.881379331721532,0,3,riboflavin transport,BP,
7706,GO:0032222,1,0.956441843839217,0,1,regulation of synaptic transmission, cholinergic,BP,
7707,GO:0032224,1,0.956441843839217,0,1,positive regulation of synaptic transmission, cholinergic,BP,
7708,GO:0032225,1,0.638399690176913,0,11,regulation of synaptic transmission, dopaminergic,BP,
7709,GO:0032226,1,0.818438121583109,0,5,positive regulation of synaptic transmission, dopaminergic,BP,
7710,GO:0032227,1,0.876803889473927,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
7712,GO:0032229,1,0.922897769107672,0,2,negative regulation of synaptic transmission, GABAergic,BP,
7715,GO:0032232,1,0.54977522041894,0,14,negative regulation of actin filament bundle assembly,BP,
7717,GO:0032237,1,0.87566421507486,0,3,activation of store-operated calcium channel activity,BP,
7718,GO:0032239,1,0.500483046055323,0,16,regulation of nucleobase-containing compound transport,BP,
7719,GO:0032240,1,0.914777322117324,0,2,negative regulation of nucleobase-containing compound transport,BP,
7720,GO:0032241,1,0.740442644972312,0,7,positive regulation of nucleobase-containing compound transport,BP,
7721,GO:0032252,1,0.877112357942041,0,3,secretory granule localization,BP,
7722,GO:0032253,1,0.958787867083198,0,1,dense core granule localization,BP,
7723,GO:0032258,1,0.921619881286631,0,2,protein localization by the Cvt pathway,BP,
7725,GO:0032261,1,0.759134083880745,0,7,purine nucleotide salvage,BP,
7726,GO:0032262,1,0.826699144267236,0,5,pyrimidine nucleotide salvage,BP,
7727,GO:0032263,1,0.927067628945206,0,2,GMP salvage,BP,
7728,GO:0032264,1,0.848971359348205,0,4,IMP salvage,BP,
7736,GO:0032274,1,0.741445802668646,0,7,gonadotropin secretion,BP,
7737,GO:0032275,1,0.806027573056386,0,5,luteinizing hormone secretion,BP,
7738,GO:0032276,1,0.88135092154304,0,3,regulation of gonadotropin secretion,BP,
7739,GO:0032277,1,0.961161759333046,0,1,negative regulation of gonadotropin secretion,BP,
7740,GO:0032278,1,0.88135092154304,0,3,positive regulation of gonadotropin secretion,BP,
7744,GO:0032286,1,0.879338199280267,0,3,central nervous system myelin maintenance,BP,
7748,GO:0032290,1,0.874941618535296,0,3,peripheral nervous system myelin formation,BP,
7751,GO:0032296,1,0.844499768059363,0,4,double-stranded RNA-specific ribonuclease activity,MF,
7752,GO:0032298,1,0.96090356467507,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
7753,GO:0032299,1,0.890903738320788,0,3,ribonuclease H2 complex,CC,
7754,GO:0032300,1,0.598036321935948,0,12,mismatch repair complex,CC,
7755,GO:0032301,1,0.916686999286711,0,2,MutSalpha complex,CC,
7756,GO:0032302,1,0.916547969472476,0,2,MutSbeta complex,CC,
7757,GO:0032303,1,0.691301778052926,0,9,regulation of icosanoid secretion,BP,
7758,GO:0032304,1,0.956478030784591,0,1,negative regulation of icosanoid secretion,BP,
7759,GO:0032305,1,0.722778262489394,0,8,positive regulation of icosanoid secretion,BP,
7760,GO:0032306,1,0.824278739718192,0,5,regulation of prostaglandin secretion,BP,
7761,GO:0032308,1,0.824278739718192,0,5,positive regulation of prostaglandin secretion,BP,
7762,GO:0032309,1,0.491840627854057,0,17,icosanoid secretion,BP,
7763,GO:0032310,1,0.788527612570745,0,6,prostaglandin secretion,BP,
7764,GO:0032311,1,0.928287216213474,0,2,angiogenin-PRI complex,CC,
7765,GO:0032324,1,0.751369614796986,0,7,molybdopterin cofactor biosynthetic process,BP,
7770,GO:0032332,1,0.621874441691656,0,11,positive regulation of chondrocyte differentiation,BP,
7771,GO:0032341,1,0.842036628105556,0,4,aldosterone metabolic process,BP,
7772,GO:0032342,1,0.842036628105556,0,4,aldosterone biosynthetic process,BP,
7773,GO:0032344,1,0.842036628105556,0,4,regulation of aldosterone metabolic process,BP,
7774,GO:0032345,1,0.879839920706303,0,3,negative regulation of aldosterone metabolic process,BP,
7775,GO:0032346,1,0.957044903232465,0,1,positive regulation of aldosterone metabolic process,BP,
7776,GO:0032347,1,0.842036628105556,0,4,regulation of aldosterone biosynthetic process,BP,
7777,GO:0032348,1,0.879839920706303,0,3,negative regulation of aldosterone biosynthetic process,BP,
7778,GO:0032349,1,0.957044903232465,0,1,positive regulation of aldosterone biosynthetic process,BP,
7780,GO:0032351,1,0.740364849006747,0,7,negative regulation of hormone metabolic process,BP,
7781,GO:0032352,1,0.711998684981289,0,8,positive regulation of hormone metabolic process,BP,
7782,GO:0032353,1,0.740364849006747,0,7,negative regulation of hormone biosynthetic process,BP,
7783,GO:0032354,1,0.600467699638243,0,12,response to follicle-stimulating hormone,BP,
7785,GO:0032356,1,0.659754177868995,0,10,oxidized DNA binding,MF,
7786,GO:0032357,1,0.686287059039694,0,9,oxidized purine DNA binding,MF,
7787,GO:0032358,1,0.965138887105781,0,1,oxidized pyrimidine DNA binding,MF,
7788,GO:0032361,1,0.96177026169185,0,1,pyridoxal phosphate catabolic process,BP,
7789,GO:0032364,1,0.812413369692713,0,5,oxygen homeostasis,BP,
7794,GO:0032369,1,0.551170184075404,0,14,negative regulation of lipid transport,BP,
7797,GO:0032372,1,0.846565486597683,0,4,negative regulation of sterol transport,BP,
7800,GO:0032375,1,0.846565486597683,0,4,negative regulation of cholesterol transport,BP,
7803,GO:0032378,1,0.957338170440611,0,1,negative regulation of intracellular lipid transport,BP,
7806,GO:0032381,1,0.957338170440611,0,1,negative regulation of intracellular sterol transport,BP,
7809,GO:0032384,1,0.957338170440611,0,1,negative regulation of intracellular cholesterol transport,BP,
7814,GO:0032389,1,0.743214727559065,0,7,MutLalpha complex,CC,
7815,GO:0032391,1,0.38111073732317,0,23,photoreceptor connecting cilium,CC,
7817,GO:0032393,1,0.928895488564352,0,2,MHC class I receptor activity,MF,
7818,GO:0032395,1,0.895071023448966,0,3,MHC class II receptor activity,MF,
7819,GO:0032397,1,0.963498797201556,0,1,activating MHC class I receptor activity,MF,
7820,GO:0032398,1,0.962872521408737,0,1,MHC class Ib protein complex,CC,
7823,GO:0032402,1,0.439355152132244,0,20,melanosome transport,BP,
7824,GO:0032404,1,0.720937975080974,0,8,mismatch repair complex binding,MF,
7825,GO:0032405,1,0.813769237571885,0,5,MutLalpha complex binding,MF,
7826,GO:0032407,1,0.8159721518726,0,5,MutSalpha complex binding,MF,
7833,GO:0032415,1,0.882502004635352,0,3,regulation of sodium:proton antiporter activity,BP,
7834,GO:0032416,1,0.961763123114709,0,1,negative regulation of sodium:proton antiporter activity,BP,
7835,GO:0032417,1,0.917594001427012,0,2,positive regulation of sodium:proton antiporter activity,BP,
7837,GO:0032419,1,0.960937814011146,0,1,extrinsic component of lysosome membrane,CC,
7840,GO:0032422,1,0.882241863850678,0,3,purine-rich negative regulatory element binding,MF,
7841,GO:0032423,1,0.957657838392433,0,1,regulation of mismatch repair,BP,
7842,GO:0032425,1,0.957657838392433,0,1,positive regulation of mismatch repair,BP,
7844,GO:0032427,1,0.91946852126181,0,2,GBD domain binding,MF,
7845,GO:0032428,1,0.957422721392941,0,1,beta-N-acetylgalactosaminidase activity,MF,
7850,GO:0032433,1,0.595672948399788,0,12,filopodium tip,CC,
7851,GO:0032434,1,0.0121907869632684,0,106,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
7852,GO:0032435,1,0.329186192035828,0,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
7853,GO:0032436,1,0.0523974934747232,0,71,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
7854,GO:0032437,1,0.88127256431805,0,3,cuticular plate,CC,
7856,GO:0032440,1,0.964120576727711,0,1,2-alkenal reductase [NAD(P)] activity,MF,
7857,GO:0032444,1,0.914777292668164,0,2,activin responsive factor complex,CC,
7859,GO:0032447,1,0.960153487129964,0,1,protein urmylation,BP,
7860,GO:0032449,1,0.809207963241456,0,5,CBM complex,CC,
7864,GO:0032453,1,0.767457820531035,0,6,histone demethylase activity (H3-K4 specific),MF,
7870,GO:0032460,1,0.584538382151764,0,13,negative regulation of protein oligomerization,BP,
7873,GO:0032463,1,0.639047497384801,0,11,negative regulation of protein homooligomerization,BP,
7874,GO:0032464,1,0.786012233213179,0,6,positive regulation of protein homooligomerization,BP,
7875,GO:0032465,1,0.0564973407348737,0,68,regulation of cytokinesis,BP,
7876,GO:0032466,1,0.784383909304453,0,6,negative regulation of cytokinesis,BP,
7877,GO:0032467,1,0.346859081218286,0,25,positive regulation of cytokinesis,BP,
7878,GO:0032468,1,0.957538546010165,0,1,Golgi calcium ion homeostasis,BP,
7879,GO:0032469,1,0.43498779761176,0,20,endoplasmic reticulum calcium ion homeostasis,BP,
7880,GO:0032470,1,0.956441843839217,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
7881,GO:0032471,1,0.757224496019373,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
7882,GO:0032472,1,0.921051545378166,0,2,Golgi calcium ion transport,BP,
7888,GO:0032483,1,0.839435784803286,0,4,regulation of Rab protein signal transduction,BP,
7889,GO:0032484,1,0.876291211921621,0,3,Ral protein signal transduction,BP,
7890,GO:0032485,1,0.876291211921621,0,3,regulation of Ral protein signal transduction,BP,
7891,GO:0032486,1,0.570559604830712,0,13,Rap protein signal transduction,BP,
7892,GO:0032487,1,0.875910237817579,0,3,regulation of Rap protein signal transduction,BP,
7895,GO:0032490,1,0.84066153917835,0,4,detection of molecule of bacterial origin,BP,
7896,GO:0032493,1,0.881651952118596,0,3,response to bacterial lipoprotein,BP,
7897,GO:0032494,1,0.808096961995154,0,5,response to peptidoglycan,BP,
7900,GO:0032497,1,0.959392282604984,0,1,detection of lipopolysaccharide,BP,
7901,GO:0032498,1,0.956635663036805,0,1,detection of muramyl dipeptide,BP,
7902,GO:0032499,1,0.956635663036805,0,1,detection of peptidoglycan,BP,
7903,GO:0032500,1,0.956635663036805,0,1,muramyl dipeptide binding,MF,
7911,GO:0032510,1,0.776078160054418,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
7912,GO:0032511,1,0.729340490953149,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
7914,GO:0032516,1,0.550019699557697,0,14,positive regulation of phosphoprotein phosphatase activity,BP,
7915,GO:0032525,1,0.77680315028879,0,6,somite rostral/caudal axis specification,BP,
7918,GO:0032528,1,0.443456940664561,0,19,microvillus organization,BP,
7919,GO:0032530,1,0.651008309688848,0,10,regulation of microvillus organization,BP,
7920,GO:0032532,1,0.845806946786931,0,4,regulation of microvillus length,BP,
7921,GO:0032534,1,0.769758078756131,0,6,regulation of microvillus assembly,BP,
7923,GO:0032536,1,0.746098160507051,0,7,regulation of cell projection size,BP,
7924,GO:0032541,1,0.814933041874837,0,5,cortical endoplasmic reticulum,CC,
7925,GO:0032542,1,0.919051578448693,0,2,sulfiredoxin activity,MF,
7926,GO:0032543,1,0.00693760888945906,0,129,mitochondrial translation,BP,
7927,GO:0032545,1,0.884567912654383,0,3,CURI complex,CC,
7930,GO:0032551,1,0.918031102339929,0,2,pyrimidine ribonucleoside binding,MF,
7931,GO:0032552,1,0.789205656579073,0,6,deoxyribonucleotide binding,MF,
7933,GO:0032554,1,0.850423680686635,0,4,purine deoxyribonucleotide binding,MF,
7935,GO:0032556,1,0.928037756749047,0,2,pyrimidine deoxyribonucleotide binding,MF,
7936,GO:0032557,1,0.882459885814261,0,3,pyrimidine ribonucleotide binding,MF,
7937,GO:0032558,1,0.887654811145048,0,3,adenyl deoxyribonucleotide binding,MF,
7939,GO:0032560,1,0.958066773890521,0,1,guanyl deoxyribonucleotide binding,MF,
7941,GO:0032564,1,0.887654811145048,0,3,dATP binding,MF,
7942,GO:0032567,1,0.958066773890521,0,1,dGTP binding,MF,
7945,GO:0032574,1,0.956987654746954,0,1,5'-3' RNA helicase activity,MF,
7946,GO:0032575,1,0.956987654746954,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
7948,GO:0032581,1,0.962319327276496,0,1,ER-dependent peroxisome organization,BP,
7949,GO:0032584,1,0.879329650952088,0,3,growth cone membrane,CC,
7955,GO:0032591,1,0.768291928052217,0,6,dendritic spine membrane,CC,
7956,GO:0032592,1,0.0721423668268944,0,65,integral component of mitochondrial membrane,CC,
7957,GO:0032593,1,0.783622999833629,0,6,insulin-responsive compartment,CC,
7959,GO:0032595,1,0.961143683422321,0,1,B cell receptor transport within lipid bilayer,BP,
7960,GO:0032596,1,0.815079744961425,0,5,protein transport into membrane raft,BP,
7961,GO:0032597,1,0.961143683422321,0,1,B cell receptor transport into membrane raft,BP,
7962,GO:0032599,1,0.961143683422321,0,1,protein transport out of membrane raft,BP,
7963,GO:0032600,1,0.961143683422321,0,1,chemokine receptor transport out of membrane raft,BP,
7965,GO:0032604,1,0.720704365766828,0,8,granulocyte macrophage colony-stimulating factor production,BP,
7970,GO:0032610,1,0.794217431427486,0,6,interleukin-1 alpha production,BP,
7974,GO:0032615,1,0.269453903397796,0,32,interleukin-12 production,BP,
7975,GO:0032616,1,0.662171635940689,0,10,interleukin-13 production,BP,
7976,GO:0032618,1,0.926786078165606,0,2,interleukin-15 production,BP,
7977,GO:0032620,1,0.595475077461591,0,13,interleukin-17 production,BP,
7978,GO:0032621,1,0.774740771651417,0,6,interleukin-18 production,BP,
7980,GO:0032625,1,0.957444408335267,0,1,interleukin-21 production,BP,
7981,GO:0032627,1,0.847977892582698,0,4,interleukin-23 production,BP,
7982,GO:0032632,1,0.918807841481926,0,2,interleukin-3 production,BP,
7984,GO:0032634,1,0.709122435961238,0,8,interleukin-5 production,BP,
7987,GO:0032639,1,0.962872521408737,0,1,TRAIL production,BP,
7989,GO:0032641,1,0.958277223529834,0,1,lymphotoxin A production,BP,
7991,GO:0032645,1,0.720704365766828,0,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,
7995,GO:0032650,1,0.822473188890918,0,5,regulation of interleukin-1 alpha production,BP,
7999,GO:0032655,1,0.28098367616918,0,31,regulation of interleukin-12 production,BP,
8000,GO:0032656,1,0.686636106841873,0,9,regulation of interleukin-13 production,BP,
8001,GO:0032658,1,0.962528160595372,0,1,regulation of interleukin-15 production,BP,
8002,GO:0032660,1,0.644448063391434,0,11,regulation of interleukin-17 production,BP,
8003,GO:0032661,1,0.80960546782958,0,5,regulation of interleukin-18 production,BP,
8005,GO:0032667,1,0.847977892582698,0,4,regulation of interleukin-23 production,BP,
8006,GO:0032672,1,0.918807841481926,0,2,regulation of interleukin-3 production,BP,
8008,GO:0032674,1,0.709122435961238,0,8,regulation of interleukin-5 production,BP,
8011,GO:0032679,1,0.962872521408737,0,1,regulation of TRAIL production,BP,
8013,GO:0032682,1,0.668130849206876,0,10,negative regulation of chemokine production,BP,
8014,GO:0032685,1,0.957936921872832,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8018,GO:0032690,1,0.963622098166324,0,1,negative regulation of interleukin-1 alpha production,BP,
8021,GO:0032693,1,0.669230427498468,0,10,negative regulation of interleukin-10 production,BP,
8022,GO:0032695,1,0.63596569102092,0,11,negative regulation of interleukin-12 production,BP,
8023,GO:0032696,1,0.881709140242806,0,3,negative regulation of interleukin-13 production,BP,
8024,GO:0032700,1,0.818575793916148,0,5,negative regulation of interleukin-17 production,BP,
8025,GO:0032701,1,0.922519794481553,0,2,negative regulation of interleukin-18 production,BP,
8027,GO:0032707,1,0.96044766226592,0,1,negative regulation of interleukin-23 production,BP,
8028,GO:0032712,1,0.960618270503813,0,1,negative regulation of interleukin-3 production,BP,
8030,GO:0032714,1,0.916691559174034,0,2,negative regulation of interleukin-5 production,BP,
8032,GO:0032717,1,0.615189584259641,0,12,negative regulation of interleukin-8 production,BP,
8035,GO:0032725,1,0.752369397827476,0,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8039,GO:0032730,1,0.853532850232799,0,4,positive regulation of interleukin-1 alpha production,BP,
8043,GO:0032735,1,0.482906843155258,0,18,positive regulation of interleukin-12 production,BP,
8044,GO:0032736,1,0.778806030287233,0,6,positive regulation of interleukin-13 production,BP,
8045,GO:0032738,1,0.962528160595372,0,1,positive regulation of interleukin-15 production,BP,
8046,GO:0032740,1,0.756677333195647,0,7,positive regulation of interleukin-17 production,BP,
8047,GO:0032741,1,0.916114797484125,0,2,positive regulation of interleukin-18 production,BP,
8048,GO:0032743,1,0.452068972411622,0,19,positive regulation of interleukin-2 production,BP,
8049,GO:0032747,1,0.918693859937163,0,2,positive regulation of interleukin-23 production,BP,
8050,GO:0032752,1,0.956479002849494,0,1,positive regulation of interleukin-3 production,BP,
8052,GO:0032754,1,0.773602459116285,0,6,positive regulation of interleukin-5 production,BP,
8055,GO:0032759,1,0.962872521408737,0,1,positive regulation of TRAIL production,BP,
8060,GO:0032765,1,0.958277223529834,0,1,positive regulation of mast cell cytokine production,BP,
8061,GO:0032767,1,0.88430214088019,0,3,copper-dependent protein binding,MF,
8063,GO:0032769,1,0.750642648570166,0,7,negative regulation of monooxygenase activity,BP,
8065,GO:0032771,1,0.956744377951467,0,1,regulation of monophenol monooxygenase activity,BP,
8066,GO:0032773,1,0.956744377951467,0,1,positive regulation of monophenol monooxygenase activity,BP,
8068,GO:0032775,1,0.95729486741685,0,1,DNA methylation on adenine,BP,
8069,GO:0032776,1,0.875711800021663,0,3,DNA methylation on cytosine,BP,
8070,GO:0032777,1,0.849123363739336,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8071,GO:0032780,1,0.75215805060797,0,7,negative regulation of ATPase activity,BP,
8072,GO:0032781,1,0.204081793064862,0,40,positive regulation of ATPase activity,BP,
8073,GO:0032782,1,0.925036856288676,0,2,bile acid secretion,BP,
8074,GO:0032783,1,0.844214720475706,0,4,ELL-EAF complex,CC,
8076,GO:0032785,1,0.631583953241293,0,11,negative regulation of DNA-templated transcription, elongation,BP,
8079,GO:0032788,1,0.963034035118357,0,1,saturated monocarboxylic acid metabolic process,BP,
8080,GO:0032789,1,0.963034035118357,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8081,GO:0032790,1,0.719102576756235,0,8,ribosome disassembly,BP,
8082,GO:0032792,1,0.848437634693639,0,4,negative regulation of CREB transcription factor activity,BP,
8085,GO:0032795,1,0.964569386240867,0,1,heterotrimeric G-protein binding,MF,
8086,GO:0032796,1,0.92109185856133,0,2,uropod organization,BP,
8087,GO:0032797,1,0.636502960060769,0,11,SMN complex,CC,
8088,GO:0032798,1,0.919270839167849,0,2,Swi5-Sfr1 complex,CC,
8096,GO:0032806,1,0.360176036534477,0,25,carboxy-terminal domain protein kinase complex,CC,
8097,GO:0032807,1,0.848407359430158,0,4,DNA ligase IV complex,CC,
8098,GO:0032808,1,0.83873186050999,0,4,lacrimal gland development,BP,
8102,GO:0032814,1,0.481673237057813,0,18,regulation of natural killer cell activation,BP,
8103,GO:0032815,1,0.823556860122861,0,5,negative regulation of natural killer cell activation,BP,
8104,GO:0032816,1,0.61162681224568,0,12,positive regulation of natural killer cell activation,BP,
8105,GO:0032817,1,0.856682857412806,0,4,regulation of natural killer cell proliferation,BP,
8106,GO:0032819,1,0.856682857412806,0,4,positive regulation of natural killer cell proliferation,BP,
8107,GO:0032823,1,0.688604426698633,0,9,regulation of natural killer cell differentiation,BP,
8108,GO:0032824,1,0.964322923966933,0,1,negative regulation of natural killer cell differentiation,BP,
8109,GO:0032825,1,0.74659502711745,0,7,positive regulation of natural killer cell differentiation,BP,
8110,GO:0032826,1,0.964322923966933,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8111,GO:0032827,1,0.964322923966933,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8115,GO:0032839,1,0.395247317190987,0,22,dendrite cytoplasm,CC,
8116,GO:0032847,1,0.921597328988633,0,2,regulation of cellular pH reduction,BP,
8117,GO:0032848,1,0.957101590816272,0,1,negative regulation of cellular pH reduction,BP,
8118,GO:0032849,1,0.962907669111412,0,1,positive regulation of cellular pH reduction,BP,
8125,GO:0032875,1,0.734864241316883,0,7,regulation of DNA endoreduplication,BP,
8126,GO:0032876,1,0.837839371253641,0,4,negative regulation of DNA endoreduplication,BP,
8127,GO:0032877,1,0.915541857437799,0,2,positive regulation of DNA endoreduplication,BP,
8128,GO:0032878,1,0.419574755644638,0,20,regulation of establishment or maintenance of cell polarity,BP,
8134,GO:0032887,1,0.956441843839217,0,1,regulation of spindle elongation,BP,
8135,GO:0032888,1,0.956441843839217,0,1,regulation of mitotic spindle elongation,BP,
8136,GO:0032889,1,0.959907158806317,0,1,regulation of vacuole fusion, non-autophagic,BP,
8138,GO:0032891,1,0.706712121339831,0,8,negative regulation of organic acid transport,BP,
8139,GO:0032892,1,0.586346406980994,0,13,positive regulation of organic acid transport,BP,
8140,GO:0032897,1,0.436254558025303,0,20,negative regulation of viral transcription,BP,
8142,GO:0032899,1,0.957059600671194,0,1,regulation of neurotrophin production,BP,
8143,GO:0032901,1,0.957059600671194,0,1,positive regulation of neurotrophin production,BP,
8146,GO:0032906,1,0.770064763031915,0,6,transforming growth factor beta2 production,BP,
8147,GO:0032907,1,0.879226058150659,0,3,transforming growth factor beta3 production,BP,
8149,GO:0032909,1,0.770064763031915,0,6,regulation of transforming growth factor beta2 production,BP,
8150,GO:0032910,1,0.879226058150659,0,3,regulation of transforming growth factor beta3 production,BP,
8152,GO:0032912,1,0.956744377951467,0,1,negative regulation of transforming growth factor beta2 production,BP,
8153,GO:0032913,1,0.961143683422321,0,1,negative regulation of transforming growth factor beta3 production,BP,
8154,GO:0032914,1,0.884237731766182,0,3,positive regulation of transforming growth factor beta1 production,BP,
8155,GO:0032915,1,0.961353321478271,0,1,positive regulation of transforming growth factor beta2 production,BP,
8156,GO:0032916,1,0.914777292668164,0,2,positive regulation of transforming growth factor beta3 production,BP,
8157,GO:0032917,1,0.930562127826944,0,2,polyamine acetylation,BP,
8158,GO:0032918,1,0.930562127826944,0,2,spermidine acetylation,BP,
8159,GO:0032919,1,0.964847993326817,0,1,spermine acetylation,BP,
8160,GO:0032920,1,0.964847993326817,0,1,putrescine acetylation,BP,
8164,GO:0032926,1,0.747350894240261,0,7,negative regulation of activin receptor signaling pathway,BP,
8167,GO:0032929,1,0.925849274488066,0,2,negative regulation of superoxide anion generation,BP,
8169,GO:0032933,1,0.711739080886311,0,8,SREBP signaling pathway,BP,
8171,GO:0032937,1,0.88080554329039,0,3,SREBP-SCAP-Insig complex,CC,
8179,GO:0032954,1,0.916114031338396,0,2,regulation of cytokinetic process,BP,
8181,GO:0032957,1,0.705287069742391,0,8,inositol trisphosphate metabolic process,BP,
8182,GO:0032958,1,0.480088277498474,0,17,inositol phosphate biosynthetic process,BP,
8183,GO:0032959,1,0.769810433182816,0,6,inositol trisphosphate biosynthetic process,BP,
8184,GO:0032960,1,0.840925523195897,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8185,GO:0032962,1,0.878988961379558,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8189,GO:0032966,1,0.817232887474639,0,5,negative regulation of collagen biosynthetic process,BP,
8193,GO:0032976,1,0.965207538270858,0,1,release of matrix enzymes from mitochondria,BP,
8194,GO:0032977,1,0.956621500750401,0,1,membrane insertase activity,MF,
8195,GO:0032978,1,0.956621500750401,0,1,protein insertion into membrane from inner side,BP,
8196,GO:0032979,1,0.956621500750401,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8197,GO:0032980,1,0.96028227666334,0,1,keratinocyte activation,BP,
8198,GO:0032981,1,0.128451689788437,0,55,mitochondrial respiratory chain complex I assembly,BP,
8199,GO:0032982,1,0.732722478842731,0,7,myosin filament,CC,
8201,GO:0032986,1,0.474818047317425,0,18,protein-DNA complex disassembly,BP,
8202,GO:0032988,1,0.586473813832674,0,13,ribonucleoprotein complex disassembly,BP,
8208,GO:0032996,1,0.962245251855588,0,1,Bcl3-Bcl10 complex,CC,
8211,GO:0033004,1,0.884543570579257,0,3,negative regulation of mast cell activation,BP,
8214,GO:0033007,1,0.884543570579257,0,3,negative regulation of mast cell activation involved in immune response,BP,
8216,GO:0033010,1,0.77643848799132,0,6,paranodal junction,CC,
8219,GO:0033015,1,0.79629585260409,0,6,tetrapyrrole catabolic process,BP,
8220,GO:0033017,1,0.448737747297633,0,19,sarcoplasmic reticulum membrane,CC,
8221,GO:0033018,1,0.921359050574262,0,2,sarcoplasmic reticulum lumen,CC,
8222,GO:0033023,1,0.915740392176029,0,2,mast cell homeostasis,BP,
8223,GO:0033024,1,0.915740392176029,0,2,mast cell apoptotic process,BP,
8224,GO:0033025,1,0.915740392176029,0,2,regulation of mast cell apoptotic process,BP,
8225,GO:0033026,1,0.956446854253897,0,1,negative regulation of mast cell apoptotic process,BP,
8227,GO:0033029,1,0.809720006967518,0,5,regulation of neutrophil apoptotic process,BP,
8228,GO:0033030,1,0.956441843839217,0,1,negative regulation of neutrophil apoptotic process,BP,
8229,GO:0033031,1,0.846609024899405,0,4,positive regulation of neutrophil apoptotic process,BP,
8231,GO:0033033,1,0.721091006772214,0,8,negative regulation of myeloid cell apoptotic process,BP,
8232,GO:0033034,1,0.781398260893333,0,6,positive regulation of myeloid cell apoptotic process,BP,
8234,GO:0033037,1,0.956441845096684,0,1,polysaccharide localization,BP,
8235,GO:0033038,1,0.803840316174191,0,6,bitter taste receptor activity,MF,
8236,GO:0033041,1,0.959796447129613,0,1,sweet taste receptor activity,MF,
8239,GO:0033045,1,0.054706663053966,0,70,regulation of sister chromatid segregation,BP,
8240,GO:0033046,1,0.228072737613545,0,36,negative regulation of sister chromatid segregation,BP,
8241,GO:0033047,1,0.0799436630659937,0,61,regulation of mitotic sister chromatid segregation,BP,
8242,GO:0033048,1,0.248771886895293,0,34,negative regulation of mitotic sister chromatid segregation,BP,
8245,GO:0033061,1,0.6922576018083,0,9,DNA recombinase mediator complex,CC,
8246,GO:0033063,1,0.753087614958005,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8247,GO:0033065,1,0.925969403833172,0,2,Rad51C-XRCC3 complex,CC,
8248,GO:0033076,1,0.962109643726768,0,1,isoquinoline alkaloid metabolic process,BP,
8250,GO:0033078,1,0.920891265230129,0,2,extrathymic T cell differentiation,BP,
8254,GO:0033082,1,0.956499395480031,0,1,regulation of extrathymic T cell differentiation,BP,
8261,GO:0033091,1,0.959693860257137,0,1,positive regulation of immature T cell proliferation,BP,
8262,GO:0033093,1,0.843674020311995,0,4,Weibel-Palade body,CC,
8263,GO:0033106,1,0.925208765212491,0,2,cis-Golgi network membrane,CC,
8264,GO:0033108,1,0.0327765435106194,0,89,mitochondrial respiratory chain complex assembly,BP,
8266,GO:0033119,1,0.405053778929802,0,22,negative regulation of RNA splicing,BP,
8268,GO:0033121,1,0.87706088323269,0,3,regulation of purine nucleotide catabolic process,BP,
8269,GO:0033122,1,0.917011116500683,0,2,negative regulation of purine nucleotide catabolic process,BP,
8270,GO:0033123,1,0.956441843839217,0,1,positive regulation of purine nucleotide catabolic process,BP,
8272,GO:0033128,1,0.923145569264865,0,2,negative regulation of histone phosphorylation,BP,
8274,GO:0033130,1,0.772138323106842,0,6,acetylcholine receptor binding,MF,
8275,GO:0033131,1,0.785283017792099,0,6,regulation of glucokinase activity,BP,
8276,GO:0033132,1,0.923156441648159,0,2,negative regulation of glucokinase activity,BP,
8277,GO:0033133,1,0.850672566690554,0,4,positive regulation of glucokinase activity,BP,
8281,GO:0033139,1,0.784999335022887,0,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8282,GO:0033140,1,0.922886951017919,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8283,GO:0033141,1,0.850613665896771,0,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8284,GO:0033142,1,0.961089464737262,0,1,progesterone receptor binding,MF,
8287,GO:0033145,1,0.589355030729099,0,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8288,GO:0033146,1,0.257303445240996,0,32,regulation of intracellular estrogen receptor signaling pathway,BP,
8289,GO:0033147,1,0.651413871713884,0,10,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8290,GO:0033148,1,0.714074195081387,0,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8291,GO:0033149,1,0.915596823218541,0,2,FFAT motif binding,MF,
8292,GO:0033151,1,0.598862240835087,0,12,V(D)J recombination,BP,
8293,GO:0033152,1,0.844173209658552,0,4,immunoglobulin V(D)J recombination,BP,
8294,GO:0033153,1,0.803731077712775,0,5,T cell receptor V(D)J recombination,BP,
8296,GO:0033158,1,0.512169238289966,0,16,regulation of protein import into nucleus, translocation,BP,
8297,GO:0033159,1,0.879456000714048,0,3,negative regulation of protein import into nucleus, translocation,BP,
8298,GO:0033160,1,0.681537502543078,0,9,positive regulation of protein import into nucleus, translocation,BP,
8299,GO:0033162,1,0.793891319008883,0,6,melanosome membrane,CC,
8300,GO:0033167,1,0.956441843839217,0,1,ARC complex,CC,
8301,GO:0033168,1,0.956441843839217,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8303,GO:0033170,1,0.724342789776859,0,8,protein-DNA loading ATPase activity,MF,
8307,GO:0033178,1,0.670901467680151,0,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8309,GO:0033180,1,0.723676298255314,0,8,proton-transporting V-type ATPase, V1 domain,CC,
8310,GO:0033181,1,0.962891714305282,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
8311,GO:0033182,1,0.65319461728155,0,10,regulation of histone ubiquitination,BP,
8312,GO:0033183,1,0.878494070778718,0,3,negative regulation of histone ubiquitination,BP,
8313,GO:0033184,1,0.805938667876671,0,5,positive regulation of histone ubiquitination,BP,
8314,GO:0033185,1,0.897621685054924,0,3,dolichol-phosphate-mannose synthase complex,CC,
8315,GO:0033186,1,0.880089430669533,0,3,CAF-1 complex,CC,
8316,GO:0033188,1,0.882000853135811,0,3,sphingomyelin synthase activity,MF,
8317,GO:0033189,1,0.636278101034695,0,11,response to vitamin A,BP,
8318,GO:0033192,1,0.805792256269309,0,5,calmodulin-dependent protein phosphatase activity,MF,
8320,GO:0033197,1,0.640437611526409,0,11,response to vitamin E,BP,
8321,GO:0033198,1,0.476538060554854,0,18,response to ATP,BP,
8322,GO:0033202,1,0.553455343261186,0,15,DNA helicase complex,CC,
8323,GO:0033204,1,0.960051825718286,0,1,ribonuclease P RNA binding,MF,
8324,GO:0033206,1,0.841135901731861,0,4,meiotic cytokinesis,BP,
8326,GO:0033210,1,0.743804290990777,0,7,leptin-mediated signaling pathway,BP,
8328,GO:0033216,1,0.809133137456612,0,5,ferric iron import,BP,
8330,GO:0033220,1,0.841012787674639,0,4,amide-transporting ATPase activity,MF,
8331,GO:0033227,1,0.882748005250634,0,3,dsRNA transport,BP,
8332,GO:0033233,1,0.439378545431317,0,20,regulation of protein sumoylation,BP,
8333,GO:0033234,1,0.65965871369616,0,10,negative regulation of protein sumoylation,BP,
8334,GO:0033235,1,0.666669492570878,0,10,positive regulation of protein sumoylation,BP,
8335,GO:0033238,1,0.101521349327727,0,59,regulation of cellular amine metabolic process,BP,
8336,GO:0033239,1,0.842140850922499,0,4,negative regulation of cellular amine metabolic process,BP,
8337,GO:0033240,1,0.755465027101498,0,7,positive regulation of cellular amine metabolic process,BP,
8338,GO:0033241,1,0.956441843839217,0,1,regulation of cellular amine catabolic process,BP,
8339,GO:0033242,1,0.956441843839217,0,1,negative regulation of cellular amine catabolic process,BP,
8340,GO:0033256,1,0.752081609295691,0,7,I-kappaB/NF-kappaB complex,CC,
8341,GO:0033257,1,0.922170705585802,0,2,Bcl3/NF-kappaB2 complex,CC,
8344,GO:0033263,1,0.839300312541047,0,4,CORVET complex,CC,
8345,GO:0033265,1,0.921162518810214,0,2,choline binding,MF,
8348,GO:0033269,1,0.919396747609451,0,2,internode region of axon,CC,
8352,GO:0033275,1,0.568566355768023,0,14,actin-myosin filament sliding,BP,
8353,GO:0033276,1,0.564120662986419,0,14,transcription factor TFTC complex,CC,
8354,GO:0033277,1,0.918995080208412,0,2,abortive mitotic cell cycle,BP,
8355,GO:0033278,1,0.839908965268516,0,4,cell proliferation in midbrain,BP,
8357,GO:0033283,1,0.957478695870549,0,1,organic acid-transporting ATPase activity,MF,
8358,GO:0033284,1,0.957478695870549,0,1,carboxylic acid-transporting ATPase activity,MF,
8359,GO:0033285,1,0.957478695870549,0,1,monocarboxylic acid-transporting ATPase activity,MF,
8360,GO:0033290,1,0.956823740907682,0,1,eukaryotic 48S preinitiation complex,CC,
8361,GO:0033291,1,0.966149511956646,0,1,eukaryotic 80S initiation complex,CC,
8362,GO:0033292,1,0.914777292668164,0,2,T-tubule organization,BP,
8364,GO:0033299,1,0.817366469932832,0,5,secretion of lysosomal enzymes,BP,
8366,GO:0033301,1,0.957241158658612,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8367,GO:0033306,1,0.921012471065368,0,2,phytol metabolic process,BP,
8368,GO:0033313,1,0.810713745463638,0,5,meiotic cell cycle checkpoint,BP,
8369,GO:0033314,1,0.719199476162743,0,8,mitotic DNA replication checkpoint,BP,
8370,GO:0033316,1,0.958436723289691,0,1,meiotic spindle assembly checkpoint,BP,
8371,GO:0033319,1,0.961443556457944,0,1,UDP-D-xylose metabolic process,BP,
8372,GO:0033320,1,0.961443556457944,0,1,UDP-D-xylose biosynthetic process,BP,
8373,GO:0033326,1,0.956498791708117,0,1,cerebrospinal fluid secretion,BP,
8374,GO:0033327,1,0.774879020501617,0,6,Leydig cell differentiation,BP,
8375,GO:0033328,1,0.957373041760869,0,1,peroxisome membrane targeting sequence binding,MF,
8376,GO:0033341,1,0.918095178884505,0,2,regulation of collagen binding,BP,
8377,GO:0033342,1,0.959910536630346,0,1,negative regulation of collagen binding,BP,
8378,GO:0033343,1,0.956441843839217,0,1,positive regulation of collagen binding,BP,
8380,GO:0033353,1,0.842279192391822,0,4,S-adenosylmethionine cycle,BP,
8382,GO:0033364,1,0.956441843839217,0,1,mast cell secretory granule organization,BP,
8384,GO:0033383,1,0.923968509693509,0,2,geranyl diphosphate metabolic process,BP,
8385,GO:0033384,1,0.923968509693509,0,2,geranyl diphosphate biosynthetic process,BP,
8386,GO:0033385,1,0.959011739105061,0,1,geranylgeranyl diphosphate metabolic process,BP,
8387,GO:0033386,1,0.959011739105061,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8388,GO:0033387,1,0.882019455835234,0,3,putrescine biosynthetic process from ornithine,BP,
8389,GO:0033388,1,0.961064169833123,0,1,putrescine biosynthetic process from arginine,BP,
8390,GO:0033391,1,0.77028009439649,0,6,chromatoid body,CC,
8391,GO:0033477,1,0.961798792450768,0,1,S-methylmethionine metabolic process,BP,
8392,GO:0033483,1,0.719366743907087,0,8,gas homeostasis,BP,
8393,GO:0033484,1,0.885514735286851,0,3,nitric oxide homeostasis,BP,
8394,GO:0033488,1,0.95833572972433,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
8395,GO:0033489,1,0.848772399530865,0,4,cholesterol biosynthetic process via desmosterol,BP,
8396,GO:0033490,1,0.848772399530865,0,4,cholesterol biosynthetic process via lathosterol,BP,
8397,GO:0033499,1,0.925377017235343,0,2,galactose catabolic process via UDP-galactose,BP,
8399,GO:0033503,1,0.845625552190925,0,4,HULC complex,CC,
8402,GO:0033512,1,0.881322240942626,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8404,GO:0033523,1,0.603018971415895,0,12,histone H2B ubiquitination,BP,
8405,GO:0033526,1,0.959314746291732,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
8406,GO:0033539,1,0.612876379685795,0,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
8408,GO:0033549,1,0.585983438145955,0,13,MAP kinase phosphatase activity,MF,
8409,GO:0033552,1,0.959697146982428,0,1,response to vitamin B3,BP,
8410,GO:0033553,1,0.845511381568077,0,4,rDNA heterochromatin,CC,
8413,GO:0033557,1,0.881379331721532,0,3,Slx1-Slx4 complex,CC,
8414,GO:0033558,1,0.163853592791224,0,43,protein deacetylase activity,MF,
8416,GO:0033560,1,0.957030454424487,0,1,folate reductase activity,MF,
8418,GO:0033564,1,0.914816490320093,0,2,anterior/posterior axon guidance,BP,
8419,GO:0033565,1,0.878946374682974,0,3,ESCRT-0 complex,CC,
8420,GO:0033566,1,0.920697069252471,0,2,gamma-tubulin complex localization,BP,
8421,GO:0033567,1,0.818084371894312,0,5,DNA replication, Okazaki fragment processing,BP,
8422,GO:0033570,1,0.956462433765706,0,1,transferrin transmembrane transporter activity,MF,
8424,GO:0033574,1,0.271244386999281,0,32,response to testosterone,BP,
8425,GO:0033577,1,0.920279311167482,0,2,protein glycosylation in endoplasmic reticulum,BP,
8427,GO:0033588,1,0.814284161915741,0,5,Elongator holoenzyme complex,CC,
8429,GO:0033591,1,0.849466939115045,0,4,response to L-ascorbic acid,BP,
8430,GO:0033592,1,0.806152826974577,0,5,RNA strand annealing activity,MF,
8431,GO:0033593,1,0.956441843839217,0,1,BRCA2-MAGE-D1 complex,CC,
8433,GO:0033596,1,0.875814486021073,0,3,TSC1-TSC2 complex,CC,
8434,GO:0033597,1,0.96122502799926,0,1,mitotic checkpoint complex,CC,
8435,GO:0033598,1,0.351621868498183,0,25,mammary gland epithelial cell proliferation,BP,
8436,GO:0033599,1,0.494353116266028,0,17,regulation of mammary gland epithelial cell proliferation,BP,
8437,GO:0033600,1,0.84477141419372,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
8438,GO:0033601,1,0.709668638455597,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
8439,GO:0033602,1,0.956499496521757,0,1,negative regulation of dopamine secretion,BP,
8440,GO:0033603,1,0.886002988003562,0,3,positive regulation of dopamine secretion,BP,
8441,GO:0033604,1,0.916586001797662,0,2,negative regulation of catecholamine secretion,BP,
8442,GO:0033605,1,0.814897542876463,0,5,positive regulation of catecholamine secretion,BP,
8443,GO:0033606,1,0.961143683422321,0,1,chemokine receptor transport within lipid bilayer,BP,
8445,GO:0033609,1,0.958787867083198,0,1,oxalate metabolic process,BP,
8446,GO:0033612,1,0.634509773839785,0,11,receptor serine/threonine kinase binding,MF,
8448,GO:0033615,1,0.885744342536554,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
8449,GO:0033617,1,0.449358186298288,0,20,mitochondrial respiratory chain complex IV assembly,BP,
8451,GO:0033622,1,0.621864276023777,0,11,integrin activation,BP,
8452,GO:0033623,1,0.771252022813798,0,6,regulation of integrin activation,BP,
8453,GO:0033624,1,0.915959257743647,0,2,negative regulation of integrin activation,BP,
8454,GO:0033625,1,0.917469192820342,0,2,positive regulation of integrin activation,BP,
8456,GO:0033628,1,0.328092421859775,0,27,regulation of cell adhesion mediated by integrin,BP,
8457,GO:0033629,1,0.745655616339852,0,7,negative regulation of cell adhesion mediated by integrin,BP,
8458,GO:0033630,1,0.608581181469325,0,12,positive regulation of cell adhesion mediated by integrin,BP,
8459,GO:0033631,1,0.68291593604266,0,9,cell-cell adhesion mediated by integrin,BP,
8460,GO:0033632,1,0.814680430374023,0,5,regulation of cell-cell adhesion mediated by integrin,BP,
8461,GO:0033633,1,0.956513898100226,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
8462,GO:0033634,1,0.884179098112951,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
8463,GO:0033643,1,0.680137557356204,0,9,host cell part,CC,
8464,GO:0033644,1,0.956808261360976,0,1,host cell membrane,CC,
8465,GO:0033646,1,0.743176253384677,0,7,host intracellular part,CC,
8466,GO:0033647,1,0.810390903717167,0,5,host intracellular organelle,CC,
8467,GO:0033648,1,0.810390903717167,0,5,host intracellular membrane-bounded organelle,CC,
8468,GO:0033650,1,0.962631511008888,0,1,host cell mitochondrion,CC,
8469,GO:0033655,1,0.845403513033032,0,4,host cell cytoplasm part,CC,
8470,GO:0033668,1,0.849895708942683,0,4,negative regulation by symbiont of host apoptotic process,BP,
8473,GO:0033676,1,0.963693591033482,0,1,double-stranded DNA-dependent ATPase activity,MF,
8474,GO:0033677,1,0.880398288474948,0,3,DNA/RNA helicase activity,MF,
8475,GO:0033678,1,0.959455159401334,0,1,5'-3' DNA/RNA helicase activity,MF,
8476,GO:0033679,1,0.956580991138864,0,1,3'-5' DNA/RNA helicase activity,MF,
8477,GO:0033680,1,0.917793115982084,0,2,ATP-dependent DNA/RNA helicase activity,MF,
8478,GO:0033681,1,0.956580991138864,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8479,GO:0033682,1,0.959455159401334,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
8481,GO:0033684,1,0.916970651184786,0,2,regulation of luteinizing hormone secretion,BP,
8482,GO:0033686,1,0.916970651184786,0,2,positive regulation of luteinizing hormone secretion,BP,
8486,GO:0033690,1,0.775265088529117,0,6,positive regulation of osteoblast proliferation,BP,
8487,GO:0033691,1,0.915204466392495,0,2,sialic acid binding,MF,
8489,GO:0033693,1,0.878708130949343,0,3,neurofilament bundle assembly,BP,
8490,GO:0033699,1,0.961702355394599,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
8492,GO:0033737,1,0.959974959431182,0,1,1-pyrroline dehydrogenase activity,MF,
8495,GO:0033746,1,0.957364396235892,0,1,histone demethylase activity (H3-R2 specific),MF,
8496,GO:0033749,1,0.957364396235892,0,1,histone demethylase activity (H4-R3 specific),MF,
8497,GO:0033750,1,0.599916817044739,0,13,ribosome localization,BP,
8498,GO:0033754,1,0.963207223515115,0,1,indoleamine 2,3-dioxygenase activity,MF,
8501,GO:0033765,1,0.92188555446637,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
8502,GO:0033768,1,0.918723876443674,0,2,SUMO-targeted ubiquitin ligase complex,CC,
8503,GO:0033787,1,0.958910370595393,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8504,GO:0033814,1,0.96365364851103,0,1,propanoyl-CoA C-acyltransferase activity,MF,
8505,GO:0033823,1,0.958536775057315,0,1,procollagen glucosyltransferase activity,MF,
8506,GO:0033829,1,0.88937605224149,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
8507,GO:0033842,1,0.916993152815545,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
8508,GO:0033857,1,0.914786712790936,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
8509,GO:0033858,1,0.958129566486896,0,1,N-acetylgalactosamine kinase activity,MF,
8511,GO:0033862,1,0.958544150054087,0,1,UMP kinase activity,MF,
8513,GO:0033865,1,0.263601491587228,0,33,nucleoside bisphosphate metabolic process,BP,
8514,GO:0033866,1,0.523117004550912,0,16,nucleoside bisphosphate biosynthetic process,BP,
8515,GO:0033867,1,0.962980604429223,0,1,Fas-activated serine/threonine kinase activity,MF,
8516,GO:0033869,1,0.964734502232411,0,1,nucleoside bisphosphate catabolic process,BP,
8517,GO:0033871,1,0.961965560697168,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
8518,GO:0033872,1,0.961673706468697,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
8519,GO:0033875,1,0.263601491587228,0,33,ribonucleoside bisphosphate metabolic process,BP,
8520,GO:0033878,1,0.957140183552993,0,1,hormone-sensitive lipase activity,MF,
8521,GO:0033882,1,0.96436678056198,0,1,choloyl-CoA hydrolase activity,MF,
8522,GO:0033883,1,0.927585015176784,0,2,pyridoxal phosphatase activity,MF,
8523,GO:0033885,1,0.961028045423662,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
8524,GO:0033897,1,0.964125911188893,0,1,ribonuclease T2 activity,MF,
8525,GO:0033906,1,0.924491567735063,0,2,hyaluronoglucuronidase activity,MF,
8526,GO:0033919,1,0.95704199370308,0,1,glucan 1,3-alpha-glucosidase activity,MF,
8527,GO:0033925,1,0.956633402815242,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
8528,GO:0033961,1,0.962646397415607,0,1,cis-stilbene-oxide hydrolase activity,MF,
8529,GO:0033962,1,0.461456233615999,0,18,cytoplasmic mRNA processing body assembly,BP,
8530,GO:0033967,1,0.964341017540768,0,1,box C/D snoRNA metabolic process,BP,
8531,GO:0033979,1,0.959731749686441,0,1,box H/ACA snoRNA metabolic process,BP,
8532,GO:0033981,1,0.965578906685504,0,1,D-dopachrome decarboxylase activity,MF,
8533,GO:0033989,1,0.959370451717241,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
8535,GO:0034012,1,0.958787867083198,0,1,FAD-AMP lyase (cyclizing) activity,MF,
8536,GO:0034014,1,0.960734563591107,0,1,response to triglyceride,BP,
8537,GO:0034030,1,0.523117004550912,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
8538,GO:0034031,1,0.964734502232411,0,1,ribonucleoside bisphosphate catabolic process,BP,
8539,GO:0034032,1,0.263601491587228,0,33,purine nucleoside bisphosphate metabolic process,BP,
8540,GO:0034033,1,0.523117004550912,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
8541,GO:0034034,1,0.964734502232411,0,1,purine nucleoside bisphosphate catabolic process,BP,
8542,GO:0034035,1,0.484634944247922,0,18,purine ribonucleoside bisphosphate metabolic process,BP,
8543,GO:0034036,1,0.778016751279417,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8544,GO:0034038,1,0.964291791553133,0,1,deoxyhypusine synthase activity,MF,
8545,GO:0034039,1,0.925831853824836,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
8546,GO:0034040,1,0.877801773207444,0,3,lipid-transporting ATPase activity,MF,
8547,GO:0034041,1,0.958547844808964,0,1,sterol-transporting ATPase activity,MF,
8549,GO:0034046,1,0.740667317052114,0,7,poly(G) binding,MF,
8550,GO:0034056,1,0.878807907003742,0,3,estrogen response element binding,MF,
8551,GO:0034057,1,0.918582506848292,0,2,RNA strand-exchange activity,MF,
8552,GO:0034058,1,0.64785411340111,0,10,endosomal vesicle fusion,BP,
8553,GO:0034059,1,0.878923913788428,0,3,response to anoxia,BP,
8554,GO:0034061,1,0.245094905332808,0,34,DNA polymerase activity,MF,
8555,GO:0034062,1,0.180273362054759,0,43,5'-3' RNA polymerase activity,MF,
8556,GO:0034063,1,0.569552931975554,0,13,stress granule assembly,BP,
8557,GO:0034066,1,0.924260182247058,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
8559,GO:0034080,1,0.216996821527685,0,40,CENP-A containing nucleosome assembly,BP,
8560,GO:0034085,1,0.743514993785241,0,7,establishment of sister chromatid cohesion,BP,
8561,GO:0034086,1,0.606663221244476,0,12,maintenance of sister chromatid cohesion,BP,
8562,GO:0034087,1,0.915720845759018,0,2,establishment of mitotic sister chromatid cohesion,BP,
8563,GO:0034088,1,0.606663221244476,0,12,maintenance of mitotic sister chromatid cohesion,BP,
8564,GO:0034091,1,0.719940220321356,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8565,GO:0034092,1,0.88278607117648,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8566,GO:0034093,1,0.815574425755208,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8568,GO:0034098,1,0.681461320661894,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
8577,GO:0034113,1,0.292763683454519,0,29,heterotypic cell-cell adhesion,BP,
8578,GO:0034114,1,0.587259434666351,0,13,regulation of heterotypic cell-cell adhesion,BP,
8579,GO:0034115,1,0.753411063438121,0,7,negative regulation of heterotypic cell-cell adhesion,BP,
8580,GO:0034116,1,0.750745397355393,0,7,positive regulation of heterotypic cell-cell adhesion,BP,
8581,GO:0034117,1,0.965768149912146,0,1,erythrocyte aggregation,BP,
8582,GO:0034118,1,0.965768149912146,0,1,regulation of erythrocyte aggregation,BP,
8583,GO:0034120,1,0.965768149912146,0,1,positive regulation of erythrocyte aggregation,BP,
8587,GO:0034124,1,0.920931089071705,0,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
8588,GO:0034127,1,0.810771030371766,0,5,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
8589,GO:0034128,1,0.842932111806579,0,4,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
8597,GO:0034141,1,0.780185487996535,0,6,positive regulation of toll-like receptor 3 signaling pathway,BP,
8601,GO:0034145,1,0.780188327005112,0,6,positive regulation of toll-like receptor 4 signaling pathway,BP,
8605,GO:0034150,1,0.956441843839217,0,1,toll-like receptor 6 signaling pathway,BP,
8606,GO:0034154,1,0.845123234210726,0,4,toll-like receptor 7 signaling pathway,BP,
8607,GO:0034155,1,0.95751905902603,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
8608,GO:0034157,1,0.95751905902603,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
8612,GO:0034165,1,0.916972109008331,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
8613,GO:0034166,1,0.957854804277275,0,1,toll-like receptor 10 signaling pathway,BP,
8614,GO:0034182,1,0.719940220321356,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
8615,GO:0034183,1,0.88278607117648,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
8616,GO:0034184,1,0.815574425755208,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
8617,GO:0034185,1,0.596203978699496,0,12,apolipoprotein binding,MF,
8618,GO:0034186,1,0.849593851264778,0,4,apolipoprotein A-I binding,MF,
8619,GO:0034188,1,0.914777292668164,0,2,apolipoprotein A-I receptor activity,MF,
8620,GO:0034189,1,0.916537752396877,0,2,very-low-density lipoprotein particle binding,MF,
8621,GO:0034190,1,0.846205094340526,0,4,apolipoprotein receptor binding,MF,
8622,GO:0034191,1,0.883924241954168,0,3,apolipoprotein A-I receptor binding,MF,
8623,GO:0034196,1,0.959677449806295,0,1,acylglycerol transport,BP,
8624,GO:0034197,1,0.959677449806295,0,1,triglyceride transport,BP,
8626,GO:0034199,1,0.648616090002982,0,10,activation of protein kinase A activity,BP,
8628,GO:0034203,1,0.956469472644329,0,1,glycolipid translocation,BP,
8631,GO:0034212,1,0.0806996854373471,0,60,peptide N-acetyltransferase activity,MF,
8632,GO:0034213,1,0.963280149525521,0,1,quinolinate catabolic process,BP,
8633,GO:0034214,1,0.741220147228882,0,7,protein hexamerization,BP,
8636,GO:0034224,1,0.960881946735522,0,1,cellular response to zinc ion starvation,BP,
8637,GO:0034227,1,0.823469609197367,0,5,tRNA thio-modification,BP,
8638,GO:0034235,1,0.815183130172264,0,5,GPI anchor binding,MF,
8639,GO:0034236,1,0.633273910060311,0,11,protein kinase A catalytic subunit binding,MF,
8640,GO:0034237,1,0.523121184511025,0,15,protein kinase A regulatory subunit binding,MF,
8641,GO:0034238,1,0.956966201529193,0,1,macrophage fusion,BP,
8642,GO:0034239,1,0.956966201529193,0,1,regulation of macrophage fusion,BP,
8643,GO:0034241,1,0.956966201529193,0,1,positive regulation of macrophage fusion,BP,
8644,GO:0034242,1,0.920016886026457,0,2,negative regulation of syncytium formation by plasma membrane fusion,BP,
8646,GO:0034244,1,0.659826759855444,0,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
8647,GO:0034245,1,0.957133730239444,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
8648,GO:0034247,1,0.964015689650189,0,1,snoRNA splicing,BP,
8653,GO:0034271,1,0.881064398592974,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8654,GO:0034272,1,0.881064398592974,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
8655,GO:0034274,1,0.876644896708552,0,3,Atg12-Atg5-Atg16 complex,CC,
8656,GO:0034275,1,0.963207223515115,0,1,kynurenic acid metabolic process,BP,
8657,GO:0034276,1,0.963207223515115,0,1,kynurenic acid biosynthetic process,BP,
8659,GO:0034285,1,0.879764564168312,0,3,response to disaccharide,BP,
8661,GO:0034309,1,0.96492184451589,0,1,primary alcohol biosynthetic process,BP,
8663,GO:0034311,1,0.509150927625683,0,17,diol metabolic process,BP,
8664,GO:0034312,1,0.551303940599277,0,15,diol biosynthetic process,BP,
8665,GO:0034314,1,0.303347523455075,0,29,Arp2/3 complex-mediated actin nucleation,BP,
8666,GO:0034315,1,0.552647128930563,0,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,
8667,GO:0034316,1,0.846604771714356,0,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
8673,GO:0034334,1,0.840061742492508,0,4,adherens junction maintenance,BP,
8674,GO:0034338,1,0.881863599859969,0,3,short-chain carboxylesterase activity,MF,
8677,GO:0034342,1,0.921703054367984,0,2,response to type III interferon,BP,
8678,GO:0034343,1,0.877923532677519,0,3,type III interferon production,BP,
8679,GO:0034344,1,0.877923532677519,0,3,regulation of type III interferon production,BP,
8680,GO:0034346,1,0.958419029815047,0,1,positive regulation of type III interferon production,BP,
8681,GO:0034349,1,0.576139370807309,0,13,glial cell apoptotic process,BP,
8682,GO:0034350,1,0.74213089504295,0,7,regulation of glial cell apoptotic process,BP,
8683,GO:0034351,1,0.74213089504295,0,7,negative regulation of glial cell apoptotic process,BP,
8684,GO:0034353,1,0.958787867083198,0,1,RNA pyrophosphohydrolase activity,MF,
8685,GO:0034355,1,0.958787867083198,0,1,NAD salvage,BP,
8686,GO:0034356,1,0.65722209642741,0,10,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
8693,GO:0034366,1,0.958913145680909,0,1,spherical high-density lipoprotein particle,CC,
8704,GO:0034379,1,0.782040386578034,0,6,very-low-density lipoprotein particle assembly,BP,
8711,GO:0034386,1,0.956499496521757,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
8712,GO:0034388,1,0.778388870129519,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
8713,GO:0034389,1,0.53950022212307,0,15,lipid particle organization,BP,
8714,GO:0034390,1,0.5804917727552,0,13,smooth muscle cell apoptotic process,BP,
8715,GO:0034391,1,0.5804917727552,0,13,regulation of smooth muscle cell apoptotic process,BP,
8716,GO:0034392,1,0.884701428727216,0,3,negative regulation of smooth muscle cell apoptotic process,BP,
8717,GO:0034393,1,0.685646965082987,0,9,positive regulation of smooth muscle cell apoptotic process,BP,
8719,GO:0034395,1,0.963274101611233,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
8723,GO:0034402,1,0.918768729039817,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
8726,GO:0034414,1,0.919746524237093,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
8727,GO:0034416,1,0.919388303544314,0,2,bisphosphoglycerate phosphatase activity,MF,
8728,GO:0034417,1,0.958910370595393,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
8729,GO:0034418,1,0.923042263360504,0,2,urate biosynthetic process,BP,
8730,GO:0034421,1,0.880295345376754,0,3,post-translational protein acetylation,BP,
8731,GO:0034423,1,0.959550820181101,0,1,autophagosome lumen,CC,
8732,GO:0034427,1,0.68118081683061,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8733,GO:0034431,1,0.851608970642098,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8734,GO:0034432,1,0.851608970642098,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
8738,GO:0034436,1,0.885374114250987,0,3,glycoprotein transport,BP,
8739,GO:0034437,1,0.917695973348392,0,2,glycoprotein transporter activity,MF,
8741,GO:0034441,1,0.962475983928828,0,1,plasma lipoprotein particle oxidation,BP,
8744,GO:0034448,1,0.858372626793839,0,4,EGO complex,CC,
8745,GO:0034450,1,0.60651498121949,0,12,ubiquitin-ubiquitin ligase activity,MF,
8746,GO:0034451,1,0.389051528567772,0,22,centriolar satellite,CC,
8747,GO:0034452,1,0.648326482106342,0,10,dynactin binding,MF,
8748,GO:0034453,1,0.372360749378222,0,23,microtubule anchoring,BP,
8749,GO:0034454,1,0.674834591632961,0,9,microtubule anchoring at centrosome,BP,
8750,GO:0034455,1,0.88043366606345,0,3,t-UTP complex,CC,
8751,GO:0034456,1,0.884567912654383,0,3,UTP-C complex,CC,
8752,GO:0034457,1,0.892884894743036,0,3,Mpp10 complex,CC,
8753,GO:0034458,1,0.918362283955434,0,2,3'-5' RNA helicase activity,MF,
8754,GO:0034459,1,0.956580991138864,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
8755,GO:0034462,1,0.960876543965003,0,1,small-subunit processome assembly,BP,
8756,GO:0034463,1,0.966149511956646,0,1,90S preribosome assembly,BP,
8757,GO:0034464,1,0.687861486752616,0,9,BBSome,CC,
8758,GO:0034465,1,0.850776990602262,0,4,response to carbon monoxide,BP,
8760,GO:0034471,1,0.470004381497575,0,19,ncRNA 5'-end processing,BP,
8761,GO:0034472,1,0.573497031780087,0,14,snRNA 3'-end processing,BP,
8762,GO:0034473,1,0.895014116581459,0,3,U1 snRNA 3'-end processing,BP,
8763,GO:0034474,1,0.956441843839217,0,1,U2 snRNA 3'-end processing,BP,
8764,GO:0034475,1,0.743564855560713,0,8,U4 snRNA 3'-end processing,BP,
8765,GO:0034476,1,0.895014116581459,0,3,U5 snRNA 3'-end processing,BP,
8766,GO:0034477,1,0.958787867083198,0,1,U6 snRNA 3'-end processing,BP,
8767,GO:0034481,1,0.844994231727009,0,4,chondroitin sulfotransferase activity,MF,
8768,GO:0034483,1,0.713372276466831,0,8,heparan sulfate sulfotransferase activity,MF,
8769,GO:0034485,1,0.842257631058863,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
8771,GO:0034498,1,0.716665125406167,0,8,early endosome to Golgi transport,BP,
8772,GO:0034499,1,0.914854612853394,0,2,late endosome to Golgi transport,BP,
8773,GO:0034501,1,0.519389068313391,0,16,protein localization to kinetochore,BP,
8774,GO:0034502,1,0.0512125246927696,0,72,protein localization to chromosome,BP,
8777,GO:0034506,1,0.956931729370711,0,1,chromosome, centromeric core domain,CC,
8778,GO:0034508,1,0.141415835620505,0,50,centromere complex assembly,BP,
8779,GO:0034511,1,0.781598827252079,0,6,U3 snoRNA binding,MF,
8780,GO:0034512,1,0.958787867083198,0,1,box C/D snoRNA binding,MF,
8781,GO:0034513,1,0.831619633930703,0,5,box H/ACA snoRNA binding,MF,
8782,GO:0034515,1,0.918374501786155,0,2,proteasome storage granule,CC,
8783,GO:0034518,1,0.606815546248943,0,12,RNA cap binding complex,CC,
8784,GO:0034545,1,0.962869317582296,0,1,fumarylpyruvate hydrolase activity,MF,
8785,GO:0034551,1,0.692586474155569,0,9,mitochondrial respiratory chain complex III assembly,BP,
8786,GO:0034552,1,0.85486938211366,0,4,respiratory chain complex II assembly,BP,
8787,GO:0034553,1,0.85486938211366,0,4,mitochondrial respiratory chain complex II assembly,BP,
8788,GO:0034584,1,0.957114104269117,0,1,piRNA binding,MF,
8789,GO:0034587,1,0.711805527339292,0,8,piRNA metabolic process,BP,
8792,GO:0034593,1,0.367025880917397,0,23,phosphatidylinositol bisphosphate phosphatase activity,MF,
8793,GO:0034594,1,0.805558709518251,0,5,phosphatidylinositol trisphosphate phosphatase activity,MF,
8794,GO:0034595,1,0.568877462332376,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
8795,GO:0034596,1,0.70370368484658,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
8796,GO:0034597,1,0.915195441957175,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
8798,GO:0034602,1,0.956732327618857,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
8799,GO:0034603,1,0.810776464118921,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8800,GO:0034604,1,0.810776464118921,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
8805,GO:0034616,1,0.602165445662395,0,12,response to laminar fluid shear stress,BP,
8806,GO:0034617,1,0.883490851770319,0,3,tetrahydrobiopterin binding,MF,
8807,GO:0034618,1,0.848724481982405,0,4,arginine binding,MF,
8810,GO:0034625,1,0.811455539240222,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8811,GO:0034626,1,0.811455539240222,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
8812,GO:0034627,1,0.91547768952439,0,2,'de novo' NAD biosynthetic process,BP,
8813,GO:0034628,1,0.91547768952439,0,2,'de novo' NAD biosynthetic process from aspartate,BP,
8814,GO:0034629,1,0.399168729535614,0,22,cellular protein-containing complex localization,BP,
8818,GO:0034638,1,0.785203231019832,0,6,phosphatidylcholine catabolic process,BP,
8819,GO:0034640,1,0.958012667701173,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
8821,GO:0034642,1,0.957131588777735,0,1,mitochondrion migration along actin filament,BP,
8822,GO:0034643,1,0.448444552522996,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
8825,GO:0034647,1,0.914777292668164,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8826,GO:0034648,1,0.8389812298324,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
8827,GO:0034649,1,0.957059600671194,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
8828,GO:0034650,1,0.805455576509218,0,5,cortisol metabolic process,BP,
8829,GO:0034651,1,0.805455576509218,0,5,cortisol biosynthetic process,BP,
8830,GO:0034653,1,0.956619352253465,0,1,retinoic acid catabolic process,BP,
8834,GO:0034657,1,0.847727245803163,0,4,GID complex,CC,
8836,GO:0034661,1,0.389101524559391,0,23,ncRNA catabolic process,BP,
8837,GO:0034663,1,0.692412684506486,0,9,endoplasmic reticulum chaperone complex,CC,
8838,GO:0034665,1,0.91556956695735,0,2,integrin alpha1-beta1 complex,CC,
8839,GO:0034666,1,0.877364815889951,0,3,integrin alpha2-beta1 complex,CC,
8840,GO:0034667,1,0.915537702413955,0,2,integrin alpha3-beta1 complex,CC,
8841,GO:0034669,1,0.956441843839217,0,1,integrin alpha4-beta7 complex,CC,
8842,GO:0034670,1,0.956441843839217,0,1,chemotaxis to arachidonic acid,BP,
8843,GO:0034673,1,0.91478999798085,0,2,inhibin-betaglycan-ActRII complex,CC,
8844,GO:0034676,1,0.95644184388463,0,1,integrin alpha6-beta4 complex,CC,
8845,GO:0034677,1,0.957189989580296,0,1,integrin alpha7-beta1 complex,CC,
8846,GO:0034678,1,0.915639049358369,0,2,integrin alpha8-beta1 complex,CC,
8847,GO:0034680,1,0.915510061912149,0,2,integrin alpha10-beta1 complex,CC,
8848,GO:0034681,1,0.957189989580296,0,1,integrin alpha11-beta1 complex,CC,
8849,GO:0034683,1,0.956441843839217,0,1,integrin alphav-beta3 complex,CC,
8852,GO:0034686,1,0.914777292668164,0,2,integrin alphav-beta8 complex,CC,
8853,GO:0034693,1,0.960122370561274,0,1,U11/U12 snRNP,CC,
8856,GO:0034696,1,0.922666520042526,0,2,response to prostaglandin F,BP,
8858,GO:0034699,1,0.880050008260668,0,3,response to luteinizing hormone,BP,
8861,GO:0034704,1,0.401732041549693,0,22,calcium channel complex,CC,
8864,GO:0034707,1,0.605097250427763,0,12,chloride channel complex,CC,
8866,GO:0034709,1,0.641314891730033,0,12,methylosome,CC,
8868,GO:0034713,1,0.714410685884451,0,8,type I transforming growth factor beta receptor binding,MF,
8869,GO:0034714,1,0.880681636683569,0,3,type III transforming growth factor beta receptor binding,MF,
8870,GO:0034715,1,0.802849661817323,0,6,pICln-Sm protein complex,CC,
8871,GO:0034718,1,0.956445672379643,0,1,SMN-Gemin2 complex,CC,
8872,GO:0034719,1,0.538371489142992,0,16,SMN-Sm protein complex,CC,
8873,GO:0034720,1,0.767457820531035,0,6,histone H3-K4 demethylation,BP,
8874,GO:0034721,1,0.914777292668164,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
8875,GO:0034722,1,0.963447368308488,0,1,gamma-glutamyl-peptidase activity,MF,
8876,GO:0034723,1,0.313054408885366,0,32,DNA replication-dependent nucleosome organization,BP,
8877,GO:0034724,1,0.136806415034392,0,51,DNA replication-independent nucleosome organization,BP,
8878,GO:0034727,1,0.956488546109679,0,1,piecemeal microautophagy of the nucleus,BP,
8880,GO:0034729,1,0.88234522540452,0,3,histone H3-K79 methylation,BP,
8881,GO:0034736,1,0.957692460089517,0,1,cholesterol O-acyltransferase activity,MF,
8882,GO:0034739,1,0.926126175206851,0,2,histone deacetylase activity (H4-K16 specific),MF,
8883,GO:0034750,1,0.915952911061129,0,2,Scrib-APC-beta-catenin complex,CC,
8884,GO:0034751,1,0.885133078045025,0,3,aryl hydrocarbon receptor complex,CC,
8885,GO:0034752,1,0.956441843839217,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8886,GO:0034753,1,0.956441843839217,0,1,nuclear aryl hydrocarbon receptor complex,CC,
8888,GO:0034755,1,0.602250173969337,0,12,iron ion transmembrane transport,BP,
8889,GO:0034756,1,0.88767023977237,0,3,regulation of iron ion transport,BP,
8890,GO:0034757,1,0.956441843839217,0,1,negative regulation of iron ion transport,BP,
8891,GO:0034759,1,0.956441843839217,0,1,regulation of iron ion transmembrane transport,BP,
8892,GO:0034760,1,0.956441843839217,0,1,negative regulation of iron ion transmembrane transport,BP,
8903,GO:0034776,1,0.915023984936219,0,2,response to histamine,BP,
8905,GO:0034959,1,0.956466376657804,0,1,endothelin maturation,BP,
8906,GO:0034963,1,0.964341017540768,0,1,box C/D snoRNA processing,BP,
8907,GO:0034964,1,0.959731749686441,0,1,box H/ACA snoRNA processing,BP,
8909,GO:0034969,1,0.662917154812656,0,10,histone arginine methylation,BP,
8910,GO:0034970,1,0.919780636433893,0,2,histone H3-R2 methylation,BP,
8911,GO:0034971,1,0.958566391302563,0,1,histone H3-R17 methylation,BP,
8912,GO:0034975,1,0.552880470058817,0,14,protein folding in endoplasmic reticulum,BP,
8914,GO:0034979,1,0.491799744464913,0,17,NAD-dependent protein deacetylase activity,MF,
8915,GO:0034982,1,0.673035824932438,0,10,mitochondrial protein processing,BP,
8916,GO:0034983,1,0.773048993223149,0,6,peptidyl-lysine deacetylation,BP,
8917,GO:0034986,1,0.956441843839217,0,1,iron chaperone activity,MF,
8918,GO:0034987,1,0.956441843839217,0,1,immunoglobulin receptor binding,MF,
8919,GO:0034988,1,0.956441843839217,0,1,Fc-gamma receptor I complex binding,MF,
8920,GO:0034991,1,0.919257957168621,0,2,nuclear meiotic cohesin complex,CC,
8923,GO:0034998,1,0.958787867083198,0,1,oligosaccharyltransferase I complex,CC,
8925,GO:0035005,1,0.767417214183891,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
8928,GO:0035020,1,0.526665697837675,0,15,regulation of Rac protein signal transduction,BP,
8929,GO:0035021,1,0.842740999514232,0,4,negative regulation of Rac protein signal transduction,BP,
8930,GO:0035022,1,0.844757415465135,0,4,positive regulation of Rac protein signal transduction,BP,
8934,GO:0035026,1,0.916254922265465,0,2,leading edge cell differentiation,BP,
8935,GO:0035032,1,0.77882410424869,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8936,GO:0035033,1,0.921679683794866,0,2,histone deacetylase regulator activity,MF,
8937,GO:0035034,1,0.921190045568354,0,2,histone acetyltransferase regulator activity,MF,
8940,GO:0035037,1,0.956622798133739,0,1,sperm entry,BP,
8943,GO:0035054,1,0.958174913278171,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
8944,GO:0035061,1,0.838869514316445,0,4,interchromatin granule,CC,
8945,GO:0035063,1,0.957275651468017,0,1,nuclear speck organization,BP,
8946,GO:0035064,1,0.0932430304000658,0,56,methylated histone binding,MF,
8949,GO:0035067,1,0.554356265484345,0,14,negative regulation of histone acetylation,BP,
8950,GO:0035068,1,0.681422497789406,0,9,micro-ribonucleoprotein complex,CC,
8952,GO:0035087,1,0.850601286018908,0,4,siRNA loading onto RISC involved in RNA interference,BP,
8954,GO:0035089,1,0.575113374575251,0,13,establishment of apical/basal cell polarity,BP,
8955,GO:0035090,1,0.810066882385835,0,5,maintenance of apical/basal cell polarity,BP,
8957,GO:0035092,1,0.875157869550021,0,3,sperm chromatin condensation,BP,
8958,GO:0035093,1,0.914778563114481,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
8959,GO:0035094,1,0.415799111165182,0,21,response to nicotine,BP,
8960,GO:0035095,1,0.843432020598065,0,4,behavioral response to nicotine,BP,
8962,GO:0035098,1,0.507100768242861,0,16,ESC/E(Z) complex,CC,
8963,GO:0035101,1,0.879325638204985,0,3,FACT complex,CC,
8964,GO:0035102,1,0.605415985626735,0,12,PRC1 complex,CC,
8967,GO:0035112,1,0.768886198159459,0,6,genitalia morphogenesis,BP,
8971,GO:0035120,1,0.956441843839217,0,1,post-embryonic appendage morphogenesis,BP,
8972,GO:0035127,1,0.956441843839217,0,1,post-embryonic limb morphogenesis,BP,
8973,GO:0035128,1,0.956441843839217,0,1,post-embryonic forelimb morphogenesis,BP,
8976,GO:0035145,1,0.417545867162068,0,21,exon-exon junction complex,CC,
8980,GO:0035166,1,0.878360175130818,0,3,post-embryonic hemopoiesis,BP,
8981,GO:0035173,1,0.560419844950192,0,14,histone kinase activity,MF,
8982,GO:0035174,1,0.783454177557146,0,6,histone serine kinase activity,MF,
8983,GO:0035175,1,0.962772532294176,0,1,histone kinase activity (H3-S10 specific),MF,
8985,GO:0035184,1,0.846707543246067,0,4,histone threonine kinase activity,MF,
8986,GO:0035188,1,0.957965721664968,0,1,hatching,BP,
8987,GO:0035189,1,0.881920696119868,0,3,Rb-E2F complex,CC,
8991,GO:0035197,1,0.680617608966923,0,9,siRNA binding,MF,
8992,GO:0035198,1,0.411182863959358,0,21,miRNA binding,MF,
8993,GO:0035226,1,0.958333453996438,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
8994,GO:0035227,1,0.958333453996438,0,1,regulation of glutamate-cysteine ligase activity,BP,
8995,GO:0035229,1,0.958333453996438,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
8996,GO:0035234,1,0.78036216139979,0,6,ectopic germ cell programmed cell death,BP,
8997,GO:0035235,1,0.68003679104294,0,9,ionotropic glutamate receptor signaling pathway,BP,
8999,GO:0035240,1,0.962109643726768,0,1,dopamine binding,MF,
9000,GO:0035241,1,0.883488932608131,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
9001,GO:0035242,1,0.752638649069104,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9002,GO:0035243,1,0.847654512236257,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9003,GO:0035246,1,0.63852702858197,0,11,peptidyl-arginine N-methylation,BP,
9004,GO:0035247,1,0.692867212113421,0,9,peptidyl-arginine omega-N-methylation,BP,
9005,GO:0035248,1,0.958849901589406,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9007,GO:0035250,1,0.402377897398671,0,22,UDP-galactosyltransferase activity,MF,
9008,GO:0035251,1,0.750700148081123,0,7,UDP-glucosyltransferase activity,MF,
9010,GO:0035253,1,0.682561349184828,0,9,ciliary rootlet,CC,
9012,GO:0035255,1,0.405488207246451,0,21,ionotropic glutamate receptor binding,MF,
9015,GO:0035258,1,0.0448704221888774,0,74,steroid hormone receptor binding,MF,
9016,GO:0035259,1,0.628148203065766,0,11,glucocorticoid receptor binding,MF,
9017,GO:0035261,1,0.914777292668164,0,2,external genitalia morphogenesis,BP,
9018,GO:0035262,1,0.956441843839217,0,1,gonad morphogenesis,BP,
9022,GO:0035268,1,0.472435142946053,0,18,protein mannosylation,BP,
9023,GO:0035269,1,0.616654654620481,0,12,protein O-linked mannosylation,BP,
9026,GO:0035276,1,0.956443188468658,0,1,ethanol binding,MF,
9027,GO:0035278,1,0.604685663778521,0,12,miRNA mediated inhibition of translation,BP,
9028,GO:0035279,1,0.917944013151186,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9029,GO:0035280,1,0.744832872673575,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9030,GO:0035281,1,0.922573169563137,0,2,pre-miRNA export from nucleus,BP,
9032,GO:0035283,1,0.957776133356968,0,1,central nervous system segmentation,BP,
9033,GO:0035284,1,0.957776133356968,0,1,brain segmentation,BP,
9034,GO:0035290,1,0.879190074232147,0,3,trunk segmentation,BP,
9037,GO:0035299,1,0.956675822829611,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9041,GO:0035306,1,0.192152822492814,0,39,positive regulation of dephosphorylation,BP,
9042,GO:0035307,1,0.282524566909856,0,30,positive regulation of protein dephosphorylation,BP,
9044,GO:0035312,1,0.774377971278984,0,6,5'-3' exodeoxyribonuclease activity,MF,
9045,GO:0035313,1,0.571310743704445,0,13,wound healing, spreading of epidermal cells,BP,
9047,GO:0035325,1,0.723513592415458,0,8,Toll-like receptor binding,MF,
9049,GO:0035327,1,0.440283786983177,0,20,transcriptionally active chromatin,CC,
9051,GO:0035330,1,0.619316644373482,0,11,regulation of hippo signaling,BP,
9052,GO:0035331,1,0.706133643468834,0,8,negative regulation of hippo signaling,BP,
9053,GO:0035332,1,0.914777292668164,0,2,positive regulation of hippo signaling,BP,
9054,GO:0035333,1,0.604512372474586,0,12,Notch receptor processing, ligand-dependent,BP,
9059,GO:0035339,1,0.857157804468412,0,4,SPOTS complex,CC,
9060,GO:0035349,1,0.883679680693187,0,3,coenzyme A transmembrane transport,BP,
9061,GO:0035350,1,0.920899247048679,0,2,FAD transmembrane transport,BP,
9062,GO:0035352,1,0.960822557325351,0,1,NAD transmembrane transport,BP,
9063,GO:0035354,1,0.957700811769664,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9064,GO:0035355,1,0.956441843839217,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9065,GO:0035356,1,0.818037932045329,0,5,cellular triglyceride homeostasis,BP,
9067,GO:0035358,1,0.778110807839488,0,6,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9068,GO:0035359,1,0.956908523440049,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9069,GO:0035360,1,0.84962254897735,0,4,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9070,GO:0035363,1,0.847198294165539,0,4,histone locus body,CC,
9071,GO:0035368,1,0.847268425954642,0,4,selenocysteine insertion sequence binding,MF,
9072,GO:0035370,1,0.922040673219931,0,2,UBC13-UEV1A complex,CC,
9074,GO:0035372,1,0.572370860312253,0,13,protein localization to microtubule,BP,
9075,GO:0035373,1,0.914777292668164,0,2,chondroitin sulfate proteoglycan binding,MF,
9077,GO:0035376,1,0.814838567430916,0,5,sterol import,BP,
9078,GO:0035381,1,0.961659370281862,0,1,ATP-gated ion channel activity,MF,
9081,GO:0035385,1,0.736570328327646,0,7,Roundabout signaling pathway,BP,
9082,GO:0035400,1,0.956451370268194,0,1,histone tyrosine kinase activity,MF,
9083,GO:0035401,1,0.956451370268194,0,1,histone kinase activity (H3-Y41 specific),MF,
9084,GO:0035402,1,0.919515032202666,0,2,histone kinase activity (H3-T11 specific),MF,
9085,GO:0035403,1,0.956441843839217,0,1,histone kinase activity (H3-T6 specific),MF,
9087,GO:0035405,1,0.846707543246067,0,4,histone-threonine phosphorylation,BP,
9088,GO:0035406,1,0.956451370268194,0,1,histone-tyrosine phosphorylation,BP,
9089,GO:0035407,1,0.919515032202666,0,2,histone H3-T11 phosphorylation,BP,
9090,GO:0035408,1,0.956441843839217,0,1,histone H3-T6 phosphorylation,BP,
9091,GO:0035409,1,0.956451370268194,0,1,histone H3-Y41 phosphorylation,BP,
9093,GO:0035425,1,0.882919107584312,0,3,autocrine signaling,BP,
9094,GO:0035426,1,0.839525808778611,0,4,extracellular matrix-cell signaling,BP,
9095,GO:0035434,1,0.778382220653057,0,6,copper ion transmembrane transport,BP,
9096,GO:0035435,1,0.71138917570064,0,8,phosphate ion transmembrane transport,BP,
9097,GO:0035437,1,0.633508951915091,0,11,maintenance of protein localization in endoplasmic reticulum,BP,
9098,GO:0035438,1,0.962837200321015,0,1,cyclic-di-GMP binding,MF,
9099,GO:0035441,1,0.956441843839217,0,1,cell migration involved in vasculogenesis,BP,
9100,GO:0035442,1,0.923889708631606,0,2,dipeptide transmembrane transport,BP,
9102,GO:0035445,1,0.958244092294393,0,1,borate transmembrane transport,BP,
9105,GO:0035457,1,0.679358673643732,0,9,cellular response to interferon-alpha,BP,
9107,GO:0035459,1,0.423725364328553,0,20,cargo loading into vesicle,BP,
9108,GO:0035461,1,0.712230277254266,0,8,vitamin transmembrane transport,BP,
9109,GO:0035469,1,0.956446954086774,0,1,determination of pancreatic left/right asymmetry,BP,
9110,GO:0035470,1,0.962452315797035,0,1,positive regulation of vascular wound healing,BP,
9111,GO:0035473,1,0.921420342337307,0,2,lipase binding,MF,
9112,GO:0035482,1,0.929415901248076,0,2,gastric motility,BP,
9113,GO:0035483,1,0.965198421423852,0,1,gastric emptying,BP,
9114,GO:0035485,1,0.962326191560289,0,1,adenine/guanine mispair binding,MF,
9115,GO:0035490,1,0.958145282645265,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9116,GO:0035491,1,0.958145282645265,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9118,GO:0035494,1,0.883293812924836,0,3,SNARE complex disassembly,BP,
9119,GO:0035497,1,0.632684459450183,0,11,cAMP response element binding,MF,
9120,GO:0035498,1,0.958787867083198,0,1,carnosine metabolic process,BP,
9121,GO:0035500,1,0.917903289419151,0,2,MH2 domain binding,MF,
9122,GO:0035501,1,0.958962085136742,0,1,MH1 domain binding,MF,
9124,GO:0035504,1,0.963423728178762,0,1,regulation of myosin light chain kinase activity,BP,
9125,GO:0035505,1,0.963423728178762,0,1,positive regulation of myosin light chain kinase activity,BP,
9127,GO:0035508,1,0.956442307639762,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9128,GO:0035509,1,0.875449730664478,0,3,negative regulation of myosin-light-chain-phosphatase activity,BP,
9130,GO:0035511,1,0.817464611117518,0,5,oxidative DNA demethylation,BP,
9131,GO:0035513,1,0.84692723903523,0,4,oxidative RNA demethylation,BP,
9132,GO:0035514,1,0.889176665100109,0,3,DNA demethylase activity,MF,
9133,GO:0035515,1,0.84692723903523,0,4,oxidative RNA demethylase activity,MF,
9134,GO:0035516,1,0.956739518605692,0,1,oxidative DNA demethylase activity,MF,
9135,GO:0035517,1,0.876231390097992,0,3,PR-DUB complex,CC,
9137,GO:0035519,1,0.857671966893732,0,4,protein K29-linked ubiquitination,BP,
9138,GO:0035520,1,0.675273406257445,0,9,monoubiquitinated protein deubiquitination,BP,
9139,GO:0035521,1,0.842719581749289,0,4,monoubiquitinated histone deubiquitination,BP,
9140,GO:0035522,1,0.842719581749289,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9141,GO:0035523,1,0.842461015067676,0,4,protein K29-linked deubiquitination,BP,
9143,GO:0035525,1,0.959731749686441,0,1,NF-kappaB p50/p65 complex,CC,
9145,GO:0035529,1,0.819324567806372,0,5,NADH pyrophosphatase activity,MF,
9146,GO:0035538,1,0.957951270041358,0,1,carbohydrate response element binding,MF,
9147,GO:0035539,1,0.928452658429404,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9148,GO:0035542,1,0.741323862130153,0,7,regulation of SNARE complex assembly,BP,
9149,GO:0035544,1,0.956642550256999,0,1,negative regulation of SNARE complex assembly,BP,
9150,GO:0035546,1,0.838062110331203,0,4,interferon-beta secretion,BP,
9151,GO:0035547,1,0.838062110331203,0,4,regulation of interferon-beta secretion,BP,
9152,GO:0035549,1,0.838062110331203,0,4,positive regulation of interferon-beta secretion,BP,
9153,GO:0035552,1,0.884392168244116,0,3,oxidative single-stranded DNA demethylation,BP,
9154,GO:0035553,1,0.882494500350524,0,3,oxidative single-stranded RNA demethylation,BP,
9158,GO:0035563,1,0.605036863863952,0,12,positive regulation of chromatin binding,BP,
9160,GO:0035568,1,0.958787867083198,0,1,N-terminal peptidyl-proline methylation,BP,
9161,GO:0035570,1,0.958787867083198,0,1,N-terminal peptidyl-serine methylation,BP,
9162,GO:0035572,1,0.958787867083198,0,1,N-terminal peptidyl-serine dimethylation,BP,
9163,GO:0035573,1,0.958787867083198,0,1,N-terminal peptidyl-serine trimethylation,BP,
9164,GO:0035574,1,0.917021318947511,0,2,histone H4-K20 demethylation,BP,
9165,GO:0035575,1,0.917021318947511,0,2,histone demethylase activity (H4-K20 specific),MF,
9169,GO:0035580,1,0.224008787725503,0,37,specific granule lumen,CC,
9171,GO:0035582,1,0.885453008779003,0,3,sequestering of BMP in extracellular matrix,BP,
9178,GO:0035589,1,0.815398803427329,0,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9179,GO:0035590,1,0.750021031139059,0,7,purinergic nucleotide receptor signaling pathway,BP,
9181,GO:0035594,1,0.883609003420173,0,3,ganglioside binding,MF,
9182,GO:0035596,1,0.921207810282727,0,2,methylthiotransferase activity,MF,
9183,GO:0035597,1,0.961688034916866,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9184,GO:0035598,1,0.957910413760217,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9185,GO:0035600,1,0.921207810282727,0,2,tRNA methylthiolation,BP,
9187,GO:0035602,1,0.95687510764142,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9188,GO:0035603,1,0.95687510764142,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9189,GO:0035604,1,0.95687510764142,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9190,GO:0035605,1,0.963953048764493,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9191,GO:0035606,1,0.930913628099342,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9192,GO:0035607,1,0.9151919195996,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9193,GO:0035608,1,0.917357702109155,0,2,protein deglutamylation,BP,
9194,GO:0035609,1,0.956660724005373,0,1,C-terminal protein deglutamylation,BP,
9195,GO:0035610,1,0.956660724005373,0,1,protein side chain deglutamylation,BP,
9196,GO:0035611,1,0.958920093517069,0,1,protein branching point deglutamylation,BP,
9198,GO:0035613,1,0.534556458113281,0,15,RNA stem-loop binding,MF,
9199,GO:0035614,1,0.890075196356199,0,3,snRNA stem-loop binding,MF,
9201,GO:0035616,1,0.876582549878322,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9202,GO:0035617,1,0.882303678342389,0,3,stress granule disassembly,BP,
9203,GO:0035620,1,0.88297728068457,0,3,ceramide transporter activity,MF,
9204,GO:0035621,1,0.919946563473448,0,2,ER to Golgi ceramide transport,BP,
9205,GO:0035622,1,0.957024743659525,0,1,intrahepatic bile duct development,BP,
9206,GO:0035623,1,0.957985152260777,0,1,renal glucose absorption,BP,
9207,GO:0035624,1,0.915735594586619,0,2,receptor transactivation,BP,
9208,GO:0035625,1,0.957443703192116,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9209,GO:0035627,1,0.778905857941071,0,6,ceramide transport,BP,
9210,GO:0035630,1,0.91651998672666,0,2,bone mineralization involved in bone maturation,BP,
9211,GO:0035631,1,0.63243468885496,0,11,CD40 receptor complex,CC,
9212,GO:0035633,1,0.91915849889591,0,2,maintenance of permeability of blood-brain barrier,BP,
9213,GO:0035634,1,0.930827345929915,0,2,response to stilbenoid,BP,
9214,GO:0035635,1,0.486286844634825,0,17,entry of bacterium into host cell,BP,
9216,GO:0035638,1,0.956541737984803,0,1,signal maturation,BP,
9220,GO:0035642,1,0.958566391302563,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9221,GO:0035646,1,0.664654376100139,0,10,endosome to melanosome transport,BP,
9222,GO:0035650,1,0.852708676257068,0,4,AP-1 adaptor complex binding,MF,
9223,GO:0035651,1,0.889105106501498,0,3,AP-3 adaptor complex binding,MF,
9224,GO:0035655,1,0.784161538149608,0,6,interleukin-18-mediated signaling pathway,BP,
9225,GO:0035658,1,0.883309922398091,0,3,Mon1-Ccz1 complex,CC,
9226,GO:0035659,1,0.962762781917351,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9227,GO:0035662,1,0.898005248187188,0,3,Toll-like receptor 4 binding,MF,
9228,GO:0035663,1,0.920598998464501,0,2,Toll-like receptor 2 binding,MF,
9229,GO:0035664,1,0.962528160595372,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9230,GO:0035665,1,0.962528160595372,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9231,GO:0035666,1,0.358194257337618,0,25,TRIF-dependent toll-like receptor signaling pathway,BP,
9232,GO:0035668,1,0.916791842427941,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9233,GO:0035669,1,0.916791842427941,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9234,GO:0035671,1,0.92188555446637,0,2,enone reductase activity,MF,
9240,GO:0035692,1,0.956486298934581,0,1,macrophage migration inhibitory factor receptor complex,CC,
9243,GO:0035697,1,0.925774918912131,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9244,GO:0035698,1,0.925774918912131,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9245,GO:0035700,1,0.962538221632504,0,1,astrocyte chemotaxis,BP,
9246,GO:0035701,1,0.882095662288037,0,3,hematopoietic stem cell migration,BP,
9247,GO:0035709,1,0.961042493422886,0,1,memory T cell activation,BP,
9249,GO:0035711,1,0.957657838392433,0,1,T-helper 1 cell activation,BP,
9250,GO:0035712,1,0.957923623162533,0,1,T-helper 2 cell activation,BP,
9251,GO:0035718,1,0.963456212296072,0,1,macrophage migration inhibitory factor binding,MF,
9252,GO:0035720,1,0.881310602900903,0,3,intraciliary anterograde transport,BP,
9253,GO:0035721,1,0.603688094126641,0,12,intraciliary retrograde transport,BP,
9254,GO:0035722,1,0.201284618907132,0,40,interleukin-12-mediated signaling pathway,BP,
9255,GO:0035723,1,0.711711718344405,0,8,interleukin-15-mediated signaling pathway,BP,
9257,GO:0035726,1,0.851039718681237,0,4,common myeloid progenitor cell proliferation,BP,
9258,GO:0035727,1,0.918947470104224,0,2,lysophosphatidic acid binding,MF,
9259,GO:0035728,1,0.630342729533884,0,11,response to hepatocyte growth factor,BP,
9260,GO:0035729,1,0.68607989878428,0,9,cellular response to hepatocyte growth factor stimulus,BP,
9261,GO:0035730,1,0.964859957860984,0,1,S-nitrosoglutathione binding,MF,
9262,GO:0035731,1,0.964859957860984,0,1,dinitrosyl-iron complex binding,MF,
9263,GO:0035732,1,0.964859957860984,0,1,nitric oxide storage,BP,
9264,GO:0035733,1,0.845477406204894,0,4,hepatic stellate cell activation,BP,
9265,GO:0035735,1,0.195651114184133,0,39,intraciliary transport involved in cilium assembly,BP,
9266,GO:0035739,1,0.844457756811103,0,4,CD4-positive, alpha-beta T cell proliferation,BP,
9267,GO:0035740,1,0.921901292635356,0,2,CD8-positive, alpha-beta T cell proliferation,BP,
9268,GO:0035743,1,0.724532414215629,0,8,CD4-positive, alpha-beta T cell cytokine production,BP,
9269,GO:0035744,1,0.964397565363727,0,1,T-helper 1 cell cytokine production,BP,
9270,GO:0035745,1,0.783531493583315,0,6,T-helper 2 cell cytokine production,BP,
9272,GO:0035748,1,0.771905447344066,0,6,myelin sheath abaxonal region,CC,
9273,GO:0035749,1,0.812004143964076,0,5,myelin sheath adaxonal region,CC,
9274,GO:0035750,1,0.956448072048591,0,1,protein localization to myelin sheath abaxonal region,BP,
9275,GO:0035751,1,0.653194062637263,0,11,regulation of lysosomal lumen pH,BP,
9276,GO:0035752,1,0.96211488694796,0,1,lysosomal lumen pH elevation,BP,
9277,GO:0035754,1,0.810745883579369,0,5,B cell chemotaxis,BP,
9278,GO:0035755,1,0.959753253487819,0,1,cardiolipin hydrolase activity,MF,
9279,GO:0035766,1,0.875555938320717,0,3,cell chemotaxis to fibroblast growth factor,BP,
9280,GO:0035767,1,0.470855607712651,0,18,endothelial cell chemotaxis,BP,
9281,GO:0035768,1,0.875555938320717,0,3,endothelial cell chemotaxis to fibroblast growth factor,BP,
9283,GO:0035771,1,0.809419188336768,0,5,interleukin-4-mediated signaling pathway,BP,
9287,GO:0035788,1,0.919628828173175,0,2,cell migration involved in metanephros development,BP,
9288,GO:0035789,1,0.919628828173175,0,2,metanephric mesenchymal cell migration,BP,
9289,GO:0035790,1,0.957103145750268,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9290,GO:0035791,1,0.680100515679587,0,9,platelet-derived growth factor receptor-beta signaling pathway,BP,
9291,GO:0035793,1,0.919628828173175,0,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9292,GO:0035794,1,0.10800793122198,0,55,positive regulation of mitochondrial membrane permeability,BP,
9293,GO:0035795,1,0.824704113846425,0,5,negative regulation of mitochondrial membrane permeability,BP,
9294,GO:0035799,1,0.878083858313835,0,3,ureter maturation,BP,
9295,GO:0035800,1,0.922395882888401,0,2,deubiquitinase activator activity,MF,
9296,GO:0035801,1,0.922567760153261,0,2,adrenal cortex development,BP,
9297,GO:0035802,1,0.922567760153261,0,2,adrenal cortex formation,BP,
9299,GO:0035809,1,0.720218938934185,0,8,regulation of urine volume,BP,
9300,GO:0035810,1,0.810965237297486,0,5,positive regulation of urine volume,BP,
9301,GO:0035811,1,0.956441843839217,0,1,negative regulation of urine volume,BP,
9302,GO:0035812,1,0.923742521027393,0,2,renal sodium excretion,BP,
9303,GO:0035813,1,0.923742521027393,0,2,regulation of renal sodium excretion,BP,
9304,GO:0035814,1,0.960806377001927,0,1,negative regulation of renal sodium excretion,BP,
9305,GO:0035815,1,0.961427324140695,0,1,positive regulation of renal sodium excretion,BP,
9307,GO:0035822,1,0.916418773614224,0,2,gene conversion,BP,
9308,GO:0035825,1,0.22419831512533,0,36,homologous recombination,BP,
9309,GO:0035838,1,0.915127779592969,0,2,growing cell tip,CC,
9310,GO:0035841,1,0.956441843839217,0,1,new growing cell tip,CC,
9311,GO:0035844,1,0.880620725057245,0,3,cloaca development,BP,
9312,GO:0035845,1,0.741963496032297,0,7,photoreceptor cell outer segment organization,BP,
9314,GO:0035851,1,0.958583811023324,0,1,Krueppel-associated box domain binding,MF,
9315,GO:0035853,1,0.956638857120515,0,1,chromosome passenger complex localization to spindle midzone,BP,
9317,GO:0035859,1,0.582216307525511,0,13,Seh1-associated complex,CC,
9318,GO:0035860,1,0.876974931253665,0,3,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9319,GO:0035861,1,0.258515258153511,0,32,site of double-strand break,CC,
9320,GO:0035862,1,0.956441843839217,0,1,dITP metabolic process,BP,
9321,GO:0035863,1,0.956441843839217,0,1,dITP catabolic process,BP,
9322,GO:0035864,1,0.785099249609738,0,6,response to potassium ion,BP,
9323,GO:0035865,1,0.889189853764901,0,3,cellular response to potassium ion,BP,
9324,GO:0035866,1,0.914777292668164,0,2,alphav-beta3 integrin-PKCalpha complex,CC,
9325,GO:0035867,1,0.914777292668164,0,2,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
9326,GO:0035868,1,0.915940419928968,0,2,alphav-beta3 integrin-HMGB1 complex,CC,
9328,GO:0035870,1,0.922497563755838,0,2,dITP diphosphatase activity,MF,
9331,GO:0035873,1,0.842886444364106,0,4,lactate transmembrane transport,BP,
9332,GO:0035877,1,0.850793422030237,0,4,death effector domain binding,MF,
9333,GO:0035878,1,0.744493569671788,0,7,nail development,BP,
9334,GO:0035879,1,0.880328058926854,0,3,plasma membrane lactate transport,BP,
9335,GO:0035880,1,0.919893710488294,0,2,embryonic nail plate morphogenesis,BP,
9336,GO:0035881,1,0.923009643824649,0,2,amacrine cell differentiation,BP,
9337,GO:0035883,1,0.511478881043658,0,16,enteroendocrine cell differentiation,BP,
9338,GO:0035886,1,0.581941779694006,0,13,vascular smooth muscle cell differentiation,BP,
9339,GO:0035887,1,0.96265960442676,0,1,aortic smooth muscle cell differentiation,BP,
9340,GO:0035890,1,0.250976952365199,0,33,exit from host,BP,
9341,GO:0035891,1,0.250976952365199,0,33,exit from host cell,BP,
9342,GO:0035897,1,0.813996030367293,0,5,proteolysis in other organism,BP,
9343,GO:0035898,1,0.881912029411923,0,3,parathyroid hormone secretion,BP,
9344,GO:0035900,1,0.786238871419388,0,6,response to isolation stress,BP,
9345,GO:0035902,1,0.51252218977718,0,16,response to immobilization stress,BP,
9347,GO:0035905,1,0.881519212663479,0,3,ascending aorta development,BP,
9348,GO:0035907,1,0.807465156664277,0,5,dorsal aorta development,BP,
9350,GO:0035910,1,0.881519212663479,0,3,ascending aorta morphogenesis,BP,
9351,GO:0035912,1,0.842952037646882,0,4,dorsal aorta morphogenesis,BP,
9353,GO:0035915,1,0.961621702672929,0,1,pore formation in membrane of other organism,BP,
9354,GO:0035921,1,0.961432735459601,0,1,desmosome disassembly,BP,
9355,GO:0035922,1,0.958142130655448,0,1,foramen ovale closure,BP,
9357,GO:0035925,1,0.62620153950646,0,11,mRNA 3'-UTR AU-rich region binding,MF,
9361,GO:0035929,1,0.747057386819811,0,7,steroid hormone secretion,BP,
9362,GO:0035930,1,0.848388650421218,0,4,corticosteroid hormone secretion,BP,
9363,GO:0035931,1,0.959299384807479,0,1,mineralocorticoid secretion,BP,
9364,GO:0035932,1,0.959299384807479,0,1,aldosterone secretion,BP,
9365,GO:0035933,1,0.884392862607483,0,3,glucocorticoid secretion,BP,
9366,GO:0035935,1,0.957916064022112,0,1,androgen secretion,BP,
9367,GO:0035936,1,0.956441843839217,0,1,testosterone secretion,BP,
9368,GO:0035938,1,0.956441843839217,0,1,estradiol secretion,BP,
9369,GO:0035945,1,0.960050111061931,0,1,mitochondrial ncRNA surveillance,BP,
9370,GO:0035946,1,0.960050111061931,0,1,mitochondrial mRNA surveillance,BP,
9372,GO:0035948,1,0.878269012928598,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
9373,GO:0035962,1,0.957108347912133,0,1,response to interleukin-13,BP,
9374,GO:0035963,1,0.957108347912133,0,1,cellular response to interleukin-13,BP,
9375,GO:0035964,1,0.779941441533733,0,6,COPI-coated vesicle budding,BP,
9376,GO:0035965,1,0.812690737680235,0,5,cardiolipin acyl-chain remodeling,BP,
9379,GO:0035970,1,0.539914442526938,0,15,peptidyl-threonine dephosphorylation,BP,
9380,GO:0035971,1,0.964205418380256,0,1,peptidyl-histidine dephosphorylation,BP,
9381,GO:0035973,1,0.742266914429945,0,7,aggrephagy,BP,
9382,GO:0035976,1,0.822773890796892,0,5,transcription factor AP-1 complex,CC,
9383,GO:0035977,1,0.844172747112833,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
9384,GO:0035978,1,0.958962085136742,0,1,histone H2A-S139 phosphorylation,BP,
9386,GO:0035983,1,0.883584911859127,0,3,response to trichostatin A,BP,
9387,GO:0035984,1,0.883584911859127,0,3,cellular response to trichostatin A,BP,
9388,GO:0035985,1,0.856036461802625,0,4,senescence-associated heterochromatin focus,CC,
9389,GO:0035986,1,0.889514662846891,0,3,senescence-associated heterochromatin focus assembly,BP,
9391,GO:0035988,1,0.743282074248118,0,7,chondrocyte proliferation,BP,
9392,GO:0035989,1,0.844199461129211,0,4,tendon development,BP,
9393,GO:0035990,1,0.922860494738326,0,2,tendon cell differentiation,BP,
9394,GO:0035992,1,0.922860494738326,0,2,tendon formation,BP,
9395,GO:0035993,1,0.886799066883091,0,3,deltoid tuberosity development,BP,
9396,GO:0035994,1,0.577277139458114,0,13,response to muscle stretch,BP,
9397,GO:0035995,1,0.956441843839217,0,1,detection of muscle stretch,BP,
9398,GO:0035998,1,0.961942591276251,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
9400,GO:0036002,1,0.266947838081224,0,32,pre-mRNA binding,MF,
9401,GO:0036003,1,0.403589451875688,0,22,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
9402,GO:0036004,1,0.964171082012651,0,1,GAF domain binding,MF,
9403,GO:0036005,1,0.81105952935662,0,5,response to macrophage colony-stimulating factor,BP,
9404,GO:0036006,1,0.81105952935662,0,5,cellular response to macrophage colony-stimulating factor stimulus,BP,
9405,GO:0036009,1,0.964341017540768,0,1,protein-glutamine N-methyltransferase activity,MF,
9412,GO:0036020,1,0.602184888743772,0,12,endolysosome membrane,CC,
9414,GO:0036022,1,0.921627008560706,0,2,limb joint morphogenesis,BP,
9415,GO:0036023,1,0.921627008560706,0,2,embryonic skeletal limb joint morphogenesis,BP,
9416,GO:0036033,1,0.837159169133185,0,4,mediator complex binding,MF,
9417,GO:0036034,1,0.921539611068661,0,2,mediator complex assembly,BP,
9419,GO:0036037,1,0.748694278521097,0,7,CD8-positive, alpha-beta T cell activation,BP,
9421,GO:0036041,1,0.794101320034289,0,6,long-chain fatty acid binding,MF,
9422,GO:0036042,1,0.859430736775659,0,4,long-chain fatty acyl-CoA binding,MF,
9423,GO:0036046,1,0.958168531529118,0,1,protein demalonylation,BP,
9424,GO:0036047,1,0.958168531529118,0,1,peptidyl-lysine demalonylation,BP,
9425,GO:0036048,1,0.958168531529118,0,1,protein desuccinylation,BP,
9426,GO:0036049,1,0.958168531529118,0,1,peptidyl-lysine desuccinylation,BP,
9427,GO:0036054,1,0.958168531529118,0,1,protein-malonyllysine demalonylase activity,MF,
9428,GO:0036055,1,0.958168531529118,0,1,protein-succinyllysine desuccinylase activity,MF,
9429,GO:0036056,1,0.836870751525595,0,4,filtration diaphragm,CC,
9430,GO:0036057,1,0.836870751525595,0,4,slit diaphragm,CC,
9432,GO:0036065,1,0.37676310536601,0,23,fucosylation,BP,
9433,GO:0036066,1,0.552014931771364,0,14,protein O-linked fucosylation,BP,
9434,GO:0036071,1,0.957891697329934,0,1,N-glycan fucosylation,BP,
9437,GO:0036080,1,0.916310332209799,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
9438,GO:0036085,1,0.958044564162137,0,1,GDP-fucose import into Golgi lumen,BP,
9440,GO:0036090,1,0.924895262636255,0,2,cleavage furrow ingression,BP,
9441,GO:0036091,1,0.845756749457727,0,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
9443,GO:0036093,1,0.893450751441367,0,3,germ cell proliferation,BP,
9445,GO:0036105,1,0.957373041760869,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
9447,GO:0036111,1,0.959370451717241,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
9448,GO:0036112,1,0.924190124218365,0,2,medium-chain fatty-acyl-CoA metabolic process,BP,
9449,GO:0036114,1,0.963332843891388,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
9450,GO:0036115,1,0.963332843891388,0,1,fatty-acyl-CoA catabolic process,BP,
9451,GO:0036116,1,0.963332843891388,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
9456,GO:0036122,1,0.881303306575805,0,3,BMP binding,MF,
9457,GO:0036123,1,0.816245759283828,0,5,histone H3-K9 dimethylation,BP,
9458,GO:0036124,1,0.548867958259533,0,14,histone H3-K9 trimethylation,BP,
9459,GO:0036125,1,0.958390964683053,0,1,fatty acid beta-oxidation multienzyme complex,CC,
9461,GO:0036128,1,0.9591515388312,0,1,CatSper complex,CC,
9462,GO:0036132,1,0.885057778050573,0,3,13-prostaglandin reductase activity,MF,
9463,GO:0036135,1,0.917021318947511,0,2,Schwann cell migration,BP,
9464,GO:0036137,1,0.922680826348854,0,2,kynurenine aminotransferase activity,MF,
9465,GO:0036138,1,0.956441843839217,0,1,peptidyl-histidine hydroxylation,BP,
9466,GO:0036139,1,0.956441843839217,0,1,peptidyl-histidine dioxygenase activity,MF,
9467,GO:0036140,1,0.956441843839217,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9468,GO:0036145,1,0.962538221632504,0,1,dendritic cell homeostasis,BP,
9469,GO:0036146,1,0.88423815046554,0,3,cellular response to mycotoxin,BP,
9470,GO:0036148,1,0.624073708851168,0,11,phosphatidylglycerol acyl-chain remodeling,BP,
9472,GO:0036150,1,0.600171421158332,0,12,phosphatidylserine acyl-chain remodeling,BP,
9473,GO:0036151,1,0.471582136674394,0,18,phosphatidylcholine acyl-chain remodeling,BP,
9474,GO:0036152,1,0.53310904140435,0,15,phosphatidylethanolamine acyl-chain remodeling,BP,
9475,GO:0036153,1,0.959017459498148,0,1,triglyceride acyl-chain remodeling,BP,
9476,GO:0036155,1,0.810758079668744,0,5,acylglycerol acyl-chain remodeling,BP,
9477,GO:0036156,1,0.914777292668164,0,2,inner dynein arm,CC,
9478,GO:0036157,1,0.883204032966617,0,3,outer dynein arm,CC,
9479,GO:0036158,1,0.782424107668697,0,6,outer dynein arm assembly,BP,
9480,GO:0036159,1,0.81073085111631,0,5,inner dynein arm assembly,BP,
9481,GO:0036164,1,0.964516792156834,0,1,cell-abiotic substrate adhesion,BP,
9484,GO:0036194,1,0.893832038902589,0,3,muscle cell projection,CC,
9485,GO:0036195,1,0.893832038902589,0,3,muscle cell projection membrane,CC,
9487,GO:0036213,1,0.961125608718277,0,1,contractile ring contraction,BP,
9488,GO:0036215,1,0.958598826789882,0,1,response to stem cell factor,BP,
9489,GO:0036216,1,0.958598826789882,0,1,cellular response to stem cell factor stimulus,BP,
9490,GO:0036219,1,0.965425347294511,0,1,GTP diphosphatase activity,MF,
9491,GO:0036220,1,0.964513019642941,0,1,ITP diphosphatase activity,MF,
9492,GO:0036222,1,0.964513019642941,0,1,XTP diphosphatase activity,MF,
9493,GO:0036228,1,0.918921567969182,0,2,protein localization to nuclear inner membrane,BP,
9495,GO:0036245,1,0.921585271884945,0,2,cellular response to menadione,BP,
9496,GO:0036250,1,0.962032509249954,0,1,peroxisome transport along microtubule,BP,
9497,GO:0036255,1,0.95712201154618,0,1,response to methylamine,BP,
9498,GO:0036257,1,0.284771324066109,0,31,multivesicular body organization,BP,
9499,GO:0036258,1,0.296965886440185,0,30,multivesicular body assembly,BP,
9500,GO:0036260,1,0.266522885323898,0,33,RNA capping,BP,
9501,GO:0036261,1,0.957268910753779,0,1,7-methylguanosine cap hypermethylation,BP,
9502,GO:0036265,1,0.857090851141847,0,4,RNA (guanine-N7)-methylation,BP,
9503,GO:0036266,1,0.959824820177024,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
9504,GO:0036269,1,0.963207223515115,0,1,swimming behavior,BP,
9505,GO:0036270,1,0.635052766406122,0,11,response to diuretic,BP,
9506,GO:0036284,1,0.921447130458164,0,2,tubulobulbar complex,CC,
9507,GO:0036289,1,0.773844293857857,0,6,peptidyl-serine autophosphorylation,BP,
9508,GO:0036290,1,0.956936800169417,0,1,protein trans-autophosphorylation,BP,
9509,GO:0036292,1,0.922497980284075,0,2,DNA rewinding,BP,
9514,GO:0036297,1,0.134261884479211,0,48,interstrand cross-link repair,BP,
9515,GO:0036301,1,0.882300868091406,0,3,macrophage colony-stimulating factor production,BP,
9516,GO:0036302,1,0.804972666412099,0,5,atrioventricular canal development,BP,
9517,GO:0036303,1,0.572592698492379,0,13,lymph vessel morphogenesis,BP,
9521,GO:0036313,1,0.920029107328992,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
9522,GO:0036314,1,0.441771132764472,0,19,response to sterol,BP,
9523,GO:0036315,1,0.569946982495673,0,13,cellular response to sterol,BP,
9524,GO:0036316,1,0.959299384807479,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
9525,GO:0036317,1,0.958787867083198,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9527,GO:0036333,1,0.959552427746578,0,1,hepatocyte homeostasis,BP,
9528,GO:0036335,1,0.956454454412148,0,1,intestinal stem cell homeostasis,BP,
9532,GO:0036343,1,0.9658000228485,0,1,psychomotor behavior,BP,
9534,GO:0036351,1,0.960639697930963,0,1,histone H2A-K13 ubiquitination,BP,
9535,GO:0036352,1,0.960639697930963,0,1,histone H2A-K15 ubiquitination,BP,
9536,GO:0036353,1,0.714284690490377,0,8,histone H2A-K119 monoubiquitination,BP,
9537,GO:0036361,1,0.960063836388062,0,1,racemase activity, acting on amino acids and derivatives,MF,
9538,GO:0036363,1,0.918180335981518,0,2,transforming growth factor beta activation,BP,
9539,GO:0036367,1,0.959773158506325,0,1,light adaption,BP,
9540,GO:0036369,1,0.914777292668164,0,2,transcription factor catabolic process,BP,
9541,GO:0036371,1,0.956441843839217,0,1,protein localization to T-tubule,BP,
9542,GO:0036372,1,0.964821598476581,0,1,opsin transport,BP,
9543,GO:0036374,1,0.884448472451438,0,3,glutathione hydrolase activity,MF,
9545,GO:0036378,1,0.924570904116035,0,2,calcitriol biosynthetic process from calciol,BP,
9547,GO:0036387,1,0.888500646288565,0,3,pre-replicative complex,CC,
9548,GO:0036388,1,0.888500646288565,0,3,pre-replicative complex assembly,BP,
9549,GO:0036392,1,0.957248930696226,0,1,chemokine (C-C motif) ligand 20 production,BP,
9550,GO:0036396,1,0.890285637218186,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
9551,GO:0036398,1,0.957908533970339,0,1,TCR signalosome,CC,
9552,GO:0036399,1,0.957908533970339,0,1,TCR signalosome assembly,BP,
9553,GO:0036402,1,0.799514352005935,0,6,proteasome-activating ATPase activity,MF,
9554,GO:0036403,1,0.959573364530808,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
9555,GO:0036404,1,0.956441843839217,0,1,conversion of ds siRNA to ss siRNA,BP,
9556,GO:0036414,1,0.958072871054507,0,1,histone citrullination,BP,
9557,GO:0036435,1,0.883794232941665,0,3,K48-linked polyubiquitin modification-dependent protein binding,MF,
9558,GO:0036438,1,0.845011090818272,0,4,maintenance of lens transparency,BP,
9559,GO:0036440,1,0.958556484743289,0,1,citrate synthase activity,MF,
9561,GO:0036444,1,0.711266427246346,0,8,calcium import into the mitochondrion,BP,
9562,GO:0036445,1,0.644985815730344,0,10,neuronal stem cell division,BP,
9564,GO:0036449,1,0.735702201473921,0,7,microtubule minus-end,CC,
9565,GO:0036451,1,0.919270839167849,0,2,cap mRNA methylation,BP,
9567,GO:0036454,1,0.8855361791881,0,3,growth factor complex,CC,
9568,GO:0036455,1,0.964454907098235,0,1,iron-sulfur transferase activity,MF,
9569,GO:0036457,1,0.83767823505529,0,4,keratohyalin granule,CC,
9570,GO:0036458,1,0.961078623376909,0,1,hepatocyte growth factor binding,MF,
9572,GO:0036461,1,0.929246803902222,0,2,BLOC-2 complex binding,MF,
9573,GO:0036462,1,0.754124267683867,0,7,TRAIL-activated apoptotic signaling pathway,BP,
9576,GO:0036466,1,0.915014122462882,0,2,synaptic vesicle recycling via endosome,BP,
9577,GO:0036470,1,0.96492184451589,0,1,tyrosine 3-monooxygenase activator activity,MF,
9578,GO:0036471,1,0.96492184451589,0,1,cellular response to glyoxal,BP,
9582,GO:0036476,1,0.891571125636965,0,3,neuron death in response to hydrogen peroxide,BP,
9584,GO:0036478,1,0.96492184451589,0,1,L-dopa decarboxylase activator activity,MF,
9585,GO:0036480,1,0.744282857545814,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
9586,GO:0036481,1,0.788932187827291,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9587,GO:0036482,1,0.925802534921023,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9588,GO:0036483,1,0.956606006240665,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
9589,GO:0036484,1,0.879190074232147,0,3,trunk neural crest cell migration,BP,
9590,GO:0036486,1,0.879190074232147,0,3,ventral trunk neural crest cell migration,BP,
9591,GO:0036487,1,0.956441843839217,0,1,nitric-oxide synthase inhibitor activity,MF,
9592,GO:0036488,1,0.928658423207038,0,2,CHOP-C/EBP complex,CC,
9597,GO:0036494,1,0.956442440375077,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9598,GO:0036496,1,0.925360287414597,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
9599,GO:0036497,1,0.960412322702609,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
9602,GO:0036500,1,0.661807080673312,0,10,ATF6-mediated unfolded protein response,BP,
9603,GO:0036501,1,0.956685207108999,0,1,UFD1-NPL4 complex,CC,
9604,GO:0036502,1,0.958204929198044,0,1,Derlin-1-VIMP complex,CC,
9606,GO:0036505,1,0.958629093573139,0,1,prosaposin receptor activity,MF,
9607,GO:0036506,1,0.88166138984477,0,3,maintenance of unfolded protein,BP,
9608,GO:0036507,1,0.395267940894038,0,22,protein demannosylation,BP,
9609,GO:0036508,1,0.395267940894038,0,22,protein alpha-1,2-demannosylation,BP,
9610,GO:0036509,1,0.922831296770934,0,2,trimming of terminal mannose on B branch,BP,
9611,GO:0036510,1,0.882628001871902,0,3,trimming of terminal mannose on C branch,BP,
9612,GO:0036511,1,0.922831296770934,0,2,trimming of first mannose on A branch,BP,
9613,GO:0036512,1,0.922831296770934,0,2,trimming of second mannose on A branch,BP,
9614,GO:0036513,1,0.65533043446669,0,10,Derlin-1 retrotranslocation complex,CC,
9617,GO:0036517,1,0.956441843839217,0,1,chemoattraction of serotonergic neuron axon,BP,
9618,GO:0036518,1,0.916887695694314,0,2,chemorepulsion of dopaminergic neuron axon,BP,
9619,GO:0036524,1,0.96492184451589,0,1,protein deglycase activity,MF,
9620,GO:0036525,1,0.96492184451589,0,1,protein deglycation,BP,
9621,GO:0036526,1,0.96492184451589,0,1,peptidyl-cysteine deglycation,BP,
9622,GO:0036527,1,0.96492184451589,0,1,peptidyl-arginine deglycation,BP,
9623,GO:0036528,1,0.96492184451589,0,1,peptidyl-lysine deglycation,BP,
9624,GO:0036529,1,0.96492184451589,0,1,protein deglycation, glyoxal removal,BP,
9625,GO:0036530,1,0.96492184451589,0,1,protein deglycation, methylglyoxal removal,BP,
9626,GO:0036531,1,0.96492184451589,0,1,glutathione deglycation,BP,
9627,GO:0038001,1,0.922911470200475,0,2,paracrine signaling,BP,
9628,GO:0038002,1,0.956448374941405,0,1,endocrine signaling,BP,
9629,GO:0038003,1,0.851561313865928,0,4,opioid receptor signaling pathway,BP,
9630,GO:0038007,1,0.877293812863444,0,3,netrin-activated signaling pathway,BP,
9631,GO:0038016,1,0.919879110330992,0,2,insulin receptor internalization,BP,
9632,GO:0038018,1,0.914934706742981,0,2,Wnt receptor catabolic process,BP,
9633,GO:0038021,1,0.956759272813498,0,1,leptin receptor activity,MF,
9636,GO:0038025,1,0.916006686596325,0,2,reelin receptor activity,MF,
9638,GO:0038027,1,0.841724248800854,0,4,apolipoprotein A-I-mediated signaling pathway,BP,
9639,GO:0038028,1,0.841470856128643,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
9640,GO:0038030,1,0.770334783494085,0,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,
9641,GO:0038031,1,0.804925447915499,0,5,non-canonical Wnt signaling pathway via JNK cascade,BP,
9642,GO:0038033,1,0.885130875449581,0,3,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
9644,GO:0038036,1,0.777693049815039,0,6,sphingosine-1-phosphate receptor activity,MF,
9645,GO:0038037,1,0.883018542835065,0,3,G-protein coupled receptor dimeric complex,CC,
9646,GO:0038039,1,0.956698105331908,0,1,G-protein coupled receptor heterodimeric complex,CC,
9647,GO:0038042,1,0.855451218173388,0,4,dimeric G-protein coupled receptor signaling pathway,BP,
9649,GO:0038047,1,0.962252164035365,0,1,morphine receptor activity,MF,
9650,GO:0038049,1,0.914777292668164,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
9651,GO:0038051,1,0.956441843839217,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
9652,GO:0038052,1,0.91831432826055,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
9654,GO:0038062,1,0.957112530813113,0,1,protein tyrosine kinase collagen receptor activity,MF,
9655,GO:0038063,1,0.732646494509596,0,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,
9656,GO:0038064,1,0.915418820445488,0,2,collagen receptor activity,MF,
9657,GO:0038065,1,0.700713917323344,0,8,collagen-activated signaling pathway,BP,
9661,GO:0038085,1,0.960046682619021,0,1,vascular endothelial growth factor binding,MF,
9662,GO:0038086,1,0.957507935744758,0,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
9663,GO:0038089,1,0.809760548337335,0,5,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
9664,GO:0038091,1,0.957507935744758,0,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
9670,GO:0038098,1,0.961646819952517,0,1,sequestering of BMP from receptor via BMP binding,BP,
9671,GO:0038101,1,0.962710557192641,0,1,sequestering of nodal from receptor via nodal binding,BP,
9672,GO:0038107,1,0.886249185445182,0,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,
9673,GO:0038108,1,0.883457174574146,0,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,
9674,GO:0038109,1,0.958598826789882,0,1,Kit signaling pathway,BP,
9675,GO:0038110,1,0.738310761977298,0,7,interleukin-2-mediated signaling pathway,BP,
9676,GO:0038111,1,0.381986911707205,0,25,interleukin-7-mediated signaling pathway,BP,
9678,GO:0038113,1,0.914810517113138,0,2,interleukin-9-mediated signaling pathway,BP,
9680,GO:0038123,1,0.957700811769664,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
9681,GO:0038124,1,0.915981524972829,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
9684,GO:0038129,1,0.922173383734665,0,2,ERBB3 signaling pathway,BP,
9687,GO:0038145,1,0.884315068698135,0,3,macrophage colony-stimulating factor signaling pathway,BP,
9688,GO:0038154,1,0.958072871054507,0,1,interleukin-11-mediated signaling pathway,BP,
9689,GO:0038155,1,0.779355700102436,0,6,interleukin-23-mediated signaling pathway,BP,
9690,GO:0038158,1,0.92210353111611,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
9691,GO:0038161,1,0.958787867083198,0,1,prolactin signaling pathway,BP,
9692,GO:0038162,1,0.96230042687993,0,1,erythropoietin-mediated signaling pathway,BP,
9693,GO:0038163,1,0.964814382377026,0,1,thrombopoietin-mediated signaling pathway,BP,
9694,GO:0038165,1,0.877234382384436,0,3,oncostatin-M-mediated signaling pathway,BP,
9695,GO:0038166,1,0.815732636384217,0,5,angiotensin-activated signaling pathway,BP,
9696,GO:0038171,1,0.88132289036229,0,3,cannabinoid signaling pathway,BP,
9697,GO:0038172,1,0.957140723293023,0,1,interleukin-33-mediated signaling pathway,BP,
9700,GO:0038181,1,0.956550284375981,0,1,bile acid receptor activity,MF,
9701,GO:0038183,1,0.956550284375981,0,1,bile acid signaling pathway,BP,
9702,GO:0038186,1,0.956550284375981,0,1,lithocholic acid receptor activity,MF,
9703,GO:0038187,1,0.779615754671755,0,6,pattern recognition receptor activity,MF,
9704,GO:0038189,1,0.845055717285452,0,4,neuropilin signaling pathway,BP,
9705,GO:0038190,1,0.9192489837951,0,2,VEGF-activated neuropilin signaling pathway,BP,
9706,GO:0038191,1,0.473428142779784,0,17,neuropilin binding,MF,
9707,GO:0038192,1,0.961659370281862,0,1,gastric inhibitory peptide signaling pathway,BP,
9708,GO:0038193,1,0.960806377001927,0,1,thromboxane A2 signaling pathway,BP,
9709,GO:0038194,1,0.957076563173688,0,1,thyroid-stimulating hormone signaling pathway,BP,
9710,GO:0038195,1,0.963601943618745,0,1,urokinase plasminogen activator signaling pathway,BP,
9711,GO:0038201,1,0.513372665585305,0,16,TOR complex,CC,
9712,GO:0038202,1,0.276508533332524,0,31,TORC1 signaling,BP,
9713,GO:0038203,1,0.746799184699022,0,7,TORC2 signaling,BP,
9714,GO:0039003,1,0.957076563173688,0,1,pronephric field specification,BP,
9715,GO:0039007,1,0.956442836694781,0,1,pronephric nephron morphogenesis,BP,
9716,GO:0039008,1,0.956442836694781,0,1,pronephric nephron tubule morphogenesis,BP,
9717,GO:0039017,1,0.957076563173688,0,1,pattern specification involved in pronephros development,BP,
9718,GO:0039019,1,0.915636842095189,0,2,pronephric nephron development,BP,
9719,GO:0039020,1,0.956442836694781,0,1,pronephric nephron tubule development,BP,
9720,GO:0039022,1,0.956442836694781,0,1,pronephric duct development,BP,
9721,GO:0039023,1,0.956442836694781,0,1,pronephric duct morphogenesis,BP,
9722,GO:0039502,1,0.956458141288418,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9723,GO:0039503,1,0.956458141288418,0,1,suppression by virus of host innate immune response,BP,
9724,GO:0039506,1,0.917390490362846,0,2,modulation by virus of host molecular function,BP,
9725,GO:0039507,1,0.917390490362846,0,2,suppression by virus of host molecular function,BP,
9726,GO:0039513,1,0.959157474640937,0,1,suppression by virus of host catalytic activity,BP,
9727,GO:0039514,1,0.956458141288418,0,1,suppression by virus of host JAK-STAT cascade,BP,
9728,GO:0039516,1,0.959157474640937,0,1,modulation by virus of host catalytic activity,BP,
9729,GO:0039519,1,0.914823000546106,0,2,modulation by virus of host autophagy,BP,
9730,GO:0039520,1,0.956442926943674,0,1,induction by virus of host autophagy,BP,
9731,GO:0039521,1,0.956488546109679,0,1,suppression by virus of host autophagy,BP,
9732,GO:0039526,1,0.888241634474252,0,3,modulation by virus of host apoptotic process,BP,
9737,GO:0039532,1,0.657633889187859,0,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
9739,GO:0039534,1,0.848995333473112,0,4,negative regulation of MDA-5 signaling pathway,BP,
9741,GO:0039536,1,0.745528629941712,0,7,negative regulation of RIG-I signaling pathway,BP,
9742,GO:0039552,1,0.956443705585263,0,1,RIG-I binding,MF,
9743,GO:0039562,1,0.956458141288418,0,1,suppression by virus of host STAT activity,BP,
9744,GO:0039563,1,0.956458141288418,0,1,suppression by virus of host STAT1 activity,BP,
9745,GO:0039564,1,0.956458141288418,0,1,suppression by virus of host STAT2 activity,BP,
9746,GO:0039650,1,0.959157474640937,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
9747,GO:0039656,1,0.922399962731537,0,2,modulation by virus of host gene expression,BP,
9748,GO:0039663,1,0.886372417110425,0,3,membrane fusion involved in viral entry into host cell,BP,
9749,GO:0039689,1,0.881879072275034,0,3,negative stranded viral RNA replication,BP,
9750,GO:0039692,1,0.664703853990358,0,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,
9751,GO:0039694,1,0.366864457125722,0,24,viral RNA genome replication,BP,
9752,GO:0039695,1,0.956580991138864,0,1,DNA-templated viral transcription,BP,
9753,GO:0039702,1,0.431220084773726,0,21,viral budding via host ESCRT complex,BP,
9755,GO:0039713,1,0.957631146660816,0,1,viral factory,CC,
9756,GO:0039714,1,0.957631146660816,0,1,cytoplasmic viral factory,CC,
9760,GO:0040009,1,0.840555984601053,0,4,regulation of growth rate,BP,
9765,GO:0040015,1,0.68712047077622,0,9,negative regulation of multicellular organism growth,BP,
9766,GO:0040016,1,0.745829980835436,0,7,embryonic cleavage,BP,
9768,GO:0040018,1,0.446401149775886,0,19,positive regulation of multicellular organism growth,BP,
9770,GO:0040020,1,0.512538373904784,0,16,regulation of meiotic nuclear division,BP,
9772,GO:0040030,1,0.957158705438603,0,1,regulation of molecular function, epigenetic,BP,
9773,GO:0040031,1,0.793021768412432,0,6,snRNA modification,BP,
9774,GO:0040032,1,0.962156755947303,0,1,post-embryonic body morphogenesis,BP,
9775,GO:0040033,1,0.604685663778521,0,12,negative regulation of translation, ncRNA-mediated,BP,
9779,GO:0040038,1,0.916233541586086,0,2,polar body extrusion after meiotic divisions,BP,
9780,GO:0042000,1,0.960287525593611,0,1,translocation of peptides or proteins into host,BP,
9781,GO:0042007,1,0.963659369110401,0,1,interleukin-18 binding,MF,
9782,GO:0042008,1,0.957502774555405,0,1,interleukin-18 receptor activity,MF,
9784,GO:0042019,1,0.961825504587889,0,1,interleukin-23 binding,MF,
9785,GO:0042020,1,0.961825504587889,0,1,interleukin-23 receptor activity,MF,
9786,GO:0042022,1,0.961825504587889,0,1,interleukin-12 receptor complex,CC,
9787,GO:0042023,1,0.704560219629204,0,8,DNA endoreduplication,BP,
9788,GO:0042025,1,0.879117691882937,0,3,host cell nucleus,CC,
9789,GO:0042026,1,0.35605064055425,0,25,protein refolding,BP,
9790,GO:0042030,1,0.914777292668164,0,2,ATPase inhibitor activity,MF,
9791,GO:0042033,1,0.726116756020016,0,8,chemokine biosynthetic process,BP,
9794,GO:0042040,1,0.956756130289669,0,1,metal incorporation into metallo-molybdopterin complex,BP,
9796,GO:0042044,1,0.631386972079672,0,11,fluid transport,BP,
9797,GO:0042045,1,0.844270098238463,0,4,epithelial fluid transport,BP,
9798,GO:0042048,1,0.803382660689342,0,5,olfactory behavior,BP,
9799,GO:0042053,1,0.689190784800486,0,9,regulation of dopamine metabolic process,BP,
9806,GO:0042069,1,0.689190784800486,0,9,regulation of catecholamine metabolic process,BP,
9807,GO:0042073,1,0.128588201830715,0,49,intraciliary transport,BP,
9808,GO:0042074,1,0.767800587822013,0,6,cell migration involved in gastrulation,BP,
9810,GO:0042083,1,0.963167399764482,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
9811,GO:0042084,1,0.956441843839217,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
9812,GO:0042088,1,0.390487080663241,0,23,T-helper 1 type immune response,BP,
9814,GO:0042090,1,0.807209706534033,0,5,interleukin-12 biosynthetic process,BP,
9815,GO:0042091,1,0.921221930406703,0,2,interleukin-10 biosynthetic process,BP,
9818,GO:0042094,1,0.665372625581191,0,10,interleukin-2 biosynthetic process,BP,
9823,GO:0042101,1,0.743937606124197,0,7,T cell receptor complex,CC,
9825,GO:0042104,1,0.530772667737442,0,16,positive regulation of activated T cell proliferation,BP,
9826,GO:0042105,1,0.960851340621743,0,1,alpha-beta T cell receptor complex,CC,
9829,GO:0042109,1,0.958277223529834,0,1,lymphotoxin A biosynthetic process,BP,
9832,GO:0042116,1,0.217352294905158,0,36,macrophage activation,BP,
9833,GO:0042117,1,0.809145479985597,0,5,monocyte activation,BP,
9834,GO:0042118,1,0.743846333566928,0,7,endothelial cell activation,BP,
9836,GO:0042126,1,0.847662026766812,0,4,nitrate metabolic process,BP,
9838,GO:0042128,1,0.960575478574431,0,1,nitrate assimilation,BP,
9842,GO:0042134,1,0.927833634602851,0,2,rRNA primary transcript binding,MF,
9843,GO:0042135,1,0.628262349794749,0,11,neurotransmitter catabolic process,BP,
9845,GO:0042137,1,0.962113139440756,0,1,sequestering of neurotransmitter,BP,
9846,GO:0042138,1,0.960571916515905,0,1,meiotic DNA double-strand break formation,BP,
9847,GO:0042140,1,0.958787867083198,0,1,late meiotic recombination nodule assembly,BP,
9848,GO:0042144,1,0.918155214198985,0,2,vacuole fusion, non-autophagic,BP,
9850,GO:0042148,1,0.720265877021167,0,8,strand invasion,BP,
9855,GO:0042162,1,0.228437761205613,0,35,telomeric DNA binding,MF,
9856,GO:0042165,1,0.457304607761506,0,19,neurotransmitter binding,MF,
9857,GO:0042166,1,0.813045149848969,0,5,acetylcholine binding,MF,
9858,GO:0042167,1,0.79629585260409,0,6,heme catabolic process,BP,
9867,GO:0042181,1,0.366425405591603,0,25,ketone biosynthetic process,BP,
9869,GO:0042214,1,0.962109643726768,0,1,terpene metabolic process,BP,
9870,GO:0042219,1,0.479150318246668,0,18,cellular modified amino acid catabolic process,BP,
9873,GO:0042222,1,0.958207088018547,0,1,interleukin-1 biosynthetic process,BP,
9874,GO:0042223,1,0.956479002849494,0,1,interleukin-3 biosynthetic process,BP,
9875,GO:0042226,1,0.658394084266903,0,10,interleukin-6 biosynthetic process,BP,
9876,GO:0042228,1,0.776845795112505,0,6,interleukin-8 biosynthetic process,BP,
9877,GO:0042231,1,0.964397565363727,0,1,interleukin-13 biosynthetic process,BP,
9878,GO:0042241,1,0.957989060654006,0,1,interleukin-18 biosynthetic process,BP,
9879,GO:0042245,1,0.918186210021215,0,2,RNA repair,BP,
9881,GO:0042247,1,0.958660956807448,0,1,establishment of planar polarity of follicular epithelium,BP,
9883,GO:0042253,1,0.922422967514953,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
9885,GO:0042255,1,0.126905487849564,0,54,ribosome assembly,BP,
9886,GO:0042256,1,0.819669304711404,0,5,mature ribosome assembly,BP,
9887,GO:0042262,1,0.829221298184179,0,5,DNA protection,BP,
9888,GO:0042264,1,0.915647752602004,0,2,peptidyl-aspartic acid hydroxylation,BP,
9889,GO:0042265,1,0.956441843839217,0,1,peptidyl-asparagine hydroxylation,BP,
9890,GO:0042267,1,0.252047882814603,0,34,natural killer cell mediated cytotoxicity,BP,
9891,GO:0042268,1,0.860502608875329,0,4,regulation of cytolysis,BP,
9892,GO:0042269,1,0.517040835030173,0,16,regulation of natural killer cell mediated cytotoxicity,BP,
9893,GO:0042270,1,0.886977700103104,0,3,protection from natural killer cell mediated cytotoxicity,BP,
9894,GO:0042271,1,0.915077615935809,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
9895,GO:0042272,1,0.914782258040259,0,2,nuclear RNA export factor complex,CC,
9896,GO:0042273,1,0.0773405572351687,0,66,ribosomal large subunit biogenesis,BP,
9897,GO:0042274,1,0.0631775501926214,0,70,ribosomal small subunit biogenesis,BP,
9898,GO:0042275,1,0.963361281418373,0,1,error-free postreplication DNA repair,BP,
9899,GO:0042276,1,0.467339213290581,0,19,error-prone translesion synthesis,BP,
9902,GO:0042281,1,0.922061763774798,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
9903,GO:0042282,1,0.956625411611973,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
9904,GO:0042284,1,0.962293545506958,0,1,sphingolipid delta-4 desaturase activity,MF,
9906,GO:0042287,1,0.536820962437378,0,15,MHC protein binding,MF,
9907,GO:0042288,1,0.688892522705164,0,9,MHC class I protein binding,MF,
9908,GO:0042289,1,0.963191933642196,0,1,MHC class II protein binding,MF,
9909,GO:0042292,1,0.960153487129964,0,1,URM1 activating enzyme activity,MF,
9910,GO:0042296,1,0.856249816570845,0,4,ISG15 transferase activity,MF,
9911,GO:0042297,1,0.837586075374803,0,4,vocal learning,BP,
9912,GO:0042301,1,0.780971139325125,0,6,phosphate ion binding,MF,
9914,GO:0042304,1,0.311998259742711,0,28,regulation of fatty acid biosynthetic process,BP,
9915,GO:0042306,1,0.180408947999766,0,41,regulation of protein import into nucleus,BP,
9916,GO:0042307,1,0.333220498654734,0,26,positive regulation of protein import into nucleus,BP,
9917,GO:0042308,1,0.747302351514869,0,7,negative regulation of protein import into nucleus,BP,
9920,GO:0042313,1,0.961427324140695,0,1,protein kinase C deactivation,BP,
9921,GO:0042316,1,0.95647281873084,0,1,penicillin metabolic process,BP,
9922,GO:0042320,1,0.956441860364028,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
9923,GO:0042321,1,0.963310309890086,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
9924,GO:0042323,1,0.963310309890086,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
9928,GO:0042328,1,0.876855096624351,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
9930,GO:0042335,1,0.879102450923601,0,3,cuticle development,BP,
9933,GO:0042350,1,0.888144931392527,0,3,GDP-L-fucose biosynthetic process,BP,
9934,GO:0042351,1,0.928034301713347,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
9935,GO:0042352,1,0.957023795656133,0,1,GDP-L-fucose salvage,BP,
9936,GO:0042354,1,0.770742267876858,0,6,L-fucose metabolic process,BP,
9937,GO:0042355,1,0.770742267876858,0,6,L-fucose catabolic process,BP,
9938,GO:0042356,1,0.963814807334626,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
9939,GO:0042357,1,0.962491165173348,0,1,thiamine diphosphate metabolic process,BP,
9940,GO:0042359,1,0.593344685479821,0,13,vitamin D metabolic process,BP,
9941,GO:0042360,1,0.96287732446197,0,1,vitamin E metabolic process,BP,
9942,GO:0042361,1,0.958084093847764,0,1,menaquinone catabolic process,BP,
9943,GO:0042362,1,0.722488197222917,0,8,fat-soluble vitamin biosynthetic process,BP,
9944,GO:0042363,1,0.843017508079401,0,4,fat-soluble vitamin catabolic process,BP,
9945,GO:0042364,1,0.714113554255432,0,8,water-soluble vitamin biosynthetic process,BP,
9946,GO:0042365,1,0.887814488617992,0,3,water-soluble vitamin catabolic process,BP,
9947,GO:0042368,1,0.783822399957903,0,6,vitamin D biosynthetic process,BP,
9948,GO:0042369,1,0.919818132958617,0,2,vitamin D catabolic process,BP,
9949,GO:0042371,1,0.957329124230061,0,1,vitamin K biosynthetic process,BP,
9950,GO:0042373,1,0.822883346858562,0,5,vitamin K metabolic process,BP,
9953,GO:0042377,1,0.958084093847764,0,1,vitamin K catabolic process,BP,
9955,GO:0042382,1,0.776257059762988,0,6,paraspeckles,CC,
9961,GO:0042401,1,0.598296815342479,0,13,cellular biogenic amine biosynthetic process,BP,
9962,GO:0042402,1,0.677974546714422,0,10,cellular biogenic amine catabolic process,BP,
9963,GO:0042403,1,0.649915866107243,0,10,thyroid hormone metabolic process,BP,
9964,GO:0042405,1,0.593583247963075,0,12,nuclear inclusion body,CC,
9965,GO:0042406,1,0.851421517044182,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
9966,GO:0042407,1,0.551088734452138,0,15,cristae formation,BP,
9967,GO:0042412,1,0.959323986822767,0,1,taurine biosynthetic process,BP,
9968,GO:0042414,1,0.920198677084929,0,2,epinephrine metabolic process,BP,
9969,GO:0042415,1,0.746334834869176,0,7,norepinephrine metabolic process,BP,
9970,GO:0042416,1,0.751431276267771,0,7,dopamine biosynthetic process,BP,
9971,GO:0042417,1,0.493903348930024,0,17,dopamine metabolic process,BP,
9972,GO:0042418,1,0.962109643726768,0,1,epinephrine biosynthetic process,BP,
9973,GO:0042420,1,0.848878582689884,0,4,dopamine catabolic process,BP,
9974,GO:0042421,1,0.883678994479173,0,3,norepinephrine biosynthetic process,BP,
9975,GO:0042423,1,0.690145288658231,0,9,catecholamine biosynthetic process,BP,
9976,GO:0042424,1,0.813538068099303,0,5,catecholamine catabolic process,BP,
9977,GO:0042426,1,0.915898847714254,0,2,choline catabolic process,BP,
9978,GO:0042428,1,0.842078394458836,0,4,serotonin metabolic process,BP,
9979,GO:0042430,1,0.722459532553931,0,8,indole-containing compound metabolic process,BP,
9980,GO:0042436,1,0.891184462161528,0,3,indole-containing compound catabolic process,BP,
9981,GO:0042438,1,0.709428795716164,0,8,melanin biosynthetic process,BP,
9982,GO:0042439,1,0.777999459062109,0,6,ethanolamine-containing compound metabolic process,BP,
9984,GO:0042441,1,0.956519923983069,0,1,eye pigment metabolic process,BP,
9987,GO:0042447,1,0.784803151293374,0,6,hormone catabolic process,BP,
9988,GO:0042448,1,0.722634374941902,0,8,progesterone metabolic process,BP,
9989,GO:0042450,1,0.961802356086505,0,1,arginine biosynthetic process via ornithine,BP,
9991,GO:0042454,1,0.555331480594841,0,15,ribonucleoside catabolic process,BP,
10002,GO:0042481,1,0.657553618605027,0,10,regulation of odontogenesis,BP,
10003,GO:0042482,1,0.814293272134567,0,5,positive regulation of odontogenesis,BP,
10004,GO:0042483,1,0.956441843839217,0,1,negative regulation of odontogenesis,BP,
10005,GO:0042487,1,0.84701191106107,0,4,regulation of odontogenesis of dentin-containing tooth,BP,
10006,GO:0042488,1,0.960240360586506,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10009,GO:0042492,1,0.806493528792379,0,5,gamma-delta T cell differentiation,BP,
10011,GO:0042494,1,0.915981524972829,0,2,detection of bacterial lipoprotein,BP,
10012,GO:0042495,1,0.957700811769664,0,1,detection of triacyl bacterial lipopeptide,BP,
10013,GO:0042496,1,0.915981524972829,0,2,detection of diacyl bacterial lipopeptide,BP,
10014,GO:0042497,1,0.957700811769664,0,1,triacyl lipopeptide binding,MF,
10015,GO:0042500,1,0.779655226902059,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10016,GO:0042501,1,0.667642152155161,0,10,serine phosphorylation of STAT protein,BP,
10017,GO:0042509,1,0.188984369855586,0,41,regulation of tyrosine phosphorylation of STAT protein,BP,
10018,GO:0042531,1,0.272962831524761,0,32,positive regulation of tyrosine phosphorylation of STAT protein,BP,
10019,GO:0042532,1,0.634132912554291,0,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10020,GO:0042533,1,0.718235580996648,0,8,tumor necrosis factor biosynthetic process,BP,
10021,GO:0042534,1,0.718235580996648,0,8,regulation of tumor necrosis factor biosynthetic process,BP,
10022,GO:0042535,1,0.845528345259457,0,4,positive regulation of tumor necrosis factor biosynthetic process,BP,
10023,GO:0042536,1,0.887947067773884,0,3,negative regulation of tumor necrosis factor biosynthetic process,BP,
10024,GO:0042537,1,0.601500708229474,0,13,benzene-containing compound metabolic process,BP,
10027,GO:0042541,1,0.781173770809398,0,6,hemoglobin biosynthetic process,BP,
10029,GO:0042543,1,0.965787286362701,0,1,protein N-linked glycosylation via arginine,BP,
10030,GO:0042546,1,0.962561648789528,0,1,cell wall biogenesis,BP,
10031,GO:0042551,1,0.345233362148564,0,25,neuron maturation,BP,
10034,GO:0042555,1,0.626897937771788,0,11,MCM complex,CC,
10036,GO:0042559,1,0.57588649273289,0,14,pteridine-containing compound biosynthetic process,BP,
10037,GO:0042560,1,0.845968059695972,0,4,pteridine-containing compound catabolic process,BP,
10039,GO:0042564,1,0.956703611372165,0,1,NLS-dependent protein nuclear import complex,CC,
10040,GO:0042565,1,0.922573169563137,0,2,RNA nuclear export complex,CC,
10041,GO:0042567,1,0.91780671039256,0,2,insulin-like growth factor ternary complex,CC,
10042,GO:0042568,1,0.964845597944193,0,1,insulin-like growth factor binary complex,CC,
10046,GO:0042575,1,0.522536326041701,0,16,DNA polymerase complex,CC,
10052,GO:0042583,1,0.810901914342741,0,5,chromaffin granule,CC,
10053,GO:0042584,1,0.845659070224734,0,4,chromaffin granule membrane,CC,
10054,GO:0042585,1,0.919358768892196,0,2,germinal vesicle,CC,
10055,GO:0042586,1,0.964374490092341,0,1,peptide deformylase activity,MF,
10056,GO:0042587,1,0.812922538830021,0,5,glycogen granule,CC,
10063,GO:0042595,1,0.957104703318769,0,1,behavioral response to starvation,BP,
10066,GO:0042602,1,0.965102009440075,0,1,riboflavin reductase (NADPH) activity,MF,
10067,GO:0042605,1,0.570238851420274,0,14,peptide antigen binding,MF,
10068,GO:0042608,1,0.889062834263701,0,3,T cell receptor binding,MF,
10069,GO:0042609,1,0.850820768694513,0,4,CD4 receptor binding,MF,
10070,GO:0042610,1,0.961501227771577,0,1,CD8 receptor binding,MF,
10071,GO:0042611,1,0.664690369009056,0,11,MHC protein complex,CC,
10072,GO:0042612,1,0.715309929702312,0,9,MHC class I protein complex,CC,
10073,GO:0042613,1,0.929281135381419,0,2,MHC class II protein complex,CC,
10074,GO:0042622,1,0.772080719141285,0,6,photoreceptor outer segment membrane,CC,
10076,GO:0042624,1,0.965480518973622,0,1,ATPase activity, uncoupled,MF,
10081,GO:0042629,1,0.666632473469849,0,10,mast cell granule,CC,
10082,GO:0042631,1,0.957427587375318,0,1,cellular response to water deprivation,BP,
10085,GO:0042634,1,0.396920457943257,0,22,regulation of hair cycle,BP,
10086,GO:0042635,1,0.670565542279772,0,10,positive regulation of hair cycle,BP,
10087,GO:0042636,1,0.838817991795214,0,4,negative regulation of hair cycle,BP,
10088,GO:0042637,1,0.84888619549928,0,4,catagen,BP,
10089,GO:0042640,1,0.838642374850811,0,4,anagen,BP,
10091,GO:0042643,1,0.958660956807448,0,1,actomyosin, actin portion,CC,
10093,GO:0042659,1,0.740433855712556,0,7,regulation of cell fate specification,BP,
10094,GO:0042660,1,0.956441843839217,0,1,positive regulation of cell fate specification,BP,
10095,GO:0042661,1,0.881283777041002,0,3,regulation of mesodermal cell fate specification,BP,
10096,GO:0042662,1,0.962464157847848,0,1,negative regulation of mesodermal cell fate specification,BP,
10097,GO:0042663,1,0.923647430817591,0,2,regulation of endodermal cell fate specification,BP,
10098,GO:0042665,1,0.957101073089762,0,1,regulation of ectodermal cell fate specification,BP,
10099,GO:0042666,1,0.957101073089762,0,1,negative regulation of ectodermal cell fate specification,BP,
10100,GO:0042668,1,0.928857129480457,0,2,auditory receptor cell fate determination,BP,
10101,GO:0042670,1,0.879331236280963,0,3,retinal cone cell differentiation,BP,
10104,GO:0042695,1,0.816782981305382,0,5,thelarche,BP,
10106,GO:0042699,1,0.924633908921312,0,2,follicle-stimulating hormone signaling pathway,BP,
10107,GO:0042700,1,0.956580264723012,0,1,luteinizing hormone signaling pathway,BP,
10108,GO:0042701,1,0.919292003082917,0,2,progesterone secretion,BP,
10109,GO:0042704,1,0.916377758775145,0,2,uterine wall breakdown,BP,
10110,GO:0042709,1,0.960497262593105,0,1,succinate-CoA ligase complex,CC,
10111,GO:0042711,1,0.77766263463637,0,6,maternal behavior,BP,
10112,GO:0042713,1,0.875333642960907,0,3,sperm ejaculation,BP,
10113,GO:0042719,1,0.828713796166675,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10114,GO:0042720,1,0.929872392942526,0,2,mitochondrial inner membrane peptidase complex,CC,
10115,GO:0042721,1,0.824240666690429,0,5,mitochondrial inner membrane protein insertion complex,CC,
10116,GO:0042723,1,0.887322675396054,0,3,thiamine-containing compound metabolic process,BP,
10117,GO:0042726,1,0.71700100391528,0,8,flavin-containing compound metabolic process,BP,
10118,GO:0042727,1,0.92274696230419,0,2,flavin-containing compound biosynthetic process,BP,
10119,GO:0042728,1,0.957076563173688,0,1,flavin-containing compound catabolic process,BP,
10122,GO:0042732,1,0.923915471201456,0,2,D-xylose metabolic process,BP,
10126,GO:0042738,1,0.752006229506502,0,7,exogenous drug catabolic process,BP,
10131,GO:0042747,1,0.851082744591766,0,4,circadian sleep/wake cycle, REM sleep,BP,
10132,GO:0042748,1,0.88120839407149,0,3,circadian sleep/wake cycle, non-REM sleep,BP,
10135,GO:0042753,1,0.772293945261718,0,6,positive regulation of circadian rhythm,BP,
10137,GO:0042755,1,0.562205721846828,0,14,eating behavior,BP,
10138,GO:0042756,1,0.88717240417235,0,3,drinking behavior,BP,
10139,GO:0042758,1,0.846656888173028,0,4,long-chain fatty acid catabolic process,BP,
10141,GO:0042760,1,0.81290910308513,0,5,very long-chain fatty acid catabolic process,BP,
10142,GO:0042761,1,0.661195926572327,0,10,very long-chain fatty acid biosynthetic process,BP,
10144,GO:0042765,1,0.815497727069396,0,5,GPI-anchor transamidase complex,CC,
10145,GO:0042766,1,0.956441843839217,0,1,nucleosome mobilization,BP,
10146,GO:0042769,1,0.225139743618612,0,37,DNA damage response, detection of DNA damage,BP,
10151,GO:0042774,1,0.958787867083198,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10154,GO:0042779,1,0.919746524237093,0,2,tRNA 3'-trailer cleavage,BP,
10155,GO:0042780,1,0.754390610260347,0,7,tRNA 3'-end processing,BP,
10156,GO:0042781,1,0.919746524237093,0,2,3'-tRNA processing endoribonuclease activity,MF,
10157,GO:0042788,1,0.33759658389674,0,29,polysomal ribosome,CC,
10159,GO:0042790,1,0.60984631915516,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10160,GO:0042791,1,0.778081332727334,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10162,GO:0042796,1,0.777528670367567,0,6,snRNA transcription by RNA polymerase III,BP,
10163,GO:0042797,1,0.778081332727334,0,6,tRNA transcription by RNA polymerase III,BP,
10169,GO:0042806,1,0.958787867083198,0,1,fucose binding,MF,
10170,GO:0042809,1,0.531114743773579,0,15,vitamin D receptor binding,MF,
10172,GO:0042816,1,0.809942175388642,0,5,vitamin B6 metabolic process,BP,
10173,GO:0042819,1,0.880466168312259,0,3,vitamin B6 biosynthetic process,BP,
10174,GO:0042820,1,0.96177026169185,0,1,vitamin B6 catabolic process,BP,
10175,GO:0042822,1,0.880856370296944,0,3,pyridoxal phosphate metabolic process,BP,
10176,GO:0042823,1,0.915876265064745,0,2,pyridoxal phosphate biosynthetic process,BP,
10177,GO:0042824,1,0.845048057514376,0,4,MHC class I peptide loading complex,CC,
10178,GO:0042825,1,0.878366019766834,0,3,TAP complex,CC,
10179,GO:0042826,1,0.0236819085228967,0,89,histone deacetylase binding,MF,
10180,GO:0042827,1,0.636259934742526,0,11,platelet dense granule,CC,
10182,GO:0042834,1,0.779314112822597,0,6,peptidoglycan binding,MF,
10183,GO:0042835,1,0.956552924507682,0,1,BRE binding,MF,
10184,GO:0042839,1,0.963498797201556,0,1,D-glucuronate metabolic process,BP,
10185,GO:0042840,1,0.963498797201556,0,1,D-glucuronate catabolic process,BP,
10186,GO:0042851,1,0.957026642911005,0,1,L-alanine metabolic process,BP,
10187,GO:0042853,1,0.957026642911005,0,1,L-alanine catabolic process,BP,
10193,GO:0042903,1,0.920459288238183,0,2,tubulin deacetylase activity,MF,
10194,GO:0042904,1,0.919246917917044,0,2,9-cis-retinoic acid biosynthetic process,BP,
10195,GO:0042905,1,0.919246917917044,0,2,9-cis-retinoic acid metabolic process,BP,
10199,GO:0042922,1,0.965198421423852,0,1,neuromedin U receptor binding,MF,
10200,GO:0042923,1,0.924395333693338,0,2,neuropeptide binding,MF,
10202,GO:0042938,1,0.923889708631606,0,2,dipeptide transport,BP,
10204,GO:0042940,1,0.879108093165766,0,3,D-amino acid transport,BP,
10205,GO:0042942,1,0.959720196884563,0,1,D-serine transport,BP,
10206,GO:0042946,1,0.958787867083198,0,1,glucoside transport,BP,
10207,GO:0042947,1,0.958787867083198,0,1,glucoside transmembrane transporter activity,MF,
10209,GO:0042954,1,0.806927033278711,0,5,lipoprotein transporter activity,MF,
10210,GO:0042974,1,0.447875224097147,0,19,retinoic acid receptor binding,MF,
10212,GO:0042976,1,0.752267722204367,0,7,activation of Janus kinase activity,BP,
10213,GO:0042978,1,0.917314641001775,0,2,ornithine decarboxylase activator activity,MF,
10214,GO:0042979,1,0.851093614098831,0,4,ornithine decarboxylase regulator activity,MF,
10217,GO:0042983,1,0.695826770957766,0,9,amyloid precursor protein biosynthetic process,BP,
10218,GO:0042984,1,0.695826770957766,0,9,regulation of amyloid precursor protein biosynthetic process,BP,
10219,GO:0042985,1,0.785360212496302,0,6,negative regulation of amyloid precursor protein biosynthetic process,BP,
10220,GO:0042986,1,0.921250463127928,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10222,GO:0042988,1,0.956460180417596,0,1,X11-like protein binding,MF,
10223,GO:0042989,1,0.797279523812454,0,6,sequestering of actin monomers,BP,
10226,GO:0042996,1,0.807000145752641,0,5,regulation of Golgi to plasma membrane protein transport,BP,
10227,GO:0042997,1,0.881375507558155,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
10228,GO:0042998,1,0.91563529998387,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10229,GO:0042999,1,0.956593539255046,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10230,GO:0043000,1,0.921754326302402,0,2,Golgi to plasma membrane CFTR protein transport,BP,
10232,GO:0043002,1,0.956593539255046,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10233,GO:0043004,1,0.956593539255046,0,1,cytoplasmic sequestering of CFTR protein,BP,
10236,GO:0043008,1,0.717272880273498,0,8,ATP-dependent protein binding,MF,
10239,GO:0043011,1,0.719811143696642,0,8,myeloid dendritic cell differentiation,BP,
10245,GO:0043023,1,0.639171145633664,0,11,ribosomal large subunit binding,MF,
10246,GO:0043024,1,0.561808187918751,0,14,ribosomal small subunit binding,MF,
10248,GO:0043027,1,0.49142967136083,0,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
10249,GO:0043028,1,0.265120768160977,0,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
10250,GO:0043029,1,0.31749621849952,0,28,T cell homeostasis,BP,
10251,GO:0043030,1,0.400785101035929,0,22,regulation of macrophage activation,BP,
10252,GO:0043031,1,0.848723953143024,0,4,negative regulation of macrophage activation,BP,
10253,GO:0043032,1,0.637557517163889,0,11,positive regulation of macrophage activation,BP,
10254,GO:0043033,1,0.956441843839217,0,1,isoamylase complex,CC,
10256,GO:0043035,1,0.957158705438603,0,1,chromatin insulator sequence binding,MF,
10257,GO:0043038,1,0.114478105706816,0,53,amino acid activation,BP,
10258,GO:0043039,1,0.119589783580159,0,52,tRNA aminoacylation,BP,
10259,GO:0043041,1,0.957438075438589,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
10262,GO:0043045,1,0.776257736194106,0,6,DNA methylation involved in embryo development,BP,
10263,GO:0043046,1,0.744951522399236,0,7,DNA methylation involved in gamete generation,BP,
10264,GO:0043047,1,0.630638354333414,0,11,single-stranded telomeric DNA binding,MF,
10265,GO:0043048,1,0.961060556757563,0,1,dolichyl monophosphate biosynthetic process,BP,
10266,GO:0043060,1,0.960101674776263,0,1,meiotic metaphase I plate congression,BP,
10275,GO:0043084,1,0.844673541985048,0,4,penile erection,BP,
10279,GO:0043090,1,0.604652101028421,0,12,amino acid import,BP,
10280,GO:0043094,1,0.279906379500849,0,32,cellular metabolic compound salvage,BP,
10281,GO:0043095,1,0.965429774928901,0,1,regulation of GTP cyclohydrolase I activity,BP,
10282,GO:0043096,1,0.82741308743037,0,5,purine nucleobase salvage,BP,
10283,GO:0043097,1,0.648763217580949,0,11,pyrimidine nucleoside salvage,BP,
10284,GO:0043101,1,0.596030717665247,0,13,purine-containing compound salvage,BP,
10285,GO:0043102,1,0.787014396224325,0,6,amino acid salvage,BP,
10286,GO:0043103,1,0.890945136446908,0,3,hypoxanthine salvage,BP,
10287,GO:0043105,1,0.965429774928901,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10288,GO:0043111,1,0.922062860709863,0,2,replication fork arrest,BP,
10292,GO:0043116,1,0.74096650001736,0,7,negative regulation of vascular permeability,BP,
10294,GO:0043120,1,0.888585500467464,0,3,tumor necrosis factor binding,MF,
10300,GO:0043126,1,0.963423728178762,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10301,GO:0043128,1,0.963423728178762,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10302,GO:0043129,1,0.807633348113106,0,5,surfactant homeostasis,BP,
10304,GO:0043131,1,0.956463626558617,0,1,erythrocyte enucleation,BP,
10305,GO:0043132,1,0.960822557325351,0,1,NAD transport,BP,
10306,GO:0043136,1,0.958207088018547,0,1,glycerol-3-phosphatase activity,MF,
10307,GO:0043137,1,0.853724927216592,0,4,DNA replication, removal of RNA primer,BP,
10308,GO:0043138,1,0.598808610246355,0,12,3'-5' DNA helicase activity,MF,
10309,GO:0043139,1,0.749837368672893,0,7,5'-3' DNA helicase activity,MF,
10310,GO:0043140,1,0.734135612333482,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
10311,GO:0043141,1,0.815482378081215,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
10312,GO:0043142,1,0.58373929908128,0,13,single-stranded DNA-dependent ATPase activity,MF,
10313,GO:0043144,1,0.741223525039834,0,8,snoRNA processing,BP,
10317,GO:0043159,1,0.957413043485265,0,1,acrosomal matrix,CC,
10320,GO:0043163,1,0.917307276233887,0,2,cell envelope organization,BP,
10326,GO:0043173,1,0.575740855300578,0,14,nucleotide salvage,BP,
10327,GO:0043174,1,0.53391719441447,0,16,nucleoside salvage,BP,
10329,GO:0043176,1,0.887725713534676,0,3,amine binding,MF,
10332,GO:0043179,1,0.961427324140695,0,1,rhythmic excitation,BP,
10336,GO:0043185,1,0.961486816800273,0,1,vascular endothelial growth factor receptor 3 binding,MF,
10337,GO:0043186,1,0.74727648281432,0,7,P granule,CC,
10339,GO:0043190,1,0.770557468991531,0,6,ATP-binding cassette (ABC) transporter complex,CC,
10340,GO:0043194,1,0.680782164756517,0,9,axon initial segment,CC,
10345,GO:0043199,1,0.884581990722491,0,3,sulfate binding,MF,
10347,GO:0043201,1,0.64798003761508,0,10,response to leucine,BP,
10349,GO:0043203,1,0.789017936366102,0,6,axon hillock,CC,
10352,GO:0043208,1,0.84680617168787,0,4,glycosphingolipid binding,MF,
10355,GO:0043218,1,0.637130321054305,0,11,compact myelin,CC,
10356,GO:0043219,1,0.848101190795649,0,4,lateral loop,CC,
10357,GO:0043220,1,0.715161486877885,0,8,Schmidt-Lanterman incisure,CC,
10358,GO:0043221,1,0.957081614670068,0,1,SMC family protein binding,MF,
10359,GO:0043224,1,0.930245112948848,0,2,nuclear SCF ubiquitin ligase complex,CC,
10371,GO:0043237,1,0.837655971003805,0,4,laminin-1 binding,MF,
10372,GO:0043240,1,0.628424848093184,0,11,Fanconi anaemia nuclear complex,CC,
10376,GO:0043247,1,0.57816236987019,0,13,telomere maintenance in response to DNA damage,BP,
10377,GO:0043248,1,0.63627489099541,0,12,proteasome assembly,BP,
10379,GO:0043250,1,0.963414842003904,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
10380,GO:0043251,1,0.963414842003904,0,1,sodium-dependent organic anion transport,BP,
10381,GO:0043252,1,0.654029614159495,0,10,sodium-independent organic anion transport,BP,
10385,GO:0043257,1,0.956441843839217,0,1,laminin-8 complex,CC,
10386,GO:0043259,1,0.874924186969474,0,3,laminin-10 complex,CC,
10388,GO:0043262,1,0.883882755801832,0,3,adenosine-diphosphatase activity,MF,
10390,GO:0043267,1,0.552970818971975,0,14,negative regulation of potassium ion transport,BP,
10391,GO:0043268,1,0.527260987217972,0,15,positive regulation of potassium ion transport,BP,
10395,GO:0043273,1,0.956446411745775,0,1,CTPase activity,MF,
10396,GO:0043274,1,0.620945798571663,0,11,phospholipase binding,MF,
10397,GO:0043276,1,0.319269374532049,0,27,anoikis,BP,
10399,GO:0043278,1,0.49549117234043,0,17,response to morphine,BP,
10403,GO:0043291,1,0.914777292668164,0,2,RAVE complex,CC,
10405,GO:0043293,1,0.920662928200797,0,2,apoptosome,CC,
10406,GO:0043295,1,0.652960512143637,0,11,glutathione binding,MF,
10408,GO:0043297,1,0.127518839000744,0,48,apical junction assembly,BP,
10411,GO:0043301,1,0.808291935406978,0,5,negative regulation of leukocyte degranulation,BP,
10415,GO:0043305,1,0.922752782439339,0,2,negative regulation of mast cell degranulation,BP,
10419,GO:0043309,1,0.924051914670481,0,2,regulation of eosinophil degranulation,BP,
10420,GO:0043311,1,0.924051914670481,0,2,positive regulation of eosinophil degranulation,BP,
10422,GO:0043313,1,0.837197258917474,0,4,regulation of neutrophil degranulation,BP,
10423,GO:0043314,1,0.914788666392714,0,2,negative regulation of neutrophil degranulation,BP,
10424,GO:0043315,1,0.956842221697132,0,1,positive regulation of neutrophil degranulation,BP,
10425,GO:0043316,1,0.91835026580286,0,2,cytotoxic T cell degranulation,BP,
10426,GO:0043317,1,0.957579866097818,0,1,regulation of cytotoxic T cell degranulation,BP,
10427,GO:0043318,1,0.957579866097818,0,1,negative regulation of cytotoxic T cell degranulation,BP,
10428,GO:0043320,1,0.778406470442091,0,6,natural killer cell degranulation,BP,
10429,GO:0043321,1,0.918034008110363,0,2,regulation of natural killer cell degranulation,BP,
10430,GO:0043323,1,0.918034008110363,0,2,positive regulation of natural killer cell degranulation,BP,
10431,GO:0043324,1,0.956519923983069,0,1,pigment metabolic process involved in developmental pigmentation,BP,
10432,GO:0043325,1,0.488416523118863,0,17,phosphatidylinositol-3,4-bisphosphate binding,MF,
10433,GO:0043328,1,0.858317611800295,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
10434,GO:0043330,1,0.345676547937876,0,26,response to exogenous dsRNA,BP,
10436,GO:0043335,1,0.922614278209283,0,2,protein unfolding,BP,
10437,GO:0043337,1,0.957149400412029,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
10438,GO:0043353,1,0.770082662644685,0,6,enucleate erythrocyte differentiation,BP,
10439,GO:0043354,1,0.956463626558617,0,1,enucleate erythrocyte maturation,BP,
10440,GO:0043366,1,0.9201908808948,0,2,beta selection,BP,
10446,GO:0043372,1,0.672065277555194,0,10,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
10448,GO:0043374,1,0.80833324792569,0,5,CD8-positive, alpha-beta T cell differentiation,BP,
10449,GO:0043375,1,0.957101590816272,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
10450,GO:0043376,1,0.957376383041178,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
10453,GO:0043382,1,0.88884296395759,0,3,positive regulation of memory T cell differentiation,BP,
10454,GO:0043383,1,0.916246047722047,0,2,negative T cell selection,BP,
10455,GO:0043385,1,0.959223330954023,0,1,mycotoxin metabolic process,BP,
10456,GO:0043387,1,0.959223330954023,0,1,mycotoxin catabolic process,BP,
10457,GO:0043388,1,0.188104570063936,0,41,positive regulation of DNA binding,BP,
10462,GO:0043396,1,0.958026563055971,0,1,corticotropin-releasing hormone secretion,BP,
10463,GO:0043397,1,0.958026563055971,0,1,regulation of corticotropin-releasing hormone secretion,BP,
10465,GO:0043400,1,0.923231272936482,0,2,cortisol secretion,BP,
10467,GO:0043402,1,0.877070642074018,0,3,glucocorticoid mediated signaling pathway,BP,
10468,GO:0043403,1,0.454567897244087,0,19,skeletal muscle tissue regeneration,BP,
10478,GO:0043415,1,0.845602114301287,0,4,positive regulation of skeletal muscle tissue regeneration,BP,
10479,GO:0043416,1,0.845602114301287,0,4,regulation of skeletal muscle tissue regeneration,BP,
10480,GO:0043418,1,0.882697777404372,0,3,homocysteine catabolic process,BP,
10482,GO:0043423,1,0.95670751217416,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
10483,GO:0043425,1,0.410288826791345,0,21,bHLH transcription factor binding,MF,
10484,GO:0043426,1,0.845056817469853,0,4,MRF binding,MF,
10487,GO:0043435,1,0.959675810896307,0,1,response to corticotropin-releasing hormone,BP,
10489,GO:0043449,1,0.959631709220558,0,1,cellular alkene metabolic process,BP,
10490,GO:0043455,1,0.715661518313154,0,8,regulation of secondary metabolic process,BP,
10491,GO:0043456,1,0.855010340922552,0,4,regulation of pentose-phosphate shunt,BP,
10493,GO:0043461,1,0.853193209364625,0,4,proton-transporting ATP synthase complex assembly,BP,
10494,GO:0043462,1,0.130088050523354,0,51,regulation of ATPase activity,BP,
10495,GO:0043465,1,0.958787867083198,0,1,regulation of fermentation,BP,
10498,GO:0043471,1,0.693937823605092,0,9,regulation of cellular carbohydrate catabolic process,BP,
10500,GO:0043474,1,0.956519923983069,0,1,pigment metabolic process involved in pigmentation,BP,
10504,GO:0043485,1,0.664654376100139,0,10,endosome to pigment granule transport,BP,
10505,GO:0043486,1,0.156793537786229,0,48,histone exchange,BP,
10508,GO:0043489,1,0.295108542469014,0,29,RNA stabilization,BP,
10509,GO:0043490,1,0.916813402664139,0,2,malate-aspartate shuttle,BP,
10513,GO:0043496,1,0.44143459178136,0,20,regulation of protein homodimerization activity,BP,
10516,GO:0043501,1,0.599919867189774,0,12,skeletal muscle adaptation,BP,
10518,GO:0043504,1,0.877744831214911,0,3,mitochondrial DNA repair,BP,
10522,GO:0043509,1,0.961161759333046,0,1,activin A complex,CC,
10523,GO:0043511,1,0.961161759333046,0,1,inhibin complex,CC,
10524,GO:0043512,1,0.961161759333046,0,1,inhibin A complex,CC,
10525,GO:0043515,1,0.810839607224187,0,5,kinetochore binding,MF,
10526,GO:0043516,1,0.369861523118789,0,24,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
10527,GO:0043517,1,0.6324015058984,0,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
10528,GO:0043518,1,0.633908330634042,0,11,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
10529,GO:0043519,1,0.961389430746383,0,1,regulation of myosin II filament organization,BP,
10530,GO:0043522,1,0.668234012894193,0,10,leucine zipper domain binding,MF,
10533,GO:0043525,1,0.208498805216335,0,38,positive regulation of neuron apoptotic process,BP,
10534,GO:0043527,1,0.821777329090571,0,5,tRNA methyltransferase complex,CC,
10535,GO:0043531,1,0.292659265059339,0,29,ADP binding,MF,
10536,GO:0043532,1,0.956441843839217,0,1,angiostatin binding,MF,
10537,GO:0043533,1,0.806227347633429,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
10542,GO:0043538,1,0.95840028639604,0,1,regulation of actin phosphorylation,BP,
10544,GO:0043541,1,0.9174161952116,0,2,UDP-N-acetylglucosamine transferase complex,CC,
10547,GO:0043544,1,0.957413043485265,0,1,lipoamide binding,MF,
10548,GO:0043545,1,0.751369614796986,0,7,molybdopterin cofactor metabolic process,BP,
10549,GO:0043546,1,0.772845696061476,0,6,molybdopterin cofactor binding,MF,
10561,GO:0043562,1,0.67618490044855,0,10,cellular response to nitrogen levels,BP,
10562,GO:0043564,1,0.920533683457261,0,2,Ku70:Ku80 complex,CC,
10566,GO:0043569,1,0.839613112249646,0,4,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
10567,GO:0043570,1,0.839132416295332,0,4,maintenance of DNA repeat elements,BP,
10568,GO:0043574,1,0.470100430591288,0,18,peroxisomal transport,BP,
10573,GO:0043585,1,0.914777317313074,0,2,nose morphogenesis,BP,
10577,GO:0043589,1,0.676348140861045,0,9,skin morphogenesis,BP,
10578,GO:0043596,1,0.183162128162455,0,41,nuclear replication fork,CC,
10579,GO:0043601,1,0.374820675641857,0,24,nuclear replisome,CC,
10580,GO:0043602,1,0.959964757059869,0,1,nitrate catabolic process,BP,
10583,GO:0043606,1,0.958160049997458,0,1,formamide metabolic process,BP,
10584,GO:0043610,1,0.956441843839217,0,1,regulation of carbohydrate utilization,BP,
10585,GO:0043614,1,0.915150747022973,0,2,multi-eIF complex,CC,
10589,GO:0043619,1,0.657342945131942,0,10,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10594,GO:0043625,1,0.85190763538409,0,4,delta DNA polymerase complex,CC,
10595,GO:0043626,1,0.963888431811021,0,1,PCNA complex,CC,
10597,GO:0043628,1,0.342358541404771,0,27,ncRNA 3'-end processing,BP,
10598,GO:0043629,1,0.956441843839217,0,1,ncRNA polyadenylation,BP,
10599,GO:0043630,1,0.956441843839217,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
10600,GO:0043631,1,0.176742401173308,0,41,RNA polyadenylation,BP,
10602,GO:0043633,1,0.727855642016872,0,8,polyadenylation-dependent RNA catabolic process,BP,
10603,GO:0043634,1,0.760904677619784,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10607,GO:0043650,1,0.71201443441033,0,8,dicarboxylic acid biosynthetic process,BP,
10609,GO:0043652,1,0.727226781747123,0,8,engulfment of apoptotic cell,BP,
10610,GO:0043653,1,0.731146225626956,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
10611,GO:0043654,1,0.878529846837066,0,3,recognition of apoptotic cell,BP,
10612,GO:0043656,1,0.743176253384677,0,7,intracellular region of host,CC,
10616,GO:0043682,1,0.914777292668164,0,2,copper-transporting ATPase activity,MF,
10617,GO:0043686,1,0.887858151917621,0,3,co-translational protein modification,BP,
10623,GO:0043734,1,0.853340623520318,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
10624,GO:0043739,1,0.957971531389916,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
10625,GO:0043754,1,0.956441843839217,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
10626,GO:0043783,1,0.960504359753247,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
10627,GO:0043795,1,0.963704959771134,0,1,glyceraldehyde oxidoreductase activity,MF,
10628,GO:0043812,1,0.87729071166869,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
10629,GO:0043813,1,0.801855098655471,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
10630,GO:0043843,1,0.959796447129613,0,1,ADP-specific glucokinase activity,MF,
10631,GO:0043849,1,0.958717873956447,0,1,Ras palmitoyltransferase activity,MF,
10632,GO:0043865,1,0.959101436414188,0,1,methionine transmembrane transporter activity,MF,
10633,GO:0043874,1,0.961727396354091,0,1,acireductone synthase activity,MF,
10634,GO:0043890,1,0.960444124881853,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
10635,GO:0043891,1,0.963953048764493,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
10640,GO:0043914,1,0.957022848732762,0,1,NADPH:sulfur oxidoreductase activity,MF,
10642,GO:0043921,1,0.383071378927947,0,23,modulation by host of viral transcription,BP,
10643,GO:0043922,1,0.688320703922538,0,9,negative regulation by host of viral transcription,BP,
10644,GO:0043923,1,0.510102275729624,0,16,positive regulation by host of viral transcription,BP,
10645,GO:0043928,1,0.26948331269839,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10647,GO:0043932,1,0.920779518569122,0,2,ossification involved in bone remodeling,BP,
10649,GO:0043946,1,0.962653003900764,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10650,GO:0043947,1,0.962653003900764,0,1,positive regulation by host of symbiont catalytic activity,BP,
10651,GO:0043949,1,0.487779788859191,0,17,regulation of cAMP-mediated signaling,BP,
10652,GO:0043950,1,0.808638765713663,0,5,positive regulation of cAMP-mediated signaling,BP,
10653,GO:0043951,1,0.687841551716416,0,9,negative regulation of cAMP-mediated signaling,BP,
10655,GO:0043966,1,0.102011494446913,0,55,histone H3 acetylation,BP,
10658,GO:0043969,1,0.956441843839217,0,1,histone H2B acetylation,BP,
10659,GO:0043970,1,0.60514180277624,0,12,histone H3-K9 acetylation,BP,
10660,GO:0043972,1,0.956547686417145,0,1,histone H3-K23 acetylation,BP,
10661,GO:0043973,1,0.961040687287477,0,1,histone H3-K4 acetylation,BP,
10662,GO:0043974,1,0.87761137653759,0,3,histone H3-K27 acetylation,BP,
10663,GO:0043981,1,0.533457584217438,0,15,histone H4-K5 acetylation,BP,
10664,GO:0043982,1,0.533457584217438,0,15,histone H4-K8 acetylation,BP,
10665,GO:0043983,1,0.749986756691377,0,7,histone H4-K12 acetylation,BP,
10666,GO:0043984,1,0.445550045182568,0,19,histone H4-K16 acetylation,BP,
10667,GO:0043985,1,0.782141840228582,0,6,histone H4-R3 methylation,BP,
10671,GO:0043994,1,0.956547686417145,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
10672,GO:0043995,1,0.65357586330005,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10673,GO:0043996,1,0.65357586330005,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10674,GO:0043997,1,0.958224430065193,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
10675,GO:0043998,1,0.957806126567431,0,1,H2A histone acetyltransferase activity,MF,
10677,GO:0044004,1,0.889306249679851,0,3,disruption by symbiont of host cell,BP,
10678,GO:0044007,1,0.956441843839217,0,1,dissemination or transmission of symbiont from host,BP,
10679,GO:0044020,1,0.852615498843532,0,4,histone methyltransferase activity (H4-R3 specific),MF,
10680,GO:0044028,1,0.916155445400982,0,2,DNA hypomethylation,BP,
10681,GO:0044029,1,0.916155445400982,0,2,hypomethylation of CpG island,BP,
10682,GO:0044030,1,0.547266406301613,0,14,regulation of DNA methylation,BP,
10683,GO:0044033,1,0.783869124667345,0,6,multi-organism metabolic process,BP,
10684,GO:0044035,1,0.963004226573629,0,1,multi-organism catabolic process,BP,
10685,GO:0044036,1,0.888201376523227,0,3,cell wall macromolecule metabolic process,BP,
10686,GO:0044038,1,0.962561648789528,0,1,cell wall macromolecule biosynthetic process,BP,
10688,GO:0044053,1,0.960287525593611,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
10690,GO:0044058,1,0.580942473831766,0,13,regulation of digestive system process,BP,
10692,GO:0044062,1,0.88841584843553,0,3,regulation of excretion,BP,
10694,GO:0044068,1,0.366033528127302,0,24,modulation by symbiont of host cellular process,BP,
10698,GO:0044088,1,0.204355620221788,0,38,regulation of vacuole organization,BP,
10700,GO:0044090,1,0.598236920310955,0,12,positive regulation of vacuole organization,BP,
10704,GO:0044094,1,0.879117691882937,0,3,host cell nuclear part,CC,
10705,GO:0044105,1,0.965159549501964,0,1,L-xylulose reductase (NAD+) activity,MF,
10706,GO:0044106,1,0.0365260119476202,0,84,cellular amine metabolic process,BP,
10707,GO:0044107,1,0.854439686784929,0,4,cellular alcohol metabolic process,BP,
10708,GO:0044108,1,0.854439686784929,0,4,cellular alcohol biosynthetic process,BP,
10709,GO:0044110,1,0.81967778050122,0,5,growth involved in symbiotic interaction,BP,
10710,GO:0044111,1,0.921054366960736,0,2,development involved in symbiotic interaction,BP,
10711,GO:0044115,1,0.963004226573629,0,1,development of symbiont involved in interaction with host,BP,
10712,GO:0044116,1,0.81967778050122,0,5,growth of symbiont involved in interaction with host,BP,
10713,GO:0044117,1,0.81967778050122,0,5,growth of symbiont in host,BP,
10714,GO:0044126,1,0.850013736680629,0,4,regulation of growth of symbiont in host,BP,
10715,GO:0044128,1,0.956470985326214,0,1,positive regulation of growth of symbiont in host,BP,
10716,GO:0044130,1,0.888707441678473,0,3,negative regulation of growth of symbiont in host,BP,
10717,GO:0044144,1,0.850013736680629,0,4,modulation of growth of symbiont involved in interaction with host,BP,
10718,GO:0044145,1,0.963004226573629,0,1,modulation of development of symbiont involved in interaction with host,BP,
10719,GO:0044146,1,0.888707441678473,0,3,negative regulation of growth of symbiont involved in interaction with host,BP,
10720,GO:0044147,1,0.963004226573629,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10721,GO:0044148,1,0.956470985326214,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
10722,GO:0044154,1,0.745757259691467,0,7,histone H3-K14 acetylation,BP,
10723,GO:0044183,1,0.259302037226583,0,33,protein binding involved in protein folding,MF,
10724,GO:0044190,1,0.962631511008888,0,1,host cell mitochondrial envelope,CC,
10725,GO:0044194,1,0.886296983778526,0,3,cytolytic granule,CC,
10726,GO:0044205,1,0.882371568032716,0,3,'de novo' UMP biosynthetic process,BP,
10727,GO:0044206,1,0.858408652564516,0,4,UMP salvage,BP,
10728,GO:0044207,1,0.956823740907682,0,1,translation initiation ternary complex,CC,
10729,GO:0044208,1,0.924120089379587,0,2,'de novo' AMP biosynthetic process,BP,
10730,GO:0044209,1,0.928278025865685,0,2,AMP salvage,BP,
10731,GO:0044210,1,0.917558708748795,0,2,'de novo' CTP biosynthetic process,BP,
10732,GO:0044211,1,0.89191949641448,0,3,CTP salvage,BP,
10735,GO:0044214,1,0.841309896269165,0,4,spanning component of plasma membrane,CC,
10739,GO:0044218,1,0.956808261360976,0,1,other organism cell membrane,CC,
10740,GO:0044220,1,0.956516750265962,0,1,host cell perinuclear region of cytoplasm,CC,
10741,GO:0044221,1,0.956808261360976,0,1,host cell synapse,CC,
10743,GO:0044228,1,0.956544386401579,0,1,host cell surface,CC,
10744,GO:0044231,1,0.956808261360976,0,1,host cell presynaptic membrane,CC,
10745,GO:0044232,1,0.466750437941755,0,18,organelle membrane contact site,CC,
10746,GO:0044233,1,0.603784991509832,0,12,ER-mitochondrion membrane contact site,CC,
10749,GO:0044241,1,0.885262313879302,0,3,lipid digestion,BP,
10756,GO:0044258,1,0.960377061592084,0,1,intestinal lipid catabolic process,BP,
10767,GO:0044279,1,0.956808261360976,0,1,other organism membrane,CC,
10771,GO:0044284,1,0.965001959562161,0,1,mitochondrial crista junction,CC,
10773,GO:0044292,1,0.656710593848322,0,10,dendrite terminus,CC,
10774,GO:0044294,1,0.737923130202861,0,7,dendritic growth cone,CC,
10778,GO:0044299,1,0.956441843839217,0,1,C-fiber,CC,
10781,GO:0044302,1,0.87765810873177,0,3,dentate gyrus mossy fiber,CC,
10783,GO:0044305,1,0.956441843839217,0,1,calyx of Held,CC,
10785,GO:0044307,1,0.956441843839217,0,1,dendritic branch,CC,
10786,GO:0044308,1,0.914889958036468,0,2,axonal spine,CC,
10788,GO:0044313,1,0.87562333985617,0,3,protein K6-linked deubiquitination,BP,
10789,GO:0044314,1,0.858792187074642,0,4,protein K27-linked ubiquitination,BP,
10790,GO:0044316,1,0.95724235074142,0,1,cone cell pedicle,CC,
10792,GO:0044319,1,0.350188388972875,0,25,wound healing, spreading of cells,BP,
10793,GO:0044320,1,0.654442626008087,0,10,cellular response to leptin stimulus,BP,
10794,GO:0044321,1,0.553867762377119,0,14,response to leptin,BP,
10795,GO:0044322,1,0.335558026066039,0,26,endoplasmic reticulum quality control compartment,CC,
10796,GO:0044323,1,0.916113619192203,0,2,retinoic acid-responsive element binding,MF,
10797,GO:0044324,1,0.964980840747837,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
10799,GO:0044326,1,0.920109520316844,0,2,dendritic spine neck,CC,
10801,GO:0044328,1,0.958787867083198,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10802,GO:0044329,1,0.958787867083198,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10803,GO:0044330,1,0.958787867083198,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10804,GO:0044331,1,0.578061496950155,0,13,cell-cell adhesion mediated by cadherin,BP,
10806,GO:0044334,1,0.916442882969539,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
10807,GO:0044335,1,0.956441843839217,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
10808,GO:0044336,1,0.87844959087473,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
10818,GO:0044349,1,0.962717105863326,0,1,DNA excision,BP,
10820,GO:0044352,1,0.843504879259053,0,4,pinosome,CC,
10821,GO:0044354,1,0.843504879259053,0,4,macropinosome,CC,
10822,GO:0044355,1,0.963587510625542,0,1,clearance of foreign intracellular DNA,BP,
10823,GO:0044356,1,0.963587510625542,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
10824,GO:0044359,1,0.784558242674338,0,6,modulation of molecular function in other organism,BP,
10825,GO:0044362,1,0.820303323294256,0,5,negative regulation of molecular function in other organism,BP,
10826,GO:0044364,1,0.568880042665647,0,15,disruption of cells of other organism,BP,
10828,GO:0044378,1,0.921548405058253,0,2,non-sequence-specific DNA binding, bending,MF,
10829,GO:0044380,1,0.132076810371109,0,47,protein localization to cytoskeleton,BP,
10831,GO:0044387,1,0.746220587471811,0,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
10832,GO:0044388,1,0.825820616356428,0,5,small protein activating enzyme binding,MF,
10834,GO:0044390,1,0.246196093830847,0,33,ubiquitin-like protein conjugating enzyme binding,MF,
10836,GO:0044393,1,0.879587637139112,0,3,microspike,CC,
10837,GO:0044395,1,0.959677449806295,0,1,protein targeting to vacuolar membrane,BP,
10840,GO:0044406,1,0.851654843290395,0,4,adhesion of symbiont to host,BP,
10842,GO:0044413,1,0.843383059472811,0,4,avoidance of host defenses,BP,
10843,GO:0044414,1,0.956458141288418,0,1,suppression of host defenses,BP,
10844,GO:0044415,1,0.843383059472811,0,4,evasion or tolerance of host defenses,BP,
10845,GO:0044416,1,0.92594695402866,0,2,induction by symbiont of host defense response,BP,
10846,GO:0044417,1,0.696997554635704,0,9,translocation of molecules into host,BP,
10868,GO:0044447,1,0.507362599210608,0,16,axoneme part,CC,
10878,GO:0044458,1,0.612362019087098,0,12,motile cilium assembly,BP,
10882,GO:0044495,1,0.965198421423852,0,1,modulation of blood pressure in other organism,BP,
10883,GO:0044497,1,0.965198421423852,0,1,positive regulation of blood pressure in other organism,BP,
10884,GO:0044501,1,0.916199426809871,0,2,modulation of signal transduction in other organism,BP,
10885,GO:0044524,1,0.96265960442676,0,1,protein sulfhydration,BP,
10886,GO:0044528,1,0.847412247335175,0,4,regulation of mitochondrial mRNA stability,BP,
10887,GO:0044530,1,0.879585400158667,0,3,supraspliceosomal complex,CC,
10888,GO:0044531,1,0.783597337102256,0,6,modulation of programmed cell death in other organism,BP,
10889,GO:0044532,1,0.783597337102256,0,6,modulation of apoptotic process in other organism,BP,
10890,GO:0044533,1,0.889306249679851,0,3,positive regulation of apoptotic process in other organism,BP,
10892,GO:0044540,1,0.96265960442676,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
10893,GO:0044545,1,0.813170644500337,0,5,NSL complex,CC,
10894,GO:0044546,1,0.680358646342103,0,9,NLRP3 inflammasome complex assembly,BP,
10895,GO:0044547,1,0.809191759309894,0,5,DNA topoisomerase binding,MF,
10897,GO:0044549,1,0.965429774928901,0,1,GTP cyclohydrolase binding,MF,
10898,GO:0044550,1,0.578913637694206,0,13,secondary metabolite biosynthetic process,BP,
10900,GO:0044565,1,0.923603909334411,0,2,dendritic cell proliferation,BP,
10901,GO:0044571,1,0.861798368276056,0,4,[2Fe-2S] cluster assembly,BP,
10902,GO:0044594,1,0.959370451717241,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
10903,GO:0044595,1,0.964083115104504,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10904,GO:0044596,1,0.964083115104504,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
10905,GO:0044597,1,0.825866856983119,0,5,daunorubicin metabolic process,BP,
10906,GO:0044598,1,0.825866856983119,0,5,doxorubicin metabolic process,BP,
10907,GO:0044599,1,0.958787867083198,0,1,AP-5 adaptor complex,CC,
10908,GO:0044601,1,0.962967973676731,0,1,protein denucleotidylation,BP,
10909,GO:0044602,1,0.962967973676731,0,1,protein deadenylylation,BP,
10910,GO:0044603,1,0.962967973676731,0,1,protein adenylylhydrolase activity,MF,
10911,GO:0044609,1,0.921668405061485,0,2,DBIRD complex,CC,
10912,GO:0044610,1,0.960822557325351,0,1,FMN transmembrane transporter activity,MF,
10913,GO:0044611,1,0.875189696317793,0,3,nuclear pore inner ring,CC,
10914,GO:0044613,1,0.610848026551144,0,12,nuclear pore central transport channel,CC,
10915,GO:0044614,1,0.840824286241954,0,4,nuclear pore cytoplasmic filaments,CC,
10916,GO:0044615,1,0.675940770987852,0,9,nuclear pore nuclear basket,CC,
10917,GO:0044620,1,0.932291866263446,0,2,ACP phosphopantetheine attachment site binding,MF,
10918,GO:0044648,1,0.958787867083198,0,1,histone H3-K4 dimethylation,BP,
10919,GO:0044650,1,0.887711404040572,0,3,adhesion of symbiont to host cell,BP,
10922,GO:0044691,1,0.915274229248006,0,2,tooth eruption,BP,
10925,GO:0044713,1,0.965425347294511,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10926,GO:0044714,1,0.965425347294511,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
10927,GO:0044715,1,0.928911707916246,0,2,8-oxo-dGDP phosphatase activity,MF,
10928,GO:0044716,1,0.963367253297087,0,1,8-oxo-GDP phosphatase activity,MF,
10929,GO:0044717,1,0.963367253297087,0,1,8-hydroxy-dADP phosphatase activity,MF,
10930,GO:0044721,1,0.962032509249954,0,1,protein import into peroxisome matrix, substrate release,BP,
10931,GO:0044725,1,0.956441843839217,0,1,chromatin reprogramming in the zygote,BP,
10932,GO:0044727,1,0.956441843839217,0,1,DNA demethylation of male pronucleus,BP,
10934,GO:0044729,1,0.878907355447803,0,3,hemi-methylated DNA-binding,MF,
10935,GO:0044730,1,0.963004226573629,0,1,bone sialoprotein binding,MF,
10936,GO:0044732,1,0.958787867083198,0,1,mitotic spindle pole body,CC,
10938,GO:0044743,1,0.220993025138564,0,38,protein transmembrane import into intracellular organelle,BP,
10939,GO:0044752,1,0.881196609810916,0,3,response to human chorionic gonadotropin,BP,
10940,GO:0044753,1,0.958758621893661,0,1,amphisome,CC,
10941,GO:0044754,1,0.72534295274003,0,8,autolysosome,CC,
10946,GO:0044771,1,0.918693464112885,0,2,meiotic cell cycle phase transition,BP,
10950,GO:0044778,1,0.922712997096927,0,2,meiotic DNA integrity checkpoint,BP,
10951,GO:0044779,1,0.958436723289691,0,1,meiotic spindle checkpoint,BP,
10954,GO:0044784,1,0.132160301977235,0,49,metaphase/anaphase transition of cell cycle,BP,
10955,GO:0044785,1,0.958436723289691,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
10958,GO:0044789,1,0.803784415769972,0,5,modulation by host of viral release from host cell,BP,
10959,GO:0044791,1,0.803784415769972,0,5,positive regulation by host of viral release from host cell,BP,
10960,GO:0044793,1,0.843121344508496,0,4,negative regulation by host of viral process,BP,
10962,GO:0044795,1,0.964371921239096,0,1,trans-Golgi network to recycling endosome transport,BP,
10963,GO:0044796,1,0.963888431811021,0,1,DNA polymerase processivity factor complex,CC,
10965,GO:0044800,1,0.886372417110425,0,3,multi-organism membrane fusion,BP,
10966,GO:0044803,1,0.847806538979854,0,4,multi-organism membrane organization,BP,
10968,GO:0044805,1,0.915545793704341,0,2,late nucleophagy,BP,
10969,GO:0044806,1,0.735899948772077,0,7,G-quadruplex DNA unwinding,BP,
10975,GO:0044828,1,0.843121344508496,0,4,negative regulation by host of viral genome replication,BP,
10977,GO:0044830,1,0.917229828714054,0,2,modulation by host of viral RNA genome replication,BP,
10978,GO:0044837,1,0.74125762188374,0,7,actomyosin contractile ring organization,BP,
10981,GO:0044848,1,0.711869901030075,0,8,biological phase,BP,
10982,GO:0044849,1,0.691319878482365,0,9,estrous cycle,BP,
10983,GO:0044851,1,0.711869901030075,0,8,hair cycle phase,BP,
10985,GO:0044854,1,0.850399233841921,0,4,plasma membrane raft assembly,BP,
10986,GO:0044855,1,0.959233901692744,0,1,plasma membrane raft distribution,BP,
10987,GO:0044856,1,0.959233901692744,0,1,plasma membrane raft localization,BP,
10988,GO:0044857,1,0.850399233841921,0,4,plasma membrane raft organization,BP,
10989,GO:0044858,1,0.959233901692744,0,1,plasma membrane raft polarization,BP,
10990,GO:0044860,1,0.847214199965495,0,4,protein localization to plasma membrane raft,BP,
10991,GO:0044861,1,0.920286974835962,0,2,protein transport into plasma membrane raft,BP,
10992,GO:0044868,1,0.956441843839217,0,1,modulation by host of viral molecular function,BP,
10995,GO:0044878,1,0.856766778064557,0,4,mitotic cytokinesis checkpoint,BP,
10996,GO:0045002,1,0.746551713187045,0,7,double-strand break repair via single-strand annealing,BP,
10997,GO:0045003,1,0.664134504879595,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
10998,GO:0045004,1,0.915873278142701,0,2,DNA replication proofreading,BP,
10999,GO:0045005,1,0.26070286954437,0,32,DNA-dependent DNA replication maintenance of fidelity,BP,
11000,GO:0045006,1,0.65386586274735,0,11,DNA deamination,BP,
11002,GO:0045008,1,0.731137744423394,0,8,depyrimidination,BP,
11003,GO:0045009,1,0.793891319008883,0,6,chitosome,CC,
11005,GO:0045016,1,0.957788422631726,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11007,GO:0045019,1,0.69584636289486,0,9,negative regulation of nitric oxide biosynthetic process,BP,
11008,GO:0045022,1,0.202680348849145,0,38,early endosome to late endosome transport,BP,
11010,GO:0045025,1,0.918370844595587,0,2,mitochondrial degradosome,CC,
11011,GO:0045026,1,0.524306829342862,0,16,plasma membrane fusion,BP,
11012,GO:0045027,1,0.961414695689025,0,1,DNA end binding,MF,
11013,GO:0045028,1,0.815398803427329,0,5,G-protein coupled purinergic nucleotide receptor activity,MF,
11014,GO:0045031,1,0.921742995476225,0,2,ATP-activated adenosine receptor activity,MF,
11015,GO:0045032,1,0.958275000686016,0,1,ADP-activated adenosine receptor activity,MF,
11016,GO:0045039,1,0.798655855837314,0,6,protein import into mitochondrial inner membrane,BP,
11017,GO:0045040,1,0.793016358857529,0,6,protein import into mitochondrial outer membrane,BP,
11018,GO:0045041,1,0.925453141040283,0,2,protein import into mitochondrial intermembrane space,BP,
11019,GO:0045046,1,0.777035965114025,0,6,protein import into peroxisome membrane,BP,
11021,GO:0045048,1,0.81596124561685,0,5,protein insertion into ER membrane,BP,
11022,GO:0045053,1,0.802834699542293,0,5,protein retention in Golgi apparatus,BP,
11023,GO:0045054,1,0.883948815457347,0,3,constitutive secretory pathway,BP,
11025,GO:0045056,1,0.534233439443114,0,15,transcytosis,BP,
11027,GO:0045059,1,0.809585940436186,0,5,positive thymic T cell selection,BP,
11028,GO:0045060,1,0.916246047722047,0,2,negative thymic T cell selection,BP,
11029,GO:0045061,1,0.650411230026387,0,10,thymic T cell selection,BP,
11030,GO:0045062,1,0.962775779500479,0,1,extrathymic T cell selection,BP,
11031,GO:0045063,1,0.600997802360173,0,12,T-helper 1 cell differentiation,BP,
11033,GO:0045065,1,0.921875901625123,0,2,cytotoxic T cell differentiation,BP,
11039,GO:0045073,1,0.752938567076012,0,7,regulation of chemokine biosynthetic process,BP,
11040,GO:0045074,1,0.921221930406703,0,2,regulation of interleukin-10 biosynthetic process,BP,
11041,GO:0045075,1,0.807209706534033,0,5,regulation of interleukin-12 biosynthetic process,BP,
11042,GO:0045076,1,0.749401629862725,0,7,regulation of interleukin-2 biosynthetic process,BP,
11043,GO:0045077,1,0.961161759333046,0,1,negative regulation of interferon-gamma biosynthetic process,BP,
11045,GO:0045079,1,0.962885322393595,0,1,negative regulation of chemokine biosynthetic process,BP,
11046,GO:0045080,1,0.781975732142581,0,6,positive regulation of chemokine biosynthetic process,BP,
11047,GO:0045081,1,0.957370375175669,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11048,GO:0045082,1,0.962245251855588,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
11049,GO:0045083,1,0.956872397367767,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11050,GO:0045084,1,0.882034173380839,0,3,positive regulation of interleukin-12 biosynthetic process,BP,
11051,GO:0045085,1,0.962667846714425,0,1,negative regulation of interleukin-2 biosynthetic process,BP,
11052,GO:0045086,1,0.778478572318811,0,6,positive regulation of interleukin-2 biosynthetic process,BP,
11056,GO:0045091,1,0.690385226205237,0,9,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11057,GO:0045092,1,0.957389837937671,0,1,interleukin-18 receptor complex,CC,
11058,GO:0045095,1,0.393675124713923,0,23,keratin filament,CC,
11059,GO:0045098,1,0.962917224904392,0,1,type III intermediate filament,CC,
11062,GO:0045105,1,0.95741442164153,0,1,intermediate filament polymerization or depolymerization,BP,
11063,GO:0045109,1,0.509509918318255,0,16,intermediate filament organization,BP,
11064,GO:0045110,1,0.77425949116664,0,6,intermediate filament bundle assembly,BP,
11066,GO:0045112,1,0.883436314964058,0,3,integrin biosynthetic process,BP,
11067,GO:0045113,1,0.923676352660544,0,2,regulation of integrin biosynthetic process,BP,
11068,GO:0045116,1,0.579118818323708,0,14,protein neddylation,BP,
11069,GO:0045117,1,0.566337707751347,0,14,azole transport,BP,
11072,GO:0045123,1,0.409104582652403,0,21,cellular extravasation,BP,
11074,GO:0045125,1,0.662802951732424,0,10,bioactive lipid receptor activity,MF,
11075,GO:0045127,1,0.963191933642196,0,1,N-acetylglucosamine kinase activity,MF,
11076,GO:0045128,1,0.95815793451167,0,1,negative regulation of reciprocal meiotic recombination,BP,
11077,GO:0045131,1,0.958554013497308,0,1,pre-mRNA branch point binding,MF,
11079,GO:0045134,1,0.846722941748577,0,4,uridine-diphosphatase activity,MF,
11083,GO:0045142,1,0.915450085280223,0,2,triplex DNA binding,MF,
11085,GO:0045144,1,0.816104020583566,0,5,meiotic sister chromatid segregation,BP,
11086,GO:0045145,1,0.918577462767361,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11087,GO:0045153,1,0.964229086206928,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11088,GO:0045155,1,0.922227711202977,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11089,GO:0045159,1,0.846076530613115,0,4,myosin II binding,MF,
11090,GO:0045161,1,0.712281259464736,0,8,neuronal ion channel clustering,BP,
11091,GO:0045162,1,0.838473343003386,0,4,clustering of voltage-gated sodium channels,BP,
11092,GO:0045163,1,0.918450757030503,0,2,clustering of voltage-gated potassium channels,BP,
11094,GO:0045167,1,0.962762781917351,0,1,asymmetric protein localization involved in cell fate determination,BP,
11095,GO:0045168,1,0.922944689711859,0,2,cell-cell signaling involved in cell fate commitment,BP,
11097,GO:0045174,1,0.929976778999366,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11101,GO:0045179,1,0.808731205008364,0,5,apical cortex,CC,
11103,GO:0045182,1,0.195185364456551,0,39,translation regulator activity,MF,
11104,GO:0045183,1,0.958787867083198,0,1,translation factor activity, non-nucleic acid binding,MF,
11107,GO:0045186,1,0.956441843839217,0,1,zonula adherens assembly,BP,
11109,GO:0045188,1,0.921347158904955,0,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11112,GO:0045196,1,0.915471442111423,0,2,establishment or maintenance of neuroblast polarity,BP,
11114,GO:0045198,1,0.655518703337182,0,10,establishment of epithelial cell apical/basal polarity,BP,
11115,GO:0045199,1,0.810066882385835,0,5,maintenance of epithelial cell apical/basal polarity,BP,
11116,GO:0045200,1,0.915471442111423,0,2,establishment of neuroblast polarity,BP,
11118,GO:0045204,1,0.875994476662621,0,3,MAPK export from nucleus,BP,
11119,GO:0045208,1,0.957439480146901,0,1,MAPK phosphatase export from nucleus,BP,
11120,GO:0045209,1,0.957439480146901,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11121,GO:0045210,1,0.914780245101489,0,2,FasL biosynthetic process,BP,
11123,GO:0045213,1,0.924978233389901,0,2,neurotransmitter receptor metabolic process,BP,
11127,GO:0045218,1,0.878329442629022,0,3,zonula adherens maintenance,BP,
11128,GO:0045219,1,0.956444930468843,0,1,regulation of FasL biosynthetic process,BP,
11129,GO:0045221,1,0.956444930468843,0,1,negative regulation of FasL biosynthetic process,BP,
11130,GO:0045222,1,0.96436678056198,0,1,CD4 biosynthetic process,BP,
11131,GO:0045223,1,0.96436678056198,0,1,regulation of CD4 biosynthetic process,BP,
11132,GO:0045225,1,0.96436678056198,0,1,negative regulation of CD4 biosynthetic process,BP,
11133,GO:0045226,1,0.919011882058377,0,2,extracellular polysaccharide biosynthetic process,BP,
11134,GO:0045229,1,0.917307276233887,0,2,external encapsulating structure organization,BP,
11135,GO:0045234,1,0.962521446367677,0,1,protein palmitoleylation,BP,
11136,GO:0045236,1,0.883950005615194,0,3,CXCR chemokine receptor binding,MF,
11139,GO:0045244,1,0.960497262593105,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11140,GO:0045251,1,0.960504359753247,0,1,electron transfer flavoprotein complex,CC,
11142,GO:0045254,1,0.745088646068114,0,7,pyruvate dehydrogenase complex,CC,
11144,GO:0045259,1,0.926210993895435,0,2,proton-transporting ATP synthase complex,CC,
11145,GO:0045263,1,0.963730469333062,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11146,GO:0045271,1,0.216744236706144,0,42,respiratory chain complex I,CC,
11147,GO:0045272,1,0.891945767070747,0,3,plasma membrane respiratory chain complex I,CC,
11150,GO:0045275,1,0.654215899594119,0,11,respiratory chain complex III,CC,
11155,GO:0045292,1,0.519742608119381,0,16,mRNA cis splicing, via spliceosome,BP,
11156,GO:0045293,1,0.890285637218186,0,3,mRNA editing complex,CC,
11157,GO:0045294,1,0.679394572274702,0,9,alpha-catenin binding,MF,
11158,GO:0045295,1,0.671386890310664,0,9,gamma-catenin binding,MF,
11161,GO:0045298,1,0.846065666966073,0,4,tubulin complex,CC,
11164,GO:0045322,1,0.919082366554763,0,2,unmethylated CpG binding,MF,
11165,GO:0045323,1,0.882494252731317,0,3,interleukin-1 receptor complex,CC,
11166,GO:0045324,1,0.642112369804191,0,11,late endosome to vacuole transport,BP,
11167,GO:0045329,1,0.84809630863397,0,4,carnitine biosynthetic process,BP,
11172,GO:0045337,1,0.884750323316971,0,3,farnesyl diphosphate biosynthetic process,BP,
11173,GO:0045338,1,0.850581192077661,0,4,farnesyl diphosphate metabolic process,BP,
11174,GO:0045340,1,0.96492184451589,0,1,mercury ion binding,MF,
11175,GO:0045341,1,0.840875234922929,0,4,MHC class I biosynthetic process,BP,
11176,GO:0045342,1,0.812347382696232,0,5,MHC class II biosynthetic process,BP,
11177,GO:0045343,1,0.840875234922929,0,4,regulation of MHC class I biosynthetic process,BP,
11178,GO:0045345,1,0.840875234922929,0,4,positive regulation of MHC class I biosynthetic process,BP,
11179,GO:0045346,1,0.812347382696232,0,5,regulation of MHC class II biosynthetic process,BP,
11180,GO:0045347,1,0.88188873540012,0,3,negative regulation of MHC class II biosynthetic process,BP,
11181,GO:0045348,1,0.887104213476453,0,3,positive regulation of MHC class II biosynthetic process,BP,
11182,GO:0045349,1,0.850563874903927,0,4,interferon-alpha biosynthetic process,BP,
11183,GO:0045350,1,0.782143799133678,0,6,interferon-beta biosynthetic process,BP,
11184,GO:0045351,1,0.724469796466338,0,8,type I interferon biosynthetic process,BP,
11185,GO:0045352,1,0.96253486933222,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11186,GO:0045353,1,0.96253486933222,0,1,interleukin-1 Type II receptor antagonist activity,MF,
11187,GO:0045354,1,0.850563874903927,0,4,regulation of interferon-alpha biosynthetic process,BP,
11188,GO:0045355,1,0.927855259708608,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
11189,GO:0045356,1,0.916711127489426,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
11190,GO:0045357,1,0.782143799133678,0,6,regulation of interferon-beta biosynthetic process,BP,
11191,GO:0045358,1,0.927894384992804,0,2,negative regulation of interferon-beta biosynthetic process,BP,
11192,GO:0045359,1,0.842945430433026,0,4,positive regulation of interferon-beta biosynthetic process,BP,
11193,GO:0045360,1,0.958207088018547,0,1,regulation of interleukin-1 biosynthetic process,BP,
11194,GO:0045362,1,0.958207088018547,0,1,positive regulation of interleukin-1 biosynthetic process,BP,
11195,GO:0045381,1,0.957989060654006,0,1,regulation of interleukin-18 biosynthetic process,BP,
11196,GO:0045399,1,0.956479002849494,0,1,regulation of interleukin-3 biosynthetic process,BP,
11197,GO:0045401,1,0.956479002849494,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11200,GO:0045408,1,0.687082656031248,0,9,regulation of interleukin-6 biosynthetic process,BP,
11201,GO:0045409,1,0.916326387115521,0,2,negative regulation of interleukin-6 biosynthetic process,BP,
11202,GO:0045410,1,0.779203992028398,0,6,positive regulation of interleukin-6 biosynthetic process,BP,
11203,GO:0045414,1,0.812080170394572,0,5,regulation of interleukin-8 biosynthetic process,BP,
11204,GO:0045415,1,0.886012913541132,0,3,negative regulation of interleukin-8 biosynthetic process,BP,
11205,GO:0045416,1,0.916575480148324,0,2,positive regulation of interleukin-8 biosynthetic process,BP,
11206,GO:0045423,1,0.956479002849494,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11207,GO:0045425,1,0.956479002849494,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11213,GO:0045448,1,0.847528968334313,0,4,mitotic cell cycle, embryonic,BP,
11219,GO:0045485,1,0.956669702652016,0,1,omega-6 fatty acid desaturase activity,MF,
11221,GO:0045495,1,0.74727648281432,0,7,pole plasm,CC,
11222,GO:0045499,1,0.475305068594288,0,17,chemorepellent activity,MF,
11224,GO:0045504,1,0.657824709346802,0,10,dynein heavy chain binding,MF,
11225,GO:0045505,1,0.41663595978794,0,21,dynein intermediate chain binding,MF,
11226,GO:0045509,1,0.917769919717854,0,2,interleukin-27 receptor activity,MF,
11227,GO:0045519,1,0.964663526577009,0,1,interleukin-23 receptor binding,MF,
11232,GO:0045569,1,0.849990709546978,0,4,TRAIL binding,MF,
11233,GO:0045575,1,0.919853436248898,0,2,basophil activation,BP,
11237,GO:0045579,1,0.659142322892014,0,10,positive regulation of B cell differentiation,BP,
11241,GO:0045583,1,0.921875901625123,0,2,regulation of cytotoxic T cell differentiation,BP,
11242,GO:0045585,1,0.921875901625123,0,2,positive regulation of cytotoxic T cell differentiation,BP,
11243,GO:0045586,1,0.875392478526997,0,3,regulation of gamma-delta T cell differentiation,BP,
11244,GO:0045588,1,0.914838911007383,0,2,positive regulation of gamma-delta T cell differentiation,BP,
11246,GO:0045590,1,0.957452189525752,0,1,negative regulation of regulatory T cell differentiation,BP,
11254,GO:0045601,1,0.442804184614452,0,19,regulation of endothelial cell differentiation,BP,
11255,GO:0045602,1,0.807404356936305,0,5,negative regulation of endothelial cell differentiation,BP,
11256,GO:0045603,1,0.739046179804218,0,7,positive regulation of endothelial cell differentiation,BP,
11258,GO:0045605,1,0.659092582307431,0,10,negative regulation of epidermal cell differentiation,BP,
11259,GO:0045606,1,0.457023377356744,0,19,positive regulation of epidermal cell differentiation,BP,
11260,GO:0045607,1,0.815854805889864,0,5,regulation of inner ear auditory receptor cell differentiation,BP,
11261,GO:0045608,1,0.882736464515157,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
11263,GO:0045617,1,0.778194751650065,0,6,negative regulation of keratinocyte differentiation,BP,
11264,GO:0045618,1,0.55723542437428,0,14,positive regulation of keratinocyte differentiation,BP,
11270,GO:0045624,1,0.700026033047771,0,9,positive regulation of T-helper cell differentiation,BP,
11271,GO:0045625,1,0.81266699463972,0,5,regulation of T-helper 1 cell differentiation,BP,
11272,GO:0045626,1,0.918547754964382,0,2,negative regulation of T-helper 1 cell differentiation,BP,
11273,GO:0045627,1,0.884749124075743,0,3,positive regulation of T-helper 1 cell differentiation,BP,
11276,GO:0045630,1,0.852823909359883,0,4,positive regulation of T-helper 2 cell differentiation,BP,
11277,GO:0045631,1,0.815854805889864,0,5,regulation of mechanoreceptor differentiation,BP,
11278,GO:0045632,1,0.850935016282364,0,4,negative regulation of mechanoreceptor differentiation,BP,
11279,GO:0045634,1,0.810504198972842,0,5,regulation of melanocyte differentiation,BP,
11280,GO:0045636,1,0.875532398793934,0,3,positive regulation of melanocyte differentiation,BP,
11284,GO:0045643,1,0.957357786768584,0,1,regulation of eosinophil differentiation,BP,
11285,GO:0045645,1,0.957357786768584,0,1,positive regulation of eosinophil differentiation,BP,
11287,GO:0045647,1,0.71803210032386,0,8,negative regulation of erythrocyte differentiation,BP,
11289,GO:0045649,1,0.629486550312613,0,11,regulation of macrophage differentiation,BP,
11290,GO:0045650,1,0.92539598968689,0,2,negative regulation of macrophage differentiation,BP,
11291,GO:0045651,1,0.680276486564603,0,9,positive regulation of macrophage differentiation,BP,
11293,GO:0045653,1,0.548935941784746,0,17,negative regulation of megakaryocyte differentiation,BP,
11294,GO:0045654,1,0.924747230660033,0,2,positive regulation of megakaryocyte differentiation,BP,
11297,GO:0045657,1,0.808256858640672,0,5,positive regulation of monocyte differentiation,BP,
11298,GO:0045658,1,0.880741143755278,0,3,regulation of neutrophil differentiation,BP,
11299,GO:0045659,1,0.915722513350461,0,2,negative regulation of neutrophil differentiation,BP,
11300,GO:0045660,1,0.961805919108119,0,1,positive regulation of neutrophil differentiation,BP,
11314,GO:0045683,1,0.577253270827374,0,13,negative regulation of epidermis development,BP,
11315,GO:0045684,1,0.294627746860374,0,30,positive regulation of epidermis development,BP,
11317,GO:0045686,1,0.609036502750737,0,12,negative regulation of glial cell differentiation,BP,
11321,GO:0045715,1,0.956441843839217,0,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11322,GO:0045716,1,0.884354184250022,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11323,GO:0045717,1,0.607649429931284,0,12,negative regulation of fatty acid biosynthetic process,BP,
11324,GO:0045719,1,0.805727525863937,0,5,negative regulation of glycogen biosynthetic process,BP,
11325,GO:0045721,1,0.746245217057883,0,7,negative regulation of gluconeogenesis,BP,
11327,GO:0045723,1,0.690672031050016,0,9,positive regulation of fatty acid biosynthetic process,BP,
11328,GO:0045724,1,0.468716246351114,0,18,positive regulation of cilium assembly,BP,
11330,GO:0045726,1,0.956459437002784,0,1,positive regulation of integrin biosynthetic process,BP,
11339,GO:0045741,1,0.776126754330088,0,6,positive regulation of epidermal growth factor-activated receptor activity,BP,
11340,GO:0045742,1,0.352415805825792,0,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,
11341,GO:0045743,1,0.780196759388574,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
11345,GO:0045747,1,0.237735306978713,0,34,positive regulation of Notch signaling pathway,BP,
11346,GO:0045751,1,0.957989060654006,0,1,negative regulation of Toll signaling pathway,BP,
11347,GO:0045759,1,0.92159293074113,0,2,negative regulation of action potential,BP,
11348,GO:0045760,1,0.773262501194331,0,6,positive regulation of action potential,BP,
11349,GO:0045761,1,0.632260828904029,0,11,regulation of adenylate cyclase activity,BP,
11350,GO:0045762,1,0.91562476632988,0,2,positive regulation of adenylate cyclase activity,BP,
11351,GO:0045763,1,0.914811764735861,0,2,negative regulation of cellular amino acid metabolic process,BP,
11352,GO:0045764,1,0.927100337848597,0,2,positive regulation of cellular amino acid metabolic process,BP,
11355,GO:0045769,1,0.956441843839217,0,1,negative regulation of asymmetric cell division,BP,
11356,GO:0045773,1,0.243598329981784,0,33,positive regulation of axon extension,BP,
11357,GO:0045776,1,0.370951839537553,0,24,negative regulation of blood pressure,BP,
11365,GO:0045792,1,0.742499734133332,0,7,negative regulation of cell size,BP,
11366,GO:0045793,1,0.684855543817168,0,9,positive regulation of cell size,BP,
11367,GO:0045794,1,0.837315842586132,0,4,negative regulation of cell volume,BP,
11368,GO:0045795,1,0.956441843839217,0,1,positive regulation of cell volume,BP,
11369,GO:0045799,1,0.921052862961409,0,2,positive regulation of chromatin assembly or disassembly,BP,
11372,GO:0045813,1,0.962464157847848,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
11375,GO:0045819,1,0.957015312091596,0,1,positive regulation of glycogen catabolic process,BP,
11376,GO:0045820,1,0.777658257659965,0,6,negative regulation of glycolytic process,BP,
11378,GO:0045822,1,0.658278155265732,0,10,negative regulation of heart contraction,BP,
11379,GO:0045823,1,0.500900709962916,0,17,positive regulation of heart contraction,BP,
11382,GO:0045830,1,0.51552401878538,0,16,positive regulation of isotype switching,BP,
11385,GO:0045835,1,0.773545371781464,0,6,negative regulation of meiotic nuclear division,BP,
11386,GO:0045836,1,0.777151195698925,0,6,positive regulation of meiotic nuclear division,BP,
11387,GO:0045837,1,0.727013641259859,0,8,negative regulation of membrane potential,BP,
11388,GO:0045838,1,0.663177176655677,0,10,positive regulation of membrane potential,BP,
11391,GO:0045841,1,0.292015308162554,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
11392,GO:0045842,1,0.7186479201461,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11393,GO:0045843,1,0.261211579506498,0,32,negative regulation of striated muscle tissue development,BP,
11396,GO:0045852,1,0.883521874240067,0,3,pH elevation,BP,
11401,GO:0045869,1,0.721848115117246,0,8,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11402,GO:0045870,1,0.956441854282437,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11403,GO:0045872,1,0.961594767891253,0,1,positive regulation of rhodopsin gene expression,BP,
11404,GO:0045875,1,0.809515743881785,0,5,negative regulation of sister chromatid cohesion,BP,
11405,GO:0045876,1,0.657928786065523,0,10,positive regulation of sister chromatid cohesion,BP,
11408,GO:0045887,1,0.956441843839217,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
11412,GO:0045899,1,0.671260579536083,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11413,GO:0045900,1,0.848267697571449,0,4,negative regulation of translational elongation,BP,
11414,GO:0045901,1,0.883750471366143,0,3,positive regulation of translational elongation,BP,
11415,GO:0045903,1,0.895164731634328,0,3,positive regulation of translational fidelity,BP,
11416,GO:0045905,1,0.921970973559921,0,2,positive regulation of translational termination,BP,
11417,GO:0045906,1,0.774350402998435,0,6,negative regulation of vasoconstriction,BP,
11420,GO:0045911,1,0.452820236924935,0,19,positive regulation of DNA recombination,BP,
11421,GO:0045912,1,0.379650171269827,0,23,negative regulation of carbohydrate metabolic process,BP,
11423,GO:0045914,1,0.920575778025374,0,2,negative regulation of catecholamine metabolic process,BP,
11424,GO:0045915,1,0.816678690160936,0,5,positive regulation of catecholamine metabolic process,BP,
11426,GO:0045917,1,0.962379230688068,0,1,positive regulation of complement activation,BP,
11427,GO:0045918,1,0.964528097000344,0,1,negative regulation of cytolysis,BP,
11428,GO:0045919,1,0.892156398320638,0,3,positive regulation of cytolysis,BP,
11429,GO:0045920,1,0.470056570172686,0,18,negative regulation of exocytosis,BP,
11431,GO:0045922,1,0.534989333498146,0,15,negative regulation of fatty acid metabolic process,BP,
11452,GO:0045950,1,0.920512704213784,0,2,negative regulation of mitotic recombination,BP,
11453,GO:0045953,1,0.726756206088104,0,8,negative regulation of natural killer cell mediated cytotoxicity,BP,
11454,GO:0045954,1,0.711594917839443,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
11455,GO:0045955,1,0.743657058937041,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11457,GO:0045963,1,0.920575778025374,0,2,negative regulation of dopamine metabolic process,BP,
11458,GO:0045964,1,0.816678690160936,0,5,positive regulation of dopamine metabolic process,BP,
11459,GO:0045967,1,0.914777292668164,0,2,negative regulation of growth rate,BP,
11460,GO:0045974,1,0.604685663778521,0,12,regulation of translation, ncRNA-mediated,BP,
11461,GO:0045976,1,0.916505621253203,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
11462,GO:0045977,1,0.96356435360397,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
11463,GO:0045980,1,0.341902761033638,0,26,negative regulation of nucleotide metabolic process,BP,
11467,GO:0045988,1,0.882418963196356,0,3,negative regulation of striated muscle contraction,BP,
11468,GO:0045989,1,0.75282979746706,0,7,positive regulation of striated muscle contraction,BP,
11469,GO:0045990,1,0.848221312637479,0,4,carbon catabolite regulation of transcription,BP,
11470,GO:0045991,1,0.848221312637479,0,4,carbon catabolite activation of transcription,BP,
11472,GO:0045993,1,0.956645115883487,0,1,negative regulation of translational initiation by iron,BP,
11473,GO:0045994,1,0.956443221750116,0,1,positive regulation of translational initiation by iron,BP,
11475,GO:0046006,1,0.367200928072965,0,25,regulation of activated T cell proliferation,BP,
11476,GO:0046007,1,0.719482072670192,0,8,negative regulation of activated T cell proliferation,BP,
11477,GO:0046015,1,0.853939936296718,0,4,regulation of transcription by glucose,BP,
11478,GO:0046016,1,0.886860615978042,0,3,positive regulation of transcription by glucose,BP,
11479,GO:0046030,1,0.622415356412509,0,11,inositol trisphosphate phosphatase activity,MF,
11481,GO:0046032,1,0.963320834933059,0,1,ADP catabolic process,BP,
11484,GO:0046035,1,0.964136567279706,0,1,CMP metabolic process,BP,
11486,GO:0046037,1,0.452006745128278,0,19,GMP metabolic process,BP,
11487,GO:0046038,1,0.963665084856912,0,1,GMP catabolic process,BP,
11489,GO:0046040,1,0.605675861191795,0,12,IMP metabolic process,BP,
11490,GO:0046041,1,0.925471666530535,0,2,ITP metabolic process,BP,
11491,GO:0046048,1,0.958682820389596,0,1,UDP metabolic process,BP,
11492,GO:0046049,1,0.697073948922502,0,9,UMP metabolic process,BP,
11494,GO:0046054,1,0.964785442296245,0,1,dGMP metabolic process,BP,
11495,GO:0046056,1,0.923661854919556,0,2,dADP metabolic process,BP,
11496,GO:0046057,1,0.963367253297087,0,1,dADP catabolic process,BP,
11498,GO:0046060,1,0.826578456756913,0,5,dATP metabolic process,BP,
11499,GO:0046061,1,0.890998008911381,0,3,dATP catabolic process,BP,
11500,GO:0046065,1,0.964473912272003,0,1,dCTP metabolic process,BP,
11501,GO:0046066,1,0.891130290515516,0,3,dGDP metabolic process,BP,
11502,GO:0046067,1,0.963367253297087,0,1,dGDP catabolic process,BP,
11504,GO:0046069,1,0.91511726637513,0,2,cGMP catabolic process,BP,
11505,GO:0046070,1,0.858137261219967,0,4,dGTP metabolic process,BP,
11506,GO:0046072,1,0.924436773665056,0,2,dTDP metabolic process,BP,
11507,GO:0046073,1,0.889315452638255,0,3,dTMP metabolic process,BP,
11508,GO:0046075,1,0.858266683340569,0,4,dTTP metabolic process,BP,
11509,GO:0046077,1,0.924436773665056,0,2,dUDP metabolic process,BP,
11510,GO:0046078,1,0.858329847898367,0,4,dUMP metabolic process,BP,
11511,GO:0046080,1,0.962224489723766,0,1,dUTP metabolic process,BP,
11512,GO:0046081,1,0.962224489723766,0,1,dUTP catabolic process,BP,
11513,GO:0046083,1,0.894958162400753,0,3,adenine metabolic process,BP,
11514,GO:0046084,1,0.894958162400753,0,3,adenine biosynthetic process,BP,
11517,GO:0046087,1,0.760274509366157,0,7,cytidine metabolic process,BP,
11518,GO:0046090,1,0.963310309890086,0,1,deoxyadenosine metabolic process,BP,
11519,GO:0046092,1,0.956476352778798,0,1,deoxycytidine metabolic process,BP,
11520,GO:0046098,1,0.849709329781157,0,4,guanine metabolic process,BP,
11521,GO:0046099,1,0.927067628945206,0,2,guanine biosynthetic process,BP,
11522,GO:0046100,1,0.823848684466634,0,5,hypoxanthine metabolic process,BP,
11523,GO:0046101,1,0.856379451448786,0,4,hypoxanthine biosynthetic process,BP,
11524,GO:0046102,1,0.887826817964017,0,3,inosine metabolic process,BP,
11525,GO:0046103,1,0.92454367387257,0,2,inosine biosynthetic process,BP,
11526,GO:0046104,1,0.882715988353685,0,3,thymidine metabolic process,BP,
11527,GO:0046108,1,0.962437067087896,0,1,uridine metabolic process,BP,
11528,GO:0046110,1,0.881253890686605,0,3,xanthine metabolic process,BP,
11529,GO:0046111,1,0.963310309890086,0,1,xanthine biosynthetic process,BP,
11530,GO:0046112,1,0.456477528252201,0,19,nucleobase biosynthetic process,BP,
11531,GO:0046113,1,0.805792117292385,0,5,nucleobase catabolic process,BP,
11532,GO:0046116,1,0.891306703277484,0,3,queuosine metabolic process,BP,
11533,GO:0046121,1,0.888642364376989,0,3,deoxyribonucleoside catabolic process,BP,
11534,GO:0046122,1,0.929336122474611,0,2,purine deoxyribonucleoside metabolic process,BP,
11535,GO:0046124,1,0.963310309890086,0,1,purine deoxyribonucleoside catabolic process,BP,
11536,GO:0046125,1,0.882715988353685,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
11537,GO:0046127,1,0.958222255349026,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
11540,GO:0046130,1,0.791825677871975,0,6,purine ribonucleoside catabolic process,BP,
11543,GO:0046133,1,0.701449807300017,0,9,pyrimidine ribonucleoside catabolic process,BP,
11546,GO:0046136,1,0.963423728178762,0,1,positive regulation of vitamin metabolic process,BP,
11547,GO:0046137,1,0.883184453943546,0,3,negative regulation of vitamin metabolic process,BP,
11548,GO:0046146,1,0.763661551750362,0,7,tetrahydrobiopterin metabolic process,BP,
11550,GO:0046149,1,0.79629585260409,0,6,pigment catabolic process,BP,
11551,GO:0046160,1,0.916757762314565,0,2,heme a metabolic process,BP,
11554,GO:0046166,1,0.926328502499788,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
11555,GO:0046167,1,0.915623536867314,0,2,glycerol-3-phosphate biosynthetic process,BP,
11556,GO:0046168,1,0.95703524330473,0,1,glycerol-3-phosphate catabolic process,BP,
11559,GO:0046176,1,0.958787867083198,0,1,aldonic acid catabolic process,BP,
11560,GO:0046177,1,0.958787867083198,0,1,D-gluconate catabolic process,BP,
11561,GO:0046184,1,0.656911876178979,0,10,aldehyde biosynthetic process,BP,
11562,GO:0046185,1,0.6997294271824,0,9,aldehyde catabolic process,BP,
11563,GO:0046189,1,0.489481196849172,0,17,phenol-containing compound biosynthetic process,BP,
11564,GO:0046203,1,0.928431612516119,0,2,spermidine catabolic process,BP,
11565,GO:0046204,1,0.964847993326817,0,1,nor-spermidine metabolic process,BP,
11566,GO:0046208,1,0.892857252312263,0,3,spermine catabolic process,BP,
11568,GO:0046210,1,0.959964757059869,0,1,nitric oxide catabolic process,BP,
11569,GO:0046218,1,0.891184462161528,0,3,indolalkylamine catabolic process,BP,
11570,GO:0046222,1,0.959223330954023,0,1,aflatoxin metabolic process,BP,
11571,GO:0046223,1,0.959223330954023,0,1,aflatoxin catabolic process,BP,
11572,GO:0046272,1,0.961028045423662,0,1,stilbene catabolic process,BP,
11573,GO:0046292,1,0.885004840156183,0,3,formaldehyde metabolic process,BP,
11574,GO:0046293,1,0.956533377435599,0,1,formaldehyde biosynthetic process,BP,
11575,GO:0046294,1,0.925227624510048,0,2,formaldehyde catabolic process,BP,
11576,GO:0046295,1,0.96492184451589,0,1,glycolate biosynthetic process,BP,
11577,GO:0046305,1,0.959323986822767,0,1,alkanesulfonate biosynthetic process,BP,
11578,GO:0046316,1,0.958787867083198,0,1,gluconokinase activity,MF,
11579,GO:0046317,1,0.956468614910803,0,1,regulation of glucosylceramide biosynthetic process,BP,
11580,GO:0046318,1,0.956468614910803,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
11583,GO:0046322,1,0.846021529985162,0,4,negative regulation of fatty acid oxidation,BP,
11586,GO:0046325,1,0.716511460889576,0,8,negative regulation of glucose import,BP,
11588,GO:0046327,1,0.961893011303364,0,1,glycerol biosynthetic process from pyruvate,BP,
11592,GO:0046331,1,0.922944689711859,0,2,lateral inhibition,BP,
11594,GO:0046333,1,0.958404959737927,0,1,octopamine metabolic process,BP,
11595,GO:0046337,1,0.531007494112742,0,15,phosphatidylethanolamine metabolic process,BP,
11596,GO:0046338,1,0.918486758998171,0,2,phosphatidylethanolamine catabolic process,BP,
11597,GO:0046339,1,0.602723618263621,0,12,diacylglycerol metabolic process,BP,
11598,GO:0046340,1,0.918149844024646,0,2,diacylglycerol catabolic process,BP,
11599,GO:0046341,1,0.553101023271474,0,14,CDP-diacylglycerol metabolic process,BP,
11600,GO:0046348,1,0.726011892444274,0,8,amino sugar catabolic process,BP,
11601,GO:0046349,1,0.635115964173601,0,11,amino sugar biosynthetic process,BP,
11603,GO:0046355,1,0.957833010849434,0,1,mannan catabolic process,BP,
11604,GO:0046356,1,0.92737481015368,0,2,acetyl-CoA catabolic process,BP,
11605,GO:0046359,1,0.962057098494237,0,1,butyrate catabolic process,BP,
11610,GO:0046368,1,0.850737755263693,0,4,GDP-L-fucose metabolic process,BP,
11611,GO:0046370,1,0.925054655162642,0,2,fructose biosynthetic process,BP,
11612,GO:0046379,1,0.919011882058377,0,2,extracellular polysaccharide metabolic process,BP,
11613,GO:0046380,1,0.957157606130705,0,1,N-acetylneuraminate biosynthetic process,BP,
11614,GO:0046381,1,0.964152519439114,0,1,CMP-N-acetylneuraminate metabolic process,BP,
11615,GO:0046385,1,0.681208905610955,0,10,deoxyribose phosphate biosynthetic process,BP,
11616,GO:0046386,1,0.47652154893039,0,19,deoxyribose phosphate catabolic process,BP,
11618,GO:0046391,1,0.884817634110099,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
11621,GO:0046398,1,0.880833561131838,0,3,UDP-glucuronate metabolic process,BP,
11622,GO:0046403,1,0.962717105863326,0,1,polynucleotide 3'-phosphatase activity,MF,
11623,GO:0046404,1,0.886384133683161,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
11625,GO:0046416,1,0.960063836388062,0,1,D-amino acid metabolic process,BP,
11628,GO:0046427,1,0.204403143627219,0,39,positive regulation of JAK-STAT cascade,BP,
11630,GO:0046437,1,0.960063836388062,0,1,D-amino acid biosynthetic process,BP,
11631,GO:0046439,1,0.808285346868196,0,5,L-cysteine metabolic process,BP,
11632,GO:0046440,1,0.881322240942626,0,3,L-lysine metabolic process,BP,
11633,GO:0046443,1,0.961875270092358,0,1,FAD metabolic process,BP,
11634,GO:0046444,1,0.959323986822767,0,1,FMN metabolic process,BP,
11635,GO:0046448,1,0.960188160832726,0,1,tropane alkaloid metabolic process,BP,
11636,GO:0046449,1,0.875185187697661,0,3,creatinine metabolic process,BP,
11637,GO:0046452,1,0.887518453789386,0,3,dihydrofolate metabolic process,BP,
11638,GO:0046456,1,0.365400631063837,0,25,icosanoid biosynthetic process,BP,
11639,GO:0046457,1,0.547550934655588,0,15,prostanoid biosynthetic process,BP,
11643,GO:0046462,1,0.922863710467252,0,2,monoacylglycerol metabolic process,BP,
11649,GO:0046469,1,0.812999843566995,0,5,platelet activating factor metabolic process,BP,
11650,GO:0046470,1,0.102984263939852,0,55,phosphatidylcholine metabolic process,BP,
11651,GO:0046471,1,0.348999342578028,0,25,phosphatidylglycerol metabolic process,BP,
11652,GO:0046473,1,0.266055663876625,0,31,phosphatidic acid metabolic process,BP,
11654,GO:0046475,1,0.537112392626673,0,15,glycerophospholipid catabolic process,BP,
11655,GO:0046476,1,0.813351682499589,0,5,glycosylceramide biosynthetic process,BP,
11656,GO:0046477,1,0.779767924395846,0,6,glycosylceramide catabolic process,BP,
11657,GO:0046478,1,0.9565224254008,0,1,lactosylceramide metabolic process,BP,
11660,GO:0046485,1,0.751042198200796,0,7,ether lipid metabolic process,BP,
11662,GO:0046487,1,0.78625194646463,0,6,glyoxylate metabolic process,BP,
11665,GO:0046491,1,0.965074228027059,0,1,L-methylmalonyl-CoA metabolic process,BP,
11666,GO:0046493,1,0.932291866263446,0,2,lipid A metabolic process,BP,
11667,GO:0046495,1,0.96029277657686,0,1,nicotinamide riboside metabolic process,BP,
11669,GO:0046497,1,0.958787867083198,0,1,nicotinate nucleotide metabolic process,BP,
11671,GO:0046499,1,0.957939783253298,0,1,S-adenosylmethioninamine metabolic process,BP,
11676,GO:0046504,1,0.814909580629098,0,5,glycerol ether biosynthetic process,BP,
11677,GO:0046511,1,0.920286974835962,0,2,sphinganine biosynthetic process,BP,
11678,GO:0046512,1,0.722052073472803,0,8,sphingosine biosynthetic process,BP,
11682,GO:0046520,1,0.691052870821758,0,9,sphingoid biosynthetic process,BP,
11683,GO:0046521,1,0.962252164035365,0,1,sphingoid catabolic process,BP,
11684,GO:0046523,1,0.958265022851505,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
11685,GO:0046525,1,0.962720377988165,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
11686,GO:0046526,1,0.959897033209647,0,1,D-xylulose reductase activity,MF,
11687,GO:0046527,1,0.559164210332027,0,14,glucosyltransferase activity,MF,
11689,GO:0046532,1,0.808213255102044,0,5,regulation of photoreceptor cell differentiation,BP,
11690,GO:0046533,1,0.844850627817657,0,4,negative regulation of photoreceptor cell differentiation,BP,
11691,GO:0046534,1,0.956649123808226,0,1,positive regulation of photoreceptor cell differentiation,BP,
11692,GO:0046538,1,0.891770568486764,0,3,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
11693,GO:0046540,1,0.385897735596084,0,24,U4/U6 x U5 tri-snRNP complex,CC,
11694,GO:0046541,1,0.921708128519514,0,2,saliva secretion,BP,
11696,GO:0046544,1,0.956469102835451,0,1,development of secondary male sexual characteristics,BP,
11700,GO:0046549,1,0.879331236280963,0,3,retinal cone cell development,BP,
11701,GO:0046554,1,0.96397217586163,0,1,malate dehydrogenase (NADP+) activity,MF,
11702,GO:0046570,1,0.964099195952749,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
11703,GO:0046573,1,0.962999508446897,0,1,lactonohydrolase activity,MF,
11704,GO:0046577,1,0.957187156502027,0,1,long-chain-alcohol oxidase activity,MF,
11708,GO:0046581,1,0.879870235471698,0,3,intercellular canaliculus,CC,
11709,GO:0046586,1,0.924924283974758,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
11710,GO:0046587,1,0.958488100763464,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
11711,GO:0046588,1,0.964985539246318,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
11712,GO:0046592,1,0.925756757679149,0,2,polyamine oxidase activity,MF,
11715,GO:0046598,1,0.819418449466525,0,5,positive regulation of viral entry into host cell,BP,
11716,GO:0046599,1,0.484761565591076,0,17,regulation of centriole replication,BP,
11717,GO:0046600,1,0.710476108299763,0,8,negative regulation of centriole replication,BP,
11718,GO:0046601,1,0.878009048804179,0,3,positive regulation of centriole replication,BP,
11719,GO:0046602,1,0.714983555899575,0,8,regulation of mitotic centrosome separation,BP,
11720,GO:0046604,1,0.883952917396025,0,3,positive regulation of mitotic centrosome separation,BP,
11722,GO:0046606,1,0.580734081267107,0,13,negative regulation of centrosome cycle,BP,
11723,GO:0046607,1,0.68233631920841,0,9,positive regulation of centrosome cycle,BP,
11725,GO:0046619,1,0.956441843839217,0,1,optic placode formation involved in camera-type eye formation,BP,
11726,GO:0046620,1,0.0915478189884859,0,56,regulation of organ growth,BP,
11727,GO:0046621,1,0.388484198110761,0,22,negative regulation of organ growth,BP,
11728,GO:0046622,1,0.346717863278355,0,25,positive regulation of organ growth,BP,
11731,GO:0046625,1,0.636232983377148,0,11,sphingolipid binding,MF,
11733,GO:0046627,1,0.326095461642992,0,27,negative regulation of insulin receptor signaling pathway,BP,
11734,GO:0046628,1,0.708214277302422,0,8,positive regulation of insulin receptor signaling pathway,BP,
11735,GO:0046629,1,0.68534015068281,0,9,gamma-delta T cell activation,BP,
11738,GO:0046633,1,0.585626163420762,0,13,alpha-beta T cell proliferation,BP,
11740,GO:0046635,1,0.358634903661583,0,25,positive regulation of alpha-beta T cell activation,BP,
11743,GO:0046638,1,0.423721699501383,0,21,positive regulation of alpha-beta T cell differentiation,BP,
11745,GO:0046640,1,0.635753969277399,0,11,regulation of alpha-beta T cell proliferation,BP,
11746,GO:0046641,1,0.754149680386765,0,7,positive regulation of alpha-beta T cell proliferation,BP,
11747,GO:0046642,1,0.880566644341843,0,3,negative regulation of alpha-beta T cell proliferation,BP,
11748,GO:0046643,1,0.837421564246878,0,4,regulation of gamma-delta T cell activation,BP,
11749,GO:0046645,1,0.875160469663113,0,3,positive regulation of gamma-delta T cell activation,BP,
11753,GO:0046654,1,0.749459662487614,0,7,tetrahydrofolate biosynthetic process,BP,
11755,GO:0046657,1,0.923110445680315,0,2,folic acid catabolic process,BP,
11759,GO:0046666,1,0.923798723707797,0,2,retinal cell programmed cell death,BP,
11760,GO:0046668,1,0.957101590816272,0,1,regulation of retinal cell programmed cell death,BP,
11761,GO:0046671,1,0.957101590816272,0,1,negative regulation of retinal cell programmed cell death,BP,
11764,GO:0046680,1,0.961450769203242,0,1,response to DDT,BP,
11766,GO:0046684,1,0.920253567780548,0,2,response to pyrethroid,BP,
11769,GO:0046687,1,0.964528097000344,0,1,response to chromate,BP,
11771,GO:0046689,1,0.816069719219161,0,5,response to mercury ion,BP,
11772,GO:0046690,1,0.95756135946994,0,1,response to tellurium ion,BP,
11773,GO:0046695,1,0.889801952726119,0,3,SLIK (SAGA-like) complex,CC,
11774,GO:0046696,1,0.920555913456557,0,2,lipopolysaccharide receptor complex,CC,
11777,GO:0046703,1,0.713600752684787,0,9,natural killer cell lectin-like receptor binding,MF,
11778,GO:0046707,1,0.921357210441198,0,2,IDP metabolic process,BP,
11779,GO:0046709,1,0.921357210441198,0,2,IDP catabolic process,BP,
11780,GO:0046710,1,0.600797977424271,0,12,GDP metabolic process,BP,
11781,GO:0046711,1,0.964785442296245,0,1,GDP biosynthetic process,BP,
11782,GO:0046712,1,0.963367253297087,0,1,GDP catabolic process,BP,
11783,GO:0046713,1,0.958244092294393,0,1,borate transport,BP,
11784,GO:0046715,1,0.958244092294393,0,1,active borate transmembrane transporter activity,MF,
11789,GO:0046724,1,0.959482102469118,0,1,oxalic acid secretion,BP,
11791,GO:0046726,1,0.840200033471378,0,4,positive regulation by virus of viral protein levels in host cell,BP,
11792,GO:0046730,1,0.92594695402866,0,2,induction of host immune response by virus,BP,
11793,GO:0046732,1,0.92594695402866,0,2,active induction of host immune response by virus,BP,
11794,GO:0046745,1,0.958787867083198,0,1,viral capsid secondary envelopment,BP,
11795,GO:0046755,1,0.381243581201072,0,24,viral budding,BP,
11797,GO:0046778,1,0.922399962731537,0,2,modification by virus of host mRNA processing,BP,
11798,GO:0046782,1,0.0888792153455825,0,59,regulation of viral transcription,BP,
11799,GO:0046784,1,0.725841075303972,0,8,viral mRNA export from host cell nucleus,BP,
11801,GO:0046786,1,0.956500718261825,0,1,viral replication complex formation and maintenance,BP,
11802,GO:0046790,1,0.885214813762,0,3,virion binding,MF,
11804,GO:0046811,1,0.956441869604328,0,1,histone deacetylase inhibitor activity,MF,
11805,GO:0046813,1,0.924856483976346,0,2,receptor-mediated virion attachment to host cell,BP,
11806,GO:0046817,1,0.964192233074412,0,1,chemokine receptor antagonist activity,MF,
11813,GO:0046831,1,0.522957184638629,0,15,regulation of RNA export from nucleus,BP,
11814,GO:0046832,1,0.914777322117324,0,2,negative regulation of RNA export from nucleus,BP,
11815,GO:0046833,1,0.740442644972312,0,7,positive regulation of RNA export from nucleus,BP,
11817,GO:0046835,1,0.365242207045007,0,24,carbohydrate phosphorylation,BP,
11818,GO:0046836,1,0.817675906216366,0,5,glycolipid transport,BP,
11822,GO:0046848,1,0.963769959183123,0,1,hydroxyapatite binding,MF,
11829,GO:0046856,1,0.399010076885163,0,21,phosphatidylinositol dephosphorylation,BP,
11830,GO:0046870,1,0.87863214224627,0,3,cadmium ion binding,MF,
11833,GO:0046874,1,0.963280149525521,0,1,quinolinate metabolic process,BP,
11836,GO:0046880,1,0.88135092154304,0,3,regulation of follicle-stimulating hormone secretion,BP,
11837,GO:0046881,1,0.88135092154304,0,3,positive regulation of follicle-stimulating hormone secretion,BP,
11838,GO:0046882,1,0.961161759333046,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
11840,GO:0046884,1,0.843036841592912,0,4,follicle-stimulating hormone secretion,BP,
11842,GO:0046886,1,0.776297490677997,0,6,positive regulation of hormone biosynthetic process,BP,
11847,GO:0046898,1,0.880360135405754,0,3,response to cycloheximide,BP,
11848,GO:0046899,1,0.919977801136378,0,2,nucleoside triphosphate adenylate kinase activity,MF,
11849,GO:0046900,1,0.924931767490884,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
11850,GO:0046901,1,0.960026136503136,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
11851,GO:0046902,1,0.0689289288297932,0,66,regulation of mitochondrial membrane permeability,BP,
11856,GO:0046912,1,0.878124523789383,0,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
11860,GO:0046920,1,0.81098245557587,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
11861,GO:0046921,1,0.957891697329934,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
11862,GO:0046922,1,0.917843909095503,0,2,peptide-O-fucosyltransferase activity,MF,
11863,GO:0046923,1,0.820034865502556,0,5,ER retention sequence binding,MF,
11866,GO:0046930,1,0.646057436274098,0,11,pore complex,CC,
11867,GO:0046931,1,0.535902882180441,0,15,pore complex assembly,BP,
11868,GO:0046933,1,0.895154042848276,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
11872,GO:0046940,1,0.815053124934947,0,5,nucleoside monophosphate phosphorylation,BP,
11875,GO:0046946,1,0.879141151351951,0,3,hydroxylysine metabolic process,BP,
11876,GO:0046947,1,0.879141151351951,0,3,hydroxylysine biosynthetic process,BP,
11878,GO:0046950,1,0.748875506559121,0,7,cellular ketone body metabolic process,BP,
11879,GO:0046951,1,0.782183116924339,0,6,ketone body biosynthetic process,BP,
11880,GO:0046952,1,0.881428045425959,0,3,ketone body catabolic process,BP,
11881,GO:0046958,1,0.957931211464724,0,1,nonassociative learning,BP,
11883,GO:0046963,1,0.924644211954896,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11884,GO:0046964,1,0.924644211954896,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
11885,GO:0046965,1,0.630499346645122,0,11,retinoid X receptor binding,MF,
11886,GO:0046966,1,0.325955341540555,0,27,thyroid hormone receptor binding,MF,
11887,GO:0046967,1,0.917329416222625,0,2,cytosol to ER transport,BP,
11888,GO:0046968,1,0.956931729370711,0,1,peptide antigen transport,BP,
11889,GO:0046969,1,0.921691244631685,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
11890,GO:0046970,1,0.961965560697168,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
11891,GO:0046972,1,0.65357586330005,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11892,GO:0046974,1,0.805300720882754,0,5,histone methyltransferase activity (H3-K9 specific),MF,
11893,GO:0046975,1,0.778274725104733,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11894,GO:0046976,1,0.80799044194555,0,5,histone methyltransferase activity (H3-K27 specific),MF,
11895,GO:0046977,1,0.846764632468523,0,4,TAP binding,MF,
11896,GO:0046978,1,0.846764632468523,0,4,TAP1 binding,MF,
11897,GO:0046979,1,0.884884410068557,0,3,TAP2 binding,MF,
11898,GO:0046980,1,0.956931729370711,0,1,tapasin binding,MF,
11901,GO:0046984,1,0.849327166424973,0,4,regulation of hemoglobin biosynthetic process,BP,
11902,GO:0046985,1,0.8878280239254,0,3,positive regulation of hemoglobin biosynthetic process,BP,
11903,GO:0046986,1,0.956645115883487,0,1,negative regulation of hemoglobin biosynthetic process,BP,
11904,GO:0046996,1,0.958787867083198,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11905,GO:0047006,1,0.963764331992281,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11906,GO:0047012,1,0.963121164903035,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
11907,GO:0047015,1,0.964880250454939,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
11908,GO:0047016,1,0.961103921302335,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
11909,GO:0047017,1,0.958787867083198,0,1,prostaglandin-F synthase activity,MF,
11910,GO:0047021,1,0.964144548147007,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
11911,GO:0047023,1,0.928527892364252,0,2,androsterone dehydrogenase activity,MF,
11912,GO:0047025,1,0.923879471891362,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
11913,GO:0047035,1,0.964778188240337,0,1,testosterone dehydrogenase (NAD+) activity,MF,
11914,GO:0047042,1,0.963764331992281,0,1,androsterone dehydrogenase (B-specific) activity,MF,
11915,GO:0047045,1,0.964149863404248,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
11916,GO:0047057,1,0.930558326319754,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
11917,GO:0047066,1,0.964905236546779,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
11918,GO:0047086,1,0.928527892364252,0,2,ketosteroid monooxygenase activity,MF,
11919,GO:0047105,1,0.959974959431182,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
11920,GO:0047115,1,0.928527892364252,0,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
11921,GO:0047117,1,0.956441843839217,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11922,GO:0047130,1,0.956441843839217,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11923,GO:0047131,1,0.956441843839217,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
11926,GO:0047150,1,0.961798792450768,0,1,betaine-homocysteine S-methyltransferase activity,MF,
11927,GO:0047159,1,0.956997685913152,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
11928,GO:0047166,1,0.962074636056528,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
11929,GO:0047179,1,0.930116081432008,0,2,platelet-activating factor acetyltransferase activity,MF,
11930,GO:0047184,1,0.814021344052147,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
11931,GO:0047186,1,0.957057626509623,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
11932,GO:0047191,1,0.956997685913152,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
11933,GO:0047192,1,0.880593925819771,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
11934,GO:0047220,1,0.959083905646544,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
11935,GO:0047223,1,0.883069969312988,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
11936,GO:0047224,1,0.960019297233385,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
11937,GO:0047237,1,0.917843719263577,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11938,GO:0047238,1,0.840464026035015,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11939,GO:0047256,1,0.956859015494478,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
11940,GO:0047263,1,0.958759945309585,0,1,N-acylsphingosine galactosyltransferase activity,MF,
11941,GO:0047273,1,0.957843875641311,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
11942,GO:0047275,1,0.957473641547761,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
11943,GO:0047277,1,0.961958496650766,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
11944,GO:0047280,1,0.956596448177887,0,1,nicotinamide phosphoribosyltransferase activity,MF,
11945,GO:0047288,1,0.920921455953551,0,2,monosialoganglioside sialyltransferase activity,MF,
11946,GO:0047290,1,0.962974291864876,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
11948,GO:0047293,1,0.962993212713458,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
11949,GO:0047298,1,0.956499496521757,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
11950,GO:0047322,1,0.914802899823571,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
11951,GO:0047323,1,0.96130274218588,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
11952,GO:0047325,1,0.957956075730342,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
11953,GO:0047326,1,0.962494535129895,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
11954,GO:0047341,1,0.957656207975024,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
11955,GO:0047349,1,0.956444859219698,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
11957,GO:0047372,1,0.690547600443249,0,9,acylglycerol lipase activity,MF,
11959,GO:0047389,1,0.916363293886539,0,2,glycerophosphocholine phosphodiesterase activity,MF,
11960,GO:0047391,1,0.922296142325036,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
11961,GO:0047395,1,0.958672511762813,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
11962,GO:0047408,1,0.92165798407579,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
11963,GO:0047409,1,0.92165798407579,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
11964,GO:0047429,1,0.69911653808635,0,9,nucleoside-triphosphate diphosphatase activity,MF,
11965,GO:0047444,1,0.964152519439114,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
11966,GO:0047451,1,0.956441843839217,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
11967,GO:0047464,1,0.956477735135559,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
11969,GO:0047485,1,0.0191842579542822,0,96,protein N-terminus binding,MF,
11970,GO:0047493,1,0.882000853135811,0,3,ceramide cholinephosphotransferase activity,MF,
11972,GO:0047497,1,0.448444552522996,0,19,mitochondrion transport along microtubule,BP,
11973,GO:0047498,1,0.77382713050167,0,6,calcium-dependent phospholipase A2 activity,MF,
11974,GO:0047499,1,0.815588109661014,0,5,calcium-independent phospholipase A2 activity,MF,
11975,GO:0047522,1,0.885057778050573,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
11976,GO:0047536,1,0.960968477693179,0,1,2-aminoadipate transaminase activity,MF,
11977,GO:0047545,1,0.956441843839217,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
11978,GO:0047555,1,0.838191141042376,0,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,
11980,GO:0047578,1,0.960160413577191,0,1,4-hydroxyglutamate transaminase activity,MF,
11981,GO:0047598,1,0.959482102469118,0,1,7-dehydrocholesterol reductase activity,MF,
11982,GO:0047617,1,0.622473290107267,0,12,acyl-CoA hydrolase activity,MF,
11983,GO:0047620,1,0.958672511762813,0,1,acylglycerol kinase activity,MF,
11984,GO:0047621,1,0.962869317582296,0,1,acylpyruvate hydrolase activity,MF,
11985,GO:0047623,1,0.915772416397962,0,2,adenosine-phosphate deaminase activity,MF,
11986,GO:0047631,1,0.828947241661589,0,5,ADP-ribose diphosphatase activity,MF,
11987,GO:0047635,1,0.957026642911005,0,1,alanine-oxo-acid transaminase activity,MF,
11989,GO:0047661,1,0.960063836388062,0,1,amino-acid racemase activity,MF,
11990,GO:0047676,1,0.956460086367034,0,1,arachidonate-CoA ligase activity,MF,
11991,GO:0047685,1,0.963404460189115,0,1,amine sulfotransferase activity,MF,
11992,GO:0047693,1,0.965425347294511,0,1,ATP diphosphatase activity,MF,
11994,GO:0047708,1,0.961551625610174,0,1,biotinidase activity,MF,
11995,GO:0047710,1,0.964545644601889,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
11996,GO:0047718,1,0.963764331992281,0,1,indanol dehydrogenase activity,MF,
11997,GO:0047726,1,0.959964757059869,0,1,iron-cytochrome-c reductase activity,MF,
11998,GO:0047734,1,0.958787867083198,0,1,CDP-glycerol diphosphatase activity,MF,
11999,GO:0047747,1,0.96044766226592,0,1,cholate-CoA ligase activity,MF,
12000,GO:0047750,1,0.930444525547164,0,2,cholestenol delta-isomerase activity,MF,
12001,GO:0047751,1,0.92188555446637,0,2,cholestenone 5-alpha-reductase activity,MF,
12002,GO:0047756,1,0.91966147945439,0,2,chondroitin 4-sulfotransferase activity,MF,
12003,GO:0047757,1,0.915251541602811,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12004,GO:0047760,1,0.957809688311412,0,1,butyrate-CoA ligase activity,MF,
12005,GO:0047800,1,0.957243544137169,0,1,cysteamine dioxygenase activity,MF,
12006,GO:0047801,1,0.961309969360537,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12007,GO:0047840,1,0.964473912272003,0,1,dCTP diphosphatase activity,MF,
12008,GO:0047844,1,0.789857264292156,0,6,deoxycytidine deaminase activity,MF,
12009,GO:0047860,1,0.964066995252176,0,1,diiodophenylpyruvate reductase activity,MF,
12010,GO:0047874,1,0.961371378356842,0,1,dolichyldiphosphatase activity,MF,
12011,GO:0047888,1,0.961954963465342,0,1,fatty acid peroxidase activity,MF,
12012,GO:0047894,1,0.927986725452884,0,2,flavonol 3-sulfotransferase activity,MF,
12013,GO:0047915,1,0.962862905627224,0,1,ganglioside galactosyltransferase activity,MF,
12014,GO:0047933,1,0.956441843839217,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12016,GO:0047939,1,0.963498797201556,0,1,L-glucuronate reductase activity,MF,
12017,GO:0047977,1,0.960461819250754,0,1,hepoxilin-epoxide hydrolase activity,MF,
12018,GO:0047982,1,0.96265960442676,0,1,homocysteine desulfhydrase activity,MF,
12020,GO:0048003,1,0.876126661661215,0,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12021,GO:0048006,1,0.957169766353492,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12022,GO:0048007,1,0.876126661661215,0,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12023,GO:0048008,1,0.169608473435081,0,41,platelet-derived growth factor receptor signaling pathway,BP,
12027,GO:0048012,1,0.634914909707816,0,11,hepatocyte growth factor receptor signaling pathway,BP,
12029,GO:0048014,1,0.956453876255052,0,1,Tie signaling pathway,BP,
12034,GO:0048019,1,0.672739434035365,0,10,receptor antagonist activity,MF,
12036,GO:0048021,1,0.875200985491293,0,3,regulation of melanin biosynthetic process,BP,
12037,GO:0048022,1,0.914777292668164,0,2,negative regulation of melanin biosynthetic process,BP,
12038,GO:0048023,1,0.956744377951467,0,1,positive regulation of melanin biosynthetic process,BP,
12039,GO:0048024,1,0.0713190740024377,0,63,regulation of mRNA splicing, via spliceosome,BP,
12040,GO:0048025,1,0.493851031363645,0,17,negative regulation of mRNA splicing, via spliceosome,BP,
12041,GO:0048026,1,0.612839434937634,0,12,positive regulation of mRNA splicing, via spliceosome,BP,
12042,GO:0048027,1,0.414125266029995,0,22,mRNA 5'-UTR binding,MF,
12043,GO:0048029,1,0.155108387848701,0,45,monosaccharide binding,MF,
12044,GO:0048030,1,0.965768149912146,0,1,disaccharide binding,MF,
12045,GO:0048033,1,0.958512331126642,0,1,heme o metabolic process,BP,
12046,GO:0048034,1,0.958512331126642,0,1,heme O biosynthetic process,BP,
12048,GO:0048038,1,0.581977466177749,0,14,quinone binding,MF,
12049,GO:0048039,1,0.795402695307778,0,6,ubiquinone binding,MF,
12050,GO:0048040,1,0.961443556457944,0,1,UDP-glucuronate decarboxylase activity,MF,
12053,GO:0048050,1,0.791304828581484,0,6,post-embryonic eye morphogenesis,BP,
12054,GO:0048058,1,0.957841153467644,0,1,compound eye corneal lens development,BP,
12055,GO:0048066,1,0.284183924186588,0,30,developmental pigmentation,BP,
12056,GO:0048069,1,0.806142273601754,0,5,eye pigmentation,BP,
12057,GO:0048070,1,0.604072736279324,0,12,regulation of developmental pigmentation,BP,
12058,GO:0048073,1,0.915303341326359,0,2,regulation of eye pigmentation,BP,
12059,GO:0048075,1,0.956729956623248,0,1,positive regulation of eye pigmentation,BP,
12060,GO:0048087,1,0.743188613731556,0,7,positive regulation of developmental pigmentation,BP,
12061,GO:0048096,1,0.715643950314744,0,8,chromatin-mediated maintenance of transcription,BP,
12073,GO:0048149,1,0.842270971840844,0,4,behavioral response to ethanol,BP,
12075,GO:0048160,1,0.956580264723012,0,1,primary follicle stage,BP,
12076,GO:0048162,1,0.962961649857946,0,1,multi-layer follicle stage,BP,
12077,GO:0048165,1,0.914910563901317,0,2,fused antrum stage,BP,
12082,GO:0048172,1,0.739744697057114,0,7,regulation of short-term neuronal synaptic plasticity,BP,
12084,GO:0048180,1,0.961161759333046,0,1,activin complex,CC,
12090,GO:0048200,1,0.779941441533733,0,6,Golgi transport vesicle coating,BP,
12091,GO:0048203,1,0.922452611981605,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12092,GO:0048205,1,0.779941441533733,0,6,COPI coating of Golgi vesicle,BP,
12095,GO:0048209,1,0.919317546387463,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12096,GO:0048210,1,0.886572199858515,0,3,Golgi vesicle fusion to target membrane,BP,
12097,GO:0048211,1,0.917923862634583,0,2,Golgi vesicle docking,BP,
12098,GO:0048213,1,0.958943824539597,0,1,Golgi vesicle prefusion complex stabilization,BP,
12101,GO:0048237,1,0.926047998071556,0,2,rough endoplasmic reticulum lumen,CC,
12102,GO:0048239,1,0.921726693165832,0,2,negative regulation of DNA recombination at telomere,BP,
12105,GO:0048244,1,0.962917224904392,0,1,phytanoyl-CoA dioxygenase activity,MF,
12106,GO:0048245,1,0.852980466734134,0,4,eosinophil chemotaxis,BP,
12109,GO:0048250,1,0.926908168279441,0,2,iron import into the mitochondrion,BP,
12111,GO:0048254,1,0.855328156107026,0,4,snoRNA localization,BP,
12112,GO:0048255,1,0.348287531684284,0,25,mRNA stabilization,BP,
12113,GO:0048256,1,0.71464668004776,0,8,flap endonuclease activity,MF,
12114,GO:0048257,1,0.920730642222316,0,2,3'-flap endonuclease activity,MF,
12117,GO:0048261,1,0.556498685468958,0,14,negative regulation of receptor-mediated endocytosis,BP,
12118,GO:0048262,1,0.81650414213946,0,5,determination of dorsal/ventral asymmetry,BP,
12119,GO:0048263,1,0.851876474277728,0,4,determination of dorsal identity,BP,
12120,GO:0048264,1,0.958490514221976,0,1,determination of ventral identity,BP,
12121,GO:0048265,1,0.714518584251316,0,8,response to pain,BP,
12122,GO:0048266,1,0.80829513011217,0,5,behavioral response to pain,BP,
12124,GO:0048269,1,0.922031113681919,0,2,methionine adenosyltransferase complex,CC,
12125,GO:0048270,1,0.961470598820274,0,1,methionine adenosyltransferase regulator activity,MF,
12126,GO:0048273,1,0.777870410848813,0,6,mitogen-activated protein kinase p38 binding,MF,
12128,GO:0048280,1,0.666706404568892,0,10,vesicle fusion with Golgi apparatus,BP,
12131,GO:0048286,1,0.354656411289233,0,24,lung alveolus development,BP,
12133,GO:0048290,1,0.78218983515386,0,6,isotype switching to IgA isotypes,BP,
12134,GO:0048291,1,0.71461805533845,0,8,isotype switching to IgG isotypes,BP,
12137,GO:0048295,1,0.92105688269097,0,2,positive regulation of isotype switching to IgE isotypes,BP,
12138,GO:0048296,1,0.81667179325235,0,5,regulation of isotype switching to IgA isotypes,BP,
12139,GO:0048297,1,0.961295514567907,0,1,negative regulation of isotype switching to IgA isotypes,BP,
12140,GO:0048298,1,0.849564539030208,0,4,positive regulation of isotype switching to IgA isotypes,BP,
12141,GO:0048302,1,0.743916230496753,0,7,regulation of isotype switching to IgG isotypes,BP,
12142,GO:0048304,1,0.81117093023291,0,5,positive regulation of isotype switching to IgG isotypes,BP,
12143,GO:0048305,1,0.670805699632722,0,10,immunoglobulin secretion,BP,
12145,GO:0048308,1,0.543215178831436,0,15,organelle inheritance,BP,
12146,GO:0048311,1,0.541498695086907,0,14,mitochondrion distribution,BP,
12147,GO:0048312,1,0.768909901687454,0,6,intracellular distribution of mitochondria,BP,
12148,GO:0048313,1,0.566592292992259,0,14,Golgi inheritance,BP,
12149,GO:0048318,1,0.816380123782307,0,5,axial mesoderm development,BP,
12150,GO:0048319,1,0.91597912418791,0,2,axial mesoderm morphogenesis,BP,
12151,GO:0048320,1,0.957698301862685,0,1,axial mesoderm formation,BP,
12153,GO:0048333,1,0.526554489490702,0,15,mesodermal cell differentiation,BP,
12154,GO:0048338,1,0.957364396235892,0,1,mesoderm structural organization,BP,
12155,GO:0048339,1,0.545771187266946,0,14,paraxial mesoderm development,BP,
12156,GO:0048340,1,0.736333022528112,0,7,paraxial mesoderm morphogenesis,BP,
12157,GO:0048341,1,0.840824788524095,0,4,paraxial mesoderm formation,BP,
12158,GO:0048352,1,0.957364396235892,0,1,paraxial mesoderm structural organization,BP,
12159,GO:0048364,1,0.965280077340104,0,1,root development,BP,
12161,GO:0048368,1,0.714052113746812,0,8,lateral mesoderm development,BP,
12162,GO:0048369,1,0.915659935701208,0,2,lateral mesoderm morphogenesis,BP,
12163,GO:0048370,1,0.915659935701208,0,2,lateral mesoderm formation,BP,
12164,GO:0048371,1,0.915659935701208,0,2,lateral mesodermal cell differentiation,BP,
12165,GO:0048372,1,0.915659935701208,0,2,lateral mesodermal cell fate commitment,BP,
12166,GO:0048377,1,0.915659935701208,0,2,lateral mesodermal cell fate specification,BP,
12167,GO:0048378,1,0.915659935701208,0,2,regulation of lateral mesodermal cell fate specification,BP,
12168,GO:0048382,1,0.917598207365313,0,2,mesendoderm development,BP,
12170,GO:0048385,1,0.636721057726364,0,11,regulation of retinoic acid receptor signaling pathway,BP,
12171,GO:0048386,1,0.844584367097462,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
12172,GO:0048387,1,0.812908217075265,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,
12173,GO:0048388,1,0.922098777877356,0,2,endosomal lumen acidification,BP,
12174,GO:0048389,1,0.962531515651986,0,1,intermediate mesoderm development,BP,
12175,GO:0048390,1,0.962531515651986,0,1,intermediate mesoderm morphogenesis,BP,
12176,GO:0048391,1,0.962531515651986,0,1,intermediate mesoderm formation,BP,
12177,GO:0048392,1,0.962531515651986,0,1,intermediate mesodermal cell differentiation,BP,
12178,GO:0048403,1,0.957059600671194,0,1,brain-derived neurotrophic factor binding,MF,
12186,GO:0048476,1,0.822547689142324,0,5,Holliday junction resolvase complex,CC,
12188,GO:0048478,1,0.747400178091849,0,7,replication fork protection,BP,
12191,GO:0048485,1,0.570716140473338,0,13,sympathetic nervous system development,BP,
12197,GO:0048495,1,0.842100669287293,0,4,Roundabout binding,MF,
12198,GO:0048496,1,0.878716709910869,0,3,maintenance of animal organ identity,BP,
12199,GO:0048499,1,0.887704047400427,0,3,synaptic vesicle membrane organization,BP,
12200,GO:0048500,1,0.700797636248193,0,9,signal recognition particle,CC,
12209,GO:0048520,1,0.841685123768715,0,4,positive regulation of behavior,BP,
12210,GO:0048521,1,0.850889123359165,0,4,negative regulation of behavior,BP,
12215,GO:0048531,1,0.614307068996818,0,12,beta-1,3-galactosyltransferase activity,MF,
12216,GO:0048532,1,0.65103119638394,0,10,anatomical structure arrangement,BP,
12218,GO:0048535,1,0.613459168241547,0,12,lymph node development,BP,
12219,GO:0048536,1,0.365867096820628,0,24,spleen development,BP,
12220,GO:0048537,1,0.812676521586167,0,5,mucosal-associated lymphoid tissue development,BP,
12222,GO:0048539,1,0.845135929022719,0,4,bone marrow development,BP,
12223,GO:0048541,1,0.812676521586167,0,5,Peyer's patch development,BP,
12226,GO:0048548,1,0.684177876108967,0,9,regulation of pinocytosis,BP,
12227,GO:0048549,1,0.841026577010384,0,4,positive regulation of pinocytosis,BP,
12228,GO:0048550,1,0.813562809847371,0,5,negative regulation of pinocytosis,BP,
12229,GO:0048557,1,0.743052320056486,0,7,embryonic digestive tract morphogenesis,BP,
12230,GO:0048560,1,0.923620560557633,0,2,establishment of anatomical structure orientation,BP,
12231,GO:0048561,1,0.960981108735378,0,1,establishment of animal organ orientation,BP,
12233,GO:0048563,1,0.756866360256408,0,7,post-embryonic animal organ morphogenesis,BP,
12237,GO:0048569,1,0.559728230128003,0,14,post-embryonic animal organ development,BP,
12247,GO:0048597,1,0.894235387564594,0,3,post-embryonic camera-type eye morphogenesis,BP,
12252,GO:0048611,1,0.958598826789882,0,1,embryonic ectodermal digestive tract development,BP,
12253,GO:0048617,1,0.801356476816219,0,5,embryonic foregut morphogenesis,BP,
12254,GO:0048619,1,0.958927055828018,0,1,embryonic hindgut morphogenesis,BP,
12255,GO:0048625,1,0.879093831866699,0,3,myoblast fate commitment,BP,
12256,GO:0048627,1,0.923232407505878,0,2,myoblast development,BP,
12257,GO:0048630,1,0.877302440366252,0,3,skeletal muscle tissue growth,BP,
12258,GO:0048631,1,0.877302440366252,0,3,regulation of skeletal muscle tissue growth,BP,
12259,GO:0048633,1,0.877302440366252,0,3,positive regulation of skeletal muscle tissue growth,BP,
12261,GO:0048635,1,0.250042265750953,0,33,negative regulation of muscle organ development,BP,
12267,GO:0048642,1,0.747765589212669,0,7,negative regulation of skeletal muscle tissue development,BP,
12277,GO:0048664,1,0.892786660688048,0,3,neuron fate determination,BP,
12286,GO:0048674,1,0.960191633845267,0,1,collateral sprouting of injured axon,BP,
12291,GO:0048680,1,0.852891768341345,0,4,positive regulation of axon regeneration,BP,
12294,GO:0048686,1,0.960191633845267,0,1,regulation of sprouting of injured axon,BP,
12295,GO:0048687,1,0.960191633845267,0,1,positive regulation of sprouting of injured axon,BP,
12296,GO:0048688,1,0.960191633845267,0,1,negative regulation of sprouting of injured axon,BP,
12297,GO:0048689,1,0.960191633845267,0,1,formation of growth cone in injured axon,BP,
12298,GO:0048693,1,0.960191633845267,0,1,regulation of collateral sprouting of injured axon,BP,
12299,GO:0048694,1,0.960191633845267,0,1,positive regulation of collateral sprouting of injured axon,BP,
12313,GO:0048712,1,0.811650571354264,0,5,negative regulation of astrocyte differentiation,BP,
12316,GO:0048715,1,0.721644023376619,0,8,negative regulation of oligodendrocyte differentiation,BP,
12321,GO:0048733,1,0.841771535812555,0,4,sebaceous gland development,BP,
12324,GO:0048739,1,0.775304508119509,0,6,cardiac muscle fiber development,BP,
12325,GO:0048741,1,0.574665179486195,0,13,skeletal muscle fiber development,BP,
12326,GO:0048742,1,0.805214666633309,0,5,regulation of skeletal muscle fiber development,BP,
12327,GO:0048743,1,0.916024134139632,0,2,positive regulation of skeletal muscle fiber development,BP,
12330,GO:0048749,1,0.957841153467644,0,1,compound eye development,BP,
12334,GO:0048755,1,0.807885064215905,0,5,branching morphogenesis of a nerve,BP,
12335,GO:0048757,1,0.664654376100139,0,10,pigment granule maturation,BP,
12338,GO:0048764,1,0.965280077340104,0,1,trichoblast maturation,BP,
12339,GO:0048765,1,0.965280077340104,0,1,root hair cell differentiation,BP,
12340,GO:0048767,1,0.965280077340104,0,1,root hair elongation,BP,
12341,GO:0048769,1,0.914777292668164,0,2,sarcomerogenesis,BP,
12345,GO:0048787,1,0.841814912908387,0,4,presynaptic active zone membrane,CC,
12348,GO:0048793,1,0.838146343360305,0,4,pronephros development,BP,
12351,GO:0048807,1,0.956576492492707,0,1,female genitalia morphogenesis,BP,
12355,GO:0048817,1,0.915087014393936,0,2,negative regulation of hair follicle maturation,BP,
12356,GO:0048818,1,0.848617702943618,0,4,positive regulation of hair follicle maturation,BP,
12357,GO:0048819,1,0.711869901030075,0,8,regulation of hair follicle maturation,BP,
12358,GO:0048820,1,0.527848210562101,0,15,hair follicle maturation,BP,
12360,GO:0048822,1,0.879398229808485,0,3,enucleate erythrocyte development,BP,
12364,GO:0048842,1,0.769207544929836,0,6,positive regulation of axon extension involved in axon guidance,BP,
12367,GO:0048845,1,0.710142152392922,0,8,venous blood vessel morphogenesis,BP,
12369,GO:0048850,1,0.914777292668164,0,2,hypophysis morphogenesis,BP,
12370,GO:0048852,1,0.879262443211051,0,3,diencephalon morphogenesis,BP,
12371,GO:0048853,1,0.741214058850269,0,7,forebrain morphogenesis,BP,
12372,GO:0048854,1,0.368587133793004,0,23,brain morphogenesis,BP,
12373,GO:0048855,1,0.956441843839217,0,1,adenohypophysis morphogenesis,BP,
12377,GO:0048859,1,0.922748889386116,0,2,formation of anatomical boundary,BP,
12378,GO:0048861,1,0.8444435514846,0,4,leukemia inhibitory factor signaling pathway,BP,
12382,GO:0048866,1,0.957024743659525,0,1,stem cell fate specification,BP,
12383,GO:0048867,1,0.964775768520543,0,1,stem cell fate determination,BP,
12389,GO:0048874,1,0.957908533970339,0,1,homeostasis of number of cells in a free-living population,BP,
12392,GO:0048880,1,0.917516582051595,0,2,sensory system development,BP,
12393,GO:0048934,1,0.777725847116438,0,6,peripheral nervous system neuron differentiation,BP,
12394,GO:0048935,1,0.777725847116438,0,6,peripheral nervous system neuron development,BP,
12395,GO:0048936,1,0.883359692829773,0,3,peripheral nervous system neuron axonogenesis,BP,
12397,GO:0050011,1,0.963148942527419,0,1,itaconyl-CoA hydratase activity,MF,
12398,GO:0050023,1,0.962262524207527,0,1,L-fuconate dehydratase activity,MF,
12399,GO:0050038,1,0.965159549501964,0,1,L-xylulose reductase (NADP+) activity,MF,
12400,GO:0050046,1,0.958787867083198,0,1,lathosterol oxidase activity,MF,
12401,GO:0050072,1,0.750550328538274,0,7,m7G(5')pppN diphosphatase activity,MF,
12403,GO:0050104,1,0.963420767403385,0,1,L-gulonate 3-dehydrogenase activity,MF,
12404,GO:0050115,1,0.95650621207061,0,1,myosin-light-chain-phosphatase activity,MF,
12405,GO:0050119,1,0.915263828157752,0,2,N-acetylglucosamine deacetylase activity,MF,
12406,GO:0050124,1,0.957157606130705,0,1,N-acylneuraminate-9-phosphatase activity,MF,
12407,GO:0050135,1,0.96344146594306,0,1,NAD(P)+ nucleosidase activity,MF,
12408,GO:0050136,1,0.251433154461222,0,38,NADH dehydrogenase (quinone) activity,MF,
12409,GO:0050144,1,0.958787867083198,0,1,nucleoside deoxyribosyltransferase activity,MF,
12410,GO:0050145,1,0.815053124934947,0,5,nucleoside phosphate kinase activity,MF,
12411,GO:0050146,1,0.956450120283217,0,1,nucleoside phosphotransferase activity,MF,
12412,GO:0050152,1,0.964058920642091,0,1,omega-amidase activity,MF,
12413,GO:0050178,1,0.932514779934249,0,2,phenylpyruvate tautomerase activity,MF,
12414,GO:0050185,1,0.956441843839217,0,1,phosphatidylinositol deacylase activity,MF,
12415,GO:0050201,1,0.957023795656133,0,1,fucokinase activity,MF,
12416,GO:0050211,1,0.919030075721439,0,2,procollagen galactosyltransferase activity,MF,
12417,GO:0050220,1,0.860640887834727,0,4,prostaglandin-E synthase activity,MF,
12418,GO:0050221,1,0.964144548147007,0,1,prostaglandin-E2 9-reductase activity,MF,
12419,GO:0050252,1,0.919096363887145,0,2,retinol O-fatty-acyltransferase activity,MF,
12420,GO:0050253,1,0.917413162980958,0,2,retinyl-palmitate esterase activity,MF,
12422,GO:0050265,1,0.87722627830031,0,3,RNA uridylyltransferase activity,MF,
12423,GO:0050277,1,0.957108347912133,0,1,sedoheptulokinase activity,MF,
12424,GO:0050290,1,0.956541155709276,0,1,sphingomyelin phosphodiesterase D activity,MF,
12426,GO:0050294,1,0.894747668375118,0,3,steroid sulfotransferase activity,MF,
12427,GO:0050308,1,0.808964898521961,0,5,sugar-phosphatase activity,MF,
12428,GO:0050309,1,0.963005798583478,0,1,sugar-terminal-phosphatase activity,MF,
12429,GO:0050313,1,0.964847993326817,0,1,sulfur dioxygenase activity,MF,
12431,GO:0050333,1,0.962491165173348,0,1,thiamin-triphosphatase activity,MF,
12432,GO:0050337,1,0.965708364492461,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
12433,GO:0050346,1,0.958787867083198,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12434,GO:0050347,1,0.922076399120138,0,2,trans-octaprenyltranstransferase activity,MF,
12435,GO:0050353,1,0.958879996988381,0,1,trimethyllysine dioxygenase activity,MF,
12436,GO:0050354,1,0.958787867083198,0,1,triokinase activity,MF,
12437,GO:0050355,1,0.95664394699563,0,1,triphosphatase activity,MF,
12438,GO:0050379,1,0.956477735135559,0,1,UDP-glucuronate 5'-epimerase activity,MF,
12439,GO:0050405,1,0.914802899823571,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
12440,GO:0050421,1,0.959654540720847,0,1,nitrite reductase (NO-forming) activity,MF,
12441,GO:0050427,1,0.484634944247922,0,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
12442,GO:0050428,1,0.778016751279417,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12445,GO:0050433,1,0.608379196482167,0,12,regulation of catecholamine secretion,BP,
12446,GO:0050434,1,0.194223281070047,0,40,positive regulation of viral transcription,BP,
12449,GO:0050444,1,0.957886117614705,0,1,aquacobalamin reductase (NADPH) activity,MF,
12450,GO:0050462,1,0.964152519439114,0,1,N-acetylneuraminate synthase activity,MF,
12451,GO:0050473,1,0.917956495227538,0,2,arachidonate 15-lipoxygenase activity,MF,
12452,GO:0050482,1,0.602506477083694,0,12,arachidonic acid secretion,BP,
12453,GO:0050497,1,0.921207810282727,0,2,transferase activity, transferring alkylthio groups,MF,
12455,GO:0050508,1,0.916795975494087,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12456,GO:0050509,1,0.916795975494087,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
12457,GO:0050510,1,0.84024055495334,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
12458,GO:0050512,1,0.96145798091186,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
12459,GO:0050542,1,0.860640448326341,0,4,icosanoid binding,MF,
12460,GO:0050543,1,0.860640448326341,0,4,icosatetraenoic acid binding,MF,
12461,GO:0050544,1,0.860640448326341,0,4,arachidonic acid binding,MF,
12462,GO:0050560,1,0.957765667178666,0,1,aspartate-tRNA(Asn) ligase activity,MF,
12463,GO:0050561,1,0.957029499916913,0,1,glutamate-tRNA(Gln) ligase activity,MF,
12464,GO:0050567,1,0.886289612020985,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
12465,GO:0050577,1,0.963814807334626,0,1,GDP-L-fucose synthase activity,MF,
12466,GO:0050610,1,0.929976778999366,0,2,methylarsonate reductase activity,MF,
12467,GO:0050613,1,0.921887823988539,0,2,delta14-sterol reductase activity,MF,
12468,GO:0050614,1,0.956742549546252,0,1,delta24-sterol reductase activity,MF,
12469,GO:0050632,1,0.96365364851103,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
12472,GO:0050652,1,0.957237590276669,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12473,GO:0050653,1,0.957237590276669,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12476,GO:0050656,1,0.844392167876564,0,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
12479,GO:0050659,1,0.914892469022609,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
12486,GO:0050666,1,0.960806377001927,0,1,regulation of homocysteine metabolic process,BP,
12488,GO:0050668,1,0.960806377001927,0,1,positive regulation of homocysteine metabolic process,BP,
12496,GO:0050681,1,0.195321082966548,0,39,androgen receptor binding,MF,
12497,GO:0050682,1,0.919043310193439,0,2,AF-2 domain binding,MF,
12498,GO:0050684,1,0.0154600707740404,0,99,regulation of mRNA processing,BP,
12499,GO:0050685,1,0.422620636272618,0,21,positive regulation of mRNA processing,BP,
12500,GO:0050686,1,0.321744071720057,0,27,negative regulation of mRNA processing,BP,
12503,GO:0050689,1,0.823139299497048,0,5,negative regulation of defense response to virus by host,BP,
12504,GO:0050690,1,0.421586694770162,0,21,regulation of defense response to virus by virus,BP,
12506,GO:0050692,1,0.920361083960445,0,2,DBD domain binding,MF,
12507,GO:0050693,1,0.847256780244194,0,4,LBD domain binding,MF,
12508,GO:0050694,1,0.959866728138754,0,1,galactose 3-O-sulfotransferase activity,MF,
12509,GO:0050698,1,0.959866728138754,0,1,proteoglycan sulfotransferase activity,MF,
12510,GO:0050699,1,0.386747651039122,0,23,WW domain binding,MF,
12511,GO:0050700,1,0.634299246765794,0,11,CARD domain binding,MF,
12512,GO:0050701,1,0.289769920909184,0,30,interleukin-1 secretion,BP,
12513,GO:0050702,1,0.364959304452762,0,24,interleukin-1 beta secretion,BP,
12514,GO:0050703,1,0.82792208429827,0,5,interleukin-1 alpha secretion,BP,
12515,GO:0050704,1,0.357676953258873,0,25,regulation of interleukin-1 secretion,BP,
12516,GO:0050705,1,0.857374385012012,0,4,regulation of interleukin-1 alpha secretion,BP,
12517,GO:0050706,1,0.434948350920061,0,20,regulation of interleukin-1 beta secretion,BP,
12521,GO:0050710,1,0.303367161062965,0,29,negative regulation of cytokine secretion,BP,
12522,GO:0050711,1,0.721453773823914,0,8,negative regulation of interleukin-1 secretion,BP,
12523,GO:0050712,1,0.963622098166324,0,1,negative regulation of interleukin-1 alpha secretion,BP,
12524,GO:0050713,1,0.81415914937976,0,5,negative regulation of interleukin-1 beta secretion,BP,
12527,GO:0050716,1,0.493503752124636,0,17,positive regulation of interleukin-1 secretion,BP,
12528,GO:0050717,1,0.889749230582702,0,3,positive regulation of interleukin-1 alpha secretion,BP,
12529,GO:0050718,1,0.555020949084289,0,14,positive regulation of interleukin-1 beta secretion,BP,
12530,GO:0050720,1,0.958207088018547,0,1,interleukin-1 beta biosynthetic process,BP,
12531,GO:0050722,1,0.958207088018547,0,1,regulation of interleukin-1 beta biosynthetic process,BP,
12532,GO:0050725,1,0.958207088018547,0,1,positive regulation of interleukin-1 beta biosynthetic process,BP,
12539,GO:0050733,1,0.84630746743949,0,4,RS domain binding,MF,
12540,GO:0050746,1,0.717708427552095,0,8,regulation of lipoprotein metabolic process,BP,
12541,GO:0050747,1,0.816843996730244,0,5,positive regulation of lipoprotein metabolic process,BP,
12542,GO:0050748,1,0.956441843839217,0,1,negative regulation of lipoprotein metabolic process,BP,
12544,GO:0050755,1,0.726116756020016,0,8,chemokine metabolic process,BP,
12545,GO:0050757,1,0.959533165082195,0,1,thymidylate synthase biosynthetic process,BP,
12546,GO:0050758,1,0.959533165082195,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12547,GO:0050760,1,0.959533165082195,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
12549,GO:0050765,1,0.688913463377325,0,9,negative regulation of phagocytosis,BP,
12563,GO:0050779,1,0.391756517042238,0,22,RNA destabilization,BP,
12565,GO:0050783,1,0.960188160832726,0,1,cocaine metabolic process,BP,
12566,GO:0050785,1,0.963878754216339,0,1,advanced glycation end-product receptor activity,MF,
12568,GO:0050787,1,0.922918504998729,0,2,detoxification of mercury ion,BP,
12576,GO:0050798,1,0.309146895054185,0,29,activated T cell proliferation,BP,
12586,GO:0050811,1,0.692705388168465,0,9,GABA receptor binding,MF,
12589,GO:0050816,1,0.883261750210172,0,3,phosphothreonine residue binding,MF,
12595,GO:0050822,1,0.957532521989717,0,1,peptide stabilization,BP,
12596,GO:0050823,1,0.957532521989717,0,1,peptide antigen stabilization,BP,
12597,GO:0050829,1,0.448264894603835,0,21,defense response to Gram-negative bacterium,BP,
12598,GO:0050830,1,0.30587275485932,0,31,defense response to Gram-positive bacterium,BP,
12599,GO:0050832,1,0.583231023459499,0,14,defense response to fungus,BP,
12600,GO:0050833,1,0.880176319609871,0,3,pyruvate transmembrane transporter activity,MF,
12603,GO:0050847,1,0.741420985874021,0,7,progesterone receptor signaling pathway,BP,
12610,GO:0050854,1,0.233891220156613,0,35,regulation of antigen receptor-mediated signaling pathway,BP,
12611,GO:0050855,1,0.60166294356789,0,12,regulation of B cell receptor signaling pathway,BP,
12612,GO:0050856,1,0.357885163403266,0,25,regulation of T cell receptor signaling pathway,BP,
12613,GO:0050857,1,0.609839943214113,0,12,positive regulation of antigen receptor-mediated signaling pathway,BP,
12614,GO:0050858,1,0.520416653635306,0,16,negative regulation of antigen receptor-mediated signaling pathway,BP,
12615,GO:0050859,1,0.884666362591893,0,3,negative regulation of B cell receptor signaling pathway,BP,
12616,GO:0050860,1,0.565284288717181,0,14,negative regulation of T cell receptor signaling pathway,BP,
12617,GO:0050861,1,0.843992803340687,0,4,positive regulation of B cell receptor signaling pathway,BP,
12618,GO:0050862,1,0.722646962591158,0,8,positive regulation of T cell receptor signaling pathway,BP,
12628,GO:0050872,1,0.684691309813203,0,9,white fat cell differentiation,BP,
12635,GO:0050882,1,0.77076359596571,0,6,voluntary musculoskeletal movement,BP,
12642,GO:0050893,1,0.886862692660237,0,3,sensory processing,BP,
12644,GO:0050897,1,0.956441843839217,0,1,cobalt ion binding,MF,
12646,GO:0050901,1,0.682076982642204,0,9,leukocyte tethering or rolling,BP,
12647,GO:0050904,1,0.91684049745324,0,2,diapedesis,BP,
12650,GO:0050907,1,0.629929124434747,0,12,detection of chemical stimulus involved in sensory perception,BP,
12653,GO:0050910,1,0.91785969504351,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
12654,GO:0050911,1,0.892007715190121,0,3,detection of chemical stimulus involved in sensory perception of smell,BP,
12655,GO:0050912,1,0.738123185154663,0,8,detection of chemical stimulus involved in sensory perception of taste,BP,
12656,GO:0050913,1,0.707143314927985,0,9,sensory perception of bitter taste,BP,
12658,GO:0050916,1,0.882559184823153,0,3,sensory perception of sweet taste,BP,
12659,GO:0050917,1,0.917986049577368,0,2,sensory perception of umami taste,BP,
12661,GO:0050919,1,0.294166120940657,0,28,negative chemotaxis,BP,
12665,GO:0050923,1,0.874965959098142,0,3,regulation of negative chemotaxis,BP,
12666,GO:0050924,1,0.956487499770039,0,1,positive regulation of negative chemotaxis,BP,
12667,GO:0050925,1,0.914777292668164,0,2,negative regulation of negative chemotaxis,BP,
12670,GO:0050928,1,0.956453876255052,0,1,negative regulation of positive chemotaxis,BP,
12671,GO:0050929,1,0.956487499770039,0,1,induction of negative chemotaxis,BP,
12673,GO:0050931,1,0.380018095308536,0,23,pigment cell differentiation,BP,
12674,GO:0050932,1,0.745045880459154,0,7,regulation of pigment cell differentiation,BP,
12675,GO:0050942,1,0.804832974599338,0,5,positive regulation of pigment cell differentiation,BP,
12676,GO:0050951,1,0.715816754160383,0,8,sensory perception of temperature stimulus,BP,
12679,GO:0050955,1,0.956845173675673,0,1,thermoception,BP,
12680,GO:0050957,1,0.956980438159021,0,1,equilibrioception,BP,
12681,GO:0050960,1,0.956845173675673,0,1,detection of temperature stimulus involved in thermoception,BP,
12682,GO:0050961,1,0.748436164579678,0,7,detection of temperature stimulus involved in sensory perception,BP,
12684,GO:0050965,1,0.748436164579678,0,7,detection of temperature stimulus involved in sensory perception of pain,BP,
12685,GO:0050966,1,0.919616712721608,0,2,detection of mechanical stimulus involved in sensory perception of pain,BP,
12686,GO:0050968,1,0.956845173675673,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
12689,GO:0050992,1,0.92652149337218,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12690,GO:0050993,1,0.92652149337218,0,2,dimethylallyl diphosphate metabolic process,BP,
12692,GO:0050995,1,0.666920897320704,0,10,negative regulation of lipid catabolic process,BP,
12693,GO:0050996,1,0.650752055170745,0,10,positive regulation of lipid catabolic process,BP,
12694,GO:0050997,1,0.611996259055963,0,12,quaternary ammonium group binding,MF,
12698,GO:0051001,1,0.852891686138569,0,4,negative regulation of nitric-oxide synthase activity,BP,
12703,GO:0051011,1,0.646974191724843,0,10,microtubule minus-end binding,MF,
12704,GO:0051012,1,0.920834548599998,0,2,microtubule sliding,BP,
12705,GO:0051013,1,0.777979050178227,0,6,microtubule severing,BP,
12706,GO:0051014,1,0.773592717736399,0,6,actin filament severing,BP,
12708,GO:0051016,1,0.606668512011434,0,12,barbed-end actin filament capping,BP,
12710,GO:0051018,1,0.205846321750935,0,37,protein kinase A binding,MF,
12711,GO:0051019,1,0.333216597722967,0,26,mitogen-activated protein kinase binding,MF,
12713,GO:0051021,1,0.849432332655074,0,4,GDP-dissociation inhibitor binding,MF,
12714,GO:0051022,1,0.849432332655074,0,4,Rho GDP-dissociation inhibitor binding,MF,
12715,GO:0051023,1,0.730895627193697,0,8,regulation of immunoglobulin secretion,BP,
12716,GO:0051024,1,0.858680480092575,0,4,positive regulation of immunoglobulin secretion,BP,
12717,GO:0051025,1,0.958338007501677,0,1,negative regulation of immunoglobulin secretion,BP,
12718,GO:0051026,1,0.848433578715598,0,4,chiasma assembly,BP,
12721,GO:0051030,1,0.859536883275796,0,4,snRNA transport,BP,
12722,GO:0051031,1,0.248589533648422,0,33,tRNA transport,BP,
12723,GO:0051032,1,0.957009704575427,0,1,nucleic acid transmembrane transporter activity,MF,
12724,GO:0051033,1,0.957009704575427,0,1,RNA transmembrane transporter activity,MF,
12725,GO:0051036,1,0.8183041650691,0,5,regulation of endosome size,BP,
12726,GO:0051040,1,0.958174913278171,0,1,regulation of calcium-independent cell-cell adhesion,BP,
12727,GO:0051042,1,0.958174913278171,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
12730,GO:0051045,1,0.74479326077563,0,7,negative regulation of membrane protein ectodomain proteolysis,BP,
12744,GO:0051059,1,0.335941989300117,0,27,NF-kappaB binding,MF,
12745,GO:0051066,1,0.92631103521794,0,2,dihydrobiopterin metabolic process,BP,
12746,GO:0051068,1,0.957413043485265,0,1,dihydrolipoamide metabolic process,BP,
12747,GO:0051081,1,0.145997330768499,0,46,nuclear envelope disassembly,BP,
12749,GO:0051083,1,0.925147469225546,0,2,'de novo' cotranslational protein folding,BP,
12750,GO:0051084,1,0.277054752926577,0,31,'de novo' posttranslational protein folding,BP,
12751,GO:0051085,1,0.340039273818583,0,26,chaperone cofactor-dependent protein refolding,BP,
12752,GO:0051086,1,0.961901875313265,0,1,chaperone mediated protein folding independent of cofactor,BP,
12753,GO:0051087,1,0.0399132506374225,0,79,chaperone binding,MF,
12754,GO:0051088,1,0.876843166962223,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
12755,GO:0051089,1,0.95701156948326,0,1,constitutive protein ectodomain proteolysis,BP,
12761,GO:0051095,1,0.686537197808822,0,9,regulation of helicase activity,BP,
12762,GO:0051096,1,0.776780338496751,0,6,positive regulation of helicase activity,BP,
12763,GO:0051097,1,0.883880604992871,0,3,negative regulation of helicase activity,BP,
12768,GO:0051102,1,0.956909339322104,0,1,DNA ligation involved in DNA recombination,BP,
12769,GO:0051103,1,0.639482560343758,0,11,DNA ligation involved in DNA repair,BP,
12770,GO:0051105,1,0.779682211622489,0,6,regulation of DNA ligation,BP,
12771,GO:0051106,1,0.813223807419382,0,5,positive regulation of DNA ligation,BP,
12772,GO:0051107,1,0.958771881359281,0,1,negative regulation of DNA ligation,BP,
12779,GO:0051124,1,0.766371870666375,0,6,synaptic growth at neuromuscular junction,BP,
12786,GO:0051131,1,0.499378330863896,0,17,chaperone-mediated protein complex assembly,BP,
12787,GO:0051132,1,0.820406640783024,0,5,NK T cell activation,BP,
12788,GO:0051133,1,0.890580430488463,0,3,regulation of NK T cell activation,BP,
12789,GO:0051135,1,0.890580430488463,0,3,positive regulation of NK T cell activation,BP,
12790,GO:0051136,1,0.804467167747012,0,5,regulation of NK T cell differentiation,BP,
12791,GO:0051138,1,0.841066744731963,0,4,positive regulation of NK T cell differentiation,BP,
12792,GO:0051139,1,0.956444441803967,0,1,metal ion:proton antiporter activity,MF,
12793,GO:0051140,1,0.930316654769864,0,2,regulation of NK T cell proliferation,BP,
12794,GO:0051142,1,0.930316654769864,0,2,positive regulation of NK T cell proliferation,BP,
12798,GO:0051148,1,0.320586108004581,0,27,negative regulation of muscle cell differentiation,BP,
12801,GO:0051151,1,0.741752574009878,0,7,negative regulation of smooth muscle cell differentiation,BP,
12804,GO:0051154,1,0.451419404425726,0,19,negative regulation of striated muscle cell differentiation,BP,
12807,GO:0051160,1,0.959897033209647,0,1,L-xylitol catabolic process,BP,
12808,GO:0051164,1,0.959897033209647,0,1,L-xylitol metabolic process,BP,
12809,GO:0051167,1,0.82321251037947,0,5,xylulose 5-phosphate metabolic process,BP,
12817,GO:0051176,1,0.88147391290009,0,3,positive regulation of sulfur metabolic process,BP,
12818,GO:0051177,1,0.849356950392546,0,4,meiotic sister chromatid cohesion,BP,
12822,GO:0051182,1,0.746385953839449,0,7,coenzyme transport,BP,
12824,GO:0051185,1,0.779235555011253,0,6,coenzyme transmembrane transporter activity,MF,
12828,GO:0051189,1,0.751369614796986,0,7,prosthetic group metabolic process,BP,
12829,GO:0051192,1,0.932291866263446,0,2,prosthetic group binding,MF,
12832,GO:0051195,1,0.683977940093678,0,9,negative regulation of cofactor metabolic process,BP,
12835,GO:0051198,1,0.777658257659965,0,6,negative regulation of coenzyme metabolic process,BP,
12836,GO:0051204,1,0.27410285568724,0,32,protein insertion into mitochondrial membrane,BP,
12848,GO:0051228,1,0.956461531260732,0,1,mitotic spindle disassembly,BP,
12849,GO:0051230,1,0.956461531260732,0,1,spindle disassembly,BP,
12850,GO:0051231,1,0.628352096900521,0,11,spindle elongation,BP,
12851,GO:0051232,1,0.960429982902874,0,1,meiotic spindle elongation,BP,
12856,GO:0051238,1,0.648604596906829,0,11,sequestering of metal ion,BP,
12870,GO:0051256,1,0.713843684191015,0,8,mitotic spindle midzone assembly,BP,
12871,GO:0051257,1,0.960101674776263,0,1,meiotic spindle midzone assembly,BP,
12877,GO:0051264,1,0.959017459498148,0,1,mono-olein transacylation activity,MF,
12878,GO:0051265,1,0.959017459498148,0,1,diolein transacylation activity,MF,
12879,GO:0051267,1,0.957977357775801,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
12890,GO:0051286,1,0.802331109608664,0,5,cell tip,CC,
12895,GO:0051292,1,0.653156219227507,0,10,nuclear pore complex assembly,BP,
12898,GO:0051295,1,0.876317117539122,0,3,establishment of meiotic spindle localization,BP,
12900,GO:0051299,1,0.553851585208764,0,14,centrosome separation,BP,
12901,GO:0051300,1,0.958787867083198,0,1,spindle pole body organization,BP,
12905,GO:0051304,1,0.0567839975624077,0,69,chromosome separation,BP,
12906,GO:0051305,1,0.805135157418034,0,5,chromosome movement towards spindle pole,BP,
12907,GO:0051306,1,0.117276760864697,0,52,mitotic sister chromatid separation,BP,
12908,GO:0051307,1,0.601843905988601,0,12,meiotic chromosome separation,BP,
12909,GO:0051308,1,0.958787867083198,0,1,male meiosis chromosome separation,BP,
12910,GO:0051310,1,0.112538825221536,0,53,metaphase plate congression,BP,
12911,GO:0051311,1,0.960101674776263,0,1,meiotic metaphase plate congression,BP,
12912,GO:0051315,1,0.584402623929738,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
12913,GO:0051316,1,0.921259787900849,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
12918,GO:0051340,1,0.72950487725419,0,8,regulation of ligase activity,BP,
12920,GO:0051342,1,0.783500259064852,0,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12921,GO:0051343,1,0.886189328051168,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12922,GO:0051344,1,0.884149861330933,0,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12928,GO:0051350,1,0.693838224655143,0,9,negative regulation of lyase activity,BP,
12929,GO:0051351,1,0.760892255241474,0,7,positive regulation of ligase activity,BP,
12930,GO:0051352,1,0.958771881359281,0,1,negative regulation of ligase activity,BP,
12932,GO:0051354,1,0.661651463731934,0,10,negative regulation of oxidoreductase activity,BP,
12933,GO:0051365,1,0.957840246962438,0,1,cellular response to potassium ion starvation,BP,
12935,GO:0051377,1,0.877774985465275,0,3,mannose-ethanolamine phosphotransferase activity,MF,
12936,GO:0051378,1,0.887725713534676,0,3,serotonin binding,MF,
12937,GO:0051379,1,0.92384989737921,0,2,epinephrine binding,MF,
12938,GO:0051380,1,0.961645026588241,0,1,norepinephrine binding,MF,
12939,GO:0051382,1,0.559946330194269,0,14,kinetochore assembly,BP,
12940,GO:0051383,1,0.454278311134104,0,19,kinetochore organization,BP,
12945,GO:0051388,1,0.841436553200593,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
12947,GO:0051391,1,0.956995395019061,0,1,tRNA acetylation,BP,
12948,GO:0051392,1,0.956995395019061,0,1,tRNA N-acetyltransferase activity,MF,
12950,GO:0051400,1,0.717041608741017,0,8,BH domain binding,MF,
12953,GO:0051409,1,0.694132796704233,0,9,response to nitrosative stress,BP,
12954,GO:0051410,1,0.817678061889679,0,5,detoxification of nitrogen compound,BP,
12955,GO:0051412,1,0.65850455644007,0,10,response to corticosterone,BP,
12956,GO:0051413,1,0.959957961717953,0,1,response to cortisone,BP,
12957,GO:0051414,1,0.807138498226553,0,5,response to cortisol,BP,
12958,GO:0051415,1,0.771328790576231,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
12959,GO:0051417,1,0.958787867083198,0,1,microtubule nucleation by spindle pole body,BP,
12960,GO:0051418,1,0.705560686197961,0,8,microtubule nucleation by microtubule organizing center,BP,
12965,GO:0051430,1,0.920332215031458,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
12967,GO:0051433,1,0.956611344248304,0,1,BH2 domain binding,MF,
12968,GO:0051434,1,0.84888176709702,0,4,BH3 domain binding,MF,
12969,GO:0051438,1,0.139057108894925,0,48,regulation of ubiquitin-protein transferase activity,BP,
12970,GO:0051443,1,0.289710046558521,0,30,positive regulation of ubiquitin-protein transferase activity,BP,
12971,GO:0051444,1,0.59807808889105,0,13,negative regulation of ubiquitin-protein transferase activity,BP,
12974,GO:0051447,1,0.653174468153769,0,10,negative regulation of meiotic cell cycle,BP,
12975,GO:0051450,1,0.69570248394335,0,9,myoblast proliferation,BP,
12976,GO:0051451,1,0.720774638754233,0,8,myoblast migration,BP,
12979,GO:0051454,1,0.883521874240067,0,3,intracellular pH elevation,BP,
12980,GO:0051455,1,0.958787867083198,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
12981,GO:0051456,1,0.960862140081554,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
12983,GO:0051458,1,0.916356893831329,0,2,corticotropin secretion,BP,
12984,GO:0051459,1,0.916356893831329,0,2,regulation of corticotropin secretion,BP,
12985,GO:0051461,1,0.916356893831329,0,2,positive regulation of corticotropin secretion,BP,
12986,GO:0051462,1,0.923231272936482,0,2,regulation of cortisol secretion,BP,
12987,GO:0051463,1,0.956441843839217,0,1,negative regulation of cortisol secretion,BP,
12988,GO:0051464,1,0.965280077340104,0,1,positive regulation of cortisol secretion,BP,
12989,GO:0051466,1,0.958026563055971,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
12991,GO:0051481,1,0.87510110371329,0,3,negative regulation of cytosolic calcium ion concentration,BP,
12994,GO:0051490,1,0.885292175589196,0,3,negative regulation of filopodium assembly,BP,
13001,GO:0051497,1,0.574842022743042,0,13,negative regulation of stress fiber assembly,BP,
13002,GO:0051499,1,0.924085639478594,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13003,GO:0051500,1,0.924085639478594,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13004,GO:0051503,1,0.610925253406237,0,12,adenine nucleotide transport,BP,
13005,GO:0051525,1,0.915048380555002,0,2,NFAT protein binding,MF,
13006,GO:0051536,1,0.0845331484462121,0,61,iron-sulfur cluster binding,MF,
13007,GO:0051537,1,0.472301849755556,0,19,2 iron, 2 sulfur cluster binding,MF,
13008,GO:0051538,1,0.885661188306855,0,3,3 iron, 4 sulfur cluster binding,MF,
13009,GO:0051539,1,0.188034719208894,0,41,4 iron, 4 sulfur cluster binding,MF,
13010,GO:0051540,1,0.0845331484462121,0,61,metal cluster binding,MF,
13011,GO:0051541,1,0.848576090381966,0,4,elastin metabolic process,BP,
13012,GO:0051542,1,0.918649610238501,0,2,elastin biosynthetic process,BP,
13013,GO:0051543,1,0.960490168225093,0,1,regulation of elastin biosynthetic process,BP,
13014,GO:0051545,1,0.960490168225093,0,1,negative regulation of elastin biosynthetic process,BP,
13015,GO:0051546,1,0.577218665998185,0,13,keratinocyte migration,BP,
13016,GO:0051547,1,0.707745832657399,0,8,regulation of keratinocyte migration,BP,
13017,GO:0051548,1,0.914778274967943,0,2,negative regulation of keratinocyte migration,BP,
13018,GO:0051549,1,0.773716364718391,0,6,positive regulation of keratinocyte migration,BP,
13019,GO:0051552,1,0.960493715058325,0,1,flavone metabolic process,BP,
13020,GO:0051560,1,0.472041558203174,0,18,mitochondrial calcium ion homeostasis,BP,
13021,GO:0051561,1,0.694739913187102,0,9,positive regulation of mitochondrial calcium ion concentration,BP,
13022,GO:0051562,1,0.919099215424178,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
13023,GO:0051563,1,0.91586139158117,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13024,GO:0051567,1,0.326081194982755,0,26,histone H3-K9 methylation,BP,
13027,GO:0051570,1,0.482396894474806,0,17,regulation of histone H3-K9 methylation,BP,
13029,GO:0051572,1,0.880058561199715,0,3,negative regulation of histone H3-K4 methylation,BP,
13030,GO:0051573,1,0.680694315574692,0,9,negative regulation of histone H3-K9 methylation,BP,
13031,GO:0051574,1,0.73955319975493,0,7,positive regulation of histone H3-K9 methylation,BP,
13032,GO:0051575,1,0.81022900873785,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13033,GO:0051580,1,0.693119128394436,0,9,regulation of neurotransmitter uptake,BP,
13034,GO:0051581,1,0.880951988592846,0,3,negative regulation of neurotransmitter uptake,BP,
13035,GO:0051582,1,0.925541355979937,0,2,positive regulation of neurotransmitter uptake,BP,
13036,GO:0051583,1,0.790761159822286,0,6,dopamine uptake involved in synaptic transmission,BP,
13037,GO:0051584,1,0.856700063449412,0,4,regulation of dopamine uptake involved in synaptic transmission,BP,
13038,GO:0051585,1,0.958131655655566,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13039,GO:0051586,1,0.96328317149868,0,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13042,GO:0051590,1,0.491884317724924,0,17,positive regulation of neurotransmitter transport,BP,
13046,GO:0051595,1,0.889386910239247,0,3,response to methylglyoxal,BP,
13047,GO:0051596,1,0.923288462087707,0,2,methylglyoxal catabolic process,BP,
13048,GO:0051597,1,0.775157791531722,0,6,response to methylmercury,BP,
13049,GO:0051598,1,0.956589717778035,0,1,meiotic recombination checkpoint,BP,
13051,GO:0051601,1,0.747909573537275,0,7,exocyst localization,BP,
13052,GO:0051602,1,0.467046520660356,0,18,response to electrical stimulus,BP,
13057,GO:0051608,1,0.725384063411216,0,8,histamine transport,BP,
13058,GO:0051610,1,0.87662828510614,0,3,serotonin uptake,BP,
13059,GO:0051611,1,0.916393637270452,0,2,regulation of serotonin uptake,BP,
13060,GO:0051612,1,0.916393637270452,0,2,negative regulation of serotonin uptake,BP,
13061,GO:0051615,1,0.956442121171472,0,1,histamine uptake,BP,
13062,GO:0051620,1,0.958131655655566,0,1,norepinephrine uptake,BP,
13063,GO:0051621,1,0.958131655655566,0,1,regulation of norepinephrine uptake,BP,
13064,GO:0051622,1,0.958131655655566,0,1,negative regulation of norepinephrine uptake,BP,
13069,GO:0051643,1,0.802781585163611,0,5,endoplasmic reticulum localization,BP,
13070,GO:0051645,1,0.60529895148518,0,12,Golgi localization,BP,
13071,GO:0051646,1,0.223687948389312,0,35,mitochondrion localization,BP,
13078,GO:0051654,1,0.429189559171286,0,20,establishment of mitochondrion localization,BP,
13080,GO:0051657,1,0.705106720371494,0,8,maintenance of organelle location,BP,
13081,GO:0051660,1,0.838929500925449,0,4,establishment of centrosome localization,BP,
13082,GO:0051661,1,0.803964256533427,0,5,maintenance of centrosome location,BP,
13083,GO:0051664,1,0.917371998989092,0,2,nuclear pore localization,BP,
13087,GO:0051673,1,0.926466284485433,0,2,membrane disruption in other organism,BP,
13089,GO:0051683,1,0.75288057383943,0,7,establishment of Golgi localization,BP,
13090,GO:0051684,1,0.877094860391066,0,3,maintenance of Golgi location,BP,
13091,GO:0051685,1,0.958787867083198,0,1,maintenance of ER location,BP,
13092,GO:0051686,1,0.956441843839217,0,1,establishment of ER localization,BP,
13094,GO:0051694,1,0.91946832699258,0,2,pointed-end actin filament capping,BP,
13095,GO:0051697,1,0.853355354356676,0,4,protein delipidation,BP,
13102,GO:0051708,1,0.929051608343514,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
13103,GO:0051709,1,0.792281400601082,0,6,regulation of killing of cells of other organism,BP,
13104,GO:0051710,1,0.964322923966933,0,1,regulation of cytolysis in other organism,BP,
13105,GO:0051712,1,0.792281400601082,0,6,positive regulation of killing of cells of other organism,BP,
13106,GO:0051714,1,0.964322923966933,0,1,positive regulation of cytolysis in other organism,BP,
13107,GO:0051715,1,0.931507000780135,0,2,cytolysis in other organism,BP,
13109,GO:0051717,1,0.917139481275042,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
13111,GO:0051722,1,0.960129277862428,0,1,protein C-terminal methylesterase activity,MF,
13112,GO:0051723,1,0.960129277862428,0,1,protein methylesterase activity,MF,
13113,GO:0051724,1,0.960822557325351,0,1,NAD transmembrane transporter activity,MF,
13114,GO:0051725,1,0.92324716010772,0,2,protein de-ADP-ribosylation,BP,
13116,GO:0051728,1,0.958536775057315,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13117,GO:0051729,1,0.958536775057315,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13118,GO:0051731,1,0.847765549341244,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13119,GO:0051732,1,0.962651352838346,0,1,polyribonucleotide kinase activity,MF,
13120,GO:0051733,1,0.886384133683161,0,3,polydeoxyribonucleotide kinase activity,MF,
13121,GO:0051734,1,0.886384133683161,0,3,ATP-dependent polynucleotide kinase activity,MF,
13122,GO:0051736,1,0.962651352838346,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
13123,GO:0051747,1,0.929388363317892,0,2,cytosine C-5 DNA demethylase activity,MF,
13124,GO:0051748,1,0.961259370841159,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
13125,GO:0051750,1,0.964083115104504,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
13126,GO:0051754,1,0.880248663683526,0,3,meiotic sister chromatid cohesion, centromeric,BP,
13127,GO:0051764,1,0.620008153403765,0,11,actin crosslink formation,BP,
13128,GO:0051765,1,0.922024381873551,0,2,inositol tetrakisphosphate kinase activity,MF,
13129,GO:0051766,1,0.808043176625819,0,5,inositol trisphosphate kinase activity,MF,
13133,GO:0051771,1,0.889833521328666,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
13134,GO:0051775,1,0.671716082937885,0,10,response to redox state,BP,
13135,GO:0051780,1,0.956842221697132,0,1,behavioral response to nutrient,BP,
13137,GO:0051782,1,0.560158787714764,0,14,negative regulation of cell division,BP,
13142,GO:0051787,1,0.367714316532234,0,24,misfolded protein binding,MF,
13143,GO:0051788,1,0.397676315916863,0,22,response to misfolded protein,BP,
13145,GO:0051791,1,0.753450473842957,0,7,medium-chain fatty acid metabolic process,BP,
13146,GO:0051792,1,0.854070014755707,0,4,medium-chain fatty acid biosynthetic process,BP,
13147,GO:0051793,1,0.882501905353932,0,3,medium-chain fatty acid catabolic process,BP,
13148,GO:0051794,1,0.84888619549928,0,4,regulation of timing of catagen,BP,
13149,GO:0051795,1,0.887275026168159,0,3,positive regulation of timing of catagen,BP,
13150,GO:0051796,1,0.956744377951467,0,1,negative regulation of timing of catagen,BP,
13151,GO:0051797,1,0.494085764690816,0,17,regulation of hair follicle development,BP,
13152,GO:0051798,1,0.670565542279772,0,10,positive regulation of hair follicle development,BP,
13153,GO:0051799,1,0.875929372531336,0,3,negative regulation of hair follicle development,BP,
13154,GO:0051800,1,0.956442870787241,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
13155,GO:0051805,1,0.917543871402858,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13157,GO:0051807,1,0.917543871402858,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
13158,GO:0051808,1,0.960287525593611,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
13160,GO:0051818,1,0.791086655734042,0,6,disruption of cells of other organism involved in symbiotic interaction,BP,
13161,GO:0051821,1,0.956441843839217,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
13164,GO:0051832,1,0.843383059472811,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
13165,GO:0051833,1,0.956458141288418,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13166,GO:0051834,1,0.843383059472811,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
13168,GO:0051836,1,0.696997554635704,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
13170,GO:0051852,1,0.857505683335197,0,4,disruption by host of symbiont cells,BP,
13171,GO:0051861,1,0.611579804208335,0,12,glycolipid binding,MF,
13172,GO:0051864,1,0.704024906915915,0,8,histone demethylase activity (H3-K36 specific),MF,
13174,GO:0051870,1,0.957030454424487,0,1,methotrexate binding,MF,
13175,GO:0051873,1,0.857505683335197,0,4,killing by host of symbiont cells,BP,
13177,GO:0051877,1,0.919487501659648,0,2,pigment granule aggregation in cell center,BP,
13178,GO:0051879,1,0.272134683221087,0,31,Hsp90 protein binding,MF,
13179,GO:0051880,1,0.734760258076436,0,7,G-quadruplex DNA binding,MF,
13182,GO:0051883,1,0.791086655734042,0,6,killing of cells in other organism involved in symbiotic interaction,BP,
13183,GO:0051884,1,0.838642374850811,0,4,regulation of timing of anagen,BP,
13184,GO:0051885,1,0.956441843839217,0,1,positive regulation of timing of anagen,BP,
13185,GO:0051886,1,0.956463102448504,0,1,negative regulation of timing of anagen,BP,
13186,GO:0051890,1,0.915102301155898,0,2,regulation of cardioblast differentiation,BP,
13187,GO:0051891,1,0.956459437002784,0,1,positive regulation of cardioblast differentiation,BP,
13188,GO:0051892,1,0.956764025780865,0,1,negative regulation of cardioblast differentiation,BP,
13194,GO:0051898,1,0.239738812433612,0,34,negative regulation of protein kinase B signaling,BP,
13197,GO:0051901,1,0.825067935652803,0,5,positive regulation of mitochondrial depolarization,BP,
13199,GO:0051903,1,0.959515561955651,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
13200,GO:0051904,1,0.439355152132244,0,20,pigment granule transport,BP,
13202,GO:0051908,1,0.95806474531641,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13203,GO:0051917,1,0.778353028377915,0,6,regulation of fibrinolysis,BP,
13204,GO:0051918,1,0.844056182506686,0,4,negative regulation of fibrinolysis,BP,
13205,GO:0051919,1,0.961569608228912,0,1,positive regulation of fibrinolysis,BP,
13206,GO:0051920,1,0.744041309492443,0,8,peroxiredoxin activity,MF,
13207,GO:0051923,1,0.693371323466593,0,9,sulfation,BP,
13214,GO:0051933,1,0.956441843839217,0,1,amino acid neurotransmitter reuptake,BP,
13215,GO:0051934,1,0.790761159822286,0,6,catecholamine uptake involved in synaptic transmission,BP,
13216,GO:0051935,1,0.956441843839217,0,1,glutamate reuptake,BP,
13218,GO:0051938,1,0.774897290112527,0,6,L-glutamate import,BP,
13219,GO:0051940,1,0.856700063449412,0,4,regulation of catecholamine uptake involved in synaptic transmission,BP,
13220,GO:0051941,1,0.956441843839217,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13221,GO:0051944,1,0.96328317149868,0,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
13222,GO:0051945,1,0.958131655655566,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
13223,GO:0051946,1,0.956441843839217,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
13225,GO:0051953,1,0.808680733640109,0,5,negative regulation of amine transport,BP,
13226,GO:0051954,1,0.609314054354012,0,12,positive regulation of amine transport,BP,
13228,GO:0051956,1,0.880791285168421,0,3,negative regulation of amino acid transport,BP,
13229,GO:0051957,1,0.776328700727322,0,6,positive regulation of amino acid transport,BP,
13230,GO:0051958,1,0.917159793935246,0,2,methotrexate transport,BP,
13236,GO:0051964,1,0.838083015454067,0,4,negative regulation of synapse assembly,BP,
13239,GO:0051967,1,0.885564156046201,0,3,negative regulation of synaptic transmission, glutamatergic,BP,
13241,GO:0051969,1,0.846128682438472,0,4,regulation of transmission of nerve impulse,BP,
13242,GO:0051971,1,0.918494334371641,0,2,positive regulation of transmission of nerve impulse,BP,
13243,GO:0051972,1,0.175810078673155,0,42,regulation of telomerase activity,BP,
13244,GO:0051973,1,0.255855038135108,0,33,positive regulation of telomerase activity,BP,
13245,GO:0051974,1,0.719541698650372,0,8,negative regulation of telomerase activity,BP,
13246,GO:0051977,1,0.96109488576946,0,1,lysophospholipid transport,BP,
13247,GO:0051978,1,0.96109488576946,0,1,lysophospholipid transporter activity,MF,
13248,GO:0051983,1,0.0243388844511033,0,89,regulation of chromosome segregation,BP,
13249,GO:0051984,1,0.334265386396218,0,26,positive regulation of chromosome segregation,BP,
13250,GO:0051985,1,0.228072737613545,0,36,negative regulation of chromosome segregation,BP,
13251,GO:0051987,1,0.813657736080719,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
13252,GO:0051988,1,0.604739313973869,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
13253,GO:0051990,1,0.921855523648121,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
13254,GO:0051996,1,0.961389430746383,0,1,squalene synthase activity,MF,
13255,GO:0051998,1,0.747178344915372,0,7,protein carboxyl O-methyltransferase activity,MF,
13256,GO:0052027,1,0.916199426809871,0,2,modulation by symbiont of host signal transduction pathway,BP,
13257,GO:0052029,1,0.956458141288418,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13258,GO:0052031,1,0.885623284338132,0,3,modulation by symbiont of host defense response,BP,
13259,GO:0052037,1,0.956458141288418,0,1,negative regulation by symbiont of host defense response,BP,
13260,GO:0052040,1,0.783597337102256,0,6,modulation by symbiont of host programmed cell death,BP,
13261,GO:0052041,1,0.849895708942683,0,4,negative regulation by symbiont of host programmed cell death,BP,
13262,GO:0052042,1,0.889306249679851,0,3,positive regulation by symbiont of host programmed cell death,BP,
13263,GO:0052047,1,0.956441843839217,0,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
13264,GO:0052053,1,0.959157474640937,0,1,negative regulation by symbiont of host catalytic activity,BP,
13265,GO:0052055,1,0.917390490362846,0,2,modulation by symbiont of host molecular function,BP,
13266,GO:0052056,1,0.917390490362846,0,2,negative regulation by symbiont of host molecular function,BP,
13267,GO:0052066,1,0.956441843839217,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
13268,GO:0052097,1,0.957908533970339,0,1,interspecies quorum sensing,BP,
13269,GO:0052106,1,0.957908533970339,0,1,quorum sensing involved in interaction with host,BP,
13270,GO:0052126,1,0.250976952365199,0,33,movement in host environment,BP,
13271,GO:0052148,1,0.959157474640937,0,1,modulation by symbiont of host catalytic activity,BP,
13272,GO:0052150,1,0.812912605014918,0,5,modulation by symbiont of host apoptotic process,BP,
13273,GO:0052151,1,0.922567402289617,0,2,positive regulation by symbiont of host apoptotic process,BP,
13274,GO:0052167,1,0.956458141288418,0,1,modulation by symbiont of host innate immune response,BP,
13275,GO:0052170,1,0.956458141288418,0,1,negative regulation by symbiont of host innate immune response,BP,
13276,GO:0052173,1,0.782383176300787,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
13277,GO:0052190,1,0.956441843839217,0,1,modulation by symbiont of host phagocytosis,BP,
13278,GO:0052191,1,0.956441843839217,0,1,positive regulation by symbiont of host phagocytosis,BP,
13279,GO:0052192,1,0.250976952365199,0,33,movement in environment of other organism involved in symbiotic interaction,BP,
13280,GO:0052199,1,0.959157474640937,0,1,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
13281,GO:0052200,1,0.782383176300787,0,6,response to host defenses,BP,
13282,GO:0052203,1,0.923332815552298,0,2,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
13283,GO:0052204,1,0.820303323294256,0,5,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
13284,GO:0052205,1,0.784558242674338,0,6,modulation of molecular function in other organism involved in symbiotic interaction,BP,
13285,GO:0052214,1,0.963004226573629,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13286,GO:0052227,1,0.963004226573629,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13287,GO:0052229,1,0.963004226573629,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13288,GO:0052231,1,0.956441843839217,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
13289,GO:0052248,1,0.783597337102256,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
13290,GO:0052250,1,0.916199426809871,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
13291,GO:0052251,1,0.92594695402866,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13292,GO:0052255,1,0.885623284338132,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13293,GO:0052261,1,0.956458141288418,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13294,GO:0052306,1,0.956458141288418,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13295,GO:0052309,1,0.956458141288418,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13296,GO:0052312,1,0.383071378927947,0,23,modulation of transcription in other organism involved in symbiotic interaction,BP,
13297,GO:0052314,1,0.962109643726768,0,1,phytoalexin metabolic process,BP,
13298,GO:0052330,1,0.889306249679851,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13299,GO:0052360,1,0.963004226573629,0,1,catabolism by host of symbiont macromolecule,BP,
13300,GO:0052361,1,0.963004226573629,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13301,GO:0052362,1,0.963004226573629,0,1,catabolism by host of symbiont protein,BP,
13302,GO:0052363,1,0.963004226573629,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13303,GO:0052364,1,0.963004226573629,0,1,catabolism by host of substance in symbiont,BP,
13304,GO:0052370,1,0.956441843839217,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
13305,GO:0052381,1,0.96130274218588,0,1,tRNA dimethylallyltransferase activity,MF,
13306,GO:0052405,1,0.894187993130717,0,3,negative regulation by host of symbiont molecular function,BP,
13307,GO:0052416,1,0.963004226573629,0,1,metabolism by host of symbiont macromolecule,BP,
13308,GO:0052417,1,0.963004226573629,0,1,metabolism by host of symbiont protein,BP,
13309,GO:0052418,1,0.963004226573629,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13310,GO:0052419,1,0.963004226573629,0,1,metabolism by host of substance in symbiont,BP,
13311,GO:0052422,1,0.962653003900764,0,1,modulation by host of symbiont catalytic activity,BP,
13312,GO:0052428,1,0.855230074360964,0,4,modulation by host of symbiont molecular function,BP,
13313,GO:0052433,1,0.783597337102256,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13314,GO:0052472,1,0.383071378927947,0,23,modulation by host of symbiont transcription,BP,
13315,GO:0052490,1,0.849895708942683,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13316,GO:0052493,1,0.956458141288418,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13317,GO:0052501,1,0.889306249679851,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13318,GO:0052509,1,0.92594695402866,0,2,positive regulation by symbiont of host defense response,BP,
13319,GO:0052510,1,0.92594695402866,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13320,GO:0052522,1,0.956441843839217,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
13323,GO:0052550,1,0.962869317582296,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13324,GO:0052552,1,0.885623284338132,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13325,GO:0052553,1,0.885623284338132,0,3,modulation by symbiont of host immune response,BP,
13326,GO:0052561,1,0.956458141288418,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13327,GO:0052562,1,0.956458141288418,0,1,negative regulation by symbiont of host immune response,BP,
13328,GO:0052564,1,0.818029362017988,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
13329,GO:0052567,1,0.962869317582296,0,1,response to defense-related host reactive oxygen species production,BP,
13330,GO:0052572,1,0.818029362017988,0,5,response to host immune response,BP,
13331,GO:0052590,1,0.956441843839217,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13332,GO:0052591,1,0.956441843839217,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
13333,GO:0052593,1,0.918264657440157,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13334,GO:0052594,1,0.918264657440157,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13335,GO:0052595,1,0.918264657440157,0,2,aliphatic-amine oxidase activity,MF,
13336,GO:0052596,1,0.918264657440157,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
13337,GO:0052629,1,0.617796548193902,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
13338,GO:0052642,1,0.962430281579337,0,1,lysophosphatidic acid phosphatase activity,MF,
13339,GO:0052646,1,0.709678897022239,0,8,alditol phosphate metabolic process,BP,
13341,GO:0052651,1,0.922863710467252,0,2,monoacylglycerol catabolic process,BP,
13343,GO:0052654,1,0.921105304694621,0,2,L-leucine transaminase activity,MF,
13344,GO:0052655,1,0.921105304694621,0,2,L-valine transaminase activity,MF,
13345,GO:0052656,1,0.921105304694621,0,2,L-isoleucine transaminase activity,MF,
13346,GO:0052657,1,0.963665084856912,0,1,guanine phosphoribosyltransferase activity,MF,
13347,GO:0052658,1,0.772266529474159,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13348,GO:0052659,1,0.676821248485019,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
13349,GO:0052666,1,0.961923130581001,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
13351,GO:0052692,1,0.963656509417758,0,1,raffinose alpha-galactosidase activity,MF,
13352,GO:0052695,1,0.750943461057885,0,7,cellular glucuronidation,BP,
13353,GO:0052696,1,0.818292665355091,0,5,flavonoid glucuronidation,BP,
13354,GO:0052697,1,0.818292665355091,0,5,xenobiotic glucuronidation,BP,
13355,GO:0052717,1,0.956441843839217,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13356,GO:0052718,1,0.956441843839217,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
13357,GO:0052723,1,0.843602754871012,0,4,inositol hexakisphosphate 1-kinase activity,MF,
13358,GO:0052724,1,0.843602754871012,0,4,inositol hexakisphosphate 3-kinase activity,MF,
13359,GO:0052725,1,0.957956075730342,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13360,GO:0052726,1,0.957956075730342,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13361,GO:0052735,1,0.882391596039096,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
13362,GO:0052739,1,0.961533633978051,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13363,GO:0052740,1,0.961533633978051,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
13365,GO:0052743,1,0.620696594647944,0,11,inositol tetrakisphosphate phosphatase activity,MF,
13366,GO:0052744,1,0.541917836015402,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
13368,GO:0052746,1,0.916449850981079,0,2,inositol phosphorylation,BP,
13369,GO:0052794,1,0.922297566784203,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13370,GO:0052795,1,0.922297566784203,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13371,GO:0052796,1,0.922297566784203,0,2,exo-alpha-(2->8)-sialidase activity,MF,
13372,GO:0052798,1,0.961425520249245,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
13373,GO:0052803,1,0.844920492874359,0,4,imidazole-containing compound metabolic process,BP,
13374,GO:0052805,1,0.918668847120462,0,2,imidazole-containing compound catabolic process,BP,
13375,GO:0052810,1,0.957223434198147,0,1,1-phosphatidylinositol-5-kinase activity,MF,
13376,GO:0052811,1,0.838103760129379,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
13377,GO:0052812,1,0.915556917261929,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
13379,GO:0052815,1,0.96436678056198,0,1,medium-chain acyl-CoA hydrolase activity,MF,
13382,GO:0052825,1,0.957956075730342,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13383,GO:0052826,1,0.958910370595393,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
13384,GO:0052827,1,0.918590625933887,0,2,inositol pentakisphosphate phosphatase activity,MF,
13385,GO:0052828,1,0.915195441957175,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
13386,GO:0052829,1,0.961448966112996,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
13387,GO:0052830,1,0.957956075730342,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13388,GO:0052831,1,0.957956075730342,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13392,GO:0052835,1,0.957956075730342,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
13393,GO:0052836,1,0.922198808469667,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13394,GO:0052839,1,0.922198808469667,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
13395,GO:0052840,1,0.851608970642098,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13396,GO:0052841,1,0.851608970642098,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13397,GO:0052842,1,0.851608970642098,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13398,GO:0052843,1,0.851608970642098,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13399,GO:0052844,1,0.851608970642098,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13400,GO:0052845,1,0.851608970642098,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13401,GO:0052846,1,0.851608970642098,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13402,GO:0052847,1,0.851608970642098,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13403,GO:0052848,1,0.851608970642098,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13404,GO:0052851,1,0.809277597205763,0,5,ferric-chelate reductase (NADPH) activity,MF,
13405,GO:0052858,1,0.957428283990781,0,1,peptidyl-lysine acetyltransferase activity,MF,
13406,GO:0052866,1,0.321675207869338,0,26,phosphatidylinositol phosphate phosphatase activity,MF,
13407,GO:0052890,1,0.962057098494237,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
13408,GO:0052894,1,0.961513833312638,0,1,norspermine:oxygen oxidoreductase activity,MF,
13409,GO:0052895,1,0.961513833312638,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
13410,GO:0052899,1,0.962814632476997,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13411,GO:0052901,1,0.925756757679149,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
13412,GO:0052902,1,0.962814632476997,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13413,GO:0052903,1,0.962814632476997,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13414,GO:0052904,1,0.962814632476997,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13415,GO:0052905,1,0.881379331721532,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
13416,GO:0052906,1,0.956452974901874,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
13417,GO:0052907,1,0.958787867083198,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13418,GO:0052909,1,0.958787867083198,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13419,GO:0052917,1,0.960426449315397,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
13420,GO:0052918,1,0.956441843839217,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13421,GO:0052925,1,0.963368745455338,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
13422,GO:0052926,1,0.956441843839217,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13423,GO:0052927,1,0.960783019309075,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13424,GO:0052928,1,0.960783019309075,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13425,GO:0052929,1,0.960783019309075,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
13429,GO:0055005,1,0.956444441803967,0,1,ventricular cardiac myofibril assembly,BP,
13433,GO:0055009,1,0.885924135823027,0,3,atrial cardiac muscle tissue morphogenesis,BP,
13434,GO:0055010,1,0.314914228743977,0,27,ventricular cardiac muscle tissue morphogenesis,BP,
13435,GO:0055011,1,0.962808171501297,0,1,atrial cardiac muscle cell differentiation,BP,
13436,GO:0055012,1,0.688637183754342,0,9,ventricular cardiac muscle cell differentiation,BP,
13438,GO:0055014,1,0.962808171501297,0,1,atrial cardiac muscle cell development,BP,
13439,GO:0055015,1,0.751732582166117,0,7,ventricular cardiac muscle cell development,BP,
13441,GO:0055018,1,0.962531515651986,0,1,regulation of cardiac muscle fiber development,BP,
13442,GO:0055020,1,0.962531515651986,0,1,positive regulation of cardiac muscle fiber development,BP,
13443,GO:0055021,1,0.268952954073552,0,31,regulation of cardiac muscle tissue growth,BP,
13444,GO:0055022,1,0.553387618107743,0,14,negative regulation of cardiac muscle tissue growth,BP,
13445,GO:0055023,1,0.487528474423859,0,17,positive regulation of cardiac muscle tissue growth,BP,
13448,GO:0055026,1,0.409161991396558,0,21,negative regulation of cardiac muscle tissue development,BP,
13449,GO:0055028,1,0.956441843839217,0,1,cortical microtubule,CC,
13453,GO:0055048,1,0.956441843839217,0,1,anastral spindle assembly,BP,
13455,GO:0055057,1,0.644985815730344,0,10,neuroblast division,BP,
13456,GO:0055059,1,0.839576142491528,0,4,asymmetric neuroblast division,BP,
13458,GO:0055064,1,0.6769649157537,0,9,chloride ion homeostasis,BP,
13467,GO:0055077,1,0.91899162654039,0,2,gap junction hemi-channel activity,MF,
13475,GO:0055087,1,0.882441916897384,0,3,Ski complex,CC,
13479,GO:0055091,1,0.838996536224016,0,4,phospholipid homeostasis,BP,
13483,GO:0055095,1,0.957115680386505,0,1,lipoprotein particle mediated signaling,BP,
13484,GO:0055096,1,0.957115680386505,0,1,low-density lipoprotein particle mediated signaling,BP,
13485,GO:0055100,1,0.880489343878128,0,3,adiponectin binding,MF,
13487,GO:0055103,1,0.957977357775801,0,1,ligase regulator activity,MF,
13488,GO:0055105,1,0.802678924334459,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13489,GO:0055106,1,0.533718173205808,0,16,ubiquitin-protein transferase regulator activity,MF,
13490,GO:0055108,1,0.961855734899517,0,1,Golgi to transport vesicle transport,BP,
13491,GO:0055113,1,0.956441843839217,0,1,epiboly involved in gastrulation with mouth forming second,BP,
13493,GO:0055117,1,0.178695310503706,0,41,regulation of cardiac muscle contraction,BP,
13494,GO:0055118,1,0.882418963196356,0,3,negative regulation of cardiac muscle contraction,BP,
13495,GO:0055119,1,0.630576959637757,0,11,relaxation of cardiac muscle,BP,
13496,GO:0055120,1,0.964648749068322,0,1,striated muscle dense body,CC,
13498,GO:0055129,1,0.853231383839427,0,4,L-proline biosynthetic process,BP,
13499,GO:0055131,1,0.819268469402203,0,5,C3HC4-type RING finger domain binding,MF,
13500,GO:0060001,1,0.956441843839217,0,1,minus-end directed microfilament motor activity,MF,
13501,GO:0060002,1,0.915437049835009,0,2,plus-end directed microfilament motor activity,MF,
13502,GO:0060003,1,0.914777292668164,0,2,copper ion export,BP,
13507,GO:0060009,1,0.685083377206813,0,9,Sertoli cell development,BP,
13508,GO:0060010,1,0.957837530103046,0,1,Sertoli cell fate commitment,BP,
13509,GO:0060011,1,0.883886734020756,0,3,Sertoli cell proliferation,BP,
13510,GO:0060012,1,0.958026563055971,0,1,synaptic transmission, glycinergic,BP,
13512,GO:0060014,1,0.958734896341551,0,1,granulosa cell differentiation,BP,
13514,GO:0060018,1,0.957024743659525,0,1,astrocyte fate commitment,BP,
13515,GO:0060019,1,0.698037395434746,0,9,radial glial cell differentiation,BP,
13516,GO:0060020,1,0.777259250940109,0,6,Bergmann glial cell differentiation,BP,
13518,GO:0060022,1,0.806123382396822,0,5,hard palate development,BP,
13520,GO:0060024,1,0.919547009549707,0,2,rhythmic synaptic transmission,BP,
13521,GO:0060025,1,0.917183449379816,0,2,regulation of synaptic activity,BP,
13526,GO:0060031,1,0.956441843839217,0,1,mediolateral intercalation,BP,
13531,GO:0060039,1,0.541967386935142,0,14,pericardium development,BP,
13532,GO:0060040,1,0.92016054174763,0,2,retinal bipolar neuron differentiation,BP,
13535,GO:0060043,1,0.390967879705522,0,22,regulation of cardiac muscle cell proliferation,BP,
13536,GO:0060044,1,0.654002623592051,0,10,negative regulation of cardiac muscle cell proliferation,BP,
13537,GO:0060045,1,0.599416689134032,0,12,positive regulation of cardiac muscle cell proliferation,BP,
13541,GO:0060049,1,0.63089373147098,0,11,regulation of protein glycosylation,BP,
13542,GO:0060050,1,0.714539552531673,0,8,positive regulation of protein glycosylation,BP,
13543,GO:0060051,1,0.923233936712477,0,2,negative regulation of protein glycosylation,BP,
13544,GO:0060052,1,0.744626665923386,0,7,neurofilament cytoskeleton organization,BP,
13546,GO:0060054,1,0.881645261752554,0,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,
13548,GO:0060056,1,0.748592435842942,0,7,mammary gland involution,BP,
13549,GO:0060057,1,0.883375695311614,0,3,apoptotic process involved in mammary gland involution,BP,
13550,GO:0060058,1,0.883375695311614,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
13551,GO:0060059,1,0.83680392495697,0,4,embryonic retina morphogenesis in camera-type eye,BP,
13552,GO:0060060,1,0.956441843839217,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
13555,GO:0060065,1,0.572205784824679,0,13,uterus development,BP,
13556,GO:0060066,1,0.921991080979329,0,2,oviduct development,BP,
13557,GO:0060067,1,0.956441843839217,0,1,cervix development,BP,
13561,GO:0060072,1,0.956441843839217,0,1,large conductance calcium-activated potassium channel activity,MF,
13562,GO:0060073,1,0.841252881039497,0,4,micturition,BP,
13564,GO:0060075,1,0.882102644675244,0,3,regulation of resting membrane potential,BP,
13565,GO:0060076,1,0.543148622280105,0,14,excitatory synapse,CC,
13571,GO:0060083,1,0.915163087085509,0,2,smooth muscle contraction involved in micturition,BP,
13572,GO:0060084,1,0.956441860364028,0,1,synaptic transmission involved in micturition,BP,
13573,GO:0060086,1,0.919053738968504,0,2,circadian temperature homeostasis,BP,
13575,GO:0060088,1,0.812094788373475,0,5,auditory receptor cell stereocilium organization,BP,
13578,GO:0060091,1,0.8160152303766,0,5,kinocilium,CC,
13579,GO:0060092,1,0.958026563055971,0,1,regulation of synaptic transmission, glycinergic,BP,
13580,GO:0060099,1,0.807306803463519,0,5,regulation of phagocytosis, engulfment,BP,
13581,GO:0060100,1,0.807306803463519,0,5,positive regulation of phagocytosis, engulfment,BP,
13585,GO:0060120,1,0.816133575657651,0,5,inner ear receptor cell fate commitment,BP,
13587,GO:0060123,1,0.838286468785609,0,4,regulation of growth hormone secretion,BP,
13588,GO:0060124,1,0.916397690240991,0,2,positive regulation of growth hormone secretion,BP,
13589,GO:0060125,1,0.956441843839217,0,1,negative regulation of growth hormone secretion,BP,
13590,GO:0060126,1,0.919650437768558,0,2,somatotropin secreting cell differentiation,BP,
13591,GO:0060127,1,0.960930601614166,0,1,prolactin secreting cell differentiation,BP,
13592,GO:0060128,1,0.958174913278171,0,1,corticotropin hormone secreting cell differentiation,BP,
13593,GO:0060129,1,0.917012897885745,0,2,thyroid-stimulating hormone-secreting cell differentiation,BP,
13594,GO:0060134,1,0.87697311214264,0,3,prepulse inhibition,BP,
13596,GO:0060136,1,0.846261461231097,0,4,embryonic process involved in female pregnancy,BP,
13597,GO:0060137,1,0.780609240105829,0,6,maternal process involved in parturition,BP,
13598,GO:0060139,1,0.922567402289617,0,2,positive regulation of apoptotic process by virus,BP,
13603,GO:0060149,1,0.560897514704926,0,14,negative regulation of posttranscriptional gene silencing,BP,
13604,GO:0060151,1,0.915182027164281,0,2,peroxisome localization,BP,
13605,GO:0060152,1,0.915182027164281,0,2,microtubule-based peroxisome localization,BP,
13606,GO:0060154,1,0.885779608718636,0,3,cellular process regulating host cell cycle in response to virus,BP,
13608,GO:0060156,1,0.958222255349026,0,1,milk ejection reflex,BP,
13609,GO:0060157,1,0.914906087251344,0,2,urinary bladder development,BP,
13610,GO:0060158,1,0.855875194286393,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
13611,GO:0060159,1,0.849088618657017,0,4,regulation of dopamine receptor signaling pathway,BP,
13612,GO:0060161,1,0.881177578573946,0,3,positive regulation of dopamine receptor signaling pathway,BP,
13613,GO:0060164,1,0.96356435360397,0,1,regulation of timing of neuron differentiation,BP,
13615,GO:0060167,1,0.963310309890086,0,1,regulation of adenosine receptor signaling pathway,BP,
13616,GO:0060169,1,0.963310309890086,0,1,negative regulation of adenosine receptor signaling pathway,BP,
13618,GO:0060171,1,0.956537425986959,0,1,stereocilium membrane,CC,
13621,GO:0060178,1,0.960847741478687,0,1,regulation of exocyst localization,BP,
13624,GO:0060183,1,0.958026563055971,0,1,apelin receptor signaling pathway,BP,
13625,GO:0060184,1,0.958536775057315,0,1,cell cycle switching,BP,
13630,GO:0060197,1,0.920731820731869,0,2,cloacal septation,BP,
13633,GO:0060200,1,0.956522932010585,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13634,GO:0060201,1,0.956522932010585,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
13637,GO:0060211,1,0.633879241766853,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13638,GO:0060212,1,0.962403089142594,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13639,GO:0060213,1,0.633879241766853,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13640,GO:0060214,1,0.96326198988714,0,1,endocardium formation,BP,
13645,GO:0060221,1,0.957024743659525,0,1,retinal rod cell differentiation,BP,
13647,GO:0060229,1,0.719252161200008,0,8,lipase activator activity,MF,
13650,GO:0060235,1,0.88049583325513,0,3,lens induction in camera-type eye,BP,
13651,GO:0060236,1,0.229717266992807,0,35,regulation of mitotic spindle organization,BP,
13652,GO:0060242,1,0.747066898526176,0,7,contact inhibition,BP,
13653,GO:0060244,1,0.883855542180977,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
13654,GO:0060245,1,0.957216426198729,0,1,detection of cell density,BP,
13655,GO:0060246,1,0.957216426198729,0,1,detection of cell density by contact stimulus,BP,
13656,GO:0060248,1,0.957216426198729,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
13660,GO:0060253,1,0.687535606827738,0,9,negative regulation of glial cell proliferation,BP,
13662,GO:0060259,1,0.740920569043501,0,7,regulation of feeding behavior,BP,
13664,GO:0060261,1,0.500290642555601,0,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
13666,GO:0060264,1,0.927386738231283,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13667,GO:0060265,1,0.965120471550531,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
13668,GO:0060266,1,0.927386738231283,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
13670,GO:0060268,1,0.886985374770425,0,3,negative regulation of respiratory burst,BP,
13673,GO:0060278,1,0.961161759333046,0,1,regulation of ovulation,BP,
13674,GO:0060279,1,0.961161759333046,0,1,positive regulation of ovulation,BP,
13675,GO:0060281,1,0.779740616449841,0,6,regulation of oocyte development,BP,
13676,GO:0060282,1,0.884105294943751,0,3,positive regulation of oocyte development,BP,
13677,GO:0060283,1,0.957622348362285,0,1,negative regulation of oocyte development,BP,
13680,GO:0060287,1,0.845858728176467,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
13681,GO:0060290,1,0.956441843839217,0,1,transdifferentiation,BP,
13683,GO:0060292,1,0.530295369399338,0,15,long term synaptic depression,BP,
13684,GO:0060293,1,0.74727648281432,0,7,germ plasm,CC,
13686,GO:0060295,1,0.812119059584258,0,5,regulation of cilium movement involved in cell motility,BP,
13687,GO:0060296,1,0.812119059584258,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
13688,GO:0060297,1,0.879485570704273,0,3,regulation of sarcomere organization,BP,
13689,GO:0060298,1,0.919546022139367,0,2,positive regulation of sarcomere organization,BP,
13690,GO:0060300,1,0.889572623636273,0,3,regulation of cytokine activity,BP,
13691,GO:0060301,1,0.960046682619021,0,1,positive regulation of cytokine activity,BP,
13692,GO:0060302,1,0.926599007116839,0,2,negative regulation of cytokine activity,BP,
13693,GO:0060304,1,0.80274818111695,0,5,regulation of phosphatidylinositol dephosphorylation,BP,
13696,GO:0060309,1,0.965291349103236,0,1,elastin catabolic process,BP,
13697,GO:0060310,1,0.965291349103236,0,1,regulation of elastin catabolic process,BP,
13698,GO:0060311,1,0.965291349103236,0,1,negative regulation of elastin catabolic process,BP,
13699,GO:0060312,1,0.780507047012629,0,6,regulation of blood vessel remodeling,BP,
13700,GO:0060313,1,0.883031879771753,0,3,negative regulation of blood vessel remodeling,BP,
13703,GO:0060316,1,0.754960235846862,0,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
13704,GO:0060317,1,0.4491027692566,0,19,cardiac epithelial to mesenchymal transition,BP,
13712,GO:0060327,1,0.958787867083198,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13714,GO:0060331,1,0.790770216824031,0,6,negative regulation of response to interferon-gamma,BP,
13715,GO:0060332,1,0.876335318422491,0,3,positive regulation of response to interferon-gamma,BP,
13718,GO:0060335,1,0.876335318422491,0,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,
13719,GO:0060336,1,0.790770216824031,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
13722,GO:0060339,1,0.744968437824367,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
13723,GO:0060340,1,0.683870911130303,0,9,positive regulation of type I interferon-mediated signaling pathway,BP,
13728,GO:0060347,1,0.717635255221877,0,8,heart trabecula formation,BP,
13733,GO:0060352,1,0.816240876051805,0,5,cell adhesion molecule production,BP,
13734,GO:0060353,1,0.889531109876949,0,3,regulation of cell adhesion molecule production,BP,
13735,GO:0060355,1,0.889531109876949,0,3,positive regulation of cell adhesion molecule production,BP,
13737,GO:0060363,1,0.749961581027517,0,7,cranial suture morphogenesis,BP,
13738,GO:0060364,1,0.846348141596374,0,4,frontal suture morphogenesis,BP,
13739,GO:0060366,1,0.956441843839217,0,1,lambdoid suture morphogenesis,BP,
13740,GO:0060367,1,0.956441843839217,0,1,sagittal suture morphogenesis,BP,
13741,GO:0060368,1,0.780793987162063,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13742,GO:0060369,1,0.84632237539659,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13743,GO:0060370,1,0.956441844283801,0,1,susceptibility to T cell mediated cytotoxicity,BP,
13744,GO:0060371,1,0.878164069791367,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
13745,GO:0060372,1,0.956441843839217,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
13746,GO:0060373,1,0.842018585635307,0,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
13750,GO:0060378,1,0.956441843839217,0,1,regulation of brood size,BP,
13751,GO:0060379,1,0.741611905782449,0,7,cardiac muscle cell myoblast differentiation,BP,
13752,GO:0060380,1,0.961551625610174,0,1,regulation of single-stranded telomeric DNA binding,BP,
13753,GO:0060381,1,0.961551625610174,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
13754,GO:0060382,1,0.915193950359693,0,2,regulation of DNA strand elongation,BP,
13755,GO:0060383,1,0.956877439770078,0,1,positive regulation of DNA strand elongation,BP,
13757,GO:0060385,1,0.918225518391051,0,2,axonogenesis involved in innervation,BP,
13758,GO:0060386,1,0.956441851901283,0,1,synapse assembly involved in innervation,BP,
13761,GO:0060391,1,0.624676333110993,0,11,positive regulation of SMAD protein signal transduction,BP,
13762,GO:0060392,1,0.927057839161653,0,2,negative regulation of SMAD protein signal transduction,BP,
13764,GO:0060394,1,0.752795683321794,0,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
13767,GO:0060397,1,0.676871358815696,0,9,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
13768,GO:0060398,1,0.875055286365319,0,3,regulation of growth hormone receptor signaling pathway,BP,
13769,GO:0060399,1,0.91478640491998,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
13770,GO:0060400,1,0.956575604562219,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
13773,GO:0060405,1,0.883139296311441,0,3,regulation of penile erection,BP,
13774,GO:0060406,1,0.916781615926474,0,2,positive regulation of penile erection,BP,
13775,GO:0060407,1,0.963310309890086,0,1,negative regulation of penile erection,BP,
13779,GO:0060414,1,0.956441843839217,0,1,aorta smooth muscle tissue morphogenesis,BP,
13783,GO:0060420,1,0.227645164735326,0,35,regulation of heart growth,BP,
13784,GO:0060421,1,0.430108626173074,0,20,positive regulation of heart growth,BP,
13785,GO:0060423,1,0.920210444693124,0,2,foregut regionalization,BP,
13786,GO:0060424,1,0.920210444693124,0,2,lung field specification,BP,
13788,GO:0060426,1,0.884497881636509,0,3,lung vasculature development,BP,
13791,GO:0060430,1,0.915223682617425,0,2,lung saccule development,BP,
13792,GO:0060431,1,0.881089436506913,0,3,primary lung bud formation,BP,
13795,GO:0060435,1,0.963911876262247,0,1,bronchiole development,BP,
13797,GO:0060438,1,0.533814788874127,0,15,trachea development,BP,
13798,GO:0060439,1,0.687598888595261,0,9,trachea morphogenesis,BP,
13799,GO:0060440,1,0.779368558615719,0,6,trachea formation,BP,
13805,GO:0060447,1,0.956441843839217,0,1,bud outgrowth involved in lung branching,BP,
13808,GO:0060452,1,0.814818821201103,0,5,positive regulation of cardiac muscle contraction,BP,
13809,GO:0060453,1,0.81126285581414,0,5,regulation of gastric acid secretion,BP,
13810,GO:0060454,1,0.956845173675673,0,1,positive regulation of gastric acid secretion,BP,
13811,GO:0060455,1,0.9234058419061,0,2,negative regulation of gastric acid secretion,BP,
13812,GO:0060456,1,0.881293541096352,0,3,positive regulation of digestive system process,BP,
13813,GO:0060457,1,0.745692749080229,0,7,negative regulation of digestive system process,BP,
13814,GO:0060459,1,0.960930601614166,0,1,left lung development,BP,
13815,GO:0060460,1,0.960930601614166,0,1,left lung morphogenesis,BP,
13816,GO:0060462,1,0.801435661550853,0,5,lung lobe development,BP,
13817,GO:0060463,1,0.801435661550853,0,5,lung lobe morphogenesis,BP,
13818,GO:0060465,1,0.957622348362285,0,1,pharynx development,BP,
13820,GO:0060474,1,0.925196399004212,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
13823,GO:0060480,1,0.963911876262247,0,1,lung goblet cell differentiation,BP,
13824,GO:0060481,1,0.922497363332712,0,2,lobar bronchus epithelium development,BP,
13825,GO:0060482,1,0.882857856360828,0,3,lobar bronchus development,BP,
13826,GO:0060484,1,0.808336171147327,0,5,lung-associated mesenchyme development,BP,
13828,GO:0060486,1,0.918647914176205,0,2,Clara cell differentiation,BP,
13834,GO:0060492,1,0.920210444693124,0,2,lung induction,BP,
13835,GO:0060501,1,0.844177568415766,0,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
13836,GO:0060502,1,0.713718667112757,0,8,epithelial cell proliferation involved in lung morphogenesis,BP,
13837,GO:0060503,1,0.962531515651986,0,1,bud dilation involved in lung branching,BP,
13839,GO:0060510,1,0.922210890989838,0,2,Type II pneumocyte differentiation,BP,
13842,GO:0060516,1,0.957024743659525,0,1,primary prostatic bud elongation,BP,
13843,GO:0060517,1,0.957024743659525,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
13844,GO:0060523,1,0.915191719624107,0,2,prostate epithelial cord elongation,BP,
13848,GO:0060528,1,0.878455208990877,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
13849,GO:0060529,1,0.915320572441118,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
13850,GO:0060532,1,0.915606102767697,0,2,bronchus cartilage development,BP,
13851,GO:0060534,1,0.741971940988943,0,7,trachea cartilage development,BP,
13852,GO:0060535,1,0.882307699611673,0,3,trachea cartilage morphogenesis,BP,
13853,GO:0060536,1,0.848270934389347,0,4,cartilage morphogenesis,BP,
13856,GO:0060539,1,0.809365499717419,0,5,diaphragm development,BP,
13858,GO:0060542,1,0.956441843839217,0,1,regulation of strand invasion,BP,
13860,GO:0060545,1,0.920749539734458,0,2,positive regulation of necroptotic process,BP,
13864,GO:0060556,1,0.813890630227357,0,5,regulation of vitamin D biosynthetic process,BP,
13865,GO:0060557,1,0.963423728178762,0,1,positive regulation of vitamin D biosynthetic process,BP,
13866,GO:0060558,1,0.846550717057787,0,4,regulation of calcidiol 1-monooxygenase activity,BP,
13867,GO:0060559,1,0.963423728178762,0,1,positive regulation of calcidiol 1-monooxygenase activity,BP,
13869,GO:0060561,1,0.463234258109795,0,18,apoptotic process involved in morphogenesis,BP,
13872,GO:0060566,1,0.956441843839217,0,1,positive regulation of DNA-templated transcription, termination,BP,
13876,GO:0060574,1,0.853818715121098,0,4,intestinal epithelial cell maturation,BP,
13877,GO:0060575,1,0.612076567692237,0,12,intestinal epithelial cell differentiation,BP,
13878,GO:0060576,1,0.695625695127899,0,9,intestinal epithelial cell development,BP,
13879,GO:0060577,1,0.960930601614166,0,1,pulmonary vein morphogenesis,BP,
13880,GO:0060578,1,0.960930601614166,0,1,superior vena cava morphogenesis,BP,
13883,GO:0060584,1,0.919732379277031,0,2,regulation of prostaglandin-endoperoxide synthase activity,BP,
13884,GO:0060585,1,0.919732379277031,0,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
13885,GO:0060586,1,0.846010242697109,0,4,multicellular organismal iron ion homeostasis,BP,
13887,GO:0060590,1,0.241118359173344,0,35,ATPase regulator activity,MF,
13888,GO:0060591,1,0.8801294928449,0,3,chondroblast differentiation,BP,
13889,GO:0060592,1,0.842600471555697,0,4,mammary gland formation,BP,
13890,GO:0060594,1,0.915191719624107,0,2,mammary gland specification,BP,
13891,GO:0060595,1,0.95687510764142,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13892,GO:0060596,1,0.956538992333406,0,1,mammary placode formation,BP,
13893,GO:0060598,1,0.964163132973511,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
13894,GO:0060599,1,0.956441843839217,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
13899,GO:0060605,1,0.884248116573373,0,3,tube lumen cavitation,BP,
13901,GO:0060611,1,0.960240360586506,0,1,mammary gland fat development,BP,
13902,GO:0060612,1,0.348077961748212,0,25,adipose tissue development,BP,
13903,GO:0060613,1,0.778372768852671,0,6,fat pad development,BP,
13904,GO:0060615,1,0.95687510764142,0,1,mammary gland bud formation,BP,
13905,GO:0060620,1,0.958787867083198,0,1,regulation of cholesterol import,BP,
13906,GO:0060623,1,0.882506739271451,0,3,regulation of chromosome condensation,BP,
13908,GO:0060628,1,0.60474807808915,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
13909,GO:0060631,1,0.87997092393029,0,3,regulation of meiosis I,BP,
13910,GO:0060632,1,0.560321860803485,0,14,regulation of microtubule-based movement,BP,
13912,GO:0060638,1,0.810358563270861,0,5,mesenchymal-epithelial cell signaling,BP,
13913,GO:0060644,1,0.634857896084732,0,11,mammary gland epithelial cell differentiation,BP,
13914,GO:0060648,1,0.95687510764142,0,1,mammary gland bud morphogenesis,BP,
13915,GO:0060661,1,0.961172605270695,0,1,submandibular salivary gland formation,BP,
13916,GO:0060662,1,0.884248116573373,0,3,salivary gland cavitation,BP,
13917,GO:0060664,1,0.916602483343528,0,2,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
13918,GO:0060665,1,0.95644205280966,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
13920,GO:0060667,1,0.95687510764142,0,1,branch elongation involved in salivary gland morphogenesis,BP,
13921,GO:0060668,1,0.957369709422506,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
13923,GO:0060670,1,0.660865019199493,0,10,branching involved in labyrinthine layer morphogenesis,BP,
13924,GO:0060671,1,0.882004787040781,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13925,GO:0060672,1,0.882004787040781,0,3,epithelial cell morphogenesis involved in placental branching,BP,
13928,GO:0060676,1,0.851494208812354,0,4,ureteric bud formation,BP,
13930,GO:0060678,1,0.960833348387573,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
13931,GO:0060681,1,0.881131407209286,0,3,branch elongation involved in ureteric bud branching,BP,
13932,GO:0060683,1,0.959124935091862,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
13933,GO:0060684,1,0.849361893731082,0,4,epithelial-mesenchymal cell signaling,BP,
13934,GO:0060685,1,0.842561196700215,0,4,regulation of prostatic bud formation,BP,
13935,GO:0060686,1,0.842561196700215,0,4,negative regulation of prostatic bud formation,BP,
13938,GO:0060689,1,0.88194289337816,0,3,cell differentiation involved in salivary gland development,BP,
13939,GO:0060690,1,0.962452315797035,0,1,epithelial cell differentiation involved in salivary gland development,BP,
13940,GO:0060691,1,0.962452315797035,0,1,epithelial cell maturation involved in salivary gland development,BP,
13941,GO:0060693,1,0.807561385850473,0,5,regulation of branching involved in salivary gland morphogenesis,BP,
13942,GO:0060694,1,0.962278046052311,0,1,regulation of cholesterol transporter activity,BP,
13943,GO:0060696,1,0.816567368665744,0,5,regulation of phospholipid catabolic process,BP,
13944,GO:0060697,1,0.959070810541141,0,1,positive regulation of phospholipid catabolic process,BP,
13945,GO:0060698,1,0.916931990064185,0,2,endoribonuclease inhibitor activity,MF,
13946,GO:0060699,1,0.848614237313979,0,4,regulation of endoribonuclease activity,BP,
13948,GO:0060701,1,0.916931990064185,0,2,negative regulation of ribonuclease activity,BP,
13949,GO:0060702,1,0.916931990064185,0,2,negative regulation of endoribonuclease activity,BP,
13950,GO:0060703,1,0.959299384807479,0,1,deoxyribonuclease inhibitor activity,MF,
13954,GO:0060709,1,0.958860813278382,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
13955,GO:0060710,1,0.776529167879287,0,6,chorio-allantoic fusion,BP,
13959,GO:0060715,1,0.882237110685798,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
13967,GO:0060729,1,0.882778197937264,0,3,intestinal epithelial structure maintenance,BP,
13968,GO:0060730,1,0.957908533970339,0,1,regulation of intestinal epithelial structure maintenance,BP,
13969,GO:0060731,1,0.957908533970339,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
13970,GO:0060732,1,0.771033139863751,0,6,positive regulation of inositol phosphate biosynthetic process,BP,
13972,GO:0060734,1,0.956569669957664,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
13973,GO:0060735,1,0.963809217719398,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
13974,GO:0060736,1,0.734938731517986,0,7,prostate gland growth,BP,
13975,GO:0060737,1,0.875854150041817,0,3,prostate gland morphogenetic growth,BP,
13976,GO:0060739,1,0.956441843839217,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
13978,GO:0060742,1,0.708662451566441,0,8,epithelial cell differentiation involved in prostate gland development,BP,
13979,GO:0060743,1,0.959809786427378,0,1,epithelial cell maturation involved in prostate gland development,BP,
13980,GO:0060744,1,0.816782981305382,0,5,mammary gland branching involved in thelarche,BP,
13981,GO:0060745,1,0.837426652428928,0,4,mammary gland branching involved in pregnancy,BP,
13982,GO:0060746,1,0.7438054479317,0,7,parental behavior,BP,
13983,GO:0060748,1,0.957044903232465,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
13984,GO:0060749,1,0.661720424933107,0,10,mammary gland alveolus development,BP,
13985,GO:0060750,1,0.843561202422494,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
13986,GO:0060751,1,0.810696069042444,0,5,branch elongation involved in mammary gland duct branching,BP,
13990,GO:0060760,1,0.212640366738115,0,37,positive regulation of response to cytokine stimulus,BP,
13993,GO:0060763,1,0.918410663309658,0,2,mammary duct terminal end bud growth,BP,
13994,GO:0060764,1,0.921944906076383,0,2,cell-cell signaling involved in mammary gland development,BP,
13997,GO:0060767,1,0.689221147868656,0,9,epithelial cell proliferation involved in prostate gland development,BP,
13998,GO:0060768,1,0.720191934355566,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
13999,GO:0060769,1,0.957654579206527,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14000,GO:0060770,1,0.786323564798945,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14001,GO:0060775,1,0.956441843839217,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14002,GO:0060784,1,0.957024743659525,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14003,GO:0060788,1,0.657988148559607,0,10,ectodermal placode formation,BP,
14004,GO:0060789,1,0.785268100337153,0,6,hair follicle placode formation,BP,
14006,GO:0060800,1,0.917181233521992,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
14007,GO:0060804,1,0.958174913278171,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14008,GO:0060809,1,0.956441843839217,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
14009,GO:0060816,1,0.916035263409977,0,2,random inactivation of X chromosome,BP,
14010,GO:0060819,1,0.914777392920772,0,2,inactivation of X chromosome by genetic imprinting,BP,
14011,GO:0060821,1,0.956441843839217,0,1,inactivation of X chromosome by DNA methylation,BP,
14012,GO:0060823,1,0.957698301862685,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14013,GO:0060825,1,0.926495743914631,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14015,GO:0060830,1,0.883340798397272,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
14017,GO:0060836,1,0.808347324671923,0,5,lymphatic endothelial cell differentiation,BP,
14018,GO:0060837,1,0.777521672185352,0,6,blood vessel endothelial cell differentiation,BP,
14019,GO:0060838,1,0.918063693673482,0,2,lymphatic endothelial cell fate commitment,BP,
14020,GO:0060839,1,0.777273353113717,0,6,endothelial cell fate commitment,BP,
14022,GO:0060841,1,0.621274541248881,0,11,venous blood vessel development,BP,
14023,GO:0060842,1,0.879918036218758,0,3,arterial endothelial cell differentiation,BP,
14024,GO:0060843,1,0.956441843839217,0,1,venous endothelial cell differentiation,BP,
14025,GO:0060844,1,0.919998146021364,0,2,arterial endothelial cell fate commitment,BP,
14026,GO:0060846,1,0.883235012191011,0,3,blood vessel endothelial cell fate commitment,BP,
14027,GO:0060847,1,0.883235012191011,0,3,endothelial cell fate specification,BP,
14028,GO:0060849,1,0.957036685293961,0,1,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
14029,GO:0060850,1,0.782368944541062,0,6,regulation of transcription involved in cell fate commitment,BP,
14030,GO:0060853,1,0.957847511414,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
14031,GO:0060856,1,0.68821399288413,0,9,establishment of blood-brain barrier,BP,
14032,GO:0060857,1,0.960779427328464,0,1,establishment of glial blood-brain barrier,BP,
14034,GO:0060873,1,0.956441843839217,0,1,anterior semicircular canal development,BP,
14035,GO:0060875,1,0.956441843839217,0,1,lateral semicircular canal development,BP,
14036,GO:0060876,1,0.960198582901171,0,1,semicircular canal formation,BP,
14037,GO:0060887,1,0.958787867083198,0,1,limb epidermis development,BP,
14038,GO:0060896,1,0.714525413970462,0,8,neural plate pattern specification,BP,
14039,GO:0060897,1,0.781127394475373,0,6,neural plate regionalization,BP,
14041,GO:0060901,1,0.956744377951467,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
14042,GO:0060903,1,0.918405459307951,0,2,positive regulation of meiosis I,BP,
14043,GO:0060904,1,0.956984038203023,0,1,regulation of protein folding in endoplasmic reticulum,BP,
14044,GO:0060907,1,0.916075467337805,0,2,positive regulation of macrophage cytokine production,BP,
14047,GO:0060913,1,0.959305523469562,0,1,cardiac cell fate determination,BP,
14048,GO:0060914,1,0.644943574872224,0,11,heart formation,BP,
14049,GO:0060915,1,0.95687510764142,0,1,mesenchymal cell differentiation involved in lung development,BP,
14050,GO:0060916,1,0.838824629553871,0,4,mesenchymal cell proliferation involved in lung development,BP,
14051,GO:0060920,1,0.875015391092959,0,3,cardiac pacemaker cell differentiation,BP,
14052,GO:0060921,1,0.914872629980002,0,2,sinoatrial node cell differentiation,BP,
14053,GO:0060922,1,0.95644185709155,0,1,atrioventricular node cell differentiation,BP,
14054,GO:0060923,1,0.8124560748749,0,5,cardiac muscle cell fate commitment,BP,
14055,GO:0060926,1,0.875015391092959,0,3,cardiac pacemaker cell development,BP,
14056,GO:0060928,1,0.95644185709155,0,1,atrioventricular node cell development,BP,
14057,GO:0060931,1,0.914872629980002,0,2,sinoatrial node cell development,BP,
14058,GO:0060932,1,0.956538992333406,0,1,His-Purkinje system cell differentiation,BP,
14059,GO:0060935,1,0.879304081245463,0,3,cardiac fibroblast cell differentiation,BP,
14060,GO:0060936,1,0.879304081245463,0,3,cardiac fibroblast cell development,BP,
14061,GO:0060938,1,0.879304081245463,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14062,GO:0060939,1,0.879304081245463,0,3,epicardium-derived cardiac fibroblast cell development,BP,
14063,GO:0060940,1,0.919356282799477,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
14064,GO:0060947,1,0.840041225194885,0,4,cardiac vascular smooth muscle cell differentiation,BP,
14065,GO:0060948,1,0.915797034529551,0,2,cardiac vascular smooth muscle cell development,BP,
14066,GO:0060956,1,0.842181031714018,0,4,endocardial cell differentiation,BP,
14067,GO:0060957,1,0.958610140007852,0,1,endocardial cell fate commitment,BP,
14069,GO:0060965,1,0.606896745845518,0,12,negative regulation of gene silencing by miRNA,BP,
14071,GO:0060967,1,0.560897514704926,0,14,negative regulation of gene silencing by RNA,BP,
14074,GO:0060971,1,0.880991715565795,0,3,embryonic heart tube left/right pattern formation,BP,
14075,GO:0060972,1,0.510771484783999,0,16,left/right pattern formation,BP,
14076,GO:0060973,1,0.653801741017978,0,10,cell migration involved in heart development,BP,
14079,GO:0060978,1,0.918225405745854,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
14080,GO:0060979,1,0.874924186969474,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
14082,GO:0060986,1,0.376519498825827,0,23,endocrine hormone secretion,BP,
14083,GO:0060987,1,0.960621840324133,0,1,lipid tube,CC,
14084,GO:0060988,1,0.919111815057139,0,2,lipid tube assembly,BP,
14087,GO:0060994,1,0.921388975518178,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
14088,GO:0060995,1,0.916617313747858,0,2,cell-cell signaling involved in kidney development,BP,
14095,GO:0061002,1,0.881229942323401,0,3,negative regulation of dendritic spine morphogenesis,BP,
14096,GO:0061003,1,0.589437521097934,0,12,positive regulation of dendritic spine morphogenesis,BP,
14097,GO:0061004,1,0.756715915442906,0,7,pattern specification involved in kidney development,BP,
14100,GO:0061009,1,0.88555726743302,0,3,common bile duct development,BP,
14101,GO:0061010,1,0.956441843839217,0,1,gall bladder development,BP,
14103,GO:0061014,1,0.216117784430279,0,36,positive regulation of mRNA catabolic process,BP,
14104,GO:0061015,1,0.928706346517792,0,2,snRNA import into nucleus,BP,
14109,GO:0061030,1,0.956951357901455,0,1,epithelial cell differentiation involved in mammary gland alveolus development,BP,
14110,GO:0061031,1,0.960930601614166,0,1,endodermal digestive tract morphogenesis,BP,
14111,GO:0061032,1,0.958503826265086,0,1,visceral serous pericardium development,BP,
14112,GO:0061034,1,0.956732327618857,0,1,olfactory bulb mitral cell layer development,BP,
14114,GO:0061036,1,0.42447018425137,0,20,positive regulation of cartilage development,BP,
14116,GO:0061038,1,0.842335685699865,0,4,uterus morphogenesis,BP,
14117,GO:0061040,1,0.956441843839217,0,1,female gonad morphogenesis,BP,
14121,GO:0061044,1,0.958145282645265,0,1,negative regulation of vascular wound healing,BP,
14123,GO:0061046,1,0.84765223235608,0,4,regulation of branching involved in lung morphogenesis,BP,
14124,GO:0061047,1,0.885725779716262,0,3,positive regulation of branching involved in lung morphogenesis,BP,
14125,GO:0061049,1,0.602761834515186,0,12,cell growth involved in cardiac muscle cell development,BP,
14126,GO:0061050,1,0.688410599126731,0,9,regulation of cell growth involved in cardiac muscle cell development,BP,
14127,GO:0061051,1,0.81351429976667,0,5,positive regulation of cell growth involved in cardiac muscle cell development,BP,
14128,GO:0061052,1,0.846277952086474,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
14130,GO:0061054,1,0.957044903232465,0,1,dermatome development,BP,
14131,GO:0061055,1,0.914938235800302,0,2,myotome development,BP,
14132,GO:0061056,1,0.958787867083198,0,1,sclerotome development,BP,
14135,GO:0061073,1,0.917534130126462,0,2,ciliary body morphogenesis,BP,
14136,GO:0061074,1,0.923009643824649,0,2,regulation of neural retina development,BP,
14137,GO:0061075,1,0.923009643824649,0,2,positive regulation of neural retina development,BP,
14139,GO:0061078,1,0.965759632463125,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
14140,GO:0061081,1,0.847781811901093,0,4,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
14142,GO:0061083,1,0.845641815040886,0,4,regulation of protein refolding,BP,
14143,GO:0061084,1,0.845641815040886,0,4,negative regulation of protein refolding,BP,
14144,GO:0061085,1,0.683965768176128,0,9,regulation of histone H3-K27 methylation,BP,
14145,GO:0061086,1,0.845929083844669,0,4,negative regulation of histone H3-K27 methylation,BP,
14146,GO:0061087,1,0.775682865399163,0,6,positive regulation of histone H3-K27 methylation,BP,
14147,GO:0061088,1,0.776914484667258,0,6,regulation of sequestering of zinc ion,BP,
14148,GO:0061091,1,0.956478626944668,0,1,regulation of phospholipid translocation,BP,
14149,GO:0061092,1,0.956478626944668,0,1,positive regulation of phospholipid translocation,BP,
14152,GO:0061099,1,0.356634514785437,0,25,negative regulation of protein tyrosine kinase activity,BP,
14153,GO:0061101,1,0.851408069977162,0,4,neuroendocrine cell differentiation,BP,
14154,GO:0061102,1,0.96356435360397,0,1,stomach neuroendocrine cell differentiation,BP,
14155,GO:0061105,1,0.96356435360397,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14156,GO:0061106,1,0.96356435360397,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
14159,GO:0061110,1,0.915612531417553,0,2,dense core granule biogenesis,BP,
14160,GO:0061113,1,0.957216426198729,0,1,pancreas morphogenesis,BP,
14161,GO:0061117,1,0.553387618107743,0,14,negative regulation of heart growth,BP,
14162,GO:0061133,1,0.827469282078845,0,5,endopeptidase activator activity,MF,
14167,GO:0061140,1,0.88892459054747,0,3,lung secretory cell differentiation,BP,
14168,GO:0061141,1,0.956441843839217,0,1,lung ciliated cell differentiation,BP,
14169,GO:0061145,1,0.915606102767697,0,2,lung smooth muscle development,BP,
14170,GO:0061146,1,0.882045911638969,0,3,Peyer's patch morphogenesis,BP,
14171,GO:0061149,1,0.962531515651986,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14172,GO:0061150,1,0.962531515651986,0,1,renal system segmentation,BP,
14173,GO:0061151,1,0.962531515651986,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14174,GO:0061152,1,0.923347919199832,0,2,trachea submucosa development,BP,
14175,GO:0061153,1,0.923347919199832,0,2,trachea gland development,BP,
14176,GO:0061154,1,0.637405814308858,0,11,endothelial tube morphogenesis,BP,
14177,GO:0061155,1,0.962531515651986,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14178,GO:0061156,1,0.880629043975102,0,3,pulmonary artery morphogenesis,BP,
14179,GO:0061157,1,0.408627156118198,0,21,mRNA destabilization,BP,
14180,GO:0061158,1,0.624360911748033,0,11,3'-UTR-mediated mRNA destabilization,BP,
14181,GO:0061162,1,0.526047601298734,0,15,establishment of monopolar cell polarity,BP,
14182,GO:0061163,1,0.958787867083198,0,1,endoplasmic reticulum polarization,BP,
14184,GO:0061179,1,0.761139936021493,0,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14186,GO:0061183,1,0.957044903232465,0,1,regulation of dermatome development,BP,
14187,GO:0061184,1,0.957044903232465,0,1,positive regulation of dermatome development,BP,
14188,GO:0061187,1,0.914783338265884,0,2,regulation of chromatin silencing at rDNA,BP,
14189,GO:0061188,1,0.914783338265884,0,2,negative regulation of chromatin silencing at rDNA,BP,
14190,GO:0061193,1,0.964775768520543,0,1,taste bud development,BP,
14191,GO:0061196,1,0.842225902657092,0,4,fungiform papilla development,BP,
14192,GO:0061197,1,0.842225902657092,0,4,fungiform papilla morphogenesis,BP,
14193,GO:0061198,1,0.880592652842539,0,3,fungiform papilla formation,BP,
14196,GO:0061205,1,0.957044903232465,0,1,paramesonephric duct development,BP,
14197,GO:0061209,1,0.883854304384753,0,3,cell proliferation involved in mesonephros development,BP,
14198,GO:0061213,1,0.558564414832219,0,14,positive regulation of mesonephros development,BP,
14199,GO:0061216,1,0.962531515651986,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14200,GO:0061217,1,0.51690937676627,0,16,regulation of mesonephros development,BP,
14201,GO:0061218,1,0.886959650541439,0,3,negative regulation of mesonephros development,BP,
14202,GO:0061227,1,0.962531515651986,0,1,pattern specification involved in mesonephros development,BP,
14204,GO:0061289,1,0.916617313747858,0,2,Wnt signaling pathway involved in kidney development,BP,
14205,GO:0061290,1,0.916617313747858,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
14206,GO:0061298,1,0.672745948667643,0,9,retina vasculature development in camera-type eye,BP,
14207,GO:0061299,1,0.768564722788869,0,6,retina vasculature morphogenesis in camera-type eye,BP,
14208,GO:0061300,1,0.921398755217639,0,2,cerebellum vasculature development,BP,
14209,GO:0061301,1,0.956441843839217,0,1,cerebellum vasculature morphogenesis,BP,
14210,GO:0061302,1,0.88028513554125,0,3,smooth muscle cell-matrix adhesion,BP,
14212,GO:0061304,1,0.836843651649466,0,4,retinal blood vessel morphogenesis,BP,
14213,GO:0061307,1,0.718530680007057,0,8,cardiac neural crest cell differentiation involved in heart development,BP,
14214,GO:0061308,1,0.718530680007057,0,8,cardiac neural crest cell development involved in heart development,BP,
14215,GO:0061309,1,0.780134589350141,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
14217,GO:0061312,1,0.816798933829842,0,5,BMP signaling pathway involved in heart development,BP,
14218,GO:0061314,1,0.806092270154679,0,5,Notch signaling involved in heart development,BP,
14219,GO:0061316,1,0.8852810623955,0,3,canonical Wnt signaling pathway involved in heart development,BP,
14220,GO:0061317,1,0.924432725524386,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
14222,GO:0061323,1,0.637372441278373,0,11,cell proliferation involved in heart morphogenesis,BP,
14223,GO:0061324,1,0.957654579206527,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
14224,GO:0061325,1,0.885750705455852,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
14228,GO:0061339,1,0.526047601298734,0,15,establishment or maintenance of monopolar cell polarity,BP,
14230,GO:0061343,1,0.838826663480746,0,4,cell adhesion involved in heart morphogenesis,BP,
14232,GO:0061347,1,0.956441843839217,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14233,GO:0061348,1,0.956441843839217,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14234,GO:0061349,1,0.956441843839217,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14235,GO:0061350,1,0.956441843839217,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14237,GO:0061354,1,0.956441843839217,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14238,GO:0061355,1,0.846536247682085,0,4,Wnt protein secretion,BP,
14239,GO:0061356,1,0.846536247682085,0,4,regulation of Wnt protein secretion,BP,
14240,GO:0061357,1,0.879753604299001,0,3,positive regulation of Wnt protein secretion,BP,
14241,GO:0061358,1,0.962252164035365,0,1,negative regulation of Wnt protein secretion,BP,
14242,GO:0061364,1,0.87497000359578,0,3,apoptotic process involved in luteolysis,BP,
14244,GO:0061369,1,0.957044903232465,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
14245,GO:0061370,1,0.918218618157187,0,2,testosterone biosynthetic process,BP,
14247,GO:0061377,1,0.661720424933107,0,10,mammary gland lobule development,BP,
14249,GO:0061384,1,0.374951130109102,0,23,heart trabecula morphogenesis,BP,
14250,GO:0061386,1,0.914777292668164,0,2,closure of optic fissure,BP,
14252,GO:0061394,1,0.925791485191817,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
14253,GO:0061395,1,0.962748131680934,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
14254,GO:0061400,1,0.958787867083198,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
14255,GO:0061408,1,0.885077275434708,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
14256,GO:0061418,1,0.0633929826557066,0,70,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14257,GO:0061419,1,0.807395643062568,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14258,GO:0061428,1,0.849072624016722,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14260,GO:0061433,1,0.961965560697168,0,1,cellular response to caloric restriction,BP,
14267,GO:0061443,1,0.916851318812644,0,2,endocardial cushion cell differentiation,BP,
14268,GO:0061444,1,0.956441843839217,0,1,endocardial cushion cell development,BP,
14269,GO:0061445,1,0.958610140007852,0,1,endocardial cushion cell fate commitment,BP,
14273,GO:0061459,1,0.956441843839217,0,1,L-arginine transmembrane transporter activity,MF,
14274,GO:0061462,1,0.260366332160003,0,32,protein localization to lysosome,BP,
14276,GO:0061470,1,0.843655120176372,0,4,T follicular helper cell differentiation,BP,
14277,GO:0061474,1,0.959846585495222,0,1,phagolysosome membrane,CC,
14279,GO:0061478,1,0.680225876030739,0,9,response to platelet aggregation inhibitor,BP,
14280,GO:0061481,1,0.965138887105781,0,1,response to TNF agonist,BP,
14281,GO:0061484,1,0.878460597142,0,3,hematopoietic stem cell homeostasis,BP,
14282,GO:0061485,1,0.956441843839217,0,1,memory T cell proliferation,BP,
14283,GO:0061495,1,0.958787867083198,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14284,GO:0061502,1,0.842596669834426,0,4,early endosome to recycling endosome transport,BP,
14285,GO:0061505,1,0.914792234565335,0,2,DNA topoisomerase II activity,MF,
14286,GO:0061507,1,0.962837200321015,0,1,cyclic-GMP-AMP binding,MF,
14287,GO:0061508,1,0.958787867083198,0,1,CDP phosphorylation,BP,
14288,GO:0061511,1,0.845437261092141,0,4,centriole elongation,BP,
14290,GO:0061513,1,0.881469235379402,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
14292,GO:0061517,1,0.958913145680909,0,1,macrophage proliferation,BP,
14293,GO:0061518,1,0.958913145680909,0,1,microglial cell proliferation,BP,
14294,GO:0061519,1,0.957403437328173,0,1,macrophage homeostasis,BP,
14296,GO:0061528,1,0.956499496521757,0,1,aspartate secretion,BP,
14297,GO:0061534,1,0.956441843839217,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
14298,GO:0061535,1,0.8755102283617,0,3,glutamate secretion, neurotransmission,BP,
14299,GO:0061536,1,0.958026563055971,0,1,glycine secretion,BP,
14300,GO:0061537,1,0.958026563055971,0,1,glycine secretion, neurotransmission,BP,
14301,GO:0061542,1,0.964083115104504,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
14302,GO:0061547,1,0.957623944391169,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
14304,GO:0061549,1,0.77065593115184,0,6,sympathetic ganglion development,BP,
14305,GO:0061550,1,0.841024113279712,0,4,cranial ganglion development,BP,
14306,GO:0061551,1,0.878222482629361,0,3,trigeminal ganglion development,BP,
14307,GO:0061552,1,0.960046682619021,0,1,ganglion morphogenesis,BP,
14309,GO:0061565,1,0.958787867083198,0,1,dAMP phosphorylation,BP,
14310,GO:0061566,1,0.958787867083198,0,1,CMP phosphorylation,BP,
14311,GO:0061567,1,0.958787867083198,0,1,dCMP phosphorylation,BP,
14312,GO:0061568,1,0.958787867083198,0,1,GDP phosphorylation,BP,
14313,GO:0061569,1,0.958787867083198,0,1,UDP phosphorylation,BP,
14314,GO:0061570,1,0.958787867083198,0,1,dCDP phosphorylation,BP,
14315,GO:0061571,1,0.958787867083198,0,1,TDP phosphorylation,BP,
14317,GO:0061573,1,0.958787867083198,0,1,actin filament bundle retrograde transport,BP,
14318,GO:0061574,1,0.883866254510907,0,3,ASAP complex,CC,
14319,GO:0061575,1,0.863542543295669,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
14320,GO:0061577,1,0.71072453321204,0,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
14322,GO:0061580,1,0.956855996245816,0,1,colon epithelial cell migration,BP,
14323,GO:0061582,1,0.915173439127026,0,2,intestinal epithelial cell migration,BP,
14328,GO:0061598,1,0.956756130289669,0,1,molybdopterin adenylyltransferase activity,MF,
14329,GO:0061599,1,0.956756130289669,0,1,molybdopterin molybdotransferase activity,MF,
14330,GO:0061604,1,0.960153487129964,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14331,GO:0061605,1,0.960153487129964,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
14332,GO:0061608,1,0.692168652998975,0,9,nuclear import signal receptor activity,MF,
14333,GO:0061611,1,0.962561648789528,0,1,mannose to fructose-6-phosphate metabolic process,BP,
14335,GO:0061615,1,0.484716552186045,0,18,glycolytic process through fructose-6-phosphate,BP,
14336,GO:0061617,1,0.729649564476682,0,8,MICOS complex,CC,
14337,GO:0061618,1,0.956441843839217,0,1,sublamina densa,CC,
14338,GO:0061620,1,0.484716552186045,0,18,glycolytic process through glucose-6-phosphate,BP,
14339,GO:0061621,1,0.50293936199934,0,17,canonical glycolysis,BP,
14340,GO:0061622,1,0.923373349529905,0,2,glycolytic process through glucose-1-phosphate,BP,
14341,GO:0061623,1,0.963817600391932,0,1,glycolytic process from galactose,BP,
14342,GO:0061624,1,0.84796849899504,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
14343,GO:0061626,1,0.781499068167014,0,6,pharyngeal arch artery morphogenesis,BP,
14344,GO:0061627,1,0.961798792450768,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
14345,GO:0061628,1,0.91888166505583,0,2,H3K27me3 modified histone binding,MF,
14346,GO:0061629,1,0.851055818199346,0,4,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
14348,GO:0061631,1,0.349113526255778,0,26,ubiquitin conjugating enzyme activity,MF,
14349,GO:0061635,1,0.752754994633934,0,7,regulation of protein complex stability,BP,
14351,GO:0061641,1,0.216996821527685,0,40,CENP-A containing chromatin organization,BP,
14352,GO:0061642,1,0.956441843839217,0,1,chemoattraction of axon,BP,
14353,GO:0061643,1,0.916887695694314,0,2,chemorepulsion of axon,BP,
14355,GO:0061646,1,0.956494207602847,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
14356,GO:0061647,1,0.213835937200312,0,36,histone H3-K9 modification,BP,
14357,GO:0061649,1,0.879464482392232,0,3,ubiquitin modification-dependent histone binding,MF,
14358,GO:0061650,1,0.336608020172396,0,27,ubiquitin-like protein conjugating enzyme activity,MF,
14359,GO:0061656,1,0.96425528533061,0,1,SUMO conjugating enzyme activity,MF,
14361,GO:0061663,1,0.956441843839217,0,1,NEDD8 ligase activity,MF,
14362,GO:0061665,1,0.815282316773105,0,5,SUMO ligase activity,MF,
14363,GO:0061668,1,0.778158310697211,0,6,mitochondrial ribosome assembly,BP,
14364,GO:0061669,1,0.914942867118787,0,2,spontaneous neurotransmitter secretion,BP,
14365,GO:0061673,1,0.809593060996167,0,5,mitotic spindle astral microtubule,CC,
14366,GO:0061676,1,0.774117645336038,0,6,importin-alpha family protein binding,MF,
14367,GO:0061684,1,0.658367814224595,0,10,chaperone-mediated autophagy,BP,
14368,GO:0061685,1,0.958787867083198,0,1,diphthine methylesterase activity,MF,
14370,GO:0061689,1,0.883446102357731,0,3,tricellular tight junction,CC,
14372,GO:0061697,1,0.958168531529118,0,1,protein-glutaryllysine deglutarylase activity,MF,
14373,GO:0061698,1,0.958168531529118,0,1,protein deglutarylation,BP,
14374,GO:0061699,1,0.958168531529118,0,1,peptidyl-lysine deglutarylation,BP,
14375,GO:0061700,1,0.687711988157339,0,9,GATOR2 complex,CC,
14376,GO:0061702,1,0.755220873108828,0,7,inflammasome complex,CC,
14377,GO:0061709,1,0.956441843839217,0,1,reticulophagy,BP,
14378,GO:0061711,1,0.925336905500216,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
14379,GO:0061712,1,0.957910413760217,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
14380,GO:0061718,1,0.50293936199934,0,17,glucose catabolic process to pyruvate,BP,
14381,GO:0061723,1,0.918344137547303,0,2,glycophagy,BP,
14382,GO:0061724,1,0.778814686186373,0,6,lipophagy,BP,
14384,GO:0061727,1,0.923288462087707,0,2,methylglyoxal catabolic process to lactate,BP,
14385,GO:0061731,1,0.87767461540119,0,3,ribonucleoside-diphosphate reductase activity,MF,
14386,GO:0061732,1,0.779040988573545,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14387,GO:0061733,1,0.107438396580776,0,53,peptide-lysine-N-acetyltransferase activity,MF,
14390,GO:0061737,1,0.922500762465884,0,2,leukotriene signaling pathway,BP,
14391,GO:0061738,1,0.88519201821385,0,3,late endosomal microautophagy,BP,
14393,GO:0061740,1,0.882382789095216,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
14394,GO:0061741,1,0.922141270698405,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
14395,GO:0061743,1,0.962464157847848,0,1,motor learning,BP,
14396,GO:0061744,1,0.923779189690791,0,2,motor behavior,BP,
14397,GO:0061749,1,0.914941416688213,0,2,forked DNA-dependent helicase activity,MF,
14398,GO:0061750,1,0.960603997012787,0,1,acid sphingomyelin phosphodiesterase activity,MF,
14399,GO:0061752,1,0.922181452770274,0,2,telomeric repeat-containing RNA binding,MF,
14401,GO:0061756,1,0.625384538451222,0,11,leukocyte adhesion to vascular endothelial cell,BP,
14402,GO:0061757,1,0.958685403078214,0,1,leukocyte adhesion to arterial endothelial cell,BP,
14403,GO:0061760,1,0.958693164439256,0,1,antifungal innate immune response,BP,
14404,GO:0061762,1,0.914806164979986,0,2,CAMKK-AMPK signaling cascade,BP,
14405,GO:0061763,1,0.92002093251356,0,2,multivesicular body-lysosome fusion,BP,
14406,GO:0061767,1,0.956441843839217,0,1,negative regulation of lung blood pressure,BP,
14407,GO:0061768,1,0.956512037460003,0,1,magnesium:sodium antiporter activity,MF,
14409,GO:0061770,1,0.961205143738116,0,1,translation elongation factor binding,MF,
14411,GO:0061772,1,0.957667655588998,0,1,drug transport across blood-nerve barrier,BP,
14413,GO:0061780,1,0.956441843839217,0,1,mitotic cohesin loading,BP,
14414,GO:0061783,1,0.929006035302533,0,2,peptidoglycan muralytic activity,MF,
14415,GO:0061789,1,0.956441843839217,0,1,dense core granule priming,BP,
14416,GO:0061792,1,0.956441843839217,0,1,secretory granule maturation,BP,
14417,GO:0061798,1,0.956825884947973,0,1,GTP 3',8'-cyclase activity,MF,
14418,GO:0061799,1,0.956825884947973,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
14419,GO:0061809,1,0.96344146594306,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
14420,GO:0061817,1,0.875443665684218,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
14421,GO:0061819,1,0.880723784124568,0,3,telomeric DNA-containing double minutes formation,BP,
14422,GO:0061820,1,0.678750553362095,0,9,telomeric D-loop disassembly,BP,
14423,GO:0061821,1,0.837925445927576,0,4,telomeric D-loop binding,MF,
14424,GO:0061825,1,0.957020014431717,0,1,podosome core,CC,
14425,GO:0061827,1,0.92462686030289,0,2,sperm head,CC,
14426,GO:0061828,1,0.956441843839217,0,1,apical tubulobulbar complex,CC,
14427,GO:0061829,1,0.956441843839217,0,1,basal tubulobulbar complex,CC,
14428,GO:0061833,1,0.919373041929172,0,2,protein localization to tricellular tight junction,BP,
14431,GO:0061845,1,0.957956075730342,0,1,neuron projection branch point,CC,
14432,GO:0061846,1,0.957956075730342,0,1,dendritic spine cytoplasm,CC,
14433,GO:0061847,1,0.960668298710852,0,1,response to cholecystokinin,BP,
14434,GO:0061849,1,0.914941416688213,0,2,telomeric G-quadruplex DNA binding,MF,
14435,GO:0061850,1,0.965034687154615,0,1,growth cone leading edge,CC,
14436,GO:0061851,1,0.959281016590193,0,1,leading edge of lamellipodium,CC,
14437,GO:0061857,1,0.917629929230123,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
14438,GO:0061880,1,0.962798469162197,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14439,GO:0061881,1,0.962798469162197,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
14440,GO:0061884,1,0.961645026588241,0,1,regulation of mini excitatory postsynaptic potential,BP,
14441,GO:0061885,1,0.961645026588241,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
14442,GO:0061888,1,0.882784005251822,0,3,regulation of astrocyte activation,BP,
14443,GO:0061889,1,0.956453247266666,0,1,negative regulation of astrocyte activation,BP,
14444,GO:0061890,1,0.922983386168999,0,2,positive regulation of astrocyte activation,BP,
14452,GO:0061920,1,0.956441843839217,0,1,protein propionyltransferase activity,MF,
14453,GO:0061921,1,0.956441843839217,0,1,peptidyl-lysine propionylation,BP,
14454,GO:0061930,1,0.956463626558617,0,1,regulation of erythrocyte enucleation,BP,
14455,GO:0061931,1,0.956463626558617,0,1,positive regulation of erythrocyte enucleation,BP,
14456,GO:0061944,1,0.956714858999147,0,1,negative regulation of protein K48-linked ubiquitination,BP,
14457,GO:0061945,1,0.882328581225699,0,3,regulation of protein K48-linked ubiquitination,BP,
14459,GO:0061953,1,0.883898775260789,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
14461,GO:0061980,1,0.304951832781488,0,28,regulatory RNA binding,MF,
14463,GO:0061983,1,0.781287214461288,0,6,meiosis II cell cycle process,BP,
14468,GO:0065001,1,0.914778242357739,0,2,specification of axis polarity,BP,
14476,GO:0065010,1,0.958787867083198,0,1,extracellular membrane-bounded organelle,CC,
14477,GO:0070001,1,0.560170804509964,0,14,aspartic-type peptidase activity,MF,
14478,GO:0070003,1,0.520699831114343,0,18,threonine-type peptidase activity,MF,
14481,GO:0070008,1,0.659159029306168,0,10,serine-type exopeptidase activity,MF,
14483,GO:0070012,1,0.920893285250626,0,2,oligopeptidase activity,MF,
14485,GO:0070016,1,0.647437218888328,0,10,armadillo repeat domain binding,MF,
14486,GO:0070022,1,0.838580024403804,0,4,transforming growth factor beta receptor complex,CC,
14487,GO:0070025,1,0.959654540720847,0,1,carbon monoxide binding,MF,
14488,GO:0070026,1,0.925929434688658,0,2,nitric oxide binding,MF,
14491,GO:0070034,1,0.4228859489466,0,21,telomerase RNA binding,MF,
14493,GO:0070037,1,0.964638879480926,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
14494,GO:0070039,1,0.920464543528033,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
14495,GO:0070042,1,0.958426093064539,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
14498,GO:0070051,1,0.917908383886795,0,2,fibrinogen binding,MF,
14499,GO:0070052,1,0.916394637136506,0,2,collagen V binding,MF,
14500,GO:0070053,1,0.917833708827567,0,2,thrombospondin receptor activity,MF,
14501,GO:0070054,1,0.880616073154928,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
14502,GO:0070055,1,0.880616073154928,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
14504,GO:0070060,1,0.956441843839217,0,1,'de novo' actin filament nucleation,BP,
14505,GO:0070061,1,0.884232539400564,0,3,fructose binding,MF,
14508,GO:0070064,1,0.444257364093879,0,19,proline-rich region binding,MF,
14514,GO:0070077,1,0.957364396235892,0,1,histone arginine demethylation,BP,
14515,GO:0070078,1,0.957364396235892,0,1,histone H3-R2 demethylation,BP,
14516,GO:0070079,1,0.957364396235892,0,1,histone H4-R3 demethylation,BP,
14520,GO:0070086,1,0.851694187743665,0,4,ubiquitin-dependent endocytosis,BP,
14522,GO:0070091,1,0.878236578728422,0,3,glucagon secretion,BP,
14523,GO:0070092,1,0.878236578728422,0,3,regulation of glucagon secretion,BP,
14524,GO:0070094,1,0.959713603586834,0,1,positive regulation of glucagon secretion,BP,
14525,GO:0070095,1,0.958119149737431,0,1,fructose-6-phosphate binding,MF,
14526,GO:0070096,1,0.957726119347696,0,1,mitochondrial outer membrane translocase complex assembly,BP,
14527,GO:0070097,1,0.91485480770516,0,2,delta-catenin binding,MF,
14529,GO:0070099,1,0.776148150374485,0,6,regulation of chemokine-mediated signaling pathway,BP,
14530,GO:0070100,1,0.843630848207671,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
14531,GO:0070101,1,0.920035919861854,0,2,positive regulation of chemokine-mediated signaling pathway,BP,
14533,GO:0070103,1,0.962791993675891,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14534,GO:0070104,1,0.962791993675891,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
14536,GO:0070110,1,0.916726701814491,0,2,ciliary neurotrophic factor receptor complex,CC,
14537,GO:0070119,1,0.956848140134744,0,1,ciliary neurotrophic factor binding,MF,
14538,GO:0070120,1,0.876788834987021,0,3,ciliary neurotrophic factor-mediated signaling pathway,BP,
14539,GO:0070121,1,0.956442836694781,0,1,Kupffer's vesicle development,BP,
14540,GO:0070122,1,0.842361128359995,0,4,isopeptidase activity,MF,
14541,GO:0070123,1,0.956441843839217,0,1,transforming growth factor beta receptor activity, type III,MF,
14542,GO:0070124,1,0.925268048978753,0,2,mitochondrial translational initiation,BP,
14543,GO:0070125,1,0.0404354181634422,0,86,mitochondrial translational elongation,BP,
14544,GO:0070126,1,0.0372991920534451,0,88,mitochondrial translational termination,BP,
14545,GO:0070127,1,0.716967816044889,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
14546,GO:0070129,1,0.482017029613812,0,18,regulation of mitochondrial translation,BP,
14547,GO:0070130,1,0.958787867083198,0,1,negative regulation of mitochondrial translation,BP,
14548,GO:0070131,1,0.640214937890403,0,11,positive regulation of mitochondrial translation,BP,
14549,GO:0070137,1,0.838308519625107,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14550,GO:0070138,1,0.877045491773408,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14551,GO:0070139,1,0.838308519625107,0,4,SUMO-specific endopeptidase activity,MF,
14552,GO:0070140,1,0.877045491773408,0,3,SUMO-specific isopeptidase activity,MF,
14555,GO:0070143,1,0.956527061547979,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
14556,GO:0070145,1,0.957765667178666,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
14557,GO:0070150,1,0.923802433510588,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
14558,GO:0070159,1,0.960398208642276,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
14561,GO:0070162,1,0.809053595650448,0,5,adiponectin secretion,BP,
14562,GO:0070163,1,0.809053595650448,0,5,regulation of adiponectin secretion,BP,
14563,GO:0070164,1,0.843841963652996,0,4,negative regulation of adiponectin secretion,BP,
14564,GO:0070165,1,0.958787867083198,0,1,positive regulation of adiponectin secretion,BP,
14567,GO:0070168,1,0.740419289234028,0,7,negative regulation of biomineral tissue development,BP,
14569,GO:0070170,1,0.916144617687003,0,2,regulation of tooth mineralization,BP,
14570,GO:0070171,1,0.956441843839217,0,1,negative regulation of tooth mineralization,BP,
14571,GO:0070172,1,0.957871317478817,0,1,positive regulation of tooth mineralization,BP,
14572,GO:0070176,1,0.962477672056185,0,1,DRM complex,CC,
14573,GO:0070178,1,0.960063836388062,0,1,D-serine metabolic process,BP,
14574,GO:0070179,1,0.960063836388062,0,1,D-serine biosynthetic process,BP,
14575,GO:0070180,1,0.965721208065227,0,1,large ribosomal subunit rRNA binding,MF,
14576,GO:0070181,1,0.734782348767015,0,8,small ribosomal subunit rRNA binding,MF,
14577,GO:0070182,1,0.476938716440856,0,18,DNA polymerase binding,MF,
14578,GO:0070183,1,0.958987531854774,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
14579,GO:0070184,1,0.961205143738116,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
14580,GO:0070187,1,0.781869234222521,0,6,shelterin complex,CC,
14581,GO:0070189,1,0.8556718109283,0,4,kynurenine metabolic process,BP,
14582,GO:0070191,1,0.922343193580411,0,2,methionine-R-sulfoxide reductase activity,MF,
14584,GO:0070193,1,0.660685357334175,0,10,synaptonemal complex organization,BP,
14585,GO:0070194,1,0.921886253022078,0,2,synaptonemal complex disassembly,BP,
14586,GO:0070195,1,0.956699748952219,0,1,growth hormone receptor complex,CC,
14588,GO:0070198,1,0.341573508046957,0,26,protein localization to chromosome, telomeric region,BP,
14589,GO:0070199,1,0.394754785481067,0,23,establishment of protein localization to chromosome,BP,
14590,GO:0070200,1,0.563817908556734,0,14,establishment of protein localization to telomere,BP,
14592,GO:0070202,1,0.640776942134495,0,11,regulation of establishment of protein localization to chromosome,BP,
14593,GO:0070203,1,0.668343071483331,0,10,regulation of establishment of protein localization to telomere,BP,
14597,GO:0070209,1,0.957795483285784,0,1,ASTRA complex,CC,
14598,GO:0070212,1,0.841821468132203,0,4,protein poly-ADP-ribosylation,BP,
14599,GO:0070213,1,0.840746079414804,0,4,protein auto-ADP-ribosylation,BP,
14600,GO:0070221,1,0.861149723631466,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
14604,GO:0070230,1,0.62504695477283,0,12,positive regulation of lymphocyte apoptotic process,BP,
14605,GO:0070231,1,0.243478573434928,0,35,T cell apoptotic process,BP,
14606,GO:0070232,1,0.381660465307411,0,24,regulation of T cell apoptotic process,BP,
14607,GO:0070233,1,0.543981722265248,0,15,negative regulation of T cell apoptotic process,BP,
14608,GO:0070234,1,0.703127721098285,0,9,positive regulation of T cell apoptotic process,BP,
14609,GO:0070235,1,0.818040033344077,0,5,regulation of activation-induced cell death of T cells,BP,
14610,GO:0070236,1,0.850326366692159,0,4,negative regulation of activation-induced cell death of T cells,BP,
14611,GO:0070242,1,0.518676308089882,0,16,thymocyte apoptotic process,BP,
14612,GO:0070243,1,0.637258138104931,0,11,regulation of thymocyte apoptotic process,BP,
14613,GO:0070244,1,0.781886125070624,0,6,negative regulation of thymocyte apoptotic process,BP,
14614,GO:0070245,1,0.815110887381556,0,5,positive regulation of thymocyte apoptotic process,BP,
14618,GO:0070256,1,0.963310309890086,0,1,negative regulation of mucus secretion,BP,
14620,GO:0070259,1,0.91787829033311,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
14621,GO:0070260,1,0.958787867083198,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14625,GO:0070267,1,0.957411666793377,0,1,oncosis,BP,
14627,GO:0070269,1,0.728306921927481,0,8,pyroptosis,BP,
14629,GO:0070274,1,0.926488676867269,0,2,RES complex,CC,
14630,GO:0070278,1,0.920395861126642,0,2,extracellular matrix constituent secretion,BP,
14632,GO:0070280,1,0.95712201154618,0,1,pyridoxal binding,MF,
14633,GO:0070283,1,0.962883723522496,0,1,radical SAM enzyme activity,MF,
14634,GO:0070286,1,0.629671617237762,0,11,axonemal dynein complex assembly,BP,
14635,GO:0070288,1,0.930509802352436,0,2,ferritin complex,CC,
14636,GO:0070290,1,0.80682613637603,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
14637,GO:0070291,1,0.846180239748461,0,4,N-acylethanolamine metabolic process,BP,
14638,GO:0070292,1,0.917036862644414,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
14639,GO:0070293,1,0.610857207787061,0,12,renal absorption,BP,
14640,GO:0070294,1,0.844569912301737,0,4,renal sodium ion absorption,BP,
14641,GO:0070295,1,0.885967785280718,0,3,renal water absorption,BP,
14642,GO:0070296,1,0.495553556897521,0,17,sarcoplasmic reticulum calcium ion transport,BP,
14648,GO:0070305,1,0.875407191654746,0,3,response to cGMP,BP,
14649,GO:0070306,1,0.465010433717567,0,18,lens fiber cell differentiation,BP,
14650,GO:0070307,1,0.717362635077861,0,8,lens fiber cell development,BP,
14651,GO:0070309,1,0.881212350597538,0,3,lens fiber cell morphogenesis,BP,
14652,GO:0070314,1,0.808663145002675,0,5,G1 to G0 transition,BP,
14653,GO:0070315,1,0.917850016120511,0,2,G1 to G0 transition involved in cell differentiation,BP,
14656,GO:0070318,1,0.84889072760654,0,4,positive regulation of G0 to G1 transition,BP,
14657,GO:0070320,1,0.9594314943995,0,1,inward rectifier potassium channel inhibitor activity,MF,
14661,GO:0070327,1,0.877610048283432,0,3,thyroid hormone transport,BP,
14663,GO:0070329,1,0.922068113727459,0,2,tRNA seleno-modification,BP,
14664,GO:0070330,1,0.750157711761441,0,7,aromatase activity,MF,
14665,GO:0070335,1,0.956441843839217,0,1,aspartate binding,MF,
14666,GO:0070336,1,0.917021318947511,0,2,flap-structured DNA binding,MF,
14667,GO:0070337,1,0.956441843839217,0,1,3'-flap-structured DNA binding,MF,
14668,GO:0070339,1,0.881651952118596,0,3,response to bacterial lipopeptide,BP,
14669,GO:0070340,1,0.915981524972829,0,2,detection of bacterial lipopeptide,BP,
14670,GO:0070341,1,0.773117156319911,0,6,fat cell proliferation,BP,
14671,GO:0070343,1,0.956739518605692,0,1,white fat cell proliferation,BP,
14672,GO:0070344,1,0.773117156319911,0,6,regulation of fat cell proliferation,BP,
14673,GO:0070345,1,0.842387948274585,0,4,negative regulation of fat cell proliferation,BP,
14674,GO:0070346,1,0.959299384807479,0,1,positive regulation of fat cell proliferation,BP,
14675,GO:0070350,1,0.956739518605692,0,1,regulation of white fat cell proliferation,BP,
14676,GO:0070358,1,0.81638404130604,0,5,actin polymerization-dependent cell motility,BP,
14677,GO:0070365,1,0.71910886930245,0,8,hepatocyte differentiation,BP,
14678,GO:0070369,1,0.876517356682633,0,3,beta-catenin-TCF7L2 complex,CC,
14679,GO:0070370,1,0.823358957964512,0,5,cellular heat acclimation,BP,
14684,GO:0070375,1,0.880755122916807,0,3,ERK5 cascade,BP,
14685,GO:0070376,1,0.958777200909209,0,1,regulation of ERK5 cascade,BP,
14686,GO:0070377,1,0.958777200909209,0,1,negative regulation of ERK5 cascade,BP,
14687,GO:0070381,1,0.916651186582713,0,2,endosome to plasma membrane transport vesicle,CC,
14689,GO:0070383,1,0.756423213643437,0,7,DNA cytosine deamination,BP,
14691,GO:0070390,1,0.962762781917351,0,1,transcription export complex 2,CC,
14692,GO:0070391,1,0.81226499481737,0,5,response to lipoteichoic acid,BP,
14693,GO:0070401,1,0.925295167934008,0,2,NADP+ binding,MF,
14696,GO:0070404,1,0.892525525266325,0,3,NADH binding,MF,
14697,GO:0070405,1,0.333524158111419,0,27,ammonium ion binding,MF,
14698,GO:0070407,1,0.958228785475146,0,1,oxidation-dependent protein catabolic process,BP,
14699,GO:0070408,1,0.956441844511705,0,1,carbamoyl phosphate metabolic process,BP,
14700,GO:0070409,1,0.956441844511705,0,1,carbamoyl phosphate biosynthetic process,BP,
14701,GO:0070410,1,0.739177590066754,0,7,co-SMAD binding,MF,
14704,GO:0070413,1,0.958618969707619,0,1,trehalose metabolism in response to stress,BP,
14706,GO:0070418,1,0.956461580693985,0,1,DNA-dependent protein kinase complex,CC,
14707,GO:0070419,1,0.746541050514444,0,7,nonhomologous end joining complex,CC,
14711,GO:0070426,1,0.921787800566082,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14718,GO:0070434,1,0.921787800566082,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14720,GO:0070436,1,0.916502298582793,0,2,Grb2-EGFR complex,CC,
14723,GO:0070446,1,0.961965560697168,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
14725,GO:0070458,1,0.88950346529638,0,3,cellular detoxification of nitrogen compound,BP,
14727,GO:0070460,1,0.957076563173688,0,1,thyroid-stimulating hormone secretion,BP,
14728,GO:0070461,1,0.341470944944116,0,26,SAGA-type complex,CC,
14729,GO:0070463,1,0.957576765771008,0,1,tubulin-dependent ATPase activity,MF,
14732,GO:0070471,1,0.877363620259841,0,3,uterine smooth muscle contraction,BP,
14733,GO:0070472,1,0.877363620259841,0,3,regulation of uterine smooth muscle contraction,BP,
14734,GO:0070474,1,0.877363620259841,0,3,positive regulation of uterine smooth muscle contraction,BP,
14735,GO:0070475,1,0.701071152531386,0,9,rRNA base methylation,BP,
14736,GO:0070476,1,0.965721208065227,0,1,rRNA (guanine-N7)-methylation,BP,
14737,GO:0070478,1,0.956805492646736,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
14738,GO:0070481,1,0.958724409862917,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14740,GO:0070483,1,0.958097431883921,0,1,detection of hypoxia,BP,
14741,GO:0070486,1,0.664761585309357,0,10,leukocyte aggregation,BP,
14742,GO:0070487,1,0.844686745776335,0,4,monocyte aggregation,BP,
14743,GO:0070488,1,0.932970265087225,0,2,neutrophil aggregation,BP,
14744,GO:0070489,1,0.956975961196286,0,1,T cell aggregation,BP,
14746,GO:0070492,1,0.851442977543896,0,4,oligosaccharide binding,MF,
14748,GO:0070494,1,0.882540942491188,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14749,GO:0070495,1,0.882540942491188,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
14751,GO:0070506,1,0.959392282604984,0,1,high-density lipoprotein particle receptor activity,MF,
14753,GO:0070508,1,0.814838567430916,0,5,cholesterol import,BP,
14755,GO:0070510,1,0.956441843839217,0,1,regulation of histone H4-K20 methylation,BP,
14756,GO:0070512,1,0.956441843839217,0,1,positive regulation of histone H4-K20 methylation,BP,
14757,GO:0070513,1,0.725002440988886,0,8,death domain binding,MF,
14758,GO:0070522,1,0.844418033725368,0,4,ERCC4-ERCC1 complex,CC,
14760,GO:0070525,1,0.595877249030308,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
14764,GO:0070531,1,0.809683034787471,0,5,BRCA1-A complex,CC,
14765,GO:0070534,1,0.189407651136369,0,40,protein K63-linked ubiquitination,BP,
14766,GO:0070535,1,0.807136877169453,0,5,histone H2A K63-linked ubiquitination,BP,
14768,GO:0070537,1,0.881947437505273,0,3,histone H2A K63-linked deubiquitination,BP,
14769,GO:0070538,1,0.96365364851103,0,1,oleic acid binding,MF,
14770,GO:0070539,1,0.957514599287353,0,1,linoleic acid binding,MF,
14773,GO:0070544,1,0.704024906915915,0,8,histone H3-K36 demethylation,BP,
14774,GO:0070545,1,0.848010164973091,0,4,PeBoW complex,CC,
14775,GO:0070548,1,0.956441843839217,0,1,L-glutamine aminotransferase activity,MF,
14776,GO:0070550,1,0.956441843839217,0,1,rDNA condensation,BP,
14777,GO:0070551,1,0.958787867083198,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14778,GO:0070552,1,0.883354232944492,0,3,BRISC complex,CC,
14779,GO:0070553,1,0.958787867083198,0,1,nicotinic acid receptor activity,MF,
14781,GO:0070557,1,0.926340180905715,0,2,PCNA-p21 complex,CC,
14783,GO:0070561,1,0.682860747392006,0,9,vitamin D receptor signaling pathway,BP,
14784,GO:0070562,1,0.776739171734398,0,6,regulation of vitamin D receptor signaling pathway,BP,
14785,GO:0070563,1,0.919580090339918,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
14786,GO:0070564,1,0.922872708295286,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
14788,GO:0070567,1,0.692323965389522,0,9,cytidylyltransferase activity,MF,
14789,GO:0070568,1,0.813833285345677,0,5,guanylyltransferase activity,MF,
14790,GO:0070569,1,0.74772265956299,0,7,uridylyltransferase activity,MF,
14793,GO:0070572,1,0.852891768341345,0,4,positive regulation of neuron projection regeneration,BP,
14794,GO:0070573,1,0.958787867083198,0,1,metallodipeptidase activity,MF,
14795,GO:0070574,1,0.881536342490456,0,3,cadmium ion transmembrane transport,BP,
14796,GO:0070576,1,0.919440192727053,0,2,vitamin D 24-hydroxylase activity,MF,
14797,GO:0070577,1,0.497331777355321,0,16,lysine-acetylated histone binding,MF,
14798,GO:0070578,1,0.690118061816191,0,9,RISC-loading complex,CC,
14800,GO:0070584,1,0.426100677123472,0,21,mitochondrion morphogenesis,BP,
14802,GO:0070586,1,0.722757184020954,0,8,cell-cell adhesion involved in gastrulation,BP,
14803,GO:0070587,1,0.753411063438121,0,7,regulation of cell-cell adhesion involved in gastrulation,BP,
14805,GO:0070589,1,0.962561648789528,0,1,cellular component macromolecule biosynthetic process,BP,
14806,GO:0070593,1,0.956441843839217,0,1,dendrite self-avoidance,BP,
14807,GO:0070601,1,0.717375077169585,0,8,centromeric sister chromatid cohesion,BP,
14808,GO:0070602,1,0.884568193964831,0,3,regulation of centromeric sister chromatid cohesion,BP,
14810,GO:0070611,1,0.959541183720232,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14811,GO:0070612,1,0.959541183720232,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
14814,GO:0070618,1,0.959379796465619,0,1,Grb2-Sos complex,CC,
14815,GO:0070625,1,0.961486816800273,0,1,zymogen granule exocytosis,BP,
14816,GO:0070626,1,0.963482675636237,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
14817,GO:0070627,1,0.956819476805938,0,1,ferrous iron import,BP,
14818,GO:0070628,1,0.487044866721544,0,18,proteasome binding,MF,
14819,GO:0070631,1,0.958787867083198,0,1,spindle pole body localization,BP,
14820,GO:0070632,1,0.958787867083198,0,1,establishment of spindle pole body localization,BP,
14821,GO:0070633,1,0.659363660096887,0,10,transepithelial transport,BP,
14822,GO:0070634,1,0.885369465753398,0,3,transepithelial ammonium transport,BP,
14823,GO:0070637,1,0.96029277657686,0,1,pyridine nucleoside metabolic process,BP,
14824,GO:0070638,1,0.96029277657686,0,1,pyridine nucleoside catabolic process,BP,
14825,GO:0070640,1,0.884292164877297,0,3,vitamin D3 metabolic process,BP,
14826,GO:0070643,1,0.963071508807238,0,1,vitamin D 25-hydroxylase activity,MF,
14827,GO:0070644,1,0.875309106660816,0,3,vitamin D response element binding,MF,
14830,GO:0070649,1,0.916233541586086,0,2,formin-nucleated actin cable assembly,BP,
14831,GO:0070650,1,0.958787867083198,0,1,actin filament bundle distribution,BP,
14832,GO:0070651,1,0.958724409862917,0,1,nonfunctional rRNA decay,BP,
14833,GO:0070652,1,0.721138764996784,0,8,HAUS complex,CC,
14835,GO:0070662,1,0.916616615922345,0,2,mast cell proliferation,BP,
14839,GO:0070666,1,0.916616615922345,0,2,regulation of mast cell proliferation,BP,
14840,GO:0070667,1,0.958359748824633,0,1,negative regulation of mast cell proliferation,BP,
14841,GO:0070668,1,0.916616615922345,0,2,positive regulation of mast cell proliferation,BP,
14842,GO:0070669,1,0.707643444424832,0,8,response to interleukin-2,BP,
14843,GO:0070670,1,0.328779592864918,0,27,response to interleukin-4,BP,
14844,GO:0070671,1,0.18511244290487,0,42,response to interleukin-12,BP,
14845,GO:0070672,1,0.680702764781379,0,9,response to interleukin-15,BP,
14846,GO:0070673,1,0.691478976207477,0,9,response to interleukin-18,BP,
14847,GO:0070676,1,0.891298718984753,0,3,intralumenal vesicle formation,BP,
14848,GO:0070678,1,0.959401666939977,0,1,preprotein binding,MF,
14849,GO:0070679,1,0.7663190021841,0,6,inositol 1,4,5 trisphosphate binding,MF,
14850,GO:0070681,1,0.886289612020985,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
14851,GO:0070682,1,0.886253700219357,0,3,proteasome regulatory particle assembly,BP,
14852,GO:0070685,1,0.961376794565665,0,1,macropinocytic cup,CC,
14853,GO:0070694,1,0.958787867083198,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
14854,GO:0070695,1,0.807765543276618,0,5,FHF complex,CC,
14855,GO:0070696,1,0.659386962269319,0,10,transmembrane receptor protein serine/threonine kinase binding,MF,
14856,GO:0070697,1,0.919292003082917,0,2,activin receptor binding,MF,
14857,GO:0070699,1,0.919292003082917,0,2,type II activin receptor binding,MF,
14858,GO:0070700,1,0.717318048978307,0,8,BMP receptor binding,MF,
14859,GO:0070704,1,0.917239804830104,0,2,sterol desaturase activity,MF,
14860,GO:0070715,1,0.957908533970339,0,1,sodium-dependent organic cation transport,BP,
14861,GO:0070717,1,0.409135704812897,0,21,poly-purine tract binding,MF,
14862,GO:0070723,1,0.481550900125187,0,17,response to cholesterol,BP,
14863,GO:0070724,1,0.958174913278171,0,1,BMP receptor complex,CC,
14865,GO:0070728,1,0.773756231595618,0,6,leucine binding,MF,
14866,GO:0070733,1,0.962967973676731,0,1,protein adenylyltransferase activity,MF,
14867,GO:0070734,1,0.473070726503012,0,18,histone H3-K27 methylation,BP,
14868,GO:0070735,1,0.957682493305144,0,1,protein-glycine ligase activity,MF,
14869,GO:0070736,1,0.957682493305144,0,1,protein-glycine ligase activity, initiating,MF,
14870,GO:0070739,1,0.775429961529797,0,6,protein-glutamic acid ligase activity,MF,
14871,GO:0070740,1,0.775429961529797,0,6,tubulin-glutamic acid ligase activity,MF,
14873,GO:0070742,1,0.604385448076091,0,12,C2H2 zinc finger domain binding,MF,
14874,GO:0070743,1,0.964663526577009,0,1,interleukin-23 complex,CC,
14876,GO:0070761,1,0.787522545534995,0,6,pre-snoRNP complex,CC,
14877,GO:0070762,1,0.958787867083198,0,1,nuclear pore transmembrane ring,CC,
14878,GO:0070765,1,0.779443538217955,0,6,gamma-secretase complex,CC,
14879,GO:0070772,1,0.958261705971806,0,1,PAS complex,CC,
14880,GO:0070773,1,0.96385658117475,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
14881,GO:0070774,1,0.956684152238897,0,1,phytoceramidase activity,MF,
14882,GO:0070775,1,0.739599846947791,0,7,H3 histone acetyltransferase complex,CC,
14883,GO:0070776,1,0.739599846947791,0,7,MOZ/MORF histone acetyltransferase complex,CC,
14884,GO:0070777,1,0.916011342091385,0,2,D-aspartate transport,BP,
14885,GO:0070778,1,0.84177426499984,0,4,L-aspartate transmembrane transport,BP,
14886,GO:0070779,1,0.916011342091385,0,2,D-aspartate import across plasma membrane,BP,
14887,GO:0070780,1,0.923629192803943,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
14888,GO:0070781,1,0.956441843839217,0,1,response to biotin,BP,
14889,GO:0070782,1,0.961215989786638,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
14890,GO:0070813,1,0.821376969061742,0,5,hydrogen sulfide metabolic process,BP,
14891,GO:0070814,1,0.851312031023448,0,4,hydrogen sulfide biosynthetic process,BP,
14892,GO:0070815,1,0.84164877208106,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
14893,GO:0070816,1,0.539637662453306,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
14894,GO:0070818,1,0.962656304908182,0,1,protoporphyrinogen oxidase activity,MF,
14897,GO:0070822,1,0.554886619559199,0,14,Sin3-type complex,CC,
14898,GO:0070826,1,0.956819476805938,0,1,paraferritin complex,CC,
14902,GO:0070830,1,0.179192070003496,0,40,bicellular tight junction assembly,BP,
14903,GO:0070831,1,0.733733383196458,0,7,basement membrane assembly,BP,
14904,GO:0070836,1,0.883676260107821,0,3,caveola assembly,BP,
14907,GO:0070840,1,0.454222355434899,0,18,dynein complex binding,MF,
14908,GO:0070841,1,0.471633559018797,0,18,inclusion body assembly,BP,
14909,GO:0070842,1,0.876290238869891,0,3,aggresome assembly,BP,
14910,GO:0070843,1,0.956855996245816,0,1,misfolded protein transport,BP,
14911,GO:0070844,1,0.956855996245816,0,1,polyubiquitinated protein transport,BP,
14912,GO:0070845,1,0.956855996245816,0,1,polyubiquitinated misfolded protein transport,BP,
14913,GO:0070846,1,0.956855996245816,0,1,Hsp90 deacetylation,BP,
14914,GO:0070847,1,0.731456228257314,0,8,core mediator complex,CC,
14918,GO:0070852,1,0.880676573910017,0,3,cell body fiber,CC,
14919,GO:0070853,1,0.914777292668164,0,2,myosin VI binding,MF,
14920,GO:0070856,1,0.956441843839217,0,1,myosin VI light chain binding,MF,
14922,GO:0070859,1,0.884164915251046,0,3,positive regulation of bile acid biosynthetic process,BP,
14923,GO:0070860,1,0.960671876208388,0,1,RNA polymerase I core factor complex,CC,
14924,GO:0070861,1,0.448678199154028,0,19,regulation of protein exit from endoplasmic reticulum,BP,
14925,GO:0070862,1,0.660879146879316,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
14926,GO:0070863,1,0.710085345551832,0,8,positive regulation of protein exit from endoplasmic reticulum,BP,
14928,GO:0070874,1,0.805727525863937,0,5,negative regulation of glycogen metabolic process,BP,
14930,GO:0070876,1,0.843142531847371,0,4,SOSS complex,CC,
14931,GO:0070877,1,0.917226977020332,0,2,microprocessor complex,CC,
14932,GO:0070878,1,0.706705950153187,0,8,primary miRNA binding,MF,
14933,GO:0070883,1,0.818233749487025,0,5,pre-miRNA binding,MF,
14935,GO:0070885,1,0.87964394329112,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
14938,GO:0070888,1,0.447338689143444,0,19,E-box binding,MF,
14940,GO:0070890,1,0.956441843839217,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
14941,GO:0070893,1,0.917289845908744,0,2,transposon integration,BP,
14942,GO:0070894,1,0.917289845908744,0,2,regulation of transposon integration,BP,
14943,GO:0070895,1,0.917289845908744,0,2,negative regulation of transposon integration,BP,
14945,GO:0070898,1,0.956441843839217,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
14946,GO:0070899,1,0.958500189320929,0,1,mitochondrial tRNA wobble uridine modification,BP,
14947,GO:0070900,1,0.69876126590185,0,9,mitochondrial tRNA modification,BP,
14948,GO:0070901,1,0.851479174769678,0,4,mitochondrial tRNA methylation,BP,
14949,GO:0070902,1,0.962910855798239,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
14950,GO:0070903,1,0.961887690774097,0,1,mitochondrial tRNA thio-modification,BP,
14951,GO:0070904,1,0.956441843839217,0,1,transepithelial L-ascorbic acid transport,BP,
14955,GO:0070915,1,0.852338297598701,0,4,lysophosphatidic acid receptor activity,MF,
14958,GO:0070922,1,0.685845793575884,0,9,small RNA loading onto RISC,BP,
14960,GO:0070926,1,0.957080602081223,0,1,regulation of ATP:ADP antiporter activity,BP,
14961,GO:0070931,1,0.956441850141088,0,1,Golgi-associated vesicle lumen,CC,
14962,GO:0070932,1,0.430132694449884,0,20,histone H3 deacetylation,BP,
14963,GO:0070933,1,0.682395316314577,0,9,histone H4 deacetylation,BP,
14964,GO:0070934,1,0.842916392333916,0,4,CRD-mediated mRNA stabilization,BP,
14965,GO:0070935,1,0.627723982211717,0,11,3'-UTR-mediated mRNA stabilization,BP,
14967,GO:0070937,1,0.806532742174103,0,5,CRD-mediated mRNA stability complex,CC,
14968,GO:0070938,1,0.626743722069878,0,11,contractile ring,CC,
14969,GO:0070939,1,0.878998632323648,0,3,Dsl1/NZR complex,CC,
14970,GO:0070940,1,0.809694232291081,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
14971,GO:0070942,1,0.852455443703259,0,4,neutrophil mediated cytotoxicity,BP,
14972,GO:0070943,1,0.889579906320497,0,3,neutrophil mediated killing of symbiont cell,BP,
14973,GO:0070944,1,0.923218022628632,0,2,neutrophil mediated killing of bacterium,BP,
14974,GO:0070945,1,0.923218022628632,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
14975,GO:0070947,1,0.96357015028942,0,1,neutrophil mediated killing of fungus,BP,
14976,GO:0070948,1,0.885336669092307,0,3,regulation of neutrophil mediated cytotoxicity,BP,
14977,GO:0070949,1,0.923890051530286,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
14978,GO:0070950,1,0.958822782263901,0,1,regulation of neutrophil mediated killing of bacterium,BP,
14979,GO:0070951,1,0.958822782263901,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
14980,GO:0070953,1,0.96357015028942,0,1,regulation of neutrophil mediated killing of fungus,BP,
14981,GO:0070960,1,0.923890051530286,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
14982,GO:0070961,1,0.923890051530286,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
14983,GO:0070962,1,0.958822782263901,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
14984,GO:0070963,1,0.958822782263901,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
14985,GO:0070965,1,0.96357015028942,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
14986,GO:0070966,1,0.877387593914737,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
14987,GO:0070970,1,0.707493312588986,0,8,interleukin-2 secretion,BP,
14988,GO:0070971,1,0.529470191733313,0,15,endoplasmic reticulum exit site,CC,
14990,GO:0070973,1,0.842833262471583,0,4,protein localization to endoplasmic reticulum exit site,BP,
14991,GO:0070975,1,0.956441843839217,0,1,FHA domain binding,MF,
14992,GO:0070976,1,0.959308595770017,0,1,TIR domain binding,MF,
14994,GO:0070979,1,0.341095239779732,0,27,protein K11-linked ubiquitination,BP,
14995,GO:0070980,1,0.960493715058325,0,1,biphenyl catabolic process,BP,
14996,GO:0070981,1,0.96059686379198,0,1,L-asparagine biosynthetic process,BP,
14997,GO:0070982,1,0.96059686379198,0,1,L-asparagine metabolic process,BP,
14998,GO:0070984,1,0.95682160486535,0,1,SET domain binding,MF,
14999,GO:0070985,1,0.928447558209375,0,2,TFIIK complex,CC,
15000,GO:0070986,1,0.603559009458207,0,12,left/right axis specification,BP,
15001,GO:0070987,1,0.483037317288998,0,18,error-free translesion synthesis,BP,
15004,GO:0070990,1,0.7969168686823,0,6,snRNP binding,MF,
15005,GO:0070991,1,0.881739731914886,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
15006,GO:0070992,1,0.925919347343941,0,2,translation initiation complex,CC,
15007,GO:0070993,1,0.915327185462718,0,2,translation preinitiation complex,CC,
15008,GO:0070995,1,0.95814843902196,0,1,NADPH oxidation,BP,
15010,GO:0071001,1,0.885745350549423,0,3,U4/U6 snRNP,CC,
15011,GO:0071004,1,0.503657562965973,0,17,U2-type prespliceosome,CC,
15012,GO:0071005,1,0.921474296444937,0,2,U2-type precatalytic spliceosome,CC,
15013,GO:0071006,1,0.883727611621208,0,3,U2-type catalytic step 1 spliceosome,CC,
15014,GO:0071007,1,0.317229722196922,0,29,U2-type catalytic step 2 spliceosome,CC,
15015,GO:0071008,1,0.849563668652123,0,4,U2-type post-mRNA release spliceosomal complex,CC,
15016,GO:0071010,1,0.413650312976296,0,22,prespliceosome,CC,
15017,GO:0071011,1,0.292032326254365,0,31,precatalytic spliceosome,CC,
15018,GO:0071012,1,0.780775578717172,0,6,catalytic step 1 spliceosome,CC,
15019,GO:0071013,1,0.0200526124571243,0,96,catalytic step 2 spliceosome,CC,
15020,GO:0071014,1,0.694630794397668,0,9,post-mRNA release spliceosomal complex,CC,
15021,GO:0071020,1,0.926760390782102,0,2,post-spliceosomal complex,CC,
15022,GO:0071021,1,0.962775779500479,0,1,U2-type post-spliceosomal complex,CC,
15023,GO:0071025,1,0.557801780458407,0,15,RNA surveillance,BP,
15024,GO:0071026,1,0.960050111061931,0,1,cytoplasmic RNA surveillance,BP,
15025,GO:0071027,1,0.606081147051141,0,13,nuclear RNA surveillance,BP,
15026,GO:0071028,1,0.606081147051141,0,13,nuclear mRNA surveillance,BP,
15027,GO:0071029,1,0.795574320132323,0,6,nuclear ncRNA surveillance,BP,
15028,GO:0071030,1,0.923376944843559,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15029,GO:0071031,1,0.926851347424836,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15030,GO:0071033,1,0.823944054857968,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15031,GO:0071034,1,0.850190877949775,0,4,CUT catabolic process,BP,
15032,GO:0071035,1,0.795574320132323,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15033,GO:0071038,1,0.829530651893335,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15034,GO:0071042,1,0.856152823051405,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15035,GO:0071043,1,0.850190877949775,0,4,CUT metabolic process,BP,
15036,GO:0071044,1,0.630525163239995,0,11,histone mRNA catabolic process,BP,
15037,GO:0071045,1,0.962983758604616,0,1,nuclear histone mRNA catabolic process,BP,
15038,GO:0071046,1,0.795574320132323,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15039,GO:0071047,1,0.856152823051405,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15040,GO:0071048,1,0.923376944843559,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
15041,GO:0071049,1,0.926851347424836,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
15042,GO:0071051,1,0.830820800037807,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
15043,GO:0071062,1,0.956753008581892,0,1,alphav-beta3 integrin-vitronectin complex,CC,
15044,GO:0071065,1,0.958170656814958,0,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15046,GO:0071072,1,0.842627401829867,0,4,negative regulation of phospholipid biosynthetic process,BP,
15048,GO:0071074,1,0.962088650047961,0,1,eukaryotic initiation factor eIF2 binding,MF,
15049,GO:0071077,1,0.883679680693187,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15051,GO:0071104,1,0.914810517113138,0,2,response to interleukin-9,BP,
15052,GO:0071105,1,0.956531193505775,0,1,response to interleukin-11,BP,
15053,GO:0071106,1,0.883679680693187,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15054,GO:0071107,1,0.876553144901621,0,3,response to parathyroid hormone,BP,
15056,GO:0071109,1,0.914777292668164,0,2,superior temporal gyrus development,BP,
15057,GO:0071110,1,0.956441843839217,0,1,histone biotinylation,BP,
15058,GO:0071133,1,0.958170656814958,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
15059,GO:0071139,1,0.917837824224154,0,2,resolution of recombination intermediates,BP,
15060,GO:0071140,1,0.917837824224154,0,2,resolution of mitotic recombination intermediates,BP,
15061,GO:0071141,1,0.736264824240503,0,7,SMAD protein complex,CC,
15062,GO:0071144,1,0.914777292668164,0,2,heteromeric SMAD protein complex,CC,
15063,GO:0071148,1,0.914786878809206,0,2,TEAD-1-YAP complex,CC,
15064,GO:0071149,1,0.919318927382611,0,2,TEAD-2-YAP complex,CC,
15066,GO:0071157,1,0.483597615829941,0,18,negative regulation of cell cycle arrest,BP,
15068,GO:0071159,1,0.926271654209175,0,2,NF-kappaB complex,CC,
15069,GO:0071163,1,0.889964004305535,0,3,DNA replication preinitiation complex assembly,BP,
15070,GO:0071164,1,0.957268910753779,0,1,RNA trimethylguanosine synthase activity,MF,
15072,GO:0071168,1,0.403854408567278,0,22,protein localization to chromatin,BP,
15073,GO:0071169,1,0.730566516431919,0,8,establishment of protein localization to chromatin,BP,
15074,GO:0071173,1,0.305105538683262,0,29,spindle assembly checkpoint,BP,
15075,GO:0071174,1,0.305105538683262,0,29,mitotic spindle checkpoint,BP,
15076,GO:0071203,1,0.776027135700766,0,6,WASH complex,CC,
15077,GO:0071204,1,0.785451448798767,0,6,histone pre-mRNA 3'end processing complex,CC,
15079,GO:0071207,1,0.920913744170728,0,2,histone pre-mRNA stem-loop binding,MF,
15080,GO:0071208,1,0.863713812033933,0,4,histone pre-mRNA DCP binding,MF,
15081,GO:0071209,1,0.892739354113597,0,3,U7 snRNA binding,MF,
15084,GO:0071215,1,0.956704721962182,0,1,cellular response to abscisic acid stimulus,BP,
15086,GO:0071218,1,0.431352166604553,0,20,cellular response to misfolded protein,BP,
15088,GO:0071220,1,0.881651952118596,0,3,cellular response to bacterial lipoprotein,BP,
15089,GO:0071221,1,0.881651952118596,0,3,cellular response to bacterial lipopeptide,BP,
15091,GO:0071223,1,0.81226499481737,0,5,cellular response to lipoteichoic acid,BP,
15092,GO:0071224,1,0.881098371489611,0,3,cellular response to peptidoglycan,BP,
15093,GO:0071225,1,0.840303248292444,0,4,cellular response to muramyl dipeptide,BP,
15094,GO:0071226,1,0.956479002849494,0,1,cellular response to molecule of fungal origin,BP,
15095,GO:0071228,1,0.958693164439256,0,1,cellular response to tumor cell,BP,
15098,GO:0071233,1,0.707001656194334,0,8,cellular response to leucine,BP,
15101,GO:0071242,1,0.253957368427531,0,33,cellular response to ammonium ion,BP,
15103,GO:0071245,1,0.957338819219958,0,1,cellular response to carbon monoxide,BP,
15104,GO:0071247,1,0.964528097000344,0,1,cellular response to chromate,BP,
15106,GO:0071253,1,0.807234660557758,0,5,connexin binding,MF,
15107,GO:0071256,1,0.863124297606178,0,4,translocon complex,CC,
15108,GO:0071257,1,0.805444674002699,0,5,cellular response to electrical stimulus,BP,
15109,GO:0071258,1,0.956842221697132,0,1,cellular response to gravity,BP,
15113,GO:0071265,1,0.757612775036709,0,7,L-methionine biosynthetic process,BP,
15114,GO:0071266,1,0.96265960442676,0,1,'de novo' L-methionine biosynthetic process,BP,
15115,GO:0071267,1,0.787014396224325,0,6,L-methionine salvage,BP,
15116,GO:0071268,1,0.960725599208896,0,1,homocysteine biosynthetic process,BP,
15117,GO:0071275,1,0.961237681137074,0,1,cellular response to aluminum ion,BP,
15120,GO:0071279,1,0.850943533821597,0,4,cellular response to cobalt ion,BP,
15122,GO:0071281,1,0.787442373654502,0,6,cellular response to iron ion,BP,
15123,GO:0071283,1,0.927602623477648,0,2,cellular response to iron(III) ion,BP,
15124,GO:0071284,1,0.839488375048542,0,4,cellular response to lead ion,BP,
15126,GO:0071286,1,0.914844434506283,0,2,cellular response to magnesium ion,BP,
15127,GO:0071287,1,0.776348346163686,0,6,cellular response to manganese ion,BP,
15131,GO:0071301,1,0.956441843839217,0,1,cellular response to vitamin B1,BP,
15133,GO:0071306,1,0.920359757929115,0,2,cellular response to vitamin E,BP,
15136,GO:0071312,1,0.455581088064242,0,19,cellular response to alkaloid,BP,
15137,GO:0071313,1,0.921888226340834,0,2,cellular response to caffeine,BP,
15138,GO:0071314,1,0.959043316010659,0,1,cellular response to cocaine,BP,
15139,GO:0071315,1,0.880715833745789,0,3,cellular response to morphine,BP,
15140,GO:0071316,1,0.816663849459282,0,5,cellular response to nicotine,BP,
15141,GO:0071317,1,0.880715833745789,0,3,cellular response to isoquinoline alkaloid,BP,
15142,GO:0071318,1,0.637756798295946,0,11,cellular response to ATP,BP,
15144,GO:0071321,1,0.875407191654746,0,3,cellular response to cGMP,BP,
15146,GO:0071324,1,0.956483797008087,0,1,cellular response to disaccharide stimulus,BP,
15148,GO:0071329,1,0.956483797008087,0,1,cellular response to sucrose stimulus,BP,
15150,GO:0071332,1,0.923452770406354,0,2,cellular response to fructose stimulus,BP,
15152,GO:0071335,1,0.961172605270695,0,1,hair follicle cell proliferation,BP,
15153,GO:0071336,1,0.961172605270695,0,1,regulation of hair follicle cell proliferation,BP,
15154,GO:0071338,1,0.961172605270695,0,1,positive regulation of hair follicle cell proliferation,BP,
15157,GO:0071344,1,0.928443519041282,0,2,diphosphate metabolic process,BP,
15161,GO:0071348,1,0.956531193505775,0,1,cellular response to interleukin-11,BP,
15162,GO:0071349,1,0.201284618907132,0,40,cellular response to interleukin-12,BP,
15163,GO:0071350,1,0.711711718344405,0,8,cellular response to interleukin-15,BP,
15164,GO:0071351,1,0.784161538149608,0,6,cellular response to interleukin-18,BP,
15165,GO:0071352,1,0.707643444424832,0,8,cellular response to interleukin-2,BP,
15166,GO:0071353,1,0.343776511930992,0,26,cellular response to interleukin-4,BP,
15168,GO:0071355,1,0.914810517113138,0,2,cellular response to interleukin-9,BP,
15172,GO:0071360,1,0.611485267491657,0,12,cellular response to exogenous dsRNA,BP,
15177,GO:0071371,1,0.574334623072016,0,13,cellular response to gonadotropin stimulus,BP,
15178,GO:0071372,1,0.711285769749397,0,8,cellular response to follicle-stimulating hormone stimulus,BP,
15179,GO:0071373,1,0.920136117046154,0,2,cellular response to luteinizing hormone stimulus,BP,
15180,GO:0071374,1,0.916480298007547,0,2,cellular response to parathyroid hormone stimulus,BP,
15182,GO:0071376,1,0.959675810896307,0,1,cellular response to corticotropin-releasing hormone stimulus,BP,
15183,GO:0071377,1,0.383084895610408,0,23,cellular response to glucagon stimulus,BP,
15190,GO:0071386,1,0.914777292668164,0,2,cellular response to corticosterone stimulus,BP,
15191,GO:0071387,1,0.956458937738547,0,1,cellular response to cortisol stimulus,BP,
15192,GO:0071389,1,0.781638833797311,0,6,cellular response to mineralocorticoid stimulus,BP,
15195,GO:0071393,1,0.956908931262264,0,1,cellular response to progesterone stimulus,BP,
15196,GO:0071394,1,0.745394692953226,0,7,cellular response to testosterone stimulus,BP,
15197,GO:0071395,1,0.928527892364252,0,2,cellular response to jasmonic acid stimulus,BP,
15199,GO:0071397,1,0.621240564974765,0,11,cellular response to cholesterol,BP,
15201,GO:0071400,1,0.918324256286871,0,2,cellular response to oleic acid,BP,
15202,GO:0071401,1,0.960734563591107,0,1,cellular response to triglyceride,BP,
15204,GO:0071403,1,0.91775214003723,0,2,cellular response to high density lipoprotein particle stimulus,BP,
15205,GO:0071404,1,0.600517428187041,0,12,cellular response to low-density lipoprotein particle stimulus,BP,
15207,GO:0071409,1,0.916923309712333,0,2,cellular response to cycloheximide,BP,
15208,GO:0071415,1,0.921888226340834,0,2,cellular response to purine-containing compound,BP,
15211,GO:0071420,1,0.915023984936219,0,2,cellular response to histamine,BP,
15212,GO:0071421,1,0.915734380651393,0,2,manganese ion transmembrane transport,BP,
15214,GO:0071423,1,0.962165461126179,0,1,malate transmembrane transport,BP,
15215,GO:0071424,1,0.958787867083198,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15216,GO:0071425,1,0.551205314870355,0,14,hematopoietic stem cell proliferation,BP,
15219,GO:0071428,1,0.55334666756156,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15220,GO:0071431,1,0.259593233035309,0,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
15221,GO:0071435,1,0.878555427167879,0,3,potassium ion export,BP,
15222,GO:0071437,1,0.572600945017798,0,13,invadopodium,CC,
15223,GO:0071438,1,0.846066587172174,0,4,invadopodium membrane,CC,
15225,GO:0071440,1,0.809685596442277,0,5,regulation of histone H3-K14 acetylation,BP,
15226,GO:0071441,1,0.957104703318769,0,1,negative regulation of histone H3-K14 acetylation,BP,
15227,GO:0071442,1,0.882359649048966,0,3,positive regulation of histone H3-K14 acetylation,BP,
15229,GO:0071449,1,0.964964371431061,0,1,cellular response to lipid hydroperoxide,BP,
15230,GO:0071450,1,0.490900400530501,0,18,cellular response to oxygen radical,BP,
15231,GO:0071451,1,0.490900400530501,0,18,cellular response to superoxide,BP,
15233,GO:0071454,1,0.956441843839217,0,1,cellular response to anoxia,BP,
15237,GO:0071459,1,0.440932341963843,0,20,protein localization to chromosome, centromeric region,BP,
15238,GO:0071460,1,0.929501842615384,0,2,cellular response to cell-matrix adhesion,BP,
15239,GO:0071461,1,0.92471111002716,0,2,cellular response to redox state,BP,
15246,GO:0071471,1,0.956633402815242,0,1,cellular response to non-ionic osmotic stress,BP,
15249,GO:0071475,1,0.887117296596583,0,3,cellular hyperosmotic salinity response,BP,
15258,GO:0071484,1,0.9161699635873,0,2,cellular response to light intensity,BP,
15259,GO:0071485,1,0.957886117614705,0,1,cellular response to absence of light,BP,
15260,GO:0071486,1,0.956453524038622,0,1,cellular response to high light intensity,BP,
15261,GO:0071492,1,0.920423935870402,0,2,cellular response to UV-A,BP,
15267,GO:0071499,1,0.7796669918818,0,6,cellular response to laminar fluid shear stress,BP,
15268,GO:0071500,1,0.821810540716843,0,5,cellular response to nitrosative stress,BP,
15269,GO:0071501,1,0.711739080886311,0,8,cellular response to sterol depletion,BP,
15270,GO:0071502,1,0.886683583683119,0,3,cellular response to temperature stimulus,BP,
15273,GO:0071505,1,0.918748703180066,0,2,response to mycophenolic acid,BP,
15274,GO:0071506,1,0.918748703180066,0,2,cellular response to mycophenolic acid,BP,
15277,GO:0071528,1,0.957062570331841,0,1,tRNA re-export from nucleus,BP,
15278,GO:0071532,1,0.841645340147826,0,4,ankyrin repeat binding,MF,
15279,GO:0071535,1,0.846608778400289,0,4,RING-like zinc finger domain binding,MF,
15280,GO:0071538,1,0.960668298710852,0,1,SH2 domain-mediated complex assembly,BP,
15281,GO:0071539,1,0.326698381855701,0,26,protein localization to centrosome,BP,
15282,GO:0071540,1,0.956450372256471,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
15283,GO:0071541,1,0.761292081490067,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15285,GO:0071543,1,0.851608970642098,0,4,diphosphoinositol polyphosphate metabolic process,BP,
15286,GO:0071544,1,0.96385658117475,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15288,GO:0071546,1,0.918008357278144,0,2,pi-body,CC,
15289,GO:0071547,1,0.959145611667106,0,1,piP-body,CC,
15292,GO:0071550,1,0.726300752968571,0,8,death-inducing signaling complex assembly,BP,
15293,GO:0071554,1,0.888201376523227,0,3,cell wall organization or biogenesis,BP,
15295,GO:0071557,1,0.802349720666596,0,5,histone H3-K27 demethylation,BP,
15296,GO:0071558,1,0.802349720666596,0,5,histone demethylase activity (H3-K27 specific),MF,
15299,GO:0071561,1,0.956476281023412,0,1,nucleus-vacuole junction,CC,
15300,GO:0071564,1,0.605383318195291,0,12,npBAF complex,CC,
15301,GO:0071565,1,0.599638104000633,0,12,nBAF complex,CC,
15302,GO:0071566,1,0.958641797683102,0,1,UFM1 activating enzyme activity,MF,
15303,GO:0071567,1,0.9266112223622,0,2,UFM1 hydrolase activity,MF,
15304,GO:0071568,1,0.924708417779275,0,2,UFM1 transferase activity,MF,
15305,GO:0071569,1,0.789107327505116,0,6,protein ufmylation,BP,
15306,GO:0071573,1,0.958676373351407,0,1,shelterin complex assembly,BP,
15309,GO:0071579,1,0.96172382065922,0,1,regulation of zinc ion transport,BP,
15310,GO:0071580,1,0.96172382065922,0,1,regulation of zinc ion transmembrane transport,BP,
15311,GO:0071581,1,0.96172382065922,0,1,regulation of zinc ion transmembrane import,BP,
15312,GO:0071582,1,0.96172382065922,0,1,negative regulation of zinc ion transport,BP,
15313,GO:0071583,1,0.96172382065922,0,1,negative regulation of zinc ion transmembrane transport,BP,
15314,GO:0071584,1,0.96172382065922,0,1,negative regulation of zinc ion transmembrane import,BP,
15315,GO:0071585,1,0.96172382065922,0,1,detoxification of cadmium ion,BP,
15316,GO:0071586,1,0.923183943796933,0,2,CAAX-box protein processing,BP,
15317,GO:0071593,1,0.881890510068873,0,3,lymphocyte aggregation,BP,
15318,GO:0071595,1,0.919270839167849,0,2,Nem1-Spo7 phosphatase complex,CC,
15319,GO:0071596,1,0.874932682086448,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
15320,GO:0071598,1,0.813561117107207,0,5,neuronal ribonucleoprotein granule,CC,
15321,GO:0071599,1,0.768320537993994,0,6,otic vesicle development,BP,
15322,GO:0071600,1,0.875854150041817,0,3,otic vesicle morphogenesis,BP,
15323,GO:0071602,1,0.956684152238897,0,1,phytosphingosine biosynthetic process,BP,
15324,GO:0071603,1,0.916049926781165,0,2,endothelial cell-cell adhesion,BP,
15327,GO:0071606,1,0.961845070778084,0,1,chemokine (C-C motif) ligand 4 production,BP,
15330,GO:0071611,1,0.921523258374291,0,2,granulocyte colony-stimulating factor production,BP,
15331,GO:0071612,1,0.956441843839217,0,1,IP-10 production,BP,
15332,GO:0071614,1,0.962269425548233,0,1,linoleic acid epoxygenase activity,MF,
15335,GO:0071619,1,0.96079200104393,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
15338,GO:0071623,1,0.956487499770039,0,1,negative regulation of granulocyte chemotaxis,BP,
15339,GO:0071624,1,0.655342281376428,0,11,positive regulation of granulocyte chemotaxis,BP,
15340,GO:0071625,1,0.618073402013321,0,11,vocalization behavior,BP,
15341,GO:0071629,1,0.962983758604616,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
15342,GO:0071630,1,0.878019385428297,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
15343,GO:0071633,1,0.958893768592492,0,1,dihydroceramidase activity,MF,
15346,GO:0071636,1,0.71257666941818,0,8,positive regulation of transforming growth factor beta production,BP,
15348,GO:0071638,1,0.923029886717133,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
15351,GO:0071641,1,0.92099474851842,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
15353,GO:0071643,1,0.961845070778084,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15354,GO:0071644,1,0.961845070778084,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15356,GO:0071650,1,0.88936566469772,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
15358,GO:0071655,1,0.921523258374291,0,2,regulation of granulocyte colony-stimulating factor production,BP,
15359,GO:0071656,1,0.960618270503813,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
15360,GO:0071657,1,0.959305523469562,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
15361,GO:0071658,1,0.956441843839217,0,1,regulation of IP-10 production,BP,
15362,GO:0071660,1,0.956441843839217,0,1,positive regulation of IP-10 production,BP,
15363,GO:0071664,1,0.839474801663451,0,4,catenin-TCF7L2 complex,CC,
15364,GO:0071665,1,0.957750084148186,0,1,gamma-catenin-TCF7L2 complex,CC,
15365,GO:0071670,1,0.815241262822021,0,5,smooth muscle cell chemotaxis,BP,
15366,GO:0071671,1,0.850773879167348,0,4,regulation of smooth muscle cell chemotaxis,BP,
15367,GO:0071672,1,0.887877204198816,0,3,negative regulation of smooth muscle cell chemotaxis,BP,
15368,GO:0071673,1,0.958221168737547,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
15371,GO:0071676,1,0.919799883285577,0,2,negative regulation of mononuclear cell migration,BP,
15372,GO:0071677,1,0.670835793820195,0,10,positive regulation of mononuclear cell migration,BP,
15373,GO:0071678,1,0.956441843839217,0,1,olfactory bulb axon guidance,BP,
15375,GO:0071680,1,0.80313909648089,0,5,response to indole-3-methanol,BP,
15376,GO:0071681,1,0.80313909648089,0,5,cellular response to indole-3-methanol,BP,
15378,GO:0071684,1,0.957965721664968,0,1,organism emergence from protective structure,BP,
15380,GO:0071691,1,0.956441843839217,0,1,cardiac muscle thin filament assembly,BP,
15384,GO:0071696,1,0.631677232702728,0,11,ectodermal placode development,BP,
15385,GO:0071697,1,0.657988148559607,0,10,ectodermal placode morphogenesis,BP,
15386,GO:0071698,1,0.91597912418791,0,2,olfactory placode development,BP,
15387,GO:0071699,1,0.91597912418791,0,2,olfactory placode morphogenesis,BP,
15388,GO:0071701,1,0.956513196555516,0,1,regulation of MAPK export from nucleus,BP,
15393,GO:0071707,1,0.964077746163258,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
15395,GO:0071711,1,0.519034949492867,0,15,basement membrane organization,BP,
15396,GO:0071712,1,0.632212468622975,0,11,ER-associated misfolded protein catabolic process,BP,
15397,GO:0071713,1,0.956552924507682,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
15398,GO:0071715,1,0.450129260114267,0,19,icosanoid transport,BP,
15399,GO:0071723,1,0.876742934342165,0,3,lipopeptide binding,MF,
15400,GO:0071724,1,0.915981524972829,0,2,response to diacyl bacterial lipopeptide,BP,
15401,GO:0071725,1,0.957700811769664,0,1,response to triacyl bacterial lipopeptide,BP,
15402,GO:0071726,1,0.915981524972829,0,2,cellular response to diacyl bacterial lipopeptide,BP,
15403,GO:0071727,1,0.957700811769664,0,1,cellular response to triacyl bacterial lipopeptide,BP,
15407,GO:0071763,1,0.775425925497655,0,6,nuclear membrane organization,BP,
15408,GO:0071765,1,0.95678917286191,0,1,nuclear inner membrane organization,BP,
15412,GO:0071782,1,0.46965846995458,0,18,endoplasmic reticulum tubular network,CC,
15413,GO:0071786,1,0.534841213033127,0,15,endoplasmic reticulum tubular network organization,BP,
15414,GO:0071787,1,0.848904719554284,0,4,endoplasmic reticulum tubular network formation,BP,
15415,GO:0071789,1,0.958787867083198,0,1,spindle pole body localization to nuclear envelope,BP,
15416,GO:0071790,1,0.958787867083198,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15417,GO:0071796,1,0.964015689650189,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
15419,GO:0071798,1,0.921472596894437,0,2,response to prostaglandin D,BP,
15420,GO:0071799,1,0.921472596894437,0,2,cellular response to prostaglandin D stimulus,BP,
15421,GO:0071800,1,0.52323842837803,0,15,podosome assembly,BP,
15422,GO:0071801,1,0.622059401206009,0,11,regulation of podosome assembly,BP,
15423,GO:0071802,1,0.956803425292439,0,1,negative regulation of podosome assembly,BP,
15424,GO:0071803,1,0.707749085500478,0,8,positive regulation of podosome assembly,BP,
15428,GO:0071812,1,0.958215743141578,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15431,GO:0071816,1,0.853134015370387,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
15432,GO:0071817,1,0.819178525811148,0,5,MMXD complex,CC,
15433,GO:0071818,1,0.885577830222718,0,3,BAT3 complex,CC,
15434,GO:0071819,1,0.924580034300061,0,2,DUBm complex,CC,
15435,GO:0071820,1,0.96356435360397,0,1,N-box binding,MF,
15436,GO:0071821,1,0.956441843839217,0,1,FANCM-MHF complex,CC,
15442,GO:0071837,1,0.713140777201562,0,8,HMG box domain binding,MF,
15444,GO:0071839,1,0.85055350235744,0,4,apoptotic process in bone marrow,BP,
15446,GO:0071847,1,0.916657638761946,0,2,TNFSF11-mediated signaling pathway,BP,
15447,GO:0071848,1,0.958215743141578,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
15448,GO:0071850,1,0.561182926952289,0,14,mitotic cell cycle arrest,BP,
15452,GO:0071865,1,0.847668491707391,0,4,regulation of apoptotic process in bone marrow,BP,
15453,GO:0071866,1,0.847668491707391,0,4,negative regulation of apoptotic process in bone marrow,BP,
15454,GO:0071867,1,0.36349685962608,0,24,response to monoamine,BP,
15455,GO:0071868,1,0.37839672033926,0,23,cellular response to monoamine stimulus,BP,
15456,GO:0071869,1,0.36349685962608,0,24,response to catecholamine,BP,
15457,GO:0071870,1,0.37839672033926,0,23,cellular response to catecholamine stimulus,BP,
15458,GO:0071871,1,0.685456402087475,0,9,response to epinephrine,BP,
15459,GO:0071872,1,0.713516247700559,0,8,cellular response to epinephrine stimulus,BP,
15460,GO:0071873,1,0.957575217996036,0,1,response to norepinephrine,BP,
15461,GO:0071874,1,0.957575217996036,0,1,cellular response to norepinephrine stimulus,BP,
15462,GO:0071875,1,0.627010537470975,0,11,adrenergic receptor signaling pathway,BP,
15463,GO:0071877,1,0.96385658117475,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15464,GO:0071878,1,0.956441843839217,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15465,GO:0071879,1,0.879549376626959,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15466,GO:0071880,1,0.707452628182383,0,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15467,GO:0071881,1,0.96385658117475,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15468,GO:0071885,1,0.958787867083198,0,1,N-terminal protein N-methyltransferase activity,MF,
15472,GO:0071893,1,0.962531515651986,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15473,GO:0071894,1,0.920592422969157,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
15475,GO:0071896,1,0.83683184945649,0,4,protein localization to adherens junction,BP,
15477,GO:0071898,1,0.88368432331404,0,3,regulation of estrogen receptor binding,BP,
15478,GO:0071899,1,0.88368432331404,0,3,negative regulation of estrogen receptor binding,BP,
15482,GO:0071907,1,0.881951991084554,0,3,determination of digestive tract left/right asymmetry,BP,
15483,GO:0071908,1,0.956446954086774,0,1,determination of intestine left/right asymmetry,BP,
15484,GO:0071909,1,0.956446954086774,0,1,determination of stomach left/right asymmetry,BP,
15486,GO:0071914,1,0.957108347912133,0,1,prominosome,CC,
15487,GO:0071918,1,0.917072420421157,0,2,urea transmembrane transport,BP,
15488,GO:0071920,1,0.922515275406479,0,2,cleavage body,CC,
15489,GO:0071921,1,0.776592617681174,0,6,cohesin loading,BP,
15490,GO:0071922,1,0.809988062685798,0,5,regulation of cohesin loading,BP,
15491,GO:0071926,1,0.88132289036229,0,3,endocannabinoid signaling pathway,BP,
15492,GO:0071929,1,0.918730578934878,0,2,alpha-tubulin acetylation,BP,
15493,GO:0071930,1,0.87765518597148,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15494,GO:0071931,1,0.958787867083198,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15495,GO:0071933,1,0.742869179834797,0,7,Arp2/3 complex binding,MF,
15496,GO:0071934,1,0.921908036876841,0,2,thiamine transmembrane transport,BP,
15498,GO:0071941,1,0.641457029461644,0,11,nitrogen cycle metabolic process,BP,
15503,GO:0071951,1,0.959193269451407,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
15504,GO:0071953,1,0.920880022754427,0,2,elastic fiber,CC,
15505,GO:0071955,1,0.914837007941864,0,2,recycling endosome to Golgi transport,BP,
15506,GO:0071960,1,0.965034687154615,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
15507,GO:0071962,1,0.889164425782547,0,3,mitotic sister chromatid cohesion, centromeric,BP,
15509,GO:0071971,1,0.780347848513384,0,6,extracellular exosome assembly,BP,
15511,GO:0071986,1,0.777662284571322,0,6,Ragulator complex,CC,
15512,GO:0071987,1,0.841633071884536,0,4,WD40-repeat domain binding,MF,
15513,GO:0071988,1,0.956441843839217,0,1,protein localization to spindle pole body,BP,
15516,GO:0072003,1,0.957076563173688,0,1,kidney rudiment formation,BP,
15517,GO:0072004,1,0.957076563173688,0,1,kidney field specification,BP,
15524,GO:0072014,1,0.848574106186587,0,4,proximal tubule development,BP,
15527,GO:0072019,1,0.961277443773412,0,1,proximal convoluted tubule development,BP,
15529,GO:0072025,1,0.957076563173688,0,1,distal convoluted tubule development,BP,
15532,GO:0072034,1,0.915912041283588,0,2,renal vesicle induction,BP,
15533,GO:0072036,1,0.957216426198729,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15534,GO:0072038,1,0.915849294705781,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15535,GO:0072039,1,0.915849294705781,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15536,GO:0072040,1,0.915849294705781,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15537,GO:0072044,1,0.7109246483652,0,8,collecting duct development,BP,
15538,GO:0072047,1,0.854957692330733,0,4,proximal/distal pattern formation involved in nephron development,BP,
15539,GO:0072048,1,0.756715915442906,0,7,renal system pattern specification,BP,
15540,GO:0072049,1,0.85566478846732,0,4,comma-shaped body morphogenesis,BP,
15542,GO:0072053,1,0.916507463167027,0,2,renal inner medulla development,BP,
15543,GO:0072054,1,0.916507463167027,0,2,renal outer medulla development,BP,
15546,GO:0072060,1,0.957037166504587,0,1,outer medullary collecting duct development,BP,
15547,GO:0072061,1,0.922298391233383,0,2,inner medullary collecting duct development,BP,
15548,GO:0072069,1,0.957076563173688,0,1,DCT cell differentiation,BP,
15550,GO:0072071,1,0.96356435360397,0,1,kidney interstitial fibroblast differentiation,BP,
15554,GO:0072076,1,0.879388529424447,0,3,nephrogenic mesenchyme development,BP,
15557,GO:0072079,1,0.638469934718464,0,11,nephron tubule formation,BP,
15559,GO:0072081,1,0.854957692330733,0,4,specification of nephron tubule identity,BP,
15560,GO:0072086,1,0.854957692330733,0,4,specification of loop of Henle identity,BP,
15567,GO:0072095,1,0.920602207656332,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
15568,GO:0072096,1,0.962531515651986,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15569,GO:0072097,1,0.962531515651986,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15570,GO:0072098,1,0.962531515651986,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15571,GO:0072099,1,0.962531515651986,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15572,GO:0072100,1,0.962531515651986,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15573,GO:0072101,1,0.962531515651986,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15574,GO:0072102,1,0.880532682157698,0,3,glomerulus morphogenesis,BP,
15575,GO:0072103,1,0.920602207656332,0,2,glomerulus vasculature morphogenesis,BP,
15576,GO:0072104,1,0.920602207656332,0,2,glomerular capillary formation,BP,
15577,GO:0072106,1,0.884979063494002,0,3,regulation of ureteric bud formation,BP,
15578,GO:0072107,1,0.884979063494002,0,3,positive regulation of ureteric bud formation,BP,
15579,GO:0072108,1,0.884345166933283,0,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
15581,GO:0072110,1,0.750058622282613,0,7,glomerular mesangial cell proliferation,BP,
15584,GO:0072114,1,0.956442836694781,0,1,pronephros morphogenesis,BP,
15585,GO:0072124,1,0.750058622282613,0,7,regulation of glomerular mesangial cell proliferation,BP,
15586,GO:0072125,1,0.882842557433746,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
15587,GO:0072126,1,0.84963037539536,0,4,positive regulation of glomerular mesangial cell proliferation,BP,
15588,GO:0072127,1,0.960833348387573,0,1,renal capsule development,BP,
15589,GO:0072128,1,0.960833348387573,0,1,renal capsule morphogenesis,BP,
15590,GO:0072129,1,0.960833348387573,0,1,renal capsule formation,BP,
15591,GO:0072130,1,0.960833348387573,0,1,renal capsule specification,BP,
15592,GO:0072131,1,0.879061402520777,0,3,kidney mesenchyme morphogenesis,BP,
15594,GO:0072133,1,0.879061402520777,0,3,metanephric mesenchyme morphogenesis,BP,
15595,GO:0072134,1,0.915241863095768,0,2,nephrogenic mesenchyme morphogenesis,BP,
15598,GO:0072137,1,0.956441843839217,0,1,condensed mesenchymal cell proliferation,BP,
15599,GO:0072138,1,0.922270464030282,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
15600,GO:0072139,1,0.961143683422321,0,1,glomerular parietal epithelial cell differentiation,BP,
15601,GO:0072141,1,0.96356435360397,0,1,renal interstitial fibroblast development,BP,
15604,GO:0072148,1,0.632540243854015,0,11,epithelial cell fate commitment,BP,
15605,GO:0072156,1,0.875260705953273,0,3,distal tubule morphogenesis,BP,
15611,GO:0072166,1,0.958503826265086,0,1,posterior mesonephric tubule development,BP,
15614,GO:0072172,1,0.851494208812354,0,4,mesonephric tubule formation,BP,
15615,GO:0072173,1,0.744804183619644,0,7,metanephric tubule morphogenesis,BP,
15616,GO:0072174,1,0.876591041060334,0,3,metanephric tubule formation,BP,
15621,GO:0072179,1,0.922441758915636,0,2,nephric duct formation,BP,
15624,GO:0072185,1,0.960475987980697,0,1,metanephric cap development,BP,
15625,GO:0072186,1,0.960475987980697,0,1,metanephric cap morphogenesis,BP,
15626,GO:0072189,1,0.739884675202752,0,7,ureter development,BP,
15627,GO:0072190,1,0.92116330825277,0,2,ureter urothelium development,BP,
15628,GO:0072191,1,0.92116330825277,0,2,ureter smooth muscle development,BP,
15629,GO:0072192,1,0.962531515651986,0,1,ureter epithelial cell differentiation,BP,
15630,GO:0072193,1,0.92116330825277,0,2,ureter smooth muscle cell differentiation,BP,
15632,GO:0072197,1,0.92116330825277,0,2,ureter morphogenesis,BP,
15633,GO:0072198,1,0.962531515651986,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15634,GO:0072199,1,0.962531515651986,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15635,GO:0072200,1,0.962531515651986,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
15636,GO:0072201,1,0.773997853217305,0,6,negative regulation of mesenchymal cell proliferation,BP,
15639,GO:0072204,1,0.916617313747858,0,2,cell-cell signaling involved in metanephros development,BP,
15640,GO:0072205,1,0.806475446137274,0,5,metanephric collecting duct development,BP,
15643,GO:0072209,1,0.958824132817469,0,1,metanephric mesangial cell differentiation,BP,
15645,GO:0072213,1,0.960833348387573,0,1,metanephric capsule development,BP,
15648,GO:0072216,1,0.66040150344135,0,10,positive regulation of metanephros development,BP,
15652,GO:0072221,1,0.957076563173688,0,1,metanephric distal convoluted tubule development,BP,
15653,GO:0072223,1,0.880617670827906,0,3,metanephric glomerular mesangium development,BP,
15655,GO:0072229,1,0.961277443773412,0,1,metanephric proximal convoluted tubule development,BP,
15659,GO:0072237,1,0.919402658001587,0,2,metanephric proximal tubule development,BP,
15660,GO:0072239,1,0.880617670827906,0,3,metanephric glomerulus vasculature development,BP,
15661,GO:0072240,1,0.957076563173688,0,1,metanephric DCT cell differentiation,BP,
15666,GO:0072254,1,0.958824132817469,0,1,metanephric glomerular mesangial cell differentiation,BP,
15667,GO:0072255,1,0.958824132817469,0,1,metanephric glomerular mesangial cell development,BP,
15669,GO:0072262,1,0.918441758014191,0,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
15670,GO:0072265,1,0.960833348387573,0,1,metanephric capsule morphogenesis,BP,
15671,GO:0072266,1,0.960833348387573,0,1,metanephric capsule formation,BP,
15672,GO:0072267,1,0.960833348387573,0,1,metanephric capsule specification,BP,
15673,GO:0072268,1,0.88705826643903,0,3,pattern specification involved in metanephros development,BP,
15674,GO:0072272,1,0.923223657487377,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
15677,GO:0072278,1,0.921213189827687,0,2,metanephric comma-shaped body morphogenesis,BP,
15678,GO:0072282,1,0.778250806344684,0,6,metanephric nephron tubule morphogenesis,BP,
15681,GO:0072285,1,0.957216426198729,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
15682,GO:0072287,1,0.956441843839217,0,1,metanephric distal tubule morphogenesis,BP,
15683,GO:0072289,1,0.915942343180111,0,2,metanephric nephron tubule formation,BP,
15684,GO:0072298,1,0.878485596795345,0,3,regulation of metanephric glomerulus development,BP,
15685,GO:0072299,1,0.958503826265086,0,1,negative regulation of metanephric glomerulus development,BP,
15686,GO:0072300,1,0.916524498597484,0,2,positive regulation of metanephric glomerulus development,BP,
15687,GO:0072301,1,0.918441758014191,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
15688,GO:0072302,1,0.958503826265086,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
15689,GO:0072303,1,0.958207088018547,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
15690,GO:0072304,1,0.957076563173688,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15691,GO:0072305,1,0.957076563173688,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15694,GO:0072309,1,0.957076563173688,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15699,GO:0072318,1,0.807991624723632,0,5,clathrin coat disassembly,BP,
15700,GO:0072319,1,0.776567980517722,0,6,vesicle uncoating,BP,
15701,GO:0072320,1,0.876672337181196,0,3,volume-sensitive chloride channel activity,MF,
15702,GO:0072321,1,0.677807057079498,0,10,chaperone-mediated protein transport,BP,
15707,GO:0072334,1,0.928339508525673,0,2,UDP-galactose transmembrane transport,BP,
15709,GO:0072338,1,0.837080691916891,0,4,cellular lactam metabolic process,BP,
15711,GO:0072343,1,0.962278046052311,0,1,pancreatic stellate cell proliferation,BP,
15712,GO:0072344,1,0.848169084431783,0,4,rescue of stalled ribosome,BP,
15713,GO:0072345,1,0.8083501298114,0,5,NAADP-sensitive calcium-release channel activity,MF,
15718,GO:0072354,1,0.962772532294176,0,1,histone kinase activity (H3-T3 specific),MF,
15719,GO:0072355,1,0.962772532294176,0,1,histone H3-T3 phosphorylation,BP,
15720,GO:0072356,1,0.956931729370711,0,1,chromosome passenger complex localization to kinetochore,BP,
15721,GO:0072357,1,0.740850750218353,0,7,PTW/PP1 phosphatase complex,CC,
15724,GO:0072361,1,0.914777292668164,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
15725,GO:0072362,1,0.956441843839217,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15726,GO:0072363,1,0.956441843839217,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15727,GO:0072364,1,0.914777292668164,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
15728,GO:0072365,1,0.956441843839217,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15729,GO:0072366,1,0.956441843839217,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15730,GO:0072367,1,0.838964978866651,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
15731,GO:0072368,1,0.91504894019713,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
15732,GO:0072369,1,0.916867024276249,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
15735,GO:0072379,1,0.885577830222718,0,3,ER membrane insertion complex,CC,
15736,GO:0072382,1,0.956441843839217,0,1,minus-end-directed vesicle transport along microtubule,BP,
15737,GO:0072383,1,0.734543143796309,0,7,plus-end-directed vesicle transport along microtubule,BP,
15739,GO:0072385,1,0.838940383653958,0,4,minus-end-directed organelle transport along microtubule,BP,
15740,GO:0072386,1,0.702528062950639,0,8,plus-end-directed organelle transport along microtubule,BP,
15741,GO:0072387,1,0.920585059503828,0,2,flavin adenine dinucleotide metabolic process,BP,
15742,GO:0072388,1,0.961875270092358,0,1,flavin adenine dinucleotide biosynthetic process,BP,
15743,GO:0072389,1,0.957076563173688,0,1,flavin adenine dinucleotide catabolic process,BP,
15744,GO:0072393,1,0.618048306994691,0,11,microtubule anchoring at microtubule organizing center,BP,
15746,GO:0072396,1,0.775664883419033,0,6,response to cell cycle checkpoint signaling,BP,
15748,GO:0072402,1,0.775664883419033,0,6,response to DNA integrity checkpoint signaling,BP,
15750,GO:0072414,1,0.956441843839217,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15752,GO:0072423,1,0.775664883419033,0,6,response to DNA damage checkpoint signaling,BP,
15753,GO:0072425,1,0.62487346057303,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15754,GO:0072428,1,0.96224179415711,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
15755,GO:0072429,1,0.884410495039648,0,3,response to intra-S DNA damage checkpoint signaling,BP,
15757,GO:0072432,1,0.956441843839217,0,1,response to G1 DNA damage checkpoint signaling,BP,
15758,GO:0072434,1,0.916790553433399,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
15759,GO:0072487,1,0.808619354657356,0,5,MSL complex,CC,
15760,GO:0072488,1,0.752392652140215,0,7,ammonium transmembrane transport,BP,
15761,GO:0072492,1,0.962631511008888,0,1,host cell mitochondrial intermembrane space,CC,
15764,GO:0072501,1,0.841463032233077,0,4,cellular divalent inorganic anion homeostasis,BP,
15765,GO:0072502,1,0.841463032233077,0,4,cellular trivalent inorganic anion homeostasis,BP,
15771,GO:0072510,1,0.956462433765706,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
15774,GO:0072513,1,0.965221192709446,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
15775,GO:0072517,1,0.957631146660816,0,1,host cell viral assembly compartment,CC,
15776,GO:0072518,1,0.956441843839217,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
15777,GO:0072520,1,0.657663725462756,0,10,seminiferous tubule development,BP,
15783,GO:0072526,1,0.851888735604816,0,4,pyridine-containing compound catabolic process,BP,
15787,GO:0072530,1,0.722480046310815,0,8,purine-containing compound transmembrane transport,BP,
15788,GO:0072531,1,0.782592615837304,0,6,pyrimidine-containing compound transmembrane transport,BP,
15789,GO:0072534,1,0.956441843839217,0,1,perineuronal net,CC,
15790,GO:0072535,1,0.958170656814958,0,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,
15791,GO:0072536,1,0.961825504587889,0,1,interleukin-23 receptor complex,CC,
15792,GO:0072537,1,0.809672941733993,0,5,fibroblast activation,BP,
15793,GO:0072538,1,0.68736298055395,0,9,T-helper 17 type immune response,BP,
15794,GO:0072539,1,0.746158330710762,0,7,T-helper 17 cell differentiation,BP,
15795,GO:0072540,1,0.850366630483648,0,4,T-helper 17 cell lineage commitment,BP,
15796,GO:0072542,1,0.752671897176965,0,7,protein phosphatase activator activity,MF,
15797,GO:0072545,1,0.961205143738116,0,1,tyrosine binding,MF,
15798,GO:0072546,1,0.655381775687221,0,10,ER membrane protein complex,CC,
15800,GO:0072554,1,0.96048839507273,0,1,blood vessel lumenization,BP,
15801,GO:0072555,1,0.963127347250878,0,1,17-beta-ketosteroid reductase activity,MF,
15802,GO:0072556,1,0.956808261360976,0,1,other organism presynaptic membrane,CC,
15803,GO:0072557,1,0.929764855583711,0,2,IPAF inflammasome complex,CC,
15804,GO:0072558,1,0.89028755676115,0,3,NLRP1 inflammasome complex,CC,
15805,GO:0072559,1,0.789630355859248,0,6,NLRP3 inflammasome complex,CC,
15806,GO:0072560,1,0.958220082623761,0,1,type B pancreatic cell maturation,BP,
15808,GO:0072563,1,0.922841414040538,0,2,endothelial microparticle,CC,
15811,GO:0072570,1,0.95798417632483,0,1,ADP-D-ribose binding,MF,
15812,GO:0072572,1,0.961273829343506,0,1,poly-ADP-D-ribose binding,MF,
15819,GO:0072579,1,0.956756130289669,0,1,glycine receptor clustering,BP,
15820,GO:0072582,1,0.963127347250878,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15822,GO:0072584,1,0.716873234124553,0,8,caveolin-mediated endocytosis,BP,
15823,GO:0072586,1,0.956628492336638,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15824,GO:0072587,1,0.956628492336638,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
15825,GO:0072588,1,0.750497677105749,0,8,box H/ACA RNP complex,CC,
15826,GO:0072589,1,0.862848891288118,0,4,box H/ACA scaRNP complex,CC,
15827,GO:0072590,1,0.956441843839217,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15828,GO:0072591,1,0.956441843839217,0,1,citrate-L-glutamate ligase activity,MF,
15829,GO:0072592,1,0.924007167025365,0,2,oxygen metabolic process,BP,
15834,GO:0072602,1,0.84264017793616,0,4,interleukin-4 secretion,BP,
15835,GO:0072603,1,0.844650844358734,0,4,interleukin-5 secretion,BP,
15838,GO:0072608,1,0.789255748389092,0,6,interleukin-10 secretion,BP,
15839,GO:0072610,1,0.84641429823333,0,4,interleukin-12 secretion,BP,
15840,GO:0072611,1,0.812412303386242,0,5,interleukin-13 secretion,BP,
15841,GO:0072615,1,0.961845070778084,0,1,interleukin-17 secretion,BP,
15842,GO:0072616,1,0.956954390388089,0,1,interleukin-18 secretion,BP,
15843,GO:0072619,1,0.957444408335267,0,1,interleukin-21 secretion,BP,
15844,GO:0072641,1,0.768204293714145,0,6,type I interferon secretion,BP,
15845,GO:0072642,1,0.768204293714145,0,6,interferon-alpha secretion,BP,
15846,GO:0072643,1,0.679081306378384,0,9,interferon-gamma secretion,BP,
15848,GO:0072656,1,0.812953847509755,0,5,maintenance of protein location in mitochondrion,BP,
15850,GO:0072658,1,0.956441843839217,0,1,maintenance of protein location in membrane,BP,
15852,GO:0072660,1,0.956441843839217,0,1,maintenance of protein location in plasma membrane,BP,
15853,GO:0072662,1,0.491097772785831,0,17,protein localization to peroxisome,BP,
15854,GO:0072663,1,0.491097772785831,0,17,establishment of protein localization to peroxisome,BP,
15857,GO:0072669,1,0.763736779534187,0,7,tRNA-splicing ligase complex,CC,
15858,GO:0072671,1,0.959824820177024,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
15859,GO:0072672,1,0.840343461371475,0,4,neutrophil extravasation,BP,
15861,GO:0072674,1,0.841098563932562,0,4,multinuclear osteoclast differentiation,BP,
15862,GO:0072675,1,0.841098563932562,0,4,osteoclast fusion,BP,
15864,GO:0072677,1,0.782685767081882,0,6,eosinophil migration,BP,
15865,GO:0072678,1,0.371224436951985,0,24,T cell migration,BP,
15866,GO:0072679,1,0.917727219426223,0,2,thymocyte migration,BP,
15867,GO:0072680,1,0.958170656814958,0,1,extracellular matrix-dependent thymocyte migration,BP,
15868,GO:0072681,1,0.958170656814958,0,1,fibronectin-dependent thymocyte migration,BP,
15869,GO:0072682,1,0.957677532435855,0,1,eosinophil extravasation,BP,
15870,GO:0072683,1,0.925774918912131,0,2,T cell extravasation,BP,
15871,GO:0072684,1,0.957130519849788,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
15873,GO:0072687,1,0.847982024444012,0,4,meiotic spindle,CC,
15874,GO:0072695,1,0.921726693165832,0,2,regulation of DNA recombination at telomere,BP,
15875,GO:0072697,1,0.626150427430698,0,11,protein localization to cell cortex,BP,
15876,GO:0072698,1,0.164316078905681,0,42,protein localization to microtubule cytoskeleton,BP,
15879,GO:0072706,1,0.959761540834595,0,1,response to sodium dodecyl sulfate,BP,
15880,GO:0072707,1,0.959761540834595,0,1,cellular response to sodium dodecyl sulfate,BP,
15881,GO:0072708,1,0.847163270852799,0,4,response to sorbitol,BP,
15882,GO:0072709,1,0.920977364385982,0,2,cellular response to sorbitol,BP,
15883,GO:0072710,1,0.678487752742712,0,9,response to hydroxyurea,BP,
15884,GO:0072711,1,0.707672671679682,0,8,cellular response to hydroxyurea,BP,
15885,GO:0072714,1,0.962674433856931,0,1,response to selenite ion,BP,
15886,GO:0072715,1,0.962674433856931,0,1,cellular response to selenite ion,BP,
15887,GO:0072716,1,0.849881264071844,0,4,response to actinomycin D,BP,
15888,GO:0072717,1,0.886421423155467,0,3,cellular response to actinomycin D,BP,
15889,GO:0072718,1,0.683485114697126,0,9,response to cisplatin,BP,
15890,GO:0072719,1,0.776988556886313,0,6,cellular response to cisplatin,BP,
15891,GO:0072720,1,0.958787867083198,0,1,response to dithiothreitol,BP,
15892,GO:0072733,1,0.887129701422581,0,3,response to staurosporine,BP,
15893,GO:0072734,1,0.887129701422581,0,3,cellular response to staurosporine,BP,
15894,GO:0072737,1,0.92248649613571,0,2,response to diamide,BP,
15895,GO:0072738,1,0.92248649613571,0,2,cellular response to diamide,BP,
15896,GO:0072739,1,0.922496139445388,0,2,response to anisomycin,BP,
15897,GO:0072740,1,0.962151529900438,0,1,cellular response to anisomycin,BP,
15898,GO:0072741,1,0.879227971604245,0,3,protein localization to cell division site,BP,
15899,GO:0072749,1,0.962443847498107,0,1,cellular response to cytochalasin B,BP,
15900,GO:0072750,1,0.964031934225656,0,1,cellular response to leptomycin B,BP,
15901,GO:0072752,1,0.956441843839217,0,1,cellular response to rapamycin,BP,
15903,GO:0072757,1,0.843657920794071,0,4,cellular response to camptothecin,BP,
15906,GO:0075109,1,0.956458141288418,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15907,GO:0075111,1,0.956458141288418,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15908,GO:0075112,1,0.956458141288418,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15909,GO:0075114,1,0.956458141288418,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15910,GO:0075136,1,0.782383176300787,0,6,response to host,BP,
15911,GO:0075341,1,0.960713053992005,0,1,host cell PML body,CC,
15912,GO:0075509,1,0.879222574585183,0,3,endocytosis involved in viral entry into host cell,BP,
15913,GO:0075519,1,0.96546510869014,0,1,microtubule-dependent intracellular transport of viral material,BP,
15914,GO:0075521,1,0.96546510869014,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15915,GO:0075522,1,0.66026188806943,0,10,IRES-dependent viral translational initiation,BP,
15916,GO:0075525,1,0.817985065584434,0,5,viral translational termination-reinitiation,BP,
15917,GO:0075528,1,0.885623284338132,0,3,modulation by virus of host immune response,BP,
15918,GO:0075606,1,0.96546510869014,0,1,transport of viral material towards nucleus,BP,
15919,GO:0075713,1,0.723996277899549,0,8,establishment of integrated proviral latency,BP,
15920,GO:0075732,1,0.914965331431349,0,2,viral penetration into host nucleus,BP,
15923,GO:0080009,1,0.666194177801527,0,10,mRNA methylation,BP,
15924,GO:0080019,1,0.919544580289203,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
15925,GO:0080023,1,0.919270839167849,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
15927,GO:0080058,1,0.96382597257255,0,1,protein deglutathionylation,BP,
15928,GO:0080084,1,0.808635294335298,0,5,5S rDNA binding,MF,
15930,GO:0080101,1,0.964778188240337,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
15932,GO:0080120,1,0.923183943796933,0,2,CAAX-box protein maturation,BP,
15933,GO:0080121,1,0.920659617962206,0,2,AMP transport,BP,
15934,GO:0080122,1,0.883679680693187,0,3,AMP transmembrane transporter activity,MF,
15935,GO:0080129,1,0.964534369259811,0,1,proteasome core complex assembly,BP,
15939,GO:0080146,1,0.96265960442676,0,1,L-cysteine desulfhydrase activity,MF,
15940,GO:0080147,1,0.965280077340104,0,1,root hair cell development,BP,
15942,GO:0080163,1,0.9603647394048,0,1,regulation of protein serine/threonine phosphatase activity,BP,
15946,GO:0085020,1,0.755613723429017,0,7,protein K6-linked ubiquitination,BP,
15948,GO:0085032,1,0.957912295364768,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
15952,GO:0086004,1,0.422929656585592,0,20,regulation of cardiac muscle cell contraction,BP,
15953,GO:0086005,1,0.520231231015,0,15,ventricular cardiac muscle cell action potential,BP,
15955,GO:0086007,1,0.915745090307797,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
15956,GO:0086008,1,0.920696091107369,0,2,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
15959,GO:0086011,1,0.629204673016014,0,11,membrane repolarization during action potential,BP,
15961,GO:0086013,1,0.714334772474402,0,8,membrane repolarization during cardiac muscle cell action potential,BP,
15962,GO:0086014,1,0.645495037382255,0,10,atrial cardiac muscle cell action potential,BP,
15963,GO:0086015,1,0.916403656854099,0,2,SA node cell action potential,BP,
15965,GO:0086017,1,0.916837687238185,0,2,Purkinje myocyte action potential,BP,
15966,GO:0086018,1,0.916403656854099,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
15968,GO:0086020,1,0.916403656854099,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
15969,GO:0086021,1,0.916403656854099,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
15970,GO:0086023,1,0.83680392495697,0,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
15971,GO:0086024,1,0.956441843839217,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
15972,GO:0086026,1,0.645495037382255,0,10,atrial cardiac muscle cell to AV node cell signaling,BP,
15974,GO:0086028,1,0.846916789080962,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
15975,GO:0086029,1,0.916837687238185,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
15976,GO:0086036,1,0.839521679613035,0,4,regulation of cardiac muscle cell membrane potential,BP,
15977,GO:0086038,1,0.958787867083198,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
15978,GO:0086039,1,0.956441843839217,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
15979,GO:0086040,1,0.956599196512343,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
15980,GO:0086042,1,0.769650663530277,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
15981,GO:0086043,1,0.846916789080962,0,4,bundle of His cell action potential,BP,
15982,GO:0086044,1,0.958142130655448,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
15983,GO:0086045,1,0.915556578879354,0,2,membrane depolarization during AV node cell action potential,BP,
15984,GO:0086046,1,0.956441843839217,0,1,membrane depolarization during SA node cell action potential,BP,
15985,GO:0086047,1,0.956894798384683,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
15986,GO:0086048,1,0.915832550090626,0,2,membrane depolarization during bundle of His cell action potential,BP,
15987,GO:0086053,1,0.916403656854099,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
15988,GO:0086054,1,0.958142130655448,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
15989,GO:0086055,1,0.958142130655448,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
15990,GO:0086056,1,0.956803425292439,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
15991,GO:0086057,1,0.957091803832729,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
15992,GO:0086064,1,0.512606929571835,0,16,cell communication by electrical coupling involved in cardiac conduction,BP,
15994,GO:0086066,1,0.645495037382255,0,10,atrial cardiac muscle cell to AV node cell communication,BP,
15996,GO:0086068,1,0.916837687238185,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
15997,GO:0086069,1,0.678886517817909,0,9,bundle of His cell to Purkinje myocyte communication,BP,
15998,GO:0086070,1,0.876479836132786,0,3,SA node cell to atrial cardiac muscle cell communication,BP,
15999,GO:0086072,1,0.960091341753476,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16000,GO:0086073,1,0.80165794851252,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16001,GO:0086075,1,0.878111684712354,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
16002,GO:0086076,1,0.958142130655448,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16003,GO:0086077,1,0.916403656854099,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
16004,GO:0086078,1,0.958142130655448,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16005,GO:0086079,1,0.958142130655448,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16006,GO:0086080,1,0.704025372350895,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
16007,GO:0086082,1,0.960091341753476,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
16008,GO:0086083,1,0.80165794851252,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16009,GO:0086089,1,0.958779864066691,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
16011,GO:0086092,1,0.956599196512343,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
16012,GO:0086096,1,0.96385658117475,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
16013,GO:0086098,1,0.918085137625816,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
16014,GO:0086100,1,0.957125193193742,0,1,endothelin receptor signaling pathway,BP,
16015,GO:0086103,1,0.740451983815279,0,7,G-protein coupled receptor signaling pathway involved in heart process,BP,
16016,GO:0089700,1,0.877267263582033,0,3,protein kinase D signaling,BP,
16017,GO:0089701,1,0.824331161040271,0,5,U2AF,CC,
16018,GO:0089709,1,0.921173732952838,0,2,L-histidine transmembrane transport,BP,
16020,GO:0089718,1,0.629001796537485,0,11,amino acid import across plasma membrane,BP,
16021,GO:0089720,1,0.788004242983897,0,6,caspase binding,MF,
16022,GO:0090009,1,0.83780198180604,0,4,primitive streak formation,BP,
16023,GO:0090022,1,0.59815422376115,0,13,regulation of neutrophil chemotaxis,BP,
16024,GO:0090023,1,0.679365772445694,0,10,positive regulation of neutrophil chemotaxis,BP,
16025,GO:0090024,1,0.956487499770039,0,1,negative regulation of neutrophil chemotaxis,BP,
16026,GO:0090025,1,0.638461031134359,0,11,regulation of monocyte chemotaxis,BP,
16027,GO:0090026,1,0.724355683089475,0,8,positive regulation of monocyte chemotaxis,BP,
16028,GO:0090027,1,0.919799883285577,0,2,negative regulation of monocyte chemotaxis,BP,
16029,GO:0090030,1,0.740084489577783,0,7,regulation of steroid hormone biosynthetic process,BP,
16030,GO:0090031,1,0.918726003133401,0,2,positive regulation of steroid hormone biosynthetic process,BP,
16031,GO:0090032,1,0.842172337361811,0,4,negative regulation of steroid hormone biosynthetic process,BP,
16032,GO:0090034,1,0.921556245027351,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16033,GO:0090035,1,0.921556245027351,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
16036,GO:0090038,1,0.917084597871847,0,2,negative regulation of protein kinase C signaling,BP,
16039,GO:0090044,1,0.963111881132099,0,1,positive regulation of tubulin deacetylation,BP,
16040,GO:0090045,1,0.781162862531966,0,6,positive regulation of deacetylase activity,BP,
16043,GO:0090051,1,0.578538071345017,0,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,
16044,GO:0090063,1,0.843471573323695,0,4,positive regulation of microtubule nucleation,BP,
16045,GO:0090065,1,0.966376925420809,0,1,regulation of production of siRNA involved in RNA interference,BP,
16047,GO:0090067,1,0.956614265908789,0,1,regulation of thalamus size,BP,
16049,GO:0090069,1,0.576920929648053,0,13,regulation of ribosome biogenesis,BP,
16050,GO:0090070,1,0.717333171709641,0,8,positive regulation of ribosome biogenesis,BP,
16051,GO:0090071,1,0.841011420652395,0,4,negative regulation of ribosome biogenesis,BP,
16052,GO:0090073,1,0.720851820798213,0,8,positive regulation of protein homodimerization activity,BP,
16053,GO:0090074,1,0.809977192997576,0,5,negative regulation of protein homodimerization activity,BP,
16056,GO:0090079,1,0.492369275090698,0,17,translation regulator activity, nucleic acid binding,MF,
16057,GO:0090080,1,0.91477749255326,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
16058,GO:0090081,1,0.962464157847848,0,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
16059,GO:0090082,1,0.962464157847848,0,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
16060,GO:0090083,1,0.562851323274214,0,14,regulation of inclusion body assembly,BP,
16061,GO:0090084,1,0.660781396006483,0,10,negative regulation of inclusion body assembly,BP,
16062,GO:0090085,1,0.635322787154799,0,11,regulation of protein deubiquitination,BP,
16063,GO:0090086,1,0.894865055239042,0,3,negative regulation of protein deubiquitination,BP,
16065,GO:0090088,1,0.923889708631606,0,2,regulation of oligopeptide transport,BP,
16066,GO:0090089,1,0.923889708631606,0,2,regulation of dipeptide transport,BP,
16068,GO:0090091,1,0.841633354741867,0,4,positive regulation of extracellular matrix disassembly,BP,
16070,GO:0090094,1,0.960475987980697,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16071,GO:0090095,1,0.960475987980697,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16072,GO:0090096,1,0.960475987980697,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
16077,GO:0090107,1,0.886377584972837,0,3,regulation of high-density lipoprotein particle assembly,BP,
16078,GO:0090108,1,0.961522834860774,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16080,GO:0090110,1,0.570652185231083,0,13,cargo loading into COPII-coated vesicle,BP,
16081,GO:0090113,1,0.961172605270695,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
16083,GO:0090116,1,0.875711800021663,0,3,C-5 methylation of cytosine,BP,
16085,GO:0090119,1,0.956617645843903,0,1,vesicle-mediated cholesterol transport,BP,
16091,GO:0090135,1,0.884441475306836,0,3,actin filament branching,BP,
16093,GO:0090138,1,0.957304913073479,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
16094,GO:0090140,1,0.450763072344376,0,19,regulation of mitochondrial fission,BP,
16095,GO:0090141,1,0.585326794990583,0,13,positive regulation of mitochondrial fission,BP,
16097,GO:0090149,1,0.918917913061575,0,2,mitochondrial membrane fission,BP,
16099,GO:0090151,1,0.633279209546126,0,12,establishment of protein localization to mitochondrial membrane,BP,
16100,GO:0090153,1,0.613983441127398,0,12,regulation of sphingolipid biosynthetic process,BP,
16101,GO:0090154,1,0.748057632287464,0,7,positive regulation of sphingolipid biosynthetic process,BP,
16102,GO:0090155,1,0.852049192955376,0,4,negative regulation of sphingolipid biosynthetic process,BP,
16103,GO:0090156,1,0.890837572469437,0,3,cellular sphingolipid homeostasis,BP,
16104,GO:0090158,1,0.815755437939377,0,5,endoplasmic reticulum membrane organization,BP,
16105,GO:0090160,1,0.712322207575934,0,8,Golgi to lysosome transport,BP,
16106,GO:0090161,1,0.621189409151827,0,11,Golgi ribbon formation,BP,
16107,GO:0090162,1,0.343175828909949,0,25,establishment of epithelial cell polarity,BP,
16108,GO:0090164,1,0.91762643379751,0,2,asymmetric Golgi ribbon formation,BP,
16109,GO:0090166,1,0.783964426254506,0,6,Golgi disassembly,BP,
16110,GO:0090168,1,0.849485408157323,0,4,Golgi reassembly,BP,
16111,GO:0090169,1,0.348624636902823,0,25,regulation of spindle assembly,BP,
16112,GO:0090170,1,0.850966086129581,0,4,regulation of Golgi inheritance,BP,
16115,GO:0090176,1,0.956442182871181,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
16120,GO:0090182,1,0.926178093933281,0,2,regulation of secretion of lysosomal enzymes,BP,
16122,GO:0090184,1,0.326133297582645,0,27,positive regulation of kidney development,BP,
16124,GO:0090186,1,0.776487735840732,0,6,regulation of pancreatic juice secretion,BP,
16125,GO:0090187,1,0.961522834860774,0,1,positive regulation of pancreatic juice secretion,BP,
16126,GO:0090188,1,0.807574258565019,0,5,negative regulation of pancreatic juice secretion,BP,
16127,GO:0090189,1,0.584720146682064,0,13,regulation of branching involved in ureteric bud morphogenesis,BP,
16128,GO:0090190,1,0.631827314138624,0,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,
16129,GO:0090191,1,0.925510504995867,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
16130,GO:0090192,1,0.690258407539059,0,9,regulation of glomerulus development,BP,
16131,GO:0090193,1,0.781908157806394,0,6,positive regulation of glomerulus development,BP,
16132,GO:0090194,1,0.882842557433746,0,3,negative regulation of glomerulus development,BP,
16136,GO:0090198,1,0.958822782263901,0,1,negative regulation of chemokine secretion,BP,
16139,GO:0090201,1,0.595783357503081,0,13,negative regulation of release of cytochrome c from mitochondria,BP,
16141,GO:0090204,1,0.88936381352269,0,3,protein localization to nuclear pore,BP,
16147,GO:0090210,1,0.917408057888583,0,2,regulation of establishment of blood-brain barrier,BP,
16148,GO:0090212,1,0.956845173675673,0,1,negative regulation of establishment of blood-brain barrier,BP,
16153,GO:0090222,1,0.914777292668164,0,2,centrosome-templated microtubule nucleation,BP,
16154,GO:0090224,1,0.201512455833175,0,38,regulation of spindle organization,BP,
16155,GO:0090226,1,0.965166424104341,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
16156,GO:0090230,1,0.840865837113156,0,4,regulation of centromere complex assembly,BP,
16159,GO:0090233,1,0.959407932504879,0,1,negative regulation of spindle checkpoint,BP,
16160,GO:0090234,1,0.879090718095152,0,3,regulation of kinetochore assembly,BP,
16161,GO:0090235,1,0.738517414667601,0,7,regulation of metaphase plate congression,BP,
16162,GO:0090237,1,0.81000448290827,0,5,regulation of arachidonic acid secretion,BP,
16163,GO:0090238,1,0.846873524179143,0,4,positive regulation of arachidonic acid secretion,BP,
16164,GO:0090239,1,0.637032477292057,0,11,regulation of histone H4 acetylation,BP,
16165,GO:0090240,1,0.754865110658682,0,7,positive regulation of histone H4 acetylation,BP,
16166,GO:0090241,1,0.848948387529852,0,4,negative regulation of histone H4 acetylation,BP,
16170,GO:0090247,1,0.959690575072104,0,1,cell motility involved in somitogenic axis elongation,BP,
16171,GO:0090249,1,0.959690575072104,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
16172,GO:0090251,1,0.956441843839217,0,1,protein localization involved in establishment of planar polarity,BP,
16174,GO:0090258,1,0.917665652588454,0,2,negative regulation of mitochondrial fission,BP,
16175,GO:0090259,1,0.879243423549996,0,3,regulation of retinal ganglion cell axon guidance,BP,
16176,GO:0090260,1,0.956487499770039,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
16177,GO:0090261,1,0.856090148691806,0,4,positive regulation of inclusion body assembly,BP,
16179,GO:0090266,1,0.589152738324211,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16180,GO:0090267,1,0.751410645761545,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16181,GO:0090269,1,0.875099641878431,0,3,fibroblast growth factor production,BP,
16182,GO:0090270,1,0.875099641878431,0,3,regulation of fibroblast growth factor production,BP,
16183,GO:0090271,1,0.914960523305034,0,2,positive regulation of fibroblast growth factor production,BP,
16184,GO:0090272,1,0.95644205280966,0,1,negative regulation of fibroblast growth factor production,BP,
16189,GO:0090280,1,0.809439146266353,0,5,positive regulation of calcium ion import,BP,
16190,GO:0090281,1,0.88389051873154,0,3,negative regulation of calcium ion import,BP,
16191,GO:0090283,1,0.883013135131404,0,3,regulation of protein glycosylation in Golgi,BP,
16192,GO:0090284,1,0.956441843839217,0,1,positive regulation of protein glycosylation in Golgi,BP,
16193,GO:0090285,1,0.923233936712477,0,2,negative regulation of protein glycosylation in Golgi,BP,
16198,GO:0090290,1,0.964665986370993,0,1,positive regulation of osteoclast proliferation,BP,
16201,GO:0090296,1,0.847144716228625,0,4,regulation of mitochondrial DNA replication,BP,
16202,GO:0090297,1,0.964050836212264,0,1,positive regulation of mitochondrial DNA replication,BP,
16203,GO:0090298,1,0.87874302632249,0,3,negative regulation of mitochondrial DNA replication,BP,
16204,GO:0090299,1,0.962923588325958,0,1,regulation of neural crest formation,BP,
16205,GO:0090301,1,0.962923588325958,0,1,negative regulation of neural crest formation,BP,
16209,GO:0090306,1,0.84515017005859,0,4,spindle assembly involved in meiosis,BP,
16210,GO:0090307,1,0.0757279529943435,0,61,mitotic spindle assembly,BP,
16212,GO:0090309,1,0.839069301949217,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
16222,GO:0090323,1,0.965759632463125,0,1,prostaglandin secretion involved in immune response,BP,
16223,GO:0090324,1,0.812098420792655,0,5,negative regulation of oxidative phosphorylation,BP,
16224,GO:0090325,1,0.916523121429566,0,2,regulation of locomotion involved in locomotory behavior,BP,
16225,GO:0090326,1,0.957882406805159,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
16226,GO:0090327,1,0.956825884947973,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
16231,GO:0090336,1,0.882196777374001,0,3,positive regulation of brown fat cell differentiation,BP,
16232,GO:0090340,1,0.961522834860774,0,1,positive regulation of secretion of lysosomal enzymes,BP,
16233,GO:0090341,1,0.963243782460965,0,1,negative regulation of secretion of lysosomal enzymes,BP,
16235,GO:0090343,1,0.671625724972101,0,10,positive regulation of cell aging,BP,
16237,GO:0090345,1,0.959964757059869,0,1,cellular organohalogen metabolic process,BP,
16238,GO:0090346,1,0.959964757059869,0,1,cellular organofluorine metabolic process,BP,
16239,GO:0090360,1,0.884322313569261,0,3,platelet-derived growth factor production,BP,
16240,GO:0090361,1,0.884322313569261,0,3,regulation of platelet-derived growth factor production,BP,
16241,GO:0090362,1,0.919699133290382,0,2,positive regulation of platelet-derived growth factor production,BP,
16242,GO:0090365,1,0.961121993962004,0,1,regulation of mRNA modification,BP,
16243,GO:0090367,1,0.961121993962004,0,1,negative regulation of mRNA modification,BP,
16244,GO:0090370,1,0.956725838498375,0,1,negative regulation of cholesterol efflux,BP,
16245,GO:0090381,1,0.962464157847848,0,1,regulation of heart induction,BP,
16248,GO:0090385,1,0.785806381363813,0,6,phagosome-lysosome fusion,BP,
16249,GO:0090386,1,0.915023460137598,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
16250,GO:0090387,1,0.915023460137598,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
16251,GO:0090389,1,0.956441843839217,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
16252,GO:0090394,1,0.843212465221528,0,4,negative regulation of excitatory postsynaptic potential,BP,
16254,GO:0090399,1,0.631132729970645,0,11,replicative senescence,BP,
16255,GO:0090400,1,0.744888086385758,0,7,stress-induced premature senescence,BP,
16256,GO:0090402,1,0.922385208454696,0,2,oncogene-induced cell senescence,BP,
16257,GO:0090403,1,0.880303035506439,0,3,oxidative stress-induced premature senescence,BP,
16259,GO:0090409,1,0.960736356812985,0,1,malonyl-CoA synthetase activity,MF,
16260,GO:0090410,1,0.960736356812985,0,1,malonate catabolic process,BP,
16261,GO:0090420,1,0.963704959771134,0,1,naphthalene-containing compound metabolic process,BP,
16262,GO:0090422,1,0.962983758604616,0,1,thiamine pyrophosphate transmembrane transporter activity,MF,
16263,GO:0090427,1,0.961042493422886,0,1,activation of meiosis,BP,
16264,GO:0090435,1,0.753283030596418,0,7,protein localization to nuclear envelope,BP,
16265,GO:0090461,1,0.956742549546252,0,1,glutamate homeostasis,BP,
16267,GO:0090480,1,0.878540614779047,0,3,purine nucleotide-sugar transmembrane transport,BP,
16268,GO:0090481,1,0.668541866706422,0,10,pyrimidine nucleotide-sugar transmembrane transport,BP,
16270,GO:0090493,1,0.790761159822286,0,6,catecholamine uptake,BP,
16271,GO:0090494,1,0.790761159822286,0,6,dopamine uptake,BP,
16272,GO:0090498,1,0.91901918780489,0,2,extrinsic component of Golgi membrane,CC,
16273,GO:0090500,1,0.922794423244687,0,2,endocardial cushion to mesenchymal transition,BP,
16274,GO:0090501,1,0.00652357656987571,0,123,RNA phosphodiester bond hydrolysis,BP,
16275,GO:0090502,1,0.091884172432979,0,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
16276,GO:0090503,1,0.236117070992355,0,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
16277,GO:0090504,1,0.334902772365424,0,26,epiboly,BP,
16278,GO:0090505,1,0.350188388972875,0,25,epiboly involved in wound healing,BP,
16279,GO:0090520,1,0.685456581604371,0,9,sphingolipid mediated signaling pathway,BP,
16280,GO:0090521,1,0.841338133621995,0,4,glomerular visceral epithelial cell migration,BP,
16282,GO:0090529,1,0.962307303735668,0,1,cell septum assembly,BP,
16285,GO:0090541,1,0.917258746790483,0,2,MIT domain binding,MF,
16286,GO:0090543,1,0.336597422151213,0,26,Flemming body,CC,
16288,GO:0090554,1,0.914777292668164,0,2,phosphatidylcholine-translocating ATPase activity,MF,
16289,GO:0090556,1,0.914777292668164,0,2,phosphatidylserine-translocating ATPase activity,MF,
16291,GO:0090558,1,0.965280077340104,0,1,plant epidermis development,BP,
16292,GO:0090559,1,0.0553740863236634,0,71,regulation of membrane permeability,BP,
16293,GO:0090560,1,0.961214182124242,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
16295,GO:0090571,1,0.887284260115836,0,3,RNA polymerase II transcription repressor complex,CC,
16297,GO:0090576,1,0.712423037631922,0,8,RNA polymerase III transcription factor complex,CC,
16302,GO:0090600,1,0.95704199370308,0,1,alpha-1,3-glucosidase activity,MF,
16303,GO:0090601,1,0.956463626558617,0,1,enucleation,BP,
16304,GO:0090611,1,0.815838131367651,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
16305,GO:0090615,1,0.920294229631875,0,2,mitochondrial mRNA processing,BP,
16306,GO:0090616,1,0.956589907309842,0,1,mitochondrial mRNA 3'-end processing,BP,
16307,GO:0090624,1,0.958787867083198,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16308,GO:0090625,1,0.958787867083198,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16309,GO:0090627,1,0.965280077340104,0,1,plant epidermal cell differentiation,BP,
16311,GO:0090646,1,0.616569980334251,0,12,mitochondrial tRNA processing,BP,
16312,GO:0090647,1,0.780057732165115,0,6,modulation of age-related behavioral decline,BP,
16313,GO:0090649,1,0.809328687443548,0,5,response to oxygen-glucose deprivation,BP,
16314,GO:0090650,1,0.809328687443548,0,5,cellular response to oxygen-glucose deprivation,BP,
16315,GO:0090656,1,0.52407071079781,0,15,t-circle formation,BP,
16316,GO:0090657,1,0.623043003542647,0,11,telomeric loop disassembly,BP,
16318,GO:0090661,1,0.833499298130555,0,5,box H/ACA telomerase RNP complex,CC,
16320,GO:0090665,1,0.629297427962076,0,11,glycoprotein complex,CC,
16321,GO:0090666,1,0.853773951089606,0,4,scaRNA localization to Cajal body,BP,
16322,GO:0090667,1,0.956441843839217,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16323,GO:0090668,1,0.956441843839217,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
16324,GO:0090669,1,0.847616102924231,0,4,telomerase RNA stabilization,BP,
16325,GO:0090670,1,0.469997649396347,0,19,RNA localization to Cajal body,BP,
16326,GO:0090671,1,0.469997649396347,0,19,telomerase RNA localization to Cajal body,BP,
16327,GO:0090672,1,0.469997649396347,0,19,telomerase RNA localization,BP,
16328,GO:0090673,1,0.956441843839217,0,1,endothelial cell-matrix adhesion,BP,
16329,GO:0090675,1,0.957567502960254,0,1,intermicrovillar adhesion,BP,
16332,GO:0090685,1,0.469997649396347,0,19,RNA localization to nucleus,BP,
16333,GO:0090694,1,0.917021318947511,0,2,Scc2-Scc4 cohesin loading complex,CC,
16336,GO:0090722,1,0.91477749255326,0,2,receptor-receptor interaction,MF,
16337,GO:0090723,1,0.630931324610489,0,11,growth cone part,CC,
16338,GO:0090724,1,0.845966408822288,0,4,central region of growth cone,CC,
16339,GO:0090725,1,0.923582323302142,0,2,peripheral region of growth cone,CC,
16341,GO:0090734,1,0.227063434936625,0,35,site of DNA damage,CC,
16342,GO:0090735,1,0.664134504879595,0,10,DNA repair complex assembly,BP,
16343,GO:0090737,1,0.52407071079781,0,15,telomere maintenance via telomere trimming,BP,
16344,GO:0090741,1,0.793891319008883,0,6,pigment granule membrane,CC,
16345,GO:0093001,1,0.95804055069069,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
16346,GO:0095500,1,0.61069941036345,0,12,acetylcholine receptor signaling pathway,BP,
16347,GO:0097001,1,0.721051297103466,0,8,ceramide binding,MF,
16348,GO:0097003,1,0.919947247375467,0,2,adipokinetic hormone receptor activity,MF,
16351,GO:0097010,1,0.87857722994807,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
16352,GO:0097011,1,0.779832054961934,0,6,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
16353,GO:0097012,1,0.779832054961934,0,6,response to granulocyte macrophage colony-stimulating factor,BP,
16355,GO:0097016,1,0.914885099877837,0,2,L27 domain binding,MF,
16356,GO:0097017,1,0.920834053047527,0,2,renal protein absorption,BP,
16357,GO:0097018,1,0.959971557397682,0,1,renal albumin absorption,BP,
16358,GO:0097020,1,0.95775526303453,0,1,COPII adaptor activity,MF,
16359,GO:0097021,1,0.920629027967131,0,2,lymphocyte migration into lymphoid organs,BP,
16360,GO:0097025,1,0.875041591008087,0,3,MPP7-DLG1-LIN7 complex,CC,
16361,GO:0097026,1,0.956441843839217,0,1,dendritic cell dendrite assembly,BP,
16362,GO:0097027,1,0.755760464801142,0,7,ubiquitin-protein transferase activator activity,MF,
16363,GO:0097028,1,0.520163844320381,0,16,dendritic cell differentiation,BP,
16364,GO:0097029,1,0.958822782263901,0,1,mature conventional dendritic cell differentiation,BP,
16366,GO:0097036,1,0.96360482652354,0,1,regulation of plasma membrane sterol distribution,BP,
16367,GO:0097037,1,0.957638381963897,0,1,heme export,BP,
16370,GO:0097045,1,0.956530518223016,0,1,phosphatidylserine exposure on blood platelet,BP,
16371,GO:0097048,1,0.841667833562041,0,4,dendritic cell apoptotic process,BP,
16372,GO:0097049,1,0.809014719937066,0,5,motor neuron apoptotic process,BP,
16373,GO:0097050,1,0.713259420827795,0,8,type B pancreatic cell apoptotic process,BP,
16374,GO:0097051,1,0.875636100096855,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
16375,GO:0097052,1,0.922680826348854,0,2,L-kynurenine metabolic process,BP,
16376,GO:0097055,1,0.921453507270969,0,2,agmatine biosynthetic process,BP,
16377,GO:0097056,1,0.851861648031816,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
16378,GO:0097057,1,0.926997543756142,0,2,TRAF2-GSTP1 complex,CC,
16379,GO:0097058,1,0.96248273445923,0,1,CRLF-CLCF1 complex,CC,
16380,GO:0097059,1,0.96248273445923,0,1,CNTFR-CLCF1 complex,CC,
16384,GO:0097064,1,0.213487910512854,0,37,ncRNA export from nucleus,BP,
16385,GO:0097065,1,0.843146866345891,0,4,anterior head development,BP,
16388,GO:0097068,1,0.878030297446919,0,3,response to thyroxine,BP,
16389,GO:0097069,1,0.917345906062125,0,2,cellular response to thyroxine stimulus,BP,
16390,GO:0097070,1,0.956441843840515,0,1,ductus arteriosus closure,BP,
16391,GO:0097084,1,0.779468307377029,0,6,vascular smooth muscle cell development,BP,
16392,GO:0097086,1,0.95731504647174,0,1,amniotic stem cell differentiation,BP,
16393,GO:0097089,1,0.962917224904392,0,1,methyl-branched fatty acid metabolic process,BP,
16396,GO:0097094,1,0.629900096850571,0,11,craniofacial suture morphogenesis,BP,
16397,GO:0097100,1,0.816385804234994,0,5,supercoiled DNA binding,MF,
16398,GO:0097101,1,0.883235012191011,0,3,blood vessel endothelial cell fate specification,BP,
16399,GO:0097102,1,0.919575017807828,0,2,endothelial tip cell fate specification,BP,
16404,GO:0097108,1,0.956441843839217,0,1,hedgehog family protein binding,MF,
16405,GO:0097109,1,0.915437115220269,0,2,neuroligin family protein binding,MF,
16407,GO:0097111,1,0.914777292668164,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
16408,GO:0097112,1,0.956756130289669,0,1,gamma-aminobutyric acid receptor clustering,BP,
16412,GO:0097117,1,0.956441843839217,0,1,guanylate kinase-associated protein clustering,BP,
16413,GO:0097118,1,0.956441843839217,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
16416,GO:0097123,1,0.96090356467507,0,1,cyclin A1-CDK2 complex,CC,
16417,GO:0097124,1,0.921544989128627,0,2,cyclin A2-CDK2 complex,CC,
16418,GO:0097125,1,0.925539036933124,0,2,cyclin B1-CDK1 complex,CC,
16419,GO:0097129,1,0.888499208874274,0,3,cyclin D2-CDK4 complex,CC,
16420,GO:0097134,1,0.924610342951422,0,2,cyclin E1-CDK2 complex,CC,
16421,GO:0097135,1,0.921744149592245,0,2,cyclin E2-CDK2 complex,CC,
16422,GO:0097136,1,0.780614116908184,0,6,Bcl-2 family protein complex,CC,
16423,GO:0097144,1,0.965207538270858,0,1,BAX complex,CC,
16424,GO:0097145,1,0.961082237055204,0,1,BAK complex,CC,
16425,GO:0097149,1,0.877756446308588,0,3,centralspindlin complex,CC,
16429,GO:0097153,1,0.624418567318584,0,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,
16430,GO:0097154,1,0.855755429082335,0,4,GABAergic neuron differentiation,BP,
16433,GO:0097157,1,0.71471505109685,0,8,pre-mRNA intronic binding,MF,
16434,GO:0097158,1,0.962986911376543,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
16437,GO:0097162,1,0.957916064022112,0,1,MADS box domain binding,MF,
16439,GO:0097165,1,0.810852608979292,0,5,nuclear stress granule,CC,
16440,GO:0097166,1,0.956441843839217,0,1,lens epithelial cell proliferation,BP,
16441,GO:0097167,1,0.846825815151279,0,4,circadian regulation of translation,BP,
16442,GO:0097168,1,0.956597622082252,0,1,mesenchymal stem cell proliferation,BP,
16443,GO:0097169,1,0.897230992426514,0,3,AIM2 inflammasome complex,CC,
16444,GO:0097176,1,0.8552150339831,0,4,epoxide metabolic process,BP,
16445,GO:0097177,1,0.890414703528588,0,3,mitochondrial ribosome binding,MF,
16456,GO:0097195,1,0.919398974482162,0,2,pilomotor reflex,BP,
16457,GO:0097196,1,0.922339812917916,0,2,Shu complex,CC,
16458,GO:0097197,1,0.811022714374038,0,5,tetraspanin-enriched microdomain,CC,
16459,GO:0097198,1,0.91673689393163,0,2,histone H3-K36 trimethylation,BP,
16460,GO:0097199,1,0.820441494043223,0,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
16461,GO:0097200,1,0.647077365301012,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
16467,GO:0097210,1,0.879449249338831,0,3,response to gonadotropin-releasing hormone,BP,
16468,GO:0097211,1,0.879449249338831,0,3,cellular response to gonadotropin-releasing hormone,BP,
16469,GO:0097212,1,0.924259795111138,0,2,lysosomal membrane organization,BP,
16470,GO:0097213,1,0.960916179986395,0,1,regulation of lysosomal membrane permeability,BP,
16471,GO:0097222,1,0.956589907309842,0,1,mitochondrial mRNA polyadenylation,BP,
16473,GO:0097224,1,0.962651352838346,0,1,sperm connecting piece,CC,
16474,GO:0097225,1,0.668326621182288,0,10,sperm midpiece,CC,
16475,GO:0097226,1,0.960750706657499,0,1,sperm mitochondrial sheath,CC,
16476,GO:0097227,1,0.842690597390256,0,4,sperm annulus,CC,
16479,GO:0097231,1,0.962753018386369,0,1,cell motility in response to calcium ion,BP,
16483,GO:0097238,1,0.929897436943776,0,2,cellular response to methylglyoxal,BP,
16485,GO:0097241,1,0.92227475904392,0,2,hematopoietic stem cell migration to bone marrow,BP,
16487,GO:0097252,1,0.881979704563584,0,3,oligodendrocyte apoptotic process,BP,
16488,GO:0097255,1,0.822709266449036,0,5,R2TP complex,CC,
16490,GO:0097267,1,0.877953724210782,0,3,omega-hydroxylase P450 pathway,BP,
16491,GO:0097272,1,0.956441843840515,0,1,ammonia homeostasis,BP,
16492,GO:0097273,1,0.956441843840515,0,1,creatinine homeostasis,BP,
16493,GO:0097274,1,0.915877760825264,0,2,urea homeostasis,BP,
16494,GO:0097275,1,0.956441843840515,0,1,cellular ammonia homeostasis,BP,
16495,GO:0097276,1,0.956441843840515,0,1,cellular creatinine homeostasis,BP,
16496,GO:0097277,1,0.956441843840515,0,1,cellular urea homeostasis,BP,
16497,GO:0097278,1,0.920521090972613,0,2,complement-dependent cytotoxicity,BP,
16498,GO:0097283,1,0.816307294096896,0,5,keratinocyte apoptotic process,BP,
16499,GO:0097284,1,0.634340467185705,0,11,hepatocyte apoptotic process,BP,
16500,GO:0097286,1,0.63187077022259,0,11,iron ion import,BP,
16501,GO:0097291,1,0.961763123114709,0,1,renal phosphate ion absorption,BP,
16503,GO:0097298,1,0.957020014431717,0,1,regulation of nucleus size,BP,
16507,GO:0097309,1,0.919270839167849,0,2,cap1 mRNA methylation,BP,
16508,GO:0097310,1,0.958787867083198,0,1,cap2 mRNA methylation,BP,
16510,GO:0097322,1,0.777592090574901,0,6,7SK snRNA binding,MF,
16511,GO:0097325,1,0.917265661869989,0,2,melanocyte proliferation,BP,
16513,GO:0097329,1,0.596530020010865,0,12,response to antimetabolite,BP,
16514,GO:0097332,1,0.923009923678626,0,2,response to antipsychotic drug,BP,
16515,GO:0097338,1,0.956638398690107,0,1,response to clozapine,BP,
16516,GO:0097340,1,0.629953231539188,0,11,inhibition of cysteine-type endopeptidase activity,BP,
16517,GO:0097341,1,0.629953231539188,0,11,zymogen inhibition,BP,
16518,GO:0097342,1,0.779650809958869,0,6,ripoptosome,CC,
16519,GO:0097343,1,0.876219905777071,0,3,ripoptosome assembly,BP,
16520,GO:0097344,1,0.92312504097429,0,2,Rix1 complex,CC,
16521,GO:0097345,1,0.137958001607568,0,49,mitochondrial outer membrane permeabilization,BP,
16523,GO:0097350,1,0.882774679792387,0,3,neutrophil clearance,BP,
16524,GO:0097352,1,0.248338943933812,0,34,autophagosome maturation,BP,
16525,GO:0097354,1,0.688849020873532,0,9,prenylation,BP,
16526,GO:0097356,1,0.956441843839217,0,1,perinucleolar compartment,CC,
16527,GO:0097359,1,0.914824533249632,0,2,UDP-glucosylation,BP,
16528,GO:0097360,1,0.91785969504351,0,2,chorionic trophoblast cell proliferation,BP,
16529,GO:0097361,1,0.850121982253801,0,4,CIA complex,CC,
16530,GO:0097362,1,0.919069210935997,0,2,MCM8-MCM9 complex,CC,
16531,GO:0097363,1,0.917023459630507,0,2,protein O-GlcNAc transferase activity,MF,
16534,GO:0097368,1,0.882179955803783,0,3,establishment of Sertoli cell barrier,BP,
16535,GO:0097371,1,0.74245141384959,0,7,MDM2/MDM4 family protein binding,MF,
16536,GO:0097372,1,0.962746502046533,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
16537,GO:0097374,1,0.960046682619021,0,1,sensory neuron axon guidance,BP,
16538,GO:0097376,1,0.963656509417758,0,1,interneuron axon guidance,BP,
16539,GO:0097381,1,0.806517501594631,0,5,photoreceptor disc membrane,CC,
16540,GO:0097382,1,0.956441843839217,0,1,deoxynucleoside-diphosphatase activity,MF,
16541,GO:0097383,1,0.956441843839217,0,1,dIDP diphosphatase activity,MF,
16542,GO:0097384,1,0.753081088011311,0,7,cellular lipid biosynthetic process,BP,
16544,GO:0097393,1,0.956441843839217,0,1,telomeric repeat-containing RNA transcription,BP,
16545,GO:0097394,1,0.956441843839217,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
16546,GO:0097396,1,0.844376741468943,0,4,response to interleukin-17,BP,
16547,GO:0097398,1,0.844376741468943,0,4,cellular response to interleukin-17,BP,
16548,GO:0097400,1,0.844376741468943,0,4,interleukin-17-mediated signaling pathway,BP,
16549,GO:0097403,1,0.958466475086436,0,1,cellular response to raffinose,BP,
16550,GO:0097409,1,0.961924900665877,0,1,glial cytoplasmic inclusion,CC,
16551,GO:0097411,1,0.844286561809517,0,4,hypoxia-inducible factor-1alpha signaling pathway,BP,
16552,GO:0097413,1,0.755424920391976,0,7,Lewy body,CC,
16553,GO:0097414,1,0.961924900665877,0,1,classical Lewy body,CC,
16554,GO:0097418,1,0.805659167075602,0,5,neurofibrillary tangle,CC,
16556,GO:0097422,1,0.810159899492557,0,5,tubular endosome,CC,
16557,GO:0097425,1,0.886816116250923,0,3,smooth endoplasmic reticulum part,CC,
16558,GO:0097427,1,0.804421665197698,0,5,microtubule bundle,CC,
16560,GO:0097431,1,0.333565008883227,0,26,mitotic spindle pole,CC,
16561,GO:0097433,1,0.813556350020026,0,5,dense body,CC,
16563,GO:0097440,1,0.622285645802496,0,11,apical dendrite,CC,
16564,GO:0097441,1,0.88401337930269,0,3,basal dendrite,CC,
16565,GO:0097442,1,0.956441957945987,0,1,CA3 pyramidal cell dendrite,CC,
16566,GO:0097443,1,0.805673149304333,0,5,sorting endosome,CC,
16567,GO:0097444,1,0.95646564060065,0,1,spine apparatus,CC,
16569,GO:0097449,1,0.775759044217728,0,6,astrocyte projection,CC,
16570,GO:0097450,1,0.917387506753053,0,2,astrocyte end-foot,CC,
16571,GO:0097451,1,0.917387506753053,0,2,glial limiting end-foot,CC,
16573,GO:0097454,1,0.883183877823139,0,3,Schwann cell microvillus,CC,
16574,GO:0097457,1,0.915780183203709,0,2,hippocampal mossy fiber,CC,
16576,GO:0097462,1,0.961924900665877,0,1,Lewy neurite,CC,
16577,GO:0097466,1,0.844172747112833,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
16579,GO:0097470,1,0.803211910907237,0,5,ribbon synapse,CC,
16581,GO:0097473,1,0.956453524038622,0,1,retinal rod cell apoptotic process,BP,
16582,GO:0097475,1,0.879201447611427,0,3,motor neuron migration,BP,
16587,GO:0097486,1,0.922980020781177,0,2,multivesicular body lumen,CC,
16590,GO:0097490,1,0.840889282995159,0,4,sympathetic neuron projection extension,BP,
16591,GO:0097491,1,0.840889282995159,0,4,sympathetic neuron projection guidance,BP,
16593,GO:0097494,1,0.84830238910651,0,4,regulation of vesicle size,BP,
16595,GO:0097498,1,0.920155128890702,0,2,endothelial tube lumen extension,BP,
16601,GO:0097504,1,0.634517169961253,0,11,Gemini of coiled bodies,CC,
16602,GO:0097505,1,0.956441845949078,0,1,Rad6-Rad18 complex,CC,
16603,GO:0097506,1,0.823750303373382,0,5,deaminated base DNA N-glycosylase activity,MF,
16604,GO:0097510,1,0.961592971414268,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
16605,GO:0097512,1,0.965478319283354,0,1,cardiac myofibril,CC,
16606,GO:0097513,1,0.874924186969474,0,3,myosin II filament,CC,
16608,GO:0097524,1,0.84303202575046,0,4,sperm plasma membrane,CC,
16609,GO:0097525,1,0.0835638886013402,0,62,spliceosomal snRNP complex,CC,
16610,GO:0097526,1,0.32208926792201,0,29,spliceosomal tri-snRNP complex,CC,
16611,GO:0097527,1,0.847133057403824,0,4,necroptotic signaling pathway,BP,
16615,GO:0097532,1,0.957507935744758,0,1,stress response to acid chemical,BP,
16616,GO:0097533,1,0.957507935744758,0,1,cellular stress response to acid chemical,BP,
16617,GO:0097534,1,0.917557782330028,0,2,lymphoid lineage cell migration,BP,
16618,GO:0097535,1,0.917557782330028,0,2,lymphoid lineage cell migration into thymus,BP,
16619,GO:0097536,1,0.959348714077931,0,1,thymus epithelium morphogenesis,BP,
16620,GO:0097539,1,0.647908248684886,0,10,ciliary transition fiber,CC,
16621,GO:0097541,1,0.958787867083198,0,1,axonemal basal plate,CC,
16623,GO:0097543,1,0.917093381492818,0,2,ciliary inversin compartment,CC,
16625,GO:0097550,1,0.788636724743539,0,6,transcriptional preinitiation complex,CC,
16627,GO:0097573,1,0.96382597257255,0,1,glutathione oxidoreductase activity,MF,
16628,GO:0097574,1,0.916661779248921,0,2,lateral part of cell,CC,
16629,GO:0097575,1,0.916661779248921,0,2,lateral cell cortex,CC,
16630,GO:0097576,1,0.918155214198985,0,2,vacuole fusion,BP,
16631,GO:0097577,1,0.894924840711735,0,3,sequestering of iron ion,BP,
16633,GO:0097598,1,0.956446562573103,0,1,sperm cytoplasmic droplet,CC,
16634,GO:0097602,1,0.498187724009014,0,17,cullin family protein binding,MF,
16635,GO:0097603,1,0.956845173675673,0,1,temperature-gated ion channel activity,MF,
16637,GO:0097621,1,0.96070051465296,0,1,monoamine oxidase activity,MF,
16638,GO:0097623,1,0.918488434925391,0,2,potassium ion export across plasma membrane,BP,
16639,GO:0097625,1,0.956441843839217,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
16640,GO:0097626,1,0.956441843839217,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
16641,GO:0097627,1,0.956441843839217,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
16642,GO:0097629,1,0.810509089324168,0,5,extrinsic component of omegasome membrane,CC,
16643,GO:0097630,1,0.958787867083198,0,1,intrinsic component of omegasome membrane,CC,
16644,GO:0097631,1,0.958787867083198,0,1,integral component of omegasome membrane,CC,
16645,GO:0097632,1,0.917034423167437,0,2,extrinsic component of phagophore assembly site membrane,CC,
16646,GO:0097635,1,0.914912964474343,0,2,extrinsic component of autophagosome membrane,CC,
16647,GO:0097636,1,0.917352055899948,0,2,intrinsic component of autophagosome membrane,CC,
16648,GO:0097637,1,0.917352055899948,0,2,integral component of autophagosome membrane,CC,
16649,GO:0097638,1,0.914777292668164,0,2,L-arginine import across plasma membrane,BP,
16650,GO:0097639,1,0.956441843839217,0,1,L-lysine import across plasma membrane,BP,
16651,GO:0097640,1,0.956441843839217,0,1,L-ornithine import across plasma membrane,BP,
16652,GO:0097642,1,0.885459693491824,0,3,calcitonin family receptor activity,MF,
16653,GO:0097643,1,0.964987887329676,0,1,amylin receptor activity,MF,
16654,GO:0097644,1,0.92299227321538,0,2,calcitonin family binding,MF,
16655,GO:0097646,1,0.855451218173388,0,4,calcitonin family receptor signaling pathway,BP,
16656,GO:0097647,1,0.894379953753958,0,3,amylin receptor signaling pathway,BP,
16657,GO:0097648,1,0.883018542835065,0,3,G-protein coupled receptor complex,CC,
16661,GO:0097676,1,0.879297175345616,0,3,histone H3-K36 dimethylation,BP,
16662,GO:0097677,1,0.783433670336047,0,6,STAT family protein binding,MF,
16663,GO:0097680,1,0.879789866385022,0,3,double-strand break repair via classical nonhomologous end joining,BP,
16664,GO:0097681,1,0.914777292668164,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
16665,GO:0097682,1,0.961396650343974,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
16667,GO:0097692,1,0.956441843839217,0,1,histone H3-K4 monomethylation,BP,
16668,GO:0097694,1,0.876968632709881,0,3,establishment of RNA localization to telomere,BP,
16669,GO:0097695,1,0.876968632709881,0,3,establishment of protein-containing complex localization to telomere,BP,
16671,GO:0097698,1,0.963450317578174,0,1,telomere maintenance via base-excision repair,BP,
16672,GO:0097699,1,0.956649598763982,0,1,vascular endothelial cell response to fluid shear stress,BP,
16673,GO:0097707,1,0.964905236546779,0,1,ferroptosis,BP,
16677,GO:0097712,1,0.958787867083198,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16678,GO:0097718,1,0.282534952314271,0,30,disordered domain specific binding,MF,
16681,GO:0097724,1,0.96237411038791,0,1,sperm flagellum movement,BP,
16682,GO:0097726,1,0.964462515643221,0,1,LEM domain binding,MF,
16685,GO:0097731,1,0.115199147122214,0,51,9+0 non-motile cilium,CC,
16686,GO:0097732,1,0.8160152303766,0,5,9+2 non-motile cilium,CC,
16687,GO:0097733,1,0.115199147122214,0,51,photoreceptor cell cilium,CC,
16688,GO:0097734,1,0.499883997300382,0,17,extracellular exosome biogenesis,BP,
16689,GO:0097742,1,0.875582273804052,0,3,de novo centriole assembly,BP,
16690,GO:0097745,1,0.887755534273355,0,3,mitochondrial tRNA 5'-end processing,BP,
16692,GO:0097747,1,0.180273362054759,0,43,RNA polymerase activity,MF,
16693,GO:0097749,1,0.956441843839217,0,1,membrane tubulation,BP,
16694,GO:0097752,1,0.881630140165889,0,3,regulation of DNA stability,BP,
16695,GO:0097753,1,0.957151036049068,0,1,membrane bending,BP,
16698,GO:0098501,1,0.823756401754012,0,5,polynucleotide dephosphorylation,BP,
16699,GO:0098502,1,0.894203457716847,0,3,DNA dephosphorylation,BP,
16700,GO:0098503,1,0.962717105863326,0,1,DNA 3' dephosphorylation,BP,
16701,GO:0098504,1,0.962717105863326,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16702,GO:0098505,1,0.659383843564935,0,10,G-rich strand telomeric DNA binding,MF,
16703,GO:0098506,1,0.962717105863326,0,1,polynucleotide 3' dephosphorylation,BP,
16704,GO:0098507,1,0.921235456348659,0,2,polynucleotide 5' dephosphorylation,BP,
16705,GO:0098508,1,0.922448117982172,0,2,endothelial to hematopoietic transition,BP,
16706,GO:0098518,1,0.886883454483197,0,3,polynucleotide phosphatase activity,MF,
16707,GO:0098519,1,0.813801572496718,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
16709,GO:0098530,1,0.956441843839217,0,1,positive regulation of strand invasion,BP,
16711,GO:0098532,1,0.789743714723241,0,6,histone H3-K27 trimethylation,BP,
16713,GO:0098534,1,0.278664786774649,0,30,centriole assembly,BP,
16714,GO:0098535,1,0.875582273804052,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
16715,GO:0098536,1,0.87612284800679,0,3,deuterosome,CC,
16717,GO:0098543,1,0.773688626676506,0,6,detection of other organism,BP,
16718,GO:0098547,1,0.960876543965003,0,1,lumenal side of Golgi membrane,CC,
16722,GO:0098556,1,0.837847252853737,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
16723,GO:0098559,1,0.88408992513432,0,3,cytoplasmic side of early endosome membrane,CC,
16724,GO:0098560,1,0.920274762959595,0,2,cytoplasmic side of late endosome membrane,CC,
16727,GO:0098573,1,0.0689937210632304,0,66,intrinsic component of mitochondrial membrane,CC,
16728,GO:0098574,1,0.844849839888694,0,4,cytoplasmic side of lysosomal membrane,CC,
16729,GO:0098575,1,0.924036454354143,0,2,lumenal side of lysosomal membrane,CC,
16730,GO:0098576,1,0.850318146566114,0,4,lumenal side of membrane,CC,
16731,GO:0098577,1,0.956441843839217,0,1,inactive sex chromosome,CC,
16732,GO:0098581,1,0.742254722905084,0,7,detection of external biotic stimulus,BP,
16733,GO:0098582,1,0.91563217109309,0,2,innate vocalization behavior,BP,
16738,GO:0098592,1,0.878845069284179,0,3,cytoplasmic side of apical plasma membrane,CC,
16739,GO:0098594,1,0.965367562771685,0,1,mucin granule,CC,
16740,GO:0098596,1,0.837586075374803,0,4,imitative learning,BP,
16741,GO:0098597,1,0.801089444912356,0,5,observational learning,BP,
16742,GO:0098598,1,0.837586075374803,0,4,learned vocalization behavior or vocal learning,BP,
16743,GO:0098599,1,0.667083106055988,0,10,palmitoyl hydrolase activity,MF,
16745,GO:0098619,1,0.962127112927552,0,1,selenocysteine-tRNA ligase activity,MF,
16746,GO:0098621,1,0.956442016918176,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
16747,GO:0098625,1,0.957148855810084,0,1,methylselenol reductase activity,MF,
16748,GO:0098626,1,0.957148855810084,0,1,methylseleninic acid reductase activity,MF,
16749,GO:0098629,1,0.958787867083198,0,1,trans-Golgi network membrane organization,BP,
16751,GO:0098632,1,0.302123166584826,0,29,cell-cell adhesion mediator activity,MF,
16752,GO:0098633,1,0.959883550924,0,1,collagen fibril binding,MF,
16753,GO:0098634,1,0.83754448982897,0,4,cell-matrix adhesion mediator activity,MF,
16755,GO:0098639,1,0.83754448982897,0,4,collagen binding involved in cell-matrix adhesion,MF,
16756,GO:0098641,1,0.46922903989531,0,19,cadherin binding involved in cell-cell adhesion,MF,
16757,GO:0098642,1,0.767973045053476,0,6,network-forming collagen trimer,CC,
16760,GO:0098645,1,0.767973045053476,0,6,collagen network,CC,
16761,GO:0098646,1,0.959574977993315,0,1,collagen sheet,CC,
16764,GO:0098651,1,0.767973045053476,0,6,basement membrane collagen trimer,CC,
16773,GO:0098664,1,0.887725713534676,0,3,G-protein coupled serotonin receptor signaling pathway,BP,
16774,GO:0098679,1,0.914777292668164,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16775,GO:0098680,1,0.966376925420809,0,1,template-free RNA nucleotidyltransferase,MF,
16779,GO:0098700,1,0.92565549106895,0,2,neurotransmitter loading into synaptic vesicle,BP,
16780,GO:0098703,1,0.773029021081203,0,6,calcium ion import across plasma membrane,BP,
16781,GO:0098705,1,0.956532965268136,0,1,copper ion import across plasma membrane,BP,
16782,GO:0098706,1,0.838666770103895,0,4,ferric iron import across plasma membrane,BP,
16783,GO:0098711,1,0.772176529343783,0,6,iron ion import across plasma membrane,BP,
16784,GO:0098712,1,0.774897290112527,0,6,L-glutamate import across plasma membrane,BP,
16785,GO:0098713,1,0.960826153981137,0,1,leucine import across plasma membrane,BP,
16786,GO:0098719,1,0.674877749709655,0,9,sodium ion import across plasma membrane,BP,
16788,GO:0098725,1,0.958787867083198,0,1,symmetric cell division,BP,
16792,GO:0098734,1,0.667083106055988,0,10,macromolecule depalmitoylation,BP,
16793,GO:0098735,1,0.8750681541618,0,3,positive regulation of the force of heart contraction,BP,
16794,GO:0098736,1,0.956441843839217,0,1,negative regulation of the force of heart contraction,BP,
16798,GO:0098745,1,0.962667846714425,0,1,Dcp1-Dcp2 complex,CC,
16799,GO:0098746,1,0.956522932010585,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
16801,GO:0098749,1,0.956582085521582,0,1,cerebellar neuron development,BP,
16808,GO:0098760,1,0.381986911707205,0,25,response to interleukin-7,BP,
16809,GO:0098761,1,0.381986911707205,0,25,cellular response to interleukin-7,BP,
16810,GO:0098770,1,0.915520428314632,0,2,FBXO family protein binding,MF,
16817,GO:0098787,1,0.553248988981929,0,14,mRNA cleavage involved in mRNA processing,BP,
16818,GO:0098789,1,0.628328253848433,0,11,pre-mRNA cleavage required for polyadenylation,BP,
16823,GO:0098795,1,0.917944013151186,0,2,mRNA cleavage involved in gene silencing,BP,
16827,GO:0098799,1,0.62321915301726,0,12,outer mitochondrial membrane protein complex,CC,
16833,GO:0098808,1,0.922280529554315,0,2,mRNA cap binding,MF,
16834,GO:0098809,1,0.959654540720847,0,1,nitrite reductase activity,MF,
16835,GO:0098810,1,0.723339350752198,0,8,neurotransmitter reuptake,BP,
16839,GO:0098816,1,0.961645026588241,0,1,mini excitatory postsynaptic potential,BP,
16840,GO:0098821,1,0.875780425471161,0,3,BMP receptor activity,MF,
16841,GO:0098822,1,0.960153487129964,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
16842,GO:0098826,1,0.848700720312047,0,4,endoplasmic reticulum tubular network membrane,CC,
16845,GO:0098829,1,0.956441843839217,0,1,intestinal folate absorption,BP,
16846,GO:0098830,1,0.956519923983069,0,1,presynaptic endosome,CC,
16848,GO:0098833,1,0.95649307800061,0,1,presynaptic endocytic zone,CC,
16849,GO:0098835,1,0.95649307800061,0,1,presynaptic endocytic zone membrane,CC,
16850,GO:0098837,1,0.885508490176546,0,3,postsynaptic recycling endosome,CC,
16851,GO:0098838,1,0.958932636110817,0,1,reduced folate transmembrane transport,BP,
16853,GO:0098840,1,0.925240543042996,0,2,protein transport along microtubule,BP,
16854,GO:0098842,1,0.922810569182942,0,2,postsynaptic early endosome,CC,
16858,GO:0098847,1,0.583494423211143,0,13,sequence-specific single stranded DNA binding,MF,
16860,GO:0098856,1,0.885262313879302,0,3,intestinal lipid absorption,BP,
16864,GO:0098868,1,0.548121226364703,0,14,bone growth,BP,
16866,GO:0098870,1,0.882603327029523,0,3,action potential propagation,BP,
16867,GO:0098871,1,0.962824313081938,0,1,postsynaptic actin cytoskeleton,CC,
16868,GO:0098875,1,0.956543203622228,0,1,epididymosome,CC,
16872,GO:0098881,1,0.880782942965904,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16873,GO:0098883,1,0.962464157847848,0,1,synapse disassembly,BP,
16875,GO:0098885,1,0.956441843839217,0,1,modification of postsynaptic actin cytoskeleton,BP,
16876,GO:0098886,1,0.917044136833384,0,2,modification of dendritic spine,BP,
16878,GO:0098888,1,0.956441843839217,0,1,extrinsic component of presynaptic membrane,CC,
16879,GO:0098890,1,0.956441843839217,0,1,extrinsic component of postsynaptic membrane,CC,
16880,GO:0098900,1,0.286214027752233,0,29,regulation of action potential,BP,
16881,GO:0098901,1,0.437937929713226,0,19,regulation of cardiac muscle cell action potential,BP,
16882,GO:0098902,1,0.80926729888168,0,5,regulation of membrane depolarization during action potential,BP,
16883,GO:0098903,1,0.771159593383213,0,6,regulation of membrane repolarization during action potential,BP,
16884,GO:0098904,1,0.919900681496951,0,2,regulation of AV node cell action potential,BP,
16885,GO:0098905,1,0.924763732624367,0,2,regulation of bundle of His cell action potential,BP,
16886,GO:0098906,1,0.958142130655448,0,1,regulation of Purkinje myocyte action potential,BP,
16887,GO:0098907,1,0.956441843839217,0,1,regulation of SA node cell action potential,BP,
16888,GO:0098908,1,0.918736271916376,0,2,regulation of neuronal action potential,BP,
16889,GO:0098909,1,0.810509854562324,0,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
16890,GO:0098910,1,0.802593296277404,0,5,regulation of atrial cardiac muscle cell action potential,BP,
16891,GO:0098911,1,0.673598076645526,0,9,regulation of ventricular cardiac muscle cell action potential,BP,
16892,GO:0098912,1,0.956803425292439,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
16893,GO:0098914,1,0.917013663873585,0,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,
16894,GO:0098915,1,0.877590016841052,0,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
16896,GO:0098917,1,0.885156755434827,0,3,retrograde trans-synaptic signaling,BP,
16897,GO:0098918,1,0.962443847498107,0,1,structural constituent of synapse,MF,
16898,GO:0098920,1,0.959267287803167,0,1,retrograde trans-synaptic signaling by lipid,BP,
16899,GO:0098921,1,0.959267287803167,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
16900,GO:0098923,1,0.956441843839217,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
16901,GO:0098924,1,0.956441843839217,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
16902,GO:0098926,1,0.956441843839217,0,1,postsynaptic signal transduction,BP,
16903,GO:0098927,1,0.178483309187905,0,41,vesicle-mediated transport between endosomal compartments,BP,
16904,GO:0098928,1,0.914777292668164,0,2,presynaptic signal transduction,BP,
16906,GO:0098935,1,0.875588662300431,0,3,dendritic transport,BP,
16908,GO:0098937,1,0.875588662300431,0,3,anterograde dendritic transport,BP,
16909,GO:0098939,1,0.956441843839217,0,1,dendritic transport of mitochondrion,BP,
16910,GO:0098943,1,0.921764474317794,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
16912,GO:0098953,1,0.882386352770934,0,3,receptor diffusion trapping,BP,
16913,GO:0098957,1,0.842970306867843,0,4,anterograde axonal transport of mitochondrion,BP,
16914,GO:0098960,1,0.812153811263803,0,5,postsynaptic neurotransmitter receptor activity,MF,
16915,GO:0098967,1,0.880782942965904,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
16916,GO:0098968,1,0.956458141288418,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
16918,GO:0098970,1,0.882386352770934,0,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,
16919,GO:0098971,1,0.915471973033881,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
16920,GO:0098972,1,0.956441843839217,0,1,anterograde dendritic transport of mitochondrion,BP,
16921,GO:0098973,1,0.962443847498107,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16922,GO:0098974,1,0.962443847498107,0,1,postsynaptic actin cytoskeleton organization,BP,
16924,GO:0098978,1,0.914790290945664,0,2,glutamatergic synapse,CC,
16928,GO:0098985,1,0.914790290945664,0,2,asymmetric, glutamatergic, excitatory synapse,CC,
16929,GO:0098988,1,0.956441843839217,0,1,G-protein coupled glutamate receptor activity,MF,
16930,GO:0098989,1,0.921437200003422,0,2,NMDA selective glutamate receptor signaling pathway,BP,
16931,GO:0098993,1,0.727092562990591,0,8,anchored component of synaptic vesicle membrane,CC,
16933,GO:0099004,1,0.914806164979986,0,2,calmodulin dependent kinase signaling pathway,BP,
16934,GO:0099010,1,0.877092467831347,0,3,modification of postsynaptic structure,BP,
16935,GO:0099011,1,0.91533985582349,0,2,neuronal dense core vesicle exocytosis,BP,
16936,GO:0099022,1,0.923492331129658,0,2,vesicle tethering,BP,
16940,GO:0099044,1,0.923492331129658,0,2,vesicle tethering to endoplasmic reticulum,BP,
16941,GO:0099046,1,0.963587510625542,0,1,clearance of foreign intracellular nucleic acids,BP,
16942,GO:0099053,1,0.882107314560019,0,3,activating signal cointegrator 1 complex,CC,
16949,GO:0099073,1,0.916317599728288,0,2,mitochondrion-derived vesicle,CC,
16950,GO:0099074,1,0.91904792696572,0,2,mitochondrion to lysosome transport,BP,
16951,GO:0099075,1,0.91904792696572,0,2,mitochondrion-derived vesicle mediated transport,BP,
16952,GO:0099077,1,0.956441843858147,0,1,histone-dependent DNA binding,MF,
16953,GO:0099078,1,0.725944934549574,0,8,BORC complex,CC,
16956,GO:0099082,1,0.964775768520543,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
16957,GO:0099083,1,0.964775768520543,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
16959,GO:0099086,1,0.491263406300602,0,17,synaptonemal structure,CC,
16960,GO:0099089,1,0.956441843839217,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
16961,GO:0099093,1,0.91702381004546,0,2,calcium export from the mitochondrion,BP,
16963,GO:0099095,1,0.958160049997458,0,1,ligand-gated anion channel activity,MF,
16964,GO:0099098,1,0.958012667701173,0,1,microtubule polymerization based movement,BP,
16965,GO:0099106,1,0.107001408142441,0,54,ion channel regulator activity,MF,
16967,GO:0099116,1,0.533550217523275,0,16,tRNA 5'-end processing,BP,
16968,GO:0099118,1,0.925240543042996,0,2,microtubule-based protein transport,BP,
16970,GO:0099130,1,0.960970281963753,0,1,estrogen binding,MF,
16975,GO:0099159,1,0.956441843839217,0,1,regulation of modification of postsynaptic structure,BP,
16976,GO:0099163,1,0.956441843839217,0,1,synaptic signaling by nitric oxide,BP,
16977,GO:0099170,1,0.879523386602031,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
16980,GO:0099174,1,0.877803864896274,0,3,regulation of presynapse organization,BP,
16983,GO:0099186,1,0.962443847498107,0,1,structural constituent of postsynapse,MF,
16984,GO:0099188,1,0.962443847498107,0,1,postsynaptic cytoskeleton organization,BP,
16986,GO:0099243,1,0.956441843839217,0,1,extrinsic component of synaptic membrane,CC,
16987,GO:0099402,1,0.965280077340104,0,1,plant organ development,BP,
16988,GO:0099403,1,0.914777292668164,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
16989,GO:0099404,1,0.914777292668164,0,2,mitotic sister chromatid cohesion, telomeric,BP,
16990,GO:0099500,1,0.663302268518514,0,10,vesicle fusion to plasma membrane,BP,
16997,GO:0099515,1,0.673124916276092,0,9,actin filament-based transport,BP,
17001,GO:0099519,1,0.958787867083198,0,1,dense core granule cytoskeletal transport,BP,
17002,GO:0099522,1,0.961655785053158,0,1,region of cytosol,CC,
17003,GO:0099523,1,0.961655785053158,0,1,presynaptic cytosol,CC,
17004,GO:0099524,1,0.961655785053158,0,1,postsynaptic cytosol,CC,
17005,GO:0099525,1,0.91533985582349,0,2,presynaptic dense core vesicle exocytosis,BP,
17006,GO:0099526,1,0.914777292668164,0,2,presynapse to nucleus signaling pathway,BP,
17007,GO:0099527,1,0.956441843839217,0,1,postsynapse to nucleus signaling pathway,BP,
17008,GO:0099528,1,0.687803453516441,0,9,G-protein coupled neurotransmitter receptor activity,MF,
17009,GO:0099529,1,0.812153811263803,0,5,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
17011,GO:0099532,1,0.914851978149943,0,2,synaptic vesicle endosomal processing,BP,
17014,GO:0099538,1,0.964775768520543,0,1,synaptic signaling via neuropeptide,BP,
17015,GO:0099540,1,0.964775768520543,0,1,trans-synaptic signaling by neuropeptide,BP,
17018,GO:0099543,1,0.956441843839217,0,1,trans-synaptic signaling by soluble gas,BP,
17020,GO:0099547,1,0.879523386602031,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17021,GO:0099548,1,0.956441843839217,0,1,trans-synaptic signaling by nitric oxide,BP,
17023,GO:0099551,1,0.964775768520543,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17031,GO:0099571,1,0.962824313081938,0,1,postsynaptic cytoskeleton,CC,
17033,GO:0099578,1,0.879523386602031,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
17034,GO:0099580,1,0.956441843839217,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
17036,GO:0099589,1,0.887725713534676,0,3,serotonin receptor activity,MF,
17041,GO:0099606,1,0.956441843839217,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17042,GO:0099607,1,0.956441843839217,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
17043,GO:0099609,1,0.914777292686263,0,2,microtubule lateral binding,MF,
17045,GO:0099617,1,0.957705842925935,0,1,matrix side of mitochondrial inner membrane,CC,
17048,GO:0099624,1,0.917013663873585,0,2,atrial cardiac muscle cell membrane repolarization,BP,
17051,GO:0099628,1,0.882386352770934,0,3,neurotransmitter receptor diffusion trapping,BP,
17053,GO:0099631,1,0.930002003409567,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
17059,GO:0099640,1,0.965013665213141,0,1,axo-dendritic protein transport,BP,
17060,GO:0099641,1,0.965013665213141,0,1,anterograde axonal protein transport,BP,
17064,GO:0100002,1,0.958860813278382,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
17065,GO:0100012,1,0.962464157847848,0,1,regulation of heart induction by canonical Wnt signaling pathway,BP,
17066,GO:0100057,1,0.956441843839217,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
17070,GO:0101006,1,0.890366752235403,0,3,protein histidine phosphatase activity,MF,
17071,GO:0101020,1,0.923891605232603,0,2,estrogen 16-alpha-hydroxylase activity,MF,
17072,GO:0101023,1,0.625020029675939,0,11,vascular endothelial cell proliferation,BP,
17073,GO:0101030,1,0.963887050156494,0,1,tRNA-guanine transglycosylation,BP,
17074,GO:0101031,1,0.640272691120135,0,11,chaperone complex,CC,
17075,GO:0102005,1,0.963394062605121,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
17076,GO:0102007,1,0.962999508446897,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
17077,GO:0102008,1,0.956482182329214,0,1,cytosolic dipeptidase activity,MF,
17078,GO:0102009,1,0.962148044651937,0,1,proline dipeptidase activity,MF,
17079,GO:0102077,1,0.961400259837265,0,1,oleamide hydrolase activity,MF,
17080,GO:0102084,1,0.920816017819461,0,2,L-dopa O-methyltransferase activity,MF,
17081,GO:0102092,1,0.914786712790936,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
17082,GO:0102113,1,0.956441843839217,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
17083,GO:0102121,1,0.920336389017573,0,2,ceramidase activity,MF,
17084,GO:0102131,1,0.956441843839217,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17085,GO:0102132,1,0.956441843839217,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
17087,GO:0102158,1,0.845046611043729,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17088,GO:0102166,1,0.956466035081377,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17089,GO:0102167,1,0.956466035081377,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17090,GO:0102200,1,0.956458054352649,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
17091,GO:0102250,1,0.917623833581945,0,2,linear malto-oligosaccharide phosphorylase activity,MF,
17092,GO:0102336,1,0.811455539240222,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17093,GO:0102337,1,0.811455539240222,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17094,GO:0102338,1,0.811455539240222,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17095,GO:0102339,1,0.959853294248506,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17096,GO:0102340,1,0.959853294248506,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17097,GO:0102341,1,0.959853294248506,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17098,GO:0102342,1,0.959853294248506,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
17099,GO:0102343,1,0.845046611043729,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17100,GO:0102344,1,0.845046611043729,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17101,GO:0102345,1,0.845046611043729,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
17102,GO:0102389,1,0.9594678223719,0,1,polyprenol reductase activity,MF,
17103,GO:0102390,1,0.959525157182243,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
17105,GO:0102420,1,0.843103234600272,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
17106,GO:0102485,1,0.917271182177342,0,2,dATP phosphohydrolase activity,MF,
17107,GO:0102486,1,0.917271182177342,0,2,dCTP phosphohydrolase activity,MF,
17108,GO:0102487,1,0.917271182177342,0,2,dUTP phosphohydrolase activity,MF,
17109,GO:0102488,1,0.917271182177342,0,2,dTTP phosphohydrolase activity,MF,
17110,GO:0102489,1,0.917271182177342,0,2,GTP phosphohydrolase activity,MF,
17111,GO:0102490,1,0.917271182177342,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17112,GO:0102491,1,0.917271182177342,0,2,dGTP phosphohydrolase activity,MF,
17113,GO:0102499,1,0.917623833581945,0,2,SHG alpha-glucan phosphorylase activity,MF,
17114,GO:0102500,1,0.956441843839217,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
17115,GO:0102521,1,0.919853395857011,0,2,tRNA-4-demethylwyosine synthase activity,MF,
17116,GO:0102522,1,0.961009989139617,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
17117,GO:0102524,1,0.958787867083198,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17118,GO:0102567,1,0.603236996898544,0,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
17119,GO:0102568,1,0.603236996898544,0,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
17120,GO:0102571,1,0.956466035081377,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17121,GO:0102704,1,0.958750693191651,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
17122,GO:0102707,1,0.959803113935219,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
17123,GO:0102751,1,0.962450622780884,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
17124,GO:0102752,1,0.958257290505709,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
17125,GO:0102756,1,0.811455539240222,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
17126,GO:0102758,1,0.964335852961828,0,1,very-long-chain enoyl-CoA reductase activity,MF,
17127,GO:0102769,1,0.963018362093173,0,1,dihydroceramide glucosyltransferase activity,MF,
17128,GO:0102773,1,0.956654388295543,0,1,dihydroceramide kinase activity,MF,
17129,GO:0102797,1,0.956491231636102,0,1,geranial:oxygen oxidoreductase activity,MF,
17130,GO:0102798,1,0.956491231636102,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
17131,GO:0102867,1,0.95923239003662,0,1,molybdenum cofactor sulfurtransferase activity,MF,
17132,GO:0102938,1,0.920816017819461,0,2,orcinol O-methyltransferase activity,MF,
17133,GO:0102953,1,0.884448472451438,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
17134,GO:0102965,1,0.919544580289203,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
17135,GO:0102991,1,0.826546643854193,0,5,myristoyl-CoA hydrolase activity,MF,
17136,GO:0103025,1,0.961114764662936,0,1,alpha-amylase activity (releasing maltohexaose),MF,
17137,GO:0103045,1,0.961515633785377,0,1,methione N-acyltransferase activity,MF,
17138,GO:0103046,1,0.956482182329214,0,1,alanylglutamate dipeptidase activity,MF,
17139,GO:0103053,1,0.926016684522019,0,2,1-ethyladenine demethylase activity,MF,
17140,GO:0103066,1,0.963121164903035,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17141,GO:0103067,1,0.963121164903035,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
17142,GO:0103068,1,0.884448472451438,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
17143,GO:0103073,1,0.961400259837265,0,1,anandamide amidohydrolase activity,MF,
17148,GO:0106004,1,0.927947083944993,0,2,tRNA (guanine-N7)-methylation,BP,
17149,GO:0106005,1,0.956441843839217,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
17150,GO:0106014,1,0.923960432834144,0,2,regulation of inflammatory response to wounding,BP,
17151,GO:0106015,1,0.923960432834144,0,2,negative regulation of inflammatory response to wounding,BP,
17152,GO:0106017,1,0.875325094939426,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
17153,GO:0106018,1,0.541477037513138,0,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
17154,GO:0106019,1,0.648064800783389,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
17155,GO:0106020,1,0.919556787298261,0,2,regulation of vesicle docking,BP,
17156,GO:0106022,1,0.957029977034742,0,1,positive regulation of vesicle docking,BP,
17160,GO:0106044,1,0.96492184451589,0,1,guanine deglycation,BP,
17161,GO:0106045,1,0.96492184451589,0,1,guanine deglycation, methylglyoxal removal,BP,
17162,GO:0106046,1,0.96492184451589,0,1,guanine deglycation, glyoxal removal,BP,
17163,GO:0106049,1,0.809865521584479,0,5,regulation of cellular response to osmotic stress,BP,
17164,GO:0106050,1,0.961923130581001,0,1,tRNA 2'-O-methyltransferase activity,MF,
17166,GO:0106057,1,0.87964394329112,0,3,negative regulation of calcineurin-mediated signaling,BP,
17168,GO:0106068,1,0.757522632961878,0,7,SUMO ligase complex,CC,
17169,GO:0106070,1,0.809137406623736,0,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17170,GO:0106071,1,0.879196292332001,0,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17171,GO:0106072,1,0.920335001161914,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17172,GO:0106073,1,0.916486544226887,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
17173,GO:0106074,1,0.601876939980044,0,12,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
17174,GO:0106075,1,0.958224430065193,0,1,peptide N-succinyltransferase activity,MF,
17175,GO:0106077,1,0.841625470272086,0,4,histone succinylation,BP,
17176,GO:0106078,1,0.958224430065193,0,1,histone succinyltransferase activity,MF,
17178,GO:0106088,1,0.956441843839217,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17179,GO:0106089,1,0.956441843839217,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17181,GO:0106101,1,0.962319327276496,0,1,ER-dependent peroxisome localization,BP,
17182,GO:0106104,1,0.918354091887011,0,2,regulation of glutamate receptor clustering,BP,
17183,GO:0110008,1,0.958387477612467,0,1,ncRNA deadenylation,BP,
17184,GO:0110009,1,0.916233541586086,0,2,formin-nucleated actin cable organization,BP,
17185,GO:0110011,1,0.800343094282434,0,5,regulation of basement membrane organization,BP,
17186,GO:0110017,1,0.929378037577743,0,2,cap-independent translational initiation of linear mRNA,BP,
17188,GO:0110021,1,0.920394491200895,0,2,cardiac muscle myoblast proliferation,BP,
17189,GO:0110022,1,0.920394491200895,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17190,GO:0110024,1,0.920394491200895,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
17191,GO:0110025,1,0.958377044402333,0,1,DNA strand resection involved in replication fork processing,BP,
17192,GO:0110026,1,0.958377044402333,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
17193,GO:0110028,1,0.956441843839217,0,1,positive regulation of mitotic spindle organization,BP,
17194,GO:0110029,1,0.95815793451167,0,1,negative regulation of meiosis I,BP,
17196,GO:0110057,1,0.956444007644885,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17197,GO:0110059,1,0.956444007644885,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
17198,GO:0110075,1,0.964905236546779,0,1,regulation of ferroptosis,BP,
17199,GO:0110076,1,0.964905236546779,0,1,negative regulation of ferroptosis,BP,
17200,GO:0110095,1,0.892767244647781,0,3,cellular detoxification of aldehyde,BP,
17201,GO:0110096,1,0.826807520957355,0,5,cellular response to aldehyde,BP,
17202,GO:0120009,1,0.812253433621247,0,5,intermembrane lipid transfer,BP,
17203,GO:0120012,1,0.956446374547937,0,1,intermembrane sphingolipid transfer,BP,
17204,GO:0120013,1,0.812253433621247,0,5,intermembrane lipid transfer activity,MF,
17205,GO:0120016,1,0.956446374547937,0,1,intermembrane sphingolipid transfer activity,MF,
17206,GO:0120017,1,0.956446374547937,0,1,intermembrane ceramide transfer activity,MF,
17216,GO:0120043,1,0.956541446563329,0,1,stereocilium shaft,CC,
17217,GO:0120044,1,0.956541446563329,0,1,stereocilium base,CC,
17218,GO:0120048,1,0.958787867083198,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17219,GO:0120049,1,0.958787867083198,0,1,snRNA (adenine-N6)-methylation,BP,
17220,GO:0120060,1,0.965198421423852,0,1,regulation of gastric emptying,BP,
17221,GO:0120061,1,0.965198421423852,0,1,negative regulation of gastric emptying,BP,
17222,GO:0120063,1,0.965198421423852,0,1,stomach smooth muscle contraction,BP,
17223,GO:0120068,1,0.965198421423852,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17224,GO:0120069,1,0.965198421423852,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
17225,GO:0120077,1,0.956441843839217,0,1,angiogenic sprout fusion,BP,
17226,GO:0120078,1,0.956441843839217,0,1,cell adhesion involved in sprouting angiogenesis,BP,
17227,GO:0120092,1,0.957756992761124,0,1,crotonyl-CoA hydratase activity,MF,
17228,GO:0120093,1,0.957756992761124,0,1,regulation of peptidyl-lysine crotonylation,BP,
17229,GO:0120094,1,0.957756992761124,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
17230,GO:0120103,1,0.676421793735865,0,9,centriolar subdistal appendage,CC,
17231,GO:0120108,1,0.961702355394599,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
17233,GO:0120114,1,0.0417239445449247,0,79,Sm-like protein family complex,CC,
17234,GO:0140007,1,0.850863896376075,0,4,KICSTOR complex,CC,
17235,GO:0140009,1,0.957322704451342,0,1,L-aspartate import across plasma membrane,BP,
17240,GO:0140031,1,0.920838043086313,0,2,phosphorylation-dependent protein binding,MF,
17241,GO:0140033,1,0.497331777355321,0,16,acetylation-dependent protein binding,MF,
17242,GO:0140034,1,0.0932430304000658,0,56,methylation-dependent protein binding,MF,
17243,GO:0140035,1,0.773232487270147,0,6,ubiquitination-like modification-dependent protein binding,MF,
17244,GO:0140036,1,0.773232487270147,0,6,ubiquitin-dependent protein binding,MF,
17245,GO:0140041,1,0.96492184451589,0,1,cellular detoxification of methylglyoxal,BP,
17246,GO:0140052,1,0.880211781864045,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
17247,GO:0140053,1,0.00256027452013357,0,153,mitochondrial gene expression,BP,
17249,GO:0140058,1,0.569339657595219,0,13,neuron projection arborization,BP,
17250,GO:0140059,1,0.809068890285418,0,5,dendrite arborization,BP,
17251,GO:0140064,1,0.956441843839217,0,1,peptide crotonyltransferase activity,MF,
17252,GO:0140065,1,0.956441843839217,0,1,peptide butyryltransferase activity,MF,
17253,GO:0140066,1,0.916035263409977,0,2,peptidyl-lysine crotonylation,BP,
17254,GO:0140067,1,0.956441843839217,0,1,peptidyl-lysine butyrylation,BP,
17255,GO:0140068,1,0.956441843839217,0,1,histone crotonyltransferase activity,MF,
17256,GO:0140069,1,0.956441843839217,0,1,histone butyryltransferase activity,MF,
17257,GO:0140074,1,0.956460512139395,0,1,cardiac endothelial to mesenchymal transition,BP,
17258,GO:0140078,1,0.677075027877337,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17259,GO:0140080,1,0.677075027877337,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17263,GO:0140101,1,0.00804531730402526,0,118,catalytic activity, acting on a tRNA,MF,
17264,GO:0140102,1,0.525279028018017,0,16,catalytic activity, acting on a rRNA,MF,
17265,GO:0140103,1,0.45187278568158,0,19,catalytic activity, acting on a glycoprotein,MF,
17266,GO:0140104,1,0.335381164737471,0,27,molecular carrier activity,MF,
17268,GO:0140112,1,0.460642369190608,0,19,extracellular vesicle biogenesis,BP,
17272,GO:0140142,1,0.470951031069885,0,18,nucleocytoplasmic carrier activity,MF,
17273,GO:0140161,1,0.891532050102327,0,3,monocarboxylate:sodium symporter activity,MF,
17274,GO:0140192,1,0.914777292668164,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17275,GO:0140193,1,0.96385658117475,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17276,GO:0140194,1,0.96385658117475,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17277,GO:0140196,1,0.956441843839217,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17278,GO:0140199,1,0.956441843839217,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17279,GO:0140200,1,0.956441843839217,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17280,GO:0150003,1,0.882929565782838,0,3,regulation of spontaneous synaptic transmission,BP,
17281,GO:0150005,1,0.671366213249069,0,10,enzyme activator complex,CC,
17282,GO:0150011,1,0.735877735263792,0,7,regulation of neuron projection arborization,BP,
17283,GO:0150012,1,0.735877735263792,0,7,positive regulation of neuron projection arborization,BP,
17284,GO:0150018,1,0.878305537977946,0,3,basal dendrite development,BP,
17285,GO:0150019,1,0.878305537977946,0,3,basal dendrite morphogenesis,BP,
17286,GO:0150020,1,0.878305537977946,0,3,basal dendrite arborization,BP,
17287,GO:0150031,1,0.956441843839217,0,1,regulation of protein localization to lysosome,BP,
17288,GO:0150033,1,0.956441843839217,0,1,negative regulation of protein localization to lysosome,BP,
17291,GO:1900003,1,0.88878146415095,0,3,regulation of serine-type endopeptidase activity,BP,
17292,GO:1900004,1,0.88878146415095,0,3,negative regulation of serine-type endopeptidase activity,BP,
17294,GO:1900015,1,0.431128445279421,0,20,regulation of cytokine production involved in inflammatory response,BP,
17295,GO:1900016,1,0.717320499059119,0,8,negative regulation of cytokine production involved in inflammatory response,BP,
17296,GO:1900017,1,0.686285011173974,0,9,positive regulation of cytokine production involved in inflammatory response,BP,
17303,GO:1900028,1,0.851344839040219,0,4,negative regulation of ruffle assembly,BP,
17305,GO:1900034,1,0.0489589365627504,0,72,regulation of cellular response to heat,BP,
17306,GO:1900036,1,0.960568355079732,0,1,positive regulation of cellular response to heat,BP,
17307,GO:1900037,1,0.666439537845251,0,10,regulation of cellular response to hypoxia,BP,
17308,GO:1900038,1,0.780691936391529,0,6,negative regulation of cellular response to hypoxia,BP,
17309,GO:1900039,1,0.964320335152988,0,1,positive regulation of cellular response to hypoxia,BP,
17310,GO:1900040,1,0.805232222281191,0,5,regulation of interleukin-2 secretion,BP,
17311,GO:1900041,1,0.880269708463418,0,3,negative regulation of interleukin-2 secretion,BP,
17312,GO:1900042,1,0.914777513800742,0,2,positive regulation of interleukin-2 secretion,BP,
17313,GO:1900044,1,0.704586202844645,0,8,regulation of protein K63-linked ubiquitination,BP,
17314,GO:1900045,1,0.804541814444232,0,5,negative regulation of protein K63-linked ubiquitination,BP,
17318,GO:1900060,1,0.852049192955376,0,4,negative regulation of ceramide biosynthetic process,BP,
17319,GO:1900062,1,0.957247132213457,0,1,regulation of replicative cell aging,BP,
17320,GO:1900063,1,0.8799127819493,0,3,regulation of peroxisome organization,BP,
17322,GO:1900077,1,0.311868205233599,0,28,negative regulation of cellular response to insulin stimulus,BP,
17324,GO:1900081,1,0.956441843839217,0,1,regulation of arginine catabolic process,BP,
17325,GO:1900082,1,0.956441843839217,0,1,negative regulation of arginine catabolic process,BP,
17326,GO:1900084,1,0.84038886958952,0,4,regulation of peptidyl-tyrosine autophosphorylation,BP,
17327,GO:1900085,1,0.9594314943995,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
17328,GO:1900086,1,0.875933625823614,0,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
17330,GO:1900094,1,0.886249185445182,0,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
17331,GO:1900095,1,0.956441843839217,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
17332,GO:1900098,1,0.962452315797035,0,1,regulation of plasma cell differentiation,BP,
17333,GO:1900100,1,0.962452315797035,0,1,positive regulation of plasma cell differentiation,BP,
17339,GO:1900107,1,0.920773465170597,0,2,regulation of nodal signaling pathway,BP,
17340,GO:1900108,1,0.962710557192641,0,1,negative regulation of nodal signaling pathway,BP,
17341,GO:1900109,1,0.928285885021681,0,2,regulation of histone H3-K9 dimethylation,BP,
17342,GO:1900110,1,0.928285885021681,0,2,negative regulation of histone H3-K9 dimethylation,BP,
17343,GO:1900112,1,0.682543549432945,0,9,regulation of histone H3-K9 trimethylation,BP,
17344,GO:1900113,1,0.81316487837089,0,5,negative regulation of histone H3-K9 trimethylation,BP,
17345,GO:1900114,1,0.914999625810196,0,2,positive regulation of histone H3-K9 trimethylation,BP,
17349,GO:1900118,1,0.748045830698936,0,7,negative regulation of execution phase of apoptosis,BP,
17351,GO:1900120,1,0.527051876640222,0,16,regulation of receptor binding,BP,
17352,GO:1900121,1,0.667038176444434,0,10,negative regulation of receptor binding,BP,
17353,GO:1900122,1,0.788652428905829,0,6,positive regulation of receptor binding,BP,
17354,GO:1900125,1,0.773522593097911,0,6,regulation of hyaluronan biosynthetic process,BP,
17355,GO:1900126,1,0.880176130771543,0,3,negative regulation of hyaluronan biosynthetic process,BP,
17356,GO:1900127,1,0.878856704217046,0,3,positive regulation of hyaluronan biosynthetic process,BP,
17357,GO:1900130,1,0.957373041760869,0,1,regulation of lipid binding,BP,
17358,GO:1900131,1,0.957373041760869,0,1,negative regulation of lipid binding,BP,
17361,GO:1900135,1,0.958822782263901,0,1,positive regulation of renin secretion into blood stream,BP,
17362,GO:1900138,1,0.886359416407815,0,3,negative regulation of phospholipase A2 activity,BP,
17363,GO:1900139,1,0.956478030784591,0,1,negative regulation of arachidonic acid secretion,BP,
17364,GO:1900141,1,0.959971557397682,0,1,regulation of oligodendrocyte apoptotic process,BP,
17365,GO:1900142,1,0.959971557397682,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
17366,GO:1900145,1,0.920773465170597,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17367,GO:1900146,1,0.962710557192641,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17368,GO:1900147,1,0.917021318947511,0,2,regulation of Schwann cell migration,BP,
17369,GO:1900148,1,0.958787867083198,0,1,negative regulation of Schwann cell migration,BP,
17370,GO:1900149,1,0.956441843839217,0,1,positive regulation of Schwann cell migration,BP,
17371,GO:1900150,1,0.923765146736584,0,2,regulation of defense response to fungus,BP,
17372,GO:1900151,1,0.55627136502615,0,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
17373,GO:1900152,1,0.962403089142594,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
17374,GO:1900153,1,0.55627136502615,0,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
17375,GO:1900154,1,0.962827537057955,0,1,regulation of bone trabecula formation,BP,
17376,GO:1900155,1,0.962827537057955,0,1,negative regulation of bone trabecula formation,BP,
17377,GO:1900161,1,0.959070810541141,0,1,regulation of phospholipid scramblase activity,BP,
17378,GO:1900163,1,0.959070810541141,0,1,positive regulation of phospholipid scramblase activity,BP,
17379,GO:1900164,1,0.886249185445182,0,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17380,GO:1900165,1,0.88078721969925,0,3,negative regulation of interleukin-6 secretion,BP,
17381,GO:1900169,1,0.917021318947511,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
17382,GO:1900170,1,0.958787867083198,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
17383,GO:1900175,1,0.920773465170597,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17384,GO:1900176,1,0.962710557192641,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17385,GO:1900180,1,0.0311400498589322,0,83,regulation of protein localization to nucleus,BP,
17386,GO:1900181,1,0.53100600722459,0,15,negative regulation of protein localization to nucleus,BP,
17387,GO:1900182,1,0.0960510578966106,0,56,positive regulation of protein localization to nucleus,BP,
17388,GO:1900186,1,0.882415494731349,0,3,negative regulation of clathrin-dependent endocytosis,BP,
17389,GO:1900193,1,0.815266650730933,0,5,regulation of oocyte maturation,BP,
17390,GO:1900194,1,0.957622348362285,0,1,negative regulation of oocyte maturation,BP,
17391,GO:1900195,1,0.924375741839493,0,2,positive regulation of oocyte maturation,BP,
17392,GO:1900200,1,0.957076563173688,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17393,GO:1900204,1,0.957076563173688,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17394,GO:1900205,1,0.957076563173688,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17395,GO:1900208,1,0.927660644112573,0,2,regulation of cardiolipin metabolic process,BP,
17396,GO:1900210,1,0.927660644112573,0,2,positive regulation of cardiolipin metabolic process,BP,
17397,GO:1900211,1,0.957076563173688,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17398,GO:1900212,1,0.957076563173688,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17399,GO:1900214,1,0.957076563173688,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17400,GO:1900215,1,0.957076563173688,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17401,GO:1900217,1,0.957076563173688,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17402,GO:1900218,1,0.957076563173688,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17405,GO:1900222,1,0.921518616891215,0,2,negative regulation of amyloid-beta clearance,BP,
17406,GO:1900223,1,0.771459929095258,0,6,positive regulation of amyloid-beta clearance,BP,
17407,GO:1900224,1,0.956441843839217,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17408,GO:1900225,1,0.680358646342103,0,9,regulation of NLRP3 inflammasome complex assembly,BP,
17409,GO:1900226,1,0.844665311952853,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
17410,GO:1900227,1,0.839710629082203,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
17411,GO:1900238,1,0.919628828173175,0,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
17413,GO:1900241,1,0.958824132817469,0,1,positive regulation of phenotypic switching,BP,
17414,GO:1900242,1,0.772589024352941,0,6,regulation of synaptic vesicle endocytosis,BP,
17415,GO:1900243,1,0.956455202777739,0,1,negative regulation of synaptic vesicle endocytosis,BP,
17416,GO:1900244,1,0.9196831045348,0,2,positive regulation of synaptic vesicle endocytosis,BP,
17419,GO:1900247,1,0.629903331938201,0,11,regulation of cytoplasmic translational elongation,BP,
17420,GO:1900248,1,0.914777858689248,0,2,negative regulation of cytoplasmic translational elongation,BP,
17421,GO:1900259,1,0.962151529900438,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17422,GO:1900260,1,0.962151529900438,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17423,GO:1900262,1,0.789882613905875,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17424,GO:1900264,1,0.789882613905875,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17429,GO:1900275,1,0.915915110068369,0,2,negative regulation of phospholipase C activity,BP,
17430,GO:1900276,1,0.957631146660816,0,1,regulation of proteinase activated receptor activity,BP,
17431,GO:1900363,1,0.600381924849182,0,12,regulation of mRNA polyadenylation,BP,
17432,GO:1900364,1,0.708882049585634,0,8,negative regulation of mRNA polyadenylation,BP,
17433,GO:1900365,1,0.879497903124353,0,3,positive regulation of mRNA polyadenylation,BP,
17434,GO:1900368,1,0.884018930406982,0,3,regulation of RNA interference,BP,
17435,GO:1900369,1,0.924280434660259,0,2,negative regulation of RNA interference,BP,
17436,GO:1900370,1,0.956447034901267,0,1,positive regulation of RNA interference,BP,
17438,GO:1900372,1,0.493224491365486,0,17,negative regulation of purine nucleotide biosynthetic process,BP,
17440,GO:1900376,1,0.837068687069894,0,4,regulation of secondary metabolite biosynthetic process,BP,
17441,GO:1900377,1,0.914777292668164,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
17442,GO:1900378,1,0.915066673617634,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
17443,GO:1900387,1,0.961432735459601,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
17444,GO:1900390,1,0.928102734246794,0,2,regulation of iron ion import,BP,
17447,GO:1900408,1,0.257247687466198,0,33,negative regulation of cellular response to oxidative stress,BP,
17450,GO:1900425,1,0.81378632209434,0,5,negative regulation of defense response to bacterium,BP,
17455,GO:1900452,1,0.843534500600383,0,4,regulation of long term synaptic depression,BP,
17456,GO:1900453,1,0.922133704076711,0,2,negative regulation of long term synaptic depression,BP,
17457,GO:1900477,1,0.961497625484495,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
17458,GO:1900483,1,0.959677449806295,0,1,regulation of protein targeting to vacuolar membrane,BP,
17459,GO:1900533,1,0.963332843891388,0,1,palmitic acid metabolic process,BP,
17460,GO:1900535,1,0.963332843891388,0,1,palmitic acid biosynthetic process,BP,
17462,GO:1900543,1,0.354379232056614,0,25,negative regulation of purine nucleotide metabolic process,BP,
17464,GO:1900623,1,0.91623542707368,0,2,regulation of monocyte aggregation,BP,
17465,GO:1900625,1,0.91623542707368,0,2,positive regulation of monocyte aggregation,BP,
17466,GO:1900673,1,0.922229886801989,0,2,olefin metabolic process,BP,
17467,GO:1900736,1,0.957631146660816,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17468,GO:1900737,1,0.957631146660816,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17469,GO:1900739,1,0.32087470085315,0,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
17470,GO:1900740,1,0.32087470085315,0,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
17475,GO:1900748,1,0.875011638253947,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
17476,GO:1900750,1,0.652960512143637,0,11,oligopeptide binding,MF,
17477,GO:1900753,1,0.956703057252421,0,1,doxorubicin transport,BP,
17478,GO:1900756,1,0.917447961572577,0,2,protein processing in phagocytic vesicle,BP,
17479,GO:1900825,1,0.846135734708479,0,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17480,GO:1900827,1,0.956441843839217,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17481,GO:1900864,1,0.69876126590185,0,9,mitochondrial RNA modification,BP,
17482,GO:1901003,1,0.958787867083198,0,1,negative regulation of fermentation,BP,
17483,GO:1901004,1,0.964064304805167,0,1,ubiquinone-6 metabolic process,BP,
17484,GO:1901006,1,0.964064304805167,0,1,ubiquinone-6 biosynthetic process,BP,
17486,GO:1901017,1,0.653884394713848,0,10,negative regulation of potassium ion transmembrane transporter activity,BP,
17487,GO:1901018,1,0.68512361674681,0,9,positive regulation of potassium ion transmembrane transporter activity,BP,
17491,GO:1901026,1,0.876219905777071,0,3,ripoptosome assembly involved in necroptotic process,BP,
17492,GO:1901028,1,0.176233634615846,0,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17493,GO:1901029,1,0.759326248831282,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17494,GO:1901030,1,0.241394349896787,0,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17496,GO:1901032,1,0.589798279858733,0,13,negative regulation of response to reactive oxygen species,BP,
17499,GO:1901069,1,0.928360745403639,0,2,guanosine-containing compound catabolic process,BP,
17501,GO:1901071,1,0.512364434725318,0,16,glucosamine-containing compound metabolic process,BP,
17502,GO:1901072,1,0.816264149579086,0,5,glucosamine-containing compound catabolic process,BP,
17503,GO:1901073,1,0.915471231064941,0,2,glucosamine-containing compound biosynthetic process,BP,
17504,GO:1901074,1,0.956441843839217,0,1,regulation of engulfment of apoptotic cell,BP,
17505,GO:1901076,1,0.956441843839217,0,1,positive regulation of engulfment of apoptotic cell,BP,
17506,GO:1901077,1,0.842525945972861,0,4,regulation of relaxation of muscle,BP,
17507,GO:1901078,1,0.956441843839217,0,1,negative regulation of relaxation of muscle,BP,
17508,GO:1901086,1,0.95647281873084,0,1,benzylpenicillin metabolic process,BP,
17509,GO:1901090,1,0.921725679883459,0,2,regulation of protein tetramerization,BP,
17510,GO:1901091,1,0.921725679883459,0,2,negative regulation of protein tetramerization,BP,
17511,GO:1901093,1,0.921725679883459,0,2,regulation of protein homotetramerization,BP,
17512,GO:1901094,1,0.921725679883459,0,2,negative regulation of protein homotetramerization,BP,
17513,GO:1901096,1,0.651272721654073,0,10,regulation of autophagosome maturation,BP,
17514,GO:1901097,1,0.844376378709923,0,4,negative regulation of autophagosome maturation,BP,
17515,GO:1901098,1,0.770815091335956,0,6,positive regulation of autophagosome maturation,BP,
17520,GO:1901142,1,0.771716238769779,0,6,insulin metabolic process,BP,
17521,GO:1901143,1,0.915882207732011,0,2,insulin catabolic process,BP,
17522,GO:1901145,1,0.915849294705781,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17523,GO:1901147,1,0.957076563173688,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
17524,GO:1901159,1,0.82321251037947,0,5,xylulose 5-phosphate biosynthetic process,BP,
17525,GO:1901160,1,0.744364213979256,0,7,primary amino compound metabolic process,BP,
17526,GO:1901162,1,0.921453507270969,0,2,primary amino compound biosynthetic process,BP,
17528,GO:1901164,1,0.895138082849776,0,3,negative regulation of trophoblast cell migration,BP,
17530,GO:1901166,1,0.879190074232147,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
17533,GO:1901186,1,0.32495910787822,0,27,positive regulation of ERBB signaling pathway,BP,
17534,GO:1901187,1,0.918647914176205,0,2,regulation of ephrin receptor signaling pathway,BP,
17535,GO:1901189,1,0.96048839507273,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17538,GO:1901201,1,0.619471910854314,0,11,regulation of extracellular matrix assembly,BP,
17539,GO:1901202,1,0.9605114596766,0,1,negative regulation of extracellular matrix assembly,BP,
17540,GO:1901203,1,0.704004107102853,0,8,positive regulation of extracellular matrix assembly,BP,
17541,GO:1901207,1,0.956976854542281,0,1,regulation of heart looping,BP,
17542,GO:1901213,1,0.717835454344561,0,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17545,GO:1901216,1,0.0693050617841142,0,64,positive regulation of neuron death,BP,
17547,GO:1901223,1,0.721936206873583,0,8,negative regulation of NIK/NF-kappaB signaling,BP,
17549,GO:1901228,1,0.956725253418938,0,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17550,GO:1901229,1,0.959690575072104,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17551,GO:1901231,1,0.959690575072104,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17552,GO:1901232,1,0.959690575072104,0,1,regulation of convergent extension involved in axis elongation,BP,
17553,GO:1901233,1,0.959690575072104,0,1,negative regulation of convergent extension involved in axis elongation,BP,
17554,GO:1901252,1,0.923120361116135,0,2,regulation of intracellular transport of viral material,BP,
17555,GO:1901253,1,0.964909985697755,0,1,negative regulation of intracellular transport of viral material,BP,
17556,GO:1901254,1,0.95669375652552,0,1,positive regulation of intracellular transport of viral material,BP,
17557,GO:1901255,1,0.921210446025598,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
17558,GO:1901256,1,0.882300868091406,0,3,regulation of macrophage colony-stimulating factor production,BP,
17559,GO:1901257,1,0.960618270503813,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
17560,GO:1901258,1,0.959305523469562,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
17563,GO:1901269,1,0.932291866263446,0,2,lipooligosaccharide metabolic process,BP,
17564,GO:1901271,1,0.932291866263446,0,2,lipooligosaccharide biosynthetic process,BP,
17565,GO:1901291,1,0.962079892990832,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
17568,GO:1901295,1,0.924432725524386,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17569,GO:1901296,1,0.962464157847848,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17570,GO:1901297,1,0.96048839507273,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17572,GO:1901299,1,0.814295188495731,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
17574,GO:1901301,1,0.917649396946629,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
17575,GO:1901303,1,0.959299384807479,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
17576,GO:1901304,1,0.962814632476997,0,1,regulation of spermidine biosynthetic process,BP,
17577,GO:1901307,1,0.962814632476997,0,1,positive regulation of spermidine biosynthetic process,BP,
17578,GO:1901314,1,0.878494070778718,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17579,GO:1901315,1,0.878494070778718,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
17580,GO:1901317,1,0.854133018782546,0,4,regulation of flagellated sperm motility,BP,
17581,GO:1901318,1,0.958787867083198,0,1,negative regulation of flagellated sperm motility,BP,
17582,GO:1901321,1,0.962464157847848,0,1,positive regulation of heart induction,BP,
17583,GO:1901328,1,0.962443847498107,0,1,response to cytochalasin B,BP,
17584,GO:1901329,1,0.922079653614987,0,2,regulation of odontoblast differentiation,BP,
17585,GO:1901331,1,0.958145282645265,0,1,positive regulation of odontoblast differentiation,BP,
17586,GO:1901337,1,0.9594678223719,0,1,thioester transport,BP,
17587,GO:1901338,1,0.888839308457112,0,3,catecholamine binding,MF,
17588,GO:1901339,1,0.802803422982705,0,5,regulation of store-operated calcium channel activity,BP,
17589,GO:1901340,1,0.956850374503266,0,1,negative regulation of store-operated calcium channel activity,BP,
17590,GO:1901341,1,0.87566421507486,0,3,positive regulation of store-operated calcium channel activity,BP,
17593,GO:1901344,1,0.964031934225656,0,1,response to leptomycin B,BP,
17594,GO:1901350,1,0.956441843839217,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
17595,GO:1901355,1,0.919336959483034,0,2,response to rapamycin,BP,
17600,GO:1901373,1,0.96365364851103,0,1,lipid hydroperoxide transport,BP,
17601,GO:1901376,1,0.959223330954023,0,1,organic heteropentacyclic compound metabolic process,BP,
17602,GO:1901377,1,0.959223330954023,0,1,organic heteropentacyclic compound catabolic process,BP,
17604,GO:1901380,1,0.653884394713848,0,10,negative regulation of potassium ion transmembrane transport,BP,
17605,GO:1901381,1,0.626750469972975,0,11,positive regulation of potassium ion transmembrane transport,BP,
17606,GO:1901382,1,0.91785969504351,0,2,regulation of chorionic trophoblast cell proliferation,BP,
17607,GO:1901385,1,0.577829291770232,0,13,regulation of voltage-gated calcium channel activity,BP,
17608,GO:1901386,1,0.847027239847142,0,4,negative regulation of voltage-gated calcium channel activity,BP,
17609,GO:1901387,1,0.876399581235624,0,3,positive regulation of voltage-gated calcium channel activity,BP,
17610,GO:1901388,1,0.959843233179047,0,1,regulation of transforming growth factor beta activation,BP,
17611,GO:1901389,1,0.959843233179047,0,1,negative regulation of transforming growth factor beta activation,BP,
17612,GO:1901407,1,0.691934718589239,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17613,GO:1901409,1,0.753522635104016,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17614,GO:1901419,1,0.956704721962182,0,1,regulation of response to alcohol,BP,
17615,GO:1901421,1,0.956704721962182,0,1,positive regulation of response to alcohol,BP,
17616,GO:1901474,1,0.847994902700898,0,4,azole transmembrane transporter activity,MF,
17617,GO:1901475,1,0.880176319609871,0,3,pyruvate transmembrane transport,BP,
17618,GO:1901490,1,0.84226179872893,0,4,regulation of lymphangiogenesis,BP,
17619,GO:1901491,1,0.915911057466843,0,2,negative regulation of lymphangiogenesis,BP,
17620,GO:1901492,1,0.919602928284471,0,2,positive regulation of lymphangiogenesis,BP,
17621,GO:1901503,1,0.814909580629098,0,5,ether biosynthetic process,BP,
17623,GO:1901509,1,0.916397228706998,0,2,regulation of endothelial tube morphogenesis,BP,
17624,GO:1901522,1,0.429528285070653,0,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
17625,GO:1901523,1,0.958787867083198,0,1,icosanoid catabolic process,BP,
17627,GO:1901525,1,0.772270770221125,0,6,negative regulation of mitophagy,BP,
17629,GO:1901529,1,0.917405227338991,0,2,positive regulation of anion channel activity,BP,
17630,GO:1901532,1,0.0193758136796032,0,103,regulation of hematopoietic progenitor cell differentiation,BP,
17631,GO:1901533,1,0.783958575079782,0,6,negative regulation of hematopoietic progenitor cell differentiation,BP,
17632,GO:1901534,1,0.916424297266538,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
17633,GO:1901535,1,0.803740519771637,0,5,regulation of DNA demethylation,BP,
17634,GO:1901536,1,0.918658155227108,0,2,negative regulation of DNA demethylation,BP,
17635,GO:1901537,1,0.874927366610461,0,3,positive regulation of DNA demethylation,BP,
17636,GO:1901538,1,0.776257736194106,0,6,changes to DNA methylation involved in embryo development,BP,
17637,GO:1901545,1,0.958466475086436,0,1,response to raffinose,BP,
17638,GO:1901550,1,0.710485363805494,0,8,regulation of endothelial cell development,BP,
17639,GO:1901551,1,0.956799314128339,0,1,negative regulation of endothelial cell development,BP,
17640,GO:1901552,1,0.916195465297404,0,2,positive regulation of endothelial cell development,BP,
17641,GO:1901555,1,0.956441843839217,0,1,response to paclitaxel,BP,
17642,GO:1901558,1,0.962278046052311,0,1,response to metformin,BP,
17644,GO:1901563,1,0.80691983171654,0,5,response to camptothecin,BP,
17648,GO:1901567,1,0.434828349542654,0,21,fatty acid derivative binding,MF,
17650,GO:1901569,1,0.814095639848964,0,5,fatty acid derivative catabolic process,BP,
17652,GO:1901571,1,0.450129260114267,0,19,fatty acid derivative transport,BP,
17655,GO:1901580,1,0.956441843839217,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17656,GO:1901581,1,0.956441843839217,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17657,GO:1901582,1,0.956441843839217,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17659,GO:1901594,1,0.956845173675673,0,1,response to capsazepine,BP,
17668,GO:1901618,1,0.532936706781395,0,15,organic hydroxy compound transmembrane transporter activity,MF,
17671,GO:1901622,1,0.959716899478148,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17677,GO:1901631,1,0.956441843839217,0,1,positive regulation of presynaptic membrane organization,BP,
17678,GO:1901639,1,0.956441843839217,0,1,XDP catabolic process,BP,
17679,GO:1901640,1,0.956441843839217,0,1,XTP binding,MF,
17680,GO:1901641,1,0.956441843839217,0,1,ITP binding,MF,
17686,GO:1901656,1,0.917271787395519,0,2,glycoside transport,BP,
17690,GO:1901660,1,0.773963929776761,0,6,calcium ion export,BP,
17693,GO:1901663,1,0.581728394349116,0,14,quinone biosynthetic process,BP,
17694,GO:1901664,1,0.886086341402624,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17695,GO:1901666,1,0.886086341402624,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
17696,GO:1901668,1,0.925152499308219,0,2,regulation of superoxide dismutase activity,BP,
17697,GO:1901671,1,0.96492184451589,0,1,positive regulation of superoxide dismutase activity,BP,
17698,GO:1901673,1,0.453329934243007,0,19,regulation of mitotic spindle assembly,BP,
17699,GO:1901674,1,0.87761137653759,0,3,regulation of histone H3-K27 acetylation,BP,
17700,GO:1901675,1,0.956441843839217,0,1,negative regulation of histone H3-K27 acetylation,BP,
17701,GO:1901676,1,0.95703141001995,0,1,positive regulation of histone H3-K27 acetylation,BP,
17702,GO:1901678,1,0.686466529556774,0,9,iron coordination entity transport,BP,
17703,GO:1901679,1,0.721752257485336,0,8,nucleotide transmembrane transport,BP,
17704,GO:1901680,1,0.956441843839217,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
17707,GO:1901685,1,0.555476793451056,0,16,glutathione derivative metabolic process,BP,
17708,GO:1901687,1,0.555476793451056,0,16,glutathione derivative biosynthetic process,BP,
17714,GO:1901707,1,0.964031934225656,0,1,leptomycin B binding,MF,
17715,GO:1901722,1,0.634930818228072,0,11,regulation of cell proliferation involved in kidney development,BP,
17716,GO:1901723,1,0.811608195691283,0,5,negative regulation of cell proliferation involved in kidney development,BP,
17717,GO:1901724,1,0.782394159516913,0,6,positive regulation of cell proliferation involved in kidney development,BP,
17718,GO:1901725,1,0.77026216748741,0,6,regulation of histone deacetylase activity,BP,
17719,GO:1901726,1,0.956441843839217,0,1,negative regulation of histone deacetylase activity,BP,
17720,GO:1901727,1,0.841694814172619,0,4,positive regulation of histone deacetylase activity,BP,
17722,GO:1901739,1,0.666362315834909,0,10,regulation of myoblast fusion,BP,
17723,GO:1901740,1,0.961919589858684,0,1,negative regulation of myoblast fusion,BP,
17724,GO:1901741,1,0.692762499022472,0,9,positive regulation of myoblast fusion,BP,
17725,GO:1901748,1,0.884448472451438,0,3,leukotriene D4 metabolic process,BP,
17726,GO:1901750,1,0.884448472451438,0,3,leukotriene D4 biosynthetic process,BP,
17727,GO:1901751,1,0.960461819250754,0,1,leukotriene A4 metabolic process,BP,
17729,GO:1901797,1,0.376614633114354,0,24,negative regulation of signal transduction by p53 class mediator,BP,
17730,GO:1901798,1,0.523430776700074,0,16,positive regulation of signal transduction by p53 class mediator,BP,
17733,GO:1901804,1,0.96032783469921,0,1,beta-glucoside metabolic process,BP,
17734,GO:1901805,1,0.96032783469921,0,1,beta-glucoside catabolic process,BP,
17735,GO:1901834,1,0.962667846714425,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17736,GO:1901835,1,0.962667846714425,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17737,GO:1901836,1,0.634836043416225,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17738,GO:1901837,1,0.924647949159758,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17739,GO:1901838,1,0.68661204910653,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17740,GO:1901841,1,0.848575692502545,0,4,regulation of high voltage-gated calcium channel activity,BP,
17741,GO:1901842,1,0.963507574705954,0,1,negative regulation of high voltage-gated calcium channel activity,BP,
17742,GO:1901843,1,0.915745090307797,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
17743,GO:1901844,1,0.748307548044834,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17744,GO:1901856,1,0.920443469955834,0,2,negative regulation of cellular respiration,BP,
17745,GO:1901857,1,0.826242844542859,0,5,positive regulation of cellular respiration,BP,
17746,GO:1901858,1,0.847144716228625,0,4,regulation of mitochondrial DNA metabolic process,BP,
17747,GO:1901859,1,0.87874302632249,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
17748,GO:1901860,1,0.964050836212264,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
17750,GO:1901862,1,0.249803084195334,0,33,negative regulation of muscle tissue development,BP,
17760,GO:1901894,1,0.88394109174526,0,3,regulation of calcium-transporting ATPase activity,BP,
17761,GO:1901895,1,0.956441843839217,0,1,negative regulation of calcium-transporting ATPase activity,BP,
17762,GO:1901896,1,0.924204074613678,0,2,positive regulation of calcium-transporting ATPase activity,BP,
17763,GO:1901897,1,0.876031568640207,0,3,regulation of relaxation of cardiac muscle,BP,
17764,GO:1901898,1,0.956441843839217,0,1,negative regulation of relaxation of cardiac muscle,BP,
17765,GO:1901906,1,0.851608970642098,0,4,diadenosine pentaphosphate metabolic process,BP,
17766,GO:1901907,1,0.851608970642098,0,4,diadenosine pentaphosphate catabolic process,BP,
17767,GO:1901908,1,0.851608970642098,0,4,diadenosine hexaphosphate metabolic process,BP,
17768,GO:1901909,1,0.851608970642098,0,4,diadenosine hexaphosphate catabolic process,BP,
17769,GO:1901910,1,0.851608970642098,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17770,GO:1901911,1,0.851608970642098,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
17771,GO:1901917,1,0.959193269451407,0,1,regulation of exoribonuclease activity,BP,
17772,GO:1901919,1,0.959193269451407,0,1,positive regulation of exoribonuclease activity,BP,
17773,GO:1901950,1,0.958787867083198,0,1,dense core granule transport,BP,
17774,GO:1901962,1,0.960955849389069,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
17775,GO:1901963,1,0.921769589308137,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
17776,GO:1901964,1,0.962531515651986,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
17777,GO:1901970,1,0.7186479201461,0,8,positive regulation of mitotic sister chromatid separation,BP,
17779,GO:1901977,1,0.781175003612321,0,6,negative regulation of cell cycle checkpoint,BP,
17781,GO:1901979,1,0.91763696366307,0,2,regulation of inward rectifier potassium channel activity,BP,
17782,GO:1901980,1,0.956441843839217,0,1,positive regulation of inward rectifier potassium channel activity,BP,
17793,GO:1901993,1,0.918693464112885,0,2,regulation of meiotic cell cycle phase transition,BP,
17794,GO:1901994,1,0.918693464112885,0,2,negative regulation of meiotic cell cycle phase transition,BP,
17799,GO:1902010,1,0.957555241268031,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
17802,GO:1902019,1,0.812119059584258,0,5,regulation of cilium-dependent cell motility,BP,
17804,GO:1902023,1,0.846583382734943,0,4,L-arginine transport,BP,
17805,GO:1902031,1,0.783337442649628,0,6,regulation of NADP metabolic process,BP,
17806,GO:1902033,1,0.811023124817205,0,5,regulation of hematopoietic stem cell proliferation,BP,
17807,GO:1902035,1,0.845428588926454,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
17808,GO:1902036,1,0.0270411347343142,0,95,regulation of hematopoietic stem cell differentiation,BP,
17809,GO:1902037,1,0.882473638030959,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
17810,GO:1902038,1,0.957627141328324,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17815,GO:1902045,1,0.960497262593105,0,1,negative regulation of Fas signaling pathway,BP,
17816,GO:1902047,1,0.814443352971844,0,5,polyamine transmembrane transport,BP,
17817,GO:1902065,1,0.686222488552182,0,9,response to L-glutamate,BP,
17818,GO:1902071,1,0.964320335152988,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17819,GO:1902073,1,0.964320335152988,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17820,GO:1902074,1,0.61462493932305,0,12,response to salt,BP,
17821,GO:1902075,1,0.786341267051402,0,6,cellular response to salt,BP,
17822,GO:1902083,1,0.803934072101896,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
17823,GO:1902093,1,0.890855604102388,0,3,positive regulation of flagellated sperm motility,BP,
17824,GO:1902098,1,0.956550284375981,0,1,calcitriol binding,MF,
17825,GO:1902099,1,0.150715117796268,0,46,regulation of metaphase/anaphase transition of cell cycle,BP,
17826,GO:1902100,1,0.292015308162554,0,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,
17827,GO:1902101,1,0.7186479201461,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17828,GO:1902102,1,0.958436723289691,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17829,GO:1902103,1,0.958436723289691,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17833,GO:1902108,1,0.112700141547301,0,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
17834,GO:1902109,1,0.893125411892153,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
17835,GO:1902110,1,0.127117944044378,0,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
17838,GO:1902117,1,0.0867249439382759,0,57,positive regulation of organelle assembly,BP,
17839,GO:1902121,1,0.956550284375981,0,1,lithocholic acid binding,MF,
17840,GO:1902145,1,0.958787867083198,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17841,GO:1902151,1,0.958787867083198,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17842,GO:1902153,1,0.958787867083198,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17843,GO:1902162,1,0.927620014088493,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17844,GO:1902164,1,0.927620014088493,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17845,GO:1902165,1,0.578389438934307,0,14,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17846,GO:1902166,1,0.624822543402585,0,12,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17847,GO:1902167,1,0.965712647677366,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17849,GO:1902172,1,0.816307294096896,0,5,regulation of keratinocyte apoptotic process,BP,
17850,GO:1902173,1,0.958103615289262,0,1,negative regulation of keratinocyte apoptotic process,BP,
17851,GO:1902174,1,0.923423792820874,0,2,positive regulation of keratinocyte apoptotic process,BP,
17852,GO:1902175,1,0.389684090522668,0,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17853,GO:1902176,1,0.523726514717265,0,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17854,GO:1902177,1,0.817358170775182,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17855,GO:1902178,1,0.956736508106928,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
17856,GO:1902186,1,0.294741646331529,0,29,regulation of viral release from host cell,BP,
17857,GO:1902187,1,0.549286613359551,0,14,negative regulation of viral release from host cell,BP,
17858,GO:1902188,1,0.537943355945618,0,15,positive regulation of viral release from host cell,BP,
17859,GO:1902202,1,0.922196086150076,0,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,
17860,GO:1902205,1,0.962791993675891,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17861,GO:1902206,1,0.962791993675891,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17862,GO:1902211,1,0.958787867083198,0,1,regulation of prolactin signaling pathway,BP,
17863,GO:1902213,1,0.958787867083198,0,1,positive regulation of prolactin signaling pathway,BP,
17864,GO:1902214,1,0.920851361114704,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
17865,GO:1902215,1,0.962791993675891,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17866,GO:1902216,1,0.956441843839217,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
17867,GO:1902218,1,0.809865521584479,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17868,GO:1902219,1,0.839660370959724,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17869,GO:1902220,1,0.964528097000344,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17870,GO:1902221,1,0.862815042308572,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
17871,GO:1902222,1,0.862815042308572,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
17872,GO:1902224,1,0.748875506559121,0,7,ketone body metabolic process,BP,
17873,GO:1902226,1,0.924508809459509,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
17874,GO:1902227,1,0.962791993675891,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17875,GO:1902228,1,0.960240360586506,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
17878,GO:1902231,1,0.794262292940626,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17879,GO:1902232,1,0.923650276605685,0,2,regulation of positive thymic T cell selection,BP,
17880,GO:1902233,1,0.962791993675891,0,1,negative regulation of positive thymic T cell selection,BP,
17882,GO:1902236,1,0.588762458858807,0,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17884,GO:1902238,1,0.956804113537241,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17885,GO:1902239,1,0.956804113537241,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17886,GO:1902253,1,0.417073861612283,0,22,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17887,GO:1902254,1,0.502041191594864,0,17,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17888,GO:1902255,1,0.899503697652953,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17889,GO:1902256,1,0.915927906554526,0,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17890,GO:1902257,1,0.957627141328324,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17892,GO:1902260,1,0.849591197095088,0,4,negative regulation of delayed rectifier potassium channel activity,BP,
17893,GO:1902261,1,0.915289042915834,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
17894,GO:1902262,1,0.849563238769688,0,4,apoptotic process involved in blood vessel morphogenesis,BP,
17895,GO:1902263,1,0.882997263107856,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
17896,GO:1902267,1,0.851093614098831,0,4,regulation of polyamine transmembrane transport,BP,
17897,GO:1902268,1,0.927822221895377,0,2,negative regulation of polyamine transmembrane transport,BP,
17898,GO:1902269,1,0.917314641001775,0,2,positive regulation of polyamine transmembrane transport,BP,
17899,GO:1902271,1,0.956550284375981,0,1,D3 vitamins binding,MF,
17901,GO:1902282,1,0.958779864066691,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
17902,GO:1902283,1,0.956936800169417,0,1,negative regulation of primary amine oxidase activity,BP,
17906,GO:1902292,1,0.964312562666044,0,1,cell cycle DNA replication initiation,BP,
17907,GO:1902296,1,0.95788983562322,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17908,GO:1902298,1,0.919051928691434,0,2,cell cycle DNA replication maintenance of fidelity,BP,
17909,GO:1902299,1,0.888500646288565,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
17910,GO:1902302,1,0.914899642753525,0,2,regulation of potassium ion export,BP,
17911,GO:1902304,1,0.956530518223016,0,1,positive regulation of potassium ion export,BP,
17913,GO:1902306,1,0.681698844576111,0,9,negative regulation of sodium ion transmembrane transport,BP,
17914,GO:1902307,1,0.577159809198651,0,13,positive regulation of sodium ion transmembrane transport,BP,
17915,GO:1902308,1,0.88403118980699,0,3,regulation of peptidyl-serine dephosphorylation,BP,
17916,GO:1902309,1,0.920476795967506,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
17917,GO:1902310,1,0.960412322702609,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,
17918,GO:1902311,1,0.962568329635982,0,1,regulation of copper ion transmembrane transport,BP,
17919,GO:1902315,1,0.964312562666044,0,1,nuclear cell cycle DNA replication initiation,BP,
17920,GO:1902319,1,0.95788983562322,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
17921,GO:1902336,1,0.9192489837951,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
17922,GO:1902337,1,0.740976641212537,0,7,regulation of apoptotic process involved in morphogenesis,BP,
17923,GO:1902338,1,0.877035314520591,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
17924,GO:1902339,1,0.883375695311614,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
17925,GO:1902356,1,0.962165461126179,0,1,oxaloacetate(2-) transmembrane transport,BP,
17926,GO:1902358,1,0.775440881494352,0,6,sulfate transmembrane transport,BP,
17927,GO:1902359,1,0.922350572140279,0,2,Notch signaling pathway involved in somitogenesis,BP,
17928,GO:1902362,1,0.959043316010659,0,1,melanocyte apoptotic process,BP,
17929,GO:1902363,1,0.956441843839217,0,1,regulation of protein localization to spindle pole body,BP,
17930,GO:1902365,1,0.956441843839217,0,1,positive regulation of protein localization to spindle pole body,BP,
17931,GO:1902366,1,0.922350572140279,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
17932,GO:1902367,1,0.922350572140279,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
17933,GO:1902369,1,0.200027561046719,0,38,negative regulation of RNA catabolic process,BP,
17934,GO:1902373,1,0.257530385413034,0,32,negative regulation of mRNA catabolic process,BP,
17935,GO:1902378,1,0.960046682619021,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
17936,GO:1902379,1,0.956441843839217,0,1,chemoattractant activity involved in axon guidance,MF,
17937,GO:1902380,1,0.960261301714898,0,1,positive regulation of endoribonuclease activity,BP,
17938,GO:1902387,1,0.958787867083198,0,1,ceramide 1-phosphate binding,MF,
17939,GO:1902388,1,0.958787867083198,0,1,ceramide 1-phosphate transporter activity,MF,
17940,GO:1902389,1,0.958787867083198,0,1,ceramide 1-phosphate transport,BP,
17941,GO:1902396,1,0.957039094088157,0,1,protein localization to bicellular tight junction,BP,
17945,GO:1902410,1,0.780839380501673,0,6,mitotic cytokinetic process,BP,
17946,GO:1902412,1,0.876202803642545,0,3,regulation of mitotic cytokinesis,BP,
17947,GO:1902414,1,0.70807995771312,0,8,protein localization to cell junction,BP,
17948,GO:1902415,1,0.693926053756278,0,9,regulation of mRNA binding,BP,
17949,GO:1902416,1,0.752026947078714,0,7,positive regulation of mRNA binding,BP,
17950,GO:1902423,1,0.919364624094049,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17951,GO:1902425,1,0.919364624094049,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17952,GO:1902426,1,0.959407932504879,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
17954,GO:1902442,1,0.957218757034698,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
17955,GO:1902443,1,0.957218757034698,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
17956,GO:1902445,1,0.894686986772694,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
17957,GO:1902455,1,0.840819012126995,0,4,negative regulation of stem cell population maintenance,BP,
17958,GO:1902459,1,0.802435769463591,0,5,positive regulation of stem cell population maintenance,BP,
17959,GO:1902460,1,0.956597622082252,0,1,regulation of mesenchymal stem cell proliferation,BP,
17960,GO:1902462,1,0.956597622082252,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
17961,GO:1902463,1,0.927805224393808,0,2,protein localization to cell leading edge,BP,
17962,GO:1902464,1,0.956674282636883,0,1,regulation of histone H3-K27 trimethylation,BP,
17963,GO:1902466,1,0.956674282636883,0,1,positive regulation of histone H3-K27 trimethylation,BP,
17968,GO:1902480,1,0.960250826874573,0,1,protein localization to mitotic spindle,BP,
17969,GO:1902488,1,0.956441843839217,0,1,cholangiocyte apoptotic process,BP,
17973,GO:1902498,1,0.877182724658952,0,3,regulation of protein autoubiquitination,BP,
17974,GO:1902499,1,0.958910370595393,0,1,positive regulation of protein autoubiquitination,BP,
17975,GO:1902504,1,0.958546612686084,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
17977,GO:1902511,1,0.959299384807479,0,1,negative regulation of apoptotic DNA fragmentation,BP,
17979,GO:1902513,1,0.775739859091896,0,6,regulation of organelle transport along microtubule,BP,
17980,GO:1902514,1,0.740878657004316,0,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
17981,GO:1902523,1,0.915705971217174,0,2,positive regulation of protein K63-linked ubiquitination,BP,
17982,GO:1902524,1,0.922254989740806,0,2,positive regulation of protein K48-linked ubiquitination,BP,
17983,GO:1902525,1,0.821142985288279,0,5,regulation of protein monoubiquitination,BP,
17984,GO:1902527,1,0.857814856589885,0,4,positive regulation of protein monoubiquitination,BP,
17985,GO:1902528,1,0.956441843839217,0,1,regulation of protein linear polyubiquitination,BP,
17986,GO:1902530,1,0.956441843839217,0,1,positive regulation of protein linear polyubiquitination,BP,
17990,GO:1902544,1,0.92457268284349,0,2,regulation of DNA N-glycosylase activity,BP,
17991,GO:1902546,1,0.965138887105781,0,1,positive regulation of DNA N-glycosylase activity,BP,
17995,GO:1902555,1,0.310948096475784,0,29,endoribonuclease complex,CC,
17996,GO:1902559,1,0.924644211954896,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
17997,GO:1902560,1,0.962193275935904,0,1,GMP reductase complex,CC,
17999,GO:1902563,1,0.837197258917474,0,4,regulation of neutrophil activation,BP,
18000,GO:1902564,1,0.914788666392714,0,2,negative regulation of neutrophil activation,BP,
18001,GO:1902565,1,0.956842221697132,0,1,positive regulation of neutrophil activation,BP,
18002,GO:1902566,1,0.924051914670481,0,2,regulation of eosinophil activation,BP,
18003,GO:1902568,1,0.924051914670481,0,2,positive regulation of eosinophil activation,BP,
18004,GO:1902570,1,0.698200164359307,0,9,protein localization to nucleolus,BP,
18005,GO:1902571,1,0.88878146415095,0,3,regulation of serine-type peptidase activity,BP,
18006,GO:1902572,1,0.88878146415095,0,3,negative regulation of serine-type peptidase activity,BP,
18009,GO:1902581,1,0.816823385819439,0,5,multi-organism cellular localization,BP,
18010,GO:1902583,1,0.816823385819439,0,5,multi-organism intracellular transport,BP,
18011,GO:1902594,1,0.914965331431349,0,2,multi-organism nuclear import,BP,
18012,GO:1902595,1,0.924538157476795,0,2,regulation of DNA replication origin binding,BP,
18014,GO:1902603,1,0.885842473866448,0,3,carnitine transmembrane transport,BP,
18015,GO:1902605,1,0.959214290549236,0,1,heterotrimeric G-protein complex assembly,BP,
18016,GO:1902606,1,0.965280077340104,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18017,GO:1902608,1,0.965280077340104,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18018,GO:1902612,1,0.959199264977267,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18019,GO:1902613,1,0.959199264977267,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
18020,GO:1902616,1,0.962231414670732,0,1,acyl carnitine transmembrane transport,BP,
18022,GO:1902618,1,0.956441843839217,0,1,cellular response to fluoride,BP,
18023,GO:1902622,1,0.525479289487111,0,16,regulation of neutrophil migration,BP,
18024,GO:1902623,1,0.956487499770039,0,1,negative regulation of neutrophil migration,BP,
18025,GO:1902624,1,0.596843889642898,0,13,positive regulation of neutrophil migration,BP,
18026,GO:1902626,1,0.89753189361367,0,3,assembly of large subunit precursor of preribosome,BP,
18027,GO:1902629,1,0.963809217719398,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
18030,GO:1902636,1,0.925902084347808,0,2,kinociliary basal body,CC,
18033,GO:1902656,1,0.773029021081203,0,6,calcium ion import into cytosol,BP,
18034,GO:1902659,1,0.887851964161627,0,3,regulation of glucose mediated signaling pathway,BP,
18035,GO:1902661,1,0.887851964161627,0,3,positive regulation of glucose mediated signaling pathway,BP,
18038,GO:1902669,1,0.769207544929836,0,6,positive regulation of axon guidance,BP,
18041,GO:1902683,1,0.91922580126215,0,2,regulation of receptor localization to synapse,BP,
18042,GO:1902685,1,0.956751765711793,0,1,positive regulation of receptor localization to synapse,BP,
18043,GO:1902686,1,0.117161755967001,0,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
18044,GO:1902688,1,0.958787867083198,0,1,regulation of NAD metabolic process,BP,
18045,GO:1902689,1,0.958787867083198,0,1,negative regulation of NAD metabolic process,BP,
18047,GO:1902710,1,0.958160049997458,0,1,GABA receptor complex,CC,
18048,GO:1902711,1,0.958160049997458,0,1,GABA-A receptor complex,CC,
18049,GO:1902713,1,0.841401472793676,0,4,regulation of interferon-gamma secretion,BP,
18050,GO:1902714,1,0.919758375591013,0,2,negative regulation of interferon-gamma secretion,BP,
18051,GO:1902715,1,0.914821019435075,0,2,positive regulation of interferon-gamma secretion,BP,
18053,GO:1902723,1,0.957822209654798,0,1,negative regulation of skeletal muscle satellite cell proliferation,BP,
18054,GO:1902724,1,0.914832606956516,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18055,GO:1902725,1,0.956441843839217,0,1,negative regulation of satellite cell differentiation,BP,
18056,GO:1902728,1,0.914832606956516,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
18057,GO:1902730,1,0.878667712618599,0,3,positive regulation of proteoglycan biosynthetic process,BP,
18058,GO:1902731,1,0.914778160966236,0,2,negative regulation of chondrocyte proliferation,BP,
18059,GO:1902732,1,0.96300265421436,0,1,positive regulation of chondrocyte proliferation,BP,
18060,GO:1902737,1,0.95669375652552,0,1,dendritic filopodium,CC,
18061,GO:1902739,1,0.768204293714145,0,6,regulation of interferon-alpha secretion,BP,
18062,GO:1902741,1,0.768204293714145,0,6,positive regulation of interferon-alpha secretion,BP,
18063,GO:1902742,1,0.388500119712311,0,22,apoptotic process involved in development,BP,
18066,GO:1902745,1,0.448328256365393,0,19,positive regulation of lamellipodium organization,BP,
18067,GO:1902746,1,0.960303284653704,0,1,regulation of lens fiber cell differentiation,BP,
18070,GO:1902751,1,0.384831117706024,0,23,positive regulation of cell cycle G2/M phase transition,BP,
18071,GO:1902766,1,0.927344963195422,0,2,skeletal muscle satellite cell migration,BP,
18072,GO:1902767,1,0.95756135946994,0,1,isoprenoid biosynthetic process via mevalonate,BP,
18073,GO:1902769,1,0.956441843839217,0,1,regulation of choline O-acetyltransferase activity,BP,
18074,GO:1902771,1,0.956441843839217,0,1,positive regulation of choline O-acetyltransferase activity,BP,
18075,GO:1902773,1,0.958420205715724,0,1,GTPase activator complex,CC,
18076,GO:1902774,1,0.780482505679253,0,6,late endosome to lysosome transport,BP,
18077,GO:1902775,1,0.878289258794086,0,3,mitochondrial large ribosomal subunit assembly,BP,
18079,GO:1902804,1,0.882487742891729,0,3,negative regulation of synaptic vesicle transport,BP,
18080,GO:1902805,1,0.914939423770191,0,2,positive regulation of synaptic vesicle transport,BP,
18086,GO:1902816,1,0.842978589020104,0,4,regulation of protein localization to microtubule,BP,
18087,GO:1902817,1,0.842978589020104,0,4,negative regulation of protein localization to microtubule,BP,
18088,GO:1902822,1,0.888795026821806,0,3,regulation of late endosome to lysosome transport,BP,
18089,GO:1902823,1,0.957882406805159,0,1,negative regulation of late endosome to lysosome transport,BP,
18090,GO:1902824,1,0.927881017857644,0,2,positive regulation of late endosome to lysosome transport,BP,
18091,GO:1902838,1,0.956463626558617,0,1,regulation of nuclear migration along microtubule,BP,
18092,GO:1902846,1,0.956441843839217,0,1,positive regulation of mitotic spindle elongation,BP,
18093,GO:1902847,1,0.958913145680909,0,1,regulation of neuronal signal transduction,BP,
18095,GO:1902855,1,0.654309694453354,0,10,regulation of non-motile cilium assembly,BP,
18096,GO:1902856,1,0.915655623999074,0,2,negative regulation of non-motile cilium assembly,BP,
18097,GO:1902857,1,0.744427096906196,0,7,positive regulation of non-motile cilium assembly,BP,
18098,GO:1902858,1,0.961277443773412,0,1,propionyl-CoA metabolic process,BP,
18099,GO:1902860,1,0.961277443773412,0,1,propionyl-CoA biosynthetic process,BP,
18100,GO:1902866,1,0.923009643824649,0,2,regulation of retina development in camera-type eye,BP,
18101,GO:1902868,1,0.923009643824649,0,2,positive regulation of retina development in camera-type eye,BP,
18102,GO:1902869,1,0.923009643824649,0,2,regulation of amacrine cell differentiation,BP,
18103,GO:1902871,1,0.923009643824649,0,2,positive regulation of amacrine cell differentiation,BP,
18105,GO:1902883,1,0.236202588772636,0,35,negative regulation of response to oxidative stress,BP,
18107,GO:1902889,1,0.956441843839217,0,1,protein localization to spindle microtubule,BP,
18108,GO:1902890,1,0.965280077340104,0,1,regulation of root hair elongation,BP,
18109,GO:1902891,1,0.965280077340104,0,1,negative regulation of root hair elongation,BP,
18112,GO:1902895,1,0.443984045015077,0,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
18113,GO:1902896,1,0.917208137695916,0,2,terminal web assembly,BP,
18114,GO:1902897,1,0.920310589499497,0,2,regulation of postsynaptic density protein 95 clustering,BP,
18115,GO:1902902,1,0.645361658833491,0,11,negative regulation of autophagosome assembly,BP,
18119,GO:1902908,1,0.956744377951467,0,1,regulation of melanosome transport,BP,
18120,GO:1902910,1,0.956744377951467,0,1,positive regulation of melanosome transport,BP,
18122,GO:1902912,1,0.958787867083198,0,1,pyruvate kinase complex,CC,
18123,GO:1902913,1,0.958145282645265,0,1,positive regulation of neuroepithelial cell differentiation,BP,
18124,GO:1902914,1,0.528922537926854,0,15,regulation of protein polyubiquitination,BP,
18125,GO:1902915,1,0.769701958840057,0,6,negative regulation of protein polyubiquitination,BP,
18126,GO:1902916,1,0.718639867387035,0,8,positive regulation of protein polyubiquitination,BP,
18131,GO:1902937,1,0.961205143738116,0,1,inward rectifier potassium channel complex,CC,
18134,GO:1902941,1,0.956842221697132,0,1,regulation of voltage-gated chloride channel activity,BP,
18135,GO:1902943,1,0.956842221697132,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18136,GO:1902946,1,0.7046704164642,0,8,protein localization to early endosome,BP,
18138,GO:1902948,1,0.956441843839217,0,1,negative regulation of tau-protein kinase activity,BP,
18141,GO:1902951,1,0.922314586690746,0,2,negative regulation of dendritic spine maintenance,BP,
18143,GO:1902953,1,0.845913532360317,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
18144,GO:1902954,1,0.914777292668164,0,2,regulation of early endosome to recycling endosome transport,BP,
18145,GO:1902955,1,0.956441843839217,0,1,positive regulation of early endosome to recycling endosome transport,BP,
18146,GO:1902956,1,0.887034715489473,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18147,GO:1902957,1,0.958131655655566,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18148,GO:1902958,1,0.925802534921023,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18150,GO:1902960,1,0.918775557725183,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18152,GO:1902962,1,0.915455651605536,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18153,GO:1902963,1,0.915455651605536,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18154,GO:1902965,1,0.767448775521936,0,6,regulation of protein localization to early endosome,BP,
18155,GO:1902966,1,0.767448775521936,0,6,positive regulation of protein localization to early endosome,BP,
18157,GO:1902975,1,0.964312562666044,0,1,mitotic DNA replication initiation,BP,
18158,GO:1902977,1,0.962050077317431,0,1,mitotic DNA replication preinitiation complex assembly,BP,
18159,GO:1902983,1,0.95788983562322,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
18160,GO:1902988,1,0.877185263695472,0,3,neurofibrillary tangle assembly,BP,
18161,GO:1902990,1,0.882087729434146,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
18167,GO:1902996,1,0.917141150879513,0,2,regulation of neurofibrillary tangle assembly,BP,
18168,GO:1902997,1,0.956441843839217,0,1,negative regulation of neurofibrillary tangle assembly,BP,
18169,GO:1902998,1,0.958913145680909,0,1,positive regulation of neurofibrillary tangle assembly,BP,
18172,GO:1903003,1,0.776203320969251,0,6,positive regulation of protein deubiquitination,BP,
18173,GO:1903004,1,0.957076563173688,0,1,regulation of protein K63-linked deubiquitination,BP,
18174,GO:1903006,1,0.957076563173688,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18175,GO:1903007,1,0.957076563173688,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
18178,GO:1903011,1,0.875810416512096,0,3,negative regulation of bone development,BP,
18180,GO:1903018,1,0.291176554153527,0,30,regulation of glycoprotein metabolic process,BP,
18181,GO:1903019,1,0.619960401177186,0,12,negative regulation of glycoprotein metabolic process,BP,
18182,GO:1903020,1,0.533937226037968,0,15,positive regulation of glycoprotein metabolic process,BP,
18183,GO:1903025,1,0.701045509375589,0,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
18184,GO:1903026,1,0.829974652348121,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
18185,GO:1903027,1,0.956441843839217,0,1,regulation of opsonization,BP,
18186,GO:1903028,1,0.956441843839217,0,1,positive regulation of opsonization,BP,
18187,GO:1903031,1,0.923337946413439,0,2,regulation of microtubule plus-end binding,BP,
18188,GO:1903033,1,0.923337946413439,0,2,positive regulation of microtubule plus-end binding,BP,
18195,GO:1903044,1,0.722079772126554,0,8,protein localization to membrane raft,BP,
18196,GO:1903045,1,0.956441961163128,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
18203,GO:1903054,1,0.820259436685929,0,5,negative regulation of extracellular matrix organization,BP,
18204,GO:1903055,1,0.597299164448643,0,12,positive regulation of extracellular matrix organization,BP,
18205,GO:1903059,1,0.846675463957943,0,4,regulation of protein lipidation,BP,
18206,GO:1903061,1,0.846675463957943,0,4,positive regulation of protein lipidation,BP,
18207,GO:1903069,1,0.691628398151399,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18208,GO:1903070,1,0.885853566032561,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18209,GO:1903071,1,0.750031637995025,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18210,GO:1903072,1,0.96492184451589,0,1,regulation of death-inducing signaling complex assembly,BP,
18211,GO:1903073,1,0.96492184451589,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18213,GO:1903077,1,0.488794035793793,0,17,negative regulation of protein localization to plasma membrane,BP,
18215,GO:1903093,1,0.889673723798113,0,3,regulation of protein K48-linked deubiquitination,BP,
18216,GO:1903094,1,0.930197287745624,0,2,negative regulation of protein K48-linked deubiquitination,BP,
18217,GO:1903095,1,0.917226977020332,0,2,ribonuclease III complex,CC,
18218,GO:1903096,1,0.958436723289691,0,1,protein localization to meiotic spindle midzone,BP,
18219,GO:1903108,1,0.956468614910803,0,1,regulation of mitochondrial transcription,BP,
18220,GO:1903109,1,0.956468614910803,0,1,positive regulation of mitochondrial transcription,BP,
18221,GO:1903115,1,0.405678644944357,0,21,regulation of actin filament-based movement,BP,
18222,GO:1903116,1,0.915722546429631,0,2,positive regulation of actin filament-based movement,BP,
18223,GO:1903119,1,0.879227971604245,0,3,protein localization to actin cytoskeleton,BP,
18224,GO:1903121,1,0.848796576142022,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
18225,GO:1903122,1,0.96492184451589,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18226,GO:1903126,1,0.961299128430515,0,1,negative regulation of centriole-centriole cohesion,BP,
18228,GO:1903135,1,0.885744236455233,0,3,cupric ion binding,MF,
18229,GO:1903136,1,0.819392179751052,0,5,cuprous ion binding,MF,
18230,GO:1903140,1,0.710485363805494,0,8,regulation of establishment of endothelial barrier,BP,
18231,GO:1903141,1,0.956799314128339,0,1,negative regulation of establishment of endothelial barrier,BP,
18232,GO:1903142,1,0.916195465297404,0,2,positive regulation of establishment of endothelial barrier,BP,
18233,GO:1903143,1,0.956483797008087,0,1,adrenomedullin receptor complex,CC,
18235,GO:1903147,1,0.715239952846499,0,8,negative regulation of autophagy of mitochondrion,BP,
18236,GO:1903165,1,0.959359571164546,0,1,response to polycyclic arene,BP,
18237,GO:1903167,1,0.96492184451589,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18238,GO:1903168,1,0.96492184451589,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18241,GO:1903173,1,0.921012471065368,0,2,fatty alcohol metabolic process,BP,
18242,GO:1903176,1,0.96492184451589,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18243,GO:1903178,1,0.96492184451589,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18244,GO:1903179,1,0.924278740791067,0,2,regulation of dopamine biosynthetic process,BP,
18245,GO:1903181,1,0.924278740791067,0,2,positive regulation of dopamine biosynthetic process,BP,
18246,GO:1903182,1,0.96425528533061,0,1,regulation of SUMO transferase activity,BP,
18247,GO:1903184,1,0.96492184451589,0,1,L-dopa metabolic process,BP,
18248,GO:1903185,1,0.96492184451589,0,1,L-dopa biosynthetic process,BP,
18249,GO:1903189,1,0.96492184451589,0,1,glyoxal metabolic process,BP,
18250,GO:1903195,1,0.96492184451589,0,1,regulation of L-dopa biosynthetic process,BP,
18251,GO:1903197,1,0.96492184451589,0,1,positive regulation of L-dopa biosynthetic process,BP,
18252,GO:1903198,1,0.96492184451589,0,1,regulation of L-dopa decarboxylase activity,BP,
18253,GO:1903200,1,0.96492184451589,0,1,positive regulation of L-dopa decarboxylase activity,BP,
18255,GO:1903202,1,0.257247687466198,0,33,negative regulation of oxidative stress-induced cell death,BP,
18256,GO:1903203,1,0.466587870945114,0,18,regulation of oxidative stress-induced neuron death,BP,
18257,GO:1903204,1,0.556580339988948,0,14,negative regulation of oxidative stress-induced neuron death,BP,
18259,GO:1903206,1,0.589798279858733,0,13,negative regulation of hydrogen peroxide-induced cell death,BP,
18260,GO:1903207,1,0.891571125636965,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
18261,GO:1903208,1,0.891571125636965,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
18264,GO:1903215,1,0.961121993962004,0,1,negative regulation of protein targeting to mitochondrion,BP,
18265,GO:1903223,1,0.876216668824634,0,3,positive regulation of oxidative stress-induced neuron death,BP,
18266,GO:1903224,1,0.844919450458544,0,4,regulation of endodermal cell differentiation,BP,
18267,GO:1903225,1,0.914777292668164,0,2,negative regulation of endodermal cell differentiation,BP,
18268,GO:1903231,1,0.958585059351351,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
18269,GO:1903232,1,0.823289357951415,0,5,melanosome assembly,BP,
18270,GO:1903233,1,0.914827379831438,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
18271,GO:1903236,1,0.883307631285736,0,3,regulation of leukocyte tethering or rolling,BP,
18272,GO:1903237,1,0.96520070168108,0,1,negative regulation of leukocyte tethering or rolling,BP,
18273,GO:1903238,1,0.915160263448934,0,2,positive regulation of leukocyte tethering or rolling,BP,
18276,GO:1903244,1,0.9565710502021,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
18277,GO:1903248,1,0.956441843839217,0,1,regulation of citrulline biosynthetic process,BP,
18278,GO:1903249,1,0.956441843839217,0,1,negative regulation of citrulline biosynthetic process,BP,
18279,GO:1903251,1,0.811156050544913,0,5,multi-ciliated epithelial cell differentiation,BP,
18280,GO:1903259,1,0.958787867083198,0,1,exon-exon junction complex disassembly,BP,
18281,GO:1903265,1,0.725543891642124,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
18282,GO:1903276,1,0.925911285303529,0,2,regulation of sodium ion export across plasma membrane,BP,
18283,GO:1903278,1,0.925911285303529,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18284,GO:1903279,1,0.920438391084662,0,2,regulation of calcium:sodium antiporter activity,BP,
18285,GO:1903281,1,0.920438391084662,0,2,positive regulation of calcium:sodium antiporter activity,BP,
18286,GO:1903282,1,0.958131655655566,0,1,regulation of glutathione peroxidase activity,BP,
18287,GO:1903284,1,0.958131655655566,0,1,positive regulation of glutathione peroxidase activity,BP,
18288,GO:1903285,1,0.958131655655566,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
18289,GO:1903286,1,0.885610405518655,0,3,regulation of potassium ion import,BP,
18290,GO:1903288,1,0.925911285303529,0,2,positive regulation of potassium ion import,BP,
18291,GO:1903292,1,0.917892869007355,0,2,protein localization to Golgi membrane,BP,
18293,GO:1903294,1,0.915389973728454,0,2,regulation of glutamate secretion, neurotransmission,BP,
18294,GO:1903296,1,0.915389973728454,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
18295,GO:1903297,1,0.815824634457005,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18296,GO:1903298,1,0.815824634457005,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18297,GO:1903299,1,0.752904124993694,0,7,regulation of hexokinase activity,BP,
18298,GO:1903300,1,0.923156441648159,0,2,negative regulation of hexokinase activity,BP,
18299,GO:1903301,1,0.81560315465444,0,5,positive regulation of hexokinase activity,BP,
18301,GO:1903306,1,0.601014393005355,0,12,negative regulation of regulated secretory pathway,BP,
18304,GO:1903312,1,0.0793702056750018,0,60,negative regulation of mRNA metabolic process,BP,
18305,GO:1903313,1,0.0952574710399069,0,56,positive regulation of mRNA metabolic process,BP,
18308,GO:1903319,1,0.605100368567165,0,12,positive regulation of protein maturation,BP,
18311,GO:1903322,1,0.0117608912567647,0,107,positive regulation of protein modification by small protein conjugation or removal,BP,
18312,GO:1903332,1,0.750109614155888,0,7,regulation of protein folding,BP,
18313,GO:1903333,1,0.816676914523404,0,5,negative regulation of protein folding,BP,
18314,GO:1903335,1,0.852948051399197,0,4,regulation of vacuolar transport,BP,
18315,GO:1903336,1,0.957882406805159,0,1,negative regulation of vacuolar transport,BP,
18316,GO:1903337,1,0.927881017857644,0,2,positive regulation of vacuolar transport,BP,
18317,GO:1903347,1,0.875449730664478,0,3,negative regulation of bicellular tight junction assembly,BP,
18318,GO:1903348,1,0.878802475571898,0,3,positive regulation of bicellular tight junction assembly,BP,
18319,GO:1903349,1,0.77709220484666,0,6,omegasome membrane,CC,
18320,GO:1903350,1,0.63178876012948,0,11,response to dopamine,BP,
18321,GO:1903351,1,0.63178876012948,0,11,cellular response to dopamine,BP,
18322,GO:1903352,1,0.840753877678645,0,4,L-ornithine transmembrane transport,BP,
18323,GO:1903358,1,0.53228855484412,0,15,regulation of Golgi organization,BP,
18324,GO:1903361,1,0.814864239059787,0,5,protein localization to basolateral plasma membrane,BP,
18329,GO:1903367,1,0.958222255349026,0,1,positive regulation of fear response,BP,
18330,GO:1903371,1,0.840686882991768,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
18331,GO:1903373,1,0.878983668236473,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
18332,GO:1903375,1,0.918225518391051,0,2,facioacoustic ganglion development,BP,
18333,GO:1903376,1,0.744282857545814,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18334,GO:1903377,1,0.849010677156867,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18335,GO:1903378,1,0.916128526788245,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18336,GO:1903381,1,0.956606006240665,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18337,GO:1903382,1,0.956606006240665,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18338,GO:1903383,1,0.925802534921023,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18339,GO:1903384,1,0.925802534921023,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18340,GO:1903385,1,0.915876240719698,0,2,regulation of homophilic cell adhesion,BP,
18341,GO:1903387,1,0.956452706908843,0,1,positive regulation of homophilic cell adhesion,BP,
18345,GO:1903394,1,0.9605114596766,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
18346,GO:1903400,1,0.878598958260512,0,3,L-arginine transmembrane transport,BP,
18348,GO:1903405,1,0.698394380392713,0,9,protein localization to nuclear body,BP,
18349,GO:1903406,1,0.957338819219958,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18350,GO:1903408,1,0.957338819219958,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
18352,GO:1903416,1,0.885044572416564,0,3,response to glycoside,BP,
18353,GO:1903420,1,0.956441843839217,0,1,protein localization to endoplasmic reticulum tubular network,BP,
18355,GO:1903422,1,0.875646542212727,0,3,negative regulation of synaptic vesicle recycling,BP,
18358,GO:1903427,1,0.50480645482395,0,17,negative regulation of reactive oxygen species biosynthetic process,BP,
18360,GO:1903429,1,0.53547656460147,0,15,regulation of cell maturation,BP,
18361,GO:1903430,1,0.851395310831818,0,4,negative regulation of cell maturation,BP,
18362,GO:1903431,1,0.7403644172675,0,7,positive regulation of cell maturation,BP,
18363,GO:1903432,1,0.372277820661843,0,24,regulation of TORC1 signaling,BP,
18364,GO:1903433,1,0.917879215530421,0,2,regulation of constitutive secretory pathway,BP,
18365,GO:1903434,1,0.957088734972423,0,1,negative regulation of constitutive secretory pathway,BP,
18366,GO:1903435,1,0.959036114894472,0,1,positive regulation of constitutive secretory pathway,BP,
18367,GO:1903436,1,0.916114031338396,0,2,regulation of mitotic cytokinetic process,BP,
18368,GO:1903438,1,0.916114031338396,0,2,positive regulation of mitotic cytokinetic process,BP,
18369,GO:1903439,1,0.92299227321538,0,2,calcitonin family receptor complex,CC,
18370,GO:1903440,1,0.964987887329676,0,1,amylin receptor complex,CC,
18372,GO:1903442,1,0.95712201154618,0,1,response to lipoic acid,BP,
18374,GO:1903445,1,0.891170572555477,0,3,protein transport from ciliary membrane to plasma membrane,BP,
18375,GO:1903450,1,0.956441843839217,0,1,regulation of G1 to G0 transition,BP,
18376,GO:1903452,1,0.956441843839217,0,1,positive regulation of G1 to G0 transition,BP,
18377,GO:1903461,1,0.958266129484494,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
18380,GO:1903465,1,0.95644205280966,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
18382,GO:1903489,1,0.962452315797035,0,1,positive regulation of lactation,BP,
18383,GO:1903490,1,0.916114031338396,0,2,positive regulation of mitotic cytokinesis,BP,
18384,GO:1903504,1,0.589152738324211,0,13,regulation of mitotic spindle checkpoint,BP,
18391,GO:1903514,1,0.518153071296029,0,16,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
18392,GO:1903515,1,0.956441843839217,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
18393,GO:1903516,1,0.882043527856846,0,3,regulation of single strand break repair,BP,
18394,GO:1903517,1,0.958769224964552,0,1,negative regulation of single strand break repair,BP,
18395,GO:1903518,1,0.919981420392982,0,2,positive regulation of single strand break repair,BP,
18396,GO:1903519,1,0.883375695311614,0,3,regulation of mammary gland involution,BP,
18397,GO:1903521,1,0.883375695311614,0,3,positive regulation of mammary gland involution,BP,
18401,GO:1903525,1,0.801621377792011,0,5,regulation of membrane tubulation,BP,
18402,GO:1903526,1,0.915851978157852,0,2,negative regulation of membrane tubulation,BP,
18403,GO:1903527,1,0.87529490162083,0,3,positive regulation of membrane tubulation,BP,
18408,GO:1903537,1,0.921019515623784,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18409,GO:1903538,1,0.921019515623784,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
18412,GO:1903541,1,0.563415856478253,0,14,regulation of exosomal secretion,BP,
18413,GO:1903542,1,0.920313631741747,0,2,negative regulation of exosomal secretion,BP,
18414,GO:1903543,1,0.563415856478253,0,14,positive regulation of exosomal secretion,BP,
18415,GO:1903544,1,0.957667655588998,0,1,response to butyrate,BP,
18416,GO:1903545,1,0.957667655588998,0,1,cellular response to butyrate,BP,
18418,GO:1903547,1,0.930031794346209,0,2,regulation of growth hormone activity,BP,
18419,GO:1903551,1,0.780347848513384,0,6,regulation of extracellular exosome assembly,BP,
18420,GO:1903553,1,0.845100684868228,0,4,positive regulation of extracellular exosome assembly,BP,
18425,GO:1903564,1,0.841411761590112,0,4,regulation of protein localization to cilium,BP,
18426,GO:1903565,1,0.957692460089517,0,1,negative regulation of protein localization to cilium,BP,
18427,GO:1903566,1,0.878592481904373,0,3,positive regulation of protein localization to cilium,BP,
18428,GO:1903567,1,0.919813585473474,0,2,regulation of protein localization to ciliary membrane,BP,
18429,GO:1903568,1,0.957692460089517,0,1,negative regulation of protein localization to ciliary membrane,BP,
18430,GO:1903569,1,0.960451200398404,0,1,positive regulation of protein localization to ciliary membrane,BP,
18431,GO:1903570,1,0.957507935744758,0,1,regulation of protein kinase D signaling,BP,
18432,GO:1903572,1,0.957507935744758,0,1,positive regulation of protein kinase D signaling,BP,
18434,GO:1903575,1,0.922771160164898,0,2,cornified envelope assembly,BP,
18435,GO:1903576,1,0.961530034609931,0,1,response to L-arginine,BP,
18437,GO:1903579,1,0.536714049320156,0,15,negative regulation of ATP metabolic process,BP,
18439,GO:1903584,1,0.956688923264148,0,1,regulation of histone deubiquitination,BP,
18440,GO:1903586,1,0.956688923264148,0,1,positive regulation of histone deubiquitination,BP,
18441,GO:1903587,1,0.814418645125748,0,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18442,GO:1903588,1,0.883010459279513,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18443,GO:1903589,1,0.922339521471354,0,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18444,GO:1903593,1,0.889270692579688,0,3,regulation of histamine secretion by mast cell,BP,
18445,GO:1903595,1,0.889270692579688,0,3,positive regulation of histamine secretion by mast cell,BP,
18446,GO:1903596,1,0.9594314943995,0,1,regulation of gap junction assembly,BP,
18447,GO:1903598,1,0.9594314943995,0,1,positive regulation of gap junction assembly,BP,
18449,GO:1903608,1,0.744798408678269,0,7,protein localization to cytoplasmic stress granule,BP,
18450,GO:1903609,1,0.9594314943995,0,1,negative regulation of inward rectifier potassium channel activity,BP,
18451,GO:1903613,1,0.956448810318504,0,1,regulation of protein tyrosine phosphatase activity,BP,
18452,GO:1903615,1,0.956448810318504,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
18453,GO:1903621,1,0.96197085668367,0,1,protein localization to photoreceptor connecting cilium,BP,
18455,GO:1903625,1,0.959299384807479,0,1,negative regulation of DNA catabolic process,BP,
18457,GO:1903630,1,0.964213317024554,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18458,GO:1903632,1,0.964213317024554,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
18459,GO:1903636,1,0.965759632463125,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18460,GO:1903638,1,0.965759632463125,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18461,GO:1903644,1,0.926946044716862,0,2,regulation of chaperone-mediated protein folding,BP,
18462,GO:1903645,1,0.965759632463125,0,1,negative regulation of chaperone-mediated protein folding,BP,
18463,GO:1903649,1,0.449409587553045,0,19,regulation of cytoplasmic transport,BP,
18464,GO:1903650,1,0.930506027773428,0,2,negative regulation of cytoplasmic transport,BP,
18465,GO:1903651,1,0.674893309168841,0,9,positive regulation of cytoplasmic transport,BP,
18466,GO:1903659,1,0.959843233179047,0,1,regulation of complement-dependent cytotoxicity,BP,
18467,GO:1903660,1,0.959843233179047,0,1,negative regulation of complement-dependent cytotoxicity,BP,
18469,GO:1903671,1,0.425613933436359,0,20,negative regulation of sprouting angiogenesis,BP,
18471,GO:1903673,1,0.962064116170112,0,1,mitotic cleavage furrow formation,BP,
18472,GO:1903674,1,0.962088650047961,0,1,regulation of cap-dependent translational initiation,BP,
18473,GO:1903676,1,0.962088650047961,0,1,positive regulation of cap-dependent translational initiation,BP,
18474,GO:1903677,1,0.887471178188713,0,3,regulation of cap-independent translational initiation,BP,
18475,GO:1903679,1,0.887471178188713,0,3,positive regulation of cap-independent translational initiation,BP,
18476,GO:1903689,1,0.765465219853562,0,6,regulation of wound healing, spreading of epidermal cells,BP,
18477,GO:1903690,1,0.836804823688386,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
18478,GO:1903691,1,0.914777292668164,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
18479,GO:1903697,1,0.957777883768419,0,1,negative regulation of microvillus assembly,BP,
18480,GO:1903699,1,0.956441843839217,0,1,tarsal gland development,BP,
18481,GO:1903701,1,0.956459437002784,0,1,substantia propria of cornea development,BP,
18482,GO:1903704,1,0.966376925420809,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
18486,GO:1903709,1,0.956441843839217,0,1,uterine gland development,BP,
18488,GO:1903717,1,0.956441844511705,0,1,response to ammonia,BP,
18489,GO:1903718,1,0.956441844511705,0,1,cellular response to ammonia,BP,
18490,GO:1903719,1,0.888174557175134,0,3,regulation of I-kappaB phosphorylation,BP,
18491,GO:1903721,1,0.888174557175134,0,3,positive regulation of I-kappaB phosphorylation,BP,
18492,GO:1903722,1,0.924195070987836,0,2,regulation of centriole elongation,BP,
18493,GO:1903723,1,0.964990234637003,0,1,negative regulation of centriole elongation,BP,
18494,GO:1903724,1,0.957727820052129,0,1,positive regulation of centriole elongation,BP,
18498,GO:1903729,1,0.681121885327126,0,9,regulation of plasma membrane organization,BP,
18500,GO:1903748,1,0.847683878658541,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
18501,GO:1903749,1,0.024810034449546,0,90,positive regulation of establishment of protein localization to mitochondrion,BP,
18502,GO:1903750,1,0.851392213025421,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18503,GO:1903751,1,0.851392213025421,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18504,GO:1903753,1,0.843034769752601,0,4,negative regulation of p38MAPK cascade,BP,
18505,GO:1903755,1,0.96425528533061,0,1,positive regulation of SUMO transferase activity,BP,
18506,GO:1903756,1,0.91868991103368,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18507,GO:1903758,1,0.91868991103368,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18509,GO:1903760,1,0.915326591361245,0,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18510,GO:1903762,1,0.956976854542281,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18512,GO:1903764,1,0.95648107706059,0,1,regulation of potassium ion export across plasma membrane,BP,
18513,GO:1903767,1,0.959796447129613,0,1,sweet taste receptor complex,CC,
18514,GO:1903768,1,0.959796447129613,0,1,taste receptor complex,CC,
18515,GO:1903770,1,0.958769224964552,0,1,negative regulation of beta-galactosidase activity,BP,
18516,GO:1903772,1,0.821005324763354,0,5,regulation of viral budding via host ESCRT complex,BP,
18517,GO:1903774,1,0.888088910636003,0,3,positive regulation of viral budding via host ESCRT complex,BP,
18518,GO:1903775,1,0.920672840316929,0,2,regulation of DNA double-strand break processing,BP,
18519,GO:1903778,1,0.917872225823107,0,2,protein localization to vacuolar membrane,BP,
18520,GO:1903779,1,0.198778181100576,0,38,regulation of cardiac conduction,BP,
18521,GO:1903781,1,0.915722546429631,0,2,positive regulation of cardiac conduction,BP,
18522,GO:1903786,1,0.959223330954023,0,1,regulation of glutathione biosynthetic process,BP,
18523,GO:1903788,1,0.959223330954023,0,1,positive regulation of glutathione biosynthetic process,BP,
18524,GO:1903789,1,0.810344580194418,0,5,regulation of amino acid transmembrane transport,BP,
18529,GO:1903797,1,0.956842221697132,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18531,GO:1903799,1,0.7105333235241,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18533,GO:1903801,1,0.960826153981137,0,1,L-leucine import across plasma membrane,BP,
18534,GO:1903803,1,0.962036024577607,0,1,L-glutamine import across plasma membrane,BP,
18535,GO:1903817,1,0.815113269035676,0,5,negative regulation of voltage-gated potassium channel activity,BP,
18536,GO:1903818,1,0.875413686067144,0,3,positive regulation of voltage-gated potassium channel activity,BP,
18537,GO:1903823,1,0.958769224964552,0,1,telomere single strand break repair,BP,
18538,GO:1903824,1,0.958769224964552,0,1,negative regulation of telomere single strand break repair,BP,
18545,GO:1903831,1,0.61069941036345,0,12,signal transduction involved in cellular response to ammonium ion,BP,
18546,GO:1903837,1,0.960084458644977,0,1,regulation of mRNA 3'-UTR binding,BP,
18547,GO:1903839,1,0.960084458644977,0,1,positive regulation of mRNA 3'-UTR binding,BP,
18550,GO:1903846,1,0.415146251149958,0,21,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
18551,GO:1903847,1,0.915049500609243,0,2,regulation of aorta morphogenesis,BP,
18552,GO:1903849,1,0.915049500609243,0,2,positive regulation of aorta morphogenesis,BP,
18553,GO:1903850,1,0.95946148728879,0,1,regulation of cristae formation,BP,
18554,GO:1903852,1,0.95946148728879,0,1,positive regulation of cristae formation,BP,
18556,GO:1903860,1,0.918894294740219,0,2,negative regulation of dendrite extension,BP,
18558,GO:1903862,1,0.82006528234263,0,5,positive regulation of oxidative phosphorylation,BP,
18560,GO:1903874,1,0.915249358247852,0,2,ferrous iron transmembrane transport,BP,
18561,GO:1903881,1,0.957248930696226,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18562,GO:1903883,1,0.957248930696226,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18563,GO:1903884,1,0.957248930696226,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18564,GO:1903886,1,0.957248930696226,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
18565,GO:1903888,1,0.965280077340104,0,1,regulation of plant epidermal cell differentiation,BP,
18566,GO:1903889,1,0.965280077340104,0,1,negative regulation of plant epidermal cell differentiation,BP,
18567,GO:1903891,1,0.843954910887884,0,4,regulation of ATF6-mediated unfolded protein response,BP,
18568,GO:1903892,1,0.91865048288903,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
18569,GO:1903893,1,0.960002219972046,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
18571,GO:1903895,1,0.844192327310836,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
18575,GO:1903899,1,0.883702072061613,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
18579,GO:1903903,1,0.88032268718011,0,3,regulation of establishment of T cell polarity,BP,
18580,GO:1903905,1,0.91774188409025,0,2,positive regulation of establishment of T cell polarity,BP,
18581,GO:1903906,1,0.959233901692744,0,1,regulation of plasma membrane raft polarization,BP,
18582,GO:1903909,1,0.809704418751588,0,5,regulation of receptor clustering,BP,
18583,GO:1903911,1,0.882581136495317,0,3,positive regulation of receptor clustering,BP,
18585,GO:1903916,1,0.960412322702609,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18586,GO:1903917,1,0.960412322702609,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18587,GO:1903918,1,0.956441843839217,0,1,regulation of actin filament severing,BP,
18588,GO:1903919,1,0.956441843839217,0,1,negative regulation of actin filament severing,BP,
18589,GO:1903921,1,0.917447961572577,0,2,regulation of protein processing in phagocytic vesicle,BP,
18590,GO:1903923,1,0.917447961572577,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
18591,GO:1903924,1,0.960970281963753,0,1,estradiol binding,MF,
18592,GO:1903925,1,0.96224179415711,0,1,response to bisphenol A,BP,
18593,GO:1903926,1,0.96224179415711,0,1,cellular response to bisphenol A,BP,
18594,GO:1903929,1,0.958137934819517,0,1,primary palate development,BP,
18595,GO:1903935,1,0.784417482003791,0,6,response to sodium arsenite,BP,
18596,GO:1903936,1,0.819322757841661,0,5,cellular response to sodium arsenite,BP,
18597,GO:1903937,1,0.95741442164153,0,1,response to acrylamide,BP,
18598,GO:1903939,1,0.957795483285784,0,1,regulation of TORC2 signaling,BP,
18599,GO:1903943,1,0.961919589858684,0,1,regulation of hepatocyte apoptotic process,BP,
18600,GO:1903944,1,0.961919589858684,0,1,negative regulation of hepatocyte apoptotic process,BP,
18601,GO:1903947,1,0.956976854542281,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18602,GO:1903949,1,0.915722546429631,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
18603,GO:1903952,1,0.956976854542281,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18604,GO:1903954,1,0.956976854542281,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18605,GO:1903955,1,0.0777834117038941,0,62,positive regulation of protein targeting to mitochondrion,BP,
18608,GO:1903961,1,0.881457412522766,0,3,positive regulation of anion transmembrane transport,BP,
18609,GO:1903963,1,0.602506477083694,0,12,arachidonate transport,BP,
18610,GO:1903964,1,0.917888869542448,0,2,monounsaturated fatty acid metabolic process,BP,
18611,GO:1903966,1,0.917888869542448,0,2,monounsaturated fatty acid biosynthetic process,BP,
18612,GO:1903969,1,0.924508809459509,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18613,GO:1903970,1,0.962791993675891,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18614,GO:1903971,1,0.960240360586506,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18615,GO:1903972,1,0.924508809459509,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18616,GO:1903973,1,0.962791993675891,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18617,GO:1903974,1,0.960240360586506,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18618,GO:1903975,1,0.78431460595961,0,6,regulation of glial cell migration,BP,
18619,GO:1903976,1,0.887261096928856,0,3,negative regulation of glial cell migration,BP,
18620,GO:1903977,1,0.918410663309658,0,2,positive regulation of glial cell migration,BP,
18621,GO:1903978,1,0.844321966899968,0,4,regulation of microglial cell activation,BP,
18622,GO:1903979,1,0.956453247266666,0,1,negative regulation of microglial cell activation,BP,
18623,GO:1903980,1,0.922983386168999,0,2,positive regulation of microglial cell activation,BP,
18624,GO:1903984,1,0.87966146435705,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
18625,GO:1903995,1,0.961120186609872,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18626,GO:1903997,1,0.961120186609872,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18627,GO:1903998,1,0.882950844424105,0,3,regulation of eating behavior,BP,
18628,GO:1903999,1,0.923168814509432,0,2,negative regulation of eating behavior,BP,
18629,GO:1904000,1,0.956441843839217,0,1,positive regulation of eating behavior,BP,
18631,GO:1904017,1,0.914777292668164,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
18634,GO:1904020,1,0.91747545235514,0,2,regulation of G-protein coupled receptor internalization,BP,
18635,GO:1904021,1,0.957675882141855,0,1,negative regulation of G-protein coupled receptor internalization,BP,
18636,GO:1904022,1,0.958026563055971,0,1,positive regulation of G-protein coupled receptor internalization,BP,
18637,GO:1904023,1,0.958787867083198,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18638,GO:1904024,1,0.958787867083198,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18639,GO:1904026,1,0.920321452512825,0,2,regulation of collagen fibril organization,BP,
18640,GO:1904027,1,0.959883550924,0,1,negative regulation of collagen fibril organization,BP,
18641,GO:1904028,1,0.958787867083198,0,1,positive regulation of collagen fibril organization,BP,
18648,GO:1904041,1,0.957886117614705,0,1,regulation of cystathionine beta-synthase activity,BP,
18649,GO:1904042,1,0.957886117614705,0,1,negative regulation of cystathionine beta-synthase activity,BP,
18651,GO:1904045,1,0.961017211132583,0,1,cellular response to aldosterone,BP,
18652,GO:1904046,1,0.928483409861855,0,2,negative regulation of vascular endothelial growth factor production,BP,
18653,GO:1904047,1,0.884640698577157,0,3,S-adenosyl-L-methionine binding,MF,
18654,GO:1904048,1,0.956610929582769,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18655,GO:1904050,1,0.956610929582769,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
18656,GO:1904054,1,0.956441843839217,0,1,regulation of cholangiocyte proliferation,BP,
18657,GO:1904056,1,0.956441843839217,0,1,positive regulation of cholangiocyte proliferation,BP,
18658,GO:1904057,1,0.963030903296506,0,1,negative regulation of sensory perception of pain,BP,
18659,GO:1904058,1,0.883305544127475,0,3,positive regulation of sensory perception of pain,BP,
18660,GO:1904059,1,0.956441843839217,0,1,regulation of locomotor rhythm,BP,
18665,GO:1904098,1,0.882482648874705,0,3,regulation of protein O-linked glycosylation,BP,
18666,GO:1904100,1,0.882482648874705,0,3,positive regulation of protein O-linked glycosylation,BP,
18667,GO:1904106,1,0.958758621893661,0,1,protein localization to microvillus,BP,
18669,GO:1904116,1,0.878518364337551,0,3,response to vasopressin,BP,
18670,GO:1904117,1,0.878518364337551,0,3,cellular response to vasopressin,BP,
18671,GO:1904121,1,0.96287732446197,0,1,phosphatidylethanolamine transporter activity,MF,
18672,GO:1904124,1,0.960240360586506,0,1,microglial cell migration,BP,
18673,GO:1904139,1,0.960240360586506,0,1,regulation of microglial cell migration,BP,
18674,GO:1904141,1,0.960240360586506,0,1,positive regulation of microglial cell migration,BP,
18675,GO:1904152,1,0.61062643881705,0,12,regulation of retrograde protein transport, ER to cytosol,BP,
18676,GO:1904153,1,0.688940423105139,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
18677,GO:1904154,1,0.88640861704521,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
18678,GO:1904155,1,0.957794599180777,0,1,DN2 thymocyte differentiation,BP,
18679,GO:1904156,1,0.957794599180777,0,1,DN3 thymocyte differentiation,BP,
18680,GO:1904167,1,0.956441843839217,0,1,regulation of thyroid hormone receptor activity,BP,
18681,GO:1904168,1,0.956441843839217,0,1,negative regulation of thyroid hormone receptor activity,BP,
18682,GO:1904170,1,0.956530249065492,0,1,regulation of bleb assembly,BP,
18683,GO:1904172,1,0.956530249065492,0,1,positive regulation of bleb assembly,BP,
18684,GO:1904177,1,0.875945369061183,0,3,regulation of adipose tissue development,BP,
18685,GO:1904179,1,0.875945369061183,0,3,positive regulation of adipose tissue development,BP,
18687,GO:1904181,1,0.755084504185779,0,7,positive regulation of membrane depolarization,BP,
18688,GO:1904192,1,0.956441843839217,0,1,regulation of cholangiocyte apoptotic process,BP,
18689,GO:1904193,1,0.956441843839217,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18690,GO:1904195,1,0.956441843839217,0,1,regulation of granulosa cell proliferation,BP,
18691,GO:1904197,1,0.956441843839217,0,1,positive regulation of granulosa cell proliferation,BP,
18692,GO:1904199,1,0.956894798384683,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
18693,GO:1904200,1,0.956441843839217,0,1,iodide transmembrane transport,BP,
18694,GO:1904201,1,0.956441843839217,0,1,regulation of iodide transport,BP,
18695,GO:1904202,1,0.956441843839217,0,1,negative regulation of iodide transport,BP,
18696,GO:1904204,1,0.914777292668164,0,2,regulation of skeletal muscle hypertrophy,BP,
18697,GO:1904205,1,0.956441843839217,0,1,negative regulation of skeletal muscle hypertrophy,BP,
18698,GO:1904206,1,0.956441843839217,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18701,GO:1904210,1,0.963753063421403,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18702,GO:1904211,1,0.920661271445506,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
18703,GO:1904212,1,0.956441843839217,0,1,regulation of iodide transmembrane transport,BP,
18704,GO:1904213,1,0.956441843839217,0,1,negative regulation of iodide transmembrane transport,BP,
18705,GO:1904217,1,0.886534255113545,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18706,GO:1904219,1,0.886534255113545,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18707,GO:1904220,1,0.849989453998417,0,4,regulation of serine C-palmitoyltransferase activity,BP,
18708,GO:1904222,1,0.886534255113545,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
18709,GO:1904226,1,0.961111150127444,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18710,GO:1904227,1,0.961111150127444,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18711,GO:1904229,1,0.956441843839217,0,1,regulation of succinate dehydrogenase activity,BP,
18712,GO:1904231,1,0.956441843839217,0,1,positive regulation of succinate dehydrogenase activity,BP,
18713,GO:1904232,1,0.956441843839217,0,1,regulation of aconitate hydratase activity,BP,
18714,GO:1904234,1,0.956441843839217,0,1,positive regulation of aconitate hydratase activity,BP,
18715,GO:1904235,1,0.956441843839217,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18716,GO:1904237,1,0.956441843839217,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18718,GO:1904239,1,0.963753063421403,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18719,GO:1904240,1,0.963753063421403,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18720,GO:1904245,1,0.922551548060364,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
18721,GO:1904246,1,0.962667846714425,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
18722,GO:1904247,1,0.958331180316967,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
18724,GO:1904253,1,0.884164915251046,0,3,positive regulation of bile acid metabolic process,BP,
18725,GO:1904259,1,0.800343094282434,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18726,GO:1904261,1,0.800343094282434,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18727,GO:1904262,1,0.633828467663772,0,11,negative regulation of TORC1 signaling,BP,
18728,GO:1904263,1,0.722729376477166,0,8,positive regulation of TORC1 signaling,BP,
18729,GO:1904265,1,0.956441843839217,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
18730,GO:1904266,1,0.956441843839217,0,1,regulation of Schwann cell chemotaxis,BP,
18731,GO:1904268,1,0.956441843839217,0,1,positive regulation of Schwann cell chemotaxis,BP,
18732,GO:1904271,1,0.960101674776263,0,1,L-proline import across plasma membrane,BP,
18733,GO:1904274,1,0.960973890670753,0,1,tricellular tight junction assembly,BP,
18734,GO:1904282,1,0.961969091550826,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18735,GO:1904283,1,0.961969091550826,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18736,GO:1904288,1,0.841852998810854,0,4,BAT3 complex binding,MF,
18737,GO:1904289,1,0.916959081517858,0,2,regulation of mitotic DNA damage checkpoint,BP,
18738,GO:1904290,1,0.956617645843903,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
18739,GO:1904292,1,0.337164447576219,0,26,regulation of ERAD pathway,BP,
18740,GO:1904293,1,0.583822979756035,0,13,negative regulation of ERAD pathway,BP,
18741,GO:1904294,1,0.580248911586093,0,13,positive regulation of ERAD pathway,BP,
18742,GO:1904298,1,0.956842221697132,0,1,regulation of transcytosis,BP,
18743,GO:1904300,1,0.956842221697132,0,1,positive regulation of transcytosis,BP,
18744,GO:1904301,1,0.956842221697132,0,1,regulation of maternal process involved in parturition,BP,
18745,GO:1904303,1,0.956842221697132,0,1,positive regulation of maternal process involved in parturition,BP,
18746,GO:1904304,1,0.923539637490508,0,2,regulation of gastro-intestinal system smooth muscle contraction,BP,
18747,GO:1904306,1,0.923539637490508,0,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
18748,GO:1904313,1,0.956984038203023,0,1,response to methamphetamine hydrochloride,BP,
18749,GO:1904315,1,0.812153811263803,0,5,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
18750,GO:1904316,1,0.956842221697132,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18751,GO:1904317,1,0.956842221697132,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18752,GO:1904321,1,0.70678867928114,0,8,response to forskolin,BP,
18753,GO:1904322,1,0.70678867928114,0,8,cellular response to forskolin,BP,
18754,GO:1904327,1,0.917021318947511,0,2,protein localization to cytosolic proteasome complex,BP,
18755,GO:1904328,1,0.959281016590193,0,1,regulation of myofibroblast contraction,BP,
18757,GO:1904339,1,0.956441843839217,0,1,negative regulation of dopaminergic neuron differentiation,BP,
18758,GO:1904340,1,0.887918324720411,0,3,positive regulation of dopaminergic neuron differentiation,BP,
18759,GO:1904350,1,0.714983857767384,0,8,regulation of protein catabolic process in the vacuole,BP,
18760,GO:1904351,1,0.880811133813781,0,3,negative regulation of protein catabolic process in the vacuole,BP,
18761,GO:1904352,1,0.845324643536901,0,4,positive regulation of protein catabolic process in the vacuole,BP,
18762,GO:1904353,1,0.347673163456706,0,25,regulation of telomere capping,BP,
18763,GO:1904354,1,0.70665626454148,0,8,negative regulation of telomere capping,BP,
18764,GO:1904355,1,0.514692870959686,0,16,positive regulation of telomere capping,BP,
18765,GO:1904356,1,0.0875412186506583,0,58,regulation of telomere maintenance via telomere lengthening,BP,
18766,GO:1904357,1,0.330545431577755,0,26,negative regulation of telomere maintenance via telomere lengthening,BP,
18767,GO:1904358,1,0.235077227929209,0,35,positive regulation of telomere maintenance via telomere lengthening,BP,
18769,GO:1904376,1,0.448764535131998,0,19,negative regulation of protein localization to cell periphery,BP,
18771,GO:1904378,1,0.88166138984477,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
18772,GO:1904379,1,0.917021318947511,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
18773,GO:1904380,1,0.451676058096063,0,19,endoplasmic reticulum mannose trimming,BP,
18774,GO:1904381,1,0.915173871254122,0,2,Golgi apparatus mannose trimming,BP,
18775,GO:1904382,1,0.844172747112833,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
18776,GO:1904383,1,0.961208759105575,0,1,response to sodium phosphate,BP,
18778,GO:1904386,1,0.878030297446919,0,3,response to L-phenylalanine derivative,BP,
18779,GO:1904387,1,0.917345906062125,0,2,cellular response to L-phenylalanine derivative,BP,
18780,GO:1904393,1,0.956441843839217,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18781,GO:1904395,1,0.956441843839217,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18782,GO:1904396,1,0.874924186969474,0,3,regulation of neuromuscular junction development,BP,
18783,GO:1904398,1,0.914777292668164,0,2,positive regulation of neuromuscular junction development,BP,
18784,GO:1904404,1,0.956441843839217,0,1,response to formaldehyde,BP,
18785,GO:1904406,1,0.69584636289486,0,9,negative regulation of nitric oxide metabolic process,BP,
18787,GO:1904408,1,0.964410350568492,0,1,melatonin binding,MF,
18788,GO:1904412,1,0.957364396235892,0,1,regulation of cardiac ventricle development,BP,
18789,GO:1904414,1,0.957364396235892,0,1,positive regulation of cardiac ventricle development,BP,
18790,GO:1904415,1,0.776761243050331,0,6,regulation of xenophagy,BP,
18791,GO:1904417,1,0.776761243050331,0,6,positive regulation of xenophagy,BP,
18796,GO:1904429,1,0.741429055668825,0,7,regulation of t-circle formation,BP,
18797,GO:1904430,1,0.878283535284871,0,3,negative regulation of t-circle formation,BP,
18798,GO:1904431,1,0.844217600066795,0,4,positive regulation of t-circle formation,BP,
18799,GO:1904432,1,0.928102734246794,0,2,regulation of ferrous iron binding,BP,
18800,GO:1904434,1,0.928102734246794,0,2,positive regulation of ferrous iron binding,BP,
18801,GO:1904435,1,0.928102734246794,0,2,regulation of transferrin receptor binding,BP,
18802,GO:1904437,1,0.928102734246794,0,2,positive regulation of transferrin receptor binding,BP,
18803,GO:1904447,1,0.956441843839217,0,1,folic acid import across plasma membrane,BP,
18804,GO:1904448,1,0.956499496521757,0,1,regulation of aspartate secretion,BP,
18805,GO:1904450,1,0.956499496521757,0,1,positive regulation of aspartate secretion,BP,
18806,GO:1904454,1,0.956441843839217,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
18807,GO:1904455,1,0.914820141103143,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
18808,GO:1904457,1,0.96032783469921,0,1,positive regulation of neuronal action potential,BP,
18809,GO:1904464,1,0.962690875752419,0,1,regulation of matrix metallopeptidase secretion,BP,
18810,GO:1904465,1,0.962690875752419,0,1,negative regulation of matrix metallopeptidase secretion,BP,
18811,GO:1904467,1,0.649834626791458,0,10,regulation of tumor necrosis factor secretion,BP,
18812,GO:1904468,1,0.882506491354121,0,3,negative regulation of tumor necrosis factor secretion,BP,
18813,GO:1904469,1,0.736408770979709,0,7,positive regulation of tumor necrosis factor secretion,BP,
18816,GO:1904481,1,0.960136189468717,0,1,response to tetrahydrofolate,BP,
18817,GO:1904482,1,0.960136189468717,0,1,cellular response to tetrahydrofolate,BP,
18818,GO:1904491,1,0.857556842836803,0,4,protein localization to ciliary transition zone,BP,
18819,GO:1904498,1,0.879227971604245,0,3,protein localization to mitotic actomyosin contractile ring,BP,
18820,GO:1904499,1,0.957654579206527,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18821,GO:1904501,1,0.957654579206527,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
18822,GO:1904502,1,0.810487471870621,0,5,regulation of lipophagy,BP,
18823,GO:1904504,1,0.810487471870621,0,5,positive regulation of lipophagy,BP,
18824,GO:1904505,1,0.842489775934597,0,4,regulation of telomere maintenance in response to DNA damage,BP,
18825,GO:1904506,1,0.842489775934597,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
18826,GO:1904515,1,0.957795483285784,0,1,positive regulation of TORC2 signaling,BP,
18828,GO:1904527,1,0.879448727200295,0,3,negative regulation of microtubule binding,BP,
18829,GO:1904528,1,0.783666692929696,0,6,positive regulation of microtubule binding,BP,
18830,GO:1904529,1,0.916536290848377,0,2,regulation of actin filament binding,BP,
18831,GO:1904530,1,0.958280561582676,0,1,negative regulation of actin filament binding,BP,
18832,GO:1904531,1,0.956442075022866,0,1,positive regulation of actin filament binding,BP,
18833,GO:1904533,1,0.879247469503236,0,3,regulation of telomeric loop disassembly,BP,
18834,GO:1904534,1,0.91914605848228,0,2,negative regulation of telomeric loop disassembly,BP,
18835,GO:1904535,1,0.956598999131008,0,1,positive regulation of telomeric loop disassembly,BP,
18836,GO:1904542,1,0.95946148728879,0,1,regulation of free ubiquitin chain polymerization,BP,
18837,GO:1904544,1,0.95946148728879,0,1,positive regulation of free ubiquitin chain polymerization,BP,
18838,GO:1904550,1,0.961533633978051,0,1,response to arachidonic acid,BP,
18839,GO:1904555,1,0.960101674776263,0,1,L-proline transmembrane transport,BP,
18840,GO:1904556,1,0.960101674776263,0,1,L-tryptophan transmembrane transport,BP,
18841,GO:1904562,1,0.914777292668164,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
18842,GO:1904565,1,0.958221168737547,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18843,GO:1904566,1,0.958221168737547,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18844,GO:1904567,1,0.958488100763464,0,1,response to wortmannin,BP,
18845,GO:1904568,1,0.958488100763464,0,1,cellular response to wortmannin,BP,
18846,GO:1904569,1,0.962674433856931,0,1,regulation of selenocysteine incorporation,BP,
18847,GO:1904570,1,0.962674433856931,0,1,negative regulation of selenocysteine incorporation,BP,
18848,GO:1904572,1,0.962674433856931,0,1,negative regulation of mRNA binding,BP,
18849,GO:1904573,1,0.962674433856931,0,1,regulation of selenocysteine insertion sequence binding,BP,
18850,GO:1904574,1,0.962674433856931,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
18851,GO:1904576,1,0.923387513039415,0,2,response to tunicamycin,BP,
18852,GO:1904577,1,0.923387513039415,0,2,cellular response to tunicamycin,BP,
18853,GO:1904578,1,0.885533792030275,0,3,response to thapsigargin,BP,
18854,GO:1904579,1,0.885533792030275,0,3,cellular response to thapsigargin,BP,
18855,GO:1904580,1,0.922681801519697,0,2,regulation of intracellular mRNA localization,BP,
18856,GO:1904582,1,0.922681801519697,0,2,positive regulation of intracellular mRNA localization,BP,
18857,GO:1904585,1,0.961208759105575,0,1,response to putrescine,BP,
18858,GO:1904586,1,0.961208759105575,0,1,cellular response to putrescine,BP,
18859,GO:1904587,1,0.844172747112833,0,4,response to glycoprotein,BP,
18860,GO:1904589,1,0.153493539997412,0,45,regulation of protein import,BP,
18861,GO:1904590,1,0.747302351514869,0,7,negative regulation of protein import,BP,
18862,GO:1904591,1,0.294900119730369,0,29,positive regulation of protein import,BP,
18863,GO:1904594,1,0.956441843839217,0,1,regulation of termination of RNA polymerase II transcription,BP,
18864,GO:1904595,1,0.956441843839217,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
18865,GO:1904596,1,0.963878754216339,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18866,GO:1904597,1,0.963878754216339,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18867,GO:1904599,1,0.963878754216339,0,1,advanced glycation end-product binding,MF,
18868,GO:1904603,1,0.963878754216339,0,1,regulation of advanced glycation end-product receptor activity,BP,
18869,GO:1904604,1,0.963878754216339,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
18870,GO:1904612,1,0.91511726637513,0,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18871,GO:1904613,1,0.91511726637513,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18872,GO:1904616,1,0.916536290848377,0,2,regulation of actin binding,BP,
18873,GO:1904617,1,0.958280561582676,0,1,negative regulation of actin binding,BP,
18874,GO:1904618,1,0.956442075022866,0,1,positive regulation of actin binding,BP,
18875,GO:1904627,1,0.963587510625542,0,1,response to phorbol 13-acetate 12-myristate,BP,
18876,GO:1904628,1,0.963587510625542,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
18877,GO:1904631,1,0.960910773001507,0,1,response to glucoside,BP,
18882,GO:1904647,1,0.956441843839217,0,1,response to rotenone,BP,
18884,GO:1904666,1,0.497002017971543,0,18,regulation of ubiquitin protein ligase activity,BP,
18885,GO:1904667,1,0.807066062297304,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18886,GO:1904668,1,0.615945002192554,0,12,positive regulation of ubiquitin protein ligase activity,BP,
18887,GO:1904672,1,0.876072916491115,0,3,regulation of somatic stem cell population maintenance,BP,
18888,GO:1904673,1,0.915849294705781,0,2,negative regulation of somatic stem cell population maintenance,BP,
18889,GO:1904674,1,0.956576492492707,0,1,positive regulation of somatic stem cell population maintenance,BP,
18891,GO:1904681,1,0.959359571164546,0,1,response to 3-methylcholanthrene,BP,
18892,GO:1904683,1,0.769769812170418,0,6,regulation of metalloendopeptidase activity,BP,
18893,GO:1904684,1,0.837623421787874,0,4,negative regulation of metalloendopeptidase activity,BP,
18894,GO:1904685,1,0.919020842364888,0,2,positive regulation of metalloendopeptidase activity,BP,
18897,GO:1904690,1,0.848805325651048,0,4,positive regulation of cytoplasmic translational initiation,BP,
18898,GO:1904691,1,0.961313582772595,0,1,negative regulation of type B pancreatic cell proliferation,BP,
18899,GO:1904693,1,0.8761489237108,0,3,midbrain morphogenesis,BP,
18900,GO:1904694,1,0.877070642074018,0,3,negative regulation of vascular smooth muscle contraction,BP,
18901,GO:1904695,1,0.962064116170112,0,1,positive regulation of vascular smooth muscle contraction,BP,
18902,GO:1904700,1,0.959664349471913,0,1,granulosa cell apoptotic process,BP,
18903,GO:1904701,1,0.962464157847848,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
18904,GO:1904705,1,0.321730365037024,0,27,regulation of vascular smooth muscle cell proliferation,BP,
18905,GO:1904706,1,0.641870627992539,0,11,negative regulation of vascular smooth muscle cell proliferation,BP,
18906,GO:1904707,1,0.482985558669622,0,17,positive regulation of vascular smooth muscle cell proliferation,BP,
18907,GO:1904708,1,0.959664349471913,0,1,regulation of granulosa cell apoptotic process,BP,
18908,GO:1904711,1,0.962464157847848,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18909,GO:1904713,1,0.958787867083198,0,1,beta-catenin destruction complex binding,MF,
18910,GO:1904714,1,0.779435450140165,0,6,regulation of chaperone-mediated autophagy,BP,
18911,GO:1904715,1,0.88569256744764,0,3,negative regulation of chaperone-mediated autophagy,BP,
18912,GO:1904716,1,0.960458278894429,0,1,positive regulation of chaperone-mediated autophagy,BP,
18913,GO:1904717,1,0.918354091887011,0,2,regulation of AMPA glutamate receptor clustering,BP,
18914,GO:1904719,1,0.960181217856468,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
18915,GO:1904720,1,0.920251648295266,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18916,GO:1904721,1,0.958338007501677,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18917,GO:1904722,1,0.960261301714898,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18918,GO:1904723,1,0.962464157847848,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18920,GO:1904732,1,0.923967167055085,0,2,regulation of electron transfer activity,BP,
18921,GO:1904734,1,0.966049419230398,0,1,positive regulation of electron transfer activity,BP,
18922,GO:1904738,1,0.596225229426937,0,12,vascular associated smooth muscle cell migration,BP,
18923,GO:1904742,1,0.848489801542035,0,4,regulation of telomeric DNA binding,BP,
18924,GO:1904743,1,0.914777292668164,0,2,negative regulation of telomeric DNA binding,BP,
18925,GO:1904744,1,0.92754976200326,0,2,positive regulation of telomeric DNA binding,BP,
18926,GO:1904746,1,0.877035314520591,0,3,negative regulation of apoptotic process involved in development,BP,
18927,GO:1904747,1,0.883375695311614,0,3,positive regulation of apoptotic process involved in development,BP,
18928,GO:1904748,1,0.740976641212537,0,7,regulation of apoptotic process involved in development,BP,
18929,GO:1904749,1,0.851613166387804,0,4,regulation of protein localization to nucleolus,BP,
18930,GO:1904750,1,0.956441843839217,0,1,negative regulation of protein localization to nucleolus,BP,
18931,GO:1904751,1,0.890406662677616,0,3,positive regulation of protein localization to nucleolus,BP,
18932,GO:1904752,1,0.596225229426937,0,12,regulation of vascular associated smooth muscle cell migration,BP,
18933,GO:1904753,1,0.883669258431096,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
18934,GO:1904754,1,0.674782610364828,0,9,positive regulation of vascular associated smooth muscle cell migration,BP,
18937,GO:1904762,1,0.95695395643193,0,1,positive regulation of myofibroblast differentiation,BP,
18938,GO:1904764,1,0.961655785053158,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
18939,GO:1904766,1,0.956441843839217,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
18941,GO:1904772,1,0.959552427746578,0,1,response to tetrachloromethane,BP,
18942,GO:1904776,1,0.770964892631137,0,6,regulation of protein localization to cell cortex,BP,
18943,GO:1904777,1,0.958787867083198,0,1,negative regulation of protein localization to cell cortex,BP,
18944,GO:1904778,1,0.804118825354134,0,5,positive regulation of protein localization to cell cortex,BP,
18945,GO:1904779,1,0.770614656122453,0,6,regulation of protein localization to centrosome,BP,
18946,GO:1904781,1,0.802508144078805,0,5,positive regulation of protein localization to centrosome,BP,
18949,GO:1904784,1,0.956443918242814,0,1,NLRP1 inflammasome complex assembly,BP,
18950,GO:1904790,1,0.958676373351407,0,1,regulation of shelterin complex assembly,BP,
18951,GO:1904792,1,0.958676373351407,0,1,positive regulation of shelterin complex assembly,BP,
18952,GO:1904793,1,0.957654579206527,0,1,regulation of euchromatin binding,BP,
18953,GO:1904796,1,0.809730136424359,0,5,regulation of core promoter binding,BP,
18954,GO:1904797,1,0.956441843839217,0,1,negative regulation of core promoter binding,BP,
18955,GO:1904798,1,0.846619614885692,0,4,positive regulation of core promoter binding,BP,
18956,GO:1904799,1,0.95699402362007,0,1,regulation of neuron remodeling,BP,
18957,GO:1904800,1,0.95699402362007,0,1,negative regulation of neuron remodeling,BP,
18958,GO:1904803,1,0.965712647677366,0,1,regulation of translation involved in cellular response to UV,BP,
18959,GO:1904806,1,0.958787867083198,0,1,regulation of protein oxidation,BP,
18960,GO:1904808,1,0.958787867083198,0,1,positive regulation of protein oxidation,BP,
18961,GO:1904812,1,0.956995395019061,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
18963,GO:1904814,1,0.591292815514071,0,13,regulation of protein localization to chromosome, telomeric region,BP,
18964,GO:1904815,1,0.922294955719797,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
18965,GO:1904816,1,0.641157635588496,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
18966,GO:1904823,1,0.921051177574091,0,2,purine nucleobase transmembrane transport,BP,
18967,GO:1904826,1,0.956441843839217,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
18968,GO:1904828,1,0.956441843839217,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
18969,GO:1904829,1,0.96265960442676,0,1,regulation of aortic smooth muscle cell differentiation,BP,
18970,GO:1904831,1,0.96265960442676,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
18971,GO:1904833,1,0.96492184451589,0,1,positive regulation of removal of superoxide radicals,BP,
18972,GO:1904835,1,0.960046682619021,0,1,dorsal root ganglion morphogenesis,BP,
18974,GO:1904842,1,0.961205143738116,0,1,response to nitroglycerin,BP,
18975,GO:1904843,1,0.961205143738116,0,1,cellular response to nitroglycerin,BP,
18978,GO:1904847,1,0.875555938320717,0,3,regulation of cell chemotaxis to fibroblast growth factor,BP,
18979,GO:1904849,1,0.91477749255326,0,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
18980,GO:1904850,1,0.958676373351407,0,1,negative regulation of establishment of protein localization to telomere,BP,
18981,GO:1904851,1,0.69717368255192,0,9,positive regulation of establishment of protein localization to telomere,BP,
18982,GO:1904854,1,0.958089214265029,0,1,proteasome core complex binding,MF,
18985,GO:1904867,1,0.698394380392713,0,9,protein localization to Cajal body,BP,
18986,GO:1904868,1,0.914777292668164,0,2,telomerase catalytic core complex assembly,BP,
18987,GO:1904869,1,0.725790293715242,0,8,regulation of protein localization to Cajal body,BP,
18988,GO:1904871,1,0.725790293715242,0,8,positive regulation of protein localization to Cajal body,BP,
18989,GO:1904872,1,0.488449543884007,0,18,regulation of telomerase RNA localization to Cajal body,BP,
18990,GO:1904874,1,0.555695768380795,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
18991,GO:1904875,1,0.9217292471316,0,2,regulation of DNA ligase activity,BP,
18992,GO:1904876,1,0.958771881359281,0,1,negative regulation of DNA ligase activity,BP,
18993,GO:1904877,1,0.961367767325818,0,1,positive regulation of DNA ligase activity,BP,
18994,GO:1904878,1,0.956441843839217,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
18995,GO:1904879,1,0.919056420307583,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
18996,GO:1904880,1,0.921114768951397,0,2,response to hydrogen sulfide,BP,
18997,GO:1904881,1,0.95946148728879,0,1,cellular response to hydrogen sulfide,BP,
18998,GO:1904882,1,0.914777292668164,0,2,regulation of telomerase catalytic core complex assembly,BP,
18999,GO:1904884,1,0.914777292668164,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
19000,GO:1904885,1,0.80488026703976,0,5,beta-catenin destruction complex assembly,BP,
19003,GO:1904889,1,0.962762781917351,0,1,regulation of excitatory synapse assembly,BP,
19004,GO:1904891,1,0.962762781917351,0,1,positive regulation of excitatory synapse assembly,BP,
19007,GO:1904894,1,0.196704732595932,0,40,positive regulation of STAT cascade,BP,
19008,GO:1904895,1,0.962914041062283,0,1,ESCRT complex assembly,BP,
19009,GO:1904896,1,0.664805289270974,0,10,ESCRT complex disassembly,BP,
19010,GO:1904902,1,0.962914041062283,0,1,ESCRT III complex assembly,BP,
19011,GO:1904903,1,0.664805289270974,0,10,ESCRT III complex disassembly,BP,
19012,GO:1904907,1,0.914777292668164,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19013,GO:1904908,1,0.914777292668164,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19014,GO:1904910,1,0.958676373351407,0,1,regulation of establishment of RNA localization to telomere,BP,
19015,GO:1904911,1,0.958676373351407,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19016,GO:1904913,1,0.958676373351407,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19017,GO:1904914,1,0.958676373351407,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
19019,GO:1904924,1,0.960319061862212,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19021,GO:1904928,1,0.91479947020379,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
19023,GO:1904933,1,0.956441843839217,0,1,regulation of cell proliferation in midbrain,BP,
19024,GO:1904934,1,0.956441843839217,0,1,negative regulation of cell proliferation in midbrain,BP,
19026,GO:1904947,1,0.958452153142485,0,1,folic acid import into mitochondrion,BP,
19033,GO:1904955,1,0.956441843839217,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19035,GO:1904958,1,0.887918324720411,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
19036,GO:1904959,1,0.923967167055085,0,2,regulation of cytochrome-c oxidase activity,BP,
19037,GO:1904960,1,0.966049419230398,0,1,positive regulation of cytochrome-c oxidase activity,BP,
19038,GO:1904970,1,0.918072667756902,0,2,brush border assembly,BP,
19039,GO:1904971,1,0.956580991138864,0,1,regulation of viral translation,BP,
19040,GO:1904973,1,0.956580991138864,0,1,positive regulation of viral translation,BP,
19041,GO:1904975,1,0.915337057233792,0,2,response to bleomycin,BP,
19042,GO:1904976,1,0.915337057233792,0,2,cellular response to bleomycin,BP,
19043,GO:1904977,1,0.958822782263901,0,1,lymphatic endothelial cell migration,BP,
19044,GO:1904978,1,0.879127134350679,0,3,regulation of endosome organization,BP,
19045,GO:1904979,1,0.960937814011146,0,1,negative regulation of endosome organization,BP,
19046,GO:1904980,1,0.956441843839217,0,1,positive regulation of endosome organization,BP,
19047,GO:1904983,1,0.961324422264128,0,1,glycine import into mitochondrion,BP,
19048,GO:1904990,1,0.960203797330898,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19049,GO:1904992,1,0.960203797330898,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19050,GO:1904994,1,0.809926591531,0,5,regulation of leukocyte adhesion to vascular endothelial cell,BP,
19051,GO:1904995,1,0.925320980851324,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
19052,GO:1904996,1,0.875311128823546,0,3,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
19053,GO:1904997,1,0.958685403078214,0,1,regulation of leukocyte adhesion to arterial endothelial cell,BP,
19054,GO:1904998,1,0.958685403078214,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
19055,GO:1905000,1,0.956441843839217,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
19056,GO:1905005,1,0.773333666901066,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19057,GO:1905006,1,0.920275653789692,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19058,GO:1905007,1,0.803750981838665,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19059,GO:1905024,1,0.915326591361245,0,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19060,GO:1905026,1,0.956976854542281,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19061,GO:1905031,1,0.875449601888727,0,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19062,GO:1905033,1,0.956976854542281,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19063,GO:1905034,1,0.958693164439256,0,1,regulation of antifungal innate immune response,BP,
19064,GO:1905035,1,0.958693164439256,0,1,negative regulation of antifungal innate immune response,BP,
19066,GO:1905038,1,0.613983441127398,0,12,regulation of membrane lipid metabolic process,BP,
19068,GO:1905040,1,0.960046682619021,0,1,otic placode development,BP,
19069,GO:1905041,1,0.919046757387378,0,2,regulation of epithelium regeneration,BP,
19070,GO:1905042,1,0.960905366649566,0,1,negative regulation of epithelium regeneration,BP,
19071,GO:1905044,1,0.958787867083198,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19072,GO:1905045,1,0.958787867083198,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19073,GO:1905048,1,0.582667499208633,0,13,regulation of metallopeptidase activity,BP,
19074,GO:1905049,1,0.773759208134906,0,6,negative regulation of metallopeptidase activity,BP,
19075,GO:1905050,1,0.753146925037321,0,7,positive regulation of metallopeptidase activity,BP,
19076,GO:1905051,1,0.929015978528576,0,2,regulation of base-excision repair,BP,
19077,GO:1905053,1,0.929015978528576,0,2,positive regulation of base-excision repair,BP,
19078,GO:1905062,1,0.959317824505889,0,1,positive regulation of cardioblast proliferation,BP,
19079,GO:1905063,1,0.811809466511281,0,5,regulation of vascular smooth muscle cell differentiation,BP,
19080,GO:1905064,1,0.917945101547991,0,2,negative regulation of vascular smooth muscle cell differentiation,BP,
19081,GO:1905065,1,0.884395984658635,0,3,positive regulation of vascular smooth muscle cell differentiation,BP,
19082,GO:1905066,1,0.924432725524386,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
19083,GO:1905067,1,0.962464157847848,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
19084,GO:1905068,1,0.96048839507273,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
19085,GO:1905069,1,0.956927530270733,0,1,allantois development,BP,
19086,GO:1905071,1,0.916360901428413,0,2,occluding junction disassembly,BP,
19087,GO:1905073,1,0.916360901428413,0,2,regulation of occluding junction disassembly,BP,
19088,GO:1905075,1,0.916360901428413,0,2,positive regulation of occluding junction disassembly,BP,
19089,GO:1905076,1,0.961845070778084,0,1,regulation of interleukin-17 secretion,BP,
19090,GO:1905077,1,0.961845070778084,0,1,negative regulation of interleukin-17 secretion,BP,
19091,GO:1905089,1,0.956441843839217,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19092,GO:1905090,1,0.956441843839217,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19094,GO:1905098,1,0.846789248419441,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
19096,GO:1905103,1,0.956951357901455,0,1,integral component of lysosomal membrane,CC,
19098,GO:1905123,1,0.915357766079641,0,2,regulation of glucosylceramidase activity,BP,
19099,GO:1905132,1,0.958436723289691,0,1,regulation of meiotic chromosome separation,BP,
19100,GO:1905133,1,0.958436723289691,0,1,negative regulation of meiotic chromosome separation,BP,
19101,GO:1905143,1,0.96326198988714,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
19102,GO:1905144,1,0.61069941036345,0,12,response to acetylcholine,BP,
19103,GO:1905145,1,0.61069941036345,0,12,cellular response to acetylcholine,BP,
19104,GO:1905146,1,0.686973591613955,0,9,lysosomal protein catabolic process,BP,
19105,GO:1905150,1,0.914988072079155,0,2,regulation of voltage-gated sodium channel activity,BP,
19106,GO:1905152,1,0.956441843839217,0,1,positive regulation of voltage-gated sodium channel activity,BP,
19107,GO:1905153,1,0.772137739829914,0,6,regulation of membrane invagination,BP,
19108,GO:1905154,1,0.956455202777739,0,1,negative regulation of membrane invagination,BP,
19109,GO:1905155,1,0.807306803463519,0,5,positive regulation of membrane invagination,BP,
19110,GO:1905161,1,0.956455202777739,0,1,protein localization to phagocytic vesicle,BP,
19111,GO:1905162,1,0.956455202777739,0,1,regulation of phagosome maturation,BP,
19112,GO:1905165,1,0.773757802903936,0,6,regulation of lysosomal protein catabolic process,BP,
19113,GO:1905166,1,0.880811133813781,0,3,negative regulation of lysosomal protein catabolic process,BP,
19114,GO:1905167,1,0.914788200312853,0,2,positive regulation of lysosomal protein catabolic process,BP,
19115,GO:1905168,1,0.957254343969317,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
19116,GO:1905169,1,0.956455202777739,0,1,regulation of protein localization to phagocytic vesicle,BP,
19117,GO:1905171,1,0.956455202777739,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19118,GO:1905172,1,0.956580991138864,0,1,RISC complex binding,MF,
19120,GO:1905176,1,0.958824132817469,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
19121,GO:1905202,1,0.918836042647092,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
19122,GO:1905203,1,0.922015421695701,0,2,regulation of connective tissue replacement,BP,
19123,GO:1905204,1,0.963878754216339,0,1,negative regulation of connective tissue replacement,BP,
19124,GO:1905205,1,0.9565710502021,0,1,positive regulation of connective tissue replacement,BP,
19128,GO:1905209,1,0.536140799098596,0,15,positive regulation of cardiocyte differentiation,BP,
19129,GO:1905214,1,0.634748769188572,0,11,regulation of RNA binding,BP,
19130,GO:1905215,1,0.962674433856931,0,1,negative regulation of RNA binding,BP,
19131,GO:1905216,1,0.719255070995622,0,8,positive regulation of RNA binding,BP,
19132,GO:1905222,1,0.958199540814593,0,1,atrioventricular canal morphogenesis,BP,
19133,GO:1905223,1,0.956441843839217,0,1,epicardium morphogenesis,BP,
19134,GO:1905224,1,0.914950227423139,0,2,clathrin-coated pit assembly,BP,
19135,GO:1905232,1,0.843050371305497,0,4,cellular response to L-glutamate,BP,
19136,GO:1905242,1,0.957726119347696,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
19139,GO:1905246,1,0.918775557725183,0,2,negative regulation of aspartic-type peptidase activity,BP,
19141,GO:1905255,1,0.956441843839217,0,1,regulation of RNA binding transcription factor activity,BP,
19142,GO:1905258,1,0.929504977801355,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19143,GO:1905259,1,0.929504977801355,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19144,GO:1905267,1,0.919746524237093,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
19147,GO:1905271,1,0.965615780180453,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19148,GO:1905273,1,0.965615780180453,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19149,GO:1905274,1,0.956441843839217,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19151,GO:1905277,1,0.958352863090148,0,1,negative regulation of epithelial tube formation,BP,
19152,GO:1905278,1,0.884979063494002,0,3,positive regulation of epithelial tube formation,BP,
19153,GO:1905279,1,0.958787867083198,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19154,GO:1905285,1,0.957364396235892,0,1,fibrous ring of heart morphogenesis,BP,
19155,GO:1905286,1,0.922394376694836,0,2,serine-type peptidase complex,CC,
19156,GO:1905288,1,0.806162113453773,0,5,vascular associated smooth muscle cell apoptotic process,BP,
19157,GO:1905292,1,0.880960225686528,0,3,regulation of neural crest cell differentiation,BP,
19158,GO:1905294,1,0.880960225686528,0,3,positive regulation of neural crest cell differentiation,BP,
19159,GO:1905301,1,0.956610929582769,0,1,regulation of macropinocytosis,BP,
19160,GO:1905302,1,0.956610929582769,0,1,negative regulation of macropinocytosis,BP,
19161,GO:1905304,1,0.956441843839217,0,1,regulation of cardiac myofibril assembly,BP,
19162,GO:1905305,1,0.956441843839217,0,1,negative regulation of cardiac myofibril assembly,BP,
19163,GO:1905309,1,0.956441843839217,0,1,positive regulation of cohesin loading,BP,
19164,GO:1905310,1,0.880960225686528,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19165,GO:1905312,1,0.880960225686528,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19166,GO:1905313,1,0.961053331004262,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19167,GO:1905314,1,0.68138006685628,0,9,semi-lunar valve development,BP,
19168,GO:1905317,1,0.956566939031699,0,1,inferior endocardial cushion morphogenesis,BP,
19172,GO:1905323,1,0.778406810547212,0,6,telomerase holoenzyme complex assembly,BP,
19175,GO:1905332,1,0.411737561075397,0,21,positive regulation of morphogenesis of an epithelium,BP,
19176,GO:1905333,1,0.929415901248076,0,2,regulation of gastric motility,BP,
19177,GO:1905335,1,0.956441843839217,0,1,regulation of aggrephagy,BP,
19178,GO:1905337,1,0.956441843839217,0,1,positive regulation of aggrephagy,BP,
19179,GO:1905340,1,0.85110929857489,0,4,regulation of protein localization to kinetochore,BP,
19180,GO:1905341,1,0.959407932504879,0,1,negative regulation of protein localization to kinetochore,BP,
19181,GO:1905342,1,0.85110929857489,0,4,positive regulation of protein localization to kinetochore,BP,
19182,GO:1905344,1,0.958787867083198,0,1,prostaglandin catabolic process,BP,
19183,GO:1905348,1,0.310948096475784,0,29,endonuclease complex,CC,
19184,GO:1905349,1,0.964259206309988,0,1,ciliary transition zone assembly,BP,
19185,GO:1905354,1,0.414711268699491,0,22,exoribonuclease complex,CC,
19186,GO:1905355,1,0.95646564060065,0,1,spine apparatus assembly,BP,
19187,GO:1905359,1,0.958436723289691,0,1,protein localization to meiotic spindle,BP,
19188,GO:1905360,1,0.440363401985197,0,20,GTPase complex,CC,
19189,GO:1905365,1,0.960937814011146,0,1,regulation of intralumenal vesicle formation,BP,
19190,GO:1905366,1,0.960937814011146,0,1,negative regulation of intralumenal vesicle formation,BP,
19191,GO:1905368,1,0.0359454263841447,0,85,peptidase complex,CC,
19192,GO:1905369,1,0.0835579108151163,0,64,endopeptidase complex,CC,
19193,GO:1905370,1,0.960319061862212,0,1,serine-type endopeptidase complex,CC,
19194,GO:1905371,1,0.921447130458164,0,2,ceramide phosphoethanolamine metabolic process,BP,
19195,GO:1905373,1,0.921447130458164,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
19196,GO:1905383,1,0.890681750231913,0,3,protein localization to presynapse,BP,
19197,GO:1905384,1,0.922978621025825,0,2,regulation of protein localization to presynapse,BP,
19198,GO:1905386,1,0.922978621025825,0,2,positive regulation of protein localization to presynapse,BP,
19199,GO:1905392,1,0.965280077340104,0,1,plant organ morphogenesis,BP,
19200,GO:1905394,1,0.882446360725567,0,3,retromer complex binding,MF,
19201,GO:1905395,1,0.923482863002949,0,2,response to flavonoid,BP,
19202,GO:1905397,1,0.926546709804805,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19203,GO:1905402,1,0.926546709804805,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19204,GO:1905403,1,0.961845070778084,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19205,GO:1905404,1,0.963304288355515,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19206,GO:1905405,1,0.956441843839217,0,1,regulation of mitotic cohesin loading,BP,
19207,GO:1905406,1,0.956441843839217,0,1,positive regulation of mitotic cohesin loading,BP,
19208,GO:1905407,1,0.957899162199986,0,1,regulation of creatine transmembrane transporter activity,BP,
19209,GO:1905408,1,0.957899162199986,0,1,negative regulation of creatine transmembrane transporter activity,BP,
19210,GO:1905419,1,0.96237411038791,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
19211,GO:1905421,1,0.965280077340104,0,1,regulation of plant organ morphogenesis,BP,
19212,GO:1905422,1,0.965280077340104,0,1,negative regulation of plant organ morphogenesis,BP,
19213,GO:1905424,1,0.922552744212727,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19214,GO:1905426,1,0.922552744212727,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19215,GO:1905429,1,0.961501227771577,0,1,response to glycine,BP,
19216,GO:1905430,1,0.961501227771577,0,1,cellular response to glycine,BP,
19217,GO:1905435,1,0.958787867083198,0,1,regulation of histone H3-K4 trimethylation,BP,
19218,GO:1905437,1,0.958787867083198,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19219,GO:1905438,1,0.956441843839217,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19220,GO:1905443,1,0.956632055155741,0,1,regulation of clathrin coat assembly,BP,
19221,GO:1905445,1,0.956632055155741,0,1,positive regulation of clathrin coat assembly,BP,
19222,GO:1905446,1,0.820969612980579,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19223,GO:1905447,1,0.958131655655566,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19224,GO:1905448,1,0.856855878256599,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19225,GO:1905449,1,0.920346561630051,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19226,GO:1905451,1,0.920346561630051,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19227,GO:1905456,1,0.746008197109501,0,7,regulation of lymphoid progenitor cell differentiation,BP,
19228,GO:1905457,1,0.888391834471914,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
19229,GO:1905458,1,0.956977748910324,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19230,GO:1905459,1,0.806162113453773,0,5,regulation of vascular associated smooth muscle cell apoptotic process,BP,
19231,GO:1905461,1,0.806162113453773,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
19232,GO:1905462,1,0.915193960353445,0,2,regulation of DNA duplex unwinding,BP,
19233,GO:1905463,1,0.956441854282437,0,1,negative regulation of DNA duplex unwinding,BP,
19234,GO:1905464,1,0.956877439770078,0,1,positive regulation of DNA duplex unwinding,BP,
19235,GO:1905468,1,0.956455202777739,0,1,regulation of clathrin-coated pit assembly,BP,
19236,GO:1905469,1,0.956455202777739,0,1,negative regulation of clathrin-coated pit assembly,BP,
19242,GO:1905508,1,0.312436131682052,0,27,protein localization to microtubule organizing center,BP,
19247,GO:1905522,1,0.858586832192622,0,4,negative regulation of macrophage migration,BP,
19249,GO:1905524,1,0.956441843839217,0,1,negative regulation of protein autoubiquitination,BP,
19250,GO:1905535,1,0.956456299395857,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19251,GO:1905537,1,0.956456299395857,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19252,GO:1905538,1,0.91715474244817,0,2,polysome binding,MF,
19253,GO:1905547,1,0.96300265421436,0,1,regulation of telomeric heterochromatin assembly,BP,
19254,GO:1905549,1,0.96300265421436,0,1,positive regulation of telomeric heterochromatin assembly,BP,
19255,GO:1905550,1,0.925737686761458,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19256,GO:1905552,1,0.925737686761458,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
19257,GO:1905553,1,0.887785622697636,0,3,regulation of blood vessel branching,BP,
19258,GO:1905555,1,0.921053085608023,0,2,positive regulation blood vessel branching,BP,
19259,GO:1905562,1,0.625020029675939,0,11,regulation of vascular endothelial cell proliferation,BP,
19260,GO:1905563,1,0.962278046052311,0,1,negative regulation of vascular endothelial cell proliferation,BP,
19261,GO:1905564,1,0.649543352867976,0,10,positive regulation of vascular endothelial cell proliferation,BP,
19262,GO:1905572,1,0.958941023946616,0,1,ganglioside GM1 transport to membrane,BP,
19263,GO:1905573,1,0.922576489442778,0,2,ganglioside GM1 binding,MF,
19264,GO:1905574,1,0.958941023946616,0,1,ganglioside GM2 binding,MF,
19265,GO:1905575,1,0.958941023946616,0,1,ganglioside GM3 binding,MF,
19266,GO:1905576,1,0.922576489442778,0,2,ganglioside GT1b binding,MF,
19267,GO:1905577,1,0.958941023946616,0,1,ganglioside GP1c binding,MF,
19268,GO:1905578,1,0.960191633845267,0,1,regulation of ERBB3 signaling pathway,BP,
19269,GO:1905580,1,0.960191633845267,0,1,positive regulation of ERBB3 signaling pathway,BP,
19270,GO:1905581,1,0.963004226573629,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19271,GO:1905590,1,0.958213576382395,0,1,fibronectin fibril organization,BP,
19272,GO:1905594,1,0.964410350568492,0,1,resveratrol binding,MF,
19273,GO:1905595,1,0.921917595787259,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
19274,GO:1905596,1,0.957338170440611,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
19275,GO:1905597,1,0.963004226573629,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19276,GO:1905598,1,0.957338170440611,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
19277,GO:1905599,1,0.963004226573629,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
19279,GO:1905601,1,0.957338170440611,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19281,GO:1905606,1,0.877803864896274,0,3,regulation of presynapse assembly,BP,
19282,GO:1905610,1,0.956456299395857,0,1,regulation of mRNA cap binding,BP,
19283,GO:1905612,1,0.956456299395857,0,1,positive regulation of mRNA cap binding,BP,
19284,GO:1905616,1,0.917035179877452,0,2,regulation of miRNA mediated inhibition of translation,BP,
19285,GO:1905618,1,0.917035179877452,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
19286,GO:1905634,1,0.774691598564902,0,6,regulation of protein localization to chromatin,BP,
19287,GO:1905636,1,0.964120576727711,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19288,GO:1905642,1,0.958787867083198,0,1,negative regulation of DNA methylation,BP,
19289,GO:1905643,1,0.956441843839217,0,1,positive regulation of DNA methylation,BP,
19290,GO:1905647,1,0.960101674776263,0,1,proline import across plasma membrane,BP,
19291,GO:1905651,1,0.877971383526959,0,3,regulation of artery morphogenesis,BP,
19292,GO:1905653,1,0.877971383526959,0,3,positive regulation of artery morphogenesis,BP,
19293,GO:1905661,1,0.920142034396501,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19294,GO:1905663,1,0.920142034396501,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
19295,GO:1905664,1,0.922314586690746,0,2,regulation of calcium ion import across plasma membrane,BP,
19296,GO:1905666,1,0.676367216240447,0,9,regulation of protein localization to endosome,BP,
19297,GO:1905668,1,0.676367216240447,0,9,positive regulation of protein localization to endosome,BP,
19298,GO:1905671,1,0.883516149209482,0,3,regulation of lysosome organization,BP,
19299,GO:1905672,1,0.961237681137074,0,1,negative regulation of lysosome organization,BP,
19300,GO:1905687,1,0.956441843858147,0,1,regulation of diacylglycerol kinase activity,BP,
19301,GO:1905689,1,0.956441843858147,0,1,positive regulation of diacylglycerol kinase activity,BP,
19302,GO:1905696,1,0.914924219396972,0,2,regulation of polysome binding,BP,
19303,GO:1905698,1,0.956580991138864,0,1,positive regulation of polysome binding,BP,
19304,GO:1905705,1,0.956441843839217,0,1,cellular response to paclitaxel,BP,
19305,GO:1905709,1,0.824704113846425,0,5,negative regulation of membrane permeability,BP,
19306,GO:1905710,1,0.10800793122198,0,55,positive regulation of membrane permeability,BP,
19307,GO:1905711,1,0.957149400412029,0,1,response to phosphatidylethanolamine,BP,
19308,GO:1905715,1,0.959849939186192,0,1,regulation of cornification,BP,
19309,GO:1905716,1,0.959849939186192,0,1,negative regulation of cornification,BP,
19310,GO:1905719,1,0.919540651722124,0,2,protein localization to perinuclear region of cytoplasm,BP,
19311,GO:1905720,1,0.956441843839217,0,1,cytoplasmic microtubule bundle,CC,
19312,GO:1905764,1,0.880723784124568,0,3,regulation of protection from non-homologous end joining at telomere,BP,
19313,GO:1905765,1,0.880723784124568,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
19314,GO:1905767,1,0.956441843839217,0,1,regulation of double-stranded telomeric DNA binding,BP,
19315,GO:1905768,1,0.956441843839217,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
19316,GO:1905770,1,0.881283777041002,0,3,regulation of mesodermal cell differentiation,BP,
19317,GO:1905771,1,0.962464157847848,0,1,negative regulation of mesodermal cell differentiation,BP,
19318,GO:1905773,1,0.875479787374631,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
19319,GO:1905774,1,0.956877439770078,0,1,regulation of DNA helicase activity,BP,
19320,GO:1905776,1,0.956877439770078,0,1,positive regulation of DNA helicase activity,BP,
19321,GO:1905777,1,0.881632368622834,0,3,regulation of exonuclease activity,BP,
19322,GO:1905778,1,0.91914605848228,0,2,negative regulation of exonuclease activity,BP,
19323,GO:1905779,1,0.959193269451407,0,1,positive regulation of exonuclease activity,BP,
19324,GO:1905793,1,0.914832826532178,0,2,protein localization to pericentriolar material,BP,
19325,GO:1905794,1,0.956441843839217,0,1,response to puromycin,BP,
19326,GO:1905795,1,0.956441843839217,0,1,cellular response to puromycin,BP,
19327,GO:1905799,1,0.965513443926689,0,1,regulation of intraciliary retrograde transport,BP,
19329,GO:1905818,1,0.112645598781493,0,53,regulation of chromosome separation,BP,
19330,GO:1905819,1,0.281894476251104,0,31,negative regulation of chromosome separation,BP,
19331,GO:1905820,1,0.687324236457284,0,9,positive regulation of chromosome separation,BP,
19332,GO:1905832,1,0.839126421229823,0,4,positive regulation of spindle assembly,BP,
19333,GO:1905838,1,0.91914605848228,0,2,regulation of telomeric D-loop disassembly,BP,
19334,GO:1905839,1,0.91914605848228,0,2,negative regulation of telomeric D-loop disassembly,BP,
19335,GO:1905843,1,0.956441843839217,0,1,regulation of cellular response to gamma radiation,BP,
19340,GO:1905863,1,0.917493028084379,0,2,invadopodium organization,BP,
19342,GO:1905874,1,0.920310589499497,0,2,regulation of postsynaptic density organization,BP,
19343,GO:1905878,1,0.956441843839217,0,1,invadopodium disassembly,BP,
19344,GO:1905879,1,0.779740616449841,0,6,regulation of oogenesis,BP,
19345,GO:1905880,1,0.957622348362285,0,1,negative regulation of oogenesis,BP,
19346,GO:1905881,1,0.884105294943751,0,3,positive regulation of oogenesis,BP,
19348,GO:1905891,1,0.958913145680909,0,1,regulation of cellular response to thapsigargin,BP,
19349,GO:1905892,1,0.958913145680909,0,1,negative regulation of cellular response to thapsigargin,BP,
19350,GO:1905894,1,0.958913145680909,0,1,regulation of cellular response to tunicamycin,BP,
19351,GO:1905895,1,0.958913145680909,0,1,negative regulation of cellular response to tunicamycin,BP,
19354,GO:1905902,1,0.881283777041002,0,3,regulation of mesoderm formation,BP,
19355,GO:1905903,1,0.962464157847848,0,1,negative regulation of mesoderm formation,BP,
19357,GO:1905907,1,0.851716211957989,0,4,negative regulation of amyloid fibril formation,BP,
19359,GO:1905912,1,0.962327906909524,0,1,regulation of calcium ion export across plasma membrane,BP,
19360,GO:1905913,1,0.962327906909524,0,1,negative regulation of calcium ion export across plasma membrane,BP,
19361,GO:1905918,1,0.96120152835738,0,1,regulation of CoA-transferase activity,BP,
19362,GO:1905920,1,0.96120152835738,0,1,positive regulation of CoA-transferase activity,BP,
19363,GO:1905927,1,0.956441843839217,0,1,regulation of invadopodium disassembly,BP,
19364,GO:1905929,1,0.956441843839217,0,1,positive regulation of invadopodium disassembly,BP,
19365,GO:1905936,1,0.930993122578742,0,2,regulation of germ cell proliferation,BP,
19366,GO:1905937,1,0.964947863667888,0,1,negative regulation of germ cell proliferation,BP,
19367,GO:1905938,1,0.964814382377026,0,1,positive regulation of germ cell proliferation,BP,
19369,GO:1905940,1,0.882451034525503,0,3,negative regulation of gonad development,BP,
19371,GO:1905942,1,0.960191633845267,0,1,regulation of formation of growth cone in injured axon,BP,
19372,GO:1905943,1,0.960191633845267,0,1,negative regulation of formation of growth cone in injured axon,BP,
19374,GO:1905953,1,0.37913562341434,0,23,negative regulation of lipid localization,BP,
19376,GO:1905957,1,0.956704721962182,0,1,regulation of cellular response to alcohol,BP,
19377,GO:1905959,1,0.956704721962182,0,1,positive regulation of cellular response to alcohol,BP,
19378,GO:1905961,1,0.721250704321659,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
19380,GO:1990001,1,0.713191583813792,0,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
19381,GO:1990003,1,0.956441843839217,0,1,IDP phosphatase activity,MF,
19382,GO:1990005,1,0.923085365861589,0,2,granular vesicle,CC,
19383,GO:1990008,1,0.962766033503394,0,1,neurosecretory vesicle,CC,
19384,GO:1990009,1,0.956453524038622,0,1,retinal cell apoptotic process,BP,
19385,GO:1990023,1,0.575058818339609,0,13,mitotic spindle midzone,CC,
19386,GO:1990026,1,0.957490318481053,0,1,hippocampal mossy fiber expansion,CC,
19387,GO:1990029,1,0.958142130655448,0,1,vasomotion,BP,
19388,GO:1990031,1,0.95814843902196,0,1,pinceau fiber,CC,
19390,GO:1990034,1,0.882469185588319,0,3,calcium ion export across plasma membrane,BP,
19391,GO:1990036,1,0.956441843839217,0,1,calcium ion import into sarcoplasmic reticulum,BP,
19392,GO:1990037,1,0.890098637300322,0,3,Lewy body core,CC,
19393,GO:1990038,1,0.961924900665877,0,1,Lewy body corona,CC,
19394,GO:1990046,1,0.964050836212264,0,1,stress-induced mitochondrial fusion,BP,
19395,GO:1990047,1,0.960768653879629,0,1,spindle matrix,CC,
19396,GO:1990048,1,0.958787867083198,0,1,anterograde neuronal dense core vesicle transport,BP,
19397,GO:1990050,1,0.791155404617293,0,6,phosphatidic acid transporter activity,MF,
19398,GO:1990051,1,0.956442075022866,0,1,activation of protein kinase C activity,BP,
19399,GO:1990070,1,0.965304853338006,0,1,TRAPPI protein complex,CC,
19400,GO:1990071,1,0.923254971776657,0,2,TRAPPII protein complex,CC,
19401,GO:1990072,1,0.925519753408818,0,2,TRAPPIII protein complex,CC,
19402,GO:1990074,1,0.957513115799692,0,1,polyuridylation-dependent mRNA catabolic process,BP,
19403,GO:1990075,1,0.878086379979589,0,3,periciliary membrane compartment,CC,
19404,GO:1990086,1,0.877706526061785,0,3,lens fiber cell apoptotic process,BP,
19407,GO:1990108,1,0.917021318947511,0,2,protein linear deubiquitination,BP,
19408,GO:1990111,1,0.858013588600617,0,4,spermatoproteasome complex,CC,
19409,GO:1990112,1,0.919270839167849,0,2,RQC complex,CC,
19410,GO:1990116,1,0.919270839167849,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19411,GO:1990117,1,0.965207538270858,0,1,B cell receptor apoptotic signaling pathway,BP,
19412,GO:1990124,1,0.740803067034504,0,7,messenger ribonucleoprotein complex,CC,
19414,GO:1990127,1,0.956804113537241,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19415,GO:1990130,1,0.811800915531293,0,5,GATOR1 complex,CC,
19416,GO:1990131,1,0.891904099801326,0,3,Gtr1-Gtr2 GTPase complex,CC,
19417,GO:1990134,1,0.956478253583737,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
19418,GO:1990136,1,0.959954565929541,0,1,linoleate 9S-lipoxygenase activity,MF,
19420,GO:1990144,1,0.785887355931221,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
19421,GO:1990145,1,0.91753386608347,0,2,maintenance of translational fidelity,BP,
19423,GO:1990165,1,0.961702355394599,0,1,single-strand break-containing DNA binding,MF,
19424,GO:1990166,1,0.882933052303861,0,3,protein localization to site of double-strand break,BP,
19425,GO:1990167,1,0.88079022368071,0,3,protein K27-linked deubiquitination,BP,
19426,GO:1990168,1,0.880838453609277,0,3,protein K33-linked deubiquitination,BP,
19428,GO:1990170,1,0.96172382065922,0,1,stress response to cadmium ion,BP,
19429,GO:1990172,1,0.956441843839217,0,1,G-protein coupled receptor catabolic process,BP,
19430,GO:1990173,1,0.667971739105006,0,10,protein localization to nucleoplasm,BP,
19431,GO:1990174,1,0.957091803832729,0,1,phosphodiesterase decapping endonuclease activity,MF,
19432,GO:1990175,1,0.95701813027708,0,1,EH domain binding,MF,
19433,GO:1990179,1,0.879227971604245,0,3,protein localization to actomyosin contractile ring,BP,
19434,GO:1990180,1,0.888826807859138,0,3,mitochondrial tRNA 3'-end processing,BP,
19435,GO:1990182,1,0.499883997300382,0,17,exosomal secretion,BP,
19437,GO:1990189,1,0.924313221637795,0,2,peptide-serine-N-acetyltransferase activity,MF,
19438,GO:1990190,1,0.965034687154615,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
19440,GO:1990226,1,0.816428464486525,0,5,histone methyltransferase binding,MF,
19442,GO:1990239,1,0.8463214747853,0,4,steroid hormone binding,MF,
19443,GO:1990246,1,0.845046611043729,0,4,uniplex complex,CC,
19444,GO:1990247,1,0.737092418626935,0,7,N6-methyladenosine-containing RNA binding,MF,
19446,GO:1990254,1,0.847390326948032,0,4,keratin filament binding,MF,
19447,GO:1990256,1,0.956441843839217,0,1,signal clustering,BP,
19448,GO:1990258,1,0.964341017540768,0,1,histone glutamine methylation,BP,
19449,GO:1990259,1,0.964341017540768,0,1,histone-glutamine methyltransferase activity,MF,
19450,GO:1990261,1,0.958787867083198,0,1,pre-mRNA catabolic process,BP,
19451,GO:1990262,1,0.959199264977267,0,1,anti-Mullerian hormone signaling pathway,BP,
19452,GO:1990264,1,0.920388852326733,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
19455,GO:1990275,1,0.958805276772183,0,1,preribosome binding,MF,
19456,GO:1990280,1,0.956441843839217,0,1,RNA localization to chromatin,BP,
19457,GO:1990298,1,0.96122502799926,0,1,bub1-bub3 complex,CC,
19458,GO:1990314,1,0.714676030828328,0,8,cellular response to insulin-like growth factor stimulus,BP,
19459,GO:1990316,1,0.707700174570447,0,8,Atg1/ULK1 kinase complex,CC,
19460,GO:1990332,1,0.956936800169417,0,1,Ire1 complex,CC,
19462,GO:1990356,1,0.96425528533061,0,1,sumoylated E2 ligase complex,CC,
19463,GO:1990357,1,0.887215638175288,0,3,terminal web,CC,
19465,GO:1990380,1,0.673714092783887,0,9,Lys48-specific deubiquitinase activity,MF,
19466,GO:1990381,1,0.575047009443435,0,13,ubiquitin-specific protease binding,MF,
19468,GO:1990386,1,0.961855734899517,0,1,mitotic cleavage furrow ingression,BP,
19469,GO:1990390,1,0.957586085891017,0,1,protein K33-linked ubiquitination,BP,
19472,GO:1990399,1,0.919046757387378,0,2,epithelium regeneration,BP,
19473,GO:1990401,1,0.959124935091862,0,1,embryonic lung development,BP,
19474,GO:1990402,1,0.961053331004262,0,1,embryonic liver development,BP,
19475,GO:1990403,1,0.712767724763395,0,8,embryonic brain development,BP,
19476,GO:1990404,1,0.920786407400097,0,2,protein ADP-ribosylase activity,MF,
19477,GO:1990405,1,0.841729260101559,0,4,protein antigen binding,MF,
19478,GO:1990406,1,0.92299227321538,0,2,CGRP receptor complex,CC,
19479,GO:1990407,1,0.964987887329676,0,1,calcitonin gene-related peptide binding,MF,
19480,GO:1990408,1,0.92299227321538,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
19481,GO:1990409,1,0.956483797008087,0,1,adrenomedullin binding,MF,
19482,GO:1990410,1,0.921641654430715,0,2,adrenomedullin receptor signaling pathway,BP,
19483,GO:1990414,1,0.845776845288287,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
19484,GO:1990415,1,0.882936263400822,0,3,Pex17p-Pex14p docking complex,CC,
19485,GO:1990416,1,0.773296314879243,0,6,cellular response to brain-derived neurotrophic factor stimulus,BP,
19486,GO:1990418,1,0.922854765121409,0,2,response to insulin-like growth factor stimulus,BP,
19487,GO:1990421,1,0.956441843839217,0,1,subtelomeric heterochromatin,CC,
19488,GO:1990423,1,0.878489954648181,0,3,RZZ complex,CC,
19489,GO:1990425,1,0.922094045234366,0,2,ryanodine receptor complex,CC,
19490,GO:1990426,1,0.919051928691434,0,2,mitotic recombination-dependent replication fork processing,BP,
19491,GO:1990428,1,0.915698143510209,0,2,miRNA transport,BP,
19492,GO:1990429,1,0.882936263400822,0,3,peroxisomal importomer complex,CC,
19493,GO:1990430,1,0.914777292668164,0,2,extracellular matrix protein binding,MF,
19494,GO:1990439,1,0.958643071110554,0,1,MAP kinase serine/threonine phosphatase activity,MF,
19495,GO:1990440,1,0.695752096434369,0,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
19497,GO:1990442,1,0.896949675335611,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
19498,GO:1990446,1,0.860019491862354,0,4,U1 snRNP binding,MF,
19499,GO:1990448,1,0.956441843839217,0,1,exon-exon junction complex binding,MF,
19500,GO:1990450,1,0.961454375188948,0,1,linear polyubiquitin binding,MF,
19501,GO:1990452,1,0.917027967928603,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
19502,GO:1990454,1,0.878489657989395,0,3,L-type voltage-gated calcium channel complex,CC,
19503,GO:1990456,1,0.957111483319017,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
19505,GO:1990460,1,0.882725153893328,0,3,leptin receptor binding,MF,
19506,GO:1990462,1,0.744200028209948,0,7,omegasome,CC,
19507,GO:1990481,1,0.851663864995834,0,4,mRNA pseudouridine synthesis,BP,
19508,GO:1990498,1,0.914777292668164,0,2,mitotic spindle microtubule,CC,
19509,GO:1990502,1,0.956441843839217,0,1,dense core granule maturation,BP,
19510,GO:1990504,1,0.875462289606107,0,3,dense core granule exocytosis,BP,
19511,GO:1990505,1,0.919051928691434,0,2,mitotic DNA replication maintenance of fidelity,BP,
19512,GO:1990511,1,0.841318766684392,0,4,piRNA biosynthetic process,BP,
19513,GO:1990518,1,0.956580991138864,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
19514,GO:1990519,1,0.921684364992934,0,2,pyrimidine nucleotide import into mitochondrion,BP,
19518,GO:1990546,1,0.963111881132099,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
19519,GO:1990564,1,0.820155651085193,0,5,protein polyufmylation,BP,
19520,GO:1990565,1,0.96288851906386,0,1,HSP90-CDC37 chaperone complex,CC,
19521,GO:1990569,1,0.919357708134558,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
19522,GO:1990570,1,0.958787867083198,0,1,GDP-mannose transmembrane transport,BP,
19523,GO:1990572,1,0.966376925420809,0,1,TERT-RMRP complex,CC,
19524,GO:1990573,1,0.88304501188067,0,3,potassium ion import across plasma membrane,BP,
19525,GO:1990575,1,0.919094529030098,0,2,mitochondrial L-ornithine transmembrane transport,BP,
19527,GO:1990579,1,0.956936800169417,0,1,peptidyl-serine trans-autophosphorylation,BP,
19528,GO:1990583,1,0.961855734899517,0,1,phospholipase D activator activity,MF,
19529,GO:1990589,1,0.920809406067256,0,2,ATF4-CREB1 transcription factor complex,CC,
19530,GO:1990590,1,0.92442981056237,0,2,ATF1-ATF4 transcription factor complex,CC,
19531,GO:1990592,1,0.820155651085193,0,5,protein K69-linked ufmylation,BP,
19533,GO:1990599,1,0.880723784124568,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
19534,GO:1990603,1,0.957886117614705,0,1,dark adaptation,BP,
19535,GO:1990604,1,0.87934568748613,0,3,IRE1-TRAF2-ASK1 complex,CC,
19536,GO:1990613,1,0.957502774555405,0,1,mitochondrial membrane fusion,BP,
19537,GO:1990617,1,0.929030911445536,0,2,CHOP-ATF4 complex,CC,
19538,GO:1990619,1,0.921691244631685,0,2,histone H3-K9 deacetylation,BP,
19539,GO:1990622,1,0.927938657213443,0,2,CHOP-ATF3 complex,CC,
19540,GO:1990630,1,0.956936800169417,0,1,IRE1-RACK1-PP2A complex,CC,
19541,GO:1990635,1,0.84595361739853,0,4,proximal dendrite,CC,
19542,GO:1990637,1,0.882594947575786,0,3,response to prolactin,BP,
19543,GO:1990641,1,0.920259791552113,0,2,response to iron ion starvation,BP,
19544,GO:1990646,1,0.958488100763464,0,1,cellular response to prolactin,BP,
19545,GO:1990654,1,0.956499395480031,0,1,sebum secreting cell proliferation,BP,
19546,GO:1990666,1,0.915645567883345,0,2,PCSK9-LDLR complex,CC,
19547,GO:1990667,1,0.921917595787259,0,2,PCSK9-AnxA2 complex,CC,
19548,GO:1990668,1,0.783763912940614,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
19549,GO:1990682,1,0.960240360586506,0,1,CSF1-CSF1R complex,CC,
19550,GO:1990698,1,0.921124539797464,0,2,palmitoleoyltransferase activity,MF,
19551,GO:1990700,1,0.957005987506866,0,1,nucleolar chromatin organization,BP,
19552,GO:1990705,1,0.956441843839217,0,1,cholangiocyte proliferation,BP,
19553,GO:1990707,1,0.956441843839217,0,1,nuclear subtelomeric heterochromatin,CC,
19554,GO:1990712,1,0.812804686201097,0,5,HFE-transferrin receptor complex,CC,
19556,GO:1990716,1,0.962753018386369,0,1,axonemal central apparatus,CC,
19557,GO:1990723,1,0.916686573931565,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
19558,GO:1990726,1,0.8341505455255,0,5,Lsm1-7-Pat1 complex,CC,
19559,GO:1990729,1,0.961919589858684,0,1,primary miRNA modification,BP,
19560,GO:1990730,1,0.91636101771064,0,2,VCP-NSFL1C complex,CC,
19561,GO:1990736,1,0.956894798384683,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
19562,GO:1990737,1,0.881163501748261,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
19563,GO:1990738,1,0.958787867083198,0,1,pseudouridine 5'-phosphatase activity,MF,
19564,GO:1990739,1,0.956441843839217,0,1,granulosa cell proliferation,BP,
19565,GO:1990742,1,0.923987509933032,0,2,microvesicle,CC,
19566,GO:1990743,1,0.885358261012132,0,3,protein sialylation,BP,
19567,GO:1990744,1,0.961919589858684,0,1,primary miRNA methylation,BP,
19568,GO:1990745,1,0.84281212422685,0,4,EARP complex,CC,
19570,GO:1990751,1,0.956441843839217,0,1,Schwann cell chemotaxis,BP,
19572,GO:1990755,1,0.958787867083198,0,1,mitotic spindle microtubule depolymerization,BP,
19573,GO:1990756,1,0.885467002622277,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
19574,GO:1990758,1,0.962358733236558,0,1,mitotic sister chromatid biorientation,BP,
19575,GO:1990761,1,0.918821810319655,0,2,growth cone lamellipodium,CC,
19576,GO:1990763,1,0.814618549932851,0,5,arrestin family protein binding,MF,
19577,GO:1990764,1,0.959281016590193,0,1,myofibroblast contraction,BP,
19579,GO:1990771,1,0.956441843839217,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
19580,GO:1990773,1,0.962690875752419,0,1,matrix metallopeptidase secretion,BP,
19581,GO:1990774,1,0.622295468789687,0,11,tumor necrosis factor secretion,BP,
19586,GO:1990784,1,0.956922523125327,0,1,response to dsDNA,BP,
19587,GO:1990785,1,0.876295575210138,0,3,response to water-immersion restraint stress,BP,
19588,GO:1990786,1,0.956922523125327,0,1,cellular response to dsDNA,BP,
19589,GO:1990791,1,0.919389779382755,0,2,dorsal root ganglion development,BP,
19590,GO:1990796,1,0.958649446485956,0,1,photoreceptor cell terminal bouton,CC,
19591,GO:1990809,1,0.848697542583279,0,4,endoplasmic reticulum tubular network membrane organization,BP,
19592,GO:1990812,1,0.879024348104774,0,3,growth cone filopodium,CC,
19593,GO:1990817,1,0.960783019309075,0,1,RNA adenylyltransferase activity,MF,
19596,GO:1990825,1,0.660615994320897,0,10,sequence-specific mRNA binding,MF,
19597,GO:1990828,1,0.961208759105575,0,1,hepatocyte dedifferentiation,BP,
19599,GO:1990832,1,0.961655785053158,0,1,slow axonal transport,BP,
19600,GO:1990833,1,0.961655785053158,0,1,clathrin-uncoating ATPase activity,MF,
19603,GO:1990839,1,0.960668298710852,0,1,response to endothelin,BP,
19606,GO:1990851,1,0.876465847169339,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
19607,GO:1990859,1,0.960668298710852,0,1,cellular response to endothelin,BP,
19608,GO:1990868,1,0.808453939550677,0,5,response to chemokine,BP,
19609,GO:1990869,1,0.808453939550677,0,5,cellular response to chemokine,BP,
19610,GO:1990874,1,0.321730365037024,0,27,vascular smooth muscle cell proliferation,BP,
19611,GO:1990876,1,0.956441843839217,0,1,cytoplasmic side of nuclear pore,CC,
19612,GO:1990879,1,0.919270839167849,0,2,CST complex,CC,
19613,GO:1990882,1,0.956995395019061,0,1,rRNA acetylation,BP,
19614,GO:1990883,1,0.956995395019061,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19615,GO:1990884,1,0.956995395019061,0,1,RNA acetylation,BP,
19616,GO:1990889,1,0.962259071901298,0,1,H4K20me3 modified histone binding,MF,
19618,GO:1990907,1,0.619427255880723,0,11,beta-catenin-TCF complex,CC,
19620,GO:1990910,1,0.887650737431877,0,3,response to hypobaric hypoxia,BP,
19621,GO:1990911,1,0.92433520802679,0,2,response to psychosocial stress,BP,
19622,GO:1990913,1,0.959843233179047,0,1,sperm head plasma membrane,CC,
19623,GO:1990917,1,0.959843233179047,0,1,ooplasm,CC,
19624,GO:1990918,1,0.917172198947032,0,2,double-strand break repair involved in meiotic recombination,BP,
19625,GO:1990923,1,0.917553047038878,0,2,PET complex,CC,
19626,GO:1990926,1,0.956617645843903,0,1,short-term synaptic potentiation,BP,
19627,GO:1990927,1,0.914958231874751,0,2,calcium ion regulated lysosome exocytosis,BP,
19628,GO:1990928,1,0.915369137300525,0,2,response to amino acid starvation,BP,
19629,GO:1990930,1,0.963201111599776,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
19630,GO:1990931,1,0.956739518605692,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
19632,GO:1990938,1,0.956951357901455,0,1,peptidyl-aspartic acid autophosphorylation,BP,
19633,GO:1990939,1,0.232853772919957,0,34,ATP-dependent microtubule motor activity,MF,
19634,GO:1990948,1,0.834727525165869,0,5,ubiquitin ligase inhibitor activity,MF,
19635,GO:1990955,1,0.956877439770078,0,1,G-rich single-stranded DNA binding,MF,
19636,GO:1990966,1,0.845003011290492,0,4,ATP generation from poly-ADP-D-ribose,BP,
19638,GO:1990968,1,0.956441843839217,0,1,modulation by host of RNA binding by virus,BP,
19639,GO:1990969,1,0.956441843839217,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
19640,GO:1990983,1,0.959707016363874,0,1,tRNA demethylation,BP,
19641,GO:1990984,1,0.959707016363874,0,1,tRNA demethylase activity,MF,
19642,GO:2000001,1,0.515490514592121,0,16,regulation of DNA damage checkpoint,BP,
19643,GO:2000002,1,0.81424034100482,0,5,negative regulation of DNA damage checkpoint,BP,
19644,GO:2000003,1,0.958787867083198,0,1,positive regulation of DNA damage checkpoint,BP,
19645,GO:2000004,1,0.962531515651986,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19646,GO:2000005,1,0.962531515651986,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19647,GO:2000006,1,0.962531515651986,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19648,GO:2000007,1,0.962531515651986,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
19652,GO:2000011,1,0.961042493422886,0,1,regulation of adaxial/abaxial pattern formation,BP,
19653,GO:2000015,1,0.885860325192016,0,3,regulation of determination of dorsal identity,BP,
19654,GO:2000016,1,0.964980840747837,0,1,negative regulation of determination of dorsal identity,BP,
19655,GO:2000017,1,0.918013953436084,0,2,positive regulation of determination of dorsal identity,BP,
19656,GO:2000018,1,0.808160648165267,0,5,regulation of male gonad development,BP,
19657,GO:2000019,1,0.957044903232465,0,1,negative regulation of male gonad development,BP,
19658,GO:2000020,1,0.844446194044952,0,4,positive regulation of male gonad development,BP,
19661,GO:2000035,1,0.886584577603539,0,3,regulation of stem cell division,BP,
19662,GO:2000036,1,0.456199000233369,0,18,regulation of stem cell population maintenance,BP,
19667,GO:2000047,1,0.819359725181571,0,5,regulation of cell-cell adhesion mediated by cadherin,BP,
19668,GO:2000048,1,0.928479916466307,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
19669,GO:2000049,1,0.882491183352579,0,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,
19675,GO:2000055,1,0.956441843839217,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19677,GO:2000059,1,0.219166949383809,0,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,
19679,GO:2000064,1,0.805455576509218,0,5,regulation of cortisol biosynthetic process,BP,
19680,GO:2000065,1,0.879839920706303,0,3,negative regulation of cortisol biosynthetic process,BP,
19681,GO:2000066,1,0.957044903232465,0,1,positive regulation of cortisol biosynthetic process,BP,
19682,GO:2000067,1,0.965280077340104,0,1,regulation of root morphogenesis,BP,
19683,GO:2000074,1,0.749230000599166,0,7,regulation of type B pancreatic cell development,BP,
19684,GO:2000077,1,0.919243594174368,0,2,negative regulation of type B pancreatic cell development,BP,
19685,GO:2000078,1,0.924227266080893,0,2,positive regulation of type B pancreatic cell development,BP,
19689,GO:2000096,1,0.773992158242915,0,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19690,GO:2000097,1,0.919736933291509,0,2,regulation of smooth muscle cell-matrix adhesion,BP,
19691,GO:2000098,1,0.958145282645265,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,
19693,GO:2000105,1,0.602249277012556,0,12,positive regulation of DNA-dependent DNA replication,BP,
19696,GO:2000108,1,0.447519084483049,0,20,positive regulation of leukocyte apoptotic process,BP,
19697,GO:2000109,1,0.786329278687498,0,6,regulation of macrophage apoptotic process,BP,
19698,GO:2000110,1,0.887191752809947,0,3,negative regulation of macrophage apoptotic process,BP,
19699,GO:2000111,1,0.922999427581937,0,2,positive regulation of macrophage apoptotic process,BP,
19702,GO:2000114,1,0.458060101830303,0,18,regulation of establishment of cell polarity,BP,
19706,GO:2000121,1,0.75009972529902,0,7,regulation of removal of superoxide radicals,BP,
19707,GO:2000124,1,0.918752535043963,0,2,regulation of endocannabinoid signaling pathway,BP,
19709,GO:2000136,1,0.634392658705044,0,11,regulation of cell proliferation involved in heart morphogenesis,BP,
19710,GO:2000137,1,0.920602207656332,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
19711,GO:2000138,1,0.811775359353784,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
19714,GO:2000144,1,0.386519541160616,0,23,positive regulation of DNA-templated transcription, initiation,BP,
19718,GO:2000152,1,0.857999833045345,0,4,regulation of ubiquitin-specific protease activity,BP,
19719,GO:2000156,1,0.917662122918949,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
19720,GO:2000157,1,0.930197287745624,0,2,negative regulation of ubiquitin-specific protease activity,BP,
19721,GO:2000158,1,0.922395882888401,0,2,positive regulation of ubiquitin-specific protease activity,BP,
19722,GO:2000167,1,0.956446954086774,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
19723,GO:2000169,1,0.803934072101896,0,5,regulation of peptidyl-cysteine S-nitrosylation,BP,
19725,GO:2000172,1,0.918894294740219,0,2,regulation of branching morphogenesis of a nerve,BP,
19726,GO:2000173,1,0.95699402362007,0,1,negative regulation of branching morphogenesis of a nerve,BP,
19727,GO:2000174,1,0.956977748910324,0,1,regulation of pro-T cell differentiation,BP,
19728,GO:2000176,1,0.956977748910324,0,1,positive regulation of pro-T cell differentiation,BP,
19733,GO:2000182,1,0.916589938824418,0,2,regulation of progesterone biosynthetic process,BP,
19734,GO:2000191,1,0.554591603417211,0,14,regulation of fatty acid transport,BP,
19735,GO:2000192,1,0.802406373722802,0,5,negative regulation of fatty acid transport,BP,
19736,GO:2000193,1,0.722778262489394,0,8,positive regulation of fatty acid transport,BP,
19738,GO:2000195,1,0.922064858425294,0,2,negative regulation of female gonad development,BP,
19740,GO:2000197,1,0.773695604320791,0,6,regulation of ribonucleoprotein complex localization,BP,
19741,GO:2000199,1,0.958281675277469,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19742,GO:2000200,1,0.958281675277469,0,1,regulation of ribosomal subunit export from nucleus,BP,
19743,GO:2000202,1,0.958281675277469,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19744,GO:2000206,1,0.958281675277469,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19745,GO:2000208,1,0.958281675277469,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
19746,GO:2000209,1,0.44805821554867,0,19,regulation of anoikis,BP,
19747,GO:2000210,1,0.788684410826665,0,6,positive regulation of anoikis,BP,
19748,GO:2000211,1,0.956477882757918,0,1,regulation of glutamate metabolic process,BP,
19749,GO:2000212,1,0.956477882757918,0,1,negative regulation of glutamate metabolic process,BP,
19750,GO:2000224,1,0.957044903232465,0,1,regulation of testosterone biosynthetic process,BP,
19751,GO:2000225,1,0.957044903232465,0,1,negative regulation of testosterone biosynthetic process,BP,
19752,GO:2000226,1,0.96356435360397,0,1,regulation of pancreatic A cell differentiation,BP,
19753,GO:2000227,1,0.96356435360397,0,1,negative regulation of pancreatic A cell differentiation,BP,
19754,GO:2000229,1,0.962278046052311,0,1,regulation of pancreatic stellate cell proliferation,BP,
19755,GO:2000230,1,0.962278046052311,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
19756,GO:2000232,1,0.629175922925093,0,11,regulation of rRNA processing,BP,
19757,GO:2000233,1,0.917125257420331,0,2,negative regulation of rRNA processing,BP,
19758,GO:2000234,1,0.717333171709641,0,8,positive regulation of rRNA processing,BP,
19763,GO:2000251,1,0.668036654740311,0,10,positive regulation of actin cytoskeleton reorganization,BP,
19764,GO:2000252,1,0.923168814509432,0,2,negative regulation of feeding behavior,BP,
19765,GO:2000253,1,0.917021318947511,0,2,positive regulation of feeding behavior,BP,
19766,GO:2000254,1,0.930993122578742,0,2,regulation of male germ cell proliferation,BP,
19767,GO:2000255,1,0.964947863667888,0,1,negative regulation of male germ cell proliferation,BP,
19768,GO:2000256,1,0.964814382377026,0,1,positive regulation of male germ cell proliferation,BP,
19771,GO:2000259,1,0.962379230688068,0,1,positive regulation of protein activation cascade,BP,
19777,GO:2000275,1,0.927356078465284,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
19778,GO:2000276,1,0.961071396363931,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
19779,GO:2000277,1,0.96492184451589,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19781,GO:2000279,1,0.321689945612893,0,27,negative regulation of DNA biosynthetic process,BP,
19782,GO:2000280,1,0.965280077340104,0,1,regulation of root development,BP,
19783,GO:2000282,1,0.922888614596841,0,2,regulation of cellular amino acid biosynthetic process,BP,
19784,GO:2000283,1,0.956441843839217,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
19785,GO:2000284,1,0.96492184451589,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
19786,GO:2000286,1,0.881475132349753,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
19787,GO:2000288,1,0.782478837107907,0,6,positive regulation of myoblast proliferation,BP,
19788,GO:2000291,1,0.721200442151699,0,8,regulation of myoblast proliferation,BP,
19789,GO:2000295,1,0.958131655655566,0,1,regulation of hydrogen peroxide catabolic process,BP,
19791,GO:2000298,1,0.919792693738995,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
19792,GO:2000299,1,0.957762192250154,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
19794,GO:2000301,1,0.882487742891729,0,3,negative regulation of synaptic vesicle exocytosis,BP,
19795,GO:2000302,1,0.914939423770191,0,2,positive regulation of synaptic vesicle exocytosis,BP,
19796,GO:2000303,1,0.613983441127398,0,12,regulation of ceramide biosynthetic process,BP,
19797,GO:2000304,1,0.748057632287464,0,7,positive regulation of ceramide biosynthetic process,BP,
19798,GO:2000307,1,0.958170656814958,0,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19799,GO:2000309,1,0.958170656814958,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19802,GO:2000312,1,0.879513243155849,0,3,regulation of kainate selective glutamate receptor activity,BP,
19803,GO:2000313,1,0.926495743914631,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19804,GO:2000314,1,0.962923588325958,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19805,GO:2000316,1,0.751400463583101,0,7,regulation of T-helper 17 type immune response,BP,
19806,GO:2000317,1,0.879118707256708,0,3,negative regulation of T-helper 17 type immune response,BP,
19807,GO:2000318,1,0.854755581712251,0,4,positive regulation of T-helper 17 type immune response,BP,
19808,GO:2000319,1,0.815661219636134,0,5,regulation of T-helper 17 cell differentiation,BP,
19809,GO:2000320,1,0.879118707256708,0,3,negative regulation of T-helper 17 cell differentiation,BP,
19810,GO:2000321,1,0.927835308691007,0,2,positive regulation of T-helper 17 cell differentiation,BP,
19813,GO:2000324,1,0.961533633978051,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
19814,GO:2000325,1,0.956441843839217,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19815,GO:2000327,1,0.956441843839217,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19816,GO:2000328,1,0.889058554436993,0,3,regulation of T-helper 17 cell lineage commitment,BP,
19817,GO:2000329,1,0.958213576382395,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
19818,GO:2000330,1,0.927835308691007,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
19819,GO:2000331,1,0.957882406805159,0,1,regulation of terminal button organization,BP,
19823,GO:2000342,1,0.920782606522067,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
19827,GO:2000346,1,0.916609855805175,0,2,negative regulation of hepatocyte proliferation,BP,
19833,GO:2000353,1,0.707642043629315,0,8,positive regulation of endothelial cell apoptotic process,BP,
19835,GO:2000355,1,0.961986733978888,0,1,negative regulation of ovarian follicle development,BP,
19838,GO:2000361,1,0.956635663036805,0,1,regulation of prostaglandin-E synthase activity,BP,
19839,GO:2000363,1,0.956635663036805,0,1,positive regulation of prostaglandin-E synthase activity,BP,
19842,GO:2000369,1,0.520573917618317,0,15,regulation of clathrin-dependent endocytosis,BP,
19843,GO:2000370,1,0.838357982260781,0,4,positive regulation of clathrin-dependent endocytosis,BP,
19844,GO:2000371,1,0.773651534260129,0,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19845,GO:2000373,1,0.773651534260129,0,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19846,GO:2000374,1,0.961621702672929,0,1,regulation of oxygen metabolic process,BP,
19848,GO:2000378,1,0.229054742395146,0,36,negative regulation of reactive oxygen species metabolic process,BP,
19850,GO:2000380,1,0.742368075453644,0,7,regulation of mesoderm development,BP,
19851,GO:2000381,1,0.847714239707695,0,4,negative regulation of mesoderm development,BP,
19852,GO:2000382,1,0.956441843839217,0,1,positive regulation of mesoderm development,BP,
19853,GO:2000383,1,0.957101073089762,0,1,regulation of ectoderm development,BP,
19854,GO:2000384,1,0.957101073089762,0,1,negative regulation of ectoderm development,BP,
19858,GO:2000389,1,0.878621177333532,0,3,regulation of neutrophil extravasation,BP,
19859,GO:2000391,1,0.878621177333532,0,3,positive regulation of neutrophil extravasation,BP,
19862,GO:2000394,1,0.806044969408303,0,5,positive regulation of lamellipodium morphogenesis,BP,
19863,GO:2000395,1,0.929347229857801,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19864,GO:2000397,1,0.929347229857801,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
19866,GO:2000402,1,0.877280204610888,0,3,negative regulation of lymphocyte migration,BP,
19868,GO:2000404,1,0.457104340130471,0,19,regulation of T cell migration,BP,
19869,GO:2000405,1,0.956443985058289,0,1,negative regulation of T cell migration,BP,
19870,GO:2000406,1,0.558808819748511,0,14,positive regulation of T cell migration,BP,
19871,GO:2000407,1,0.925774918912131,0,2,regulation of T cell extravasation,BP,
19872,GO:2000409,1,0.962303865874249,0,1,positive regulation of T cell extravasation,BP,
19873,GO:2000410,1,0.958170656814958,0,1,regulation of thymocyte migration,BP,
19874,GO:2000412,1,0.958170656814958,0,1,positive regulation of thymocyte migration,BP,
19875,GO:2000413,1,0.958170656814958,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
19876,GO:2000415,1,0.958170656814958,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
19877,GO:2000416,1,0.880491862263077,0,3,regulation of eosinophil migration,BP,
19878,GO:2000417,1,0.957677532435855,0,1,negative regulation of eosinophil migration,BP,
19879,GO:2000418,1,0.919410116906458,0,2,positive regulation of eosinophil migration,BP,
19880,GO:2000419,1,0.957677532435855,0,1,regulation of eosinophil extravasation,BP,
19881,GO:2000420,1,0.957677532435855,0,1,negative regulation of eosinophil extravasation,BP,
19882,GO:2000422,1,0.959550820181101,0,1,regulation of eosinophil chemotaxis,BP,
19883,GO:2000424,1,0.959550820181101,0,1,positive regulation of eosinophil chemotaxis,BP,
19884,GO:2000425,1,0.915940419928968,0,2,regulation of apoptotic cell clearance,BP,
19885,GO:2000426,1,0.957657838392433,0,1,negative regulation of apoptotic cell clearance,BP,
19886,GO:2000427,1,0.956441843839217,0,1,positive regulation of apoptotic cell clearance,BP,
19887,GO:2000434,1,0.931546016734921,0,2,regulation of protein neddylation,BP,
19888,GO:2000435,1,0.931546016734921,0,2,negative regulation of protein neddylation,BP,
19889,GO:2000449,1,0.925774918912131,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19890,GO:2000451,1,0.962303865874249,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19891,GO:2000452,1,0.925774918912131,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19892,GO:2000454,1,0.962303865874249,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19893,GO:2000458,1,0.962538221632504,0,1,regulation of astrocyte chemotaxis,BP,
19895,GO:2000465,1,0.772286616562635,0,6,regulation of glycogen (starch) synthase activity,BP,
19896,GO:2000466,1,0.880653270540298,0,3,negative regulation of glycogen (starch) synthase activity,BP,
19897,GO:2000467,1,0.879218016661195,0,3,positive regulation of glycogen (starch) synthase activity,BP,
19898,GO:2000468,1,0.958131655655566,0,1,regulation of peroxidase activity,BP,
19899,GO:2000470,1,0.958131655655566,0,1,positive regulation of peroxidase activity,BP,
19900,GO:2000474,1,0.956911792675449,0,1,regulation of opioid receptor signaling pathway,BP,
19901,GO:2000479,1,0.609298178299507,0,12,regulation of cAMP-dependent protein kinase activity,BP,
19902,GO:2000480,1,0.753158760748957,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
19903,GO:2000481,1,0.841940733475883,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
19905,GO:2000483,1,0.818239051888866,0,5,negative regulation of interleukin-8 secretion,BP,
19907,GO:2000489,1,0.882246817552656,0,3,regulation of hepatic stellate cell activation,BP,
19908,GO:2000490,1,0.920812829418296,0,2,negative regulation of hepatic stellate cell activation,BP,
19909,GO:2000491,1,0.958124352055151,0,1,positive regulation of hepatic stellate cell activation,BP,
19910,GO:2000492,1,0.958546612686084,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
19911,GO:2000494,1,0.958546612686084,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
19914,GO:2000504,1,0.960497262593105,0,1,positive regulation of blood vessel remodeling,BP,
19915,GO:2000508,1,0.853037152974345,0,4,regulation of dendritic cell chemotaxis,BP,
19916,GO:2000510,1,0.853037152974345,0,4,positive regulation of dendritic cell chemotaxis,BP,
19919,GO:2000516,1,0.590432960015026,0,13,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
19920,GO:2000520,1,0.925741575029812,0,2,regulation of immunological synapse formation,BP,
19921,GO:2000521,1,0.925741575029812,0,2,negative regulation of immunological synapse formation,BP,
19922,GO:2000532,1,0.959971557397682,0,1,regulation of renal albumin absorption,BP,
19923,GO:2000533,1,0.959971557397682,0,1,negative regulation of renal albumin absorption,BP,
19924,GO:2000535,1,0.807276625595065,0,5,regulation of entry of bacterium into host cell,BP,
19925,GO:2000536,1,0.956441843839217,0,1,negative regulation of entry of bacterium into host cell,BP,
19926,GO:2000537,1,0.95670751217416,0,1,regulation of B cell chemotaxis,BP,
19927,GO:2000538,1,0.95670751217416,0,1,positive regulation of B cell chemotaxis,BP,
19928,GO:2000542,1,0.842654894634192,0,4,negative regulation of gastrulation,BP,
19930,GO:2000544,1,0.875555938320717,0,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
19931,GO:2000546,1,0.91477749255326,0,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
19932,GO:2000551,1,0.850009742834504,0,4,regulation of T-helper 2 cell cytokine production,BP,
19933,GO:2000552,1,0.96357015028942,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
19934,GO:2000553,1,0.8821546282264,0,3,positive regulation of T-helper 2 cell cytokine production,BP,
19935,GO:2000561,1,0.844457756811103,0,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19936,GO:2000562,1,0.920676237560784,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19937,GO:2000563,1,0.917228089870407,0,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19938,GO:2000564,1,0.921901292635356,0,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
19939,GO:2000566,1,0.962872521408737,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
19940,GO:2000567,1,0.961042493422886,0,1,regulation of memory T cell activation,BP,
19941,GO:2000568,1,0.961042493422886,0,1,positive regulation of memory T cell activation,BP,
19942,GO:2000569,1,0.957923623162533,0,1,regulation of T-helper 2 cell activation,BP,
19943,GO:2000570,1,0.957923623162533,0,1,positive regulation of T-helper 2 cell activation,BP,
19945,GO:2000574,1,0.724959696323221,0,8,regulation of microtubule motor activity,BP,
19946,GO:2000576,1,0.824387752740972,0,5,positive regulation of microtubule motor activity,BP,
19947,GO:2000580,1,0.859834107921227,0,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19948,GO:2000582,1,0.859834107921227,0,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19949,GO:2000583,1,0.957103145750268,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19950,GO:2000584,1,0.957103145750268,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19951,GO:2000586,1,0.742415570422752,0,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19952,GO:2000587,1,0.811450127924244,0,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19953,GO:2000588,1,0.914959234237239,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19954,GO:2000589,1,0.919628828173175,0,2,regulation of metanephric mesenchymal cell migration,BP,
19955,GO:2000591,1,0.919628828173175,0,2,positive regulation of metanephric mesenchymal cell migration,BP,
19956,GO:2000592,1,0.957076563173688,0,1,regulation of metanephric DCT cell differentiation,BP,
19957,GO:2000594,1,0.957076563173688,0,1,positive regulation of metanephric DCT cell differentiation,BP,
19958,GO:2000601,1,0.769587288567916,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
19959,GO:2000606,1,0.958352863090148,0,1,regulation of cell proliferation involved in mesonephros development,BP,
19960,GO:2000607,1,0.958352863090148,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
19961,GO:2000609,1,0.882527507289062,0,3,regulation of thyroid hormone generation,BP,
19962,GO:2000611,1,0.917213562057432,0,2,positive regulation of thyroid hormone generation,BP,
19963,GO:2000612,1,0.957076563173688,0,1,regulation of thyroid-stimulating hormone secretion,BP,
19964,GO:2000615,1,0.659276571437984,0,10,regulation of histone H3-K9 acetylation,BP,
19965,GO:2000616,1,0.920298994885871,0,2,negative regulation of histone H3-K9 acetylation,BP,
19966,GO:2000617,1,0.778872113613032,0,6,positive regulation of histone H3-K9 acetylation,BP,
19967,GO:2000618,1,0.808629460681286,0,5,regulation of histone H4-K16 acetylation,BP,
19968,GO:2000619,1,0.883983075739251,0,3,negative regulation of histone H4-K16 acetylation,BP,
19969,GO:2000620,1,0.914777292668164,0,2,positive regulation of histone H4-K16 acetylation,BP,
19970,GO:2000622,1,0.840116274362351,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
19971,GO:2000623,1,0.840116274362351,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
19972,GO:2000625,1,0.917649712731911,0,2,regulation of miRNA catabolic process,BP,
19973,GO:2000627,1,0.917649712731911,0,2,positive regulation of miRNA catabolic process,BP,
19974,GO:2000628,1,0.746383850058351,0,7,regulation of miRNA metabolic process,BP,
19975,GO:2000630,1,0.812676125292849,0,5,positive regulation of miRNA metabolic process,BP,
19976,GO:2000631,1,0.957977357775801,0,1,regulation of pre-miRNA processing,BP,
19977,GO:2000632,1,0.957977357775801,0,1,negative regulation of pre-miRNA processing,BP,
19979,GO:2000638,1,0.918255949441091,0,2,regulation of SREBP signaling pathway,BP,
19980,GO:2000639,1,0.918255949441091,0,2,negative regulation of SREBP signaling pathway,BP,
19981,GO:2000641,1,0.490137419310522,0,17,regulation of early endosome to late endosome transport,BP,
19982,GO:2000642,1,0.930506027773428,0,2,negative regulation of early endosome to late endosome transport,BP,
19983,GO:2000643,1,0.705651624027748,0,8,positive regulation of early endosome to late endosome transport,BP,
19988,GO:2000648,1,0.375640310820273,0,23,positive regulation of stem cell proliferation,BP,
19990,GO:2000650,1,0.70612534820687,0,8,negative regulation of sodium ion transmembrane transporter activity,BP,
19991,GO:2000651,1,0.652039513443711,0,10,positive regulation of sodium ion transmembrane transporter activity,BP,
19992,GO:2000653,1,0.877868955136146,0,3,regulation of genetic imprinting,BP,
19993,GO:2000654,1,0.957104703318769,0,1,regulation of cellular response to testosterone stimulus,BP,
19994,GO:2000655,1,0.957104703318769,0,1,negative regulation of cellular response to testosterone stimulus,BP,
19995,GO:2000656,1,0.962203689813222,0,1,regulation of apolipoprotein binding,BP,
19996,GO:2000657,1,0.962203689813222,0,1,negative regulation of apolipoprotein binding,BP,
19997,GO:2000659,1,0.784348150837229,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
19998,GO:2000660,1,0.85253258942615,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
19999,GO:2000661,1,0.956500718261825,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
20000,GO:2000662,1,0.844650844358734,0,4,regulation of interleukin-5 secretion,BP,
20001,GO:2000663,1,0.957349902176802,0,1,negative regulation of interleukin-5 secretion,BP,
20002,GO:2000664,1,0.882290040108846,0,3,positive regulation of interleukin-5 secretion,BP,
20003,GO:2000665,1,0.812412303386242,0,5,regulation of interleukin-13 secretion,BP,
20004,GO:2000666,1,0.920819083423594,0,2,negative regulation of interleukin-13 secretion,BP,
20005,GO:2000667,1,0.882290040108846,0,3,positive regulation of interleukin-13 secretion,BP,
20006,GO:2000668,1,0.841667833562041,0,4,regulation of dendritic cell apoptotic process,BP,
20007,GO:2000669,1,0.918251992345859,0,2,negative regulation of dendritic cell apoptotic process,BP,
20008,GO:2000670,1,0.916611813751375,0,2,positive regulation of dendritic cell apoptotic process,BP,
20009,GO:2000671,1,0.878967636645373,0,3,regulation of motor neuron apoptotic process,BP,
20010,GO:2000672,1,0.878967636645373,0,3,negative regulation of motor neuron apoptotic process,BP,
20011,GO:2000674,1,0.713259420827795,0,8,regulation of type B pancreatic cell apoptotic process,BP,
20012,GO:2000675,1,0.840330260995845,0,4,negative regulation of type B pancreatic cell apoptotic process,BP,
20013,GO:2000676,1,0.848834218107352,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
20014,GO:2000677,1,0.255592498951203,0,33,regulation of transcription regulatory region DNA binding,BP,
20015,GO:2000678,1,0.568920698622103,0,14,negative regulation of transcription regulatory region DNA binding,BP,
20016,GO:2000679,1,0.536735551303688,0,15,positive regulation of transcription regulatory region DNA binding,BP,
20017,GO:2000683,1,0.919020704920821,0,2,regulation of cellular response to X-ray,BP,
20018,GO:2000685,1,0.958962085136742,0,1,positive regulation of cellular response to X-ray,BP,
20019,GO:2000690,1,0.956764025780865,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20020,GO:2000691,1,0.956764025780865,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
20023,GO:2000698,1,0.849974275108874,0,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,
20024,GO:2000699,1,0.958352863090148,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20025,GO:2000701,1,0.958352863090148,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20026,GO:2000702,1,0.958352863090148,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20027,GO:2000703,1,0.958352863090148,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20028,GO:2000705,1,0.915612531417553,0,2,regulation of dense core granule biogenesis,BP,
20029,GO:2000706,1,0.95731504647174,0,1,negative regulation of dense core granule biogenesis,BP,
20030,GO:2000707,1,0.956441843839217,0,1,positive regulation of dense core granule biogenesis,BP,
20031,GO:2000718,1,0.965034687154615,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20032,GO:2000719,1,0.965034687154615,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20033,GO:2000721,1,0.956594504803907,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20034,GO:2000722,1,0.958787867083198,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20035,GO:2000724,1,0.958787867083198,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20036,GO:2000725,1,0.399695826189881,0,22,regulation of cardiac muscle cell differentiation,BP,
20037,GO:2000726,1,0.625882588436071,0,11,negative regulation of cardiac muscle cell differentiation,BP,
20038,GO:2000727,1,0.638886535528095,0,11,positive regulation of cardiac muscle cell differentiation,BP,
20039,GO:2000733,1,0.958352863090148,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20040,GO:2000734,1,0.958352863090148,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20041,GO:2000736,1,0.00892213214670584,0,121,regulation of stem cell differentiation,BP,
20042,GO:2000737,1,0.503838733375471,0,16,negative regulation of stem cell differentiation,BP,
20043,GO:2000738,1,0.653615782542676,0,10,positive regulation of stem cell differentiation,BP,
20044,GO:2000739,1,0.838215231355375,0,4,regulation of mesenchymal stem cell differentiation,BP,
20045,GO:2000740,1,0.95731504647174,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20046,GO:2000741,1,0.875600114817603,0,3,positive regulation of mesenchymal stem cell differentiation,BP,
20047,GO:2000742,1,0.961468796467614,0,1,regulation of anterior head development,BP,
20048,GO:2000744,1,0.961468796467614,0,1,positive regulation of anterior head development,BP,
20049,GO:2000752,1,0.959070810541141,0,1,regulation of glucosylceramide catabolic process,BP,
20050,GO:2000753,1,0.959070810541141,0,1,positive regulation of glucosylceramide catabolic process,BP,
20051,GO:2000754,1,0.959070810541141,0,1,regulation of sphingomyelin catabolic process,BP,
20052,GO:2000755,1,0.959070810541141,0,1,positive regulation of sphingomyelin catabolic process,BP,
20056,GO:2000759,1,0.956509306997002,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
20057,GO:2000761,1,0.956509306997002,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
20060,GO:2000767,1,0.715099923616468,0,8,positive regulation of cytoplasmic translation,BP,
20061,GO:2000768,1,0.961143683422321,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
20064,GO:2000774,1,0.700953587928019,0,9,positive regulation of cellular senescence,BP,
20065,GO:2000775,1,0.961450769203242,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
20066,GO:2000777,1,0.923924818601138,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
20070,GO:2000781,1,0.550406263046367,0,14,positive regulation of double-strand break repair,BP,
20071,GO:2000785,1,0.240633846129855,0,34,regulation of autophagosome assembly,BP,
20072,GO:2000786,1,0.621242297964659,0,11,positive regulation of autophagosome assembly,BP,
20073,GO:2000790,1,0.915409843413132,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20074,GO:2000791,1,0.915409843413132,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
20075,GO:2000793,1,0.914777292668164,0,2,cell proliferation involved in heart valve development,BP,
20076,GO:2000794,1,0.772681453433117,0,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20077,GO:2000795,1,0.956441843839217,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20078,GO:2000797,1,0.95731504647174,0,1,regulation of amniotic stem cell differentiation,BP,
20079,GO:2000798,1,0.95731504647174,0,1,negative regulation of amniotic stem cell differentiation,BP,
20080,GO:2000804,1,0.956441843839217,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20081,GO:2000806,1,0.956441843839217,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20083,GO:2000808,1,0.956442870787241,0,1,negative regulation of synaptic vesicle clustering,BP,
20085,GO:2000810,1,0.500992294421497,0,16,regulation of bicellular tight junction assembly,BP,
20086,GO:2000811,1,0.573499849139449,0,13,negative regulation of anoikis,BP,
20087,GO:2000812,1,0.957066545641122,0,1,regulation of barbed-end actin filament capping,BP,
20088,GO:2000816,1,0.281894476251104,0,31,negative regulation of mitotic sister chromatid separation,BP,
20089,GO:2000819,1,0.91832383130803,0,2,regulation of nucleotide-excision repair,BP,
20090,GO:2000820,1,0.956441843839217,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20091,GO:2000821,1,0.92374045252914,0,2,regulation of grooming behavior,BP,
20093,GO:2000823,1,0.858483836083776,0,4,regulation of androgen receptor activity,BP,
20094,GO:2000825,1,0.858483836083776,0,4,positive regulation of androgen receptor activity,BP,
20095,GO:2000826,1,0.362977254129684,0,24,regulation of heart morphogenesis,BP,
20096,GO:2000827,1,0.960050111061931,0,1,mitochondrial RNA surveillance,BP,
20097,GO:2000828,1,0.920243942125411,0,2,regulation of parathyroid hormone secretion,BP,
20098,GO:2000830,1,0.95644205280966,0,1,positive regulation of parathyroid hormone secretion,BP,
20099,GO:2000831,1,0.812673347813716,0,5,regulation of steroid hormone secretion,BP,
20100,GO:2000832,1,0.916209194044606,0,2,negative regulation of steroid hormone secretion,BP,
20101,GO:2000833,1,0.887014477675862,0,3,positive regulation of steroid hormone secretion,BP,
20102,GO:2000834,1,0.957916064022112,0,1,regulation of androgen secretion,BP,
20103,GO:2000836,1,0.957916064022112,0,1,positive regulation of androgen secretion,BP,
20104,GO:2000843,1,0.956441843839217,0,1,regulation of testosterone secretion,BP,
20105,GO:2000845,1,0.956441843839217,0,1,positive regulation of testosterone secretion,BP,
20106,GO:2000846,1,0.848388650421218,0,4,regulation of corticosteroid hormone secretion,BP,
20107,GO:2000847,1,0.916209194044606,0,2,negative regulation of corticosteroid hormone secretion,BP,
20108,GO:2000848,1,0.925989788071915,0,2,positive regulation of corticosteroid hormone secretion,BP,
20109,GO:2000849,1,0.884392862607483,0,3,regulation of glucocorticoid secretion,BP,
20110,GO:2000850,1,0.916209194044606,0,2,negative regulation of glucocorticoid secretion,BP,
20111,GO:2000851,1,0.965280077340104,0,1,positive regulation of glucocorticoid secretion,BP,
20112,GO:2000855,1,0.959299384807479,0,1,regulation of mineralocorticoid secretion,BP,
20113,GO:2000857,1,0.959299384807479,0,1,positive regulation of mineralocorticoid secretion,BP,
20114,GO:2000858,1,0.959299384807479,0,1,regulation of aldosterone secretion,BP,
20115,GO:2000860,1,0.959299384807479,0,1,positive regulation of aldosterone secretion,BP,
20116,GO:2000864,1,0.956441843839217,0,1,regulation of estradiol secretion,BP,
20117,GO:2000878,1,0.923889708631606,0,2,positive regulation of oligopeptide transport,BP,
20118,GO:2000880,1,0.923889708631606,0,2,positive regulation of dipeptide transport,BP,
20119,GO:2000909,1,0.958787867083198,0,1,regulation of sterol import,BP,
20120,GO:2000969,1,0.919754259714368,0,2,positive regulation of AMPA receptor activity,BP,
20121,GO:2000973,1,0.779563500360473,0,6,regulation of pro-B cell differentiation,BP,
20122,GO:2000974,1,0.888391834471914,0,3,negative regulation of pro-B cell differentiation,BP,
20123,GO:2000977,1,0.928857129480457,0,2,regulation of forebrain neuron differentiation,BP,
20124,GO:2000978,1,0.928857129480457,0,2,negative regulation of forebrain neuron differentiation,BP,
20125,GO:2000980,1,0.815854805889864,0,5,regulation of inner ear receptor cell differentiation,BP,
20126,GO:2000981,1,0.850935016282364,0,4,negative regulation of inner ear receptor cell differentiation,BP,
20127,GO:2000983,1,0.930936037246189,0,2,regulation of ATP citrate synthase activity,BP,
20128,GO:2000984,1,0.930936037246189,0,2,negative regulation of ATP citrate synthase activity,BP,
20129,GO:2000987,1,0.958222255349026,0,1,positive regulation of behavioral fear response,BP,
20131,GO:2001013,1,0.914827636126595,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
20133,GO:2001015,1,0.916246047722047,0,2,negative regulation of skeletal muscle cell differentiation,BP,
20139,GO:2001024,1,0.475935377251112,0,18,negative regulation of response to drug,BP,
20141,GO:2001026,1,0.602082606887603,0,12,regulation of endothelial cell chemotaxis,BP,
20142,GO:2001027,1,0.914777292668164,0,2,negative regulation of endothelial cell chemotaxis,BP,
20143,GO:2001028,1,0.687727703165853,0,9,positive regulation of endothelial cell chemotaxis,BP,
20144,GO:2001029,1,0.956443188468658,0,1,regulation of cellular glucuronidation,BP,
20145,GO:2001031,1,0.956443188468658,0,1,positive regulation of cellular glucuronidation,BP,
20146,GO:2001032,1,0.604944853634811,0,12,regulation of double-strand break repair via nonhomologous end joining,BP,
20147,GO:2001033,1,0.816768724760758,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
20148,GO:2001034,1,0.807450933287562,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
20152,GO:2001039,1,0.589798279858733,0,13,negative regulation of cellular response to drug,BP,
20155,GO:2001045,1,0.915484266341109,0,2,negative regulation of integrin-mediated signaling pathway,BP,
20159,GO:2001055,1,0.961042493422886,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
20162,GO:2001069,1,0.920476262011906,0,2,glycogen binding,MF,
20163,GO:2001070,1,0.918346535173138,0,2,starch binding,MF,
20164,GO:2001074,1,0.922577424169566,0,2,regulation of metanephric ureteric bud development,BP,
20165,GO:2001076,1,0.922577424169566,0,2,positive regulation of metanephric ureteric bud development,BP,
20168,GO:2001109,1,0.956441843839217,0,1,regulation of lens epithelial cell proliferation,BP,
20169,GO:2001111,1,0.956441843839217,0,1,positive regulation of lens epithelial cell proliferation,BP,
20170,GO:2001135,1,0.709814134526133,0,8,regulation of endocytic recycling,BP,
20171,GO:2001136,1,0.957783145394427,0,1,negative regulation of endocytic recycling,BP,
20172,GO:2001137,1,0.87688175784747,0,3,positive regulation of endocytic recycling,BP,
20176,GO:2001144,1,0.961121993962004,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20177,GO:2001145,1,0.961121993962004,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20178,GO:2001148,1,0.923889708631606,0,2,regulation of dipeptide transmembrane transport,BP,
20179,GO:2001150,1,0.923889708631606,0,2,positive regulation of dipeptide transmembrane transport,BP,
20180,GO:2001151,1,0.958026563055971,0,1,regulation of renal water transport,BP,
20181,GO:2001153,1,0.958026563055971,0,1,positive regulation of renal water transport,BP,
20182,GO:2001160,1,0.922535666359048,0,2,regulation of histone H3-K79 methylation,BP,
20183,GO:2001162,1,0.922535666359048,0,2,positive regulation of histone H3-K79 methylation,BP,
20184,GO:2001163,1,0.96079200104393,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20185,GO:2001165,1,0.96079200104393,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20186,GO:2001166,1,0.808452716433657,0,5,regulation of histone H2B ubiquitination,BP,
20187,GO:2001168,1,0.841011938375522,0,4,positive regulation of histone H2B ubiquitination,BP,
20189,GO:2001170,1,0.684777342393642,0,9,negative regulation of ATP biosynthetic process,BP,
20191,GO:2001173,1,0.961299128430515,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
20192,GO:2001176,1,0.921539611068661,0,2,regulation of mediator complex assembly,BP,
20193,GO:2001178,1,0.921539611068661,0,2,positive regulation of mediator complex assembly,BP,
20194,GO:2001179,1,0.823164629584768,0,5,regulation of interleukin-10 secretion,BP,
20195,GO:2001180,1,0.921139157889673,0,2,negative regulation of interleukin-10 secretion,BP,
20196,GO:2001181,1,0.893654604531008,0,3,positive regulation of interleukin-10 secretion,BP,
20197,GO:2001182,1,0.84641429823333,0,4,regulation of interleukin-12 secretion,BP,
20198,GO:2001183,1,0.96217937654882,0,1,negative regulation of interleukin-12 secretion,BP,
20199,GO:2001184,1,0.918800148789523,0,2,positive regulation of interleukin-12 secretion,BP,
20200,GO:2001185,1,0.849025599587302,0,4,regulation of CD8-positive, alpha-beta T cell activation,BP,
20201,GO:2001186,1,0.961969091550826,0,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
20202,GO:2001187,1,0.962872521408737,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
20203,GO:2001188,1,0.925741575029812,0,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20204,GO:2001189,1,0.925741575029812,0,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20205,GO:2001197,1,0.800343094282434,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
20206,GO:2001198,1,0.889070060983407,0,3,regulation of dendritic cell differentiation,BP,
20207,GO:2001199,1,0.963179677505297,0,1,negative regulation of dendritic cell differentiation,BP,
20208,GO:2001200,1,0.923063027850671,0,2,positive regulation of dendritic cell differentiation,BP,
20209,GO:2001201,1,0.91479762702459,0,2,regulation of transforming growth factor-beta secretion,BP,
20210,GO:2001202,1,0.956441843839217,0,1,negative regulation of transforming growth factor-beta secretion,BP,
20211,GO:2001203,1,0.956463102448504,0,1,positive regulation of transforming growth factor-beta secretion,BP,
20213,GO:2001205,1,0.875810416512096,0,3,negative regulation of osteoclast development,BP,
20215,GO:2001212,1,0.742958763081464,0,7,regulation of vasculogenesis,BP,
20216,GO:2001213,1,0.956441845348625,0,1,negative regulation of vasculogenesis,BP,
20217,GO:2001214,1,0.812188921541779,0,5,positive regulation of vasculogenesis,BP,
20219,GO:2001223,1,0.811003790901249,0,5,negative regulation of neuron migration,BP,
20223,GO:2001228,1,0.914777292668164,0,2,regulation of response to gamma radiation,BP,
20224,GO:2001229,1,0.956441843839217,0,1,negative regulation of response to gamma radiation,BP,
20233,GO:2001241,1,0.617018454212814,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
20237,GO:2001245,1,0.915580773711993,0,2,regulation of phosphatidylcholine biosynthetic process,BP,
20238,GO:2001246,1,0.956997685913152,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
20239,GO:2001247,1,0.956725838498375,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
20242,GO:2001253,1,0.958490514221976,0,1,regulation of histone H3-K36 trimethylation,BP,
20248,GO:2001268,1,0.826178333486321,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
20250,GO:2001270,1,0.84935513959978,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20251,GO:2001271,1,0.880042310350601,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20252,GO:2001272,1,0.965138887105781,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20254,GO:2001274,1,0.91753628123552,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
20256,GO:2001279,1,0.845478960126206,0,4,regulation of unsaturated fatty acid biosynthetic process,BP,
20257,GO:2001280,1,0.921898377868058,0,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,
20258,GO:2001286,1,0.843869434298954,0,4,regulation of caveolin-mediated endocytosis,BP,
20259,GO:2001287,1,0.922049456214021,0,2,negative regulation of caveolin-mediated endocytosis,BP,
20260,GO:2001288,1,0.956441843839217,0,1,positive regulation of caveolin-mediated endocytosis,BP,
20263,GO:2001295,1,0.914777292668164,0,2,malonyl-CoA biosynthetic process,BP,
20264,GO:2001300,1,0.960461819250754,0,1,lipoxin metabolic process,BP,
20265,GO:2001301,1,0.960461819250754,0,1,lipoxin biosynthetic process,BP,
20266,GO:2001302,1,0.960461819250754,0,1,lipoxin A4 metabolic process,BP,
20267,GO:2001303,1,0.960461819250754,0,1,lipoxin A4 biosynthetic process,BP,
20268,GO:2001304,1,0.960461819250754,0,1,lipoxin B4 metabolic process,BP,
20269,GO:2001306,1,0.960461819250754,0,1,lipoxin B4 biosynthetic process,BP,
20270,GO:2001311,1,0.962430281579337,0,1,lysobisphosphatidic acid metabolic process,BP,
1435,GO:0003676,1.00000000000513,0,70,3238,nucleic acid binding,MF,TNFAIP3;PEG3;HES2;ZNF704;NDN;S100A4;ASH2L;TNS1;SRSF5;TST;EGFR;THRA;NYNRIN;OAS2;H1F0;TCEA2;GLI2;BCL6;NSUN7;ZNF318;CERS4;UNK;POU3F1;DHX32;ZFPM1;DNM1;ETV5;HR;SALL2;FOXO1;ZSCAN18;SOX12;DDB2;TBX1;TRERF1;YEATS4;MNT;TET1;ZNF266;RPL13A;ZNF687;SMARCA1;TCFL5;ZNF362;ZBTB42;DDX60;SREBF1;ENDOG;XPC;NFATC4;RTF1;PCBP4;ZNF554;MBD1;ZDHHC1;H2AFJ;STAT1;H1FX;CRY2;ZMYM3;IFI16;DBP;PER3;MEX3A;CXXC5;ZNF446;ZCCHC24;SP100;MPG;DDX59
8820,GO:0034641,1.00000000001925,0,139,5144,cellular nitrogen compound metabolic process,BP,TNFAIP3;PEG3;HES2;APOE;ZNF704;NDN;ASH2L;HTRA1;GAMT;SRSF5;ST3GAL5;TST;EGFR;CRAT;THRA;CITED4;NYNRIN;OAS2;H1F0;TCEA2;GLI2;FGFR4;IRF2BPL;BCL6;PGM1;TENM2;ZNF318;CERS4;SFRP1;UNK;POU3F1;MN1;DHTKD1;INSR;KMT5C;DHX32;PKD2;ZFPM1;RGMA;ETV5;NT5E;HR;SALL2;TP53INP2;WWTR1;FOXO1;ZSCAN18;SOX12;UROS;DDB2;DAB2IP;TBX1;H6PD;TSC22D1;TRERF1;YEATS4;MNT;TET1;FAM20C;EPHA4;ZNF266;RPL13A;RNPEPL1;MAGEF1;ZNF687;F2R;SMARCA1;TCFL5;RPS6KA5;SEC14L2;HEXB;ZNF362;PGLS;ZBTB42;ATP6V0A2;PLXND1;SREBF1;ENDOG;PIK3R1;PTHLH;TRIM22;NCK2;ACVR1B;XPC;NAB2;NFATC4;CPT1C;RTF1;ZP3;RBCK1;PCBP4;ZNF554;SCG5;MBD1;TP53INP1;SLC2A9;MDK;TRPV4;MTHFR;MSRB2;SDHA;PTMS;ADORA2B;NMRK1;MAFIP;MC1R;IMPACT;NEO1;CRTC1;IGFBP4;ERBB2;RNF187;H2AFJ;STAT1;TULP3;NME4;CRY2;COX5B;ZMYM3;FURIN;IFI16;PCSK1;RPRD2;DBP;PER3;ALOXE3;SMURF1;MEX3A;CXXC5;CAMK1;ZNF446;TCIRG1;NADK;ST6GALNAC6;MDFI;SCMH1;SP100;MPG;DDX59
